Citrus Sinensis ID: 018018

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360--
Protein Sequence
MKKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLSGF
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHcccccccccEEEEEEEcccccEEEEEEEEccccHHHHHHHHHHHHHHHccccccEEEEEEEEEEccEEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEcccccccHHHHHHccccccccccccccccccccccccccccHHHHHHHHHHHHHccccccccccccccccHHHHHHHcccccccccccccccHHHHHHHHHHHcccccccccHHHHHccHHHHHcccccccHHHHHHHHccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccEEEccccccccccccHcccccccccccccccccccccccccccccccccccccccccHHHHHEEEEEccccccEEEEEEEcccccEEHHHHHHHHHHHHHHHHHHHHHHHHHHccccEEEEEEEEEccccccEEEEEcccccEHHHHccHcccccHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccccccEcccHHHccHHHHHcccccccHHHHHHHHHHHHHHcccccccccccccHHHHHHHHHHccccccccccccccccHHHHHHHHHHHcccHHHcccHHHHHccccHHcccHHHHHHcccccccccccccccccccc
Coil and Loop (DISEMBL)
mkkgglnpnvklklslpsseeaSFTKFLtksgtfmdgdllvnkdgvrivsqteteapplikpsdnqlnledidtikvvgkgsggIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKinqssqcpyvVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYlhhekhiihrdlkpsnllinhrgevkitdfGVSAIMAstsgqantfvgtynymsperisggkygyksDIWSLGLVLLEcatgqfpysppeqqdgWTSFYELMEAivdqpppsapsdqfspeFCSFISACvqkepqqrlsaqelmthpflkmygdlnvdlseyftdagsplatlsnlsgf
Flexible Loop (DISEMBL)
mkkgglnpnvklklslpsseEASFTKFLTksgtfmdgdllVNKDGVRIVSQteteapplikpsdnqlnlEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELkinqssqcPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIhrdlkpsnllINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAgsplatlsnlsgf
Low Complexity Region (SEG)
MKKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTikvvgkgsggivQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLSGF
Disordered region (IsUnstruct)
*************************KFLTKSGTFMDGDLLVNKDGVRIV*****************LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV**************EFCSFISACVQ*********QELMTHPFLKMYGDLNVDLSEYFTDA*************
Disordered Region (DISOPRED)
******************************************************************LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS****QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLAT*******
Disordered Region (DISEMBL)
MKKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLSGF
Disordered Region (DISPRO)
******NPNVKLKLSLPSSE********************************************NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLA********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLSGF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	362	2.2.26 [Sep-21-2011]
Q9S7U9	363	Mitogen-activated protein	yes	no	0.991	0.988	0.725	1e-158
Q94A06	354	Mitogen-activated protein	no	no	0.977	1.0	0.678	1e-142
Q5QN75	355	Mitogen-activated protein	no	no	0.928	0.946	0.632	1e-132
Q9FJV0	356	Mitogen-activated protein	no	no	0.914	0.929	0.630	1e-128
Q63932	401	Dual specificity mitogen-	yes	no	0.770	0.695	0.380	1e-62
P31938	393	Dual specificity mitogen-	no	no	0.770	0.709	0.395	1e-62
Q01986	393	Dual specificity mitogen-	yes	no	0.770	0.709	0.395	1e-62
Q02750	393	Dual specificity mitogen-	yes	no	0.770	0.709	0.392	1e-62
P29678	393	Dual specificity mitogen-	yes	no	0.770	0.709	0.392	2e-62
Q90891	398	Dual specificity mitogen-	yes	no	0.770	0.701	0.387	2e-62

>sp|Q9S7U9|M2K2_ARATH Mitogen-activated protein kinase kinase 2 OS=Arabidopsis thaliana GN=MKK2 PE=1 SV=2

 Score =  556 bits (1433), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 262/361 (72%), Positives = 304/361 (84%), Gaps = 2/361 (0%)

Query: 1   MKKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLI 60
           MKKGG + N  LKL++P + E S TKFLT+SGTF DGDL VNKDGVRI+SQ E E    I
Sbjct: 1   MKKGGFSNN--LKLAIPVAGEQSITKFLTQSGTFKDGDLRVNKDGVRIISQLEPEVLSPI 58

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK 120
           KP+D+QL+L D+D +KV+GKGS G+VQLVQHKWTGQFFALKVIQ+N++E+ R+ IAQELK
Sbjct: 59  KPADDQLSLSDLDMVKVIGKGSSGVVQLVQHKWTGQFFALKVIQLNIDEAIRKAIAQELK 118

Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           INQSSQCP +V  YQSFY NGAIS+ILEYMDGGSLADFLK VK IP+ YL+AI  QVL+G
Sbjct: 119 INQSSQCPNLVTSYQSFYDNGAISLILEYMDGGSLADFLKSVKAIPDSYLSAIFRQVLQG 178

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L+YLHH++HIIHRDLKPSNLLINHRGEVKITDFGVS +M +T+G ANTFVGTYNYMSPER
Sbjct: 179 LIYLHHDRHIIHRDLKPSNLLINHRGEVKITDFGVSTVMTNTAGLANTFVGTYNYMSPER 238

Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
           I G KYG KSDIWSLGLV+LECATG+FPY+PP Q++ WTS +ELMEAIVDQPPP+ PS  
Sbjct: 239 IVGNKYGNKSDIWSLGLVVLECATGKFPYAPPNQEETWTSVFELMEAIVDQPPPALPSGN 298

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLS 360
           FSPE  SFIS C+QK+P  R SA+ELM HPFL  Y    ++L+ YFTDAGSPLATL NLS
Sbjct: 299 FSPELSSFISTCLQKDPNSRSSAKELMEHPFLNKYDYSGINLASYFTDAGSPLATLGNLS 358

Query: 361 G 361
           G
Sbjct: 359 G 359

May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates by phosphorylation the downstream MPK4 and MPK6.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 2EC: .EC: 2

>sp|Q94A06|M2K1_ARATH Mitogen-activated protein kinase kinase 1 OS=Arabidopsis thaliana GN=MKK1 PE=1 SV=2

 Score =  505 bits (1300), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 243/358 (67%), Positives = 290/358 (81%), Gaps = 4/358 (1%)

Query: 1   MKKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLI 60
           M +G L PN    + LP  E+ S +KFLT+SGTF DGDL VNKDG++ VS +E  APP I
Sbjct: 1   MNRGSLCPN---PICLPPLEQ-SISKFLTQSGTFKDGDLRVNKDGIQTVSLSEPGAPPPI 56

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK 120
           +P DNQL+L D++ IKV+GKGS G VQLV+HK T QFFALKVIQ+N EES  R I+QEL+
Sbjct: 57  EPLDNQLSLADLEVIKVIGKGSSGNVQLVKHKLTQQFFALKVIQLNTEESTCRAISQELR 116

Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           IN SSQCPY+V CYQSFY NG +SIILE+MDGGSLAD LKKV  +PE  L+AIC++VL+G
Sbjct: 117 INLSSQCPYLVSCYQSFYHNGLVSIILEFMDGGSLADLLKKVGKVPENMLSAICKRVLRG 176

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L Y+HHE+ IIHRDLKPSNLLINHRGEVKITDFGVS I+ STS  AN+FVGTY YMSPER
Sbjct: 177 LCYIHHERRIIHRDLKPSNLLINHRGEVKITDFGVSKILTSTSSLANSFVGTYPYMSPER 236

Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
           ISG  Y  KSDIWSLGLVLLECATG+FPY+PPE + GW+S YEL++AIV+ PPP APS+ 
Sbjct: 237 ISGSLYSNKSDIWSLGLVLLECATGKFPYTPPEHKKGWSSVYELVDAIVENPPPCAPSNL 296

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSN 358
           FSPEFCSFIS CVQK+P+ R SA+EL+ H F+KM+ D + +LS YFTDAGS +  L+N
Sbjct: 297 FSPEFCSFISQCVQKDPRDRKSAKELLEHKFVKMFEDSDTNLSAYFTDAGSLIPPLAN 354

May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Phosphorylates MPK4 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q5QN75|M2K1_ORYSJ Mitogen-activated protein kinase kinase 1 OS=Oryza sativa subsp. japonica GN=MEK1 PE=1 SV=1

 Score =  471 bits (1211), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 215/340 (63%), Positives = 282/340 (82%), Gaps = 4/340 (1%)

Query: 5   GLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPL--IKP 62
           G  P+ +LKLS+P+ +E    KFLT SGTF DG+L +N+ G++++S+   + P    +K 
Sbjct: 3   GKKPHKELKLSVPA-QETPVDKFLTASGTFKDGELRLNQRGLQLISEETADEPQSTNLKV 61

Query: 63  SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN 122
            D QL+++D++ I+V+GKGSGGIVQLV+HKW G  +ALK IQMN++E+ R+QI QELKIN
Sbjct: 62  EDVQLSMDDLEMIQVIGKGSGGIVQLVRHKWVGTLYALKGIQMNIQEAVRKQIVQELKIN 121

Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
           Q++Q  ++V+C+QSFY NG I ++LEYMD GSLAD +K+VKTI E YLA +C+QVL+GLL
Sbjct: 122 QATQNAHIVLCHQSFYHNGVIYLVLEYMDRGSLADIIKQVKTILEPYLAVLCKQVLEGLL 181

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           YLHHE+H+IHRD+KPSNLL+N +GEVKITDFGVSA++AS+ GQ +TFVGTYNYM+PERIS
Sbjct: 182 YLHHERHVIHRDIKPSNLLVNRKGEVKITDFGVSAVLASSMGQRDTFVGTYNYMAPERIS 241

Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  Y YKSDIWSLGLV+LECA G+FPY P E + GW SFYEL+EAIVDQPPPSAP+DQFS
Sbjct: 242 GSSYDYKSDIWSLGLVILECAIGRFPYIPSEGE-GWLSFYELLEAIVDQPPPSAPADQFS 300

Query: 303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
           PEFC+FIS+C+QK+P +R+SA EL+ HPF+K + D ++DL
Sbjct: 301 PEFCAFISSCIQKDPAERMSASELLNHPFIKKFEDKDLDL 340

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q9FJV0|M2K6_ARATH Mitogen-activated protein kinase kinase 6 OS=Arabidopsis thaliana GN=MKK6 PE=1 SV=1

 Score =  457 bits (1176), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 210/333 (63%), Positives = 270/333 (81%), Gaps = 2/333 (0%)

Query: 11  KLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLE 70
           +LKLS+P+ +E+  + FLT SGTF DGD L+N+ G+R+ S  +       K  D ++  E
Sbjct: 10  QLKLSVPA-QESPISSFLTASGTFHDGDFLLNQKGLRLTSDEKQSRQSDSKELDFEITAE 68

Query: 71  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQ-SSQCPY 129
           D++T+KV+GKGSGG+VQLV+HKW G+FFA+KVIQMN++E  R+QI QELKINQ SSQCP+
Sbjct: 69  DLETVKVIGKGSGGVVQLVRHKWVGKFFAMKVIQMNIQEEIRKQIVQELKINQASSQCPH 128

Query: 130 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 189
           VVVCY SFY NGA S++LEYMD GSLAD +++VKTI E YLA +C+QVL GL+YLH+E+H
Sbjct: 129 VVVCYHSFYHNGAFSLVLEYMDRGSLADVIRQVKTILEPYLAVVCKQVLLGLVYLHNERH 188

Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 249
           +IHRD+KPSNLL+NH+GEVKI+DFGVSA +AS+ GQ +TFVGTYNYMSPERISG  Y Y 
Sbjct: 189 VIHRDIKPSNLLVNHKGEVKISDFGVSASLASSMGQRDTFVGTYNYMSPERISGSTYDYS 248

Query: 250 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           SDIWSLG+ +LECA G+FPY   E Q    SFYEL+ AIV+ PPP+APSDQFSPEFCSF+
Sbjct: 249 SDIWSLGMSVLECAIGRFPYLESEDQQNPPSFYELLAAIVENPPPTAPSDQFSPEFCSFV 308

Query: 310 SACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
           SAC+QK+P  R S+ +L++HPF+K + D ++DL
Sbjct: 309 SACIQKDPPARASSLDLLSHPFIKKFEDKDIDL 341

Involved in the regulation of plant cytokinesis during meiosis and mitosis. Activates MPK13 in vitro.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q63932|MP2K2_MOUSE Dual specificity mitogen-activated protein kinase kinase 2 OS=Mus musculus GN=Map2k2 PE=1 SV=2

 Score =  240 bits (613), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 122/321 (38%), Positives = 182/321 (56%), Gaps = 42/321 (13%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 125
           +L  +D + I  +G G+GG+V   +H+ +G   A K+I + ++ + R QI +EL++    
Sbjct: 66  ELKDDDFERISELGAGNGGVVTKARHRPSGLIMARKLIHLEIKPAVRNQIIRELQVLHEC 125

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
             PY+V  Y +FYS+G ISI +E+MDGGSL   LK+ K IPE+ L  +   VL+GL YL 
Sbjct: 126 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEDILGKVSIAVLRGLAYLR 185

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 186 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 243

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF------------------------ 281
           Y  +SDIWS+GL L+E A G++P  PP+ ++   SF                        
Sbjct: 244 YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEASFGRPVVDGADGEPHSVSPRPRPPGR 303

Query: 282 ----------------YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
                           +EL++ IV++PPP  PS  FS +F  F++ C+ K P +R   + 
Sbjct: 304 PISVGHGMDSRPAMAIFELLDYIVNEPPPKLPSGVFSSDFQEFVNKCLIKNPAERADLKL 363

Query: 326 LMTHPFLKMYGDLNVDLSEYF 346
           LM H F+K      VD + + 
Sbjct: 364 LMNHAFIKRSEGEEVDFAGWL 384

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P31938|MP2K1_MOUSE Dual specificity mitogen-activated protein kinase kinase 1 OS=Mus musculus GN=Map2k1 PE=1 SV=2

 Score =  240 bits (612), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 125/316 (39%), Positives = 182/316 (57%), Gaps = 37/316 (11%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 125
           +L  +D + I  +G G+GG+V  V HK +G   A K+I + ++ + R QI +EL++    
Sbjct: 62  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 121

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
             PY+V  Y +FYS+G ISI +E+MDGGSL   LKK   IPE+ L  +   V+KGL YL 
Sbjct: 122 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 181

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 182 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 239

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQD----------------------------- 276
           Y  +SDIWS+GL L+E A G++P  PP+ ++                             
Sbjct: 240 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELLFGCHVEGDAAETPPRPRTPGRPLSS 299

Query: 277 -GWTS-----FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 330
            G  S      +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++LM H 
Sbjct: 300 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 359

Query: 331 FLKMYGDLNVDLSEYF 346
           F+K      VD + + 
Sbjct: 360 FIKRSDAEEVDFAGWL 375

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q01986|MP2K1_RAT Dual specificity mitogen-activated protein kinase kinase 1 OS=Rattus norvegicus GN=Map2k1 PE=1 SV=2

 Score =  240 bits (612), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 125/316 (39%), Positives = 182/316 (57%), Gaps = 37/316 (11%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 125
           +L  +D + I  +G G+GG+V  V HK +G   A K+I + ++ + R QI +EL++    
Sbjct: 62  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 121

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
             PY+V  Y +FYS+G ISI +E+MDGGSL   LKK   IPE+ L  +   V+KGL YL 
Sbjct: 122 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 181

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 182 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 239

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQD----------------------------- 276
           Y  +SDIWS+GL L+E A G++P  PP+ ++                             
Sbjct: 240 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELLFGCQVEGDAAETPPRPRTPGRPLSS 299

Query: 277 -GWTS-----FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 330
            G  S      +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++LM H 
Sbjct: 300 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 359

Query: 331 FLKMYGDLNVDLSEYF 346
           F+K      VD + + 
Sbjct: 360 FIKRSDAEEVDFAGWL 375

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q02750|MP2K1_HUMAN Dual specificity mitogen-activated protein kinase kinase 1 OS=Homo sapiens GN=MAP2K1 PE=1 SV=2

 Score =  240 bits (612), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 124/316 (39%), Positives = 181/316 (57%), Gaps = 37/316 (11%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 125
           +L  +D + I  +G G+GG+V  V HK +G   A K+I + ++ + R QI +EL++    
Sbjct: 62  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 121

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
             PY+V  Y +FYS+G ISI +E+MDGGSL   LKK   IPE+ L  +   V+KGL YL 
Sbjct: 122 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 181

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 182 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 239

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF------------------------ 281
           Y  +SDIWS+GL L+E A G++P  PP+ ++    F                        
Sbjct: 240 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 299

Query: 282 -----------YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 330
                      +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++LM H 
Sbjct: 300 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 359

Query: 331 FLKMYGDLNVDLSEYF 346
           F+K      VD + + 
Sbjct: 360 FIKRSDAEEVDFAGWL 375

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|P29678|MP2K1_RABIT Dual specificity mitogen-activated protein kinase kinase 1 OS=Oryctolagus cuniculus GN=MAP2K1 PE=1 SV=2

 Score =  240 bits (612), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 124/316 (39%), Positives = 181/316 (57%), Gaps = 37/316 (11%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 125
           +L  +D + I  +G G+GG+V  V HK +G   A K+I + ++ + R QI +EL++    
Sbjct: 62  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 121

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
             PY+V  Y +FYS+G ISI +E+MDGGSL   LKK   IPE+ L  +   V+KGL YL 
Sbjct: 122 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 181

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 182 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 239

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF------------------------ 281
           Y  +SDIWS+GL L+E A G++P  PP+ ++    F                        
Sbjct: 240 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 299

Query: 282 -----------YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 330
                      +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++LM H 
Sbjct: 300 YGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 359

Query: 331 FLKMYGDLNVDLSEYF 346
           F+K      VD + + 
Sbjct: 360 FIKRSDAEEVDFAGWL 375

Dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates RAS and this initiates RAF1 activation. RAF1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Depending on the cellular context, this pathway mediates diverse biological functions such as cell growth, adhesion, survival and differentiation, predominantly through the regulation of transcription, metabolism and cytoskeletal rearrangements. One target of the MAPK/ERK cascade is peroxisome proliferator-activated receptor gamma (PPARG), a nuclear receptor that promotes differentiation and apoptosis. MAP2K1/MEK1 has been shown to export PPARG from the nucleus. The MAPK/ERK cascade is also involved in the regulation of endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC), as well as in the fragmentation of the Golgi apparatus during mitosis.

Oryctolagus cuniculus (taxid: 9986)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

>sp|Q90891|MP2K2_CHICK Dual specificity mitogen-activated protein kinase kinase 2 OS=Gallus gallus GN=MAP2K2 PE=2 SV=1

 Score =  239 bits (611), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 124/320 (38%), Positives = 184/320 (57%), Gaps = 41/320 (12%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 125
           +L  +D + I  +G G+GG+V  VQHK +G   A K+I + ++ + R QI +EL++    
Sbjct: 64  ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 123

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
             PY+V  Y +FYS+G ISI +E+MDGGSL   LK+ K IPEE L  +   VL+GL YL 
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 183

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 184 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 241

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQ-----------DG----------WT----- 279
           Y  +SDIWS+GL L+E + G++P  PP+ +           DG          W      
Sbjct: 242 YSVQSDIWSMGLSLVELSIGRYPIPPPDSKELEAIFGRPVVDGAEGESHSVSPWARPPGR 301

Query: 280 -------------SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
                        + +EL++ IV++PPP  P+  F+ +F  F++ C+ K P +R   + L
Sbjct: 302 PISGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTQDFQEFVNKCLIKNPAERADLKML 361

Query: 327 MTHPFLKMYGDLNVDLSEYF 346
           M H F+K      VD + + 
Sbjct: 362 MNHTFIKRSEVEEVDFAGWL 381

Catalyzes the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in MAP kinases. Activates the ERK1 and ERK2 MAP kinases.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	362
224142910	364	predicted protein [Populus trichocarpa]	0.983	0.978	0.834	1e-178
225444840	354	PREDICTED: mitogen-activated protein kin	0.977	1.0	0.825	1e-175
224087969	355	predicted protein [Populus trichocarpa]	0.980	1.0	0.823	1e-167
42601214	354	mitogen-activated protein kinase kinase	0.977	1.0	0.797	1e-167
7682432	357	MAP kinase kinase [Nicotiana tabacum]	0.986	1.0	0.779	1e-166
51471926	357	MAPKK [Solanum lycopersicum]	0.986	1.0	0.768	1e-166
267881840	354	mitogen-activated protein kinase kinase	0.977	1.0	0.780	1e-166
350536161	357	MAP kinase kinase [Solanum lycopersicum]	0.986	1.0	0.768	1e-166
255546067	340	mitogen activated protein kinase kinase,	0.906	0.964	0.850	1e-165
356547903	356	PREDICTED: mitogen-activated protein kin	0.977	0.994	0.782	1e-160

>gi|224142910|ref|XP_002324775.1| predicted protein [Populus trichocarpa] gi|222866209|gb|EEF03340.1| predicted protein [Populus trichocarpa]

 Score =  632 bits (1629), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 297/356 (83%), Positives = 323/356 (90%)

Query: 1   MKKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLI 60
           MKKG LNPNVKLKLSLP  +E SF KFLT+SGTF DGDLLVN+DGVR+VSQTE+E PP I
Sbjct: 1   MKKGSLNPNVKLKLSLPPPDEVSFAKFLTQSGTFKDGDLLVNRDGVRVVSQTESEPPPPI 60

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK 120
            PSDNQL+L D+D +KV+GKGS GIVQLVQHKWT QFFALKVIQMN+EE AR+ IAQELK
Sbjct: 61  TPSDNQLSLADMDMVKVIGKGSSGIVQLVQHKWTSQFFALKVIQMNIEEPARKAIAQELK 120

Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           INQSSQCPYVV+ YQSFY NGAISIILEYMDGGSLADFLK VKTIPE YLAAIC+QVLKG
Sbjct: 121 INQSSQCPYVVMSYQSFYDNGAISIILEYMDGGSLADFLKSVKTIPEPYLAAICKQVLKG 180

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           LLYLHHEKHIIHRDLKPSNLL+NHRGEVKITDFGVSAIM STSGQAN+FVGTYNYMSPER
Sbjct: 181 LLYLHHEKHIIHRDLKPSNLLVNHRGEVKITDFGVSAIMQSTSGQANSFVGTYNYMSPER 240

Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
           ISGGKYGYKSDIWSLGLVLLECATGQFP+SPPE  +GWT+ YELMEAIVD PPPSA SD 
Sbjct: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPFSPPELDEGWTNVYELMEAIVDHPPPSASSDH 300

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATL 356
           FSPEFCSFISACVQK+P+ R +A ELM HPF+ +Y DL+VDL+ YFT+AGSPLATL
Sbjct: 301 FSPEFCSFISACVQKDPKDRQAAHELMAHPFMNLYEDLHVDLATYFTNAGSPLATL 356

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225444840|ref|XP_002280877.1| PREDICTED: mitogen-activated protein kinase kinase 2 [Vitis vinifera] gi|37625027|gb|AAQ96337.1| putative mitogen-activated protein kinase kinase [Vitis aestivalis] gi|297738625|emb|CBI27870.3| unnamed protein product [Vitis vinifera]

 Score =  619 bits (1597), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 294/356 (82%), Positives = 322/356 (90%), Gaps = 2/356 (0%)

Query: 1   MKKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLI 60
           M++G LNP+  LKL+LP  E+ S TKFLT+SGTFMDGDLLVN+DGVRIVS++E E PPLI
Sbjct: 1   MRRGPLNPS-NLKLTLPPDED-SLTKFLTQSGTFMDGDLLVNRDGVRIVSKSEAEVPPLI 58

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK 120
           KPSDNQL+L DIDTIKV+GKG+GG VQLVQHKWTGQFFALKVIQMN++E+A + IAQELK
Sbjct: 59  KPSDNQLSLADIDTIKVIGKGAGGTVQLVQHKWTGQFFALKVIQMNIQEAALKHIAQELK 118

Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           INQSSQCPYVVVCY+SFY NGA SIILEYMDGGSL DFLKKVK+IPE YLAAIC QVLKG
Sbjct: 119 INQSSQCPYVVVCYKSFYDNGAFSIILEYMDGGSLLDFLKKVKSIPEPYLAAICNQVLKG 178

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L YLHHE+HIIHRDLKPSNLLINHRGEVKITDFGVSAI+ STSGQANTFVGTYNYMSPER
Sbjct: 179 LSYLHHERHIIHRDLKPSNLLINHRGEVKITDFGVSAILTSTSGQANTFVGTYNYMSPER 238

Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
           ISGGKYG KSDIWSLGLVLLECATGQFPYSPPEQ +GWTSFYELMEAIVDQPPP A ++Q
Sbjct: 239 ISGGKYGSKSDIWSLGLVLLECATGQFPYSPPEQGEGWTSFYELMEAIVDQPPPCASTNQ 298

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATL 356
           FS EFCSFISAC+QK+P  R SA ELM HPF+ MY DLNVDL+ YFT+AGSPLAT 
Sbjct: 299 FSAEFCSFISACIQKDPNDRKSAHELMAHPFISMYRDLNVDLATYFTNAGSPLATF 354

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224087969|ref|XP_002308276.1| predicted protein [Populus trichocarpa] gi|222854252|gb|EEE91799.1| predicted protein [Populus trichocarpa]

 Score =  593 bits (1529), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 293/356 (82%), Positives = 315/356 (88%), Gaps = 1/356 (0%)

Query: 1   MKKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLI 60
           MKKGGLNPNVKLKLSLP   E SF KFLT+SGTF DGDLLVN+DGVRIVSQ +T+ PP I
Sbjct: 1   MKKGGLNPNVKLKLSLPPPNEVSFAKFLTQSGTFRDGDLLVNRDGVRIVSQIDTQPPPPI 60

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK 120
            P+DNQL+L DID +KV+GKGS GIVQLVQHKWT QFFALKVIQMN+EESAR+ I QELK
Sbjct: 61  TPTDNQLSLADIDMVKVIGKGSSGIVQLVQHKWTSQFFALKVIQMNIEESARKAITQELK 120

Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           INQSSQCPYVV+CYQSFY NGAISIILEYMDGGSLADFLK VK I E YLAAI +QVLKG
Sbjct: 121 INQSSQCPYVVMCYQSFYDNGAISIILEYMDGGSLADFLKSVKKISEPYLAAIFKQVLKG 180

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM STSGQANTFVGTYNYMSPER
Sbjct: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMQSTSGQANTFVGTYNYMSPER 240

Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
           ISGG+Y YKSDIWSLGLVLLECATG+F  +PP   +GWT+ YELM AIVDQPPPSAP DQ
Sbjct: 241 ISGGRYDYKSDIWSLGLVLLECATGEFSITPPVPNEGWTNVYELMVAIVDQPPPSAPPDQ 300

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATL 356
           FSPEFCSFISACVQK+P+ R SA ELM HPF+ MY D +VDLS YFT+AGS LATL
Sbjct: 301 FSPEFCSFISACVQKDPKDRQSAHELMEHPFMNMYEDQHVDLSSYFTNAGS-LATL 355

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|42601214|gb|AAS21304.1| mitogen-activated protein kinase kinase 2 [Petroselinum crispum]

 Score =  592 bits (1527), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 284/356 (79%), Positives = 317/356 (89%), Gaps = 2/356 (0%)

Query: 1   MKKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLI 60
           MKKG L P   LKLSLP  +E S TKFLT+SGTFMDGDLLVN+DGVRIVSQT+ +A P I
Sbjct: 1   MKKGNLGPG--LKLSLPPPDEDSLTKFLTQSGTFMDGDLLVNRDGVRIVSQTDVQAAPPI 58

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK 120
           + +DNQL+L D D IKVVGKGSGGIV+LVQHKWTGQFFALKVIQMN++ESAR+QIAQELK
Sbjct: 59  QATDNQLSLADFDAIKVVGKGSGGIVRLVQHKWTGQFFALKVIQMNIQESARKQIAQELK 118

Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           INQSSQC  VVVCYQSFY NGAISIILEYMDGGSLADFLK VK IPE YLAAI +QVLKG
Sbjct: 119 INQSSQCLNVVVCYQSFYDNGAISIILEYMDGGSLADFLKIVKNIPEPYLAAIFKQVLKG 178

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI+A+TSGQANTFVGTYNYMSPER
Sbjct: 179 LWYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAILATTSGQANTFVGTYNYMSPER 238

Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
           ISGG++GY SDIWSLGLVLLECATG FPYSPPEQ +GW++ +ELM+ IV+Q PP AP D+
Sbjct: 239 ISGGQHGYSSDIWSLGLVLLECATGYFPYSPPEQDEGWSNVFELMDTIVNQAPPCAPPDE 298

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATL 356
           FSPEFCSF+SACVQK+P++R SA EL+ HPF+ MY  LN+DL+ YFT+AGSPLATL
Sbjct: 299 FSPEFCSFVSACVQKDPRKRPSANELLRHPFINMYEHLNIDLAGYFTEAGSPLATL 354

Source: Petroselinum crispum

Species: Petroselinum crispum

Genus: Petroselinum

Family: Apiaceae

Order: Apiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|7682432|gb|AAF67262.1|AF165186_1 MAP kinase kinase [Nicotiana tabacum]

 Score =  592 bits (1525), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 280/359 (77%), Positives = 313/359 (87%), Gaps = 2/359 (0%)

Query: 1   MKKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLI 60
           MKKG L PN  LKLSLP  +E + +KFLT+SGTF DGDLLVN+DGVRIVSQ+E EAP +I
Sbjct: 1   MKKGSLAPN--LKLSLPPPDEVNLSKFLTESGTFKDGDLLVNRDGVRIVSQSEVEAPSVI 58

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK 120
           +PSDNQL L D + +KV+GKG+GGIV+LVQHKWTGQFFALK IQMN+EES R+ IAQEL+
Sbjct: 59  QPSDNQLCLADFEAVKVIGKGNGGIVRLVQHKWTGQFFALKAIQMNIEESMRKHIAQELR 118

Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           INQSSQ PYVV+ YQSF+ NGAISIILEYMDGGSLADFLKKVKTIPE YLAAIC+QVLKG
Sbjct: 119 INQSSQVPYVVISYQSFFDNGAISIILEYMDGGSLADFLKKVKTIPERYLAAICKQVLKG 178

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L YLHHEKHIIHRDLKPSNLLINH G+VKITDFGVSA++ASTSG ANTFVGTYNYMSPER
Sbjct: 179 LWYLHHEKHIIHRDLKPSNLLINHIGDVKITDFGVSAVLASTSGLANTFVGTYNYMSPER 238

Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
           I GG YGY+SDIWSLGLVLLECATG FPYSPP+  +GW + YELME IVDQP PSAP DQ
Sbjct: 239 ILGGAYGYRSDIWSLGLVLLECATGVFPYSPPQADEGWVNVYELMETIVDQPAPSAPPDQ 298

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNL 359
           FSP+FCSFISACVQK+ + RLSA ELM HPF+ MY DL++DL  YFT AG PLATL+ L
Sbjct: 299 FSPQFCSFISACVQKDQKDRLSANELMRHPFITMYDDLDIDLGSYFTSAGPPLATLTEL 357

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|51471926|gb|AAU04433.1| MAPKK [Solanum lycopersicum]

 Score =  590 bits (1521), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 276/359 (76%), Positives = 312/359 (86%), Gaps = 2/359 (0%)

Query: 1   MKKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLI 60
           MKKG   PN  LKLSLP  +E + +KFLT+SGTF DGDLLVN+DGVRIVSQ+E  AP +I
Sbjct: 1   MKKGSFAPN--LKLSLPPPDEVALSKFLTESGTFKDGDLLVNRDGVRIVSQSEVAAPSVI 58

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK 120
           +PSDNQL L D + +KV+GKG+GGIV+LVQHKWTGQFFALKVIQMN++ES R+ IAQEL+
Sbjct: 59  QPSDNQLCLADFEAVKVIGKGNGGIVRLVQHKWTGQFFALKVIQMNIDESMRKHIAQELR 118

Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           INQSSQCPYVV+CYQSF+ NGAIS+ILEYMDGGSLADFLKKVKTIPE +LA IC+QVLKG
Sbjct: 119 INQSSQCPYVVICYQSFFDNGAISLILEYMDGGSLADFLKKVKTIPERFLAVICKQVLKG 178

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L YLHHEKHIIHRDLKPSNLLINHRG+VKITDFGVSA++ASTSG ANTFVGTYNYMSPER
Sbjct: 179 LWYLHHEKHIIHRDLKPSNLLINHRGDVKITDFGVSAVLASTSGLANTFVGTYNYMSPER 238

Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
           ISGG Y YKSDIWSLGLVLLECATG FPY+PPE  +GW + YELME IVDQP P AP DQ
Sbjct: 239 ISGGAYDYKSDIWSLGLVLLECATGHFPYNPPEGDEGWVNVYELMETIVDQPEPCAPPDQ 298

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNL 359
           FSP+FCSFISACVQK  + RLSA +LM+HPF+ MY D ++DL  YFT AG PLATL+ L
Sbjct: 299 FSPQFCSFISACVQKHQKDRLSANDLMSHPFITMYDDQDIDLGSYFTSAGPPLATLTEL 357

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|267881840|gb|ACY82515.1| mitogen-activated protein kinase kinase [Malus x domestica]

 Score =  590 bits (1520), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 278/356 (78%), Positives = 312/356 (87%), Gaps = 2/356 (0%)

Query: 1   MKKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLI 60
           MKKG L  N  LKL+LP  +E S +KFLT+SGTFMDGDLLVN++GVRIVS  E E PP I
Sbjct: 1   MKKGSLGSN--LKLTLPPPDEVSISKFLTQSGTFMDGDLLVNREGVRIVSHREVEVPPPI 58

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK 120
           + SDNQ+ L D+D IKV+GKG+GG+VQLVQHKWT QFFALKVIQMN+EES R+QIAQELK
Sbjct: 59  QASDNQMILADLDAIKVIGKGNGGVVQLVQHKWTHQFFALKVIQMNIEESIRKQIAQELK 118

Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           I+QSSQCP +VVCYQSFY NGAISIILEYMDGGSLAD LKKVKTIPE YLAAIC+QVL+G
Sbjct: 119 IDQSSQCPNIVVCYQSFYENGAISIILEYMDGGSLADLLKKVKTIPEFYLAAICKQVLQG 178

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L YLHHEKHIIHRD KPSNLLINHRGE+KITDFGVSAI ASTS QANTFVGTYNYMSPER
Sbjct: 179 LCYLHHEKHIIHRDFKPSNLLINHRGEIKITDFGVSAIKASTSEQANTFVGTYNYMSPER 238

Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
           I G  Y YKSDIWSLGLVLLECATGQFPY+PP+Q + W +F+ELM AIV+QPP  APSDQ
Sbjct: 239 IVGSNYSYKSDIWSLGLVLLECATGQFPYTPPDQSEAWDNFFELMSAIVEQPPSCAPSDQ 298

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATL 356
           FSPEFCSFISACVQK+P+ RLSAQ+L+ HPF+ MY D+++DLS YFT+AGSPLAT 
Sbjct: 299 FSPEFCSFISACVQKDPKDRLSAQDLLRHPFISMYDDVHIDLSPYFTEAGSPLATF 354

Source: Malus x domestica

Species: Malus x domestica

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|350536161|ref|NP_001234744.1| MAP kinase kinase [Solanum lycopersicum] gi|9843771|emb|CAA04261.2| MAP kinase kinase [Solanum lycopersicum]

 Score =  590 bits (1520), Expect = e-166,   Method: Compositional matrix adjust.
 Identities = 276/359 (76%), Positives = 311/359 (86%), Gaps = 2/359 (0%)

Query: 1   MKKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLI 60
           MKKG   PN  LKLSLP  +E + +KFLT+SGTF DGDLLVN+DGVRIVSQ+E  AP +I
Sbjct: 1   MKKGSFAPN--LKLSLPPPDEVALSKFLTESGTFKDGDLLVNRDGVRIVSQSEVAAPSVI 58

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK 120
           +PSDNQL L D + +KV+GKG+GGIV+LVQHKWTGQFFALKVIQMN++ES R+ IAQEL+
Sbjct: 59  QPSDNQLCLADFEAVKVIGKGNGGIVRLVQHKWTGQFFALKVIQMNIDESMRKHIAQELR 118

Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           INQSSQCPYVV+CYQSF+ NGAIS+ILEYMDGGSLADFLKKVKTIPE +LA IC+QVLKG
Sbjct: 119 INQSSQCPYVVICYQSFFDNGAISLILEYMDGGSLADFLKKVKTIPERFLAVICKQVLKG 178

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L YLHHEKHIIHRDLKPSNLLINHRG+VKITDFGVSA++ASTSG ANTFVGTYNYMSPER
Sbjct: 179 LWYLHHEKHIIHRDLKPSNLLINHRGDVKITDFGVSAVLASTSGLANTFVGTYNYMSPER 238

Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
           ISGG Y YKSDIWSLGLVLLECATG FPY PPE  +GW + YELME IVDQP P AP DQ
Sbjct: 239 ISGGAYDYKSDIWSLGLVLLECATGHFPYKPPEGDEGWVNVYELMETIVDQPEPCAPPDQ 298

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNL 359
           FSP+FCSFISACVQK  + RLSA +LM+HPF+ MY D ++DL  YFT AG PLATL+ L
Sbjct: 299 FSPQFCSFISACVQKHQKDRLSANDLMSHPFITMYDDQDIDLGSYFTSAGPPLATLTEL 357

Source: Solanum lycopersicum

Species: Solanum lycopersicum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255546067|ref|XP_002514093.1| mitogen activated protein kinase kinase, mapkk2, putative [Ricinus communis] gi|223546549|gb|EEF48047.1| mitogen activated protein kinase kinase, mapkk2, putative [Ricinus communis]

 Score =  588 bits (1515), Expect = e-165,   Method: Compositional matrix adjust.
 Identities = 279/328 (85%), Positives = 301/328 (91%)

Query: 1   MKKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLI 60
           MKKG LNP V+LKL+LP  +E SF KFLT+SGTFMDGDLLVN+DGVR+VSQTE EAPP I
Sbjct: 1   MKKGTLNPIVELKLALPPPDEVSFAKFLTQSGTFMDGDLLVNRDGVRLVSQTEPEAPPPI 60

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK 120
           KP DNQL+L DIDTIKV+GKGS GIVQLVQHKWTGQFFALKVIQMN+EE++R+ IAQELK
Sbjct: 61  KPLDNQLSLADIDTIKVIGKGSSGIVQLVQHKWTGQFFALKVIQMNIEENSRKAIAQELK 120

Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           INQSSQCPYVV+CYQSFY NGAISIILEYMDGGSLAD LKKVKTIPE YLAAIC+QVLKG
Sbjct: 121 INQSSQCPYVVMCYQSFYDNGAISIILEYMDGGSLADLLKKVKTIPEPYLAAICKQVLKG 180

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           LLYLH EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG ANTFVGTYNYMSPER
Sbjct: 181 LLYLHQEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGLANTFVGTYNYMSPER 240

Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
           ISG KYGYKSDIWSLGLVLLECATG+FPYSPPEQ + W + YELMEA+V+QP PSAPSDQ
Sbjct: 241 ISGAKYGYKSDIWSLGLVLLECATGKFPYSPPEQGEDWVNVYELMEAVVEQPQPSAPSDQ 300

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMT 328
           FSPEFCSF+S+CVQK+P  RLSA ELM 
Sbjct: 301 FSPEFCSFVSSCVQKDPNNRLSAHELMA 328

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356547903|ref|XP_003542344.1| PREDICTED: mitogen-activated protein kinase kinase 2-like [Glycine max]

 Score =  570 bits (1469), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 280/358 (78%), Positives = 317/358 (88%), Gaps = 4/358 (1%)

Query: 1   MKKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLI 60
           MKKG L   + LKLS+P S++++F +FLT+SGTF DGDLLVN+DGVRIVSQ + EAPP I
Sbjct: 1   MKKGNLG--LGLKLSVPVSDQSNFARFLTESGTFKDGDLLVNRDGVRIVSQNDVEAPPPI 58

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK 120
           KP+DNQL L DID IKVVGKG+GG+VQLVQHKWT QFFALKVIQMN+EES R+QIAQELK
Sbjct: 59  KPTDNQLTLADIDVIKVVGKGNGGVVQLVQHKWTSQFFALKVIQMNIEESMRKQIAQELK 118

Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           INQ +QCPYVVVCYQSFY NG ISIILEYMDGGSLAD LKKVKTIPE+YLAAIC+QVLKG
Sbjct: 119 INQQAQCPYVVVCYQSFYENGVISIILEYMDGGSLADLLKKVKTIPEDYLAAICKQVLKG 178

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L+YLHHEKHIIHRDLKPSNLLINH GEVKITDFGVSAIM STSGQANTF+GTYNYMSPER
Sbjct: 179 LVYLHHEKHIIHRDLKPSNLLINHIGEVKITDFGVSAIMESTSGQANTFIGTYNYMSPER 238

Query: 241 ISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 298
           I+G +  Y YKSDIWSLGL+LLECA G+FPY+PP+Q + W S +EL+E IVD+PPP  PS
Sbjct: 239 INGSQRGYNYKSDIWSLGLILLECALGRFPYAPPDQSETWESIFELIETIVDKPPPIPPS 298

Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATL 356
           +QFS EFCSFISAC+QK+P+ RLSAQELM HPF+ MY DL VDLS YF++AGSPLATL
Sbjct: 299 EQFSTEFCSFISACLQKDPKDRLSAQELMAHPFVNMYDDLEVDLSAYFSNAGSPLATL 356

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	362
TAIR|locus:2120855	354	MEK1 "MAP kinase/ ERK kinase 1	0.977	1.0	0.653	4.4e-123
TAIR|locus:2164981	356	MKK6 "MAP kinase kinase 6" [Ar	0.928	0.943	0.598	1.8e-110
DICTYBASE|DDB_G0269152	660	mekA "MAP kinase kinase (MAP2K	0.574	0.315	0.490	4.2e-72
TAIR|locus:2170578	520	MKK3 "AT5G40440" [Arabidopsis	0.712	0.496	0.462	2.5e-58
UNIPROTKB|F1PJI7	380	MAP2K1 "Uncharacterized protei	0.560	0.534	0.473	4.8e-58
UNIPROTKB|J9P5W6	393	MAP2K1 "Uncharacterized protei	0.560	0.516	0.473	4.8e-58
UNIPROTKB|Q0VD16	393	MAP2K1 "MAP2K1 protein" [Bos t	0.560	0.516	0.468	1.6e-57
UNIPROTKB|Q02750	393	MAP2K1 "Dual specificity mitog	0.560	0.516	0.468	1.6e-57
RGD|70495	393	Map2k1 "mitogen activated prot	0.560	0.516	0.468	2e-57
MGI|MGI:1346866	393	Map2k1 "mitogen-activated prot	0.560	0.516	0.468	2.6e-57

TAIR|locus:2120855 MEK1 "MAP kinase/ ERK kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1210 (431.0 bits), Expect = 4.4e-123, P = 4.4e-123
 Identities = 234/358 (65%), Positives = 280/358 (78%)

Query:     1 MKKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLI 60
             M +G L PN    + LP  E+ S +KFLT+SGTF DGDL VNKDG++ VS +E  APP I
Sbjct:     1 MNRGSLCPN---PICLPPLEQ-SISKFLTQSGTFKDGDLRVNKDGIQTVSLSEPGAPPPI 56

Query:    61 KPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK 120
             +P DNQL+L D++             QLV+HK T QFFALKVIQ+N EES  R I+QEL+
Sbjct:    57 EPLDNQLSLADLEVIKVIGKGSSGNVQLVKHKLTQQFFALKVIQLNTEESTCRAISQELR 116

Query:   121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
             IN SSQCPY+V CYQSFY NG +SIILE+MDGGSLAD LKKV  +PE  L+AIC++VL+G
Sbjct:   117 INLSSQCPYLVSCYQSFYHNGLVSIILEFMDGGSLADLLKKVGKVPENMLSAICKRVLRG 176

Query:   181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
             L Y+HHE+ IIHRDLKPSNLLINHRGEVKITDFGVS I+ STS  AN+FVGTY YMSPER
Sbjct:   177 LCYIHHERRIIHRDLKPSNLLINHRGEVKITDFGVSKILTSTSSLANSFVGTYPYMSPER 236

Query:   241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
             ISG  Y  KSDIWSLGLVLLECATG+FPY+PPE + GW+S YEL++AIV+ PPP APS+ 
Sbjct:   237 ISGSLYSNKSDIWSLGLVLLECATGKFPYTPPEHKKGWSSVYELVDAIVENPPPCAPSNL 296

Query:   301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSN 358
             FSPEFCSFIS CVQK+P+ R SA+EL+ H F+KM+ D + +LS YFTDAGS +  L+N
Sbjct:   297 FSPEFCSFISQCVQKDPRDRKSAKELLEHKFVKMFEDSDTNLSAYFTDAGSLIPPLAN 354

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IDA;TAS

GO:0042542 "response to hydrogen peroxide" evidence=IEP;IDA

GO:0000165 "MAPK cascade" evidence=IC;RCA

GO:0005515 "protein binding" evidence=IPI

GO:0042742 "defense response to bacterium" evidence=RCA;IDA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA;IDA

GO:0009414 "response to water deprivation" evidence=IMP

GO:0009814 "defense response, incompatible interaction" evidence=IGI;RCA

GO:0000023 "maltose metabolic process" evidence=RCA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0019252 "starch biosynthetic process" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0019761 "glucosinolate biosynthetic process" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0009611 "response to wounding" evidence=IEP

TAIR|locus:2164981 MKK6 "MAP kinase kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1091 (389.1 bits), Expect = 1.8e-110, P = 1.8e-110
 Identities = 203/339 (59%), Positives = 261/339 (76%)

Query:     6 LNPNVK-LKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSD 64
             +  N+K LKLS+P+ +E+  + FLT SGTF DGD L+N+ G+R+ S  +       K  D
Sbjct:     4 IKSNLKQLKLSVPA-QESPISSFLTASGTFHDGDFLLNQKGLRLTSDEKQSRQSDSKELD 62

Query:    65 NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQ- 123
              ++  ED++T            QLV+HKW G+FFA+KVIQMN++E  R+QI QELKINQ 
Sbjct:    63 FEITAEDLETVKVIGKGSGGVVQLVRHKWVGKFFAMKVIQMNIQEEIRKQIVQELKINQA 122

Query:   124 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 183
             SSQCP+VVVCY SFY NGA S++LEYMD GSLAD +++VKTI E YLA +C+QVL GL+Y
Sbjct:   123 SSQCPHVVVCYHSFYHNGAFSLVLEYMDRGSLADVIRQVKTILEPYLAVVCKQVLLGLVY 182

Query:   184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
             LH+E+H+IHRD+KPSNLL+NH+GEVKI+DFGVSA +AS+ GQ +TFVGTYNYMSPERISG
Sbjct:   183 LHNERHVIHRDIKPSNLLVNHKGEVKISDFGVSASLASSMGQRDTFVGTYNYMSPERISG 242

Query:   244 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP 303
               Y Y SDIWSLG+ +LECA G+FPY   E Q    SFYEL+ AIV+ PPP+APSDQFSP
Sbjct:   243 STYDYSSDIWSLGMSVLECAIGRFPYLESEDQQNPPSFYELLAAIVENPPPTAPSDQFSP 302

Query:   304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
             EFCSF+SAC+QK+P  R S+ +L++HPF+K + D ++DL
Sbjct:   303 EFCSFVSACIQKDPPARASSLDLLSHPFIKKFEDKDIDL 341

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IDA;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0006275 "regulation of DNA replication" evidence=RCA

GO:0010389 "regulation of G2/M transition of mitotic cell cycle" evidence=RCA

GO:0045727 "positive regulation of translation" evidence=RCA

DICTYBASE|DDB_G0269152 mekA "MAP kinase kinase (MAP2K)" [Dictyostelium discoideum (taxid:44689)]

 Score = 532 (192.3 bits), Expect = 4.2e-72, Sum P(3) = 4.2e-72
 Identities = 103/210 (49%), Positives = 141/210 (67%)

Query:    68 NLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC 127
             +L+D+              +L  H+ +G + ALKVI ++++E+ R+QI  ELK    +  
Sbjct:   288 DLKDLKIIRVLGRGAGGVVKLAYHETSGTYIALKVITLDIQENIRKQIILELKTLHKTSY 347

Query:   128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 187
             PY+V  Y +FY+ G+I I LE+M+ GSL+D +KK  TIPE  L  I  QVL+GL+YLH +
Sbjct:   348 PYIVSFYDAFYTEGSIFIALEFMELGSLSDIMKKTSTIPEPVLGKIAFQVLQGLVYLHRK 407

Query:   188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 247
              H+IHRD+KPSN+L+N++GE KI DFGVS  +  T  +A T+VGT  YMSPERISG  Y 
Sbjct:   408 LHLIHRDIKPSNILVNNKGEAKIADFGVSGQLQHTLSKAVTWVGTVTYMSPERISGRSYS 467

Query:   248 YKSDIWSLGLVLLECATGQFPYSP--PEQQ 275
             + S+IWSLGL +LECA G+FPY    P QQ
Sbjct:   468 FDSEIWSLGLTILECAIGKFPYGSNLPHQQ 497

GO:0030587 "sorocarp development" evidence=IMP

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0016020 "membrane" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0031152 "aggregation involved in sorocarp development" evidence=TAS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0006935 "chemotaxis" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2170578 MKK3 "AT5G40440" [Arabidopsis thaliana (taxid:3702)]

 Score = 599 (215.9 bits), Expect = 2.5e-58, P = 2.5e-58
 Identities = 124/268 (46%), Positives = 169/268 (63%)

Query:    96 QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ-SFYS--NGAISIILEYMDG 152
             +  ALK I +  E   R+Q+  E++    + C   +V +  +FYS  +G ISI LEYM+G
Sbjct:   107 RILALKKINI-FEREKRQQLLTEIRTLCEAPCHEGLVDFHGAFYSPDSGQISIALEYMNG 165

Query:   153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
             GSLAD LK  K IPE  L+++  ++L+GL YLH  +H++HRD+KP+NLLIN +GE KITD
Sbjct:   166 GSLADILKVTKKIPEPVLSSLFHKLLQGLSYLHGVRHLVHRDIKPANLLINLKGEPKITD 225

Query:   213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 272
             FG+SA + ++     TFVGT  YMSPERI    Y Y +DIWSLGL L EC TG+FPY   
Sbjct:   226 FGISAGLENSMAMCATFVGTVTYMSPERIRNDSYSYPADIWSLGLALFECGTGEFPYIAN 285

Query:   273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
             E          LM  I+D P P+ P  +FSPEFCSFI AC+QK+P  R +A +L++HPF+
Sbjct:   286 EGP------VNLMLQILDDPSPTPPKQEFSPEFCSFIDACLQKDPDARPTADQLLSHPFI 339

Query:   333 KMYGDLNVDLSEYFTDAGSPLATLSNLS 360
               +    VDL+ +      P   L +L+
Sbjct:   340 TKHEKERVDLATFVQSIFDPTQRLKDLA 367

GO:0000165 "MAPK cascade" evidence=ISS

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IEP

GO:0009866 "induced systemic resistance, ethylene mediated signaling pathway" evidence=IEP

GO:0009814 "defense response, incompatible interaction" evidence=IMP

GO:0004707 "MAP kinase activity" evidence=IDA

UNIPROTKB|F1PJI7 MAP2K1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 478 (173.3 bits), Expect = 4.8e-58, Sum P(2) = 4.8e-58
 Identities = 98/207 (47%), Positives = 136/207 (65%)

Query:    89 VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
             V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct:    85 VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 144

Query:   149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGE 207
             +MDGGSL   LKK   IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE
Sbjct:   145 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGE 203

Query:   208 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF 267
             +K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++
Sbjct:   204 IKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 261

Query:   268 PYSPPEQQDGWTSFYELMEAIVDQPPP 294
             P  PP+ ++    F   +E  V + PP
Sbjct:   262 PIPPPDAKELELMFGCQVEGDVAETPP 288

GO:0090398 "cellular senescence" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0030182 "neuron differentiation" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0007050 "cell cycle arrest" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|J9P5W6 MAP2K1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 478 (173.3 bits), Expect = 4.8e-58, Sum P(2) = 4.8e-58
 Identities = 98/207 (47%), Positives = 136/207 (65%)

Query:    89 VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
             V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct:    85 VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 144

Query:   149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGE 207
             +MDGGSL   LKK   IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE
Sbjct:   145 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGE 203

Query:   208 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF 267
             +K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++
Sbjct:   204 IKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 261

Query:   268 PYSPPEQQDGWTSFYELMEAIVDQPPP 294
             P  PP+ ++    F   +E  V + PP
Sbjct:   262 PIPPPDAKELELMFGCQVEGDVAETPP 288

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q0VD16 MAP2K1 "MAP2K1 protein" [Bos taurus (taxid:9913)]

 Score = 474 (171.9 bits), Expect = 1.6e-57, Sum P(2) = 1.6e-57
 Identities = 97/207 (46%), Positives = 135/207 (65%)

Query:    89 VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
             V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct:    85 VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 144

Query:   149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGE 207
             +MDGGSL   LKK   IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE
Sbjct:   145 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGE 203

Query:   208 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF 267
             +K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++
Sbjct:   204 IKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 261

Query:   268 PYSPPEQQDGWTSFYELMEAIVDQPPP 294
             P  PP+ ++    F   +E    + PP
Sbjct:   262 PIPPPDAKELELMFGCQVEGDAAETPP 288

GO:0090398 "cellular senescence" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0030182 "neuron differentiation" evidence=IEA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA

GO:0007050 "cell cycle arrest" evidence=IEA

GO:0005886 "plasma membrane" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|Q02750 MAP2K1 "Dual specificity mitogen-activated protein kinase kinase 1" [Homo sapiens (taxid:9606)]

 Score = 474 (171.9 bits), Expect = 1.6e-57, Sum P(2) = 1.6e-57
 Identities = 97/207 (46%), Positives = 135/207 (65%)

Query:    89 VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
             V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct:    85 VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 144

Query:   149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGE 207
             +MDGGSL   LKK   IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE
Sbjct:   145 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGE 203

Query:   208 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF 267
             +K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++
Sbjct:   204 IKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 261

Query:   268 PYSPPEQQDGWTSFYELMEAIVDQPPP 294
             P  PP+ ++    F   +E    + PP
Sbjct:   262 PIPPPDAKELELMFGCQVEGDAAETPP 288

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0003056 "regulation of vascular smooth muscle contraction" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005938 "cell cortex" evidence=IEA

GO:0006979 "response to oxidative stress" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0008283 "cell proliferation" evidence=IEA

GO:0017016 "Ras GTPase binding" evidence=IEA

GO:0030216 "keratinocyte differentiation" evidence=IEA

GO:0030335 "positive regulation of cell migration" evidence=IEA

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=IEA

GO:0032320 "positive regulation of Ras GTPase activity" evidence=IEA

GO:0032402 "melanosome transport" evidence=IEA

GO:0032839 "dendrite cytoplasm" evidence=IEA

GO:0032968 "positive regulation of transcription elongation from RNA polymerase II promoter" evidence=IEA

GO:0033267 "axon part" evidence=IEA

GO:0034111 "negative regulation of homotypic cell-cell adhesion" evidence=IEA

GO:0043204 "perikaryon" evidence=IEA

GO:0045597 "positive regulation of cell differentiation" evidence=IEA

GO:0046579 "positive regulation of Ras protein signal transduction" evidence=IEA

GO:0047496 "vesicle transport along microtubule" evidence=IEA

GO:0048313 "Golgi inheritance" evidence=IEA

GO:0048471 "perinuclear region of cytoplasm" evidence=IEA

GO:0048678 "response to axon injury" evidence=IEA

GO:0048870 "cell motility" evidence=IEA

GO:0051291 "protein heterooligomerization" evidence=IEA

GO:0051384 "response to glucocorticoid stimulus" evidence=IEA

GO:0060674 "placenta blood vessel development" evidence=IEA

GO:0060711 "labyrinthine layer development" evidence=IEA

GO:0005816 "spindle pole body" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=TAS

GO:0005634 "nucleus" evidence=TAS

GO:0000187 "activation of MAPK activity" evidence=TAS

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=TAS

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0005739 "mitochondrion" evidence=TAS

GO:0005925 "focal adhesion" evidence=TAS

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=IDA

GO:0004708 "MAP kinase kinase activity" evidence=IDA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IDA

GO:0004672 "protein kinase activity" evidence=TAS

GO:0006928 "cellular component movement" evidence=TAS

GO:0006935 "chemotaxis" evidence=TAS

GO:0007165 "signal transduction" evidence=TAS

GO:0000165 "MAPK cascade" evidence=TAS

GO:0000186 "activation of MAPKK activity" evidence=TAS

GO:0002224 "toll-like receptor signaling pathway" evidence=TAS

GO:0002755 "MyD88-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0002756 "MyD88-independent toll-like receptor signaling pathway" evidence=TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=TAS

GO:0007173 "epidermal growth factor receptor signaling pathway" evidence=TAS

GO:0007264 "small GTPase mediated signal transduction" evidence=TAS

GO:0007265 "Ras protein signal transduction" evidence=TAS

GO:0007411 "axon guidance" evidence=TAS

GO:0008063 "Toll signaling pathway" evidence=TAS

GO:0008286 "insulin receptor signaling pathway" evidence=TAS

GO:0008543 "fibroblast growth factor receptor signaling pathway" evidence=TAS

GO:0034130 "toll-like receptor 1 signaling pathway" evidence=TAS

GO:0034134 "toll-like receptor 2 signaling pathway" evidence=TAS

GO:0034138 "toll-like receptor 3 signaling pathway" evidence=TAS

GO:0034142 "toll-like receptor 4 signaling pathway" evidence=TAS

GO:0035666 "TRIF-dependent toll-like receptor signaling pathway" evidence=TAS

GO:0045087 "innate immune response" evidence=TAS

GO:0048011 "neurotrophin TRK receptor signaling pathway" evidence=TAS

GO:0051403 "stress-activated MAPK cascade" evidence=TAS

GO:0007050 "cell cycle arrest" evidence=IMP

GO:0008285 "negative regulation of cell proliferation" evidence=IDA

GO:0090398 "cellular senescence" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

RGD|70495 Map2k1 "mitogen activated protein kinase kinase 1" [Rattus norvegicus (taxid:10116)]

 Score = 473 (171.6 bits), Expect = 2.0e-57, Sum P(2) = 2.0e-57
 Identities = 97/207 (46%), Positives = 135/207 (65%)

Query:    89 VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
             V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct:    85 VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 144

Query:   149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGE 207
             +MDGGSL   LKK   IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE
Sbjct:   145 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGE 203

Query:   208 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF 267
             +K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++
Sbjct:   204 IKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 261

Query:   268 PYSPPEQQDGWTSFYELMEAIVDQPPP 294
             P  PP+ ++    F   +E    + PP
Sbjct:   262 PIPPPDAKELELLFGCQVEGDAAETPP 288

GO:0000165 "MAPK cascade" evidence=IMP

GO:0000187 "activation of MAPK activity" evidence=ISO;IDA;TAS

GO:0003056 "regulation of vascular smooth muscle contraction" evidence=IMP

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO;IMP;IDA;TAS

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IEA;ISO

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IDA

GO:0005634 "nucleus" evidence=TAS

GO:0005737 "cytoplasm" evidence=ISO

GO:0005739 "mitochondrion" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=IDA;TAS

GO:0005816 "spindle pole body" evidence=IEA

GO:0005829 "cytosol" evidence=IDA;TAS

GO:0005886 "plasma membrane" evidence=ISO;IDA

GO:0005925 "focal adhesion" evidence=TAS

GO:0005938 "cell cortex" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=ISO;IDA;TAS

GO:0006979 "response to oxidative stress" evidence=IDA

GO:0007050 "cell cycle arrest" evidence=IEA;ISO

GO:0007067 "mitosis" evidence=IDA

GO:0007243 "intracellular protein kinase cascade" evidence=TAS

GO:0008283 "cell proliferation" evidence=IDA

GO:0008285 "negative regulation of cell proliferation" evidence=IEA;ISO

GO:0017016 "Ras GTPase binding" evidence=IPI

GO:0019901 "protein kinase binding" evidence=IPI

GO:0030182 "neuron differentiation" evidence=ISO;IMP

GO:0030216 "keratinocyte differentiation" evidence=IEA;ISO

GO:0030335 "positive regulation of cell migration" evidence=IMP

GO:0030425 "dendrite" evidence=IDA

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=IDA;IPI

GO:0032320 "positive regulation of Ras GTPase activity" evidence=IMP

GO:0032402 "melanosome transport" evidence=IDA

GO:0032839 "dendrite cytoplasm" evidence=IDA

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0032968 "positive regulation of transcription elongation from RNA polymerase II promoter" evidence=IMP

GO:0033267 "axon part" evidence=IDA

GO:0034111 "negative regulation of homotypic cell-cell adhesion" evidence=IMP

GO:0043204 "perikaryon" evidence=IDA

GO:0043539 "protein serine/threonine kinase activator activity" evidence=IEA;ISO

GO:0045597 "positive regulation of cell differentiation" evidence=IEA;ISO

GO:0046579 "positive regulation of Ras protein signal transduction" evidence=IMP

GO:0047496 "vesicle transport along microtubule" evidence=IDA

GO:0048313 "Golgi inheritance" evidence=IMP

GO:0048471 "perinuclear region of cytoplasm" evidence=IDA

GO:0048678 "response to axon injury" evidence=IMP

GO:0048812 "neuron projection morphogenesis" evidence=IMP

GO:0048870 "cell motility" evidence=IEA;ISO

GO:0051291 "protein heterooligomerization" evidence=IPI

GO:0051384 "response to glucocorticoid stimulus" evidence=IDA

GO:0060674 "placenta blood vessel development" evidence=IEA;ISO

GO:0060711 "labyrinthine layer development" evidence=IEA;ISO

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=ISO

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0090398 "cellular senescence" evidence=IEA;ISO

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

GO:0005874 "microtubule" evidence=IDA

MGI|MGI:1346866 Map2k1 "mitogen-activated protein kinase kinase 1" [Mus musculus (taxid:10090)]

 Score = 472 (171.2 bits), Expect = 2.6e-57, Sum P(2) = 2.6e-57
 Identities = 97/207 (46%), Positives = 135/207 (65%)

Query:    89 VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
             V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct:    85 VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 144

Query:   149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGE 207
             +MDGGSL   LKK   IPE+ L  +   V+KGL YL  EKH I+HRD+KPSN+L+N RGE
Sbjct:   145 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR-EKHKIMHRDVKPSNILVNSRGE 203

Query:   208 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF 267
             +K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++
Sbjct:   204 IKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 261

Query:   268 PYSPPEQQDGWTSFYELMEAIVDQPPP 294
             P  PP+ ++    F   +E    + PP
Sbjct:   262 PIPPPDAKELELLFGCHVEGDAAETPP 288

GO:0000165 "MAPK cascade" evidence=ISO

GO:0000166 "nucleotide binding" evidence=IEA

GO:0000187 "activation of MAPK activity" evidence=ISO;IMP;TAS

GO:0003056 "regulation of vascular smooth muscle contraction" evidence=ISO

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004708 "MAP kinase kinase activity" evidence=ISO;IMP

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=TAS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0004728 "receptor signaling protein tyrosine phosphatase activity" evidence=IMP

GO:0005524 "ATP binding" evidence=ISO

GO:0005634 "nucleus" evidence=TAS

GO:0005737 "cytoplasm" evidence=IEA

GO:0005739 "mitochondrion" evidence=TAS

GO:0005769 "early endosome" evidence=TAS

GO:0005770 "late endosome" evidence=TAS

GO:0005794 "Golgi apparatus" evidence=ISO;TAS

GO:0005829 "cytosol" evidence=ISO;TAS

GO:0005856 "cytoskeleton" evidence=IEA

GO:0005874 "microtubule" evidence=ISO

GO:0005886 "plasma membrane" evidence=ISO

GO:0005925 "focal adhesion" evidence=TAS

GO:0005938 "cell cortex" evidence=ISO

GO:0006468 "protein phosphorylation" evidence=IEA;ISO;IMP

GO:0006979 "response to oxidative stress" evidence=ISO

GO:0007050 "cell cycle arrest" evidence=ISO

GO:0007067 "mitosis" evidence=ISO

GO:0008283 "cell proliferation" evidence=ISO

GO:0008285 "negative regulation of cell proliferation" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0017016 "Ras GTPase binding" evidence=ISO

GO:0019901 "protein kinase binding" evidence=ISO

GO:0030182 "neuron differentiation" evidence=ISO;IMP

GO:0030216 "keratinocyte differentiation" evidence=IMP

GO:0030335 "positive regulation of cell migration" evidence=ISO

GO:0030425 "dendrite" evidence=ISO

GO:0031435 "mitogen-activated protein kinase kinase kinase binding" evidence=ISO

GO:0032320 "positive regulation of Ras GTPase activity" evidence=ISO

GO:0032402 "melanosome transport" evidence=ISO

GO:0032839 "dendrite cytoplasm" evidence=ISO

GO:0032872 "regulation of stress-activated MAPK cascade" evidence=TAS

GO:0032968 "positive regulation of transcription elongation from RNA polymerase II promoter" evidence=ISO

GO:0033267 "axon part" evidence=ISO

GO:0034111 "negative regulation of homotypic cell-cell adhesion" evidence=ISO

GO:0043204 "perikaryon" evidence=ISO

GO:0043539 "protein serine/threonine kinase activator activity" evidence=ISO

GO:0045597 "positive regulation of cell differentiation" evidence=IDA

GO:0046579 "positive regulation of Ras protein signal transduction" evidence=ISO

GO:0047496 "vesicle transport along microtubule" evidence=ISO

GO:0048313 "Golgi inheritance" evidence=ISO

GO:0048471 "perinuclear region of cytoplasm" evidence=ISO

GO:0048678 "response to axon injury" evidence=ISO

GO:0048812 "neuron projection morphogenesis" evidence=ISO

GO:0048870 "cell motility" evidence=IMP

GO:0051291 "protein heterooligomerization" evidence=ISO

GO:0051384 "response to glucocorticoid stimulus" evidence=ISO

GO:0060674 "placenta blood vessel development" evidence=IMP

GO:0060711 "labyrinthine layer development" evidence=IMP

GO:0071902 "positive regulation of protein serine/threonine kinase activity" evidence=ISO

GO:0090170 "regulation of Golgi inheritance" evidence=TAS

GO:0090398 "cellular senescence" evidence=ISO

GO:2000641 "regulation of early endosome to late endosome transport" evidence=TAS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9S7U9	M2K2_ARATH	2, ., 7, ., 1, 2, ., 2	0.7257	0.9917	0.9889	yes	no
P10506	BYR1_SCHPO	2, ., 7, ., 1, 2, ., 2	0.3699	0.8867	0.9441	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.12.2	0.979
3rd Layer	2.7.12	0.983
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	362
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-157
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-136
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-99
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-94
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-91
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-88
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-87
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-83
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-79
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-78
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	8e-78
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-77
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-76
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-76
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-76
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-75
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-74
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-74
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-71
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-67
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-65
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-64
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-64
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-61
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-60
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-59
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-59
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-57
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	8e-57
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-56
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-54
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-53
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-50
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-50
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-50
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-49
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-48
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-48
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	8e-48
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-47
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-46
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-46
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-46
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-46
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	9e-46
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-45
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-45
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-45
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-45
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-44
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-44
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-44
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-44
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	9e-44
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-42
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-42
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	7e-42
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-42
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-41
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-41
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-40
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-40
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-40
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-39
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-39
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-39
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-39
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-39
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-38
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-38
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-38
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-37
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-37
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-37
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-37
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-37
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-37
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-37
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-36
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-36
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-36
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-36
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-36
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-35
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-35
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-35
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-35
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-35
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	4e-35
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-35
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-35
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-34
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-34
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-34
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-34
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-34
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-34
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-34
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-33
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-33
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-32
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-32
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-32
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-32
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-32
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-32
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	5e-32
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-31
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-31
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-31
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-31
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-31
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-31
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-31
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-31
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	7e-31
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-31
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	8e-31
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-30
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-30
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-30
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-30
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-30
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-30
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-30
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-29
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-29
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-29
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-29
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	6e-29
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-29
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-28
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-28
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-28
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-28
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-28
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-28
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	9e-28
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-27
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-27
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-27
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-27
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-27
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-27
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-27
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-27
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-26
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-26
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-26
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-26
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-25
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-25
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-25
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-25
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-25
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	7e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-24
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-24
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-24
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-24
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-24
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-24
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-23
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-23
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-23
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-23
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-23
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-23
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-23
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-22
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-22
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-22
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-22
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-22
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-22
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-22
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-22
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-21
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-21
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-21
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	7e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-20
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-20
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-20
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-20
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-20
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	8e-20
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-19
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-19
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-19
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-19
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-19
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-19
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-19
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	6e-19
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-19
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	6e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	7e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-19
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-18
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-18
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-18
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-18
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-18
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-18
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	3e-18
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-18
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-18
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	4e-18
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	8e-18
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-18
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-17
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-17
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-17
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-17
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-16
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-16
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-16
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-16
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-16
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-16
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-16
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-16
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-16
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	8e-16
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-16
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-15
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	4e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-14
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-14
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	6e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	8e-14
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-13
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-13
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-13
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-13
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	8e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-13
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-12
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-12
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-12
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-12
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	4e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-12
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-12
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-12
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-11
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-11
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-11
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	4e-11
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-11
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-11
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-10
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	5e-10
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	6e-09
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	1e-08
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	9e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-07
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-05
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	5e-05
cd05145	190	cd05145, RIO1_like, RIO kinase family; RIO1, RIO3	6e-05
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-04
cd05119	187	cd05119, RIO, RIO kinase family, catalytic domain	2e-04
COG0661	517	COG0661, AarF, Predicted unusual protein kinase [G	3e-04
cd05144	198	cd05144, RIO2_C, RIO kinase family; RIO2, C-termin	3e-04
COG3642	204	COG3642, COG3642, Mn2+-dependent serine/threonine	6e-04
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	6e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	0.001
COG1718	268	COG1718, RIO1, Serine/threonine protein kinase inv	0.003

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  440 bits (1135), Expect = e-157
 Identities = 159/266 (59%), Positives = 201/266 (75%), Gaps = 4/266 (1%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 129
            D++ +KV+G+GS G+V  V+HK TG+ +ALK I ++ +E  R+Q+ +ELK  +S + PY
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60

Query: 130 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 189
           VV CY +FY  G ISI+LEYMDGGSLAD LKKV  IPE  LA I  Q+LKGL YLH ++H
Sbjct: 61  VVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120

Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 249
           IIHRD+KPSNLLIN +GEVKI DFG+S ++ +T  Q NTFVGT  YMSPERI G  Y Y 
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180

Query: 250 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           +DIWSLGL LLECA G+FP+ PP Q     SF+ELM+AI D PPPS P+++FSPEF  FI
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQ----PSFFELMQAICDGPPPSLPAEEFSPEFRDFI 236

Query: 310 SACVQKEPQQRLSAQELMTHPFLKMY 335
           SAC+QK+P++R SA EL+ HPF+K  
Sbjct: 237 SACLQKDPKKRPSAAELLQHPFIKKA 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  387 bits (995), Expect = e-136
 Identities = 131/267 (49%), Positives = 182/267 (68%), Gaps = 5/267 (1%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 129
           +D++ +  +G G+ G+V  V H+ TG+  A+K I++ + E+ ++QI +EL I      PY
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 130 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEK 188
           +V  Y +FY+NG ISI +EYMDGGSL   LK+V   IPE  L  I   VLKGL YLH + 
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH 120

Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 248
            IIHRD+KPSN+L+N RG++K+ DFGVS  +   +  A TFVGT +YM+PERI G  Y  
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKTFVGTSSYMAPERIQGNDYSV 178

Query: 249 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 308
           KSDIWSLGL L+E ATG+FPY P    D     +EL++ IV++PPP  PS +FSP+F  F
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPE--NDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDF 236

Query: 309 ISACVQKEPQQRLSAQELMTHPFLKMY 335
           ++ C+ K+P++R S +EL+ HPF+K Y
Sbjct: 237 VNLCLIKDPRERPSYKELLEHPFIKKY 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score =  296 bits (760), Expect = 2e-99
 Identities = 125/305 (40%), Positives = 179/305 (58%), Gaps = 31/305 (10%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 129
           +D + +  +G G+GG+V  V H+ +G   A K+I + ++ + R QI +ELK+      PY
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 130 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 189
           +V  Y +FYS+G ISI +E+MDGGSL   LKK   IPE  L  I   VL+GL YL  +  
Sbjct: 61  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK 120

Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 249
           I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYTVQ 178

Query: 250 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSF---------------------------- 281
           SDIWSLGL L+E A G++P  PP+ ++    F                            
Sbjct: 179 SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA 238

Query: 282 -YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 340
            +EL++ IV++PPP  PS  FS EF  F+  C++K P++R   +EL  HPF+K      V
Sbjct: 239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEEV 298

Query: 341 DLSEY 345
           D + +
Sbjct: 299 DFAGW 303

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  280 bits (718), Expect = 7e-94
 Identities = 97/261 (37%), Positives = 146/261 (55%), Gaps = 9/261 (3%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV 132
           + ++ +G+GS G V L + K TG+  A+KVI+    +  R +I +E+KI +  + P +V 
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVR 61

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            Y  F     + +++EY +GG L D LKK   + E+       Q+L  L YL H K I+H
Sbjct: 62  LYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYL-HSKGIVH 120

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           RDLKP N+L++  G VK+ DFG++  +     +  TFVGT  YM+PE + G  YG   DI
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV-DQPPPSAPSDQFSPEFCSFISA 311
           WSLG++L E  TG+ P+   +Q        EL + I   +PP   P    SPE    I  
Sbjct: 180 WSLGVILYELLTGKPPFPGDDQLL------ELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233

Query: 312 CVQKEPQQRLSAQELMTHPFL 332
            + K+P++RL+A+E + HPF 
Sbjct: 234 LLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  275 bits (705), Expect = 2e-91
 Identities = 120/284 (42%), Positives = 174/284 (61%), Gaps = 7/284 (2%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 126
           L  ED++TI  +G G+GG V  V+H  TG   A KV+ +  + S R+QI +EL+I    +
Sbjct: 2   LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR 61

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 186
            PY+V  Y +F +   I + +E+MD GSL    KK   IP E L  I   V++GL YL++
Sbjct: 62  SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYN 121

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 246
              I+HRD+KPSN+L+N RG++K+ DFGVS  + ++   A+TFVGT  YMSPERI GGKY
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFVGTSTYMSPERIQGGKY 179

Query: 247 GYKSDIWSLGLVLLECATGQFPYSPPEQ----QDGWTSFYELMEAIVDQPPPSAPSDQFS 302
             KSD+WSLG+ ++E A G+FP++        QD      +L++ IV +PPP  PS  F 
Sbjct: 180 TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP 239

Query: 303 PEFCSFISACVQKEPQQRLSAQELM-THPFLKMYGDLNVDLSEY 345
            +   F+ AC+ K+P +R + Q+L    PF++     NVDL  +
Sbjct: 240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDLQAW 283

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  270 bits (691), Expect = 2e-88
 Identities = 128/288 (44%), Positives = 174/288 (60%), Gaps = 15/288 (5%)

Query: 50  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE 109
           S + + +           +L +++ +  +G G+GG V  V H+ TG+ +ALKVI  N E+
Sbjct: 54  SSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHED 113

Query: 110 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY 169
           + RRQI +E++I +    P VV C+  F  NG I ++LE+MDGGS    L+      E++
Sbjct: 114 TVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS----LEGTHIADEQF 169

Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 229
           LA +  Q+L G+ YL H +HI+HRD+KPSNLLIN    VKI DFGVS I+A T    N+ 
Sbjct: 170 LADVARQILSGIAYL-HRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228

Query: 230 VGTYNYMSPERISG----GKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 284
           VGT  YMSPERI+     G Y GY  DIWSLG+ +LE   G+FP+    Q D W S   L
Sbjct: 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WAS---L 284

Query: 285 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           M AI    PP AP+   S EF  FIS C+Q+EP +R SA +L+ HPF+
Sbjct: 285 MCAICMSQPPEAPATA-SREFRHFISCCLQREPAKRWSAMQLLQHPFI 331

Length = 353

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  262 bits (673), Expect = 4e-87
 Identities = 101/261 (38%), Positives = 158/261 (60%), Gaps = 12/261 (4%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV 132
           + ++ +GKG  G V   +HK TG+  A+KVI++  +E  + +I  E++I +  + P +V 
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK-KEKIINEIQILKKCKHPNIVK 61

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
            Y S+     + I++E+  GGSL D LK   +T+ E  +A +C+++LKGL YLH    II
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH-SNGII 120

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           HRD+K +N+L+   GEVK+ DFG+SA ++ T    NT VGT  +M+PE I+G  Y YK+D
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLSDT-KARNTMVGTPYWMAPEVINGKPYDYKAD 179

Query: 252 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD-QFSPEFCSFIS 310
           IWSLG+  +E A G+ PYS            + +  I    PP   +  ++S EF  F+ 
Sbjct: 180 IWSLGITAIELAEGKPPYSELP-------PMKALFKIATNGPPGLRNPEKWSDEFKDFLK 232

Query: 311 ACVQKEPQQRLSAQELMTHPF 331
            C+QK P++R +A++L+ HPF
Sbjct: 233 KCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  254 bits (651), Expect = 1e-83
 Identities = 87/261 (33%), Positives = 141/261 (54%), Gaps = 5/261 (1%)

Query: 74  TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVV 132
            ++ +G GS G V   +HK TG+  A+K+++  + +    +   +E++I +    P +V 
Sbjct: 3   LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
              +F     + +++EY +GG L D+L +   + E+    I  Q+L+GL YLH    IIH
Sbjct: 63  LIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLH-SNGIIH 121

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSD 251
           RDLKP N+L++  G VKI DFG++  +  +S    TFVGT  YM+PE + GG  YG K D
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVD 181

Query: 252 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 311
           +WSLG++L E  TG+ P+S     D       ++   +            S E    I  
Sbjct: 182 VWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL--EFDEPKWSSGSEEAKDLIKK 239

Query: 312 CVQKEPQQRLSAQELMTHPFL 332
           C+ K+P +R +A+E++ HP+ 
Sbjct: 240 CLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score =  244 bits (624), Expect = 2e-79
 Identities = 118/273 (43%), Positives = 172/273 (63%), Gaps = 7/273 (2%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 129
           +DI   +++G G+GG V    H  T +  A+KVI +++    ++QI  EL+I      PY
Sbjct: 1   QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPY 60

Query: 130 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 189
           ++  Y +F+    ISI  E+MDGGSL D  +K   IPE  L  I   V+KGL YL   K 
Sbjct: 61  IIGFYGAFFVENRISICTEFMDGGSL-DVYRK---IPEHVLGRIAVAVVKGLTYLWSLK- 115

Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 249
           I+HRD+KPSN+L+N RG+VK+ DFGVS  + ++   A T+VGT  YM+PERISG +YG  
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYVGTNAYMAPERISGEQYGIH 173

Query: 250 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           SD+WSLG+  +E A G+FPY   ++  G     +L++ IVD+ PP  P  QFS +F  FI
Sbjct: 174 SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI 233

Query: 310 SACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
           + C++K+P++R + + LM HPF+  Y D N ++
Sbjct: 234 TQCMRKQPKERPAPENLMDHPFIVQYNDGNAEV 266

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  239 bits (613), Expect = 4e-78
 Identities = 106/268 (39%), Positives = 157/268 (58%), Gaps = 19/268 (7%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 129
           E  D ++ +G+GS G V    HK TGQ  A+KV+ +  +     +I +E+ I +    PY
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ---EIIKEISILKQCDSPY 59

Query: 130 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEK 188
           +V  Y S++ N  + I++EY   GS++D +K   KT+ EE +AAI  Q LKGL YLH   
Sbjct: 60  IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH-SN 118

Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 248
             IHRD+K  N+L+N  G+ K+ DFGVS  +  T  + NT +GT  +M+PE I    Y  
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178

Query: 249 KSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFSPE 304
           K+DIWSLG+  +E A G+ PYS   P +          +  I ++PPP  S P  ++SPE
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRA---------IFMIPNKPPPTLSDPE-KWSPE 228

Query: 305 FCSFISACVQKEPQQRLSAQELMTHPFL 332
           F  F+  C+ K+P++R SA +L+ HPF+
Sbjct: 229 FNDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  240 bits (614), Expect = 8e-78
 Identities = 118/287 (41%), Positives = 171/287 (59%), Gaps = 16/287 (5%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 129
           E I  +  +G+G+GG V   + K TG  FALK I  +     ++QI +EL+IN+S + PY
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 130 VVVCYQSFYSN--GAISIILEYMDGGSLADFLKKVKT----IPEEYLAAICEQVLKGLLY 183
           +V  Y +F      +I I +EY +GGSL    KKVK     I E+ L  I E VLKGL Y
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
           LH  + IIHRD+KPSN+L+  +G+VK+ DFGVS  + ++   A TF GT  YM+PERI G
Sbjct: 121 LH-SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS--LAGTFTGTSFYMAPERIQG 177

Query: 244 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD---- 299
             Y   SD+WSLGL LLE A  +FP+ PPE +       EL+  IV+ P P    +    
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNRFPF-PPEGEPPLGPI-ELLSYIVNMPNPELKDEPGNG 235

Query: 300 -QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEY 345
            ++S EF  FI  C++K+P +R +  +++ HP++K      V+++++
Sbjct: 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAKF 282

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  238 bits (611), Expect = 1e-77
 Identities = 92/263 (34%), Positives = 142/263 (53%), Gaps = 14/263 (5%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVCY 134
           +++G+GS G V L   K TG+  A+K +++    E     + +E++I  S Q P +V  Y
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 135 QSFYSNGA--ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            S        ++I LEY+ GGSL+  LKK   +PE  +     Q+L+GL YLH    I+H
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLH-SNGIVH 124

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMAS--TSGQANTFVGTYNYMSPERISGGKYGYKS 250
           RD+K +N+L++  G VK+ DFG +  +    T     +  GT  +M+PE I G +YG  +
Sbjct: 125 RDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAA 184

Query: 251 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV-DQPPPSAPSDQFSPEFCSFI 309
           DIWSLG  ++E ATG+ P+S              +  I     PP  P    S E   F+
Sbjct: 185 DIWSLGCTVIEMATGKPPWSELGNP------MAALYKIGSSGEPPEIPEH-LSEEAKDFL 237

Query: 310 SACVQKEPQQRLSAQELMTHPFL 332
             C++++P++R +A EL+ HPFL
Sbjct: 238 RKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  235 bits (603), Expect = 3e-76
 Identities = 107/263 (40%), Positives = 147/263 (55%), Gaps = 19/263 (7%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVVC 133
           + +GKGS G V     K T Q  A+KVI  ++EE+      I QE++     + PY+   
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRSPYITKY 64

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR 193
           Y SF     + II+EY  GGS  D LK  K + E Y+A I  +VL GL YLH E  I HR
Sbjct: 65  YGSFLKGSKLWIIMEYCGGGSCLDLLKPGK-LDETYIAFILREVLLGLEYLHEEGKI-HR 122

Query: 194 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIW 253
           D+K +N+L++  G+VK+ DFGVS  + ST  + NTFVGT  +M+PE I    Y  K+DIW
Sbjct: 123 DIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIW 182

Query: 254 SLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA---IVDQPPPSAPSDQFSPEFCSFIS 310
           SLG+  +E A G+ P S              M     I    PPS   ++FS  F  F+S
Sbjct: 183 SLGITAIELAKGEPPLSD----------LHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVS 232

Query: 311 ACVQKEPQQRLSAQELMTHPFLK 333
            C+ K+P++R SA+EL+ H F+K
Sbjct: 233 LCLNKDPKERPSAKELLKHKFIK 255

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score =  238 bits (607), Expect = 3e-76
 Identities = 122/307 (39%), Positives = 179/307 (58%), Gaps = 41/307 (13%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 125
           +L  +D + I  +G G+GG+V  VQHK +G   A K+I + ++ + R QI +EL++    
Sbjct: 1   ELKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
             PY+V  Y +FYS+G ISI +E+MDGGSL   LK+ K IPEE L  +   VL+GL YL 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 120

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 178

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF------------------------ 281
           Y  +SDIWS+GL L+E A G++P  PP+ ++    F                        
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGR 238

Query: 282 ---------------YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
                          +EL++ IV++PPP  P+  F+P+F  F++ C+ K P +R   + L
Sbjct: 239 PVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML 298

Query: 327 MTHPFLK 333
           M H F+K
Sbjct: 299 MNHTFIK 305

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score =  235 bits (601), Expect = 7e-76
 Identities = 113/289 (39%), Positives = 175/289 (60%), Gaps = 16/289 (5%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 129
           ++I+ +  +GKG+ G V  V H+ TG   A+K I++ ++ES   QI  EL I   +  PY
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPY 60

Query: 130 VVVCYQSFYSNGAISIILEYMDGGS---LADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 186
           +V  Y +F+  GA+ + +EYMD GS   L       + IPE+ L  I   V+KGL +L  
Sbjct: 61  IVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-- 244
           E +IIHRD+KP+N+L+N  G+VK+ DFGVS  + ++  + N  +G  +YM+PERI  G  
Sbjct: 121 EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIKSGGP 178

Query: 245 ----KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
                Y  +SD+WSLGL +LE A G++PY PPE    + + +  + AIVD  PP+ PS  
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPY-PPET---YANIFAQLSAIVDGDPPTLPSG- 233

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA 349
           +S +   F++ C+ K P +R +  +L+ HP+L  Y + +VD++E+ T A
Sbjct: 234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWVTGA 282

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score =  236 bits (603), Expect = 1e-75
 Identities = 123/318 (38%), Positives = 180/318 (56%), Gaps = 39/318 (12%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 125
           +L  +D + I  +G G+GG+V  V HK +G   A K+I + ++ + R QI +EL++    
Sbjct: 1   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
             PY+V  Y +FYS+G ISI +E+MDGGSL   LKK   IPE+ L  +   V+KGL YL 
Sbjct: 61  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 178

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF------------------------ 281
           Y  +SDIWS+GL L+E A G++P  PP+ ++    F                        
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPL 238

Query: 282 -------------YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
                        +EL++ IV++PPP  PS  F  EF  F++ C+ K P +R   ++LM 
Sbjct: 239 SSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298

Query: 329 HPFLKMYGDLNVDLSEYF 346
           H F+K      VD + + 
Sbjct: 299 HAFIKRSEAEEVDFAGWL 316

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  231 bits (592), Expect = 2e-74
 Identities = 99/277 (35%), Positives = 157/277 (56%), Gaps = 22/277 (7%)

Query: 62  PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI 121
           P +   NLE I      G+G+ G V     + TG+  A+K  +M + +  +  I  E+ I
Sbjct: 17  PRELYKNLEKI------GEGASGEVYKATDRATGKEVAIK--KMRLRKQNKELIINEILI 68

Query: 122 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKG 180
            +  + P +V  Y S+     + +++EYMDGGSL D + +    + E  +A +C +VL+G
Sbjct: 69  MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQG 128

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L YLH  +++IHRD+K  N+L++  G VK+ DFG +A +     + N+ VGT  +M+PE 
Sbjct: 129 LEYLH-SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEV 187

Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGWTSFYELMEAIVDQ-PPPSAP 297
           I    YG K DIWSLG++ +E A G+ PY   PP +          +  I  +  PP   
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR---------ALFLITTKGIPPLKN 238

Query: 298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 334
            +++SPEF  F++ C+ K+P++R SA+EL+ HPFLK 
Sbjct: 239 PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  230 bits (590), Expect = 2e-74
 Identities = 102/263 (38%), Positives = 148/263 (56%), Gaps = 14/263 (5%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVC 133
           IK +GKGS G V LV+ K  G+ + LK I + N+ E  R     E+KI +    P ++  
Sbjct: 5   IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKH 189
           Y+SF   G + I++EY DGG L+  +KK     K  PEE +     Q+   L YLH  + 
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH-SRK 123

Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 249
           I+HRD+KP N+ +   G VK+ DFG+S +++ST   A T VGT  Y+SPE      Y YK
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYK 183

Query: 250 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           SDIWSLG VL E  T + P+      +G  +  EL   I+    P  PS Q+S E  + +
Sbjct: 184 SDIWSLGCVLYELCTLKHPF------EG-ENLLELALKILKGQYPPIPS-QYSSELRNLV 235

Query: 310 SACVQKEPQQRLSAQELMTHPFL 332
           S+ +QK+P++R S  +++  PF+
Sbjct: 236 SSLLQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score =  223 bits (570), Expect = 3e-71
 Identities = 107/286 (37%), Positives = 173/286 (60%), Gaps = 19/286 (6%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCP 128
           +D++ I+ +G+G+ G+V  ++H  TG   A+K I+  V    ++++  +L I+ +S  CP
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYL 184
           Y V  Y + +  G + I +E MD  SL  F KKV     TIPE+ L  I   ++K L YL
Sbjct: 61  YTVTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119

Query: 185 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF-VGTYNYMSPERISG 243
           H +  +IHRD+KPSN+LIN  G+VK+ DFG+S  +      A T   G   YM+PERI+ 
Sbjct: 120 HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTIDAGCKPYMAPERINP 177

Query: 244 GK----YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD 299
                 Y  KSD+WSLG+ ++E ATG+FPY      D W + ++ ++ +V++P P  P++
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGRFPY------DSWKTPFQQLKQVVEEPSPQLPAE 231

Query: 300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEY 345
           +FSPEF  F++ C++K  ++R +  EL+ HPF +++   N D++ +
Sbjct: 232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVASF 277

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  212 bits (541), Expect = 1e-67
 Identities = 86/256 (33%), Positives = 130/256 (50%), Gaps = 44/256 (17%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF 137
           +G+G  G V L + K TG+  A+K+I+     S   ++ +E++I +    P +V  Y  F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 138 YSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 196
                + +++EY +GGSL D LK+    + E+ +  I  Q+L+GL YL H   IIHRDLK
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYL-HSNGIIHRDLK 119

Query: 197 PSNLLINHR-GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWS 254
           P N+L++   G+VK+ DFG+S ++ S      T VGT  YM+PE + G G Y  KSDIWS
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179

Query: 255 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 314
           LG++L E                                         PE    I   +Q
Sbjct: 180 LGVILYEL----------------------------------------PELKDLIRKMLQ 199

Query: 315 KEPQQRLSAQELMTHP 330
           K+P++R SA+E++ H 
Sbjct: 200 KDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  208 bits (531), Expect = 1e-65
 Identities = 93/263 (35%), Positives = 138/263 (52%), Gaps = 23/263 (8%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQ 135
           +GKGS G V LV+ K TG+ +A+KV+  +  ++         E  I      P++V  + 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 136 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLKGLLYLHHEKHII 191
           +F +   + ++LEY  GG L   L K     EE    Y A I       L YLH    II
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVL----ALEYLH-SLGII 115

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           +RDLKP N+L++  G +K+TDFG++  ++S   + NTF GT  Y++PE + G  YG   D
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVD 175

Query: 252 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 311
            WSLG++L E  TG+ P+   +++       E+ E I+   P   P    SPE    IS 
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDRK-------EIYEKILKD-PLRFPEF-LSPEARDLISG 226

Query: 312 CVQKEPQQRL---SAQELMTHPF 331
            +QK+P +RL    A+E+  HPF
Sbjct: 227 LLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  206 bits (527), Expect = 1e-64
 Identities = 109/292 (37%), Positives = 168/292 (57%), Gaps = 25/292 (8%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQSSQ 126
           L D++ +  +G G+ G V  ++ K TG   A+K ++   N EE+ R  I  +L +   S 
Sbjct: 14  LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKR--ILMDLDVVLKSH 71

Query: 127 -CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLY 183
            CPY+V CY  F ++  + I +E M   +  D L K     IPE+ L  +   ++K L Y
Sbjct: 72  DCPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHY 129

Query: 184 LHHEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERI 241
           L  EKH +IHRD+KPSN+L++  G VK+ DFG+S  +     +A T   G   YM+PERI
Sbjct: 130 LK-EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRSAGCAAYMAPERI 186

Query: 242 ----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 297
                  KY  ++D+WSLG+ L+E ATGQFPY          + +E++  I+ + PPS P
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFPY------KNCKTEFEVLTKILQEEPPSLP 240

Query: 298 SDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 348
            ++ FSP+FCSF+  C+ K+ ++R   +EL+ HPF++ Y    VD++ +F D
Sbjct: 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDVAGWFQD 292

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score =  205 bits (524), Expect = 3e-64
 Identities = 108/294 (36%), Positives = 163/294 (55%), Gaps = 23/294 (7%)

Query: 68  NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK-INQSSQ 126
           +L+D+  I   G+G+ G V  + HK +G   A+K I+  V+E  ++++  +L  + +SS 
Sbjct: 5   DLKDLGEI---GRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSD 61

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-----KTIPEEYLAAICEQVLKGL 181
           CPY+V  Y + +  G   I +E MD  SL  F K V       IPEE L  I    +K L
Sbjct: 62  CPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKAL 120

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 241
            YL  E  IIHRD+KPSN+L++  G +K+ DFG+S  +  +  +     G   YM+PERI
Sbjct: 121 NYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERI 179

Query: 242 -SGGKYGY--KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 298
               + GY  +SD+WSLG+ L E ATG+FPY        W S ++ +  +V   PP   +
Sbjct: 180 DPSARDGYDVRSDVWSLGITLYEVATGKFPY------PKWNSVFDQLTQVVKGDPPILSN 233

Query: 299 D---QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA 349
               +FSP F +FI+ C+ K+  +R   +EL+ HPF+K Y + NVD++ Y    
Sbjct: 234 SEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVAAYVQRI 287

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  197 bits (503), Expect = 2e-61
 Identities = 91/262 (34%), Positives = 139/262 (53%), Gaps = 20/262 (7%)

Query: 77  VVGKGSGGIVQLVQHKWTGQFFALK-VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ 135
           ++G+G+ G+V    +  TG F A+K +    ++E A + I QE+ + ++ + P +V    
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 136 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 195
           S  ++ ++ IILEY + GSL   +KK    PE  +A    QVL+GL YLH +  +IHRD+
Sbjct: 67  SIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG-VIHRDI 125

Query: 196 KPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSL 255
           K +N+L    G VK+ DFGV+  +   S    + VGT  +M+PE I        SDIWSL
Sbjct: 126 KAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSL 185

Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYEL-----MEAIVDQPPPSAPSDQFSPEFCSFIS 310
           G  ++E  TG  PY            Y+L     +  IV    P  P    SPE   F+ 
Sbjct: 186 GCTVIELLTGNPPY------------YDLNPMAALFRIVQDDHPPLPEG-ISPELKDFLM 232

Query: 311 ACVQKEPQQRLSAQELMTHPFL 332
            C QK+P  R +A++L+ HP++
Sbjct: 233 QCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  195 bits (498), Expect = 1e-60
 Identities = 92/275 (33%), Positives = 146/275 (53%), Gaps = 26/275 (9%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
            ED + I+ +G G+ G V   +   TG+  A+KVI++         I QE+ + +  + P
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKL-EPGDDFEIIQQEISMLKECRHP 60

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHE 187
            +V  + S+     + I++EY  GGSL D  +  +  + E  +A +C + LKGL YLH E
Sbjct: 61  NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH-E 119

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI---SGG 244
              IHRD+K +N+L+   G+VK+ DFGVSA + +T  +  +F+GT  +M+PE       G
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKG 179

Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--MEAI------VDQPPPSA 296
            Y  K DIW+LG+  +E A  Q P             ++L  M A+         PP   
Sbjct: 180 GYDGKCDIWALGITAIELAELQPPM------------FDLHPMRALFLISKSNFPPPKLK 227

Query: 297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
             +++SP F  FI  C+ K+P++R +A +L+ HPF
Sbjct: 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  193 bits (492), Expect = 1e-59
 Identities = 96/270 (35%), Positives = 155/270 (57%), Gaps = 13/270 (4%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS---SQCPYVV 131
           ++++G+G+ G V   +H  TG+  ALK+I ++  +     I +E+ +      SQ P + 
Sbjct: 6   LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
             Y S+     + II+EY +GGS+   L K   I E+Y++ I  +VL  L Y+H    +I
Sbjct: 66  KYYGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHKVG-VI 123

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKS 250
           HRD+K +N+L+ + G VK+ DFGV+A++   S + +TFVGT  +M+PE I+ GK Y  K+
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKA 183

Query: 251 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 310
           DIWSLG+ + E ATG  PYS  +        +  M  I    PP    + +S     F++
Sbjct: 184 DIWSLGITIYEMATGNPPYSDVDA-------FRAMMLIPKSKPPRLEDNGYSKLLREFVA 236

Query: 311 ACVQKEPQQRLSAQELMTHPFLKMYGDLNV 340
           AC+ +EP++RLSA+EL+   ++K +    V
Sbjct: 237 ACLDEEPKERLSAEELLKSKWIKAHSKTPV 266

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  191 bits (487), Expect = 7e-59
 Identities = 99/280 (35%), Positives = 152/280 (54%), Gaps = 37/280 (13%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS-SQCPYVVVC 133
           ++V+G+G+ G V   +HK TGQ  A+K+  M++ E    +I +E  I +  S  P +   
Sbjct: 11  VEVIGEGTYGKVYKARHKKTGQLVAIKI--MDIIEDEEEEIKEEYNILRKYSNHPNIATF 68

Query: 134 YQSFYSNGA------ISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLY 183
           Y +F           + +++E   GGS+ D +K +    K + EE++A I  + L+GL Y
Sbjct: 69  YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
           LH E  +IHRD+K  N+L+    EVK+ DFGVSA + ST G+ NTF+GT  +M+PE I+ 
Sbjct: 129 LH-ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIAC 187

Query: 244 GK-----YGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA---IVDQPP 293
            +     Y  +SD+WSLG+  +E A G+ P     P            M A   I   PP
Sbjct: 188 DEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP------------MRALFKIPRNPP 235

Query: 294 PS-APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           P+    + +S +F  FIS C+ K  +QR   +EL+ HPF+
Sbjct: 236 PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  187 bits (477), Expect = 3e-57
 Identities = 93/272 (34%), Positives = 151/272 (55%), Gaps = 17/272 (6%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCP 128
             +D    +G+GS GIV +   K TG+  A+K  +M++ +  RR++   E+ I +  Q P
Sbjct: 19  SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVK--KMDLRKQQRRELLFNEVVIMRDYQHP 76

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            +V  Y S+     + +++E+++GG+L D +   + + EE +A +C  VLK L +LH + 
Sbjct: 77  NIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALSFLHAQG 135

Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 248
            +IHRD+K  ++L+   G VK++DFG  A ++    +  + VGT  +M+PE IS   YG 
Sbjct: 136 -VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGT 194

Query: 249 KSDIWSLGLVLLECATGQFPY--SPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEF 305
           + DIWSLG++++E   G+ PY   PP Q          M+ I D  PP      + SP  
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNEPPLQA---------MKRIRDNLPPKLKNLHKVSPRL 245

Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
            SF+   + ++P QR +A EL+ HPFL   G 
Sbjct: 246 RSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  186 bits (474), Expect = 8e-57
 Identities = 92/267 (34%), Positives = 147/267 (55%), Gaps = 18/267 (6%)

Query: 79  GKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY 138
           G G+ G V   QHK TG F A K+IQ+  EE     +  E+ I    + P +V  Y++++
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV-EIDILSECKHPNIVGLYEAYF 72

Query: 139 SNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
               + I++E+ DGG+L   + ++ + + E  +  +C Q+L+ L +LH    +IHRDLK 
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH-SHKVIHRDLKA 131

Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSDI 252
            N+L+   G+VK+ DFGVSA   ST  + +TF+GT  +M+PE +         Y YK+DI
Sbjct: 132 GNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADI 191

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFSPEFCSFIS 310
           WSLG+ L+E A  + P+          +   ++  I+   PP    PS ++S  F  F+ 
Sbjct: 192 WSLGITLIELAQMEPPHHE-------LNPMRVLLKILKSEPPTLDQPS-KWSSSFNDFLK 243

Query: 311 ACVQKEPQQRLSAQELMTHPFLKMYGD 337
           +C+ K+P  R +A EL+ HPF+    D
Sbjct: 244 SCLVKDPDDRPTAAELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  183 bits (466), Expect = 7e-56
 Identities = 93/276 (33%), Positives = 145/276 (52%), Gaps = 24/276 (8%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 129
           +D + I+V+G G+  +V         +  A+K I +   +++  ++ +E++       P 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60

Query: 130 VVVCYQSFYSNGAISIILEYMDGGSLADFLK---KVKTIPEEYLAAICEQVLKGLLYLHH 186
           VV  Y SF     + +++ Y+ GGSL D +K       + E  +A + ++VLKGL YLH 
Sbjct: 61  VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA----STSGQANTFVGTYNYMSPERIS 242
              I HRD+K  N+L+   G VKI DFGVSA +A     T     TFVGT  +M+PE + 
Sbjct: 121 NGQI-HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179

Query: 243 GGK-YGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSD 299
               Y +K+DIWS G+  +E ATG  PYS  PP          +++   +   PPS  + 
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPP---------MKVLMLTLQNDPPSLETG 230

Query: 300 ----QFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
               ++S  F   IS C+QK+P +R +A+EL+ H F
Sbjct: 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  178 bits (453), Expect = 6e-54
 Identities = 88/264 (33%), Positives = 148/264 (56%), Gaps = 16/264 (6%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-SARRQIAQELKINQSSQCPYVVVCYQS 136
           +G G+ G V    +  TG+  A+K I++   +    ++IA E+K+ +  + P +V  Y  
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 137 FYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 196
                 + I +EY  GG+L + L+  + + E  +     Q+L+GL YLH    I+HRD+K
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH-SHGIVHRDIK 126

Query: 197 PSNLLINHRGEVKITDFGVSAIMASTS----GQANTFVGTYNYMSPERISGGK---YGYK 249
           P+N+ ++H G +K+ DFG +  + + +     +  +  GT  YM+PE I+GGK   +G  
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRA 186

Query: 250 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP-SDQFSPEFCSF 308
           +DIWSLG V+LE ATG+ P+S  E  + +    ++M  +     P  P S Q SPE   F
Sbjct: 187 ADIWSLGCVVLEMATGKRPWS--ELDNEF----QIMFHVGAGHKPPIPDSLQLSPEGKDF 240

Query: 309 ISACVQKEPQQRLSAQELMTHPFL 332
           +  C++ +P++R +A EL+ HPF+
Sbjct: 241 LDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  175 bits (446), Expect = 6e-53
 Identities = 88/275 (32%), Positives = 141/275 (51%), Gaps = 23/275 (8%)

Query: 71  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI---QMNVEESARRQIAQELKINQSSQC 127
           D + ++ +GKGS G V+ V+ K  G+    K I    M  +E  ++Q+  E+ I +  + 
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE--KQQLVSEVNILRELKH 58

Query: 128 PYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAICEQVLKGL 181
           P +V  Y      SN  + I++EY +GG LA  ++K K     I EE++  I  Q+L  L
Sbjct: 59  PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118

Query: 182 LYLHHEKH----IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 237
              H+       ++HRDLKP+N+ ++    VK+ DFG++ I+   S  A T+VGT  YMS
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178

Query: 238 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 297
           PE+++   Y  KSDIWSLG ++ E        SPP       +  +L   I +      P
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCAL----SPPFTA---RNQLQLASKIKEGKFRRIP 231

Query: 298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
             ++S E    I + +  +P +R S +EL+  P +
Sbjct: 232 Y-RYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  170 bits (431), Expect = 1e-50
 Identities = 97/260 (37%), Positives = 143/260 (55%), Gaps = 14/260 (5%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF 137
           +GKGS G V       T +  A+K+I +   E     I QE+ +      PY+   Y S+
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 138 YSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
                + II+EY+ GGS  D LK    + E Y+A I  ++LKGL YLH E+ I HRD+K 
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKI-HRDIKA 129

Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 257
           +N+L++ +G+VK+ DFGV+  +  T  + NTFVGT  +M+PE I    Y +K+DIWSLG+
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGI 189

Query: 258 VLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFSPEFCSFISACVQK 315
             +E A G+ P S              M  +   P  S P+   Q+S  F  F+ AC+ K
Sbjct: 190 TAIELAKGEPPNSD----------LHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNK 239

Query: 316 EPQQRLSAQELMTHPFLKMY 335
           +P+ R +A+EL+ H F+  Y
Sbjct: 240 DPRFRPTAKELLKHKFITRY 259

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  168 bits (428), Expect = 2e-50
 Identities = 91/262 (34%), Positives = 144/262 (54%), Gaps = 14/262 (5%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE----ESARRQIAQELKINQSSQCPYVV 131
           +++G GS G V    +   G FFA+K + +  +    + A +Q+ QE+ +    Q P +V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
               +      + I LE + GGSLA  LKK  + PE  +     Q+L GL YL H+++ +
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYL-HDRNTV 124

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SGGKYGYKS 250
           HRD+K +N+L++  G VK+ DFG++  +      A +F G+  +M+PE I   G YG  +
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQV-VEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183

Query: 251 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 310
           DIWSLG  +LE ATG+ P+S   Q +G  + +++  +    P P    D  S E   FI 
Sbjct: 184 DIWSLGCTVLEMATGKPPWS---QLEGVAAVFKIGRSKELPPIP----DHLSDEAKDFIL 236

Query: 311 ACVQKEPQQRLSAQELMTHPFL 332
            C+Q++P  R +A EL+ HPF+
Sbjct: 237 KCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  167 bits (425), Expect = 8e-50
 Identities = 84/263 (31%), Positives = 132/263 (50%), Gaps = 14/263 (5%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVV 132
           ++V+GKG+ G V +VQ + T + FA+K +  Q  VE+ + R +  E +I Q    P++V 
Sbjct: 5   LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAA-ICEQVLKGLLYLHHEKHII 191
            + SF     + ++++ + GG L   L +     EE +   ICE VL  L YLH  K II
Sbjct: 65  LWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVL-ALEYLH-SKGII 122

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           HRD+KP N+L++ +G V ITDF + A   +      +  GT  YM+PE +    Y    D
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNI-ATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVD 181

Query: 252 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 311
            WSLG+   EC  G+ PY                +   D   P+     +S E    I+ 
Sbjct: 182 WWSLGVTAYECLRGKRPY--RGHSRTIRDQIRAKQETADVLYPAT----WSTEAIDAINK 235

Query: 312 CVQKEPQQRLS--AQELMTHPFL 332
            ++++PQ+RL    ++L  HP+ 
Sbjct: 236 LLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  166 bits (423), Expect = 3e-49
 Identities = 81/300 (27%), Positives = 134/300 (44%), Gaps = 59/300 (19%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQ------ 123
           +D    K++G+GS   V L + K T + +A+K++        +RQ+ +E K+        
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILD-------KRQLIKEKKVKYVKIEKE 53

Query: 124 ----SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
                +  P ++  Y +F     +  +LEY   G L  +++K  ++ E+       ++L 
Sbjct: 54  VLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILL 113

Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS---------------- 223
            L YLH  K IIHRDLKP N+L++    +KITDFG + ++   S                
Sbjct: 114 ALEYLH-SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 224 ----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT 279
                +  +FVGT  Y+SPE ++    G  SD+W+LG ++ +  TG+ P+    +     
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----- 227

Query: 280 SFYELMEAIV----DQPPPSAPSDQFSPEFCSFISACVQKEPQQRL----SAQELMTHPF 331
             Y   + I+      PP       F P+    I   +  +PQ RL       EL  HPF
Sbjct: 228 --YLTFQKILKLEYSFPP------NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  164 bits (417), Expect = 1e-48
 Identities = 75/261 (28%), Positives = 123/261 (47%), Gaps = 14/261 (5%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQ 135
           +G G  G V+LV+ K   + FALK ++    VE   +  I  E +I +    P++V  Y+
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 136 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 195
           +F     I +++EY  GG L   L+      E         V+    YLH+ + II+RDL
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDL 119

Query: 196 KPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSL 255
           KP NLL++  G VK+ DFG +  + S   +  TF GT  Y++PE I    Y +  D WSL
Sbjct: 120 KPENLLLDSNGYVKLVDFGFAKKLKS-GQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSL 178

Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 315
           G++L E  TG+ P+   ++        E+   I+         +         I   +++
Sbjct: 179 GILLYELLTGRPPFGEDDEDP-----MEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR 233

Query: 316 EPQQRL-----SAQELMTHPF 331
            P++RL       +++  H +
Sbjct: 234 NPEERLGNLKGGIKDIKKHKW 254

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  162 bits (412), Expect = 7e-48
 Identities = 88/276 (31%), Positives = 133/276 (48%), Gaps = 33/276 (11%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVI------QMNVEESARRQIAQELKINQSSQCPYVV 131
           + KG+ G V L + K TG  +A+KVI      + N  +    Q+  E  I   +Q PYVV
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVD----QVLTERDILSQAQSPYVV 56

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
             Y SF     + +++EY+ GG LA  L+ V ++ E+       +++  L YLH    II
Sbjct: 57  KLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNG-II 115

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAI--------MASTSGQANTFVGTYNYMSPERISG 243
           HRDLKP N+LI+  G +K+TDFG+S +        +     +    VGT +Y++PE I G
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175

Query: 244 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAPSDQF 301
             +    D WSLG +L E   G  P+     +       E+ + I+      P       
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-------EIFQNILNGKIEWPEDVEV-- 226

Query: 302 SPEFCSFISACVQKEPQQRL---SAQELMTHPFLKM 334
           S E    IS  +  +P++RL   S +E+  HPF K 
Sbjct: 227 SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  163 bits (413), Expect = 8e-48
 Identities = 95/276 (34%), Positives = 161/276 (58%), Gaps = 16/276 (5%)

Query: 59  LIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-Q 117
           ++   D +  LE+   IK+ G+GS GIV + + K +G+  A+K+  M++ +  RR++   
Sbjct: 13  VVDQGDPRSLLENY--IKI-GEGSTGIVCIAREKHSGRQVAVKM--MDLRKQQRRELLFN 67

Query: 118 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 177
           E+ I +  Q   VV  Y+S+     + +++E++ GG+L D + + + + EE +A +CE V
Sbjct: 68  EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESV 126

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 237
           L+ L YLH +  +IHRD+K  ++L+   G VK++DFG  A ++    +  + VGT  +M+
Sbjct: 127 LQALCYLHSQG-VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 185

Query: 238 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 297
           PE IS   YG + DIWSLG++++E   G+ PY          S  + M+ + D PPP   
Sbjct: 186 PEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFS-------DSPVQAMKRLRDSPPPKLK 238

Query: 298 -SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
            + + SP    F+   + +EPQ+R +AQEL+ HPFL
Sbjct: 239 NAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score =  162 bits (410), Expect = 2e-47
 Identities = 96/277 (34%), Positives = 148/277 (53%), Gaps = 30/277 (10%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK-INQSSQCPYVV 131
           + ++VVG G+ G V   +H  TGQ  A+KV  M+V E    +I  E+  + + S    + 
Sbjct: 19  ELVEVVGNGTYGQVYKGRHVKTGQLAAIKV--MDVTEDEEEEIKLEINMLKKYSHHRNIA 76

Query: 132 VCYQSFYS------NGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLY 183
             Y +F        +  + +++E+   GS+ D +K  K   + E+++A IC ++L+GL +
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAH 136

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS- 242
           LH    +IHRD+K  N+L+    EVK+ DFGVSA +  T G+ NTF+GT  +M+PE I+ 
Sbjct: 137 LH-AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 195

Query: 243 ----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA---IVDQPPPS 295
                  Y Y+SDIWSLG+  +E A G    +PP            M A   I   PPP 
Sbjct: 196 DENPDATYDYRSDIWSLGITAIEMAEG----APP------LCDMHPMRALFLIPRNPPPK 245

Query: 296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
             S ++S +F  FI  C+ K    R S ++L+ HPF+
Sbjct: 246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  162 bits (411), Expect = 1e-46
 Identities = 93/309 (30%), Positives = 147/309 (47%), Gaps = 30/309 (9%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQS-SQCPYVV 131
           ++ +G+GS G V L + +   +  ALKV+  ++  +     +  +E++I  S +  P +V
Sbjct: 5   LRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKK---VKTIPEEYLAAICEQVLKGLLYLHHEK 188
             Y  F   G++ +++EY+DGGSL D LKK      + E     I  Q+L  L YLH  K
Sbjct: 62  KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH-SK 120

Query: 189 HIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSG------QANTFVGTYNYMSPERI 241
            IIHRD+KP N+L++  G  VK+ DFG++ ++             +T VGT  YM+PE +
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180

Query: 242 SG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 298
            G         SDIWSLG+ L E  TG  P+         ++  + ++ I++ P PS  S
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE---KNSSATSQTLKIILELPTPSLAS 237

Query: 299 D-------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGS 351
                     S      +   + K+P+ RLS+   ++H  L        DLS+      S
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDS 297

Query: 352 PLATLSNLS 360
               LS   
Sbjct: 298 APLRLSLPP 306

Length = 384

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  159 bits (404), Expect = 1e-46
 Identities = 86/261 (32%), Positives = 131/261 (50%), Gaps = 12/261 (4%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQSSQ 126
           L +    K +GKG   +V        G+  ALK +Q+   ++  AR+   +E+ + +   
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLL 182
            P V+    SF  N  ++I+LE  D G L+  +K  K     IPE  +     Q+   L 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           ++H  K I+HRD+KP+N+ I   G VK+ D G+    +S +  A++ VGT  YMSPERI 
Sbjct: 121 HMH-SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
              Y +KSDIWSLG +L E A  Q P+      D   + Y L + I     P  P+D +S
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF----YGDK-MNLYSLCKKIEKCDYPPLPADHYS 234

Query: 303 PEFCSFISACVQKEPQQRLSA 323
            E    +S C+  +P++R   
Sbjct: 235 EELRDLVSRCINPDPEKRPDI 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  158 bits (400), Expect = 4e-46
 Identities = 96/255 (37%), Positives = 139/255 (54%), Gaps = 10/255 (3%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF 137
           +GKGS G V       T Q  A+K+I +   E     I QE+ +      PYV   Y S+
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 138 YSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
                + II+EY+ GGS  D L+      E  +A + +++LKGL YLH EK I HRD+K 
Sbjct: 72  LKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKI-HRDIKA 129

Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 257
           +N+L++ +G+VK+ DFGV+  +  T  + NTFVGT  +M+PE I    Y  K+DIWSLG+
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGI 189

Query: 258 VLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEP 317
             +E A G+ P S             ++  I    PP+   + FS  F  FI AC+ K+P
Sbjct: 190 TAIELAKGEPPNSDMHPM-------RVLFLIPKNNPPTLTGE-FSKPFKEFIDACLNKDP 241

Query: 318 QQRLSAQELMTHPFL 332
             R +A+EL+ H F+
Sbjct: 242 SFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  158 bits (401), Expect = 8e-46
 Identities = 90/278 (32%), Positives = 140/278 (50%), Gaps = 34/278 (12%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESAR-RQIAQ---ELKINQSS 125
           +D + IK +G GS G V LV+HK +G+++ALK+  ++  +  + +Q+     E +I QS 
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKI--LSKAKIVKLKQVEHVLNEKRILQSI 58

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLKGL 181
           + P++V  Y SF  +  + +++EY+ GG L   L+K    PE     Y A    QV+  L
Sbjct: 59  RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAA----QVVLAL 114

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 241
            YLH    I++RDLKP NLL++  G +KITDFG +  +    G+  T  GT  Y++PE I
Sbjct: 115 EYLHS-LDIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYTLCGTPEYLAPEII 170

Query: 242 SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL-MEAIVDQPPPSAPSDQ 300
               YG   D W+LG+++ E   G  P+            YE  +E  V  P        
Sbjct: 171 LSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ----IYEKILEGKVRFPSF------ 220

Query: 301 FSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 333
           FSP+    I   +Q +  +RL        ++  HP+  
Sbjct: 221 FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  157 bits (397), Expect = 9e-46
 Identities = 95/274 (34%), Positives = 149/274 (54%), Gaps = 24/274 (8%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK-INQSSQCPYVV 131
           + +++VG G+ G V   +H  TGQ  A+KV  M+V      +I QE+  + + S    + 
Sbjct: 9   ELVELVGNGTYGQVYKGRHVKTGQLAAIKV--MDVTGDEEEEIKQEINMLKKYSHHRNIA 66

Query: 132 VCYQSFYS------NGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLY 183
             Y +F        +  + +++E+   GS+ D +K  K  T+ EE++A IC ++L+GL +
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSH 126

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS- 242
           LH  K +IHRD+K  N+L+    EVK+ DFGVSA +  T G+ NTF+GT  +M+PE I+ 
Sbjct: 127 LHQHK-VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185

Query: 243 ----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 298
                  Y +KSD+WSLG+  +E A G  P                +  I   P P   S
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-------LFLIPRNPAPRLKS 238

Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
            ++S +F SFI +C+ K   QR + ++LM HPF+
Sbjct: 239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  156 bits (397), Expect = 1e-45
 Identities = 83/263 (31%), Positives = 131/263 (49%), Gaps = 16/263 (6%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVC 133
           I+V+GKG+ G   L +          K + +  + E  RR    E+ I    Q P ++  
Sbjct: 5   IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAY 64

Query: 134 YQSFYSNGAISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
           Y  F  +  + I +EY +GG+L D +  +K +   EE +     Q++  + Y+H +  I+
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH-KAGIL 123

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           HRD+K  N+ +   G +K+ DFG+S I+ S    A T VGT  YMSPE   G KY +KSD
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSD 183

Query: 252 IWSLGLVLLE--CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           IW+LG VL E       F  + P           L+  IV Q   +     +S E  S +
Sbjct: 184 IWALGCVLYELLTLKRTFDATNP---------LNLVVKIV-QGNYTPVVSVYSSELISLV 233

Query: 310 SACVQKEPQQRLSAQELMTHPFL 332
            + +Q++P++R +A E++  P L
Sbjct: 234 HSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  156 bits (395), Expect = 2e-45
 Identities = 88/269 (32%), Positives = 143/269 (53%), Gaps = 20/269 (7%)

Query: 71  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQC 127
           D + +  +GKGS G+V  V  K   + +A+K  Q+++ +  RR+  +   E ++      
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMK--QIDLSKMNRREREEAIDEARVLAKLDS 58

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH 185
            Y++  Y+SF   G ++I++EY + G L   LK    + +PE+ +     Q+L GL +LH
Sbjct: 59  SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
            +K I+HRD+K  NL ++    VKI D GV+ +++  +  ANT VGT  Y+SPE      
Sbjct: 119 SKK-ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP 177

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ--PPPSAPSDQFSP 303
           Y  KSD+W+LG+VL EC TG+ P+    Q         L+  I+    PP S     +S 
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDANNQG-------ALILKIIRGVFPPVSQM---YSQ 227

Query: 304 EFCSFISACVQKEPQQRLSAQELMTHPFL 332
           +    I  C+ K+ +QR    +L+ +P L
Sbjct: 228 QLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  155 bits (393), Expect = 4e-45
 Identities = 95/258 (36%), Positives = 142/258 (55%), Gaps = 10/258 (3%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 134
           ++ +GKGS G V       T +  A+K+I +   E     I QE+ +      PYV   Y
Sbjct: 9   LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 135 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 194
            S+  +  + II+EY+ GGS  D L+    + E  +A I  ++LKGL YLH EK I HRD
Sbjct: 69  GSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKI-HRD 126

Query: 195 LKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWS 254
           +K +N+L++  GEVK+ DFGV+  +  T  + NTFVGT  +M+PE I    Y  K+DIWS
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 186

Query: 255 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 314
           LG+  +E A G+ P+S            +++  I    PP+   + +S     F+ AC+ 
Sbjct: 187 LGITAIELAKGEPPHSELHPM-------KVLFLIPKNNPPTLEGN-YSKPLKEFVEACLN 238

Query: 315 KEPQQRLSAQELMTHPFL 332
           KEP  R +A+EL+ H F+
Sbjct: 239 KEPSFRPTAKELLKHKFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  155 bits (394), Expect = 5e-45
 Identities = 96/282 (34%), Positives = 158/282 (56%), Gaps = 20/282 (7%)

Query: 59  LIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-Q 117
           ++ P D +   E +D+   +G+GS GIV +   K TG+  A+K  +M++ +  RR++   
Sbjct: 14  VVSPGDPR---EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVK--KMDLRKQQRRELLFN 68

Query: 118 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 177
           E+ I +      VV  Y S+     + +++E+++GG+L D +   + + EE +A +C  V
Sbjct: 69  EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLSV 127

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 237
           L+ L YLH++  +IHRD+K  ++L+   G +K++DFG  A ++    +  + VGT  +M+
Sbjct: 128 LRALSYLHNQG-VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186

Query: 238 PERISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGWTSFYELMEAIVDQPPPS 295
           PE IS   YG + DIWSLG++++E   G+ PY   PP Q          M  I D  PP 
Sbjct: 187 PEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA---------MRRIRDNLPPR 237

Query: 296 AP-SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 336
              S + S     F+   + +EP QR +AQEL+ HPFLK+ G
Sbjct: 238 VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  153 bits (389), Expect = 2e-44
 Identities = 90/268 (33%), Positives = 139/268 (51%), Gaps = 25/268 (9%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARR----QIAQELKINQSSQCPYVV 131
           K++G+G+ G V L     TG+  A+K +  + +    +     +  E+++ ++ Q   +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
             Y     +  +SI +EYM GGS+ D LK    + E        Q+L+G+ YLH    I+
Sbjct: 68  QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLH-SNMIV 126

Query: 192 HRDLKPSNLLINHRGEVKITDFGVS----AIMASTSGQANTFVGTYNYMSPERISGGKYG 247
           HRD+K +N+L +  G VK+ DFG S     I +S +G   +  GT  +MSPE ISG  YG
Sbjct: 127 HRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM-KSVTGTPYWMSPEVISGEGYG 185

Query: 248 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA---IVDQPP-PSAPSDQFSP 303
            K+D+WS+G  ++E  T +    PP     W  F E M A   I  QP  P  PS   SP
Sbjct: 186 RKADVWSVGCTVVEMLTEK----PP-----WAEF-EAMAAIFKIATQPTNPQLPSH-VSP 234

Query: 304 EFCSFISACVQKEPQQRLSAQELMTHPF 331
           +  +F+     +  ++R SA+EL+ H F
Sbjct: 235 DARNFLRRTFVENAKKRPSAEELLRHFF 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  155 bits (394), Expect = 3e-44
 Identities = 96/307 (31%), Positives = 146/307 (47%), Gaps = 61/307 (19%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARR-QIA---QELKINQSS 125
           +D + IKV+G+G+ G V LV+ K TGQ +A+KV  +   +  +R QIA    E  I   +
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKV--LRKSDMIKRNQIAHVRAERDILADA 58

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLKGL 181
             P++V  Y SF     + +++EYM GG L + L +    PEE    Y+A +        
Sbjct: 59  DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELV------- 111

Query: 182 LYLH--HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-------------- 225
           L L   H+   IHRD+KP N+LI+  G +K+ DFG+   M     +              
Sbjct: 112 LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171

Query: 226 ---------------ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS 270
                          AN+ VGT +Y++PE + G  YG + D WSLG++L E   G  P+ 
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFY 231

Query: 271 PPEQQDGW---TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-SAQEL 326
               Q+ +    ++ E +       PP  P    SPE    I   +  +P+ RL S +E+
Sbjct: 232 SDTLQETYNKIINWKESLRF-----PPDPP---VSPEAIDLICRLLC-DPEDRLGSFEEI 282

Query: 327 MTHPFLK 333
            +HPF K
Sbjct: 283 KSHPFFK 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  154 bits (389), Expect = 3e-44
 Identities = 96/282 (34%), Positives = 159/282 (56%), Gaps = 20/282 (7%)

Query: 59  LIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-Q 117
           ++ P D +  L++   IK+ G+GS GIV +   K +G+  A+K  +M++ +  RR++   
Sbjct: 12  VVDPGDPRTYLDNF--IKI-GEGSTGIVCIATVKSSGKLVAVK--KMDLRKQQRRELLFN 66

Query: 118 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 177
           E+ I +  Q   VV  Y S+     + +++E+++GG+L D +   + + EE +AA+C  V
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAV 125

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 237
           LK L  LH +  +IHRD+K  ++L+ H G VK++DFG  A ++    +  + VGT  +M+
Sbjct: 126 LKALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 184

Query: 238 PERISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGWTSFYELMEAIVDQPPPS 295
           PE IS   YG + DIWSLG++++E   G+ PY   PP          + M+ I D  PP 
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---------LKAMKMIRDNLPPK 235

Query: 296 APS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 336
             +  + SP    F+   + ++P QR +A EL+ HPFL   G
Sbjct: 236 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  152 bits (386), Expect = 4e-44
 Identities = 89/267 (33%), Positives = 138/267 (51%), Gaps = 16/267 (5%)

Query: 71  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPY 129
           D   +K +GKGS G V  V+     QF+ALK + +       R+ A  E++I  S   P 
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 130 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAICEQVLKGLLYLH 185
           ++   ++F     + I++EY   G L+  + K K     IPE+ +  I  Q+L+GL  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
            +K I+HRDLK +N+L+     VKI D G+S ++      A T +GT +YM+PE   G  
Sbjct: 121 EQK-ILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKTQIGTPHYMAPEVWKGRP 177

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 305
           Y YKSDIWSLG +L E AT   P+     QD     Y++        PP      +S + 
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYKVQRGKYPPIPPI-----YSQDL 229

Query: 306 CSFISACVQKEPQQRLSAQELMTHPFL 332
            +FI + +Q +P+ R +  +++  P +
Sbjct: 230 QNFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  152 bits (385), Expect = 9e-44
 Identities = 91/262 (34%), Positives = 143/262 (54%), Gaps = 14/262 (5%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF 137
           +G G+ G V   ++K TG   A KVI+   EE     +  E++I  +   PY+V    +F
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV-EIEILATCNHPYIVKLLGAF 78

Query: 138 YSNGAISIILEYMDGGSL-ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 196
           Y +G + I++E+  GG++ A  L+  + + E  +  IC Q+L+ L YLH  K IIHRDLK
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK-IIHRDLK 137

Query: 197 PSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSD 251
             N+L+   G++K+ DFGVSA    T  + ++F+GT  +M+PE +         Y YK+D
Sbjct: 138 AGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKAD 197

Query: 252 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 311
           IWSLG+ L+E A       PP  +        L++    +PP  +   ++S EF  F+  
Sbjct: 198 IWSLGITLIEMAQ----IEPPHHE--LNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKT 251

Query: 312 CVQKEPQQRLSAQELMTHPFLK 333
            + K P+ R SA +L+ HPF+ 
Sbjct: 252 ALDKHPETRPSAAQLLEHPFVS 273

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  149 bits (377), Expect = 1e-42
 Identities = 77/251 (30%), Positives = 131/251 (52%), Gaps = 23/251 (9%)

Query: 94  TGQFFALKVI---------QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           TG   A+K +         Q  V E+ R++I    ++N     P+++    +   +   +
Sbjct: 24  TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH----PHIIRMLGATCEDSHFN 79

Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           + +E+M GGS++  L K     E  +    EQ+L+GL YLH E  IIHRD+K +NLLI+ 
Sbjct: 80  LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLH-ENQIIHRDVKGANLLIDS 138

Query: 205 RGE-VKITDFGVSAIMASTSGQANTF----VGTYNYMSPERISGGKYGYKSDIWSLGLVL 259
            G+ ++I DFG +A +A+    A  F    +GT  +M+PE + G +YG   D+WS+G V+
Sbjct: 139 TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVI 198

Query: 260 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ 319
           +E AT + P++  +  +     +++  A      PS P    SP        C++ +P+ 
Sbjct: 199 IEMATAKPPWNAEKHSNHLALIFKIASAT---TAPSIPE-HLSPGLRDVTLRCLELQPED 254

Query: 320 RLSAQELMTHP 330
           R  ++EL+ HP
Sbjct: 255 RPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  147 bits (373), Expect = 4e-42
 Identities = 88/269 (32%), Positives = 133/269 (49%), Gaps = 17/269 (6%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ---------IAQELKINQSSQ 126
           +++GKG+ G V L  +  TG+  A+K +++    + R           +  E++  +   
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 186
              +V       +   +SI LEY+ GGS+   L+      E+ +    EQVL+GL YLH 
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH- 125

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS--TSGQANTFVGTYNYMSPERISGG 244
            K I+HRDLK  NLL++  G  KI+DFG+S        + Q  +  G+  +M+PE I   
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 245 KYGY--KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
             GY  K DIWSLG V+LE   G+ P+S  E      + ++L       P P   S   S
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---IAAMFKLGNKRSAPPIPPDVSMNLS 242

Query: 303 PEFCSFISACVQKEPQQRLSAQELMTHPF 331
           P    F++AC    P  R +A+EL+ HPF
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  147 bits (373), Expect = 7e-42
 Identities = 83/258 (32%), Positives = 146/258 (56%), Gaps = 11/258 (4%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQS 136
           +G+G+ G V       TGQ  A+K  QMN+++  +++ I  E+ + + ++ P +V    S
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIK--QMNLQQQPKKELIINEILVMRENKHPNIVNYLDS 84

Query: 137 FYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 196
           +     + +++EY+ GGSL D + +   + E  +AA+C + L+ L +LH    +IHRD+K
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLH-SNQVIHRDIK 142

Query: 197 PSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 256
             N+L+   G VK+TDFG  A +     + +T VGT  +M+PE ++   YG K DIWSLG
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 257 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE 316
           ++ +E   G+ PY     ++   + Y +     +  P     ++ S  F  F++ C++ +
Sbjct: 203 IMAIEMVEGEPPYL---NENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLEMD 256

Query: 317 PQQRLSAQELMTHPFLKM 334
            ++R SA+EL+ HPFLK+
Sbjct: 257 VEKRGSAKELLQHPFLKI 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  147 bits (373), Expect = 9e-42
 Identities = 85/262 (32%), Positives = 140/262 (53%), Gaps = 21/262 (8%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVVCYQ 135
           +G GS G V   +   T +  A+K +  + ++S  +   I +E++  Q  + P  +    
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 136 SFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLH-HEKHIIHR 193
            +       +++EY  G S +D L+   K + E  +AAIC   L+GL YLH HE+  IHR
Sbjct: 83  CYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER--IHR 139

Query: 194 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG---GKYGYKS 250
           D+K  N+L+   G VK+ DFG +++++     AN+FVGT  +M+PE I     G+Y  K 
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSASLVSP----ANSFVGTPYWMAPEVILAMDEGQYDGKV 195

Query: 251 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 310
           D+WSLG+  +E A  + P       +  ++ Y     I     P+  S+ +S  F +F+ 
Sbjct: 196 DVWSLGITCIELAERKPPLF---NMNAMSALYH----IAQNDSPTLSSNDWSDYFRNFVD 248

Query: 311 ACVQKEPQQRLSAQELMTHPFL 332
           +C+QK PQ R S++EL+ H F+
Sbjct: 249 SCLQKIPQDRPSSEELLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  144 bits (366), Expect = 3e-41
 Identities = 89/265 (33%), Positives = 144/265 (54%), Gaps = 24/265 (9%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVI---QMNVEESARRQIAQELKINQSSQCPYVV 131
           I+VVG+G+ GIV L + K   +   +K I   QM  +E  R     E ++ +    P ++
Sbjct: 5   IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDE--RLAAQNECQVLKLLSHPNII 62

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKH 189
             Y++F  + A+ I++EY  GG+LA++++K     + E+ +     Q+L  L ++H  K 
Sbjct: 63  EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH-TKL 121

Query: 190 IIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 248
           I+HRDLK  N+L++ H+  VKI DFG+S I++S S +A T VGT  Y+SPE   G  Y  
Sbjct: 122 ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KAYTVVGTPCYISPELCEGKPYNQ 180

Query: 249 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--AP-SDQFSPEF 305
           KSDIW+LG VL E A+ +  +               + A+V +      AP SD++SP+ 
Sbjct: 181 KSDIWALGCVLYELASLKRAFEA-----------ANLPALVLKIMSGTFAPISDRYSPDL 229

Query: 306 CSFISACVQKEPQQRLSAQELMTHP 330
              I + +  +P +R    ++M  P
Sbjct: 230 RQLILSMLNLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  145 bits (368), Expect = 3e-41
 Identities = 95/290 (32%), Positives = 149/290 (51%), Gaps = 17/290 (5%)

Query: 67  LNLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 125
           LN E+  + I  +G G+ G V   Q+K TG   A KVI    EE     +  E+ I  S 
Sbjct: 1   LNPEEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMV-EIDILASC 59

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSL-ADFLKKVKTIPEEYLAAICEQVLKGLLYL 184
             P +V    +FY    + I++E+  GG++ A  L+  + + E  +  +C+Q L+ L YL
Sbjct: 60  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119

Query: 185 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI--- 241
           H  K IIHRDLK  N+L    G++K+ DFGVSA    T  + ++F+GT  +M+PE +   
Sbjct: 120 HENK-IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 242 --SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD 299
                 Y YK+D+WSLG+ L+E A       PP  +        L++    +PP  A   
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMAQ----IEPPHHE--LNPMRVLLKIAKSEPPTLAQPS 232

Query: 300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA 349
           ++S EF  F+  C++K    R +  +L+ HPF+ +  + N  + E   +A
Sbjct: 233 RWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTV--NSNKPIRELIAEA 280

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  143 bits (361), Expect = 2e-40
 Identities = 89/277 (32%), Positives = 140/277 (50%), Gaps = 40/277 (14%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQI----AQELKINQSSQCPYV 130
           +K + KG+ G V L + + TG +FA+KV++ + +  A+ Q+    A+   +    + PYV
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKS-DMIAKNQVTNVKAERAIMMIQGESPYV 59

Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 190
              Y SF S   + +++EY++GG  A  +K +  +PE++      +V+ G+  LH ++ I
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLH-QRGI 118

Query: 191 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGGKYGYK 249
           IHRD+KP NLLI+  G +K+TDFG+S       G  N  FVGT +Y++PE I G      
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDKM 173

Query: 250 SDIWSLGLVLLECATGQFPYSP--PEQ--------QDGWTSFYELMEAIVDQPPPSAPSD 299
           SD WSLG V+ E   G  P+    P+         +  W    +                
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFC------------- 220

Query: 300 QFSPEFCSFISACVQKEPQQRLSA---QELMTHPFLK 333
             SPE    I+  +  +P +RL A   QE+ +HPF K
Sbjct: 221 --SPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  142 bits (360), Expect = 2e-40
 Identities = 84/262 (32%), Positives = 141/262 (53%), Gaps = 13/262 (4%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVC 133
           ++VVGKGS G V LV+H+  G+ + +K + + N     R+   QE ++    + P +V  
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64

Query: 134 YQSFY-SNGAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLHHEKHI 190
            +S+   +G + I++ + +GG L   LK  K K +PE  +     Q+   L YLH EKHI
Sbjct: 65  RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH-EKHI 123

Query: 191 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKS 250
           +HRDLK  N+ +     +K+ D G++ ++ +    A+T +GT  YMSPE  S   Y YKS
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKS 183

Query: 251 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 310
           D+W+LG  + E AT +  ++  +          L+  I++   P  P D +SPE    I+
Sbjct: 184 DVWALGCCVYEMATLKHAFNAKDMN-------SLVYRIIEGKLPPMPKD-YSPELGELIA 235

Query: 311 ACVQKEPQQRLSAQELMTHPFL 332
             + K P++R S + ++  P++
Sbjct: 236 TMLSKRPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  141 bits (358), Expect = 7e-40
 Identities = 75/275 (27%), Positives = 124/275 (45%), Gaps = 42/275 (15%)

Query: 72  IDTIKVVGKGSGGIVQL----VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC 127
           +   K +G+G+ G V       +        A+K ++ +  E    +  +E +I +    
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 128 PYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLL 182
           P VV    VC +       + I++EYM+GG L  +L+K +  +    L +   Q+ +G+ 
Sbjct: 61  PNVVKLLGVCTEE----EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGME 116

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS------AIMASTSGQANTFVGTYNYM 236
           YL   K+ IHRDL   N L+     VKI+DFG+S             G+         +M
Sbjct: 117 YLE-SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL-----PIRWM 170

Query: 237 SPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----Q 291
           +PE +  GK+  KSD+WS G++L E  T G+ PY          S  E++E + +     
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY-------PGMSNEEVLEYLKNGYRLP 223

Query: 292 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
            PP+ P     PE    +  C  ++P+ R +  EL
Sbjct: 224 QPPNCP-----PELYDLMLQCWAEDPEDRPTFSEL 253

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  142 bits (358), Expect = 1e-39
 Identities = 83/258 (32%), Positives = 146/258 (56%), Gaps = 11/258 (4%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQS 136
           +G+G+ G V       TGQ  A+K  QMN+++  +++ I  E+ + + ++ P +V    S
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIK--QMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 137 FYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 196
           +     + +++EY+ GGSL D + +   + E  +AA+C + L+ L +LH  + +IHRD+K
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ-VIHRDIK 142

Query: 197 PSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 256
             N+L+   G VK+TDFG  A +     + +T VGT  +M+PE ++   YG K DIWSLG
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 257 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE 316
           ++ +E   G+ PY     ++   + Y +     +  P     ++ S  F  F++ C++ +
Sbjct: 203 IMAIEMVEGEPPYL---NENPLRALYLIA---TNGTPELQNPERLSAVFRDFLNRCLEMD 256

Query: 317 PQQRLSAQELMTHPFLKM 334
             +R SA+EL+ HPFLK+
Sbjct: 257 VDRRGSAKELLQHPFLKL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  141 bits (355), Expect = 3e-39
 Identities = 84/258 (32%), Positives = 146/258 (56%), Gaps = 11/258 (4%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQS 136
           +G+G+ G V       TGQ  A+K  Q+N+++  +++ I  E+ + +  + P +V    S
Sbjct: 27  IGQGASGTVFTAIDVATGQEVAIK--QINLQKQPKKELIINEILVMKELKNPNIVNFLDS 84

Query: 137 FYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 196
           F     + +++EY+ GGSL D + +   + E  +AA+C + L+ L +LH    +IHRD+K
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLH-ANQVIHRDIK 142

Query: 197 PSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 256
             N+L+   G VK+TDFG  A +     + +T VGT  +M+PE ++   YG K DIWSLG
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202

Query: 257 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE 316
           ++ +E   G+ PY     ++   + Y +     +  P     ++ SP F  F++ C++ +
Sbjct: 203 IMAIEMVEGEPPYL---NENPLRALYLIA---TNGTPELQNPEKLSPIFRDFLNRCLEMD 256

Query: 317 PQQRLSAQELMTHPFLKM 334
            ++R SA+EL+ HPFLK+
Sbjct: 257 VEKRGSAKELLQHPFLKL 274

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  141 bits (357), Expect = 5e-39
 Identities = 82/270 (30%), Positives = 132/270 (48%), Gaps = 17/270 (6%)

Query: 71  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA--RRQIAQELKINQSSQCP 128
           D   +  VG+G  G V L + K TG+  ALK ++ ++       R +  E  I  +++  
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLKGLLYL 184
           ++V    +F  +  + + +EY+ GG     L  +  + E+    Y+A + E V   L   
Sbjct: 62  WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAV-DAL--- 117

Query: 185 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 244
            HE   IHRDLKP N LI+  G +K+TDFG+S  + +    AN+ VG+ +YM+PE + G 
Sbjct: 118 -HELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGK 173

Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 304
            Y +  D WSLG +L E   G  P+S     + W +     E  + +P    P    S E
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-TLQRPVYDDPRFNLSDE 232

Query: 305 FCSFISACVQKEPQQRL-SAQELMTHPFLK 333
               I+  +  +P +R  S +++  HPF K
Sbjct: 233 AWDLITKLIN-DPSRRFGSLEDIKNHPFFK 261

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  139 bits (353), Expect = 6e-39
 Identities = 86/294 (29%), Positives = 137/294 (46%), Gaps = 51/294 (17%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIA--QELKINQSSQC 127
           ++ +G+G+ G+V   + K TG+  ALK I+++ EE     +A R+I+  +ELK       
Sbjct: 4   LEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK------H 57

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHH 186
           P +V      ++   + ++ EY D   L  +L K    +    + +I  Q+L+GL Y H 
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH- 115

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVS-----AIMASTSGQANTFVGTYNYMSPERI 241
              I+HRDLKP N+LIN  G +K+ DFG++      +   T       V T  Y +PE +
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE-----VVTLWYRAPEIL 170

Query: 242 SGGK-YGYKSDIWSLGLVLLECATGQ--FPY---------------SPPEQQDGWTSFYE 283
            G K Y    DIWS+G +  E  TG+  FP                +P E+   W    +
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES--WPGVTK 228

Query: 284 LME--AIVDQPPPSAPSDQFS---PEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           L +      + PP           PE    +S  +Q  P +R+SA+E + HP+ 
Sbjct: 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  140 bits (354), Expect = 7e-39
 Identities = 95/290 (32%), Positives = 144/290 (49%), Gaps = 39/290 (13%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQC 127
           ED +TIK++  G+ G V LV+HK T Q FA+K I  Q  +  +  +Q+  E  I   ++ 
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLKGLLY 183
           P+VV  + SF +   + +++EY++GG  A  LK +  +P +    Y A   E VL  L Y
Sbjct: 61  PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFA---ETVL-ALEY 116

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI--MASTSG--------QANTFV--- 230
           LH+   I+HRDLKP NLLI   G +K+TDFG+S I  M+ T+             F+   
Sbjct: 117 LHNYG-IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175

Query: 231 --GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--SPPEQQDGWTSFYELME 286
             GT  Y++PE I    YG   D W++G++L E   G  P+    PE+  G     ++  
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235

Query: 287 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLK 333
              D+  P         +    IS  +++ P +RL    A E+  H F  
Sbjct: 236 PEGDEALP--------ADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  139 bits (352), Expect = 1e-38
 Identities = 87/267 (32%), Positives = 145/267 (54%), Gaps = 22/267 (8%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN---QSSQCPYVVV 132
           K++GKG+ G V LV+ K TG+++A+K+++  V   A+ ++A  L  N   Q+S+ P++  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTA 59

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
              SF ++  +  ++EY +GG L   L + +   E+       +++  L YLH EK++++
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           RDLK  NL+++  G +KITDFG+            TF GT  Y++PE +    YG   D 
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 179

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFIS 310
           W LG+V+ E   G+ P+   + +      +E  LME I  + P +      SPE  S +S
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEEI--RFPRT-----LSPEAKSLLS 228

Query: 311 ACVQKEPQQRL-----SAQELMTHPFL 332
             ++K+P+QRL      A+E+M H F 
Sbjct: 229 GLLKKDPKQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  138 bits (349), Expect = 2e-38
 Identities = 82/289 (28%), Positives = 136/289 (47%), Gaps = 38/289 (13%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVC 133
           I  +G+G+ G V   ++K TG+  ALK I+M N +E       +E+K+ Q  + P +V  
Sbjct: 4   IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRL 63

Query: 134 YQSFYS--NGAISIILEYMDGGSLADFL--KKVK-TIPEEYLAAICEQVLKGLLYLHHEK 188
            +   S   G+I ++ EYMD   L   L   +VK T  +  +    +Q+L+GL YLH   
Sbjct: 64  KEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQ--IKCYMKQLLEGLQYLHS-N 119

Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF-VGTYNYMSPERISGG-KY 246
            I+HRD+K SN+LIN+ G +K+ DFG++      +    T  V T  Y  PE + G  +Y
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRY 179

Query: 247 GYKSDIWSLGLVLLECATGQFPY-----------------SPPEQQDGWTSFYELMEAIV 289
           G + D+WS+G +L E   G+  +                 SP ++   W    +L     
Sbjct: 180 GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN--WPGVSKLPWFEN 237

Query: 290 DQPPPSAPS---DQF----SPEFCSFISACVQKEPQQRLSAQELMTHPF 331
            +P         + F     P     +   +  +P++R+SA + + H +
Sbjct: 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  136 bits (346), Expect = 3e-38
 Identities = 77/276 (27%), Positives = 124/276 (44%), Gaps = 43/276 (15%)

Query: 72  IDTIKVVGKGSGGIV---QLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKINQSSQC 127
           +   K +G+G+ G V    L       +   A+K ++ +  E    +  +E +I +    
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60

Query: 128 PYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGL 181
           P +V    VC +       + I++EYM GG L D+L+K   K +    L +   Q+ +G+
Sbjct: 61  PNIVKLLGVCTEE----EPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGM 116

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS------AIMASTSGQANTFVGTYNY 235
            YL   K+ IHRDL   N L+     VKI+DFG+S             G+         +
Sbjct: 117 EYLE-SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-----PIRW 170

Query: 236 MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD---- 290
           M+PE +  GK+  KSD+WS G++L E  T G+ PY          S  E++E +      
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPG-------MSNAEVLEYLKKGYRL 223

Query: 291 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
             PP+ P     PE    +  C  ++P+ R +  EL
Sbjct: 224 PKPPNCP-----PELYKLMLQCWAEDPEDRPTFSEL 254

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  134 bits (340), Expect = 3e-37
 Identities = 70/257 (27%), Positives = 114/257 (44%), Gaps = 55/257 (21%)

Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++ +  E  R+   +E ++ +    P VV    VC +       + ++LEYM+GG 
Sbjct: 27  AVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE----EEPLYLVLEYMEGGD 82

Query: 155 LADFLKKVK---------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           L D+L+K +         T+  + L +   Q+ KG+ YL   K  +HRDL   N L+   
Sbjct: 83  LLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA-SKKFVHRDLAARNCLVGED 141

Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNY-----------MSPERISGGKYGYKSDIWS 254
             VKI+DFG+S          + +   Y             M+PE +  G +  KSD+WS
Sbjct: 142 LVVKISDFGLS---------RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWS 192

Query: 255 LGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFI 309
            G++L E  T G  PY       G ++  E++E +        P   P      E    +
Sbjct: 193 FGVLLWEIFTLGATPYP------GLSNE-EVLEYLRKGYRLPKPEYCP-----DELYELM 240

Query: 310 SACVQKEPQQRLSAQEL 326
            +C Q +P+ R +  EL
Sbjct: 241 LSCWQLDPEDRPTFSEL 257

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  135 bits (340), Expect = 4e-37
 Identities = 81/258 (31%), Positives = 145/258 (56%), Gaps = 11/258 (4%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQS 136
           +G+G+ G V       TGQ  A++  QMN+++  +++ I  E+ + + ++ P +V    S
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIR--QMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 137 FYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 196
           +     + +++EY+ GGSL D + +   + E  +AA+C + L+ L +LH  + +IHRD+K
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ-VIHRDIK 143

Query: 197 PSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 256
             N+L+   G VK+TDFG  A +     + +T VGT  +M+PE ++   YG K DIWSLG
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203

Query: 257 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE 316
           ++ +E   G+ PY     ++   + Y +     +  P     ++ S  F  F++ C+  +
Sbjct: 204 IMAIEMIEGEPPYL---NENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLDMD 257

Query: 317 PQQRLSAQELMTHPFLKM 334
            ++R SA+EL+ H FLK+
Sbjct: 258 VEKRGSAKELLQHQFLKI 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  134 bits (338), Expect = 4e-37
 Identities = 83/265 (31%), Positives = 137/265 (51%), Gaps = 9/265 (3%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 129
           ED + I+ +G G+ G V   ++  TG+  A+KVI++   E     + QE+ + +  +   
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFA-VVQQEIIMMKDCKHSN 67

Query: 130 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 189
           +V  + S+     + I +E+  GGSL D       + E  +A +  + L+GL YLH  K 
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS-KG 126

Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS---GGKY 246
            +HRD+K +N+L+   G VK+ DFGVSA + +T  +  +F+GT  +M+PE  +    G Y
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186

Query: 247 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 306
               DIW++G+  +E A  Q    PP           LM     QPP      ++S  F 
Sbjct: 187 NQLCDIWAVGITAIELAELQ----PPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242

Query: 307 SFISACVQKEPQQRLSAQELMTHPF 331
            F+   + K P++R +A++L+ HPF
Sbjct: 243 HFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  133 bits (337), Expect = 5e-37
 Identities = 84/260 (32%), Positives = 137/260 (52%), Gaps = 11/260 (4%)

Query: 71  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV 130
             + ++VVG+GS G   LVQH  + Q +A+K I++    SA     +E  +    + P +
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60

Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLHHEK 188
           V   +SF ++G + I++EY DGG L   +K  + K  PE+ +     Q+  G+ ++H EK
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH-EK 119

Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 248
            ++HRD+K  N+ +   G+VK+ DFG + ++ S    A T+VGT  Y+ PE      Y  
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNN 179

Query: 249 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 308
           KSDIWSLG +L E  T + P+    Q + W +    +     +P PS     +S E  S 
Sbjct: 180 KSDIWSLGCILYELCTLKHPF----QANSWKNLILKVCQGSYKPLPS----HYSYELRSL 231

Query: 309 ISACVQKEPQQRLSAQELMT 328
           I    ++ P+ R SA  +++
Sbjct: 232 IKQMFKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  134 bits (339), Expect = 6e-37
 Identities = 78/288 (27%), Positives = 132/288 (45%), Gaps = 36/288 (12%)

Query: 74  TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVV 132
            +  +G+G+ G+V   + K TG+  A+K I++  E     + A +E+K+ +    P ++ 
Sbjct: 3   KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIK 62

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAICEQVLKGLLYLHHEK 188
               F   G + ++ E+MD     D  K +K     +PE  + +   Q+L+GL + H   
Sbjct: 63  LLDVFRHKGDLYLVFEFMD----TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH--S 116

Query: 189 H-IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-Y 246
           H I+HRDLKP NLLIN  G +K+ DFG++    S       +V T  Y +PE + G K Y
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 247 GYKSDIWSLGLVLLECATGQ--FP--------------YSPPEQQDGWTSFYELMEAIV- 289
               DIWS+G +  E  + +  FP                 P+ +  W  F  L      
Sbjct: 177 STPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEV-WPKFTSLARNYKF 235

Query: 290 --DQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
              +         F   SP+    +S  +  +P +R++A++ + HP+ 
Sbjct: 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  133 bits (337), Expect = 7e-37
 Identities = 81/251 (32%), Positives = 129/251 (51%), Gaps = 12/251 (4%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVC 133
           K +G+G    V        G   ALK +Q+   ++  AR    +E+ + +    P V+  
Sbjct: 8   KKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 67

Query: 134 YQSFYSNGAISIILEYMDGGSLAD----FLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 189
           Y SF  +  ++I+LE  D G L+     F K+ + IPE+ +     Q+   L ++H  + 
Sbjct: 68  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH-SRR 126

Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 249
           ++HRD+KP+N+ I   G VK+ D G+    +S +  A++ VGT  YMSPERI    Y +K
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFK 186

Query: 250 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           SDIWSLG +L E A  Q P+   +      + Y L + I     P  PSD +S E    +
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCDYPPLPSDHYSEELRQLV 241

Query: 310 SACVQKEPQQR 320
           + C+  +P++R
Sbjct: 242 NMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  134 bits (338), Expect = 7e-37
 Identities = 83/281 (29%), Positives = 146/281 (51%), Gaps = 29/281 (10%)

Query: 71  DIDTIKVVGKGSGGIVQLVQH---KWTGQFFALKVI--------QMNVEES-ARRQIAQE 118
           + + ++V+G G+ G V LV+       G+ +A+KV+            E +   RQ+ + 
Sbjct: 1   NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60

Query: 119 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 178
           ++     +CP++V  + +F ++  + +IL+Y++GG L   L + +   E  +     +++
Sbjct: 61  VR-----RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIV 115

Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMS 237
             L +LH    II+RD+K  N+L++  G V +TDFG+S    +    +A +F GT  YM+
Sbjct: 116 LALDHLHQLG-IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174

Query: 238 PERISGGKYGYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 295
           PE I GG  G+    D WSLG++  E  TG  P++   +Q+   S  E+   I+   PP 
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN---SQSEISRRILKSKPPF 231

Query: 296 APSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLK 333
             +   S E   FI   ++K+P++RL    A E+  HPF +
Sbjct: 232 PKT--MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score =  134 bits (338), Expect = 2e-36
 Identities = 78/311 (25%), Positives = 126/311 (40%), Gaps = 46/311 (14%)

Query: 77  VVGKG--SGGIVQLVQHKWTGQFFALKVIQMNVEESAR-RQIAQELKINQSSQCPYVVVC 133
           ++GK      IV L +HK T    A+K I ++       + + QE+  ++  Q P ++  
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHII 191
             SF  +  + ++   M  GS  D LK      +PE  +A I + VL  L Y+H  K  I
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS-KGFI 123

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--------NYMSPE---- 239
           HR +K S++L++  G+V ++    S  M    G+    V  +         ++SPE    
Sbjct: 124 HRSVKASHILLSGDGKVVLSGLRYSVSMIK-HGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182

Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPYS-------------------------PPEQ 274
            + G  Y  KSDI+S+G+   E A G  P+                          P  +
Sbjct: 183 NLQG--YNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240

Query: 275 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 334
                S                 +  FS  F  F+  C+Q++P+ R SA +L+ H F K 
Sbjct: 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQ 300

Query: 335 YGDLNVDLSEY 345
               N  L + 
Sbjct: 301 CKRRNTSLLDL 311

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  133 bits (336), Expect = 2e-36
 Identities = 81/283 (28%), Positives = 133/283 (46%), Gaps = 33/283 (11%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVCYQS 136
           +G+G+ GIV   + + TG+  ALK + +  +E     Q  +E+K  Q+ Q PYVV     
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 137 FYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 195
           F       +++EYM    L++ L+   + +PE  + +    +LKG+ Y+H    I+HRDL
Sbjct: 68  FPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG-IMHRDL 125

Query: 196 KPSNLLINHRGEVKITDFGVSAIMASTSGQANTF-VGTYNYMSPERISGG-KYGYKSDIW 253
           KP+NLLI+  G +KI DFG++ + +    +  +  V T  Y +PE + G  KY    D+W
Sbjct: 126 KPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLW 185

Query: 254 SLGLVLLECATGQ--FPY---------------SPPEQQDGWTSFYEL--MEAIVDQPPP 294
           ++G +  E   G   FP                +P E+   W     L     I      
Sbjct: 186 AVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEET--WPGLTSLPDYNKITFPESK 243

Query: 295 SAPSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
             P ++  P+  S      +   +  +P +RLSA E + HP+ 
Sbjct: 244 PIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  131 bits (333), Expect = 3e-36
 Identities = 78/271 (28%), Positives = 123/271 (45%), Gaps = 33/271 (12%)

Query: 72  IDTIKVVGKGSGGIVQLVQHKWTGQFF------ALKVIQMNVEESARRQIAQELKINQSS 125
           ++  K +G+G+ G V   +    G         A+K ++    E  R +  +E  I +  
Sbjct: 1   LELGKKLGEGAFGEV--YKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL 58

Query: 126 QCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKG 180
             P +V    VC Q       + I+ EYM GG L DFL+K    +  + L  +  Q+ KG
Sbjct: 59  SHPNIVRLLGVCTQG----EPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKG 114

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTFVGTY---NYM 236
           + YL   K+ +HRDL   N L+     VKI+DFG+S  I      +     G      +M
Sbjct: 115 MEYL-ESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWM 171

Query: 237 SPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 295
           +PE +  GK+  KSD+WS G++L E  T G+ PY       G ++  E++E + D     
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYP------GMSN-EEVLELLEDGYRLP 224

Query: 296 APSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
            P +    E    +  C   +P+ R +  EL
Sbjct: 225 RP-ENCPDELYELMLQCWAYDPEDRPTFSEL 254

Length = 258

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  132 bits (332), Expect = 4e-36
 Identities = 84/265 (31%), Positives = 139/265 (52%), Gaps = 9/265 (3%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 129
            D + I+ VG G+ G V   ++  TG+  A+K+I++   +     I QE+ + +  +   
Sbjct: 9   HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFS-LIQQEIFMVKECKHCN 67

Query: 130 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 189
           +V  + S+ S   + I +EY  GGSL D       + E  +A +C + L+GL YLH  K 
Sbjct: 68  IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLH-SKG 126

Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS---GGKY 246
            +HRD+K +N+L+   G+VK+ DFGV+A + +T  +  +F+GT  +M+PE  +    G Y
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186

Query: 247 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 306
               DIW++G+  +E A  Q    PP           LM     QPP      ++S  F 
Sbjct: 187 NQLCDIWAVGITAIELAELQ----PPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFH 242

Query: 307 SFISACVQKEPQQRLSAQELMTHPF 331
           +F+   + K P++R +A+ L+TH F
Sbjct: 243 NFVKISLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  132 bits (335), Expect = 4e-36
 Identities = 76/266 (28%), Positives = 138/266 (51%), Gaps = 18/266 (6%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVV 132
           KV+GKGS G V L + K T + +A+KV++ +V   ++     + ++  +  + + P++  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            +  F +   +  ++EY++GG L   +++     E        +++ GL +LH E+ II+
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH-ERGIIY 119

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           RDLK  N+L++  G +KI DFG+           +TF GT +Y++PE +S   YG   D 
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDW 179

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 312
           W+LG++L E   GQ P+   + +D      EL ++I++           S E  S + + 
Sbjct: 180 WALGVLLYEMLAGQSPF-EGDDED------ELFQSILEDEVRYPRW--LSKEAKSILKSF 230

Query: 313 VQKEPQQRLSA-----QELMTHPFLK 333
           + K P++RL       Q++  HPF +
Sbjct: 231 LTKNPEKRLGCLPTGEQDIKGHPFFR 256

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  132 bits (333), Expect = 1e-35
 Identities = 86/304 (28%), Positives = 139/304 (45%), Gaps = 53/304 (17%)

Query: 71  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCP 128
               IK++GKG  G V LV+ K TG+ FALKV+  +  ++ +  +++  E +I  +   P
Sbjct: 2   HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEE----YLAAICEQVLKGLL 182
           ++   Y SF +   + ++++Y  GG L   L++   K + EE    Y A    +VL  L 
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAA----EVLLALE 117

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-------------------------- 216
           YLH    I++RDLKP N+L++  G + ++DF +S                          
Sbjct: 118 YLHLLG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 217 ---AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 273
                    S ++N+FVGT  Y++PE ISG  +G   D W+LG++L E   G  P+    
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236

Query: 274 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL----SAQELMTH 329
           +        E    I+ +      S   S      I   + K+P +RL     A E+  H
Sbjct: 237 RD-------ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289

Query: 330 PFLK 333
           PF +
Sbjct: 290 PFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  131 bits (332), Expect = 1e-35
 Identities = 80/264 (30%), Positives = 140/264 (53%), Gaps = 18/264 (6%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVV 132
           KV+GKGS G V L + K T +FFA+K ++ +V   ++     + +   +  + + P++  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            + +F +   +  ++EY++GG L   ++      E        +++ GL +LH +K II+
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH-KKGIIY 119

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           RDLK  N+L++  G +KI DFG+     +  G+A+TF GT +Y++PE + G KY    D 
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSFIS 310
           WS G++L E   GQ P+   E +D      EL ++I++  P  P       S E    +S
Sbjct: 180 WSFGVLLYEMLIGQSPFH-GEDED------ELFDSILNDRPHFPR----WISKEAKDCLS 228

Query: 311 ACVQKEPQQRL-SAQELMTHPFLK 333
              +++P +RL    ++  HPF +
Sbjct: 229 KLFERDPTKRLGVDGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  131 bits (331), Expect = 1e-35
 Identities = 84/266 (31%), Positives = 144/266 (54%), Gaps = 21/266 (7%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVVV 132
           K++GKG+ G V LV+ K TG+++A+K+++  V   A+ ++A    E ++ Q+++ P++  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTA 59

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
              +F ++  +  ++EY +GG L   L + +   EE       +++  L YLH  + +++
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-SRDVVY 118

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           RD+K  NL+++  G +KITDFG+     S      TF GT  Y++PE +    YG   D 
Sbjct: 119 RDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYE-LMEAIVDQPPPSAPSDQFSPEFCSFISA 311
           W LG+V+ E   G+ P+     QD    F   LME I  + P +      SPE  S ++ 
Sbjct: 179 WGLGVVMYEMMCGRLPFY---NQDHERLFELILMEEI--RFPRT-----LSPEAKSLLAG 228

Query: 312 CVQKEPQQRL-----SAQELMTHPFL 332
            ++K+P+QRL      A+E+M H F 
Sbjct: 229 LLKKDPKQRLGGGPSDAKEVMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  129 bits (326), Expect = 3e-35
 Identities = 77/258 (29%), Positives = 129/258 (50%), Gaps = 12/258 (4%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQSSQ 126
           L +    K +G+G    V         +  ALK +Q+   ++  AR+   +E+ + +   
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLAD----FLKKVKTIPEEYLAAICEQVLKGLL 182
            P V+    SF  +  ++I+LE  D G L+     F K+ + IPE  +     Q+   + 
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           ++H  + ++HRD+KP+N+ I   G VK+ D G+    +S +  A++ VGT  YMSPERI 
Sbjct: 121 HMH-SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 179

Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
              Y +KSDIWSLG +L E A  Q P+   +      + + L + I     P  P++ +S
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQKIEQCDYPPLPTEHYS 234

Query: 303 PEFCSFISACVQKEPQQR 320
            +    +S C+  +P QR
Sbjct: 235 EKLRELVSMCIYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  129 bits (325), Expect = 3e-35
 Identities = 80/272 (29%), Positives = 139/272 (51%), Gaps = 27/272 (9%)

Query: 77  VVGKGSGGIVQLVQHKWTGQFFALKVIQM---NVEESARRQ-----IAQELKINQSSQCP 128
           ++G GS G V L  +  +G+  A+K +++   +     R++     +A+E+ + +  Q  
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            +V    S      ++I LEY+ GGS+A  L       E  +     Q+LKGL YLH+  
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126

Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVS------AIMASTSGQANTFVGTYNYMSPERIS 242
            IIHRD+K +N+L++++G +KI+DFG+S      ++   T+G   +  G+  +M+PE + 
Sbjct: 127 -IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVK 185

Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI--VDQPPPSAPSDQ 300
              Y  K+DIWSLG +++E  TG+ P+    Q          ++AI  + +         
Sbjct: 186 QTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ----------LQAIFKIGENASPEIPSN 235

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
            S E   F+    + +  +R +A EL+ HPFL
Sbjct: 236 ISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  128 bits (324), Expect = 4e-35
 Identities = 91/267 (34%), Positives = 136/267 (50%), Gaps = 26/267 (9%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQ------MNVEESARRQIAQELKINQSSQCPYVV 131
           +GKGS G V LV+ K       LKV++      +N  E+   Q  QE ++      P +V
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV--QANQEAQLLSKLDHPAIV 65

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYLHHE 187
             + SF    A  II EY +G  L   L+++K    T+ E  +     Q+L G+ Y+H +
Sbjct: 66  KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH-Q 124

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 247
           + I+HRDLK  N+ +     +KI DFGVS ++  +   A TF GT  YMSPE +    Y 
Sbjct: 125 RRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYD 183

Query: 248 YKSDIWSLGLVLLE--CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 305
            KSDIWSLG +L E  C    F            +F  ++  IV+ P PS P + +S + 
Sbjct: 184 SKSDIWSLGCILYEMCCLAHAFEGQ---------NFLSVVLRIVEGPTPSLP-ETYSRQL 233

Query: 306 CSFISACVQKEPQQRLSAQELMTHPFL 332
            S + + + K+P  R SA E++ +PF+
Sbjct: 234 NSIMQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  129 bits (325), Expect = 4e-35
 Identities = 93/271 (34%), Positives = 138/271 (50%), Gaps = 32/271 (11%)

Query: 77  VVGKGSGGIVQLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQ 135
           V+GKG+ GIV   +   T    A+K I + +      + + +E+ ++   +   +V    
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYV--QPLHEEIALHSYLKHRNIVQYLG 72

Query: 136 SFYSNGAISIILEYMDGGSLADFLKKVKTIP----EEYLAAICEQVLKGLLYLHHEKHII 191
           S   NG   I +E + GGSL+  L+  K  P    E+ +    +Q+L+GL YLH +  I+
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRS-KWGPLKDNEQTIIFYTKQILEGLKYLH-DNQIV 130

Query: 192 HRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY-- 248
           HRD+K  N+L+N + G VKI+DFG S  +A  +    TF GT  YM+PE I  G  GY  
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGA 190

Query: 249 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD-------QPPPSAPSDQF 301
            +DIWSLG  ++E ATG+    PP        F EL E           +  P  P +  
Sbjct: 191 PADIWSLGCTIVEMATGK----PP--------FIELGEPQAAMFKVGMFKIHPEIP-ESL 237

Query: 302 SPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           S E  +FI  C + +P +R SA +L+  PFL
Sbjct: 238 SAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  129 bits (325), Expect = 6e-35
 Identities = 97/293 (33%), Positives = 149/293 (50%), Gaps = 36/293 (12%)

Query: 59  LIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNVEESARRQIA 116
           L  P+D        + I+ +GKG+ G V  V +K  G   A+K++    +V+E    +I 
Sbjct: 17  LGDPTDTW------EIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE----EIE 66

Query: 117 QELKINQS-SQCPYVVVCYQSFY-----SNGAISIILEYMDGGSLADFLKKV----KTIP 166
            E  I QS    P VV  Y  FY       G + ++LE  +GGS+ + +K +    + + 
Sbjct: 67  AEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLD 126

Query: 167 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 226
           E  ++ I    L GL +LH+ + IIHRD+K +N+L+   G VK+ DFGVSA + ST  + 
Sbjct: 127 EAMISYILYGALLGLQHLHNNR-IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185

Query: 227 NTFVGTYNYMSPERISGGK-----YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 281
           NT VGT  +M+PE I+  +     Y  + D+WSLG+  +E   G  P    +     T F
Sbjct: 186 NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF--DMHPVKTLF 243

Query: 282 YELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
                 I   PPP+    +++   F  FIS C+ K+ + R S   L+ HPF+K
Sbjct: 244 -----KIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  128 bits (323), Expect = 1e-34
 Identities = 79/267 (29%), Positives = 130/267 (48%), Gaps = 20/267 (7%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ----ELKINQSSQCPYVVVC 133
           +GKG  G V   Q K TG+ +A K  +++ +   +R+  Q    E KI +     ++V  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACK--KLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL 58

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHII 191
             +F +   + +++  M+GG L   +  V     PE        Q++ GL +LH ++ I+
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH-QRRIV 117

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           +RDLKP N+L++  G V+I+D G+ A+      +     GT  YM+PE + G  Y +  D
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGL-AVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVD 176

Query: 252 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 311
            ++LG  L E   G+ P+    Q+       EL    ++        D+FSPE      A
Sbjct: 177 WFALGCTLYEMIAGRSPF---RQRKEKVEKEELKRRTLEM--AVEYPDKFSPEAKDLCEA 231

Query: 312 CVQKEPQQRL-----SAQELMTHPFLK 333
            +QK+P++RL     SA E+  HP  K
Sbjct: 232 LLQKDPEKRLGCRGGSADEVREHPLFK 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  129 bits (326), Expect = 1e-34
 Identities = 83/268 (30%), Positives = 137/268 (51%), Gaps = 27/268 (10%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVV 132
           KV+GKGS G V L +HK  G+F+A+KV+Q      ++  +  +A+   + ++ + P++V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            + SF +   +  +L+Y++GG L   L++ ++ PE        ++   L YLH   +II+
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLH-SLNIIY 119

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           RDLKP N+L++ +G V +TDFG+       S   +TF GT  Y++PE +    Y    D 
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDW 179

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPPPSAPSDQFSPEFCS 307
           W LG VL E   G     PP        FY     E+ + I+++P    P+   S     
Sbjct: 180 WCLGAVLYEMLYGL----PP--------FYSRDTAEMYDNILNKPLRLKPN--ISVSARH 225

Query: 308 FISACVQKEPQQRLSAQ----ELMTHPF 331
            +   +QK+  +RL A+    E+  H F
Sbjct: 226 LLEGLLQKDRTKRLGAKDDFLEIKNHVF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  129 bits (326), Expect = 2e-34
 Identities = 84/301 (27%), Positives = 141/301 (46%), Gaps = 46/301 (15%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES---ARRQIAQELKINQSSQCPYVV 131
           +K +G G+ G+V     K TG+  A+K I  NV +    A+R I +E+K+ +  +   ++
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIKKI-SNVFDDLIDAKR-ILREIKLLRHLRHENII 62

Query: 132 VCYQSFYSN-----GAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLL 182
                           + I+ E M+     D L KV    + + ++++     Q+L+GL 
Sbjct: 63  GLLDILRPPSPEDFNDVYIVTELME----TD-LHKVIKSPQPLTDDHIQYFLYQILRGLK 117

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM---ASTSGQANTFVGTYNYMSPE 239
           YLH   ++IHRDLKPSN+L+N   ++KI DFG++  +       G    +V T  Y +PE
Sbjct: 118 YLH-SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE 176

Query: 240 RI-SGGKYGYKSDIWSLGLVLLECATGQ--FP---Y------------SPPEQQDGWTSF 281
            + S  +Y    DIWS+G +  E  T +  FP   Y            +P E+   + + 
Sbjct: 177 LLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS 236

Query: 282 YELMEAIVDQPP-PSAP-SDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 336
            +    +   P  P  P S  F   SPE    +   +  +P++R++A E + HP+L    
Sbjct: 237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296

Query: 337 D 337
           D
Sbjct: 297 D 297

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  127 bits (319), Expect = 3e-34
 Identities = 90/271 (33%), Positives = 136/271 (50%), Gaps = 24/271 (8%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKIN--QSSQCPYVV 131
           K++G+G+ G V L     TG+  A K +Q + E  E+++   A E +I   ++ Q   +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67

Query: 132 VCYQSFYSNG--AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 189
             Y          ++I +EYM GGS+ D LK    + E        Q+L+G+ YLH    
Sbjct: 68  QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLH-SNM 126

Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVS----AIMASTSGQANTFVGTYNYMSPERISGGK 245
           I+HRD+K +N+L +  G VK+ DFG S     I  S +G   +  GT  +MSPE ISG  
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG-IRSVTGTPYWMSPEVISGEG 185

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI--VDQPPPSAPSDQFSP 303
           YG K+D+WSLG  ++E  T + P++           YE M AI  +   P +        
Sbjct: 186 YGRKADVWSLGCTVVEMLTEKPPWAE----------YEAMAAIFKIATQPTNPQLPSHIS 235

Query: 304 EFCSFISACVQKEPQQRLSAQELMTHPFLKM 334
           E       C+  E + R SA+EL+ HPF ++
Sbjct: 236 EHARDFLGCIFVEARHRPSAEELLRHPFAQL 266

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  126 bits (318), Expect = 4e-34
 Identities = 81/272 (29%), Positives = 137/272 (50%), Gaps = 27/272 (9%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-----ESARRQIAQELKINQSSQCPYV 130
           +V+GKG+ G V        GQ  A+K ++++       E    ++ +E+ + +S +   +
Sbjct: 6   EVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 190
           V    +   +  ISI +E++ GGS++  L +   +PE       +Q+L G+ YLH    +
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLH-NNCV 123

Query: 191 IHRDLKPSNLLINHRGEVKITDFGVSAIMA------STSGQANTFVGTYNYMSPERISGG 244
           +HRD+K +N+++   G +K+ DFG +  +A      + S    +  GT  +M+PE I+  
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183

Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--MEAIVDQ--PPPSAPSDQ 300
            YG KSDIWS+G  + E ATG+    PP       S   L  M  I       P  P D 
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGK----PP-----LASMDRLAAMFYIGAHRGLMPRLP-DS 233

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           FS     F+++C+ ++  +R SA +L+ H FL
Sbjct: 234 FSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  128 bits (322), Expect = 4e-34
 Identities = 81/264 (30%), Positives = 140/264 (53%), Gaps = 19/264 (7%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQEL---KINQSSQCPYVVV 132
           K++GKG+ G V LV+ K TG+++A+K+++  V   A+ ++A  L   ++ Q+++ P++  
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQNTRHPFLTA 59

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
              SF ++  +  ++EY +GG L   L + +   E+       +++  L YLH    +++
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLH-SCDVVY 118

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           RDLK  NL+++  G +KITDFG+     S      TF GT  Y++PE +    YG   D 
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 312
           W LG+V+ E   G+ P+     QD    F  ++   +  P         SPE  S ++  
Sbjct: 179 WGLGVVMYEMMCGRLPFY---NQDHEKLFELILMEEIRFP------RTLSPEAKSLLAGL 229

Query: 313 VQKEPQQRL-----SAQELMTHPF 331
           ++K+P+QRL      A+E+M H F
Sbjct: 230 LKKDPKQRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  126 bits (319), Expect = 6e-34
 Identities = 85/300 (28%), Positives = 134/300 (44%), Gaps = 64/300 (21%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVV- 131
           +G+G+ G V   +   TG+F ALK +++ + E     S  R+IA  LK  +S + P +V 
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIAL-LKQLESFEHPNIVR 65

Query: 132 ---VCYQSFYSNG-AISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLH 185
              VC+         ++++ E++D   LA +L K     +P E +  +  Q+L+G+ +LH
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH 124

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI----MASTSGQANTFVGTYNYMSPERI 241
             + I+HRDLKP N+L+   G+VKI DFG++ I    MA TS      V T  Y +PE +
Sbjct: 125 SHR-IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS-----VVVTLWYRAPEVL 178

Query: 242 SGGKYGYKSDIWSLGLVLLE--------CATG---------QFPYSPPEQQ------DGW 278
               Y    D+WS+G +  E          T               P E++         
Sbjct: 179 LQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPR 238

Query: 279 TSFYELMEAIVDQPPPSAPSD--QFSPEFCS----FISACVQKEPQQRLSAQELMTHPFL 332
           +SF           P   P     F PE C      +   +   P +R+SA E + HP+ 
Sbjct: 239 SSF-----------PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  125 bits (316), Expect = 2e-33
 Identities = 75/288 (26%), Positives = 141/288 (48%), Gaps = 31/288 (10%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVV 131
           + + VVG+G+ G+V   ++K TG+  A+K  + + + E  ++   +E+K+ +  +   +V
Sbjct: 4   EVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIV 63

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
              ++F   G + ++ EY++   L         +P + + +   Q+L+ + Y H   +II
Sbjct: 64  NLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH-SHNII 122

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISG-GKYGYK 249
           HRD+KP N+L++  G +K+ DFG +  + +      T +V T  Y +PE + G   YG  
Sbjct: 123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKP 182

Query: 250 SDIWSLGLVLLECATGQ--FP--------YS--------PPEQQDGWTSFYELMEAIVDQ 291
            D+W++G ++ E   G+  FP        Y         PP  Q+ ++S           
Sbjct: 183 VDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAF-- 240

Query: 292 PPPSAP-------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           P PS P         + S     F+ AC++ +P++RL+  EL+ HP+ 
Sbjct: 241 PEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  123 bits (312), Expect = 6e-33
 Identities = 90/295 (30%), Positives = 141/295 (47%), Gaps = 50/295 (16%)

Query: 74  TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-----NVEESAR-RQIAQELKINQSSQC 127
            IK +G G+ G V L ++K TG+  A+K  +M     + EE    R++    K+N+    
Sbjct: 3   VIKQLGDGTFGSVYLARNKETGELVAIK--KMKKKFYSWEECMNLREVKSLRKLNEH--- 57

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLH 185
           P +V   + F  N  +  + EYM+G +L   +K  K K   E  + +I  Q+L+GL ++H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 186 HEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMAS----TSGQANTFVGTYNYMSPER 240
             KH   HRDLKP NLL++    VKI DFG++  + S    T      +V T  Y +PE 
Sbjct: 117 --KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT-----DYVSTRWYRAPEI 169

Query: 241 I-SGGKYGYKSDIWSLGLVLLECATGQ--FPYS--------------PPEQQDGWTSFYE 283
           +     Y    DIW+LG ++ E  T +  FP S               P +QD W   Y+
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD-WPEGYK 228

Query: 284 LMEAIVDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           L   +  + P  AP+         SPE    I   ++ +P++R +A + + HP+ 
Sbjct: 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  121 bits (306), Expect = 2e-32
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 12/261 (4%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVC 133
           +K +G+GS G   LV+ K  G+ + +K I ++      R+ + +E+ +  + + P +V  
Sbjct: 5   VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKKVKTI--PEEYLAAICEQVLKGLLYLHHEKHII 191
            +SF  NG + I+++Y +GG L   +   + +  PE+ +     Q+   L ++H  K I+
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK-IL 123

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           HRD+K  N+ +   G +K+ DFG++ ++ ST   A T +GT  Y+SPE      Y  KSD
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSD 183

Query: 252 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 311
           IW+LG VL E  T +  +     ++       L+  I+    P   S  +S +  + +S 
Sbjct: 184 IWALGCVLYEMCTLKHAFEAGNMKN-------LVLKIIRGSYPPVSS-HYSYDLRNLVSQ 235

Query: 312 CVQKEPQQRLSAQELMTHPFL 332
             ++ P+ R S   ++   F+
Sbjct: 236 LFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  123 bits (310), Expect = 2e-32
 Identities = 81/276 (29%), Positives = 134/276 (48%), Gaps = 24/276 (8%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSS---QCPYVV 131
           +GKG+ G V  V+ K T + +A+KV+    E  A++++A    E  I   +   + P++V
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKK-EIVAKKEVAHTIGERNILVRTLLDESPFIV 59

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
               SF ++  + ++ +YM GG L   L+K     E+       +++  L +LH +  I+
Sbjct: 60  GLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLH-KYDIV 118

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKS 250
           +RDLKP N+L++  G + + DFG+S    + +   NTF GT  Y++PE +   K Y    
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHV 178

Query: 251 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 310
           D WSLG+++ E   G  P+   + Q         M   +       P +  S E   F+ 
Sbjct: 179 DFWSLGVLVFEMCCGWSPFYAEDTQQ--------MYRNIAFGKVRFPKNVLSDEGRQFVK 230

Query: 311 ACVQKEPQQRLSA----QELMTHPFLKMYGDLNVDL 342
             + + PQ RL A     EL  HPF     D++ DL
Sbjct: 231 GLLNRNPQHRLGAHRDAVELKEHPFFA---DIDWDL 263

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  122 bits (307), Expect = 2e-32
 Identities = 90/278 (32%), Positives = 143/278 (51%), Gaps = 30/278 (10%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNVEESARRQIAQELKINQS-SQCPY 129
           + I+ +GKG+ G V  V +K  G   A+K++    +++E    +I  E  I ++ S  P 
Sbjct: 21  EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE----EIEAEYNILKALSDHPN 76

Query: 130 VVVCYQSFYSNGAIS-----IILEYMDGGSLAD----FLKKVKTIPEEYLAAICEQVLKG 180
           VV  Y  +Y     +     ++LE  +GGS+ D    FLK+ + + E  +A I  + L G
Sbjct: 77  VVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMG 136

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L +LH  K  IHRD+K +N+L+   G VK+ DFGVSA + ST  + NT VGT  +M+PE 
Sbjct: 137 LQHLHVNK-TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEV 195

Query: 241 IS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 295
           I+        Y  + D+WSLG+  +E   G  P +              +  I   PPP+
Sbjct: 196 IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-------LFKIPRNPPPT 248

Query: 296 APSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
               + +S EF  FI  C+ K+ ++R +  +L+ H F+
Sbjct: 249 LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  123 bits (310), Expect = 2e-32
 Identities = 80/281 (28%), Positives = 145/281 (51%), Gaps = 27/281 (9%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ---MNVEESARRQIAQELKINQSSQCPYVVV 132
           +V+G+GS   V LV+ K T + +A+KV++   +N +E       ++    Q+S  P++V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            +  F +   +  ++EY++GG L   +++ + +PEE+      ++   L YLH E+ II+
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH-ERGIIY 119

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           RDLK  N+L++  G +K+TD+G+           +TF GT NY++PE + G  YG+  D 
Sbjct: 120 RDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 253 WSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 306
           W+LG+++ E   G+ P+        P+Q      F  ++E  +  P         S +  
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP------RSLSVKAA 233

Query: 307 SFISACVQKEPQQRLSA------QELMTHPFLKMYGDLNVD 341
           S + + + K+P++RL         ++  HPF +     NVD
Sbjct: 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR-----NVD 269

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  123 bits (309), Expect = 3e-32
 Identities = 80/267 (29%), Positives = 143/267 (53%), Gaps = 23/267 (8%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQEL---KINQSSQCPYVVV 132
           K++GKG+ G V LV+ K +G+++A+K+++  V   A+ ++A  L   ++ ++++ P++  
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVI-IAKDEVAHTLTESRVLKNTRHPFLTS 59

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
              SF +   +  ++EY++GG L   L + +   E+       +++  L YLH  K I++
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK-IVY 118

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           RDLK  NL+++  G +KITDFG+     + +    TF GT  Y++PE +    YG   D 
Sbjct: 119 RDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDW 178

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFIS 310
           W LG+V+ E   G+ P+   + +      +E  LME I  + P +  +D       S +S
Sbjct: 179 WGLGVVMYEMMCGRLPFYNQDHE----KLFELILMEDI--KFPRTLSADA-----KSLLS 227

Query: 311 ACVQKEPQQRL-----SAQELMTHPFL 332
             + K+P +RL      A+E+M H F 
Sbjct: 228 GLLIKDPNKRLGGGPDDAKEIMRHSFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  122 bits (307), Expect = 4e-32
 Identities = 72/267 (26%), Positives = 140/267 (52%), Gaps = 12/267 (4%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVV 132
           +V+G+GS   V LV+ K   Q +A+KV++  +   +E       ++    Q+S  P++V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            +  F +   + +++EY++GG L   +++ + +PEE+      ++   L +LH E+ II+
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLH-ERGIIY 119

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           RDLK  N+L++  G +K+TD+G+           +TF GT NY++PE + G +YG+  D 
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 312
           W+LG+++ E   G+ P+          +   L + I+++P         S +    +   
Sbjct: 180 WALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--LSVKASHVLKGF 237

Query: 313 VQKEPQQRLSAQ------ELMTHPFLK 333
           + K+P++RL  Q      ++ +H F +
Sbjct: 238 LNKDPKERLGCQPQTGFSDIKSHTFFR 264

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  122 bits (307), Expect = 5e-32
 Identities = 78/276 (28%), Positives = 144/276 (52%), Gaps = 28/276 (10%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ---MNVEESARRQIAQELKINQSSQCPYVVV 132
           +V+G+GS   V LV+ K T + +A+KVI+   +N +E       ++     +S  P++V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            +  F +   +  ++E++ GG L   +++ + +PEE+      ++   L +LH E+ II+
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLH-ERGIIY 119

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           RDLK  N+L++  G +K+TD+G+           +TF GT NY++PE + G  YG+  D 
Sbjct: 120 RDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW 179

Query: 253 WSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQP---PPSAPSDQFSP 303
           W+LG+++ E   G+ P+        P+Q    T  Y L + I+++    P S      S 
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSDNPDQN---TEDY-LFQVILEKQIRIPRS-----LSV 230

Query: 304 EFCSFISACVQKEPQQRLSAQ------ELMTHPFLK 333
           +  S +   + K+P++RL         ++ +HPF +
Sbjct: 231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR 266

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  121 bits (304), Expect = 2e-31
 Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 6/211 (2%)

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQE 118
           KP  +   L D +  + +G GS G V++ +HK TG+++A+K +  +  ++    + +AQE
Sbjct: 9   KPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQE 68

Query: 119 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 178
             I      P++V    SF     +  +LE++ GG L   L+K    P +       +++
Sbjct: 69  KSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELV 128

Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 238
               YLH  K II+RDLKP NLL++++G VK+TDFG +        +  T  GT  Y++P
Sbjct: 129 LAFEYLH-SKDIIYRDLKPENLLLDNKGHVKVTDFGFA---KKVPDRTFTLCGTPEYLAP 184

Query: 239 ERISGGKYGYKSDIWSLGLVLLECATGQFPY 269
           E I    +G   D W++G++L E   G  P+
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215

Length = 329

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 2e-31
 Identities = 71/270 (26%), Positives = 130/270 (48%), Gaps = 22/270 (8%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-----QCPYV 130
           +V+GKG  G V   Q + TG+ +A K ++   ++  +++  + + +N+          +V
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKQILEKVNSRFV 62

Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEK 188
           V    ++ +  A+ ++L  M+GG L   +  +      EE       ++  GL  LH E+
Sbjct: 63  VSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER 122

Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 248
            I++RDLKP N+L++  G ++I+D G+ A+           VGT  YM+PE +   +Y +
Sbjct: 123 -IVYRDLKPENILLDDYGHIRISDLGL-AVEIPEGETIRGRVGTVGYMAPEVVKNERYTF 180

Query: 249 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 308
             D W LG ++ E   G+ P+   +++       E +E  V +      S++FS    S 
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKR----EEVERRVKEDQEEY-SEKFSEAARSI 235

Query: 309 ISACVQKEPQQRL-----SAQELMTHPFLK 333
               + K+P  RL      A+E+  HPF +
Sbjct: 236 CRQLLTKDPGFRLGCRGEGAEEVKAHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  120 bits (302), Expect = 3e-31
 Identities = 79/272 (29%), Positives = 139/272 (51%), Gaps = 25/272 (9%)

Query: 75  IKVVGKGSGGIVQLV---QHKWTGQFFALKVIQ-----MNVEESARRQIAQELKINQSSQ 126
           +KV+GKG  G V  V       TG+ FA+KV++      N +++A  +   E  I ++ +
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNILEAVK 58

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 186
            P++V    +F + G + +ILEY+ GG L   L++     E+       ++   L +LH 
Sbjct: 59  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ 118

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 246
            + II+RDLKP N+L++ +G VK+TDFG+           +TF GT  YM+PE +    +
Sbjct: 119 -QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH 177

Query: 247 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 306
           G   D WSLG ++ +  TG  P++   ++    +  ++++  ++ PP        +PE  
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAENRK---KTIDKILKGKLNLPP------YLTPEAR 228

Query: 307 SFISACVQKEPQQRL-----SAQELMTHPFLK 333
             +   +++ P  RL      A E+ +HPF +
Sbjct: 229 DLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  120 bits (301), Expect = 3e-31
 Identities = 86/264 (32%), Positives = 142/264 (53%), Gaps = 19/264 (7%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVV 132
           ++ +G GS G V   +   T +  A+K +  + ++S  +   I +E+K  Q  + P  + 
Sbjct: 30  LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE 89

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
               +       +++EY  G S +D L+   K + E  +AAI    L+GL YLH   ++I
Sbjct: 90  YKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH-SHNMI 147

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG---GKYGY 248
           HRD+K  N+L+   G+VK+ DFG SA +AS    AN+FVGT  +M+PE I     G+Y  
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFG-SASIASP---ANSFVGTPYWMAPEVILAMDEGQYDG 203

Query: 249 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 308
           K D+WSLG+  +E A  +    P    +  ++ Y     I     P+  S+++S  F +F
Sbjct: 204 KVDVWSLGITCIELAERK---PPLFNMNAMSALYH----IAQNESPTLQSNEWSDYFRNF 256

Query: 309 ISACVQKEPQQRLSAQELMTHPFL 332
           + +C+QK PQ R +++EL+ H F+
Sbjct: 257 VDSCLQKIPQDRPTSEELLKHMFV 280

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  119 bits (300), Expect = 4e-31
 Identities = 76/260 (29%), Positives = 125/260 (48%), Gaps = 15/260 (5%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQ 135
           +GKGS G V  V+ + T + +ALK I+    V  S       E  +     CP++V    
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 136 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 195
           SF S   + ++L +++GG L   L++              ++L  L  LH + ++I+RDL
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLH-KFNVIYRDL 119

Query: 196 KPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSL 255
           KP N+L++++G + + DFG+  +      + NTF GT  Y++PE + G  Y    D W+L
Sbjct: 120 KPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTL 179

Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 315
           G++L E  TG  P+      +        M   + Q P   P D F  +    +   + +
Sbjct: 180 GVLLYEMLTGLPPFYDENVNE--------MYRKILQEPLRFP-DGFDRDAKDLLIGLLSR 230

Query: 316 EPQQRL---SAQELMTHPFL 332
           +P +RL    AQE+  HPF 
Sbjct: 231 DPTRRLGYNGAQEIKNHPFF 250

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  119 bits (300), Expect = 4e-31
 Identities = 90/287 (31%), Positives = 145/287 (50%), Gaps = 21/287 (7%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVVCYQ 135
           +G GS G V    +  T +  A+K +  + +++  +   I +E+K  Q  + P  +    
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 136 SFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 194
            +       +++EY  G S +D L+   K + E  +AAI    L+GL YLH   ++IHRD
Sbjct: 89  CYLKEHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLH-SHNMIHRD 146

Query: 195 LKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG---GKYGYKSD 251
           +K  N+L+   G+VK+ DFG     AS S  AN+FVGT  +M+PE I     G+Y  K D
Sbjct: 147 IKAGNILLTEPGQVKLADFG----SASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVD 202

Query: 252 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 311
           +WSLG+  +E A  +    P    +  ++ Y     I     P+  S++++  F  F+  
Sbjct: 203 VWSLGITCIELAERK---PPLFNMNAMSALYH----IAQNDSPTLQSNEWTDSFRGFVDY 255

Query: 312 CVQKEPQQRLSAQELMTHPFLKMYGDLNV--DLSEYFTDAGSPLATL 356
           C+QK PQ+R ++ EL+ H F++      V  DL +   DA   L  L
Sbjct: 256 CLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQRTKDAVRELDNL 302

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  120 bits (302), Expect = 5e-31
 Identities = 80/276 (28%), Positives = 141/276 (51%), Gaps = 14/276 (5%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQ 123
           Q+  ED D +KV+G+G+ G VQLV+HK + + +A+K++     ++ S      +E  I  
Sbjct: 39  QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98

Query: 124 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 183
            +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +V+  L  
Sbjct: 99  FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDA 157

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERIS 242
           + H   +IHRD+KP N+L++  G +K+ DFG    M  T   + +T VGT +Y+SPE + 
Sbjct: 158 I-HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLK 216

Query: 243 G----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 298
                G YG + D WS+G+ L E   G  P+        ++   +   ++ + P     S
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL-NFPEDVEIS 275

Query: 299 DQFSPEFCSFISACVQKEPQ-QRLSAQELMTHPFLK 333
                  C+F++    +E +  R   +E+  HPF K
Sbjct: 276 KHAKNLICAFLT---DREVRLGRNGVEEIKQHPFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  120 bits (302), Expect = 7e-31
 Identities = 89/321 (27%), Positives = 138/321 (42%), Gaps = 69/321 (21%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQ 126
           ED  T+KV+GKG+ G V+LVQ K TG+ +A+K + +  E   + Q+A    E  +   S 
Sbjct: 1   EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVKAERDVLAESD 59

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE---YLAAICEQVLKGLLY 183
            P+VV  Y SF     + +I+E++ GG L   L K  T  E+   +  A C   ++ +  
Sbjct: 60  SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV-- 117

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-------------------------- 217
             H+   IHRD+KP N+LI+  G +K++DFG+S                           
Sbjct: 118 --HKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDN 175

Query: 218 ----------IMASTSGQANTF-----------VGTYNYMSPERISGGKYGYKSDIWSLG 256
                     +  S+  Q  T+           VGT +Y++PE      YG + D WSLG
Sbjct: 176 RNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235

Query: 257 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD-QFSPEFCSFISACVQK 315
            ++ EC  G  P+      + +       E +        P D   S E    I   +  
Sbjct: 236 AIMFECLIGWPPFCSENSHETYRKIINWRETL------YFPDDIHLSVEAEDLIRRLIT- 288

Query: 316 EPQQRL---SAQELMTHPFLK 333
             + RL    A E+ +HPF +
Sbjct: 289 NAENRLGRGGAHEIKSHPFFR 309

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  119 bits (299), Expect = 7e-31
 Identities = 80/265 (30%), Positives = 136/265 (51%), Gaps = 17/265 (6%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ---IAQELKINQSSQCPYVVV 132
           KV+GKGS G V L + K  G+ +A+KV+Q  +  + + Q   +A+   + ++ + P++V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            + SF +   +  +L++++GG L   L++ ++ PE        ++   L YLH    I++
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN-IVY 119

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           RDLKP N+L++ +G V +TDFG+     + S    TF GT  Y++PE I    Y    D 
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDW 179

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 312
           W LG VL E   G  P+   +         E+ + I+ +P    P    S    S +   
Sbjct: 180 WCLGAVLYEMLYGLPPFYCRDV-------AEMYDNILHKPLVLRPG--ASLTAWSILEEL 230

Query: 313 VQKEPQQRLSAQ----ELMTHPFLK 333
           ++K+ Q+RL A+    E+  HPF +
Sbjct: 231 LEKDRQRRLGAKEDFLEIQEHPFFE 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  119 bits (299), Expect = 7e-31
 Identities = 89/273 (32%), Positives = 143/273 (52%), Gaps = 33/273 (12%)

Query: 75  IKVVGKGSGGIVQLVQHKW---TGQFFALKVIQ---MNVEESARRQIAQELKINQSSQCP 128
           +KV+G+GS G V LV+       GQ +A+KV++   + V +  R ++  E  I      P
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKM--ERDILAEVNHP 58

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLKGLLYL 184
           ++V  + +F + G + +IL+++ GG L   L K     EE    YLA   E  L  L +L
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---ELAL-ALDHL 114

Query: 185 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 244
           H    II+RDLKP N+L++  G +K+TDFG+S        +A +F GT  YM+PE ++  
Sbjct: 115 H-SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 173

Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF-SP 303
            +   +D WS G+++ E  TG  P+   ++++  T    +++A +  P       QF SP
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT---MILKAKLGMP-------QFLSP 223

Query: 304 EFCSFISACVQKEPQQRLSA-----QELMTHPF 331
           E  S + A  ++ P  RL A     +E+  HPF
Sbjct: 224 EAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  117 bits (295), Expect = 8e-31
 Identities = 75/259 (28%), Positives = 123/259 (47%), Gaps = 25/259 (9%)

Query: 78  VGKGSGGIVQLVQHKWTGQ-FFALKVIQMN---------VEESARRQIAQELK-INQSSQ 126
           +G G+ G V  V+ K  GQ   ALK I ++           + +   I  E+  I +  +
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLL 182
            P +V  Y++F  N  + I+++ ++G  L +    +K       EE +  I  Q++  L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           YLH EK I+HRDL P+N+++    +V ITDFG+ A       +  + VGT  Y  PE + 
Sbjct: 128 YLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL-AKQKQPESKLTSVVGTILYSCPEIVK 186

Query: 243 GGKYGYKSDIWSLGLVLLECATGQFP-YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 301
              YG K+D+W+ G +L +  T Q P YS        T+   L   IV+      P   +
Sbjct: 187 NEPYGEKADVWAFGCILYQMCTLQPPFYS--------TNMLSLATKIVEAVYEPLPEGMY 238

Query: 302 SPEFCSFISACVQKEPQQR 320
           S +    I++C+  + + R
Sbjct: 239 SEDVTDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  118 bits (296), Expect = 1e-30
 Identities = 74/268 (27%), Positives = 136/268 (50%), Gaps = 26/268 (9%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVV 132
           K++GKGS G V L + K T QFFA+K ++ +V   ++     + ++  ++ + + P++  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            Y +F +   +  ++EY++GG L   ++               +++ GL +LH  K I++
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH-SKGIVY 119

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           RDLK  N+L++  G +KI DFG+         +  TF GT +Y++PE + G KY    D 
Sbjct: 120 RDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDW 179

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI-VDQPPPSAPSDQFSPEFCS---- 307
           WS G++L E   GQ P+   +++       EL ++I +D P          P + +    
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEE-------ELFQSIRMDNP--------CYPRWLTREAK 224

Query: 308 -FISACVQKEPQQRLSAQ-ELMTHPFLK 333
             +     +EP++RL  + ++  HPF +
Sbjct: 225 DILVKLFVREPERRLGVKGDIRQHPFFR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  116 bits (292), Expect = 2e-30
 Identities = 90/271 (33%), Positives = 134/271 (49%), Gaps = 28/271 (10%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQ-SSQCPYVVV 132
           K++G+G+ G V L     TG+  A+K +Q + E  E+++   A E +I    +     +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 133 CYQSFYSNG---AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 189
            Y     +     +SI +E+M GGS+ D LK    + E        Q+L+G+ YLH    
Sbjct: 68  QYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH-SNM 126

Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVS----AIMASTSGQANTFVGTYNYMSPERISGGK 245
           I+HRD+K +N+L +  G VK+ DFG S     I  S +G   +  GT  +MSPE ISG  
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGM-KSVTGTPYWMSPEVISGEG 185

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPE 304
           YG K+DIWS+G  ++E  T +    PP     W  F E M AI      P+ P     P 
Sbjct: 186 YGRKADIWSVGCTVVEMLTEK----PP-----WAEF-EAMAAIFKIATQPTNP--VLPPH 233

Query: 305 FCSFISACVQK---EPQQRLSAQELMTHPFL 332
                   +++   E + R SA EL+ H F+
Sbjct: 234 VSDHCRDFLKRIFVEAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score =  117 bits (293), Expect = 3e-30
 Identities = 81/264 (30%), Positives = 137/264 (51%), Gaps = 19/264 (7%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVV 132
           ++ +G GS G V   +     +  A+K +  + ++S  +   I +E++  Q  + P  + 
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
               +       +++EY  G S +D L+   K + E  +AA+    L+GL YLH   ++I
Sbjct: 80  YRGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH-NMI 137

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG---GKYGY 248
           HRD+K  N+L++  G VK+ DFG ++IMA     AN FVGT  +M+PE I     G+Y  
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANXFVGTPYWMAPEVILAMDEGQYDG 193

Query: 249 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 308
           K D+WSLG+  +E A  +    P    +  ++ Y     I     P+  S  +S  F +F
Sbjct: 194 KVDVWSLGITCIELAERK---PPLFNMNAMSALYH----IAQNESPALQSGHWSEYFRNF 246

Query: 309 ISACVQKEPQQRLSAQELMTHPFL 332
           + +C+QK PQ R +++ L+ H F+
Sbjct: 247 VDSCLQKIPQDRPTSEVLLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  118 bits (297), Expect = 3e-30
 Identities = 86/287 (29%), Positives = 138/287 (48%), Gaps = 36/287 (12%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA----QELKI 121
           ++  ED D IKV+G+G+ G VQLV+HK + Q +A+K   ++  E  +R  +    +E  I
Sbjct: 39  RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMK--LLSKFEMIKRSDSAFFWEERDI 96

Query: 122 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 181
              +   ++V  + +F  +  + +++EYM GG L + +     IPE++      +V+  L
Sbjct: 97  MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLAL 155

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPE 239
             + H    IHRD+KP N+L++  G +K+ DFG    M +  G    +T VGT +Y+SPE
Sbjct: 156 DAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN-GMVRCDTAVGTPDYISPE 213

Query: 240 RISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ---- 291
            +      G YG + D WS+G+ L E   G      P   D     Y     I+D     
Sbjct: 214 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGD----TPFYADSLVGTY---SKIMDHKNSL 266

Query: 292 --PPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLK 333
             P     S Q     C+F++       + RL      E+ +HPF K
Sbjct: 267 TFPDDIEISKQAKDLICAFLTD-----REVRLGRNGVDEIKSHPFFK 308

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  115 bits (290), Expect = 3e-30
 Identities = 79/264 (29%), Positives = 133/264 (50%), Gaps = 13/264 (4%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ-ELKINQSSQCPYVV 131
           + IK +G+GS G + L + K   +   +K I +       ++ ++ E+ +    + P +V
Sbjct: 3   EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIV 62

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI--PEEYLAAICEQVLKGLLYLHHEKH 189
             + SF  NG + I++EY DGG L   + + + +   E+ + +   Q+  GL ++H  K 
Sbjct: 63  TFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK- 121

Query: 190 IIHRDLKPSNLLINHRGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 248
           I+HRD+K  N+ ++  G V K+ DFG++  +  +   A T VGT  Y+SPE      Y  
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNN 181

Query: 249 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 308
           K+DIWSLG VL E  T + P+          + ++L+  I  Q   +  S  FS +  S 
Sbjct: 182 KTDIWSLGCVLYELCTLKHPFEG-------NNLHQLVLKIC-QGYFAPISPNFSRDLRSL 233

Query: 309 ISACVQKEPQQRLSAQELMTHPFL 332
           IS   +  P+ R S   ++  PFL
Sbjct: 234 ISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  117 bits (294), Expect = 4e-30
 Identities = 75/270 (27%), Positives = 135/270 (50%), Gaps = 23/270 (8%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQC---PY 129
           + V+G+G  G V L ++K TG+ +A+K ++    +       +  E +I +++     P+
Sbjct: 4   LAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 130 VVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
           +V  +  F +   +  ++EY  GG L   +   V + P     A C  V+ GL YLH E 
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC--VVLGLQYLH-EN 120

Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 248
            I++RDLK  NLL++  G VKI DFG+         + +TF GT  +++PE ++   Y  
Sbjct: 121 KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTR 180

Query: 249 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 308
             D W LG+++ E   G+ P+ P + ++      E+ ++IV+      P    S E  S 
Sbjct: 181 AVDWWGLGVLIYEMLVGESPF-PGDDEE------EVFDSIVNDEVRY-PR-FLSREAISI 231

Query: 309 ISACVQKEPQQRL-----SAQELMTHPFLK 333
           +   +++ P++RL      A+++   PF +
Sbjct: 232 MRRLLRRNPERRLGSGEKDAEDVKKQPFFR 261

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  115 bits (291), Expect = 5e-30
 Identities = 79/287 (27%), Positives = 139/287 (48%), Gaps = 27/287 (9%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCP 128
           E  + +  +G+GS G+V   +++ TGQ  A+K    + ++   ++IA +E+++ +  + P
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            +V   + F     + ++ EY D   L +  K  + +PE  +  I  Q L+ + + H   
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120

Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYG 247
             IHRD+KP N+LI  +G++K+ DFG + I+         +V T  Y +PE + G  +YG
Sbjct: 121 -CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYG 179

Query: 248 YKSDIWSLGLVLLECATGQFPYSP-------------------PEQQDGWTSFYELMEAI 288
              D+W++G V  E  TGQ P  P                   P  Q  +++        
Sbjct: 180 PPVDVWAIGCVFAELLTGQ-PLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS 238

Query: 289 VDQPPPSAP-SDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPF 331
           + +P    P   +F   S    SF+  C+Q +P +RLS +EL+ HP+
Sbjct: 239 IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  116 bits (291), Expect = 1e-29
 Identities = 74/271 (27%), Positives = 134/271 (49%), Gaps = 18/271 (6%)

Query: 71  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQC 127
           D + + V+GKGS G V L + K T + +A+K+++ +V   ++     + ++  +    + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 187
           P++   +  F +   +  ++EY++GG L   +++V    E +      ++  GL +LH  
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH-S 119

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 247
           K II+RDLK  N++++  G +KI DFG+            TF GT +Y++PE I+   YG
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYG 179

Query: 248 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 307
              D W+ G++L E   GQ P+   E +D      EL ++I++       S   S E  S
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFD-GEDED------ELFQSIMEHNVSYPKS--LSKEAVS 230

Query: 308 FISACVQKEPQQRLSA-----QELMTHPFLK 333
                + K P +RL       +++  H F +
Sbjct: 231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  116 bits (292), Expect = 1e-29
 Identities = 79/281 (28%), Positives = 140/281 (49%), Gaps = 14/281 (4%)

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM--NVEESARRQIAQE 118
           K  D ++  ED + +KV+G+G+ G VQLV+HK T + +A+K++     ++ S      +E
Sbjct: 34  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 119 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 178
             I   +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +V+
Sbjct: 94  RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVV 152

Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMS 237
             L  + H    IHRD+KP N+L++  G +K+ DFG    M      + +T VGT +Y+S
Sbjct: 153 LALDAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 211

Query: 238 PERISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 293
           PE +      G YG + D WS+G+ L E   G  P+        ++       ++   P 
Sbjct: 212 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT-FPD 270

Query: 294 PSAPSDQFSPEFCSFISACVQKEPQ-QRLSAQELMTHPFLK 333
            +  S +     C+F++    +E +  R   +E+  H F K
Sbjct: 271 DNDISKEAKNLICAFLT---DREVRLGRNGVEEIKRHLFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  114 bits (287), Expect = 2e-29
 Identities = 81/284 (28%), Positives = 148/284 (52%), Gaps = 33/284 (11%)

Query: 71  DIDTIKVVGKGSGGIVQLVQ----HKWTGQFFALKVIQ-------MNVEESAR--RQIAQ 117
           + + +KV+G G+ G V LV+    H  +G+ +A+KV++           E  R  RQ+ +
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHD-SGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59

Query: 118 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 177
            ++     Q P++V  + +F ++  + +IL+Y++GG L   L + +   E+ +     ++
Sbjct: 60  HIR-----QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEI 114

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTSGQANTFVGTYNYM 236
           +  L +LH +  II+RD+K  N+L++  G V +TDFG+S         +A +F GT  YM
Sbjct: 115 VLALEHLH-KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 237 SPERISGGKYGYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP 294
           +P+ + GG  G+    D WS+G+++ E  TG  P++   +++   S  E+   I+   PP
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSEPP 230

Query: 295 SAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 333
             P +  S      I   + K+P++RL      A E+  HPF +
Sbjct: 231 -YPQE-MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQ 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  114 bits (287), Expect = 3e-29
 Identities = 76/293 (25%), Positives = 132/293 (45%), Gaps = 41/293 (13%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ----ELKINQSSQCP 128
           +  K +G+G+  +V   + K TG+  A+K I++   + A+  I      E+K+ Q  + P
Sbjct: 3   EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---KTIP--EEYLAAICEQVLKGLLY 183
            ++     F     I+++ E+M+     D L+KV   K+I      + +     L+GL Y
Sbjct: 63  NIIGLLDVFGHKSNINLVFEFMET----D-LEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
           LH    I+HRDLKP+NLLI   G +K+ DFG++    S + +    V T  Y +PE + G
Sbjct: 118 LH-SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG 176

Query: 244 GK-YGYKSDIWSLGLVLLECATGQFPYSP-----------------PEQQDGWTSFYELM 285
            + YG   D+WS+G +  E    + P+ P                 P  ++ W     L 
Sbjct: 177 ARHYGVGVDMWSVGCIFAELLL-RVPFLPGDSDIDQLGKIFEALGTPT-EENWPGVTSLP 234

Query: 286 E--AIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
           +       PP       F   S +    +   +   P +R++A++ + HP+  
Sbjct: 235 DYVEFKPFPPTPL-KQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  113 bits (284), Expect = 6e-29
 Identities = 79/292 (27%), Positives = 139/292 (47%), Gaps = 37/292 (12%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCP 128
           E  + + +VG+GS G+V   +HK TGQ  A+K    + ++   ++IA +E+++ +  +  
Sbjct: 1   EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            +V   + F     + ++ E++D   L D  K    + E  +     Q+L+G+ + H   
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSH- 119

Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGG-KY 246
           +IIHRD+KP N+L++  G VK+ DFG +  +A+  G+  T +V T  Y +PE + G  KY
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYTDYVATRWYRAPELLVGDTKY 178

Query: 247 GYKSDIWSLGLVLLECATGQ--FPYSPPEQQDGWTSFYELM----------EAIVDQPPP 294
           G   DIW++G ++ E  TG+  FP      Q      Y ++          + I  + P 
Sbjct: 179 GRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ-----LYHIIKCLGNLIPRHQEIFQKNPL 233

Query: 295 SA----PSDQ-----------FSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
            A    P  +            S         C++ +P  R S+ +L+ H F
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  112 bits (282), Expect = 8e-29
 Identities = 80/281 (28%), Positives = 132/281 (46%), Gaps = 42/281 (14%)

Query: 75  IKVVGKGSGGIVQLVQHKW----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV 130
           IK +G+G  G V+L ++      TG+  A+K +  + EE  R    +E++I ++     +
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 131 V----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLH 185
           V    VC +    +  + +I+EY+  GSL D+L++ +  I  + L     Q+ KG+ YL 
Sbjct: 69  VKYKGVCEKPGGRS--LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--------GQANTFVGTYNYMS 237
             +  IHRDL   N+L+     VKI+DFG++ ++            G++  F     + +
Sbjct: 127 -SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF-----WYA 180

Query: 238 PERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ----------QDGWTSFYELME 286
           PE +   K+   SD+WS G+ L E  T G    SPP +          Q   T   EL++
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240

Query: 287 AIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
                P PPS P + +       +  C + EPQ R S  +L
Sbjct: 241 EGERLPRPPSCPDEVY-----DLMKLCWEAEPQDRPSFADL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  113 bits (283), Expect = 1e-28
 Identities = 78/265 (29%), Positives = 127/265 (47%), Gaps = 19/265 (7%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ---IAQELKINQSSQCPYVVV 132
           KV+GKGS G V L + K  G F+A+KV+Q       + Q   +A+   + ++ + P++V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            + SF +   +  +L+Y++GG L   L++ +   E        +V   + YLH   +II+
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLH-SLNIIY 119

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           RDLKP N+L++ +G V +TDFG+           +TF GT  Y++PE +    Y    D 
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDW 179

Query: 253 WSLGLVLLECATGQFP-YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 311
           W LG VL E   G  P YS    Q        + + I+ +P         +   C  +  
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRDVSQ--------MYDNILHKPLQLPGGK--TVAACDLLVG 229

Query: 312 CVQKEPQQRLSA----QELMTHPFL 332
            + K+ ++RL A     E+  H F 
Sbjct: 230 LLHKDQRRRLGAKADFLEIKNHVFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  113 bits (283), Expect = 1e-28
 Identities = 78/263 (29%), Positives = 137/263 (52%), Gaps = 16/263 (6%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVV 132
           KV+GKGS G V L + K  G++FA+K ++ +V   ++     + ++  +  + + P++  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI-CEQVLKGLLYLHHEKHII 191
            Y +F +   +  ++E+++GG L  F  + K   + Y A     +++ GL +LH  K II
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLM-FHIQDKGRFDLYRATFYAAEIVCGLQFLH-SKGII 118

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           +RDLK  N++++  G +KI DFG+         +A+TF GT +Y++PE + G KY +  D
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVD 178

Query: 252 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 311
            WS G++L E   GQ P+   ++        EL E+I     P  P    + E    +  
Sbjct: 179 WWSFGVLLYEMLIGQSPFHGDDED-------ELFESI-RVDTPHYPR-WITKESKDILEK 229

Query: 312 CVQKEPQQRLSAQ-ELMTHPFLK 333
             +++P +RL     +  HPF K
Sbjct: 230 LFERDPTRRLGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  112 bits (281), Expect = 1e-28
 Identities = 59/204 (28%), Positives = 106/204 (51%), Gaps = 10/204 (4%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESAR-RQIAQ---ELKINQSS 125
           +D++ IK VG G+ G V LV+ + +  ++ALKV  M + E  R +Q      E ++ +  
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKV--MAIPEVIRLKQEQHVHNEKRVLKEV 58

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
             P+++  + + +    + +++EY+ GG L  +L+               +++  L YLH
Sbjct: 59  SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLH 118

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
             K I++RDLKP N+L++  G +K+TDFG +        +  T  GT  Y++PE I    
Sbjct: 119 -SKEIVYRDLKPENILLDKEGHIKLTDFGFA---KKLRDRTWTLCGTPEYLAPEVIQSKG 174

Query: 246 YGYKSDIWSLGLVLLECATGQFPY 269
           +    D W+LG+++ E   G  P+
Sbjct: 175 HNKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  111 bits (280), Expect = 4e-28
 Identities = 81/282 (28%), Positives = 134/282 (47%), Gaps = 37/282 (13%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQC 127
           +D D   +VG+G  G VQ+V+ K TG  +A+KV++ +V   +       +E  I   S  
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE-----YLAAICEQVLKGLL 182
           P++     +F     + +++EY  GG L   L + +   +E     YLA +       +L
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAEL-------VL 113

Query: 183 YLH--HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF--VGTYNYMSP 238
            +H  H+   +HRD+KP N+LI+  G +K+ DFG +A + + +   N+   VGT +Y++P
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNSKLPVGTPDYIAP 172

Query: 239 ERI------SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP 292
           E +        G YG + D WSLG++  E   G+ P+        + +       +    
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFL---- 228

Query: 293 PPSAPSD-QFSPEFCSFISA--CVQKEPQQRLSAQELMTHPF 331
               P D + S +F   I +  C QKE   RL  + L  HPF
Sbjct: 229 --KFPEDPKVSSDFLDLIQSLLCGQKE---RLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  111 bits (279), Expect = 4e-28
 Identities = 75/271 (27%), Positives = 133/271 (49%), Gaps = 18/271 (6%)

Query: 71  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQC 127
           D + + V+GKGS G V L + K T + +A+K+++ +V   ++     + ++  +  S + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 187
           P++   +  F +   +  ++EY++GG L   +++V    E +      ++  GL +LH  
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLH-S 119

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 247
           K II+RDLK  N++++  G +KI DFG+            TF GT +Y++PE I+   YG
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYG 179

Query: 248 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 307
              D W+ G++L E   GQ P+   E +D    F  +ME  V  P         S E  +
Sbjct: 180 KSVDWWAFGVLLYEMLAGQAPF---EGEDEDELFQSIMEHNVAYP------KSMSKEAVA 230

Query: 308 FISACVQKEPQQRLSA-----QELMTHPFLK 333
                + K P +RL       +++  H F +
Sbjct: 231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 261

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  110 bits (277), Expect = 8e-28
 Identities = 73/267 (27%), Positives = 135/267 (50%), Gaps = 19/267 (7%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVV 132
           +V+GKGS G V L + K +G+ +A+KV++ +V   ++     + ++  ++ +   P++  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            Y  F +   +  ++E+++GG L   ++K +   E        ++   L++LH +K II+
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH-DKGIIY 119

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           RDLK  N+L++H G  K+ DFG+           +TF GT +Y++PE +    YG   D 
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 312
           W++G++L E   G  P+   E +D      +L EAI++           S +    + A 
Sbjct: 180 WAMGVLLYEMLCGHAPFE-AENED------DLFEAILND--EVVYPTWLSQDAVDILKAF 230

Query: 313 VQKEPQQRLSA------QELMTHPFLK 333
           + K P  RL +      + ++ HPF K
Sbjct: 231 MTKNPTMRLGSLTLGGEEAILRHPFFK 257

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  110 bits (277), Expect = 9e-28
 Identities = 70/254 (27%), Positives = 125/254 (49%), Gaps = 13/254 (5%)

Query: 71  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQC 127
           D + + V+GKGS G V L + K T + +A+K+++ +V   ++     + ++  +    + 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 187
           P++   +  F +   +  ++EY++GG L   +++V    E        ++  GL +LH  
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH-R 119

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 247
           + II+RDLK  N++++  G +KI DFG+            TF GT +Y++PE I+   YG
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYG 179

Query: 248 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 307
              D W+ G++L E   GQ P+   ++ +    F  +ME  V  P         S E  S
Sbjct: 180 KSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSIMEHNVSYP------KSLSKEAVS 230

Query: 308 FISACVQKEPQQRL 321
                + K P +RL
Sbjct: 231 ICKGLMTKHPSKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  109 bits (274), Expect = 1e-27
 Identities = 76/287 (26%), Positives = 139/287 (48%), Gaps = 25/287 (8%)

Query: 77  VVGKGSGGIVQLVQHKWTGQFFALKV-----IQMNVEESARRQIAQELKINQSSQCPYVV 131
           ++G+G  G V   +   TG+ +A+K      I+M   E+        L +  +  CP++V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
               +F++   +  IL+ M+GG L   L +     E+ +     +++ GL ++H+ + ++
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN-RFVV 119

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKS 250
           +RDLKP+N+L++  G V+I+D G++   +     A+  VGT+ YM+PE +  G  Y   +
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGTAYDSSA 177

Query: 251 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 310
           D +SLG +L +   G  P+   + +D        +   V+ P      D FSPE  S + 
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELP------DSFSPELKSLLE 231

Query: 311 ACVQKEPQQRL-----SAQELMTHPFLKMYGDLNVDLSEYFTDAGSP 352
             +Q++  +RL      AQE+  H F K      +D  + +     P
Sbjct: 232 GLLQRDVSKRLGCLGRGAQEVKEHVFFK-----GIDWQQVYLQKYPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  110 bits (276), Expect = 1e-27
 Identities = 79/289 (27%), Positives = 146/289 (50%), Gaps = 24/289 (8%)

Query: 71  DIDTIKVVGKGSGGIVQLVQHKW---TGQFFALKVIQ----MNVEESARRQIAQELKINQ 123
           + + +KV+G G+ G V LV+      TG+ +A+KV+Q    +   ++      +   +  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 124 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 183
             Q P++V  + +F +   + +IL+Y+ GG +   L +     E+ +     +++  L +
Sbjct: 61  VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTSGQANTFVGTYNYMSPERIS 242
           LH +  I++RD+K  N+L++  G V +TDFG+S   ++    +  +F GT  YM+PE I 
Sbjct: 121 LH-KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR 179

Query: 243 G-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 301
           G G +G   D WSLG+++ E  TG  P++   +++   +  E+   I+   PP       
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN---TQSEVSRRILKCDPPFPS--FI 234

Query: 302 SPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDLN-VDLSE 344
            PE    +   ++K+P++RL      A E+  HPF K    L+   L+ 
Sbjct: 235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK---GLDWEALAL 280

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 2e-27
 Identities = 91/312 (29%), Positives = 143/312 (45%), Gaps = 60/312 (19%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQ 126
           +D ++IKV+G+G+ G V+LVQ K TG  +A+K ++ + E   + Q+A    E  I   + 
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKS-EMLEKEQVAHVRAERDILAEAD 59

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLKGLL 182
            P+VV  Y SF     + +I+EY+ GG +   L K  T  EE    Y+A   E +L   +
Sbjct: 60  NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA---ETILA--I 114

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV--------------------------- 215
              H+   IHRD+KP NLL++ +G +K++DFG+                           
Sbjct: 115 DSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174

Query: 216 SAIMASTSGQANTF-----------VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
            +   S+  +A T+           VGT +Y++PE      Y  + D WSLG+++ E   
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234

Query: 265 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL--- 321
           G  P+     Q+ +       E +  Q P   P    SPE    I      E ++RL   
Sbjct: 235 GYPPFCSDNPQETYRKIINWKETL--QFPDEVP---LSPEAKDLIKRLCC-EAERRLGNN 288

Query: 322 SAQELMTHPFLK 333
              E+ +HPF K
Sbjct: 289 GVNEIKSHPFFK 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  108 bits (270), Expect = 3e-27
 Identities = 77/267 (28%), Positives = 132/267 (49%), Gaps = 16/267 (5%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIA-QELKINQSSQCPYVVVC 133
           +V+GKG  G V   Q + TG+ +A K ++   +++     +A  E +I +     +VV  
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHII 191
             ++ +  A+ ++L  M+GG L   +  +      E        ++  GL  LH E+ I+
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER-IV 124

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           +RDLKP N+L++  G ++I+D G+ A+           VGT  YM+PE +   +Y +  D
Sbjct: 125 YRDLKPENILLDDHGHIRISDLGL-AVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPD 183

Query: 252 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 311
            W+LG +L E   GQ P+    QQ       E +E +V +      S++FSP+  S    
Sbjct: 184 WWALGCLLYEMIAGQSPF----QQRKKKIKREEVERLVKEVQEEY-SEKFSPDARSLCKM 238

Query: 312 CVQKEPQQRL-----SAQELMTHPFLK 333
            + K+P++RL      A+E+  HP  K
Sbjct: 239 LLCKDPKERLGCQGGGAREVKEHPLFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  108 bits (270), Expect = 5e-27
 Identities = 73/269 (27%), Positives = 133/269 (49%), Gaps = 21/269 (7%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ----ELKINQSSQCPYVVVC 133
           +GKG  G V   Q + TG+ +A K  ++N +   +R+  +    E +I       ++V  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACK--KLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAICEQVLKGLLYLHHEKH 189
             +F +   + +++  M+GG L   +  V       PE        Q++ GL +LH ++ 
Sbjct: 59  AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH-QRR 117

Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 249
           II+RDLKP N+L+++ G V+I+D G++  +     +   + GT  +M+PE + G +Y + 
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFS 177

Query: 250 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
            D ++LG+ L E    + P+    ++       EL + I++        D+FSP   SF 
Sbjct: 178 VDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRILND--SVTYPDKFSPASKSFC 232

Query: 310 SACVQKEPQQRL-----SAQELMTHPFLK 333
            A + K+P++RL     +   L THP  +
Sbjct: 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFR 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  107 bits (270), Expect = 5e-27
 Identities = 81/285 (28%), Positives = 131/285 (45%), Gaps = 40/285 (14%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF 137
           +G+G+   V   +++ TG+  ALK I ++ EE       +E+ + +  +   +V  +   
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 138 YSNGAISIILEYMDGGSLADFLKKVKT------IPEEYLAAICEQVLKGLLYLHHEKHII 191
           ++   + ++ EYMD     D  K + T      +    + +   Q+LKG+ + H E  ++
Sbjct: 68  HTENKLMLVFEYMDK----DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH-ENRVL 122

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTF---VGTYNYMSPERISGGK-Y 246
           HRDLKP NLLIN RGE+K+ DFG    +A   G   NTF   V T  Y +P+ + G + Y
Sbjct: 123 HRDLKPQNLLINKRGELKLADFG----LARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY 178

Query: 247 GYKSDIWSLGLVLLECATGQ--FPYSPPEQQ-------------DGWTSFYELMEAIVDQ 291
               DIWS+G ++ E  TG+  FP +  E Q               W    +L E     
Sbjct: 179 STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238

Query: 292 PP-PSAPSDQFSPEF----CSFISACVQKEPQQRLSAQELMTHPF 331
           P  P     Q  P         +   +Q  P+ R+SA + + HP+
Sbjct: 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  107 bits (270), Expect = 6e-27
 Identities = 83/300 (27%), Positives = 134/300 (44%), Gaps = 48/300 (16%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           LE    +  +G+GS   V   + K TGQ  ALK I++  EE A     +E  + +  +  
Sbjct: 4   LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHA 63

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICE--------QVLKG 180
            +V  +   ++   ++++ EY+D          +K   ++    +          Q+L+G
Sbjct: 64  NIVTLHDIIHTKKTLTLVFEYLD--------TDLKQYMDDCGGGLSMHNVRLFLFQLLRG 115

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF---VGTYNYMS 237
           L Y H  + ++HRDLKP NLLI+ RGE+K+ DFG++    + S  + T+   V T  Y  
Sbjct: 116 LAYCHQ-RRVLHRDLKPQNLLISERGELKLADFGLA---RAKSVPSKTYSNEVVTLWYRP 171

Query: 238 PERISGG-KYGYKSDIWSLGLVLLECATGQ--FP-YSPPEQQ-------------DGW-- 278
           P+ + G  +Y    D+W +G +  E ATG+  FP  +  E Q             + W  
Sbjct: 172 PDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPG 231

Query: 279 -TSFYELMEAIVDQPPPS-----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
            +S  E         PP      AP     P         +Q EP++R+SA E M HP+ 
Sbjct: 232 VSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  108 bits (271), Expect = 7e-27
 Identities = 74/270 (27%), Positives = 131/270 (48%), Gaps = 24/270 (8%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVV 132
           KV+GKGS G V L + K T + +A+KV++ +V   ++     + ++  +  +++ P++  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            +  F +   +  ++EY++GG L   +++ +   E        +V   L++LH    +I+
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG-VIY 119

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           RDLK  N+L++  G  K+ DFG+            TF GT +Y++PE +   +YG   D 
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDW 179

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAPSDQFSPEFCSFIS 310
           W+LG+++ E   GQ P+    + D       L E+I+  D   P       S E  S + 
Sbjct: 180 WALGVLMYEMMAGQPPFEADNEDD-------LFESILHDDVLYPV----WLSKEAVSILK 228

Query: 311 ACVQKEPQQRLSA-------QELMTHPFLK 333
           A + K P +RL           +  HPF K
Sbjct: 229 AFMTKNPNKRLGCVASQGGEDAIKQHPFFK 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  107 bits (269), Expect = 1e-26
 Identities = 79/273 (28%), Positives = 136/273 (49%), Gaps = 19/273 (6%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKIN-QSSQCPYVVV 132
           KV+GKGS G V L +HK   +F+A+KV+Q    +++   + I  E  +  ++ + P++V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            + SF +   +  +L+Y++GG L   L++ +   E        ++   L YLH   +I++
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH-SLNIVY 119

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           RDLKP N+L++ +G + +TDFG+       +G  +TF GT  Y++PE +    Y    D 
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDW 179

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 312
           W LG VL E   G  P+             E+ + I+++P    P+   S      +   
Sbjct: 180 WCLGAVLYEMLYGLPPFYSRNTA-------EMYDNILNKPLQLKPNITNSAR--HLLEGL 230

Query: 313 VQKEPQQRLSAQ----ELMTHPFLKM--YGDLN 339
           +QK+  +RL A+    E+  H F     + DL 
Sbjct: 231 LQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLI 263

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  105 bits (264), Expect = 2e-26
 Identities = 86/269 (31%), Positives = 134/269 (49%), Gaps = 26/269 (9%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKIN--QSSQCPYVV 131
           K++G+G+ G V L     TG+  A+K +  +   +E+++   A E +I   ++ +   +V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 132 VCYQSF--YSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 189
             Y          +SI +EYM GGS+ D LK    + E        Q+L+G+ YLH    
Sbjct: 68  QYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH-SNM 126

Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVS----AIMASTSGQANTFVGTYNYMSPERISGGK 245
           I+HRD+K +N+L +  G VK+ DFG S     I  S +G   +  GT  +MSPE ISG  
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTG-IKSVTGTPYWMSPEVISGEG 185

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA---IVDQPPPSAPSDQFS 302
           YG K+D+WS+   ++E  T + P++           YE M A   I  QP      D  S
Sbjct: 186 YGRKADVWSVACTVVEMLTEKPPWAE----------YEAMAAIFKIATQPTKPMLPDGVS 235

Query: 303 PEFCSFISACVQKEPQQRLSAQELMTHPF 331
                F+     +E ++R +A+ L+ HPF
Sbjct: 236 DACRDFLKQIFVEE-KRRPTAEFLLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  106 bits (265), Expect = 2e-26
 Identities = 75/268 (27%), Positives = 135/268 (50%), Gaps = 20/268 (7%)

Query: 77  VVGKGSGGIVQLVQHKWTGQFFALKV-----IQMNVEESARRQIAQELKINQSSQCPYVV 131
           ++G+G  G V   +   TG+ +A+K      I+M   E+        L +  +  CP++V
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
               +F++   +S IL+ M+GG L   L +     E  +     +++ GL ++H+ + ++
Sbjct: 61  CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN-RFVV 119

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKS 250
           +RDLKP+N+L++  G V+I+D G++   +     A+  VGT+ YM+PE +  G  Y   +
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSA 177

Query: 251 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 310
           D +SLG +L +   G  P+   + +D        +   V+ P      D FSPE  S + 
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP------DSFSPELRSLLE 231

Query: 311 ACVQKEPQQRL-----SAQELMTHPFLK 333
             +Q++  +RL      AQE+  HPF +
Sbjct: 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFR 259

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  106 bits (265), Expect = 7e-26
 Identities = 82/305 (26%), Positives = 140/305 (45%), Gaps = 49/305 (16%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQC 127
           +D +++KV+G+G+ G V+LVQ K TG  +A+K+++    +E+     I  E  I   +  
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA-AICEQVLKGLLYLHH 186
            +VV  + SF     + +I+E++ GG +   L K  T+ EE     I E VL   +   H
Sbjct: 61  AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLA--IDAIH 118

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA------------------------ST 222
           +   IHRD+KP NLL++ +G VK++DFG+   +                         ++
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 223 SGQANTF-----------VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 271
             +A T+           VGT +Y++PE      Y    D WSLG+++ E   G  P+  
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238

Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMT 328
              Q+ +       E +V   PP  P  + + +    +  C   E   R+     +E+ +
Sbjct: 239 ETPQETYRKVMNWKETLVF--PPEVPISEKAKDL--ILRFCTDSE--NRIGSNGVEEIKS 292

Query: 329 HPFLK 333
           HPF +
Sbjct: 293 HPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  103 bits (259), Expect = 1e-25
 Identities = 75/267 (28%), Positives = 129/267 (48%), Gaps = 16/267 (5%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIA-QELKINQSSQCPYVVVC 133
           +V+GKG  G V   Q + TG+ +A K ++   +++     +A  E +I +     +VV  
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHII 191
             ++ +  A+ ++L  M+GG L   +  +      EE       ++L GL  LH E + +
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE-NTV 124

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           +RDLKP N+L++  G ++I+D G+ A+           VGT  YM+PE ++  +Y    D
Sbjct: 125 YRDLKPENILLDDYGHIRISDLGL-AVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPD 183

Query: 252 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 311
            W LG ++ E   GQ P+   +++       E ++  V        S +FS E  S    
Sbjct: 184 YWGLGCLIYEMIEGQSPFRGRKEKVK----REEVDRRV-LETEEVYSAKFSEEAKSICKM 238

Query: 312 CVQKEPQQRLSAQ-----ELMTHPFLK 333
            + K+P+QRL  Q     E+  HPF +
Sbjct: 239 LLTKDPKQRLGCQEEGAGEVKRHPFFR 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 2e-25
 Identities = 80/284 (28%), Positives = 136/284 (47%), Gaps = 38/284 (13%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ----IAQELKINQSS 125
           +D + +KV+G+G+ G V +V+ K TGQ +A+K+  +N  E  +R       +E  +  + 
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKI--LNKWEMLKRAETACFREERDVLVNG 58

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEE----YLAAICEQVLKG 180
              ++   + +F     + ++++Y  GG L   L K    +PE+    YLA   E VL  
Sbjct: 59  DRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA---EMVLA- 114

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTFVGTYNYMSPE 239
            +   H+   +HRD+KP N+L++  G +++ DFG    ++A  + Q+N  VGT +Y+SPE
Sbjct: 115 -IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPE 173

Query: 240 RISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD---- 290
            +       G+YG + D WSLG+ + E   G+ P+          S  E    I++    
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-------ESLVETYGKIMNHKEH 226

Query: 291 -QPPPSAP--SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
            Q PP     S++        I  C  +    R   Q+   HPF
Sbjct: 227 FQFPPDVTDVSEEAKDLIRRLI--CSPETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  104 bits (260), Expect = 2e-25
 Identities = 65/215 (30%), Positives = 117/215 (54%), Gaps = 22/215 (10%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ----IAQELKINQSS 125
           +D + IKV+G+G+ G V +V+ K T + +A+K+  +N  E  +R       +E  +  + 
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKI--LNKWEMLKRAETACFREERNVLVNG 58

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEE----YLAAICEQVLKG 180
            C ++   + +F     + ++++Y  GG L   L K +  +PE+    Y+A   E VL  
Sbjct: 59  DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA---EMVLA- 114

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTFVGTYNYMSPE 239
            ++  H+ H +HRD+KP N+L++  G +++ DFG    +    + Q++  VGT +Y+SPE
Sbjct: 115 -IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173

Query: 240 RISG-----GKYGYKSDIWSLGLVLLECATGQFPY 269
            +       GKYG + D WSLG+ + E   G+ P+
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  102 bits (256), Expect = 4e-25
 Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 26/211 (12%)

Query: 75  IKVVGKGSGGIVQLVQHK--WTGQF------FALKVIQMNVEESARRQIAQELKINQSSQ 126
           IKV+G G+ G V    +K  W  +        A+KV++      A ++I  E  +  S  
Sbjct: 12  IKVLGSGAFGTV----YKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67

Query: 127 CPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGL 181
            P+VV    +C  S      + +I + M  G L D+++  K  I  +YL   C Q+ KG+
Sbjct: 68  HPHVVRLLGICLSS-----QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGM 122

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPE 239
            YL  EK ++HRDL   N+L+     VKITDFG++ ++     + +   G     +M+ E
Sbjct: 123 SYLE-EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181

Query: 240 RISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
            I    Y +KSD+WS G+ + E  T G  PY
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  105 bits (263), Expect = 5e-25
 Identities = 85/285 (29%), Positives = 140/285 (49%), Gaps = 44/285 (15%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ---MNVEESARRQIAQELKINQSSQCPY--V 130
           +V+G G+ G V   +    G+ FA+KV+    M+  +  R Q      +N    C +  +
Sbjct: 38  RVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLN----CDFFSI 93

Query: 131 VVCYQSF-YSNGA-------ISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVL 178
           V C++ F   +         I+++L+Y + G L   +K      +T  E     +  QVL
Sbjct: 94  VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153

Query: 179 KGLLYLHH--EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYN 234
              L +HH   KH+IHRD+K +N+L+   G VK+ DFG S + A+T       TF GT  
Sbjct: 154 ---LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210

Query: 235 YMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV----D 290
           Y++PE      Y  K+D++SLG++L E  T + P+      DG  +  E+M   +    D
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF------DG-ENMEEVMHKTLAGRYD 263

Query: 291 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
             PPS      SPE    ++A +  +P++R S+ +L+  P  K++
Sbjct: 264 PLPPS-----ISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303

Length = 496

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  102 bits (255), Expect = 5e-25
 Identities = 78/284 (27%), Positives = 128/284 (45%), Gaps = 28/284 (9%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 134
           ++ +G+GS   V     +  GQ  ALKVI M  EE       +E  + +  +   +V+ +
Sbjct: 10  LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLH 69

Query: 135 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKHIIHR 193
              ++   ++ + EYM    LA ++ +       Y +     Q+L+GL Y+H  +HI+HR
Sbjct: 70  DIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHR 127

Query: 194 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDI 252
           DLKP NLLI++ GE+K+ DFG++   +  S   ++ V T  Y  P+ + G   Y    DI
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187

Query: 253 WSLGLVLLECATGQ--FP--YSPPEQ------------QDGWTSFYELMEAIVD-QPPPS 295
           W  G + +E   GQ  FP      EQ            +D W    +L     +   P  
Sbjct: 188 WGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCK 247

Query: 296 APS-----DQFS--PEFCSFISACVQKEPQQRLSAQELMTHPFL 332
                    + S  P+     S  +   P+ R+SAQ+ + HP+ 
Sbjct: 248 PQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 7e-25
 Identities = 71/292 (24%), Positives = 120/292 (41%), Gaps = 53/292 (18%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQ--LVQHKWTGQFF---ALKVIQMNVEESARRQIAQELK 120
           +L  E I  I+ +G+GS G+V   L +    G+     A+K +  N     R +   E  
Sbjct: 2   ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS 61

Query: 121 INQSSQCPYVVVCYQSFYSNGAIS------IILEYMDGGSLADFLKK----------VKT 164
           + +   C +VV         G +S      +++E M  G L  +L+           +  
Sbjct: 62  VMKEFNCHHVVRLL------GVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP 115

Query: 165 IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-- 222
              +    +  ++  G+ YL   K  +HRDL   N ++     VKI DFG++  +  T  
Sbjct: 116 PTLQKFIQMAAEIADGMAYLA-AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY 174

Query: 223 ---SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 278
               G+    V    +M+PE +  G +  KSD+WS G+VL E AT  + PY         
Sbjct: 175 YRKGGKGLLPV---RWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQG------- 224

Query: 279 TSFYELMEAIVDQ---PPPSAPSDQFSPEFC-SFISACVQKEPQQRLSAQEL 326
            S  E+++ ++D      P        P+     +  C Q  P+ R +  E+
Sbjct: 225 LSNEEVLKFVIDGGHLDLPENC-----PDKLLELMRMCWQYNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  100 bits (252), Expect = 1e-24
 Identities = 69/267 (25%), Positives = 126/267 (47%), Gaps = 37/267 (13%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQF-FALKVIQ---MNVEESARRQIAQELKINQSSQCPYV 130
           +K +G G  G+V L   KW G+   A+K+I+   M+ ++       +E K+      P +
Sbjct: 9   LKELGSGQFGVVHL--GKWRGKIDVAIKMIREGAMSEDD-----FIEEAKVMMKLSHPNL 61

Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHHEKH 189
           V  Y        I I+ EYM  G L ++L++ K     E+L  +C  V + + YL     
Sbjct: 62  VQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE-SNG 120

Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKY 246
            IHRDL   N L+     VK++DFG++  +     TS Q   F     +  PE     ++
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKF--PVKWAPPEVFDYSRF 178

Query: 247 GYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI-----VDQPPPSAPSDQ 300
             KSD+WS G+++ E  + G+ PY      + +++  E++E++     + +P        
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPY------ERFSN-SEVVESVSAGYRLYRP------KL 225

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELM 327
              E  + + +C  ++P+ R + ++L+
Sbjct: 226 APTEVYTIMYSCWHEKPEDRPAFKKLL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  101 bits (253), Expect = 1e-24
 Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 54/297 (18%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-----VEESARRQIA--QELKINQSS 125
           + ++ +G+G+ G V   +++ T +  ALK ++++     V  SA R+I   +ELK     
Sbjct: 3   EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN-- 60

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICE----QVLKGL 181
               +V  Y   +S+  ++++ EY D     D  K   +   +    I +    Q+LKGL
Sbjct: 61  ----IVRLYDVLHSDKKLTLVFEYCD----QDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 241
            + H   +++HRDLKP NLLIN  GE+K+ DFG++          +  V T  Y  P+ +
Sbjct: 113 AFCH-SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVL 171

Query: 242 SGGK-YGYKSDIWSLGLVLLECATGQFPY------------------SPPEQQDGWTSFY 282
            G K Y    D+WS G +  E A    P                   +P E+   W    
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEES--WPGVS 229

Query: 283 ELMEAIVDQPPPSAPS--------DQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
           +L +    +P P  P+         + +      +   +   P QR+SA+E + HP+
Sbjct: 230 KLPD---YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  102 bits (255), Expect = 1e-24
 Identities = 81/298 (27%), Positives = 144/298 (48%), Gaps = 40/298 (13%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVV 132
           I+ +G G+ G+V       +G+  A+K I    +V   A+R + +ELKI +  +   ++ 
Sbjct: 10  IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTL-RELKILRHFKHDNIIA 68

Query: 133 CYQSFYSNGA----ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
                   GA    + ++++ M    L   +   + + EE++     Q+L+GL Y+H   
Sbjct: 69  IRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN 127

Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF----VGTYNYMSPE-RISG 243
            +IHRDLKPSNLL+N   E++I DFG++  ++S+  +   F    V T  Y +PE  +S 
Sbjct: 128 -VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSL 186

Query: 244 GKYGYKSDIWSLGLVLLECATGQ--FP---Y------------SPPEQ---QDGWTSFYE 283
            +Y    D+WS+G +  E    +  FP   Y            SP E+   + G     +
Sbjct: 187 PEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRK 246

Query: 284 LMEAIVDQPPPSAPSDQF----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
            ++ +  + P   P  +     SPE    +S  +Q +P++R++ ++ + HPFL  Y D
Sbjct: 247 YIQNLPRKQP--VPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHD 302

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  102 bits (255), Expect = 2e-24
 Identities = 84/307 (27%), Positives = 140/307 (45%), Gaps = 53/307 (17%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQC 127
           ED +++KV+G+G+ G V+LVQ K TG  +A+K+++    +E+     I  E  I   +  
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA-AICEQVLKGLLYLHH 186
            +VV  + SF     + +I+E++ GG +   L K  T+ EE     I E VL   +   H
Sbjct: 61  LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLA--IDSIH 118

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA------------------------ST 222
           +   IHRD+KP NLL++ +G VK++DFG+   +                         ++
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 223 SGQANTF-----------VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 271
             +A T+           VGT +Y++PE      Y    D WSLG+++ E   G  P+  
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238

Query: 272 PEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSA---QEL 326
              Q+ +       E ++  P  P S  +      FC         E + R+ A   +E+
Sbjct: 239 ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC--------EWEHRIGAPGVEEI 290

Query: 327 MTHPFLK 333
            T+PF +
Sbjct: 291 KTNPFFE 297

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  100 bits (251), Expect = 2e-24
 Identities = 78/292 (26%), Positives = 135/292 (46%), Gaps = 25/292 (8%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           LE    +  +G+G+   V   + K T    ALK I++  EE A     +E+ + +  +  
Sbjct: 5   LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHE 187
            +V  +   ++  +++++ EY+D   L  +L     +I    +     Q+L+GL Y H  
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KY 246
           K ++HRDLKP NLLIN RGE+K+ DFG++   +  +   +  V T  Y  P+ + G   Y
Sbjct: 124 K-VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDY 182

Query: 247 GYKSDIWSLGLVLLECATGQ--FPYSPPEQQ-------------DGWTSFYELMEAIVDQ 291
             + D+W +G +  E +TG+  FP S  E+Q             + W       E     
Sbjct: 183 STQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN 242

Query: 292 PPPSAP------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
            P          + +   +    +S  +Q E ++R+SA+E M HP+    G+
Sbjct: 243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGE 294

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  100 bits (249), Expect = 3e-24
 Identities = 76/271 (28%), Positives = 130/271 (47%), Gaps = 24/271 (8%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIA-QELKINQSSQCPYVVVC 133
           +V+GKG  G V   Q + TG+ +A K ++   +++     +A  E +I +     +VV  
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEE----YLAAICEQVLKGLLYLHHE 187
             ++ +  A+ ++L  M+GG L   +  +      E+    Y A +C     GL  L  E
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELC----CGLEDLQRE 121

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 247
           + I++RDLKP N+L++ RG ++I+D G+ A+           VGT  YM+PE I+  KY 
Sbjct: 122 R-IVYRDLKPENILLDDRGHIRISDLGL-AVQIPEGETVRGRVGTVGYMAPEVINNEKYT 179

Query: 248 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS 307
           +  D W LG ++ E   GQ P+   +++         ++   DQ      S++FS +  S
Sbjct: 180 FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE--DQ---EEYSEKFSEDAKS 234

Query: 308 FISACVQKEPQQRL-----SAQELMTHPFLK 333
                + K P++RL      A  +  HP  K
Sbjct: 235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 98.9 bits (246), Expect = 1e-23
 Identities = 76/291 (26%), Positives = 137/291 (47%), Gaps = 25/291 (8%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +E    ++ +G+G+   V   + K T    ALK I++  EE A     +E+ + +  +  
Sbjct: 5   METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHA 64

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI-CEQVLKGLLYLHHE 187
            +V  +   +++ +++++ EY+D   L  ++     I   +   I   Q+L+GL Y H  
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKY 246
           K ++HRDLKP NLLIN RGE+K+ DFG++   +  +   +  V T  Y  P+ + G  +Y
Sbjct: 124 K-VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY 182

Query: 247 GYKSDIWSLGLVLLECATGQ--FPYSPPEQ-------------QDGWTSFYELMEAIVDQ 291
             + D+W +G +  E A+G+  FP S  E              ++ W       E     
Sbjct: 183 STQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN 242

Query: 292 PPPSAP------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 336
            P   P      + +   E    ++  +Q E ++R+SA+E M H + +  G
Sbjct: 243 FPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 99.4 bits (247), Expect = 2e-23
 Identities = 65/215 (30%), Positives = 119/215 (55%), Gaps = 22/215 (10%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ----MNVEESARRQIAQELKINQSS 125
           ED + +KV+G+G+ G V +V+ K   + FA+K++     +   E+A  +  +++ +N  +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEE----YLAAICEQVLKG 180
           Q  ++   + +F     + ++++Y  GG L   L K +  +PE+    YLA   E V+  
Sbjct: 61  Q--WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLA---EMVIA- 114

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTFVGTYNYMSPE 239
            +   H+ H +HRD+KP N+L++  G +++ DFG    +M   + Q++  VGT +Y+SPE
Sbjct: 115 -IDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE 173

Query: 240 RISG-----GKYGYKSDIWSLGLVLLECATGQFPY 269
            +       GKYG + D WSLG+ + E   G+ P+
Sbjct: 174 ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 98.2 bits (245), Expect = 3e-23
 Identities = 65/200 (32%), Positives = 103/200 (51%), Gaps = 19/200 (9%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVV----V 132
           +G+G+ G V   +HK T Q  ALK + M  E+      A +E+KI Q  +   VV    +
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 133 CYQ--SFYSN--GAISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHH 186
           C    + Y+   G+  ++ E+ +   LA  L  K VK    E +  + + +L GL Y+H 
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSE-IKKVMKMLLNGLYYIHR 137

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTF---VGTYNYMSPERIS 242
            K I+HRD+K +N+LI   G +K+ DFG++ A   S + + N +   V T  Y  PE + 
Sbjct: 138 NK-ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLL 196

Query: 243 GGK-YGYKSDIWSLGLVLLE 261
           G + YG   D+W  G ++ E
Sbjct: 197 GERDYGPPIDMWGAGCIMAE 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 97.5 bits (243), Expect = 3e-23
 Identities = 83/286 (29%), Positives = 133/286 (46%), Gaps = 52/286 (18%)

Query: 75  IKVVGKGSGGIVQLVQHK----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV 130
           I+ +GKG+ G V+L ++      TG+  A+K +Q +  E  R    +E++I +S Q   +
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLR-DFEREIEILKSLQHDNI 67

Query: 131 V----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLH 185
           V    VCY +   N  + +++EY+  GSL D+L+K +  +    L     Q+ KG+ YL 
Sbjct: 68  VKYKGVCYSAGRRN--LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI--------MASTSGQANTFVGTYNYMS 237
             K  +HRDL   N+L+     VKI DFG++ +             G++  F     + +
Sbjct: 126 -SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIF-----WYA 179

Query: 238 PERISGGKYGYKSDIWSLGLVLLECATGQFPY-----SPPE--------QQDGWTSFYEL 284
           PE ++  K+   SD+WS G+VL E     F Y     SPP          + G    Y L
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYEL----FTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235

Query: 285 MEAIVDQ----PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           +E + +      PP  P+     E  + +  C   +P QR S  EL
Sbjct: 236 IELLKNNGRLPAPPGCPA-----EIYAIMKECWNNDPSQRPSFSEL 276

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 96.8 bits (242), Expect = 3e-23
 Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 18/206 (8%)

Query: 68  NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM---NVEESARRQIAQELKINQS 124
           N E +  +K++  G  G V +++HK T + F  K+I+    N  E     + Q +K N  
Sbjct: 15  NCEIVKKLKLI-DGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPM---VHQLMKDN-- 68

Query: 125 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL 184
              P  +  Y S  +     +I++Y+  G L D LKK   + E  +  I  Q+++ L  L
Sbjct: 69  ---PNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDL 125

Query: 185 HHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
           H + +IIH D+K  N+L +  +  + + D+G+  I+ + S     + GT +Y SPE+I G
Sbjct: 126 H-KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS----CYDGTLDYFSPEKIKG 180

Query: 244 GKYGYKSDIWSLGLVLLECATGQFPY 269
             Y    D W++G++  E  TG+ P+
Sbjct: 181 HNYDVSFDWWAVGVLTYELLTGKHPF 206

Length = 267

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 97.4 bits (242), Expect = 3e-23
 Identities = 64/205 (31%), Positives = 112/205 (54%), Gaps = 4/205 (1%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVV 131
           + + VVG+G+ G+V   +HK T +  A+K  + + E E  +    +ELK+ ++ +   +V
Sbjct: 4   EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIV 63

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
              ++F   G + ++ EY++   L    +    +P E + +   Q++K + + H +  I+
Sbjct: 64  ELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH-KNDIV 122

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGGKYGYKS 250
           HRD+KP NLLI+H   +K+ DFG +  ++  S    T +V T  Y SPE + G  YG   
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAV 182

Query: 251 DIWSLGLVLLECATGQFPYSPPEQQ 275
           D+WS+G +L E + GQ P  P E +
Sbjct: 183 DMWSVGCILGELSDGQ-PLFPGESE 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 96.3 bits (240), Expect = 8e-23
 Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 5/198 (2%)

Query: 71  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPY 129
           D   I+ +G+G+ G+V   ++K TGQ  A+K I++  EE      A +E+ + +  Q P 
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60

Query: 130 VVVCYQSFYSNGAISIILEY--MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 187
           +V           + +I E+  MD     D L K + +  E + +   Q+L+G+L+ H  
Sbjct: 61  IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH-S 119

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KY 246
           + ++HRDLKP NLLI+++G +K+ DFG++             V T  Y +PE + G  +Y
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179

Query: 247 GYKSDIWSLGLVLLECAT 264
               DIWS+G +  E AT
Sbjct: 180 STPVDIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 96.0 bits (239), Expect = 1e-22
 Identities = 81/309 (26%), Positives = 145/309 (46%), Gaps = 55/309 (17%)

Query: 68  NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKIN 122
            ++  D I  +G+G+ G V   + K TG+  ALK ++++ E+     +A R+I    ++N
Sbjct: 5   CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN 64

Query: 123 QSSQCPYVVVCYQSFYSN-----------GAISIILEYMDGGSLADFLKKVKTIPEEYLA 171
             +     +V  +   ++           GA  ++ EYMD   +      +    E+++ 
Sbjct: 65  HRN-----IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK 119

Query: 172 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FV 230
           +  +Q+L+GL Y H +K+ +HRD+K SN+L+N++G++K+ DFG++ +  S   +  T  V
Sbjct: 120 SFMKQLLEGLNYCH-KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178

Query: 231 GTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 289
            T  Y  PE + G  +YG   D+WS G +L E     F   P  Q +   +  EL+  + 
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGEL----FTKKPIFQANQELAQLELISRLC 234

Query: 290 DQPPPSA--------------PSDQFS----PEFCSFISA--------CVQKEPQQRLSA 323
             P P+               P  Q+      EF SFI           +  +P +R +A
Sbjct: 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTA 293

Query: 324 QELMTHPFL 332
           +E +  P+L
Sbjct: 294 EEALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 95.6 bits (238), Expect = 1e-22
 Identities = 76/293 (25%), Positives = 133/293 (45%), Gaps = 41/293 (13%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQS-SQCPYVV- 131
           ++ +G+G+ G V   + K TG+  ALK  ++ ++E      A +E+ + Q  S+  Y+V 
Sbjct: 6   LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVR 65

Query: 132 -VCYQSFYSNGA---ISIILEYMDGGSLADFL-----KKVKTIPEEYLAAICEQVLKGLL 182
            +  +          + ++ EY+D   L  F+        + +P + + +   Q+LKG+ 
Sbjct: 66  LLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124

Query: 183 YLHHEKH-IIHRDLKPSNLLINHRGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           + H  KH ++HRDLKP NLL++ +  + KI D G+    +         + T  Y +PE 
Sbjct: 125 HCH--KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEV 182

Query: 241 ISGGK-YGYKSDIWSLGLVLLECATGQ--FP---------------YSPPEQQDGWTSFY 282
           + G   Y    DIWS+G +  E +  Q  FP                +P EQ   W    
Sbjct: 183 LLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV--WPGVS 240

Query: 283 ELME-AIVDQPPP---SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
           +L +     Q  P   S      SPE    +   ++ +P +R+SA+  +THP+
Sbjct: 241 KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 99.0 bits (246), Expect = 1e-22
 Identities = 86/308 (27%), Positives = 141/308 (45%), Gaps = 41/308 (13%)

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQEL 119
           K  D +  L + + IK +G G  G V LV+HK T +FF  K I    ++E  + Q+  E+
Sbjct: 4   KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEV 63

Query: 120 KINQSSQCPYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAI 173
            + +  +   +V     F   +N  + I++E+ D G L+  ++K       I E  +  I
Sbjct: 64  NVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123

Query: 174 CEQVLKGLLYLHHEK------HIIHRDLKPSNLL----INHRGEV-------------KI 210
             Q+L  L Y H+ K       ++HRDLKP N+     I H G++             KI
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183

Query: 211 TDFGVSAIMASTSGQANTFVGTYNYMSPERI--SGGKYGYKSDIWSLGLVLLECATGQFP 268
            DFG+S  +   S  A++ VGT  Y SPE +      Y  KSD+W+LG ++ E  +G+ P
Sbjct: 184 GDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242

Query: 269 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
           +          +F +L+  +  +  P  P    S E    I   +    ++R SA + + 
Sbjct: 243 FHKA------NNFSQLISEL--KRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294

Query: 329 HPFLKMYG 336
           +  +K  G
Sbjct: 295 YQIIKNVG 302

Length = 1021

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 96.4 bits (240), Expect = 2e-22
 Identities = 82/321 (25%), Positives = 122/321 (38%), Gaps = 83/321 (25%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVV 131
           IK +G G+ G V LV+   T   +A+K ++   +   R Q A    E  I   +   +VV
Sbjct: 6   IKTIGIGAFGEVCLVRKVDTNALYAMKTLR-KADVLMRNQAAHVKAERDILAEADNEWVV 64

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYL 184
             Y SF     +  +++Y+ GG +   L ++    E+        L    E V       
Sbjct: 65  KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESV------- 117

Query: 185 HHEKHIIHRDLKPSNLLINHRGEVKITDFG------------------------------ 214
            H+   IHRD+KP N+LI+  G +K+TDFG                              
Sbjct: 118 -HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEE 176

Query: 215 VSAIMAS-------------TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
            S I                    A++ VGT NY++PE +    Y    D WS+G++L E
Sbjct: 177 WSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236

Query: 262 CATGQFPY---SPPEQQD---GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 315
              GQ P+   +P E Q     W +   +        P  A   + S E    I      
Sbjct: 237 MLVGQPPFLADTPAETQLKVINWETTLHI--------PSQA---KLSREASDLILRLC-C 284

Query: 316 EPQQRL---SAQELMTHPFLK 333
             + RL    A E+  HPF K
Sbjct: 285 GAEDRLGKNGADEIKAHPFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 94.8 bits (236), Expect = 3e-22
 Identities = 73/289 (25%), Positives = 126/289 (43%), Gaps = 45/289 (15%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQ--HKWTGQFF---ALKVIQMNVEESARRQIAQELKI 121
           +  + I   + +G+G+ G V L +  H          A+K ++      AR+   +E ++
Sbjct: 2   VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAEL 61

Query: 122 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK--------------KVKTIPE 167
             + Q   +V  Y          ++ EYM+ G L  FL+               +  +  
Sbjct: 62  LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121

Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST----- 222
             L  I  Q+  G++YL   +H +HRDL   N L+ +   VKI DFG+S  + +T     
Sbjct: 122 SQLLQIAVQIASGMVYLA-SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRV 180

Query: 223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSF 281
            G     +    +M PE I   K+  +SD+WS G+VL E  T G+ P+          S 
Sbjct: 181 GGHTMLPI---RWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG-------LSN 230

Query: 282 YELMEAI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
            E++E I    + Q P + P      E    +  C +++PQQR++ +++
Sbjct: 231 EEVIECITQGRLLQRPRTCP-----SEVYDIMLGCWKRDPQQRINIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 95.8 bits (238), Expect = 3e-22
 Identities = 74/279 (26%), Positives = 131/279 (46%), Gaps = 32/279 (11%)

Query: 64  DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF--FALKVIQMN--VEESARRQIAQEL 119
            N++  ED + I+ +G GS G V L  +K    F   A+K  + +  +++     +  E 
Sbjct: 24  KNKMKYEDFNFIRTLGTGSFGRVILATYK-NEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82

Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           KI      P+ V  Y SF     + ++LE++ GG    FL++ K  P +       Q++ 
Sbjct: 83  KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142

Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YL    +I++RDLKP NLL++  G +K+TDFG + ++ +   +  T  GT  Y++PE
Sbjct: 143 IFEYLQ-SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT---RTYTLCGTPEYIAPE 198

Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD 299
            +    +G  +D W+LG+ + E   G  P+   E       + +++E I+  P       
Sbjct: 199 ILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP---LLIYQKILEGIIYFP------- 248

Query: 300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL 338
           +F    C  +              ++L++H   K YG+L
Sbjct: 249 KFLDNNCKHL-------------MKKLLSHDLTKRYGNL 274

Length = 340

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 94.3 bits (235), Expect = 4e-22
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 68/300 (22%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIA--QELKINQSSQCPYV 130
           +G+G+ G+V   + K TG+  ALK I++  E+     +A R+I+  +EL        P +
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN------HPNI 60

Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAA-----ICEQVLKGLLYLH 185
           V      +S   + ++ E++D     D  K + + P   L          Q+L+G+ Y H
Sbjct: 61  VRLLDVVHSENKLYLVFEFLD----LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH 116

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF---VGTYN-------Y 235
             + ++HRDLKP NLLI+  G +K+ DFG+          A  F   V TY        Y
Sbjct: 117 SHR-VLHRDLKPQNLLIDREGALKLADFGL----------ARAFGVPVRTYTHEVVTLWY 165

Query: 236 MSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---------------YSPPEQQDG 277
            +PE + G + Y    DIWS+G +  E    +  FP                +P E  D 
Sbjct: 166 RAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDE--DV 223

Query: 278 W---TSFYELMEAIVDQPPPSAPSD--QFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           W   TS  +                      +    +S  +  +P +R+SA+  + HP+ 
Sbjct: 224 WPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 94.3 bits (234), Expect = 5e-22
 Identities = 73/278 (26%), Positives = 131/278 (47%), Gaps = 25/278 (8%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF 137
           +G+G+   V   + K T    ALK I++  EE A     +E+ + ++ +   +V  +   
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 138 YSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICE-QVLKGLLYLHHEKHIIHRDLK 196
           ++   ++++ EY+D   L  +L     +   +   I   Q+L+GL Y H  K I+HRDLK
Sbjct: 73  HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK-ILHRDLK 130

Query: 197 PSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSL 255
           P NLLIN +GE+K+ DFG++   +  +   +  V T  Y  P+ + G  +Y    D+W +
Sbjct: 131 PQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGV 190

Query: 256 GLVLLECATGQ--FPYSPPEQ-------------QDGW---TSFYELMEAIVDQPPPSA- 296
           G +L E ATG+  FP S  ++             ++ W   TS  E    +  Q      
Sbjct: 191 GCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPL 250

Query: 297 --PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
              + +   +    +S+ +  E + R+SA+  + H + 
Sbjct: 251 INHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 93.1 bits (232), Expect = 1e-21
 Identities = 82/308 (26%), Positives = 135/308 (43%), Gaps = 47/308 (15%)

Query: 68  NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKIN 122
            L D + +  +G+G+ G V   +   TG+  ALK I M+ E+     +A R+I    K+ 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK 65

Query: 123 QSSQCPYVVVCY----QSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQ 176
             +  P + +      +S    G++ ++  YMD   L+  L+   VK + E  +     Q
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVK-LTESQIKCYMLQ 123

Query: 177 VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI------MASTSGQANT-- 228
           +L+G+ YLH E HI+HRD+K +N+LI+++G +KI DFG++             G   T  
Sbjct: 124 LLEGINYLH-ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182

Query: 229 ---FVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FPYS------------ 270
               V T  Y  PE + G + Y    DIW +G V  E  T +                  
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242

Query: 271 --PPEQQD--GWTSFYELMEAIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSA 323
              P ++   GW S             P    ++F    PE    +S  +  +P +RL+A
Sbjct: 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTA 302

Query: 324 QELMTHPF 331
            + + HP+
Sbjct: 303 SDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 93.4 bits (232), Expect = 2e-21
 Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 53/299 (17%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA-RRQIAQELKINQSSQCPYVVVC 133
           ++ VG G+ G+V   + + TGQ  A+K I          ++  +ELK+ +  +   ++  
Sbjct: 15  LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISL 74

Query: 134 YQSFYSNGA-ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
              F S    I  + E + G  L   L   + + ++++     Q+L+GL Y+H    ++H
Sbjct: 75  SDIFISPLEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVH-SAGVVH 131

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSD 251
           RDLKPSN+LIN   ++KI DFG++ I      Q   +V T  Y +PE  ++  KY  + D
Sbjct: 132 RDLKPSNILINENCDLKICDFGLARIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVD 188

Query: 252 IWSLGLVLLECATGQ--FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS-- 307
           IWS G +  E   G+  FP      Q     F  + + +        P D      CS  
Sbjct: 189 IWSAGCIFAEMLEGKPLFPGKDHVNQ-----FSIITDLL------GTPPDDVINTICSEN 237

Query: 308 ---FISACVQKE--------------------------PQQRLSAQELMTHPFLKMYGD 337
              F+ +  ++E                          PQ+R+SA E + HP+L  Y D
Sbjct: 238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 92.4 bits (230), Expect = 3e-21
 Identities = 60/194 (30%), Positives = 97/194 (50%), Gaps = 17/194 (8%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIA--QELKINQSSQCPYV 130
           +G+G+ GIV   +   +G+  ALK ++M+ E      S+ R+I     L+     +   V
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 131 VVCYQSFYSNGAISIILEY--MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
           VV         +I +++EY   D  SL D +    +  +  +  +  Q+L+GL YLH   
Sbjct: 75  VVGKHL----DSIFLVMEYCEQDLASLLDNMPTPFSESQ--VKCLMLQLLRGLQYLHEN- 127

Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 248
            IIHRDLK SNLL+  +G +KI DFG++      +      V T  Y +PE + G     
Sbjct: 128 FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYT 187

Query: 249 KS-DIWSLGLVLLE 261
            + D+W++G +L E
Sbjct: 188 TAIDMWAVGCILAE 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 91.0 bits (226), Expect = 4e-21
 Identities = 75/263 (28%), Positives = 118/263 (44%), Gaps = 34/263 (12%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VC 133
           +GKG+ G V     K      A+K  +  +    +R+  QE +I +    P +V    VC
Sbjct: 3   IGKGNFGDVYKGVLK-GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            Q       I I++E + GGSL  FL+K K  +  + L  +      G+ YL   K+ IH
Sbjct: 62  VQKQ----PIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE-SKNCIH 116

Query: 193 RDLKPSNLLINHRGEVKITDFGVS-----AIMASTSGQANTFVGTYNYMSPERISGGKYG 247
           RDL   N L+     +KI+DFG+S      I   + G     +    + +PE ++ G+Y 
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI---KWTAPEALNYGRYT 173

Query: 248 YKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTS--FYELMEAIVDQPPPSAPSDQFSPE 304
            +SD+WS G++L E  + G  PY       G ++    E +E+    P P     Q  PE
Sbjct: 174 SESDVWSYGILLWETFSLGDTPYP------GMSNQQTRERIESGYRMPAP-----QLCPE 222

Query: 305 FCSFI-SACVQKEPQQRLSAQEL 326
               +   C   +P+ R S  E+
Sbjct: 223 EIYRLMLQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 90.3 bits (224), Expect = 7e-21
 Identities = 62/210 (29%), Positives = 109/210 (51%), Gaps = 15/210 (7%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF-FALKVIQMNVEES-ARRQIAQELKINQS 124
           ++ +D+  +K +G G  G+V+    KW GQ+  A+K+I+   E S +  +  +E K+   
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKY--GKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMK 55

Query: 125 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLY 183
                +V  Y        I I+ EYM  G L ++L++     +   L  +C+ V +G+ Y
Sbjct: 56  LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAY 115

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMSPER 240
           L   K  IHRDL   N L++ +G VK++DFG+S  +     +  + VG+     +  PE 
Sbjct: 116 LE-SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEV 172

Query: 241 ISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           +   K+  KSD+W+ G+++ E  + G+ PY
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPY 202

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 89.9 bits (223), Expect = 9e-21
 Identities = 74/272 (27%), Positives = 128/272 (47%), Gaps = 31/272 (11%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF-FALKVIQMNVEESARRQIAQELKINQSS 125
           +N  ++  +K +G G  G+V L   KW  Q   A+K I  N    +     +E K+    
Sbjct: 1   INPSELTFMKELGSGQFGVVHL--GKWRAQIKVAIKAI--NEGAMSEEDFIEEAKVMMKL 56

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYL 184
             P +V  Y        + I+ E+M+ G L ++L++ +  + ++ L ++C+ V +G+ YL
Sbjct: 57  SHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYL 116

Query: 185 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERI 241
                 IHRDL   N L++  G VK++DFG++  +     TS     F     +  PE  
Sbjct: 117 E-RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKF--PVKWSPPEVF 173

Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
           +  KY  KSD+WS G+++ E  T G+ P+          S YE++E I      S     
Sbjct: 174 NFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK-------KSNYEVVEMI------SRGFRL 220

Query: 301 FSPEFCS-----FISACVQKEPQQRLSAQELM 327
           + P+  S      + +C  ++P+ R +  EL+
Sbjct: 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 89.2 bits (221), Expect = 2e-20
 Identities = 74/269 (27%), Positives = 136/269 (50%), Gaps = 33/269 (12%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA-RRQIAQELKINQSS 125
           LNL+ +   +++G+G  G V  +Q ++TGQ  A+K I+ +V   A   + A   K++  +
Sbjct: 3   LNLQKLTLGEIIGEGEFGAV--LQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKN 60

Query: 126 QCPYV-VVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLL 182
               + V+ +   Y      I++E M  G+L +FL+      +    L      V +G+ 
Sbjct: 61  LVRLLGVILHNGLY------IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           YL  +K ++HRDL   N+L++  G  K++DFG++     + G  N+ +    + +PE + 
Sbjct: 115 YLESKK-LVHRDLAARNILVSEDGVAKVSDFGLAR--VGSMGVDNSKLPV-KWTAPEALK 170

Query: 243 GGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAP 297
             K+  KSD+WS G++L E  + G+ PY  P+      S  E+ E +      +PP   P
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPY--PK-----MSLKEVKECVEKGYRMEPPEGCP 223

Query: 298 SDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           +D +       +++C + EP++R S  +L
Sbjct: 224 ADVY-----VLMTSCWETEPKKRPSFHKL 247

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 89.6 bits (223), Expect = 2e-20
 Identities = 83/288 (28%), Positives = 135/288 (46%), Gaps = 48/288 (16%)

Query: 81  GSGGIVQLVQHKWTGQFFALKVIQMNVEES-----ARRQIAQELKINQSS--QCPYVVVC 133
           G+ G+V   + K TG+  ALK ++M  E+      + R+I   LK+   +      VVV 
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV- 74

Query: 134 YQSFYSNGA----ISIILEYM--DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 187
                  G+    I +++EY+  D  SL + +K+     E  +  +  Q+L G+ +LH +
Sbjct: 75  -------GSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSE--VKCLMLQLLSGVAHLH-D 124

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-Y 246
             I+HRDLK SNLL+N+RG +KI DFG++    S        V T  Y +PE + G K Y
Sbjct: 125 NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEY 184

Query: 247 GYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------QDGWTSFYELMEA---I 288
               D+WS+G +  E  T +  FP  S  +Q            +  W  F EL  A    
Sbjct: 185 STAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKT 244

Query: 289 VDQPPPSAPSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPF 331
             + P +    +F     S      ++  +  +P +R+SA++ + HP+
Sbjct: 245 FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 89.9 bits (224), Expect = 3e-20
 Identities = 86/314 (27%), Positives = 138/314 (43%), Gaps = 77/314 (24%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVI----QMNVEESAR--RQIA--QELKINQS 124
           + ++ +GKG+ GIV     + T +  ALK I    + N  ++ R  R+I   QEL     
Sbjct: 10  EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELG---- 64

Query: 125 SQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKV--KTIPEE----YLAAICEQ 176
              P +V       +  +  I ++ EYM+     D L  V    I E+    Y   I  Q
Sbjct: 65  -DHPNIVKLLNVIKAENDKDIYLVFEYME----TD-LHAVIRANILEDVHKRY---IMYQ 115

Query: 177 VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG----VSAIMASTSGQANT-FVG 231
           +LK L Y+H   ++IHRDLKPSN+L+N    VK+ DFG    +S +  +      T +V 
Sbjct: 116 LLKALKYIH-SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 232 TYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FPYS--------------PPEQ 274
           T  Y +PE + G  +Y    D+WS+G +L E   G+  FP +              PP  
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234

Query: 275 QD--------GWTSFYELMEAIVDQPP-------PSAPSDQFSPEFCSFISACVQKEPQQ 319
           +D          T    +++++  +P        P A  D         +   +   P +
Sbjct: 235 EDIESIKSPFAAT----MLDSLPSRPRKPLDELLPKASDDAL-----DLLKKLLVFNPNK 285

Query: 320 RLSAQELMTHPFLK 333
           RL+A+E + HP++ 
Sbjct: 286 RLTAEEALEHPYVA 299

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 88.9 bits (220), Expect = 3e-20
 Identities = 77/285 (27%), Positives = 127/285 (44%), Gaps = 34/285 (11%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVV- 131
           +G G+ G V   +   +G F ALK +++   E     S  R++A  LK  ++   P +V 
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVAL-LKRLEAFDHPNIVR 66

Query: 132 ---VCYQSFYSNGA-ISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLH 185
              VC  S       ++++ E++D   L  +L KV    +P E +  +  Q L+GL +LH
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
               I+HRDLKP N+L+   G+VK+ DFG++ I  S        V T  Y +PE +    
Sbjct: 126 ANC-IVHRDLKPENILVTSGGQVKLADFGLARIY-SCQMALTPVVVTLWYRAPEVLLQST 183

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP---SAPSDQFS 302
           Y    D+WS+G +  E    +  +    + D     ++L+    +   P   + P   FS
Sbjct: 184 YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFS 243

Query: 303 PEFCSFISACVQK---------------EPQQRLSAQELMTHPFL 332
           P     + + V +                P +R+SA   + HPF 
Sbjct: 244 PRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 88.9 bits (221), Expect = 4e-20
 Identities = 74/290 (25%), Positives = 134/290 (46%), Gaps = 44/290 (15%)

Query: 76  KVVGK-GSGGI--VQLVQHKWTGQFFALKVIQMN-----VEESAR-RQIAQELKINQSSQ 126
           K++GK G G    V   Q + TG+++A+K   M      +E+    R+I Q L+  + S 
Sbjct: 2   KILGKIGEGTFSEVLKAQSRKTGKYYAIK--CMKKHFKSLEQVNNLREI-QALR--RLSP 56

Query: 127 CPYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLY 183
            P ++   +  +    G ++++ E MD  +L + +K  K  +PE+ + +   Q+LK L +
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-S 242
           +H    I HRD+KP N+LI     +K+ DFG S     +      ++ T  Y +PE + +
Sbjct: 116 MHR-NGIFHRDIKPENILI-KDDILKLADFG-SCRGIYSKPPYTEYISTRWYRAPECLLT 172

Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ-DGWTSFYELM-----EAIVDQPPPSA 296
            G YG K DIW++G V  E  +  FP  P   + D     ++++     E +        
Sbjct: 173 DGYYGPKMDIWAVGCVFFEILS-LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231

Query: 297 PSDQF---------------SPEFCSFISACVQKEPQQRLSAQELMTHPF 331
            +  F               S E    +   +  +P +R++A++ + HP+
Sbjct: 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 88.3 bits (219), Expect = 6e-20
 Identities = 78/292 (26%), Positives = 131/292 (44%), Gaps = 48/292 (16%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-----ESARRQIAQELKINQSSQCPY 129
           ++ +G+G+ G+V   ++K TG+  ALK I+++ E      +A R+I+   ++N     P 
Sbjct: 5   VEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH----PN 60

Query: 130 VVVCYQSFYSNGAISIILE--------YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 181
           +V      ++   + ++ E        +MD   L+        IP   + +   Q+L+GL
Sbjct: 61  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSG-------IPLPLIKSYLFQLLQGL 113

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 241
            + H  + ++HRDLKP NLLIN  G +K+ DFG++             V T  Y +PE +
Sbjct: 114 AFCHSHR-VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 172

Query: 242 SGGKYGYKS--DIWSLGLVLLECATGQ--FPY-SPPEQ------------QDGWTSFYEL 284
            G KY Y +  DIWSLG +  E  T +  FP  S  +Q            +  W     L
Sbjct: 173 LGCKY-YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231

Query: 285 MEAIVDQP--PPSAPSD---QFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
            +     P       S        +    +S  +  +P +R+SA+  + HPF
Sbjct: 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 89.3 bits (221), Expect = 8e-20
 Identities = 92/331 (27%), Positives = 137/331 (41%), Gaps = 78/331 (23%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVV 131
           IK +G G+ G V L +   T   +A+K ++   +   R Q+A    E  I   +   +VV
Sbjct: 6   IKTLGIGAFGEVCLARKVDTKALYAMKTLRKK-DVLLRNQVAHVKAERDILAEADNEWVV 64

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
             Y SF     +  +++Y+ GG +   L ++   PE+ LA      L   +   H+   I
Sbjct: 65  RLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPED-LARFYIAELTCAVESVHKMGFI 123

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMAST-------SGQ------------------- 225
           HRD+KP N+LI+  G +K+TDFG+      T       SG                    
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183

Query: 226 ---------------------ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
                                A++ VGT NY++PE +    Y    D WS+G++L E   
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 243

Query: 265 GQFPY---SPPEQQDGWTSFYELMEAIVDQP----PPSAPSDQFSPEFCSFI-SACVQKE 316
           GQ P+   +P E Q         M+ I  Q     PP A   + SPE    I   C  + 
Sbjct: 244 GQPPFLAQTPLETQ---------MKVINWQTSLHIPPQA---KLSPEASDLIIKLC--RG 289

Query: 317 PQQRL---SAQELMTHPFLKMYGDLNVDLSE 344
           P+ RL    A E+  HPF K   D + DL +
Sbjct: 290 PEDRLGKNGADEIKAHPFFKTI-DFSSDLRQ 319

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 87.1 bits (216), Expect = 9e-20
 Identities = 66/270 (24%), Positives = 121/270 (44%), Gaps = 31/270 (11%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 126
           +N +++     +GKG  G V  +   + GQ  A+K ++ +   +A +    E  +  + +
Sbjct: 3   INSKELKLGATIGKGEFGDV--MLGDYRGQKVAVKCLKDDS--TAAQAFLAEASVMTTLR 58

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYL 184
            P +V           + I+ EYM  GSL D+L+      I           V +G+ YL
Sbjct: 59  HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYL 118

Query: 185 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERIS 242
             EK+ +HRDL   N+L++     K++DFG++    ++ GQ     G     + +PE + 
Sbjct: 119 E-EKNFVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQD---SGKLPVKWTAPEALR 172

Query: 243 GGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAP 297
             K+  KSD+WS G++L E  + G+ PY P           +++  +      + P   P
Sbjct: 173 EKKFSTKSDVWSFGILLWEIYSFGRVPY-PRIPLK------DVVPHVEKGYRMEAPEGCP 225

Query: 298 SDQFSPEFCSFISACVQKEPQQRLSAQELM 327
                PE    +  C + +P +R + ++L 
Sbjct: 226 -----PEVYKVMKDCWELDPAKRPTFKQLR 250

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 86.9 bits (215), Expect = 1e-19
 Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 19/200 (9%)

Query: 86  VQLVQHKWTGQFFAL---------KVIQMNVEESA--RRQIAQELKINQSSQCPYVVVCY 134
           + LVQ   +GQF  +         KV    + E A       +E ++      P +V  Y
Sbjct: 6   LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLY 65

Query: 135 QSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHR 193
                   I ++ E+M+ G L+D+L+  +    +E L  +C  V +G+ YL    ++IHR
Sbjct: 66  GVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE-SSNVIHR 124

Query: 194 DLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKS 250
           DL   N L+     VK++DFG++  +     TS     F     + SPE  S  KY  KS
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF--PVKWSSPEVFSFSKYSSKS 182

Query: 251 DIWSLGLVLLEC-ATGQFPY 269
           D+WS G+++ E  + G+ PY
Sbjct: 183 DVWSFGVLMWEVFSEGKTPY 202

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 86.7 bits (215), Expect = 1e-19
 Identities = 60/244 (24%), Positives = 110/244 (45%), Gaps = 14/244 (5%)

Query: 81  GSGGIVQLVQHKWTGQF-FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS 139
           GSG   ++ +  W  +   A+K+++ +     +    +E++  +  +  +++  +     
Sbjct: 15  GSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQ-DFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 140 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
              + II E M+ GSL  FL+    + +P   L  +  QV +G+ YL  E++ IHRDL  
Sbjct: 74  GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE-EQNSIHRDLAA 132

Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 257
            N+L+      K+ DFG++ ++      ++     Y + +PE  S G +  KSD+WS G+
Sbjct: 133 RNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGI 192

Query: 258 VLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE 316
           +L E  T GQ PY      +    + ++        P   P      E    +  C   E
Sbjct: 193 LLYEMFTYGQVPYPGMNNHE---VYDQITAGYRMPCPAKCP-----QEIYKIMLECWAAE 244

Query: 317 PQQR 320
           P+ R
Sbjct: 245 PEDR 248

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 1e-19
 Identities = 61/189 (32%), Positives = 96/189 (50%), Gaps = 27/189 (14%)

Query: 143 ISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 200
           I I+ EYM  GSL DFLK    K +    L  +  Q+ +G+ YL   ++ IHRDL   N+
Sbjct: 76  IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE-SRNYIHRDLAARNI 134

Query: 201 LINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 257
           L+      KI DFG++ ++     T+ +   F     + +PE  + G++  KSD+WS G+
Sbjct: 135 LVGENLVCKIADFGLARLIEDDEYTAREGAKF--PIKWTAPEAANYGRFTIKSDVWSFGI 192

Query: 258 VLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQ----P-PPSAPSDQFSPEFCSFISA 311
           +L E  T G+ PY       G T+  E++E  V++    P PP+ P      E    +  
Sbjct: 193 LLTEIVTYGRVPYP------GMTN-REVLEQ-VERGYRMPRPPNCP-----EELYDLMLQ 239

Query: 312 CVQKEPQQR 320
           C  K+P++R
Sbjct: 240 CWDKDPEER 248

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 86.6 bits (215), Expect = 2e-19
 Identities = 58/180 (32%), Positives = 93/180 (51%), Gaps = 16/180 (8%)

Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++     + +++  +E  +      P +V    VC         + +++E    G 
Sbjct: 27  AVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE-----PLMLVMELAPLGP 81

Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 214
           L  +LKK + IP   L  +  QV  G+ YL   KH +HRDL   N+L+ +R + KI+DFG
Sbjct: 82  LLKYLKKRREIPVSDLKELAHQVAMGMAYLE-SKHFVHRDLAARNVLLVNRHQAKISDFG 140

Query: 215 VS-AIMA-STSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           +S A+ A S   +A T  G +   + +PE I+ GK+  KSD+WS G+ L E  + G  PY
Sbjct: 141 MSRALGAGSDYYRATT-AGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 83/291 (28%), Positives = 134/291 (46%), Gaps = 49/291 (16%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA--RRQIAQELKINQSSQCPYV 130
           D I+++GKG  G V L       +  ALK I+ ++ E+   +++  +E KI      P +
Sbjct: 5   DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGI 64

Query: 131 VVCYQSFYSNG-AISIILEYMDGGSLADFLKKV---KTIPEEY--------LAAICEQVL 178
           V  Y S  S+G  +   + Y++G +L   LK V   +++ +E           +I  ++ 
Sbjct: 65  VPVY-SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123

Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG------------------VSAIMA 220
             + Y+H  K ++HRDLKP N+L+   GEV I D+G                     I  
Sbjct: 124 ATIEYVH-SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 221 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 280
           S+       VGT +YM+PER+ G      +DI++LG++L +  T  FPY    ++ G   
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY---RRKKGRKI 239

Query: 281 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK----EPQQRL-SAQEL 326
            Y   + I+  P   AP  +  P    F+S    K    +P +R  S QEL
Sbjct: 240 SYR--DVILS-PIEVAPYREIPP----FLSQIAMKALAVDPAERYSSVQEL 283

Length = 932

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 61/186 (32%), Positives = 89/186 (47%), Gaps = 29/186 (15%)

Query: 176 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 235
           Q+L+GL Y+H    IIHRDLKPSN+ +N   E+KI DFG++     T  +   +V T  Y
Sbjct: 126 QILRGLKYIH-SAGIIHRDLKPSNIAVNEDCELKILDFGLA---RHTDDEMTGYVATRWY 181

Query: 236 MSPERI-SGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQ-------DGWTSFYELM 285
            +PE + +   Y    DIWS+G ++ E  TG+  FP S    Q        G T   EL+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG-TPDEELL 240

Query: 286 EAIVD-------QPPPSAPSDQF-------SPEFCSFISACVQKEPQQRLSAQELMTHPF 331
           + I         Q  P  P   F       +P     +   +  +P +R++A E + HP+
Sbjct: 241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300

Query: 332 LKMYGD 337
           L  Y D
Sbjct: 301 LAEYHD 306

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 85.8 bits (212), Expect = 4e-19
 Identities = 66/258 (25%), Positives = 121/258 (46%), Gaps = 12/258 (4%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQ 135
           +GKG  G V  VQ K TG+ +A K +      ++S  +    E +I +    P++V    
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 136 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI--CEQVLKGLLYLHHEKHIIHR 193
           +F S   + +++  M+GG L   +  V     E    I    Q+  G+L+LH    I++R
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH-SMDIVYR 119

Query: 194 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGGKYGYKSDI 252
           D+KP N+L++ +G  +++D G++  +    G+  T   GT  YM+PE +    Y Y  D 
Sbjct: 120 DMKPENVLLDDQGNCRLSDLGLAVELK--DGKTITQRAGTNGYMAPEILKEEPYSYPVDW 177

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 312
           +++G  + E   G+ P+   +++    +  EL    + +         F+ E        
Sbjct: 178 FAMGCSIYEMVAGRTPFKDHKEK---VAKEELKRRTL-EDEVKFEHQNFTEESKDICRLF 233

Query: 313 VQKEPQQRLSAQELMTHP 330
           + K+P+ RL ++E    P
Sbjct: 234 LAKKPEDRLGSREKNDDP 251

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 84.5 bits (209), Expect = 5e-19
 Identities = 67/253 (26%), Positives = 111/253 (43%), Gaps = 32/253 (12%)

Query: 86  VQLVQHKWTGQFFALKVIQMNVEES-ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           V LV    T Q F LK ++ + E S  R  I            P +V  ++   S  ++ 
Sbjct: 9   VLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPH-------CVPNMVCLHKYIVSEDSVF 61

Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           ++L++ +GG L   + K   IPEE +     +++  L  LH E  I+ RDL P+N+L++ 
Sbjct: 62  LVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG-IVCRDLNPNNILLDD 120

Query: 205 RGEVKITDFGV-SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
           RG +++T F   S +  S  G+A   +    Y +PE     +     D WSLG +L E  
Sbjct: 121 RGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPEVGGISEETEACDWWSLGAILFELL 176

Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
           TG              +  E   + ++        +  S E  S +   +Q  P +RL A
Sbjct: 177 TG-------------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223

Query: 324 -----QELMTHPF 331
                +++ +HPF
Sbjct: 224 GVAGVEDIKSHPF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 86.2 bits (214), Expect = 6e-19
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 28/217 (12%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI-----QMNVEESARRQIAQELKINQS 124
                +  +G+G+ G+V    HK TG   A+K I     Q   + + R     E+KI + 
Sbjct: 5   PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-----EIKILRR 59

Query: 125 SQCPYV-----VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQV 177
            +   +     ++   SF S   + I+ E M+     D  K +KT  +  +++     Q+
Sbjct: 60  FKHENIIGILDIIRPPSFESFNDVYIVQELME----TDLYKLIKTQHLSNDHIQYFLYQI 115

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST---SGQANTFVGTYN 234
           L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ I       +G    +V T  
Sbjct: 116 LRGLKYIH-SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 235 YMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FP 268
           Y +PE  ++   Y    DIWS+G +L E  + +  FP
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFP 211

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 85.9 bits (212), Expect = 6e-19
 Identities = 73/285 (25%), Positives = 125/285 (43%), Gaps = 26/285 (9%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV 132
           + ++ +G+GS   V   + K  G+  ALKVI++  EE       +E  + +  +   +V+
Sbjct: 8   EKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVL 67

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            +   ++   ++++ EY+         K    +  E +     Q+L+GL Y+H +++I+H
Sbjct: 68  LHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH-QRYILH 126

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSD 251
           RDLKP NLLI+  GE+K+ DFG++   +  S   +  V T  Y  P+ + G  +Y    D
Sbjct: 127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLD 186

Query: 252 IWSLGLVLLECATG--QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           +W +G + +E   G   FP     Q      F  L     D  P       F PE  +  
Sbjct: 187 MWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLY 246

Query: 310 SA----------------------CVQKEPQQRLSAQELMTHPFL 332
           S                        +Q  P+ RLSAQ  ++H + 
Sbjct: 247 SPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 85.4 bits (211), Expect = 6e-19
 Identities = 74/252 (29%), Positives = 114/252 (45%), Gaps = 40/252 (15%)

Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K ++    ESAR+   +E ++    Q  ++V  Y        + ++ EYM  G L  F
Sbjct: 39  AVKALK-EASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRF 97

Query: 159 LKK----VKTIPE-----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           L+      K +               + AI  Q+  G++YL    H +HRDL   N L+ 
Sbjct: 98  LRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA-SLHFVHRDLATRNCLVG 156

Query: 204 HRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 258
               VKI DFG+S  + ST      G+    +    +M PE I   K+  +SDIWS G+V
Sbjct: 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI---RWMPPESILYRKFTTESDIWSFGVV 213

Query: 259 LLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 314
           L E  T G+ P+   S  E  +  T   EL      + P + P     PE  + +  C Q
Sbjct: 214 LWEIFTYGKQPWYQLSNTEAIECITQGREL------ERPRTCP-----PEVYAIMQGCWQ 262

Query: 315 KEPQQRLSAQEL 326
           +EPQQR+  +++
Sbjct: 263 REPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 85.0 bits (210), Expect = 6e-19
 Identities = 56/181 (30%), Positives = 94/181 (51%), Gaps = 17/181 (9%)

Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+KV++   E+S R ++ +E +I      PY+V    VC        A+ +++E   GG 
Sbjct: 26  AIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE-----ALMLVMEMASGGP 80

Query: 155 LADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L  FL  K   I    +  +  QV  G+ YL   K+ +HRDL   N+L+ ++   KI+DF
Sbjct: 81  LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE-GKNFVHRDLAARNVLLVNQHYAKISDF 139

Query: 214 GVSAIMASTSG--QANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFP 268
           G+S  + +     +A +  G +   + +PE I+  K+  +SD+WS G+ + E  + GQ P
Sbjct: 140 GLSKALGADDSYYKARSA-GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198

Query: 269 Y 269
           Y
Sbjct: 199 Y 199

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 84.9 bits (210), Expect = 7e-19
 Identities = 50/147 (34%), Positives = 80/147 (54%), Gaps = 15/147 (10%)

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLHH 186
           Y VV  +  Y      II EYM+ GSL DFLK  +   +    L  +  Q+ +G+ ++  
Sbjct: 67  YAVVTQEPIY------IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE- 119

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 243
            K+ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 177

Query: 244 GKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G +  KSD+WS G++L E  T G+ PY
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 84.3 bits (208), Expect = 8e-19
 Identities = 77/271 (28%), Positives = 119/271 (43%), Gaps = 41/271 (15%)

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VC 133
           +G+G+ G V   + +      A+K  +  +    + +  QE +I +    P +V    VC
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLK------KVKTIPEEYLAAICEQVLKGLLYLHHE 187
            Q       I I++E + GG    FL+      KVK      L  + E    G+ YL   
Sbjct: 63  TQ----KQPIYIVMELVQGGDFLTFLRTEGPRLKVKE-----LIQMVENAAAGMEYLE-S 112

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVS-----AIMASTSGQANTFVGTYNYMSPERIS 242
           KH IHRDL   N L+  +  +KI+DFG+S      + AST G     V    + +PE ++
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPV---KWTAPEALN 169

Query: 243 GGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 301
            G+Y  +SD+WS G++L E  + G  PY+    Q       E +E  V  P P    +  
Sbjct: 170 YGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT----REAIEQGVRLPCP----ELC 221

Query: 302 SPEFCSFISACVQKEPQQRLS----AQELMT 328
                  +  C + +P QR S     QEL +
Sbjct: 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 9e-19
 Identities = 73/319 (22%), Positives = 134/319 (42%), Gaps = 76/319 (23%)

Query: 78  VGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEE------SARRQIA--QELKINQSSQC 127
           +G+G+ G V   + K    G+ +A+K  + + E+      SA R+IA  +ELK       
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK------H 61

Query: 128 PYVVVCYQSFYSNGA--ISIILEYMDGGSLADFL--------KKVKTIPEEYLAAICEQV 177
             VV   + F  +    + ++ +Y +     D           K  +IP   + ++  Q+
Sbjct: 62  ENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSAIMASTSGQ---ANTFV 230
           L G+ YLH    ++HRDLKP+N+L+      RG VKI D G++ +  +        +  V
Sbjct: 118 LNGVHYLH-SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176

Query: 231 GTYNYMSPERISGGKYGYKS-DIWSLGLVLLE---------CATGQFPYSPPEQQDGWTS 280
            T  Y +PE + G ++  K+ DIW++G +  E             +   S P Q+D    
Sbjct: 177 VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236

Query: 281 FYELM--------EAIVDQPPPSAPSDQFSPEF--CSFISACVQK--------------- 315
            +E++          I   P        F  +    + ++  ++K               
Sbjct: 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKL 296

Query: 316 ---EPQQRLSAQELMTHPF 331
              +P +R++A+E + HP+
Sbjct: 297 LEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 22/209 (10%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQF------FALKVIQMNVEESARRQIAQELKINQSSQCP 128
           IKV+G G+ G V   +  W  +        A+K ++      A ++I  E  +  S   P
Sbjct: 12  IKVLGSGAFGTVY--KGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNP 69

Query: 129 YVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLY 183
           +V     +C  S      + +I + M  G L D++++ K  I  +YL   C Q+ KG+ Y
Sbjct: 70  HVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 124

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 241
           L  E+ ++HRDL   N+L+     VKITDFG++ ++ +   + +   G     +M+ E I
Sbjct: 125 LE-ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183

Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
               Y ++SD+WS G+ + E  T G  PY
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKPY 212

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 84.3 bits (208), Expect = 1e-18
 Identities = 58/209 (27%), Positives = 102/209 (48%), Gaps = 17/209 (8%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA---RRQIAQELKINQ 123
           LN++++  ++ +GKG  G V L  ++  G   A+K I+ +    A      +  +L+ + 
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSN 60

Query: 124 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGL 181
             Q   V+V        G + I+ EYM  GSL D+L+      +  + L      V + +
Sbjct: 61  LVQLLGVIV-----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 241
            YL    + +HRDL   N+L++     K++DFG++   +ST       V    + +PE +
Sbjct: 116 EYLE-ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEAL 171

Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
              K+  KSD+WS G++L E  + G+ PY
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGRVPY 200

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 78/312 (25%), Positives = 134/312 (42%), Gaps = 59/312 (18%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFA---LKVIQMNVEESARRQ----------IAQELKIN 122
             +G+G+ G V+      TG+  A   +K+I+++ + +  RQ            +ELKI 
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---KT-IPEEYLAAICEQVL 178
              +   ++     +     I+++++ M        LKKV   K  + E  +  I  Q+L
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIMASD-----LKKVVDRKIRLTESQVKCILLQIL 129

Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS------AIMASTSGQANTF--- 229
            GL  LH + + +HRDL P+N+ IN +G  KI DFG++          + S         
Sbjct: 130 NGLNVLH-KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188

Query: 230 -----VGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQ-DGWTSFY 282
                V T  Y +PE + G  KY +  D+WS+G +  E  TG+ P  P E + D     +
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PLFPGENEIDQLGRIF 247

Query: 283 ELMEAIVDQPPPSAPS----DQFSP----------EFCS-----FISACVQKEPQQRLSA 323
           EL+    +   P A       +F+P             S      + + ++  P +R+SA
Sbjct: 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISA 307

Query: 324 QELMTHPFLKMY 335
           +E + H + K  
Sbjct: 308 KEALKHEYFKSD 319

Length = 335

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 84.1 bits (208), Expect = 1e-18
 Identities = 66/248 (26%), Positives = 112/248 (45%), Gaps = 42/248 (16%)

Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++    +  +++  +E  +  +   P +V    VC      N    II+E M+GG 
Sbjct: 30  AVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL----NEPQYIIMELMEGGD 85

Query: 155 LADFLKKVK---------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           L  +L+  +         T+ E  L  IC  V KG +YL  + H IHRDL   N L++ +
Sbjct: 86  LLSYLRDARVERFGPPLLTLKE--LLDICLDVAKGCVYLE-QMHFIHRDLAARNCLVSEK 142

Query: 206 GE-----VKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSL 255
           G      VKI DFG++  +  +      G+    V    +M+PE +  GK+  +SD+WS 
Sbjct: 143 GYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV---RWMAPESLLDGKFTTQSDVWSF 199

Query: 256 GLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 314
           G+++ E  T GQ PY     Q+       +      Q P + P   +       ++ C  
Sbjct: 200 GVLMWEILTLGQQPYPALNNQE---VLQHVTAGGRLQKPENCPDKIY-----QLMTNCWA 251

Query: 315 KEPQQRLS 322
           ++P +R +
Sbjct: 252 QDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 76/308 (24%), Positives = 132/308 (42%), Gaps = 58/308 (18%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 134
           ++ +G GS G+V         +  A+K I +   +S +  + +E+KI +      +V  Y
Sbjct: 10  LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHAL-REIKIIRRLDHDNIVKVY 68

Query: 135 QSFYSNG--------------AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           +    +G              ++ I+ EYM+   LA+ L++   + EE+      Q+L+G
Sbjct: 69  EVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRG 126

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMA---STSGQANTFVGTYNYM 236
           L Y+H   +++HRDLKP+N+ IN    V KI DFG++ I+    S  G  +  + T  Y 
Sbjct: 127 LKYIH-SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185

Query: 237 SPERI-SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-- 293
           SP  + S   Y    D+W+ G +  E  TG+  ++   +        E M+ I++  P  
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE-------LEQMQLILESVPVV 238

Query: 294 ----------------------PSAPSDQFSPEFCS----FISACVQKEPQQRLSAQELM 327
                                 P  P     P        F+   +   P  RL+A+E +
Sbjct: 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298

Query: 328 THPFLKMY 335
            HP++  Y
Sbjct: 299 MHPYMSCY 306

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 83.6 bits (207), Expect = 2e-18
 Identities = 54/189 (28%), Positives = 88/189 (46%), Gaps = 27/189 (14%)

Query: 143 ISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 200
           I I+ E M  GSL ++L+    + +    L  +  QV  G+ YL   ++ IHRDL   N+
Sbjct: 76  IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE-AQNYIHRDLAARNV 134

Query: 201 LINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGL 257
           L+      K+ DFG++ ++     +A    G      + +PE     ++  KSD+WS G+
Sbjct: 135 LVGENNICKVADFGLARVIKEDIYEARE--GAKFPIKWTAPEAALYNRFSIKSDVWSFGI 192

Query: 258 VLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQ-----PPPSAPSDQFSPEFCSFISA 311
           +L E  T G+ PY       G T+  E+++  VDQ      PP  P      E    +  
Sbjct: 193 LLTEIVTYGRMPYP------GMTN-AEVLQQ-VDQGYRMPCPPGCP-----KELYDIMLD 239

Query: 312 CVQKEPQQR 320
           C +++P  R
Sbjct: 240 CWKEDPDDR 248

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 75/291 (25%), Positives = 132/291 (45%), Gaps = 47/291 (16%)

Query: 78  VGKGS-GGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVV 131
           +G+G+ G + +    K  G+F ALK +++   E     S  R++A  L+  ++ + P VV
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVV 67

Query: 132 ----VCYQSFYS-NGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYL 184
               VC  S       ++++ E++D   L  +L KV    +P E +  +  Q+L+GL +L
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 126

Query: 185 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 244
           H  + ++HRDLKP N+L+   G++K+ DFG++ I  S      + V T  Y +PE +   
Sbjct: 127 HSHR-VVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEVLLQS 184

Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSP--------------------PEQQDGWTSFYEL 284
            Y    D+WS+G +  E     F   P                    P ++D W     L
Sbjct: 185 SYATPVDLWSVGCIFAE----MFRRKPLFRGSSDVDQLGKILDVIGLPGEED-WPRDVAL 239

Query: 285 MEAIVDQPPPSAPSDQFSPEF----CSFISACVQKEPQQRLSAQELMTHPF 331
                     + P ++F  +        +  C+   P +R+SA   ++HP+
Sbjct: 240 PRQAF-HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 86.4 bits (214), Expect = 2e-18
 Identities = 51/186 (27%), Positives = 89/186 (47%), Gaps = 14/186 (7%)

Query: 94  TGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVVCYQSFYS-NGAISIILEYM 150
           TG   A+K+++ +  E   +  +  +E  +      P +V    S  +  G +  + EY+
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 151 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---E 207
            G +L + L     +P      +  QVL  L   H  + I+HRDLKP N++++  G    
Sbjct: 62  PGRTLREVLAADGALPAGETGRLMLQVLDALACAH-NQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 208 VKITDFGVSAIM-------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
            K+ DFG+  ++        +T  +    +GT  Y +PE++ G      SD+++ GL+ L
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180

Query: 261 ECATGQ 266
           EC TGQ
Sbjct: 181 ECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 83.8 bits (207), Expect = 3e-18
 Identities = 76/314 (24%), Positives = 135/314 (42%), Gaps = 56/314 (17%)

Query: 73  DTIKVVGKGSGGI--VQLVQHKWTGQFFALKVIQMNVEESARRQIAQ-ELKINQSSQCPY 129
           + + V+G+G   +  V L ++K TG++  ++ I +    +      Q EL +++    P 
Sbjct: 1   ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPN 60

Query: 130 VVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHE 187
           +V    +F ++  + ++  +M  GS  D +    +  + E  +A I + VLK L Y+HH 
Sbjct: 61  IVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM 120

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGTYN--------YMSP 238
            ++ HR +K S++LI+  G+V ++  G+ + ++  + GQ    V  +         ++SP
Sbjct: 121 GYV-HRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSP 177

Query: 239 ERISGGKYGY--KSDIWSLGLVLLECATGQFPYS-------------------------P 271
           E +     GY  KSDI+S+G+   E A G  P+                          P
Sbjct: 178 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237

Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSD------------QFSPEFCSFISACVQKEPQQ 319
            E+     S       + +    S P               FSP F  F+  C+Q+ P  
Sbjct: 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDA 297

Query: 320 RLSAQELMTHPFLK 333
           R SA  L+ H F K
Sbjct: 298 RPSASTLLNHSFFK 311

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 81/302 (26%), Positives = 138/302 (45%), Gaps = 43/302 (14%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQC 127
           ++  + ++ +G+G+ G+V   + + T +  ALK I++  E+      A +E+ + +  Q 
Sbjct: 1   MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60

Query: 128 PYVVVCYQSFYSNGAISIILEYMD------GGSLADFLKKVKTIPEEYLAAICEQVLKGL 181
             +V      +S   + ++ EY+D        S  DF K  + I + YL     Q+L+G+
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLI-KTYLY----QILRGI 115

Query: 182 LYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTSG-QANTF---VGTYNYM 236
            Y H  + ++HRDLKP NLLI+ R   +K+ DFG    +A   G    TF   V T  Y 
Sbjct: 116 AYCHSHR-VLHRDLKPQNLLIDRRTNALKLADFG----LARAFGIPVRTFTHEVVTLWYR 170

Query: 237 SPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---------------YSPPEQQ-DG 277
           +PE + G + Y    DIWS+G +  E    +  FP                +P E+   G
Sbjct: 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230

Query: 278 WTSFYELMEAIVDQPPPSAPS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
            TS  +   A    PP    +      P     +S  ++ +P +R++A+  + H + K  
Sbjct: 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290

Query: 336 GD 337
           GD
Sbjct: 291 GD 292

Length = 294

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 83.1 bits (205), Expect = 4e-18
 Identities = 67/248 (27%), Positives = 114/248 (45%), Gaps = 25/248 (10%)

Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+KV++ N    A ++I  E  +      PYV     +C  S      + ++ + M  G 
Sbjct: 40  AIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-----TVQLVTQLMPYGC 94

Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  + L   C Q+ KG+ YL  E  ++HRDL   N+L+     VKITDF
Sbjct: 95  LLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE-EVRLVHRDLAARNVLVKSPNHVKITDF 153

Query: 214 GVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 270
           G++ ++    T   A+       +M+ E I   ++ ++SD+WS G+ + E  T G  PY 
Sbjct: 154 GLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213

Query: 271 PPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
               ++      +L+E     P PP    D +       +  C   + + R   +EL+  
Sbjct: 214 GIPARE----IPDLLEKGERLPQPPICTIDVY-----MIMVKCWMIDSECRPRFRELV-D 263

Query: 330 PFLKMYGD 337
            F +M  D
Sbjct: 264 EFSRMARD 271

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 83.6 bits (207), Expect = 4e-18
 Identities = 59/208 (28%), Positives = 107/208 (51%), Gaps = 21/208 (10%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES---ARRQIAQELKINQSSQCPYVV 131
           IK +G+G+ GIV   ++  T +  A+K I  N  ++   A+R + +E+K+ +      V+
Sbjct: 10  IKPIGRGAYGIVCSAKNSETNEKVAIKKIA-NAFDNRIDAKRTL-REIKLLRHLDHENVI 67

Query: 132 --------VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 183
                      ++F     + I+ E MD   L   ++  +T+ +++      Q+L+GL Y
Sbjct: 68  AIKDIMPPPHREAFND---VYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKY 123

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-S 242
           +H   +++HRDLKPSNLL+N   ++KI DFG++   +        +V T  Y +PE + +
Sbjct: 124 IH-SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN 182

Query: 243 GGKYGYKSDIWSLGLVLLECATGQ--FP 268
             +Y    D+WS+G +  E    +  FP
Sbjct: 183 CSEYTTAIDVWSVGCIFAELLGRKPLFP 210

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 79.8 bits (197), Expect = 8e-18
 Identities = 51/189 (26%), Positives = 81/189 (42%), Gaps = 28/189 (14%)

Query: 153 GSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 211
            SLAD L+     + EE + A+C Q L  L  LH +        K  N+L+   G +K+ 
Sbjct: 1   VSLADILEVRGRPLNEEEIWAVCLQCLGALRELHRQA-------KSGNILLTWDGLLKL- 52

Query: 212 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 271
             G  A          +    Y +M+PE I G  Y  K+DI+SLG+ L E    + PY+ 
Sbjct: 53  -DGSVAFK----TPEQSRPDPY-FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106

Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-------FCSFISACVQKEPQQRLSAQ 324
             +         ++E +++  P   P D+ + E       F  F+  C  + PQ+R +A 
Sbjct: 107 ERE------LSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAAN 160

Query: 325 ELMTHPFLK 333
             + H    
Sbjct: 161 HYLAHCRAL 169

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 83.9 bits (207), Expect = 8e-18
 Identities = 65/226 (28%), Positives = 110/226 (48%), Gaps = 29/226 (12%)

Query: 130 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH---- 185
           +V  +  F S+  + +I+EY  GG   D  K++K   +E+L     +V  GLL+      
Sbjct: 127 IVKHFDDFKSDDKLLLIMEYGSGG---DLNKQIKQRLKEHLPFQEYEV--GLLFYQIVLA 181

Query: 186 ----HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPE 239
               H + ++HRDLK +N+ +   G +K+ DFG S   + +     A++F GT  Y++PE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241

Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV---DQPPPSA 296
                +Y  K+D+WSLG++L E  T   P+  P Q+       E+M+ ++     P P  
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-------EIMQQVLYGKYDPFPCP 294

Query: 297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
            S        + +   + K P  R + Q+L+   FLK   +L  D+
Sbjct: 295 VSSGMK----ALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQDI 336

Length = 478

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 83.8 bits (207), Expect = 1e-17
 Identities = 49/153 (32%), Positives = 83/153 (54%), Gaps = 5/153 (3%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQ 126
           +E+   +K + +G+ G V L + K   + +A+KV++    + ++   Q+  E      S+
Sbjct: 3   IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK 62

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 186
            P++V  Y S  S   + +++EY+ GG +   L       EE       +V   L YLH 
Sbjct: 63  SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH- 121

Query: 187 EKH-IIHRDLKPSNLLINHRGEVKITDFGVSAI 218
            +H IIHRDLKP N+LI++ G +K+TDFG+S +
Sbjct: 122 -RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 59/182 (32%), Positives = 88/182 (48%), Gaps = 26/182 (14%)

Query: 176 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF-VGTYN 234
           Q+L+GL YLH    I+HRD+KP NLL+N    +KI DFG++ +      +  T  V T  
Sbjct: 111 QILRGLKYLH-SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY 169

Query: 235 YMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPY---SPPEQQD------GWTSFYEL 284
           Y +PE + G + Y    DIWS+G +  E    +  +   SP +Q D      G  S   +
Sbjct: 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAM 229

Query: 285 MEA-------IVDQP--PPSAP-----SDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 330
             A       I+  P  PPS P     S Q + E    +   +  +P +R+SA + + HP
Sbjct: 230 RSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP 289

Query: 331 FL 332
           +L
Sbjct: 290 YL 291

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 67/269 (24%), Positives = 116/269 (43%), Gaps = 55/269 (20%)

Query: 98  FALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGG 153
            A+KV++ +  ++AR    +E+KI      P +     VC         + +I+EYM+ G
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVD----PPLCMIMEYMENG 104

Query: 154 SLADFLKK-----------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
            L  FL+K            K++    L  +  Q+  G+ YL    + +HRDL   N L+
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE-SLNFVHRDLATRNCLV 163

Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTY-----------NYMSPERISGGKYGYKSD 251
                +KI DFG+S          N +   Y            +M+ E +  GK+  KSD
Sbjct: 164 GKNYTIKIADFGMS---------RNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSD 214

Query: 252 IWSLGLVLLECAT--GQFPYSP-PEQQ--DGWTSFYEL--MEAIVDQPPPSAPSDQFSPE 304
           +W+ G+ L E  T   + PY    +QQ  +    F+     +  + +PP   P D +   
Sbjct: 215 VWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNC-PKDIY--- 270

Query: 305 FCSFISACVQKEPQQRLSAQELMTHPFLK 333
               +  C +++ + R + +E+  H FL+
Sbjct: 271 --ELMLECWRRDEEDRPTFREI--HLFLQ 295

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 80.1 bits (198), Expect = 3e-17
 Identities = 69/266 (25%), Positives = 119/266 (44%), Gaps = 26/266 (9%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV 132
           KV+G G  G V   + K  G+     A+K ++    +  R     E  I      P ++ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHI 190
                  +  + II EYM+ GSL  FL++   K    + +  +   +  G+ YL  E + 
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLR-GIASGMKYLS-EMNY 127

Query: 191 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG--TYNYMSPERISGGKYGY 248
           +HRDL   N+L+N     K++DFG+S  +  +     T  G     + +PE I+  K+  
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTS 187

Query: 249 KSDIWSLGLVLLE-CATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSP 303
            SD+WS G+V+ E  + G+ PY     QD       +++A+ D     PP   PS  +  
Sbjct: 188 ASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIKAVEDGYRLPPPMDCPSALY-- 238

Query: 304 EFCSFISACVQKEPQQRLSAQELMTH 329
                +  C QK+  +R +  ++++ 
Sbjct: 239 ---QLMLDCWQKDRNERPTFSQIVST 261

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 80.3 bits (198), Expect = 3e-17
 Identities = 69/234 (29%), Positives = 106/234 (45%), Gaps = 22/234 (9%)

Query: 99  ALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 157
            LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D
Sbjct: 38  TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLD 91

Query: 158 FLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           +L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+
Sbjct: 92  YLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGL 150

Query: 216 SAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPE 273
           S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY   +
Sbjct: 151 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210

Query: 274 QQDGWTSFYELME-AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
                   YEL+E     + P   P     P+    + AC Q  P  R S  E+
Sbjct: 211 LSQ----VYELLEKGYRMERPEGCP-----PKVYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 80.3 bits (198), Expect = 3e-17
 Identities = 76/287 (26%), Positives = 126/287 (43%), Gaps = 40/287 (13%)

Query: 75  IKVVGKGSGGIVQLVQHK----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV 130
           I+V+G+G  G V L  +      TG+  A+K ++    +       +E+ I ++     +
Sbjct: 9   IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68

Query: 131 VVCYQSFYSNGA---ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 187
           V  Y+   S      + +I+EY+  GSL D+L K K +    L    +Q+ +G+ YLH  
Sbjct: 69  VK-YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK-LNLAQLLLFAQQICEGMAYLH-S 125

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIM--------ASTSGQANTFVGTYNYMSPE 239
           +H IHRDL   N+L+++   VKI DFG++  +            G +  F     + + E
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-----WYAVE 180

Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY-SPPEQ----------QDGWTSFYELMEAI 288
            +   K+ Y SD+WS G+ L E  T      SPP++          Q       EL+E  
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240

Query: 289 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
           +  P P         E    +  C + E + R + + L+  P LK  
Sbjct: 241 MRLPCP----KNCPQEVYILMKNCWETEAKFRPTFRSLI--PILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 78.9 bits (194), Expect = 7e-17
 Identities = 67/230 (29%), Positives = 110/230 (47%), Gaps = 30/230 (13%)

Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           QI ++L+ ++  Q  Y VV  +  Y      I+ EYM  GSL DFLK    +   +P   
Sbjct: 53  QIMKKLRHDKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKDGEGRALKLPN-- 103

Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  QV  G+ Y+    +I HRDL+ +N+L+      KI DFG++ ++     T+ Q 
Sbjct: 104 LVDMAAQVAAGMAYIERMNYI-HRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162

Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     +       E++
Sbjct: 163 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR-------EVL 213

Query: 286 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
           E +        P D         +  C +K+P++R + + L +  FL+ Y
Sbjct: 214 EQVERGYRMPCPQDC-PISLHELMLQCWKKDPEERPTFEYLQS--FLEDY 260

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 79.0 bits (195), Expect = 8e-17
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 21/208 (10%)

Query: 76  KVVGKGSGGIVQLVQHKWT---GQFF--ALKVIQMNVEESARRQIAQELKINQSSQCPYV 130
           K +G GS G+V+  + +W+   G+    A+K ++ +          +E  I  S     +
Sbjct: 1   KKLGDGSFGVVR--RGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENL 58

Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEK 188
           +  Y    ++  + ++ E    GSL D L+K          L     Q+  G+ YL   K
Sbjct: 59  IRLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE-SK 116

Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN------YMSPERIS 242
             IHRDL   N+L+    +VKI DFG   +M +     + +V   +      + +PE + 
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFG---LMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173

Query: 243 GGKYGYKSDIWSLGLVLLECAT-GQFPY 269
              + + SD+W  G+ L E  T G+ P+
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEPW 201

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 78.4 bits (193), Expect = 1e-16
 Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 13/211 (6%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV 132
           KV+G G  G V   + K  G+     A+K ++    E  RR    E  I      P ++ 
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKH 189
                  +  + I+ EYM+ GSL  FL+K     T+ +  L  +   +  G+ YL    +
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQ--LVGMLRGIASGMKYLSDMGY 127

Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG---TYNYMSPERISGGKY 246
           + HRDL   N+L+N     K++DFG+S ++      A T  G      + +PE I+  K+
Sbjct: 128 V-HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186

Query: 247 GYKSDIWSLGLVLLECAT-GQFPYSPPEQQD 276
              SD+WS G+V+ E  + G+ PY     QD
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERPYWEMSNQD 217

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 78.6 bits (193), Expect = 1e-16
 Identities = 65/230 (28%), Positives = 109/230 (47%), Gaps = 30/230 (13%)

Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 53  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 103

Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 104 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162

Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 163 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 216

Query: 286 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
           E     P P    +      C     C +KEP++R + + L    FL+ Y
Sbjct: 217 ERGYRMPCPPECPESLHDLMCQ----CWRKEPEERPTFEYL--QAFLEDY 260

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 78.1 bits (192), Expect = 1e-16
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 32/216 (14%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQF-----FALKVIQ---MNVEESARRQIAQELKI 121
           E I  +K +G G  G V      W G +      A+K ++   M+V+        +E  +
Sbjct: 6   ESIKLVKKLGAGQFGEV------WMGYYNNSTKVAVKTLKPGTMSVQ-----AFLEEANL 54

Query: 122 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAAICEQV 177
            ++ Q   +V  Y        I II EYM  GSL DFLK  +     +P+  L     Q+
Sbjct: 55  MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPK--LIDFSAQI 112

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYN 234
            +G+ Y+   K+ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     
Sbjct: 113 AEGMAYIE-RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF--PIK 169

Query: 235 YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           + +PE I+ G +  KSD+WS G++L E  T G+ PY
Sbjct: 170 WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 39/206 (18%)

Query: 161 KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 220
           K + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N   E+KI DFG++    
Sbjct: 113 KCQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNEDCELKILDFGLA---R 168

Query: 221 STSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDG 277
            T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  TG+  FP +    Q  
Sbjct: 169 HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-- 226

Query: 278 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ------------KEPQ------- 318
                +L+  +V  P         S    ++I +  Q              P        
Sbjct: 227 ----LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK 282

Query: 319 -------QRLSAQELMTHPFLKMYGD 337
                  +R++A + + H +   Y D
Sbjct: 283 MLVLDSDKRITAAQALAHAYFAQYHD 308

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 46/126 (36%), Positives = 63/126 (50%), Gaps = 11/126 (8%)

Query: 176 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 235
           Q+L G+ +LH    IIHRDLKPSN+++     +KI DFG+ A  A TS     +V T  Y
Sbjct: 126 QMLCGIKHLH-SAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYY 183

Query: 236 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 295
            +PE I G  Y    DIWS+G ++ E   G   +   +  D W    E +          
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL---------G 234

Query: 296 APSDQF 301
            PSD+F
Sbjct: 235 TPSDEF 240

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 51/161 (31%), Positives = 76/161 (47%), Gaps = 3/161 (1%)

Query: 107 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 166
           ++   R   A E  I ++   P ++    +F  N    +IL       L  +L   + I 
Sbjct: 122 IKAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIA 180

Query: 167 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-TSGQ 225
              + AI   VL+ + YLH E  IIHRD+K  N+ INH G+V + DFG +       + +
Sbjct: 181 ICDILAIERSVLRAIQYLH-ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239

Query: 226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ 266
              + GT    +PE ++   YG   DIWS G+VL E AT  
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 60/229 (26%), Positives = 100/229 (43%), Gaps = 40/229 (17%)

Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + +++E MD    A+  + +   +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 101 VYLVMELMD----ANLCQVIHMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 155

Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A T+     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 156 VKSDCTLKILDFGL-ARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214

Query: 262 CATGQFPYSPPEQQDGWTSFYE------------LMEAIVD--QPPPSAPSDQFSPEFCS 307
              G   +   +  D W    E            L   + +  +  P  P   F   F  
Sbjct: 215 LVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPD 274

Query: 308 FI-------------------SACVQKEPQQRLSAQELMTHPFLKMYGD 337
           +I                   S  +  +P +R+S  E + HP++ ++ D
Sbjct: 275 WIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 78.4 bits (193), Expect = 3e-16
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 40/229 (17%)

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKKVKTIP--EEYLAAICEQVLKGLLYLHHEKHII 191
           +Q FY      +++ YM        L+K+   P  E+ +  +  Q+L GL Y+H    II
Sbjct: 92  FQDFY------LVMPYMQTD-----LQKIMGHPLSEDKVQYLVYQMLCGLKYIH-SAGII 139

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SGGKYGYKS 250
           HRDLKP NL +N   E+KI DFG++        +   +V T  Y +PE I +   Y    
Sbjct: 140 HRDLKPGNLAVNEDCELKILDFGLA---RHADAEMTGYVVTRWYRAPEVILNWMHYNQTV 196

Query: 251 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFY--------ELMEAIVD-------QPPPS 295
           DIWS+G ++ E  TG+  +   +  D  T           E ++ + D       +  P 
Sbjct: 197 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPK 256

Query: 296 APSDQFS-------PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
            P   FS       P+    +   ++ +  +RL+A E + HP+   + D
Sbjct: 257 YPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 77/300 (25%), Positives = 130/300 (43%), Gaps = 53/300 (17%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ---MNVEESARRQIAQELKINQSSQCPYVV- 131
           +V+GKGS G+V       TG+  A+K I     +V ++ R  I +E+K+ +  + P +V 
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATR--ILREIKLLRLLRHPDIVE 63

Query: 132 ----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 187
               +   S      I ++ E M+   L   +K    +  E+      Q+L+ L Y+H  
Sbjct: 64  IKHIMLPPSRREFKDIYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIH-T 121

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA---NTFVGTYNYMSPERISG- 243
            ++ HRDLKP N+L N   ++KI DFG++ +  + +  A     +V T  Y +PE + G 
Sbjct: 122 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-LCGS 180

Query: 244 --GKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDGWTSFYELMEAIVDQPPPSA--- 296
              KY    DIWS+G +  E  TG+  FP      Q       +L+  ++  P P     
Sbjct: 181 FFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ------LDLITDLLGTPSPETISR 234

Query: 297 ----------------PSDQFSPEF-------CSFISACVQKEPQQRLSAQELMTHPFLK 333
                               FS +F          +   +  +P+ R +A+E +  P+ K
Sbjct: 235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 76/298 (25%), Positives = 131/298 (43%), Gaps = 46/298 (15%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNVEESARRQIAQELKINQSSQCPYVVV 132
           +K VG G+ G V     + TG   A+K +      E  A+R   +EL++ +  +   V+ 
Sbjct: 20  LKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIG 78

Query: 133 CYQSFYSNGAIS------IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 186
               F  + ++       +++ +M G  L   +K  K + E+ +  +  Q+LKGL Y+H 
Sbjct: 79  LLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK-LSEDRIQFLVYQMLKGLKYIH- 135

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SGGK 245
              IIHRDLKP NL +N   E+KI DFG++     T  +   +V T  Y +PE I +   
Sbjct: 136 AAGIIHRDLKPGNLAVNEDCELKILDFGLA---RQTDSEMTGYVVTRWYRAPEVILNWMH 192

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP------------ 293
           Y    DIWS+G ++ E  TG+  +   +  D      E+M+ +   P             
Sbjct: 193 YTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLM---EIMK-VTGTPSKEFVQKLQSEDA 248

Query: 294 -------PSAPSDQF-------SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
                  P      F       +P   + +   +  + + R++A E + HP+ + + D
Sbjct: 249 KNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 77.0 bits (189), Expect = 4e-16
 Identities = 46/133 (34%), Positives = 76/133 (57%), Gaps = 9/133 (6%)

Query: 143 ISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 200
           I II E+M  GSL DFLK  +    P   L     Q+ +G+ ++  +++ IHRDL+ +N+
Sbjct: 75  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANI 133

Query: 201 LINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 257
           L++     KI DFG++ ++     T+ +   F     + +PE I+ G +  KSD+WS G+
Sbjct: 134 LVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTIKSDVWSFGI 191

Query: 258 VLLECAT-GQFPY 269
           +L+E  T G+ PY
Sbjct: 192 LLMEIVTYGRIPY 204

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 77.0 bits (189), Expect = 5e-16
 Identities = 70/253 (27%), Positives = 118/253 (46%), Gaps = 40/253 (15%)

Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K ++ +  ++AR+   +E ++  + Q  ++V  Y        + ++ EYM  G L  F
Sbjct: 39  AVKTLK-DASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 97

Query: 159 LKK-------------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           L+                 + +  +  I +Q+  G++YL   +H +HRDL   N L+   
Sbjct: 98  LRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA-SQHFVHRDLATRNCLVGEN 156

Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYN-----YMSPERISGGKYGYKSDIWSLGLVLL 260
             VKI DFG+S  + ST       VG +      +M PE I   K+  +SD+WSLG+VL 
Sbjct: 157 LLVKIGDFGMSRDVYSTDYYR---VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLW 213

Query: 261 ECAT-GQFPYSPPEQQDGWTSFYELMEAI----VDQPPPSAPSDQFSPEFCSFISACVQK 315
           E  T G+ P+          S  E++E I    V Q P + P + +       +  C Q+
Sbjct: 214 EIFTYGKQPWYQ-------LSNNEVIECITQGRVLQRPRTCPKEVY-----DLMLGCWQR 261

Query: 316 EPQQRLSAQELMT 328
           EP  RL+ +E+ +
Sbjct: 262 EPHMRLNIKEIHS 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 76.5 bits (188), Expect = 7e-16
 Identities = 64/274 (23%), Positives = 122/274 (44%), Gaps = 55/274 (20%)

Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K+++ N   S  R +  E  + +    P+V+  Y +   +G + +I+EY   GSL  F
Sbjct: 34  AVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSF 93

Query: 159 LKKVKTIPEEYLAAICE------------------------QVLKGLLYLHHEKHIIHRD 194
           L++ + +   YL +                           Q+ +G+ YL  E  ++HRD
Sbjct: 94  LRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA-EMKLVHRD 152

Query: 195 LKPSNLLINHRGEVKITDFGVS-------AIMASTSGQANTFVGTYNYMSPERISGGKYG 247
           L   N+L+    ++KI+DFG+S       + +  + G+         +M+ E +    Y 
Sbjct: 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPV-----KWMAIESLFDHIYT 207

Query: 248 YKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEA--IVDQPPPSAPSDQFS 302
            +SD+WS G++L E  T G  PY    PE+       + L++    +++P      +  S
Sbjct: 208 TQSDVWSFGVLLWEIVTLGGNPYPGIAPER------LFNLLKTGYRMERP------ENCS 255

Query: 303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 336
            E  + +  C ++EP +R +  ++ +    KM  
Sbjct: 256 EEMYNLMLTCWKQEPDKRPTFADI-SKELEKMMV 288

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 76.8 bits (189), Expect = 8e-16
 Identities = 70/237 (29%), Positives = 117/237 (49%), Gaps = 20/237 (8%)

Query: 99  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 157
           A+K+++     S R  +  ELKI +       +V    +    G I +I EY   G L +
Sbjct: 69  AVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLN 128

Query: 158 FL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           FL  K+   +  E L +   QV KG+ +L   K+ IHRDL   N+L+ H   VKI DFG+
Sbjct: 129 FLRRKRESFLTLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNVLLTHGKIVKICDFGL 187

Query: 216 SAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           +  + + S    + N  +    +M+PE I    Y ++SD+WS G++L E  + G  PY P
Sbjct: 188 ARDIMNDSNYVVKGNARL-PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY-P 245

Query: 272 PEQQDGWTSFYELMEA--IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
               D  + FY+L++    + Q P  AP++ +       +  C   +P +R + +++
Sbjct: 246 GMPVD--SKFYKLIKEGYRMAQ-PEHAPAEIY-----DIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 76.6 bits (188), Expect = 8e-16
 Identities = 68/240 (28%), Positives = 109/240 (45%), Gaps = 36/240 (15%)

Query: 110 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-------- 161
           +AR+   +E ++  + Q  ++V  Y        + ++ EYM  G L  FL+         
Sbjct: 49  AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 108

Query: 162 VKTIPEE--------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           V   P +         +  I  Q+  G++YL   +H +HRDL   N L+     VKI DF
Sbjct: 109 VDGQPRQAKGELGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVGANLLVKIGDF 167

Query: 214 GVSAIMASTSGQANTFVGTYN-----YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQF 267
           G+S  + ST       VG +      +M PE I   K+  +SD+WS G++L E  T G+ 
Sbjct: 168 GMSRDVYSTDYYR---VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224

Query: 268 PYSPPEQQDGWTSFYE-LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           P+     Q   T   E + +  V + P   P + +       +  C Q+EPQQRL+ +E+
Sbjct: 225 PWF----QLSNTEVIECITQGRVLERPRVCPKEVY-----DIMLGCWQREPQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 52/190 (27%), Positives = 85/190 (44%), Gaps = 30/190 (15%)

Query: 176 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV----SAIMASTSGQANTFVG 231
           Q+L GL Y+H   +++HRDLKP NLL+N   E+KI DFG+    S      +G    +V 
Sbjct: 113 QILCGLKYIH-SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171

Query: 232 TYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQFPY------------------SPP 272
           T  Y +PE  +S   Y    D+WS+G +L E    + P                   +P 
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKDYVDQLNQILQVLGTPD 230

Query: 273 E---QQDGWTSFYELMEAIVDQPPPSAPSD--QFSPEFCSFISACVQKEPQQRLSAQELM 327
           E    + G       + ++ + P     S     +P     +   +  +P +R+S +E +
Sbjct: 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290

Query: 328 THPFLKMYGD 337
            HP+L ++ D
Sbjct: 291 EHPYLAIWHD 300

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 22/213 (10%)

Query: 71  DIDTIKVVGKGSGGIVQLVQHKWTGQF------FALKVIQMNVEESARRQIAQELKINQS 124
           ++  +KV+G G+ G V   +  W  +        A+K++       A  +   E  I  S
Sbjct: 8   ELKRVKVLGSGAFGTV--YKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS 65

Query: 125 SQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLK 179
              P++V    VC         I ++ + M  G L D++ + K  I  + L   C Q+ K
Sbjct: 66  MDHPHLVRLLGVCLSP-----TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120

Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMS 237
           G++YL  E+ ++HRDL   N+L+     VKITDFG++ ++     + N   G     +M+
Sbjct: 121 GMMYLE-ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMA 179

Query: 238 PERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
            E I   K+ ++SD+WS G+ + E  T G  PY
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 55/300 (18%)

Query: 86  VQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           V L +H  TG    +++  + N  E   + +  E+ ++   + P ++  +  F +   + 
Sbjct: 16  VYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLW 75

Query: 145 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           +I  +M  GS    LK    + + E  +  I    L+GL YLH   +I HR++K S++LI
Sbjct: 76  VISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYI-HRNIKASHILI 134

Query: 203 NHRGEVKITDFGVSAIMAST-SGQANTFVGTYN--------YMSPERISGGKYGY--KSD 251
           +  G V ++  G+S + +   +GQ    V  +         ++SPE +    YGY  KSD
Sbjct: 135 SGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSD 192

Query: 252 IWSLGLVLLECATGQFP------------------YSP-------------PEQQDGWTS 280
           I+S+G+   E ATG+ P                  YSP                Q G  S
Sbjct: 193 IYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDS 252

Query: 281 ------FYELMEAIVDQPPPSAPSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
                     M   +       PS + FSP F + +  C+Q++P++R SA  L++H F K
Sbjct: 253 GIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFK 312

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 74.9 bits (184), Expect = 3e-15
 Identities = 66/247 (26%), Positives = 108/247 (43%), Gaps = 29/247 (11%)

Query: 71  DIDTIK---VVGKGSGGIVQLVQHKWTG---QFFALKVIQMNVEESARRQIAQELKINQS 124
           D+  +K   V+G G  G V   + K  G    F A+K ++    E  RR    E  I   
Sbjct: 2   DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQ 61

Query: 125 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLY 183
              P ++        +  + II E+M+ G+L  FL+          L  +   +  G+ Y
Sbjct: 62  FDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 121

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN------YMS 237
           L  E + +HRDL   N+L+N     K++DFG+S  +   +    T+  +        + +
Sbjct: 122 LS-EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP-TYTSSLGGKIPIRWTA 179

Query: 238 PERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQ----- 291
           PE I+  K+   SD+WS G+V+ E  + G+ PY     QD       ++ AI +Q     
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD-------VINAI-EQDYRLP 231

Query: 292 PPPSAPS 298
           PP   P+
Sbjct: 232 PPMDCPT 238

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 74.3 bits (182), Expect = 4e-15
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 25/206 (12%)

Query: 139 SNGAISIILEYMDGGSLADFLK----KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 194
           S   I I+ E+M  GSL DFLK    K   +P+  L  +  Q+  G+ Y+    +I HRD
Sbjct: 71  SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQ--LVDMAAQIADGMAYIERMNYI-HRD 127

Query: 195 LKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           L+ +N+L+      KI DFG++ ++     T+ Q   F     + +PE    G++  KSD
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSD 185

Query: 252 IWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFI 309
           +WS G++L E  T G+ PY     +       E++E +  +     P  Q  PE     +
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNR-------EVLEQV--ERGYRMPCPQGCPESLHELM 236

Query: 310 SACVQKEPQQRLSAQELMTHPFLKMY 335
             C +K+P +R + + + +  FL+ Y
Sbjct: 237 KLCWKKDPDERPTFEYIQS--FLEDY 260

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 73.8 bits (181), Expect = 5e-15
 Identities = 57/204 (27%), Positives = 109/204 (53%), Gaps = 19/204 (9%)

Query: 78  VGKGSGGIVQ--LVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVV--- 131
           +G G+ G V+  + + K + +  A+K+++  N + + + ++ +E  + Q    PY+V   
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 132 -VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 190
            +C        +  +++E  + G L  FL+K K + E+ +  +  QV  G+ YL  E + 
Sbjct: 63  GICEAE-----SWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE-ETNF 116

Query: 191 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTY--NYMSPERISGGKY 246
           +HRDL   N+L+  +   KI+DFG+S  + +     +A T  G +   + +PE ++  K+
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH-GKWPVKWYAPECMNYYKF 175

Query: 247 GYKSDIWSLGLVLLEC-ATGQFPY 269
             KSD+WS G+++ E  + GQ PY
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 72.8 bits (179), Expect = 1e-14
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 36/216 (16%)

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICE 175
           VC Q     G + +++EY   G+L DFL+  +   E                  L +   
Sbjct: 84  VCTQ----EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 176 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG--TY 233
           QV +G+ +L  +K  IHRDL   N+L+     +KI DFG++  +        T  G    
Sbjct: 140 QVARGMEFLASKK-CIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPV 198

Query: 234 NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVD 290
            +M+PE +    Y ++SD+WS G++L E  T G  PY   P E+      F  L E    
Sbjct: 199 KWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-----FKLLKEGYRM 253

Query: 291 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           + P +   + +       +  C  + P QR + ++L
Sbjct: 254 EKPQNCTQELY-----HLMRDCWHEVPSQRPTFKQL 284

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 45/151 (29%), Positives = 65/151 (43%), Gaps = 28/151 (18%)

Query: 145 IILEYMDGGSLADFLK---------------KVKTIPEEYLA-------AICEQVLKGLL 182
           ++ EYM  G L +FL+                 +      L         I +QV  G+ 
Sbjct: 85  LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMA 144

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS---GQANTFVGTYNYMSPE 239
           YL  E+  +HRDL   N L+     VKI DFG+S  + S        N  +    +M PE
Sbjct: 145 YLS-ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAI-PIRWMPPE 202

Query: 240 RISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 269
            I   +Y  +SD+W+ G+VL E  + G  PY
Sbjct: 203 SIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 52/161 (32%), Positives = 81/161 (50%), Gaps = 15/161 (9%)

Query: 145 IILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           II EYM+ G+L  +L+        Y L  +   +  G+ YL  + + +HRDL   N+L+N
Sbjct: 83  IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS-DMNYVHRDLAARNILVN 141

Query: 204 HRGEVKITDFGVSAIMASTSGQANTFVG---TYNYMSPERISGGKYGYKSDIWSLGLVLL 260
              E K++DFG+S ++        T  G      + +PE I+  K+   SD+WS G+V+ 
Sbjct: 142 SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 201

Query: 261 ECAT-GQFPYSPPEQQDGW-TSFYELMEAIVDQPPPSAPSD 299
           E  + G+ PY        W  S +E+M+AI D     AP D
Sbjct: 202 EVMSFGERPY--------WDMSNHEVMKAINDGFRLPAPMD 234

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 84/312 (26%), Positives = 130/312 (41%), Gaps = 49/312 (15%)

Query: 70  EDIDTIKVVGKGSGG--IVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQ 126
           EDI    V+G+G+ G  I  +++        A+K+++    E+  R  A EL++  +   
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYL 170
            P ++    +  + G + I +EY   G+L DFL+K +                T+  + L
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 171 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS----AIMASTSGQA 226
                 V  G+ YL  EK  IHRDL   N+L+      KI DFG+S      +  T G+ 
Sbjct: 122 LQFASDVATGMQYLS-EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180

Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT--SFYE 283
                   +M+ E ++   Y  KSD+WS G++L E  + G  PY       G T    YE
Sbjct: 181 PV-----RWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYC------GMTCAELYE 229

Query: 284 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR-----LSAQELMTHPFLKMYGDL 338
            +        P    D    E    +  C +  P +R     +S Q        K Y  +
Sbjct: 230 KLPQGYRMEKPRNCDD----EVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKAY--V 283

Query: 339 NVDLSEYFTDAG 350
           N+ L E FT AG
Sbjct: 284 NMALFENFTYAG 295

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 59/196 (30%), Positives = 84/196 (42%), Gaps = 36/196 (18%)

Query: 145 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           I+LE M GG L  FL++ +  PE         L      V KG  YL  E H IHRD+  
Sbjct: 86  ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE-ENHFIHRDIAA 144

Query: 198 SNLLINHRGE---VKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYK 249
            N L+  +G     KI DFG++  +   S     G+A   +    +M PE    G +  K
Sbjct: 145 RNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI---KWMPPEAFLDGIFTSK 201

Query: 250 SDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPE 304
           +D+WS G++L E  + G  PY     Q       E+ME +       PP   P   +   
Sbjct: 202 TDVWSFGVLLWEIFSLGYMPYPGRTNQ-------EVMEFVTGGGRLDPPKGCPGPVY--- 251

Query: 305 FCSFISACVQKEPQQR 320
               ++ C Q  P+ R
Sbjct: 252 --RIMTDCWQHTPEDR 265

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 71.2 bits (174), Expect = 6e-14
 Identities = 56/201 (27%), Positives = 85/201 (42%), Gaps = 22/201 (10%)

Query: 96  QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL 155
           Q  A+K ++   E   R +   E  +    Q P +V           +S+I  Y     L
Sbjct: 36  QAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95

Query: 156 ADFL---------------KKVKTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS 198
            +FL               K VK+   P +++  I  Q+  G+ +L    H++H+DL   
Sbjct: 96  HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH-IVTQIAAGMEFLS-SHHVVHKDLATR 153

Query: 199 NLLINHRGEVKITDFGV--SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 256
           N+L+  +  VKI+D G+      A         +    +MSPE I  GK+   SDIWS G
Sbjct: 154 NVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYG 213

Query: 257 LVLLEC-ATGQFPYSPPEQQD 276
           +VL E  + G  PY     QD
Sbjct: 214 VVLWEVFSYGLQPYCGYSNQD 234

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 70.8 bits (173), Expect = 8e-14
 Identities = 58/225 (25%), Positives = 107/225 (47%), Gaps = 29/225 (12%)

Query: 71  DIDTIKVVGKGSGGIVQLVQHK--WT--GQFFALKVIQMNVEESARRQIAQELKINQ--- 123
           ++  +K++G G  G V    HK  W   G    + V    +++ + RQ  QE+  +    
Sbjct: 8   ELRKLKLLGSGVFGTV----HKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63

Query: 124 -SSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQV 177
            S    Y+V    +C        ++ ++ +    GSL D +++ + ++  + L   C Q+
Sbjct: 64  GSLDHAYIVRLLGIC-----PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI 118

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNY 235
            KG+ YL  E  ++HR+L   N+L+     V+I DFGV+ ++     +   +       +
Sbjct: 119 AKGMYYLE-EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKW 177

Query: 236 MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS---PPEQQD 276
           M+ E I  G+Y ++SD+WS G+ + E  + G  PY+   P E  D
Sbjct: 178 MALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 7/142 (4%)

Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158

Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

Query: 262 CATGQFPYSPPEQQDGWTSFYE 283
              G   +   +  D W    E
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIE 239

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 70.5 bits (172), Expect = 2e-13
 Identities = 54/205 (26%), Positives = 88/205 (42%), Gaps = 37/205 (18%)

Query: 161 KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 220
           K + + +E++  +  Q+L+GL Y+H    IIHRDLKPSN+ +N   E++I DFG++    
Sbjct: 111 KCQKLSDEHVQFLIYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDCELRILDFGLA---R 166

Query: 221 STSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDG 277
               +   +V T  Y +PE  ++   Y    DIWS+G ++ E   G+  FP +     D 
Sbjct: 167 QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN-----DY 221

Query: 278 WTSFYELMEAIVDQPP------------------PSAPSDQFSPEF-------CSFISAC 312
                 +ME +    P                  P  P       F          +   
Sbjct: 222 IDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKM 281

Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +  +  +R+SA E + HP+   Y D
Sbjct: 282 LVLDSDKRISASEALAHPYFSQYHD 306

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 69.4 bits (170), Expect = 2e-13
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 46/206 (22%)

Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICE--------QVLKGLLYLHHEKHIIHRDLK 196
           ++  YM+ G+L  FL++ +        A+          Q+  G+ YLH ++ +IH+D+ 
Sbjct: 86  VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH-KRGVIHKDIA 144

Query: 197 PSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN-----------YMSPERISGGK 245
             N +I+   +VKITD  +S          + F   Y+           +M+ E +   +
Sbjct: 145 ARNCVIDEELQVKITDNALSR---------DLFPMDYHCLGDNENRPVKWMALESLVNKE 195

Query: 246 YGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQ 300
           Y   SD+WS G++L E  T GQ PY    + D     +E+   + D      P + P   
Sbjct: 196 YSSASDVWSFGVLLWELMTLGQTPY---VEIDP----FEMAAYLKDGYRLAQPINCPD-- 246

Query: 301 FSPEFCSFISACVQKEPQQRLSAQEL 326
              E  + ++ C   +P++R S  +L
Sbjct: 247 ---ELFAVMACCWALDPEERPSFSQL 269

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 59/194 (30%), Positives = 91/194 (46%), Gaps = 30/194 (15%)

Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K+++ +  ++AR    +E+KI    + P ++    VC  S      + +I EYM+ G 
Sbjct: 50  AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITS----DPLCMITEYMENGD 105

Query: 155 LADFLKK-----------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           L  FL +           V TI    L  +  Q+  G+ YL    + +HRDL   N L+ 
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS-SLNFVHRDLATRNCLVG 164

Query: 204 HRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 258
               +KI DFG+S  + S       G+A   V    +MS E I  GK+   SD+W+ G+ 
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRA---VLPIRWMSWESILLGKFTTASDVWAFGVT 221

Query: 259 LLECAT--GQFPYS 270
           L E  T   + PYS
Sbjct: 222 LWEILTLCKEQPYS 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 69.0 bits (169), Expect = 3e-13
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 34/224 (15%)

Query: 66  QLNLEDIDTIKVVGKGSGGIV---QLVQ--HKWTGQFFALKVIQMNVEESARRQIAQELK 120
           ++ L  +  ++ +G+G+ G V   +L     + +    A+K ++ N E   +++  QE +
Sbjct: 1   EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60

Query: 121 INQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFL---------------KK 161
           +    Q P +V    VC +         ++ EY+  G L +FL               + 
Sbjct: 61  LMSDLQHPNIVCLLGVCTKE----QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116

Query: 162 VKTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 219
           VK+     ++L  I  Q+  G+ YL    H +HRDL   N L+     VKI+DFG+S  +
Sbjct: 117 VKSSLDCSDFLH-IAIQIAAGMEYLS-SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174

Query: 220 ASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
            S       +  +    +M PE I  GK+  +SDIWS G+VL E
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 67.7 bits (165), Expect = 5e-13
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 18/181 (9%)

Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K  + ++ +  + +   E +I +    P +V    VC Q       I I++E + GG 
Sbjct: 23  AVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ----RQPIYIVMELVPGGD 78

Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
              FL+K K  +  + L         G+ YL   K+ IHRDL   N L+     +KI+DF
Sbjct: 79  FLSFLRKKKDELKTKQLVKFALDAAAGMAYLE-SKNCIHRDLAARNCLVGENNVLKISDF 137

Query: 214 GVSAI----MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFP 268
           G+S      + S+SG     +    + +PE ++ G+Y  +SD+WS G++L E  + G  P
Sbjct: 138 GMSRQEDDGIYSSSGLKQIPI---KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCP 194

Query: 269 Y 269
           Y
Sbjct: 195 Y 195

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 68.6 bits (167), Expect = 8e-13
 Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 40/229 (17%)

Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 97  VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 151

Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 152 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210

Query: 262 CATGQFPYSPPEQQDGW--------TSFYELMEAI-------VDQPPPSA---------- 296
               +  +   +  D W        T   E M+ +       V+  P  A          
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 270

Query: 297 ---PSDQ-----FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
              P+D       + +    +S  +  +P +R+S  E + HP++ ++ D
Sbjct: 271 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 68.4 bits (167), Expect = 8e-13
 Identities = 43/134 (32%), Positives = 67/134 (50%), Gaps = 2/134 (1%)

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 187
           P V+    +  S     ++L +          K+ + +P +    I +Q+L+GL YLH +
Sbjct: 117 PSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ 176

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 247
           + IIHRD+K  N+ IN   +V I D G +A     +       GT    +PE ++  KY 
Sbjct: 177 R-IIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVETNAPEVLARDKYN 234

Query: 248 YKSDIWSLGLVLLE 261
            K+DIWS G+VL E
Sbjct: 235 SKADIWSAGIVLFE 248

Length = 357

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 66/251 (26%), Positives = 105/251 (41%), Gaps = 49/251 (19%)

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLK-----------KVKTIPEEYLA-----AICE 175
           VC Q     G + +I+EY   G+L +FL+            +  +PEE L+     +   
Sbjct: 86  VCTQ----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAY 141

Query: 176 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN- 234
           QV +G+ YL   +  IHRDL   N+L+     +KI DFG    +A      + +  T N 
Sbjct: 142 QVARGMEYLE-SRRCIHRDLAARNVLVTEDNVMKIADFG----LARGVHDIDYYKKTSNG 196

Query: 235 -----YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELME 286
                +M+PE +    Y ++SD+WS G+++ E  T G  PY   P E+      F  L E
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL-----FKLLRE 251

Query: 287 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 346
                 P +        E    +  C    P QR + ++L     ++    +   +SE +
Sbjct: 252 GHRMDKPSNCTH-----ELYMLMRECWHAVPTQRPTFKQL-----VEALDKVLAAVSEEY 301

Query: 347 TDAGSPLATLS 357
            D   P    S
Sbjct: 302 LDLSMPFEQYS 312

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 54/228 (23%), Positives = 102/228 (44%), Gaps = 31/228 (13%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTG-----QFFALKVIQMNVEESA----RRQIAQ 117
               ++  I  +G+G  G V L + K            +K +Q   +E+     RR++  
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 118 ELKINQSSQCPYVVVCYQS--FYSNGAISIILEYMDGGSLADFL----KKVKTIPEEYLA 171
             K++  +    + +C ++   Y      +ILEY D G L  FL     K + +    L+
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPHY------MILEYTDLGDLKQFLRATKSKDEKLKPPPLS 115

Query: 172 -----AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--G 224
                A+C Q+  G+ +L      +HRDL   N L++ + EVK++   +S  + ++    
Sbjct: 116 TKQKVALCTQIALGMDHLS-NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK 174

Query: 225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
             N  +    +++PE +    +  KSD+WS G+++ E  T G+ P+  
Sbjct: 175 LRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 78/333 (23%), Positives = 136/333 (40%), Gaps = 77/333 (23%)

Query: 70  EDIDT-------IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE---SARRQIAQEL 119
           EDID        + ++G+G+ G V     +   ++ A+K+++ NV +    A+ +I    
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVR-NVPKYTRDAKIEIQFME 180

Query: 120 KINQSSQCP-YVVVCYQSFYSN--GAISIIL-EYMDGGSLADFLKKVKTIPEEYLAAICE 175
           K+ Q+     + ++  Q ++ N  G + I++ +Y  G  L D++ K       +LA I  
Sbjct: 181 KVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIF 238

Query: 176 QVLKGLLYLHHEKHIIHRDLKPSNLLI----------NHRG------EVKITDFGVSAIM 219
           Q    L Y H E H++H DLKP N+L+           +R        V+I D G     
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--- 295

Query: 220 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT 279
                     V T +Y SPE + G  + Y +D+WS+G ++ E  TG+  Y   +  D   
Sbjct: 296 CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY---DTHDNLE 352

Query: 280 SFYELMEAIVDQPP-----------------------PSAPSDQFS-------------- 302
             + LME  + + P                       P       +              
Sbjct: 353 HLH-LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRD 411

Query: 303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
              C  I   +  + Q+RL+A+++ THP++  Y
Sbjct: 412 DLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444

Length = 467

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 66.6 bits (162), Expect = 2e-12
 Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 24/208 (11%)

Query: 132 VCYQSFYSNGAIS--IILEYMDGGSLADFLKKVKT------IPEEYLAAICEQVLKGLLY 183
           VC Q+  S G  S  +IL +M  G L  FL   +       +P + L      +  G+ Y
Sbjct: 68  VCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEY 127

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERI 241
           L   K  IHRDL   N ++N    V + DFG+S  + +     Q         +++ E +
Sbjct: 128 LS-SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL 186

Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEA--IVDQPPPSAPS 298
           +   Y  KSD+WS G+ + E AT GQ PY   E  +     Y+ +     + QPP     
Sbjct: 187 ADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE----IYDYLRQGNRLKQPPDCLDG 242

Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQEL 326
                   S +S+C    P+ R S + L
Sbjct: 243 ------LYSLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 66.2 bits (161), Expect = 2e-12
 Identities = 67/277 (24%), Positives = 112/277 (40%), Gaps = 27/277 (9%)

Query: 70  EDIDTIKVVGKGSGGIV-----QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS 124
           E I   + +G+GS G+V     + V         A+K +        R +   E  + + 
Sbjct: 6   EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 65

Query: 125 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE----------EYLAAIC 174
             C +VV             +I+E M  G L  +L+ ++   E          + +  + 
Sbjct: 66  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMA 125

Query: 175 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY- 233
            ++  G+ YL+  K  +HRDL   N ++     VKI DFG++  +  T        G   
Sbjct: 126 GEIADGMAYLNANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 234 -NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQ 291
             +MSPE +  G +   SD+WS G+VL E AT  + PY     +        +ME  +  
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRFVMEGGLLD 241

Query: 292 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
            P + P   F       +  C Q  P+ R S  E+++
Sbjct: 242 KPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 55/195 (28%), Positives = 92/195 (47%), Gaps = 31/195 (15%)

Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K+++ +V ++AR    +E+KI    + P ++    VC         + +I EYM+ G 
Sbjct: 48  AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD----DPLCMITEYMENGD 103

Query: 155 LADFLKK------------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           L  FL +            + ++    L  +  Q+  G+ YL    + +HRDL   N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL-ASLNFVHRDLATRNCLV 162

Query: 203 NHRGEVKITDFGVSAIMAST-----SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 257
            +   +KI DFG+S  + S       G+A   V    +M+ E I  GK+   SD+W+ G+
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRA---VLPIRWMAWESILLGKFTTASDVWAFGV 219

Query: 258 VLLECAT--GQFPYS 270
            L E  T   + PYS
Sbjct: 220 TLWEMFTLCKEQPYS 234

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 68/228 (29%), Positives = 112/228 (49%), Gaps = 35/228 (15%)

Query: 78  VGKGSGGIVQLVQHK--WTGQFFALKVIQ-MNVEESARRQIA--QELKINQSSQCPYVVV 132
           VG+G+ G V   + K     + +ALK I+   +  SA R+IA  +ELK       P V+ 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELK------HPNVIA 62

Query: 133 CYQSF--YSNGAISIILEYMDG----------GSLADFLKKVKTIPEEYLAAICEQVLKG 180
             + F  +S+  + ++ +Y +            S A+  KK   +P   + ++  Q+L G
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN--KKPMQLPRSMVKSLLYQILDG 120

Query: 181 LLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSAIMAS---TSGQANTFVGTY 233
           + YLH    ++HRDLKP+N+L+      RG VKI D G + +  S        +  V T+
Sbjct: 121 IHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 234 NYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPPEQQDGWTS 280
            Y +PE + G ++  K+ DIW++G +  E  T + P     Q+D  TS
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTS 226

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 65.9 bits (160), Expect = 3e-12
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 30/217 (13%)

Query: 77  VVGKGSGG--IVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVC 133
           V+G+G+ G  +   ++        A+K ++    +   R  A EL++  +    P ++  
Sbjct: 2   VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQV 177
             +    G + + +EY   G+L DFL+K +                T+  + L      V
Sbjct: 62  LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS----AIMASTSGQANTFVGTY 233
            +G+ YL  +K  IHRDL   N+L+      KI DFG+S      +  T G+        
Sbjct: 122 ARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV----- 175

Query: 234 NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
            +M+ E ++   Y   SD+WS G++L E  + G  PY
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 212

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 66/277 (23%), Positives = 122/277 (44%), Gaps = 32/277 (11%)

Query: 75  IKVVGKGSGGIVQLVQHK----WTGQFFALKVIQMNVEESARRQIAQELKI----NQSSQ 126
           I+ +G+G  G V+L ++      TG+  A+K ++     +    + +E++I       + 
Sbjct: 9   IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLH 185
             Y  +C +       I +I+E++  GSL ++L + K  I  +       Q+ KG+ YL 
Sbjct: 69  VKYKGICTED--GGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMSPERIS 242
             +++ HRDL   N+L+    +VKI DFG++  + +        +       + +PE + 
Sbjct: 127 SRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 243 GGKYGYKSDIWSLGLVLLE----CATGQFPYS-------PPEQQDGWTSFYELMEAIVDQ 291
             K+   SD+WS G+ L E    C +   P +       P   Q   T    ++E     
Sbjct: 186 QSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRL 245

Query: 292 P-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
           P PP+ P      E    +  C + +P +R + Q L+
Sbjct: 246 PRPPNCPE-----EVYQLMRKCWEFQPSKRTTFQNLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 65.7 bits (160), Expect = 3e-12
 Identities = 71/274 (25%), Positives = 120/274 (43%), Gaps = 36/274 (13%)

Query: 76  KVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESAR-----RQIAQELKINQSSQC 127
           +++GKG  G V   QL     + Q  A+K+++ ++  S+      R+ A   + +  +  
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 128 PYVVVCYQSFYSNGAISI---ILEYMDGGSLADFLKKVK------TIPEEYLAAICEQVL 178
             + V  +S  + G + I   IL +M  G L  FL   +      T+P + L      + 
Sbjct: 65  KLIGVSLRS-RAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123

Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS----TSGQANTFVGTYN 234
            G+ YL   K+ IHRDL   N ++N    V + DFG+S  + S      G A+       
Sbjct: 124 SGMEYLS-SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL--PVK 180

Query: 235 YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYE-LMEAIVDQP 292
           +++ E ++   Y   SD+W+ G+ + E  T GQ PY+  E  +     Y  L++    + 
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE----IYNYLIKGNRLKQ 236

Query: 293 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           PP    D +       +  C   EP+ R S Q L
Sbjct: 237 PPDCLEDVY-----ELMCQCWSPEPKCRPSFQHL 265

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 36/111 (32%), Positives = 56/111 (50%), Gaps = 3/111 (2%)

Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 214
           L  ++ +   +P E    I  ++L+ L YLH  + IIHRD+K  N+ ++      + DFG
Sbjct: 172 LFTYVDRSGPLPLEQAITIQRRLLEALAYLH-GRGIIHRDVKTENIFLDEPENAVLGDFG 230

Query: 215 VSA--IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
            +        + Q   + GT    SPE ++   Y  K+DIWS GLVL E +
Sbjct: 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281

Length = 392

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 65.6 bits (160), Expect = 4e-12
 Identities = 65/279 (23%), Positives = 114/279 (40%), Gaps = 40/279 (14%)

Query: 76  KVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC----- 127
           K++G+G  G V   QL Q   +    A+K   M ++     +I + L     + C     
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKT--MKLDIHTYSEIEEFLS---EAACMKDFD 59

Query: 128 -PYVV----VCYQSFYSNGAIS--IILEYMDGGSLADFLKKVKT------IPEEYLAAIC 174
            P V+    VC+++          +IL +M  G L  FL   +       +P + L    
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 175 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY- 233
             +  G+ YL + ++ IHRDL   N ++     V + DFG+S  + S        +    
Sbjct: 120 VDIALGMEYLSN-RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP 178

Query: 234 -NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYE-LMEAIVD 290
             +++ E ++   Y  KSD+W+ G+ + E AT GQ PY   E  +     Y+ L      
Sbjct: 179 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE----IYDYLRHGNRL 234

Query: 291 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
           + P          E    + +C + +P+ R +  +L   
Sbjct: 235 KQPEDCLD-----ELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 81/316 (25%), Positives = 120/316 (37%), Gaps = 71/316 (22%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVV 131
           IK +G G+ G V L     T   +A+K ++   +   R Q+A    E  I   +   +VV
Sbjct: 6   IKTLGIGAFGEVCLACKVDTHALYAMKTLRKK-DVLNRNQVAHVKAERDILAEADNEWVV 64

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
             Y SF     +  +++Y+ GG +   L +++  PE  LA      L   +   H+   I
Sbjct: 65  KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPE-VLARFYIAELTLAIESVHKMGFI 123

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY---NYMSPERISGGKYGY 248
           HRD+KP N+LI+  G +K+TDFG+      T        G++   + M P          
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP---------- 173

Query: 249 KSDIWS------LG--LVLLE-------------CATGQFPYSPPEQQ---------DGW 278
            SD+W        G  L  LE                G   Y  PE           D W
Sbjct: 174 -SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWW 232

Query: 279 TSFYELMEAIVDQPPPSAPSD--------------------QFSPEFCSFIS--ACVQKE 316
           +    L E +V QPP  AP+                     + SPE    I+   C  +E
Sbjct: 233 SVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEE 292

Query: 317 PQQRLSAQELMTHPFL 332
              R  A ++  HPF 
Sbjct: 293 RLGRNGADDIKAHPFF 308

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 65.5 bits (159), Expect = 6e-12
 Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 35/228 (15%)

Query: 78  VGKGSGGIVQLVQHK--WTGQFFALKVIQ-MNVEESARRQIA--QELKINQSSQCPYVVV 132
           VG+G+ G V   + K     + +ALK I+   +  SA R+IA  +ELK       P V+ 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELK------HPNVIS 62

Query: 133 CYQSFYSNG--AISIILEYMDG----------GSLADFLKKVKTIPEEYLAAICEQVLKG 180
             + F S+    + ++ +Y +            S A+  KK   +P   + ++  Q+L G
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN--KKPVQLPRGMVKSLLYQILDG 120

Query: 181 LLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSAIMAS---TSGQANTFVGTY 233
           + YLH    ++HRDLKP+N+L+      RG VKI D G + +  S        +  V T+
Sbjct: 121 IHYLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 234 NYMSPERISGGKYGYKS-DIWSLGLVLLECATGQFPYSPPEQQDGWTS 280
            Y +PE + G ++  K+ DIW++G +  E  T + P     Q+D  TS
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTS 226

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)

Query: 140 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+            +  +P+E      L +   QV +G+ Y
Sbjct: 93  DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEY 152

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 153 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEAL 211

Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 212 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 240

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 84/315 (26%), Positives = 132/315 (41%), Gaps = 49/315 (15%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF--ALKVIQMNVEESARRQIAQELKI-NQ 123
           L   DI    V+G+G+ G V   + K  G     A+K ++    +   R  A EL++  +
Sbjct: 4   LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 63

Query: 124 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPE 167
               P ++    +    G + + +EY   G+L DFL+K +                T+  
Sbjct: 64  LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123

Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS----AIMASTS 223
           + L      V +G+ YL  +K  IHRDL   N+L+      KI DFG+S      +  T 
Sbjct: 124 QQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182

Query: 224 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT--S 280
           G+         +M+ E ++   Y   SD+WS G++L E  + G  PY       G T   
Sbjct: 183 GRLPV-----RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC------GMTCAE 231

Query: 281 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-AQELMTHPFL----KMY 335
            YE +        P    D    E    +  C +++P +R S AQ L++   +    K Y
Sbjct: 232 LYEKLPQGYRLEKPLNCDD----EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 287

Query: 336 GDLNVDLSEYFTDAG 350
             +N  L E FT AG
Sbjct: 288 --VNTTLYEKFTYAG 300

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 64.3 bits (156), Expect = 2e-11
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 39/234 (16%)

Query: 140 NGAISIILEYMDGGSLADFLKKVK-----------TIPEEYLA-----AICEQVLKGLLY 183
           +G + +++EY   G+L ++L+  +            +PEE L      +   QV +G+ Y
Sbjct: 90  DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEY 149

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 150 LASQK-CIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEAL 208

Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 298
               Y ++SD+WS G++L E  T G  PY   P E+      F  L E      P +   
Sbjct: 209 FDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL-----FKLLKEGHRMDKPANCTH 263

Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQEL-------MTHPFLKMYGDLNVDLSEY 345
           + +       +  C    P QR + ++L       +T      Y DL+V   +Y
Sbjct: 264 ELY-----MIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYLDLSVPFEQY 312

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 52/160 (32%), Positives = 78/160 (48%), Gaps = 19/160 (11%)

Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS---- 223
           E L +   QV KG+ +L   K+ IHRDL   N+L+ H    KI DFG++  + + S    
Sbjct: 214 EDLLSFSYQVAKGMSFLA-SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272

Query: 224 -GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSF 281
            G A   V    +M+PE I    Y ++SD+WS G++L E  + G  PY P    D  + F
Sbjct: 273 KGNARLPV---KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY-PGMPVD--SKF 326

Query: 282 YELM-EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
           Y+++ E      P  AP      E    + +C   +P +R
Sbjct: 327 YKMIKEGYRMLSPECAP-----SEMYDIMKSCWDADPLKR 361

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 63/276 (22%), Positives = 115/276 (41%), Gaps = 27/276 (9%)

Query: 70  EDIDTIKVVGKGSGGIV-QLVQHKWTGQFFALKVIQMNVEESA----RRQIAQELKINQS 124
           E I  ++ +G+GS G+V +             +V    V ESA    R +   E  + + 
Sbjct: 6   EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKG 65

Query: 125 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE----------EYLAAIC 174
             C +VV             +++E M  G L  +L+ ++   E          + +  + 
Sbjct: 66  FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125

Query: 175 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY- 233
            ++  G+ YL+ +K  +HRDL   N ++ H   VKI DFG++  +  T        G   
Sbjct: 126 AEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 184

Query: 234 -NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQ 291
             +M+PE +  G +   SD+WS G+VL E  +  + PY     +       ++++ ++D 
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-------QVLKFVMDG 237

Query: 292 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
                P D         +  C Q  P+ R +  E++
Sbjct: 238 GYLDQP-DNCPERVTDLMRMCWQFNPKMRPTFLEIV 272

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 62/247 (25%), Positives = 99/247 (40%), Gaps = 31/247 (12%)

Query: 95  GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGS 154
            Q  A+K ++         +  QE  +      P +V           + ++ EY++ G 
Sbjct: 34  AQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGD 93

Query: 155 LADFL----------------KKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           L +FL                  VK+ +       I  Q+  G+ YL      +H+DL  
Sbjct: 94  LHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS-SHFFVHKDLAA 152

Query: 198 SNLLINHRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWS 254
            N+LI  +  VKI+D G+S  + S      Q  + +    +M PE I  GK+   SDIWS
Sbjct: 153 RNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL-PIRWMPPEAIMYGKFSSDSDIWS 211

Query: 255 LGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
            G+VL E  + G  PY     Q       E++E +  +       D   P   S ++ C 
Sbjct: 212 FGVVLWEIFSFGLQPYYGFSNQ-------EVIEMVRKRQLLPCSED-CPPRMYSLMTECW 263

Query: 314 QKEPQQR 320
           Q+ P +R
Sbjct: 264 QEGPSRR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 62.2 bits (151), Expect = 4e-11
 Identities = 49/187 (26%), Positives = 79/187 (42%), Gaps = 28/187 (14%)

Query: 145 IILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           I+ EYM  G+L  FL+K +  +    L  +   +  G+ YL  E   +H+ L    +L+N
Sbjct: 83  IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS-EMGYVHKGLAAHKVLVN 141

Query: 204 HRGEVKITDFG------VSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 257
                KI+ F         AI  + SG++        + +PE I    +   SD+WS G+
Sbjct: 142 SDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-----WAAPEAIQYHHFSSASDVWSFGI 196

Query: 258 VLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSFISACV 313
           V+ E  + G+ PY     QD       +++A+ D    P P              +  C 
Sbjct: 197 VMWEVMSYGERPYWDMSGQD-------VIKAVEDGFRLPAPR----NCPNLLHQLMLDCW 245

Query: 314 QKEPQQR 320
           QKE  +R
Sbjct: 246 QKERGER 252

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 59/179 (32%), Positives = 82/179 (45%), Gaps = 19/179 (10%)

Query: 157 DFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 216
           D  KKV T+  E L     QV KG+ +L   K  IHRDL   N+L++    VKI DFG++
Sbjct: 170 DLYKKVLTL--EDLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLA 226

Query: 217 AIMAST-----SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYS 270
             +         G A        +M+PE I    Y  +SD+WS G++L E  + G  PY 
Sbjct: 227 RDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY- 282

Query: 271 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
           P  + D      E    + +     AP D  +PE    +  C   EP QR +  EL+ H
Sbjct: 283 PGVKID-----EEFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 20/149 (13%)

Query: 140 NGAISIILEYMDGGSLADFLKKVK-----------TIPEEYLA-----AICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+  +            +PEE L+     +   QV +G+ Y
Sbjct: 96  DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEY 155

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 156 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 214

Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
               Y ++SD+WS G++L E  T G  PY
Sbjct: 215 FDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 61/270 (22%), Positives = 105/270 (38%), Gaps = 53/270 (19%)

Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K+++ +  ++AR    +E+KI    + P ++           + +I EYM+ G L  F
Sbjct: 50  AVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQF 109

Query: 159 LK-------------------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN 199
           L                     +  I    L  +  Q+  G+ YL    + +HRDL   N
Sbjct: 110 LSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL-SSLNFVHRDLATRN 168

Query: 200 LLINHRGEVKITDFGVSAIMASTSGQANTFVGTY-----------NYMSPERISGGKYGY 248
            L+     +KI DFG+S          N + G Y            +M+ E I  GK+  
Sbjct: 169 CLVGENLTIKIADFGMS---------RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT 219

Query: 249 KSDIWSLGLVLLE----CATGQFPYSPPEQ--QDGWTSFYELMEAIVDQPPPSAPSDQFS 302
            SD+W+ G+ L E    C    +     EQ  ++    F +    +    PP  P   + 
Sbjct: 220 ASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLY- 278

Query: 303 PEFCSFISACVQKEPQQRLSAQELMTHPFL 332
                 +  C  ++ ++R S  ++  H FL
Sbjct: 279 ----ELMLQCWSRDCRERPSFSDI--HAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 49/160 (30%), Positives = 73/160 (45%), Gaps = 17/160 (10%)

Query: 176 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-----SGQANTFV 230
           QV +G+ +L   K  IHRDL   N+L++    VKI DFG++  +         G A    
Sbjct: 181 QVARGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 237

Query: 231 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIV 289
               +M+PE I    Y  +SD+WS G++L E  + G  PY P  Q D      E    + 
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY-PGVQID-----EEFCRRLK 290

Query: 290 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
           +     AP +  +PE  S +  C    P+ R +  EL+  
Sbjct: 291 EGTRMRAP-EYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 48/153 (31%), Positives = 77/153 (50%), Gaps = 21/153 (13%)

Query: 176 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTS----GQANTFV 230
           QV +G+ +L   K+ IHRD+   N+L+      KI DFG++  IM  ++    G A   V
Sbjct: 220 QVAQGMDFLA-SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPV 278

Query: 231 GTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEA-- 287
               +M+PE I    Y  +SD+WS G++L E  + G+ PY P    +  + FY++++   
Sbjct: 279 ---KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY-PGILVN--SKFYKMVKRGY 332

Query: 288 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
            + +P      D   PE  S +  C   EP +R
Sbjct: 333 QMSRP------DFAPPEIYSIMKMCWNLEPTER 359

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 5/97 (5%)

Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 229
           + A+  Q+L  + Y+H E  IIHRD+K  N+L+N   ++ + DFG +A  A  S      
Sbjct: 262 VTAVARQLLSAIDYIHGEG-IIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTPFH 319

Query: 230 ---VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
               GT +  +PE ++G  Y    DIWS GLV+ E A
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 52/169 (30%), Positives = 81/169 (47%), Gaps = 22/169 (13%)

Query: 176 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-----SGQANTFV 230
           QV +G+ +L   K  IHRDL   N+L++    VKI DFG++  +         G A    
Sbjct: 182 QVARGMEFLASRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL-- 238

Query: 231 GTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIV 289
               +M+PE I    Y  +SD+WS G++L E  + G  PY P  Q +      E  + + 
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY-PGVQIN-----EEFCQRLK 291

Query: 290 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL 338
           D     AP +  +PE    + AC Q +P++R +   L     +++ GDL
Sbjct: 292 DGTRMRAP-ENATPEIYRIMLACWQGDPKERPTFSAL-----VEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 59.4 bits (144), Expect = 4e-10
 Identities = 52/201 (25%), Positives = 89/201 (44%), Gaps = 15/201 (7%)

Query: 70  EDIDTIKVVGKGSGGIV-QLVQHKWTGQFF--ALKVIQMNVEESARRQIAQELKINQSSQ 126
           EDI   + +G+G  G V Q V      +    A+K  +     S R +  QE  I +   
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 127 CPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGL 181
            P++V    V      +   + I++E    G L  +L+  K  +    L     Q+   L
Sbjct: 66  HPHIVKLIGVI-----TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTAL 120

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTFVGTYNYMSPER 240
            YL   K  +HRD+   N+L++    VK+ DFG+S  +   +  +A+       +M+PE 
Sbjct: 121 AYLE-SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPES 179

Query: 241 ISGGKYGYKSDIWSLGLVLLE 261
           I+  ++   SD+W  G+ + E
Sbjct: 180 INFRRFTSASDVWMFGVCMWE 200

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.1 bits (145), Expect = 5e-10
 Identities = 35/97 (36%), Positives = 54/97 (55%), Gaps = 2/97 (2%)

Query: 172 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG-VSAIMASTSGQANTFV 230
           AI +Q+L  + Y+H +K +IHRD+K  N+ +N  G++ + DFG               +V
Sbjct: 271 AIMKQLLCAVEYIH-DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWV 329

Query: 231 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF 267
           GT    SPE ++G  Y   +DIWS GL+LL+  +  F
Sbjct: 330 GTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDF 366

Length = 501

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 59.3 bits (143), Expect = 9e-10
 Identities = 50/161 (31%), Positives = 80/161 (49%), Gaps = 13/161 (8%)

Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTS--GQA 226
           L +   QV +G+ +L   K+ +HRDL   N+L+     VKI DFG++  IM  ++   + 
Sbjct: 239 LLSFTYQVARGMEFLA-SKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKG 297

Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM 285
           +TF+    +M+PE I    Y   SD+WS G++L E  + G  PY P    D  ++FY  +
Sbjct: 298 STFLPV-KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY-PGMIVD--STFYNKI 353

Query: 286 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           ++      P    D  + E    +  C   EP++R S   L
Sbjct: 354 KSGYRMAKP----DHATQEVYDIMVKCWNSEPEKRPSFLHL 390

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 7/138 (5%)

Query: 139 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL   K  +HRDL  
Sbjct: 68  SEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA-SKKFVHRDLAA 126

Query: 198 SNLLINHRGEVKITDFGVSAIMAST---SGQANTFVG-TYNYMSPERISGGKYGYKSDIW 253
            N +++    VK+ DFG++  +      S   +T       +M+ E +   K+  KSD+W
Sbjct: 127 RNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVW 186

Query: 254 SLGLVLLECAT-GQFPYS 270
           S G++L E  T G  PY 
Sbjct: 187 SFGVLLWELMTRGAPPYP 204

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 24/192 (12%)

Query: 176 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE-VKITDFGVSAIMASTSGQANTFVGTYN 234
           Q+ + L Y+H  K I HRDLKP NLLI+     +K+ DFG SA       ++ +++ +  
Sbjct: 178 QLCRALAYIH-SKFICHRDLKPQNLLIDPNTHTLKLCDFG-SAKNLLAGQRSVSYICSRF 235

Query: 235 YMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP- 292
           Y +PE + G   Y    D+WSLG ++ E   G   +S     D      +++    +   
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295

Query: 293 ------------PPSAPSD------QFSP-EFCSFISACVQKEPQQRLSAQELMTHPFLK 333
                       P   P D      + +P +  +FIS  ++ EP +RL+  E +  PF  
Sbjct: 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFD 355

Query: 334 MYGDLNVDLSEY 345
              D  + L +Y
Sbjct: 356 DLRDPCIKLPKY 367

Length = 440

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 56.8 bits (137), Expect = 3e-09
 Identities = 53/191 (27%), Positives = 88/191 (46%), Gaps = 31/191 (16%)

Query: 145 IILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           ++ E+++ G L   L+K K  +P  +   + +Q+   L YL  +K+++H ++   N+L+ 
Sbjct: 93  MVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE-DKNLVHGNVCAKNILLA 151

Query: 204 HRGE-------VKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SGGKYGYKSDIWSL 255
             G        +K++D GVS    S   +    V    +++PE +  G      +D WS 
Sbjct: 152 RLGLAEGTSPFIKLSDPGVSFTALSREER----VERIPWIAPECVPGGNSLSTAADKWSF 207

Query: 256 GLVLLE-CATGQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 311
           G  LLE C  G+ P    +P E++     FYE    +   P PS        E  + IS 
Sbjct: 208 GTTLLEICFDGEVPLKERTPSEKE----RFYEKKHRL---PEPSCK------ELATLISQ 254

Query: 312 CVQKEPQQRLS 322
           C+  EP QR S
Sbjct: 255 CLTYEPTQRPS 265

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 45/131 (34%), Positives = 67/131 (51%), Gaps = 13/131 (9%)

Query: 176 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTS--GQANTFVGT 232
           QV  G+ +L   K+ +HRDL   N+LI     VKI DFG++  IM  ++   + +TF+  
Sbjct: 247 QVANGMEFLA-SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL-P 304

Query: 233 YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIV 289
             +M+PE I    Y   SD+WS G++L E  T G  PY   P  +Q     FY  ++   
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ-----FYNAIKRGY 359

Query: 290 DQPPPSAPSDQ 300
               P+  SD+
Sbjct: 360 RMAKPAHASDE 370

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 54.5 bits (132), Expect = 1e-08
 Identities = 27/90 (30%), Positives = 41/90 (45%), Gaps = 11/90 (12%)

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 186
            P V   Y     N    I++EY++G  L D +        E    I   V  G L   H
Sbjct: 63  VPAV---YFVDPENF--IIVMEYIEGEPLKDLINSNGMEELELSREIGRLV--GKL---H 112

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVS 216
              IIH DL  SN++++  G++ + DFG++
Sbjct: 113 SAGIIHGDLTTSNMILSG-GKIYLIDFGLA 141

Length = 211

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 53.2 bits (127), Expect = 9e-08
 Identities = 49/164 (29%), Positives = 74/164 (45%), Gaps = 16/164 (9%)

Query: 153 GSLADFLKKVKTIPEE---------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           G L +F+   K IP+           +  +  QVL GL  LH    I+HRD+KP NLL+ 
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLH-RIGIVHRDIKPENLLVT 343

Query: 204 HRGEVKITDFGVSAIMASTSGQANTFVGTYN--YMSPERISGGKYGYKSDIWSLGLVLLE 261
             G+VKI DFG +  M  T    N   G  +  Y  PE +   +   ++   ++  +L  
Sbjct: 344 VDGQVKIIDFGAAVDMC-TGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSP 402

Query: 262 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 305
            A   + Y  P+  D +T+   LM+  V +  P A    F+ E 
Sbjct: 403 FA---WLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTEL 443

Length = 507

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 38/130 (29%), Positives = 64/130 (49%), Gaps = 7/130 (5%)

Query: 143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           +S+ILEY   G L + L K K +  +    +     KGL  L+   +  +++L   + L+
Sbjct: 97  LSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV 156

Query: 203 NHRGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVL 259
               ++KI   G+  I++S      N  V    Y S + ++    +Y  K DI+SLG+VL
Sbjct: 157 TENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKDDIYSLGVVL 212

Query: 260 LECATGQFPY 269
            E  TG+ P+
Sbjct: 213 WEIFTGKIPF 222

Length = 283

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 29/123 (23%), Positives = 59/123 (47%), Gaps = 8/123 (6%)

Query: 154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           +  +  K++K   ++ +  I + +L  L Y+H E  I H D+KP N++++      I D+
Sbjct: 112 NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIH-EHGISHGDIKPENIMVDGNNRGYIIDY 170

Query: 214 GVSAI-------MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ 266
           G+++        +  +  Q +   GT  Y   +  +G     + D+ SLG  +L+ A  +
Sbjct: 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIK 230

Query: 267 FPY 269
            P+
Sbjct: 231 LPW 233

Length = 294

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 51/209 (24%), Positives = 85/209 (40%), Gaps = 35/209 (16%)

Query: 145 IILEYMDGGSLADFLKKVKTI------PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS 198
           ++LE+   G L ++L+  + +       +      CE V  GLL+LH +   IH DL   
Sbjct: 72  LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACE-VASGLLWLH-QADFIHSDLALR 129

Query: 199 NLLINHRGEVKITDFGV--SAIMASTSGQANTFVGTYNYMSPE-------RISGGKYGYK 249
           N  +     VKI D+G+             +       +++PE        +       K
Sbjct: 130 NCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKK 189

Query: 250 SDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP---SDQFSP-- 303
           S+IWSLG+ + E  T    PY  P+  D       + E  +  P P      SD++    
Sbjct: 190 SNIWSLGVTMWELFTAADQPY--PDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVM 247

Query: 304 EFCSFISACVQKEPQQRLSAQE---LMTH 329
           +FC         +P+ R +A+E   L+T+
Sbjct: 248 QFCWL-------DPETRPTAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.9 bits (104), Expect = 2e-05
 Identities = 30/143 (20%), Positives = 62/143 (43%), Gaps = 23/143 (16%)

Query: 85  IVQLVQHKWTGQFFALK------VIQMNVEESARRQIAQELKI-----NQSSQCPYVVVC 133
            ++L++   T + + L       V+++N          +E+ I      +    P V+  
Sbjct: 2   SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLAS 61

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH--EKHII 191
            +S   +G   +++E+++G +L +       + EE    I EQ+ + L  LH      + 
Sbjct: 62  GES---DGWSYLLMEWIEGETLDE-------VSEEEKEDIAEQLAELLAKLHQLPLLVLC 111

Query: 192 HRDLKPSNLLINHRGEVKITDFG 214
           H DL P N+L++    + I D+ 
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 43.4 bits (103), Expect = 5e-05
 Identities = 23/73 (31%), Positives = 37/73 (50%), Gaps = 9/73 (12%)

Query: 144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           +I++EY++G  L D    ++   +E L  I   V  G L   H+  I+H DL  SN+++ 
Sbjct: 73  TIVMEYIEGKPLKD---VIEEGNDELLREIGRLV--GKL---HKAGIVHGDLTTSNIIVR 124

Query: 204 HRGEVKITDFGVS 216
                 I DFG+ 
Sbjct: 125 DDKLYLI-DFGLG 136

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|240168 cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

 Score = 43.3 bits (103), Expect = 6e-05
 Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 10/89 (11%)

Query: 127 CPYVVVCYQSFYSNGAISIILEYM-DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
            P  ++       N    +++E++ D GS A  LK V  + EE    + EQV++ +  L+
Sbjct: 83  VPEPIL----LKKN---VLVMEFIGDDGSPAPRLKDVP-LEEEEAEELYEQVVEQMRRLY 134

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFG 214
            E  ++H DL   N+L  H G+  I D  
Sbjct: 135 QEAGLVHGDLSEYNILY-HDGKPYIIDVS 162

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and chromosome maintenance. The biological substrates for RIO1 are unknown. The function of RIO3 is also unknown. Length = 190

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 48/192 (25%), Positives = 81/192 (42%), Gaps = 32/192 (16%)

Query: 145 IILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           ++ EY+  G L  FL + K  +   +   + +Q+   L YL  +K ++H ++   N+L+ 
Sbjct: 77  MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE-DKKLVHGNVCGKNILVA 135

Query: 204 HRGE-------VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG--KYGYKSDIWS 254
             G        +K++D G+      T       V    +++PE I  G       +D WS
Sbjct: 136 RYGLNEGYVPFIKLSDPGIP----ITVLSREERVERIPWIAPECIRNGQASLTIAADKWS 191

Query: 255 LGLVLLE-CATGQFP---YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 310
            G  LLE C+ G+ P    S  E++     FY+      DQ     P      E  + I+
Sbjct: 192 FGTTLLEICSNGEEPLSTLSSSEKER----FYQ------DQHRLPMPD---CAELANLIN 238

Query: 311 ACVQKEPQQRLS 322
            C   +P +R S
Sbjct: 239 QCWTYDPTKRPS 250

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain

 Score = 41.7 bits (99), Expect = 2e-04
 Identities = 19/71 (26%), Positives = 37/71 (52%), Gaps = 4/71 (5%)

Query: 145 IILEYMDGGSLADF-LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           +++E++ G  +    LK V+    E    + +Q+L+ +  L+ E  ++H DL   N+L+ 
Sbjct: 92  LVMEFIGGDGIPAPRLKDVR--LLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV- 148

Query: 204 HRGEVKITDFG 214
             G+V I D  
Sbjct: 149 DDGKVYIIDVP 159

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187

>gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only]

 Score = 42.3 bits (100), Expect = 3e-04
 Identities = 20/79 (25%), Positives = 35/79 (44%), Gaps = 7/79 (8%)

Query: 138 YSNGAISIILEYMDGGSLADF--LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 195
           Y+   + + +E++DG  ++D   LK      +E    +    L+ LL         H D 
Sbjct: 237 YTTRRV-LTMEWIDGIKISDIAALKSAGIDRKELAELLVRAFLRQLL----RDGFFHADP 291

Query: 196 KPSNLLINHRGEVKITDFG 214
            P N+L+   G + + DFG
Sbjct: 292 HPGNILVRSDGRIVLLDFG 310

Length = 517

>gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain

 Score = 41.0 bits (97), Expect = 3e-04
 Identities = 24/71 (33%), Positives = 40/71 (56%), Gaps = 11/71 (15%)

Query: 145 IILEYMDGGSLADFLKKVKTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           +++EY+DG      L +V+ +  PEE L  I E+++K   Y H    IIH DL   N+L+
Sbjct: 108 VVMEYIDG----VELYRVRVLEDPEEVLDEILEEIVK--AYKHG---IIHGDLSEFNILV 158

Query: 203 NHRGEVKITDF 213
           +   ++ I D+
Sbjct: 159 DDDEKIYIIDW 169

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198

>gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

 Score = 40.3 bits (95), Expect = 6e-04
 Identities = 24/90 (26%), Positives = 39/90 (43%), Gaps = 14/90 (15%)

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 186
            P V              I++EY++G  L D L+       + L  +   V  G L   H
Sbjct: 63  VPIVY-----DVDPDNGLIVMEYIEGELLKDALE---EARPDLLREVGRLV--GKL---H 109

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVS 216
           +  I+H DL  SN++++  G +   DFG+ 
Sbjct: 110 KAGIVHGDLTTSNIILS-GGRIYFIDFGLG 138

Length = 204

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.4 bits (98), Expect = 6e-04
 Identities = 22/71 (30%), Positives = 34/71 (47%), Gaps = 10/71 (14%)

Query: 144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           +I++EY+ G  L D L+       E +  + E V K    LH    I+H DL  SN ++ 
Sbjct: 412 TIVMEYIGGKDLKDVLEGN----PELVRKVGEIVAK----LHKAG-IVHGDLTTSNFIV- 461

Query: 204 HRGEVKITDFG 214
               + + DFG
Sbjct: 462 RDDRLYLIDFG 472

Length = 535

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 47/189 (24%), Positives = 79/189 (41%), Gaps = 26/189 (13%)

Query: 145 IILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           ++ EY+  GSL  +LKK K  I   +   + +Q+   L +L  +K + H ++   N+L+ 
Sbjct: 76  MVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE-DKGLTHGNVCAKNVLLI 134

Query: 204 HRGE--------VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWS 254
              +        +K++D G+S  +          +    ++ PE I   +     +D WS
Sbjct: 135 REEDRKTGNPPFIKLSDPGISITVLPK----EILLERIPWVPPECIENPQNLSLAADKWS 190

Query: 255 LGLVLLE-CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
            G  L E  + G  P S  + Q     FYE      D+    AP      E  + I+ C+
Sbjct: 191 FGTTLWEIFSGGDKPLSALDSQKK-LQFYE------DRHQLPAPK---WTELANLINQCM 240

Query: 314 QKEPQQRLS 322
             EP  R S
Sbjct: 241 DYEPDFRPS 249

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|224632 COG1718, RIO1, Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

 Score = 38.8 bits (91), Expect = 0.003
 Identities = 22/71 (30%), Positives = 37/71 (52%), Gaps = 3/71 (4%)

Query: 145 IILEYM-DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           +++E++ D G  A  LK V  +  E    + E V++ +  L+ E  ++H DL   N+L+ 
Sbjct: 143 LVMEFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV- 200

Query: 204 HRGEVKITDFG 214
           H GE  I D  
Sbjct: 201 HDGEPYIIDVS 211

Length = 268

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	362
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.98
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.94
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.93
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.91
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
PRK10345	210	hypothetical protein; Provisional	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
smart00090	237	RIO RIO-like kinase.	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.81
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.75
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.72
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.7
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.68
KOG1243	690	consensus Protein kinase [General function predict	99.61
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.58
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.58
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.51
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.48
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.4
KOG3087	229	consensus Serine/threonine protein kinase [General	99.34
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.3
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.21
COG4248	637	Uncharacterized protein with protein kinase and he	99.19
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.18
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.16
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.13
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.0
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.98
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.83
PRK09902	216	hypothetical protein; Provisional	98.82
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.78
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.7
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.67
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.64
PF01636	239	APH: Phosphotransferase enzyme family This family	98.61
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.57
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.43
PLN02876	822	acyl-CoA dehydrogenase	98.35
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.33
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	98.29
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.27
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.21
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.2
KOG2270	520	consensus Serine/threonine protein kinase involved	98.09
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.08
PRK10593	297	hypothetical protein; Provisional	97.94
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.84
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.81
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.79
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.7
PRK05231	319	homoserine kinase; Provisional	97.7
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.68
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.65
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.54
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.36
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.32
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.22
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.21
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.16
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.98
PLN02236	344	choline kinase	96.84
PLN02756	418	S-methyl-5-thioribose kinase	96.79
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.76
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.63
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.59
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.57
PRK12396	409	5-methylribose kinase; Reviewed	96.5
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.33
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.29
PRK11768	325	serine/threonine protein kinase; Provisional	95.79
PRK06148	1013	hypothetical protein; Provisional	95.71
KOG2269	531	consensus Serine/threonine protein kinase [Signal	95.45
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.44
PTZ00384	383	choline kinase; Provisional	94.59
PRK10271	188	thiK thiamine kinase; Provisional	93.83

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-67  Score=471.15  Aligned_cols=351  Identities=49%  Similarity=0.820  Sum_probs=300.4

Q ss_pred             CCCCCCCCCceeecCCCCCCCcccccccCcceeeCCCeeecCCCceecccCCCCCCCCCCCCCCCCCccCceeeeeeeee
Q 018018            2 KKGGLNPNVKLKLSLPSSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKG   81 (362)
Q Consensus         2 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G   81 (362)
                      ..+.++|..++.++... ++...+...+-.++..+.+...+.......+..........+.....+...+.+.+..||+|
T Consensus        12 ~~~~~~~~~~~~~~~~~-~~~~ls~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~i~~~dle~~~~lG~G   90 (364)
T KOG0581|consen   12 ELGSLRPDLSLPLPPDY-DSAILSARDTLPSTSESLELTDNSPPLSKISLSSSSANSELSEDDNGISLSDLERLGVLGSG   90 (364)
T ss_pred             cccccCcccccCCCCCC-ccccccccccCCccccccccccccccccccccccccccccccccccccCHHHhhhhhhcccC
Confidence            34555666555555332 45555555555555555554444444333333333333333333556777899999999999


Q ss_pred             CCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC-eEEEEEeccCCCCHHHHHH
Q 018018           82 SGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-AISIILEYMDGGSLADFLK  160 (362)
Q Consensus        82 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~-~~~lV~e~~~~gsL~~~l~  160 (362)
                      ..|+||+|+|+.+++.+|+|++....+++.++++.+|+++++..+|||||.+|++|..++ .++++||||++|||.+++.
T Consensus        91 ~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k  170 (364)
T KOG0581|consen   91 NGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILK  170 (364)
T ss_pred             CCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHh
Confidence            999999999999999999999988889999999999999999999999999999999999 4999999999999999999


Q ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCCcccCcce
Q 018018          161 KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER  240 (362)
Q Consensus       161 ~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  240 (362)
                      ..+++++.....++.++++||.|||++++|+||||||+|||++..|.|||||||.+..+...  ...+++||..|||||.
T Consensus       171 ~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPER  248 (364)
T KOG0581|consen  171 RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPER  248 (364)
T ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hcccccccccccChhh
Confidence            99999999999999999999999996699999999999999999999999999999887654  5678899999999999


Q ss_pred             ecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCC
Q 018018          241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR  320 (362)
Q Consensus       241 ~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  320 (362)
                      +.+..|+.++||||||++++|+++|++||...  ...+....+++..+...++|..+...++++++++|..||++||.+|
T Consensus       249 i~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~--~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R  326 (364)
T KOG0581|consen  249 ISGESYSVKSDIWSLGLSLLELAIGRFPYPPP--NPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSER  326 (364)
T ss_pred             hcCCcCCcccceecccHHHHHHhhCCCCCCCc--CCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccC
Confidence            99999999999999999999999999999876  3445678899999999888777766799999999999999999999


Q ss_pred             CCHHHHHcCCcccccCCCCCCHHHHHHHhCCCccccc
Q 018018          321 LSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLS  357 (362)
Q Consensus       321 pt~~eil~hp~~~~~~~~~~~l~~~~~~~~~~~~~~~  357 (362)
                      ||+.|+++|||++.+...++++..|+.+..++..++.
T Consensus       327 ~s~~qLl~Hpfi~~~~~~~vd~~~~~~~~~~~~~~~~  363 (364)
T KOG0581|consen  327 PSAKQLLQHPFIKKFEDPNVDMASFVRKALSPPRSLP  363 (364)
T ss_pred             CCHHHHhcCHHHhhcccccccHHHHHHHhcccCCCCC
Confidence            9999999999999999999999999999998887764

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.4e-60  Score=423.56  Aligned_cols=263  Identities=31%  Similarity=0.465  Sum_probs=229.1

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch------HHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE------SARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ..+.|.+.+.||+|+||.|-+|..+.+|+.||||++......      .....+.+|+++|++++||||++++++|....
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            457788899999999999999999999999999999765221      12334679999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC---CcEEEeeccCCcc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAI  218 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~---~~vkl~DFg~a~~  218 (362)
                      ..|+||||+.||+|.+.+-.++.+.++..+.+++||+.|+.|||+ +||+||||||+|||++.+   ..+||+|||+|+.
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~-~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHS-QGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHH-cCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            999999999999999999999999999999999999999999998 999999999999999876   6899999999998


Q ss_pred             cccCCCCCCccccCCcccCcceecCCCC---CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--
Q 018018          219 MASTSGQANTFVGTYNYMSPERISGGKY---GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--  293 (362)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  293 (362)
                      .+ ......+.|||+.|.|||++.++.+   ..++||||+||+||-+++|.+||.+.....      .+.+.+..+..  
T Consensus       329 ~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------sl~eQI~~G~y~f  401 (475)
T KOG0615|consen  329 SG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------SLKEQILKGRYAF  401 (475)
T ss_pred             cc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc------cHHHHHhcCcccc
Confidence            76 4556788999999999999988653   447899999999999999999998754321      24445544433  


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       294 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      -+..+..++.+..+||.+||..||++|||++|+|+||||+.....
T Consensus       402 ~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~  446 (475)
T KOG0615|consen  402 GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCL  446 (475)
T ss_pred             cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccccc
Confidence            234567899999999999999999999999999999999977643

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-59  Score=415.19  Aligned_cols=264  Identities=33%  Similarity=0.552  Sum_probs=241.2

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      ....++|+++++||+|+||+||+++.+.+++.||+|++++.  ......+....|..++..++||+|+.++..|++.+.+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            45679999999999999999999999999999999999876  3344577899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      |+|+||+.||.|...|++.+.++++.++.++.+|+.||.|||+ +|||||||||+|||++.+|+++|+|||+|+.....+
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~-~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~  179 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHS-KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG  179 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence            9999999999999999999999999999999999999999998 999999999999999999999999999999877777


Q ss_pred             CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          224 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                      ..+.+.|||+.|||||++.+..|+..+|+||||+++|||++|.+||.+.+       ..++.+++...+. ...+..++.
T Consensus       180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~-------~~~~~~~I~~~k~-~~~p~~ls~  251 (357)
T KOG0598|consen  180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED-------VKKMYDKILKGKL-PLPPGYLSE  251 (357)
T ss_pred             CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc-------HHHHHHHHhcCcC-CCCCccCCH
Confidence            77888999999999999999999999999999999999999999998844       3466677776663 233456899


Q ss_pred             HHHHHHHHhhhcCcCCCC----CHHHHHcCCcccccCCC
Q 018018          304 EFCSFISACVQKEPQQRL----SAQELMTHPFLKMYGDL  338 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rp----t~~eil~hp~~~~~~~~  338 (362)
                      +++++++++|+.||++|.    .+++|.+||||+...+.
T Consensus       252 ~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~  290 (357)
T KOG0598|consen  252 EARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE  290 (357)
T ss_pred             HHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence            999999999999999995    79999999999887653

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-58  Score=433.41  Aligned_cols=258  Identities=29%  Similarity=0.475  Sum_probs=237.8

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      .+|+..+.||+|+|+.+|.+++..+|+.||+|++.+.  .+..++..+.+|+++.+.|+|||||+++++|++..++|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6799999999999999999999999999999999875  45667888999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      |+|..++|..++++.++++|.+++.+++||+.||.|||+ ++|+|||||..|++++++.+|||+|||+|+.+....+...
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~-~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~  176 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHS-LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK  176 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHh-cCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence            999999999999999999999999999999999999998 9999999999999999999999999999999988888899


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  307 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (362)
                      +.||||.|.|||++....+++.+||||+||+||.|+.|++||..       ....+...++.....  ..+..++.++.+
T Consensus       177 TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet-------k~vkety~~Ik~~~Y--~~P~~ls~~A~d  247 (592)
T KOG0575|consen  177 TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET-------KTVKETYNKIKLNEY--SMPSHLSAEAKD  247 (592)
T ss_pred             eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc-------chHHHHHHHHHhcCc--ccccccCHHHHH
Confidence            99999999999999999999999999999999999999999976       344556666655443  334589999999


Q ss_pred             HHHHhhhcCcCCCCCHHHHHcCCcc-cccCC
Q 018018          308 FISACVQKEPQQRLSAQELMTHPFL-KMYGD  337 (362)
Q Consensus       308 li~~~L~~dP~~Rpt~~eil~hp~~-~~~~~  337 (362)
                      ||.+||+.||.+|||+++||.|+|| ++...
T Consensus       248 LI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p  278 (592)
T KOG0575|consen  248 LIRKLLRPNPSERPSLDEVLDHPFFKSGFTP  278 (592)
T ss_pred             HHHHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence            9999999999999999999999999 44443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.4e-56  Score=412.83  Aligned_cols=270  Identities=30%  Similarity=0.549  Sum_probs=238.9

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ...+..++|++++.||+|+||.||+|+.+.+|..||+|+++++  ........++.|.++|...++|+||++|-.|++..
T Consensus       135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~  214 (550)
T KOG0605|consen  135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE  214 (550)
T ss_pred             cccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence            3466889999999999999999999999999999999999877  34556788999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .+||||||++||++..+|.+.+.|+++.++.++.+++.|++.||+ .|++||||||+|+|||..|++||+|||||+.+..
T Consensus       215 ~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~-~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQ-LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             eeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHH-cCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            999999999999999999999999999999999999999999998 9999999999999999999999999999855421


Q ss_pred             C---------------------C--C-----C-------------------CCccccCCcccCcceecCCCCCccccHHH
Q 018018          222 T---------------------S--G-----Q-------------------ANTFVGTYNYMSPERISGGKYGYKSDIWS  254 (362)
Q Consensus       222 ~---------------------~--~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Diws  254 (362)
                      .                     .  .     .                   ....+|||.|+|||++.+..|+..+|+||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence            0                     0  0     0                   11247999999999999999999999999


Q ss_pred             HHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCC---HHHHHcCCc
Q 018018          255 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS---AQELMTHPF  331 (362)
Q Consensus       255 lG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~eil~hp~  331 (362)
                      ||||+|||+.|.+||.+.++.+.+..+..+...+.     .+....+++++++||.+||. ||++|..   ++||..|||
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-----fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPf  447 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-----FPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPF  447 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-----CCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCc
Confidence            99999999999999999888777766665554433     22335677999999999999 9999994   999999999


Q ss_pred             ccccCCCCC
Q 018018          332 LKMYGDLNV  340 (362)
Q Consensus       332 ~~~~~~~~~  340 (362)
                      |+..++.++
T Consensus       448 F~~v~W~~l  456 (550)
T KOG0605|consen  448 FKGVDWDHL  456 (550)
T ss_pred             cccCCcchh
Confidence            999987665

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-56  Score=382.81  Aligned_cols=260  Identities=29%  Similarity=0.533  Sum_probs=238.1

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      ..+++|+.++.||.|+||.|.+++++.+|..||+|++++.  ..-.+..+..+|..+++.+.||+++++++.+.+.+.+|
T Consensus        41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly  120 (355)
T KOG0616|consen   41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY  120 (355)
T ss_pred             cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence            7789999999999999999999999999999999999766  34456678899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      +||||++||.|+.++++.+++++..++.++.|++.||+|||+ ++|++|||||+|||+|.+|.+||+|||+|+....   
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~-~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---  196 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHS-LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---  196 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHh-cCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence            999999999999999999999999999999999999999998 9999999999999999999999999999988643   


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      .+-+.||||.|+|||+++.+.|+.++|+|||||++|||+.|.+||.+.++       ..+.+++..+....  +..++++
T Consensus       197 rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~KI~~~~v~f--P~~fs~~  267 (355)
T KOG0616|consen  197 RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYEKILEGKVKF--PSYFSSD  267 (355)
T ss_pred             cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHHHHHhCcccC--CcccCHH
Confidence            46788999999999999999999999999999999999999999987544       46677777776543  4588999


Q ss_pred             HHHHHHHhhhcCcCCCC-----CHHHHHcCCcccccCCCC
Q 018018          305 FCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~~~~  339 (362)
                      +++||+.+|+.|-.+|.     ..++|..||||+...++.
T Consensus       268 ~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~  307 (355)
T KOG0616|consen  268 AKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA  307 (355)
T ss_pred             HHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence            99999999999999994     678999999999877643

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-55  Score=406.22  Aligned_cols=264  Identities=31%  Similarity=0.538  Sum_probs=233.6

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCe
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~  142 (362)
                      .-...+|..++.||.|+|++|++|+++.+++.||||++.+.  ..+.-.+-+..|-.+|..| .||.|+++|..|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            44678999999999999999999999999999999998654  2233334567888888888 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      +|+|+||+++|+|.++|++.+.+++..++.++.||+.||+|||+ +|||||||||+|||++.+++++|+|||.|+.+...
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~-~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHS-NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence            99999999999999999999999999999999999999999998 99999999999999999999999999999887532


Q ss_pred             CCC-----------C--CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh
Q 018018          223 SGQ-----------A--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV  289 (362)
Q Consensus       223 ~~~-----------~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~  289 (362)
                      ...           .  .+++||..|.+||+|..+..++.+|||+|||++|.|+.|.+||.+.++       +.+++++.
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne-------yliFqkI~  300 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE-------YLIFQKIQ  300 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH-------HHHHHHHH
Confidence            211           1  447999999999999999999999999999999999999999988544       35555655


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          290 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                      ...  ...+..+++.+.+||+++|..||++|+|+++|.+||||...++.+
T Consensus       301 ~l~--y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  301 ALD--YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWEN  348 (604)
T ss_pred             Hhc--ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhh
Confidence            443  334568899999999999999999999999999999999998777

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.7e-56  Score=386.94  Aligned_cols=268  Identities=25%  Similarity=0.474  Sum_probs=228.4

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +++|+.+..+|+|+||+||+|+++.+|+.||||++..+.+ +...+-.++|+++++.++|+|+|.++++|.....+++|+
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence            4789999999999999999999999999999999977744 555566689999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          148 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       148 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      |||+. ++.+.++. ...++...++++++|++.|+.|+|+ ++++||||||+|||++.+|.+||||||+|+.+..++...
T Consensus        81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk-~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHK-NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhh-cCeecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            99987 65555554 5679999999999999999999998 999999999999999999999999999999998788888


Q ss_pred             CccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHH-------hcCC------
Q 018018          227 NTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI-------VDQP------  292 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~-------~~~~------  292 (362)
                      +.++.|.+|+|||.+.| .+|+..+||||+||++.||++|.+.|++.++.+....+...+..+       ....      
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            88999999999999998 679999999999999999999999999987765444333322111       0000      


Q ss_pred             -CCC--------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          293 -PPS--------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       293 -~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                       .|.        .....++.-+.+|+..||+.||++|++.+|++.||||.++-+.
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er  293 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER  293 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence             000        0112355668899999999999999999999999999777543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-55  Score=391.72  Aligned_cols=260  Identities=29%  Similarity=0.521  Sum_probs=231.3

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      ...+|...+.||+|+||+||+++++.++..||||.+.+.. .......+..|+.+++.++|||||.++++...++.+|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            3478999999999999999999999999999999997763 667778889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC------CcEEEeeccCCcccc
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR------GEVKITDFGVSAIMA  220 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~------~~vkl~DFg~a~~~~  220 (362)
                      ||||.||+|.+|+++.+.+++.+++.++.|++.||++||+ ++||||||||+|||++..      -.+||+|||+|+.+.
T Consensus        88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~-~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHE-NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            9999999999999999999999999999999999999998 999999999999999875      468999999999886


Q ss_pred             cCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC-CCCCCCCC
Q 018018          221 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ-PPPSAPSD  299 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  299 (362)
                       .+....+.||++.|||||++....|+.|+|+||+|+++|++++|+.||...+.       .+++..+..+ ...+..+.
T Consensus       167 -~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~-------~eL~~~~~k~~~~~~~~~~  238 (429)
T KOG0595|consen  167 -PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP-------KELLLYIKKGNEIVPVLPA  238 (429)
T ss_pred             -chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH-------HHHHHHHhccccccCchhh
Confidence             44456778999999999999999999999999999999999999999987443       3444444332 23344556


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      .+++...+|+...|+.+|.+|.+..+-+.|+++....
T Consensus       239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  239 ELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             hccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            6777888999999999999999999999999986654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-56  Score=381.96  Aligned_cols=252  Identities=33%  Similarity=0.589  Sum_probs=230.3

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEee-eEEecCe
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQ-SFYSNGA  142 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~-~~~~~~~  142 (362)
                      .+....+|++++.||+|+||.||++.+..+|..+|.|.++.. .+...+..+..|+.+++.|+||||+++++ .|.++..
T Consensus        14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            456778999999999999999999999999999999998865 56677888999999999999999999998 5666666


Q ss_pred             -EEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHh--CCC-eEeecCCCCcEEEccCCcEEEeecc
Q 018018          143 -ISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHH--EKH-IIHRDLKPSNLLINHRGEVKITDFG  214 (362)
Q Consensus       143 -~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~--~~~-ivH~Dlkp~NIll~~~~~vkl~DFg  214 (362)
                       ++||||||.+|+|...++.    ++.+++.++++++.|++.||.++|+  .+| |.||||||.||+++.+|.|||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence             9999999999999999854    4579999999999999999999997  333 9999999999999999999999999


Q ss_pred             CCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018018          215 VSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP  294 (362)
Q Consensus       215 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  294 (362)
                      +++.+.+......+++|||.||+||.+.+..|++++||||+||++|||+.-.+||.+.       +..++..++..+..+
T Consensus       174 L~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-------n~~~L~~KI~qgd~~  246 (375)
T KOG0591|consen  174 LGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-------NLLSLCKKIEQGDYP  246 (375)
T ss_pred             hHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-------cHHHHHHHHHcCCCC
Confidence            9999988888888999999999999999999999999999999999999999999883       567888889888777


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCcCCCCCH
Q 018018          295 SAPSDQFSPEFCSFISACVQKEPQQRLSA  323 (362)
Q Consensus       295 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  323 (362)
                      +.+...+|.++..||..|+..||+.||+.
T Consensus       247 ~~p~~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  247 PLPDEHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             CCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence            77668899999999999999999999984

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-54  Score=407.89  Aligned_cols=265  Identities=32%  Similarity=0.543  Sum_probs=240.8

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      ..-|++++.||.|+-|.|.+|++..+|+..|||++.+.  ..+.....+.+|+.+|+.+.||||+.+|+++.+..++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            46788999999999999999999999999999999765  3445567899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      .||++||.|++++..++++++.++.++++||+.|+.|+|. .+|+|||+||+|+|++..+++||+|||+|... ..+.-.
T Consensus        91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~-~~icHRDLKpENlLLd~~~nIKIADFGMAsLe-~~gklL  168 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHA-FNICHRDLKPENLLLDVKNNIKIADFGMASLE-VPGKLL  168 (786)
T ss_pred             EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhh-hcceeccCCchhhhhhcccCEeeeccceeecc-cCCccc
Confidence            9999999999999999999999999999999999999998 99999999999999999999999999998764 344567


Q ss_pred             CccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          227 NTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      .+.||++.|.|||++.|.+| +.++||||.|||||.|++|++||.+       .++..++.++..+...  .+..+++++
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-------dNir~LLlKV~~G~f~--MPs~Is~ea  239 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-------DNIRVLLLKVQRGVFE--MPSNISSEA  239 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-------ccHHHHHHHHHcCccc--CCCcCCHHH
Confidence            78899999999999999998 6899999999999999999999985       4566778888777643  457899999


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHH
Q 018018          306 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE  344 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~  344 (362)
                      ++||++||+.||++|+|.+||++|||+.++.......+.
T Consensus       240 QdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~  278 (786)
T KOG0588|consen  240 QDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSL  278 (786)
T ss_pred             HHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhc
Confidence            999999999999999999999999999999887765433

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-53  Score=397.44  Aligned_cols=260  Identities=30%  Similarity=0.552  Sum_probs=230.5

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc---c-hHHHHHHHHHHHHHhcCC-CCcceEEeeeEEec
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---E-ESARRQIAQELKINQSSQ-CPYVVVCYQSFYSN  140 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~-~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~  140 (362)
                      .....+|.+.+.||+|+||+|+++.+..+|..||+|++....   . ......+.+|+.+++.++ ||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            345689999999999999999999999999999999876641   1 134566779999999999 99999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC-CcEEEeeccCCccc
Q 018018          141 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIM  219 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~-~~vkl~DFg~a~~~  219 (362)
                      ..+|+||||+.||+|.+++.+.+++.+.+++.+++|++.|++|||+ +||+||||||+|||++.+ +++||+|||++...
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~-~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHS-RGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence            9999999999999999999999999999999999999999999998 999999999999999999 99999999999887


Q ss_pred             ccCCCCCCccccCCcccCcceecCCC-CC-ccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          220 ASTSGQANTFVGTYNYMSPERISGGK-YG-YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      ........+.+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||.+.       ....+..++..+...  .
T Consensus       172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-------~~~~l~~ki~~~~~~--~  242 (370)
T KOG0583|consen  172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-------NVPNLYRKIRKGEFK--I  242 (370)
T ss_pred             CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-------cHHHHHHHHhcCCcc--C
Confidence            44456778899999999999999977 85 7999999999999999999999872       334555555555433  3


Q ss_pred             CCCC-CHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          298 SDQF-SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       298 ~~~~-~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      +..+ ++++.+|+++||..||.+|+|+.+|+.||||+..
T Consensus       243 p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~  281 (370)
T KOG0583|consen  243 PSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQKE  281 (370)
T ss_pred             CCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhccC
Confidence            3455 9999999999999999999999999999999973

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-54  Score=397.08  Aligned_cols=269  Identities=25%  Similarity=0.388  Sum_probs=226.9

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecC-eEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNG-AISI  145 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~-~~~l  145 (362)
                      .+++|.+++.||.|+||.||+|+...+|..||||.++........-.-++|++.+++++ ||||+++.+++.+.. .+|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            46899999999999999999999999999999999987654444445579999999999 999999999999888 9999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          146 ILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      |||||+. +|.++++.+ ..+++..++.|+.||++||+|+|. +|+.|||+||+|||++....+||+|||+|+...+.. 
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk-~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp-  164 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHK-HGFFHRDLKPENILISGNDVIKIADFGLAREVRSKP-  164 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHh-cCcccccCChhheEecccceeEecccccccccccCC-
Confidence            9999965 999999754 679999999999999999999998 999999999999999989999999999999876543 


Q ss_pred             CCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH---------------HHH
Q 018018          225 QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM---------------EAI  288 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~---------------~~~  288 (362)
                      ..+.++.|.+|+|||++.. +-|+.+.||||+||+++|+.+-++.|.+.++.|....+.+++               ..+
T Consensus       165 PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~m  244 (538)
T KOG0661|consen  165 PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAM  244 (538)
T ss_pred             CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHh
Confidence            4667899999999999755 668999999999999999999999999977765433333332               111


Q ss_pred             hcCCCCC-------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCC
Q 018018          289 VDQPPPS-------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  340 (362)
Q Consensus       289 ~~~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~  340 (362)
                      - ...|.       ......++++.+||.+||.|||++||||.++++||||+.......
T Consensus       245 n-f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~~~~  302 (538)
T KOG0661|consen  245 N-FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRASGS  302 (538)
T ss_pred             c-cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccccccc
Confidence            1 00111       011236789999999999999999999999999999988765433

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.3e-53  Score=396.39  Aligned_cols=255  Identities=33%  Similarity=0.570  Sum_probs=236.2

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +++|.+.+.||+|+||.||+++.+.+.+.||||.+.+. ..+...+.+.+|+++++.++||||+.++++|+...++++|+
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence            46889999999999999999999999999999998765 45556788999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      ||+.| +|..++...+.++++.++.++.|++.||.|||+ ++|+|||+||.|||++.+|.+|+||||+|+.+.....-..
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs-~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlt  158 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHS-NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLT  158 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-cCcccccCCcceeeecCCCceeechhhhhhhcccCceeee
Confidence            99977 999999999999999999999999999999998 9999999999999999999999999999999877665566


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  307 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (362)
                      ...|||.|||||++.+++|+..+|+|||||++||+++|++||..       ..+.++...+...+.+++  ...+..+.+
T Consensus       159 sikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a-------~si~~Lv~~I~~d~v~~p--~~~S~~f~n  229 (808)
T KOG0597|consen  159 SIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA-------RSITQLVKSILKDPVKPP--STASSSFVN  229 (808)
T ss_pred             eccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH-------HHHHHHHHHHhcCCCCCc--ccccHHHHH
Confidence            77899999999999999999999999999999999999999976       677888888877665443  488999999


Q ss_pred             HHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          308 FISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       308 li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      ++..+|++||.+|.|..+++.|||.+.
T Consensus       230 fl~gLL~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  230 FLQGLLIKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             HHHHHhhcChhhcccHHHHhcChHHhh
Confidence            999999999999999999999999754

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-52  Score=399.22  Aligned_cols=263  Identities=29%  Similarity=0.524  Sum_probs=235.5

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEec
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSN  140 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~  140 (362)
                      ...+.+++|..+++||+|+||+|+++..+.+++.||||++++.  .........+.|.+++... +||+++.++..|++.
T Consensus       362 ~~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~  441 (694)
T KOG0694|consen  362 RGPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK  441 (694)
T ss_pred             CCcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccC
Confidence            3578899999999999999999999999999999999999877  3455567778888887665 599999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          141 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      .++|+||||+.||++ ..++..+.+++..++.++..++.||.|||+ +|||+||||.+|||+|.+|++||+|||+++...
T Consensus       442 ~~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~-~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m  519 (694)
T KOG0694|consen  442 EHLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHE-NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM  519 (694)
T ss_pred             CeEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHh-cCceeeecchhheEEcccCcEEecccccccccC
Confidence            999999999999993 334445889999999999999999999998 999999999999999999999999999999877


Q ss_pred             cCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          221 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      ..+..+.++||||.|||||++.+..|+.++|+|||||+||||+.|..||.+.+++       ++...+......  .+..
T Consensus       520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------e~FdsI~~d~~~--yP~~  590 (694)
T KOG0694|consen  520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------EVFDSIVNDEVR--YPRF  590 (694)
T ss_pred             CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHhcCCCC--CCCc
Confidence            6777889999999999999999999999999999999999999999999985543       667777665543  4568


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCC-----HHHHHcCCcccccCC
Q 018018          301 FSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGD  337 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt-----~~eil~hp~~~~~~~  337 (362)
                      ++.++.++++++|++||++|..     +++|..||||+...+
T Consensus       591 ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w  632 (694)
T KOG0694|consen  591 LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDW  632 (694)
T ss_pred             ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCH
Confidence            9999999999999999999995     689999999998874

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-52  Score=377.49  Aligned_cols=261  Identities=35%  Similarity=0.582  Sum_probs=221.8

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC--eEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISII  146 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~--~~~lV  146 (362)
                      ..++...+.||+|+||+||++.+..+|..+|||.+....... ...+.+|+.+++.++|||||++++......  .+++.
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            456788899999999999999999999999999987763333 677999999999999999999999744433  69999


Q ss_pred             EeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc-CCcEEEeeccCCccccc---
Q 018018          147 LEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMAS---  221 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-~~~vkl~DFg~a~~~~~---  221 (362)
                      |||+++|+|.+++.+.+ .+++..++.+.+|+++||+|||+ +|++|+||||+|||++. ++.+||+|||++.....   
T Consensus        95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs-~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHS-KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999999999999877 79999999999999999999998 99999999999999999 79999999999987663   


Q ss_pred             CCCCCCccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      .........||+.|||||++.++. ...++|||||||++.||+||+.||...      ......+-.+......+..+..
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~------~~~~~~~~~ig~~~~~P~ip~~  247 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF------FEEAEALLLIGREDSLPEIPDS  247 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh------cchHHHHHHHhccCCCCCCCcc
Confidence            122244578999999999999643 345999999999999999999999763      1112333333333333466778


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ++++++++|.+|+.+||++||||+++|.|||.+....
T Consensus       248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            9999999999999999999999999999999987655

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.9e-51  Score=379.86  Aligned_cols=283  Identities=43%  Similarity=0.804  Sum_probs=242.3

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      +..++|++.+.||+|+||.||++++..++..+|+|++...........+.+|+++++.++||||+++++.+...+..++|
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            45689999999999999999999999999999999998765666677899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+..+|+||||||+||+++.++.+||+|||++......  ..
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  159 (331)
T cd06649          82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA  159 (331)
T ss_pred             eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--cc
Confidence            9999999999999988899999999999999999999997346999999999999999999999999998765332  23


Q ss_pred             CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc-----------------------------
Q 018018          227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG-----------------------------  277 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~-----------------------------  277 (362)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.                             
T Consensus       160 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (331)
T cd06649         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRP  239 (331)
T ss_pred             ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccc
Confidence            445789999999999999999999999999999999999999965432110                             


Q ss_pred             ----------hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHH
Q 018018          278 ----------WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFT  347 (362)
Q Consensus       278 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~  347 (362)
                                ..........+.....+......+++++.+||.+||++||++|||++|+++||||+.......++..+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~~~  319 (331)
T cd06649         240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVEEVDFAGWLC  319 (331)
T ss_pred             ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcccccccHHHHHH
Confidence                      0111222333333333333344678999999999999999999999999999999999999999998887


Q ss_pred             HhCC
Q 018018          348 DAGS  351 (362)
Q Consensus       348 ~~~~  351 (362)
                      +..+
T Consensus       320 ~~~~  323 (331)
T cd06649         320 KTLR  323 (331)
T ss_pred             Hhhc
Confidence            7655

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.1e-52  Score=355.88  Aligned_cols=265  Identities=26%  Similarity=0.454  Sum_probs=222.5

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .+|..++.||+|.||.||++++..+|+.||||.++.... +.......+|++.++.++|+||+.+.++|.+.+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            578899999999999999999999999999999987632 2334667899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          149 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       149 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      |++. +|...++.. ..++...++.++.++++||+|||+ +.|+||||||.|+|++++|.+||+|||+|+.+..+.....
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~-~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS-KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh-hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            9976 999999764 579999999999999999999998 9999999999999999999999999999999987776665


Q ss_pred             ccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH---------------HHH--h
Q 018018          228 TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM---------------EAI--V  289 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~---------------~~~--~  289 (362)
                      ..+-|.+|+|||.+.|. .|+..+||||.||++.||+-|.+-|.+.++-++...+...+               ...  .
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence            56889999999999885 59999999999999999999998888765543322222111               111  1


Q ss_pred             cCCCCC--CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          290 DQPPPS--APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       290 ~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ..+.++  ......++++.+|+.+||..||.+|+|+.|+++|+||+...
T Consensus       240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P  288 (318)
T KOG0659|consen  240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLP  288 (318)
T ss_pred             cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCC
Confidence            011110  01233567789999999999999999999999999998654

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-51  Score=373.07  Aligned_cols=271  Identities=32%  Similarity=0.549  Sum_probs=233.7

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      .+....++|++...||.|..++||+|++...+..||||++..+.-......+.+|+..++.++||||+.++..|..+..+
T Consensus        20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            44556789999999999999999999999999999999998875555688999999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          144 SIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      |+||.||.+||+.++++..  ..+++..+..+.+++++||.|||+ +|-||||||+.||||+.+|.|||+|||.+..+..
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~-~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~  178 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ-NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFD  178 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh-cCceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence            9999999999999999864  469999999999999999999998 9999999999999999999999999998877765


Q ss_pred             CCCCC----CccccCCcccCcceecC--CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--
Q 018018          222 TSGQA----NTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--  293 (362)
Q Consensus       222 ~~~~~----~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  293 (362)
                      .+...    .+.+||++|||||++..  ..|+.|+||||||++..||.+|..||....+.      .-++.++...++  
T Consensus       179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~pp~~  252 (516)
T KOG0582|consen  179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQNDPPTL  252 (516)
T ss_pred             cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCCCCCc
Confidence            44322    55699999999999644  45999999999999999999999999875442      234444444433  


Q ss_pred             -----CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCC
Q 018018          294 -----PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD  341 (362)
Q Consensus       294 -----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~  341 (362)
                           +......++..++.+|..||++||++|||++++++|+||+.......-
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~  305 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYL  305 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhc
Confidence                 222234567789999999999999999999999999999888765443

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-52  Score=383.18  Aligned_cols=263  Identities=25%  Similarity=0.434  Sum_probs=223.7

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEec--CeEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAIS  144 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~--~~~~  144 (362)
                      ..+.|+.+++||+|+||.||+|++..+|+.||+|.++.+. ++.......+|+.|+++++||||+++.+...+.  +.+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            4567899999999999999999999999999999998874 455567788999999999999999999998876  7899


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          145 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ||+|||+. +|..++... -.+++.+++.++.||+.||+|||+ +||+|||||..||||+.+|.+||+|||+|+.+....
T Consensus       195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~-~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~  272 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS-RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG  272 (560)
T ss_pred             EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh-cCeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence            99999987 999999873 589999999999999999999998 999999999999999999999999999999765544


Q ss_pred             CC-CCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-----CC-
Q 018018          224 GQ-ANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-----PS-  295 (362)
Q Consensus       224 ~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----~~-  295 (362)
                      .. .+..+-|.+|+|||++.|. .|+.++|+||+||||.||++|++.|.+.++.++...++.+.........     |. 
T Consensus       273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~  352 (560)
T KOG0600|consen  273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHA  352 (560)
T ss_pred             CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcc
Confidence            33 4556789999999999985 5999999999999999999999999998776554444443322111110     00 


Q ss_pred             -------C-------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          296 -------A-------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       296 -------~-------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                             .       ....+++...+|+..||..||.+|.||.++|+|+||
T Consensus       353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence                   0       012356778999999999999999999999999999

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-52  Score=386.13  Aligned_cols=259  Identities=34%  Similarity=0.606  Sum_probs=231.1

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      ...|.....||+|+.|.||.++...+++.||||.+.... ...+.-+.+|+.+|+..+|+||+.+++.|...+.++.|||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            356788899999999999999999999999999987652 2234567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      |++||+|.+.+.. ..+++.++..++++++.||+|||. +||+|||||.+|||++.+|.+||+|||+|..+........+
T Consensus       351 ym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~-~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T  428 (550)
T KOG0578|consen  351 YMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHA-RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST  428 (550)
T ss_pred             ecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHh-cceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence            9999999999987 459999999999999999999998 99999999999999999999999999999998877777888


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018018          229 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  308 (362)
Q Consensus       229 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  308 (362)
                      .+||++|||||+.....|++++||||||++++||+-|.+||-..++      ...+......+.+....+..+++.++++
T Consensus       429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------lrAlyLIa~ng~P~lk~~~klS~~~kdF  502 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------LRALYLIATNGTPKLKNPEKLSPELKDF  502 (550)
T ss_pred             ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------HHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence            9999999999999999999999999999999999999999976333      2223333334555556678999999999


Q ss_pred             HHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          309 ISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      +.+||+.|+++|++|.|+|+||||+..+
T Consensus       503 L~~cL~~dv~~RasA~eLL~HpFl~~a~  530 (550)
T KOG0578|consen  503 LDRCLVVDVEQRASAKELLEHPFLKMAK  530 (550)
T ss_pred             HHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence            9999999999999999999999997664

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.6e-52  Score=370.20  Aligned_cols=279  Identities=29%  Similarity=0.462  Sum_probs=233.2

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec--C---eEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN--G---AIS  144 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~--~---~~~  144 (362)
                      -.|...+++|+|+||.||.++...+++.||||.+-.+.     +.--+|+.+|+.++||||+.+..+|...  .   ...
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            45778899999999999999999999999999875442     1234789999999999999999888743  2   456


Q ss_pred             EEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC-CcEEEeeccCCccc
Q 018018          145 IILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIM  219 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~-~~vkl~DFg~a~~~  219 (362)
                      +||||++. +|.++++.    +..++...++-+++||++||+|||+ .||+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~-~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS-HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh-cCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            89999976 99999974    5789999999999999999999998 999999999999999976 89999999999998


Q ss_pred             ccCCCCCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHH-----HHhcCC-
Q 018018          220 ASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME-----AIVDQP-  292 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~-----~~~~~~-  292 (362)
                      .... ...++..|..|+|||.+.|. .|+.+.||||.||++.||+.|++-|.+.+..++...+..++.     .+.... 
T Consensus       177 ~~~e-pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~  255 (364)
T KOG0658|consen  177 VKGE-PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP  255 (364)
T ss_pred             ccCC-CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence            6544 44677889999999999885 599999999999999999999999998766544333333221     010000 


Q ss_pred             --------------CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHHHhCCCcccccc
Q 018018          293 --------------PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSN  358 (362)
Q Consensus       293 --------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~~~~~~~~~~~~  358 (362)
                                    .........++++.+|+.++|+++|++|.++.|++.||||....+.+..+++     +.++++|+|
T Consensus       256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~~~l~~-----g~~lp~lf~  330 (364)
T KOG0658|consen  256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPNTKLPN-----GRPLPPLFN  330 (364)
T ss_pred             ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcCccCcC-----CCcCCCccC
Confidence                          0011345678999999999999999999999999999999999999999998     889999999


Q ss_pred             CCC
Q 018018          359 LSG  361 (362)
Q Consensus       359 ~~~  361 (362)
                      |..
T Consensus       331 f~~  333 (364)
T KOG0658|consen  331 FKR  333 (364)
T ss_pred             chH
Confidence            864

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-53  Score=356.70  Aligned_cols=260  Identities=29%  Similarity=0.457  Sum_probs=228.2

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      -.+.|++.+.||+|.|+.|+.+.+..+|+.+|+|++... ......+++.+|+++-+.|+||||+.+.+.+.+.+..|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            347899999999999999999999999999999998654 2333567899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC---CcEEEeeccCCcccccCC
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTS  223 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~---~~vkl~DFg~a~~~~~~~  223 (362)
                      +|++.|++|..-+-..-.+++..+-.+++||++||.|+|. +||||||+||+|+++.+.   .-+||+|||+|..+. .+
T Consensus        89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~-n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g  166 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHS-NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DG  166 (355)
T ss_pred             EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh-cCceeccCChhheeeeeccCCCceeecccceEEEeC-Cc
Confidence            9999999998877666778999999999999999999998 999999999999999643   359999999999887 44


Q ss_pred             CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC--CCCCCCCCCC
Q 018018          224 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ--PPPSAPSDQF  301 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  301 (362)
                      ......+|||.|||||++...+|+..+|||+.|++||-|+.|.+||.+.+..       .+.+.+..+  ..+++.++.+
T Consensus       167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-------rlye~I~~g~yd~~~~~w~~i  239 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-------RLYEQIKAGAYDYPSPEWDTV  239 (355)
T ss_pred             cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-------HHHHHHhccccCCCCcccCcC
Confidence            4556789999999999999999999999999999999999999999985432       344444433  3445567899


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ++++++|+++||..||.+|+|+.|+|+|||++.-+
T Consensus       240 s~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  240 TPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             CHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence            99999999999999999999999999999986543

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.7e-51  Score=360.12  Aligned_cols=268  Identities=25%  Similarity=0.412  Sum_probs=226.3

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHH-HHHHHHHHHHhcCCCCcceEEeeeEEe--cCe
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESAR-RQIAQELKINQSSQCPYVVVCYQSFYS--NGA  142 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~-~~~~~e~~~~~~l~hp~I~~~~~~~~~--~~~  142 (362)
                      .-..++|+.+..|++|+||.||.++++.++..||+|.++.+.+.... -.-++|+.++.+++||||+.+-.+...  -+.
T Consensus        72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~  151 (419)
T KOG0663|consen   72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK  151 (419)
T ss_pred             cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence            34568899999999999999999999999999999999877543322 245799999999999999999988763  467


Q ss_pred             EEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          143 ISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      +|+|||||+. +|..++..-+ ++...+++.++.|+++|++|||+ +.|+||||||+|+|++..|.+||+|||+|+.+++
T Consensus       152 iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~-~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  152 IYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD-NWILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             eeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh-ceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            9999999976 9999998765 89999999999999999999998 9999999999999999999999999999999988


Q ss_pred             CCCCCCccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC------
Q 018018          222 TSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP------  294 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~------  294 (362)
                      +....+..+-|.+|+|||.+.+.+ |+.+.|+||+|||+.||+++++.|.+....++...+..++..-.....|      
T Consensus       230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence            877778889999999999998854 9999999999999999999999999877765544444433211110000      


Q ss_pred             -----------------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          295 -----------------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       295 -----------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                                       ......++....+|+..+|.+||.+|.||+|.|+|+||...
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence                             00011155788999999999999999999999999999873

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.1e-50  Score=376.17  Aligned_cols=260  Identities=28%  Similarity=0.503  Sum_probs=226.4

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ......++|++.+.||+|+||.||+|++..+++.||+|+++...  .......+.+|+.+++.++||||+++++.+.+.+
T Consensus        12 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   91 (329)
T PTZ00263         12 TSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN   91 (329)
T ss_pred             cCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence            34456789999999999999999999999999999999987542  2234567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ..++||||+.+++|.+++...+.+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++.....
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHS-KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            999999999999999999988899999999999999999999998 9999999999999999999999999999876532


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                         .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.       ......+......  .+..+
T Consensus       171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-------~~~~~~i~~~~~~--~p~~~  238 (329)
T PTZ00263        171 ---RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-------FRIYEKILAGRLK--FPNWF  238 (329)
T ss_pred             ---CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcCCcC--CCCCC
Confidence               23346799999999999999999999999999999999999999976432       2334444444322  33468


Q ss_pred             CHHHHHHHHHhhhcCcCCCCC-----HHHHHcCCcccccC
Q 018018          302 SPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYG  336 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt-----~~eil~hp~~~~~~  336 (362)
                      +..+.+||.+||+.||++||+     +++++.||||+...
T Consensus       239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~  278 (329)
T PTZ00263        239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGAN  278 (329)
T ss_pred             CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCC
Confidence            899999999999999999997     79999999998753

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-51  Score=363.46  Aligned_cols=268  Identities=28%  Similarity=0.456  Sum_probs=223.2

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe-----cCeE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS-----NGAI  143 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~-----~~~~  143 (362)
                      ..|..++.||+|+||.|+.+.++.+|+.||||.+... ......++..+|+++++.++|+||+.+++.+..     -..+
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            4555579999999999999999999999999998643 345567788999999999999999999998765     3679


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC-
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-  222 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~-  222 (362)
                      |+|+|+|+ .+|...++.+..++++.++.+++|+++||+|+|+ .||+||||||.|++++.++.+||||||+|+..... 
T Consensus       102 YiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHS-AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~  179 (359)
T KOG0660|consen  102 YLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHS-ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF  179 (359)
T ss_pred             EEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhc-ccccccccchhheeeccCCCEEeccccceeeccccC
Confidence            99999994 5999999998889999999999999999999998 99999999999999999999999999999987542 


Q ss_pred             -CCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH---------------
Q 018018          223 -SGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM---------------  285 (362)
Q Consensus       223 -~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~---------------  285 (362)
                       ....+.++.|.+|+|||++.. ..|+.+.||||+||+++||++|++.|.+.+..+....+.++.               
T Consensus       180 ~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~  259 (359)
T KOG0660|consen  180 EDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEK  259 (359)
T ss_pred             cccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHH
Confidence             334466889999999999755 569999999999999999999999999876654322222211               


Q ss_pred             --HHHhcCCC-C----CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          286 --EAIVDQPP-P----SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       286 --~~~~~~~~-~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                        ..+...+. +    .....+.++.+.+|+++||..||.+|+|++|+|.|||+..+.+..
T Consensus       260 ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~  320 (359)
T KOG0660|consen  260 ARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE  320 (359)
T ss_pred             HHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence              11111111 1    112346789999999999999999999999999999998887543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-50  Score=372.56  Aligned_cols=255  Identities=25%  Similarity=0.465  Sum_probs=222.1

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++|++.+.||+|+||.||++.+..+|+.||+|++....  .......+.+|+.+++.++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47899999999999999999999999999999987542  2234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      ||+++++|.+++...+.+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++....   ...
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~---~~~  156 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS-KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD---RTW  156 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEEEecCcchhccC---Ccc
Confidence            999999999999988899999999999999999999998 9999999999999999999999999999876532   233


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  307 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (362)
                      ..+|++.|+|||++.+..++.++|||||||++|+|++|..||...+.       ......+.....  ..+..+++.+.+
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~~--~~~~~~~~~~~~  227 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-------FGIYEKILAGKL--EFPRHLDLYAKD  227 (291)
T ss_pred             cccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCc--CCCccCCHHHHH
Confidence            45789999999999998999999999999999999999999976432       233344443332  233467899999


Q ss_pred             HHHHhhhcCcCCCCC-----HHHHHcCCcccccCC
Q 018018          308 FISACVQKEPQQRLS-----AQELMTHPFLKMYGD  337 (362)
Q Consensus       308 li~~~L~~dP~~Rpt-----~~eil~hp~~~~~~~  337 (362)
                      ||.+||+.||++||+     ++++++||||+....
T Consensus       228 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~  262 (291)
T cd05612         228 LIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDW  262 (291)
T ss_pred             HHHHHcCCCHHHccCCccCCHHHHhcCccccCCCH
Confidence            999999999999995     999999999987654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4e-50  Score=373.80  Aligned_cols=255  Identities=29%  Similarity=0.517  Sum_probs=220.9

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcE-EEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF-FALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ...++..+..+.+.||+|+||+||.+..  .|+. ||+|++... .+......|.+|+.++.+++||||+++++++.+..
T Consensus        35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~  112 (362)
T KOG0192|consen   35 EEEIDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP  112 (362)
T ss_pred             ceecChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            3445667777788899999999998766  5777 999999765 23333789999999999999999999999999877


Q ss_pred             -eEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCC-eEeecCCCCcEEEccCC-cEEEeeccCC
Q 018018          142 -AISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRG-EVKITDFGVS  216 (362)
Q Consensus       142 -~~~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~al~~LH~~~~-ivH~Dlkp~NIll~~~~-~vkl~DFg~a  216 (362)
                       .+++||||+++|+|.+++..  ...++...+..++.|+++||+|||+ ++ ||||||||+|||++.++ ++||+|||++
T Consensus       113 ~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~-~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  113 GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS-EGPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc-CCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence             79999999999999999987  6889999999999999999999998 88 99999999999999997 9999999999


Q ss_pred             cccccCCCCCCccccCCcccCcceec--CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018018          217 AIMASTSGQANTFVGTYNYMSPERIS--GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP  294 (362)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  294 (362)
                      +.............||+.|||||++.  ...|+.++||||||+++|||+||+.||.+...       .++...+.....+
T Consensus       192 r~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-------~~~~~~v~~~~~R  264 (362)
T KOG0192|consen  192 REKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-------VQVASAVVVGGLR  264 (362)
T ss_pred             eeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcCCC
Confidence            88765433344478999999999999  56899999999999999999999999987543       3556666655555


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          295 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       295 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +..+..+++.+..||.+||+.||++||++.+++.
T Consensus       265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            6666679999999999999999999999999864

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.3e-50  Score=375.04  Aligned_cols=251  Identities=31%  Similarity=0.564  Sum_probs=218.5

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  153 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~g  153 (362)
                      +.||+|+||.||++++..+|+.||+|+++...  .......+.+|+.+++.++||||+.+++.+...+.+++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997542  2334566789999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCC
Q 018018          154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY  233 (362)
Q Consensus       154 sL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~  233 (362)
                      +|.+++.....+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++............+||+
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  159 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHS-CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence            999999988899999999999999999999998 9999999999999999999999999999876443444445568999


Q ss_pred             cccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhh
Q 018018          234 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV  313 (362)
Q Consensus       234 ~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  313 (362)
                      .|+|||++.+..++.++||||+||++|||++|..||.+.+.       ......+.....  ..+..+++++.+||.+||
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~~~~~~~--~~p~~~~~~~~~li~~~L  230 (323)
T cd05571         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEI--RFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCCC--CCCCCCCHHHHHHHHHHc
Confidence            99999999999999999999999999999999999976432       233333333322  234578999999999999


Q ss_pred             hcCcCCCC-----CHHHHHcCCcccccC
Q 018018          314 QKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       314 ~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      +.||++||     ++.++++||||+...
T Consensus       231 ~~dP~~R~~~~~~~~~~ll~h~~f~~~~  258 (323)
T cd05571         231 KKDPKQRLGGGPEDAKEIMEHRFFASIN  258 (323)
T ss_pred             cCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            99999999     899999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.6e-51  Score=345.43  Aligned_cols=261  Identities=31%  Similarity=0.487  Sum_probs=231.7

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      ......+++|++.+.||+|-||.||+++.+.++..||+|++.++  .......++.+|+++...|+||||+++|++|.+.
T Consensus        15 ~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   15 ATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS   94 (281)
T ss_pred             cccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence            34567889999999999999999999999999999999998655  2334457889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          141 GAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~--~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      ...|+++||...|++...++  ...++++..+..++.|++.||.|+|. ++|+||||||+|+|++..+.+||+|||.+..
T Consensus        95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~-k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen   95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL-KRVIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc-CCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence            99999999999999999998  56789999999999999999999998 9999999999999999999999999999876


Q ss_pred             cccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          219 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      ..  .....+.|||..|.+||...+..++..+|+|++|++.||++.|.+||.+...       .+...++......  .+
T Consensus       174 ~p--~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-------~etYkrI~k~~~~--~p  242 (281)
T KOG0580|consen  174 AP--SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-------SETYKRIRKVDLK--FP  242 (281)
T ss_pred             cC--CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-------HHHHHHHHHcccc--CC
Confidence            53  4556788999999999999999999999999999999999999999987542       2334444333322  23


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      ..++.++.+||.+||.++|.+|.+..|++.|||+...
T Consensus       243 ~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  243 STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            6899999999999999999999999999999998754

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.4e-49  Score=370.81  Aligned_cols=281  Identities=43%  Similarity=0.803  Sum_probs=236.7

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      +..++|++.+.||+|+||.||++.+..++..+|+|++...........+.+|+++++.++||||+++++.+.+.+..++|
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            44589999999999999999999999999999999988765666677899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+..+++|+||||+||+++.++.+||+|||++......  ..
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~  159 (333)
T cd06650          82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MA  159 (333)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--cc
Confidence            9999999999999988889999999999999999999997357999999999999999999999999998765322  22


Q ss_pred             CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCch----------------------------
Q 018018          227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW----------------------------  278 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~----------------------------  278 (362)
                      ....|+..|+|||++.+..++.++|+|||||++|+|++|+.||......+..                            
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (333)
T cd06650         160 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLS  239 (333)
T ss_pred             ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhh
Confidence            3457899999999999988999999999999999999999999754321100                            


Q ss_pred             ---------hhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHHHh
Q 018018          279 ---------TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA  349 (362)
Q Consensus       279 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~~~  349 (362)
                               .........+.....+......++.++.+||.+||++||++|||++|++.||||+.......+++.++.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~~~~~~~~~~~  319 (333)
T cd06650         240 SYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAEEVDFAGWLCST  319 (333)
T ss_pred             hhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCccccccHHHHHHHH
Confidence                     00111222223333333333457889999999999999999999999999999999887788888777543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-50  Score=370.43  Aligned_cols=265  Identities=31%  Similarity=0.523  Sum_probs=226.5

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch-------------HHHHHHHHHHHHHhcCCCCcce
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-------------SARRQIAQELKINQSSQCPYVV  131 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~e~~~~~~l~hp~I~  131 (362)
                      ....++.|++++.||+|.||.|.+|++..+++.||||++.+....             .......+|+.++++++|||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV  171 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVV  171 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCee
Confidence            344578899999999999999999999999999999999654111             1235789999999999999999


Q ss_pred             EEeeeEEe--cCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEE
Q 018018          132 VCYQSFYS--NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK  209 (362)
Q Consensus       132 ~~~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vk  209 (362)
                      +++++..+  ...+|||+|||..|.+...-.....+++.++++++++++.||+|||. +||+||||||.|+|++.+|+||
T Consensus       172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~-QgiiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  172 KLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHY-QGIIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             EEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEEcCCCcEE
Confidence            99998764  47899999999988876544443349999999999999999999998 9999999999999999999999


Q ss_pred             EeeccCCcccccCC-----CCCCccccCCcccCcceecCCC----CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhh
Q 018018          210 ITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGK----YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS  280 (362)
Q Consensus       210 l~DFg~a~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~  280 (362)
                      |+|||.+.......     ......+|||.|+|||.+.++.    -+++.||||+||+||.|+.|+.||-+       ..
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~-------~~  323 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFD-------DF  323 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCccc-------ch
Confidence            99999887652221     1223368999999999988743    36789999999999999999999977       55


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          281 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ..++..+++..+...+....+.+.+++||.+||++||++|++..+|..|||....++
T Consensus       324 ~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~  380 (576)
T KOG0585|consen  324 ELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD  380 (576)
T ss_pred             HHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence            678899999888877777778999999999999999999999999999999977754

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.6e-50  Score=368.76  Aligned_cols=260  Identities=25%  Similarity=0.433  Sum_probs=214.4

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++++|++.+.||.|+||.||++.+..++..||+|+++..........+.+|+.+++.++||||+++++.+.+....++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF   82 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence            46789999999999999999999999999999999876544444456789999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          148 EYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      ||+++ +|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++.........
T Consensus        83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK-RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence            99975 9999887654 57999999999999999999998 999999999999999999999999999987654433334


Q ss_pred             CccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC--------------
Q 018018          227 NTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ--------------  291 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--------------  291 (362)
                      ....+++.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+...   .........              
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH---LIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             cCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChHHhhccccchhh
Confidence            45578999999999876 568999999999999999999999997654322111   111110000              


Q ss_pred             ---CCC-------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          292 ---PPP-------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       292 ---~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                         ..+       ......+++++.+||.+||++||++|||++|+++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence               000       00123467889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-52  Score=376.88  Aligned_cols=259  Identities=36%  Similarity=0.584  Sum_probs=235.9

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      ..|..++.||+|+||.||++.+..+++.||+|++.....+.....+.+|+.++..++++||.++|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777799999999999999999999999999999887888888999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      |.||++.+.++....+.+..+..++++++.||.|||. .+.+|||||+.|||+..+|.+||+|||.+..+........++
T Consensus        93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~-~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tf  171 (467)
T KOG0201|consen   93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHS-EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTF  171 (467)
T ss_pred             hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhh-cceecccccccceeEeccCcEEEEecceeeeeechhhccccc
Confidence            9999999999998888999999999999999999998 899999999999999999999999999999888777777899


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  309 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  309 (362)
                      +||+.|||||++.+..|+.++||||||++.+||++|.+|+....+..       ++..+.. ..|+.....+++.++++|
T Consensus       172 vGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr-------vlflIpk-~~PP~L~~~~S~~~kEFV  243 (467)
T KOG0201|consen  172 VGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR-------VLFLIPK-SAPPRLDGDFSPPFKEFV  243 (467)
T ss_pred             cccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce-------EEEeccC-CCCCccccccCHHHHHHH
Confidence            99999999999998899999999999999999999999998765521       2222223 334555568999999999


Q ss_pred             HHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          310 SACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ..||++||+.||+|.++|+|+|++..+.
T Consensus       244 ~~CL~k~P~~RpsA~~LLKh~FIk~a~k  271 (467)
T KOG0201|consen  244 EACLDKNPEFRPSAKELLKHKFIKRAKK  271 (467)
T ss_pred             HHHhhcCcccCcCHHHHhhhHHHHhcCC
Confidence            9999999999999999999999999663

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.9e-51  Score=364.95  Aligned_cols=253  Identities=27%  Similarity=0.501  Sum_probs=229.0

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      ..+|++.+.||+|+||+|-+|++...|+.||||-++++  .++...-.+.+|++||..|+||||+.+|.+|+..+.+.||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            47899999999999999999999999999999999876  4555667899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      |||..+|.|.+|+.+.+.+++.+++.+++||+.|+.|+|. ++++|||||.+|||+|.++++||+|||++..+. .....
T Consensus       132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHk-nrVvHRDLKLENILLD~N~NiKIADFGLSNly~-~~kfL  209 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHK-NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA-DKKFL  209 (668)
T ss_pred             EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhh-ccceecccchhheeecCCCCeeeeccchhhhhc-cccHH
Confidence            9999999999999999999999999999999999999998 999999999999999999999999999987764 33456


Q ss_pred             CccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          227 NTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      .++||++.|.+||+..|.+| +..+|-||||++||.|+.|..||.+.+       ...+++.+..+....+   .-+..+
T Consensus       210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-------hk~lvrQIs~GaYrEP---~~PSdA  279 (668)
T KOG0611|consen  210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-------HKRLVRQISRGAYREP---ETPSDA  279 (668)
T ss_pred             HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-------HHHHHHHhhcccccCC---CCCchH
Confidence            78999999999999999998 678999999999999999999998843       3466777766654432   345688


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHcCCccc
Q 018018          306 CSFISACVQKEPQQRLSAQELMTHPFLK  333 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~hp~~~  333 (362)
                      .-||+.||..||++|.|++||..|.|+.
T Consensus       280 ~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  280 SGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             HHHHHHHHhcCcccchhHHHHhhhheee
Confidence            8999999999999999999999999973

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.6e-49  Score=367.01  Aligned_cols=266  Identities=24%  Similarity=0.401  Sum_probs=215.1

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .++|++.+.||+|+||.||++++..+++.||+|+++..........+.+|+.+++.++||||+++++.+.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            47899999999999999999999999999999999765444444567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          149 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       149 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      |+. ++|.+++... ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++...........
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ-RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence            996 5888877654 578999999999999999999998 9999999999999999999999999999876544333344


Q ss_pred             ccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-------------
Q 018018          228 TFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-------------  293 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-------------  293 (362)
                      ...+++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.....  ...............             
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhhccccc
Confidence            5678999999999876 458899999999999999999999998643211  111111111000000             


Q ss_pred             --------CC-----CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          294 --------PS-----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       294 --------~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                              +.     ......++.+.+||.+||+.||++|||++|+++||||+.....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~~  297 (303)
T cd07869         240 PERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPPR  297 (303)
T ss_pred             cccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCChh
Confidence                    00     0011245678999999999999999999999999999887543

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.3e-50  Score=359.47  Aligned_cols=270  Identities=30%  Similarity=0.487  Sum_probs=235.4

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      .+..+.+..|+.++.||.|.-|+||+|+...++..+|+|++.+..  ......+...|.+|+..++||.+..+|..|+.+
T Consensus        70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~  149 (459)
T KOG0610|consen   70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD  149 (459)
T ss_pred             CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence            456778899999999999999999999999999999999997652  233446678899999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          141 GAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      ...|+|||||+||+|..+++++  +.+++..++.++.+++.||+|||- .|||.|||||+||||.++|++.|+||.++..
T Consensus       150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEecCCcEEeeecccccc
Confidence            9999999999999999999775  579999999999999999999998 9999999999999999999999999998744


Q ss_pred             ccc---------------------------------C-C----------------------CCCCccccCCcccCcceec
Q 018018          219 MAS---------------------------------T-S----------------------GQANTFVGTYNYMSPERIS  242 (362)
Q Consensus       219 ~~~---------------------------------~-~----------------------~~~~~~~gt~~y~aPE~~~  242 (362)
                      ...                                 . .                      .....++||-.|.|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            310                                 0 0                      0123358999999999999


Q ss_pred             CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCC
Q 018018          243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS  322 (362)
Q Consensus       243 ~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  322 (362)
                      |...+.++|+|+||+++|||+.|..||.+.+..       +.+..++......+....++..+++||+++|.+||++|..
T Consensus       309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~-------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg  381 (459)
T KOG0610|consen  309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK-------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLG  381 (459)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch-------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhc
Confidence            999999999999999999999999999987654       4455566665555555578899999999999999999998


Q ss_pred             ----HHHHHcCCcccccCCCCC
Q 018018          323 ----AQELMTHPFLKMYGDLNV  340 (362)
Q Consensus       323 ----~~eil~hp~~~~~~~~~~  340 (362)
                          |+||-+||||++..+.-+
T Consensus       382 ~~rGA~eIK~HpFF~gVnWaLi  403 (459)
T KOG0610|consen  382 SKRGAAEIKRHPFFEGVNWALI  403 (459)
T ss_pred             cccchHHhhcCccccCCChhhe
Confidence                999999999999987533

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.6e-49  Score=371.33  Aligned_cols=262  Identities=26%  Similarity=0.425  Sum_probs=225.8

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccCC-cEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEe
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTG-QFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYS  139 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~  139 (362)
                      ....+..++|++.+.||+|+||.||+|++..++ ..||+|++....  .......+.+|+.+++.++||||+++++.+.+
T Consensus        23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~  102 (340)
T PTZ00426         23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD  102 (340)
T ss_pred             cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence            345567899999999999999999999876554 689999986542  23345678899999999999999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          140 NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      .+..++||||+++|+|.+++.....+++..+..++.|++.||+|||+ +|++||||||+|||++.++.+||+|||++...
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQS-LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            99999999999999999999988899999999999999999999998 99999999999999999999999999999765


Q ss_pred             ccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          220 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      ..   .....+||+.|+|||++.+..++.++||||+||++|||++|..||.+.+.       ......+.....  ..+.
T Consensus       182 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~~~i~~~~~--~~p~  249 (340)
T PTZ00426        182 DT---RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-------LLIYQKILEGII--YFPK  249 (340)
T ss_pred             CC---CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-------HHHHHHHhcCCC--CCCC
Confidence            32   23456799999999999998899999999999999999999999976433       123334443332  2345


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCC-----CHHHHHcCCcccccCC
Q 018018          300 QFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGD  337 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~~  337 (362)
                      .+++.+.++|++||+.||++|+     +++++++||||++...
T Consensus       250 ~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~  292 (340)
T PTZ00426        250 FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDW  292 (340)
T ss_pred             CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCH
Confidence            6789999999999999999995     8999999999988653

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4e-49  Score=373.55  Aligned_cols=259  Identities=29%  Similarity=0.453  Sum_probs=217.4

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++|++.+.||+|+||+||+|++..+++.||+|+++...  .......+..|+.++..++|+||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47899999999999999999999999999999997542  2344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC---
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---  224 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~---  224 (362)
                      ||+++|+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+++.......   
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQ-LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            999999999999988899999999999999999999998 9999999999999999999999999999875432110   


Q ss_pred             --------------------------------CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 018018          225 --------------------------------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP  272 (362)
Q Consensus       225 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~  272 (362)
                                                      .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                            012357999999999999999999999999999999999999999764


Q ss_pred             ccCCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhhcCcC---CCCCHHHHHcCCcccccCC
Q 018018          273 EQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQ---QRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~---~Rpt~~eil~hp~~~~~~~  337 (362)
                      +..       +....+....  ...+....+++++.++|.+|+. +|+   .||+++|+++||||+..+.
T Consensus       240 ~~~-------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~  301 (363)
T cd05628         240 TPQ-------ETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDW  301 (363)
T ss_pred             CHH-------HHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCH
Confidence            432       2333333221  1112223578999999999775 444   4689999999999987754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-49  Score=369.45  Aligned_cols=248  Identities=30%  Similarity=0.523  Sum_probs=216.9

Q ss_pred             eeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCCH
Q 018018           78 VGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  155 (362)
Q Consensus        78 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL  155 (362)
                      ||+|+||.||++++..+++.||+|+++..  ........+.+|+.++..++||||+++++.+.+....++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999999999999999998754  2334456788999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCCcc
Q 018018          156 ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY  235 (362)
Q Consensus       156 ~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y  235 (362)
                      .+++...+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++............+||+.|
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y  159 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHK-FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY  159 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence            9999888899999999999999999999998 999999999999999999999999999988654444444556899999


Q ss_pred             cCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 018018          236 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK  315 (362)
Q Consensus       236 ~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  315 (362)
                      +|||++.+..++.++||||+||++|+|++|..||.+.+.       .+....+....  ...+..+++++.+||.+||+.
T Consensus       160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-------~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~  230 (312)
T cd05585         160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-------NEMYRKILQEP--LRFPDGFDRDAKDLLIGLLSR  230 (312)
T ss_pred             CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-------HHHHHHHHcCC--CCCCCcCCHHHHHHHHHHcCC
Confidence            999999999999999999999999999999999976432       23444444433  233457899999999999999


Q ss_pred             CcCCCC---CHHHHHcCCccccc
Q 018018          316 EPQQRL---SAQELMTHPFLKMY  335 (362)
Q Consensus       316 dP~~Rp---t~~eil~hp~~~~~  335 (362)
                      ||++||   ++.+++.||||+..
T Consensus       231 dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         231 DPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CHHHcCCCCCHHHHHcCCCcCCC
Confidence            999997   58999999999875

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-49  Score=372.12  Aligned_cols=262  Identities=29%  Similarity=0.504  Sum_probs=221.0

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++|++.+.||+|+||.||+|++..+++.||+|+++...  .......+..|+.++..++||||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46899999999999999999999999999999997552  2234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      ||+++++|.+++.....+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.....   ...
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~  156 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE-LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YAN  156 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccC
Confidence            999999999999988899999999999999999999998 9999999999999999999999999999876543   334


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  307 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (362)
                      ...||+.|+|||++.+..++.++|||||||++|||++|..||...+..+....+..... ....+........+++++.+
T Consensus       157 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~s~~~~~  235 (333)
T cd05600         157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-TLQRPVYDDPRFNLSDEAWD  235 (333)
T ss_pred             CcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc-cccCCCCCccccccCHHHHH
Confidence            56799999999999999999999999999999999999999976543221111111000 00111111111356899999


Q ss_pred             HHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          308 FISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       308 li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ||.+||+.+|++||+++++++||||+...
T Consensus       236 li~~~l~~~~~rr~s~~~ll~h~~~~~~~  264 (333)
T cd05600         236 LITKLINDPSRRFGSLEDIKNHPFFKEVD  264 (333)
T ss_pred             HHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence            99999999999999999999999998764

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.1e-49  Score=366.54  Aligned_cols=251  Identities=31%  Similarity=0.575  Sum_probs=217.1

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  153 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~g  153 (362)
                      +.||+|+||.||++++..+|+.||+|+++...  .......+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997642  3344566788999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCC
Q 018018          154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY  233 (362)
Q Consensus       154 sL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~  233 (362)
                      +|..++.....+++..++.++.|++.||+|||+ +|++||||||+|||++.++.+||+|||++..............||+
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  159 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence            999999888899999999999999999999998 9999999999999999999999999999876433333344567999


Q ss_pred             cccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhh
Q 018018          234 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV  313 (362)
Q Consensus       234 ~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  313 (362)
                      .|+|||++.+..++.++|||||||++|+|++|+.||...+..       .....+.....  ..+..+++++.+||.+||
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-------~~~~~~~~~~~--~~p~~~~~~~~~li~~~L  230 (323)
T cd05595         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEEI--RFPRTLSPEAKSLLAGLL  230 (323)
T ss_pred             CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-------HHHHHHhcCCC--CCCCCCCHHHHHHHHHHc
Confidence            999999999999999999999999999999999999764321       23333332222  234578999999999999


Q ss_pred             hcCcCCCC-----CHHHHHcCCcccccC
Q 018018          314 QKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       314 ~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      +.||++|+     ++.++++||||....
T Consensus       231 ~~dP~~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         231 KKDPKQRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             cCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            99999998     999999999998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.3e-49  Score=368.45  Aligned_cols=258  Identities=27%  Similarity=0.527  Sum_probs=216.8

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||.||++++..+++.||+|+++...  .......+..|..++..+ +||||+.+++.+.+...+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999999999999998642  334456688899998887 699999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccC
Q 018018          153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  232 (362)
Q Consensus       153 gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt  232 (362)
                      |+|.+++...+.+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++............+||
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE-RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence            9999999888899999999999999999999998 999999999999999999999999999987543333444567899


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCC--chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 018018          233 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS  310 (362)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  310 (362)
                      +.|+|||++.+..++.++|+|||||++|+|++|+.||......+  ...........+.....  ..+..+++.+.++|.
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~li~  237 (329)
T cd05588         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI--RIPRSLSVKASSVLK  237 (329)
T ss_pred             ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC--CCCCCCCHHHHHHHH
Confidence            99999999999999999999999999999999999996432211  11111122233333322  234578899999999


Q ss_pred             HhhhcCcCCCCC------HHHHHcCCcccccC
Q 018018          311 ACVQKEPQQRLS------AQELMTHPFLKMYG  336 (362)
Q Consensus       311 ~~L~~dP~~Rpt------~~eil~hp~~~~~~  336 (362)
                      +||+.||++|+|      ++++++||||+...
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~  269 (329)
T cd05588         238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRNID  269 (329)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence            999999999997      78999999997654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.1e-49  Score=367.28  Aligned_cols=251  Identities=29%  Similarity=0.550  Sum_probs=217.1

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  153 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~g  153 (362)
                      +.||+|+||.||++++..+|+.||+|++....  .......+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997542  3344567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCC
Q 018018          154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY  233 (362)
Q Consensus       154 sL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~  233 (362)
                      +|..++.....+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++............+||+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  159 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHS-GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP  159 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence            999999888899999999999999999999998 9999999999999999999999999999876433333344567999


Q ss_pred             cccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhh
Q 018018          234 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV  313 (362)
Q Consensus       234 ~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  313 (362)
                      .|+|||++.+..++.++|||||||++|+|++|..||...+.       .+....+....  ...+..+++++.+||++||
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~-------~~~~~~~~~~~--~~~p~~~~~~~~~li~~~L  230 (328)
T cd05593         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMED--IKFPRTLSADAKSLLSGLL  230 (328)
T ss_pred             CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH-------HHHHHHhccCC--ccCCCCCCHHHHHHHHHHc
Confidence            99999999999999999999999999999999999976432       12333333222  2234578999999999999


Q ss_pred             hcCcCCCC-----CHHHHHcCCcccccC
Q 018018          314 QKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       314 ~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      +.||++|+     ++.++++||||....
T Consensus       231 ~~dP~~R~~~~~~~~~~il~h~~~~~~~  258 (328)
T cd05593         231 IKDPNKRLGGGPDDAKEIMRHSFFTGVN  258 (328)
T ss_pred             CCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            99999997     899999999997653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1e-48  Score=358.61  Aligned_cols=259  Identities=27%  Similarity=0.448  Sum_probs=218.1

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      |+..+.||+|+||.||++.+..+|+.||+|++....  .......+.+|+.+++.++|++|+.+++.+.+.+..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            778899999999999999999999999999987542  223345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          150 MDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       150 ~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      +++|+|.+++...  ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++|+|||++...... ....
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~  159 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR-ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVR  159 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-Ceec
Confidence            9999999888643  368999999999999999999998 99999999999999999999999999998765322 2234


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  307 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (362)
                      ...|+..|+|||++.+..++.++||||+||++|+|++|+.||..........   .....+...  ....+..+++++.+
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~~~--~~~~~~~~s~~~~~  234 (285)
T cd05631         160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVKED--QEEYSEKFSEDAKS  234 (285)
T ss_pred             CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhhcc--cccCCccCCHHHHH
Confidence            4578999999999999999999999999999999999999998754432111   222222221  12234568999999


Q ss_pred             HHHHhhhcCcCCCCC-----HHHHHcCCcccccCC
Q 018018          308 FISACVQKEPQQRLS-----AQELMTHPFLKMYGD  337 (362)
Q Consensus       308 li~~~L~~dP~~Rpt-----~~eil~hp~~~~~~~  337 (362)
                      ||++||+.||++||+     ++++++||||+....
T Consensus       235 li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~  269 (285)
T cd05631         235 ICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINF  269 (285)
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCH
Confidence            999999999999997     899999999988653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-49  Score=372.53  Aligned_cols=259  Identities=31%  Similarity=0.518  Sum_probs=220.2

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++|++++.||+|+||.||++++..+|+.||||+++...  .......+.+|+.++..++||||+++++.+.+...+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999999999999999997542  2344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC---
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---  224 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~---  224 (362)
                      ||+++|+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.++|+|||++........   
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK-LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            999999999999988899999999999999999999998 9999999999999999999999999999875432110   


Q ss_pred             -----------------------------------CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCC
Q 018018          225 -----------------------------------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY  269 (362)
Q Consensus       225 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf  269 (362)
                                                         .....+||+.|+|||++.+..++.++|||||||++|+|++|..||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence                                               011346999999999999999999999999999999999999999


Q ss_pred             CCCccCCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhhcCcCCCCC---HHHHHcCCcccccCC
Q 018018          270 SPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLS---AQELMTHPFLKMYGD  337 (362)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~~~~  337 (362)
                      .+.+..       +....+....  ...+....+++++.+||.+||. +|.+|++   +++++.||||+..+.
T Consensus       240 ~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         240 CSDNPQ-------ETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             CCCCHH-------HHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            764432       2233333222  1122233578999999999997 9999998   999999999987653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-51  Score=357.00  Aligned_cols=266  Identities=30%  Similarity=0.552  Sum_probs=240.4

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      ....+.+++|+.+++||+|.||+|.+|+.+.+|+.||||++++.  ...+...+-..|-++++..+||++..+.-.|+..
T Consensus       161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~  240 (516)
T KOG0690|consen  161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ  240 (516)
T ss_pred             ccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence            45567899999999999999999999999999999999999876  4555667788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          141 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      +++|+||||+.||.|+-.+++...++++.++.+...|+.||.|||+ ++||.||||.+|+|+|.+|++||+|||+++.-.
T Consensus       241 drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs-~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  241 DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHS-RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhh-CCeeeeechhhhheeccCCceEeeecccchhcc
Confidence            9999999999999999999999999999999999999999999998 999999999999999999999999999999877


Q ss_pred             cCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          221 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      ..+....++||||.|.|||++....|+.++|+|.+||++|||++|++||.+.+..       .++..+......  .+..
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-------kLFeLIl~ed~k--FPr~  390 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-------KLFELILMEDLK--FPRT  390 (516)
T ss_pred             cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-------HHHHHHHhhhcc--CCcc
Confidence            7777888999999999999999999999999999999999999999999886543       333443333222  2468


Q ss_pred             CCHHHHHHHHHhhhcCcCCCC-----CHHHHHcCCcccccCCC
Q 018018          301 FSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDL  338 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~~~  338 (362)
                      ++++++.|+..+|.+||++|.     .+.||.+|+||....+.
T Consensus       391 ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~  433 (516)
T KOG0690|consen  391 LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE  433 (516)
T ss_pred             CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence            999999999999999999998     58999999999988764

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-50  Score=342.09  Aligned_cols=277  Identities=34%  Similarity=0.691  Sum_probs=241.6

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~  144 (362)
                      +.+.++.+.+..||+|+.|+|++++.+.+|..+|||.++.+.+.+..+++++.++++... ++|+|++++++|..+...+
T Consensus        88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~  167 (391)
T KOG0983|consen   88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF  167 (391)
T ss_pred             ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH
Confidence            445677888899999999999999999999999999999998888888899999887654 5999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          145 IILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      +-||.|. ..+..++++ .+++++..+-++...++.||.||.+.+||+|||+||.|||+|+.|++||||||++-++.+..
T Consensus       168 IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  168 ICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            9999984 477777754 57899999999999999999999988899999999999999999999999999998876543


Q ss_pred             CCCCccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC-C
Q 018018          224 GQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-D  299 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  299 (362)
                      . .....|-+.|||||.+.-   ..|+.++||||||++++||.||.+||.+-+      ...+++.++.+..+|.... .
T Consensus       247 A-htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~------tdFe~ltkvln~ePP~L~~~~  319 (391)
T KOG0983|consen  247 A-HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK------TDFEVLTKVLNEEPPLLPGHM  319 (391)
T ss_pred             c-cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC------ccHHHHHHHHhcCCCCCCccc
Confidence            3 344578899999999865   458999999999999999999999998743      2346677776655544433 3


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHHHhC
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAG  350 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~~~~  350 (362)
                      ++++++.+++..||++|+.+||.+.++|+|||+..++...++..+||+|+-
T Consensus       320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~~dVa~WF~dV~  370 (391)
T KOG0983|consen  320 GFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYETAEVDVASWFKDVM  370 (391)
T ss_pred             CcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecchhhccHHHHHHHHH
Confidence            489999999999999999999999999999999999999999999999974

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-49  Score=371.46  Aligned_cols=259  Identities=34%  Similarity=0.581  Sum_probs=222.8

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++|.+.+.||+|+||.||+|++..+|+.||||+++...  .......+..|+.++..++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999999999999999997542  2244567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC----
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS----  223 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~----  223 (362)
                      ||+++++|.+++.....+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++.......    
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK-LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            999999999999988899999999999999999999998 999999999999999999999999999998765433    


Q ss_pred             -------------------------CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCch
Q 018018          224 -------------------------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW  278 (362)
Q Consensus       224 -------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~  278 (362)
                                               .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~---  236 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ---  236 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH---
Confidence                                     1233457999999999999999999999999999999999999999875422   


Q ss_pred             hhHHHHHHHHhc--CCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCC-HHHHHcCCcccccCC
Q 018018          279 TSFYELMEAIVD--QPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-AQELMTHPFLKMYGD  337 (362)
Q Consensus       279 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-~~eil~hp~~~~~~~  337 (362)
                          .....+..  .....+....+++++.+||.+||+ ||++||+ ++++++||||+....
T Consensus       237 ----~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~  293 (350)
T cd05573         237 ----ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDW  293 (350)
T ss_pred             ----HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCH
Confidence                22333333  222222233479999999999998 9999999 999999999987643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=9.6e-50  Score=355.60  Aligned_cols=268  Identities=27%  Similarity=0.485  Sum_probs=223.4

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch-HHHHHHHHHHHHHhcCCCCc-ceEEeeeEEecC-----
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-SARRQIAQELKINQSSQCPY-VVVCYQSFYSNG-----  141 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~hp~-I~~~~~~~~~~~-----  141 (362)
                      +..|+.++.||+|+||+||+|+.+.+|+.||+|+++...++ -.-....+|+.+++.++|+| |+.+++++....     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            67788899999999999999999999999999999877442 23345689999999999999 999999998877     


Q ss_pred             -eEEEEEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCC
Q 018018          142 -AISIILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  216 (362)
Q Consensus       142 -~~~lV~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a  216 (362)
                       .+++|+||++. +|..++....    .++...++.+++||+.||+|||+ ++|+||||||+||||+++|.+||+|||+|
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~-~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS-HGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCcceEEECCCCcEeeeccchH
Confidence             89999999965 9999998765    58889999999999999999998 99999999999999999999999999999


Q ss_pred             cccccCCCCCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh------
Q 018018          217 AIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV------  289 (362)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~------  289 (362)
                      +....+.......++|.+|+|||++.+. .|+...||||+||+++||++++..|.+....+....+.+++..-.      
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            9887666667778899999999999987 699999999999999999999999988765433222222221110      


Q ss_pred             -----cCCCCCCC----------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          290 -----DQPPPSAP----------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       290 -----~~~~~~~~----------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                           +...+...          .....++..+++.+||+.+|.+|.|++.++.||||+..++.
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence                 00000000          11223578999999999999999999999999999988654

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.7e-49  Score=362.36  Aligned_cols=262  Identities=25%  Similarity=0.439  Sum_probs=214.0

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      ++|++.+.||+|+||.||+++++.+++.||+|+++... .......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999999999999999987552 33445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC-CCC
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QAN  227 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~-~~~  227 (362)
                      |++++.+..+......+++..++.++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++........ ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK-NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            99987777666656789999999999999999999998 9999999999999999999999999999987643222 223


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH--------HHHhcC------CC
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM--------EAIVDQ------PP  293 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~~~------~~  293 (362)
                      ...|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....+....        ......      ..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            4578999999999999899999999999999999999999998754322111111100        000000      00


Q ss_pred             CC---------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          294 PS---------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       294 ~~---------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      +.         .....++.++.+||.+||++||++|||++++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            00         0112367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=366.54  Aligned_cols=262  Identities=31%  Similarity=0.528  Sum_probs=231.4

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc--hHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~~  144 (362)
                      ..+.|++.+.||+|.||.||.|+++.+|+.+|+|++.+...  ......+.+|+.+++.+. ||||+.+++.|.+...++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            34679999999999999999999999999999999976632  234578899999999998 999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC----CcEEEeeccCCcccc
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR----GEVKITDFGVSAIMA  220 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~----~~vkl~DFg~a~~~~  220 (362)
                      +|||+|.||.|.+.+... .+++..+..++.|++.|++|||+ .||+||||||+|+|+...    +.+|++|||+|....
T Consensus       113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~-~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~  190 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHS-LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK  190 (382)
T ss_pred             EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHh-CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence            999999999999999876 49999999999999999999998 999999999999999643    479999999999877


Q ss_pred             cCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCCC
Q 018018          221 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPS  298 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  298 (362)
                      . .......+||+.|+|||++.+..|+..+||||+|+++|.|++|..||.+.+...       ....+..+.  .....+
T Consensus       191 ~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~-------~~~~i~~~~~~f~~~~w  262 (382)
T KOG0032|consen  191 P-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE-------IFLAILRGDFDFTSEPW  262 (382)
T ss_pred             C-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH-------HHHHHHcCCCCCCCCCc
Confidence            6 556778899999999999999999999999999999999999999999865432       222333332  345567


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                      ..++..+.++|+.||..||.+|+|+.++|+|||++...+.+
T Consensus       263 ~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~  303 (382)
T KOG0032|consen  263 DDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEAT  303 (382)
T ss_pred             cccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccc
Confidence            78899999999999999999999999999999999875443

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.7e-49  Score=367.01  Aligned_cols=252  Identities=32%  Similarity=0.568  Sum_probs=216.9

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  153 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~g  153 (362)
                      +.||+|+||.||++++..+|..||+|+++...  .......+..|++++..++||||+.+++.+......++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997642  2334566778999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCC
Q 018018          154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY  233 (362)
Q Consensus       154 sL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~  233 (362)
                      +|..++.....+++..+..++.|++.||+|||+.+||+||||||+|||++.++.+||+|||+++.............||+
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP  160 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence            99999988889999999999999999999999647999999999999999999999999999876443333344567999


Q ss_pred             cccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhh
Q 018018          234 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV  313 (362)
Q Consensus       234 ~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  313 (362)
                      .|+|||++.+..++.++|||||||++|+|++|..||.+.+.       ......+.....  ..+..+++++.+||.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~-------~~~~~~i~~~~~--~~p~~~~~~~~~li~~~L  231 (325)
T cd05594         161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEI--RFPRTLSPEAKSLLSGLL  231 (325)
T ss_pred             ccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH-------HHHHHHHhcCCC--CCCCCCCHHHHHHHHHHh
Confidence            99999999999999999999999999999999999976432       223333332222  234568999999999999


Q ss_pred             hcCcCCCC-----CHHHHHcCCcccccC
Q 018018          314 QKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       314 ~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      +.||++|+     ++.++++||||+...
T Consensus       232 ~~dP~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         232 KKDPKQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             hcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence            99999997     999999999998764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.1e-48  Score=364.26  Aligned_cols=251  Identities=29%  Similarity=0.537  Sum_probs=215.8

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||.||+++++.+++.||+|+++...  .......+..|..++..+ +||||+++++.+.+.+.+++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999987542  233455667788877665 699999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccC
Q 018018          153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  232 (362)
Q Consensus       153 gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt  232 (362)
                      |+|.+++.....+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++.............||
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~-~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHD-KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT  159 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence            9999999988899999999999999999999998 999999999999999999999999999987644333344556799


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018018          233 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  312 (362)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  312 (362)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+.       .++...+.....  ..+..+++++.++|++|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-------~~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (320)
T cd05590         160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-------DDLFEAILNDEV--VYPTWLSQDAVDILKAF  230 (320)
T ss_pred             ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhcCCC--CCCCCCCHHHHHHHHHH
Confidence            999999999999999999999999999999999999976432       233444443332  23356889999999999


Q ss_pred             hhcCcCCCCCH------HHHHcCCcccccC
Q 018018          313 VQKEPQQRLSA------QELMTHPFLKMYG  336 (362)
Q Consensus       313 L~~dP~~Rpt~------~eil~hp~~~~~~  336 (362)
                      |+.||++||++      +++++||||+...
T Consensus       231 L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~  260 (320)
T cd05590         231 MTKNPTMRLGSLTLGGEEAILRHPFFKELD  260 (320)
T ss_pred             cccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence            99999999998      9999999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.2e-48  Score=361.85  Aligned_cols=256  Identities=28%  Similarity=0.505  Sum_probs=219.7

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCC-cceEEeeeEEecCeEEEEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCP-YVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp-~I~~~~~~~~~~~~~~lV~  147 (362)
                      +|++++.||+|+||.||+|++..+++.||+|+++...  .......+..|..++..+.|+ +|+.+++.+.+.+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5889999999999999999999999999999997642  234456678889998888764 5888999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      ||+++|+|.+++.....+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++...........
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR  159 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence            999999999999988899999999999999999999998 9999999999999999999999999999875433333344


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  307 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (362)
                      ..+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.       .+....+.....  ..+..+++++.+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~~~~~--~~~~~~~~~~~~  230 (324)
T cd05587         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-------DELFQSIMEHNV--SYPKSLSKEAVS  230 (324)
T ss_pred             eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCC--CCCCCCCHHHHH
Confidence            56799999999999999999999999999999999999999976432       233344443332  234578999999


Q ss_pred             HHHHhhhcCcCCCCCH-----HHHHcCCcccccC
Q 018018          308 FISACVQKEPQQRLSA-----QELMTHPFLKMYG  336 (362)
Q Consensus       308 li~~~L~~dP~~Rpt~-----~eil~hp~~~~~~  336 (362)
                      ++.+||+.||++|++.     +++++||||+...
T Consensus       231 li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~  264 (324)
T cd05587         231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID  264 (324)
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999999999986     8999999998754

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.6e-48  Score=364.56  Aligned_cols=258  Identities=28%  Similarity=0.527  Sum_probs=215.4

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||.||++++..+++.||+|+++..  ........+..|..++..+ +||||+++++.+.+....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999765  2334456677888887665 799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccC
Q 018018          153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  232 (362)
Q Consensus       153 gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt  232 (362)
                      ++|..++.....+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++............+||
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  159 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence            9999999888899999999999999999999998 999999999999999999999999999987644333344556899


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc--hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 018018          233 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG--WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS  310 (362)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  310 (362)
                      +.|+|||++.+..++.++|||||||++|+|++|..||........  ..........+....  ...+..++..+.+||.
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~ll~  237 (329)
T cd05618         160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--IRIPRSLSVKAASVLK  237 (329)
T ss_pred             ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--CCCCCCCCHHHHHHHH
Confidence            999999999999999999999999999999999999964222111  111112222333222  2234578899999999


Q ss_pred             HhhhcCcCCCCC------HHHHHcCCcccccC
Q 018018          311 ACVQKEPQQRLS------AQELMTHPFLKMYG  336 (362)
Q Consensus       311 ~~L~~dP~~Rpt------~~eil~hp~~~~~~  336 (362)
                      +||+.||++||+      ++++++||||+...
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  269 (329)
T cd05618         238 SFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  269 (329)
T ss_pred             HHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence            999999999998      58999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.5e-48  Score=364.11  Aligned_cols=254  Identities=28%  Similarity=0.507  Sum_probs=215.8

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHH---hcCCCCcceEEeeeEEecCeEEEE
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKIN---QSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~---~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      |++.+.||+|+||.||++.+..+|+.||||+++...  .......+.+|.+++   +.++||||+++++.+.+....|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            678899999999999999999999999999997542  223345566666554   567899999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      |||+++++|..++.. ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++.........
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE-NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            999999999988865 579999999999999999999998 999999999999999999999999999987644333344


Q ss_pred             CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018018          227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  306 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (362)
                      ...+|++.|+|||.+.+..++.++|||||||++|+|++|..||.+.+.       .+....+.....  ..+..+++.+.
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~~~--~~p~~~~~~~~  229 (324)
T cd05589         159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE-------EEVFDSIVNDEV--RYPRFLSREAI  229 (324)
T ss_pred             cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC--CCCCCCCHHHH
Confidence            556899999999999999999999999999999999999999976433       233334433332  23456899999


Q ss_pred             HHHHHhhhcCcCCCC-----CHHHHHcCCcccccC
Q 018018          307 SFISACVQKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       307 ~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      ++|.+||+.||++||     ++.++++||||++..
T Consensus       230 ~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~  264 (324)
T cd05589         230 SIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN  264 (324)
T ss_pred             HHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence            999999999999999     799999999998764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.3e-48  Score=369.62  Aligned_cols=258  Identities=28%  Similarity=0.464  Sum_probs=216.3

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .|+.++.||+|+||+||++++..+++.||+|+++..  ........+.+|+.+++.++||||+++++.+.+...+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            588999999999999999999999999999999754  234456778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC-----
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-----  223 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~-----  223 (362)
                      |+++|+|.+++.....+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||++.......     
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK-MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            99999999999988899999999999999999999998 999999999999999999999999999975431000     


Q ss_pred             ------------------------------------------CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHH
Q 018018          224 ------------------------------------------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  261 (362)
Q Consensus       224 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~e  261 (362)
                                                                ......+||+.|+|||++.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e  240 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE  240 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence                                                      00123579999999999999899999999999999999


Q ss_pred             HHcCCCCCCCCccCCchhhHHHHHHHHhc--CCCCCCCCCCCCHHHHHHHHHhhh--cCcCCCCCHHHHHcCCcccccC
Q 018018          262 CATGQFPYSPPEQQDGWTSFYELMEAIVD--QPPPSAPSDQFSPEFCSFISACVQ--KEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       262 lltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~--~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      |++|..||...+..       +....+..  .....+....+++++.+||.+|+.  .+|..|+++++++.||||+...
T Consensus       241 lltG~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~  312 (381)
T cd05626         241 MLVGQPPFLAPTPT-------ETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD  312 (381)
T ss_pred             HHhCCCCCcCCCHH-------HHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence            99999999765432       11122221  112222334689999999999665  4555699999999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-48  Score=370.77  Aligned_cols=258  Identities=31%  Similarity=0.519  Sum_probs=216.2

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++|.+++.||+|+||.||++.+..+++.||||++....  .......+.+|+.+++.++||||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47899999999999999999999999999999986542  3344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC---
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---  224 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~---  224 (362)
                      ||+++|+|.+++.....+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++.......   
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~-~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK-LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            999999999999988899999999999999999999998 9999999999999999999999999999863321000   


Q ss_pred             --------------------------------------------CCCccccCCcccCcceecCCCCCccccHHHHHHHHH
Q 018018          225 --------------------------------------------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  260 (362)
Q Consensus       225 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~  260 (362)
                                                                  .....+||+.|+|||++.+..++.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  239 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF  239 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence                                                        001246999999999999999999999999999999


Q ss_pred             HHHcCCCCCCCCccCCchhhHHHHHHHHhcC--CCCCCCCCCCCHHHHHHHHHhhhcCcCCC---CCHHHHHcCCccccc
Q 018018          261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQ--PPPSAPSDQFSPEFCSFISACVQKEPQQR---LSAQELMTHPFLKMY  335 (362)
Q Consensus       261 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R---pt~~eil~hp~~~~~  335 (362)
                      ||++|..||.+.+..       +....+...  ....+....++.++.+||.+||+ +|.+|   +|+.|++.||||+..
T Consensus       240 elltG~~Pf~~~~~~-------~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         240 ECLIGWPPFCSENSH-------ETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             hhhcCCCCCCCCCHH-------HHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            999999999764432       222233221  11122223578999999999998 77765   599999999999865


Q ss_pred             C
Q 018018          336 G  336 (362)
Q Consensus       336 ~  336 (362)
                      .
T Consensus       312 ~  312 (377)
T cd05629         312 D  312 (377)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.1e-48  Score=364.65  Aligned_cols=261  Identities=46%  Similarity=0.773  Sum_probs=218.0

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ....++|+.++.||+|+||.||++++..+++.||||++...........+.+|+++++.++|+||+++++.+.+.+.+++
T Consensus        70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  149 (353)
T PLN00034         70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV  149 (353)
T ss_pred             CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence            34568899999999999999999999999999999999766566667789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      ||||+.+++|.+.    ...++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++........
T Consensus       150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHR-RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence            9999999998653    345778889999999999999998 99999999999999999999999999999876543333


Q ss_pred             CCccccCCcccCcceecC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          226 ANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      .....||..|+|||.+..     ...+.++|||||||++|||++|+.||...... .+   ......+.... .......
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~---~~~~~~~~~~~-~~~~~~~  299 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DW---ASLMCAICMSQ-PPEAPAT  299 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cH---HHHHHHHhccC-CCCCCCc
Confidence            445689999999998743     23457899999999999999999999743221 12   22222222222 2333457


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ++.++.+||.+||+.||++|||+.|+++||||....
T Consensus       300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            889999999999999999999999999999997763

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.2e-48  Score=369.85  Aligned_cols=257  Identities=28%  Similarity=0.482  Sum_probs=217.0

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .|+.++.||+|+||.||++++..+++.||+|++....  .......+.+|+++++.++||||+++++.+.+...+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5889999999999999999999999999999987542  23455678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC-----
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-----  223 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~-----  223 (362)
                      |+++|+|.+++.+.+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|.......     
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~-~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            99999999999888889999999999999999999998 999999999999999999999999999975321000     


Q ss_pred             ------------------------------------------CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHH
Q 018018          224 ------------------------------------------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE  261 (362)
Q Consensus       224 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~e  261 (362)
                                                                ......+||+.|+|||++.+..++.++|||||||++||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence                                                      00123479999999999999999999999999999999


Q ss_pred             HHcCCCCCCCCccCCchhhHHHHHHHHhc--CCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCC---HHHHHcCCcccccC
Q 018018          262 CATGQFPYSPPEQQDGWTSFYELMEAIVD--QPPPSAPSDQFSPEFCSFISACVQKEPQQRLS---AQELMTHPFLKMYG  336 (362)
Q Consensus       262 lltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~~~  336 (362)
                      |++|+.||.+.+..       +....+..  .....+....+++++.++|.+|+ .+|++|++   ++++++||||+...
T Consensus       241 lltG~~Pf~~~~~~-------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~  312 (382)
T cd05625         241 MLVGQPPFLAQTPL-------ETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTID  312 (382)
T ss_pred             HHhCCCCCCCCCHH-------HHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCcC
Confidence            99999999764332       22222222  11222233568999999999986 59999997   99999999998754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3.9e-48  Score=367.55  Aligned_cols=262  Identities=30%  Similarity=0.500  Sum_probs=220.6

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      .+..++|++.+.||+|+||.||++++..+++.||+|+++...  .......+.+|+.+++.++||||+++++.+.+....
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            456789999999999999999999999999999999997531  223345577899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++.......
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~  196 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG  196 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence            999999999999999876 468999999999999999999998 999999999999999999999999999987654322


Q ss_pred             C-CCCccccCCcccCcceecCC----CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCC
Q 018018          224 G-QANTFVGTYNYMSPERISGG----KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSA  296 (362)
Q Consensus       224 ~-~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~  296 (362)
                      . .....+||+.|+|||++.+.    .++.++|||||||++|||++|..||.+.+.       ......+....  ...+
T Consensus       197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~~  269 (370)
T cd05596         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKIMDHKNSLTFP  269 (370)
T ss_pred             cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH-------HHHHHHHHcCCCcCCCC
Confidence            2 23456799999999998653    378999999999999999999999986432       22333443322  1222


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCC--CCCHHHHHcCCcccccC
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYG  336 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~--Rpt~~eil~hp~~~~~~  336 (362)
                      ....++.++.+||++||+.+|++  |+|++++++||||++..
T Consensus       270 ~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~  311 (370)
T cd05596         270 DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQ  311 (370)
T ss_pred             CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCC
Confidence            22357999999999999999988  99999999999998743

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.1e-48  Score=370.34  Aligned_cols=258  Identities=27%  Similarity=0.436  Sum_probs=216.9

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      .+|++++.||+|+||.||++++..+++.||+|++....  .......+.+|+.+++.++|+||+++++.+.+.+.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            37999999999999999999999999999999986542  2234566889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC-----
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-----  222 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~-----  222 (362)
                      ||+++|+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|......     
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            999999999999988889999999999999999999998 99999999999999999999999999997532100     


Q ss_pred             --------------------------------------CCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc
Q 018018          223 --------------------------------------SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT  264 (362)
Q Consensus       223 --------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt  264 (362)
                                                            .......+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~  239 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence                                                  000123579999999999999999999999999999999999


Q ss_pred             CCCCCCCCccCCchhhHHHHHHHHhcC--CCCCCCCCCCCHHHHHHHHHhhhcCcCCCC---CHHHHHcCCcccccC
Q 018018          265 GQFPYSPPEQQDGWTSFYELMEAIVDQ--PPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLKMYG  336 (362)
Q Consensus       265 g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~~~~~  336 (362)
                      |+.||.+.+..       +....+...  .........+++++.++|.+|+ .+|++|+   |+.++++||||+..+
T Consensus       240 G~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         240 GQPPFLADTPA-------ETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             CCCCCCCCCHH-------HHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence            99999875432       112222221  1122223468899999999976 5999999   999999999998753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.8e-48  Score=360.52  Aligned_cols=258  Identities=26%  Similarity=0.524  Sum_probs=218.1

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||.||++++..+++.||+|+++...  .......+..|..++..+ +||+|+.+++.+.+...+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999998652  234456788899888777 699999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccC
Q 018018          153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  232 (362)
Q Consensus       153 gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt  232 (362)
                      ++|..++...+.+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++............+||
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE-RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT  159 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence            9999999888899999999999999999999998 999999999999999999999999999987543333344557899


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018018          233 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  312 (362)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  312 (362)
                      +.|+|||++.+..++.++|||||||++|+|++|..||..................+....  ...+..++..+.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~li~~~  237 (327)
T cd05617         160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--IRIPRFLSVKASHVLKGF  237 (327)
T ss_pred             cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--CCCCCCCCHHHHHHHHHH
Confidence            999999999999999999999999999999999999975433222222222333333332  224456889999999999


Q ss_pred             hhcCcCCCCC------HHHHHcCCcccccC
Q 018018          313 VQKEPQQRLS------AQELMTHPFLKMYG  336 (362)
Q Consensus       313 L~~dP~~Rpt------~~eil~hp~~~~~~  336 (362)
                      |+.||++|++      +++++.||||+...
T Consensus       238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         238 LNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             hccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            9999999998      57999999998764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.8e-48  Score=360.84  Aligned_cols=251  Identities=29%  Similarity=0.496  Sum_probs=215.5

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||.||++++..+++.||+|+++...  .......+..|.+++..+ +||||+.+++.+.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            36999999999999999999999999997642  233445677788888754 799999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccC
Q 018018          153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  232 (362)
Q Consensus       153 gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt  232 (362)
                      ++|..++.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.............+||
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHR-HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT  159 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence            9999999988899999999999999999999998 999999999999999999999999999987654333344556799


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018018          233 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  312 (362)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  312 (362)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||...+.       ......+.....  ..+..+++++.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~-------~~~~~~i~~~~~--~~p~~~~~~~~~ll~~~  230 (321)
T cd05591         160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-------DDLFESILHDDV--LYPVWLSKEAVSILKAF  230 (321)
T ss_pred             ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence            999999999999999999999999999999999999976433       233344443332  22345789999999999


Q ss_pred             hhcCcCCCC-------CHHHHHcCCcccccC
Q 018018          313 VQKEPQQRL-------SAQELMTHPFLKMYG  336 (362)
Q Consensus       313 L~~dP~~Rp-------t~~eil~hp~~~~~~  336 (362)
                      |+.||++||       +++++++||||+...
T Consensus       231 L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~  261 (321)
T cd05591         231 MTKNPNKRLGCVASQGGEDAIKQHPFFKEID  261 (321)
T ss_pred             hccCHHHcCCCCCCCCCHHHHhcCCccCCCC
Confidence            999999999       999999999997754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.3e-48  Score=359.26  Aligned_cols=256  Identities=29%  Similarity=0.509  Sum_probs=218.6

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEEEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +|.+.+.||+|+||.||++++..+++.||+|+++...  .......+..|..++..+ +|++|+.+++.+.+.+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5889999999999999999999999999999997642  223344566777777665 5799999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      ||+++|+|.+++.....+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++..........
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~  159 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK  159 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence            999999999999888899999999999999999999998 9999999999999999999999999999876443333445


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  307 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (362)
                      ..+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+.       ......+.....  ..+..+++++.+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~-------~~~~~~i~~~~~--~~p~~~s~~~~~  230 (323)
T cd05616         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIMEHNV--AYPKSMSKEAVA  230 (323)
T ss_pred             cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC--CCCCcCCHHHHH
Confidence            56899999999999999999999999999999999999999976432       233444444332  233568999999


Q ss_pred             HHHHhhhcCcCCCCCH-----HHHHcCCcccccC
Q 018018          308 FISACVQKEPQQRLSA-----QELMTHPFLKMYG  336 (362)
Q Consensus       308 li~~~L~~dP~~Rpt~-----~eil~hp~~~~~~  336 (362)
                      ++.+||+.||++|+++     .++++||||+...
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         231 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             HHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999999999984     8999999998654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.1e-48  Score=361.03  Aligned_cols=251  Identities=30%  Similarity=0.518  Sum_probs=215.9

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||+||++.+..+++.||||+++...  .......+..|..++..+ +||||+++++.+.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999998652  233455667888888776 699999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccC
Q 018018          153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  232 (362)
Q Consensus       153 gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt  232 (362)
                      ++|..++.....+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++............+|+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  159 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHE-RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT  159 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence            9999999988899999999999999999999998 999999999999999999999999999987543333334456799


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018018          233 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  312 (362)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  312 (362)
                      +.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+.       ......+.....  ..+..+++.+.+||++|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-------~~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (318)
T cd05570         160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-------DELFQSILEDEV--RYPRWLSKEAKSILKSF  230 (318)
T ss_pred             ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCC--CCCCcCCHHHHHHHHHH
Confidence            999999999999999999999999999999999999976432       233333333332  23456889999999999


Q ss_pred             hhcCcCCCCCH-----HHHHcCCcccccC
Q 018018          313 VQKEPQQRLSA-----QELMTHPFLKMYG  336 (362)
Q Consensus       313 L~~dP~~Rpt~-----~eil~hp~~~~~~  336 (362)
                      |+.||++|||+     .+++.||||+...
T Consensus       231 l~~dP~~R~s~~~~~~~~ll~~~~~~~~~  259 (318)
T cd05570         231 LTKNPEKRLGCLPTGEQDIKGHPFFREID  259 (318)
T ss_pred             ccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            99999999999     9999999998864

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=6.2e-48  Score=359.73  Aligned_cols=251  Identities=30%  Similarity=0.516  Sum_probs=215.8

Q ss_pred             eeeeeeCCeEEEEEEEc---cCCcEEEEEEeeccc---chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           76 KVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +.||+|+||.||++++.   .+++.||+|+++...   .......+..|+.+++.++||||+++++.+..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999864   478899999987542   223345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      +++++|.+++...+.+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++............
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ-QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF  160 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence            9999999999988899999999999999999999998 999999999999999999999999999987544344344556


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  309 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  309 (362)
                      .|++.|+|||++.+..++.++|||||||++|||++|+.||...+.       ......+.....  ..+..+++++.++|
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~-------~~~~~~~~~~~~--~~~~~~~~~~~~li  231 (323)
T cd05584         161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR-------KKTIDKILKGKL--NLPPYLTPEARDLL  231 (323)
T ss_pred             CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCC--CCCCCCCHHHHHHH
Confidence            799999999999998899999999999999999999999976432       233344433332  23456889999999


Q ss_pred             HHhhhcCcCCCC-----CHHHHHcCCcccccC
Q 018018          310 SACVQKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       310 ~~~L~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      .+||+.||++||     +++++++||||+...
T Consensus       232 ~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         232 KKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             HHHcccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence            999999999999     899999999997653

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.6e-48  Score=358.93  Aligned_cols=251  Identities=29%  Similarity=0.504  Sum_probs=212.8

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhc-CCCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~-l~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||.||++++..+|..||+|+++...  .......+..|..++.. .+||||+++++.+.+.+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999999999999997642  12334456667777764 5899999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccC
Q 018018          153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  232 (362)
Q Consensus       153 gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt  232 (362)
                      ++|..++.....+++..+..++.|++.||+|||+ +||+||||||+||+++.++.++|+|||+++............+||
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHS-KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT  159 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence            9999999888899999999999999999999998 999999999999999999999999999987543333344556799


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018018          233 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  312 (362)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  312 (362)
                      +.|+|||++.+..++.++||||+||++|+|++|..||.+.+.       .+....+....  +..+..++.++.+||.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-------~~~~~~~~~~~--~~~~~~~~~~~~~li~~~  230 (316)
T cd05620         160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-------DELFESIRVDT--PHYPRWITKESKDILEKL  230 (316)
T ss_pred             cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCC--CCCCCCCCHHHHHHHHHH
Confidence            999999999999999999999999999999999999976432       23333333322  223346889999999999


Q ss_pred             hhcCcCCCCCH-HHHHcCCcccccC
Q 018018          313 VQKEPQQRLSA-QELMTHPFLKMYG  336 (362)
Q Consensus       313 L~~dP~~Rpt~-~eil~hp~~~~~~  336 (362)
                      |+.||++||++ +++++||||+...
T Consensus       231 l~~dP~~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         231 FERDPTRRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             ccCCHHHcCCChHHHHcCCCcCCCC
Confidence            99999999998 5899999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-49  Score=366.57  Aligned_cols=259  Identities=34%  Similarity=0.556  Sum_probs=235.1

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe-EEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-ISII  146 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~-~~lV  146 (362)
                      ++.|+.++++|+|+||.+++++++.+++.|++|.+... ..+..++...+|+.++++++||||+.+++.|..++. ++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            57899999999999999999999999999999999876 345556688999999999999999999999999888 9999


Q ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          147 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      |+||+||++.+.+...  ..++++.+..++.|++.|+.|||+ +.|+|||||+.||+++.++.|+|+|||+|+.+.....
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~-~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE-NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh-hhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence            9999999999999654  468999999999999999999997 9999999999999999999999999999999987766


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      ...+.+||+.|+.||.+.+.+|+.++|||||||++|||++-+.+|.+.       +...++.++..... .+.+..++.+
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~-------~m~~Li~ki~~~~~-~Plp~~ys~e  233 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS-------NMSELILKINRGLY-SPLPSMYSSE  233 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc-------chHHHHHHHhhccC-CCCCccccHH
Confidence            778889999999999999999999999999999999999999999873       44566666666653 3445789999


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          305 FCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ++.||..||..+|+.||++.++|.+|.++.+-
T Consensus       234 l~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  234 LRSLVKSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             HHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            99999999999999999999999999988664

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.3e-48  Score=362.01  Aligned_cols=275  Identities=26%  Similarity=0.463  Sum_probs=222.2

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      .+++|.+.+.||+|+||.||++++..++..||+|+++..........+.+|+.+++.++||||+++++.+..++..++||
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   83 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF   83 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence            45889999999999999999999999999999999876544444456778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          148 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       148 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      ||+++ +|.+++... ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++..........
T Consensus        84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR-RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence            99975 888888654 458999999999999999999998 999999999999999999999999999987654433333


Q ss_pred             CccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHH--------HH------hcC
Q 018018          227 NTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME--------AI------VDQ  291 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~--------~~------~~~  291 (362)
                      ....+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+..+....+.....        .+      ...
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNY  241 (309)
T ss_pred             ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhh
Confidence            44578899999999865 4589999999999999999999999977544322111111100        00      000


Q ss_pred             CCCC-------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHH
Q 018018          292 PPPS-------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE  344 (362)
Q Consensus       292 ~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~  344 (362)
                      ..+.       .....+++++.+||.+||+.||++|||++|+++||||+.......+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~  301 (309)
T cd07872         242 NFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLPE  301 (309)
T ss_pred             hcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccccccCCc
Confidence            0000       1123478899999999999999999999999999999988765555544

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.9e-47  Score=352.89  Aligned_cols=275  Identities=45%  Similarity=0.825  Sum_probs=229.9

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+...........+.+|+++++.++||||+++++.+.+++.+++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999999999999999987665566667789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      +++++|.+++...+.+++..+..++.|++.||.|||+..+++|+||||+||+++.++.++|+|||++......  .....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~  158 (308)
T cd06615          81 MDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSF  158 (308)
T ss_pred             cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--ccccC
Confidence            9999999999988899999999999999999999997458999999999999999999999999998654322  23446


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCch-----------------------------hh
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW-----------------------------TS  280 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~-----------------------------~~  280 (362)
                      .++..|+|||++.+..++.++|+||+|+++|+|++|+.||...+.....                             ..
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (308)
T cd06615         159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA  238 (308)
T ss_pred             CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhh
Confidence            7899999999998888999999999999999999999999653321100                             01


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHH
Q 018018          281 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF  346 (362)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~  346 (362)
                      ..+..........+......++.++.+++.+||+.||++|||+.++++||||+++.....+.+.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~  304 (308)
T cd06615         239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELEEVDFAGWV  304 (308)
T ss_pred             HHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccccchhhhhh
Confidence            111222222222222233347889999999999999999999999999999999877666665543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.4e-48  Score=358.14  Aligned_cols=251  Identities=31%  Similarity=0.549  Sum_probs=212.5

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHh-cCCCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQ-SSQCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~-~l~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||.||++++..+++.||+|+++...  .......+..|..++. ..+||||+++++.+......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999997642  2223344555666655 45899999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccC
Q 018018          153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  232 (362)
Q Consensus       153 gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt  232 (362)
                      |+|.+++.....+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++............+||
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  159 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK-KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT  159 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence            9999999988899999999999999999999998 999999999999999999999999999997654433444556899


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018018          233 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  312 (362)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  312 (362)
                      +.|+|||++.+..++.++|||||||++|+|++|..||.+.+.       .+....+....  +..+..++.++.+||.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~--~~~~~~~~~~~~~ll~~~  230 (316)
T cd05592         160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-------DELFDSILNDR--PHFPRWISKEAKDCLSKL  230 (316)
T ss_pred             ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCC--CCCCCCCCHHHHHHHHHH
Confidence            999999999999999999999999999999999999976432       23333333322  233456889999999999


Q ss_pred             hhcCcCCCCCH-HHHHcCCcccccC
Q 018018          313 VQKEPQQRLSA-QELMTHPFLKMYG  336 (362)
Q Consensus       313 L~~dP~~Rpt~-~eil~hp~~~~~~  336 (362)
                      |+.||++||++ .++++||||+...
T Consensus       231 l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         231 FERDPTKRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             ccCCHHHcCCChHHHHcCcccCCCC
Confidence            99999999986 5889999998764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.9e-48  Score=366.38  Aligned_cols=259  Identities=29%  Similarity=0.490  Sum_probs=218.5

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++|++++.||+|+||.||++.+..+++.||+|+++...  .......+..|+.++..++||+|+++++.+.+...+++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47899999999999999999999999999999997542  3344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC----
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS----  223 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~----  223 (362)
                      ||+++|+|.+++.+...+++..++.++.|++.||+|||+ +||+||||||+||+++.+++++|+|||++.......    
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~-~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ-LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            999999999999988899999999999999999999998 999999999999999999999999999987542211    


Q ss_pred             -------------------------------CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 018018          224 -------------------------------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP  272 (362)
Q Consensus       224 -------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~  272 (362)
                                                     ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence                                           0012357999999999999999999999999999999999999999765


Q ss_pred             ccCCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhhcCcCCCC---CHHHHHcCCcccccCC
Q 018018          273 EQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLKMYGD  337 (362)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~~~~~~  337 (362)
                      +..       .....+....  ...+....+++++.+||.+|+. ||++|+   +++++++||||++...
T Consensus       240 ~~~-------~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~  301 (360)
T cd05627         240 TPQ-------ETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDW  301 (360)
T ss_pred             CHH-------HHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCH
Confidence            432       2223333211  1111223478999999999874 999999   4899999999998653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.7e-48  Score=360.02  Aligned_cols=260  Identities=29%  Similarity=0.511  Sum_probs=217.4

Q ss_pred             CceeeeeeeeeCCeEEEEEEEc---cCCcEEEEEEeeccc---chHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNV---EESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~  143 (362)
                      +|++++.||+|+||.||++++.   .+++.||+|+++...   .......+..|+.+++.++ |++|+.+++.+...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5889999999999999998874   478999999987542   2234456788999999984 89999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ++||||+++|+|.+++.....+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK-LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            9999999999999999888899999999999999999999998 999999999999999999999999999987653322


Q ss_pred             -CCCCccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          224 -GQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       224 -~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                       ......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.........   ..+...+....  +..+..+
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~~--~~~~~~~  234 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILKCD--PPFPSFI  234 (332)
T ss_pred             CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhcCC--CCCCCCC
Confidence             2233467999999999998754 789999999999999999999999754433222   22333333322  2234568


Q ss_pred             CHHHHHHHHHhhhcCcCCCC-----CHHHHHcCCcccccC
Q 018018          302 SPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      ++.+.++|.+||+.||++||     +++++++||||+...
T Consensus       235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            99999999999999999999     889999999998753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3e-47  Score=347.69  Aligned_cols=267  Identities=43%  Similarity=0.794  Sum_probs=227.2

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      ++|++.+.||+|+||.||++.+..+++.||+|++...........+.+|+++++.++||||+++++.+......++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            46888999999999999999999999999999987665555667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      +++++|..+    ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++......  .....
T Consensus        81 ~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~  153 (279)
T cd06619          81 MDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWS-LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTY  153 (279)
T ss_pred             CCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccCC
Confidence            999998655    457899999999999999999998 99999999999999999999999999998765322  23446


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  309 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  309 (362)
                      +|+..|+|||.+.+..++.++|+||||+++|+|++|..||..................+.....+.......++++.++|
T Consensus       154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  233 (279)
T cd06619         154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFI  233 (279)
T ss_pred             CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHH
Confidence            78999999999999999999999999999999999999997644333222223334444444333333456789999999


Q ss_pred             HHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHH
Q 018018          310 SACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS  343 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~  343 (362)
                      .+||+.||++||+++|+++||||+..+..+..+.
T Consensus       234 ~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~~~~  267 (279)
T cd06619         234 TQCMRKQPKERPAPENLMDHPFIVQYNDGNAEVV  267 (279)
T ss_pred             HHHhhCChhhCCCHHHHhcCcccccccCccHHHH
Confidence            9999999999999999999999999977776553

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=5.9e-48  Score=359.86  Aligned_cols=251  Identities=32%  Similarity=0.536  Sum_probs=213.2

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHH-HHhcCCCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELK-INQSSQCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~-~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||+||++++..+|+.||+|++....  ......++..|.. +++.++||||+++++.+.+....++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999999999999999987542  2223344555554 56789999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccC
Q 018018          153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  232 (362)
Q Consensus       153 gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt  232 (362)
                      |+|..++.....+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++.............+||
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHS-LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence            9999999988899999999999999999999998 999999999999999999999999999987644333344556799


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018018          233 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  312 (362)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  312 (362)
                      +.|+|||++.+..++.++|||||||++|+|++|..||.+.+.       .+....+.....  .....+++.+.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (323)
T cd05575         160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-------AEMYDNILNKPL--RLKPNISVSARHLLEGL  230 (323)
T ss_pred             hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-------HHHHHHHHcCCC--CCCCCCCHHHHHHHHHH
Confidence            999999999999999999999999999999999999976432       233444443332  23346799999999999


Q ss_pred             hhcCcCCCCCH----HHHHcCCcccccC
Q 018018          313 VQKEPQQRLSA----QELMTHPFLKMYG  336 (362)
Q Consensus       313 L~~dP~~Rpt~----~eil~hp~~~~~~  336 (362)
                      |+.||++||++    .++++||||....
T Consensus       231 l~~~p~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         231 LQKDRTKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             hhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence            99999999987    6999999998754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.5e-48  Score=367.61  Aligned_cols=261  Identities=24%  Similarity=0.342  Sum_probs=212.6

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      +...+|.+++.||+|+||.||+|.+..+++.||+|...       ...+.+|+.+++.++||||+++++.+......++|
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv  161 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI  161 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence            45578999999999999999999999999999999753       23467899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC-CC
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQ  225 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~-~~  225 (362)
                      +|++. ++|..++.....+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+|....... ..
T Consensus       162 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~-~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        162 LPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHE-NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            99995 6999999888889999999999999999999998 999999999999999999999999999987543221 22


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCch----hhHHHHHHH--------------
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW----TSFYELMEA--------------  287 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~----~~~~~~~~~--------------  287 (362)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|..||...+..++.    .....+...              
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~  319 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA  319 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence            34467999999999999999999999999999999999999887543321110    000011110              


Q ss_pred             --------HhcCCC-CCC------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          288 --------IVDQPP-PSA------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       288 --------~~~~~~-~~~------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                              ...... .+.      ....++.++.+||.+||++||++|||++|+++||||+...
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence                    000000 000      0013466899999999999999999999999999998764

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.6e-48  Score=362.36  Aligned_cols=265  Identities=25%  Similarity=0.386  Sum_probs=212.4

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEec-----CeEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAIS  144 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~-----~~~~  144 (362)
                      +|++.+.||+|+||.||++++..+|+.||||+++... .......+.+|+.+++.++||||+++++++...     ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5889999999999999999999999999999987432 223445688999999999999999999887543     3589


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      +||||+. ++|.+++.....+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++.......
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHT-ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            9999995 6999999988899999999999999999999998 9999999999999999999999999999876532221


Q ss_pred             ---CCCccccCCcccCcceecC--CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhH------------------
Q 018018          225 ---QANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF------------------  281 (362)
Q Consensus       225 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~------------------  281 (362)
                         ......||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.+.......+                  
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence               1234578999999999876  67899999999999999999999999764321110000                  


Q ss_pred             --HHHHHHHhcCCCC--CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          282 --YELMEAIVDQPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       282 --~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                        .............  ......+++.+.++|.+||+.||++|||++|+++||||+....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~  298 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK  298 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence              0001111111100  0112346788999999999999999999999999999987654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.3e-47  Score=356.38  Aligned_cols=251  Identities=29%  Similarity=0.515  Sum_probs=212.8

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhc-CCCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~-l~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||.||++++..+++.||+|+++...  ..........|..++.. ++||||+++++.+.+.+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999997652  12233455667777665 5899999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccC
Q 018018          153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  232 (362)
Q Consensus       153 gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt  232 (362)
                      |+|.+++.....+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++..............||
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHS-KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT  159 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence            9999999988889999999999999999999998 999999999999999999999999999987543333334456799


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018018          233 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  312 (362)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  312 (362)
                      +.|+|||++.+..++.++||||+||++|+|++|..||.+.+.       .+....+....+  ..+..++.++.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (316)
T cd05619         160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-------EELFQSIRMDNP--CYPRWLTREAKDILVKL  230 (316)
T ss_pred             ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC--CCCccCCHHHHHHHHHH
Confidence            999999999999999999999999999999999999976432       233333332222  23346889999999999


Q ss_pred             hhcCcCCCCCHH-HHHcCCcccccC
Q 018018          313 VQKEPQQRLSAQ-ELMTHPFLKMYG  336 (362)
Q Consensus       313 L~~dP~~Rpt~~-eil~hp~~~~~~  336 (362)
                      |+.||++||++. ++++||||+...
T Consensus       231 l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         231 FVREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             hccCHhhcCCChHHHHcCcccCCCC
Confidence            999999999996 999999998865

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.5e-48  Score=361.66  Aligned_cols=259  Identities=27%  Similarity=0.494  Sum_probs=218.8

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++|++.+.||+|+||.||++++..+|+.||+|+++...  .......+.+|+.+++.++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47899999999999999999999999999999997652  2345567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC-C
Q 018018          148 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-Q  225 (362)
Q Consensus       148 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~-~  225 (362)
                      ||+++++|.+++... ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++........ .
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ-MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            999999999999876 689999999999999999999998 9999999999999999999999999999976643322 1


Q ss_pred             CCccccCCcccCcceec------CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCC
Q 018018          226 ANTFVGTYNYMSPERIS------GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAP  297 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  297 (362)
                      .....||+.|+|||++.      +..++.++|||||||++|+|++|..||...+..       .....+....  ...+.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~  232 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA-------KTYNNIMNFQRFLKFPE  232 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH-------HHHHHHHcCCCccCCCC
Confidence            23347899999999986      456789999999999999999999999764332       2222332221  11122


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ...+++++.+||.+||+ +|++|||+++++.||||+..+.
T Consensus       233 ~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~  271 (330)
T cd05601         233 DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDW  271 (330)
T ss_pred             CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCH
Confidence            23578999999999998 9999999999999999987654

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3e-49  Score=338.67  Aligned_cols=257  Identities=27%  Similarity=0.501  Sum_probs=224.0

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-------chHHHHHHHHHHHHHhcC-CCCcceEEeeeEEec
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-------EESARRQIAQELKINQSS-QCPYVVVCYQSFYSN  140 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~  140 (362)
                      ...|+-.+.||.|..++|..+.++.+|+.+|+|++....       ....+..-.+|+.+++++ .||+|+++.+.|+.+
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            367888899999999999999999999999999986431       123345567899998875 699999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          141 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ...++|+|.|+.|.|++++.+.-.+++...+.+++|+++|++|||. ++||||||||+|||++++.++||+|||+|..+.
T Consensus        96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa-~~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHA-RNIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHH-hhhhhcccChhheeeccccceEEeccceeeccC
Confidence            9999999999999999999999999999999999999999999998 999999999999999999999999999998875


Q ss_pred             cCCCCCCccccCCcccCcceecC------CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--
Q 018018          221 STSGQANTFVGTYNYMSPERISG------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--  292 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--  292 (362)
                       ++......||||.|.|||.+..      ..|+..+|+||+|+++|.|+.|.+||....       ..-+++.+..+.  
T Consensus       175 -~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------QmlMLR~ImeGkyq  246 (411)
T KOG0599|consen  175 -PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QMLMLRMIMEGKYQ  246 (411)
T ss_pred             -CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HHHHHHHHHhcccc
Confidence             4556777899999999998743      457889999999999999999999997632       234455555554  


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          293 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       293 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      ..++.+..++...++||++||+.||.+|+|++|+|.||||..
T Consensus       247 F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  247 FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence            345567789999999999999999999999999999999943

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.2e-47  Score=350.73  Aligned_cols=254  Identities=28%  Similarity=0.481  Sum_probs=213.8

Q ss_pred             eeeeCCeEEEEEEEccCCcEEEEEEeecccc--hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCCH
Q 018018           78 VGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  155 (362)
Q Consensus        78 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL  155 (362)
                      ||+|+||+||++.+..+++.||+|++.....  ......+..|+.+++.++|+||+.+.+.+......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            6999999999999999999999999875422  22345678899999999999999999999999999999999999999


Q ss_pred             HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcccc
Q 018018          156 ADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG  231 (362)
Q Consensus       156 ~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~g  231 (362)
                      ..++..    ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++.++|+|||++..............|
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g  159 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ-RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG  159 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence            988743    3568999999999999999999998 99999999999999999999999999998776544444455678


Q ss_pred             CCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 018018          232 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA  311 (362)
Q Consensus       232 t~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  311 (362)
                      ++.|+|||.+.+..++.++|+||+||++|+|++|+.||........   .......+....  ...+..+++.+.+++.+
T Consensus       160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~~~li~~  234 (280)
T cd05608         160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRILNDS--VTYPDKFSPASKSFCEA  234 (280)
T ss_pred             CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh---HHHHHHhhcccC--CCCcccCCHHHHHHHHH
Confidence            9999999999999999999999999999999999999976443211   122222332222  23345689999999999


Q ss_pred             hhhcCcCCCC-----CHHHHHcCCcccccCC
Q 018018          312 CVQKEPQQRL-----SAQELMTHPFLKMYGD  337 (362)
Q Consensus       312 ~L~~dP~~Rp-----t~~eil~hp~~~~~~~  337 (362)
                      ||+.||++||     |++++++||||+....
T Consensus       235 ~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~  265 (280)
T cd05608         235 LLAKDPEKRLGFRDGNCDGLRTHPLFRDLNW  265 (280)
T ss_pred             HhcCCHHHhcCCCCCCHHHHhcChhhhcCCH
Confidence            9999999999     8899999999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.1e-47  Score=364.17  Aligned_cols=261  Identities=30%  Similarity=0.528  Sum_probs=217.7

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      ....++|++.+.||+|+||.||++++..+++.+|+|++...  ........+.+|+.+++.++||||+++++.+.++..+
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            45668999999999999999999999999999999998653  2223345678899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|.......
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~-~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHS-MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG  196 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence            999999999999999976 468999999999999999999998 999999999999999999999999999998764322


Q ss_pred             C-CCCccccCCcccCcceecCCC----CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCC
Q 018018          224 G-QANTFVGTYNYMSPERISGGK----YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSA  296 (362)
Q Consensus       224 ~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~  296 (362)
                      . .....+||+.|+|||++.+..    ++.++||||+||++|+|++|..||.+.+.       ......+....  ...+
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~p  269 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-------VGTYSKIMDHKNSLNFP  269 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCcccCCC
Confidence            2 234567999999999987643    78899999999999999999999976432       12333333322  1122


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCC--CCCHHHHHcCCccccc
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMY  335 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~--Rpt~~eil~hp~~~~~  335 (362)
                      ....++..+.+++..||+.++.+  |+|++|+++||||+..
T Consensus       270 ~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         270 EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            22357899999999999865544  8999999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.3e-48  Score=374.10  Aligned_cols=278  Identities=24%  Similarity=0.390  Sum_probs=217.5

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec------
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------  140 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~------  140 (362)
                      ....+|++.+.||+|+||.||++.+..+++.||||++....     ....+|+.+++.++||||+++++++...      
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            34578999999999999999999999999999999886432     1234699999999999999998876432      


Q ss_pred             --CeEEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC-cEEEeec
Q 018018          141 --GAISIILEYMDGGSLADFLK----KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDF  213 (362)
Q Consensus       141 --~~~~lV~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-~vkl~DF  213 (362)
                        ..+++||||+++ +|.+++.    ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+||
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~-~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS-KFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCcCHHHEEEcCCCCceeeecc
Confidence              247799999975 7877764    34679999999999999999999998 9999999999999998665 7999999


Q ss_pred             cCCcccccCCCCCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc--
Q 018018          214 GVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD--  290 (362)
Q Consensus       214 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--  290 (362)
                      |+|+..... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+..   ...+.....  
T Consensus       216 Gla~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~---~~i~~~~~~p~  291 (440)
T PTZ00036        216 GSAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQL---VRIIQVLGTPT  291 (440)
T ss_pred             ccchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCC
Confidence            999876432 233456789999999998764 6899999999999999999999999875433211   111111100  


Q ss_pred             -------------CCCC--------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHHHh
Q 018018          291 -------------QPPP--------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA  349 (362)
Q Consensus       291 -------------~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~~~  349 (362)
                                   ...+        ...+...++++.+||.+||++||++|||+.|++.||||+...+....++.+.   
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~~~~~~~~~---  368 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYI---  368 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcccccCCCCC---
Confidence                         0000        0112356789999999999999999999999999999998887766666543   


Q ss_pred             CCCccccccC
Q 018018          350 GSPLATLSNL  359 (362)
Q Consensus       350 ~~~~~~~~~~  359 (362)
                       ..+++++++
T Consensus       369 -~~~~~~~~~  377 (440)
T PTZ00036        369 -DKLPDLFNF  377 (440)
T ss_pred             -CCCCCCcCC
Confidence             344445544

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.1e-47  Score=354.19  Aligned_cols=256  Identities=28%  Similarity=0.508  Sum_probs=218.1

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeEEEEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +|+..+.||+|+||.||+|++..+|+.||+|+++...  .......+..|..++..+. |++|+.+++.+.+.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4778899999999999999999999999999997542  2334456778888887776 577888999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      ||+++|+|.+++.....+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++..........
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~  159 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHR-RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR  159 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence            999999999999988899999999999999999999998 9999999999999999999999999999876543333344


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  307 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (362)
                      ...||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.       ......+.....  ..+..+++++.+
T Consensus       160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-------~~~~~~i~~~~~--~~p~~~~~~~~~  230 (323)
T cd05615         160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-------DELFQSIMEHNV--SYPKSLSKEAVS  230 (323)
T ss_pred             CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCC--CCCccCCHHHHH
Confidence            56799999999999999999999999999999999999999976432       233334433332  233568899999


Q ss_pred             HHHHhhhcCcCCCCC-----HHHHHcCCcccccC
Q 018018          308 FISACVQKEPQQRLS-----AQELMTHPFLKMYG  336 (362)
Q Consensus       308 li~~~L~~dP~~Rpt-----~~eil~hp~~~~~~  336 (362)
                      ++.+||+.+|++|++     .+++++||||+...
T Consensus       231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~  264 (323)
T cd05615         231 ICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID  264 (323)
T ss_pred             HHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence            999999999999997     57999999998764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-47  Score=357.00  Aligned_cols=251  Identities=32%  Similarity=0.521  Sum_probs=215.2

Q ss_pred             eeeeeeCCeEEEEEEE---ccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccC
Q 018018           76 KVVGKGSGGIVQLVQH---KWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD  151 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~  151 (362)
                      +.||+|+||.||++++   ..+|+.||+|+++... .......+..|+++++.++||||+++++.+.+.+.+|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999986   3578999999997642 22334567789999999999999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcccc
Q 018018          152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG  231 (362)
Q Consensus       152 ~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~g  231 (362)
                      +++|.+++.....+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++..............|
T Consensus        82 ~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  160 (318)
T cd05582          82 GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG  160 (318)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence            99999999888889999999999999999999998 99999999999999999999999999998876544334455689


Q ss_pred             CCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 018018          232 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA  311 (362)
Q Consensus       232 t~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  311 (362)
                      ++.|+|||.+.+..++.++|||||||++|+|++|+.||...+.       ......+.....  ..+..+++.+.+||++
T Consensus       161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~-------~~~~~~i~~~~~--~~p~~~~~~~~~li~~  231 (318)
T cd05582         161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR-------KETMTMILKAKL--GMPQFLSPEAQSLLRA  231 (318)
T ss_pred             ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH-------HHHHHHHHcCCC--CCCCCCCHHHHHHHHH
Confidence            9999999999998899999999999999999999999976432       223333333322  2345688999999999


Q ss_pred             hhhcCcCCCCC-----HHHHHcCCcccccC
Q 018018          312 CVQKEPQQRLS-----AQELMTHPFLKMYG  336 (362)
Q Consensus       312 ~L~~dP~~Rpt-----~~eil~hp~~~~~~  336 (362)
                      ||+.||++||+     +++++.||||+...
T Consensus       232 ~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         232 LFKRNPANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhCCCCcCCCC
Confidence            99999999999     77899999998764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2e-47  Score=362.77  Aligned_cols=263  Identities=29%  Similarity=0.509  Sum_probs=219.2

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ...+..++|++.+.||+|+||.||++++..+++.||+|++...  ........+.+|+.+++.++||||+++++.+.++.
T Consensus        37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (371)
T cd05622          37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR  116 (371)
T ss_pred             hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            4456679999999999999999999999999999999998653  22334456788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ..++||||+++|+|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++.....
T Consensus       117 ~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~  194 (371)
T cd05622         117 YLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  194 (371)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence            99999999999999999976 468999999999999999999998 9999999999999999999999999999987643


Q ss_pred             CCC-CCCccccCCcccCcceecCCC----CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CC
Q 018018          222 TSG-QANTFVGTYNYMSPERISGGK----YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PP  294 (362)
Q Consensus       222 ~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~  294 (362)
                      ... .....+||+.|+|||++.+..    ++.++|||||||++|+|++|..||.+.+.       ......+....  ..
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~  267 (371)
T cd05622         195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-------VGTYSKIMNHKNSLT  267 (371)
T ss_pred             CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCccc
Confidence            222 234567999999999987643    78999999999999999999999986433       22333333322  22


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCcCC--CCCHHHHHcCCccccc
Q 018018          295 SAPSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMY  335 (362)
Q Consensus       295 ~~~~~~~~~~~~~li~~~L~~dP~~--Rpt~~eil~hp~~~~~  335 (362)
                      .+....++..+.++|.+||+.++.+  |++++++++|+||++.
T Consensus       268 ~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         268 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            2233468999999999999844433  7899999999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.3e-47  Score=356.14  Aligned_cols=251  Identities=31%  Similarity=0.528  Sum_probs=212.8

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHH-HHhcCCCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELK-INQSSQCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~-~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||.||++++..+|+.||+|++....  .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999987542  2233445555555 46779999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccC
Q 018018          153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  232 (362)
Q Consensus       153 gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt  232 (362)
                      |+|..++.....+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++............+||
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHS-INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence            9999999988899999999999999999999998 999999999999999999999999999987644333444556899


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018018          233 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  312 (362)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  312 (362)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+.       .+....+.....  ......+..+.++|++|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-------~~~~~~~~~~~~--~~~~~~~~~~~~ll~~l  230 (325)
T cd05604         160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-------AEMYDNILHKPL--VLRPGASLTAWSILEEL  230 (325)
T ss_pred             hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-------HHHHHHHHcCCc--cCCCCCCHHHHHHHHHH
Confidence            999999999999999999999999999999999999976432       233344443332  22345789999999999


Q ss_pred             hhcCcCCCCCH----HHHHcCCcccccC
Q 018018          313 VQKEPQQRLSA----QELMTHPFLKMYG  336 (362)
Q Consensus       313 L~~dP~~Rpt~----~eil~hp~~~~~~  336 (362)
                      |+.+|++||++    .+++.||||+...
T Consensus       231 l~~~p~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         231 LEKDRQRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             hccCHHhcCCCCCCHHHHhcCCCcCCCC
Confidence            99999999977    5999999998653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-47  Score=357.58  Aligned_cols=254  Identities=26%  Similarity=0.405  Sum_probs=216.9

Q ss_pred             CCCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           62 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        62 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ...+++..+.+..++.||+|-||.|+++... ....||+|.++..  ......+.+|+++|++|+|++||++++++..++
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~--~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~  274 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG--SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE  274 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEecc--ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence            4456677788889999999999999999875 2348999998754  222356779999999999999999999999988


Q ss_pred             eEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          142 AISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      .+||||||++.|+|.++|+.  +..+.......++.|||+|++||++ +++|||||..+||||+++..+||+|||+|+..
T Consensus       275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes-~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~  353 (468)
T KOG0197|consen  275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES-KNYIHRDLAARNILVDEDLVVKISDFGLARLI  353 (468)
T ss_pred             ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh-CCccchhhhhhheeeccCceEEEccccccccc
Confidence            99999999999999999987  5679999999999999999999998 99999999999999999999999999999955


Q ss_pred             ccCCCC-CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          220 ASTSGQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       220 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      .+.... ....--+..|.|||++..+.++.+||||||||+||||+| |+.||...+       ..++++.+..+...+ .
T Consensus       354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-------n~ev~~~le~GyRlp-~  425 (468)
T KOG0197|consen  354 GDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-------NEEVLELLERGYRLP-R  425 (468)
T ss_pred             CCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-------HHHHHHHHhccCcCC-C
Confidence            433321 222334679999999999999999999999999999999 999998754       346666666665433 3


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELM  327 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil  327 (362)
                      +..+|+++.+++..||..+|++|||++.+.
T Consensus       426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  426 PEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence            467999999999999999999999999664

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-47  Score=345.77  Aligned_cols=259  Identities=26%  Similarity=0.461  Sum_probs=217.8

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .|++.+.||+|+||.||++.+..+++.||+|++....  .......+.+|+.+++.++||||+.+++.+.++...++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4788999999999999999999999999999987542  22234557789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          149 YMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       149 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++....... ..
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~  158 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR-ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TI  158 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-cc
Confidence            99999999988653  468999999999999999999998 999999999999999999999999999987653222 22


Q ss_pred             CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018018          227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  306 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (362)
                      ...+|++.|+|||++.+..++.++||||+||++|+|++|..||.+.+......   .+...+....  ...+..+++.+.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~--~~~~~~~~~~~~  233 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE---EVERRVKEDQ--EEYSEKFSEAAR  233 (285)
T ss_pred             ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH---HHHHHhhhcc--cccCcccCHHHH
Confidence            34578999999999999899999999999999999999999998754432221   2222222221  223456889999


Q ss_pred             HHHHHhhhcCcCCCC-----CHHHHHcCCcccccC
Q 018018          307 SFISACVQKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       307 ~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      +||.+||+.||++||     +++++++||||...+
T Consensus       234 ~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05605         234 SICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN  268 (285)
T ss_pred             HHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence            999999999999999     999999999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.5e-47  Score=371.72  Aligned_cols=274  Identities=23%  Similarity=0.376  Sum_probs=210.6

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC------CCcceEEeeeEEec-C
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ------CPYVVVCYQSFYSN-G  141 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~------hp~I~~~~~~~~~~-~  141 (362)
                      .++|++.+.||+|+||+||++.+..+++.||||+++..  .........|+.+++.++      |.+++.+++++... .
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~  205 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV--PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG  205 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc--hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence            47899999999999999999999999999999998643  122233445555555543      45688888887654 5


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC---------------
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---------------  206 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~---------------  206 (362)
                      .+++||+++ +++|.+++...+.+++..+..++.|++.||+|||++.||+||||||+|||++.++               
T Consensus       206 ~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~  284 (467)
T PTZ00284        206 HMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP  284 (467)
T ss_pred             eEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence            789999998 6799999988889999999999999999999999735999999999999998765               


Q ss_pred             -cEEEeeccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH
Q 018018          207 -EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM  285 (362)
Q Consensus       207 -~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  285 (362)
                       .+||+|||.+....   ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+....
T Consensus       285 ~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~  361 (467)
T PTZ00284        285 CRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTL  361 (467)
T ss_pred             ceEEECCCCccccCc---cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHc
Confidence             49999999875432   23345689999999999999999999999999999999999999997654322111111100


Q ss_pred             H----------------HHhcC---CCCCC--------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          286 E----------------AIVDQ---PPPSA--------------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       286 ~----------------~~~~~---~~~~~--------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      .                .+...   ..+..              ......+.+.+||.+||++||++|||++|+|+||||
T Consensus       362 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~  441 (467)
T PTZ00284        362 GRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV  441 (467)
T ss_pred             CCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccc
Confidence            0                00000   00000              000124567899999999999999999999999999


Q ss_pred             cccCCCCCCHHHHHHH
Q 018018          333 KMYGDLNVDLSEYFTD  348 (362)
Q Consensus       333 ~~~~~~~~~l~~~~~~  348 (362)
                      +.+-......++|+.+
T Consensus       442 ~~~~~~~~~~~~~~~~  457 (467)
T PTZ00284        442 LKYYPECRQHPNYPDN  457 (467)
T ss_pred             cccCCccccCCCCCCc
Confidence            9988777777777654

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=6.1e-47  Score=352.73  Aligned_cols=251  Identities=30%  Similarity=0.508  Sum_probs=212.2

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHH-HHhcCCCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELK-INQSSQCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~-~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||.||++++..+++.||+|++....  .......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999999999999987542  2223344555554 57889999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccC
Q 018018          153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  232 (362)
Q Consensus       153 gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt  232 (362)
                      ++|...+.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++............+||
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHS-LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence            9999999888889999999999999999999998 999999999999999999999999999987643333344556799


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018018          233 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  312 (362)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  312 (362)
                      +.|+|||++.+..++.++|||||||++|+|++|..||...+.       ......+.....  ..+...+..+.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (321)
T cd05603         160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-------SQMYDNILHKPL--QLPGGKTVAACDLLVGL  230 (321)
T ss_pred             cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-------HHHHHHHhcCCC--CCCCCCCHHHHHHHHHH
Confidence            999999999998999999999999999999999999976432       233444444332  23356788999999999


Q ss_pred             hhcCcCCCCCH----HHHHcCCcccccC
Q 018018          313 VQKEPQQRLSA----QELMTHPFLKMYG  336 (362)
Q Consensus       313 L~~dP~~Rpt~----~eil~hp~~~~~~  336 (362)
                      |+.||++||++    .++++|+||....
T Consensus       231 l~~~p~~R~~~~~~~~~~~~~~~~~~~~  258 (321)
T cd05603         231 LHKDQRRRLGAKADFLEIKNHVFFSPIN  258 (321)
T ss_pred             ccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence            99999999975    5999999998654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.7e-47  Score=354.09  Aligned_cols=251  Identities=30%  Similarity=0.520  Sum_probs=211.7

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHH-HHhcCCCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELK-INQSSQCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~-~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||+||++++..+++.||+|++....  .......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999999999999999987542  1222334444444 56788999999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccC
Q 018018          153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  232 (362)
Q Consensus       153 gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt  232 (362)
                      ++|.+++.....+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++............+||
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence            9999999988889999999999999999999998 999999999999999999999999999987654444445566899


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018018          233 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  312 (362)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  312 (362)
                      +.|+|||++.+..++.++|||||||++|+|++|..||.+.+.       .+....+.....  .....+++.+.++|.+|
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~~--~~~~~~~~~~~~li~~~  230 (325)
T cd05602         160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEMYDNILNKPL--QLKPNITNSARHLLEGL  230 (325)
T ss_pred             ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-------HHHHHHHHhCCc--CCCCCCCHHHHHHHHHH
Confidence            999999999999999999999999999999999999976432       223333333322  23346889999999999


Q ss_pred             hhcCcCCCCCHH----HHHcCCcccccC
Q 018018          313 VQKEPQQRLSAQ----ELMTHPFLKMYG  336 (362)
Q Consensus       313 L~~dP~~Rpt~~----eil~hp~~~~~~  336 (362)
                      |+.||++|+++.    ++++|+||....
T Consensus       231 l~~~p~~R~~~~~~~~~i~~~~~~~~~~  258 (325)
T cd05602         231 LQKDRTKRLGAKDDFMEIKNHIFFSPIN  258 (325)
T ss_pred             cccCHHHCCCCCCCHHHHhcCcccCCCC
Confidence            999999999876    899999997654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.4e-47  Score=352.14  Aligned_cols=273  Identities=26%  Similarity=0.462  Sum_probs=221.0

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ..++|++.+.||+|+||.||++++..+++.||+|.++..........+.+|+.+++.++||||+++++.+......++||
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence            46889999999999999999999999999999999876544444556778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          148 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       148 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      ||++ ++|.+++... ..+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||++..........
T Consensus        84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (301)
T cd07873          84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR-RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY  161 (301)
T ss_pred             eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence            9997 5999888653 568999999999999999999998 999999999999999999999999999987654333333


Q ss_pred             CccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH--------HHHhc------C
Q 018018          227 NTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM--------EAIVD------Q  291 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~~------~  291 (362)
                      ....+++.|+|||.+.+. .++.++|||||||++|+|++|++||...+..+....+....        .....      .
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (301)
T cd07873         162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY  241 (301)
T ss_pred             cccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccc
Confidence            445678999999998764 47889999999999999999999998654321111111000        00000      0


Q ss_pred             CCC-------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCH
Q 018018          292 PPP-------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL  342 (362)
Q Consensus       292 ~~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l  342 (362)
                      ..+       ......+++++.+||.+||+.||++|||++|+++||||+..++.--.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~~~  299 (301)
T cd07873         242 NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKL  299 (301)
T ss_pred             ccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhhcC
Confidence            000       011235788999999999999999999999999999999998765444

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-46  Score=337.60  Aligned_cols=255  Identities=31%  Similarity=0.503  Sum_probs=218.8

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc----hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE----ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      +.|++.+.||+|++|.||.+.+..+++.+|+|.+.....    ......+.+|+.+++.++||||+++++.+.++...++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            568899999999999999999999999999999875421    2234568899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      |+||+++++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||+++........
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            99999999999999988889999999999999999999998 99999999999999999999999999998765432211


Q ss_pred             C---CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018018          226 A---NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  302 (362)
Q Consensus       226 ~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (362)
                      .   ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||.+.+..       ...............+..++
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~  233 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-------AAIFKIATQPTNPQLPSHVS  233 (263)
T ss_pred             cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-------HHHHHHhccCCCCCCCccCC
Confidence            1   2346788999999999988999999999999999999999999764321       22223333333344556789


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      ..+.++|.+||+.+|++|||+.++++||||
T Consensus       234 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         234 PDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.2e-47  Score=358.05  Aligned_cols=265  Identities=25%  Similarity=0.436  Sum_probs=212.6

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec------
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------  140 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~------  140 (362)
                      ..++|++.+.||+|+||.||++.+..+|..||+|++... ........+.+|+.+++.++||||+++++++...      
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            358999999999999999999999999999999998754 2334456788999999999999999999988644      


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          141 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ...|+||||+.+ +|.+.+..  .+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++...
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~-~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence            357999999975 67776643  58999999999999999999998 999999999999999999999999999987643


Q ss_pred             cCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH---------------HH
Q 018018          221 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---------------LM  285 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~---------------~~  285 (362)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.....               ..
T Consensus       175 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         175 TN-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             cC-ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            22 223445789999999999999999999999999999999999999987654322211111               00


Q ss_pred             HHHhcCCCC------------------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          286 EAIVDQPPP------------------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       286 ~~~~~~~~~------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      .......+.                  .......++++.+||.+||+.||++|||+.|+++||||+.+-+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  323 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD  323 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence            111111000                  0011224678999999999999999999999999999987654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.3e-47  Score=349.09  Aligned_cols=257  Identities=24%  Similarity=0.431  Sum_probs=203.5

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEcc-CCcEEEEEEeecccc-hHHHHHHHHHHHHHhc---CCCCcceEEeeeEE-----e
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKW-TGQFFALKVIQMNVE-ESARRQIAQELKINQS---SQCPYVVVCYQSFY-----S  139 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~---l~hp~I~~~~~~~~-----~  139 (362)
                      ++|++.+.||+|+||.||+|++.. ++..||+|+++.... ......+.+|+.+++.   ++||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            478999999999999999999854 468899999875422 2223345566666655   47999999999875     3


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          140 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      ...+++||||+. ++|.+++...  ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            456899999996 5999999753  458999999999999999999998 999999999999999999999999999987


Q ss_pred             ccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC----
Q 018018          218 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP----  293 (362)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----  293 (362)
                      ..... .......|++.|+|||++.+..++.++||||+||++|||++|.+||.+.+..+..   ..+.........    
T Consensus       159 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~---~~i~~~~~~~~~~~~~  234 (290)
T cd07862         159 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGEEDWP  234 (290)
T ss_pred             eccCC-cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHHhCCCChhhch
Confidence            65433 2334567899999999999989999999999999999999999999875432211   111111100000    


Q ss_pred             -----------------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          294 -----------------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       294 -----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                                       .......+++.+.+|+.+||+.||++|||+.|+++||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                             000113467888999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-46  Score=351.91  Aligned_cols=259  Identities=25%  Similarity=0.477  Sum_probs=214.1

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++|++.+.||+|+||.||++++..+++.||+|++...  ........+.+|..++..++|+||+.+++.+.+.+.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4799999999999999999999999999999998753  22334556788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC-C
Q 018018          148 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-Q  225 (362)
Q Consensus       148 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~-~  225 (362)
                      ||+++|+|.+++.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++........ .
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ-LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            99999999999976 4679999999999999999999998 9999999999999999999999999999876543322 2


Q ss_pred             CCccccCCcccCcceecC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC---CCCCC
Q 018018          226 ANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP---PPSAP  297 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  297 (362)
                      ....+||+.|+|||++.+     ..++.++||||+||++|+|++|+.||.+.+..       +....+....   ..+..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~-------~~~~~i~~~~~~~~~~~~  232 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-------ETYGKIMNHKEHFQFPPD  232 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH-------HHHHHHHcCCCcccCCCc
Confidence            223569999999999873     45788999999999999999999999764321       2222332211   11222


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCC--CCCHHHHHcCCcccccC
Q 018018          298 SDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYG  336 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~--Rpt~~eil~hp~~~~~~  336 (362)
                      ...+++.+.++|++||..++++  |++++++++||||....
T Consensus       233 ~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~  273 (331)
T cd05597         233 VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID  273 (331)
T ss_pred             cCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence            2457899999999999764443  88999999999998764

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=4.7e-47  Score=341.80  Aligned_cols=256  Identities=39%  Similarity=0.665  Sum_probs=215.4

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHH-HHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEecc
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA-RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  150 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~  150 (362)
                      |++.+.||+|+||+||++++..+++.||+|++........ .....+|+.+++.++||||+++++.+......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            7889999999999999999999999999999987743333 334567999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccc
Q 018018          151 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV  230 (362)
Q Consensus       151 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~  230 (362)
                      .+++|.+++.....+++..+..++.|++.||++||+ +|++|+||||+||+++.++.++|+|||.+..............
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~-~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHS-KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHH-TTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999988999999999999999999999998 9999999999999999999999999999876433334455667


Q ss_pred             cCCcccCcceec-CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC--CCCCCCHHHHH
Q 018018          231 GTYNYMSPERIS-GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFSPEFCS  307 (362)
Q Consensus       231 gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  307 (362)
                      ++..|+|||++. +..++.++|+||||+++|+|++|..||......    .................  .....++.+.+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD----DQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH----HHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccch----hhhhhhhhcccccccccccccchhHHHHHH
Confidence            899999999998 788999999999999999999999999875211    12222222221111111  11122389999


Q ss_pred             HHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          308 FISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       308 li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      +|.+||+.||++|||+.++++||||
T Consensus       236 li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCCCC
Confidence            9999999999999999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-47  Score=356.65  Aligned_cols=250  Identities=29%  Similarity=0.481  Sum_probs=209.2

Q ss_pred             eeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcC---CCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           78 VGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS---QCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        78 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l---~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      ||+|+||+||++++..+++.||+|++....  ..........|..++...   +||||+.++..+.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999999999999999986531  222333445566666554   699999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccC
Q 018018          153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  232 (362)
Q Consensus       153 gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt  232 (362)
                      |+|..++.....+++..+..++.|++.||+|||+ +||+||||||+|||++.++.++|+|||++.............+||
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~-~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  159 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHK-YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT  159 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence            9999999988899999999999999999999998 999999999999999999999999999987654444444567899


Q ss_pred             CcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 018018          233 YNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA  311 (362)
Q Consensus       233 ~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  311 (362)
                      +.|+|||++.+. .++.++|||||||++|+|++|..||...+.       .+....+...... .....+++++.++|.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~-~~~~~~~~~~~~li~~  231 (330)
T cd05586         160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-------QQMYRNIAFGKVR-FPKNVLSDEGRQFVKG  231 (330)
T ss_pred             ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-------HHHHHHHHcCCCC-CCCccCCHHHHHHHHH
Confidence            999999998765 489999999999999999999999976432       2333444333322 2234578999999999


Q ss_pred             hhhcCcCCCC----CHHHHHcCCcccccC
Q 018018          312 CVQKEPQQRL----SAQELMTHPFLKMYG  336 (362)
Q Consensus       312 ~L~~dP~~Rp----t~~eil~hp~~~~~~  336 (362)
                      ||+.||++||    +++++++||||+...
T Consensus       232 ~L~~~P~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         232 LLNRNPQHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             HcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence            9999999998    799999999998654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-46  Score=342.21  Aligned_cols=270  Identities=40%  Similarity=0.729  Sum_probs=228.5

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      ++|++++.||+|+||.||++.+..++..||+|.++..........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            47889999999999999999999999999999987665555667889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          150 MDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       150 ~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      +++++|..++...   ..+++..+..++.|++.||.|||+..|++|+||||+||+++.++.++|+|||++......  ..
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~  158 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LA  158 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--cc
Confidence            9999999998763   379999999999999999999996469999999999999999999999999998765322  23


Q ss_pred             CccccCCcccCcceecCC------CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          227 NTFVGTYNYMSPERISGG------KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      ....++..|+|||.+.+.      .++.++|+||+||++|+|++|..||.....    .........+.....+ ..+..
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~-~~~~~  233 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY----ANIFAQLSAIVDGDPP-TLPSG  233 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch----hhHHHHHHHHhhcCCC-CCCcc
Confidence            344678899999998654      358899999999999999999999975432    1222233333333332 33445


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHH
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF  346 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~  346 (362)
                      +++++.++|.+||+.+|++||++++++.||||..+.....++..+.
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~~~~~~~~~  279 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWV  279 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCCccchHHHH
Confidence            8999999999999999999999999999999999998888777764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.7e-46  Score=352.02  Aligned_cols=256  Identities=26%  Similarity=0.405  Sum_probs=209.3

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEc-----cCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEE
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFY  138 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~  138 (362)
                      +++..++|++.+.||+|+||.||++.+.     .++..||+|+++..........+.+|+.++..+ +||||+++++.+.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            3456689999999999999999999752     345689999997655555567789999999998 8999999999877


Q ss_pred             ec-CeEEEEEeccCCCCHHHHHHHc-------------------------------------------------------
Q 018018          139 SN-GAISIILEYMDGGSLADFLKKV-------------------------------------------------------  162 (362)
Q Consensus       139 ~~-~~~~lV~e~~~~gsL~~~l~~~-------------------------------------------------------  162 (362)
                      .. ..+++||||+++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            54 4689999999999999999652                                                       


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC--CCCccccCC
Q 018018          163 -------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTY  233 (362)
Q Consensus       163 -------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~  233 (362)
                             .++++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++.......  ......++.
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                   247788899999999999999998 9999999999999999999999999999976532221  112234567


Q ss_pred             cccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018018          234 NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  312 (362)
Q Consensus       234 ~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  312 (362)
                      .|+|||++.+..++.++|||||||++|||++ |..||.+....+      .....+..+.. ...+..+++.+.+|+.+|
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~-~~~~~~~~~~l~~li~~c  313 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTR-MRAPENATPEIYRIMLAC  313 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCC-CCCCCCCCHHHHHHHHHH
Confidence            8999999999999999999999999999997 999997643321      22223333322 223457889999999999


Q ss_pred             hhcCcCCCCCHHHHHc
Q 018018          313 VQKEPQQRLSAQELMT  328 (362)
Q Consensus       313 L~~dP~~Rpt~~eil~  328 (362)
                      |+.||++|||+.|+++
T Consensus       314 l~~dp~~RPs~~el~~  329 (338)
T cd05102         314 WQGDPKERPTFSALVE  329 (338)
T ss_pred             ccCChhhCcCHHHHHH
Confidence            9999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.4e-46  Score=366.00  Aligned_cols=262  Identities=29%  Similarity=0.457  Sum_probs=221.9

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC-----
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-----  141 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~-----  141 (362)
                      ..++|.+.+.||+|+||+||++++..+|+.||||++... ........+.+|+.++..++|+||++++..+....     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            447999999999999999999999999999999998765 34455667889999999999999999987765332     


Q ss_pred             ---eEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeecc
Q 018018          142 ---AISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG  214 (362)
Q Consensus       142 ---~~~lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg  214 (362)
                         .+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~-~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS-KHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEeCCCCEEEEecc
Confidence               378999999999999998653    468999999999999999999998 999999999999999999999999999


Q ss_pred             CCcccccCC--CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          215 VSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       215 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                      +++......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+       ..+.+.......
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-------~~~~~~~~~~~~  261 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-------MEEVMHKTLAGR  261 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHhcCC
Confidence            987654321  22345679999999999999999999999999999999999999997632       234444444443


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          293 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       293 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      .. ..+..+++++.+++.+||+.||++||++.++++|||++.+...
T Consensus       262 ~~-~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~~  306 (496)
T PTZ00283        262 YD-PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISG  306 (496)
T ss_pred             CC-CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhhh
Confidence            32 2346789999999999999999999999999999999876543

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-46  Score=339.86  Aligned_cols=261  Identities=40%  Similarity=0.637  Sum_probs=226.4

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      ++|++.+.||.|++|.||++.+..+++.+|+|++...........+.+|+.+++.++|+||+++++.+.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888999999999999999999999999999987665455566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      +++++|.+++... ++++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||+++............
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (274)
T cd06609          81 CGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHE-EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF  158 (274)
T ss_pred             eCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccc
Confidence            9999999999875 89999999999999999999998 999999999999999999999999999998876544444556


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  309 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  309 (362)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..       .....+.....+......+++++.+++
T Consensus       159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l  231 (274)
T cd06609         159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-------RVLFLIPKNNPPSLEGNKFSKPFKDFV  231 (274)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-------HHHHHhhhcCCCCCcccccCHHHHHHH
Confidence            7888999999999988999999999999999999999999764321       222233333333332233889999999


Q ss_pred             HHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          310 SACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                      .+||+.+|++|||++++++||||+..++.+
T Consensus       232 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~  261 (274)
T cd06609         232 SLCLNKDPKERPSAKELLKHKFIKKAKKTS  261 (274)
T ss_pred             HHHhhCChhhCcCHHHHhhChhhcCCCccc
Confidence            999999999999999999999999988774

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.5e-47  Score=360.71  Aligned_cols=259  Identities=28%  Similarity=0.476  Sum_probs=214.1

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-C-----CcceEEeeeEEecCeE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-C-----PYVVVCYQSFYSNGAI  143 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h-----p~I~~~~~~~~~~~~~  143 (362)
                      .+|++++.||+|+||.|.+|.+..+++.||||+++.  .....++...|+.++..++ |     -|+|+++++|...+++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN--~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl  263 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN--KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL  263 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeecc--ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence            468999999999999999999999999999999974  3556677888999998887 3     5799999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC--CcEEEeeccCCccc
Q 018018          144 SIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIM  219 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~vkl~DFg~a~~~  219 (362)
                      |||+|.+. .+|.++++.+  ..++...++.++.||+.||..||+ .||||+||||+|||+...  ..|||+|||.|...
T Consensus       264 ciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~-l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  264 CIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE-LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99999995 5999999875  468999999999999999999998 999999999999999754  37999999998775


Q ss_pred             ccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHH------------
Q 018018          220 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA------------  287 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~------------  287 (362)
                      ..   ...+++.+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.++.+....+.+++..            
T Consensus       342 ~q---~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~  418 (586)
T KOG0667|consen  342 SQ---RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKA  418 (586)
T ss_pred             CC---cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcccc
Confidence            43   234889999999999999999999999999999999999999999887665544444333210            


Q ss_pred             -----------------------------------HhcCCCCCC-------CCCCCCHHHHHHHHHhhhcCcCCCCCHHH
Q 018018          288 -----------------------------------IVDQPPPSA-------PSDQFSPEFCSFISACVQKEPQQRLSAQE  325 (362)
Q Consensus       288 -----------------------------------~~~~~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  325 (362)
                                                         ......|+.       ........+.++|.+||++||.+|+|+.+
T Consensus       419 ~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~q  498 (586)
T KOG0667|consen  419 HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQ  498 (586)
T ss_pred             ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHH
Confidence                                               000000000       00011235789999999999999999999


Q ss_pred             HHcCCccccc
Q 018018          326 LMTHPFLKMY  335 (362)
Q Consensus       326 il~hp~~~~~  335 (362)
                      +|+||||...
T Consensus       499 al~Hpfl~~~  508 (586)
T KOG0667|consen  499 ALNHPFLTGT  508 (586)
T ss_pred             HhcCcccccc
Confidence            9999999843

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.5e-46  Score=339.75  Aligned_cols=264  Identities=49%  Similarity=0.903  Sum_probs=227.5

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      ++|+..+.||+|++|.||++.+..+++.+|+|.+...........+.+|+++++.++||||+++++.+......++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36788899999999999999999999999999998776566777889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          150 MDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       150 ~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      +++++|.+++... ..+++..+..++.|++.||+|||+..|++|+||+|+||+++.++.++|+|||.+........  ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~  158 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--KT  158 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--hc
Confidence            9999999999876 78999999999999999999999647999999999999999999999999999876543222  22


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018018          229 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  308 (362)
Q Consensus       229 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  308 (362)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..  ................+......+++++.++
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (265)
T cd06605         159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP--PDGIFELLQYIVNEPPPRLPSGKFSPDFQDF  236 (265)
T ss_pred             ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc--cccHHHHHHHHhcCCCCCCChhhcCHHHHHH
Confidence            67888999999999999999999999999999999999999764321  1223344555555544443333488999999


Q ss_pred             HHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          309 ISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      |.+||..||++|||+.+++.||||+.|+.
T Consensus       237 i~~~l~~~p~~Rpt~~~ll~~~~~~~~~~  265 (265)
T cd06605         237 VNLCLIKDPRERPSYKELLEHPFIKKYES  265 (265)
T ss_pred             HHHHcCCCchhCcCHHHHhhCchhhcccC
Confidence            99999999999999999999999998863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.9e-46  Score=356.35  Aligned_cols=263  Identities=25%  Similarity=0.398  Sum_probs=213.6

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC-----eEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-----AIS  144 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~-----~~~  144 (362)
                      +|++.+.||+|+||.||++.+..+|+.||||++... ........+.+|+.+++.++|+||+++++.+....     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999999999999999998654 23344567889999999999999999999988766     789


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      +|+||+. ++|.+++.....+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+++.......
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS-AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            9999996 5899999888889999999999999999999998 9999999999999999999999999999876543221


Q ss_pred             -CCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH----------------HHH
Q 018018          225 -QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE----------------LME  286 (362)
Q Consensus       225 -~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~----------------~~~  286 (362)
                       ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+.+..+....+..                ...
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence             22335678999999999874 479999999999999999999999987543221111110                000


Q ss_pred             HHhcCCC-CC------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          287 AIVDQPP-PS------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       287 ~~~~~~~-~~------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      .+..... ++      ......++++.+||.+||+.||++|||+.|+++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence            1111111 10      1223457899999999999999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4.4e-46  Score=348.55  Aligned_cols=259  Identities=25%  Similarity=0.473  Sum_probs=214.9

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++|++.+.||+|+||.||++++..+++.+|+|++...  ........+..|+.++..++|++|+.+++.+.+...+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            4789999999999999999999999999999998643  12233455788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC-C
Q 018018          148 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-Q  225 (362)
Q Consensus       148 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~-~  225 (362)
                      ||+++|+|.+++.+ ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++........ .
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~-~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence            99999999999976 4679999999999999999999998 9999999999999999999999999999876533222 2


Q ss_pred             CCccccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC---CCCC
Q 018018          226 ANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP---PSAP  297 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  297 (362)
                      ....+||+.|+|||++.     ...++.++|||||||++|||++|+.||...+.       .+....+.....   .+..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~p~~  232 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHKERFQFPAQ  232 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH-------HHHHHHHhCCCccccCCCc
Confidence            23457999999999986     34588999999999999999999999976432       233333333221   1222


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCC--CCCHHHHHcCCcccccC
Q 018018          298 SDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYG  336 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~--Rpt~~eil~hp~~~~~~  336 (362)
                      ...+++++.+||++||..++++  |++++++++||||++..
T Consensus       233 ~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~  273 (332)
T cd05623         233 VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID  273 (332)
T ss_pred             cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence            3467999999999999765544  68999999999998754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-48  Score=382.92  Aligned_cols=265  Identities=29%  Similarity=0.513  Sum_probs=228.1

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      .+..++|+++++||+|+||.|.+++++.+++.||+|++++-  .....-..|..|.++|..-+.+.|+.++.+|+++.++
T Consensus        71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~L  150 (1317)
T KOG0612|consen   71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYL  150 (1317)
T ss_pred             hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccce
Confidence            45679999999999999999999999999999999998752  1233346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc-C
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-T  222 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~-~  222 (362)
                      |+||||++||+|..++.+..+++++.++.++..|+.||..||+ .|.|||||||+|||+|..|++||+|||.|-.+.. .
T Consensus       151 YlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG  229 (1317)
T KOG0612|consen  151 YLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG  229 (1317)
T ss_pred             EEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecccCcEeeccchhHHhcCCCC
Confidence            9999999999999999998899999999999999999999998 9999999999999999999999999998877763 3


Q ss_pred             CCCCCccccCCcccCcceecC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CC
Q 018018          223 SGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PS  295 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~  295 (362)
                      .-.....+|||.|++||++..     +.|+..+|+||+||++|||+.|..||...       ...+...++..-..  ..
T Consensus       230 ~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad-------slveTY~KIm~hk~~l~F  302 (1317)
T KOG0612|consen  230 TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD-------SLVETYGKIMNHKESLSF  302 (1317)
T ss_pred             cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH-------HHHHHHHHHhchhhhcCC
Confidence            335667899999999999853     56899999999999999999999999873       33344444433311  11


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCC---HHHHHcCCcccccCCCC
Q 018018          296 APSDQFSPEFCSFISACVQKEPQQRLS---AQELMTHPFLKMYGDLN  339 (362)
Q Consensus       296 ~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~~~~~~  339 (362)
                      +....+|+++++||+++++ +|+.|..   ++++..||||.+.++.+
T Consensus       303 P~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~  348 (1317)
T KOG0612|consen  303 PDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDN  348 (1317)
T ss_pred             CcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhh
Confidence            1224599999999999887 6778998   99999999999998833

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-46  Score=341.37  Aligned_cols=275  Identities=43%  Similarity=0.747  Sum_probs=229.9

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      +..++|++.+.||+|+||+||++.+..+|+.||+|++...........+.+|+++++.++||||+++++.+......++|
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   81 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC   81 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence            34578999999999999999999999999999999987665566678899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+..+++|+||+|+||+++.++.++|+|||++......  ..
T Consensus        82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~~  159 (284)
T cd06620          82 MEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--IA  159 (284)
T ss_pred             EecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--cc
Confidence            9999999999999888889999999999999999999996468999999999999999999999999998654322  22


Q ss_pred             CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccC----CchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018018          227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ----DGWTSFYELMEAIVDQPPPSAPSDQFS  302 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (362)
                      ....|+..|+|||++.+..++.++|+||+||++|+|++|..||......    .....+......+.....+......++
T Consensus       160 ~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd06620         160 DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFP  239 (284)
T ss_pred             CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcC
Confidence            3457899999999998889999999999999999999999999865432    111222334444444333333333478


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc-CCCCCCHH
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMY-GDLNVDLS  343 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~-~~~~~~l~  343 (362)
                      ..+.+|+.+||+.||++|||+.|+++|+||... .+..+++.
T Consensus       240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~~~~~~  281 (284)
T cd06620         240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRASNVDLQ  281 (284)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccccCCcc
Confidence            899999999999999999999999999988543 33444443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2e-46  Score=343.45  Aligned_cols=256  Identities=25%  Similarity=0.445  Sum_probs=202.8

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-hHHHHHHHHHHHHHhc---CCCCcceEEeeeEEe-----cC
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQS---SQCPYVVVCYQSFYS-----NG  141 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~---l~hp~I~~~~~~~~~-----~~  141 (362)
                      +|++.+.||+|+||.||+++++.+++.||+|+++.... ......+.+|+.+++.   ++||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            58899999999999999999999999999999875422 1122334456665554   479999999998764     34


Q ss_pred             eEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          142 AISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      ..++||||+.+ +|.+++...  ..+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            58999999975 899988764  358999999999999999999998 99999999999999999999999999998765


Q ss_pred             ccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-------
Q 018018          220 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-------  292 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------  292 (362)
                      ... .......++..|+|||++.+..++.++||||+||++|+|++|.+||......+...   ..........       
T Consensus       159 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         159 SCQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG---KIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             cCc-ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH---HHHHHhCCCChhhCccc
Confidence            432 22334578999999999999899999999999999999999999997654322111   1111110000       


Q ss_pred             -------C-------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          293 -------P-------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       293 -------~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                             .       .......++..+.+||.+||+.||++|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence                   0       000113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-47  Score=351.50  Aligned_cols=257  Identities=29%  Similarity=0.502  Sum_probs=227.3

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .-|.+.+.||+|.|++|.+|++.-+|..||||++.+. .+.....++.+|++.|+..+||||+++|++...+..+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            5578889999999999999999999999999999876 455567889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEE-ccCCcEEEeeccCCcccccCCCCC
Q 018018          149 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI-NHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       149 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll-~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      .-.+|+|++||-++ ..+.++.++++++||+.|+.|+|+ ..+|||||||+|+++ ..-|-|||.|||++..+. ++...
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-PG~kL  175 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-PGKKL  175 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccccccCC-Ccchh
Confidence            99999999999654 679999999999999999999998 999999999999877 456899999999987764 55677


Q ss_pred             CccccCCcccCcceecCCCCC-ccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          227 NTFVGTYNYMSPERISGGKYG-YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      .+.||+..|.|||++.|..|+ +++|||||||+||-|++|++||...+..+..       ..+.+-+  ...+..++.++
T Consensus       176 ~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL-------TmImDCK--YtvPshvS~eC  246 (864)
T KOG4717|consen  176 TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL-------TMIMDCK--YTVPSHVSKEC  246 (864)
T ss_pred             hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh-------hhhhccc--ccCchhhhHHH
Confidence            889999999999999999996 5789999999999999999999876654433       2332222  23456889999


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          306 CSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ++||..||..||++|.+.++|..|+|++..+.
T Consensus       247 rdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  247 RDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             HHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence            99999999999999999999999999998875

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.7e-46  Score=339.03  Aligned_cols=253  Identities=25%  Similarity=0.442  Sum_probs=209.8

Q ss_pred             eeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCCH
Q 018018           78 VGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  155 (362)
Q Consensus        78 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL  155 (362)
                      ||+|+||.||+++++.+|+.||+|++....  .......+..|+++++.++||||+++++.+......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999999999999999986532  122344556799999999999999999999999999999999999999


Q ss_pred             HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCC
Q 018018          156 ADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY  233 (362)
Q Consensus       156 ~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~  233 (362)
                      .+++...  ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++|+|||++....... ......|+.
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~  158 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS-MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTN  158 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH-CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCC
Confidence            9988654  358999999999999999999998 999999999999999999999999999987654322 223456899


Q ss_pred             cccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhh
Q 018018          234 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV  313 (362)
Q Consensus       234 ~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  313 (362)
                      .|+|||++.+..++.++|+||+||++|+|++|..||.......   ....+.........+. ....+++++.+||.+||
T Consensus       159 ~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L  234 (277)
T cd05607         159 GYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV---AKEELKRRTLEDEVKF-EHQNFTEESKDICRLFL  234 (277)
T ss_pred             CccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh---hHHHHHHHhhcccccc-ccccCCHHHHHHHHHHh
Confidence            9999999999899999999999999999999999997643221   1123333333322222 23468999999999999


Q ss_pred             hcCcCCCCCH----HHHHcCCcccccC
Q 018018          314 QKEPQQRLSA----QELMTHPFLKMYG  336 (362)
Q Consensus       314 ~~dP~~Rpt~----~eil~hp~~~~~~  336 (362)
                      +.||++||++    ++++.||||+.+.
T Consensus       235 ~~~P~~R~~~~~~~~~~~~h~~f~~~~  261 (277)
T cd05607         235 AKKPEDRLGSREKNDDPRKHEFFKTIN  261 (277)
T ss_pred             ccCHhhCCCCccchhhhhcChhhcCCC
Confidence            9999999999    7788999998753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-45  Score=361.88  Aligned_cols=257  Identities=25%  Similarity=0.386  Sum_probs=219.1

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccC-CcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWT-GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ...|.+.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+++.++||||+++++.+...+..|+||
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence            45699999999999999999998877 788999987544 3444566788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          148 EYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       148 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ||+++|+|.+++..    ..++++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++......
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS-RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            99999999988754    3568999999999999999999998 999999999999999999999999999998764322


Q ss_pred             C--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          224 G--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       224 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.       .+.+..+..+... ..+..+
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-------~~~~~~~~~~~~~-~~~~~~  295 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-------REIMQQVLYGKYD-PFPCPV  295 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCC-CCCccC
Confidence            1  23446799999999999999999999999999999999999999976432       2344444433332 233568


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      ++++.++|.+||+.||++||++++++.|+|++..
T Consensus       296 s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~  329 (478)
T PTZ00267        296 SSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV  329 (478)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence            8999999999999999999999999999998653

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=8.1e-46  Score=339.45  Aligned_cols=258  Identities=27%  Similarity=0.480  Sum_probs=215.6

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .|+..+.||+|+||.||++.+..+++.||+|.+....  .......+..|+.+++.++|++|+.+++.+.+....++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3678899999999999999999999999999986542  22334567789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          149 YMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       149 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++....... ..
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~  158 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ-ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TI  158 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-cc
Confidence            99999999998643  368999999999999999999998 999999999999999999999999999987653222 22


Q ss_pred             CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018018          227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  306 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (362)
                      ....|+..|+|||.+.+..++.++||||+||++|+|++|..||...................     +......+++++.
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~  233 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV-----QEEYSEKFSPDAR  233 (285)
T ss_pred             cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhh-----hhhcCccCCHHHH
Confidence            34578999999999999999999999999999999999999998654322111111111111     1123456889999


Q ss_pred             HHHHHhhhcCcCCCCC-----HHHHHcCCccccc
Q 018018          307 SFISACVQKEPQQRLS-----AQELMTHPFLKMY  335 (362)
Q Consensus       307 ~li~~~L~~dP~~Rpt-----~~eil~hp~~~~~  335 (362)
                      +|+.+||+.||++|||     ++|+++||||+..
T Consensus       234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         234 SLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            9999999999999999     9999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.9e-46  Score=354.24  Aligned_cols=265  Identities=25%  Similarity=0.426  Sum_probs=212.6

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec------
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------  140 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~------  140 (362)
                      ..++|++.+.||+|+||.||++.+..+++.||+|++... ........+.+|+.+++.++||||+++++.+...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            458999999999999999999999999999999998754 2344456778999999999999999999987643      


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          141 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ...++||||+++ ++.+.+..  .+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++...
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~-~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence            357999999965 77777754  58999999999999999999998 999999999999999999999999999997654


Q ss_pred             cCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH---------------HH
Q 018018          221 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---------------LM  285 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~---------------~~  285 (362)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.....               ..
T Consensus       171 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         171 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             Cc-cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence            32 223456789999999999999999999999999999999999999987543222111110               00


Q ss_pred             HHHhcCCC------------------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          286 EAIVDQPP------------------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       286 ~~~~~~~~------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      .......+                  ........+.++.+||.+||+.||++|||+.|+++||||+.+.+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~  319 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD  319 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence            00000000                  00111234567899999999999999999999999999987643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3e-46  Score=354.07  Aligned_cols=266  Identities=25%  Similarity=0.422  Sum_probs=213.0

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec------
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------  140 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~------  140 (362)
                      ..++|.+.+.||+|+||.||++.+..+++.||||++... ........+.+|+.+++.++||||+.+++.+...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            358999999999999999999999999999999998754 2334456788999999999999999999877543      


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          141 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ...|+||||+++ +|.+++..  .+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence            457999999965 78887754  58899999999999999999998 999999999999999999999999999997654


Q ss_pred             cCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH---------------H
Q 018018          221 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL---------------M  285 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~---------------~  285 (362)
                      .. .......+|..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+...               .
T Consensus       178 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (364)
T cd07875         178 TS-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  256 (364)
T ss_pred             CC-CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence            32 2234467899999999999999999999999999999999999999875543222111110               0


Q ss_pred             HHHhcCCC------------------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          286 EAIVDQPP------------------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       286 ~~~~~~~~------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      .......+                  ........+.++.+||.+||+.||++|||++|+++||||..+.+.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  327 (364)
T cd07875         257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP  327 (364)
T ss_pred             HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCc
Confidence            00000000                  000112235678999999999999999999999999999876543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.6e-46  Score=349.05  Aligned_cols=259  Identities=25%  Similarity=0.492  Sum_probs=215.1

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++|++.+.||+|+||.||++++..+++.||+|++...  ........+.+|..++..++|++|+.+++.+.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4799999999999999999999999999999998753  22333455788899999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC-C
Q 018018          148 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-Q  225 (362)
Q Consensus       148 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~-~  225 (362)
                      ||++||+|.+++.. ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++........ .
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~-~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ-LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence            99999999999987 4689999999999999999999998 9999999999999999999999999999876543322 2


Q ss_pred             CCccccCCcccCcceecC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC---CCCC
Q 018018          226 ANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP---PSAP  297 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  297 (362)
                      ....+|++.|+|||++.+     +.++.++||||+||++|+|++|+.||...+.       .+....+.....   .+..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~p~~  232 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-------VETYGKIMNHEERFQFPSH  232 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-------HHHHHHHHcCCCcccCCCc
Confidence            233579999999999876     4678999999999999999999999976432       122333332211   1122


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCC--CCCHHHHHcCCcccccC
Q 018018          298 SDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYG  336 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~--Rpt~~eil~hp~~~~~~  336 (362)
                      ...+++++.++|.+||+.++++  |++++++++||||+...
T Consensus       233 ~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~  273 (331)
T cd05624         233 ITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGID  273 (331)
T ss_pred             cccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCC
Confidence            2457899999999999876654  56999999999998754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-45  Score=351.47  Aligned_cols=267  Identities=19%  Similarity=0.305  Sum_probs=216.4

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEc--cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ...+|.+++.||+|+||.||++...  .++..||+|.+...      ....+|+++++.++||||+++++.+......++
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l  163 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM  163 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence            3467999999999999999999764  35678999987643      234579999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC-
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-  224 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~-  224 (362)
                      |||++. ++|.+++.....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.++|+|||++........ 
T Consensus       164 v~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~-~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        164 VMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG-RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             EehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence            999996 5999999877899999999999999999999998 9999999999999999999999999999876543322 


Q ss_pred             -CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC------------
Q 018018          225 -QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ------------  291 (362)
Q Consensus       225 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~------------  291 (362)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............+...+...            
T Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~  321 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL  321 (392)
T ss_pred             ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhH
Confidence             2234579999999999999999999999999999999999999997754432222222222211100            


Q ss_pred             ----------CCC-CC-----CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCH
Q 018018          292 ----------PPP-SA-----PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL  342 (362)
Q Consensus       292 ----------~~~-~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l  342 (362)
                                ..+ ..     ....++.++.++|++||+.||++|||+.|++.||||+..+...+.+
T Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~~~  388 (392)
T PHA03207        322 CKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLLNI  388 (392)
T ss_pred             HHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhhcC
Confidence                      000 00     0123567889999999999999999999999999998876655544

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.6e-45  Score=329.90  Aligned_cols=253  Identities=34%  Similarity=0.615  Sum_probs=220.2

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +|.+.+.||+|++|.||++.+..+++.|++|.+... ........+.+|+++++.++||||+++++.+.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            578889999999999999999999999999998754 3445567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          150 MDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       150 ~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS-KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            9999999999764  578999999999999999999998 9999999999999999999999999999887655444444


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  307 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (362)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+.       ......+.....+. ....++..+.+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~~  231 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-------GALILKIIRGVFPP-VSQMYSQQLAQ  231 (256)
T ss_pred             ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCC-CccccCHHHHH
Confidence            55788999999999999999999999999999999999999976442       23334444443332 33468899999


Q ss_pred             HHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          308 FISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       308 li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      ++.+||+.+|++||++.++++|||+
T Consensus       232 ~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         232 LIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHccCCcccCcCHHHHhhCCCC
Confidence            9999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.5e-45  Score=328.68  Aligned_cols=253  Identities=31%  Similarity=0.586  Sum_probs=216.2

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe-cCeEEEEEe
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS-NGAISIILE  148 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~-~~~~~lV~e  148 (362)
                      +|++.+.||+|++|.||++++..+++.+|+|.+... ........+.+|+++++.++|+|++++++.+.. +..+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            588999999999999999999999999999998754 234456678899999999999999999988764 456899999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          149 YMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       149 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      |+++++|.+++...  ..+++.+++.++.|++.||++||+ +|++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~-~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE-KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence            99999999999763  468999999999999999999998 999999999999999999999999999998765444444


Q ss_pred             CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018018          227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  306 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (362)
                      ....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.       ......+.....+ ..+..+++++.
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~  231 (257)
T cd08223         160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-------NSLVYRIIEGKLP-PMPKDYSPELG  231 (257)
T ss_pred             ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhcCCC-CCccccCHHHH
Confidence            556789999999999999999999999999999999999999975332       1223333333332 23456889999


Q ss_pred             HHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          307 SFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       307 ~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      +++.+||+.||++|||+.++++||||
T Consensus       232 ~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         232 ELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHHhccCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.3e-45  Score=338.30  Aligned_cols=261  Identities=30%  Similarity=0.568  Sum_probs=221.3

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      ..+|++.+.||+|+||.||++.+..+++.||+|.+...... ....+.+|+.+++.++|+||+++++.+......++|||
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            36899999999999999999999999999999998765333 34668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      |+++++|.+++.. ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++............
T Consensus        98 ~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~-~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  175 (296)
T cd06654          98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (296)
T ss_pred             ccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence            9999999999865 568999999999999999999998 99999999999999999999999999998765433333344


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018018          229 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  308 (362)
Q Consensus       229 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  308 (362)
                      ..+++.|+|||.+.+..++.++|+||+||++|+|++|+.||...+...      ..........++...+..+++.+.++
T Consensus       176 ~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~l  249 (296)
T cd06654         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGTPELQNPEKLSAIFRDF  249 (296)
T ss_pred             ccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCCCCCCCCccccCHHHHHH
Confidence            578899999999998889999999999999999999999997654321      11111122222222345688999999


Q ss_pred             HHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          309 ISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      |.+||..||++|||+.+++.||||......
T Consensus       250 i~~~l~~~p~~Rpt~~eil~~~~~~~~~~~  279 (296)
T cd06654         250 LNRCLDMDVEKRGSAKELLQHQFLKIAKPL  279 (296)
T ss_pred             HHHHCcCCcccCcCHHHHhhChhhhccCCc
Confidence            999999999999999999999999876553

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3e-45  Score=336.58  Aligned_cols=262  Identities=33%  Similarity=0.566  Sum_probs=220.3

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .+.|++++.||.|+||.||++++..+++.+|+|++... +......+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            46799999999999999999999999999999998754 34456778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          149 YMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       149 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      |+++++|..++.+ ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++...........
T Consensus        90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS-MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc-CCeeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence            9999999988754 4678999999999999999999998 9999999999999999999999999999876544333344


Q ss_pred             ccccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-CCCCCCCC
Q 018018          228 TFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQF  301 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  301 (362)
                      ...+++.|+|||.+.     ...++.++|+|||||++|+|++|..||...+..       ........... ....+..+
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~  241 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSEPPTLSQPSKW  241 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-------HHHHHHhcCCCccCCCCccc
Confidence            557889999999985     345788999999999999999999999764321       22222222222 22234567


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                      +.++.++|.+||+.||++||+++++++||||+......
T Consensus       242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  279 (292)
T cd06644         242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR  279 (292)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence            88999999999999999999999999999998776544

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-47  Score=328.07  Aligned_cols=258  Identities=29%  Similarity=0.419  Sum_probs=216.7

Q ss_pred             ccCceee-eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHH-HhcCCCCcceEEeeeEEe----cCe
Q 018018           69 LEDIDTI-KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYS----NGA  142 (362)
Q Consensus        69 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-~~~l~hp~I~~~~~~~~~----~~~  142 (362)
                      .++|.+- ++||-|-.|+|..|.++.+|+.+|+|++...      ....+|+++ +....||||+.++++|.+    ...
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            4666654 6799999999999999999999999998643      233455554 345579999999998764    466


Q ss_pred             EEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc---CCcEEEeeccCCc
Q 018018          143 ISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVSA  217 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---~~~vkl~DFg~a~  217 (362)
                      +.+|||.++||.|++.++.++.  +++.++..|++||+.|+.|||+ .+|+||||||+|+|.+.   |..+||+|||+|+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~-~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK  212 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS-MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK  212 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh-cchhhccCChhheeeecCCCCcceEeccccccc
Confidence            8899999999999999988754  9999999999999999999998 99999999999999974   4579999999998


Q ss_pred             ccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc--CCCCC
Q 018018          218 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD--QPPPS  295 (362)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~  295 (362)
                      .... .....+.|-|+.|.|||++...+|+..+|+||+||++|-|++|.+||........-   -.+..++..  ...|.
T Consensus       213 ~t~~-~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais---pgMk~rI~~gqy~FP~  288 (400)
T KOG0604|consen  213 ETQE-PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKRRIRTGQYEFPE  288 (400)
T ss_pred             ccCC-CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC---hhHHhHhhccCccCCC
Confidence            7654 34566778999999999999999999999999999999999999999875542211   123344433  34566


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       296 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      +.+..+|+..+++|+.+|..+|++|.|+++++.|||+..+..
T Consensus       289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence            677889999999999999999999999999999999987764

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=2.7e-45  Score=334.98  Aligned_cols=270  Identities=39%  Similarity=0.737  Sum_probs=221.5

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHH-HhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      ++|++.+.||+|+||.||++.+..+|..||+|+++..........+..|+.+ ++.++||||+++++.+..++..++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            4789999999999999999999999999999999876444444556666664 566789999999999999999999999


Q ss_pred             ccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC-CeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          149 YMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       149 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~-~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      |++ ++|.+++..    ...+++..++.++.|++.||+|||+ + +++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS-KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            996 588888754    2468999999999999999999998 6 99999999999999999999999999987654322


Q ss_pred             CCCCccccCCcccCcceecC----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          224 GQANTFVGTYNYMSPERISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                       ......++..|+|||.+.+    ..++.++|+||+||++|+|++|+.||......     . +..........+.....
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~-~~~~~~~~~~~~~~~~~  231 (283)
T cd06617         159 -AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-----F-QQLKQVVEEPSPQLPAE  231 (283)
T ss_pred             -ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-----H-HHHHHHHhcCCCCCCcc
Confidence             1223467889999999865    44688999999999999999999999643211     1 11222233333333345


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHHH
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD  348 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~~  348 (362)
                      .++.++.++|.+||+.+|++|||+++++.||||+.....+.+++.+.+.
T Consensus       232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~  280 (283)
T cd06617         232 KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVASFVSL  280 (283)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccccHHHHHHHHh
Confidence            6889999999999999999999999999999999999888888876654

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-45  Score=334.44  Aligned_cols=256  Identities=30%  Similarity=0.526  Sum_probs=215.4

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ..++|.+.+.||+|+||.||++.+..+++.||+|+++.... .....+.+|+.+++.++||||+++++.+...+..++||
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~   85 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICM   85 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEE
Confidence            44689999999999999999999999999999999876533 33455788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++...........
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645          86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS-KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            999999999999988899999999999999999999998 9999999999999999999999999999876654433344


Q ss_pred             ccccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC--CCCCCC
Q 018018          228 TFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFS  302 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~  302 (362)
                      ...|+..|+|||.+.   ...++.++|+|||||++|+|++|..||.......      ...........++.  ....++
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR------ALFLMTKSNFQPPKLKDKMKWS  238 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh------hHHhhhccCCCCCcccccCCCC
Confidence            567899999999874   4568899999999999999999999996543211      11111111111111  122577


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCc
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPF  331 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~  331 (362)
                      ..+.++|.+||+.+|++|||++++++|||
T Consensus       239 ~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         239 NSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            89999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.6e-45  Score=335.27  Aligned_cols=260  Identities=32%  Similarity=0.569  Sum_probs=217.6

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEecc
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  150 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~  150 (362)
                      -|++.+.||+|+||.||++.+..++..+++|.+... .......+.+|+.+++.++||||+++++.+......++|+||+
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC-CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            367889999999999999999999999999998654 3345567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          151 DGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       151 ~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      ++++|..++.. ..++++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.............
T Consensus        85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~-~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE-NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence            99999998865 4679999999999999999999998 999999999999999999999999999987654433334456


Q ss_pred             ccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          230 VGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       230 ~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      .++..|+|||.+.     +..++.++|+||+||++|+|++|..||...+..      ................+..++.+
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  237 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEPPTLAQPSRWSSE  237 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHHhhcCCCCCCCccccCHH
Confidence            7899999999984     345788999999999999999999999764321      11122211222222234567899


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          305 FCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      +.++|.+||+.||++|||++++++||||+.....
T Consensus       238 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~  271 (282)
T cd06643         238 FKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNK  271 (282)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCCCEeccCCC
Confidence            9999999999999999999999999999876543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.9e-45  Score=338.94  Aligned_cols=262  Identities=31%  Similarity=0.579  Sum_probs=222.1

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      .+|++.+.||+|+||.||++.+..+++.||+|.+...... ....+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            7899999999999999999999999999999998755332 345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      +++++|.+++.+ ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++.............
T Consensus        98 ~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~-~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~  175 (297)
T cd06656          98 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  175 (297)
T ss_pred             cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcc
Confidence            999999999875 568999999999999999999998 999999999999999999999999999987654433333445


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  309 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  309 (362)
                      .+++.|+|||.+.+..++.++|+||+||++|+|++|..||...+....      .........++...+..++..+.+++
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li  249 (297)
T cd06656         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNGTPELQNPERLSAVFRDFL  249 (297)
T ss_pred             cCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh------eeeeccCCCCCCCCccccCHHHHHHH
Confidence            788999999999998899999999999999999999999976543211      11111112222223456788999999


Q ss_pred             HHhhhcCcCCCCCHHHHHcCCcccccCCCCC
Q 018018          310 SACVQKEPQQRLSAQELMTHPFLKMYGDLNV  340 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~  340 (362)
                      .+||+.||++||+++++++||||+.......
T Consensus       250 ~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (297)
T cd06656         250 NRCLEMDVDRRGSAKELLQHPFLKLAKPLSS  280 (297)
T ss_pred             HHHccCChhhCcCHHHHhcCchhcccccccc
Confidence            9999999999999999999999987766544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-49  Score=341.27  Aligned_cols=257  Identities=35%  Similarity=0.613  Sum_probs=227.3

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +-|.++.+||+|+||.||++.++++|+.+|||.+...   ....++..|+.+++.++.|+++++|+.+.....+++||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            6688999999999999999999999999999998754   4467899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          150 MDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       150 ~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      |..|++.+.++. .++++++++..+++..+.||+|||. ..-+|||||..|||++.+|.+||+|||.|-.+.+.-...++
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~-~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHD-LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHH-HHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            999999999964 5789999999999999999999998 88999999999999999999999999999887766666788


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018018          229 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  308 (362)
Q Consensus       229 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  308 (362)
                      ..||+.|||||++..-.|+.++||||||++..||..|++||.+..+..      .++..-...++....+..++.++.++
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR------AIFMIPT~PPPTF~KPE~WS~~F~DF  262 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR------AIFMIPTKPPPTFKKPEEWSSEFNDF  262 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc------eeEeccCCCCCCCCChHhhhhHHHHH
Confidence            899999999999999999999999999999999999999998754321      11111122223333456678899999


Q ss_pred             HHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          309 ISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      +++||-++|++|-|+.++++|||+++..
T Consensus       263 i~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  263 IRSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             HHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence            9999999999999999999999998875

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-45  Score=336.87  Aligned_cols=260  Identities=35%  Similarity=0.626  Sum_probs=221.1

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .++|++.+.||.|+||.||++.+..++..+|+|++... .......+.+|+.+++.++||||+++++.+..+...++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            36799999999999999999999989999999998754 34455678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          149 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       149 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      |+++++|.+++... ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++...........
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS-HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD  161 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence            99999999999764 579999999999999999999998 9999999999999999999999999999876544443444


Q ss_pred             ccccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC-CCCCCCC
Q 018018          228 TFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQF  301 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  301 (362)
                      ...+++.|+|||.+.     ...++.++|+||+|+++|+|++|..||...+..       .....+.....+ ...+..+
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~  234 (280)
T cd06611         162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM-------RVLLKILKSEPPTLDQPSKW  234 (280)
T ss_pred             eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH-------HHHHHHhcCCCCCcCCcccC
Confidence            567899999999975     345788999999999999999999999764321       222333333222 2234567


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      +.++.++|.+||+.+|++||+++++++||||....+
T Consensus       235 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (280)
T cd06611         235 SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD  270 (280)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence            899999999999999999999999999999998854

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.7e-45  Score=329.47  Aligned_cols=263  Identities=60%  Similarity=1.042  Sum_probs=229.2

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      ++|++.+.||+|++|.||++++..+++.||+|++...........+.+|+..+..++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36889999999999999999999999999999988765545677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      +++++|.+++.....+++..+..++.|++.|++|||+..|++|+||+|+||+++.++.++|+|||.+.............
T Consensus        81 ~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~  160 (264)
T cd06623          81 MDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF  160 (264)
T ss_pred             cCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccce
Confidence            99999999999888999999999999999999999954899999999999999999999999999988765444444456


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  309 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  309 (362)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..    ...+....+.....+......++..+.++|
T Consensus       161 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  236 (264)
T cd06623         161 VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP----SFFELMQAICDGPPPSLPAEEFSPEFRDFI  236 (264)
T ss_pred             eecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc----CHHHHHHHHhcCCCCCCCcccCCHHHHHHH
Confidence            7889999999999988999999999999999999999999776531    223444454444443333333889999999


Q ss_pred             HHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          310 SACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      .+||+.+|++|||+.++++||||+.+.
T Consensus       237 ~~~l~~~p~~R~~~~~ll~~~~~~~~~  263 (264)
T cd06623         237 SACLQKDPKKRPSAAELLQHPFIKKAD  263 (264)
T ss_pred             HHHccCChhhCCCHHHHHhCHHHHhcc
Confidence            999999999999999999999998764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.8e-45  Score=334.99  Aligned_cols=254  Identities=33%  Similarity=0.559  Sum_probs=221.7

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++|++.+.||+|+||.||++.+..+++.+|+|+++...  .......+.+|+++++.++||||+++++.+.+....++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47899999999999999999999999999999987542  2334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      ||+++++|.+++.....+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++.+||+|||++......   ..
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~-~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~  156 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS-LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TY  156 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CC
Confidence            999999999999988899999999999999999999998 99999999999999999999999999998775433   33


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  307 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (362)
                      ...+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.       ......+.....  ..+..+++.+.+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~--~~~~~~~~~l~~  227 (290)
T cd05580         157 TLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-------IQIYEKILEGKV--RFPSFFSPDAKD  227 (290)
T ss_pred             CCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCc--cCCccCCHHHHH
Confidence            45788999999999888899999999999999999999999976442       123333333322  233467899999


Q ss_pred             HHHHhhhcCcCCCC-----CHHHHHcCCcccccC
Q 018018          308 FISACVQKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       308 li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      +|.+||+.||++|+     +++|+++||||+...
T Consensus       228 li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             HHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence            99999999999999     999999999998876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-45  Score=346.56  Aligned_cols=258  Identities=24%  Similarity=0.347  Sum_probs=204.4

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      ....+|.+++.||+|+||.||++++..++..||+|+....       ....|+.+++.++||||+++++.+......++|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            3456799999999999999999999999999999985432       234688899999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          147 LEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      +|++. ++|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++..... ..
T Consensus       136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~  212 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHA-QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-PA  212 (357)
T ss_pred             EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEecCccccccccC-cc
Confidence            99995 588888865 4679999999999999999999998 99999999999999999999999999998754322 22


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCC-CCCCCccCC--ch----hhHHHHHHHHhcCCC--C--
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF-PYSPPEQQD--GW----TSFYELMEAIVDQPP--P--  294 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~-pf~~~~~~~--~~----~~~~~~~~~~~~~~~--~--  294 (362)
                      .....||+.|+|||++.+..++.++|||||||++|||+++.. +|.......  ..    ..+...+......+.  +  
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            344678999999999999999999999999999999998544 444322110  00    011111111110000  0  


Q ss_pred             ------------------------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          295 ------------------------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       295 ------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                                              ......++.++.+||.+||+.||++|||+.|+++||||+.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                                    0011245667788999999999999999999999999986

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.8e-45  Score=336.84  Aligned_cols=259  Identities=32%  Similarity=0.588  Sum_probs=220.7

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      .+|++.+.||.|++|.||++.+..+++.||+|.+..... .....+.+|+.+++.++||||+.+++.+......++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ-PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC-chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            679999999999999999999999999999999875432 2346678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      +++++|..++.. ..+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++.++|+|||++.............
T Consensus        98 ~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~-~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  175 (296)
T cd06655          98 LAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHA-NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM  175 (296)
T ss_pred             cCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCc
Confidence            999999999876 468999999999999999999998 999999999999999999999999999987654433333445


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  309 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  309 (362)
                      .++..|+|||.+.+..++.++|+|||||++|+|++|..||...+...      ...............+..+++.+.++|
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~li  249 (296)
T cd06655         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNGTPELQNPEKLSPIFRDFL  249 (296)
T ss_pred             CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcCCcccCCcccCCHHHHHHH
Confidence            78899999999998889999999999999999999999997654321      111111122222234456889999999


Q ss_pred             HHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          310 SACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ++||..||++|||+.+++.||||+...+
T Consensus       250 ~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         250 NRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             HHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            9999999999999999999999987653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2e-45  Score=333.05  Aligned_cols=258  Identities=31%  Similarity=0.535  Sum_probs=213.8

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ...+|++.+.||+|+||.||++++..+++.||+|++..... .....+.+|+.+++.++||||+++++.+......++||
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            34689999999999999999999999999999999875422 23456788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||++...........
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS-KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence            999999999999888899999999999999999999998 9999999999999999999999999999987644333334


Q ss_pred             ccccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          228 TFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      ...++..|+|||.+.   ...++.++|+||+||++|+|++|..||......+..   ... ...............++..
T Consensus       165 ~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~---~~~-~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---FLM-SKSNFQPPKLKDKTKWSST  240 (267)
T ss_pred             ccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh---eee-ecCCCCCCCCccccccCHH
Confidence            567889999999884   345788999999999999999999999654322110   000 0000011111122357889


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHcCCc
Q 018018          305 FCSFISACVQKEPQQRLSAQELMTHPF  331 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~hp~  331 (362)
                      +.++|++||+.+|++|||++++++|+|
T Consensus       241 ~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         241 FHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.4e-45  Score=337.22  Aligned_cols=260  Identities=25%  Similarity=0.475  Sum_probs=209.6

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +|++.+.||+|++|.||++++..++..||+|+++... .......+.+|+.+++.++||||+++++.+.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            5889999999999999999999999999999987542 233446778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          150 MDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       150 ~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      ++ ++|.+++...   ..+++..++.++.|++.||+|||+ +|++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS-RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence            97 5898888653   468999999999999999999998 999999999999999999999999999987654433333


Q ss_pred             CccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH------------------HHHH
Q 018018          227 NTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE------------------LMEA  287 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~------------------~~~~  287 (362)
                      ....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+.......                  ....
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            344678899999988764 478999999999999999999999976432111000000                  0000


Q ss_pred             Hhc--CCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          288 IVD--QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       288 ~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      ...  ..........+++++.++|.+||+.||++|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            000  000011123578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-47  Score=356.72  Aligned_cols=261  Identities=31%  Similarity=0.556  Sum_probs=227.5

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +-|+++..||.|+||+||+|..+.++-..|.|+|... .++....++-|++|+..++||+|+++++.|..++.++++.||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            5578889999999999999999999989999998644 556677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          150 MDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       150 ~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      |.||-+...+-. ...|++..++.+++|++.||.|||+ ++|+|||||..|||++-+|.++|+|||.+...........+
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs-~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs  189 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS-QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS  189 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh-cchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence            999999888754 5689999999999999999999998 99999999999999999999999999998776666666778


Q ss_pred             cccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          229 FVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       229 ~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                      ++|||+|||||+..     ..+|++++||||||++|.||.-+.+|....+.      +..++..-...++...-+..++.
T Consensus       190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MRVllKiaKSePPTLlqPS~Ws~  263 (1187)
T KOG0579|consen  190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSEPPTLLQPSHWSR  263 (1187)
T ss_pred             ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HHHHHHHhhcCCCcccCcchhhh
Confidence            99999999999864     46799999999999999999999999865332      22233333334444445677899


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      .+.+++.+||.+||+.||+++++++||||++..+.
T Consensus       264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn  298 (1187)
T KOG0579|consen  264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN  298 (1187)
T ss_pred             HHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence            99999999999999999999999999999988764

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-45  Score=338.64  Aligned_cols=265  Identities=31%  Similarity=0.516  Sum_probs=224.4

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch--HHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE--SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++|++.+.||+|++|.||++.+..+++.||+|.+......  .....+..|+++++.++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            4789999999999999999999999999999998765322  35567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC-
Q 018018          148 EYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-  224 (362)
Q Consensus       148 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~-  224 (362)
                      ||+.+++|.+++...  ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL-LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence            999999999999764  578999999999999999999998 9999999999999999999999999998865432111 


Q ss_pred             ----------------------------CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCC
Q 018018          225 ----------------------------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD  276 (362)
Q Consensus       225 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~  276 (362)
                                                  ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.+.+.. 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~-  238 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD-  238 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH-
Confidence                                        112346788999999999988999999999999999999999999765432 


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCC----HHHHHcCCcccccCCCCCCH
Q 018018          277 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS----AQELMTHPFLKMYGDLNVDL  342 (362)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~eil~hp~~~~~~~~~~~l  342 (362)
                            .....+............+++.+.++|.+||+.||++|||    +++++.||||+..+...+.+
T Consensus       239 ------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~  302 (316)
T cd05574         239 ------ETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRH  302 (316)
T ss_pred             ------HHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhccc
Confidence                  2223333333333333347899999999999999999999    99999999999887766666

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.8e-45  Score=336.43  Aligned_cols=262  Identities=28%  Similarity=0.515  Sum_probs=214.3

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      ++|++.+.||+|+||.||++.+..+|+.||+|++.... .....+.+.+|+.+++.++|+||+++++.+......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            47899999999999999999999999999999986542 22334567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      |+++++|..++.....+++..++.++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||++............
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK-HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            99998888888777789999999999999999999998 99999999999999999999999999999876544433445


Q ss_pred             cccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHH-------Hhc------C-CC
Q 018018          229 FVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA-------IVD------Q-PP  293 (362)
Q Consensus       229 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~-------~~~------~-~~  293 (362)
                      ..++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+..+....+......       ...      . ..
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            567889999999876 45789999999999999999999999865432211111110000       000      0 00


Q ss_pred             CC--------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          294 PS--------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       294 ~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      +.        .....++..+.+||.+||+.+|++|||+.|++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            00        0013467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-45  Score=346.20  Aligned_cols=264  Identities=25%  Similarity=0.416  Sum_probs=210.6

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEec------C
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN------G  141 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~------~  141 (362)
                      .++|++++.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++||||+++++++...      .
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            378999999999999999999999999999999987542 223445677899999999999999999877533      4


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ..+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++....
T Consensus        94 ~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHS-AGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             cEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            578999998 6799888764 679999999999999999999998 9999999999999999999999999999976542


Q ss_pred             CCCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH--------H-------
Q 018018          222 TSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--------M-------  285 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~--------~-------  285 (362)
                         ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...        .       
T Consensus       171 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07878         171 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH  247 (343)
T ss_pred             ---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhh
Confidence               2345678999999999877 56899999999999999999999999764332111111000        0       


Q ss_pred             -HHHhcCCC--CC----CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          286 -EAIVDQPP--PS----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       286 -~~~~~~~~--~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                       ........  +.    ......++.+.+||.+||+.||++|||+.|++.||||..+.+.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             HHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence             00000000  00    0112456778999999999999999999999999999877543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=5.5e-45  Score=330.96  Aligned_cols=253  Identities=36%  Similarity=0.645  Sum_probs=211.0

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEec------Ce
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSN------GA  142 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~------~~  142 (362)
                      +.|.+.+.||+|+||.||++.+..+++.||+|++....  .....+.+|+.++..+ +|+||+++++.+...      ..
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            56888899999999999999999999999999987543  2335678888888887 699999999988753      46


Q ss_pred             EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          143 ISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      +++||||+++++|.+++...  ..+++..+..++.|++.||+|||+ ++++|+||+|+||+++.++.++|+|||++....
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~  162 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence            89999999999999999864  468999999999999999999998 999999999999999999999999999987654


Q ss_pred             cCCCCCCccccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018018          221 STSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  295 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (362)
                      ..........|+..|+|||++.     +..++.++|+||+||++|+|++|..||.......       ..........+.
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~-------~~~~~~~~~~~~  235 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-------ALFLIPRNPAPR  235 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH-------HHHHHhcCCCCC
Confidence            4333445567899999999986     3457889999999999999999999996543211       111122222333


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       296 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      .....++.++.+|+.+||+.||++|||+.+++.||||
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         236 LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            3345678999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.8e-45  Score=332.20  Aligned_cols=261  Identities=36%  Similarity=0.586  Sum_probs=223.7

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      ..|+.++.||.|+||.||++.+..++..||+|++...........+.+|+.+++.++||||+++++.+.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            46788899999999999999999999999999988665555667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      +++++|.+++.. .++++..+..++.|++.||+|||+ ++++|+||+|+||+++.++.++|+|||++.............
T Consensus        84 ~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~-~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06640          84 LGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHS-EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence            999999999875 578999999999999999999998 999999999999999999999999999987765433333445


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  309 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  309 (362)
                      .++..|+|||.+.+..++.++|+|||||++|+|++|..||...+..       .....+.. ..++.....++..+.+++
T Consensus       162 ~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~~~~~-~~~~~~~~~~~~~~~~li  233 (277)
T cd06640         162 VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM-------RVLFLIPK-NNPPTLTGEFSKPFKEFI  233 (277)
T ss_pred             cCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH-------hHhhhhhc-CCCCCCchhhhHHHHHHH
Confidence            6788999999999888999999999999999999999999764332       11111111 222333456788999999


Q ss_pred             HHhhhcCcCCCCCHHHHHcCCcccccCCCCC
Q 018018          310 SACVQKEPQQRLSAQELMTHPFLKMYGDLNV  340 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~  340 (362)
                      .+||+.+|++||++++++.||||...+....
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~  264 (277)
T cd06640         234 DACLNKDPSFRPTAKELLKHKFIVKNAKKTS  264 (277)
T ss_pred             HHHcccCcccCcCHHHHHhChHhhhcchhhh
Confidence            9999999999999999999999988876533

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.7e-45  Score=333.32  Aligned_cols=259  Identities=27%  Similarity=0.451  Sum_probs=216.7

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      |...+.||+|+||+||++.+..+++.+|+|++....  .......+.+|+.+++.++|+||+.+++.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            677899999999999999999999999999986542  223345577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          150 MDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       150 ~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+ +||+||||||+||+++.++.++|+|||++...... ....
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~  159 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR-ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIR  159 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-Cccc
Confidence            9999999888653  369999999999999999999998 99999999999999999999999999998765322 2223


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  307 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (362)
                      ...|+..|+|||.+.+..++.++|+||+||++|+|++|..||.+......   ...+........  ......+++.+.+
T Consensus       160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~~~  234 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETE--EVYSAKFSEEAKS  234 (285)
T ss_pred             CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccc--cccCccCCHHHHH
Confidence            45789999999999998999999999999999999999999976433211   112222222221  2234568899999


Q ss_pred             HHHHhhhcCcCCCCC-----HHHHHcCCcccccCC
Q 018018          308 FISACVQKEPQQRLS-----AQELMTHPFLKMYGD  337 (362)
Q Consensus       308 li~~~L~~dP~~Rpt-----~~eil~hp~~~~~~~  337 (362)
                      |+..||+.||++||+     +.+++.|+||+....
T Consensus       235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~  269 (285)
T cd05632         235 ICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNF  269 (285)
T ss_pred             HHHHHccCCHhHcCCCcccChHHHHcChhhhcCCH
Confidence            999999999999999     899999999988743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=8.4e-45  Score=328.11  Aligned_cols=254  Identities=29%  Similarity=0.479  Sum_probs=218.5

Q ss_pred             eeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCCH
Q 018018           78 VGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  155 (362)
Q Consensus        78 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL  155 (362)
                      ||.|++|.||++++..+++.+|+|++....  .......+.+|+.+++.++||||+++++.+.+....++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999999999999999987653  234557789999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCCcc
Q 018018          156 ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY  235 (362)
Q Consensus       156 ~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y  235 (362)
                      .+++.+...+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++.++|+|||++....... ......++..|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~  158 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHN-RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEY  158 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCc
Confidence            9999988889999999999999999999998 999999999999999999999999999988765432 23345788999


Q ss_pred             cCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 018018          236 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK  315 (362)
Q Consensus       236 ~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  315 (362)
                      +|||.+.+..++.++|+||+|+++|+|++|..||...+..     .......+.........+...++++.++|.+||+.
T Consensus       159 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  233 (262)
T cd05572         159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED-----PMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR  233 (262)
T ss_pred             cChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC-----HHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence            9999998888999999999999999999999999765431     12333444432333333445689999999999999


Q ss_pred             CcCCCCC-----HHHHHcCCcccccCCC
Q 018018          316 EPQQRLS-----AQELMTHPFLKMYGDL  338 (362)
Q Consensus       316 dP~~Rpt-----~~eil~hp~~~~~~~~  338 (362)
                      +|++||+     ++|+++||||+.++.+
T Consensus       234 ~p~~R~~~~~~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         234 NPEERLGNLKGGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             ChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence            9999999     9999999999987654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.3e-44  Score=327.85  Aligned_cols=256  Identities=32%  Similarity=0.512  Sum_probs=212.7

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc----chHHHHHHHHHHHHHhcCCCCcceEEeeeEEe--cCeE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV----EESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAI  143 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~--~~~~  143 (362)
                      .+|+..+.||+|+||.||++.+..++..||+|++....    .......+.+|+.+++.++||||+++++.+.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888999999999999999999999999999986442    22344568899999999999999999998765  3678


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ++++||+++++|.+++.....+++...+.++.|++.||+|||+ ++++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~-~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            9999999999999999888889999999999999999999998 999999999999999999999999999987653211


Q ss_pred             ---CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          224 ---GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       224 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                         .......++..|+|||.+.+..++.++|+||+||++|+|++|+.||...+..       ............+..+..
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~  233 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-------AAIFKIATQPTNPQLPSH  233 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-------HHHHHHhcCCCCCCCchh
Confidence               1122345788999999999988999999999999999999999999764321       112222222222333456


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      +++.+.+++ +||..+|++||+++|+++||||+.
T Consensus       234 ~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~~  266 (266)
T cd06651         234 ISEHARDFL-GCIFVEARHRPSAEELLRHPFAQL  266 (266)
T ss_pred             cCHHHHHHH-HHhcCChhhCcCHHHHhcCccccC
Confidence            788899999 688889999999999999999973

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5.4e-45  Score=334.06  Aligned_cols=271  Identities=38%  Similarity=0.702  Sum_probs=222.6

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      .++|+..+.||+|+||.||++.+..+++.+|+|.+...........+.+|+.++.++. |+||+++++.+..+...+++|
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            3567788899999999999999999999999999876655556677889999998886 999999999999999999999


Q ss_pred             eccCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          148 EYMDGGSLADFLK-----KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       148 e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      ||+.. ++.++..     ....+++..+..++.|++.||+|||+..|++||||||+||+++.++.++|+|||++......
T Consensus        83 e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          83 ELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            99864 6655442     23679999999999999999999997459999999999999999999999999998765432


Q ss_pred             CCCCCccccCCcccCcceecCC---CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC---C
Q 018018          223 SGQANTFVGTYNYMSPERISGG---KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS---A  296 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~  296 (362)
                      . ......|+..|+|||.+.+.   .++.++||||+||++|+|++|+.||....      ...+..........+.   .
T Consensus       162 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd06616         162 I-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN------SVFDQLTQVVKGDPPILSNS  234 (288)
T ss_pred             C-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc------hHHHHHhhhcCCCCCcCCCc
Confidence            2 22334678899999999876   68999999999999999999999996532      1222223332222221   1


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHH
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFT  347 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~  347 (362)
                      ....++.++.+||.+||+.||++|||+++++.||||+.+.+.+....++.+
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~~~~~~~~~  285 (288)
T cd06616         235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVAAYVQ  285 (288)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcchhHHHHHH
Confidence            223588999999999999999999999999999999999988888777654

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=9e-45  Score=332.24  Aligned_cols=241  Identities=20%  Similarity=0.267  Sum_probs=204.4

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEe----cCeEEEEEec
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGAISIILEY  149 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~----~~~~~lV~e~  149 (362)
                      ..||+|++|.||+++.  +|+.||||+++...  .......+.+|+.+++.++||||+++++++.+    ....++||||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            6799999999999987  68999999987652  23335678899999999999999999999876    4578999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      +++|+|.+++.....+++.....++.|++.||.|||+..+++||||||+||+++.++.+||+|||+++.....   ....
T Consensus       104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~~~  180 (283)
T PHA02988        104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---PFKN  180 (283)
T ss_pred             CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---cccc
Confidence            9999999999988899999999999999999999997458999999999999999999999999998765432   2234


Q ss_pred             ccCCcccCcceecC--CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018018          230 VGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  307 (362)
Q Consensus       230 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (362)
                      .|+..|+|||++.+  ..++.++|||||||++|||++|..||.+.+.       .++...+.........+..+++.+.+
T Consensus       181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~l~~  253 (283)
T PHA02988        181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-------KEIYDLIINKNNSLKLPLDCPLEIKC  253 (283)
T ss_pred             cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcCCCCCCCCcCcHHHHH
Confidence            68899999999976  6799999999999999999999999986432       23334443333333344468899999


Q ss_pred             HHHHhhhcCcCCCCCHHHHHc
Q 018018          308 FISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       308 li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ++.+||+.||++|||+.++++
T Consensus       254 li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        254 IVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHHhcCCcccCcCHHHHHH
Confidence            999999999999999999985

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-44  Score=326.50  Aligned_cols=254  Identities=35%  Similarity=0.607  Sum_probs=216.0

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      ++|++.+.||.|+||.||++.+..+++.+++|++...... ....+.+|+.+++.++||||+++++.+.+...++++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            6899999999999999999999999999999999765333 567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          150 MDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       150 ~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      +++++|.+++... ..+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++.++|+|||++............
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  160 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE-TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS  160 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence            9999999999876 789999999999999999999998 99999999999999999999999999998776543333345


Q ss_pred             cccCCcccCcceecCC---CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc--CCCCCCCCCCCCH
Q 018018          229 FVGTYNYMSPERISGG---KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD--QPPPSAPSDQFSP  303 (362)
Q Consensus       229 ~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  303 (362)
                      ..++..|+|||.+.+.   .++.++|+||+|+++|+|++|..||...+...      ........  ..........++.
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  234 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR------ALFLISKSNFPPPKLKDKEKWSP  234 (262)
T ss_pred             ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhccCCCccccchhhhhH
Confidence            5788899999999876   78999999999999999999999997644221      11111111  1111112334678


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHcCCc
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMTHPF  331 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~hp~  331 (362)
                      ++.+++++||+.+|.+|||+.+++.|+|
T Consensus       235 ~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         235 VFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            8999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.4e-44  Score=327.02  Aligned_cols=255  Identities=35%  Similarity=0.616  Sum_probs=216.5

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      ++|++.+.||.|+||+||++....++..+|+|++...........+.+|+.+++.++|+||+++++.+......++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47899999999999999999998899999999987654444677899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC-
Q 018018          150 MDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-  225 (362)
Q Consensus       150 ~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~-  225 (362)
                      +++++|.+++...   ..+++..+..++.|++.||+|||+ +|++|+||+|+||++++++.++|+|||++......... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~-~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS-NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            9999999999764   458999999999999999999998 99999999999999999999999999998776543322 


Q ss_pred             ---CCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC-C---
Q 018018          226 ---ANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA-P---  297 (362)
Q Consensus       226 ---~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---  297 (362)
                         .....|+..|+|||.+... .++.++|+||||+++|+|++|..||...+...       ..........+.. .   
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~  232 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-------VLMLTLQNDPPSLETGAD  232 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-------hHHHHhcCCCCCcCCccc
Confidence               1334688999999998877 68999999999999999999999997653321       1112222211111 1   


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      ...+++.+.+++.+||+.||++|||+++++.||||
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            13578899999999999999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4e-47  Score=353.27  Aligned_cols=270  Identities=26%  Similarity=0.415  Sum_probs=228.7

Q ss_pred             CCCCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           61 KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        61 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      ....+++.++...-++-||+|+.|.||+++..  ++.||||+++.-        -..+++-+++|+||||+.|.++|...
T Consensus       115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqs  184 (904)
T KOG4721|consen  115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQS  184 (904)
T ss_pred             hhhhccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCC
Confidence            34567888888888999999999999999874  889999987522        23567778999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          141 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ..+|||||||..|.|...|+....++......|..+|+.|+.|||. +.|||||||.-||||+.+..|||+|||-++...
T Consensus       185 PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~-hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~  263 (904)
T KOG4721|consen  185 PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHL-HKIIHRDLKSPNILISYDDVVKISDFGTSKELS  263 (904)
T ss_pred             ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHH-hhHhhhccCCCceEeeccceEEeccccchHhhh
Confidence            9999999999999999999999999999999999999999999998 899999999999999999999999999887765


Q ss_pred             cCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          221 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      .. .....++||..|||||++.+.+.++|+|||||||+||||+||..||.+.+..       .++--+.....--+.+..
T Consensus       264 ~~-STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-------AIIwGVGsNsL~LpvPst  335 (904)
T KOG4721|consen  264 DK-STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-------AIIWGVGSNSLHLPVPST  335 (904)
T ss_pred             hh-hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-------eeEEeccCCcccccCccc
Confidence            54 3456689999999999999999999999999999999999999999875432       111122222223344567


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHHHh
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA  349 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~~~  349 (362)
                      ++..++=||++||+-.|..||++.+|+.|-=+...+=....=.+||+.|
T Consensus       336 cP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~tee~yf~sq  384 (904)
T KOG4721|consen  336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTEETYFKSQ  384 (904)
T ss_pred             CchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccHHHHHHHH
Confidence            8899999999999999999999999999965555544444556677665

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-44  Score=328.14  Aligned_cols=258  Identities=27%  Similarity=0.528  Sum_probs=218.0

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-----chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-----EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      +|+..+.||+|++|.||++.+..+++.+|+|+++...     .......+.+|+++++.++|+||+++++.+.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4778899999999999999999999999999987542     12345778899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC-cEEEeeccCCcccccCCC
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSG  224 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-~vkl~DFg~a~~~~~~~~  224 (362)
                      |+||+++++|.+++...+++++..+..++.|++.||+|||+ +|++|+||+|+||+++.++ .++|+|||.+........
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~-~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE-NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            99999999999999988899999999999999999999998 9999999999999998776 599999999877643321


Q ss_pred             C----CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          225 Q----ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       225 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      .    .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+...    ..............+..+..
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN----HLALIFKIASATTAPSIPEH  235 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc----hHHHHHHHhccCCCCCCchh
Confidence            1    123467889999999988889999999999999999999999997543321    12222232222333444557


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccc
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  333 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  333 (362)
                      +++++.+++.+||+.+|++|||+.++++||||+
T Consensus       236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         236 LSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             hCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            889999999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=7e-45  Score=339.71  Aligned_cols=256  Identities=27%  Similarity=0.452  Sum_probs=206.3

Q ss_pred             eeeeeeee--CCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEecc
Q 018018           74 TIKVVGKG--SGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  150 (362)
Q Consensus        74 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~  150 (362)
                      ++++||+|  +|++||++.++.+|+.||+|+++... .......+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  67899999999999999999997653 3445567788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC----
Q 018018          151 DGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG----  224 (362)
Q Consensus       151 ~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~----  224 (362)
                      ++++|.+++...  ..+++..++.++.|++.||+|||+ +|++||||||+||+++.++.++++||+.+........    
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            999999999653  468999999999999999999998 9999999999999999999999999986544322111    


Q ss_pred             ---CCCccccCCcccCcceecC--CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-------
Q 018018          225 ---QANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-------  292 (362)
Q Consensus       225 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------  292 (362)
                         ......++..|+|||++.+  ..++.++||||+||++|+|++|..||........      .........       
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~~  234 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM------LLEKLNGTVPCLLDTT  234 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH------HHHHhcCCcccccccc
Confidence               1122356778999999976  4589999999999999999999999975432110      000000000       


Q ss_pred             ------------------------------------CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          293 ------------------------------------PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       293 ------------------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                                                          ........+++.+.+||.+||+.||++|||++++++||||+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence                                                00011223577899999999999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-46  Score=351.74  Aligned_cols=271  Identities=32%  Similarity=0.510  Sum_probs=234.8

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ..|.-++.||.|+||.||.+++..+...||||.+..+.  ..+-...+..|++.++.++|||++.+.++|..+...+|||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            45777899999999999999999999999999987763  3344578999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          148 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       148 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      |||- ||-.+++.-. +++.+.++..|+.+.+.||+|||+ .+.||||||..|||+++.|.|||+|||.|....    ..
T Consensus       106 EYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS-~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~----PA  179 (948)
T KOG0577|consen  106 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-HNRIHRDIKAGNILLSEPGLVKLADFGSASIMA----PA  179 (948)
T ss_pred             HHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH-hhHHhhhccccceEecCCCeeeeccccchhhcC----ch
Confidence            9995 5999999654 689999999999999999999999 999999999999999999999999999887653    35


Q ss_pred             CccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          227 NTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                      ++++|||+|||||++..   +.|+-++||||||++..||...++|+-+.+       ....+..+.....|......++.
T Consensus       180 nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMN-------AMSALYHIAQNesPtLqs~eWS~  252 (948)
T KOG0577|consen  180 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNESPTLQSNEWSD  252 (948)
T ss_pred             hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCch-------HHHHHHHHHhcCCCCCCCchhHH
Confidence            67899999999999854   679999999999999999999999986643       33455666666666666778899


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCC--CHHHHHHHhCCCc
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV--DLSEYFTDAGSPL  353 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~--~l~~~~~~~~~~~  353 (362)
                      .+++++..||++-|.+|||.++++.|+|+..-....+  +|-.--||+|..|
T Consensus       253 ~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~tvi~dLIqRTKdaVrEL  304 (948)
T KOG0577|consen  253 YFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPPTVIMDLIQRTKDAVREL  304 (948)
T ss_pred             HHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCchHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999987766554  5555556666554

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=6.4e-45  Score=327.31  Aligned_cols=253  Identities=40%  Similarity=0.680  Sum_probs=216.2

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      ++|++.+.||+|+||.||++....+++.+++|.++....   ...+.+|+++++.++||||+++++.+.+....++++||
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            678999999999999999999998899999999875422   67889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          150 MDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       150 ~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      +++++|.+++.. ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++............
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHS-NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT  158 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence            999999999975 4578999999999999999999998 99999999999999999999999999998876544333344


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018018          229 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  308 (362)
Q Consensus       229 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  308 (362)
                      ..++..|+|||.+.+..++.++||||+|+++|+|++|+.||.......      ...............+..++..+.++
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd06612         159 VIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR------AIFMIPNKPPPTLSDPEKWSPEFNDF  232 (256)
T ss_pred             ccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh------hhhhhccCCCCCCCchhhcCHHHHHH
Confidence            568889999999999899999999999999999999999997643321      11111111111122234577899999


Q ss_pred             HHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          309 ISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      |.+||+.||++|||+.|++.||||
T Consensus       233 i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         233 VKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHHhcChhhCcCHHHHhcCCCC
Confidence            999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.5e-45  Score=335.42  Aligned_cols=258  Identities=26%  Similarity=0.460  Sum_probs=208.2

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +|++.+.||+|+||.||++++..+|+.+|+|.++... .......+.+|+.+++.++||||+++++.+.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            5889999999999999999999999999999987542 223345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          150 MDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       150 ~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      +.+ +|.+++.. ...+++..++.++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++............
T Consensus        81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHS-HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            974 88888765 5679999999999999999999998 99999999999999999999999999998866544333344


Q ss_pred             cccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHH--------------hcCCC
Q 018018          229 FVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI--------------VDQPP  293 (362)
Q Consensus       229 ~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~~  293 (362)
                      ..++..|+|||++.+.. ++.++|||||||++|+|++|..||.......  ..........              .....
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            56789999999987754 7899999999999999999988864322211  1111111100              00000


Q ss_pred             C---------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          294 P---------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       294 ~---------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      .         ......+++++.++|.+||+.||++|||+++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            0         00123467899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.3e-44  Score=324.94  Aligned_cols=255  Identities=31%  Similarity=0.469  Sum_probs=213.5

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc----chHHHHHHHHHHHHHhcCCCCcceEEeeeEEec--CeE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV----EESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAI  143 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~--~~~  143 (362)
                      .+|.+.+.||+|+||.||.+.+..++..||+|++....    .......+.+|+.+++.++||||+++++.+.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57899999999999999999999999999999986431    223456788999999999999999999987753  568


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ++||||+++++|.+++.+...+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS-NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            8999999999999999888889999999999999999999998 999999999999999999999999999987653211


Q ss_pred             ---CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          224 ---GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       224 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                         .......++..|+|||++.+..++.++|+|||||++|+|++|+.||...+.      .... .........+..+..
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~-~~~~~~~~~~~~~~~  233 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA------MAAI-FKIATQPTNPVLPPH  233 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch------HHHH-HHHhcCCCCCCCchh
Confidence               122334688899999999988899999999999999999999999975322      1122 222222223334456


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccc
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  333 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  333 (362)
                      ++..+.++|++||. +|++||+++|+++|||+.
T Consensus       234 ~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         234 VSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             hCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            78889999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.7e-44  Score=326.69  Aligned_cols=254  Identities=29%  Similarity=0.523  Sum_probs=213.6

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-----chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-----EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      +|.+.+.||.|+||.||++.. .+++.+|+|.++...     .......+.+|+.+++.++|+||+++++.+.+....++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            477889999999999999986 478899999986542     22344668899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC--
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--  223 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~--  223 (362)
                      |+||+++++|.+++.+...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++.......  
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN-NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            99999999999999888889999999999999999999998 999999999999999999999999999987643211  


Q ss_pred             ----CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          224 ----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       224 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                          .......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+...      ............+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~  232 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA------AMFYIGAHRGLMPRLPD  232 (265)
T ss_pred             ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH------HHHHhhhccCCCCCCCC
Confidence                11233568899999999999889999999999999999999999997643211      11111112122233445


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      .++.++.++|++||+.+|++||++.+++.||||
T Consensus       233 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         233 SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            788999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.8e-44  Score=322.59  Aligned_cols=253  Identities=32%  Similarity=0.531  Sum_probs=219.9

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +|+.++.||.|+||.||.+++..+++.+++|.+... .+......+.+|+.+++.++|+||+++++.+.+....++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            588999999999999999999999999999998754 3455567788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          150 MDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       150 ~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      +++++|.+++...  ..+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.+||+|||++...........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK-AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            9999999999764  468999999999999999999998 9999999999999999999999999999877654443344


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  307 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (362)
                      ...+++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.       .+....+..+..++ ....++.++.+
T Consensus       160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~~~  231 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-------LNLVVKIVQGNYTP-VVSVYSSELIS  231 (256)
T ss_pred             ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCCC-CccccCHHHHH
Confidence            56789999999999988899999999999999999999999975332       23333443333332 33667899999


Q ss_pred             HHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          308 FISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       308 li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      +|.+||+.+|++|||+.++++|||+
T Consensus       232 ~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         232 LVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHHcccCcccCCCHHHHhhCcCC
Confidence            9999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.1e-44  Score=326.35  Aligned_cols=253  Identities=31%  Similarity=0.513  Sum_probs=214.8

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc--------hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--------ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      +|.+...||+|++|.||++.+..+++.+|+|.+.....        ......+.+|+.+++.++||||+++++.+.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            46778899999999999999998999999998864421        1234568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      .++|+||+++++|.+++...+.+++..+..++.|++.||+|||+ +|++||||+|+||+++.++.++|+|||+++.....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~-~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN-RGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHh-cCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            99999999999999999988899999999999999999999998 99999999999999999999999999998776422


Q ss_pred             CC------CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018018          223 SG------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  296 (362)
Q Consensus       223 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
                      ..      ......|+..|+|||.+.+..++.++|+||+||++|+|++|..||...+..       .......... .+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~-~~~  231 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-------QAIFKIGENA-SPE  231 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-------HHHHHHhccC-CCc
Confidence            11      112346788999999999988999999999999999999999999764321       1122222222 223


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      .+..++..+.++|++||+.||++||++.++++||||
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         232 IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            345688999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.3e-44  Score=331.83  Aligned_cols=260  Identities=32%  Similarity=0.509  Sum_probs=218.5

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc--hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++|++.+.||+|+||.||++.+..+++.||+|.+.....  ......+.+|+.+++.++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            468999999999999999999999999999999876532  234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC----
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS----  223 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~----  223 (362)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||+++......    
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN-YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            999999999999888889999999999999999999998 999999999999999999999999999886421000    


Q ss_pred             -----------CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          224 -----------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       224 -----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                                 .......++..|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.       .++........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-------~~~~~~~~~~~  232 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-------EELFGQVISDD  232 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcc
Confidence                       011123578899999999988899999999999999999999999976432       23333333332


Q ss_pred             CC-CCCCCCCCHHHHHHHHHhhhcCcCCCCC---HHHHHcCCcccccCC
Q 018018          293 PP-SAPSDQFSPEFCSFISACVQKEPQQRLS---AQELMTHPFLKMYGD  337 (362)
Q Consensus       293 ~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~~~~  337 (362)
                      .. +.....++.++.++|.+||+.||++||+   +.++++||||+..+.
T Consensus       233 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~  281 (305)
T cd05609         233 IEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDW  281 (305)
T ss_pred             cCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCH
Confidence            21 2222367899999999999999999998   799999999977654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-44  Score=329.36  Aligned_cols=263  Identities=35%  Similarity=0.632  Sum_probs=221.2

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC---CCcceEEeeeEEecCeEEEEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ---CPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      .|+..+.||+|+||.||++.+..++..||+|+++..........+.+|+.+++.++   |||++++++.+......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            47788999999999999999999999999999876655556677888999988886   999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      ||+++++|.++++. ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++...........
T Consensus        82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06917          82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHK-VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS  159 (277)
T ss_pred             ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccc
Confidence            99999999999876 489999999999999999999998 9999999999999999999999999999987655444444


Q ss_pred             ccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018018          228 TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  306 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (362)
                      ...|+..|+|||.+.++ .++.++|+||||+++|+|++|..||...+..       .....+.....+......++.++.
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~  232 (277)
T cd06917         160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-------RAMMLIPKSKPPRLEDNGYSKLLR  232 (277)
T ss_pred             cccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-------hhhhccccCCCCCCCcccCCHHHH
Confidence            55789999999988754 4689999999999999999999999764332       111122222222223334788999


Q ss_pred             HHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCH
Q 018018          307 SFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL  342 (362)
Q Consensus       307 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l  342 (362)
                      +++.+||+.||++||++.+++.|+||+.........
T Consensus       233 ~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~~~~~  268 (277)
T cd06917         233 EFVAACLDEEPKERLSAEELLKSKWIKAHSKTPVSI  268 (277)
T ss_pred             HHHHHHcCCCcccCcCHHHHhhChHhhccccCchhh
Confidence            999999999999999999999999998876544433

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.5e-44  Score=323.76  Aligned_cols=253  Identities=28%  Similarity=0.510  Sum_probs=217.4

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +|++.+.||+|+||.+|++++..+|+.||+|.+... .......++.+|+.+++.++||||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            588999999999999999999999999999998754 2344556789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          150 MDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       150 ~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      +.+++|.+++...  ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            9999999999764  358999999999999999999998 9999999999999999999999999999876644333333


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  307 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (362)
                      ...|++.|+|||.+.+..++.++|+||+||++++|++|..||...+.       .+....+..+..+ ..+..++.++.+
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~~  231 (256)
T cd08218         160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-------KNLVLKIIRGSYP-PVSSHYSYDLRN  231 (256)
T ss_pred             hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-------HHHHHHHhcCCCC-CCcccCCHHHHH
Confidence            45688899999999998899999999999999999999999975322       2233333333332 234568899999


Q ss_pred             HHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          308 FISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       308 li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      +|.+||+.+|++||++.++++||||
T Consensus       232 li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         232 LVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHHhhCChhhCcCHHHHhhCcCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.2e-44  Score=334.62  Aligned_cols=259  Identities=22%  Similarity=0.317  Sum_probs=206.9

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEcc----------------CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcce
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKW----------------TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV  131 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~  131 (362)
                      ..++|.+.+.||+|+||.||+|.+..                ++..||+|+++..........+.+|+.++..++||||+
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence            44789999999999999999998542                34479999998765666778899999999999999999


Q ss_pred             EEeeeEEecCeEEEEEeccCCCCHHHHHHHc-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEe
Q 018018          132 VCYQSFYSNGAISIILEYMDGGSLADFLKKV-------------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIH  192 (362)
Q Consensus       132 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-------------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH  192 (362)
                      ++++.+.+....++||||+++++|.+++...                   ..+++..+..++.|++.||.|||+ +|++|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~ivH  161 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS-LNFVH  161 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH-CCccc
Confidence            9999999999999999999999999998653                   236778899999999999999998 99999


Q ss_pred             ecCCCCcEEEccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc--CCCC
Q 018018          193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT--GQFP  268 (362)
Q Consensus       193 ~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt--g~~p  268 (362)
                      |||||+||+++.++.+||+|||+++.......  ......++..|+|||++.++.++.++||||||+++|+|++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999876533221  1223345788999999998899999999999999999986  6678


Q ss_pred             CCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          269 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       269 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      |...+..+.............. ......+..++..+.+|+.+||+.||++|||++++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQGR-QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhccc-cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            8764432211111111111111 1111223457889999999999999999999999943

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.3e-45  Score=345.93  Aligned_cols=257  Identities=25%  Similarity=0.356  Sum_probs=210.3

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccC-----CcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeE
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT-----GQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSF  137 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~  137 (362)
                      .+.+..++|++.+.||+|+||.||++++...     +..||+|+++..........+.+|+.+++.+ +|+||+++++.+
T Consensus        32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~  111 (374)
T cd05106          32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC  111 (374)
T ss_pred             cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence            3456678999999999999999999986443     4579999998665555667788999999998 899999999999


Q ss_pred             EecCeEEEEEeccCCCCHHHHHHHc-------------------------------------------------------
Q 018018          138 YSNGAISIILEYMDGGSLADFLKKV-------------------------------------------------------  162 (362)
Q Consensus       138 ~~~~~~~lV~e~~~~gsL~~~l~~~-------------------------------------------------------  162 (362)
                      ...+..++||||+++|+|.+++...                                                       
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            9999999999999999999998542                                                       


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC--
Q 018018          163 ---------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--  225 (362)
Q Consensus       163 ---------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~--  225 (362)
                                     .++++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++........  
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS-KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                           247888899999999999999998 99999999999999999999999999998765432211  


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      .....++..|+|||++.+..++.++|||||||++|+|++ |+.||.......      ..... .........+...+++
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~-~~~~~~~~~~~~~~~~  343 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKM-VKRGYQMSRPDFAPPE  343 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHH-HHcccCccCCCCCCHH
Confidence            112234567999999998899999999999999999997 999997643321      11111 1222222334557899


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          305 FCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +.+++.+||+.||++|||+.++++
T Consensus       344 l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         344 IYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.5e-45  Score=334.49  Aligned_cols=260  Identities=37%  Similarity=0.631  Sum_probs=221.8

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +.|+..+.||+|+||.||++.+..++..||+|+++..........+.+|+.+++.++||||+++++.+..+...++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            45777889999999999999999899999999987665555667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      +++++|.+++.. ..+++..+..++.|++.|+.|||+ +|++|+||+|+||+++.++.++|+|||++.............
T Consensus        84 ~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~-~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06642          84 LGGGSALDLLKP-GPLEETYIATILREILKGLDYLHS-ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             cCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc-CCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence            999999999865 678999999999999999999998 999999999999999999999999999987765433333345


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  309 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  309 (362)
                      .++..|+|||.+.+..++.++|+|||||++|+|++|..||......       .....+.... ++.....++..+.++|
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~~~~li  233 (277)
T cd06642         162 VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-------RVLFLIPKNS-PPTLEGQYSKPFKEFV  233 (277)
T ss_pred             cCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-------hHHhhhhcCC-CCCCCcccCHHHHHHH
Confidence            6888999999999988999999999999999999999999754332       1112222222 2233446788999999


Q ss_pred             HHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          310 SACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                      .+||+.+|++|||+.+++.||||+.+....
T Consensus       234 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~  263 (277)
T cd06642         234 EACLNKDPRFRPTAKELLKHKFITRYTKKT  263 (277)
T ss_pred             HHHccCCcccCcCHHHHHHhHHHHHHhhhH
Confidence            999999999999999999999999886543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-44  Score=330.73  Aligned_cols=254  Identities=26%  Similarity=0.395  Sum_probs=215.9

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCC-----cEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTG-----QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      +..++|++.+.||+|+||.||++.....+     ..+|+|.++..........+.+|+.+++.++||||+++++.+....
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence            45678999999999999999999976555     6899999876666666778999999999999999999999999899


Q ss_pred             eEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC
Q 018018          142 AISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR  205 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~  205 (362)
                      ..+++|||+++++|.+++...                ..+++..+..++.|++.||+|||+ +|++|+||||+||+++.+
T Consensus        82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS-HHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccccceEEEcCC
Confidence            999999999999999999764                457889999999999999999998 999999999999999999


Q ss_pred             CcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHH
Q 018018          206 GEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY  282 (362)
Q Consensus       206 ~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~  282 (362)
                      +.++|+|||+++.......  ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+...       .
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-------~  233 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-------Q  233 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-------H
Confidence            9999999999876532221  1233456789999999998899999999999999999998 9999976433       2


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          283 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +....+.....+ ..+..+++++.+|+.+||+.||++||++.|++++
T Consensus       234 ~~~~~i~~~~~~-~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         234 EVIEMIRSRQLL-PCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHcCCcC-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            334444444333 3356789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=8.7e-45  Score=337.40  Aligned_cols=253  Identities=23%  Similarity=0.404  Sum_probs=194.7

Q ss_pred             eeeeeeeCCeEEEEEEEc--cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe--cCeEEEEEecc
Q 018018           75 IKVVGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIILEYM  150 (362)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~--~~~~~lV~e~~  150 (362)
                      .+.||+|+||.||+|+++  .+++.||+|.+.....   ...+.+|+.+++.++||||+++++.+..  +...++||||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            367999999999999975  4678999999865422   2346789999999999999999998854  46789999999


Q ss_pred             CCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEE----ccCCcEEEeeccCCc
Q 018018          151 DGGSLADFLKKV---------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSA  217 (362)
Q Consensus       151 ~~gsL~~~l~~~---------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll----~~~~~vkl~DFg~a~  217 (362)
                      . ++|.+++...         ..+++..++.++.|++.||.|||+ +||+||||||+|||+    +.++.+||+|||+|+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            6 4898887532         258999999999999999999998 999999999999999    456789999999997


Q ss_pred             ccccCCC---CCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCch------hhHHHHHHH
Q 018018          218 IMASTSG---QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW------TSFYELMEA  287 (362)
Q Consensus       218 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~------~~~~~~~~~  287 (362)
                      .......   ......||+.|+|||++.+. .++.++||||+||++|+|++|++||.........      .....+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV  240 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence            7543221   23346789999999998874 5899999999999999999999999754332110      000011000


Q ss_pred             H------------------------hcCCCC--------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          288 I------------------------VDQPPP--------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       288 ~------------------------~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      .                        ......        .......+..+.+||.+||++||++|||++|+++||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            0                        000000        00011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2e-44  Score=329.23  Aligned_cols=255  Identities=35%  Similarity=0.645  Sum_probs=211.9

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEe------c
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYS------N  140 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~------~  140 (362)
                      ..+.|++.+.||.|+||.||++++..+++.+|+|++...  ......+..|+.+++.+ +|+||+++++.+..      .
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC--hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            347889999999999999999999999999999998654  23445678888888887 69999999998853      4


Q ss_pred             CeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          141 GAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      ...+++|||+++++|.+++...  ..+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++.++|+|||++..
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~ivH~dl~~~nili~~~~~~~l~dfg~~~~  170 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA-HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  170 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence            6789999999999999999763  458899999999999999999998 9999999999999999999999999999876


Q ss_pred             cccCCCCCCccccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC
Q 018018          219 MASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP  293 (362)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  293 (362)
                      ............|+..|+|||.+.     +..++.++|+|||||++|+|++|..||.......      .. ........
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~------~~-~~~~~~~~  243 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR------AL-FLIPRNPP  243 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh------hh-hhHhhCCC
Confidence            543333344567899999999986     3468889999999999999999999997543211      11 11222223


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       294 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      +......++.++.+||.+||+.||++|||+.|++.||||
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         244 PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            333345688999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.9e-44  Score=328.93  Aligned_cols=255  Identities=35%  Similarity=0.563  Sum_probs=210.1

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEec-----Ce
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSN-----GA  142 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~-----~~  142 (362)
                      .++|.+.+.||+|+||.||++.+..+++.+|+|++....  .....+.+|+.+++.+ +||||+++++.+...     +.
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~   98 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ   98 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence            578999999999999999999999999999999986432  2235567888888888 799999999988753     46


Q ss_pred             EEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          143 ISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      .++||||+++++|.++++.    ...+++..++.++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||++..
T Consensus        99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~dlkp~nili~~~~~~kl~dfg~~~~  177 (291)
T cd06639          99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN-NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ  177 (291)
T ss_pred             eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence            8999999999999998863    4578999999999999999999998 9999999999999999999999999999887


Q ss_pred             cccCCCCCCccccCCcccCcceecCC-----CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC-C
Q 018018          219 MASTSGQANTFVGTYNYMSPERISGG-----KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ-P  292 (362)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~  292 (362)
                      ............|+..|+|||.+...     .++.++||||+||++|+|++|+.||...+..      .... .+... .
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------~~~~-~~~~~~~  250 (291)
T cd06639         178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------KTLF-KIPRNPP  250 (291)
T ss_pred             cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------HHHH-HHhcCCC
Confidence            65443334445788999999998653     3688999999999999999999999764321      1122 22222 1


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccc
Q 018018          293 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  333 (362)
Q Consensus       293 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  333 (362)
                      .....+..++..+.+||.+||+.+|++||++.++++||||+
T Consensus       251 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         251 PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            11122345678899999999999999999999999999995

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4e-44  Score=323.19  Aligned_cols=253  Identities=33%  Similarity=0.577  Sum_probs=217.5

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe--cCeEEEEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIIL  147 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~--~~~~~lV~  147 (362)
                      +|++.+.||.|+||.||++.+..+++.+|+|++... ........+..|+.+++.++|+||+++++.+..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            588999999999999999999999999999998754 344556778899999999999999999987753  45689999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          148 EYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLH-----HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       148 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH-----~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      ||+++++|.+++..    ...+++..++.++.|++.||+|||     + .+++|+||+|+||+++.++.+||+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~-~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG-NTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc-CcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            99999999999975    367899999999999999999999     7 8999999999999999999999999999987


Q ss_pred             cccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          219 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      ............+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.       ..+...+..... +..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~  231 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-------LQLASKIKEGKF-RRIP  231 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-------HHHHHHHhcCCC-CCCc
Confidence            76544334456789999999999998899999999999999999999999976432       233333333332 3345


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      ..++..+.+++.+||+.+|++|||+.++++|||+
T Consensus       232 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            6788999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.1e-44  Score=325.56  Aligned_cols=253  Identities=21%  Similarity=0.279  Sum_probs=212.1

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEc---cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      +...+|++.+.||+|+||.||++...   ..+..||+|.++..........+.+|+..++.++||||+++++.+......
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            45578999999999999999999765   346689999998765556667889999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          144 SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      ++||||+++++|.+++... ..+++..++.++.|++.||+|||+ +|++||||||+||+++.++.++++|||.+......
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE-MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            9999999999999999764 578999999999999999999998 99999999999999999999999999987654222


Q ss_pred             CC-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          223 SG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       223 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      .. ......++..|+|||.+.+..++.++||||+||++||+++ |..||.+.+.       ......+...... ..+..
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~  232 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-------QDVIKAVEDGFRL-PAPRN  232 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHCCCCC-CCCCC
Confidence            11 1112345678999999999999999999999999999875 9999976432       2333444443332 23467


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ++..+.+++.+||+.+|++|||++++++
T Consensus       233 ~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         233 CPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            8899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.9e-44  Score=326.45  Aligned_cols=270  Identities=42%  Similarity=0.740  Sum_probs=221.2

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe--cCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~--~~~~~lV~  147 (362)
                      ++|+..+.||.|++|.||++.+..+++.+|+|.+...........+.+|+++++.++||||+++++.+.+  .+.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4688999999999999999999999999999999866555666788999999999999999999998864  34789999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          148 EYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       148 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ||+++++|.+++..    ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS-RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            99999999988753    3568999999999999999999998 999999999999999999999999999987654322


Q ss_pred             CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC-----CCC
Q 018018          224 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-----APS  298 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~  298 (362)
                        .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......  ....+....+.....+.     ...
T Consensus       160 --~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd06621         160 --AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP--LGPIELLSYIVNMPNPELKDEPGNG  235 (287)
T ss_pred             --cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC--CChHHHHHHHhcCCchhhccCCCCC
Confidence              223467889999999999899999999999999999999999998653311  11122333333221111     111


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHH
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE  344 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~  344 (362)
                      ..+++.+.++|.+||+.+|++|||+.|++.||||++..........
T Consensus       236 ~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~~~~~~~  281 (287)
T cd06621         236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAK  281 (287)
T ss_pred             CchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccchhhHHH
Confidence            2356789999999999999999999999999999888776554433

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-44  Score=350.44  Aligned_cols=257  Identities=21%  Similarity=0.297  Sum_probs=205.7

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      ...|.+.+.||+|+||.||++.+..+++.||||....       ..+.+|+++++.++|+||+++++.+...+..++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            4579999999999999999999999999999996432       235689999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC--C
Q 018018          149 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--Q  225 (362)
Q Consensus       149 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~--~  225 (362)
                      ++. ++|.+++... ..+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++.......  .
T Consensus       241 ~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~  318 (461)
T PHA03211        241 KYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHG-EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF  318 (461)
T ss_pred             ccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence            995 6898888654 579999999999999999999998 9999999999999999999999999999976532221  1


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc----hhhHHHHHHHHhcC----------
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG----WTSFYELMEAIVDQ----------  291 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~----~~~~~~~~~~~~~~----------  291 (362)
                      .....||+.|+|||++.+..++.++|||||||++|||++|..|+........    ...+...+......          
T Consensus       319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~  398 (461)
T PHA03211        319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGS  398 (461)
T ss_pred             ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcch
Confidence            2245799999999999999999999999999999999998765533221110    11111222111100          


Q ss_pred             -------------CCCC------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          292 -------------PPPS------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       292 -------------~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                                   ..+.      .....++..+.+||.+||+.||++|||+.|+|+||||+.
T Consensus       399 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        399 RLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             HHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                         0000      000135568999999999999999999999999999974

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.5e-44  Score=365.58  Aligned_cols=265  Identities=31%  Similarity=0.510  Sum_probs=218.5

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe--c
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS--N  140 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~--~  140 (362)
                      +......+|.+++.||+|+||+||+|++..++..+|+|++... ........+..|+.+++.++||||+++++.|.+  .
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            4456678999999999999999999999999999999998754 344556778999999999999999999998864  4


Q ss_pred             CeEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC------CCeEeecCCCCcEEEccC-----
Q 018018          141 GAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHE------KHIIHRDLKPSNLLINHR-----  205 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~al~~LH~~------~~ivH~Dlkp~NIll~~~-----  205 (362)
                      ..+|+||||+++++|.+++...    ..+++..++.++.||+.||.|||+.      ++|+||||||+||||+.+     
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            5799999999999999999653    5799999999999999999999972      249999999999999642     


Q ss_pred             ------------CcEEEeeccCCcccccCCCCCCccccCCcccCcceecC--CCCCccccHHHHHHHHHHHHcCCCCCCC
Q 018018          206 ------------GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYSP  271 (362)
Q Consensus       206 ------------~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~elltg~~pf~~  271 (362)
                                  +.+||+|||++....... .....+||+.|+|||++.+  ..++.++|||||||++|+|++|..||..
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                        348999999997654322 2344579999999999865  4588999999999999999999999975


Q ss_pred             CccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      .+.      ...++..+...+  .......+.++.+||..||+.+|++||++.|+|.|||++....
T Consensus       246 ~~~------~~qli~~lk~~p--~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        246 ANN------FSQLISELKRGP--DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             CCc------HHHHHHHHhcCC--CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            322      223333333322  2222457899999999999999999999999999999987654

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=5.3e-44  Score=327.39  Aligned_cols=258  Identities=34%  Similarity=0.627  Sum_probs=218.6

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEecc
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  150 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~  150 (362)
                      .|...+.||+|++|.||++.+..+++.+++|++... .......+.+|+.+++.++||||+++++.+......++|+||+
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~   98 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL   98 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc-chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence            455568999999999999999999999999998654 3334566889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccc
Q 018018          151 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV  230 (362)
Q Consensus       151 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~  230 (362)
                      ++++|.+++.. .++++..+..++.|++.||+|||+ +|++||||+|+||+++.++.++|+|||++..............
T Consensus        99 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  176 (285)
T cd06648          99 EGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHA-QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV  176 (285)
T ss_pred             CCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence            99999999987 679999999999999999999998 9999999999999999999999999998876543333334456


Q ss_pred             cCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC-CCCCCCCHHHHHHH
Q 018018          231 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-APSDQFSPEFCSFI  309 (362)
Q Consensus       231 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li  309 (362)
                      |++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.       ......+.....+. .....++..+.+++
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li  249 (285)
T cd06648         177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-------LQAMKRIRDNLPPKLKNLHKVSPRLRSFL  249 (285)
T ss_pred             CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHHHhcCCCCCcccccCCHHHHHHH
Confidence            89999999999988899999999999999999999999976432       12223333332211 12234788999999


Q ss_pred             HHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          310 SACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      .+||+.+|++|||+.++++||||+++++.
T Consensus       250 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         250 DRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             HHHcccChhhCcCHHHHccCcccccCCCc
Confidence            99999999999999999999999998763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.2e-44  Score=322.26  Aligned_cols=250  Identities=32%  Similarity=0.513  Sum_probs=215.7

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEecc
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  150 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~  150 (362)
                      +|++.+.||+|+||.||++++..+++.+|+|.++..........+.+|+.+++.++|+||+++++.+.+...+++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            58899999999999999999999999999999876555556677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          151 DGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       151 ~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      ++++|.+++...  ..+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+............
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE-KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT  159 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence            999999998653  458999999999999999999998 99999999999999999999999999998876544444445


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018018          229 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  308 (362)
Q Consensus       229 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  308 (362)
                      ..+++.|+|||++.+..++.++|+||+|+++|+|++|..||...+.       ......+...... ..+..++..+.++
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~~l  231 (255)
T cd08219         160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-------KNLILKVCQGSYK-PLPSHYSYELRSL  231 (255)
T ss_pred             ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-------HHHHHHHhcCCCC-CCCcccCHHHHHH
Confidence            6789999999999998899999999999999999999999975322       1223333333322 2345688999999


Q ss_pred             HHHhhhcCcCCCCCHHHHHcC
Q 018018          309 ISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~eil~h  329 (362)
                      |.+||+.||++|||+.+++.-
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-44  Score=332.76  Aligned_cols=260  Identities=28%  Similarity=0.496  Sum_probs=208.9

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ..++|++.+.||+|++|.||+++++.+++.||+|.+...........+.+|+.+++.++|+||+++++++.+....++||
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            35789999999999999999999999999999999876543333445678999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          148 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       148 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      ||+.+ +|.+++... ..+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+++.........
T Consensus        83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQ-RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence            99975 999988764 468999999999999999999998 999999999999999999999999999987654322222


Q ss_pred             CccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC------------
Q 018018          227 NTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP------------  293 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------  293 (362)
                      ....++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.......  ....... .......            
T Consensus       161 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIF-RVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHH-HhcCCCChhhhhhhhhccc
Confidence            33456889999999876 458899999999999999999999997654210  1111110 0000000            


Q ss_pred             ----------CC---CCCCCCC--HHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          294 ----------PS---APSDQFS--PEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       294 ----------~~---~~~~~~~--~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                                +.   .....++  ..+.+++.+||+.+|++|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                      00   0001233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.1e-44  Score=325.44  Aligned_cols=259  Identities=36%  Similarity=0.592  Sum_probs=221.1

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEecc
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  150 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~  150 (362)
                      -|+..+.||+|+||.||++.+..++..+|+|++...........+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            46778899999999999999999999999999876655556678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccc
Q 018018          151 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV  230 (362)
Q Consensus       151 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~  230 (362)
                      ++++|.+++.. ..+++..+..++.|++.|+.+||+ +|++|+||+|+||+++.++.++|+|||++..............
T Consensus        85 ~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  162 (277)
T cd06641          85 GGGSALDLLEP-GPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV  162 (277)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHcc-CCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence            99999999875 578999999999999999999998 9999999999999999999999999999876544332333456


Q ss_pred             cCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 018018          231 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS  310 (362)
Q Consensus       231 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  310 (362)
                      ++..|+|||.+.+..++.++|+||+||++|+|++|..||......       .....+.... ++.....++.++.+++.
T Consensus       163 ~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~~~~~i~  234 (277)
T cd06641         163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-------KVLFLIPKNN-PPTLEGNYSKPLKEFVE  234 (277)
T ss_pred             CCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-------HHHHHHhcCC-CCCCCcccCHHHHHHHH
Confidence            888999999998888899999999999999999999999753321       2222222222 23334567899999999


Q ss_pred             HhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          311 ACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       311 ~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                      +||+.+|++||++.++++||||.......
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~~~~~~~~~~~  263 (277)
T cd06641         235 ACLNKEPSFRPTAKELLKHKFIVRFAKKT  263 (277)
T ss_pred             HHccCChhhCcCHHHHHhCHHHhhhhhcc
Confidence            99999999999999999999998876543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.8e-45  Score=358.57  Aligned_cols=253  Identities=28%  Similarity=0.437  Sum_probs=224.2

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEcc-----CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS  139 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~  139 (362)
                      .++...+....+.||+|+||+||+++...     +.+.||||.++...+..++.+|.+|++++..++|||||+++|++.+
T Consensus       481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~  560 (774)
T KOG1026|consen  481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE  560 (774)
T ss_pred             eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence            35667788888999999999999998653     3457999999988777799999999999999999999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC
Q 018018          140 NGAISIILEYMDGGSLADFLKKV--------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR  205 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~  205 (362)
                      ++.+++|+|||..|+|.+||+..              .+++..+.+.|+.||+.|+.||-+ +.+|||||..+|+||.++
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~-~~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS-HHFVHRDLATRNCLVGEN  639 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-Ccccccchhhhhceeccc
Confidence            99999999999999999999643              138899999999999999999998 899999999999999999


Q ss_pred             CcEEEeeccCCcccccCCCCCC--ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHH
Q 018018          206 GEVKITDFGVSAIMASTSGQAN--TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY  282 (362)
Q Consensus       206 ~~vkl~DFg~a~~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~  282 (362)
                      -.|||+|||+++...+......  ...-+.+|||||.+..++++.+|||||+||+|||+++ |..||.+...       .
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-------~  712 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-------Q  712 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch-------H
Confidence            9999999999988765443221  1234789999999999999999999999999999999 9999988554       4


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHH
Q 018018          283 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL  326 (362)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ei  326 (362)
                      ++++.+..+.. -..++.+|.++.+||..||+.+|++||++.||
T Consensus       713 EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  713 EVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            78888888777 55678999999999999999999999999998

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.7e-44  Score=323.40  Aligned_cols=256  Identities=33%  Similarity=0.519  Sum_probs=210.4

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .+.......||+|+||.||++++..++..||+|.+.... ......+.+|+.+++.++|+||+++++.+..+...++|+|
T Consensus         7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624           7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence            344445578999999999999999999999999987553 3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc-CCcEEEeeccCCcccccCCC
Q 018018          149 YMDGGSLADFLKKV-KTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       149 ~~~~gsL~~~l~~~-~~l--~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-~~~vkl~DFg~a~~~~~~~~  224 (362)
                      |+++++|.+++... ..+  ++..+..++.|++.||+|||+ +|++||||||+||+++. ++.++|+|||++........
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~  164 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD-NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP  164 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence            99999999999764 455  888999999999999999998 99999999999999976 67999999999876543333


Q ss_pred             CCCccccCCcccCcceecCCC--CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018018          225 QANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  302 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (362)
                      ......++..|+|||.+.+..  ++.++|+||+|+++|+|++|..||.......     .... ........+..+..++
T Consensus       165 ~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~-----~~~~-~~~~~~~~~~~~~~~~  238 (268)
T cd06624         165 CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-----AAMF-KVGMFKIHPEIPESLS  238 (268)
T ss_pred             ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh-----hhHh-hhhhhccCCCCCcccC
Confidence            334456889999999987644  7889999999999999999999996533211     0111 1111111223345688


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      +++.+++.+||+.+|++|||+.+++.||||
T Consensus       239 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         239 AEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            999999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.9e-44  Score=342.88  Aligned_cols=258  Identities=24%  Similarity=0.367  Sum_probs=210.0

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEE-----ccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeE
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQH-----KWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSF  137 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~  137 (362)
                      .+.+..++|++.+.||+|+||.||+++.     ..++..||+|+++..........+.+|+.++..+ +||||+++++.+
T Consensus        29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~  108 (375)
T cd05104          29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC  108 (375)
T ss_pred             ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence            3455567899999999999999999974     3456789999997654445566788999999999 899999999999


Q ss_pred             EecCeEEEEEeccCCCCHHHHHHHcC------------------------------------------------------
Q 018018          138 YSNGAISIILEYMDGGSLADFLKKVK------------------------------------------------------  163 (362)
Q Consensus       138 ~~~~~~~lV~e~~~~gsL~~~l~~~~------------------------------------------------------  163 (362)
                      .+.+..++||||+++|+|.+++....                                                      
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            99999999999999999999986421                                                      


Q ss_pred             ---------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          164 ---------------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       164 ---------------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                                           .+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++.....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS-KNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                                 46788899999999999999998 99999999999999999999999999999765433


Q ss_pred             CCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          223 SGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       223 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      ...  .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.......      .....+.... ....+.
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~~~~~~~~~-~~~~~~  340 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KFYKMIKEGY-RMLSPE  340 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HHHHHHHhCc-cCCCCC
Confidence            221  112334667999999999999999999999999999998 899997643221      1222222222 222234


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ..+.++.+||.+||+.||++|||+.|+++.
T Consensus       341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4.4e-45  Score=334.02  Aligned_cols=262  Identities=27%  Similarity=0.464  Sum_probs=213.2

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      ++|++.+.||+|+||.||++.+..+++.||+|++..... ......+.+|+++++.++||||+++++.+......++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            478999999999999999999998999999999765432 2345667899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      |+++++|..+......+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++............
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS-HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            99999998888776779999999999999999999998 99999999999999999999999999998776544433445


Q ss_pred             cccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHH-------HH------hcCC-C
Q 018018          229 FVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME-------AI------VDQP-P  293 (362)
Q Consensus       229 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~-------~~------~~~~-~  293 (362)
                      ..++..|+|||.+.+ ..++.++||||+|+++|+|++|..||...+..+..........       ..      .... .
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            678899999999876 3478899999999999999999999975432211111110000       00      0000 0


Q ss_pred             CC--------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          294 PS--------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       294 ~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      +.        .....++..+.+|+.+||+.+|++||++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            00        0123567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6.8e-44  Score=328.31  Aligned_cols=278  Identities=36%  Similarity=0.733  Sum_probs=227.7

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCe
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~  142 (362)
                      ...+..++|++.+.||+|+||.||++++..+++.||||+++.........++..|+.++... .|+||+++++.+.+...
T Consensus         9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618           9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            34567789999999999999999999999889999999998665445556667777766555 59999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          143 ISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .++||||+. +++.+++.. ...+++..+..++.|++.||+|||+..|++||||+|+||+++.++.+||+|||++.....
T Consensus        89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            999999985 478887765 457899999999999999999999735999999999999999999999999999876543


Q ss_pred             CCCCCCccccCCcccCcceecCCC----CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC-C
Q 018018          222 TSGQANTFVGTYNYMSPERISGGK----YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-A  296 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~  296 (362)
                      ... .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||......      .+..........+. .
T Consensus       168 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~  240 (296)
T cd06618         168 SKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE------FEVLTKILQEEPPSLP  240 (296)
T ss_pred             CCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH------HHHHHHHhcCCCCCCC
Confidence            222 22335788999999987654    788999999999999999999999653221      22333333332222 2


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHHHh
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA  349 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~~~  349 (362)
                      ....++.++.+|+.+||+.||++|||+++++.||||+.+....-+++.+|-+.
T Consensus       241 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~~~~~~~~  293 (296)
T cd06618         241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDVAGWFQDV  293 (296)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhHHHHHHHHHHH
Confidence            22347899999999999999999999999999999999999999999888764

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.1e-44  Score=331.71  Aligned_cols=264  Identities=25%  Similarity=0.399  Sum_probs=215.6

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc----hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE----ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      +|++.+.||+|++|.||++.+..+|+.||+|.++....    ......+..|+++++.++|+||+++++.+.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            47888999999999999999999999999999976532    23445677899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          147 LEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      |||+ +++|.+++.... .+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  158 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS-NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK  158 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence            9999 889999998766 79999999999999999999998 99999999999999999999999999999876544333


Q ss_pred             CCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC------------
Q 018018          226 ANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP------------  292 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~------------  292 (362)
                      .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+..+..   ...........            
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL---GKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH---HHHHHHcCCCchhhhhhcccccc
Confidence            444466888999998865 45789999999999999999998888765432211   11111110000            


Q ss_pred             -------C---CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          293 -------P---PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       293 -------~---~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                             .   ........+..+.++|.+||++||++|||+.|++.||||++.....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence                   0   0001134567899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.2e-44  Score=321.07  Aligned_cols=253  Identities=35%  Similarity=0.545  Sum_probs=216.5

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc----chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV----EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      +|+..+.||+|++|.||++....++..|++|.+....    .......+.+|+.+++.++|+||+++++.+.....+++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4677789999999999999999899999999986542    234567789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      +||+++++|.+++.+...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.+||+|||++....... ..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~  158 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD-RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FA  158 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEccCccceeccccc-cc
Confidence            9999999999999988889999999999999999999998 999999999999999999999999999987654332 23


Q ss_pred             CccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          227 NTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      ....++..|+|||.+.... ++.++|+||+|+++|+|++|..||.....       .............+..+..+++.+
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~  231 (258)
T cd06632         159 KSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-------VAAVFKIGRSKELPPIPDHLSDEA  231 (258)
T ss_pred             cccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-------HHHHHHHHhcccCCCcCCCcCHHH
Confidence            4456889999999988776 89999999999999999999999976432       122222222222233445688999


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          306 CSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      .+++.+||+.+|++||++.+++.|||+
T Consensus       232 ~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         232 KDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.1e-44  Score=324.78  Aligned_cols=254  Identities=29%  Similarity=0.513  Sum_probs=219.3

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      +|++.+.||.|+||.||++.+..++..||+|++....  .....+.+.+|+.+++.++||||+++++.+.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4889999999999999999999999999999987542  23456788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      |+.+++|.+++.....+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~  158 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHS-KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTS  158 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cccc
Confidence            99999999999887899999999999999999999998 999999999999999999999999999987654332 2344


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018018          229 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  308 (362)
Q Consensus       229 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  308 (362)
                      ..|+..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..    ...........  .....+..++..+.++
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~--~~~~~~~~~~~~~~~~  232 (258)
T cd05578         159 TSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT----IRDQIRAKQET--ADVLYPATWSTEAIDA  232 (258)
T ss_pred             cCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc----HHHHHHHHhcc--ccccCcccCcHHHHHH
Confidence            56888999999999888999999999999999999999999865432    11122222222  2233345688999999


Q ss_pred             HHHhhhcCcCCCCCH--HHHHcCCcc
Q 018018          309 ISACVQKEPQQRLSA--QELMTHPFL  332 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~--~eil~hp~~  332 (362)
                      |.+||+.||.+||++  .|+++||||
T Consensus       233 i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         233 INKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHccCChhHcCCccHHHHhcCCCC
Confidence            999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.1e-44  Score=333.17  Aligned_cols=260  Identities=34%  Similarity=0.613  Sum_probs=218.4

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +.|.....||+|+||.||++.+..++..||||.+... .......+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR-KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc-hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            4455567899999999999999999999999998654 334456688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      +++++|.+++.. +.+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++|+|||++.............
T Consensus       101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  178 (292)
T cd06658         101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHN-QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL  178 (292)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence            999999998865 578999999999999999999998 999999999999999999999999999987654333333456


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-CCCCCCCCCCHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSF  308 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  308 (362)
                      .++..|+|||.+.+..++.++|+||+|+++|||++|..||...+..       .....+.... ........++..+.++
T Consensus       179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l  251 (292)
T cd06658         179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL-------QAMRRIRDNLPPRVKDSHKVSSVLRGF  251 (292)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCCCccccccccCHHHHHH
Confidence            7899999999999888999999999999999999999999764321       1112221111 1112233578899999


Q ss_pred             HHHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          309 ISACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                      +.+||+.||++|||++++++||||+.....+
T Consensus       252 i~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~  282 (292)
T cd06658         252 LDLMLVREPSQRATAQELLQHPFLKLAGPPS  282 (292)
T ss_pred             HHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence            9999999999999999999999999887655

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6.4e-44  Score=323.11  Aligned_cols=253  Identities=30%  Similarity=0.514  Sum_probs=216.1

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++|++.+.||+|+||.||++++..+++.||||.++..  .+......+.+|+.+++.++||||+++++.+.+.+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            6899999999999999999999999999999988643  34455667889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          148 EYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       148 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ||+++++|.+++..    ...+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            99999999998853    3458999999999999999999998 999999999999999999999999999988765443


Q ss_pred             CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          224 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                      .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.....     ........+.....++.....++.
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLFSLCQKIEQCDYPPLPTEHYSE  235 (267)
T ss_pred             HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-----cHHHHHHHHhcCCCCCCChhhcCH
Confidence            333445788999999999988899999999999999999999999965322     122334444443444444456788


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .+.++|.+||+.+|++||++.++++
T Consensus       236 ~~~~li~~cl~~~p~~Rp~~~~vl~  260 (267)
T cd08228         236 KLRELVSMCIYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             HHHHHHHHHCCCCcccCcCHHHHHH
Confidence            9999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5.2e-44  Score=326.50  Aligned_cols=251  Identities=27%  Similarity=0.506  Sum_probs=204.0

Q ss_pred             eeeeeCCeEEEEEEEccCCcEEEEEEeecccc--hHHHHHHHHHH---HHHhcCCCCcceEEeeeEEecCeEEEEEeccC
Q 018018           77 VVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQEL---KINQSSQCPYVVVCYQSFYSNGAISIILEYMD  151 (362)
Q Consensus        77 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~---~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~  151 (362)
                      .||+|+||.||++.+..+++.+|+|++.....  ........+|.   .++...+||+|+.+++.+...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            48999999999999999999999999865421  11122233333   33444679999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcccc
Q 018018          152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG  231 (362)
Q Consensus       152 ~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~g  231 (362)
                      +++|.+++...+.+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||++......  ......|
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~  157 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVG  157 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCcCC
Confidence            99999999888899999999999999999999998 99999999999999999999999999998755332  2233578


Q ss_pred             CCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 018018          232 TYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS  310 (362)
Q Consensus       232 t~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  310 (362)
                      +..|+|||.+.+ ..++.++|+||+||++|+|++|..||........ .   .. ..... ......+..+++++.++|.
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~---~~-~~~~~-~~~~~~~~~~~~~~~~li~  231 (279)
T cd05633         158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-H---EI-DRMTL-TVNVELPDSFSPELKSLLE  231 (279)
T ss_pred             CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-H---HH-HHHhh-cCCcCCccccCHHHHHHHH
Confidence            999999999864 5589999999999999999999999976433211 1   11 11111 1222344568899999999


Q ss_pred             HhhhcCcCCCC-----CHHHHHcCCcccccC
Q 018018          311 ACVQKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       311 ~~L~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      +||+.||++||     |++++++||||+.+.
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             HHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence            99999999999     699999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=7.4e-44  Score=327.08  Aligned_cols=260  Identities=27%  Similarity=0.415  Sum_probs=208.0

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      ..+|.+.+.||+|+||.||++.+..+|..||+|+++..........+.+|+.+++.++|+||+++++.+......++|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            37899999999999999999999999999999998765444444466789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          149 YMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       149 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      |+. +++.+++.. ...+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||+++..........
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  161 (291)
T cd07870          84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHG-QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS  161 (291)
T ss_pred             ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence            996 577777654 3568899999999999999999998 9999999999999999999999999999876544333334


Q ss_pred             ccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh--------------c--
Q 018018          228 TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--------------D--  290 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~--------------~--  290 (362)
                      ...+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...+...  ....+......              .  
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (291)
T cd07870         162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVSKLPNYK  239 (291)
T ss_pred             CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhhhccccc
Confidence            45678999999998764 47889999999999999999999997643210  11111100000              0  


Q ss_pred             -----CCCCCC-----CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          291 -----QPPPSA-----PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       291 -----~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                           ...+..     .....++.+.+++.+||+.||++|||+.|++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         240 PEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             chhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                 000000     001235788999999999999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-44  Score=325.39  Aligned_cols=254  Identities=36%  Similarity=0.635  Sum_probs=211.1

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecC------
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNG------  141 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~------  141 (362)
                      .++|++.+.||+|++|.||++++..+++.+++|++.....  ....+.+|+.+++.+ .|+||+++++.+.+..      
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            3789999999999999999999998999999999875532  346788999999988 6999999999987644      


Q ss_pred             eEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          142 AISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      .+++||||+++++|.+++..    ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~-~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE-NKVIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEEccCCeEEECCCccce
Confidence            48999999999999999865    3579999999999999999999998 999999999999999999999999999987


Q ss_pred             ccccCCCCCCccccCCcccCcceecC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          218 IMASTSGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                      .............++..|+|||.+..     ..++.++||||||+++|+|++|..||......       .....+....
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~  234 (275)
T cd06608         162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-------RALFKIPRNP  234 (275)
T ss_pred             ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-------HHHHHhhccC
Confidence            66544444445678999999998754     34678999999999999999999999753221       1111222222


Q ss_pred             C-CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          293 P-PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       293 ~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      . .......++.++.+||.+||+.||++|||+.+++.|||+
T Consensus       235 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         235 PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            2 122223477899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.6e-45  Score=344.67  Aligned_cols=264  Identities=28%  Similarity=0.464  Sum_probs=235.4

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      ..+.....|.+.+.||+|.|++|.++++..++..||||++.++ .+...+..+.+|++++..++||||++++.+...+..
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            5556678899999999999999999999999999999999876 445556679999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      +|+||||+.+|.+++++.+++...+.+++.++.|++.|++|||+ ++|+|||||.+|||++.+.++||+|||++..+. .
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~-k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-~  207 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHS-KNIVHRDLKAENILLDENMNIKIADFGFSTFFD-Y  207 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhh-cceeccccchhhcccccccceeeeccccceeec-c
Confidence            99999999999999999999999999999999999999999998 999999999999999999999999999999876 5


Q ss_pred             CCCCCccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          223 SGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      .....+.||++.|.|||++.+..| ++.+|+||+|+++|.|+.|.+||.+..-       .++.++...+..  ..+..+
T Consensus       208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-------k~Lr~rvl~gk~--rIp~~m  278 (596)
T KOG0586|consen  208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-------KELRPRVLRGKY--RIPFYM  278 (596)
T ss_pred             cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-------ccccchheeeee--ccccee
Confidence            567788999999999999999887 6799999999999999999999987332       233444444432  233467


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      +.++.+||+++|-.+|.+|++.++++.|.|....-+.
T Consensus       279 s~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             echhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            8899999999999999999999999999999776555

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-45  Score=343.93  Aligned_cols=262  Identities=27%  Similarity=0.440  Sum_probs=226.9

Q ss_pred             CCCCCCCCCCccCceeeeeeeeeCCeEEEEEEEccCCc---E-EEEEEeec--ccchHHHHHHHHHHHHHhcCCCCcceE
Q 018018           59 LIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ---F-FALKVIQM--NVEESARRQIAQELKINQSSQCPYVVV  132 (362)
Q Consensus        59 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~-vaiK~~~~--~~~~~~~~~~~~e~~~~~~l~hp~I~~  132 (362)
                      ++..+.+++..++..+.+.||+|+||.||+++.+..+.   . ||+|..+.  ......+.++.+|+++++.++||||++
T Consensus       146 PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr  225 (474)
T KOG0194|consen  146 PIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVR  225 (474)
T ss_pred             cccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEE
Confidence            45667889999999999999999999999999876433   3 89999875  356788999999999999999999999


Q ss_pred             EeeeEEecCeEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEe
Q 018018          133 CYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT  211 (362)
Q Consensus       133 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~  211 (362)
                      +||+......+++|||+|+||+|.++|+..+ .++..+...++.+.+.||+|||+ ++++||||..+|+|++.++.+||+
T Consensus       226 ~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~-k~~IHRDIAARNcL~~~~~~vKIS  304 (474)
T KOG0194|consen  226 FYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHS-KNCIHRDIAARNCLYSKKGVVKIS  304 (474)
T ss_pred             EEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHH-CCCcchhHhHHHheecCCCeEEeC
Confidence            9999999999999999999999999999876 49999999999999999999998 999999999999999999999999


Q ss_pred             eccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhc
Q 018018          212 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD  290 (362)
Q Consensus       212 DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  290 (362)
                      |||+++............--+..|+|||.+..+.|++++||||+||++||+++ |..||.+...       .++..++..
T Consensus       305 DFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~-------~~v~~kI~~  377 (474)
T KOG0194|consen  305 DFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN-------YEVKAKIVK  377 (474)
T ss_pred             ccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH-------HHHHHHHHh
Confidence            99998765422111112234679999999999999999999999999999999 8889987543       466677755


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          291 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       291 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ...+...+...+.++..++.+||..+|++|||+.++.+
T Consensus       378 ~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  378 NGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             cCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            55555566688899999999999999999999999865

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.2e-44  Score=330.15  Aligned_cols=259  Identities=31%  Similarity=0.581  Sum_probs=219.4

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      ..+|++.+.||+|+||.||++.+..++..||+|.+.... ......+.+|+.+++.++||||+++++.+......++|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc-chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            378999999999999999999999899999999986542 2334668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      |+++++|.+++.+ ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++............
T Consensus        97 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~-~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~  174 (293)
T cd06647          97 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (293)
T ss_pred             cCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh-CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence            9999999999876 468899999999999999999998 99999999999999999999999999988766544433444


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018018          229 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  308 (362)
Q Consensus       229 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  308 (362)
                      ..+++.|+|||.+.+..++.++|+||+|+++|++++|..||...+...      ..........+....+..++..+.++
T Consensus       175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~l  248 (293)
T cd06647         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIATNGTPELQNPEKLSAIFRDF  248 (293)
T ss_pred             ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh------heeehhcCCCCCCCCccccCHHHHHH
Confidence            578899999999998889999999999999999999999997643321      11111112222222344578899999


Q ss_pred             HHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          309 ISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      |++||+.+|++||++.+++.|+||+...
T Consensus       249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         249 LNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            9999999999999999999999998775

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.1e-44  Score=327.15  Aligned_cols=255  Identities=33%  Similarity=0.542  Sum_probs=209.2

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEE-----ecC
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFY-----SNG  141 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~-----~~~  141 (362)
                      ..++|++.+.||+|+||.||++++..+++.+|+|++....  .....+..|+.+++.+ +||||+++++.+.     .+.
T Consensus        16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   93 (286)
T cd06638          16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD   93 (286)
T ss_pred             cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence            4588999999999999999999999999999999976432  2235577888888888 6999999999874     346


Q ss_pred             eEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          142 AISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      ..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nili~~~~~~kl~dfg~~~  172 (286)
T cd06638          94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV-NKTIHRDVKGNNILLTTEGGVKLVDFGVSA  172 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh-CCccccCCCHHhEEECCCCCEEEccCCcee
Confidence            79999999999999998753    3568999999999999999999998 999999999999999999999999999987


Q ss_pred             ccccCCCCCCccccCCcccCcceecC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          218 IMASTSGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                      .............|++.|+|||.+..     ..++.++||||+||++|+|++|..||.......      ... ......
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~------~~~-~~~~~~  245 (286)
T cd06638         173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR------ALF-KIPRNP  245 (286)
T ss_pred             ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH------HHh-hccccC
Confidence            76543333445578999999998853     447889999999999999999999997643321      111 111111


Q ss_pred             -CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          293 -PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       293 -~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                       .....+..++..+.++|.+||+.||++|||+.|+++|+||
T Consensus       246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence             1122234567899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.5e-43  Score=319.81  Aligned_cols=255  Identities=34%  Similarity=0.611  Sum_probs=216.5

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +|++.+.||+|+||.||++.+..+++.||+|+++.... ......+.+|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            58889999999999999999998999999999876633 35678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC---
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA---  226 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~---  226 (362)
                      +++++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||++..........   
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS-HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            9999999999987789999999999999999999998 999999999999999999999999999988765433222   


Q ss_pred             -CccccCCcccCcceecCCC---CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC-CCCCCCCCCC
Q 018018          227 -NTFVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ-PPPSAPSDQF  301 (362)
Q Consensus       227 -~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  301 (362)
                       ....++..|+|||.+.+..   ++.++||||+|+++|++++|..||...+..  +    .....+... ....+....+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~----~~~~~~~~~~~~~~~~~~~~  233 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--F----QIMFHVGAGHKPPIPDSLQL  233 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--H----HHHHHHhcCCCCCCCccccc
Confidence             1356788999999998766   889999999999999999999999754321  1    111122222 1112222345


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      ++.+.++|.+||+.+|++|||+++++.|||+
T Consensus       234 ~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         234 SPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            8899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.3e-44  Score=330.51  Aligned_cols=264  Identities=24%  Similarity=0.402  Sum_probs=211.7

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-hHHHHHHHHHHHHHhcCCCCcceEEeeeEEec--CeEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAIS  144 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~--~~~~  144 (362)
                      ..++|++.+.||+|+||.||++.+..+|+.||+|+++.... ......+.+|+.+++.++|+||+++++.+.+.  ...+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            45889999999999999999999999999999999875432 22233466799999999999999999988754  5689


Q ss_pred             EEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          145 IILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      +||||+.+ +|.+++.. ...+++..+..++.|++.||+|||+ .|++||||||+||+++.++.+||+|||++.......
T Consensus        85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHE-NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            99999965 89888876 3679999999999999999999998 999999999999999999999999999998765443


Q ss_pred             CCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC-----------
Q 018018          224 GQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ-----------  291 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-----------  291 (362)
                      .......++..|+|||.+.+ ..++.++||||+||++|+|++|..||.+.+..+....   ........           
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL---IIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCChhhchhhhcc
Confidence            33333456788999999876 4579999999999999999999999986543221111   11110000           


Q ss_pred             ------CCCCC-------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          292 ------PPPSA-------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       292 ------~~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                            ..+..       .....++.+.++|.+||+.||++|||+++++.||||+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~  297 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP  297 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence                  00000       0122578899999999999999999999999999998654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.8e-44  Score=323.57  Aligned_cols=258  Identities=33%  Similarity=0.529  Sum_probs=211.2

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc---------hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE---------ESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      +|.+.+.||+|+||.||++.+..+|+.+|+|.++....         ....+.+.+|+.+++.++||||+++++.+....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            47788999999999999999999999999998864311         112356788999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ..++||||+++++|.+++...+.+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS-KGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh-CCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            999999999999999999888899999999999999999999998 9999999999999999999999999999876532


Q ss_pred             CCC--CCCccccCCcccCcceecCCC--CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          222 TSG--QANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       222 ~~~--~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      ...  ......++..|+|||.+.+..  ++.++|+||||+++|++++|..||...+...   ..............+...
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~  237 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA---AMFKLGNKRSAPPIPPDV  237 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH---HHHHhhccccCCcCCccc
Confidence            211  123346788999999987755  7899999999999999999999996532211   111111111111112222


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      ...++..+.++|.+||+.+|++|||++++++||||
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            33568899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.6e-44  Score=327.08  Aligned_cols=257  Identities=26%  Similarity=0.501  Sum_probs=209.6

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +|+..+.||.|++|.||++++..+|+.||||.++... .......+.+|+++++.++||||+++++.+.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4888999999999999999999999999999987543 223345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          150 MDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       150 ~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      +. ++|.+++..  ...+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~-~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence            96 589998865  3568999999999999999999998 9999999999999999999999999999876544333334


Q ss_pred             ccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--------------
Q 018018          228 TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--------------  292 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------  292 (362)
                      ...++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...+..+   .............              
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            446788999999987654 6889999999999999999999997644321   1111111110000              


Q ss_pred             --CC-------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          293 --PP-------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       293 --~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                        .+       ......+++.+.++|.+||+.||++|||+++++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence              00       00113467889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.2e-43  Score=317.28  Aligned_cols=252  Identities=33%  Similarity=0.561  Sum_probs=215.0

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +|+..+.||+|+||.||++.+..+++.+|+|.+... ........+.+|+.+++.++||||+++++.+......++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            588999999999999999999999999999998754 2344567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC-cEEEeeccCCcccccCCCCC
Q 018018          150 MDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       150 ~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-~vkl~DFg~a~~~~~~~~~~  226 (362)
                      +++++|.+++...  ..+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++ .++|+|||++....... ..
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-~~  158 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT-KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-KA  158 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-cc
Confidence            9999999999764  358999999999999999999998 9999999999999998654 68999999988764332 23


Q ss_pred             CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018018          227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  306 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (362)
                      ....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..       ........... ...+..+++++.
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~l~  230 (256)
T cd08220         159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-------ALVLKIMSGTF-APISDRYSPDLR  230 (256)
T ss_pred             cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-------HHHHHHHhcCC-CCCCCCcCHHHH
Confidence            3456889999999999888999999999999999999999999764321       22223332222 223456889999


Q ss_pred             HHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          307 SFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       307 ~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      +++.+||+.+|++|||+.|++.||||
T Consensus       231 ~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         231 QLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHHccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.5e-43  Score=324.74  Aligned_cols=262  Identities=23%  Similarity=0.379  Sum_probs=214.9

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEcc-----CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      ++..++|++.+.||+|+||.||++.++.     .+..||+|.++..........+.+|+.+++.++||||+++++.+...
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4567899999999999999999987653     35589999987654444556688899999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEE
Q 018018          141 GAISIILEYMDGGSLADFLKKV----------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI  210 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl  210 (362)
                      ...++||||+++|+|.+++...          ..++...+..++.|++.||.|||+ +|++||||||+||+++.++.++|
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA-KKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999999753          234677889999999999999998 99999999999999999999999


Q ss_pred             eeccCCcccccCCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHH
Q 018018          211 TDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEA  287 (362)
Q Consensus       211 ~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~  287 (362)
                      +|||+++........  .....++..|+|||.+.++.++.++|+|||||++|||++ |..||.+.+.       .+....
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-------~~~~~~  233 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-------EQVLKF  233 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHH
Confidence            999998765332211  112245678999999999899999999999999999998 7889976432       233333


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc------CCcccccC
Q 018018          288 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT------HPFLKMYG  336 (362)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~------hp~~~~~~  336 (362)
                      +...... ..+...++.+.+++.+||+.||++|||+.++++      ||||+...
T Consensus       234 ~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~  287 (288)
T cd05061         234 VMDGGYL-DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS  287 (288)
T ss_pred             HHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCC
Confidence            3333222 223467899999999999999999999999987      99998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-44  Score=328.45  Aligned_cols=259  Identities=25%  Similarity=0.511  Sum_probs=214.3

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      ++|++.+.||+|+||.||++.+..+++.||+|+++.. ........+.+|+++++.++|+||+++++.+...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            3689999999999999999999999999999998754 234456778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC-CCC
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QAN  227 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~-~~~  227 (362)
                      |++++.+..+......+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS-HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            99987777777766779999999999999999999998 9999999999999999999999999999887654432 334


Q ss_pred             ccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc----------------
Q 018018          228 TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD----------------  290 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----------------  290 (362)
                      ...++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+....+.   ..........                
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ---LYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHHhhhcccCcccc
Confidence            46788999999999888 789999999999999999999999976433211   1111000000                


Q ss_pred             C--CCC--------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          291 Q--PPP--------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       291 ~--~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      .  ...        ...+..+++++.+||.+||+.+|++|||+++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            0  000        01122358889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6.7e-44  Score=325.16  Aligned_cols=253  Identities=30%  Similarity=0.482  Sum_probs=212.0

Q ss_pred             eeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCCH
Q 018018           78 VGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  155 (362)
Q Consensus        78 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL  155 (362)
                      ||+|+||+||+|.+..+|+.||+|++....  .......+..|+.+++.++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999999999999999987542  223345567899999999999999999999999999999999999999


Q ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCC
Q 018018          156 ADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY  233 (362)
Q Consensus       156 ~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~  233 (362)
                      .+++....  .+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++..... ........++.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~  158 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ-RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRAGTP  158 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccccCCC
Confidence            99997765  79999999999999999999998 9999999999999999999999999999876543 22233456788


Q ss_pred             cccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhh
Q 018018          234 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV  313 (362)
Q Consensus       234 ~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  313 (362)
                      .|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.....   ..+......  .+...+..+++.+.++|.+||
T Consensus       159 ~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l  233 (277)
T cd05577         159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EELKRRTLE--MAVEYPDKFSPEAKDLCEALL  233 (277)
T ss_pred             CcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HHHHhcccc--ccccCCccCCHHHHHHHHHHc
Confidence            999999998888999999999999999999999999765442211   122222221  122334567899999999999


Q ss_pred             hcCcCCCC-----CHHHHHcCCcccccCC
Q 018018          314 QKEPQQRL-----SAQELMTHPFLKMYGD  337 (362)
Q Consensus       314 ~~dP~~Rp-----t~~eil~hp~~~~~~~  337 (362)
                      +.||++||     ++.+++.||||.....
T Consensus       234 ~~~p~~R~~~~~~~~~~ll~h~~~~~~~~  262 (277)
T cd05577         234 QKDPEKRLGCRGGSADEVREHPLFKDLNW  262 (277)
T ss_pred             cCChhHccCCCcccHHHHHhChhhhcCCh
Confidence            99999999     8899999999987654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.8e-44  Score=338.22  Aligned_cols=264  Identities=26%  Similarity=0.457  Sum_probs=211.3

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec------C
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------G  141 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~------~  141 (362)
                      ..+|++.+.||+|+||.||++.+..+|+.||+|++... ........+.+|+.+++.++||||+++++.+...      .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            47899999999999999999999999999999998654 2334456677899999999999999999987643      3


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ..|+||||+.+ +|.+.+...  +++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++.....
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850          95 DVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             cEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            57999999964 898888753  9999999999999999999998 9999999999999999999999999999976543


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH---------------HH
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL---------------ME  286 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~---------------~~  286 (362)
                      .. ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..+.+..+...               ..
T Consensus       171 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (353)
T cd07850         171 SF-MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVR  249 (353)
T ss_pred             CC-CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhh
Confidence            22 233456889999999999999999999999999999999999999765432211111100               00


Q ss_pred             HHhcCCC----------------CC---CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          287 AIVDQPP----------------PS---APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       287 ~~~~~~~----------------~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      .......                +.   ......++.+.++|.+||+.||++|||+.|++.||||+.|-.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         250 NYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             HHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence            0000000                00   001234667899999999999999999999999999986543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.7e-43  Score=321.10  Aligned_cols=249  Identities=27%  Similarity=0.483  Sum_probs=204.0

Q ss_pred             cCceeeeee--eeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHh-cCCCCcceEEeeeEEecCeEEEE
Q 018018           70 EDIDTIKVV--GKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQ-SSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        70 ~~~~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~-~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      ++|++.+.+  |+|+||.||++.++.++..+|+|++........      |..... ..+||||+++++.+...+..++|
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI------EPMVHQLMKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh------hHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence            455666665  999999999999999999999999875421111      111221 12799999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC-cEEEeeccCCcccccCCCC
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-~vkl~DFg~a~~~~~~~~~  225 (362)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++ .++|+|||++.....    
T Consensus        88 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~----  162 (267)
T PHA03390         88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK-HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT----  162 (267)
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC----
Confidence            9999999999999888899999999999999999999998 9999999999999999988 999999999876532    


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      .....++..|+|||++.+..++.++|+||+|+++|+|++|..||......+  .....+.... .  ........+++.+
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~-~--~~~~~~~~~~~~~  237 (267)
T PHA03390        163 PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE--LDLESLLKRQ-Q--KKLPFIKNVSKNA  237 (267)
T ss_pred             CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch--hhHHHHHHhh-c--ccCCcccccCHHH
Confidence            223468899999999999899999999999999999999999998543322  1112222222 2  1223344789999


Q ss_pred             HHHHHHhhhcCcCCCCC-HHHHHcCCcccc
Q 018018          306 CSFISACVQKEPQQRLS-AQELMTHPFLKM  334 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt-~~eil~hp~~~~  334 (362)
                      .++|.+||+.+|++||+ ++++++||||++
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            99999999999999996 699999999974

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4e-44  Score=330.21  Aligned_cols=258  Identities=34%  Similarity=0.632  Sum_probs=216.9

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      ..|+....||+|+||.||++.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+..+...++|+||
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            345556689999999999999999999999999865432 3345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      +++++|..++.. ..+++..+..++.|++.||+|||+ +|++||||+|+||+++.++.++|+|||++.............
T Consensus       100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  177 (297)
T cd06659         100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHS-QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  177 (297)
T ss_pred             CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence            999999998765 678999999999999999999998 999999999999999999999999999987654433334456


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-CCCCCCCCCCHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSF  308 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  308 (362)
                      .++..|+|||.+.+..++.++|+||+||++|+|++|+.||...+..       +....+.... ........++..+.++
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~~  250 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV-------QAMKRLRDSPPPKLKNAHKISPVLRDF  250 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHhccCCCCccccCCCCHHHHHH
Confidence            7899999999999888999999999999999999999999754321       1222222221 1222334678899999


Q ss_pred             HHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          309 ISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      |.+||+.+|++||+++++++||||.....
T Consensus       251 i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         251 LERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             HHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence            99999999999999999999999987753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.6e-44  Score=326.95  Aligned_cols=260  Identities=26%  Similarity=0.474  Sum_probs=211.4

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEecc
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  150 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~  150 (362)
                      +|++.+.||.|++|.||++++..+|..||||+++..........+.+|+.+++.++|+||+++++.+.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            58899999999999999999999999999999987644444566778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          151 DGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       151 ~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      ++ +|.+++...   ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE-NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS  158 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence            75 899988654   368999999999999999999998 9999999999999999999999999999876544333334


Q ss_pred             ccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH--------HHHhcC-----CC
Q 018018          228 TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM--------EAIVDQ-----PP  293 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~~~-----~~  293 (362)
                      ...++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+.+..+......+..        ..+...     ..
T Consensus       159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07836         159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF  238 (284)
T ss_pred             cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence            45678899999998664 57899999999999999999999998765432211111110        000000     00


Q ss_pred             CC-------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          294 PS-------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       294 ~~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      +.       ......++.+.++|.+||+.||++||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            00       0012457889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=353.40  Aligned_cols=253  Identities=28%  Similarity=0.406  Sum_probs=212.4

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeee-EEe----
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQS-FYS----  139 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~-~~~----  139 (362)
                      .+...++++.+.|.+|||+.||+|++...|..||+|.+-.. ++...+.+.+|+++|+.|. |+|||.+++. ...    
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            45567888999999999999999999988899999998666 8888899999999999998 9999999993 221    


Q ss_pred             --cCeEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCC--eEeecCCCCcEEEccCCcEEEeec
Q 018018          140 --NGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLINHRGEVKITDF  213 (362)
Q Consensus       140 --~~~~~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~vkl~DF  213 (362)
                        ..+++|+||||.||.|-+++..  ...|++.++++|++|+++|+++||. ..  |||||||-+||||+.+|+.|||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcc
Confidence              2457899999999999999974  3569999999999999999999998 65  999999999999999999999999


Q ss_pred             cCCcccccCCCCCCc---------cccCCcccCccee---cCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhH
Q 018018          214 GVSAIMASTSGQANT---------FVGTYNYMSPERI---SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF  281 (362)
Q Consensus       214 g~a~~~~~~~~~~~~---------~~gt~~y~aPE~~---~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~  281 (362)
                      |.|............         ...|+.|+|||.+   .+...++|+|||+|||+||.|+....||+.....      
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------  264 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------  264 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------
Confidence            998765433321111         2468999999975   6778899999999999999999999999864221      


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCc
Q 018018          282 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  331 (362)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~  331 (362)
                           .|..+....+....++..+.+||+.||+.||++||++.+++.+-+
T Consensus       265 -----aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  265 -----AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             -----eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence                 233343333444688999999999999999999999999987644

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.2e-44  Score=328.10  Aligned_cols=265  Identities=23%  Similarity=0.449  Sum_probs=213.1

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +++|++.+.||+|++|.||++.+..+|+.||+|.++... .......+.+|+++++.++||||+++++.+.+....++||
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence            368999999999999999999999999999999986542 2234466888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc-CCcEEEeeccCCcccccCCC
Q 018018          148 EYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-~~~vkl~DFg~a~~~~~~~~  224 (362)
                      ||++ ++|.+++....  .+++..+..++.|++.||+|||+ +|++|+||+|+||+++. ++.+||+|||++........
T Consensus        81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~  158 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS-HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR  158 (294)
T ss_pred             eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence            9996 58888886544  35888899999999999999998 99999999999999985 56799999999976543333


Q ss_pred             CCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-----------
Q 018018          225 QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-----------  292 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-----------  292 (362)
                      ......+++.|+|||.+.+. .++.++||||+|+++|+|++|..||...+..+.   ............           
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE---LFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChhhccccccch
Confidence            33445678899999998764 578999999999999999999999976543211   111111110000           


Q ss_pred             ------C--CC----CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          293 ------P--PS----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       293 ------~--~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                            .  +.    .....+++++.+++.+||+.+|++||++.+++.||||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~~  293 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA  293 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhcC
Confidence                  0  00    0123567889999999999999999999999999999988753

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-45  Score=318.56  Aligned_cols=262  Identities=27%  Similarity=0.417  Sum_probs=223.4

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeEEEEEeccCCCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGS  154 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~~lV~e~~~~gs  154 (362)
                      +.||+|+|+.|--|....+|..||||++.+. ....+.++.+|++++..++ |+||++++++|+++..+|||||-+.||+
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            6799999999999999999999999999876 5567788999999998875 9999999999999999999999999999


Q ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC---cEEEeeccCCcccccCC-------C
Q 018018          155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTS-------G  224 (362)
Q Consensus       155 L~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~---~vkl~DFg~a~~~~~~~-------~  224 (362)
                      |...|.++..+++.++.++..+++.||.+||. +||+|||+||+|||.....   -||||||.+..-.....       .
T Consensus       163 lLshI~~~~~F~E~EAs~vvkdia~aLdFlH~-kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP  241 (463)
T KOG0607|consen  163 LLSHIQKRKHFNEREASRVVKDIASALDFLHT-KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP  241 (463)
T ss_pred             HHHHHHHhhhccHHHHHHHHHHHHHHHHHHhh-cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence            99999999999999999999999999999998 9999999999999996654   38999999875543221       1


Q ss_pred             CCCccccCCcccCcceec---C--CCCCccccHHHHHHHHHHHHcCCCCCCCCccCC-------chhh-HHHHHHHHhcC
Q 018018          225 QANTFVGTYNYMSPERIS---G--GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD-------GWTS-FYELMEAIVDQ  291 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~---~--~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~-------~~~~-~~~~~~~~~~~  291 (362)
                      ...+.+|+..|||||+..   +  ..|+.++|.||||+++|-|++|.+||.+.-..+       .... ...+++.+..+
T Consensus       242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG  321 (463)
T KOG0607|consen  242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG  321 (463)
T ss_pred             cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc
Confidence            234568999999999863   2  348999999999999999999999998754322       2222 23466777766


Q ss_pred             CC--CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          292 PP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       292 ~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                      ..  |...+..++.+..+||+.+|-.|+.+|.++.++++|||++....++
T Consensus       322 kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ek  371 (463)
T KOG0607|consen  322 KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEK  371 (463)
T ss_pred             CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhc
Confidence            54  3445677899999999999999999999999999999999887653

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1e-43  Score=320.51  Aligned_cols=251  Identities=34%  Similarity=0.555  Sum_probs=213.9

Q ss_pred             eeeeCCeEEEEEEEccCCcEEEEEEeecccc--hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCCH
Q 018018           78 VGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  155 (362)
Q Consensus        78 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL  155 (362)
                      ||.|+||.||++++..+|+.+|+|++.....  ......+.+|+.+++.++||||+++++.+......++|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999999999999999875422  34567788999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC--------CCC
Q 018018          156 ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--------QAN  227 (362)
Q Consensus       156 ~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~--------~~~  227 (362)
                      .+++.+...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++........        ...
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  159 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHS-NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK  159 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence            9999987899999999999999999999998 9999999999999999999999999999876543321        223


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  307 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (362)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|..||.....       ......+............+++.+.+
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (265)
T cd05579         160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-------EEIFQNILNGKIEWPEDVEVSDEAID  232 (265)
T ss_pred             CcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCcCCCccccCCHHHHH
Confidence            35678899999999888899999999999999999999999976432       23333444333333322335899999


Q ss_pred             HHHHhhhcCcCCCCCH---HHHHcCCcccccC
Q 018018          308 FISACVQKEPQQRLSA---QELMTHPFLKMYG  336 (362)
Q Consensus       308 li~~~L~~dP~~Rpt~---~eil~hp~~~~~~  336 (362)
                      ++.+||+.+|++|||+   .++++||||+...
T Consensus       233 ~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~  264 (265)
T cd05579         233 LISKLLVPDPEKRLGAKSIEEIKNHPFFKGID  264 (265)
T ss_pred             HHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence            9999999999999999   9999999998653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-45  Score=333.63  Aligned_cols=268  Identities=28%  Similarity=0.468  Sum_probs=229.2

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      .+..+.|...++||+|+||.||-|+.+.+|+.||+|.+.+.  .........+.|..++.+.+.++||.+--+|++.+.+
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L  260 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL  260 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence            34567888999999999999999999999999999987543  2223344567899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          144 SIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ++|+..|.||+|.-.|-+.+  .+++..++.++.+|+.||++||+ .+||.||+||+|||+|+.|+++|+|.|+|..+..
T Consensus       261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~-~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR-RRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh-cceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            99999999999999997765  79999999999999999999998 8999999999999999999999999999988754


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      .. .....+||..|||||++.++.|+...|+|||||++|||+.|+.||........+.   ++-+++....  ...++++
T Consensus       340 g~-~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e---Evdrr~~~~~--~ey~~kF  413 (591)
T KOG0986|consen  340 GK-PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE---EVDRRTLEDP--EEYSDKF  413 (591)
T ss_pred             CC-ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH---HHHHHHhcch--hhccccc
Confidence            33 3344599999999999999999999999999999999999999998765543332   3333333333  2334789


Q ss_pred             CHHHHHHHHHhhhcCcCCCC-----CHHHHHcCCcccccCCCCC
Q 018018          302 SPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGDLNV  340 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~~~~~  340 (362)
                      ++++++|.+.+|++||++|.     +++++.+||||+......+
T Consensus       414 S~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl  457 (591)
T KOG0986|consen  414 SEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL  457 (591)
T ss_pred             CHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence            99999999999999999998     5789999999998765444

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=8.9e-44  Score=325.26  Aligned_cols=258  Identities=29%  Similarity=0.496  Sum_probs=211.4

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +|++.+.||+|++|.||++.+..+|..||+|++.... .......+.+|+.+++.++||||+++++.+..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            5889999999999999999999999999999987653 244456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC-CCC
Q 018018          150 MDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QAN  227 (362)
Q Consensus       150 ~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~-~~~  227 (362)
                      + +++|.+++.. ...+++..++.++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++........ ...
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHA-NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence            9 9999999865 4579999999999999999999998 9999999999999999999999999999887654322 233


Q ss_pred             ccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--------------
Q 018018          228 TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--------------  292 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------  292 (362)
                      ...++..|+|||.+.+.. ++.++||||+|+++|+|++|.+||.+......+   ...........              
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHHHhhccCcchhh
Confidence            457889999999987644 689999999999999999998888664332111   11111110000              


Q ss_pred             ---CC-------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccc
Q 018018          293 ---PP-------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  333 (362)
Q Consensus       293 ---~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  333 (362)
                         .+       .......+..+.++|.+||+.+|++|||+++++.||||.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence               00       001124568899999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.7e-44  Score=327.69  Aligned_cols=259  Identities=26%  Similarity=0.437  Sum_probs=210.5

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch-HHHHHHHHHHHHHhcCCCCcceEEeeeEEec--CeEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-SARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISI  145 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~--~~~~l  145 (362)
                      .++|++.+.||.|+||.||+|++..+++.+|+|.++..... .....+.+|+.+++.++||||+++++.+...  ...++
T Consensus         4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence            46899999999999999999999999999999999765322 2334567899999999999999999998877  89999


Q ss_pred             EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          146 ILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      |+||+++ +|.+++.... .+++..++.++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||++........
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD-NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence            9999975 9999987644 58999999999999999999998 9999999999999999999999999999887655433


Q ss_pred             CCCccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc-------------
Q 018018          225 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD-------------  290 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------------  290 (362)
                      ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||...+..+..   .........             
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQL---NKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCchHHHHHhhccc
Confidence            344456788999999987644 689999999999999999999999765432111   111110000             


Q ss_pred             ----C--------CCCCCCCCC-CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          291 ----Q--------PPPSAPSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       291 ----~--------~~~~~~~~~-~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                          .        ......+.. +++.+.++|.+||+.||++|||+.|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                0        000011111 57889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.5e-43  Score=322.28  Aligned_cols=254  Identities=25%  Similarity=0.388  Sum_probs=211.8

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEc----cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHK----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      +.+.+|++.+.||+|+||+||++...    .++..+|+|.+...........+.+|+.+++.++||||+++++.+.....
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   81 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP   81 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence            45688999999999999999999853    45678999998765555566788899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC
Q 018018          143 ISIILEYMDGGSLADFLKKV-----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR  205 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~  205 (362)
                      .++||||+++++|.+++...                 ..+++..+..++.|++.||+|||+ +|++||||||+||+++.+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~nili~~~  160 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS-HFFVHKDLAARNILIGEQ  160 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-cCeehhccccceEEEcCC
Confidence            99999999999999998532                 247888999999999999999998 999999999999999999


Q ss_pred             CcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHH
Q 018018          206 GEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY  282 (362)
Q Consensus       206 ~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~  282 (362)
                      +.+||+|||+++.......  ......++..|+|||.+.+..++.++|+|||||++|||++ |..||.+...       .
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-------~  233 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-------Q  233 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-------H
Confidence            9999999999976543221  1233345678999999998889999999999999999998 9999976432       2


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          283 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .....+..... ...+..+++.+.+++.+||+.||++||++.+++++
T Consensus       234 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         234 EVIEMVRKRQL-LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            33333333332 23446788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4e-43  Score=324.94  Aligned_cols=255  Identities=32%  Similarity=0.538  Sum_probs=214.0

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      .+.|...+.||+|+||.||++++..+++.||+|++...  ........+.+|+.+++.++||||+++++.+.+....++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            36699999999999999999999999999999998644  2334456788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          147 LEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      +||+. |++.+++.. ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.....    
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~-~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~----  167 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHS-HERIHRDIKAGNILLTEPGTVKLADFGSASLVSP----  167 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEECCCCCEEEeecCcceecCC----
Confidence            99997 588777754 4679999999999999999999998 9999999999999999999999999999865432    


Q ss_pred             CCccccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018018          226 ANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  302 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (362)
                      .....++..|+|||++.   ...++.++||||+|+++|+|++|..||.+.+..       .....+.....+......++
T Consensus       168 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~  240 (307)
T cd06607         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNDSPTLSSNDWS  240 (307)
T ss_pred             CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-------HHHHHHhcCCCCCCCchhhC
Confidence            23456788999999984   356889999999999999999999999764321       22222333333333344578


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ..+.++|.+||+.||++||++.+++.||||..-.
T Consensus       241 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         241 DYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            8999999999999999999999999999998754

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.5e-43  Score=314.91  Aligned_cols=253  Identities=38%  Similarity=0.639  Sum_probs=220.7

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +|.+.+.||.|+||.||++.+..++..||+|++.... .......+.+|+++++.++|+|++++.+.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5888999999999999999999999999999987653 335667788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          150 MDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       150 ~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      +++++|.+++...    ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS-RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence            9999999999764    779999999999999999999998 89999999999999999999999999998876554433


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      .....|++.|+|||.+.+..++.++|+||+|+++++|++|..||...+.       ............ ...+..++..+
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~  231 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-------LELALKILKGQY-PPIPSQYSSEL  231 (258)
T ss_pred             ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-------HHHHHHHhcCCC-CCCCCCCCHHH
Confidence            4456789999999999988899999999999999999999999966432       233344444333 23345788999


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          306 CSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      .+++.+||..+|++|||+.+++.||||
T Consensus       232 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         232 RNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.2e-43  Score=332.78  Aligned_cols=257  Identities=25%  Similarity=0.392  Sum_probs=209.2

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEcc-----CCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEE
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFY  138 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~  138 (362)
                      +++..++|++.+.||+|+||.||++.+..     +++.||+|+++..........+.+|+.++..+ +|+||+++++.+.
T Consensus         2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~   81 (337)
T cd05054           2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT   81 (337)
T ss_pred             cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence            45566789999999999999999997543     45789999987654445556788999999998 7999999999876


Q ss_pred             e-cCeEEEEEeccCCCCHHHHHHHc-------------------------------------------------------
Q 018018          139 S-NGAISIILEYMDGGSLADFLKKV-------------------------------------------------------  162 (362)
Q Consensus       139 ~-~~~~~lV~e~~~~gsL~~~l~~~-------------------------------------------------------  162 (362)
                      . +..++++|||+++++|.+++...                                                       
T Consensus        82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (337)
T cd05054          82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE  161 (337)
T ss_pred             cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence            4 46788999999999999998542                                                       


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC--CCCccccCCc
Q 018018          163 ------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYN  234 (362)
Q Consensus       163 ------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~  234 (362)
                            ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.++|+|||+++.......  ......++..
T Consensus       162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         162 GDELYKEPLTLEDLISYSFQVARGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hhHHhhcCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence                  267899999999999999999998 9999999999999999999999999999987543221  1223455778


Q ss_pred             ccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhh
Q 018018          235 YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV  313 (362)
Q Consensus       235 y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  313 (362)
                      |+|||++.+..++.++|||||||++|||++ |..||.+....+      .....+.... ....+...++++.+++.+||
T Consensus       241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~-~~~~~~~~~~~~~~l~~~cl  313 (337)
T cd05054         241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGT-RMRAPEYATPEIYSIMLDCW  313 (337)
T ss_pred             ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccC-CCCCCccCCHHHHHHHHHHc
Confidence            999999999999999999999999999998 999997643321      1222222222 22234567899999999999


Q ss_pred             hcCcCCCCCHHHHHcC
Q 018018          314 QKEPQQRLSAQELMTH  329 (362)
Q Consensus       314 ~~dP~~Rpt~~eil~h  329 (362)
                      +.+|++||+++|+++|
T Consensus       314 ~~~p~~RPs~~ell~~  329 (337)
T cd05054         314 HNNPEDRPTFSELVEI  329 (337)
T ss_pred             cCChhhCcCHHHHHHH
Confidence            9999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.2e-43  Score=321.68  Aligned_cols=255  Identities=24%  Similarity=0.368  Sum_probs=209.5

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEc-----cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      .+..++|++.+.||+|+||.||++.+.     .++..||+|++..........++.+|+.+++.++||||+++++.+.+.
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            345688999999999999999998864     245689999986554444566788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEE
Q 018018          141 GAISIILEYMDGGSLADFLKKVK----------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI  210 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~----------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl  210 (362)
                      ...++||||+++++|.+++....          .++...+..++.|++.||+|||+ .|++|+||||+||+++.++.++|
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCcchheEEEcCCCCEEE
Confidence            99999999999999999997532          35778899999999999999998 99999999999999999999999


Q ss_pred             eeccCCcccccCCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHH
Q 018018          211 TDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEA  287 (362)
Q Consensus       211 ~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~  287 (362)
                      +|||+++........  .....+++.|+|||.+.++.++.++|||||||++|||++ |..||.....       .+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~-------~~~~~~  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN-------EQVLRF  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHH
Confidence            999998765332211  112345778999999999899999999999999999999 7889976432       123333


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          288 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ...... ...+..+++.+.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         234 VMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            333322 22345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-43  Score=318.16  Aligned_cols=249  Identities=34%  Similarity=0.588  Sum_probs=206.6

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHH-HhcCCCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~-~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||.||+|.+..+++.||+|+++...  .......+..|..+ ....+|+||+++++.+......++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56899999999999999999999999987542  12223344455444 4456899999999999999999999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccC
Q 018018          153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT  232 (362)
Q Consensus       153 gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt  232 (362)
                      ++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.....    .....++
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~  156 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQ-RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGT  156 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCC
Confidence            9999999988899999999999999999999998 9999999999999999999999999999875432    2345688


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHHHH
Q 018018          233 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFIS  310 (362)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~  310 (362)
                      ..|+|||.+.+..++.++||||+|+++|+|++|..||...+..       .....+....  .+......+++.+.++|.
T Consensus       157 ~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  229 (260)
T cd05611         157 PDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD-------AVFDNILSRRINWPEEVKEFCSPEAVDLIN  229 (260)
T ss_pred             cCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH-------HHHHHHHhcccCCCCcccccCCHHHHHHHH
Confidence            8999999999888999999999999999999999999764331       2222222221  122233467899999999


Q ss_pred             HhhhcCcCCCC---CHHHHHcCCcccccC
Q 018018          311 ACVQKEPQQRL---SAQELMTHPFLKMYG  336 (362)
Q Consensus       311 ~~L~~dP~~Rp---t~~eil~hp~~~~~~  336 (362)
                      +||+.||++||   +++|++.||||++.+
T Consensus       230 ~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         230 RLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             HHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence            99999999999   458999999998764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-43  Score=348.74  Aligned_cols=277  Identities=20%  Similarity=0.255  Sum_probs=205.9

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCc-EEEEEEe--------------ec--ccchHHHHHHHHHHHHHhcCCCCcce
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQ-FFALKVI--------------QM--NVEESARRQIAQELKINQSSQCPYVV  131 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~-~vaiK~~--------------~~--~~~~~~~~~~~~e~~~~~~l~hp~I~  131 (362)
                      .++|++++.||+|+||+||+|..+.... ..+.|.+              ..  .........+.+|+.+++.++||||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            5789999999999999999987654322 2222211              00  11223456688999999999999999


Q ss_pred             EEeeeEEecCeEEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC
Q 018018          132 VCYQSFYSNGAISIILEYMDGGSLADFLKKV-----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG  206 (362)
Q Consensus       132 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~  206 (362)
                      ++++++.+....|+|++++. ++|.+++...     .......++.++.|++.||+|||+ +||+||||||+|||++.++
T Consensus       227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~-~gIiHrDLKP~NILl~~~~  304 (501)
T PHA03210        227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD-KKLIHRDIKLENIFLNCDG  304 (501)
T ss_pred             cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCC
Confidence            99999999999999999995 4888877542     234567788999999999999998 9999999999999999999


Q ss_pred             cEEEeeccCCcccccCCC-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH
Q 018018          207 EVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM  285 (362)
Q Consensus       207 ~vkl~DFg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  285 (362)
                      .+||+|||+++....... .....+||..|+|||++.+..++.++|||||||++|||++|..++.............+.+
T Consensus       305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~  384 (501)
T PHA03210        305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKII  384 (501)
T ss_pred             CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHH
Confidence            999999999987653322 2234679999999999999999999999999999999999875443322211111222221


Q ss_pred             HHHh------------------cCCC--------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          286 EAIV------------------DQPP--------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       286 ~~~~------------------~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                      ..+.                  ....        .......++.++.++|.+||++||++|||+.|++.||||....+..
T Consensus       385 ~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~~~~  464 (501)
T PHA03210        385 DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEEEEE  464 (501)
T ss_pred             HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCCchH
Confidence            1110                  0000        0001123567788899999999999999999999999999887666


Q ss_pred             CCHHHHHH
Q 018018          340 VDLSEYFT  347 (362)
Q Consensus       340 ~~l~~~~~  347 (362)
                      ..+..-++
T Consensus       465 ~~~~~~~~  472 (501)
T PHA03210        465 ILFIHGLK  472 (501)
T ss_pred             HHHHHhhh
Confidence            55444433

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.7e-43  Score=322.56  Aligned_cols=259  Identities=36%  Similarity=0.651  Sum_probs=220.8

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .+.|+..+.||+|++|.||++.+..++..+|+|++.....  ....+.+|+++++.++|+||+++++.+......++|+|
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            3668888999999999999999998999999999976533  55678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          149 YMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      |+++++|.+++.... .+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++...........
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~-~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  174 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHS-QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN  174 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence            999999999998876 89999999999999999999998 9999999999999999999999999998876544333334


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC-CCCCCCCCCCCHHHH
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ-PPPSAPSDQFSPEFC  306 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  306 (362)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..       .....+... .........++..+.
T Consensus       175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~  247 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL-------RALFLITTKGIPPLKNPEKWSPEFK  247 (286)
T ss_pred             cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcCCCCCcchhhCCHHHH
Confidence            456788999999999888999999999999999999999999753321       111222222 222222334789999


Q ss_pred             HHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          307 SFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       307 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ++|.+||+.+|.+|||+.+++.|+||+..+.
T Consensus       248 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  278 (286)
T cd06614         248 DFLNKCLVKDPEKRPSAEELLQHPFLKKACP  278 (286)
T ss_pred             HHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence            9999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.3e-43  Score=324.27  Aligned_cols=259  Identities=25%  Similarity=0.453  Sum_probs=207.0

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-hHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCe-----
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGA-----  142 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~-----  142 (362)
                      ++|++.+.||+|+||.||++.+..+++.||+|+++.... ......+.+|+.+++.+. ||||+++++.+.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            468999999999999999999999999999999865532 223456788999999985 6999999998887665     


Q ss_pred             EEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc-CCcEEEeeccCC
Q 018018          143 ISIILEYMDGGSLADFLKKV-----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVS  216 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-~~~vkl~DFg~a  216 (362)
                      .|+||||+++ +|.+++...     ..+++..++.++.|++.||.|||+ +|++||||+|+||+++. ++.+||+|||++
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK-HGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEecCCCeEEEeecccc
Confidence            8999999986 898888642     357999999999999999999998 99999999999999998 889999999998


Q ss_pred             cccccCCCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--
Q 018018          217 AIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--  293 (362)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  293 (362)
                      ..............+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+....   .......+.....  
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~  235 (295)
T cd07837         159 RAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ---LLHIFKLLGTPTEQV  235 (295)
T ss_pred             eecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHhCCCChhh
Confidence            765443333334467889999998865 4579999999999999999999999976433211   1111111100000  


Q ss_pred             --------------------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccc
Q 018018          294 --------------------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  333 (362)
Q Consensus       294 --------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  333 (362)
                                          .......+++.+.++|.+||+.||++|||+.|++.||||+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                                0001135788999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=6.7e-43  Score=313.66  Aligned_cols=255  Identities=35%  Similarity=0.608  Sum_probs=220.9

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEec--CeEEEEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISIIL  147 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~--~~~~lV~  147 (362)
                      +|...+.||+|++|.||++.+..+++.+++|++.... .......+.+|+.+++.++||||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999999999999999987653 235567889999999999999999999999888  8999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC--C
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--Q  225 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~--~  225 (362)
                      ||+++++|.+++.....+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||.+........  .
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS-NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            999999999999988899999999999999999999998 9999999999999999999999999999887654432  1


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.      .................+..++..+
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~l  233 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN------PMAALYKIGSSGEPPEIPEHLSEEA  233 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------hHHHHHhccccCCCcCCCcccCHHH
Confidence            3445788999999999988899999999999999999999999976541      1222333333333344556778999


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          306 CSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      .++|.+||+.||++||++.+++.||||
T Consensus       234 ~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         234 KDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.9e-43  Score=322.19  Aligned_cols=252  Identities=27%  Similarity=0.422  Sum_probs=212.3

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEcc-----CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      ..++|.+.+.||+|+||.||++++..     ++..||+|+++.....+....+.+|+++++.++|+||+++++.+.....
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            45778999999999999999998753     4678999999876556567889999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcE
Q 018018          143 ISIILEYMDGGSLADFLKKV--------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV  208 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~v  208 (362)
                      .++||||+++++|.+++...              ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS-QHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeeccccccceEEEcCCCeE
Confidence            99999999999999999754              247889999999999999999998 999999999999999999999


Q ss_pred             EEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHH
Q 018018          209 KITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM  285 (362)
Q Consensus       209 kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~  285 (362)
                      +|+|||++........  ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||...+..       ...
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-------~~~  234 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-------EVI  234 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-------HHH
Confidence            9999999875432211  1223345788999999999999999999999999999998 99999764331       233


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          286 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+..+..+ ..+..++..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         235 ECITQGRLL-QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHcCCcC-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            333333332 234578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2e-43  Score=319.84  Aligned_cols=253  Identities=32%  Similarity=0.543  Sum_probs=215.3

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++|.+.+.||+|+||.||++.+..++..+|||.+...  ........+.+|+.+++.++|+||+++++.+.+.+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            5788999999999999999999999999999987653  23345567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          148 EYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       148 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            99999999999864    3568999999999999999999998 999999999999999999999999999987765443


Q ss_pred             CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          224 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                      .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.+...     ........+.....++.....+++
T Consensus       161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08229         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCDYPPLPSDHYSE  235 (267)
T ss_pred             cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-----hHHHHhhhhhcCCCCCCCcccccH
Confidence            333455788999999999988899999999999999999999999965322     122334444444444444456889


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .+.+++.+||+.||++|||+.+|++
T Consensus       236 ~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         236 ELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.4e-43  Score=327.80  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=209.3

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCc----EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ----FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      +...+|++.+.||+|+||.||++++..++.    .||+|+++.........++.+|+.+++.++||||+++++.+... .
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            456789999999999999999999766655    48999987655556677889999999999999999999988754 5


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          143 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .++|++|+++|+|.+++... ..++...+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEE-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHh-cCeeccccchhheEecCCCcEEEccccccccccC
Confidence            78999999999999999874 468999999999999999999998 9999999999999999999999999999987643


Q ss_pred             CCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          222 TSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       222 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      ....  .....++..|+|||.+.+..++.++||||||+++|||++ |..||.+...    .   +......... ....+
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~----~---~~~~~~~~~~-~~~~~  233 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----S---EISSILEKGE-RLPQP  233 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----H---HHHHHHhCCC-CCCCC
Confidence            3221  122334678999999999999999999999999999998 9999976432    1   1222222222 22233


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ..++.++.+++.+||+.||++|||+.+++.+
T Consensus       234 ~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         234 PICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            5678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.4e-43  Score=320.93  Aligned_cols=253  Identities=28%  Similarity=0.524  Sum_probs=205.6

Q ss_pred             eeeeeCCeEEEEEEEccCCcEEEEEEeecccc--hHHHHHHHHH---HHHHhcCCCCcceEEeeeEEecCeEEEEEeccC
Q 018018           77 VVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQE---LKINQSSQCPYVVVCYQSFYSNGAISIILEYMD  151 (362)
Q Consensus        77 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e---~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~  151 (362)
                      .||+|+||.||++.+..+++.||+|++.....  .........|   ...++...||+|+.+++.+.+....++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999999999999999865421  1111122233   344555789999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcccc
Q 018018          152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG  231 (362)
Q Consensus       152 ~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~g  231 (362)
                      |++|.+++...+.+++..+..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||++......  ......|
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~  157 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVG  157 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCcCC
Confidence            99999999888889999999999999999999998 99999999999999999999999999998765432  2334578


Q ss_pred             CCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 018018          232 TYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS  310 (362)
Q Consensus       232 t~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  310 (362)
                      +..|+|||.+.++ .++.++||||+|+++|+|++|+.||........    .........  .....+..+++++.+++.
T Consensus       158 ~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~--~~~~~~~~~s~~~~~li~  231 (278)
T cd05606         158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK----HEIDRMTLT--MAVELPDSFSPELRSLLE  231 (278)
T ss_pred             CcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch----HHHHHHhhc--cCCCCCCcCCHHHHHHHH
Confidence            9999999998754 589999999999999999999999976533211    111111111  122234457899999999


Q ss_pred             HhhhcCcCCCC-----CHHHHHcCCcccccCCC
Q 018018          311 ACVQKEPQQRL-----SAQELMTHPFLKMYGDL  338 (362)
Q Consensus       311 ~~L~~dP~~Rp-----t~~eil~hp~~~~~~~~  338 (362)
                      +||..+|++||     ++.++++||||+.....
T Consensus       232 ~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~  264 (278)
T cd05606         232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ  264 (278)
T ss_pred             HHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence            99999999999     99999999999887543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-43  Score=329.24  Aligned_cols=252  Identities=23%  Similarity=0.409  Sum_probs=193.5

Q ss_pred             eeeeeeCCeEEEEEEEcc--CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEE--ecCeEEEEEeccC
Q 018018           76 KVVGKGSGGIVQLVQHKW--TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY--SNGAISIILEYMD  151 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~--~~~~~~lV~e~~~  151 (362)
                      ..||+|+||.||+|++..  ++..||+|.+....   ....+.+|+.+++.++||||+++++.+.  .+...++|+||+.
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            579999999999999754  56789999986542   2235678999999999999999999885  3567899999996


Q ss_pred             CCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEE----ccCCcEEEeeccCCcc
Q 018018          152 GGSLADFLKKV---------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSAI  218 (362)
Q Consensus       152 ~gsL~~~l~~~---------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll----~~~~~vkl~DFg~a~~  218 (362)
                      + +|.+++...         ..+++..++.++.|++.||.|||+ +|++||||||+||++    +.++++||+|||+++.
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh-CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            5 888887532         258899999999999999999998 999999999999999    5667999999999987


Q ss_pred             cccCCC---CCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCch------hhHHHHHHHH
Q 018018          219 MASTSG---QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW------TSFYELMEAI  288 (362)
Q Consensus       219 ~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~------~~~~~~~~~~  288 (362)
                      ......   ......+|+.|+|||++.+. .++.++||||+||++|||++|.+||.........      ..........
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM  241 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence            643321   22345789999999998774 5899999999999999999999999754332110      0000000000


Q ss_pred             h------------------------cCCC--------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          289 V------------------------DQPP--------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       289 ~------------------------~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      .                        ....        ........+..+.+||.+||+.||++|||++|+++||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            0                        0000        000111245678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=7.4e-43  Score=315.85  Aligned_cols=253  Identities=33%  Similarity=0.559  Sum_probs=215.8

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++|++.+.||+|+||.||++.+..+|+.||+|.++..  .+......+.+|+++++.++|+||+++++.+...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            5799999999999999999999999999999998643  33445678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          148 EYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       148 e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ||+++++|.+++..    ...+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS-KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh-CCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            99999999999864    3458999999999999999999998 999999999999999999999999999987665443


Q ss_pred             CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          224 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                      .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||....     .........+.....++.....++.
T Consensus       161 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~  235 (267)
T cd08224         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-----MNLYSLCKKIEKCDYPPLPADHYSE  235 (267)
T ss_pred             cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-----ccHHHHHhhhhcCCCCCCChhhcCH
Confidence            33444578899999999998889999999999999999999999996533     1223344444444333333346788


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .+.++|.+||+.+|++|||+.++++
T Consensus       236 ~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         236 ELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.7e-43  Score=331.80  Aligned_cols=269  Identities=23%  Similarity=0.384  Sum_probs=216.1

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEec-----CeE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAI  143 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~-----~~~  143 (362)
                      .+|.+.+.||+|+||+||++++..++..||||.++... .......+.+|+.+++.++|+||+++++.+...     ...
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            57999999999999999999999999999999987542 233345677899999999999999999877643     358


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ++|+||+. ++|.+++.....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||++.......
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  162 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG  162 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence            99999996 6999999888899999999999999999999998 999999999999999999999999999998765443


Q ss_pred             CCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH-------------------
Q 018018          224 GQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE-------------------  283 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~-------------------  283 (362)
                      .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+..                   
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07858         163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKAR  242 (337)
T ss_pred             ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhh
Confidence            33445678899999998865 4689999999999999999999999976532111110000                   


Q ss_pred             -HHHHHhcCCCC--CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCC
Q 018018          284 -LMEAIVDQPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  340 (362)
Q Consensus       284 -~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~  340 (362)
                       ..........+  ......+++++.++|++||+.+|++|||++++++||||+...+.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~~  302 (337)
T cd07858         243 RYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPSD  302 (337)
T ss_pred             HHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCccc
Confidence             00000000000  0112457889999999999999999999999999999988766543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-44  Score=333.39  Aligned_cols=264  Identities=27%  Similarity=0.471  Sum_probs=210.8

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEe-ecccchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~  143 (362)
                      .+....|+++++||+||.+.||++..... +.||+|.+ -...+.....-+..|+.++.+++ |.+|++++++-..++.+
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            35668899999999999999999988644 45555544 44467778889999999999986 89999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCC-CHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          144 SIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l-~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      |+||||-+ .+|..+|+..... +.-.++.+..||+.|+.++|. .||||.||||.|+|+ -.|.+||+|||+|..+...
T Consensus       436 YmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~-~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~D  512 (677)
T KOG0596|consen  436 YMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQ-HGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPD  512 (677)
T ss_pred             EEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHH-hceeecCCCcccEEE-EeeeEEeeeechhcccCcc
Confidence            99999885 4999999887544 335888999999999999998 999999999999999 7899999999999887654


Q ss_pred             CCC--CCccccCCcccCcceecCCC-----------CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh
Q 018018          223 SGQ--ANTFVGTYNYMSPERISGGK-----------YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV  289 (362)
Q Consensus       223 ~~~--~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~  289 (362)
                      ...  ..+.+||+.||+||.+....           .++++|||||||+||+|+.|+.||...      .....-+..+.
T Consensus       513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~------~n~~aKl~aI~  586 (677)
T KOG0596|consen  513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI------INQIAKLHAIT  586 (677)
T ss_pred             ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH------HHHHHHHHhhc
Confidence            432  34569999999999985432           467999999999999999999999642      22223333343


Q ss_pred             cCCCCCCCCCCCC-HHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          290 DQPPPSAPSDQFS-PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       290 ~~~~~~~~~~~~~-~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                      +..-.-..+..-+ .++.++++.||.+||++|||+.++|+|||++...-..
T Consensus       587 ~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~  637 (677)
T KOG0596|consen  587 DPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIPV  637 (677)
T ss_pred             CCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccccccc
Confidence            3321111111112 2399999999999999999999999999998865433

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.5e-43  Score=315.70  Aligned_cols=244  Identities=25%  Similarity=0.386  Sum_probs=204.1

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCCH
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  155 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL  155 (362)
                      +.||+|+||.||++++..+++.+|+|.+...........+.+|+++++.++||||+++++.+......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36899999999999999999999999987665566677899999999999999999999999999999999999999999


Q ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC--CccccC
Q 018018          156 ADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGT  232 (362)
Q Consensus       156 ~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~--~~~~gt  232 (362)
                      .+++... ..+++..++.++.|++.||+|||+ +|++|+||||+||+++.++.+||+|||++..........  .....+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  159 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLES-KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP  159 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence            9999764 468999999999999999999998 999999999999999999999999999987643211111  111234


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 018018          233 YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA  311 (362)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  311 (362)
                      ..|+|||.+.++.++.++|+||||+++|+|++ |..||......       .....+.... +...+..++..+.+++.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~~~~li~~  231 (252)
T cd05084         160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-------QTREAIEQGV-RLPCPELCPDAVYRLMER  231 (252)
T ss_pred             eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-------HHHHHHHcCC-CCCCcccCCHHHHHHHHH
Confidence            57999999999999999999999999999998 89999654321       2222222222 223345678999999999


Q ss_pred             hhhcCcCCCCCHHHHHc
Q 018018          312 CVQKEPQQRLSAQELMT  328 (362)
Q Consensus       312 ~L~~dP~~Rpt~~eil~  328 (362)
                      ||+.+|++|||+.++++
T Consensus       232 ~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         232 CWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=312.04  Aligned_cols=253  Identities=35%  Similarity=0.566  Sum_probs=219.4

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +|++.+.||+|++|.||++++..+++.|++|.+..... ......+.+|+++++.++|+|++++++.+.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            57889999999999999999999999999999876532 24567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      +++++|.+++.....+++..+..++.|++.||.+||+ .|++||||+|+||+++.++.++|+|||.+.............
T Consensus        81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHE-QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            9999999999988899999999999999999999998 999999999999999999999999999998775544433456


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  309 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  309 (362)
                      .++..|+|||.+.+..++.++|+||+|+++|+|++|..||...+..       .......... ....+..+++.+.+++
T Consensus       160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~~~~~i  231 (254)
T cd06627         160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-------AALFRIVQDD-HPPLPEGISPELKDFL  231 (254)
T ss_pred             ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-------HHHHHHhccC-CCCCCCCCCHHHHHHH
Confidence            7889999999998888899999999999999999999999764321       1112222222 2234457889999999


Q ss_pred             HHhhhcCcCCCCCHHHHHcCCcc
Q 018018          310 SACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      .+||+.+|++|||+.+++.||||
T Consensus       232 ~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         232 MQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHHHhCChhhCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.5e-43  Score=316.21  Aligned_cols=253  Identities=30%  Similarity=0.495  Sum_probs=214.4

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +|.+.+.||+|+||.||++.++.+|..+|+|.+.... .......+.+|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            5788999999999999999999999999999986542 223445678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC-cEEEeeccCCcccccCCCCC
Q 018018          150 MDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       150 ~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-~vkl~DFg~a~~~~~~~~~~  226 (362)
                      +++++|.+++....  .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD-RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            99999999997643  57999999999999999999998 9999999999999998886 46999999987765443333


Q ss_pred             CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018018          227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  306 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (362)
                      ....|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+.       .+........... .....++.++.
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~~~  231 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-------HQLVLKICQGYFA-PISPNFSRDLR  231 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHhcccCC-CCCCCCCHHHH
Confidence            445688999999999888899999999999999999999999975432       1222333333222 22346788999


Q ss_pred             HHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          307 SFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       307 ~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      ++|.+||+.+|++|||+.|++.||||
T Consensus       232 ~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         232 SLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHHhccChhhCcCHHHHhhCCCC
Confidence            99999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=338.94  Aligned_cols=254  Identities=24%  Similarity=0.389  Sum_probs=214.2

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ..+.+..+++.+.+.||+|+||+||++++-   -.||||+++.. ...+..+.|+.|+.++++.+|-||+-|.|++..+.
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            456677788899999999999999999774   34999999876 45667889999999999999999999999998777


Q ss_pred             eEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          142 AISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      . .||+.||+|-+|+.++.- ...+.....+.|++|+++|+.|||. ++|||||||..||++.++++|||+|||++....
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHA-K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~  539 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHA-KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT  539 (678)
T ss_pred             e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhh-hhhhhhhccccceEEccCCcEEEecccceeeee
Confidence            6 999999999999999964 3579999999999999999999998 999999999999999999999999999997754


Q ss_pred             cCC--CCCCccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC---C
Q 018018          221 STS--GQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ---P  292 (362)
Q Consensus       221 ~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~  292 (362)
                      ...  .......|...|||||+++.   .+|++.+||||||+++|||++|.+||..... +      +++-.+..+   +
T Consensus       540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-d------qIifmVGrG~l~p  612 (678)
T KOG0193|consen  540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-D------QIIFMVGRGYLMP  612 (678)
T ss_pred             eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-h------heEEEecccccCc
Confidence            332  23344578899999999865   4589999999999999999999999984222 1      222223333   3


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          293 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       293 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ........++.++++|+..||..++++||++.+||.
T Consensus       613 d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  613 DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            334445667889999999999999999999999987

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.4e-43  Score=321.04  Aligned_cols=253  Identities=30%  Similarity=0.554  Sum_probs=217.8

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~~lV  146 (362)
                      ++|.+.+.||+|+||.||++++..+++.||+|++...  ........+.+|+.+++.++ ||||+++++.+...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4789999999999999999999999999999998753  23344567889999999998 99999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC--
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--  224 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~--  224 (362)
                      |||+++++|.+++.....+++..++.++.|++.||.+||+ .|++|+||+|+||+++.+++++|+|||++........  
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~-~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS-KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            9999999999999988899999999999999999999998 9999999999999999999999999999876643321  


Q ss_pred             ------------------CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHH
Q 018018          225 ------------------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME  286 (362)
Q Consensus       225 ------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  286 (362)
                                        ......++..|+|||.+.+..++.++|+||||++++++++|..||...+.       .....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~  232 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-------YLTFQ  232 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH-------HHHHH
Confidence                              12234678899999999888899999999999999999999999986542       12223


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCH----HHHHcCCcc
Q 018018          287 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA----QELMTHPFL  332 (362)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~----~eil~hp~~  332 (362)
                      ......  ...+..+++.+.++|.+||+.+|++|||+    +++++||||
T Consensus       233 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         233 KILKLE--YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             HHHhcC--CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            332222  22345678999999999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.4e-43  Score=335.29  Aligned_cols=258  Identities=26%  Similarity=0.342  Sum_probs=211.8

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccC-----CcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeee
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT-----GQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQS  136 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~  136 (362)
                      +...+..++|.+.+.||+|+||.||++++...     +..||||+++..........+.+|+++++.+. ||||++++++
T Consensus        30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~  109 (400)
T cd05105          30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA  109 (400)
T ss_pred             CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence            34556678999999999999999999987433     34699999976655666678999999999996 9999999999


Q ss_pred             EEecCeEEEEEeccCCCCHHHHHHHc------------------------------------------------------
Q 018018          137 FYSNGAISIILEYMDGGSLADFLKKV------------------------------------------------------  162 (362)
Q Consensus       137 ~~~~~~~~lV~e~~~~gsL~~~l~~~------------------------------------------------------  162 (362)
                      +.+....++||||+++|+|.+++...                                                      
T Consensus       110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         110 CTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             EccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence            99999999999999999999988542                                                      


Q ss_pred             ------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcE
Q 018018          163 ------------------------------------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  200 (362)
Q Consensus       163 ------------------------------------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NI  200 (362)
                                                                ..+++..+..++.|++.||+|||+ +|++||||||+||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivH~dikp~Ni  268 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS-KNCVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChHhE
Confidence                                                      237788889999999999999998 9999999999999


Q ss_pred             EEccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCc
Q 018018          201 LINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDG  277 (362)
Q Consensus       201 ll~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~  277 (362)
                      +++.++.+||+|||+++.......  ......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... 
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-  347 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-  347 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-
Confidence            999999999999999876543221  1223456788999999999899999999999999999997 999997643211 


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          278 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                           .....+.... ....+..++..+.+++.+||+.||++|||+.++.+
T Consensus       348 -----~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         348 -----TFYNKIKSGY-RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             -----HHHHHHhcCC-CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence                 1222222222 22334578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-45  Score=345.40  Aligned_cols=252  Identities=33%  Similarity=0.523  Sum_probs=223.1

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCCH
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  155 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL  155 (362)
                      -+||+|+||+||.++++.+...+|||-+... +.....-++.|+.+.+.++|.||+++.|.+.+++++-+.||-++||||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek-dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK-DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccc-cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            4699999999999999999999999998755 344556789999999999999999999999999999999999999999


Q ss_pred             HHHHHHc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc-CCcEEEeeccCCcccccCCCCCCcccc
Q 018018          156 ADFLKKV-KTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTSGQANTFVG  231 (362)
Q Consensus       156 ~~~l~~~-~~l--~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-~~~vkl~DFg~a~~~~~~~~~~~~~~g  231 (362)
                      .++++.. +++  .+.++-.+.+||++||.|||+ +.|||||||-+|+||+. .|.+||+|||-++++..-..-+.++.|
T Consensus       660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHe-n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHE-NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhh-cceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            9999876 667  888899999999999999998 99999999999999964 689999999999998877777888999


Q ss_pred             CCcccCcceecCCC--CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018018          232 TYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  309 (362)
Q Consensus       232 t~~y~aPE~~~~~~--~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  309 (362)
                      |..|||||++..++  |+.++|||||||++.||.||++||......      ...+-++.-.+.-++.+..++.+++++|
T Consensus       739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgsp------qAAMFkVGmyKvHP~iPeelsaeak~Fi  812 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSP------QAAMFKVGMYKVHPPIPEELSAEAKNFI  812 (1226)
T ss_pred             chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCCh------hHhhhhhcceecCCCCcHHHHHHHHHHH
Confidence            99999999998765  889999999999999999999999754322      2334444444555667788999999999


Q ss_pred             HHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          310 SACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      .+|+..||.+||+|.++|.+||++..
T Consensus       813 lrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  813 LRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             HHHcCCCcccCccHHHhccCcccccC
Confidence            99999999999999999999999876

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.1e-43  Score=319.35  Aligned_cols=254  Identities=25%  Similarity=0.386  Sum_probs=211.3

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEcc-----CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      +..++|.+.+.||+|++|.||++.+..     ++..||+|.++..........+..|+.+++.++|+||+++++.+.+..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            345789999999999999999999987     678899999876655666677899999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC---cEEEe
Q 018018          142 AISIILEYMDGGSLADFLKKVK-------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKIT  211 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~---~vkl~  211 (362)
                      ..++||||+++++|.+++....       .+++..+..++.|++.||+|||+ ++++|+||||+||+++.++   .+||+
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchheEEEeccCCCcceEec
Confidence            9999999999999999997653       58999999999999999999998 9999999999999998765   59999


Q ss_pred             eccCCcccccCCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHH
Q 018018          212 DFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI  288 (362)
Q Consensus       212 DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  288 (362)
                      |||+++........  ......+..|+|||++.+..++.++|||||||++|+|++ |..||...+..       .....+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-------~~~~~~  234 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-------EVMEFV  234 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHH
Confidence            99998865322111  112233568999999999999999999999999999997 99999764331       223333


Q ss_pred             hcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          289 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .... ....+..++..+.+++.+||+.+|++|||+.++++|
T Consensus       235 ~~~~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         235 TGGG-RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             HcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            2222 223345688999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-44  Score=325.65  Aligned_cols=266  Identities=28%  Similarity=0.504  Sum_probs=233.1

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecC
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNG  141 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~  141 (362)
                      ..+...+|..+.+||+|+||+|.++..+.+.+.||||+++++.  ......--+.|-+++.... -|.+++++..|++.+
T Consensus       344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD  423 (683)
T KOG0696|consen  344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD  423 (683)
T ss_pred             cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence            3567789999999999999999999999999999999998762  2223333456667776654 588999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .+|+||||+.||+|...+++.+.+-+..+..++.+|+.||-+||+ +||+.||||.+||+++.+|++||+|||+++....
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~-kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhc-CCeeeeeccccceEeccCCceEeeeccccccccc
Confidence            999999999999999999999999999999999999999999998 9999999999999999999999999999988777


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      ....+.+.||||.|+|||++...+|+.++|+||+||+||||+.|++||.+.++.       ++.+.+.+...  ..+..+
T Consensus       503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~-------elF~aI~ehnv--syPKsl  573 (683)
T KOG0696|consen  503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-------ELFQAIMEHNV--SYPKSL  573 (683)
T ss_pred             CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHHccC--cCcccc
Confidence            777788899999999999999999999999999999999999999999886543       55555555443  234688


Q ss_pred             CHHHHHHHHHhhhcCcCCCCC-----HHHHHcCCcccccCCCCC
Q 018018          302 SPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGDLNV  340 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt-----~~eil~hp~~~~~~~~~~  340 (362)
                      |.++.+++...|.+.|.+|..     -.+|-.||||+..++..+
T Consensus       574 SkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~  617 (683)
T KOG0696|consen  574 SKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKL  617 (683)
T ss_pred             cHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHH
Confidence            999999999999999999985     478999999999886544

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-43  Score=330.44  Aligned_cols=266  Identities=25%  Similarity=0.424  Sum_probs=211.1

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec-----CeEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAIS  144 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~-----~~~~  144 (362)
                      ++|++.+.||+|+||.||++.+..+|+.||+|++...........+.+|+.+++.++|+||+++++.+...     ...+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   84 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVY   84 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEE
Confidence            68999999999999999999999999999999987544444556788899999999999999999876543     3589


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      +|+||+.+ +|.+++.. ..+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++........
T Consensus        85 lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  161 (336)
T cd07849          85 IVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD  161 (336)
T ss_pred             EEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence            99999965 88888755 579999999999999999999998 9999999999999999999999999999876543222


Q ss_pred             ---CCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH--------HHHHh---
Q 018018          225 ---QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--------MEAIV---  289 (362)
Q Consensus       225 ---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~--------~~~~~---  289 (362)
                         ......|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+.......+...        ...+.   
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (336)
T cd07849         162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR  241 (336)
T ss_pred             ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchh
Confidence               1233578999999998755 56899999999999999999999999764322111100000        00000   


Q ss_pred             -----cC-CCCCC-----CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          290 -----DQ-PPPSA-----PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       290 -----~~-~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                           .. .....     .....++++.++|.+||+.||++|||+.++++||||+.+.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             hhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence                 00 00000     112457889999999999999999999999999999988653

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.9e-43  Score=316.05  Aligned_cols=253  Identities=24%  Similarity=0.378  Sum_probs=212.7

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccC---CcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      ..++|++.+.||+|+||.||++....+   ...||+|+++..........+.+|+.+++.++||||+++++.+...+..+
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM   81 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence            347899999999999999999988654   45799999877666667778899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          145 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      +||||+++++|.+++... +.+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||++.......
T Consensus        82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd05033          82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE  160 (266)
T ss_pred             EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCCCEEECccchhhcccccc
Confidence            999999999999999764 478999999999999999999998 999999999999999999999999999998764222


Q ss_pred             CC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          224 GQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       224 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      ..  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....       .+....+...... ..+..
T Consensus       161 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~  232 (266)
T cd05033         161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-------QDVIKAVEDGYRL-PPPMD  232 (266)
T ss_pred             cceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-------HHHHHHHHcCCCC-CCCCC
Confidence            11  122344678999999999899999999999999999998 9999965322       2333344333222 22356


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +++.+.+++.+||+.+|++||++.+++++
T Consensus       233 ~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         233 CPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            78999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=323.97  Aligned_cols=256  Identities=24%  Similarity=0.464  Sum_probs=209.3

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEecc
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  150 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~  150 (362)
                      |++.+.||.|++|.||++.+..+|..||+|++..... ......+.+|+++++.++||||+++++.+.+....++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            6778999999999999999999999999999875532 223456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          151 DGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       151 ~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      + ++|.+++....  .+++..+..++.|++.||+|||+ ++++||||+|+||+++.++.++|+|||++............
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~-~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS-HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence            5 59999997765  79999999999999999999998 99999999999999999999999999998765433333333


Q ss_pred             cccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHH--------------------
Q 018018          229 FVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA--------------------  287 (362)
Q Consensus       229 ~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~--------------------  287 (362)
                      ..++..|+|||.+.+. .++.++|+||+|+++|+|++|..||...+...   ......+.                    
T Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07835         159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID---QLFRIFRTLGTPDEDVWPGVTSLPDYKP  235 (283)
T ss_pred             cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence            4668899999988764 57899999999999999999999997653321   11111110                    


Q ss_pred             -HhcCC--CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          288 -IVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       288 -~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                       .....  ........++..+.++|.+||+.||++|||++|++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence             00000  0011234577899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-42  Score=313.61  Aligned_cols=254  Identities=30%  Similarity=0.477  Sum_probs=215.3

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc----cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec--CeE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN----VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAI  143 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~--~~~  143 (362)
                      .+|.+.+.||+|+||.||++++..++..||+|.+...    ........+.+|+.+++.++|+||+++++.+.+.  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5789999999999999999999999999999987543    1234456788999999999999999999988653  568


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ++|+||+++++|.+++.....+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||+++......
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS-NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            8999999999999999887889999999999999999999998 999999999999999999999999999987653211


Q ss_pred             ---CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          224 ---GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       224 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                         .......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.....       ............++..+..
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~p~~  233 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-------MAAIFKIATQPTKPMLPDG  233 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-------HHHHHHHHcCCCCCCCCcc
Confidence               112335688999999999988899999999999999999999999975422       1222333344444455678


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      +++.+.++|.+||+ +|.+||++.+++.|||.
T Consensus       234 ~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         234 VSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             cCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            89999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.5e-43  Score=355.01  Aligned_cols=254  Identities=26%  Similarity=0.436  Sum_probs=208.7

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      +++|++.+.||+|+||.||++.+..+|+.||+|+++..  ..+....++.+|+.+++.++||||+++++.+.+.+..++|
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            36899999999999999999999999999999998754  2344567889999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccC
Q 018018          147 LEYMDGGSLADFLKKV-----------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  215 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~-----------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~  215 (362)
                      |||++|++|.+++...           ..++...+..++.|++.||+|||+ +||+||||||+||+++.++.++|+|||+
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs-~GIIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS-KGVLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH-CCccccCCchheEEEcCCCCEEEEecCc
Confidence            9999999999998642           235667788999999999999998 9999999999999999999999999999


Q ss_pred             CcccccCC------------------CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc
Q 018018          216 SAIMASTS------------------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG  277 (362)
Q Consensus       216 a~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~  277 (362)
                      ++......                  ......+||+.|+|||++.+..++.++||||+||++|||++|..||...+... 
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k-  238 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK-  238 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh-
Confidence            97652111                  01123479999999999999999999999999999999999999997643221 


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          278 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                           .........+........+++.+.+++.+||+.||++||+..+.+.+
T Consensus       239 -----i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        239 -----ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             -----hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                 01111111111122234688999999999999999999887665544

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9.8e-43  Score=315.00  Aligned_cols=252  Identities=25%  Similarity=0.380  Sum_probs=211.7

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      .+...+|.+.+.||+|+||.||++.+..+++.+|+|++..+  ......+.+|+++++.++|+||+++++.+..+...++
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   79 (263)
T cd05052           2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   79 (263)
T ss_pred             CCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC--chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEE
Confidence            34567799999999999999999999999999999998644  2335678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          146 ILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ||||+++++|.+++...  ..+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          80 ITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            99999999999999764  358999999999999999999998 999999999999999999999999999987654322


Q ss_pred             CCC-CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          224 GQA-NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       224 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      ... ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+.       .+....+.... ....+..+
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~-~~~~~~~~  230 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-------SQVYELLEKGY-RMERPEGC  230 (263)
T ss_pred             eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCC-CCCCCCCC
Confidence            111 12234567999999999999999999999999999998 9999976432       22333333322 23345678


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ++++.+++.+||+.||++|||+.++++
T Consensus       231 ~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         231 PPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1e-42  Score=317.54  Aligned_cols=252  Identities=25%  Similarity=0.398  Sum_probs=209.3

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCc----EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ----FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      +...+|++.+.||+|+||+||+++...++.    .||+|+++..........+.+|+.+++.+.||||+.+++.+.. ..
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~   82 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-ST   82 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CC
Confidence            456789999999999999999999877766    4899998776666667789999999999999999999998864 45


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          143 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .+++++|+++|+|.+++... ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++....
T Consensus        83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE-VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            78999999999999999764 569999999999999999999998 9999999999999999999999999999887643


Q ss_pred             CCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          222 TSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       222 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      ....  .....++..|+|||.+.+..++.++|||||||++|||++ |..||......       .....+..... ...+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~-~~~~  233 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR-------EIPDLLEKGER-LPQP  233 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCCc-CCCC
Confidence            2221  122234678999999999899999999999999999998 89999654321       22222222222 2234


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..++.++.+++.+||+.||++||++.++++
T Consensus       234 ~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         234 PICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            568899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-43  Score=317.08  Aligned_cols=254  Identities=25%  Similarity=0.397  Sum_probs=212.2

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccC-----CcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWT-----GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      ++..++|.+.+.||+|+||.||++.+...     +..||+|.+...........+.+|+.+++.++||||+++++.+...
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (277)
T cd05032           2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG   81 (277)
T ss_pred             ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence            45668999999999999999999998654     3789999987665555567788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEE
Q 018018          141 GAISIILEYMDGGSLADFLKKVK----------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI  210 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~----------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl  210 (362)
                      ...++||||+++++|.+++....          .+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.+||
T Consensus        82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA-KKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccChheEEEcCCCCEEE
Confidence            99999999999999999996532          36788999999999999999998 99999999999999999999999


Q ss_pred             eeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHH
Q 018018          211 TDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEA  287 (362)
Q Consensus       211 ~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~  287 (362)
                      +|||+++.......  ......++..|+|||.+.++.++.++|||||||++|+|++ |..||...+.       .+....
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------~~~~~~  233 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-------EEVLKF  233 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-------HHHHHH
Confidence            99999876543221  1223456788999999988889999999999999999998 9999975432       123333


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          288 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +..... ...+..++..+.+++.+||+.+|++|||+.+++.
T Consensus       234 ~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         234 VIDGGH-LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             HhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            333322 2334567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.1e-42  Score=309.21  Aligned_cols=251  Identities=39%  Similarity=0.710  Sum_probs=214.6

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEecc
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  150 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~  150 (362)
                      +|...+.||+|++|.||++.+..+++.+++|++..... .....+.+|+.+++.++|+||+++++.+......++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            57888999999999999999998999999999876533 45678899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          151 DGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       151 ~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      ++++|.+++... ..+++..+..++.|++.||++||+ +|++|+||+|+||+++.++.++|+|||.+........ ....
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~-~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~  157 (253)
T cd05122          80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS-NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTM  157 (253)
T ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhc-CCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccce
Confidence            999999999876 689999999999999999999998 9999999999999999999999999999877654332 3455


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-CCCCCCCCCHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSF  308 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  308 (362)
                      .++..|+|||.+.+..++.++|+||||+++|+|++|..||...+..       ........... .......++..+.++
T Consensus       158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (253)
T cd05122         158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-------KALFKIATNGPPGLRNPEKWSDEFKDF  230 (253)
T ss_pred             ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-------HHHHHHHhcCCCCcCcccccCHHHHHH
Confidence            7889999999999888999999999999999999999999764321       11111111211 112222348899999


Q ss_pred             HHHhhhcCcCCCCCHHHHHcCCc
Q 018018          309 ISACVQKEPQQRLSAQELMTHPF  331 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~eil~hp~  331 (362)
                      |.+||+.||++|||+.+++.|||
T Consensus       231 i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         231 LKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHHccCChhhCCCHHHHhcCCC
Confidence            99999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.3e-43  Score=330.43  Aligned_cols=267  Identities=25%  Similarity=0.431  Sum_probs=213.8

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEE----ecCeEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFY----SNGAIS  144 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~----~~~~~~  144 (362)
                      ++|++.+.||+|+||.||++.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++.+.    .....+
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            68999999999999999999999999999999987542 2334566778999999999999999998775    345789


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      +||||+. ++|.+++.....+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++........
T Consensus        85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHS-ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            9999996 5999999887889999999999999999999998 9999999999999999999999999999876543222


Q ss_pred             C----CCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH---------------
Q 018018          225 Q----ANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL---------------  284 (362)
Q Consensus       225 ~----~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~---------------  284 (362)
                      .    .....++..|+|||.+.+ ..++.++||||+||++|+|++|+.||.+.+.......+...               
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence            1    124578899999999866 45899999999999999999999999765432111100000               


Q ss_pred             -HHH-HhcCCCCCC-----CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          285 -MEA-IVDQPPPSA-----PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       285 -~~~-~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                       ... .........     .....++++.++|.+||+.+|++|||+++++.||||+.+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~  303 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP  303 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence             000 000000000     113468899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=292.38  Aligned_cols=266  Identities=23%  Similarity=0.434  Sum_probs=218.7

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchH-HHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES-ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .+|.-.++||+|.||+||+++...+++.||+|.++.+.+.+ .-....+|+-+++.++|.||++++++...+..+.+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            45677789999999999999999999999999998774443 34567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          149 YMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       149 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      ||.. +|..+... ++.++.+.++.++.|+++||.++|+ +++.|||+||.|.+|+.+|.+||+|||+|+.++.+..-..
T Consensus        82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchs-hnvlhrdlkpqnllin~ngelkladfglarafgipvrcys  159 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHS-HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS  159 (292)
T ss_pred             HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhh-hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence            9965 99998865 4789999999999999999999998 9999999999999999999999999999999876655555


Q ss_pred             ccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCC-----------
Q 018018          228 TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPP-----------  294 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------  294 (362)
                      ..+-|.+|++|.++.+.+ |+...|+||.||++.|+.. |++.|.+.+-.+....+..++........|           
T Consensus       160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence            567899999999999866 8999999999999999987 888888765544333332222111111111           


Q ss_pred             CCC---------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          295 SAP---------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       295 ~~~---------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      +..         -.++...-++|+.++|.-+|.+|++++++++||||.....
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s~  291 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFSP  291 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccCC
Confidence            000         0112334579999999999999999999999999987643

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=3.5e-43  Score=325.03  Aligned_cols=259  Identities=25%  Similarity=0.396  Sum_probs=204.9

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC-----
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-----  141 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~-----  141 (362)
                      ..++|++.+.||+|+||.||++.+..+++.||||++.... .......+.+|+.+++.++||||+++++.+....     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            4578999999999999999999999999999999986542 2223345668999999999999999999876543     


Q ss_pred             ---eEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          142 ---AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       142 ---~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                         ..++||||+.+ +|.+++... ..+++.+++.++.|++.||+|||+ +|++|+||||+||+++.++.+||+|||++.
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR-NKILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence               45999999965 888888654 378999999999999999999998 999999999999999999999999999987


Q ss_pred             ccccCCCC----CCccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          218 IMASTSGQ----ANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       218 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                      ........    .....++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||.+.+.....    ..+..+....
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~----~~~~~~~~~~  243 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL----TLISQLCGSI  243 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHHhCCC
Confidence            65432221    12345788999999887644 788999999999999999999999765432111    1111111110


Q ss_pred             CCC---------------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          293 PPS---------------------------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       293 ~~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      ++.                           ......++.+.++|.+||+.||++|||++++++||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence            000                           0011235678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.1e-43  Score=318.99  Aligned_cols=247  Identities=32%  Similarity=0.537  Sum_probs=203.4

Q ss_pred             eeeeeeeeeCCeEEEEEEEc----cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           73 DTIKVVGKGSGGIVQLVQHK----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      ++.+.||.|.||.||.+...    ..+..|+||+++..........+.+|++.++.++||||+++++.+...+..++|+|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e   81 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME   81 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence            46789999999999999987    34668999999766566668899999999999999999999999998888999999


Q ss_pred             ccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC--
Q 018018          149 YMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--  224 (362)
Q Consensus       149 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~--  224 (362)
                      |+++|+|.+++...  ..+++..+..++.|++.||.|||+ ++++|++|+++||+++.++.+||+|||++........  
T Consensus        82 ~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~-~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   82 YCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS-NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             --TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH-TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999886  789999999999999999999998 8999999999999999999999999999877622211  


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                      ..........|+|||.+.+..++.++||||||+++|||++ |+.||...+       ..++...+..... ...+..++.
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~  232 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD-------NEEIIEKLKQGQR-LPIPDNCPK  232 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC-------HHHHHHHHHTTEE-TTSBTTSBH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccc-------ccccccccccccc-ceeccchhH
Confidence            1233456789999999998889999999999999999999 789986642       2344455544433 334567899


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .+.++|.+||+.||++|||+.++++
T Consensus       233 ~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  233 DIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHh
Confidence            9999999999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.6e-43  Score=328.30  Aligned_cols=264  Identities=29%  Similarity=0.463  Sum_probs=212.0

Q ss_pred             eeeee--CCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCC
Q 018018           77 VVGKG--SGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  153 (362)
Q Consensus        77 ~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~g  153 (362)
                      .||+|  ++|.||++++..+++.||+|+++.. ........+.+|+.+++.++|+||+++++.+......+++|||++++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            34444  5567788888889999999998765 34556678999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC-------
Q 018018          154 SLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-------  224 (362)
Q Consensus       154 sL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~-------  224 (362)
                      +|.+++...  ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.++|+|||.+........       
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~-~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS-KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            999999764  468999999999999999999998 9999999999999999999999999998865532221       


Q ss_pred             CCCccccCCcccCcceecCC--CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC----------
Q 018018          225 QANTFVGTYNYMSPERISGG--KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP----------  292 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----------  292 (362)
                      ......++..|+|||.+.+.  .++.++|+||+||++|+|++|..||.......      ..........          
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ------MLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhccCccccccCchh
Confidence            12234567889999998763  58899999999999999999999997643221      1111111000          


Q ss_pred             ---------------------CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHH
Q 018018          293 ---------------------PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFT  347 (362)
Q Consensus       293 ---------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~  347 (362)
                                           ........++.++.+|+.+||++||++|||++++++||||+...+.+.++.+.++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~~~~~~~~  313 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTSLLDLLK  313 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccchhHHHhhC
Confidence                                 0001112234678899999999999999999999999999999888888777654

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.2e-43  Score=323.64  Aligned_cols=253  Identities=26%  Similarity=0.391  Sum_probs=208.7

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcE--EEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF--FALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~  143 (362)
                      +...+|++.+.||+|+||.||+|.+..++..  +|+|.++..........+.+|+.++..+ +|+||+++++.+.+.+..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~   83 (303)
T cd05088           4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL   83 (303)
T ss_pred             cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence            4567899999999999999999999877764  5777776544555667888999999998 899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc
Q 018018          144 SIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE  207 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~  207 (362)
                      ++||||+++++|.+++....                .+++..++.++.|++.||+|||+ +|++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh-CCccccccchheEEecCCCc
Confidence            99999999999999997542                57899999999999999999998 99999999999999999999


Q ss_pred             EEEeeccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHH
Q 018018          208 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELME  286 (362)
Q Consensus       208 vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~  286 (362)
                      +||+|||++...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..       +...
T Consensus       163 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-------~~~~  234 (303)
T cd05088         163 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-------ELYE  234 (303)
T ss_pred             EEeCccccCcccchh-hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-------HHHH
Confidence            999999998643211 11122234667999999988889999999999999999998 99999754321       2233


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          287 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ...... ....+..+++++.+|+.+||+.+|++||++++++.+
T Consensus       235 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         235 KLPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HHhcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            332221 222334578999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-43  Score=328.70  Aligned_cols=263  Identities=27%  Similarity=0.433  Sum_probs=217.1

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC-----eEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-----AIS  144 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~-----~~~  144 (362)
                      +|++.+.||+|++|.||++++..+++.||+|++..... ....+.+.+|+.+++.++|+||+++++.+....     .+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            58899999999999999999998999999999876532 445567889999999999999999999887765     789


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC-
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-  223 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~-  223 (362)
                      +||||+++ +|.+++.....+++..++.++.|++.||+|||+ +|++|+||||.||+++.++.++|+|||++....... 
T Consensus        81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~-~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHS-ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            99999974 899999887899999999999999999999998 999999999999999999999999999998765443 


Q ss_pred             --CCCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc----------
Q 018018          224 --GQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD----------  290 (362)
Q Consensus       224 --~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~----------  290 (362)
                        .......++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.+..+..   .........          
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL---NLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHhcCCCChhHhhhcc
Confidence              123445678999999999887 7899999999999999999999999775432111   111110000          


Q ss_pred             ----------CCCC-----CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          291 ----------QPPP-----SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       291 ----------~~~~-----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                                ....     ......+++.+.++|.+||+++|++|||+++++.||||+.+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                      0000     00123467889999999999999999999999999999887654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=9.7e-43  Score=317.74  Aligned_cols=257  Identities=23%  Similarity=0.417  Sum_probs=203.5

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEec--CeEEEEEe
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSN--GAISIILE  148 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~--~~~~lV~e  148 (362)
                      |++.+.||+|+||.||++.+..+++.||+|+++............+|+.++..+. |+||+++++.+.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            6788999999999999999999999999999876533333334557888888775 99999999999987  89999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          149 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       149 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      |+++ +|.+++... ..+++..+..++.|++.||+|||+ .|++||||+|+||+++. +.+||+|||++....... ...
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-~~~  156 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHR-NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-PYT  156 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEcC-CCeEEEecccccccccCC-CcC
Confidence            9974 888888763 578999999999999999999998 99999999999999999 999999999997764332 223


Q ss_pred             ccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH--------HHHHHhcCCC-CC--
Q 018018          228 TFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--------LMEAIVDQPP-PS--  295 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~--------~~~~~~~~~~-~~--  295 (362)
                      ...++..|+|||.+.. +.++.++||||+||++|+|++|..||.+.+..+.......        +......... ..  
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07831         157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNF  236 (282)
T ss_pred             CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccC
Confidence            4567899999997654 5578899999999999999999999977543221111110        0000000000 00  


Q ss_pred             ---------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          296 ---------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       296 ---------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                               .....++..+.++|.+||+.+|++|||++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         237 PSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence                     0012467899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=9.7e-43  Score=320.21  Aligned_cols=259  Identities=34%  Similarity=0.597  Sum_probs=216.7

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEecc
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  150 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~  150 (362)
                      .|+....||+|+||.||++....+++.+|+|++... .......+.+|+.+++.++|+||+++++.+......++||||+
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR-KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc-chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            344457899999999999999999999999998643 3345567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccc
Q 018018          151 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV  230 (362)
Q Consensus       151 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~  230 (362)
                      ++++|.+++.. ..+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++..............
T Consensus       100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~-~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~  177 (292)
T cd06657         100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV  177 (292)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence            99999998755 578999999999999999999998 9999999999999999999999999998876544333334457


Q ss_pred             cCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-CCCCCCCCCHHHHHHH
Q 018018          231 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFI  309 (362)
Q Consensus       231 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li  309 (362)
                      +++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+..       +....+....+ .......+++.+.+++
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~l~~li  250 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-------KAMKMIRDNLPPKLKNLHKVSPSLKGFL  250 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhhCCcccCCcccCCHHHHHHH
Confidence            889999999998888999999999999999999999999764321       11222211111 1112345789999999


Q ss_pred             HHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          310 SACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                      .+||+.||.+||++.+++.||||..+...+
T Consensus       251 ~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         251 DRLLVRDPAQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             HHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence            999999999999999999999999887544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.4e-42  Score=320.70  Aligned_cols=256  Identities=26%  Similarity=0.384  Sum_probs=212.2

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEE-----ccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEE
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQH-----KWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFY  138 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~  138 (362)
                      ..+..++|.+.+.||+|+||.||++.+     ..++..+|+|+++..........+.+|+.+++.+ +||||+++++.+.
T Consensus        30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  109 (302)
T cd05055          30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT  109 (302)
T ss_pred             ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence            456678899999999999999999975     3345689999987665555667889999999999 7999999999999


Q ss_pred             ecCeEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCC
Q 018018          139 SNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  216 (362)
Q Consensus       139 ~~~~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a  216 (362)
                      ..+..++||||+++++|.+++....  .+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.++|+|||++
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeehhhhccceEEEcCCCeEEECCCccc
Confidence            9999999999999999999997643  38999999999999999999998 99999999999999999999999999998


Q ss_pred             cccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCC
Q 018018          217 AIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPP  293 (362)
Q Consensus       217 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  293 (362)
                      +.......  ......++..|+|||.+.+..++.++||||+||++|+|++ |..||......       ...........
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-------~~~~~~~~~~~  261 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-------SKFYKLIKEGY  261 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-------HHHHHHHHcCC
Confidence            76543221  1122345778999999999999999999999999999998 99999764332       11112222222


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       294 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ....+...++++.+++.+||+.+|++|||+.|++.
T Consensus       262 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         262 RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            23334567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.7e-43  Score=329.06  Aligned_cols=264  Identities=23%  Similarity=0.362  Sum_probs=211.4

Q ss_pred             cCce-eeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchH-------------HHHHHHHHHHHHhcCCCCcceEEee
Q 018018           70 EDID-TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES-------------ARRQIAQELKINQSSQCPYVVVCYQ  135 (362)
Q Consensus        70 ~~~~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------~~~~~~~e~~~~~~l~hp~I~~~~~  135 (362)
                      ++|. +.+.||+|+||+||++.+..+++.||+|+++......             ....+.+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            5565 4577999999999999999999999999986542221             1124778999999999999999999


Q ss_pred             eEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccC
Q 018018          136 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  215 (362)
Q Consensus       136 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~  215 (362)
                      .+......++||||+. ++|.+++.....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~-~~i~H~dl~~~nill~~~~~~kl~dfg~  165 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHK-WYFMHRDLSPANIFINSKGICKIADFGL  165 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHeEECCCCCEEECCccc
Confidence            9999999999999997 5999999888889999999999999999999998 9999999999999999999999999999


Q ss_pred             Cccccc--------------CCCCCCccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhh
Q 018018          216 SAIMAS--------------TSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS  280 (362)
Q Consensus       216 a~~~~~--------------~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~  280 (362)
                      +.....              .........++..|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+..+....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~  245 (335)
T PTZ00024        166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR  245 (335)
T ss_pred             eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            876541              111122335688899999987644 68999999999999999999999987654321111


Q ss_pred             HHHHHHHHhcCCCC-------------------C---CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          281 FYELMEAIVDQPPP-------------------S---APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       281 ~~~~~~~~~~~~~~-------------------~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                         +..........                   .   ......+.++.++|.+||+.+|++|||++|++.||||+.+.-.
T Consensus       246 ---i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~  322 (335)
T PTZ00024        246 ---IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP  322 (335)
T ss_pred             ---HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence               11111100000                   0   0012457889999999999999999999999999999877543

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=5.7e-43  Score=319.83  Aligned_cols=254  Identities=24%  Similarity=0.370  Sum_probs=212.3

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEcc-----CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      +.+.+|.+.+.||+|+||.||++.+..     .++.||+|+++..........+..|+.++..++||||+++++.+.+..
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            456778899999999999999998754     357899999986655556677889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC
Q 018018          142 AISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR  205 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~  205 (362)
                      ..++++||+.+++|.+++...                ..+++..+..++.|++.||.|||+ +|++||||||+||+++.+
T Consensus        82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~-~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS-HHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-cCccccccchhheEecCC
Confidence            999999999999999998532                347888999999999999999998 999999999999999999


Q ss_pred             CcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHH
Q 018018          206 GEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY  282 (362)
Q Consensus       206 ~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~  282 (362)
                      +.+||+|||+++.......  ......+++.|+|||.+.++.++.++|||||||++|||++ |..||.+...       .
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~  233 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-------Q  233 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-------H
Confidence            9999999999876543221  1123345778999999998889999999999999999998 8889876432       2


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          283 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +....+...... ..+..++..+.+|+.+||+.+|++||++.+++..
T Consensus       234 ~~~~~i~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         234 DVIEMIRNRQVL-PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHHHHHHcCCcC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            344444444332 3346789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-44  Score=303.26  Aligned_cols=256  Identities=25%  Similarity=0.373  Sum_probs=208.1

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec-----C
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----G  141 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~-----~  141 (362)
                      +..++|.+.+.||+|||+.||+++...++..||+|++.... .+.+...++|++..++.+|||+++++++...+     .
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~   96 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH   96 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence            45689999999999999999999999999999999998774 55677889999999999999999998765433     4


Q ss_pred             eEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCC--eEeecCCCCcEEEccCCcEEEeeccC
Q 018018          142 AISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLINHRGEVKITDFGV  215 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~vkl~DFg~  215 (362)
                      ..|++++|...|||.+.++..    ..+++.+++.++.++++||++||+ ..  .+||||||.|||++..+.++|.|||.
T Consensus        97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~-~~~~yAH~DiKP~NILls~~~~~vl~D~GS  175 (302)
T KOG2345|consen   97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE-KEPPYAHRDIKPANILLSDSGLPVLMDLGS  175 (302)
T ss_pred             eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc-cCCcccccCCCcceeEecCCCceEEEeccC
Confidence            599999999999999999653    479999999999999999999998 77  99999999999999999999999998


Q ss_pred             CcccccCCCCC---------CccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH
Q 018018          216 SAIMASTSGQA---------NTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE  283 (362)
Q Consensus       216 a~~~~~~~~~~---------~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~  283 (362)
                      ++...-.-...         .....|..|+|||.+.-   ...++++|||||||++|+|+.|..||...-...+ +-   
T Consensus       176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-Sl---  251 (302)
T KOG2345|consen  176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-SL---  251 (302)
T ss_pred             ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-eE---
Confidence            87653221111         11245889999999865   4468999999999999999999999975433221 11   


Q ss_pred             HHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          284 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                       .-.+..+....+....+++.+.++|..||+.||.+||++.+++.+
T Consensus       252 -aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  252 -ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             -EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence             111112222222334589999999999999999999999999864

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.2e-42  Score=319.37  Aligned_cols=257  Identities=23%  Similarity=0.380  Sum_probs=213.4

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccC-----CcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeE
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT-----GQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSF  137 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~  137 (362)
                      ...+..++|++.+.||+|+||.||++.....     ...+|+|.+...........+.+|+.++..+ +|+||+++++.+
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            4456678999999999999999999987643     3689999987665555567788999999999 799999999999


Q ss_pred             EecCeEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEE
Q 018018          138 YSNGAISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL  201 (362)
Q Consensus       138 ~~~~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIl  201 (362)
                      ...+..++||||+++++|.+++...                ..+++..+..++.|++.||+|||+ +|++||||||+||+
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~Nil  164 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS-KKCIHRDLAARNVL  164 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCccccccceeeEE
Confidence            9999999999999999999999642                468899999999999999999998 99999999999999


Q ss_pred             EccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCch
Q 018018          202 INHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW  278 (362)
Q Consensus       202 l~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~  278 (362)
                      ++.++.+||+|||+++.......  ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+...    
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----  240 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----  240 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH----
Confidence            99999999999999886543221  1122234678999999998899999999999999999998 9999976432    


Q ss_pred             hhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          279 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                         .+....+..... ...+...+..+.+|+.+||+.||++|||+.+++++
T Consensus       241 ---~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         241 ---EELFKLLKEGYR-MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             ---HHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence               223333333322 23345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-42  Score=311.88  Aligned_cols=245  Identities=29%  Similarity=0.441  Sum_probs=211.5

Q ss_pred             eeeeeeCCeEEEEEEEccC---CcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||.||++.+...   +..||+|+++..........+.+|++.++.++|+||+++++.+......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4689999999999999876   8899999998775555678899999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          153 GSLADFLKKV---------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       153 gsL~~~l~~~---------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ++|.+++...         ..+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS-KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc-CCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence            9999999875         789999999999999999999998 999999999999999999999999999998765432


Q ss_pred             --CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          224 --GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       224 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                        .......++..|+|||.+.+..++.++||||+|+++|+|++ |..||...+.       .+....+.... ....+..
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~-~~~~~~~  231 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-------EEVLEYLRKGY-RLPKPEY  231 (262)
T ss_pred             ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCC-CCCCCcc
Confidence              22334567889999999998889999999999999999999 6999987532       23334444332 2233456


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +++++.+++.+||+.+|++|||+.|++++
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         232 CPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            78999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-43  Score=311.93  Aligned_cols=274  Identities=27%  Similarity=0.488  Sum_probs=233.3

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhc-CCCCcceEEeeeEEe
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQS-SQCPYVVVCYQSFYS  139 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~-l~hp~I~~~~~~~~~  139 (362)
                      ..+.+.+.+|.++++||+|+|++|.+++.+.+.+.||+|++++.  .+.+.+.-...|-.+... .+||+++-+...|++
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            34567889999999999999999999999999999999999876  344445556667666544 579999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          140 NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      +..+++|.||++||+|.-.++++..++++.++.+...|+.||.|||+ +||+.||||.+|+|++..|++||.|+|.++..
T Consensus       323 esrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~-rgiiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHE-RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhh-cCeeeeeccccceEEccCCceeecccchhhcC
Confidence            99999999999999999999999999999999999999999999998 99999999999999999999999999999987


Q ss_pred             ccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchh-hHHHHHHHHhcCCCCCCCC
Q 018018          220 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT-SFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  298 (362)
                      ..++..+.++||||.|.|||++++..|.+.+|+|+||++++||+.|+.||.-..-..... ...-+++.+.....  ..+
T Consensus       402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi--rip  479 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI--RIP  479 (593)
T ss_pred             CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--ccc
Confidence            777888899999999999999999999999999999999999999999996432111111 11123333333222  234


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCC------CHHHHHcCCcccccCCCC
Q 018018          299 DQFSPEFCSFISACVQKEPQQRL------SAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rp------t~~eil~hp~~~~~~~~~  339 (362)
                      ..++-.+..+++..|++||++|.      .+.++..|+||+..++.-
T Consensus       480 rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~  526 (593)
T KOG0695|consen  480 RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDL  526 (593)
T ss_pred             ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHH
Confidence            56778888999999999999997      478999999999887643

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.1e-42  Score=311.50  Aligned_cols=249  Identities=26%  Similarity=0.460  Sum_probs=207.2

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +.++|++.+.||+|+||.||++..+ ++..+|+|.+....  .....+.+|+.+++.++||||+++++.+......++||
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~   78 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT   78 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence            3467999999999999999999875 45689999876432  22456888999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC-
Q 018018          148 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-  225 (362)
Q Consensus       148 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~-  225 (362)
                      ||+++|+|.+++... ..+++..+..++.|++.||+|||+ +|++|+||+|+||+++.++.+||+|||.++........ 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER-NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            999999999999753 568999999999999999999998 99999999999999999999999999998765322211 


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      .....++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||...+.       .+....+.....+ ..+...+..
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-------~~~~~~i~~~~~~-~~~~~~~~~  229 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-------YEVVEMISRGFRL-YRPKLASMT  229 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHHCCCCC-CCCCCCCHH
Confidence            122345668999999998889999999999999999999 9999976432       2334444443322 223457889


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          305 FCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +.+++.+||+.+|++|||++++++
T Consensus       230 ~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         230 VYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.2e-42  Score=311.67  Aligned_cols=242  Identities=24%  Similarity=0.382  Sum_probs=202.0

Q ss_pred             eeeeeCCeEEEEEEE--ccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCC
Q 018018           77 VVGKGSGGIVQLVQH--KWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  153 (362)
Q Consensus        77 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~g  153 (362)
                      .||+|+||.||++..  ..++..+|+|+++... ......++..|+.+++.++||||+++++.+. ....++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999864  4578899999987553 3445678899999999999999999998765 55679999999999


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC---CCccc
Q 018018          154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFV  230 (362)
Q Consensus       154 sL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~---~~~~~  230 (362)
                      +|.+++.....+++..+..++.|++.||+|||+ +|++||||||.||+++.++.+||+|||++.........   .....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE-TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            999999888889999999999999999999998 99999999999999999999999999999776433221   12223


Q ss_pred             cCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018018          231 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  309 (362)
Q Consensus       231 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  309 (362)
                      ++..|+|||.+.+..++.++|+|||||++|||++ |..||.+...       ......+..+.. ...+..+++++.++|
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~i~~~~~-~~~~~~~~~~l~~li  231 (257)
T cd05116         160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-------NEVTQMIESGER-MECPQRCPPEMYDLM  231 (257)
T ss_pred             CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHCCCC-CCCCCCCCHHHHHHH
Confidence            4578999999988889999999999999999998 9999976432       133334443332 234457899999999


Q ss_pred             HHhhhcCcCCCCCHHHHHc
Q 018018          310 SACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~  328 (362)
                      .+||+.||++||++++|..
T Consensus       232 ~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         232 KLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHhccCchhCcCHHHHHH
Confidence            9999999999999999964

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.1e-42  Score=312.33  Aligned_cols=251  Identities=26%  Similarity=0.416  Sum_probs=209.2

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      .+..++|++.+.||+|+||.||++... ++..||+|.+...  ......+.+|+.+++.++|+||+++++.+.+....++
T Consensus         2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05072           2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG--TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI   78 (261)
T ss_pred             cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC--chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence            456789999999999999999999865 5678999987643  2235678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          146 ILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ||||+++++|.+++...  ..++...+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||++.......
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER-KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            99999999999999653  568999999999999999999998 999999999999999999999999999998764322


Q ss_pred             CC-CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          224 GQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       224 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      .. .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......       .....+..... ......+
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~~~-~~~~~~~  229 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-------DVMSALQRGYR-MPRMENC  229 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-------HHHHHHHcCCC-CCCCCCC
Confidence            11 122345678999999998889999999999999999998 99999764321       22333332222 2233568


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +.++.+++.+||+.+|++|||++++++
T Consensus       230 ~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         230 PDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.6e-42  Score=320.83  Aligned_cols=257  Identities=23%  Similarity=0.362  Sum_probs=211.1

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEcc-------CCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEee
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKW-------TGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQ  135 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~  135 (362)
                      ..++..++|.+.+.||+|+||.||++++..       ++..+|+|+++.........++..|+.+++.+ +||||+++++
T Consensus        12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (307)
T cd05098          12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG   91 (307)
T ss_pred             cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            445556899999999999999999998643       33579999998654455567788999999998 7999999999


Q ss_pred             eEEecCeEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCc
Q 018018          136 SFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN  199 (362)
Q Consensus       136 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~N  199 (362)
                      .+...+..++||||+++++|.+++....                .++...+..++.|++.||+|||+ +|++||||||+|
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~N  170 (307)
T cd05098          92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN  170 (307)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHHh
Confidence            9999999999999999999999997642                47889999999999999999998 999999999999


Q ss_pred             EEEccCCcEEEeeccCCcccccCCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCC
Q 018018          200 LLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD  276 (362)
Q Consensus       200 Ill~~~~~vkl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~  276 (362)
                      |+++.++.++|+|||+++........  .....+++.|+|||.+.+..++.++|+|||||++|+|++ |..||.....  
T Consensus       171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~--  248 (307)
T cd05098         171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--  248 (307)
T ss_pred             eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH--
Confidence            99999999999999998765422211  112234568999999999899999999999999999998 8899865322  


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          277 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                           .++...+.... ....+..++.++.+|+.+||..+|++|||+.+++++
T Consensus       249 -----~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         249 -----EELFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             -----HHHHHHHHcCC-CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence                 22333333332 223345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3e-42  Score=314.78  Aligned_cols=252  Identities=23%  Similarity=0.362  Sum_probs=205.8

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCc----EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ----FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      +..++|++.+.||+|+||.||++....++.    .+++|.+..........++..|+..++.++||||+++++.+. ...
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~   82 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS   82 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence            455788999999999999999999877776    477777754444445567888888899999999999999765 456


Q ss_pred             EEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          143 ISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .++++||+++|+|.+++.. ...+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE-HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            7899999999999999976 4578999999999999999999998 9999999999999999999999999999976543


Q ss_pred             CCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          222 TSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       222 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      ...  ......++..|+|||.+.++.++.++||||||+++|||++ |..||.+....       .....+.... ....+
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~  233 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-------EVPDLLEKGE-RLAQP  233 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHCCC-cCCCC
Confidence            221  1223456778999999999899999999999999999998 99999764321       1222222222 22334


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..++.++.+++.+||..||++|||+.|+++
T Consensus       234 ~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         234 QICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            457789999999999999999999999966

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1e-42  Score=320.02  Aligned_cols=259  Identities=23%  Similarity=0.357  Sum_probs=209.6

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCC----------------cEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcce
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTG----------------QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV  131 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~  131 (362)
                      ...+|++.+.||+|+||.||++++...+                ..||+|++...........+.+|+++++.++||||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence            4578999999999999999999876543                568999998776666778899999999999999999


Q ss_pred             EEeeeEEecCeEEEEEeccCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcE
Q 018018          132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-----------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  200 (362)
Q Consensus       132 ~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NI  200 (362)
                      ++++.+..+...++||||+++++|.+++....           .+++..++.++.|++.||+|||+ +|++|+||||+||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~-~~i~H~dlkp~Ni  161 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES-LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH-cCccccccchhce
Confidence            99999999999999999999999999997765           78999999999999999999998 9999999999999


Q ss_pred             EEccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc--CCCCCCCCccCC
Q 018018          201 LINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT--GQFPYSPPEQQD  276 (362)
Q Consensus       201 ll~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt--g~~pf~~~~~~~  276 (362)
                      +++.++.++|+|||+++.......  ......++..|+|||.+.+..++.++|||||||++|+|++  +..||...+..+
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ  241 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence            999999999999999876533221  1223456778999999998889999999999999999998  778886543221


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          277 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .+.......... ........+..++.++.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         242 VIENAGHFFRDD-GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHhccccc-cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            111111100000 111111223456789999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.6e-42  Score=310.15  Aligned_cols=251  Identities=33%  Similarity=0.545  Sum_probs=216.7

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +|++.+.||+|+||.||++++..+++.+|+|.+.... .......+.+|+.+++.++|+||+++++.+.+....++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            5889999999999999999999999999999987642 344566778999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          150 MDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       150 ~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      +++++|.+++..    ...+++..+..++.|++.||+|||+ .|++|+||+|.||+++.++.+||+|||++......  .
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~-~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE-QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--M  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh-CCcccCCCCcceEEEecCCcEEEeeccchhhhccC--C
Confidence            999999999866    3578999999999999999999998 99999999999999999999999999998776543  2


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      .....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...+.       .+..........+. ....++.++
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~-~~~~~~~~~  229 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-------QDLRYKVQRGKYPP-IPPIYSQDL  229 (256)
T ss_pred             cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCCCC-CchhhCHHH
Confidence            3345688999999999998899999999999999999999999976432       12333333333332 334788999


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          306 CSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      .+++.+||+.+|++|||+.++++||++
T Consensus       230 ~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         230 QNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=320.61  Aligned_cols=260  Identities=23%  Similarity=0.403  Sum_probs=206.2

Q ss_pred             CceeeeeeeeeCCeEEEEEEEcc--CCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEec--CeEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKW--TGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAIS  144 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~--~~~~  144 (362)
                      +|.+.+.||+|+||.||++.+..  ++..||+|++....  .......+.+|+.+++.++||||+++++.+.+.  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            48889999999999999999988  89999999987632  122345677899999999999999999999988  8899


Q ss_pred             EEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc----CCcEEEeeccC
Q 018018          145 IILEYMDGGSLADFLKKV-----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH----RGEVKITDFGV  215 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~----~~~vkl~DFg~  215 (362)
                      +||||+++ +|.+++...     ..+++..++.++.|++.||+|||+ +|++||||||+||+++.    ++.+||+|||+
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS-NWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh-CCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            99999975 787777532     368999999999999999999998 99999999999999999    89999999999


Q ss_pred             CcccccCCC---CCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCc------hhhHHHHH
Q 018018          216 SAIMASTSG---QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG------WTSFYELM  285 (362)
Q Consensus       216 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~------~~~~~~~~  285 (362)
                      +........   ......+++.|+|||.+.+. .++.++|||||||++|+|++|..||...+....      ......+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            887543322   22344678899999988764 578999999999999999999999986554320      00111111


Q ss_pred             HHHhc--------------------CCCCCCC-----------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          286 EAIVD--------------------QPPPSAP-----------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       286 ~~~~~--------------------~~~~~~~-----------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      ..+..                    .......           ....+..+.+++.+||+.||++|||+.|++.||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            11000                    0000000           01466789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-44  Score=336.66  Aligned_cols=253  Identities=30%  Similarity=0.529  Sum_probs=221.6

Q ss_pred             eeeeeeeeeCCeEEEEEEEccCCcEEE---EEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe--EEEEE
Q 018018           73 DTIKVVGKGSGGIVQLVQHKWTGQFFA---LKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA--ISIIL  147 (362)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~~~~~va---iK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~--~~lV~  147 (362)
                      ....+||+|+|-+||+|.|..+|..||   +|+-....++....++..|+++++.|+||||+++|.++.+...  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            344689999999999999999999888   4433334556667899999999999999999999999987655  88999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeEeecCCCCcEEEcc-CCcEEEeeccCCcccccCCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-KHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~-~~ivH~Dlkp~NIll~~-~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      |.+..|+|..|+++.+.++...++.|++||++||.|||++ ..|+|||||-+||+|+. -|.|||+|+|+|+.....  .
T Consensus       123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--~  200 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--H  200 (632)
T ss_pred             ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc--c
Confidence            9999999999999999999999999999999999999983 35999999999999974 589999999999886533  3


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      ....+|||.|||||.+. ..|++.+||||||+|+.||+|+.+||..-      ..-.++..++..+..|.....--.+++
T Consensus       201 aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC------~n~AQIYKKV~SGiKP~sl~kV~dPev  273 (632)
T KOG0584|consen  201 AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSEC------TNPAQIYKKVTSGIKPAALSKVKDPEV  273 (632)
T ss_pred             cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhh------CCHHHHHHHHHcCCCHHHhhccCCHHH
Confidence            34479999999999998 78999999999999999999999999743      334467788888888877777778999


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          306 CSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      +++|.+||.. .++|+|+.|+|.||||+.-
T Consensus       274 r~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  274 REFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            9999999999 8999999999999999875

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.1e-42  Score=316.03  Aligned_cols=251  Identities=28%  Similarity=0.438  Sum_probs=208.9

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEc-----cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      ..++|.+.+.||+|+||.||++.+.     .++..+|+|.+... .......+.+|+.+++.++||||+++++.+.....
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP   81 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            4467899999999999999999863     34567999988654 34456678999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEE
Q 018018          143 ISIILEYMDGGSLADFLKKVK-------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK  209 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~-------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vk  209 (362)
                      .++||||+++++|.+++...+             .+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~-~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          82 LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEccCCcEE
Confidence            999999999999999997543             48999999999999999999998 9999999999999999999999


Q ss_pred             EeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHH
Q 018018          210 ITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELME  286 (362)
Q Consensus       210 l~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~  286 (362)
                      |+|||++........  ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.....       .....
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-------~~~~~  233 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEVIE  233 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH
Confidence            999999876532221  1122345778999999999899999999999999999998 9999976432       23334


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          287 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .+...... ..+..+++++.+|+.+||+.||.+|||+.+++.
T Consensus       234 ~i~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         234 CITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHcCCcC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            44443332 234568899999999999999999999999954

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.6e-42  Score=318.01  Aligned_cols=250  Identities=28%  Similarity=0.396  Sum_probs=206.6

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCc--EEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQ--FFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      ++|++.+.||+|+||.||++....++.  .+++|.++..........+.+|+.++.++ +||||+++++.+...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578999999999999999999887765  47888887544455567788999999888 799999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEE
Q 018018          147 LEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI  210 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl  210 (362)
                      +||+++++|.+++....                .+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE-KQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCcCCcceEEECCCCeEEE
Confidence            99999999999997532                48899999999999999999998 99999999999999999999999


Q ss_pred             eeccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHh
Q 018018          211 TDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIV  289 (362)
Q Consensus       211 ~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~  289 (362)
                      +|||++....... .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.....       ......+.
T Consensus       161 ~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-------~~~~~~~~  232 (297)
T cd05089         161 ADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-------AELYEKLP  232 (297)
T ss_pred             CCcCCCcccccee-ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHh
Confidence            9999986432111 1111233557999999998889999999999999999997 9999976432       22333443


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          290 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .... ...+..++..+.+|+.+||+.+|.+|||++++++.
T Consensus       233 ~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         233 QGYR-MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             cCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            3322 22345688999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-45  Score=335.59  Aligned_cols=282  Identities=26%  Similarity=0.401  Sum_probs=245.0

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ..++.+.+++.+..||-|+||.|-+++.......+|+|++++.  .+..+..++..|.++|..++.|+|+++|..|.++.
T Consensus       414 ~a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~k  493 (732)
T KOG0614|consen  414 FAQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSK  493 (732)
T ss_pred             hcccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccch
Confidence            4456788899999999999999999988766667999998765  56667788999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ++|++||-|-||.|...++..+.+++.+++.++..+++|++|||+ +|||.|||||+|.+++.+|.+||.|||+|+.+..
T Consensus       494 yvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~-k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  494 YVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHR-KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             hhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHh-cCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            999999999999999999999999999999999999999999998 9999999999999999999999999999998764


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                       +..+-++|||+.|.|||++.++..+.++|.||||+++|||++|.+||.+.++...       ...+..+......+..+
T Consensus       573 -g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-------Yn~ILkGid~i~~Pr~I  644 (732)
T KOG0614|consen  573 -GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-------YNLILKGIDKIEFPRRI  644 (732)
T ss_pred             -CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-------HHHHHhhhhhhhccccc
Confidence             4467789999999999999999999999999999999999999999999877432       23333333333445788


Q ss_pred             CHHHHHHHHHhhhcCcCCCCC-----HHHHHcCCcccccCCCCCCHHHHHHHhCCCcc
Q 018018          302 SPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGDLNVDLSEYFTDAGSPLA  354 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt-----~~eil~hp~~~~~~~~~~~l~~~~~~~~~~~~  354 (362)
                      +....+||+++...+|.+|..     +.||-+|-||.+.++..+..-..-+--.++|+
T Consensus       645 ~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va  702 (732)
T KOG0614|consen  645 TKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVA  702 (732)
T ss_pred             chhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCC
Confidence            999999999999999999996     89999999999999877644433333334443

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.2e-42  Score=317.11  Aligned_cols=258  Identities=31%  Similarity=0.519  Sum_probs=214.1

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +.|...+.||+|+||+||++++..++..||+|++....  .......+.+|+.+++.++|||++++++.+.+....++||
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  100 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM  100 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence            34667788999999999999999999999999987542  3344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          148 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       148 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      ||+. +++.+++.. ..++++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++....    ..
T Consensus       101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~-~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----~~  174 (313)
T cd06633         101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS----PA  174 (313)
T ss_pred             ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChhhEEECCCCCEEEeecCCCcccC----CC
Confidence            9996 478777755 4578999999999999999999998 999999999999999999999999999875432    23


Q ss_pred             CccccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          227 NTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                      ....|+..|+|||.+.   +..++.++|+|||||++|+|++|..||...+..       ...........+......++.
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~  247 (313)
T cd06633         175 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNDSPTLQSNEWTD  247 (313)
T ss_pred             CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHHhcCCCCCCccccCH
Confidence            3457889999999984   456889999999999999999999999764321       222222223333333456778


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCC
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  340 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~  340 (362)
                      .+.+|+.+||+.+|++||++.+++.||||+......+
T Consensus       248 ~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~~~~~  284 (313)
T cd06633         248 SFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARV  284 (313)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCcccCCCchhHH
Confidence            8999999999999999999999999999998664443

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.4e-42  Score=314.57  Aligned_cols=261  Identities=28%  Similarity=0.513  Sum_probs=216.1

Q ss_pred             CceeeeeeeeeCCeEEEEEEEc---cCCcEEEEEEeeccc---chHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNV---EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~  143 (362)
                      +|++.+.||.|+||.||++++.   .+|..||+|+++...   ......++.+|+.++..+ +|+||+.+++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788999999999999999875   478999999987542   223446678899999998 589999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ++|+||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            9999999999999999888889999999999999999999998 999999999999999999999999999987654322


Q ss_pred             -CCCCccccCCcccCcceecCC--CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          224 -GQANTFVGTYNYMSPERISGG--KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       224 -~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                       .......|+..|+|||.+.+.  .++.++||||+|+++|+|++|..||.......   ..............  ..+..
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~~--~~~~~  234 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSEP--PYPQE  234 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc---cHHHHHHHhhccCC--CCCcc
Confidence             122345688999999998763  46889999999999999999999996533221   12233333333222  23456


Q ss_pred             CCHHHHHHHHHhhhcCcCCCC-----CHHHHHcCCcccccCC
Q 018018          301 FSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYGD  337 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~~  337 (362)
                      +++.+.+++.+||+.||++||     ++++++.||||+....
T Consensus       235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence            889999999999999999997     8999999999998864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.9e-42  Score=311.13  Aligned_cols=252  Identities=26%  Similarity=0.400  Sum_probs=209.9

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCc---EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      ...+|++.+.||+|+||.||++.+..++.   .+|+|.++..........+..|+.+++.++||||+++++.+..++..+
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVM   81 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            35788999999999999999998865443   799999876655556678899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          145 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      +||||+++++|.+++... ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++|+|||++.......
T Consensus        82 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          82 IVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            999999999999999764 468999999999999999999998 999999999999999999999999999988764332


Q ss_pred             CCC---CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          224 GQA---NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       224 ~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      ...   ....++..|+|||.+.+..++.++|+||||+++|++++ |..||...+..       +....+..... .....
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-------~~~~~~~~~~~-~~~~~  232 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-------DVIKAIEEGYR-LPAPM  232 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-------HHHHHHhCCCc-CCCCC
Confidence            211   11223568999999998899999999999999999887 99999764331       22333333322 22335


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .+++.+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         233 DCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            67899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.6e-42  Score=329.83  Aligned_cols=259  Identities=26%  Similarity=0.363  Sum_probs=211.7

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEc-----cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeee
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQS  136 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~  136 (362)
                      ..+.+..++|.+.+.||+|+||.||++++.     .++..||+|+++..........+.+|++++..+. ||||+++++.
T Consensus        30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            346677788999999999999999999854     3456899999986655555567889999999997 9999999999


Q ss_pred             EEecCeEEEEEeccCCCCHHHHHHHcC-----------------------------------------------------
Q 018018          137 FYSNGAISIILEYMDGGSLADFLKKVK-----------------------------------------------------  163 (362)
Q Consensus       137 ~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------------------------------------------  163 (362)
                      +...+..++||||+++|+|.+++....                                                     
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            999999999999999999999996431                                                     


Q ss_pred             ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCC
Q 018018          164 ---------------------------------------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS  198 (362)
Q Consensus       164 ---------------------------------------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~  198 (362)
                                                                   .+++..+..++.|++.||+|||+ +|++||||||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrdlkp~  268 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS-KNCVHRDLAAR  268 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCcCcccCCcc
Confidence                                                         25667788999999999999998 99999999999


Q ss_pred             cEEEccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccC
Q 018018          199 NLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ  275 (362)
Q Consensus       199 NIll~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~  275 (362)
                      |||++.++.+||+|||+++.......  ......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999876532221  1223456788999999998889999999999999999998 89999654321


Q ss_pred             CchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          276 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +      .....+... .....+..++.++.+|+.+||+.+|++||++.++++.
T Consensus       349 ~------~~~~~~~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         349 E------QFYNAIKRG-YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             H------HHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            1      122222222 2223345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.3e-42  Score=313.02  Aligned_cols=254  Identities=25%  Similarity=0.388  Sum_probs=203.1

Q ss_pred             ceeeeeeeeeCCeEEEEEE----EccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec--CeEEE
Q 018018           72 IDTIKVVGKGSGGIVQLVQ----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISI  145 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~--~~~~l  145 (362)
                      |+..+.||+|+||+||++.    ...++..||+|+++..........+.+|+++++.++||||+++++.+...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            4889999999999998865    33568899999997665455567788999999999999999999987653  46899


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      ||||+++++|.+++.. ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||+++........
T Consensus        86 v~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  163 (283)
T cd05080          86 IMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHS-QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY  163 (283)
T ss_pred             EecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence            9999999999999976 469999999999999999999998 99999999999999999999999999998765432211


Q ss_pred             ---CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCC--------chhhHHHHHHHHhcCCCC
Q 018018          226 ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD--------GWTSFYELMEAIVDQPPP  294 (362)
Q Consensus       226 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~~  294 (362)
                         .....++..|+|||.+.+..++.++||||||+++|+|++|..||.......        .............. ...
T Consensus       164 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  242 (283)
T cd05080         164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER-GMR  242 (283)
T ss_pred             hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc-CCC
Confidence               122345667999999998899999999999999999999999986543210        00001111111111 112


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          295 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       295 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ...+..++.++.+++.+||+.+|++|||++++++
T Consensus       243 ~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            2234567899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=5.1e-42  Score=318.54  Aligned_cols=255  Identities=22%  Similarity=0.353  Sum_probs=210.1

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEcc-------CCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeee
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKW-------TGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQS  136 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~  136 (362)
                      +.+..++|.+.+.||+|+||.||++++..       ....+|+|+++..........+..|+.+++.+ +||||+++++.
T Consensus         7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (314)
T cd05099           7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV   86 (314)
T ss_pred             ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence            44566889999999999999999998642       34579999987665555667788999999988 69999999999


Q ss_pred             EEecCeEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcE
Q 018018          137 FYSNGAISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  200 (362)
Q Consensus       137 ~~~~~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NI  200 (362)
                      +...+..++||||+++|+|.+++...                ..+++..+..++.|++.||.|||+ +|++||||||+||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~-~gi~H~dlkp~Ni  165 (314)
T cd05099          87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES-RRCIHRDLAARNV  165 (314)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeeccccceeE
Confidence            99999999999999999999999753                348889999999999999999998 9999999999999


Q ss_pred             EEccCCcEEEeeccCCcccccCCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCc
Q 018018          201 LINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDG  277 (362)
Q Consensus       201 ll~~~~~vkl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~  277 (362)
                      +++.++.+||+|||+++........  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.   
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---  242 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---  242 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---
Confidence            9999999999999999765432211  112234567999999999899999999999999999999 8999976432   


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          278 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                          ......+..... ...+..++.++.+++.+||+.||++|||+.++++
T Consensus       243 ----~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         243 ----EELFKLLREGHR-MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             ----HHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                223333333322 2234567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.9e-42  Score=312.39  Aligned_cols=250  Identities=25%  Similarity=0.383  Sum_probs=211.2

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ...+|++.+.||.|+||.||++.+.. +..+|+|++.... ......+..|+.+++.++|+||+++++.+.+....++||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   81 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT   81 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence            34679999999999999999999987 8899999987553 334556889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          148 EYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       148 e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.+||+|||.+.........
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE-QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            999999999999753  468999999999999999999998 99999999999999999999999999998776433322


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+.       .+....+..... ...+..+++.
T Consensus       161 ~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~  232 (261)
T cd05148         161 SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-------HEVYDQITAGYR-MPCPAKCPQE  232 (261)
T ss_pred             ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHHhCCc-CCCCCCCCHH
Confidence            333456778999999998899999999999999999998 8999976432       123333333322 2334578899


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          305 FCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +.+++.+||+.||++|||+.++++
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         233 IYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHH
Confidence            999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.3e-42  Score=324.90  Aligned_cols=257  Identities=27%  Similarity=0.406  Sum_probs=207.3

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEE-----ccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEE
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQH-----KWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFY  138 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~  138 (362)
                      +.+..++|++.+.||+|+||.||+|.+     ..+++.||||+++..........+.+|+.++..+ +||||+++++.+.
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            345668999999999999999999984     3467899999998665555567788999999998 6899999999876


Q ss_pred             e-cCeEEEEEeccCCCCHHHHHHHc-------------------------------------------------------
Q 018018          139 S-NGAISIILEYMDGGSLADFLKKV-------------------------------------------------------  162 (362)
Q Consensus       139 ~-~~~~~lV~e~~~~gsL~~~l~~~-------------------------------------------------------  162 (362)
                      . ....++||||+++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            4 45688999999999999998642                                                       


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC--CCCc
Q 018018          163 ------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANT  228 (362)
Q Consensus       163 ------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~--~~~~  228 (362)
                                  ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++........  ....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                        236778889999999999999998 9999999999999999999999999999876532221  1122


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHH
Q 018018          229 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS  307 (362)
Q Consensus       229 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (362)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..||......      ......+..+.. ...+...++++.+
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~~~~~-~~~~~~~~~~~~~  313 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID------EEFCRRLKEGTR-MRAPDYTTPEMYQ  313 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc------HHHHHHHhccCC-CCCCCCCCHHHHH
Confidence            345678999999999899999999999999999997 99999764321      112222222222 2223457889999


Q ss_pred             HHHHhhhcCcCCCCCHHHHHcC
Q 018018          308 FISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       308 li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ++.+||+.||++|||+.++++|
T Consensus       314 ~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         314 TMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             HHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-42  Score=318.53  Aligned_cols=259  Identities=23%  Similarity=0.356  Sum_probs=206.4

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCC--------------cEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTG--------------QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVC  133 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~--------------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~  133 (362)
                      ...+|++.+.||+|+||.||+|++...+              ..||+|+++..........+.+|+++++.++|+||+++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            4468999999999999999999875432              35899998766556667789999999999999999999


Q ss_pred             eeeEEecCeEEEEEeccCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEE
Q 018018          134 YQSFYSNGAISIILEYMDGGSLADFLKKVK------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL  201 (362)
Q Consensus       134 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIl  201 (362)
                      ++.+......++||||+++++|.+++....            .+++..+..++.|++.||+|||+ +|++|+||||+||+
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil  161 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS-LNFVHRDLATRNCL  161 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh-cCeeccccChhhEE
Confidence            999999999999999999999999996532            36888999999999999999998 99999999999999


Q ss_pred             EccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc--CCCCCCCCccCCc
Q 018018          202 INHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT--GQFPYSPPEQQDG  277 (362)
Q Consensus       202 l~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt--g~~pf~~~~~~~~  277 (362)
                      ++.++.+||+|||++........  ......++..|+|||.+.++.++.++|+|||||++|+|++  +..||......+.
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999876532221  1122345678999999999899999999999999999988  6678876433211


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          278 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .....+...... .......+..+++.+.+|+.+||+.||++|||++++++
T Consensus       242 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         242 IENTGEFFRNQG-RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHhhhhcc-ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            111111111111 11112223457899999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.9e-42  Score=309.39  Aligned_cols=250  Identities=25%  Similarity=0.425  Sum_probs=207.3

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +.++|.+.+.||+|+||.||+++.. .+..+|+|.++...  .....+.+|+.+++.++||||+++++.+.+....++||
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT   78 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence            4578999999999999999999775 34569999886442  22356889999999999999999999999889999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC-
Q 018018          148 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-  225 (362)
Q Consensus       148 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~-  225 (362)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.+||+|||+++........ 
T Consensus        79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES-KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            999999999999764 478999999999999999999998 99999999999999999999999999998765432211 


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.....       ......+...... ......+..
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~~  229 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-------SETVEKVSQGLRL-YRPHLASEK  229 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-------HHHHHHHhcCCCC-CCCCCCCHH
Confidence            112235678999999998889999999999999999998 9999975432       1233344433332 234457899


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          305 FCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +.+++.+||+.||++|||+.+++.+
T Consensus       230 ~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         230 VYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHHh
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-44  Score=331.32  Aligned_cols=252  Identities=30%  Similarity=0.499  Sum_probs=216.3

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGS  154 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gs  154 (362)
                      +.||+|.||+||-++++.+|+.||||++.+- ........+..|+.|++.++||.|+.+-..|++.+.++.|||-+.|.-
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM  649 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM  649 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence            7899999999999999999999999998654 334455789999999999999999999999999999999999997644


Q ss_pred             HHHHH-HHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC---cEEEeeccCCcccccCCCCCCccc
Q 018018          155 LADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTSGQANTFV  230 (362)
Q Consensus       155 L~~~l-~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~---~vkl~DFg~a~~~~~~~~~~~~~~  230 (362)
                      |.-.+ .+.+++++...+.++.||+.||.|||. ++|+|.||||+|||+.+..   .+||||||+|+.++... ...+.+
T Consensus       650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~-knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-FRrsVV  727 (888)
T KOG4236|consen  650 LEMILSSEKGRLPERITKFLVTQILVALRYLHF-KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-FRRSVV  727 (888)
T ss_pred             HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh-cceeeccCCchheeeccCCCCCceeeccccceeecchhh-hhhhhc
Confidence            44444 345789999999999999999999998 9999999999999996543   79999999999987543 445679


Q ss_pred             cCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHH
Q 018018          231 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS  310 (362)
Q Consensus       231 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  310 (362)
                      ||+.|.|||+++++.|+..-|+||+|+++|--++|..||...++      +.+.++. .....|+.++..+++++.+||.
T Consensus       728 GTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd------IndQIQN-AaFMyPp~PW~eis~~AidlIn  800 (888)
T KOG4236|consen  728 GTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED------INDQIQN-AAFMYPPNPWSEISPEAIDLIN  800 (888)
T ss_pred             CCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc------hhHHhhc-cccccCCCchhhcCHHHHHHHH
Confidence            99999999999999999999999999999999999999965432      1122222 2233456667889999999999


Q ss_pred             HhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          311 ACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       311 ~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      .+|+..-++|.|.+..+.|||++++.
T Consensus       801 ~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  801 NLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHHHhcchHhhccchhhhcch
Confidence            99999999999999999999998873

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.7e-42  Score=314.30  Aligned_cols=251  Identities=28%  Similarity=0.419  Sum_probs=208.4

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEc-----cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      ...+|.+.+.||+|+||.||++++.     .++..+++|.+... .......+.+|+.+++.++|+||+++++.+.....
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc-cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            4567899999999999999999854     34567999988644 33445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC
Q 018018          143 ISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG  206 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~  206 (362)
                      .++||||+++++|.+++....                .+++..++.++.|++.||+|||+ +|++||||||+||+++.++
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~-~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS-QHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccCcceEEEccCC
Confidence            999999999999999997542                37899999999999999999998 9999999999999999999


Q ss_pred             cEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHH
Q 018018          207 EVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYE  283 (362)
Q Consensus       207 ~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~  283 (362)
                      .++|+|||++........  ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.....       .+
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-------~~  233 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN-------TE  233 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HH
Confidence            999999999876543221  1223456788999999999999999999999999999998 9999976433       12


Q ss_pred             HHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          284 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ....+.....+ .....++..+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         234 VIECITQGRVL-ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HHHHHhCCCCC-CCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            33334333332 234567899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9e-42  Score=307.27  Aligned_cols=246  Identities=24%  Similarity=0.415  Sum_probs=209.4

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      +..++|++.+.||.|+||.||++...  |+.||+|.++....  ...++.+|+.+++.++|+||+++++.+.+....++|
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   78 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV   78 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence            45678999999999999999999874  88999999875533  567789999999999999999999999989999999


Q ss_pred             EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          147 LEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||.+....... 
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-  156 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE-KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-  156 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence            99999999999998765  79999999999999999999998 999999999999999999999999999988763221 


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                        .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||.....       ......+.... ....+..+++
T Consensus       157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~  226 (256)
T cd05039         157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVVPHVEKGY-RMEAPEGCPP  226 (256)
T ss_pred             --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHhcCC-CCCCccCCCH
Confidence              12344667999999998889999999999999999997 9999975432       22333333322 2233456789


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .+.++|.+||+.+|++|||+.+++.
T Consensus       227 ~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         227 EVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHHHHHhccChhhCcCHHHHHH
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=7.7e-42  Score=315.83  Aligned_cols=257  Identities=21%  Similarity=0.363  Sum_probs=213.1

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEc-------cCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEee
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHK-------WTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQ  135 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~  135 (362)
                      ...+..++|.+.+.||+|+||.||++++.       .++..+|+|++...........+.+|+.+++.+ +||||+++++
T Consensus         9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   88 (304)
T cd05101           9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG   88 (304)
T ss_pred             cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence            34577899999999999999999999753       234579999987655555667899999999998 8999999999


Q ss_pred             eEEecCeEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCc
Q 018018          136 SFYSNGAISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN  199 (362)
Q Consensus       136 ~~~~~~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~N  199 (362)
                      .+......++||||+++++|.+++...                ..++...+..++.|++.||.|||+ +|++||||||+|
T Consensus        89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~N  167 (304)
T cd05101          89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS-QKCIHRDLAARN  167 (304)
T ss_pred             EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH-CCeeecccccce
Confidence            999999999999999999999999763                247788899999999999999998 999999999999


Q ss_pred             EEEccCCcEEEeeccCCcccccCCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCC
Q 018018          200 LLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD  276 (362)
Q Consensus       200 Ill~~~~~vkl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~  276 (362)
                      |+++.++.+||+|||+++........  .....++..|+|||++.+..++.++||||||+++|+|++ |..||...+.  
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--  245 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--  245 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--
Confidence            99999999999999999876433221  222345678999999999889999999999999999998 8888865322  


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          277 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                           .++...+..... ...+..++..+.+++.+||+.+|++|||+.++++.
T Consensus       246 -----~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         246 -----EELFKLLKEGHR-MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             -----HHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence                 233444433332 23345688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-42  Score=307.23  Aligned_cols=245  Identities=36%  Similarity=0.607  Sum_probs=213.3

Q ss_pred             eeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCCH
Q 018018           78 VGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  155 (362)
Q Consensus        78 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL  155 (362)
                      ||.|+||.||.+.+..+++.+|+|+++...  .......+..|+.+++.++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            689999999999999899999999987652  233566788999999999999999999999999999999999999999


Q ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCCcc
Q 018018          156 ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY  235 (362)
Q Consensus       156 ~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y  235 (362)
                      .+++.....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..............++..|
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~-~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHS-LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY  159 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence            9999988889999999999999999999998 999999999999999999999999999987765443344556788899


Q ss_pred             cCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 018018          236 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK  315 (362)
Q Consensus       236 ~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  315 (362)
                      +|||...+..++.++|+||||+++|++++|..||...+.       ......+....  ...+...+..+.++|.+||+.
T Consensus       160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-------~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~  230 (250)
T cd05123         160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-------KEIYEKILKDP--LRFPEFLSPEARDLISGLLQK  230 (250)
T ss_pred             cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHhcCC--CCCCCCCCHHHHHHHHHHhcC
Confidence            999999988889999999999999999999999976432       23333333322  234456689999999999999


Q ss_pred             CcCCCCCH---HHHHcCCcc
Q 018018          316 EPQQRLSA---QELMTHPFL  332 (362)
Q Consensus       316 dP~~Rpt~---~eil~hp~~  332 (362)
                      ||++||++   +++++||||
T Consensus       231 ~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         231 DPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CHhhCCCcccHHHHHhCCCC
Confidence            99999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1e-41  Score=308.90  Aligned_cols=252  Identities=25%  Similarity=0.364  Sum_probs=210.7

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCc---EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      ...+|+..+.||+|+||.||++.+..++.   .+|+|.++..........+..|+.+++.++||||+++++.+...+..+
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            44678899999999999999999876655   799999876655556678899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          145 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      +||||+++++|.+++... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++.......
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  161 (268)
T cd05063          83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD-MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP  161 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence            999999999999999764 578999999999999999999998 999999999999999999999999999987664322


Q ss_pred             CCCC---ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          224 GQAN---TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       224 ~~~~---~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      ....   ....+..|+|||.+.+..++.++|||||||++|+|++ |..||...+.       ......+..... .+...
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-------~~~~~~i~~~~~-~~~~~  233 (268)
T cd05063         162 EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-------HEVMKAINDGFR-LPAPM  233 (268)
T ss_pred             ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-------HHHHHHHhcCCC-CCCCC
Confidence            2111   1123457999999998889999999999999999997 9999975432       133333333322 22334


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .++..+.+++.+||+.+|++||++.++++
T Consensus       234 ~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         234 DCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            67899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.9e-42  Score=307.29  Aligned_cols=243  Identities=26%  Similarity=0.411  Sum_probs=202.2

Q ss_pred             eeeeeeCCeEEEEEEEccCC---cEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTG---QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||.||++.....+   ..+|+|.+...........+.+|+.+++.+.|+||+++++.+. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999876554   7899999886654456678899999999999999999999765 5568999999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC---cc
Q 018018          153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN---TF  229 (362)
Q Consensus       153 gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~---~~  229 (362)
                      ++|.+++.....+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.+||+|||+++..........   ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~-~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~  158 (257)
T cd05060          80 GPLLKYLKKRREIPVSDLKELAHQVAMGMAYLES-KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG  158 (257)
T ss_pred             CcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhh-cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence            9999999988889999999999999999999998 9999999999999999999999999999887643332111   11


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  308 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  308 (362)
                      .++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.       .+....+.... +...+..+++.+.++
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~~l~~l  230 (257)
T cd05060         159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-------AEVIAMLESGE-RLPRPEECPQEIYSI  230 (257)
T ss_pred             cccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHcCC-cCCCCCCCCHHHHHH
Confidence            23467999999999899999999999999999998 9999976432       12223332222 223445688999999


Q ss_pred             HHHhhhcCcCCCCCHHHHHc
Q 018018          309 ISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~eil~  328 (362)
                      |.+||+.+|++|||+.++++
T Consensus       231 i~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         231 MLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHhcCChhhCcCHHHHHH
Confidence            99999999999999999965

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.4e-42  Score=322.71  Aligned_cols=256  Identities=25%  Similarity=0.456  Sum_probs=203.5

Q ss_pred             eeeeee--CCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKG--SGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      ..||.|  +||+||++++..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++..+...++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  89999999999999999999987542 334457788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC-----
Q 018018          153 GSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-----  225 (362)
Q Consensus       153 gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~-----  225 (362)
                      ++|.+++.+.  ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++++||+.+.........     
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ-NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            9999999764  358999999999999999999998 99999999999999999999999999865433211111     


Q ss_pred             --CCccccCCcccCcceecCC--CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC----------
Q 018018          226 --ANTFVGTYNYMSPERISGG--KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ----------  291 (362)
Q Consensus       226 --~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----------  291 (362)
                        .....++..|+|||++.+.  .++.++||||+||++|+|++|+.||.......      .........          
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ------MLLQKLKGPPYSPLDITTF  236 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH------HHHHHhcCCCCCCcccccc
Confidence              1112345679999999774  47899999999999999999999997643211      111111000          


Q ss_pred             ----------------------------------CCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          292 ----------------------------------PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       292 ----------------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                                                        .........+++.+.+||++||+.||++|||+.|+++||||+...+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                              0001112345678999999999999999999999999999988765


Q ss_pred             C
Q 018018          338 L  338 (362)
Q Consensus       338 ~  338 (362)
                      .
T Consensus       317 ~  317 (328)
T cd08226         317 Q  317 (328)
T ss_pred             h
Confidence            3

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.7e-42  Score=316.06  Aligned_cols=258  Identities=25%  Similarity=0.373  Sum_probs=206.5

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEcc----------------CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKW----------------TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV  132 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~  132 (362)
                      .++|++.+.||+|+||.||++.+..                ++..+|+|+++..........+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            4679999999999999999986432                345799999886656666778999999999999999999


Q ss_pred             EeeeEEecCeEEEEEeccCCCCHHHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEE
Q 018018          133 CYQSFYSNGAISIILEYMDGGSLADFLKKVK-----------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL  201 (362)
Q Consensus       133 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIl  201 (362)
                      +++.+......++||||+++++|.+++....           .+++..+..++.|++.||+|||+ +|++|+||||+||+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dlkp~Nil  162 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS-LNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH-CCeecccCChheEE
Confidence            9999999999999999999999999997642           36778899999999999999998 99999999999999


Q ss_pred             EccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc--CCCCCCCCccCCc
Q 018018          202 INHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT--GQFPYSPPEQQDG  277 (362)
Q Consensus       202 l~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt--g~~pf~~~~~~~~  277 (362)
                      ++.++.++|+|||+++.......  ......++..|+|||...++.++.++|+|||||++|||++  |..||...+..+.
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            99999999999999876533221  1122344678999999888899999999999999999998  7789876543322


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          278 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .............. .....+..+++.+.+|+.+||+.||++||++.++++
T Consensus       243 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         243 IENTGEFFRDQGRQ-VYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHhhcccc-ccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            11111111111111 111223457899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=8.2e-42  Score=308.16  Aligned_cols=242  Identities=26%  Similarity=0.392  Sum_probs=199.8

Q ss_pred             eeeeeCCeEEEEEEEc--cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCC
Q 018018           77 VVGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGS  154 (362)
Q Consensus        77 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gs  154 (362)
                      .||+|+||.||++...  ..+..||+|++...........+.+|+.+++.++||||+++++.+. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999998765  3456799999876655666678999999999999999999999875 557899999999999


Q ss_pred             HHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC---Cccc
Q 018018          155 LADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA---NTFV  230 (362)
Q Consensus       155 L~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~---~~~~  230 (362)
                      |.+++.. ...+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++..........   ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG-KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK  159 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence            9999975 4579999999999999999999998 999999999999999999999999999987654322211   1122


Q ss_pred             cCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018018          231 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  309 (362)
Q Consensus       231 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  309 (362)
                      ++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....       .....+..+.. ...+...++++.++|
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~l~~li  231 (257)
T cd05115         160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-------EVMSFIEQGKR-LDCPAECPPEMYALM  231 (257)
T ss_pred             CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-------HHHHHHHCCCC-CCCCCCCCHHHHHHH
Confidence            3578999999998889999999999999999996 99999764331       23333333332 334456789999999


Q ss_pred             HHhhhcCcCCCCCHHHHHc
Q 018018          310 SACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~  328 (362)
                      .+||+.||++||++.++.+
T Consensus       232 ~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         232 KDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHcCCChhhCcCHHHHHH
Confidence            9999999999999999965

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-41  Score=307.07  Aligned_cols=251  Identities=22%  Similarity=0.367  Sum_probs=207.9

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ++..++|++.+.||+|++|.||++.+. ++..||+|.++...  .....+.+|+.+++.++||||+++++.+...+..++
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   78 (261)
T cd05068           2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI   78 (261)
T ss_pred             ccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence            345678999999999999999999875 45789999987542  234568889999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          146 ILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ||||+++++|.+++....  .+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.++|+|||++.......
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA-QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            999999999999997644  78999999999999999999998 999999999999999999999999999988765322


Q ss_pred             CC-CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          224 GQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       224 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      .. ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+...       ......+..... ......+
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~~  229 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-------AEVLQQVDQGYR-MPCPPGC  229 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCC-CCCCCcC
Confidence            11 111223457999999998899999999999999999999 9999976432       123333333222 2234567


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +..+.+++.+||+.+|++||++.++++
T Consensus       230 ~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         230 PKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             CHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=316.79  Aligned_cols=256  Identities=27%  Similarity=0.521  Sum_probs=210.2

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEecc
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  150 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~  150 (362)
                      |++.+.||+|++|.||++.+..+++.+++|.++... .......+.+|+.+++.++|+||+++++.+..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999999999999999999987653 2244567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          151 DGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       151 ~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      ++ +|.+++... ..+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||.+.............
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS-HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHH-CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence            75 888888763 689999999999999999999998 999999999999999999999999999987765443223345


Q ss_pred             ccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC----------------
Q 018018          230 VGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP----------------  292 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----------------  292 (362)
                      .++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||...+..+..   ...........                
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL---FKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCchHhcccchhhhhhhhh
Confidence            678899999998876 6899999999999999999999999765432211   11111110000                


Q ss_pred             --------CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          293 --------PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       293 --------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                              ........++.++.++|.+||+.||.+||++.+++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                    0001123467889999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=308.01  Aligned_cols=270  Identities=34%  Similarity=0.610  Sum_probs=230.9

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHH-HhcCCCCcceEEeeeEEecCeE
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~-~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      ..+..++.+-+..||.|+||+|++..++.+|+.+|||.++....+....+++.|.+. ++.-++|||+++|++...++..
T Consensus        59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc  138 (361)
T KOG1006|consen   59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC  138 (361)
T ss_pred             cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence            356667888889999999999999999999999999999988777777888888885 5667899999999999999999


Q ss_pred             EEEEeccCCCCHHHHHH-----HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          144 SIILEYMDGGSLADFLK-----KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~-----~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      ++-||.|. .||..+-.     ....+++...-.+....+.||.||..+..|+|||+||+|||++..|.+||||||++-.
T Consensus       139 WiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  139 WICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ  217 (361)
T ss_pred             eeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence            99999995 48776653     3468999999999999999999999888999999999999999999999999999877


Q ss_pred             cccCCCCCCccccCCcccCcceecC--CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018018          219 MASTSGQANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  296 (362)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
                      +...- ......|-..|||||.+..  ..|+.++|+||||++|||+.||..|+.      .|.++.+-+..+..+.+|..
T Consensus       218 Lv~Si-AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr------~w~svfeql~~Vv~gdpp~l  290 (361)
T KOG1006|consen  218 LVDSI-AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR------KWDSVFEQLCQVVIGDPPIL  290 (361)
T ss_pred             HHHHH-HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc------hHHHHHHHHHHHHcCCCCee
Confidence            65332 2334578889999999865  348999999999999999999999995      57777777777776665543


Q ss_pred             CC----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCH
Q 018018          297 PS----DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL  342 (362)
Q Consensus       297 ~~----~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l  342 (362)
                      ..    -.++..+..+|.-||.+|-+.||++.+++++||++.+..+..++
T Consensus       291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~~v  340 (361)
T KOG1006|consen  291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGPDV  340 (361)
T ss_pred             cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCCce
Confidence            32    23788999999999999999999999999999999998766653

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=349.16  Aligned_cols=253  Identities=26%  Similarity=0.431  Sum_probs=218.1

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCc-----EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ-----FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      +.....+..+.||+|.||.||.+.......     .||||.++...+......|.+|..+|+.++||||++++|++.+.+
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~  768 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG  768 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence            456677888999999999999998765333     499999998888889999999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeecc
Q 018018          142 AISIILEYMDGGSLADFLKKV-------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG  214 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~-------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg  214 (362)
                      ..++++|||.||+|..||++.       ..++..+...++.|+++|+.||++ +++|||||..+|+|++....|||+|||
T Consensus       769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~-~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES-KHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh-CCCcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999999875       358999999999999999999998 999999999999999999999999999


Q ss_pred             CCcccccCCCCCC-c-cccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcC
Q 018018          215 VSAIMASTSGQAN-T-FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQ  291 (362)
Q Consensus       215 ~a~~~~~~~~~~~-~-~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  291 (362)
                      +|+.+........ . ..-+..|||||.+..+.++.++|||||||++||++| |..||.+.+..       +++.....+
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-------~v~~~~~~g  920 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-------EVLLDVLEG  920 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-------HHHHHHHhC
Confidence            9996543322111 1 234579999999999999999999999999999999 99999885442       344433333


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          292 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       292 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      . .-..+..++..+.++|.+||+.+|++||++..|++
T Consensus       921 g-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  921 G-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             C-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            3 33445789999999999999999999999999988

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.4e-42  Score=313.38  Aligned_cols=249  Identities=24%  Similarity=0.403  Sum_probs=205.8

Q ss_pred             CceeeeeeeeeCCeEEEEEEEcc-----CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      +|++.+.||+|+||.||++.+..     ....+|+|.+...........+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            47788999999999999998753     2356899988766555556778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEE
Q 018018          146 ILEYMDGGSLADFLKKV------------------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL  201 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIl  201 (362)
                      |+||+.+++|.+++...                        ..+++..+..++.|++.||.|||+ +|++||||||+||+
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~ivH~dikp~nil  159 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE-MKLVHRDLAARNVL  159 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH-CCeehhhhhhheEE
Confidence            99999999999998642                        247889999999999999999998 99999999999999


Q ss_pred             EccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCch
Q 018018          202 INHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW  278 (362)
Q Consensus       202 l~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~  278 (362)
                      ++.++.+||+|||+++.......  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....   
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---  236 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---  236 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH---
Confidence            99999999999999876533221  1122345678999999988889999999999999999998 99999764322   


Q ss_pred             hhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          279 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                          .+........ ....+..++.++.+++.+||+.+|++||++.++++
T Consensus       237 ----~~~~~~~~~~-~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         237 ----RLFNLLKTGY-RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             ----HHHHHHhCCC-CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                2222222222 22234678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-42  Score=308.49  Aligned_cols=250  Identities=24%  Similarity=0.435  Sum_probs=205.6

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +..+|++.+.||+|+||.||++.+. ++..+|+|++.....  ....+.+|+.+++.++||||+++++.+...+..++||
T Consensus         2 ~~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (256)
T cd05059           2 DPSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT   78 (256)
T ss_pred             ChHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence            3467889999999999999999886 567899999864322  2345778999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          148 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       148 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      ||+++++|.+++... ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++.........
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLES-NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            999999999999763 578999999999999999999998 999999999999999999999999999987654322111


Q ss_pred             -CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          227 -NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       227 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                       ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..       +....+.... ....+..+++.
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~  229 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-------EVVESVSAGY-RLYRPKLAPTE  229 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-------HHHHHHHcCC-cCCCCCCCCHH
Confidence             11223457999999999899999999999999999999 89999754332       2222333222 22233568999


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          305 FCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +.+++.+||+.+|++|||+.|+++.
T Consensus       230 ~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         230 VYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5e-42  Score=316.39  Aligned_cols=259  Identities=28%  Similarity=0.459  Sum_probs=208.0

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC-----
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-----  141 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~-----  141 (362)
                      ..++|++.+.||+|+||.||++.+..+|+.||+|+++.... ......+.+|+.+++.++||||+++++.+.+..     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            45789999999999999999999999999999999875532 233356778999999999999999999887654     


Q ss_pred             -----eEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccC
Q 018018          142 -----AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  215 (362)
Q Consensus       142 -----~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~  215 (362)
                           .+++|+||+++ ++..++... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.+||+|||+
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK-KNFLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCcEEeCcccc
Confidence                 79999999976 777777653 478999999999999999999998 9999999999999999999999999999


Q ss_pred             CcccccCCCC-CCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC
Q 018018          216 SAIMASTSGQ-ANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP  293 (362)
Q Consensus       216 a~~~~~~~~~-~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  293 (362)
                      +......... .....++..|+|||.+.+. .++.++||||+||++|+|++|+.||...+..+    ....+........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~  238 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA----QLELISRLCGSPC  238 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCC
Confidence            8766433321 1223567889999988654 47889999999999999999999997643321    1111222211111


Q ss_pred             CC-------------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          294 PS-------------------------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       294 ~~-------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      +.                         .....+++.+.++|.+||+.||++|||+++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            00                         0122468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.8e-41  Score=314.07  Aligned_cols=258  Identities=32%  Similarity=0.528  Sum_probs=215.3

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +.|...+.||+|+||.||++++..++..+|+|++...  ........+.+|+++++.++|||++++++.+.++...++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            4578889999999999999999999999999998754  23344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          148 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       148 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      ||+.+ +|.+.+.. ..++++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++.....    .
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~-~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----~  178 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS-HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----A  178 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcccEEECCCCCEEEecCCCccccCC----c
Confidence            99975 78777754 5679999999999999999999998 9999999999999999999999999998765432    2


Q ss_pred             CccccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          227 NTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                      ....+++.|+|||.+.   ++.++.++|+||+||++|+|++|..||...+.       ......+.....+......+++
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  251 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPTLQSNEWSD  251 (317)
T ss_pred             ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHhccCCCCCCccccH
Confidence            3456888999999974   45688999999999999999999999976422       1222333333333334456788


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCC
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  340 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~  340 (362)
                      .+.+++.+||+.+|++||++.++++|+|+.......+
T Consensus       252 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~  288 (317)
T cd06635         252 YFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV  288 (317)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence            9999999999999999999999999999976655444

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.3e-43  Score=309.02  Aligned_cols=268  Identities=23%  Similarity=0.409  Sum_probs=208.9

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCc----EEEEEEeecccchHH-HHHHHHHHHHHhcCCCCcceEEeeeEEe-cC
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQ----FFALKVIQMNVEESA-RRQIAQELKINQSSQCPYVVVCYQSFYS-NG  141 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~-~~~~~~e~~~~~~l~hp~I~~~~~~~~~-~~  141 (362)
                      ....|+.+..||+|+||.||+|..+.++.    .||||.++.+.+... -...-+|+.+++.++|||++.+..+|.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            35789999999999999999997665433    689999976533221 2345688999999999999999999887 88


Q ss_pred             eEEEEEeccCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC----CcEEEee
Q 018018          142 AISIILEYMDGGSLADFLKKV-----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR----GEVKITD  212 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~-----~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~----~~vkl~D  212 (362)
                      .+++++||++. +|...|+-+     +.++...++.++.||+.|+.|||+ +-|+||||||.|||+..+    |+|||+|
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~-NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS-NWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh-hheeeccCCcceEEEeccCCccCeeEeec
Confidence            99999999987 999999543     579999999999999999999998 889999999999999877    8999999


Q ss_pred             ccCCcccccCCC---CCCccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCch------hhHH
Q 018018          213 FGVSAIMASTSG---QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW------TSFY  282 (362)
Q Consensus       213 Fg~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~------~~~~  282 (362)
                      ||+|+.+..+-.   .....+-|.+|+|||.+.|.. |+.+.|+||+||++.||++-.+.|.+.+..-..      ....
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            999998765433   234457799999999999855 899999999999999999999888764432110      0111


Q ss_pred             HHHHHHhcCC---CC---------------------CC-------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCc
Q 018018          283 ELMEAIVDQP---PP---------------------SA-------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  331 (362)
Q Consensus       283 ~~~~~~~~~~---~~---------------------~~-------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~  331 (362)
                      .+++.+....   .|                     ..       ....-++...+|+.+||++||.+|+|++++++|+|
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            1111111000   00                     00       01112345789999999999999999999999999


Q ss_pred             ccccCC
Q 018018          332 LKMYGD  337 (362)
Q Consensus       332 ~~~~~~  337 (362)
                      |+.-+-
T Consensus       340 F~~d~l  345 (438)
T KOG0666|consen  340 FTEDPL  345 (438)
T ss_pred             cccCCC
Confidence            987643

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-42  Score=322.09  Aligned_cols=257  Identities=26%  Similarity=0.431  Sum_probs=203.5

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC-eEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-AISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~-~~~lV~  147 (362)
                      .++|..-+.||+|+||.||++... +|..||||.+....... .++|..|+.++.+++|||+++++|+|.+.+ ..+||+
T Consensus        74 T~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY  151 (361)
T KOG1187|consen   74 TNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY  151 (361)
T ss_pred             HhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence            467777789999999999999886 45899999877654332 566999999999999999999999999988 599999


Q ss_pred             eccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--CeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          148 EYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEK--HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~--~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ||+++|+|.+++....  +++|..+.+|+.++++||+|||...  .|+||||||.|||+|++.++||+|||+|+......
T Consensus       152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~  231 (361)
T KOG1187|consen  152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD  231 (361)
T ss_pred             EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence            9999999999997654  8999999999999999999999854  39999999999999999999999999996543212


Q ss_pred             CCCCcc-ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHH-hcCC----CCCCC
Q 018018          224 GQANTF-VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI-VDQP----PPSAP  297 (362)
Q Consensus       224 ~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~  297 (362)
                      ....+. .||..|+|||.+..+..+.++||||||+++.||+||+.+......... ....++.... ....    ..+..
T Consensus       232 ~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~-~~l~~w~~~~~~~~~~~eiiD~~l  310 (361)
T KOG1187|consen  232 TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGE-LSLVEWAKPLLEEGKLREIVDPRL  310 (361)
T ss_pred             cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccc-ccHHHHHHHHHHCcchhheeCCCc
Confidence            222222 799999999999999999999999999999999999988765431111 1122322111 1111    11111


Q ss_pred             C-CCCC-----HHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          298 S-DQFS-----PEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       298 ~-~~~~-----~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      . ...+     ..+..+..+|++.+|++||++.|+++
T Consensus       311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            1 2223     23567889999999999999999754

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-42  Score=313.95  Aligned_cols=256  Identities=29%  Similarity=0.479  Sum_probs=207.7

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEec--CeEEEEEe
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAISIILE  148 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~--~~~~lV~e  148 (362)
                      |++.+.||+|++|.||++++..+++.+|+|++.... .......+.+|+.+++.++|+|++++++.+...  +..++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678899999999999999999999999999998663 333446688999999999999999999999887  89999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC-CC
Q 018018          149 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QA  226 (362)
Q Consensus       149 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~-~~  226 (362)
                      |+++ +|.+++... ..+++..++.++.|++.||+|||+ .|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS-NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence            9975 899988765 589999999999999999999998 9999999999999999999999999999887654332 12


Q ss_pred             CccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-------------
Q 018018          227 NTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-------------  292 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------------  292 (362)
                      ....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...+......   ..........             
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCchhhccccccchhh
Confidence            23456788999998765 457899999999999999999999997654321111   1111100000             


Q ss_pred             ----CC--------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          293 ----PP--------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       293 ----~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                          ..        ......+++.+.+++++||+.+|++||++++++.||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                00        00011137889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1e-41  Score=311.39  Aligned_cols=251  Identities=30%  Similarity=0.440  Sum_probs=207.7

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEc-----cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      ...+|...+.||+|+||.||++...     .++..+|+|.++.. .......+.+|+++++.++|+||+++++.+.....
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            4567888999999999999999753     35668999988654 34456678999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc
Q 018018          143 ISIILEYMDGGSLADFLKKVK---------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE  207 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~---------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~  207 (362)
                      .++||||+++++|.+++....               .+++..+..++.|++.||+|||+ +|++||||||+||+++.++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS-LHFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH-CCeecccccHhhEEEcCCCC
Confidence            999999999999999997643               47899999999999999999998 99999999999999999999


Q ss_pred             EEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHH
Q 018018          208 VKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYEL  284 (362)
Q Consensus       208 vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~  284 (362)
                      +||+|||++........  ......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......       ..
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~  233 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-------EA  233 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-------HH
Confidence            99999999875432211  1122345678999999999999999999999999999998 99999654321       22


Q ss_pred             HHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          285 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ......... ...+..+++.+.++|.+||+.||++||++++++.
T Consensus       234 ~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         234 IECITQGRE-LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             HHHHHcCcc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            333333322 2234578899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.2e-42  Score=320.76  Aligned_cols=263  Identities=27%  Similarity=0.444  Sum_probs=211.0

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC------
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG------  141 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~------  141 (362)
                      .++|++.+.||+|+||.||++.+..++..||+|++.... .......+.+|+.+++.++||||+++++.+....      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            478999999999999999999999999999999986542 3334567889999999999999999999887543      


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .+++||||+ +++|.+++.. ..+++..++.++.|++.||+|||+ .|++||||||+||+++.++.++|+|||++.....
T Consensus        94 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~-~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880          94 DFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            468999999 6799988875 679999999999999999999998 9999999999999999999999999999876532


Q ss_pred             CCCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHH--------HHHHHH----
Q 018018          222 TSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY--------ELMEAI----  288 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~--------~~~~~~----  288 (362)
                         ......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.......+.        .+...+    
T Consensus       171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07880         171 ---EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED  247 (343)
T ss_pred             ---CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchh
Confidence               2234467889999999876 458899999999999999999999997643211100000        000000    


Q ss_pred             ----hcCCC------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          289 ----VDQPP------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       289 ----~~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                          ....+      .......+++++.++|.+||+.||++|||+.+++.||||+.+.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             HHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                00000      00112457888999999999999999999999999999988754

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-42  Score=313.23  Aligned_cols=255  Identities=26%  Similarity=0.457  Sum_probs=203.7

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch-HHHHHHHHHHHHHhcC---CCCcceEEeeeEEecCe-----
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-SARRQIAQELKINQSS---QCPYVVVCYQSFYSNGA-----  142 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l---~hp~I~~~~~~~~~~~~-----  142 (362)
                      |++.+.||+|+||.||++++..+++.||+|+++..... .....+.+|+.+++.+   +|+||+++++.+.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            67889999999999999999988999999999754322 2234455677666554   69999999999988776     


Q ss_pred             EEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          143 ISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      .+++|||+.+ +|.+++....  .+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~-~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS-HRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence            9999999975 8999887643  58999999999999999999998 999999999999999999999999999987764


Q ss_pred             cCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC---------
Q 018018          221 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ---------  291 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---------  291 (362)
                      ... ......++..|+|||.+.+..++.++|+||+||++|+|++|.+||.+....+....   ........         
T Consensus       159 ~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         159 FEM-ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDK---IFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             CCc-ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHH---HHHHcCCCChHhcCCCc
Confidence            332 22334578899999999999999999999999999999999999986544322111   11111000         


Q ss_pred             ---------CCC---CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          292 ---------PPP---SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       292 ---------~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                               ...   ......+++.+.++|.+||+.||++||++++++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                     000   00012345778999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-41  Score=308.88  Aligned_cols=249  Identities=23%  Similarity=0.356  Sum_probs=204.2

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccC---CcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe-----
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-----  142 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~-----  142 (362)
                      |.+.+.||+|+||.||.+....+   +..||+|+++... .......+.+|+..++.++||||+++++.+.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56788999999999999987654   4789999987652 34455678999999999999999999998765444     


Q ss_pred             -EEEEEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccC
Q 018018          143 -ISIILEYMDGGSLADFLKKV------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  215 (362)
Q Consensus       143 -~~lV~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~  215 (362)
                       .++|+||+++++|..++...      ..+++..+..++.|++.||+|||+ +|++||||||+||++++++.+||+|||+
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN-RNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchheEEECCCCeEEECCccc
Confidence             79999999999999998542      368999999999999999999998 9999999999999999999999999999


Q ss_pred             CcccccCCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          216 SAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       216 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                      ++........  .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+.       .+....+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~  232 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-------HEIYDYLRHGN  232 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCC
Confidence            8865433221  112234678999999988889999999999999999999 8999976432       13333443333


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          293 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       293 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      . ...+..+++++.+++.+||+.||++|||+.|++++
T Consensus       233 ~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         233 R-LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             C-CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2 23345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.2e-41  Score=309.77  Aligned_cols=254  Identities=23%  Similarity=0.385  Sum_probs=212.6

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEcc-----CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      ..++|.+.+.||+|+||.||+++.+.     +.+.+++|.+...........+.+|+++++.++|+||+++++.+.+...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            34789999999999999999999754     3567999998765555567789999999999999999999999998899


Q ss_pred             EEEEEeccCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeec
Q 018018          143 ISIILEYMDGGSLADFLKKVK---------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF  213 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~---------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DF  213 (362)
                      .++||||+++++|.+++....         .+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++++||
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN-ARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh-cCcccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999998655         68999999999999999999998 99999999999999999999999999


Q ss_pred             cCCcccccCC-CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcC
Q 018018          214 GVSAIMASTS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQ  291 (362)
Q Consensus       214 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  291 (362)
                      |++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.....       ..........
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-------~~~~~~~~~~  234 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-------EEVLNRLQAG  234 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-------HHHHHHHHcC
Confidence            9986543221 12233456778999999988889999999999999999998 8889965332       1233334333


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          292 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       292 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .........++..+.+++.+||+.+|++|||+.|++.+
T Consensus       235 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         235 KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            33333445788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.2e-41  Score=318.86  Aligned_cols=258  Identities=22%  Similarity=0.357  Sum_probs=212.5

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccC-------CcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEee
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT-------GQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQ  135 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~  135 (362)
                      .+++...+|++.+.||+|+||.||++++...       +..+|+|+++..........+.+|+.+++.+ +||||+++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            4566677899999999999999999986432       2368999987665566677899999999999 7999999999


Q ss_pred             eEEecCeEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCc
Q 018018          136 SFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN  199 (362)
Q Consensus       136 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~N  199 (362)
                      .+...+..++++||+++|+|.+++....                .++...+..++.|++.||+|||+ +|++||||||+|
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~-~givH~dlkp~N  164 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS-QKCIHRDLAARN  164 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccccce
Confidence            9999999999999999999999997532                47788899999999999999998 999999999999


Q ss_pred             EEEccCCcEEEeeccCCcccccCCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCC
Q 018018          200 LLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD  276 (362)
Q Consensus       200 Ill~~~~~vkl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~  276 (362)
                      |+++.++.+||+|||+++........  .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+.+.  
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--  242 (334)
T cd05100         165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV--  242 (334)
T ss_pred             EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence            99999999999999998765432211  122234567999999999999999999999999999998 8899976432  


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCC
Q 018018          277 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP  330 (362)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp  330 (362)
                           .+....+..... ...+..++.++.+++.+||+.+|++|||+.+++.+-
T Consensus       243 -----~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         243 -----EELFKLLKEGHR-MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             -----HHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence                 233333333322 223456788999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=8.3e-42  Score=345.79  Aligned_cols=148  Identities=32%  Similarity=0.549  Sum_probs=137.9

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      +++|.+++.||+|+||.||++.+..+++.||||+++..  ........+..|+.++..++||||++++..+.....+|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            57899999999999999999999999999999999754  2344557788999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      |||+.+++|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~-~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHR-HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999888889999999999999999999998 899999999999999999999999999885

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.4e-41  Score=308.36  Aligned_cols=252  Identities=25%  Similarity=0.426  Sum_probs=209.3

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCc---EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      ...+|++.+.||+|+||.||++.+..++.   .||+|++...........+..|+.+++.++||||+++++.+.++...+
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   81 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM   81 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence            34678899999999999999999887665   699999876655666788999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          145 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      +||||+++++|.+++... +.+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||++.......
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~-~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE-MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            999999999999999763 568999999999999999999998 999999999999999999999999999987654322


Q ss_pred             CCC--C-cc--ccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          224 GQA--N-TF--VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       224 ~~~--~-~~--~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      ...  . ..  ..+..|+|||.+.+..++.++||||+||++||+++ |..||...+..       .....+... .+...
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-------~~~~~i~~~-~~~~~  232 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-------DVINAIEQD-YRLPP  232 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcC-CcCCC
Confidence            111  1 11  12457999999999999999999999999999886 99999764321       223333222 22223


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +..++..+.+++.+||+.+|++||++++++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         233 PMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            3467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-41  Score=312.25  Aligned_cols=253  Identities=24%  Similarity=0.366  Sum_probs=210.7

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEcc-----CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      +..++|++.+.||+|+||.||++.+..     ++..||+|++...........+.+|+.+++.++||||+++++.+..+.
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~   81 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK   81 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence            345789999999999999999998753     678899999886655666778999999999999999999999999989


Q ss_pred             eEEEEEeccCCCCHHHHHHHcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCc
Q 018018          142 AISIILEYMDGGSLADFLKKVK----------------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN  199 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~----------------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~N  199 (362)
                      ..++|+||+++++|.+++....                      .+++..+..++.|++.||+|||+ +|++||||||+|
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~-~~i~H~dl~p~n  160 (288)
T cd05050          82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE-RKFVHRDLATRN  160 (288)
T ss_pred             ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCeecccccHhh
Confidence            9999999999999999997532                      46788899999999999999998 999999999999


Q ss_pred             EEEccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCC
Q 018018          200 LLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD  276 (362)
Q Consensus       200 Ill~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~  276 (362)
                      |+++.++.++|+|||++........  .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+...  
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~--  238 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH--  238 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence            9999999999999999875432221  1222344667999999998899999999999999999997 8889865433  


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          277 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                           .+....+...... ..+..++.++.+||.+||+.||++|||+.|+++
T Consensus       239 -----~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         239 -----EEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             -----HHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence                 2333444433332 223567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=4.6e-42  Score=321.36  Aligned_cols=265  Identities=25%  Similarity=0.410  Sum_probs=208.9

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccC--CcEEEEEEeeccc-chHHHHHHHHHHHHHhcC-CCCcceEEeeeEEe----cCe
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWT--GQFFALKVIQMNV-EESARRQIAQELKINQSS-QCPYVVVCYQSFYS----NGA  142 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~----~~~  142 (362)
                      +|++.+.||+|+||.||++++..+  +..||+|+++... .......+.+|+.+++.+ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            478899999999999999999888  8999999987542 223455678899999888 59999999986542    245


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      .+++++|+. ++|.+++.....+++..++.++.|++.||+|||+ +|++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS-ANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            788899986 5999999888899999999999999999999998 99999999999999999999999999999765432


Q ss_pred             CC----CCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH--------HHH---
Q 018018          223 SG----QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--------LME---  286 (362)
Q Consensus       223 ~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~--------~~~---  286 (362)
                      ..    ......|+..|+|||.+.+ ..++.++||||+|+++|+|++|..||...+..+.......        ...   
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            21    2234578999999998766 4689999999999999999999999976442111100000        000   


Q ss_pred             ---------HHhcCC--CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          287 ---------AIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       287 ---------~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                               ......  .........+..+.+++.+||+.||++|||+.+++.||||+.|.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence                     000000  001112346789999999999999999999999999999998865

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=5.6e-42  Score=309.30  Aligned_cols=252  Identities=33%  Similarity=0.505  Sum_probs=210.2

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc----cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN----VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      +|.+.+.||+|+||.||++++...+..+++|+++..    ........+..|+.+++.++||||+++++.+.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            588899999999999999999888777777776542    1222334566788999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          147 LEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      +||+++++|.+++..    ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++ ++.++|+|||++......
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~~l~~~nili~-~~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-RRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH-cCccccCCChhheEee-cCCEeecccCceeecCCC
Confidence            999999999998864    3578999999999999999999998 9999999999999996 467999999998776544


Q ss_pred             CCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018018          223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  302 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (362)
                      ........+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+..       ............. +..+..++
T Consensus       159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~  230 (260)
T cd08222         159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN-------FLSVVLRIVEGPT-PSLPETYS  230 (260)
T ss_pred             cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-------HHHHHHHHHcCCC-CCCcchhc
Confidence            444445568889999999988888999999999999999999999996532       1233333333332 33345788


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      .++.++|.+||+.||++||++.++++||||
T Consensus       231 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         231 RQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.1e-41  Score=312.12  Aligned_cols=261  Identities=30%  Similarity=0.538  Sum_probs=214.5

Q ss_pred             CceeeeeeeeeCCeEEEEEEEc---cCCcEEEEEEeeccc---chHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNV---EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~  143 (362)
                      +|++.+.||+|++|.||++++.   .++..||+|+++...   .......+.+|+.++..+ +||||+.+++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4788999999999999999864   467899999987542   123345678899999998 599999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~-~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQ-LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            9999999999999999887889999999999999999999998 999999999999999999999999999987654332


Q ss_pred             C-CCCccccCCcccCcceecCCC--CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          224 G-QANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       224 ~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      . ......|+..|+|||.+.+..  .+.++|+||+|+++|+|++|..||........   ..+..........  ..+..
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~--~~~~~  234 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS---QSEISRRILKSKP--PFPKT  234 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch---HHHHHHHHHccCC--CCCcc
Confidence            2 122346889999999987765  78899999999999999999999965332211   1222233333222  23456


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCC---HHHHHcCCcccccCC
Q 018018          301 FSPEFCSFISACVQKEPQQRLS---AQELMTHPFLKMYGD  337 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~~~~  337 (362)
                      +++.+.++|.+||+.||++|||   +.++++||||+.+..
T Consensus       235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            8899999999999999999998   567799999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.4e-41  Score=306.09  Aligned_cols=246  Identities=25%  Similarity=0.427  Sum_probs=205.0

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEE-ecCeEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY-SNGAIS  144 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~-~~~~~~  144 (362)
                      .+...+|++.+.||+|+||.||++...  |..+|+|.++..   .....+.+|+.+++.++|+|++++++.+. .....+
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           2 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             CccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            456789999999999999999999764  888999998643   23456889999999999999999998764 456789


Q ss_pred             EEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          145 IILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      +||||+++++|.+++....  .+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            9999999999999997643  48899999999999999999998 99999999999999999999999999998764332


Q ss_pred             CCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      .   ....++..|+|||++.+..++.++|||||||++|+|++ |+.||...+.       ......+.... .......+
T Consensus       156 ~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~-------~~~~~~~~~~~-~~~~~~~~  224 (256)
T cd05082         156 Q---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-------KDVVPRVEKGY-KMDAPDGC  224 (256)
T ss_pred             C---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhcCC-CCCCCCCC
Confidence            2   23345668999999998889999999999999999997 9999975322       23333333332 23344678


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ++.+.+++.+||+.+|++|||+.++++
T Consensus       225 ~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         225 PPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-41  Score=311.40  Aligned_cols=258  Identities=23%  Similarity=0.363  Sum_probs=207.2

Q ss_pred             cCceeeeeeeeeCCeEEEEEEE----ccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec--CeE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQH----KWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN--GAI  143 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~--~~~  143 (362)
                      .-|++++.||+|+||.||+++.    ..++..||+|.++..........+.+|+.+++.++||||+++++.+...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578899999999999999984    4568899999987665555667899999999999999999999988765  568


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          144 SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      ++||||+++++|.+++... ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++|+|||+++.....
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~-~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  162 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence            9999999999999999764 468999999999999999999998 99999999999999999999999999998876433


Q ss_pred             CCC---CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccC--------CchhhHHHHHHHHhcC
Q 018018          223 SGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ--------DGWTSFYELMEAIVDQ  291 (362)
Q Consensus       223 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~--------~~~~~~~~~~~~~~~~  291 (362)
                      ...   .....++..|+|||.+.+..++.++||||||+++|+|+++..|+......        ................
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG  242 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence            221   12345677899999999888999999999999999999987665332110        0001111122222222


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          292 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       292 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      . ....+..++..+.+|+.+||+.||++|||+.+++++
T Consensus       243 ~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         243 K-RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             c-cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            2 223345688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.3e-41  Score=315.07  Aligned_cols=258  Identities=31%  Similarity=0.510  Sum_probs=215.2

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ..|+..+.||+|+||.||++++..++..+|+|.+...  ........+.+|+++++.++|+|++++++.+......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            5577889999999999999999999999999998643  23344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          148 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       148 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      ||+. +++.+++.. ...+++..+..++.|++.||.|||+ +|++||||+|+||+++.++.++|+|||++.....    .
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~-~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----~  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHhEEECCCCcEEECCcccceeecC----c
Confidence            9996 588887754 4568999999999999999999998 9999999999999999999999999998865432    2


Q ss_pred             CccccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          227 NTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                      ....+++.|+|||.+.   ...++.++|||||||++|+|++|..||...+..       ...........+......++.
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~  241 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPALQSGHWSE  241 (308)
T ss_pred             ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-------HHHHHHhhcCCCCcCcccccH
Confidence            3456888999999974   356788999999999999999999998654321       222223333333333456888


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCC
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  340 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~  340 (362)
                      .+.+||.+||+.+|++||++++++.|||+.+......
T Consensus       242 ~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~~~~  278 (308)
T cd06634         242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTV  278 (308)
T ss_pred             HHHHHHHHHhhCCcccCCCHHHHhhCccccccCChhH
Confidence            9999999999999999999999999999998766544

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-41  Score=320.66  Aligned_cols=265  Identities=24%  Similarity=0.403  Sum_probs=209.9

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEec------C
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN------G  141 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~------~  141 (362)
                      .++|++.+.||+|+||.||++.+..+++.||+|++.... .......+.+|+.+++.++||||+++++.+...      .
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            488999999999999999999999999999999987542 233345678899999999999999999887543      3


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ..+++++++ +++|.++++. ..+++..++.++.|++.||+|||+ +|++||||||+||+++.++.++|+|||++.....
T Consensus        96 ~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877          96 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             cEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            478888887 6799888865 469999999999999999999998 9999999999999999999999999999876432


Q ss_pred             CCCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH-----------------
Q 018018          222 TSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE-----------------  283 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~-----------------  283 (362)
                         ......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||...+.......+..                 
T Consensus       173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (345)
T cd07877         173 ---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  249 (345)
T ss_pred             ---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHh
Confidence               2334578899999999876 5688999999999999999999999976433211000000                 


Q ss_pred             ---HHHHHhcCCCC--CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          284 ---LMEAIVDQPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       284 ---~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                         ...........  .......++++.++|.+||+.||++|||+.+++.||||+.+....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~  310 (345)
T cd07877         250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  310 (345)
T ss_pred             HHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence               00000000000  001124578899999999999999999999999999999876543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.9e-41  Score=305.97  Aligned_cols=250  Identities=26%  Similarity=0.441  Sum_probs=206.0

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ++..++|++.+.||+|+||.||+|... +++.||+|.+.....  ....+.+|+.+++.++|+||+++++.+ .....++
T Consensus         2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~   77 (260)
T cd05067           2 EVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYI   77 (260)
T ss_pred             ccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEE
Confidence            345578999999999999999999865 678899999875432  235688899999999999999999876 4567899


Q ss_pred             EEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          146 ILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ||||+.+++|.+++...  ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~-~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER-KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            99999999999998653  468999999999999999999998 999999999999999999999999999987654222


Q ss_pred             C-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          224 G-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       224 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      . ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..       +....+.... ....+...
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~  228 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-------EVIQNLERGY-RMPRPDNC  228 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-------HHHHHHHcCC-CCCCCCCC
Confidence            1 1223345678999999998899999999999999999999 99999764321       2223333322 22334567


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +.++.+++.+||+.+|++|||+++++.
T Consensus       229 ~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         229 PEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.5e-41  Score=307.22  Aligned_cols=249  Identities=24%  Similarity=0.399  Sum_probs=203.9

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      +..++|++.+.||+|+||.||++++..+ ..||+|+++....  ....+.+|+.+++.++||||+++++.+. ....++|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv   78 (262)
T cd05071           3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIV   78 (262)
T ss_pred             CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEE
Confidence            4557899999999999999999988755 4699999875322  2346888999999999999999998764 5668999


Q ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          147 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      |||+++++|.+++...  ..+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||.++.......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            9999999999999763  458999999999999999999998 9999999999999999999999999999876543222


Q ss_pred             C-CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018018          225 Q-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  302 (362)
Q Consensus       225 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (362)
                      . .....++..|+|||...+..++.++|+||||+++|+|++ |..||.+....       .....+..... ......++
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-------~~~~~~~~~~~-~~~~~~~~  229 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-------EVLDQVERGYR-MPCPPECP  229 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-------HHHHHHhcCCC-CCCccccC
Confidence            1 123346678999999998899999999999999999999 88899764321       22233332222 22345688


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+.+++.+||+.||++||++.+++.
T Consensus       230 ~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         230 ESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHHH
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.2e-42  Score=316.79  Aligned_cols=259  Identities=29%  Similarity=0.471  Sum_probs=203.7

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-hHHHHHHHHHHHHHhcCCCCcceEEeeeEEec------
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSN------  140 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~------  140 (362)
                      ..++|.+.+.||+|+||.||++.+..+++.+|+|++..... ......+.+|+++++.++||||+++++.+.+.      
T Consensus         6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            36899999999999999999999999999999999865422 22234567899999999999999999876543      


Q ss_pred             --CeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          141 --GAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       141 --~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                        ..+++|+||+.+ ++...+.. ...+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||++.
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  163 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE-NHILHRDIKAANILIDNQGILKIADFGLAR  163 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEECcCccch
Confidence              357999999965 77777654 4579999999999999999999998 999999999999999999999999999987


Q ss_pred             ccccCCCC-----------CCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH
Q 018018          218 IMASTSGQ-----------ANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM  285 (362)
Q Consensus       218 ~~~~~~~~-----------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  285 (362)
                      ........           .....+++.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+......   ...
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~---~~~  240 (311)
T cd07866         164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH---LIF  240 (311)
T ss_pred             hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH
Confidence            65432211           1223568889999988664 57899999999999999999999997654321111   111


Q ss_pred             HHHhcCCC----------------------CC---CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          286 EAIVDQPP----------------------PS---APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       286 ~~~~~~~~----------------------~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                       .......                      +.   .....+++.+.++|.+||+.||++|||+.+++.||||
T Consensus       241 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         241 -KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             -HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence             1111000                      00   0012345788999999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.6e-41  Score=308.29  Aligned_cols=248  Identities=25%  Similarity=0.354  Sum_probs=201.2

Q ss_pred             eeeeeeeeeCCeEEEEEEEccCCc--EEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec------CeE
Q 018018           73 DTIKVVGKGSGGIVQLVQHKWTGQ--FFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GAI  143 (362)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~------~~~  143 (362)
                      .+.+.||+|+||.||++....++.  .+|+|.++.. ........+..|+.+++.++||||+++++.+...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            466889999999999999887765  6999998765 2344567788999999999999999999876432      357


Q ss_pred             EEEEeccCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          144 SIILEYMDGGSLADFLKK------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      ++||||+++|+|.+++..      ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS-KSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH-CCeeccccchhheEEcCCCCEEECCCCccc
Confidence            899999999999998842      2348999999999999999999998 999999999999999999999999999988


Q ss_pred             ccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018018          218 IMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPP  294 (362)
Q Consensus       218 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  294 (362)
                      .......  ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..       .....+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~~~~~~~~~~~  233 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS-------EIYDYLRQGNRL  233 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHHHHcCCCC
Confidence            7643221  1122345778999999999999999999999999999999 89999764321       233333333322


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          295 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       295 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                       .....++..+.++|.+||+.||++|||+.+++++
T Consensus       234 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         234 -KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence             2234678899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-42  Score=325.45  Aligned_cols=265  Identities=25%  Similarity=0.436  Sum_probs=212.0

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe-----
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-----  142 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~-----  142 (362)
                      .++|++.+.||+|++|.||++++..+++.||+|++.... .......+.+|+.+++.++||||+++.+.+.....     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            468999999999999999999999999999999986542 23344667789999999999999999887765554     


Q ss_pred             -EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          143 -ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       143 -~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                       .++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+ .|++||||+|+||+++.++.++|+|||++.....
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~-~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHS-AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence             89999999 5699999876 579999999999999999999998 9999999999999999999999999999876532


Q ss_pred             CCCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH--------HH-----
Q 018018          222 TSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM--------EA-----  287 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~--------~~-----  287 (362)
                      .   .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+.......+....        .+     
T Consensus       171 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  247 (343)
T cd07851         171 E---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES  247 (343)
T ss_pred             c---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchh
Confidence            2   344567889999999865 367899999999999999999999997654321111110000        00     


Q ss_pred             -------HhcCCCC--CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          288 -------IVDQPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       288 -------~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                             .......  ......+++.+.++|.+||+.||++|||+.+++.||||+.+....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~  308 (343)
T cd07851         248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE  308 (343)
T ss_pred             HHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence                   0000000  001124588999999999999999999999999999999886543

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-42  Score=315.46  Aligned_cols=259  Identities=28%  Similarity=0.505  Sum_probs=210.1

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEecc
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  150 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~  150 (362)
                      |+..+.||+|++|.||+++...+++.||+|++.... .......+..|+.+++.++|+||+++++.+.+....++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            567788999999999999999999999999987653 2334466778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          151 DGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       151 ~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      + ++|.+++... ..+++..+..++.|++.||+|||+ +|++||||+|+||+++.++.++|+|||++.............
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS-HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            7 5999999876 589999999999999999999998 999999999999999999999999999987765443333445


Q ss_pred             ccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH--------HHHh-----cCCCCC
Q 018018          230 VGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM--------EAIV-----DQPPPS  295 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~-----~~~~~~  295 (362)
                      .++..|+|||.+.+. .++.++|+||||+++|+|++|..||...+..+....+....        ....     ....+.
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK  238 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence            667889999998776 78999999999999999999999997644321111111000        0000     000000


Q ss_pred             -------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          296 -------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       296 -------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                             .....++..+.++|++||+.||++||++++++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                   0112347789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.7e-41  Score=303.77  Aligned_cols=248  Identities=28%  Similarity=0.438  Sum_probs=209.8

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCC----cEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTG----QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +++.+.||.|+||.||++++..++    ..+|+|+++..........+..|+.++..++|+||+++++.+.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            356789999999999999998766    8999999976655556778999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          148 EYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      ||+++++|.+++.....  +++..+..++.|++.||++||+ .|++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~-~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES-KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc-CCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            99999999999976544  9999999999999999999998 99999999999999999999999999998776543221


Q ss_pred             CC-ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          226 AN-TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       226 ~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                      .. ...+++.|+|||.+.+..++.++|+||+|+++|+|++ |..||...+.       ......+...... ..+...+.
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~-~~~~~~~~  231 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-------EEVLEYLKKGYRL-PKPENCPP  231 (258)
T ss_pred             ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHhcCCCC-CCCCcCCH
Confidence            11 1236789999999988889999999999999999998 8888876322       2333344333332 23445889


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ++.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      232 EIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHHHHCcCChhhCcCHHHHHh
Confidence            9999999999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.1e-41  Score=320.07  Aligned_cols=263  Identities=26%  Similarity=0.427  Sum_probs=205.9

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec---------
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN---------  140 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~---------  140 (362)
                      .+|.+.+.||.|+||.||++.+..+|+.||+|++..... ...+.+.+|+++++.++||||+++++.+...         
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            789999999999999999999999999999999875533 4456788999999999999999998766543         


Q ss_pred             -----CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc-CCcEEEeecc
Q 018018          141 -----GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFG  214 (362)
Q Consensus       141 -----~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-~~~vkl~DFg  214 (362)
                           ...++||||++ ++|.+++.. ..+++..++.++.|++.||.|||+ .|++||||||+||+++. ++.++|+|||
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~-~givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCceEEECCcc
Confidence                 35899999997 489888865 579999999999999999999998 99999999999999974 5578999999


Q ss_pred             CCcccccCCC---CCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHH--------
Q 018018          215 VSAIMASTSG---QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY--------  282 (362)
Q Consensus       215 ~a~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~--------  282 (362)
                      ++........   ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...+..+......        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE  240 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9876532211   1122357889999998755 457889999999999999999999997643311100000        


Q ss_pred             ----HHH----HHHh-cCCCCC----CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          283 ----ELM----EAIV-DQPPPS----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       283 ----~~~----~~~~-~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                          ...    .... ....+.    .....++.++.+||.+||+.||++|||+.+++.||||+.+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~  307 (342)
T cd07854         241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYS  307 (342)
T ss_pred             HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccccc
Confidence                000    0000 000000    01235778899999999999999999999999999998663

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.5e-41  Score=308.47  Aligned_cols=253  Identities=21%  Similarity=0.318  Sum_probs=210.0

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEcc----CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe-cC
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKW----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-NG  141 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~-~~  141 (362)
                      +..++|++.+.||+|+||.||.+.+..    .+..|++|.+...........+.+|+.+++.++|+||+++++.+.. ..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            456889999999999999999999876    3578999998766666677888999999999999999999998765 57


Q ss_pred             eEEEEEeccCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeec
Q 018018          142 AISIILEYMDGGSLADFLKKV--------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF  213 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~--------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DF  213 (362)
                      ..+++++|+++++|.+++...        ..+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.+||+||
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK-RGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCHhhEEEcCCCcEEECCC
Confidence            789999999999999999653        458999999999999999999998 99999999999999999999999999


Q ss_pred             cCCcccccCCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhc
Q 018018          214 GVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD  290 (362)
Q Consensus       214 g~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~  290 (362)
                      |+++.+......  .....++..|+|||++.+..++.++||||||+++|++++ |+.||...+.       .+....+..
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-------FEMAAYLKD  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-------HHHHHHHHc
Confidence            999765322211  122345678999999998889999999999999999999 9999976432       122333333


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          291 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       291 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ... ......+++++.+++.+||+.||++|||+.++++
T Consensus       235 ~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         235 GYR-LAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCC-CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            322 2233457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.2e-41  Score=305.60  Aligned_cols=250  Identities=26%  Similarity=0.415  Sum_probs=205.3

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ++..++|++.+.||+|+||.||++.+. ++..+|+|.++....  ....+.+|+.+++.++|+||+++++.+. ....++
T Consensus         2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (260)
T cd05070           2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI   77 (260)
T ss_pred             CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence            455678999999999999999999876 567799999875422  2346889999999999999999998775 566899


Q ss_pred             EEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          146 ILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ||||+++++|.+++...  ..+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER-MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            99999999999999753  458999999999999999999998 999999999999999999999999999987654322


Q ss_pred             C-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          224 G-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       224 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      . ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+.       .+....+..... ...+...
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~~  228 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-------REVLEQVERGYR-MPCPQDC  228 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCC-CCCCCcC
Confidence            1 1122345668999999998889999999999999999999 8999976432       123333333322 2334567


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +..+.+|+.+||+.+|++|||++++..
T Consensus       229 ~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         229 PISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-41  Score=320.17  Aligned_cols=261  Identities=28%  Similarity=0.446  Sum_probs=207.0

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEec------Ce
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GA  142 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~------~~  142 (362)
                      .+|.+.+.||+|+||.||++.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++...      ..
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            68999999999999999999999999999999987542 233445678999999999999999999987654      34


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      +++|+||+.. +|..++.  ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++|+|||+++.... 
T Consensus        95 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~-~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-  169 (342)
T cd07879          95 FYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHS-AGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-  169 (342)
T ss_pred             EEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence            6999999964 7777653  478999999999999999999998 9999999999999999999999999999875422 


Q ss_pred             CCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH--------H--------
Q 018018          223 SGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--------M--------  285 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~--------~--------  285 (362)
                        ......++..|+|||.+.+ ..++.++|+|||||++|||++|+.||.+.+.......+...        .        
T Consensus       170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (342)
T cd07879         170 --EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAA  247 (342)
T ss_pred             --CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccch
Confidence              2234567889999999876 45899999999999999999999999865422111100000        0        


Q ss_pred             HHHhcCCCCC------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          286 EAIVDQPPPS------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       286 ~~~~~~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      .......+..      ......++.+.+||.+||+.||++||++++++.||||+.+.+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         248 KSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            0000000000      001246788999999999999999999999999999988764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.9e-41  Score=307.82  Aligned_cols=256  Identities=28%  Similarity=0.435  Sum_probs=203.3

Q ss_pred             cCceeeeeeeeeCCeEEEEEEE----ccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe--cCeE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQH----KWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAI  143 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~--~~~~  143 (362)
                      .+|++.+.||+|+||.||.+..    ..++..||+|.+... .......+.+|+++++.++||||+++++.+..  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS-TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            5788999999999999999873    457889999998754 34455778899999999999999999987653  3568


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          144 SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      ++||||+++++|.+++... ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++|+|||++......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~-~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS-KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            9999999999999999764 468999999999999999999998 99999999999999999999999999999875432


Q ss_pred             CCC---CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCC-------c--hhhHHHHHHHHhc
Q 018018          223 SGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD-------G--WTSFYELMEAIVD  290 (362)
Q Consensus       223 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~-------~--~~~~~~~~~~~~~  290 (362)
                      ...   .....++..|+|||.+.+..++.++||||||+++|||++|..|+.......       .  ......+......
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN  241 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence            211   111233456999999999899999999999999999999877764432110       0  0011112222222


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          291 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       291 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                       .........++.++.+|+.+||+.+|++|||+.+++.
T Consensus       242 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         242 -NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             -CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence             2222334568899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.4e-41  Score=317.67  Aligned_cols=265  Identities=28%  Similarity=0.466  Sum_probs=212.1

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe-cCeEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS-NGAISI  145 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~-~~~~~l  145 (362)
                      ..++|++.+.||.|+||.||++.+..++..||+|++... ........+.+|+.+++.++||||+++++.+.. ....++
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~l   87 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYF   87 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEE
Confidence            347899999999999999999999999999999988643 223345677899999999999999999998875 567899


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      |+||+ +++|..+++. ..+++..+..++.|++.||+|||+ +|++|+||+|.||+++.++.++|+|||++.....   .
T Consensus        88 v~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~-~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---~  161 (328)
T cd07856          88 VTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHS-AGVVHRDLKPSNILINENCDLKICDFGLARIQDP---Q  161 (328)
T ss_pred             Eeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEeECCCCCEEeCccccccccCC---C
Confidence            99999 5689888865 568999999999999999999998 9999999999999999999999999999875432   2


Q ss_pred             CCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH--------------------
Q 018018          226 ANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--------------------  284 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~--------------------  284 (362)
                      .....++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||...+.........+.                    
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF  241 (328)
T ss_pred             cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence            234567889999999866 56899999999999999999999999765432111111100                    


Q ss_pred             HHHHhcCCC--CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          285 MEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       285 ~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      .........  .......+++.+.++|.+||+.+|++|||+++++.||||+.+.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence            000000000  001113467899999999999999999999999999999877654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.1e-41  Score=307.02  Aligned_cols=252  Identities=27%  Similarity=0.409  Sum_probs=210.2

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCc----EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ----FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      +...+|++.+.||+|+||.||++.+..+|.    .+|+|.++..........+.+|+.+++.++||||+++++.+.. ..
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   82 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ   82 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence            456789999999999999999999876665    5899998766556666788999999999999999999998876 78


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          143 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE-KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            99999999999999999764 569999999999999999999998 9999999999999999999999999999987643


Q ss_pred             CCCCC--CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          222 TSGQA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       222 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      .....  ....++..|+|||.+.+..++.++|+||+|+++||+++ |..||.....       .++...+..... ...+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~  233 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-------VEIPDLLEKGER-LPQP  233 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHhCCCC-CCCC
Confidence            22211  11223568999999988889999999999999999998 9999976432       233333333322 2223


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ...+..+.+++.+||..||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         234 PICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            457889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=5.2e-42  Score=321.61  Aligned_cols=266  Identities=26%  Similarity=0.441  Sum_probs=211.0

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEec--CeEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSN--GAIS  144 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~--~~~~  144 (362)
                      .++|++.+.||+|+||.||++.+..+|+.+|+|++... ........+.+|+.+++.+ +||||+++++.+...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            47899999999999999999999989999999987543 2233445677899999999 999999999987643  4689


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      +||||++ ++|..++... .+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.+||+|||++........
T Consensus        86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~-~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHS-GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            9999997 4999998875 88999999999999999999998 9999999999999999999999999999876643321


Q ss_pred             -----CCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH---------------
Q 018018          225 -----QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---------------  283 (362)
Q Consensus       225 -----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~---------------  283 (362)
                           ......|+..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+....+.......               
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKS  242 (337)
T ss_pred             cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHh
Confidence                 2234568999999998865 4578999999999999999999999976443211000000               


Q ss_pred             -----HHHHHhcCC--CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          284 -----LMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       284 -----~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                           .........  ........++.++.++|.+||+.||++|||+.++++||||+.+..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~  303 (337)
T cd07852         243 PFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN  303 (337)
T ss_pred             hhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence                 000000000  001112336889999999999999999999999999999988754

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.3e-41  Score=301.64  Aligned_cols=243  Identities=24%  Similarity=0.378  Sum_probs=202.2

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCCH
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  155 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL  155 (362)
                      +.||+|+||.||++... ++..+|+|+++..........+.+|+.+++.++||||+++++.+......++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            36899999999999865 68899999987665555666788999999999999999999999999999999999999999


Q ss_pred             HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC-CccccCC
Q 018018          156 ADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA-NTFVGTY  233 (362)
Q Consensus       156 ~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~-~~~~gt~  233 (362)
                      .+++... ..+++..+..++.|++.||.|||+ +|++|+||+|+||+++.++.++|+|||++.......... ....++.
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLES-KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI  158 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence            9998753 468999999999999999999998 999999999999999999999999999986543221111 1223456


Q ss_pred             cccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHh
Q 018018          234 NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC  312 (362)
Q Consensus       234 ~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  312 (362)
                      .|+|||.+.+..++.++||||||+++|++++ |..||......       .....+.... ....+..++..+.+++.+|
T Consensus       159 ~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~~~~li~~~  230 (250)
T cd05085         159 KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-------QAREQVEKGY-RMSCPQKCPDDVYKVMQRC  230 (250)
T ss_pred             cccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-------HHHHHHHcCC-CCCCCCCCCHHHHHHHHHH
Confidence            7999999998899999999999999999998 99999764321       2222232222 2233456889999999999


Q ss_pred             hhcCcCCCCCHHHHHc
Q 018018          313 VQKEPQQRLSAQELMT  328 (362)
Q Consensus       313 L~~dP~~Rpt~~eil~  328 (362)
                      |+.+|++|||+.++++
T Consensus       231 l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         231 WDYKPENRPKFSELQK  246 (250)
T ss_pred             cccCcccCCCHHHHHH
Confidence            9999999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-44  Score=359.03  Aligned_cols=261  Identities=32%  Similarity=0.548  Sum_probs=227.1

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      -+++....||.|.||.||-|.+..+|...|+|-++... .......+.+|..++..++|||++.+|++-.+....+|.||
T Consensus      1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            35566788999999999999999999999999987663 34556788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC----C
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS----G  224 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~----~  224 (362)
                      ||++|+|.++++..+-.++...+.+..|++.|++|||+ .|||||||||+||+++.+|.+|++|||.|.......    .
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~-~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~ 1393 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHE-HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPG 1393 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHh-cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCH
Confidence            99999999999998888898889999999999999998 999999999999999999999999999998775432    1


Q ss_pred             CCCccccCCcccCcceecCCC---CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          225 QANTFVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      ......||+-|||||++.+..   ...++|||||||++.||+||+.||...+.+      ..++.++..+-.|.. +..+
T Consensus      1394 el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne------~aIMy~V~~gh~Pq~-P~~l 1466 (1509)
T KOG4645|consen 1394 ELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE------WAIMYHVAAGHKPQI-PERL 1466 (1509)
T ss_pred             HHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch------hHHHhHHhccCCCCC-chhh
Confidence            234578999999999998744   567899999999999999999999865432      356666666666554 4559


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      +++-.++|.+||+.||++|.++.|+++|.|-+...+.
T Consensus      1467 s~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~d~ 1503 (1509)
T KOG4645|consen 1467 SSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCTDE 1503 (1509)
T ss_pred             hHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccccc
Confidence            9999999999999999999999999999998765543

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-41  Score=301.86  Aligned_cols=243  Identities=27%  Similarity=0.381  Sum_probs=203.1

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCCH
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL  155 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL  155 (362)
                      +.||.|+||.||++.+.. ++.||+|+++..........+.+|+++++.++|+||+++++.+......++||||+.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            468999999999999987 9999999987665555667899999999999999999999999999999999999999999


Q ss_pred             HHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC--CccccC
Q 018018          156 ADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGT  232 (362)
Q Consensus       156 ~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~--~~~~gt  232 (362)
                      .+++.. ...++...+..++.|++.||+|||+ +|++||||+|+||+++.++.++|+|||++..........  .....+
T Consensus        80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~-~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (251)
T cd05041          80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES-KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP  158 (251)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence            999965 3568999999999999999999998 999999999999999999999999999987653211111  112335


Q ss_pred             CcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 018018          233 YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA  311 (362)
Q Consensus       233 ~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  311 (362)
                      ..|+|||.+.++.++.++|+||||+++|+|++ |..||......       .....+... .....+...+.++.+++.+
T Consensus       159 ~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-------~~~~~~~~~-~~~~~~~~~~~~~~~li~~  230 (251)
T cd05041         159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-------QTRERIESG-YRMPAPQLCPEEIYRLMLQ  230 (251)
T ss_pred             eccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-------HHHHHHhcC-CCCCCCccCCHHHHHHHHH
Confidence            67999999998899999999999999999999 88998764321       122222222 1223345778999999999


Q ss_pred             hhhcCcCCCCCHHHHHc
Q 018018          312 CVQKEPQQRLSAQELMT  328 (362)
Q Consensus       312 ~L~~dP~~Rpt~~eil~  328 (362)
                      ||+.+|++|||+.|+++
T Consensus       231 ~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         231 CWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HhccChhhCcCHHHHHH
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4e-41  Score=303.07  Aligned_cols=244  Identities=23%  Similarity=0.367  Sum_probs=203.2

Q ss_pred             eeeeeeCCeEEEEEEEcc-CCc--EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKW-TGQ--FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|++|.||++.+.. .+.  .+|+|.++..........+.+|+.+++.++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999865 333  6999999876544667889999999999999999999999888 899999999999


Q ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC---CC
Q 018018          153 GSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---AN  227 (362)
Q Consensus       153 gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~---~~  227 (362)
                      ++|.+++....  .+++..++.++.|++.||.|||+ +|++|+||+|+||+++.++.+||+|||++.........   ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES-KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh-CCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence            99999997754  68999999999999999999998 99999999999999999999999999998876432211   12


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  306 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (362)
                      ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..       +....+.........+...+..+.
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~  231 (257)
T cd05040         159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-------QILKKIDKEGERLERPEACPQDIY  231 (257)
T ss_pred             CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHhcCCcCCCCccCCHHHH
Confidence            2456788999999999899999999999999999998 99999654321       222222222222223456789999


Q ss_pred             HHHHHhhhcCcCCCCCHHHHHc
Q 018018          307 SFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       307 ~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +++.+||+.+|++|||+.++++
T Consensus       232 ~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         232 NVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHCCCCcccCCCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-41  Score=303.39  Aligned_cols=251  Identities=26%  Similarity=0.413  Sum_probs=208.2

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ++..++|.+.+.||+|+||.||++.+. ++..+|+|.+.....  ....+.+|+.+++.++|+||+++++.+......++
T Consensus         2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   78 (261)
T cd05034           2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI   78 (261)
T ss_pred             ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence            356789999999999999999999976 557899999875422  34568899999999999999999999998899999


Q ss_pred             EEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          146 ILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ||||+++++|.+++...  ..+++..+..++.|++.|+.|||+ +|++|+||+|+||+++.++.++|+|||++.......
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~-~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES-RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            99999999999999764  368999999999999999999998 999999999999999999999999999987654321


Q ss_pred             C-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          224 G-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       224 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      . ......++..|+|||.+.+..++.++|+||+|+++|+|++ |+.||.+.+.       ......+..... ...+...
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~~  229 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN-------REVLEQVERGYR-MPRPPNC  229 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCC-CCCCCCC
Confidence            1 1112234568999999998889999999999999999998 9999975432       123333333222 2233456


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +.++.+++.+||+.+|++||+++++++
T Consensus       230 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         230 PEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-41  Score=305.98  Aligned_cols=243  Identities=26%  Similarity=0.392  Sum_probs=199.4

Q ss_pred             eeeeeeCCeEEEEEEEccCCc--EEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQ--FFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||.||++++..++.  .+|+|.++..........+.+|+.++..+ +||||+++++.+...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999988776  46888887554555667888999999998 799999999999999999999999999


Q ss_pred             CCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCC
Q 018018          153 GSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  216 (362)
Q Consensus       153 gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a  216 (362)
                      ++|.+++....                .+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccccceEEEcCCCeEEECCCCCc
Confidence            99999997542                47899999999999999999998 99999999999999999999999999998


Q ss_pred             cccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018018          217 AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  295 (362)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (362)
                      ....... .......+..|+|||++.+..++.++|+|||||++|+|++ |..||.+.+.       ......+.... ..
T Consensus       160 ~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-------~~~~~~~~~~~-~~  230 (270)
T cd05047         160 RGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELYEKLPQGY-RL  230 (270)
T ss_pred             cccchhh-hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-------HHHHHHHhCCC-CC
Confidence            5332111 1112234567999999988889999999999999999997 9999965432       12333333322 22


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       296 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+..++.++.+++.+||..||.+|||+++++.
T Consensus       231 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         231 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            233467889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.6e-42  Score=346.48  Aligned_cols=256  Identities=30%  Similarity=0.502  Sum_probs=209.3

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe---------
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS---------  139 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~---------  139 (362)
                      ..+|+.++.||+||||.||+|+.+-+|+.||||+|+...+......+.+|+..+++|+|||||.+|..+.+         
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            36788999999999999999999999999999999887777778899999999999999999999843311         


Q ss_pred             --------------------------------------------------------------------------------
Q 018018          140 --------------------------------------------------------------------------------  139 (362)
Q Consensus       140 --------------------------------------------------------------------------------  139 (362)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------------c--------CeEEEEEeccCCCCHHHHHHHcCCC-CHHHHHHHHHHHHHHHHHHHhCC
Q 018018          140 ----------------------N--------GAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHHEK  188 (362)
Q Consensus       140 ----------------------~--------~~~~lV~e~~~~gsL~~~l~~~~~l-~~~~~~~i~~ql~~al~~LH~~~  188 (362)
                                            +        ..+||-||||+..++.++++++... ..+.++.+++||++||+|+|+ +
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~-~  716 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD-Q  716 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh-C
Confidence                                  0        1278889999987777777776554 578899999999999999998 9


Q ss_pred             CeEeecCCCCcEEEccCCcEEEeeccCCcccc------------------cCCCCCCccccCCcccCcceecCCC---CC
Q 018018          189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMA------------------STSGQANTFVGTYNYMSPERISGGK---YG  247 (362)
Q Consensus       189 ~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~------------------~~~~~~~~~~gt~~y~aPE~~~~~~---~~  247 (362)
                      |+|||||||.||++++++.|||+|||+|+...                  ......+..+||..|+|||++.+..   |+
T Consensus       717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            99999999999999999999999999998721                  0111234568999999999997754   99


Q ss_pred             ccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC--CCCCCCHHHHHHHHHhhhcCcCCCCCHHH
Q 018018          248 YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFSPEFCSFISACVQKEPQQRLSAQE  325 (362)
Q Consensus       248 ~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  325 (362)
                      .|+|+||||++++||+.   ||.-.      ......+..+.++..|.+  ....--+.-..+|+.||+.||.+||||.|
T Consensus       797 ~KiDmYSLGIVlFEM~y---PF~Ts------MERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~e  867 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY---PFGTS------MERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATE  867 (1351)
T ss_pred             chhhhHHHHHHHHHHhc---cCCch------HHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHH
Confidence            99999999999999986   46431      223345555555555444  12223345678999999999999999999


Q ss_pred             HHcCCcccc
Q 018018          326 LMTHPFLKM  334 (362)
Q Consensus       326 il~hp~~~~  334 (362)
                      +|++.||..
T Consensus       868 LL~s~llpp  876 (1351)
T KOG1035|consen  868 LLNSELLPP  876 (1351)
T ss_pred             HhhccCCCc
Confidence            999999986

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1e-41  Score=303.86  Aligned_cols=229  Identities=26%  Similarity=0.361  Sum_probs=192.5

Q ss_pred             eCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCCHHHHHH
Q 018018           81 GSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK  160 (362)
Q Consensus        81 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~  160 (362)
                      |.+|.||+|++..+++.||+|.++...      ....|...+....||||+++++.+.+....++||||+++++|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            899999999999999999999987542      22334444455679999999999999999999999999999999998


Q ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCCcccCcce
Q 018018          161 KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER  240 (362)
Q Consensus       161 ~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~  240 (362)
                      ....+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++++|||.+......   .....++..|+|||.
T Consensus        78 ~~~~l~~~~~~~~~~ql~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE~  153 (237)
T cd05576          78 KFLNIPEECVKRWAAEMVVALDALHR-EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPEV  153 (237)
T ss_pred             HhcCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCcc
Confidence            87889999999999999999999998 99999999999999999999999999987655432   223455778999999


Q ss_pred             ecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCC
Q 018018          241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR  320 (362)
Q Consensus       241 ~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  320 (362)
                      +.+..++.++|+||+|+++|+|++|..||......             .........+..+++.+.++|.+||+.||++|
T Consensus       154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R  220 (237)
T cd05576         154 GGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------------INTHTTLNIPEWVSEEARSLLQQLLQFNPTER  220 (237)
T ss_pred             cCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------------cccccccCCcccCCHHHHHHHHHHccCCHHHh
Confidence            98888999999999999999999999887542110             00001112234678999999999999999999


Q ss_pred             CCH-----HHHHcCCcc
Q 018018          321 LSA-----QELMTHPFL  332 (362)
Q Consensus       321 pt~-----~eil~hp~~  332 (362)
                      |++     +++++||||
T Consensus       221 ~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         221 LGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             cCCCccchHHHHcCCCC
Confidence            986     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-42  Score=311.51  Aligned_cols=257  Identities=28%  Similarity=0.432  Sum_probs=205.9

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeEEEEEecc
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYM  150 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~~lV~e~~  150 (362)
                      |.+.+.||+|++|.||+++...+++.||||.+.............+|+..++.++ |+||+++++.+..+...++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            6778999999999999999998999999999876533333344567888898999 999999999999999999999999


Q ss_pred             CCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          151 DGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       151 ~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                       +++|.+++....  .+++..+..++.|++.+|.|||+ +|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~-~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-~~~~  157 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK-HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-PYTD  157 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-CcCC
Confidence             779999997764  78999999999999999999998 999999999999999999999999999987654322 2334


Q ss_pred             cccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH---------------HHHHhcCC
Q 018018          229 FVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL---------------MEAIVDQP  292 (362)
Q Consensus       229 ~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~---------------~~~~~~~~  292 (362)
                      ..++..|+|||.+.+ ..++.++|+||||+++++|++|..||......+........               .... ...
T Consensus       158 ~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  236 (283)
T cd07830         158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL-GFR  236 (283)
T ss_pred             CCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc-ccc
Confidence            568889999998854 45789999999999999999999999765432111100000               0000 000


Q ss_pred             CC-------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          293 PP-------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       293 ~~-------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      .+       .......+..+.++|++||+.||++|||++|++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            00       00011236789999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=6.7e-41  Score=302.47  Aligned_cols=249  Identities=25%  Similarity=0.392  Sum_probs=203.3

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      +..++|.+.+.||+|++|.||++.+..+ ..+|+|.+....  .....+.+|+.+++.++|+||+++++.+. ....++|
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   78 (260)
T cd05069           3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV   78 (260)
T ss_pred             CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence            4457899999999999999999988654 469999876432  23456788999999999999999998765 5668999


Q ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          147 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      |||+++++|.+++...  ..+++..+..++.|++.||+|||+ .|++|+||||+||++++++.++|+|||++........
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~-~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER-MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY  157 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence            9999999999999764  348999999999999999999998 9999999999999999999999999999876543221


Q ss_pred             -CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018018          225 -QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  302 (362)
Q Consensus       225 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (362)
                       ......++..|+|||...+..++.++||||||+++|+|++ |..||.+....       +....+..... ...+...+
T Consensus       158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-------~~~~~~~~~~~-~~~~~~~~  229 (260)
T cd05069         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-------EVLEQVERGYR-MPCPQGCP  229 (260)
T ss_pred             cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHHcCCC-CCCCcccC
Confidence             1122345678999999998899999999999999999999 99999764321       22233333222 22345688


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+.+++++||+.||++||+++++++
T Consensus       230 ~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         230 ESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHH
Confidence            99999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.4e-41  Score=310.75  Aligned_cols=253  Identities=25%  Similarity=0.392  Sum_probs=207.4

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCc----EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ----FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      +..++|+..+.||+|+||.||++.+..+|.    .+|+|.+..........++.+|+.+++.++||||+++++.+.. ..
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~   82 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PT   82 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CC
Confidence            455788899999999999999999877776    5789988765555556678899999999999999999998764 45


Q ss_pred             EEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          143 ISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .++++||+++|+|.+++.... .+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE-RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh-cCeeccccccceeeecCCCceEEccccccccccC
Confidence            779999999999999997644 68999999999999999999998 9999999999999999999999999999986543


Q ss_pred             CCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          222 TSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       222 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      ...  ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+...    .   .....+..... ...+
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~----~---~~~~~~~~~~~-~~~~  233 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT----R---EIPDLLEKGER-LPQP  233 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH----H---HHHHHHHCCCC-CCCC
Confidence            222  1222345678999999999899999999999999999997 8999975422    1   12222222222 2233


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ...+..+.+++.+||..+|++||+++++++.
T Consensus       234 ~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         234 PICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4578899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5.8e-41  Score=304.44  Aligned_cols=248  Identities=22%  Similarity=0.316  Sum_probs=194.3

Q ss_pred             eeeeeeCCeEEEEEEEc--cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCC
Q 018018           76 KVVGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  153 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~g  153 (362)
                      +.||+|+||.||++...  .++..+|+|.++..........+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36899999999999764  3456799999876654555567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC--CC
Q 018018          154 SLADFLKKVK-----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QA  226 (362)
Q Consensus       154 sL~~~l~~~~-----~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~--~~  226 (362)
                      +|.+++....     ..++..++.++.|++.||+|||+ +|++|+||||+||+++.+++++|+|||++........  ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~  159 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP  159 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence            9999997532     45677888999999999999998 9999999999999999999999999999865432221  12


Q ss_pred             CccccCCcccCcceecCC-------CCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          227 NTFVGTYNYMSPERISGG-------KYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      ....++..|+|||++.+.       .++.++|+||+|+++|||++ |..||...+..+..   .............+...
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TYTVREQQLKLPKPRLK  236 (269)
T ss_pred             CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HHHhhcccCCCCCCccC
Confidence            234577889999998642       35789999999999999996 99999764432110   01111111111112223


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ...++.+.+++.+|| .+|++|||++|++.
T Consensus       237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            356788999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.6e-41  Score=303.82  Aligned_cols=251  Identities=27%  Similarity=0.504  Sum_probs=209.0

Q ss_pred             CceeeeeeeeeCCeEEEEEEEcc-CCcEEEEEEeecc---------cchHHHHHHHHHHHHHhc-CCCCcceEEeeeEEe
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKW-TGQFFALKVIQMN---------VEESARRQIAQELKINQS-SQCPYVVVCYQSFYS  139 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~---------~~~~~~~~~~~e~~~~~~-l~hp~I~~~~~~~~~  139 (362)
                      .|++.+.||+|+||.||++.+.. .++.+|+|.+...         ........+.+|+.++.. ++||||+++++.+.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999987 6889999987543         123344567788887764 799999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccC
Q 018018          140 NGAISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  215 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~  215 (362)
                      .+..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+..|++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999998843    356899999999999999999999647899999999999999999999999999


Q ss_pred             CcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018018          216 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  295 (362)
Q Consensus       216 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (362)
                      +....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.       ......+......+
T Consensus       161 ~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~  232 (269)
T cd08528         161 AKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-------LSLATKIVEAVYEP  232 (269)
T ss_pred             eeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-------HHHHHHHhhccCCc
Confidence            87754433 33455788999999999998899999999999999999999999965322       23333444444333


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       296 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .....+++.+.++|.+||+.||++||++.|+..+
T Consensus       233 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         233 LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            3344678999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-42  Score=309.27  Aligned_cols=257  Identities=27%  Similarity=0.438  Sum_probs=209.0

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCC--Cc----ceEEeeeEEecCe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC--PY----VVVCYQSFYSNGA  142 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h--p~----I~~~~~~~~~~~~  142 (362)
                      ..+|+++..+|+|+||.|-.+.+..++..||||+++.-  ...+...+-|++++.++.+  |+    ++++.++|...++
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            68999999999999999999999999999999998632  3344445678888887732  32    7788888999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc----------------
Q 018018          143 ISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH----------------  204 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~----------------  204 (362)
                      .|+|+|.+ |-|+.+++.++  .+++...++.+++|+++++++||+ .+++|.||||+|||+.+                
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~-~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~  243 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD-LKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI  243 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh-cceeecCCChheEEEeccceEEEeccCCcccee
Confidence            99999999 56999999775  478999999999999999999998 99999999999999942                


Q ss_pred             ----CCcEEEeeccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhh
Q 018018          205 ----RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS  280 (362)
Q Consensus       205 ----~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~  280 (362)
                          +..|+|+|||.|+...   ....+.+.|..|+|||++.+-.++.++||||+||||+||++|...|..-+.    ..
T Consensus       244 r~~ks~~I~vIDFGsAtf~~---e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen----~E  316 (415)
T KOG0671|consen  244 RPLKSTAIKVIDFGSATFDH---EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN----LE  316 (415)
T ss_pred             ccCCCcceEEEecCCcceec---cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc----HH
Confidence                2358999999987643   233667899999999999999999999999999999999999999986543    23


Q ss_pred             HHHHHHHHhcCCCCCCC-----------------------------------------CCCCCHHHHHHHHHhhhcCcCC
Q 018018          281 FYELMEAIVDQPPPSAP-----------------------------------------SDQFSPEFCSFISACVQKEPQQ  319 (362)
Q Consensus       281 ~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~li~~~L~~dP~~  319 (362)
                      ...+++++....+..-.                                         .+....++.+||++||..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            33566665542221000                                         0001124789999999999999


Q ss_pred             CCCHHHHHcCCcccccC
Q 018018          320 RLSAQELMTHPFLKMYG  336 (362)
Q Consensus       320 Rpt~~eil~hp~~~~~~  336 (362)
                      |+|+.|+|.||||....
T Consensus       397 RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  397 RITLREALSHPFFARLT  413 (415)
T ss_pred             cccHHHHhcCHHhhcCC
Confidence            99999999999998754

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.1e-41  Score=304.66  Aligned_cols=248  Identities=21%  Similarity=0.341  Sum_probs=193.5

Q ss_pred             eeeeeeCCeEEEEEEEcc--CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCC
Q 018018           76 KVVGKGSGGIVQLVQHKW--TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  153 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~g  153 (362)
                      +.||+|+||.||++....  ....+|+|.+...........+.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            358999999999986532  345789998766555556677889999999999999999999999999999999999999


Q ss_pred             CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC--CC
Q 018018          154 SLADFLKKVK-----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QA  226 (362)
Q Consensus       154 sL~~~l~~~~-----~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~--~~  226 (362)
                      +|.+++....     ..++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++........  ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK  159 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh-cCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence            9999997643     24678889999999999999998 9999999999999999999999999999865432211  12


Q ss_pred             CccccCCcccCcceecC-------CCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          227 NTFVGTYNYMSPERISG-------GKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      ....++..|+|||++..       ..++.++|||||||++|||++ |..||......+   .............+.+...
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05042         160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VLKQVVREQDIKLPKPQLD  236 (269)
T ss_pred             CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHhhccCccCCCCccc
Confidence            23345678999998743       356889999999999999999 888987543211   1111111111111222334


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+++.+.+++..|| .||++|||++++++
T Consensus       237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             ccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            567888999999998 59999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.1e-40  Score=301.06  Aligned_cols=244  Identities=24%  Similarity=0.358  Sum_probs=196.4

Q ss_pred             eeeeeeCCeEEEEEEEcc---CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEE-ecCeEEEEEeccC
Q 018018           76 KVVGKGSGGIVQLVQHKW---TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY-SNGAISIILEYMD  151 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~-~~~~~~lV~e~~~  151 (362)
                      +.||+|+||.||++.+..   .+..+|+|.+...........+.+|+.+++.++||||+++++.+. .++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            368999999999998653   345799999865444555677889999999999999999999765 4566899999999


Q ss_pred             CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC----CC
Q 018018          152 GGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG----QA  226 (362)
Q Consensus       152 ~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~----~~  226 (362)
                      +++|.+++... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++.......    ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS-KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence            99999999764 456788889999999999999998 9999999999999999999999999999876532211    11


Q ss_pred             CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      ....++..|+|||.+.+..++.++|||||||++|||++ |.+||...+.       .+.......... ...+..+++.+
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~~  231 (262)
T cd05058         160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-------FDITVYLLQGRR-LLQPEYCPDPL  231 (262)
T ss_pred             ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-------HHHHHHHhcCCC-CCCCCcCCHHH
Confidence            22345678999999988899999999999999999999 5666754322       223333333322 23345678999


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHc
Q 018018          306 CSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .+++.+||+.+|++||++.+++.
T Consensus       232 ~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         232 YEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHH
Confidence            99999999999999999999976

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.4e-42  Score=321.47  Aligned_cols=260  Identities=26%  Similarity=0.411  Sum_probs=220.8

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      -|..++.||-|+||.|.++...++...||+|.+++.  ...........|.+|+..-+.+.||++|..|++.+.+|+||+
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            466788999999999999999999999999998765  344566788899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc-------
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-------  221 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~-------  221 (362)
                      |++||++..+|-+.+-+.+..++.++.++..|+++.|. .|+|||||||+|||||.+|++||.|||||+-+.=       
T Consensus       710 YIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYY  788 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  788 (1034)
T ss_pred             ccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEccCCceeeeeccccccceeccccccc
Confidence            99999999999998999999999999999999999998 9999999999999999999999999999965410       


Q ss_pred             -CCC----------------------------------CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCC
Q 018018          222 -TSG----------------------------------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ  266 (362)
Q Consensus       222 -~~~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~  266 (362)
                       .+.                                  .....+||+.|+|||++....|+..+|+||.||+||||+.|+
T Consensus       789 q~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~  868 (1034)
T KOG0608|consen  789 QEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQ  868 (1034)
T ss_pred             cCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCC
Confidence             000                                  012347999999999999999999999999999999999999


Q ss_pred             CCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCC---CHHHHHcCCcccccCC
Q 018018          267 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLKMYGD  337 (362)
Q Consensus       267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~~~~~~  337 (362)
                      .||-+..+.+....+..+...     .......++++++.+||.++. .++++|.   .++|+..||||+..+-
T Consensus       869 ~pf~~~tp~~tq~kv~nw~~~-----l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDf  936 (1034)
T KOG0608|consen  869 PPFLADTPGETQYKVINWRNF-----LHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDF  936 (1034)
T ss_pred             CCccCCCCCcceeeeeehhhc-----cccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccch
Confidence            999887776654433333221     122334678999999998865 4677888   4788999999998754

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-42  Score=325.59  Aligned_cols=245  Identities=26%  Similarity=0.399  Sum_probs=210.1

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHh-cCCCCcceEEeeeEEecCeEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQ-SSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~-~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      ..+.|+....+|.|+|+.|-.+.+..+++.+++|++...     .....+|..++. .-+||||+++.+.+.+..+.|+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccc-----ccccccccchhhhhcCCCcceeecceecCCceeeee
Confidence            357888888999999999999999999999999999765     122334554433 34799999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEE-ccCCcEEEeeccCCcccccCCCC
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI-NHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll-~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      ||.+.|+-+.+.+....... ..+..|++||+.|+.|||+ +|||||||||+|||+ +..++++|+|||.++.....   
T Consensus       395 ~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~-~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---  469 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHE-QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---  469 (612)
T ss_pred             ehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHh-cCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence            99999999988888766555 8888999999999999998 999999999999999 68999999999998765433   


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      ..+.+-|..|.|||++....|++++||||||++||+|++|+.||......      .++..++..+..    ...+|..+
T Consensus       470 ~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~----s~~vS~~A  539 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKF----SECVSDEA  539 (612)
T ss_pred             hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCcc----ccccCHHH
Confidence            44557789999999999999999999999999999999999999875543      244444443322    26899999


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          306 CSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      ++||++||+.||.+|+++.++..||||
T Consensus       540 KdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  540 KDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHHHhccCChhhCcChhhhccCcch
Confidence            999999999999999999999999999

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.2e-40  Score=299.14  Aligned_cols=250  Identities=24%  Similarity=0.404  Sum_probs=206.0

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ++..++|++.+.||+|+||.||++... .+..+|+|.+...  ......+.+|+.+++.++|+||+++++.+.+ ...++
T Consensus         2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   77 (260)
T cd05073           2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG--SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI   77 (260)
T ss_pred             cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC--hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence            456789999999999999999999865 5667999987643  3345678899999999999999999998877 78899


Q ss_pred             EEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          146 ILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      +|||+++++|.+++...  ..++...+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++.......
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh-CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            99999999999999763  457888999999999999999998 999999999999999999999999999987654322


Q ss_pred             C-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          224 G-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       224 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      . ......++..|+|||.+.+..++.++|+|||||++|++++ |..||...+..       .....+..... .......
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-------~~~~~~~~~~~-~~~~~~~  228 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-------EVIRALERGYR-MPRPENC  228 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-------HHHHHHhCCCC-CCCcccC
Confidence            1 1122345678999999998889999999999999999998 99999764321       22333333322 2234568


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +.++.+++.+||+.+|++||++.+++.
T Consensus       229 ~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         229 PEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             CHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.9e-40  Score=301.12  Aligned_cols=252  Identities=23%  Similarity=0.322  Sum_probs=207.2

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccC---CcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      ..++|.+.+.||+|+||.||++.+...   ...+|||.............+.+|+.+++.++||||+++++.+.+ ...+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            456788999999999999999987543   346999998766556667789999999999999999999998764 5678


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          145 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      +||||+++++|.+++... ..+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||+++......
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES-KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            999999999999999764 368999999999999999999998 999999999999999999999999999987654332


Q ss_pred             CC-CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          224 GQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       224 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      .. .....++..|+|||.+.+..++.++||||||+++|++++ |..||...+..       +....+...... ..+..+
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-------~~~~~~~~~~~~-~~~~~~  233 (270)
T cd05056         162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-------DVIGRIENGERL-PMPPNC  233 (270)
T ss_pred             ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHcCCcC-CCCCCC
Confidence            11 112234568999999988889999999999999999986 99999765432       222333333222 234578


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ++.+.++|.+||..+|++|||+.+++..
T Consensus       234 ~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         234 PPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-40  Score=304.28  Aligned_cols=258  Identities=26%  Similarity=0.402  Sum_probs=208.5

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEcc----CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe--cCe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKW----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGA  142 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~--~~~  142 (362)
                      .++|++.+.||+|+||.||+++...    ++..+|+|+++..........+.+|+++++.+.|+||+++++++..  ...
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence            4678888999999999999998643    4789999999766444456789999999999999999999998876  567


Q ss_pred             EEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          143 ISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .++||||+++++|.+++.... .+++..+..++.|++.||+|||+ +|++|+||||+||+++.++.++|+|||++.....
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS-QRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            999999999999999997654 69999999999999999999998 9999999999999999999999999999887652


Q ss_pred             CCCC---CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCch--------hhHHHHHHHHhc
Q 018018          222 TSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW--------TSFYELMEAIVD  290 (362)
Q Consensus       222 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~--------~~~~~~~~~~~~  290 (362)
                      ....   .....++..|+|||.+.+..++.++||||||+++|+|++|..||.........        .....+...+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence            2211   11234456799999998889999999999999999999999998654322100        111222222222


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          291 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       291 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                       ......+..++.++.+++.+||+.+|++|||+.|++.
T Consensus       242 -~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         242 -GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             -CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             2222334567889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.3e-40  Score=297.93  Aligned_cols=250  Identities=25%  Similarity=0.429  Sum_probs=206.3

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ...+|++.+.||+|+||.||++.+. ++..+|+|+++....  ....+.+|+++++.++||||+++++.+......++||
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~   78 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM--SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF   78 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC--CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence            3468899999999999999999875 477899999865422  2346788999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC-
Q 018018          148 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-  225 (362)
Q Consensus       148 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~-  225 (362)
                      ||+++++|.+++... ..+++..+..++.|++.|++|||+ .|++|+||||+||+++.++.++|+|||++......... 
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES-SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH-CCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            999999999999764 568999999999999999999998 99999999999999999999999999998765332211 


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      .....++..|+|||.+.++.++.++|+||+|+++|+|++ |..||.....       ......+..... ...+...+..
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~~  229 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-------SEVVETINAGFR-LYKPRLASQS  229 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-------HHHHHHHhCCCC-CCCCCCCCHH
Confidence            122335678999999998899999999999999999998 9999975332       223333332222 1223457899


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          305 FCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +.+|+.+||+.+|++|||+.+++++
T Consensus       230 ~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         230 VYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHHHHcccChhhCCCHHHHHHh
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.8e-40  Score=298.49  Aligned_cols=244  Identities=26%  Similarity=0.457  Sum_probs=202.5

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      +..++|++.+.||+|+||.||.+.  .+++.||+|+++...   ....+.+|+.+++.++||||+++++.+... ..++|
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v   76 (254)
T cd05083           3 LNLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV   76 (254)
T ss_pred             ccHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence            345789999999999999999875  478899999986542   235688899999999999999999988654 57999


Q ss_pred             EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          147 LEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++......  
T Consensus        77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--  153 (254)
T cd05083          77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES-KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--  153 (254)
T ss_pred             EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence            99999999999997643  58999999999999999999998 99999999999999999999999999998754321  


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                       ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+.       .+....+..... ......+++
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~~~~  224 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-------KEVKECVEKGYR-MEPPEGCPA  224 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-------HHHHHHHhCCCC-CCCCCcCCH
Confidence             122334568999999998899999999999999999997 9999976432       123333333322 223457889


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .+.+++.+||+.+|++||++++++.
T Consensus       225 ~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         225 DVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1e-40  Score=302.52  Aligned_cols=244  Identities=25%  Similarity=0.443  Sum_probs=200.6

Q ss_pred             eeeeeeCCeEEEEEEEccCC------cEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           76 KVVGKGSGGIVQLVQHKWTG------QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +.||+|+||.||+++.....      +.+|+|.+...........+.+|+.+++.++||||+++++.+......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            36899999999999986543      689999987654445567888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC-----cEEEeeccCCc
Q 018018          150 MDGGSLADFLKKV-------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-----EVKITDFGVSA  217 (362)
Q Consensus       150 ~~~gsL~~~l~~~-------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-----~vkl~DFg~a~  217 (362)
                      +++++|.+++...       ..+++..+..++.|++.||+|||+ ++++|+||+|+||+++.++     .++|+|||++.
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ-MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh-CCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            9999999999642       347889999999999999999998 9999999999999999887     89999999987


Q ss_pred             ccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018018          218 IMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPP  294 (362)
Q Consensus       218 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  294 (362)
                      .......  ......++..|+|||.+.++.++.++|||||||++|+|++ |..||...+..       +....+.... .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-------~~~~~~~~~~-~  231 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-------EVLQHVTAGG-R  231 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-------HHHHHHhcCC-c
Confidence            6532211  1122345678999999999999999999999999999998 99999754321       2222222222 2


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          295 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       295 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ...+..++..+.++|.+||+.+|++||++.++++
T Consensus       232 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         232 LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            2334567899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.3e-40  Score=298.19  Aligned_cols=235  Identities=21%  Similarity=0.319  Sum_probs=192.6

Q ss_pred             eeeeeeCCeEEEEEEEccCC----------cEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           76 KVVGKGSGGIVQLVQHKWTG----------QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      +.||+|+||.||++.+..++          ..+++|++......  ...+.+|+.+++.++||||+++++.+.. ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence            46899999999999998776          35788877544222  6778899999999999999999998887 77899


Q ss_pred             EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC-------cEEEeeccCCc
Q 018018          146 ILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-------EVKITDFGVSA  217 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-------~vkl~DFg~a~  217 (362)
                      ||||+++++|.+++.... .++...+..++.|++.||+|||+ +|++||||||+||+++.++       .+||+|||++.
T Consensus        78 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~-~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~  156 (259)
T cd05037          78 VEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED-KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI  156 (259)
T ss_pred             EEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh-CCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence            999999999999998766 79999999999999999999998 9999999999999999887       79999999987


Q ss_pred             ccccCCCCCCccccCCcccCcceecCC--CCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018018          218 IMASTSGQANTFVGTYNYMSPERISGG--KYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPP  294 (362)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  294 (362)
                      ....    .....++..|+|||.+.+.  .++.++||||||+++|+|++ |..||...+...       .......... 
T Consensus       157 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-------~~~~~~~~~~-  224 (259)
T cd05037         157 TVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-------KERFYQDQHR-  224 (259)
T ss_pred             cccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh-------HHHHHhcCCC-
Confidence            6543    2234567789999999876  78999999999999999999 688886653211       1111111111 


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          295 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       295 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                        .+......+.++|.+||+.+|++|||+.++++
T Consensus       225 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         225 --LPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             --CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence              11122378999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.7e-40  Score=297.46  Aligned_cols=248  Identities=18%  Similarity=0.295  Sum_probs=192.3

Q ss_pred             eeeeeeCCeEEEEEEEccC--CcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCC
Q 018018           76 KVVGKGSGGIVQLVQHKWT--GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  153 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~g  153 (362)
                      +.||+|+||.||++....+  ...+++|.++..........+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3689999999999875433  33567777765544556678999999999999999999999999999999999999999


Q ss_pred             CHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC--CCCC
Q 018018          154 SLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQAN  227 (362)
Q Consensus       154 sL~~~l~~~----~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~--~~~~  227 (362)
                      +|.+++...    ...+...+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||++.......  ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  159 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED  159 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH-CCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence            999999763    346777888999999999999998 999999999999999999999999999976432211  1223


Q ss_pred             ccccCCcccCcceecC-------CCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          228 TFVGTYNYMSPERISG-------GKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      ...++..|+|||++..       ..++.++||||||+++|||++ +..||...+..+   ...............+....
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd05086         160 DKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE---VLNHVIKDQQVKLFKPQLEL  236 (268)
T ss_pred             CCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHhhcccccCCCccCC
Confidence            4567889999999753       245789999999999999997 577886533211   11111111111112233344


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .+++.+.+++..|| .+|++||+++++++
T Consensus       237 ~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         237 PYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             CCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            57889999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7.3e-40  Score=301.37  Aligned_cols=257  Identities=17%  Similarity=0.212  Sum_probs=195.7

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccC---CcEEEEEEeecccchHH----------HHHHHHHHHHHhcCCCCcceEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNVEESA----------RRQIAQELKINQSSQCPYVVVC  133 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~----------~~~~~~e~~~~~~l~hp~I~~~  133 (362)
                      +...+|++.+.||+|+||+||++.+..+   +..+|+|+.........          ......+...+..+.|++|+.+
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            3447899999999999999999998877   66788887543321110          0112233445566789999999


Q ss_pred             eeeEEecC----eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEE
Q 018018          134 YQSFYSNG----AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK  209 (362)
Q Consensus       134 ~~~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vk  209 (362)
                      ++.+....    ..+++++++. .++.+.+......++..+..++.|++.||+|||+ ++++||||||+|||++.++.++
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHE-HGISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCcEE
Confidence            98765432    4577888874 4788888776667899999999999999999998 9999999999999999999999


Q ss_pred             EeeccCCcccccCCC-------CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhh--
Q 018018          210 ITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS--  280 (362)
Q Consensus       210 l~DFg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~--  280 (362)
                      |+|||+|+.......       ......||+.|+|||++.+..++.++|||||||++|||++|..||...........  
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            999999987642211       12234699999999999999999999999999999999999999987643221111  


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          281 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .......+.....   .....++.+.+++..||+.+|++||+++++++
T Consensus       247 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        247 KCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            1112223322221   12356789999999999999999999999975

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.8e-40  Score=298.21  Aligned_cols=238  Identities=18%  Similarity=0.327  Sum_probs=190.9

Q ss_pred             eeeeeeCCeEEEEEEEcc------------CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           76 KVVGKGSGGIVQLVQHKW------------TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      +.||+|+||.||+++...            ....+|+|++... .......+.+|+.+++.++||||+++++++......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS-HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh-hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            368999999999998532            1235888987644 334455788889999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc-------EEEeeccC
Q 018018          144 SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE-------VKITDFGV  215 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~-------vkl~DFg~  215 (362)
                      ++||||+++++|..++... ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.       ++++|||+
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~  158 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED-KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI  158 (262)
T ss_pred             EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh-CCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence            9999999999999998753 568999999999999999999998 99999999999999987664       89999999


Q ss_pred             CcccccCCCCCCccccCCcccCcceec-CCCCCccccHHHHHHHHHHHH-cCCCCCCCCccCCchhhHHHHHHHHhcCCC
Q 018018          216 SAIMASTSGQANTFVGTYNYMSPERIS-GGKYGYKSDIWSLGLVLLECA-TGQFPYSPPEQQDGWTSFYELMEAIVDQPP  293 (362)
Q Consensus       216 a~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  293 (362)
                      +.....    .....++..|+|||++. +..++.++|||||||++|+|+ +|..||......       +. ........
T Consensus       159 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-------~~-~~~~~~~~  226 (262)
T cd05077         159 PITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA-------EK-ERFYEGQC  226 (262)
T ss_pred             CccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh-------HH-HHHHhcCc
Confidence            865432    22345788899999987 466899999999999999997 588888654321       11 11111111


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       294 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .  .....++++.+||.+||+.||++||++.+|+++
T Consensus       227 ~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         227 M--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             c--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            1  122346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.5e-41  Score=301.56  Aligned_cols=238  Identities=21%  Similarity=0.324  Sum_probs=192.2

Q ss_pred             eeeeeeCCeEEEEEEEccCCc-------EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQ-------FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      +.||+|+||.||++.+...+.       .+|+|.+... .......+..|+.+++.+.||||+++++.+......++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS-HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch-hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            368999999999999865544       4888887543 23445678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc--------EEEeeccCCccc
Q 018018          149 YMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--------VKITDFGVSAIM  219 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~--------vkl~DFg~a~~~  219 (362)
                      |+++|+|.+++...+ .+++..+..++.|++.||+|||+ +|++||||||+||+++.++.        ++++|||++...
T Consensus        80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~  158 (258)
T cd05078          80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED-KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV  158 (258)
T ss_pred             cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence            999999999997644 58999999999999999999998 99999999999999987765        699999988654


Q ss_pred             ccCCCCCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcC-CCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          220 ASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATG-QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      ..    .....++..|+|||++.+. .++.++||||||+++|+|++| ..||...+..       ........ .  ...
T Consensus       159 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-------~~~~~~~~-~--~~~  224 (258)
T cd05078         159 LP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-------KKLQFYED-R--HQL  224 (258)
T ss_pred             CC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-------HHHHHHHc-c--ccC
Confidence            32    2335678899999999874 579999999999999999998 4666543321       11111111 1  122


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +...+.++.+||.+||+.||++|||++++++.
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         225 PAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             CCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            33456889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.9e-40  Score=300.10  Aligned_cols=237  Identities=21%  Similarity=0.334  Sum_probs=189.8

Q ss_pred             eeeeeCCeEEEEEEEccC------------------------CcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceE
Q 018018           77 VVGKGSGGIVQLVQHKWT------------------------GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV  132 (362)
Q Consensus        77 ~lg~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~  132 (362)
                      .||+|+||.||++....+                        ...||+|++... .......+.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-HRDIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH-HHHHHHHHHHHHHHHhcCCCCCeee
Confidence            589999999999875321                        235889988644 2334567888999999999999999


Q ss_pred             EeeeEEecCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC-----
Q 018018          133 CYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-----  206 (362)
Q Consensus       133 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-----  206 (362)
                      +++++.+....++||||+++++|..++.. .+.+++..+..++.|++.||+|||+ +|++||||||+||+++..+     
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~iiH~dlkp~Nill~~~~~~~~~  159 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED-KNLVHGNVCAKNILLARLGLAEGT  159 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCccCCCCCcccEEEeccCcccCc
Confidence            99999999999999999999999999965 4678999999999999999999998 9999999999999997644     


Q ss_pred             --cEEEeeccCCcccccCCCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHH-cCCCCCCCCccCCchhhHH
Q 018018          207 --EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECA-TGQFPYSPPEQQDGWTSFY  282 (362)
Q Consensus       207 --~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~ell-tg~~pf~~~~~~~~~~~~~  282 (362)
                        .++++|||++......    ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||......+    ..
T Consensus       160 ~~~~kl~d~g~~~~~~~~----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~----~~  231 (274)
T cd05076         160 SPFIKLSDPGVSFTALSR----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE----KE  231 (274)
T ss_pred             cceeeecCCccccccccc----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH----HH
Confidence              4899999987543221    22356788999998876 56899999999999999994 6999997654321    11


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          283 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ....   ...   ..+...++.+.++|.+||+.+|++|||+.+++++
T Consensus       232 ~~~~---~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         232 RFYE---KKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHH---hcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            1111   111   1123356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=322.61  Aligned_cols=258  Identities=35%  Similarity=0.620  Sum_probs=221.6

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEE-----ecCe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFY-----SNGA  142 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~-----~~~~  142 (362)
                      .+.|++.+.||.|.+|.||+++++.+++..|+|+.....+  ...++..|.++++.+ .|||++.+|++|.     .++.
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            4678999999999999999999999999999999876533  345677788887765 5899999999986     3578


Q ss_pred             EEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          143 ISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ++||||||.|||+.++++.  ..++.|..+..|++.++.|+.+||. +.++|||||-.|||++.++.|||+|||.+..+.
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~-nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN-NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh-cceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            9999999999999999976  4578999999999999999999998 889999999999999999999999999999998


Q ss_pred             cCCCCCCccccCCcccCcceecC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018018          221 STSGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  295 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (362)
                      .......+.+||+.|||||++..     ..|+.++|+||||++..||..|.+|+.+.-+.      ..++......++..
T Consensus       175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------raLF~IpRNPPPkL  248 (953)
T KOG0587|consen  175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIPRNPPPKL  248 (953)
T ss_pred             cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh------hhhccCCCCCCccc
Confidence            88888899999999999999854     34788999999999999999999999876442      12222222222222


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       296 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      .-+.+++.++.++|..||.+|.++||+..++++|||++..
T Consensus       249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            3367788999999999999999999999999999999843

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-41  Score=313.03  Aligned_cols=256  Identities=25%  Similarity=0.375  Sum_probs=214.6

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ++......+.+.||+|-||.|.+|.-. .+..||+|.++.......++.|.+|++++.+++||||+.++++|..++.+++
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm  612 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM  612 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence            345566788899999999999999875 3689999999988888889999999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          146 ILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      |+||++.|+|.+++..+.  .+.......++.||+.|++||.+ .++|||||.++|+|++.++++||+|||.++.+....
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecCcccEEecCcccccccccCC
Confidence            999999999999998863  33455566799999999999998 999999999999999999999999999998765443


Q ss_pred             CCC--CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc--CCCCCCCCccCCchhhHHHHHHHHhcCCC---CCC
Q 018018          224 GQA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT--GQFPYSPPEQQDGWTSFYELMEAIVDQPP---PSA  296 (362)
Q Consensus       224 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~  296 (362)
                      ...  ...+-+.+|||||.+..++++.++|+|++|+++||+++  ...||....+++..    +-...+.....   -..
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv----en~~~~~~~~~~~~~l~  767 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV----ENAGEFFRDQGRQVVLS  767 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH----HhhhhhcCCCCcceecc
Confidence            322  22456789999999999999999999999999999966  78899876553322    22222222211   123


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRLSAQELM  327 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil  327 (362)
                      .+.-++..+.+||.+||..|-++||+++++.
T Consensus       768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh  798 (807)
T KOG1094|consen  768 RPPACPQGLYELMLRCWRRESEQRPSFEQLH  798 (807)
T ss_pred             CCCcCcHHHHHHHHHHhchhhhcCCCHHHHH
Confidence            3567889999999999999999999999994

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.8e-39  Score=294.90  Aligned_cols=249  Identities=25%  Similarity=0.362  Sum_probs=200.3

Q ss_pred             ceeeeeeeeeCCeEEEEEEEcc---CCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC------
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKW---TGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG------  141 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~------  141 (362)
                      |.+.+.||+|+||.||++....   +++.+|||++.... ......++.+|+.+++.++||||+++++.+....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            5677899999999999998653   57899999987653 3445677889999999999999999999876432      


Q ss_pred             eEEEEEeccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccC
Q 018018          142 AISIILEYMDGGSLADFLKKV------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  215 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~  215 (362)
                      ..+++++|+.+|+|.+++...      ..++...+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS-KNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeecccchhhEEEcCCCCEEECcccc
Confidence            347889999999999887432      257899999999999999999998 9999999999999999999999999999


Q ss_pred             CcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          216 SAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       216 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                      ++.......  ......+++.|++||.+.+..++.++|||||||++|+|++ |..||...+.       .+....+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~  232 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-------SEIYNYLIKGN  232 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-------HHHHHHHHcCC
Confidence            886543221  1122345678999999998889999999999999999999 8999975432       12333333322


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          293 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       293 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      . .......+..+.+++.+||+.+|++|||+.+++.+
T Consensus       233 ~-~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         233 R-LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             c-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2 22234578899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=312.22  Aligned_cols=250  Identities=23%  Similarity=0.364  Sum_probs=212.9

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccC--C--cEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWT--G--QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~--~--~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      ..+..+..+.||.|.||.||++.....  |  --||||..+.+.+.+....|+.|+.+++.++||||++++|++.+ ...
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~  465 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM  465 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence            344455668899999999999886533  2  25899999887777778899999999999999999999999874 578


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          144 SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      ++|||.++.|.|..|++.. ..++......++.|++.||+|||+ ..+|||||..+|||+.+...|||+|||+++.+...
T Consensus       466 WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeS-krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLES-KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             eEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHh-hchhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            9999999999999999765 579999999999999999999999 99999999999999999999999999999998765


Q ss_pred             CCCCC-ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          223 SGQAN-TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       223 ~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      ..... ...-+..|||||.+.-..++.++|||.|||++||++. |..||.+....+       ++..+..+.. .+.+++
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-------VI~~iEnGeR-lP~P~n  616 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-------VIGHIENGER-LPCPPN  616 (974)
T ss_pred             chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-------eEEEecCCCC-CCCCCC
Confidence            54332 2344779999999999999999999999999999988 999999876543       3333333333 445678


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHH
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELM  327 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil  327 (362)
                      +|+.+..|+.+||.++|.+||++.++.
T Consensus       617 CPp~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  617 CPPALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             CChHHHHHHHHHhccCcccCCcHHHHH
Confidence            999999999999999999999988774

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=310.14  Aligned_cols=252  Identities=26%  Similarity=0.394  Sum_probs=218.2

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      .++....+..+.++||-|.||.||.+..+...-.||||.++.+  .....+|+.|+.+|+.++|||+++++++|..+..+
T Consensus       261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED--tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc--chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            4455666777889999999999999999999999999998754  44568899999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          144 SIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      |||+|||..|+|.+|+++..  .++.-..+.++.||..|++||.. +++|||||..+|+|+.++..||++|||+++.+..
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk-knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH-hhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            99999999999999998754  57888889999999999999998 9999999999999999999999999999998764


Q ss_pred             CCCCCC-ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          222 TSGQAN-TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       222 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      ...... ..--++.|.|||.+....++.++|||+|||+|||+.| |-.||.+.+.    ++++.++++-..    ...++
T Consensus       418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl----SqVY~LLEkgyR----M~~Pe  489 (1157)
T KOG4278|consen  418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL----SQVYGLLEKGYR----MDGPE  489 (1157)
T ss_pred             CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH----HHHHHHHhcccc----ccCCC
Confidence            332221 2234678999999999999999999999999999999 8899987543    555666555433    33457


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHH
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQEL  326 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~ei  326 (362)
                      .+++.+.+|++.||+|+|.+||+++|+
T Consensus       490 GCPpkVYeLMraCW~WsPsDRPsFaei  516 (1157)
T KOG4278|consen  490 GCPPKVYELMRACWNWSPSDRPSFAEI  516 (1157)
T ss_pred             CCCHHHHHHHHHHhcCCcccCccHHHH
Confidence            899999999999999999999999998

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.5e-42  Score=290.60  Aligned_cols=278  Identities=23%  Similarity=0.366  Sum_probs=215.8

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchH-HHHHHHHHHHHHhcCCCCcceEEeeeEE--------
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES-ARRQIAQELKINQSSQCPYVVVCYQSFY--------  138 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~l~hp~I~~~~~~~~--------  138 (362)
                      ....|+-+..+|+|.||.||+|+.+.+|+.||+|++-.....+ .-....+|++++..++|+|++.+++.+.        
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            3467888899999999999999999999999998764432222 2234578999999999999998887654        


Q ss_pred             ecCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          139 SNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       139 ~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      +...+|+||++|+. +|..++.+. .+++..++..++.++..||.|+|+ ..|+|||+|++|+||+.+|.+||+|||+|+
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr-~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR-NKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH-hhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            23559999999976 999999775 689999999999999999999998 899999999999999999999999999998


Q ss_pred             ccccCCC----CCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH-------
Q 018018          218 IMASTSG----QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM-------  285 (362)
Q Consensus       218 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~-------  285 (362)
                      .+.....    .....+-|.+|++||.+.| ..|+.+.|||+.||++.||.++.+-+.+.++......+..+.       
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            7753221    2223456999999999988 459999999999999999999999998765543322222221       


Q ss_pred             ----------HHHhcCCCCCCC---------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHH
Q 018018          286 ----------EAIVDQPPPSAP---------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF  346 (362)
Q Consensus       286 ----------~~~~~~~~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~  346 (362)
                                +.+...+.+...         +-.-.++..+|+.+||..||.+|+++.++++|.||..-.....++...+
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqanl~~ml  332 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQANLQDML  332 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchhhHHHHH
Confidence                      111111100000         0011357889999999999999999999999999987766655555544


Q ss_pred             H
Q 018018          347 T  347 (362)
Q Consensus       347 ~  347 (362)
                      +
T Consensus       333 ~  333 (376)
T KOG0669|consen  333 S  333 (376)
T ss_pred             H
Confidence            3

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=5.3e-39  Score=318.25  Aligned_cols=272  Identities=20%  Similarity=0.236  Sum_probs=183.7

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccC----CcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeee---
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT----GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQS---  136 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~---  136 (362)
                      ...+..++|++.+.||+|+||.||++++..+    +..||+|++......+.   ...+ .+ ....+.++..+...   
T Consensus       126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~---~~~e-~l-~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI---WMNE-RV-RRACPNSCADFVYGFLE  200 (566)
T ss_pred             CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH---HHHH-HH-HhhchhhHHHHHHhhhc
Confidence            3455678999999999999999999999988    89999998764321111   1111 11 11111122111111   


Q ss_pred             ---EEecCeEEEEEeccCCCCHHHHHHHcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCeEee
Q 018018          137 ---FYSNGAISIILEYMDGGSLADFLKKVKT--------------------IPEEYLAAICEQVLKGLLYLHHEKHIIHR  193 (362)
Q Consensus       137 ---~~~~~~~~lV~e~~~~gsL~~~l~~~~~--------------------l~~~~~~~i~~ql~~al~~LH~~~~ivH~  193 (362)
                         .......++|+||+.+++|.+++.....                    .....+..++.|++.||+|||+ +||+||
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~-~gIiHR  279 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS-TGIVHR  279 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH-CCEEeC
Confidence               2356789999999999999999875321                    1234567899999999999998 999999


Q ss_pred             cCCCCcEEEcc-CCcEEEeeccCCcccccCC-CCCCccccCCcccCcceecCC----------------------CCCcc
Q 018018          194 DLKPSNLLINH-RGEVKITDFGVSAIMASTS-GQANTFVGTYNYMSPERISGG----------------------KYGYK  249 (362)
Q Consensus       194 Dlkp~NIll~~-~~~vkl~DFg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~  249 (362)
                      ||||+|||++. ++.+||+|||+|+.+.... ......++++.|+|||.+...                      .++.+
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999999985 5799999999997654322 223456889999999976432                      23456


Q ss_pred             ccHHHHHHHHHHHHcCCCCCCCCccC------CchhhHHHHHHHHhcCCCC-----CCCCCCCCHHHHHHHHHhhhcCcC
Q 018018          250 SDIWSLGLVLLECATGQFPYSPPEQQ------DGWTSFYELMEAIVDQPPP-----SAPSDQFSPEFCSFISACVQKEPQ  318 (362)
Q Consensus       250 ~DiwslG~~l~elltg~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dP~  318 (362)
                      +||||+||++|||+++..++......      ........+.........+     ....+......++||.+||+.||+
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            79999999999999977665321000      0000000111100000000     001112234566999999999999


Q ss_pred             CCCCHHHHHcCCcccccCCCCCC
Q 018018          319 QRLSAQELMTHPFLKMYGDLNVD  341 (362)
Q Consensus       319 ~Rpt~~eil~hp~~~~~~~~~~~  341 (362)
                      +|||+.++++||||+......+.
T Consensus       440 kR~ta~e~L~Hpff~~~~~~~~~  462 (566)
T PLN03225        440 QRISAKAALAHPYFDREGLLGLS  462 (566)
T ss_pred             cCCCHHHHhCCcCcCCCCccccc
Confidence            99999999999999987765443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=317.35  Aligned_cols=256  Identities=25%  Similarity=0.418  Sum_probs=226.1

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCc---EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      .+++.....+.++||.|.||.|+.++.+..|+   .||||.++....+.+++.|+.|+.||-+.+||||+.+-++.....
T Consensus       624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~  703 (996)
T KOG0196|consen  624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK  703 (996)
T ss_pred             hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence            35666778899999999999999999987775   699999999999999999999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          142 AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ...||+|||++|+|..||+.+ ++++..+...+++.|+.|++||.+ .|.|||||..+|||++.+-..|++|||+++.+.
T Consensus       704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeeccceEEEeccccceeecc
Confidence            999999999999999999765 679999999999999999999997 999999999999999999999999999999886


Q ss_pred             cCCCCCCccc-c--CCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018018          221 STSGQANTFV-G--TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  296 (362)
Q Consensus       221 ~~~~~~~~~~-g--t~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
                      +......+.. |  +.+|.|||.+...+++.++||||+|++|||.++ |..||.+.+.       ++++..+.++...++
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-------QdVIkaIe~gyRLPp  855 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-------QDVIKAIEQGYRLPP  855 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-------HHHHHHHHhccCCCC
Confidence            6553333222 2  579999999999999999999999999999988 9999987654       356666665554333


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                       +-.+|..+.+|+..||++|-.+||++.+|+.+
T Consensus       856 -PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  856 -PMDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             -CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence             34789999999999999999999999999874

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=3e-38  Score=280.29  Aligned_cols=243  Identities=39%  Similarity=0.662  Sum_probs=207.1

Q ss_pred             CCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCCHHHHHHH
Q 018018           82 SGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK  161 (362)
Q Consensus        82 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~  161 (362)
                      +||.||++....+|+.+|+|++...........+.+|++.++.++|+||+++++.+......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999999899999999987654433367889999999999999999999999999999999999999999999988


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCCcccCccee
Q 018018          162 VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI  241 (362)
Q Consensus       162 ~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~  241 (362)
                      ...++...+..++.+++.++.+||+ .+++|+||+|.||+++.++.++|+|||.+....... ......++..|+|||.+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~  158 (244)
T smart00220       81 RGRLSEDEARFYARQILSALEYLHS-NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVL  158 (244)
T ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHH-cCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHH
Confidence            7779999999999999999999998 899999999999999999999999999988765332 33455688899999999


Q ss_pred             cCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC-CCHHHHHHHHHhhhcCcCCC
Q 018018          242 SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ-FSPEFCSFISACVQKEPQQR  320 (362)
Q Consensus       242 ~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dP~~R  320 (362)
                      .+..++.++|+||+|+++++|++|..||.....      .................... ++.++.+++.+||..+|++|
T Consensus       159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R  232 (244)
T smart00220      159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ------LLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKR  232 (244)
T ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhc
Confidence            988899999999999999999999999965321      12333333333332222222 88999999999999999999


Q ss_pred             CCHHHHHcCCcc
Q 018018          321 LSAQELMTHPFL  332 (362)
Q Consensus       321 pt~~eil~hp~~  332 (362)
                      |++.++++||||
T Consensus       233 p~~~~~~~~~~~  244 (244)
T smart00220      233 LTAEEALQHPFF  244 (244)
T ss_pred             cCHHHHhhCCCC
Confidence            999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-40  Score=297.09  Aligned_cols=264  Identities=29%  Similarity=0.485  Sum_probs=216.9

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc------chHHHHHHHHHHHHHhcCCCCcceEEeeeEE-ec
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV------EESARRQIAQELKINQSSQCPYVVVCYQSFY-SN  140 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~-~~  140 (362)
                      -.++|.++++||+|+|+.||+|-+...+++||||+-..+.      .+...+...+|.+|.+.|+||.||++|++|. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            3478999999999999999999999999999999865442      2334566779999999999999999999987 56


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-CCeEeecCCCCcEEEcc---CCcEEEeeccCC
Q 018018          141 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-KHIIHRDLKPSNLLINH---RGEVKITDFGVS  216 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~-~~ivH~Dlkp~NIll~~---~~~vkl~DFg~a  216 (362)
                      ..+|-|+|||+|.+|.-|++.++-+++.+++.|+.|++.||.||.+- ..|+|-||||.|||+-.   -|.+||.|||++
T Consensus       541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS  620 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS  620 (775)
T ss_pred             ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence            77899999999999999999999999999999999999999999862 45999999999999943   467999999999


Q ss_pred             cccccCCCC-------CCccccCCcccCcceecCC----CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH
Q 018018          217 AIMASTSGQ-------ANTFVGTYNYMSPERISGG----KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM  285 (362)
Q Consensus       217 ~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~  285 (362)
                      +.+......       +....||.+|.+||++.-+    +.+.++||||+||++|.++.|+.||.......   .+.+.-
T Consensus       621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ---dILqeN  697 (775)
T KOG1151|consen  621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ---DILQEN  697 (775)
T ss_pred             hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH---HHHhhh
Confidence            998765543       2345799999999998543    36889999999999999999999997643221   111111


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          286 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      ..+.......+....+++++.++|++||++.-++|....++..||+|..
T Consensus       698 TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  698 TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            1111111222334578999999999999999999999999999999976

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=311.50  Aligned_cols=247  Identities=28%  Similarity=0.470  Sum_probs=200.2

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec------CeE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GAI  143 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~------~~~  143 (362)
                      .-+...+.||+|+||.||.++++.+|..||||.++.......+...-+|++++++++|+|||+++++-.+.      ...
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            44566789999999999999999999999999998766666677888999999999999999999875433      356


Q ss_pred             EEEEeccCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc--CC--cEEEeeccCC
Q 018018          144 SIILEYMDGGSLADFLKK---VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH--RG--EVKITDFGVS  216 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~--~~--~vkl~DFg~a  216 (362)
                      .+|||||.||||...+++   ...|++.+.+.+..++..||.|||+ +||+||||||.||++-.  +|  .-||+|||.|
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE-n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE-NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH-cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            899999999999999964   4679999999999999999999997 99999999999999843  23  3799999999


Q ss_pred             cccccCCCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018018          217 AIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  295 (362)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (362)
                      +.+.... ...+.+||..|.+||.+.. +.|+..+|.||+||++|+++||..||.+....   ....+++..+...++..
T Consensus       172 rel~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p---k~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  172 RELDDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP---KNNKEIMWHIITKKPSG  247 (732)
T ss_pred             ccCCCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc---cccchhhhhhhccCCCc
Confidence            9876554 6677899999999999984 88999999999999999999999999764332   11223333322222100


Q ss_pred             -------------------CCCCCCC----HHHHHHHHHhhhcCcCCCC
Q 018018          296 -------------------APSDQFS----PEFCSFISACVQKEPQQRL  321 (362)
Q Consensus       296 -------------------~~~~~~~----~~~~~li~~~L~~dP~~Rp  321 (362)
                                         +.+..++    ..+..++..||+++|++|-
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                               1122223    2356788999999999998

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=285.86  Aligned_cols=267  Identities=27%  Similarity=0.431  Sum_probs=202.3

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-----C---CcceEEeee
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-----C---PYVVVCYQS  136 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----h---p~I~~~~~~  136 (362)
                      ..+...+|-+.++||-|.|++||+|.+....+.||+|+.+..  .........|+++++.++     |   ..||++++.
T Consensus        73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~  150 (590)
T KOG1290|consen   73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH  150 (590)
T ss_pred             ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence            345568999999999999999999999999999999998733  333445667888877652     3   469999999


Q ss_pred             EEe----cCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC-----
Q 018018          137 FYS----NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-----  205 (362)
Q Consensus       137 ~~~----~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~-----  205 (362)
                      |..    +.++|+|+|++ |.+|..+|...  +.++...+++|++|++.||.|||++.||+|.||||+|||+..+     
T Consensus       151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~  229 (590)
T KOG1290|consen  151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPA  229 (590)
T ss_pred             ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchh
Confidence            874    57899999999 66999999764  6799999999999999999999999999999999999999300     


Q ss_pred             --------------------------------------------------------------------------------
Q 018018          206 --------------------------------------------------------------------------------  205 (362)
Q Consensus       206 --------------------------------------------------------------------------------  205 (362)
                                                                                                      
T Consensus       230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~  309 (590)
T KOG1290|consen  230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI  309 (590)
T ss_pred             hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 018018          206 --------------------------------------------------------------------------------  205 (362)
Q Consensus       206 --------------------------------------------------------------------------------  205 (362)
                                                                                                      
T Consensus       310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~  389 (590)
T KOG1290|consen  310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC  389 (590)
T ss_pred             CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence                                                                                            


Q ss_pred             -CcEEEeeccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCch---hhH
Q 018018          206 -GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW---TSF  281 (362)
Q Consensus       206 -~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~---~~~  281 (362)
                       -++||+|||.|.....   +.+..+.|..|+|||++.+..|++.+||||++|+++||+||.+.|...+...-.   ..+
T Consensus       390 di~vKIaDlGNACW~~k---hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi  466 (590)
T KOG1290|consen  390 DIRVKIADLGNACWVHK---HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI  466 (590)
T ss_pred             ceeEEEeeccchhhhhh---hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence             0134555554443221   122346788999999999999999999999999999999999999765443321   122


Q ss_pred             HHHHHHHhcCCCCC------------------------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHH
Q 018018          282 YELMEAIVDQPPPS------------------------------------APSDQFSPEFCSFISACVQKEPQQRLSAQE  325 (362)
Q Consensus       282 ~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  325 (362)
                      ..+++.+..-+...                                    ..+.....++.+++.-||+.+|++||||.+
T Consensus       467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~  546 (590)
T KOG1290|consen  467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ  546 (590)
T ss_pred             HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence            22222222111000                                    001111245789999999999999999999


Q ss_pred             HHcCCcccccCC
Q 018018          326 LMTHPFLKMYGD  337 (362)
Q Consensus       326 il~hp~~~~~~~  337 (362)
                      +|+|||+.....
T Consensus       547 cl~hPwLn~~~~  558 (590)
T KOG1290|consen  547 CLKHPWLNPVAG  558 (590)
T ss_pred             HhcCccccCCCC
Confidence            999999986654

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-39  Score=305.96  Aligned_cols=258  Identities=22%  Similarity=0.332  Sum_probs=216.7

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccC-Cc--EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWT-GQ--FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~--~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      +..++...+++||+|.||+|+.+..... |+  .||||+++..........|++|+.+|.+|+|+|++++|++..+ ...
T Consensus       107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~  185 (1039)
T KOG0199|consen  107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA  185 (1039)
T ss_pred             ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence            4456778889999999999999887653 33  5899999877555577899999999999999999999999876 788


Q ss_pred             EEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          144 SIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .+|||.++.|||.+.|+.  ...|.......++.||+.|+.||.+ +++|||||..+|+|+-....|||+|||+.+.+..
T Consensus       186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes-krlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES-KRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh-hhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999999999999999977  3468888999999999999999998 9999999999999999999999999999998865


Q ss_pred             CCCCCCc---cccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          222 TSGQANT---FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       222 ~~~~~~~---~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      .......   .--...|+|||.+....++.++|+|++||++|||++ |.-||.+...       ..+++.+..+ ..-..
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-------~qIL~~iD~~-erLpR  336 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-------IQILKNIDAG-ERLPR  336 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-------HHHHHhcccc-ccCCC
Confidence            4433311   123678999999999999999999999999999999 8999988543       2444444432 33334


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      ++.++.++++++.+||..+|.+|||+..|...-+.+.
T Consensus       337 Pk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  337 PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             CCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence            5689999999999999999999999999976655433

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.1e-37  Score=300.17  Aligned_cols=270  Identities=20%  Similarity=0.252  Sum_probs=192.0

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEc----------------cCCcEEEEEEeecccchHH-------------HHH
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHK----------------WTGQFFALKVIQMNVEESA-------------RRQ  114 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~~~~-------------~~~  114 (362)
                      ...+..++|.+.++||+|+||+||++...                ..++.||||.+........             ...
T Consensus       139 ~~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~  218 (507)
T PLN03224        139 NSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAET  218 (507)
T ss_pred             CCCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccch
Confidence            34567889999999999999999998642                3456899999865422111             112


Q ss_pred             HHHHHHHHhcCCCCcc-----eEEeeeEE--------ecCeEEEEEeccCCCCHHHHHHHc-------------------
Q 018018          115 IAQELKINQSSQCPYV-----VVCYQSFY--------SNGAISIILEYMDGGSLADFLKKV-------------------  162 (362)
Q Consensus       115 ~~~e~~~~~~l~hp~I-----~~~~~~~~--------~~~~~~lV~e~~~~gsL~~~l~~~-------------------  162 (362)
                      ...|+.++..++|.++     +.+++++.        +.+..++||||+++++|.+++...                   
T Consensus       219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~  298 (507)
T PLN03224        219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP  298 (507)
T ss_pred             hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence            2345556666665543     45555443        245689999999999999988642                   


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC-CCCccccCCccc
Q 018018          163 -----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYM  236 (362)
Q Consensus       163 -----~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~-~~~~~~gt~~y~  236 (362)
                           ..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........ ......+++.|+
T Consensus       299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~-~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~  377 (507)
T PLN03224        299 DNMPQDKRDINVIKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS  377 (507)
T ss_pred             hhcccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence                 124567788999999999999998 9999999999999999999999999999876533221 111223478999


Q ss_pred             CcceecCCC--------------------CC--ccccHHHHHHHHHHHHcCCC-CCCCCccCC----chhhHHHHHHHHh
Q 018018          237 SPERISGGK--------------------YG--YKSDIWSLGLVLLECATGQF-PYSPPEQQD----GWTSFYELMEAIV  289 (362)
Q Consensus       237 aPE~~~~~~--------------------~~--~~~DiwslG~~l~elltg~~-pf~~~~~~~----~~~~~~~~~~~~~  289 (362)
                      |||.+....                    |+  .+.|+||+||++|+|+++.. ||.+.....    .........+...
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~  457 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK  457 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence            999986432                    11  24799999999999999875 775422111    0111111122222


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhhcCc---CCCCCHHHHHcCCcccc
Q 018018          290 DQPPPSAPSDQFSPEFCSFISACVQKEP---QQRLSAQELMTHPFLKM  334 (362)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~li~~~L~~dP---~~Rpt~~eil~hp~~~~  334 (362)
                      .........+..++..++|+.+||+.+|   .+|+|++|+|+||||..
T Consensus       458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            2333333456788999999999999866   68999999999999964

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=281.92  Aligned_cols=262  Identities=26%  Similarity=0.419  Sum_probs=214.5

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec------
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------  140 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~------  140 (362)
                      ...+|.-++.+|.|.- .|..+-+...+++||+|.+... .+....++..+|..++..+.|+||+.++.+|.-.      
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~   93 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF   93 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence            3467888899999998 7778888889999999987544 2334456788999999999999999999988643      


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          141 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ...|+|||++.. +|...+.  -.++-..+..+..|++.|++|||+ .||+||||||+||++..++.+||+|||+|+...
T Consensus        94 ~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs-~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~  169 (369)
T KOG0665|consen   94 QEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHS-AGIIHRDLKPSNIVVNSDCTLKILDFGLARTED  169 (369)
T ss_pred             HhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHh-cceeecccCcccceecchhheeeccchhhcccC
Confidence            458999999964 9999888  478889999999999999999998 999999999999999999999999999998754


Q ss_pred             cCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHH-------------
Q 018018          221 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA-------------  287 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~-------------  287 (362)
                      .. -....++.|..|+|||++.+-.|.+.+||||+||++.||++|...|.+.+..+.|..+.+....             
T Consensus       170 ~~-~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~  248 (369)
T KOG0665|consen  170 TD-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV  248 (369)
T ss_pred             cc-cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence            33 3456788999999999999988999999999999999999999999988777766655444311             


Q ss_pred             --HhcCC----------------CCC--CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          288 --IVDQP----------------PPS--APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       288 --~~~~~----------------~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                        .....                .+.  .....-...+++|+.+||-.||++|.+++++|+|||++-|
T Consensus       249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw  316 (369)
T KOG0665|consen  249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW  316 (369)
T ss_pred             HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence              00000                000  0011223457899999999999999999999999999844

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=3.8e-39  Score=297.41  Aligned_cols=259  Identities=22%  Similarity=0.381  Sum_probs=209.8

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCC------CcceEEeeeEEecCeE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC------PYVVVCYQSFYSNGAI  143 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h------p~I~~~~~~~~~~~~~  143 (362)
                      .+|.+....|+|-|++|..|.+...|+.||||+|+.  ++.+.+.=+.|++++++|..      -+++.++..|....++
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn--NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL  509 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN--NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL  509 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeec--chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence            578888899999999999999999999999999974  45666777899999999863      4788999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC-cEEEeeccCCccc
Q 018018          144 SIILEYMDGGSLADFLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIM  219 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-~vkl~DFg~a~~~  219 (362)
                      |||+|-+. .+|.++++..+   .|....++.++.|++.||..|-. .||+|.||||.||||+++. .+||||||.|...
T Consensus       510 ClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~  587 (752)
T KOG0670|consen  510 CLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFGSASFA  587 (752)
T ss_pred             EEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCcccccc
Confidence            99999984 59999998764   58899999999999999999998 9999999999999998764 6899999998765


Q ss_pred             ccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc---------
Q 018018          220 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD---------  290 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~---------  290 (362)
                      ...  ....+.-+..|.|||++.|.+|++..|+||+||+||||+||+..|++.+..+....+.++..++..         
T Consensus       588 ~en--eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~  665 (752)
T KOG0670|consen  588 SEN--EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFK  665 (752)
T ss_pred             ccc--cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchh
Confidence            433  345566678999999999999999999999999999999999999987665433322222111000         


Q ss_pred             -----CC-----------------------CC--------------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          291 -----QP-----------------------PP--------------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       291 -----~~-----------------------~~--------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                           ..                       .|              +......-.++.+|+.+||..||++|.|..++|.
T Consensus       666 dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  666 DQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             hhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                 00                       00              0000011134789999999999999999999999


Q ss_pred             CCcccc
Q 018018          329 HPFLKM  334 (362)
Q Consensus       329 hp~~~~  334 (362)
                      ||||+.
T Consensus       746 HpFi~~  751 (752)
T KOG0670|consen  746 HPFITE  751 (752)
T ss_pred             CCcccC
Confidence            999974

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.7e-38  Score=265.18  Aligned_cols=260  Identities=23%  Similarity=0.405  Sum_probs=207.4

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEe--cCeEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYS--NGAIS  144 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~--~~~~~  144 (362)
                      ..++|++.+.+|+|-++.||.+....+++.++||+++.    -..+.+.+|++++..+. ||||+++++...+  +....
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            35899999999999999999999999999999999864    34577899999999987 9999999998875  46688


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC-cEEEeeccCCcccccCC
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTS  223 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-~vkl~DFg~a~~~~~~~  223 (362)
                      +|+||+.+.+...+.   ..++..+++.++.|++.||.|+|+ .||.|||+||.|++|+... .++|+|+|+|.... ++
T Consensus       112 LiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS-~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH-p~  186 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHS-MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PG  186 (338)
T ss_pred             hHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHh-cCcccccCCcceeeechhhceeeeeecchHhhcC-CC
Confidence            999999876555443   468889999999999999999999 9999999999999998654 69999999998764 44


Q ss_pred             CCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCC-CccCCchhhHHHHH---------HH-----
Q 018018          224 GQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSP-PEQQDGWTSFYELM---------EA-----  287 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~-~~~~~~~~~~~~~~---------~~-----  287 (362)
                      ...+..+.+..|..||.+.. ..|+++-|+|||||++..|+..+-||-. .+..++...+..++         .+     
T Consensus       187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            44556677889999999876 4589999999999999999998888743 33333222222111         11     


Q ss_pred             ------HhcCC--------CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          288 ------IVDQP--------PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       288 ------~~~~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                            +...-        ..+....-.++++.+|+.++|..|..+|+||.|++.||||....
T Consensus       267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~  329 (338)
T KOG0668|consen  267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR  329 (338)
T ss_pred             ChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence                  00000        01111223468999999999999999999999999999997653

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=255.70  Aligned_cols=230  Identities=37%  Similarity=0.713  Sum_probs=193.0

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhc-CCCCcceEEeeeEEecCeEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~-l~hp~I~~~~~~~~~~~~~~  144 (362)
                      ++..++...+..||+|++|.|-+.++..+|+..|+|.++...+....+++++|+++... ..||+++.+|+...+.+..+
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw  121 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW  121 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence            34556677778999999999999999999999999999988888888889999997654 57999999999999999999


Q ss_pred             EEEeccCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          145 IILEYMDGGSLADFL----KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       145 lV~e~~~~gsL~~~l----~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      +.||.+.. ||..+-    ..++.+++..+-+++..++.||.|||+...++|||+||.|||++.+|+||+||||++-.+.
T Consensus       122 IcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  122 ICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             EeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            99999964 887765    4467899999999999999999999998899999999999999999999999999998775


Q ss_pred             cCCCCCCccccCCcccCcceecC----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018018          221 STSGQANTFVGTYNYMSPERISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  296 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
                      +.-. .....|.-.|||||.+..    ..|+.++||||||+++.||.++++||..      |..-.+.+..++..+.|..
T Consensus       201 dSiA-kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~------w~tpF~qLkqvVeep~P~L  273 (282)
T KOG0984|consen  201 DSIA-KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES------WGTPFQQLKQVVEEPSPQL  273 (282)
T ss_pred             hhhH-HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc------cCCHHHHHHHHhcCCCCCC
Confidence            4332 222456778999998754    4689999999999999999999999963      5555666677777666655


Q ss_pred             CCCCCCH
Q 018018          297 PSDQFSP  303 (362)
Q Consensus       297 ~~~~~~~  303 (362)
                      +...+|+
T Consensus       274 p~~~FS~  280 (282)
T KOG0984|consen  274 PADTFSP  280 (282)
T ss_pred             cccccCC
Confidence            5444443

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=304.52  Aligned_cols=257  Identities=25%  Similarity=0.398  Sum_probs=215.5

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEcc-------CCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEee
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKW-------TGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQ  135 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~  135 (362)
                      .+++..++..+.+.||+|.||.|+++....       ....||||.++........+.+..|+++++.+. |+||+.+.+
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            456666777788899999999999987542       145799999988777788899999999998875 999999999


Q ss_pred             eEEecCeEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCc
Q 018018          136 SFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN  199 (362)
Q Consensus       136 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~N  199 (362)
                      ++...+.+++|+||+..|+|.++++..+                .++..+...++.|++.|++||++ .+++||||..+|
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~-~~~vHRDLAaRN  448 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS-VPCVHRDLAARN  448 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh-CCccchhhhhhh
Confidence            9999999999999999999999998755                38899999999999999999998 899999999999


Q ss_pred             EEEccCCcEEEeeccCCcccccCCCCC-Cccc--cCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccC
Q 018018          200 LLINHRGEVKITDFGVSAIMASTSGQA-NTFV--GTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ  275 (362)
Q Consensus       200 Ill~~~~~vkl~DFg~a~~~~~~~~~~-~~~~--gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~  275 (362)
                      ||++.+..+||+|||+|+......... ....  -+..|||||.+....|+.++||||+|++||||++ |..||.+..  
T Consensus       449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~--  526 (609)
T KOG0200|consen  449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP--  526 (609)
T ss_pred             EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC--
Confidence            999999999999999998654333222 1112  3567999999999999999999999999999999 999997632  


Q ss_pred             CchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          276 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                          ...++.+.+..+.. ...+..+++++.++++.||+.+|++||++.++.+
T Consensus       527 ----~~~~l~~~l~~G~r-~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  527 ----PTEELLEFLKEGNR-MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             ----cHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence                12344554555444 3445678999999999999999999999999865

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-38  Score=299.74  Aligned_cols=273  Identities=32%  Similarity=0.532  Sum_probs=229.3

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .++|+.++.+|+|+||.||+++++.+++..|+|+++... .....-+.+|+-+++.++||||+.+++.+.....+++.||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep-~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP-GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccC-CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            378999999999999999999999999999999998763 2345667889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      ||.||+|.+.-.-.+++++.++..+++..+.|++|||+ .|-+|||||-.||++++.|.+|++|||.+..++..-.....
T Consensus        93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs-~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krks  171 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHS-QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKS  171 (829)
T ss_pred             ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhc-CCcccccccccceeecccCceeecccCchhhhhhhhhhhhc
Confidence            99999999999888999999999999999999999998 99999999999999999999999999998877766666778


Q ss_pred             cccCCcccCccee---cCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          229 FVGTYNYMSPERI---SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       229 ~~gt~~y~aPE~~---~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      +.||++|||||+.   +.+.|...+|||++|++..|+-.-++|..+.-+.    ...-++.+..-.++...-..+.++.+
T Consensus       172 fiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm----r~l~LmTkS~~qpp~lkDk~kws~~f  247 (829)
T KOG0576|consen  172 FIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM----RALFLMTKSGFQPPTLKDKTKWSEFF  247 (829)
T ss_pred             ccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH----HHHHHhhccCCCCCcccCCccchHHH
Confidence            8999999999986   4467999999999999999998888776543221    11112222222223333445678899


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHHHh
Q 018018          306 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA  349 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~~~  349 (362)
                      -+|++.+|.++|++|||++.+|.|||....  .+..+...+-|.
T Consensus       248 h~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~eLLdK  289 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAIELLDK  289 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHHHHHHH
Confidence            999999999999999999999999999877  333444434333

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=278.99  Aligned_cols=257  Identities=26%  Similarity=0.386  Sum_probs=196.4

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhc--CCCCcceEEeeeEEec
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS--SQCPYVVVCYQSFYSN  140 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~hp~I~~~~~~~~~~  140 (362)
                      +..-......+..+++|+|.||.||+++.  +++.||||+++.    ...+.+..|.+|.+.  ++|+||++|++.-...
T Consensus       203 sspl~~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~  276 (534)
T KOG3653|consen  203 SSPLLELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRG  276 (534)
T ss_pred             CcccccCCchhhHHHhhcCccceeehhhc--cCceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence            34445677888899999999999999977  479999999864    355677788887655  6899999999876544


Q ss_pred             C----eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCeEeecCCCCcEEEccCCcE
Q 018018          141 G----AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE--------KHIIHRDLKPSNLLINHRGEV  208 (362)
Q Consensus       141 ~----~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~--------~~ivH~Dlkp~NIll~~~~~v  208 (362)
                      .    .++||++|.+.|+|.+||.. ..+++....+++..|++||+|||++        .+|+|||||+.||||..|++.
T Consensus       277 t~~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc  355 (534)
T KOG3653|consen  277 TADRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC  355 (534)
T ss_pred             CccccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence            4    79999999999999999998 6799999999999999999999973        459999999999999999999


Q ss_pred             EEeeccCCcccccCCC--CCCccccCCcccCcceecCCCC------CccccHHHHHHHHHHHHcCCCCC--------CCC
Q 018018          209 KITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKY------GYKSDIWSLGLVLLECATGQFPY--------SPP  272 (362)
Q Consensus       209 kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~------~~~~DiwslG~~l~elltg~~pf--------~~~  272 (362)
                      .|+|||+|..+.....  .....+||.+|||||++.+...      -.+.||||+|.+||||++.-.-+        ..+
T Consensus       356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp  435 (534)
T KOG3653|consen  356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP  435 (534)
T ss_pred             EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence            9999999988763332  2344689999999999987432      23789999999999999843222        111


Q ss_pred             cc--CCchhhHHHHHHHHhcCCCCCCCCCC-----CCHHHHHHHHHhhhcCcCCCCCHHHH
Q 018018          273 EQ--QDGWTSFYELMEAIVDQPPPSAPSDQ-----FSPEFCSFISACVQKEPQQRLSAQEL  326 (362)
Q Consensus       273 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~L~~dP~~Rpt~~ei  326 (362)
                      -+  ......+.++...++..+.++..+..     -...+++.++.||..||+.|.|+.-+
T Consensus       436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence            11  01112233333333333333322211     22457899999999999999998765

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.1e-36  Score=317.35  Aligned_cols=245  Identities=20%  Similarity=0.296  Sum_probs=190.4

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      ..+...+.||+|+||.||++++..++..||+|.++.....     ...|++.++.++||||+++++++.+....++||||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            3456667899999999999999999999999998643221     12457788899999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--CCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH--EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~--~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      +++|+|.++++   .+++..+..++.|++.||+|||.  ..+++||||||+||+++.++..++. ||.+....    ...
T Consensus       765 ~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~----~~~  836 (968)
T PLN00113        765 IEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC----TDT  836 (968)
T ss_pred             CCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc----cCC
Confidence            99999999996   38999999999999999999993  1689999999999999988888775 66544322    122


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh---------cCCCCC--C
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV---------DQPPPS--A  296 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~---------~~~~~~--~  296 (362)
                      ...+++.|+|||++.+..++.++||||+||++|||++|+.||.......  ....++.+...         +.....  .
T Consensus       837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (968)
T PLN00113        837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH--GSIVEWARYCYSDCHLDMWIDPSIRGDVS  914 (968)
T ss_pred             CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC--CcHHHHHHHhcCccchhheeCccccCCCC
Confidence            3367899999999999999999999999999999999999995432211  12222222111         111100  0


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .......++.+++.+||+.||++|||++|+++.
T Consensus       915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            011112356789999999999999999999874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=272.49  Aligned_cols=261  Identities=24%  Similarity=0.405  Sum_probs=206.4

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec-----CeEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAIS  144 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~-----~~~~  144 (362)
                      +.+-.+.||-|+||+||.+++..+|+.||+|++..- ..-...+.+.+|++++...+|.|++...+..+-.     ..+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            334457899999999999999999999999987532 2333457788999999999999999887765432     3478


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      .|+|.++. +|...+-....++.+.++-+.+||++||+|||+ .+|.||||||.|.|++++..+||||||+|+.......
T Consensus       134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHs-A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~  211 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHT-ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR  211 (449)
T ss_pred             HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhh-cchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence            88999965 899999888899999999999999999999998 9999999999999999999999999999987653332


Q ss_pred             -CCCccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH----------------H
Q 018018          225 -QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM----------------E  286 (362)
Q Consensus       225 -~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~----------------~  286 (362)
                       .....+-|-+|+|||++.|.. |+.+.||||+||++.||+..+..|...++.+....+.+++                .
T Consensus       212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~  291 (449)
T KOG0664|consen  212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKN  291 (449)
T ss_pred             hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHH
Confidence             233346788999999998854 8999999999999999999999998766544333332221                1


Q ss_pred             HHhcCCC-CCCC--------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccc
Q 018018          287 AIVDQPP-PSAP--------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  333 (362)
Q Consensus       287 ~~~~~~~-~~~~--------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  333 (362)
                      .+..+.. ++..        +..-..+...++.+||..||++|.+.++++.|++..
T Consensus       292 H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~  347 (449)
T KOG0664|consen  292 HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE  347 (449)
T ss_pred             HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence            1111111 1111        112234677899999999999999999999999964

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=281.70  Aligned_cols=202  Identities=30%  Similarity=0.484  Sum_probs=178.8

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc---chHHH----HHHHHHHHHHhcCC---CCcceEEeee
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESAR----RQIAQELKINQSSQ---CPYVVVCYQS  136 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~----~~~~~e~~~~~~l~---hp~I~~~~~~  136 (362)
                      ..+.+|..++.+|+|+||.|++|.++.....|+||.+.+..   +...+    -.+-.|+.||..++   |+||+++++.
T Consensus       558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf  637 (772)
T KOG1152|consen  558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF  637 (772)
T ss_pred             cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence            35678999999999999999999999999999999987551   11111    23458899998887   9999999999


Q ss_pred             EEecCeEEEEEecc-CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccC
Q 018018          137 FYSNGAISIILEYM-DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  215 (362)
Q Consensus       137 ~~~~~~~~lV~e~~-~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~  215 (362)
                      |++++.+||+||-- +|.+|++++..+..+++.++..|++|++.|+++||+ +||||||||-+|++++.+|.+||+|||.
T Consensus       638 FEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~-~~ivhrdikdenvivd~~g~~klidfgs  716 (772)
T KOG1152|consen  638 FEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD-QGIVHRDIKDENVIVDSNGFVKLIDFGS  716 (772)
T ss_pred             eecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccc-cCceecccccccEEEecCCeEEEeeccc
Confidence            99999999999975 456999999999999999999999999999999998 9999999999999999999999999998


Q ss_pred             CcccccCCCCCCccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCC
Q 018018          216 SAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP  271 (362)
Q Consensus       216 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~elltg~~pf~~  271 (362)
                      |...  ..+....++||..|.|||++.|.+| +..-|||+||++||.++....||.+
T Consensus       717 aa~~--ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  717 AAYT--KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhh--cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            8765  3445677899999999999999987 6778999999999999999999864

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=292.43  Aligned_cols=244  Identities=27%  Similarity=0.348  Sum_probs=190.1

Q ss_pred             eeeeeeCCeEE-EEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEEEEeccCCC
Q 018018           76 KVVGKGSGGIV-QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILEYMDGG  153 (362)
Q Consensus        76 ~~lg~G~~g~V-~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~lV~e~~~~g  153 (362)
                      +++|.|+.|+| |++..  .|+.||||.+-..    -.....+|+..++.. .||||+++|+.-.++...|+..|.|.. 
T Consensus       515 eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-  587 (903)
T KOG1027|consen  515 EILGYGSNGTVVFRGVY--EGREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-  587 (903)
T ss_pred             HHcccCCCCcEEEEEee--CCceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-
Confidence            67889988765 66655  6889999987532    344567899988776 599999999999999999999999964 


Q ss_pred             CHHHHHHHc-C---CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc---C--CcEEEeeccCCcccccCCC
Q 018018          154 SLADFLKKV-K---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---R--GEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       154 sL~~~l~~~-~---~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---~--~~vkl~DFg~a~~~~~~~~  224 (362)
                      +|.+++... .   .......+.+..|++.||++||+ .+||||||||.||||+.   +  .+++|+|||+++.+.....
T Consensus       588 sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s  666 (903)
T KOG1027|consen  588 SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS  666 (903)
T ss_pred             hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence            999999874 1   11224567899999999999999 99999999999999976   3  4799999999998864332


Q ss_pred             ---CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCC-CCCC
Q 018018          225 ---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPS-APSD  299 (362)
Q Consensus       225 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  299 (362)
                         ...+..||-.|+|||++....-+.++||||+||++|+.++ |..||.+.-..+         ..+..+...- ....
T Consensus       667 S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~---------~NIl~~~~~L~~L~~  737 (903)
T KOG1027|consen  667 SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ---------ANILTGNYTLVHLEP  737 (903)
T ss_pred             hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh---------hhhhcCccceeeecc
Confidence               2345679999999999999888899999999999999999 599998643221         0111111100 0001


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ....++.+||.+|++.+|..||+|.++|.||+|=.++
T Consensus       738 ~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~e  774 (903)
T KOG1027|consen  738 LPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSE  774 (903)
T ss_pred             CchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChH
Confidence            1112899999999999999999999999999995543

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=286.73  Aligned_cols=247  Identities=24%  Similarity=0.361  Sum_probs=209.1

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCc----EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQ----FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      .....++||+|+||+||++..--.|+    +||||++........-.++++|+-+|.+++|||++++++++..+. +.||
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            34455899999999999988654444    799999887767777789999999999999999999999988655 8899


Q ss_pred             EeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          147 LEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      ++|+++|+|.++++.+ .++..+..+.|..||++|+.|||+ +.++||||..+|+||.+-..+|+.|||+|+.+......
T Consensus       776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~-qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e  854 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE-QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE  854 (1177)
T ss_pred             HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh-cchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence            9999999999999765 689999999999999999999998 99999999999999999999999999999987655444


Q ss_pred             CCc--cccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018018          226 ANT--FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  302 (362)
Q Consensus       226 ~~~--~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (362)
                      ...  ..-.+.|||=|.+....|+.++||||+||++||++| |..|+.+....       ++...+..+.. -.-+..++
T Consensus       855 y~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-------eI~dlle~geR-LsqPpiCt  926 (1177)
T KOG1025|consen  855 YSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-------EIPDLLEKGER-LSQPPICT  926 (1177)
T ss_pred             ccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-------HhhHHHhcccc-CCCCCCcc
Confidence            333  234678999999999999999999999999999999 99999875432       33333333333 33446788


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHH
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELM  327 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil  327 (362)
                      -+++-++.+||..|++.||+++++.
T Consensus       927 iDVy~~mvkCwmid~~~rp~fkel~  951 (1177)
T KOG1025|consen  927 IDVYMVMVKCWMIDADSRPTFKELA  951 (1177)
T ss_pred             HHHHHHHHHHhccCcccCccHHHHH
Confidence            9999999999999999999999874

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-35  Score=266.73  Aligned_cols=249  Identities=28%  Similarity=0.429  Sum_probs=193.6

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhc--CCCCcceEEeeeEEec----CeE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS--SQCPYVVVCYQSFYSN----GAI  143 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~hp~I~~~~~~~~~~----~~~  143 (362)
                      ....+.+.||+|.||.||.++.  .|..||||++....    ++...+|.++.+.  ++|+||+.|++.-..+    ..+
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL  284 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL  284 (513)
T ss_pred             heeEEEEEecCccccceeeccc--cCCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence            5667889999999999988855  69999999996442    2445566776554  7999999999875432    458


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-------CCeEeecCCCCcEEEccCCcEEEeeccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKPSNLLINHRGEVKITDFGVS  216 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~-------~~ivH~Dlkp~NIll~~~~~vkl~DFg~a  216 (362)
                      +||++|.+.|||+|||.+ ..++...+.+++..++.||+|||-+       ..|+|||||+.||||..++..-|+|+|+|
T Consensus       285 wLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA  363 (513)
T KOG2052|consen  285 WLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  363 (513)
T ss_pred             EEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence            999999999999999998 7899999999999999999999952       34999999999999999999999999999


Q ss_pred             cccccCCC----CCCccccCCcccCcceecCCC----C--CccccHHHHHHHHHHHHcC----------CCCCCCCccCC
Q 018018          217 AIMASTSG----QANTFVGTYNYMSPERISGGK----Y--GYKSDIWSLGLVLLECATG----------QFPYSPPEQQD  276 (362)
Q Consensus       217 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~----~--~~~~DiwslG~~l~elltg----------~~pf~~~~~~~  276 (362)
                      ........    ..+..+||.+|||||++...-    +  -..+||||||.++||+.-.          ++||.+.-+.+
T Consensus       364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D  443 (513)
T KOG2052|consen  364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD  443 (513)
T ss_pred             EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence            87654422    345579999999999997632    1  2368999999999999752          37887765544


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCC--CH---HHHHHHHHhhhcCcCCCCCHHHHH
Q 018018          277 GWTSFYELMEAIVDQPPPSAPSDQF--SP---EFCSFISACVQKEPQQRLSAQELM  327 (362)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~---~~~~li~~~L~~dP~~Rpt~~eil  327 (362)
                        .++.++..-+......+..+..+  .+   .+.++++.||..||.-|.|+--+-
T Consensus       444 --Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  444 --PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             --CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence              34445544444443333332222  22   356899999999999999987664

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=6.2e-33  Score=240.10  Aligned_cols=212  Identities=40%  Similarity=0.677  Sum_probs=190.0

Q ss_pred             eeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCCHHH
Q 018018           78 VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD  157 (362)
Q Consensus        78 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL~~  157 (362)
                      ||+|++|.||++....+++.+++|++...........+.+|+..++.+.|++|+++++.+......++++||+.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999888999999998766443356788999999999999999999999998899999999999899999


Q ss_pred             HHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc-CCcEEEeeccCCcccccCCCCCCccccCCcc
Q 018018          158 FLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTSGQANTFVGTYNY  235 (362)
Q Consensus       158 ~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y  235 (362)
                      ++... ..++...+..++.+++.++++||+ .|++|+||+|.||+++. ++.++|+|||.+..............+...|
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLHS-NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY  159 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence            99876 579999999999999999999998 89999999999999998 8999999999987664433223345678899


Q ss_pred             cCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhh
Q 018018          236 MSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ  314 (362)
Q Consensus       236 ~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  314 (362)
                      ++||.+... .++.++|+|++|+++++|                                        ..+.+++.+|++
T Consensus       160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------~~~~~~l~~~l~  199 (215)
T cd00180         160 MAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------PELKDLIRKMLQ  199 (215)
T ss_pred             cChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------HHHHHHHHHHhh
Confidence            999999887 788999999999999999                                        578899999999


Q ss_pred             cCcCCCCCHHHHHcCC
Q 018018          315 KEPQQRLSAQELMTHP  330 (362)
Q Consensus       315 ~dP~~Rpt~~eil~hp  330 (362)
                      .||++||+++++++|+
T Consensus       200 ~~p~~R~~~~~l~~~~  215 (215)
T cd00180         200 KDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCcccCcCHHHHhhCC
Confidence            9999999999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=9.5e-34  Score=256.77  Aligned_cols=266  Identities=24%  Similarity=0.388  Sum_probs=205.7

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEcc---CCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKW---TGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~  143 (362)
                      ....|..+++||+|+|++||++.+..   .+..||+|.+......   ..+..|++++..+. +.||+.+.+.+..++..
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v  110 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQV  110 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence            34778899999999999999999887   6889999998765443   34889999998875 79999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc-CCcEEEeeccCCcccccC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMAST  222 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-~~~vkl~DFg~a~~~~~~  222 (362)
                      .+|+||++..+-.++...   ++...++.+++.++.||.++|. +|||||||||.|+|.+. .++-.|+|||+|......
T Consensus       111 ~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~-~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~  186 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHK-NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY  186 (418)
T ss_pred             EEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhc-cCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence            999999999888888775   7789999999999999999998 99999999999999975 467899999999722100


Q ss_pred             -------C------CC-------------------------------CCccccCCcccCcceecCC-CCCccccHHHHHH
Q 018018          223 -------S------GQ-------------------------------ANTFVGTYNYMSPERISGG-KYGYKSDIWSLGL  257 (362)
Q Consensus       223 -------~------~~-------------------------------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~  257 (362)
                             .      ..                               .....||+.|+|||++... ..+.++||||.|+
T Consensus       187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV  266 (418)
T KOG1167|consen  187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV  266 (418)
T ss_pred             hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence                   0      00                               0012699999999998764 4688999999999


Q ss_pred             HHHHHHcCCCCCCCCccCC-c---------hhhHH---------------------HHH---HHH-----hc--C--CCC
Q 018018          258 VLLECATGQFPYSPPEQQD-G---------WTSFY---------------------ELM---EAI-----VD--Q--PPP  294 (362)
Q Consensus       258 ~l~elltg~~pf~~~~~~~-~---------~~~~~---------------------~~~---~~~-----~~--~--~~~  294 (362)
                      ++.-++++.+||-.....- .         +..+.                     +..   +.+     ..  .  ...
T Consensus       267 I~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~  346 (418)
T KOG1167|consen  267 ILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTER  346 (418)
T ss_pred             eeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceee
Confidence            9999999999985432211 0         00000                     000   000     00  0  011


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCC
Q 018018          295 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  340 (362)
Q Consensus       295 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~  340 (362)
                      ....+..+..+.+|+.+||+.||.+|.|++++|+||||...++..-
T Consensus       347 ~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~~~  392 (418)
T KOG1167|consen  347 EIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRTER  392 (418)
T ss_pred             ccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhhhh
Confidence            1223445668899999999999999999999999999986655433

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.98  E-value=4.4e-31  Score=232.06  Aligned_cols=199  Identities=36%  Similarity=0.592  Sum_probs=176.5

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccC
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD  151 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~  151 (362)
                      |.+.+.||+|++|.||++.+..+++.+|+|.+...........+.+|++.++.++|+|++++++.+......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            56778999999999999999988999999998765433356788899999999999999999999988899999999999


Q ss_pred             CCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC-CCCCcc
Q 018018          152 GGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-GQANTF  229 (362)
Q Consensus       152 ~gsL~~~l~~~~~-l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~-~~~~~~  229 (362)
                      +++|.+++..... +++..+..++.|++.++.+||+ .+++|+||+|.||+++.++.++|+|||.+....... ......
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~-~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHS-LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV  159 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence            9999999988766 8999999999999999999998 899999999999999999999999999987765432 122445


Q ss_pred             ccCCcccCccee-cCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 018018          230 VGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQFPYSP  271 (362)
Q Consensus       230 ~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~elltg~~pf~~  271 (362)
                      .++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            678899999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=6.7e-33  Score=238.02  Aligned_cols=254  Identities=22%  Similarity=0.389  Sum_probs=198.5

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeee-EEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQS-FYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~-~~~~~~~~lV~  147 (362)
                      +.|.+.+.||+|.||.+-+|.++.+++.+++|.+...  ....+.|.+|..---.| .|.||+.-|++ |+..+.+.+++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p--~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP--QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc--hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            6799999999999999999999999999999998754  34567889998876555 48999987765 66788899999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEc--cCCcEEEeeccCCcccccCCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN--HRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~--~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      ||++.|+|.+-+.. ..+.+.....++.|++.|+.|||+ +++||||||.+||||-  +..+|||||||+++..+..-. 
T Consensus       102 E~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHs-knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~-  178 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHS-KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVK-  178 (378)
T ss_pred             ccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhc-cchhhcccccceEEEecCCccEEEeeecccccccCceeh-
Confidence            99999999988876 578999999999999999999998 9999999999999994  234899999998766443221 


Q ss_pred             CCccccCCcccCcceecC---CC--CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC-CCCCCCCC
Q 018018          226 ANTFVGTYNYMSPERISG---GK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ-PPPSAPSD  299 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~---~~--~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  299 (362)
                        ..-.+..|.|||....   +.  ....+|+|.||+++|.++||.+||....-.+.  ...+++.-.... +..+....
T Consensus       179 --~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~--~Y~~~~~w~~rk~~~~P~~F~  254 (378)
T KOG1345|consen  179 --YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK--PYWEWEQWLKRKNPALPKKFN  254 (378)
T ss_pred             --hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc--hHHHHHHHhcccCccCchhhc
Confidence              1223567899997643   22  36789999999999999999999985433321  222222222211 12233345


Q ss_pred             CCCHHHHHHHHHhhhcCcCCC---CCHHHHHcCCcc
Q 018018          300 QFSPEFCSFISACVQKEPQQR---LSAQELMTHPFL  332 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~R---pt~~eil~hp~~  332 (362)
                      .+++.+..+.++-|..+|++|   -++.......|.
T Consensus       255 ~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  255 PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            688999999999999999999   566666776775

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=2.9e-32  Score=282.24  Aligned_cols=196  Identities=21%  Similarity=0.216  Sum_probs=144.3

Q ss_pred             CcceEEeeeE-------EecCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCc
Q 018018          128 PYVVVCYQSF-------YSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN  199 (362)
Q Consensus       128 p~I~~~~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~N  199 (362)
                      .||..+++.+       .....++.++||+ +++|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~gIvHrDlKP~N  110 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS-QGIVVHNVRPSC  110 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh-CCeeeccCCchh
Confidence            4565555554       2334677888988 5699999975 3569999999999999999999998 999999999999


Q ss_pred             EEEccC-------------------CcEEEeeccCCcccccCC----------------CCCCccccCCcccCcceecCC
Q 018018          200 LLINHR-------------------GEVKITDFGVSAIMASTS----------------GQANTFVGTYNYMSPERISGG  244 (362)
Q Consensus       200 Ill~~~-------------------~~vkl~DFg~a~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~  244 (362)
                      |||+..                   +.+|++|||+++......                ......+||+.|||||++.+.
T Consensus       111 iLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~  190 (793)
T PLN00181        111 FVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGS  190 (793)
T ss_pred             EEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccC
Confidence            999654                   445666666665321100                001124688999999999999


Q ss_pred             CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHH
Q 018018          245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ  324 (362)
Q Consensus       245 ~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  324 (362)
                      .|+.++|||||||++|||++|..|+....     ..+..+..    ...++.. ....+...+++.+||+.+|.+||++.
T Consensus       191 ~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~L~~~P~~Rps~~  260 (793)
T PLN00181        191 SSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRH----RVLPPQI-LLNWPKEASFCLWLLHPEPSCRPSMS  260 (793)
T ss_pred             CCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHH----hhcChhh-hhcCHHHHHHHHHhCCCChhhCcChH
Confidence            99999999999999999999988875321     11111111    1111111 11245677899999999999999999


Q ss_pred             HHHcCCccccc
Q 018018          325 ELMTHPFLKMY  335 (362)
Q Consensus       325 eil~hp~~~~~  335 (362)
                      |+++||||...
T Consensus       261 eil~h~~~~~~  271 (793)
T PLN00181        261 ELLQSEFINEP  271 (793)
T ss_pred             HHhhchhhhhh
Confidence            99999999764

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=239.32  Aligned_cols=254  Identities=20%  Similarity=0.269  Sum_probs=208.4

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccC-----CcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe-
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWT-----GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-  139 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~-  139 (362)
                      ++..+++.....+.+|.||.||.+...+.     .+.+-+|.++...++-+...+..|.-.+..+.|||+....++..+ 
T Consensus       280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~  359 (563)
T KOG1024|consen  280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIED  359 (563)
T ss_pred             hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeec
Confidence            45567778888899999999999966543     334667777766667777888999999999999999999988765 


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEe
Q 018018          140 NGAISIILEYMDGGSLADFLKKV--------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT  211 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~~--------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~  211 (362)
                      ....+.++.+..-|+|..++...        ..++..+...++.|++.|++|||+ +||+|.||..+|.+|++.-+|||+
T Consensus       360 ~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~-~~ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  360 YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN-HGVIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh-cCcccchhhhhcceehhheeEEec
Confidence            46677888999889999999732        346777888999999999999998 999999999999999999999999


Q ss_pred             eccCCcccccCCCCC--CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHH
Q 018018          212 DFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI  288 (362)
Q Consensus       212 DFg~a~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~  288 (362)
                      |-.+++.+-......  .....+..||+||.+.+..|+.++|+||||+++|||+| |+.|+...++.       ++...+
T Consensus       439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf-------Em~~yl  511 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF-------EMEHYL  511 (563)
T ss_pred             cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH-------HHHHHH
Confidence            999998765332211  22235678999999999999999999999999999999 99999876653       444445


Q ss_pred             hcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          289 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .++.. -.-+-++|+++..++.-||..+|++||+++|++.
T Consensus       512 kdGyR-laQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  512 KDGYR-LAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             hccce-ecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            55443 3334689999999999999999999999999864

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=8.5e-32  Score=266.42  Aligned_cols=263  Identities=22%  Similarity=0.361  Sum_probs=210.4

Q ss_pred             eeeeeeeeeCCeEEEEEEEccCCcEEEEEEee----cc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           73 DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ----MN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~----~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      .....+|.|++|.|+.+........++.|..+    .. ........+..|+-+-..+.|||++.......+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45678999999999999888777777777654    22 22222333778888888999999988877777666666669


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC--
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--  225 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~--  225 (362)
                      |||++ +|+.++...+.++..++..++.|++.|++|+|+ .|+.|||+|++|++++.+|.+||+|||.+.........  
T Consensus       401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~-~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~  478 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHS-MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI  478 (601)
T ss_pred             hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHh-cCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence            99999 999999998899999999999999999999998 99999999999999999999999999998877544432  


Q ss_pred             --CCccccCCcccCcceecCCCCCc-cccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018018          226 --ANTFVGTYNYMSPERISGGKYGY-KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  302 (362)
Q Consensus       226 --~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (362)
                        ....+|+..|+|||++.+..|+. ..||||.|++++.|.+|+.||..+...+.................+......++
T Consensus       479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp  558 (601)
T KOG0590|consen  479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLP  558 (601)
T ss_pred             hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhch
Confidence              35578999999999999999975 689999999999999999999887665432100001111111112233345577


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ...+.+|.+||++||.+|.|+++|++.+||+....
T Consensus       559 ~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  559 RETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             hhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            88999999999999999999999999999987654

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=2.4e-30  Score=219.81  Aligned_cols=166  Identities=29%  Similarity=0.454  Sum_probs=129.6

Q ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcccc
Q 018018          153 GSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG  231 (362)
Q Consensus       153 gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~g  231 (362)
                      |+|.+++.. ...+++..++.++.|++.||.|||+ ++      ||+||+++.++.+++  ||++......     ...|
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g   66 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR-QA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRV   66 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cC------CcccEeEcCccceee--ccceEeeccc-----cCCC
Confidence            689999986 4569999999999999999999998 76      999999999999999  9998765432     2268


Q ss_pred             CCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC-CCCCCCCCH--HHHHH
Q 018018          232 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSP--EFCSF  308 (362)
Q Consensus       232 t~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~l  308 (362)
                      ++.|+|||++.+..++.++||||+||++|||++|+.||.......  .....+.......... ......++.  ++.++
T Consensus        67 ~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (176)
T smart00750       67 DPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADDPRDRSNLESVSAARSFADF  144 (176)
T ss_pred             cccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence            899999999999999999999999999999999999997543321  1111122111111100 011122333  69999


Q ss_pred             HHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          309 ISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      |.+||+.||++|||+.+++.|+|+..
T Consensus       145 i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      145 MRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999999753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=9.6e-28  Score=223.39  Aligned_cols=252  Identities=23%  Similarity=0.281  Sum_probs=195.3

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCC-cEEEEEEeecccchHHHHHHHHHHHHHhcCC----CCcceEEeeeE-EecCeEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTG-QFFALKVIQMNVEESARRQIAQELKINQSSQ----CPYVVVCYQSF-YSNGAIS  144 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~----hp~I~~~~~~~-~~~~~~~  144 (362)
                      +|.+.+.||+|+||.||++.+..++ ..+|+|+.......... .+..|..++..+.    .+++..+++.+ .....-+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            8999999999999999999998775 67999987654222222 5667777777765    36888888888 4778899


Q ss_pred             EEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC-----CcEEEeeccCCc
Q 018018          145 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-----GEVKITDFGVSA  217 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~-----~~vkl~DFg~a~  217 (362)
                      +||+.+ |.+|.++....  +.++..++..++.|++.+|++||+ .|++||||||.|+++...     ..++|.|||+|+
T Consensus        98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~-~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS-KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh-cCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            999999 77999998654  589999999999999999999998 999999999999999865     369999999998


Q ss_pred             --ccccCCC-------C-CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHH
Q 018018          218 --IMASTSG-------Q-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA  287 (362)
Q Consensus       218 --~~~~~~~-------~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~  287 (362)
                        .......       . .....||..|+++.+..+...+++.|+||+++++.+++.|.+||...+..............
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~  255 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRK  255 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhh
Confidence              3221111       1 22356999999999999999999999999999999999999999776543322222222222


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          288 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ....   . .....+.++.++...+-..+...+|.+..+...
T Consensus       256 ~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  256 LLTD---R-FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hccc---c-ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            1111   1 223455677777777777899999999888654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=2e-26  Score=212.06  Aligned_cols=259  Identities=34%  Similarity=0.570  Sum_probs=210.2

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchH--HHHHHHHHHHHHhcCCCC-cceEEeeeEEecCeEEEEEe
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES--ARRQIAQELKINQSSQCP-YVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~l~hp-~I~~~~~~~~~~~~~~lV~e  148 (362)
                      |.+.+.||.|+||.||.+.+.   ..+++|.+.......  ....+.+|..+++.+.|+ +|+.+++.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            778899999999999999987   889999987664433  578899999999999988 79999999987787899999


Q ss_pred             ccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC-cEEEeeccCCcccccCCC
Q 018018          149 YMDGGSLADFLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSG  224 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~---~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-~vkl~DFg~a~~~~~~~~  224 (362)
                      ++.++++.+++....   .++......++.|++.++.|+|+ .+++|||+||+||+++..+ .++++|||.+........
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~-~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS-KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            999999998887765   79999999999999999999998 9999999999999999988 799999999876544332


Q ss_pred             ------CCCccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC-
Q 018018          225 ------QANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-  294 (362)
Q Consensus       225 ------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-  294 (362)
                            ......|+..|+|||.+.+   ..++...|+||+|++++++++|..||.......   ........+.....+ 
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~  234 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS---ATSQTLKIILELPTPS  234 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccc---cHHHHHHHHHhcCCcc
Confidence                  2456789999999999988   578999999999999999999999976644310   112222222222221 


Q ss_pred             --CCCCCCC----CHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          295 --SAPSDQF----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       295 --~~~~~~~----~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                        .......    ...+.+++..++..+|..|.+..+...++|......
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~~  283 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKL  283 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCccc
Confidence              1111111    257899999999999999999999999977655543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=8.3e-28  Score=203.58  Aligned_cols=254  Identities=19%  Similarity=0.289  Sum_probs=201.9

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCC-CcceEEeeeEEecCeEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC-PYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-p~I~~~~~~~~~~~~~~  144 (362)
                      .+...+|.+++.||+|+||.+|++....+|..||||+-+..   ....++.-|.++.+.+++ ..|..+..++.+..+-.
T Consensus        11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~---a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynv   87 (341)
T KOG1163|consen   11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK---AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNV   87 (341)
T ss_pred             heeccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc---CCCcchhHHHHHHHHhccCCCCchhhhhccccccce
Confidence            35568999999999999999999999999999999986533   233567778888888875 77777777778888899


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC---CcEEEeeccCCcccc
Q 018018          145 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMA  220 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~---~~vkl~DFg~a~~~~  220 (362)
                      +||+.+ |.||.+++.-. ..++..+++-++-|++.-++|+|. ++++||||||+|+|+.-+   ..+.|+|||+|+...
T Consensus        88 lVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~-r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   88 LVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHL-RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHh-hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            999999 77999998754 579999999999999999999998 999999999999999643   469999999998875


Q ss_pred             cCCCC-------CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC
Q 018018          221 STSGQ-------ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP  293 (362)
Q Consensus       221 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  293 (362)
                      +....       .....||.+|.+-....+...+.+.|+-|+|+++.++.-|.+||.+............+.++... .+
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s-~~  244 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS-TP  244 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC-CC
Confidence            44332       23357999999999888888899999999999999999999999987665433333333333222 22


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHH
Q 018018          294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQE  325 (362)
Q Consensus       294 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  325 (362)
                      .......+|.++.-.+.-|-..--++-|...-
T Consensus       245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y  276 (341)
T KOG1163|consen  245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY  276 (341)
T ss_pred             HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH
Confidence            23345678888888888887666666676543

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=7.7e-27  Score=217.71  Aligned_cols=167  Identities=18%  Similarity=0.182  Sum_probs=133.1

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEcc-CCcEEEEEEeecc----cchHHHHHHHHHHHHHhcCCCCcceE-EeeeEE
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKW-TGQFFALKVIQMN----VEESARRQIAQELKINQSSQCPYVVV-CYQSFY  138 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~----~~~~~~~~~~~e~~~~~~l~hp~I~~-~~~~~~  138 (362)
                      ...-.++|.+.+.||+|+||+||+|.+.. +++.+|||++...    ........+.+|+++++.++|+||+. ++.   
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---   89 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---   89 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence            34456889999999999999999999876 6788899986533    12345667999999999999999984 443   


Q ss_pred             ecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecC-CCCcEEEccCCcEEEeeccCCc
Q 018018          139 SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL-KPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       139 ~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dl-kp~NIll~~~~~vkl~DFg~a~  217 (362)
                       .+..|+||||++|++|... .   ...   ...++.|++.||.|||+ +||+|||| ||+|||++.++++||+|||+|+
T Consensus        90 -~~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~-~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~  160 (365)
T PRK09188         90 -TGKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHR-AGITHNDLAKPQNWLMGPDGEAAVIDFQLAS  160 (365)
T ss_pred             -cCCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHH-CCCeeCCCCCcceEEEcCCCCEEEEECccce
Confidence             2568999999999999732 1   111   14678999999999998 99999999 9999999999999999999998


Q ss_pred             ccccCCCC--------CCccccCCcccCcceecC
Q 018018          218 IMASTSGQ--------ANTFVGTYNYMSPERISG  243 (362)
Q Consensus       218 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~  243 (362)
                      ........        .....+++.|+|||.+..
T Consensus       161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            76543321        123467889999998865

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=6e-26  Score=200.41  Aligned_cols=250  Identities=21%  Similarity=0.321  Sum_probs=198.0

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeEEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~~l  145 (362)
                      +..-.|.+.++||.|+||..+.++...++++||||.-....   ...++..|.+..+.|. .++|...|-+..++.+-.|
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL  101 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL  101 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence            34568999999999999999999999999999999865442   3356777777776665 6999999988888888999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC-----cEEEeeccCCccc
Q 018018          146 ILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-----EVKITDFGVSAIM  219 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-----~vkl~DFg~a~~~  219 (362)
                      |+|.+ |.||.|++.-+ ..++..++..++.||+.-++|+|+ +.+|.|||||+|+||..-+     .+.++|||+|+..
T Consensus       102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~-k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHE-KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHh-cceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            99999 77999999765 579999999999999999999998 9999999999999997433     5999999999987


Q ss_pred             ccCCCC-------CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          220 ASTSGQ-------ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       220 ~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                      .++...       .....||.+||+-.-..|.+.+.+.|+-|||-++++.+-|.+||.+...... .   +-.+++.+.+
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-K---~kYeKIGe~K  255 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-K---EKYEKIGETK  255 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch-H---HHHHHhcccc
Confidence            655432       2346799999999999999999999999999999999999999998655322 1   2223333222


Q ss_pred             ---CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHH
Q 018018          293 ---PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE  325 (362)
Q Consensus       293 ---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  325 (362)
                         +.......+|.++..-++-.-..+-.+-|.++-
T Consensus       256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdy  291 (449)
T KOG1165|consen  256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDY  291 (449)
T ss_pred             ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHH
Confidence               222234556777766666655555556665543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.94  E-value=4.5e-28  Score=230.36  Aligned_cols=242  Identities=29%  Similarity=0.434  Sum_probs=204.0

Q ss_pred             eeeeeCCeEEEEEEE---ccCCcEEEEEEeecccc-hHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeEEEEEeccC
Q 018018           77 VVGKGSGGIVQLVQH---KWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMD  151 (362)
Q Consensus        77 ~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~~lV~e~~~  151 (362)
                      .+|.|+||.|+++..   ...|..||+|+.++... ...+.....|..++...+ ||.++.+...++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            378999999998763   34577899999876521 111225567777777777 9999999999999999999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcccc
Q 018018          152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG  231 (362)
Q Consensus       152 ~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~g  231 (362)
                      ||.|...+.....+.+.....+...++-+++++|+ .|++|||+|++||+++.+|++++.|||+++........    ||
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~-l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----cg  155 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHK-LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----CG  155 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcch-hHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----cc
Confidence            99999999988899999999999999999999998 99999999999999999999999999998876543322    99


Q ss_pred             CCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 018018          232 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA  311 (362)
Q Consensus       232 t~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  311 (362)
                      |..|||||++.  ....++|+||+|+++++|++|..||..           +.+..+.....  ..+..++..+.+++.+
T Consensus       156 t~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-----------~~~~~Il~~~~--~~p~~l~~~a~~~~~~  220 (612)
T KOG0603|consen  156 TYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-----------DTMKRILKAEL--EMPRELSAEARSLFRQ  220 (612)
T ss_pred             chhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-----------HHHHHHhhhcc--CCchhhhHHHHHHHHH
Confidence            99999999998  567889999999999999999999975           34444444332  2345788899999999


Q ss_pred             hhhcCcCCCCC-----HHHHHcCCcccccCCC
Q 018018          312 CVQKEPQQRLS-----AQELMTHPFLKMYGDL  338 (362)
Q Consensus       312 ~L~~dP~~Rpt-----~~eil~hp~~~~~~~~  338 (362)
                      ++..+|.+|.-     +.++++|+||+..++.
T Consensus       221 l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  221 LFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             HHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence            99999999985     5899999999888754

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.93  E-value=3.8e-27  Score=234.60  Aligned_cols=242  Identities=21%  Similarity=0.230  Sum_probs=184.7

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHH---HHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESAR---RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ++...+.||++.|=+|.++++.+ | .|+||++-+....-..   .+...|++ ...+++||.+.+..+-..+...|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            67788999999999998888753 4 4999998655433222   33334444 55678999999988877888899999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC-
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA-  226 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~-  226 (362)
                      +|... +|.|.+.....+...+.+-++.|++.||..+|. .||+|||||.+||||+.-+.+.|+||...+...-+.... 
T Consensus       101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~-~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHK-LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHH-cCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            99976 999999988889999999999999999999998 999999999999999999999999998765543222221 


Q ss_pred             ------CccccCCcccCcceecCC----------C-CCccccHHHHHHHHHHHHc-CCCCCCCCcc----CCchhhHHHH
Q 018018          227 ------NTFVGTYNYMSPERISGG----------K-YGYKSDIWSLGLVLLECAT-GQFPYSPPEQ----QDGWTSFYEL  284 (362)
Q Consensus       227 ------~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~~l~ellt-g~~pf~~~~~----~~~~~~~~~~  284 (362)
                            .+.....+|.|||.+...          . .+++.||||+||+++||++ |++||.-..-    .........+
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~  258 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL  258 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence                  122334589999987541          1 5678999999999999998 7999853100    0000111112


Q ss_pred             HHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          285 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +++            --+..+++||..|++.||++|.+|++.|+.
T Consensus       259 Le~------------Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  259 LEK------------IEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHh------------CcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            222            223478999999999999999999999874

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.9e-26  Score=204.74  Aligned_cols=253  Identities=18%  Similarity=0.281  Sum_probs=182.9

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCc-----------------------------------EEEEEEe-ecc-
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ-----------------------------------FFALKVI-QMN-  106 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----------------------------------~vaiK~~-~~~-  106 (362)
                      +..+.+++|++.+.||+|-.+.||.+....+|+                                   +.|||.+ ..+ 
T Consensus       151 dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~  230 (598)
T KOG4158|consen  151 DSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEH  230 (598)
T ss_pred             hcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhccccc
Confidence            456788999999999999999999988654211                                   3455543 111 


Q ss_pred             --cchHHHHHHHHHHHH--------------Hh--------cCCCCcceEEeeeEEe-----------------------
Q 018018          107 --VEESARRQIAQELKI--------------NQ--------SSQCPYVVVCYQSFYS-----------------------  139 (362)
Q Consensus       107 --~~~~~~~~~~~e~~~--------------~~--------~l~hp~I~~~~~~~~~-----------------------  139 (362)
                        .+....+.+.+|..-              .+        .-+||||+.++..|.+                       
T Consensus       231 ~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~  310 (598)
T KOG4158|consen  231 DSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPS  310 (598)
T ss_pred             CCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccc
Confidence              122233333333321              01        1269999999876643                       


Q ss_pred             ----cCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEc--cCC--cEEEe
Q 018018          140 ----NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN--HRG--EVKIT  211 (362)
Q Consensus       140 ----~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~--~~~--~vkl~  211 (362)
                          ...+|+||.-++. +|..++.. ...+.....-++.|+++|+.|||. +||.|||+|++|||+.  +|+  .++|+
T Consensus       311 g~g~~~tlylvMkrY~~-tLr~yl~~-~~~s~r~~~~~laQlLEav~hL~~-hgvAhRDlKSDNiL~ElddD~~P~LVva  387 (598)
T KOG4158|consen  311 GAGEPKTLYLVMKRYRQ-TLREYLWT-RHRSYRTGRVILAQLLEAVTHLHK-HGVAHRDLKSDNILLELDDDEIPQLVVA  387 (598)
T ss_pred             ccCCCceEEEehhcchh-hHHHHHhc-CCCchHHHHHHHHHHHHHHHHHHH-ccchhhcccccceEEEecCCCCcEEEEc
Confidence                3558999998865 99999977 456777888999999999999998 9999999999999994  333  58999


Q ss_pred             eccCCcccccCCC------CCCccccCCcccCcceecCCCC------CccccHHHHHHHHHHHHcCCCCCCCCccCCchh
Q 018018          212 DFGVSAIMASTSG------QANTFVGTYNYMSPERISGGKY------GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT  279 (362)
Q Consensus       212 DFg~a~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~------~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~  279 (362)
                      |||++-.-...+-      ......|...-||||+....+-      -.++|.|+.|.+.||+++...||....+..-  
T Consensus       388 DFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L--  465 (598)
T KOG4158|consen  388 DFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL--  465 (598)
T ss_pred             ccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee--
Confidence            9998755433221      2233467889999999876331      2489999999999999999999987432211  


Q ss_pred             hHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHH
Q 018018          280 SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL  326 (362)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ei  326 (362)
                           -.+.......+..++.+++.+++|+..+|+.||++|+++.-+
T Consensus       466 -----~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iA  507 (598)
T KOG4158|consen  466 -----DTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIA  507 (598)
T ss_pred             -----chhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence                 111123333456678899999999999999999999986544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=5e-25  Score=197.44  Aligned_cols=232  Identities=20%  Similarity=0.281  Sum_probs=149.9

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCC----------CCcceEEeeeEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQ----------CPYVVVCYQSFY  138 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~----------hp~I~~~~~~~~  138 (362)
                      .+...+.||.|+++.||.+++..+|+.+|+|++....  .....+.+.+|.-....+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            3456789999999999999999999999999976543  2223455555554433322          212332222221


Q ss_pred             ---------ec---C-----eEEEEEeccCCCCHHHHHH---HcCC----CCHHHHHHHHHHHHHHHHHHHhCCCeEeec
Q 018018          139 ---------SN---G-----AISIILEYMDGGSLADFLK---KVKT----IPEEYLAAICEQVLKGLLYLHHEKHIIHRD  194 (362)
Q Consensus       139 ---------~~---~-----~~~lV~e~~~~gsL~~~l~---~~~~----l~~~~~~~i~~ql~~al~~LH~~~~ivH~D  194 (362)
                               ..   .     ..+++|+-+. ++|.+++.   ....    +.......+..|+++.+++||+ .|++|+|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~-~GlVHgd  170 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS-YGLVHGD  170 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEEEST
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh-cceEecc
Confidence                     11   1     2467888885 48888764   2222    2233345666999999999998 9999999


Q ss_pred             CCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCCcccCcceecC--------CCCCccccHHHHHHHHHHHHcCC
Q 018018          195 LKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG--------GKYGYKSDIWSLGLVLLECATGQ  266 (362)
Q Consensus       195 lkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~~l~elltg~  266 (362)
                      |+|+|++++.+|.++|+||+.....+....   ....+..|.+||....        -.++.+.|.|+||+++|.|.++.
T Consensus       171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~---~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~  247 (288)
T PF14531_consen  171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYR---CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGR  247 (288)
T ss_dssp             -SGGGEEE-TTS-EEE--GGGEEETTEEEE---GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS
T ss_pred             cceeeEEEcCCCCEEEcChHHHeecCceee---ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHcc
Confidence            999999999999999999997665443221   1334577999997643        24788999999999999999999


Q ss_pred             CCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCC
Q 018018          267 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR  320 (362)
Q Consensus       267 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  320 (362)
                      .||...........            ..... ..+|+.++.||++||++||++|
T Consensus       248 lPf~~~~~~~~~~~------------~f~~C-~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  248 LPFGLSSPEADPEW------------DFSRC-RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             -STCCCGGGSTSGG------------GGTTS-S---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCCccccccc------------cchhc-CCcCHHHHHHHHHHccCCcccC
Confidence            99986644322111            11122 3788999999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.91  E-value=1.4e-24  Score=186.49  Aligned_cols=140  Identities=17%  Similarity=0.182  Sum_probs=109.9

Q ss_pred             eeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch--H-----------------------HHHHHHHHHHHHhcCCCCc
Q 018018           75 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE--S-----------------------ARRQIAQELKINQSSQCPY  129 (362)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~-----------------------~~~~~~~e~~~~~~l~hp~  129 (362)
                      ...||+|+||.||+|.+. +|+.||||+++.....  .                       .......|+.++..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999997 8999999999754211  0                       0122345888888887766


Q ss_pred             ceEEeeeEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HhCCCeEeecCCCCcEEEccCCcE
Q 018018          130 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL-HHEKHIIHRDLKPSNLLINHRGEV  208 (362)
Q Consensus       130 I~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~L-H~~~~ivH~Dlkp~NIll~~~~~v  208 (362)
                      +........  ...++||||++|+++...+.....++...+..++.|++.+|.++ |+ .||+||||||+||+++ ++.+
T Consensus        81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~-~giiHrDlkP~NIli~-~~~v  156 (190)
T cd05147          81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQD-CRLVHADLSEYNLLYH-DGKL  156 (190)
T ss_pred             CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEE-CCcE
Confidence            543322211  22389999999887776655557899999999999999999999 67 8999999999999997 5889


Q ss_pred             EEeeccCCccc
Q 018018          209 KITDFGVSAIM  219 (362)
Q Consensus       209 kl~DFg~a~~~  219 (362)
                      +|+|||+|...
T Consensus       157 ~LiDFG~a~~~  167 (190)
T cd05147         157 YIIDVSQSVEH  167 (190)
T ss_pred             EEEEccccccC
Confidence            99999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.91  E-value=5.2e-25  Score=219.22  Aligned_cols=225  Identities=34%  Similarity=0.543  Sum_probs=172.9

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ...+|+.++.+..|+||.||+++++.+.+++|+|+=+.+   ...+.      ++.....|.++                
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~---lilRn------ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN---LILRN------ILTFAGNPFVV----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcccccc---hhhhc------cccccCCccee----------------
Confidence            347899999999999999999999999999999653211   11111      22222333333                


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC---
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---  224 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~---  224 (362)
                           |+=...++.-++++.+.        +.+++|||+ -||+|||+||+|.+|+.-|++|+.|||+++.......   
T Consensus       136 -----gDc~tllk~~g~lPvdm--------vla~Eylh~-ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 -----GDCATLLKNIGPLPVDM--------VLAVEYLHS-YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             -----chhhhhcccCCCCcchh--------hHHhHhhcc-CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence                 45556666666677544        889999998 9999999999999999999999999999865421100   


Q ss_pred             ------------CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          225 ------------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       225 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                                  .....+||+.|+|||++....|+..+|+|++|+++||.+-|..||.+..++       +++..++...
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe-------elfg~visd~  274 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE-------ELFGQVISDD  274 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH-------HHHhhhhhhh
Confidence                        123358999999999999999999999999999999999999999886654       3333333222


Q ss_pred             -CCCCCCCCCCHHHHHHHHHhhhcCcCCCC---CHHHHHcCCcccccCCC
Q 018018          293 -PPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFLKMYGDL  338 (362)
Q Consensus       293 -~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---t~~eil~hp~~~~~~~~  338 (362)
                       ..+.....++++++++|.++|+.+|..|.   .+-++.+|+||+..++.
T Consensus       275 i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  275 IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence             22223567889999999999999999997   67899999999988765

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=2.1e-24  Score=187.97  Aligned_cols=172  Identities=21%  Similarity=0.274  Sum_probs=133.2

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHH------HHHHHHHHhcCCCCcceEEeeeEEe
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQ------IAQELKINQSSQCPYVVVCYQSFYS  139 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~------~~~e~~~~~~l~hp~I~~~~~~~~~  139 (362)
                      -..+|..+++||.|+||.||++..  ++..+|+|+++...  .+.....      +.+|+..+.++.|++|..+...+..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            357899999999999999999755  46789999997552  2222223      5789999999999999988887553


Q ss_pred             c--------CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEe
Q 018018          140 N--------GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT  211 (362)
Q Consensus       140 ~--------~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~  211 (362)
                      .        +..++||||++|.+|.++..    +++    ....+++.++..+|+ .|++|||+||.||+++.+| ++|+
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~-~gi~H~Dikp~Nili~~~g-i~li  176 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQ-HGMVSGDPHKGNFIVSKNG-LRII  176 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHH-cCCccCCCChHHEEEeCCC-EEEE
Confidence            3        45899999999999988732    333    346699999999998 9999999999999999988 9999


Q ss_pred             eccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHH
Q 018018          212 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA  263 (362)
Q Consensus       212 DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ell  263 (362)
                      |||.+.......  ..          ........|+.++|+||||+++..+.
T Consensus       177 Dfg~~~~~~e~~--a~----------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        177 DLSGKRCTAQRK--AK----------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ECCCcccccchh--hH----------HHHHHHhHhcccccccceeEeehHHH
Confidence            999875542111  00          01233445778999999999988775

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=2.2e-23  Score=179.32  Aligned_cols=142  Identities=18%  Similarity=0.170  Sum_probs=112.7

Q ss_pred             eeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch-------------------------HHHHHHHHHHHHHhcCCCCc
Q 018018           75 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-------------------------SARRQIAQELKINQSSQCPY  129 (362)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~e~~~~~~l~hp~  129 (362)
                      ...||+|++|.||+|++. +|+.||||+++.....                         .....+..|...+..+.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999987 8999999998765211                         00123457888898888888


Q ss_pred             ceEEeeeEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEE
Q 018018          130 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK  209 (362)
Q Consensus       130 I~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vk  209 (362)
                      |.........  ..++||||++|+++.........++...+..++.|++.++.++|+.+||+||||||+||+++ ++.++
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            7544333222  24899999998865544334467889999999999999999999758999999999999998 89999


Q ss_pred             EeeccCCcccc
Q 018018          210 ITDFGVSAIMA  220 (362)
Q Consensus       210 l~DFg~a~~~~  220 (362)
                      |+|||+|+...
T Consensus       158 liDFG~a~~~~  168 (190)
T cd05145         158 IIDVSQAVELD  168 (190)
T ss_pred             EEEcccceecC
Confidence            99999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.89  E-value=1.3e-24  Score=203.19  Aligned_cols=176  Identities=31%  Similarity=0.498  Sum_probs=141.2

Q ss_pred             EEEEEeccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          143 ISIILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      +|+.|++|...+|.+|+...   ...+....+.++.|++.|++|    +|.+|+|+||.||+...++.+||+|||+.+..
T Consensus       331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y----k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY----KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh----ccchhhhccccccccccchhhhhhhhhheeec
Confidence            67889999999999999753   356788899999999999999    68999999999999999999999999998776


Q ss_pred             ccCC------CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          220 ASTS------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       220 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                      ....      ......+||..||+||++.+..|+.++||||||++|+||+. -..+|.          ....+..+.++.
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e----------r~~t~~d~r~g~  476 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE----------RIATLTDIRDGI  476 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH----------HHHhhhhhhcCC
Confidence            5443      12344689999999999999999999999999999999997 333332          123444555555


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccc
Q 018018          293 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  333 (362)
Q Consensus       293 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  333 (362)
                      .|+...... +.-..|+.+||...|.+||++.+.-.|+|.+
T Consensus       477 ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  477 IPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             CChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence            553333333 4556899999999999999999888888764

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.4e-23  Score=180.90  Aligned_cols=246  Identities=17%  Similarity=0.280  Sum_probs=193.7

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      .++......+.+|.+...|..|+++.  .|..++.|++... .....-+.|..|.-.++...||||+.+++.+.....+.
T Consensus       186 gid~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv  263 (448)
T KOG0195|consen  186 GIDVSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV  263 (448)
T ss_pred             CcchhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence            35566777888999999999988755  5777888887654 23334467888888888899999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeE-eecCCCCcEEEccCCcEEEe--eccCCccc
Q 018018          145 IILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHII-HRDLKPSNLLINHRGEVKIT--DFGVSAIM  219 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~al~~LH~~~~iv-H~Dlkp~NIll~~~~~vkl~--DFg~a~~~  219 (362)
                      ++..|++.|||+..+.....  .+..++.+++.++++|++|||+-..++ ---|.+..++++++-+.+|.  |--++.  
T Consensus       264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--  341 (448)
T KOG0195|consen  264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--  341 (448)
T ss_pred             EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--
Confidence            99999999999999987654  577889999999999999999833344 44788999999998776654  432221  


Q ss_pred             ccCCCCCCccccCCcccCcceecCCCCC---ccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018018          220 ASTSGQANTFVGTYNYMSPERISGGKYG---YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  296 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
                           +.......+.||+||.++.++-+   +++|+|||++++|||.|...||.+.++.+       .-.++.-......
T Consensus       342 -----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme-------cgmkialeglrv~  409 (448)
T KOG0195|consen  342 -----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME-------CGMKIALEGLRVH  409 (448)
T ss_pred             -----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh-------hhhhhhhcccccc
Confidence                 12233457899999999887643   57999999999999999999998765542       2223333344455


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRLSAQELM  327 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil  327 (362)
                      .+..+++.+.+|+.-|++.||-+||.+..++
T Consensus       410 ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             CCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            6678999999999999999999999988764

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=2.9e-22  Score=171.16  Aligned_cols=186  Identities=13%  Similarity=0.061  Sum_probs=139.3

Q ss_pred             eeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc---hHHHHHHHHHHHHHhcCCC-CcceEEeeeEEecCeEEEEEe
Q 018018           73 DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE---ESARRQIAQELKINQSSQC-PYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~h-p~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .+...|++|+||+|+++..  .+.+++.+.+.....   ..+...+.+|+++++.+.| ++|..++++    ...+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3557899999999997765  678888777654422   2223457899999999964 778888875    34699999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecC-CCCcEEEccCCcEEEeeccCCcccccCCCC--
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL-KPSNLLINHRGEVKITDFGVSAIMASTSGQ--  225 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dl-kp~NIll~~~~~vkl~DFg~a~~~~~~~~~--  225 (362)
                      |+.|.+|...+..       ....++.|++.+|.++|+ +||+|||| ||+|||++.++.++|+|||+|.........  
T Consensus        79 yI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~-~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r  150 (218)
T PRK12274         79 YLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHR-CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMR  150 (218)
T ss_pred             eecCccHHhhhhh-------hhHHHHHHHHHHHHHHHH-CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHH
Confidence            9999898754322       123578899999999998 99999999 799999999999999999999865433211  


Q ss_pred             -----------CCccccCCcccCcceecCC-CCC-ccccHHHHHHHHHHHHcCCCCCCCC
Q 018018          226 -----------ANTFVGTYNYMSPERISGG-KYG-YKSDIWSLGLVLLECATGQFPYSPP  272 (362)
Q Consensus       226 -----------~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~~l~elltg~~pf~~~  272 (362)
                                 ......++.|+.|+...-- ..+ .+.++++.|+-+|.++|+..++...
T Consensus       151 ~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        151 LLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                       0011256777777754322 233 4678889999999999999887554

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=2.3e-21  Score=168.16  Aligned_cols=135  Identities=21%  Similarity=0.250  Sum_probs=107.6

Q ss_pred             eeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-----CCCcceEEeeeEEecC---eEE-
Q 018018           74 TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-----QCPYVVVCYQSFYSNG---AIS-  144 (362)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-----~hp~I~~~~~~~~~~~---~~~-  144 (362)
                      -.+.||+|+||.||.  ++.++.. +||++.... ....+.+.+|+.+++.+     .||||+++++++.++.   ..+ 
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            347899999999995  7777766 699887542 22446789999999988     6799999999998763   434 


Q ss_pred             EEEec--cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHH-HHHHhCCCeEeecCCCCcEEEccC----CcEEEeeccCC
Q 018018          145 IILEY--MDGGSLADFLKKVKTIPEEYLAAICEQVLKGL-LYLHHEKHIIHRDLKPSNLLINHR----GEVKITDFGVS  216 (362)
Q Consensus       145 lV~e~--~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al-~~LH~~~~ivH~Dlkp~NIll~~~----~~vkl~DFg~a  216 (362)
                      +|+||  +.+++|.+++++ ..+++.  ..++.|++.++ +|||+ ++|+||||||+|||++..    .+++|+||+-+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~-~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLD-NRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHH-CCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            78999  557999999977 356665  35678888877 99998 999999999999999743    37999995433

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=3.9e-22  Score=202.10  Aligned_cols=201  Identities=23%  Similarity=0.287  Sum_probs=163.2

Q ss_pred             CCCCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC---CCcceEEeeeE
Q 018018           61 KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ---CPYVVVCYQSF  137 (362)
Q Consensus        61 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---hp~I~~~~~~~  137 (362)
                      ...+.++..+.|.|.+.||+|+||+||+|.+.. |+.||+|+-+....    .+|.--.+++.+|+   -+-|..+...+
T Consensus       689 ~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~----WEfYI~~q~~~RLk~~~~~~~~~~~~a~  763 (974)
T KOG1166|consen  689 PNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP----WEFYICLQVMERLKPQMLPSIMHISSAH  763 (974)
T ss_pred             ccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc----eeeeehHHHHHhhchhhhcchHHHHHHH
Confidence            344567788999999999999999999999986 99999999765422    22222233333333   23455555566


Q ss_pred             EecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc-------CCcEEE
Q 018018          138 YSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-------RGEVKI  210 (362)
Q Consensus       138 ~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-------~~~vkl  210 (362)
                      .-.+..++|+||.+.|+|.++++..+.+++..+..++.||+..+++||. .+|||+||||+|+||..       ..-++|
T Consensus       764 ~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~-~~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  764 VFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHA-MGIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             ccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHh-cceecccCCcceeEeecccCCCCcccceEE
Confidence            6677889999999999999999988899999999999999999999998 99999999999999952       335999


Q ss_pred             eeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCC
Q 018018          211 TDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  267 (362)
Q Consensus       211 ~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~  267 (362)
                      +|||.+..+..-..  .....++|-.+--+|...|.+|++.+|.|+++.+++-|+.|++
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            99999987753332  3344578888999999999999999999999999999999863

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=5.3e-21  Score=169.72  Aligned_cols=143  Identities=20%  Similarity=0.158  Sum_probs=114.1

Q ss_pred             CceeeeeeeeeCCeEEEEEE-EccCCcEEEEEEeecccch-----------------------HHHHHHHHHHHHHhcCC
Q 018018           71 DIDTIKVVGKGSGGIVQLVQ-HKWTGQFFALKVIQMNVEE-----------------------SARRQIAQELKINQSSQ  126 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~-----------------------~~~~~~~~e~~~~~~l~  126 (362)
                      -|.+.+.||+|+||.||+|. +..+|+.||+|+++.....                       .....+.+|+.++..+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998 6678999999998754210                       11234568999988887


Q ss_pred             CCc--ceEEeeeEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCC-eEeecCCCCcEEEc
Q 018018          127 CPY--VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLIN  203 (362)
Q Consensus       127 hp~--I~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~-ivH~Dlkp~NIll~  203 (362)
                      +.+  +.+++..    ...++||||++|.+|.........+....+..++.|++.++.+||+ .| ++||||||+||+++
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~g~iiH~Dikp~NIli~  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYK-EGELVHGDLSEYNILVH  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHh-cCCEEeCCCChhhEEEE
Confidence            532  3344432    2358999999998887766444567777788999999999999998 89 99999999999998


Q ss_pred             cCCcEEEeeccCCccc
Q 018018          204 HRGEVKITDFGVSAIM  219 (362)
Q Consensus       204 ~~~~vkl~DFg~a~~~  219 (362)
                       ++.++|+|||.|...
T Consensus       184 -~~~i~LiDFg~a~~~  198 (237)
T smart00090      184 -DGKVVIIDVSQSVEL  198 (237)
T ss_pred             -CCCEEEEEChhhhcc
Confidence             889999999987654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=8.3e-21  Score=180.69  Aligned_cols=204  Identities=22%  Similarity=0.339  Sum_probs=160.1

Q ss_pred             HhcCCCCcceEEeeeEEecCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcE
Q 018018          122 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  200 (362)
Q Consensus       122 ~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NI  200 (362)
                      ++.+.|.|+.++++.+.++...+.|.+||+-|+|.+.+.. ...++......++++++.||+|+|......|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            3567899999999999999999999999999999999987 457888889999999999999999854459999999999


Q ss_pred             EEccCCcEEEeeccCCcccccC--CCCCCccccCCcccCcceecCCC-------CCccccHHHHHHHHHHHHcCCCCCCC
Q 018018          201 LINHRGEVKITDFGVSAIMAST--SGQANTFVGTYNYMSPERISGGK-------YGYKSDIWSLGLVLLECATGQFPYSP  271 (362)
Q Consensus       201 ll~~~~~vkl~DFg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~~l~elltg~~pf~~  271 (362)
                      +++..-.+||+|||+.......  ............|.|||.+.+..       .+.+.||||+|++++|+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            9999999999999998765321  11122223466899999998742       35679999999999999999999987


Q ss_pred             CccCCchhhHHHHHHHHhc-CC--CCCCCC-C-CCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          272 PEQQDGWTSFYELMEAIVD-QP--PPSAPS-D-QFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~-~~--~~~~~~-~-~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .......   .+++..+.. +.  ..+... . ..++++..++.+||..+|++||+++++-.
T Consensus       161 ~~~~~~~---~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDP---DEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCCh---HHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            5444332   233333333 21  111111 1 45567999999999999999999999844

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=2.2e-19  Score=156.97  Aligned_cols=135  Identities=22%  Similarity=0.313  Sum_probs=113.5

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-------hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-------ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      +.||+|++|.||++..  .|..+++|+......       ......+.+|+.++..+.|++|......+.+....++|||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999987  678899998653211       1123467789999999999888776666667788899999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      |++|++|.+++.....    ....++.+++.+|.++|+ .|++|+|++|.||+++ ++.++|+|||++..
T Consensus        80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~-~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHS-AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHh-CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999999876432    888999999999999998 9999999999999998 88999999998765

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=2.2e-21  Score=192.53  Aligned_cols=261  Identities=27%  Similarity=0.391  Sum_probs=210.9

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccC-CcEEEEEEeecc-cchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWT-GQFFALKVIQMN-VEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~~l  145 (362)
                      ...|.+.+.||+|+|+.|-++....+ ...+|.|.+... ........+..|..+-..+. |+|++.+++...+....++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            46677888899999999988776433 445777776554 23445566677888877777 9999999999999999999


Q ss_pred             EEeccCCCCHHHHH-HHcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCeEeecCCCCcEEEccCC-cEEEeeccCCccccc
Q 018018          146 ILEYMDGGSLADFL-KKVK-TIPEEYLAAICEQVLKGLLYLH-HEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMAS  221 (362)
Q Consensus       146 V~e~~~~gsL~~~l-~~~~-~l~~~~~~~i~~ql~~al~~LH-~~~~ivH~Dlkp~NIll~~~~-~vkl~DFg~a~~~~~  221 (362)
                      +++|..|+++.+.+ .... ..+...+..++.|+..++.|+| . .++.|+|+||+|.+++..+ .++++|||+|+....
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~-~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE-NGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc-cccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            99999999999999 5544 7888899999999999999999 6 9999999999999999999 999999999988765


Q ss_pred             -CCC--CCCcccc-CCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018018          222 -TSG--QANTFVG-TYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  296 (362)
Q Consensus       222 -~~~--~~~~~~g-t~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
                       .+.  .....+| ++.|+|||...+.. .....|+||.|+++..+++|..||......+...  ..++..-  ......
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~--~~~~~~~--~~~~~~  253 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY--SSWKSNK--GRFTQL  253 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc--eeecccc--cccccC
Confidence             222  2234578 99999999999854 5788999999999999999999998766544211  1111111  111234


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      .+..++....+++.+++..+|+.|.+.+++..++|+..
T Consensus       254 ~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  254 PWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            45678899999999999999999999999999999988

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.81  E-value=2.3e-19  Score=155.40  Aligned_cols=131  Identities=21%  Similarity=0.317  Sum_probs=106.7

Q ss_pred             eeeeeCCeEEEEEEEccCCcEEEEEEeeccc-------chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           77 VVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-------EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        77 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      .||+|+||.||++.  .+|..+++|+.....       ......++.+|++++..+.|+++......+......++||||
T Consensus         1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            37999999999998  467889999854321       111235678899999999887765544445566777999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      ++|++|.+++.....       .++.|++.+|.+||+ .|++|+|++|.||+++ ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~-~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHK-AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHH-CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999998865321       889999999999998 9999999999999998 89999999998765

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.79  E-value=6.3e-19  Score=152.67  Aligned_cols=137  Identities=20%  Similarity=0.207  Sum_probs=107.6

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch---------------------HHHHHHHHHHHHHhcCCCCc-
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE---------------------SARRQIAQELKINQSSQCPY-  129 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------------~~~~~~~~e~~~~~~l~hp~-  129 (362)
                      |.+.+.||+|+||.||++... +|+.+|||+++.+...                     ........|..++..+.+++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            666789999999999999875 7999999997654210                     01123567888888887764 


Q ss_pred             -ceEEeeeEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcE
Q 018018          130 -VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV  208 (362)
Q Consensus       130 -I~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~v  208 (362)
                       +...++    ....++||||++|++|......      .....++.+++.++.++|+ .|++||||+|+||+++.++.+
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~-~gi~H~Dl~p~Nill~~~~~~  164 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYK-HGIIHGDLSEFNILVDDDEKI  164 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHH-CCCCcCCCCcccEEEcCCCcE
Confidence             334333    3456899999999998776431      3456889999999999998 999999999999999999999


Q ss_pred             EEeeccCCcccc
Q 018018          209 KITDFGVSAIMA  220 (362)
Q Consensus       209 kl~DFg~a~~~~  220 (362)
                      +|+|||++....
T Consensus       165 ~liDfg~~~~~~  176 (198)
T cd05144         165 YIIDWPQMVSTD  176 (198)
T ss_pred             EEEECCccccCC
Confidence            999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=3.3e-18  Score=169.84  Aligned_cols=137  Identities=20%  Similarity=0.235  Sum_probs=110.9

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEee-cc-c-----chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MN-V-----EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~-~-----~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      ..|...+.||+|+||+||++...  +..+++|+.. .. .     .......+.+|+++++.++|++++.....+.....
T Consensus       333 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        333 RRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             cccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            44566789999999999998764  3344444321 11 1     11234568899999999999999887777777777


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      .++||||++|++|.+++.        ....++.|++.+|.+||+ .|++||||||+||++ .++.++|+|||+++.
T Consensus       411 ~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~-~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHK-AGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHh-CCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            899999999999999886        356899999999999998 999999999999999 688999999999865

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.75  E-value=7.7e-18  Score=144.34  Aligned_cols=138  Identities=21%  Similarity=0.287  Sum_probs=97.9

Q ss_pred             eeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch-HHHHH----------------------HHHHHHHHhcCCCCc--
Q 018018           75 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-SARRQ----------------------IAQELKINQSSQCPY--  129 (362)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~----------------------~~~e~~~~~~l~hp~--  129 (362)
                      .+.||+|+||+||++.+. +|+.||||+++..... .....                      ...|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999987 8999999998754211 11111                      134555555544332  


Q ss_pred             ceEEeeeEEecCeEEEEEeccCCCCHHH-HHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcE
Q 018018          130 VVVCYQSFYSNGAISIILEYMDGGSLAD-FLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV  208 (362)
Q Consensus       130 I~~~~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~v  208 (362)
                      +.+++..    ...++||||++++++.. .+.... .. ..+..++.+++.++.++|.++|++|+||||+||+++ ++.+
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            3344432    24689999999854321 122111 11 678899999999999999658999999999999999 8999


Q ss_pred             EEeeccCCcccc
Q 018018          209 KITDFGVSAIMA  220 (362)
Q Consensus       209 kl~DFg~a~~~~  220 (362)
                      +|+|||.+....
T Consensus       154 ~liDfg~a~~~~  165 (187)
T cd05119         154 YIIDVPQAVEID  165 (187)
T ss_pred             EEEECccccccc
Confidence            999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.72  E-value=1.1e-16  Score=142.40  Aligned_cols=135  Identities=20%  Similarity=0.304  Sum_probs=104.4

Q ss_pred             eeee-eeCCeEEEEEEEccCCcEEEEEEeeccc------------chHHHHHHHHHHHHHhcCCCCcc--eEEeeeEEe-
Q 018018           76 KVVG-KGSGGIVQLVQHKWTGQFFALKVIQMNV------------EESARRQIAQELKINQSSQCPYV--VVCYQSFYS-  139 (362)
Q Consensus        76 ~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~~~~~~e~~~~~~l~hp~I--~~~~~~~~~-  139 (362)
                      ..|| .|+.|+||.+...  +..++||.+....            +......+.+|+.++..+.|++|  +..++.... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            5677 7888999988774  7889999875321            11234567889999999998775  555554332 


Q ss_pred             cC---eEEEEEeccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccC
Q 018018          140 NG---AISIILEYMDG-GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  215 (362)
Q Consensus       140 ~~---~~~lV~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~  215 (362)
                      ..   ..++|||+++| .+|.+++.. ..+++..    +.|++.+|.+||+ +||+||||||+|||++.++.++|+|||.
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~-~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHD-AGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHH-CCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence            22   23599999997 689988865 4566543    5789999999998 9999999999999999999999999998


Q ss_pred             Ccc
Q 018018          216 SAI  218 (362)
Q Consensus       216 a~~  218 (362)
                      +..
T Consensus       189 ~~~  191 (239)
T PRK01723        189 GEL  191 (239)
T ss_pred             ccc
Confidence            764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.70  E-value=7.6e-18  Score=168.59  Aligned_cols=269  Identities=27%  Similarity=0.389  Sum_probs=212.9

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      ....+.+.+.+-+.+|+++.++.+.-..+|...++|+.....  .....+.+..+-.+.-.-++|.++.....+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            456788889999999999999999988888777777654331  111123333444444444567777766666677889


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC-
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-  222 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~-  222 (362)
                      ++|++|+.+++|...++..+..+.+-++.....+..++++||. ..+.|+|++|.|++...+++.++.|||........ 
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s-~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~  958 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHS-SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP  958 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhcccc-chhhcccccccchhhcccCCcccCcccccccccccc
Confidence            9999999999999999998889999999999999999999998 77999999999999999999999999843222110 


Q ss_pred             -----C-------------------------CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 018018          223 -----S-------------------------GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP  272 (362)
Q Consensus       223 -----~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~  272 (362)
                           .                         .......||+.|.+||.+.+......+|+|++|++++|.++|.+||.+.
T Consensus       959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                 0                         0012346899999999999999999999999999999999999999886


Q ss_pred             ccCCchhhHHHHHHHHhcCCCCC-CCCCCCCHHHHHHHHHhhhcCcCCCCCHH---HHHcCCcccccCCCCCCH
Q 018018          273 EQQDGWTSFYELMEAIVDQPPPS-APSDQFSPEFCSFISACVQKEPQQRLSAQ---ELMTHPFLKMYGDLNVDL  342 (362)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~---eil~hp~~~~~~~~~~~l  342 (362)
                      ..+       ..++.+..+..+. ..+...+....+++...|..+|.+|..+.   ++-.|+||+...+.++.+
T Consensus      1039 tpq-------~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1039 TPQ-------QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred             chh-------hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccccc
Confidence            654       3445555444433 34556788999999999999999999988   999999999998877754

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=1.5e-16  Score=130.54  Aligned_cols=133  Identities=26%  Similarity=0.301  Sum_probs=111.2

Q ss_pred             eeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCC--CcceEEeeeEEecCeEEEEEeccC
Q 018018           74 TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC--PYVVVCYQSFYSNGAISIILEYMD  151 (362)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h--p~I~~~~~~~~~~~~~~lV~e~~~  151 (362)
                      +.+.||+|.++.||++...  +..+++|+.+....   ...+..|...++.+.+  .++.+++......+..+++|||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            3578999999999999985  37899999865533   4567888888888876  488888888777788999999999


Q ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC--CCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE--KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       152 ~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~--~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      ++++..+       +......++.+++.+++++|..  .+++|+|++|+||+++..+.++++|||.+..
T Consensus        77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8777655       5567778899999999999972  3699999999999999989999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=8.1e-17  Score=153.69  Aligned_cols=254  Identities=23%  Similarity=0.287  Sum_probs=196.4

Q ss_pred             ccCceeeeeeee--eCCeEEEEEEE--ccCCcEEEEEEeecccc-hHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCe
Q 018018           69 LEDIDTIKVVGK--GSGGIVQLVQH--KWTGQFFALKVIQMNVE-ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        69 ~~~~~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~  142 (362)
                      -..+.+.+.+|.  |.+|.||....  ..++..+|+|.-+.... ......-.+|....+.+ .|++.+..+..+.+.+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            355677789999  99999999998  88999999998432211 11222334455544444 48999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHH----HHHHHHhCCCeEeecCCCCcEEEccC-CcEEEeeccCC
Q 018018          143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLK----GLLYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVS  216 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~ql~~----al~~LH~~~~ivH~Dlkp~NIll~~~-~~vkl~DFg~a  216 (362)
                      .++-+|++. .+|..+...... ++...++....+...    ||.++|+ .+++|-|+||.||+...+ ...+++|||+.
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs-~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS-NNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC-CcccccccchhheecccccceeecCCccee
Confidence            999999995 688888876555 899999999999999    9999998 999999999999999999 88999999998


Q ss_pred             cccccCCCCCCc-----cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC
Q 018018          217 AIMASTSGQANT-----FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ  291 (362)
Q Consensus       217 ~~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  291 (362)
                      ..+....-....     ..|...|++||++.+ .++...|++++|.++.+-.++..++... ....|..+...       
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g-~~~~W~~~r~~-------  341 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVG-KNSSWSQLRQG-------  341 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCC-CCCCccccccc-------
Confidence            877654432222     267789999998874 7789999999999999999987666432 11233322211       


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccc
Q 018018          292 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK  333 (362)
Q Consensus       292 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  333 (362)
                      ..+.......+.++...+.+|++.+|..|++++.++.|+++.
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~  383 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH  383 (524)
T ss_pred             cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence            122233345566777899999999999999999999999985

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.61  E-value=1.8e-14  Score=139.09  Aligned_cols=170  Identities=18%  Similarity=0.287  Sum_probs=132.3

Q ss_pred             EEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCCHHHHHHHcCCCCHH
Q 018018           89 VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE  168 (362)
Q Consensus        89 ~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~  168 (362)
                      +..+.++.++.|.+.+.... .......+.++-++.++||||++++..+..++.+|+|+|-+.  .|..++++.+   ..
T Consensus        31 ~t~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~~  104 (690)
T KOG1243|consen   31 GTRKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---KE  104 (690)
T ss_pred             cceeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---HH
Confidence            44567889999998876644 445567788888999999999999999999999999999983  7888887643   67


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCCcccCcceecCCCCCc
Q 018018          169 YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY  248 (362)
Q Consensus       169 ~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  248 (362)
                      .+.--+.||+.||.+||++.+++|++|+...|+|+..|..||++|-.+...............--.|..|+.+....  -
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--c
Confidence            77778899999999999778999999999999999999999999998754332221111122222355565443322  4


Q ss_pred             cccHHHHHHHHHHHHcCC
Q 018018          249 KSDIWSLGLVLLECATGQ  266 (362)
Q Consensus       249 ~~DiwslG~~l~elltg~  266 (362)
                      ..|.|.|||++++++.|.
T Consensus       183 s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             chhhhhHHHHHHHHhCcc
Confidence            569999999999999993

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.58  E-value=1.4e-14  Score=139.76  Aligned_cols=139  Identities=20%  Similarity=0.302  Sum_probs=97.7

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHH---------------------------------H------HHH
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESAR---------------------------------R------QIA  116 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---------------------------------~------~~~  116 (362)
                      +.||+|++|.||+|+.+ +|+.||||+.+....+...                                 .      .+.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            67999999999999875 7999999998655221110                                 0      123


Q ss_pred             HHHHHHhcC----CC-CcceEEeeeE-EecCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 018018          117 QELKINQSS----QC-PYVVVCYQSF-YSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLK-GLLYLHHEK  188 (362)
Q Consensus       117 ~e~~~~~~l----~h-p~I~~~~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~-al~~LH~~~  188 (362)
                      +|+..+..+    .+ +++. +-..+ ......++||||++|++|.++.... ...   ....++.+++. .+..+|. .
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~-~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLR-D  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHh-C
Confidence            344433332    23 3332 22222 2244579999999999999887542 122   23456666666 4788897 9


Q ss_pred             CeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       189 ~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      |++|+|+||.||+++.+++++++|||++..+.
T Consensus       277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            99999999999999999999999999987764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.58  E-value=2e-15  Score=147.35  Aligned_cols=143  Identities=17%  Similarity=0.310  Sum_probs=96.3

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch---------------------------------HHHHHH
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE---------------------------------SARRQI  115 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------------------------~~~~~~  115 (362)
                      +.+|+. +.||+|++|.||.|+.+.+|+.||||+.+....+                                 +..+.+
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345666 7899999999999999888999999999755211                                 111222


Q ss_pred             HHHHHH------HhcC----CCCcceEEeeeEEe-cCeEEEEEeccCCCCHHHHH--HHcC----CCCHHHHHHHHHHHH
Q 018018          116 AQELKI------NQSS----QCPYVVVCYQSFYS-NGAISIILEYMDGGSLADFL--KKVK----TIPEEYLAAICEQVL  178 (362)
Q Consensus       116 ~~e~~~------~~~l----~hp~I~~~~~~~~~-~~~~~lV~e~~~~gsL~~~l--~~~~----~l~~~~~~~i~~ql~  178 (362)
                      .+|++.      +..+    .+...+.+-.++.+ ....++||||+.|+++.++-  ...+    .+.+..+..++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence            333332      2222    23333333333322 45678999999999998753  3322    23444444455554 


Q ss_pred             HHHHHHHhCCCeEeecCCCCcEEEccCC----cEEEeeccCCcccc
Q 018018          179 KGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMA  220 (362)
Q Consensus       179 ~al~~LH~~~~ivH~Dlkp~NIll~~~~----~vkl~DFg~a~~~~  220 (362)
                            .. .|++|+|+||.||+++.++    +++++|||++..+.
T Consensus       277 ------f~-~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 ------FR-DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ------Hh-CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                  34 7999999999999999988    99999999987664

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.51  E-value=2.3e-13  Score=116.27  Aligned_cols=139  Identities=17%  Similarity=0.170  Sum_probs=99.2

Q ss_pred             eeeeeeCCeEEEEEEEcc------CCcEEEEEEeeccc------------c---------hHHHHHHH----HHHHHHhc
Q 018018           76 KVVGKGSGGIVQLVQHKW------TGQFFALKVIQMNV------------E---------ESARRQIA----QELKINQS  124 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~------------~---------~~~~~~~~----~e~~~~~~  124 (362)
                      ..||.|--+.||.+....      .+..+|||+.+.+.            +         ...+..+.    +|++.+++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998653      35789999886431            0         01122222    78887777


Q ss_pred             CCC--CcceEEeeeEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HhCCCeEeecCCCCcEE
Q 018018          125 SQC--PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL-HHEKHIIHRDLKPSNLL  201 (362)
Q Consensus       125 l~h--p~I~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~L-H~~~~ivH~Dlkp~NIl  201 (362)
                      +..  -++...+..    ..-++||||+.+..+....-....++......+..|++.+|..| |+ .|++|+||++.||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~-~glVHGDLs~~NIL  157 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKE-CNLVHADLSEYNML  157 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEE
Confidence            643  334444443    45689999997654432222223566667788899999999999 77 89999999999999


Q ss_pred             EccCCcEEEeeccCCcccc
Q 018018          202 INHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       202 l~~~~~vkl~DFg~a~~~~  220 (362)
                      ++ ++.++|+|||.|....
T Consensus       158 ~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             EE-CCcEEEEECCCceeCC
Confidence            95 5789999999886654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.49  E-value=4.4e-14  Score=125.65  Aligned_cols=207  Identities=24%  Similarity=0.327  Sum_probs=143.8

Q ss_pred             HhcCCCCcceEEeeeEEec-----CeEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC-CCeE
Q 018018          122 NQSSQCPYVVVCYQSFYSN-----GAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHE-KHII  191 (362)
Q Consensus       122 ~~~l~hp~I~~~~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~al~~LH~~-~~iv  191 (362)
                      +-.+.|.||++++.++.+.     ....++.||+..|++..+|++.    ..+......+|+.|++.||.|||+. ..++
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii  200 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII  200 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence            3345789999998877643     4578999999999999999753    5688999999999999999999984 3499


Q ss_pred             eecCCCCcEEEccCCcEEEeeccCCccccc----CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCC
Q 018018          192 HRDLKPSNLLINHRGEVKITDFGVSAIMAS----TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF  267 (362)
Q Consensus       192 H~Dlkp~NIll~~~~~vkl~DFg~a~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~  267 (362)
                      |+++..+.|++..+|-+|+.--........    .........+-+.|.|||.=.....+.++|||++|.+..+|..+..
T Consensus       201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi  280 (458)
T KOG1266|consen  201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI  280 (458)
T ss_pred             cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence            999999999999999888763221111100    0001112245678999996555556779999999999999987653


Q ss_pred             C-CCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCC
Q 018018          268 P-YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  340 (362)
Q Consensus       268 p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~  340 (362)
                      - -.+.+...    ..+.......+.        ....-+.++..||+-.|..||++.+++.||-+=.....++
T Consensus       281 q~tnseS~~~----~ee~ia~~i~~l--------en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVhslkl  342 (458)
T KOG1266|consen  281 QSTNSESKVE----VEENIANVIIGL--------ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVHSLKL  342 (458)
T ss_pred             ccCCCcceee----hhhhhhhheeec--------cCccccCcCcccccCCCCCCcchhhhhcCceeeecchHHH
Confidence            2 11111111    111111111111        1123356899999999999999999999998766655444

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=1.4e-13  Score=115.83  Aligned_cols=127  Identities=18%  Similarity=0.186  Sum_probs=92.8

Q ss_pred             eeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcc-eEEeeeEEecCeEEEEEeccCCC
Q 018018           75 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV-VVCYQSFYSNGAISIILEYMDGG  153 (362)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I-~~~~~~~~~~~~~~lV~e~~~~g  153 (362)
                      ++.|+.|.++.||.++..  +..|++|+......  ....+..|+.+++.+.+.++ .+++..  .....++||||++|.
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCC
Confidence            467899999999999864  78899999754422  12235677777776654443 334433  233458999999998


Q ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCC-----eEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH-----IIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       154 sL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~-----ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      ++...        .......+.+++++|+.||+ .+     ++|+|++|.||+++ ++.++++|||.+.
T Consensus        77 ~l~~~--------~~~~~~~~~~l~~~l~~LH~-~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          77 ELLTE--------DFSDPENLEKIAKLLKKLHS-SPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc--------cccCHHHHHHHHHHHHHHhC-CCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            87653        01123457899999999998 76     49999999999998 7789999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=4.9e-14  Score=134.82  Aligned_cols=253  Identities=22%  Similarity=0.188  Sum_probs=184.1

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEc-cCCcEEEEEEeecccch-HHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHK-WTGQFFALKVIQMNVEE-SARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~  143 (362)
                      ....+|..+..||.|.|+.|+.+... .++..|++|.+...... .....-..|+.+...+ .|.+++..+..+......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34567888999999999999987755 67889999987654221 1112223444444443 478888888888878888


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC-CcEEEeeccCCcccccC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIMAST  222 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~-~~vkl~DFg~a~~~~~~  222 (362)
                      |+=-|||.++++...+.-...+.+...+.+..|++.++.++|+ +.++|+|++|.||++..+ +.-+++|||+++.+...
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s-~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~  420 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS-KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS  420 (524)
T ss_pred             cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc-hhhhcccccccceeeccchhhhhcccccccccccee
Confidence            8889999999988877666678999999999999999999998 999999999999999775 78899999998754322


Q ss_pred             CCCCCccccCCcc-cCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          223 SGQANTFVGTYNY-MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       223 ~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      .  ......+..| .+++......+..++|++|||..+.+.+++..--.....          ...+..+..+.  ....
T Consensus       421 ~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----------~~~i~~~~~p~--~~~~  486 (524)
T KOG0601|consen  421 S--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ----------SLTIRSGDTPN--LPGL  486 (524)
T ss_pred             c--ccccccccccccchhhccccccccccccccccccccccccCcccCccccc----------ceeeecccccC--CCch
Confidence            2  1112223334 355555666788899999999999999997643222111          11111221111  1233


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      ..++..+...|...++..||.+.++..|.-|..
T Consensus       487 ~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  487 KLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             HHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            478889999999999999999999998876643

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=3.6e-12  Score=105.61  Aligned_cols=132  Identities=23%  Similarity=0.339  Sum_probs=99.1

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEE-eecc-----cc-hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKV-IQMN-----VE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~-~~~~-----~~-~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      ..+++|+-+.++.+..  -|..+++|. +++.     .+ .-...+..+|+.++..++--.|....-.+.+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            3578899999988744  455677775 2222     11 2234567789999888765454444444557788899999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      |++|..|.+.+...       ...++..+-.-+.-||. .||+|+||+++||+++. +.+.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~-~givHGDLTtsNiIl~~-~~i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHK-AGIVHGDLTTSNIILSG-GRIYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHh-cCeecCCCccceEEEeC-CcEEEEECCcccc
Confidence            99999999999875       25677888888999998 99999999999999954 4599999999864

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.34  E-value=2.2e-11  Score=100.55  Aligned_cols=143  Identities=22%  Similarity=0.342  Sum_probs=106.4

Q ss_pred             eeeeeeeeCCeEEEEEEEccCCcEEEEEEe-ecc------cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           74 TIKVVGKGSGGIVQLVQHKWTGQFFALKVI-QMN------VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~-~~~------~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      .+..+.+|+-+.|+.+..  .|+.+.||.= .+.      ...-.+.+..+|++++.++.--.|.-..-.+.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            567899999999987755  6898888852 111      2233467788999998887644444333345566777899


Q ss_pred             EeccCC-CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC---cEEEeeccCCccc
Q 018018          147 LEYMDG-GSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIM  219 (362)
Q Consensus       147 ~e~~~~-gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~---~vkl~DFg~a~~~  219 (362)
                      |||++| .++.+++....  .....-...+++++-+.+.-||. ++++|+||..+||++.+++   .+.++|||++...
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~-ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD-NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh-CCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence            999976 47888887643  22333337899999999999998 9999999999999997766   3589999997543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.30  E-value=1.2e-11  Score=108.48  Aligned_cols=141  Identities=18%  Similarity=0.252  Sum_probs=103.2

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCC--cceEEeeeEEec---CeEEEEEecc
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP--YVVVCYQSFYSN---GAISIILEYM  150 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp--~I~~~~~~~~~~---~~~~lV~e~~  150 (362)
                      +.|+.|..+.||++... +|..+++|+............+..|+.+++.+.+.  ++.+++......   +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            67899999999999875 36889999976543222345678888888887653  345555554432   3678999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 018018          151 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH--------------------------------------------  186 (362)
Q Consensus       151 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~--------------------------------------------  186 (362)
                      +|.++.+.+.. ..+++.....++.+++++|..||+                                            
T Consensus        83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            99888775532 356666667777777777777773                                            


Q ss_pred             -----------CCCeEeecCCCCcEEEcc--CCcEEEeeccCCcc
Q 018018          187 -----------EKHIIHRDLKPSNLLINH--RGEVKITDFGVSAI  218 (362)
Q Consensus       187 -----------~~~ivH~Dlkp~NIll~~--~~~vkl~DFg~a~~  218 (362)
                                 ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                       134799999999999988  56789999997653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.21  E-value=4.4e-10  Score=101.27  Aligned_cols=139  Identities=15%  Similarity=0.076  Sum_probs=95.5

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHH----------HHHHHHHHHhcCC-----CCcceEEeeeEEe-
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARR----------QIAQELKINQSSQ-----CPYVVVCYQSFYS-  139 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~----------~~~~e~~~~~~l~-----hp~I~~~~~~~~~-  139 (362)
                      +.+-......|+.+  ...|+.|.||...........+          ...+|...+..+.     .|.++-+...... 
T Consensus        28 e~v~~~~~rrvvr~--~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRF--ELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEE--EECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            34444444456554  3467889999764332221111          3567777766653     3433333211111 


Q ss_pred             -cCeEEEEEeccCCC-CHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc-------CCcE
Q 018018          140 -NGAISIILEYMDGG-SLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-------RGEV  208 (362)
Q Consensus       140 -~~~~~lV~e~~~~g-sL~~~l~~--~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-------~~~v  208 (362)
                       ....++|||++++. +|.+++..  ..+.+......++.+++..+..||+ .||+|+|+++.|||++.       +..+
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~-~Gi~HgDL~~~NiLl~~~~~~~~~~~~~  184 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA-AGINHRDCYICHFLLHLPFPGREEDLKL  184 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH-CcCccCCCChhhEEEeccccCCCCCceE
Confidence             24578999999876 79999864  3456777888999999999999998 99999999999999975       4689


Q ss_pred             EEeeccCCc
Q 018018          209 KITDFGVSA  217 (362)
Q Consensus       209 kl~DFg~a~  217 (362)
                      .|+||+.+.
T Consensus       185 ~LIDl~r~~  193 (268)
T PRK15123        185 SVIDLHRAQ  193 (268)
T ss_pred             EEEECCccc
Confidence            999999764

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.19  E-value=4.9e-10  Score=103.43  Aligned_cols=243  Identities=15%  Similarity=0.215  Sum_probs=158.4

Q ss_pred             eeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceE--------EeeeEEecCeEEE
Q 018018           74 TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV--------CYQSFYSNGAISI  145 (362)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~--------~~~~~~~~~~~~l  145 (362)
                      ..+.||+|+-+.+|-.-..   ...+.|++...... ...+...|+  ...-.||-+-.        +++. ..+..+-+
T Consensus        15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa-~~aqk~a~l--a~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGf   87 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPA-AQAQKVAEL--AATPDAPLLNYRVAWPQATLHGG-RRGKVIGF   87 (637)
T ss_pred             CCccccCCccceeeecchh---hchhheeecCCCch-HHHHHHHHh--ccCCCCcchhhhhcccHHHhhCC-CccceeEE
Confidence            3467999999999876443   23456777544222 222222222  22234443322        1221 22334778


Q ss_pred             EEeccCCC-CHHHHHH------HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          146 ILEYMDGG-SLADFLK------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       146 V~e~~~~g-sL~~~l~------~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      +|..++|. .+..+.+      ......++.+..+++.++.+.+.||. .|-+-+|+.++|+|+++++.|.|.|-..-..
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~-~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE-HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh-cCCcccccCccceeeecCceEEEEcccceee
Confidence            88888765 3444442      22457899999999999999999998 9999999999999999999999998653322


Q ss_pred             cccCCCCCCccccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcC-CCCCCCCccCCchhhHHH---------
Q 018018          219 MASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATG-QFPYSPPEQQDGWTSFYE---------  283 (362)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~elltg-~~pf~~~~~~~~~~~~~~---------  283 (362)
                       ...+......+|...|.+||.-.     +..-+..+|.|.||+++++++.| +.||.+.........-.+         
T Consensus       167 -~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~  245 (637)
T COG4248         167 -NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA  245 (637)
T ss_pred             -ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence             23334445568999999999754     34457789999999999999885 999987433221111111         


Q ss_pred             HHHHHh---cCCCCCCCCCCCCHHHHHHHHHhhhc--CcCCCCCHHH
Q 018018          284 LMEAIV---DQPPPSAPSDQFSPEFCSFISACVQK--EPQQRLSAQE  325 (362)
Q Consensus       284 ~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~--dP~~Rpt~~e  325 (362)
                      ....-.   ...+......-+++++..|..+|++.  ++.-|||++.
T Consensus       246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence            011111   11122234456789999999999975  4678998753

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.18  E-value=1.3e-11  Score=120.13  Aligned_cols=157  Identities=18%  Similarity=0.326  Sum_probs=117.9

Q ss_pred             HHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC---------CCccccCCcccCcceecCCCC
Q 018018          176 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---------ANTFVGTYNYMSPERISGGKY  246 (362)
Q Consensus       176 ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~---------~~~~~gt~~y~aPE~~~~~~~  246 (362)
                      +.+.|+.++|.+.++||+.|.|++|.++.++..||+.|+++.........         .........|.|||.+.+...
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            33499999999899999999999999999999999999987654431110         011235679999999999888


Q ss_pred             CccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHH
Q 018018          247 GYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE  325 (362)
Q Consensus       247 ~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  325 (362)
                      +.++|+||+|+++|.+.. |+.-+.......    .+.. ...............+++++++=+.+++..++..||++.+
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~----~~~~-~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~  261 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLL----SYSF-SRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL  261 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcc----hhhh-hhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence            999999999999999994 555554432211    1111 1111122222334678999999999999999999999999


Q ss_pred             HHcCCcccccCC
Q 018018          326 LMTHPFLKMYGD  337 (362)
Q Consensus       326 il~hp~~~~~~~  337 (362)
                      +..-|||+..+-
T Consensus       262 l~~~~ff~D~~~  273 (700)
T KOG2137|consen  262 LLSIPFFSDPGL  273 (700)
T ss_pred             hhcccccCCchh
Confidence            999999987753

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.16  E-value=1.5e-09  Score=102.57  Aligned_cols=213  Identities=17%  Similarity=0.246  Sum_probs=153.2

Q ss_pred             CCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEE----ecCeEEEEEeccCC-CCHH
Q 018018           82 SGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY----SNGAISIILEYMDG-GSLA  156 (362)
Q Consensus        82 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~----~~~~~~lV~e~~~~-gsL~  156 (362)
                      .-.+.|++....+|..|++|.+..... ........-++.++++.|+|||++.++|.    .+..+++|++|+++ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRD-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccc-cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            346889999999999999999843311 11123345677889999999999999887    35668999999976 4677


Q ss_pred             HHHH---------------HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          157 DFLK---------------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       157 ~~l~---------------~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ++--               .....++...|.++.|+..||.++|+ .|+..+-|.|.+|+++.+.+++|...|+......
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs-sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS-SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh-cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            6552               12357899999999999999999998 9999999999999998888999988776544432


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH-HHHHhcCCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL-MEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  300 (362)
                      ..            .  |-+.   -..+-|.=.||.++..|.||..-=.   +.+   ...+. +..+         ...
T Consensus       446 d~------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~---~~d---~~~~s~~~~I---------~~~  493 (655)
T KOG3741|consen  446 DP------------T--EPLE---SQQQNDLRDLGLLLLALATGTENSN---RTD---STQSSHLTRI---------TTT  493 (655)
T ss_pred             CC------------C--cchh---HHhhhhHHHHHHHHHHHhhcccccc---ccc---chHHHHHHHh---------hhh
Confidence            21            0  0011   1235688899999999999843210   000   00111 1111         245


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ++.+++++|.-+...++++ -++.+++.|
T Consensus       494 yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  494 YSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             hhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            7788999999999988887 677887765

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.13  E-value=4.5e-10  Score=95.61  Aligned_cols=126  Identities=22%  Similarity=0.288  Sum_probs=82.6

Q ss_pred             EEEEEEEccCCcEEEEEEeeccc-------------------------chHHHHHHHHHHHHHhcCCCC--cceEEeeeE
Q 018018           85 IVQLVQHKWTGQFFALKVIQMNV-------------------------EESARRQIAQELKINQSSQCP--YVVVCYQSF  137 (362)
Q Consensus        85 ~V~~~~~~~~~~~vaiK~~~~~~-------------------------~~~~~~~~~~e~~~~~~l~hp--~I~~~~~~~  137 (362)
                      .||.|... +|..+|+|+.+...                         .........+|.+.|..+..-  ++.+.+.. 
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-   78 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-   78 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence            37888774 67899999875431                         011234567899999888765  45555543 


Q ss_pred             EecCeEEEEEeccC--CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH-HhCCCeEeecCCCCcEEEccCCcEEEeecc
Q 018018          138 YSNGAISIILEYMD--GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL-HHEKHIIHRDLKPSNLLINHRGEVKITDFG  214 (362)
Q Consensus       138 ~~~~~~~lV~e~~~--~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~L-H~~~~ivH~Dlkp~NIll~~~~~vkl~DFg  214 (362)
                       .  .-++||||++  |..+..+...  .++......++.+++..+..+ |+ .|++|+|+++.||+++.+ .+.++|||
T Consensus        79 -~--~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~-~~~iIDf~  151 (188)
T PF01163_consen   79 -N--RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG-KVYIIDFG  151 (188)
T ss_dssp             -E--TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-CEEE--GT
T ss_pred             -e--CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-eEEEEecC
Confidence             2  3479999998  6556554433  222455677888888866664 66 999999999999999776 99999999


Q ss_pred             CCccc
Q 018018          215 VSAIM  219 (362)
Q Consensus       215 ~a~~~  219 (362)
                      .|...
T Consensus       152 qav~~  156 (188)
T PF01163_consen  152 QAVDS  156 (188)
T ss_dssp             TEEET
T ss_pred             cceec
Confidence            87654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.00  E-value=3.7e-09  Score=92.99  Aligned_cols=135  Identities=19%  Similarity=0.242  Sum_probs=99.2

Q ss_pred             eeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc---------------------hHHHHHHHHHHHHHhcCCCC--cc
Q 018018           74 TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE---------------------ESARRQIAQELKINQSSQCP--YV  130 (362)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------~~~~~~~~~e~~~~~~l~hp--~I  130 (362)
                      +...||-|--|.||.+.+. .|.++|||.=+....                     ...+....+|.+.|..+...  .+
T Consensus        95 iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          95 IGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            5588999999999999987 789999997543210                     11234556888888887654  56


Q ss_pred             eEEeeeEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEE
Q 018018          131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI  210 (362)
Q Consensus       131 ~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl  210 (362)
                      ...++    .+..++|||++.|-.|...-     ++......++..++.-+.-+-. .|+||+|+++-||+++++|.+++
T Consensus       174 P~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~-~GiVHGDlSefNIlV~~dg~~~v  243 (304)
T COG0478         174 PKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYR-RGIVHGDLSEFNILVTEDGDIVV  243 (304)
T ss_pred             CCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHH-cCccccCCchheEEEecCCCEEE
Confidence            65554    46678999999987665543     2344455555666665555555 89999999999999999999999


Q ss_pred             eeccCCccc
Q 018018          211 TDFGVSAIM  219 (362)
Q Consensus       211 ~DFg~a~~~  219 (362)
                      +||-.+...
T Consensus       244 IDwPQ~v~~  252 (304)
T COG0478         244 IDWPQAVPI  252 (304)
T ss_pred             EeCcccccC
Confidence            999876543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.98  E-value=5.8e-09  Score=90.78  Aligned_cols=105  Identities=20%  Similarity=0.250  Sum_probs=79.9

Q ss_pred             HHHHHHHHHHhcCC-----CCcceEEeeeEEe-cCeEEEEEeccCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 018018          113 RQIAQELKINQSSQ-----CPYVVVCYQSFYS-NGAISIILEYMDGG-SLADFLKKVKTIPEEYLAAICEQVLKGLLYLH  185 (362)
Q Consensus       113 ~~~~~e~~~~~~l~-----hp~I~~~~~~~~~-~~~~~lV~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH  185 (362)
                      ....+|...+..+.     -|..+-+...-.. ....++|+|++++. +|.+++......+......++.+++..++-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            34556666555543     3444333221000 13468999999874 89999988666888889999999999999999


Q ss_pred             hCCCeEeecCCCCcEEEccCC---cEEEeeccCCcc
Q 018018          186 HEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAI  218 (362)
Q Consensus       186 ~~~~ivH~Dlkp~NIll~~~~---~vkl~DFg~a~~  218 (362)
                      + +||+|+|+++.|||++.++   .+.++||+-++.
T Consensus       136 ~-~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 D-AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             H-CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            8 9999999999999999887   899999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.83  E-value=6.9e-08  Score=83.28  Aligned_cols=136  Identities=21%  Similarity=0.339  Sum_probs=88.2

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHH---------HHHHHH---HhcCCCCcceEEeee
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQI---------AQELKI---NQSSQCPYVVVCYQS  136 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~---------~~e~~~---~~~l~hp~I~~~~~~  136 (362)
                      -.+|...+++.......|.+.  ..+|..+++|..+..... ..+.+         .+++..   +..........++.+
T Consensus        30 ~~~~~~~kv~k~~~r~~ValI--ei~~~kyIlK~pr~~~~r-~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALI--EIDGKKYILKEPREENRR-PERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             hCCceEEEeecCCCccEEEEE--EECCcEEEEeccchhhhh-HHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            467888888888777777554  457899999987643211 11111         122222   222222223232222


Q ss_pred             -----EEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEe
Q 018018          137 -----FYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT  211 (362)
Q Consensus       137 -----~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~  211 (362)
                           +.-....++||||++|..|.+...    +++    .+...+.+++..||+ .|++|+|.+|.|++++. +.++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~-~G~~HGD~hpgNFlv~~-~~i~iI  176 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHK-HGFYHGDPHPGNFLVSN-NGIRII  176 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHH-cCCccCCCCcCcEEEEC-CcEEEE
Confidence                 222345678999999988877643    232    244667788999998 99999999999999975 559999


Q ss_pred             eccCCc
Q 018018          212 DFGVSA  217 (362)
Q Consensus       212 DFg~a~  217 (362)
                      ||+..+
T Consensus       177 D~~~k~  182 (229)
T PF06176_consen  177 DTQGKR  182 (229)
T ss_pred             ECcccc
Confidence            998643

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.82  E-value=6.6e-08  Score=83.08  Aligned_cols=137  Identities=17%  Similarity=0.128  Sum_probs=97.9

Q ss_pred             eeeCCeEEEEEEEccCCcEEEEEEeecccc-----hHHHHHHHHHHHHHhcCCCCc--ceEEeeeEE--e--cCeEEEEE
Q 018018           79 GKGSGGIVQLVQHKWTGQFFALKVIQMNVE-----ESARRQIAQELKINQSSQCPY--VVVCYQSFY--S--NGAISIIL  147 (362)
Q Consensus        79 g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~~~~l~hp~--I~~~~~~~~--~--~~~~~lV~  147 (362)
                      |+||-+-|+....  .|+.+-+|.-.....     +.-+..+.+|...+..+..-+  +.+......  .  ....+||+
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            4577788877655  355688886431111     224567888888887765322  333331111  1  23478999


Q ss_pred             eccCC-CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc--EEEeeccCCcc
Q 018018          148 EYMDG-GSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAI  218 (362)
Q Consensus       148 e~~~~-gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~--vkl~DFg~a~~  218 (362)
                      |-+.| .+|.+++...  .+.+......++.+++.+++-||+ .|+.|+|+.+.||+++.++.  +.++||--++.
T Consensus       105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~-~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS-VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            97754 4899998663  456888889999999999999998 99999999999999986777  99999986544

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.78  E-value=4.8e-08  Score=95.35  Aligned_cols=139  Identities=22%  Similarity=0.316  Sum_probs=91.1

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHH---------------------------------HHH------HH
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA---------------------------------RRQ------IA  116 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---------------------------------~~~------~~  116 (362)
                      +.|+.++-|.||.|+.+ +|+.||||+.+.+..+..                                 .+.      +.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            67899999999999987 599999999876532211                                 111      22


Q ss_pred             HHHHHHhcC----C-CCcceEEeeeEEecCeEEEEEeccCCCCHHHHH--HHcCCCCHHHHHHHHHHHHHH-HHHHHhCC
Q 018018          117 QELKINQSS----Q-CPYVVVCYQSFYSNGAISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKG-LLYLHHEK  188 (362)
Q Consensus       117 ~e~~~~~~l----~-hp~I~~~~~~~~~~~~~~lV~e~~~~gsL~~~l--~~~~~l~~~~~~~i~~ql~~a-l~~LH~~~  188 (362)
                      +|+..+..+    + .+++.-..=++...+.-.++|||+.|-.+.+..  +. ...+...   ++..++++ +..+-. .
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~---ia~~~~~~f~~q~~~-d  284 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKE---LAELLVRAFLRQLLR-D  284 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHH---HHHHHHHHHHHHHHh-c
Confidence            333333322    2 344332222223356778999999999998885  33 4445322   33333332 222223 6


Q ss_pred             CeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       189 ~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      |++|.|.+|.||+++.+|++.+.|||+...+.
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            89999999999999999999999999876654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.70  E-value=3.2e-08  Score=86.23  Aligned_cols=138  Identities=20%  Similarity=0.250  Sum_probs=91.7

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHH-----------------------HHHHHHHHHHHhcCC--CCcc
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA-----------------------RRQIAQELKINQSSQ--CPYV  130 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----------------------~~~~~~e~~~~~~l~--hp~I  130 (362)
                      ..|++|--+.||+|.. .++..+|+|+++.....-.                       ..-...|..-|.++.  +-.+
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            4788889999999876 4788999999875421100                       011234444444432  2223


Q ss_pred             eEEeeeEEecCeEEEEEeccCCCCH-HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEE
Q 018018          131 VVCYQSFYSNGAISIILEYMDGGSL-ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK  209 (362)
Q Consensus       131 ~~~~~~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vk  209 (362)
                      .+.+..    ..-.|||||+..... .-.|+. -++...++..+..++++.+.-|-...++||+||+.-|||+. ++.+.
T Consensus       133 P~Pi~~----~~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         133 PEPIAF----RNNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             CCceee----cCCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence            333332    234799999965311 111111 23344478889999999998887658999999999999997 89999


Q ss_pred             EeeccCCcccc
Q 018018          210 ITDFGVSAIMA  220 (362)
Q Consensus       210 l~DFg~a~~~~  220 (362)
                      ++|||.|....
T Consensus       207 iID~~QaV~~~  217 (268)
T COG1718         207 IIDVSQAVTID  217 (268)
T ss_pred             EEECccccccC
Confidence            99999887654

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.67  E-value=1.8e-09  Score=104.35  Aligned_cols=245  Identities=20%  Similarity=0.184  Sum_probs=171.2

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCc-ceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY-VVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~-I~~~~~~~~~~~~~~lV~  147 (362)
                      ...+...+-+++|+++++++.+...+...+ .+++...      ....-+++++.+++||| .+..++.+..+....+++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~  313 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM  313 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence            345666778899999999998876655555 6766543      44556788899999999 777777777788899999


Q ss_pred             eccCCC-CHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          148 EYMDGG-SLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       148 e~~~~g-sL~~~l~-~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      +++.++ +....+. ....+.+.....+.+.-+++++++|+ ---+|+|    ||+. .++..+.+||+....+.... .
T Consensus       314 ~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~-~~~~~~d----~~l~-s~~~~~~~~~~v~~~L~~~~-~  386 (829)
T KOG0576|consen  314 RICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHS-SYKVHRD----NILG-SEEEVKLLDFAVPPQLTRTM-K  386 (829)
T ss_pred             hhhcCCccccccCChhhHhhhhhhhhhhhhhhccccccccc-ccccCcc----cccc-cccccccccccCCcccCccc-c
Confidence            999877 3322221 11234455556677788889999998 4458888    7777 44789999999887665332 4


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-CCCCCC-CCCCH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPS-DQFSP  303 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~  303 (362)
                      ..+..+++.++|||+.....+....|.|++|.-..++.-|.+|-..+...-         ..+..++ .+.... ...++
T Consensus       387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~~---------~~~g~~p~s~~L~~~~aw~~  457 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAVL---------PMIGNGPNSPMLTDKSAWSP  457 (829)
T ss_pred             cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcccc---------CCCCCCCCccccchhhhcCc
Confidence            566789999999999999999999999999998888877777654422110         0000000 000000 00111


Q ss_pred             HHH-HHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          304 EFC-SFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       304 ~~~-~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ... ++...|+...|..|+....++.|-+|..+.
T Consensus       458 ~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  458 VFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             ccccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence            111 366778999999999999999998887764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.64  E-value=3.9e-07  Score=93.99  Aligned_cols=209  Identities=23%  Similarity=0.299  Sum_probs=148.6

Q ss_pred             HHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE----EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 018018          112 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE  187 (362)
Q Consensus       112 ~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~----lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~  187 (362)
                      +....-|...+....|+|+..++.+.......-    +..+++...++...++....++....+.+..+++.|++|+|+ 
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~-  304 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHS-  304 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHH-
Confidence            344456666778889999999988766443322    335789999999999999999999999999999999999998 


Q ss_pred             CCeEeecCCCC---cEEEccCCcEEEe--eccCCcccccCCCCCCccccCCcccCcceecCCCCCc--cccHHHHHHHHH
Q 018018          188 KHIIHRDLKPS---NLLINHRGEVKIT--DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY--KSDIWSLGLVLL  260 (362)
Q Consensus       188 ~~ivH~Dlkp~---NIll~~~~~vkl~--DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~~DiwslG~~l~  260 (362)
                      ....|.-+...   +-.++..+.+.+.  ||+.+........ ......+..+.|+|......++.  ..|+|.+|....
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL  383 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCccc-chhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence            65555544444   3334455666666  8887766544332 23334566788888887766554  479999999999


Q ss_pred             HHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCC
Q 018018          261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  340 (362)
Q Consensus       261 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~  340 (362)
                      .+..|..+-.-          ......+.        .........+++.+|+..++++|+++.+++.|+|.+..++...
T Consensus       384 ~~~~~~~i~~~----------~~~~~~~l--------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~  445 (1351)
T KOG1035|consen  384 QLSQGEDISEK----------SAVPVSLL--------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNES  445 (1351)
T ss_pred             hhhhcCccccc----------ccchhhhh--------ccccchhhhhhhhhhcchhhhhccchhhhhhchhccccccccc
Confidence            99887543211          01111111        1112226788999999999999999999999999987765443

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.61  E-value=8.9e-07  Score=77.97  Aligned_cols=138  Identities=24%  Similarity=0.265  Sum_probs=79.9

Q ss_pred             eeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCC--cceEEeee---EEecCeEEEEEec
Q 018018           75 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP--YVVVCYQS---FYSNGAISIILEY  149 (362)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp--~I~~~~~~---~~~~~~~~lV~e~  149 (362)
                      ++.|+.|..+.||.+....  ..+++|+....   .....+..|..+++.+...  .+..++..   .......+++|++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~   76 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEY   76 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEE
Confidence            4789999999999998864  58999997543   4455666777776665422  23444442   2344568999999


Q ss_pred             cCCCCHHH----------------HHH---Hc----CCCCHHH------HHH---------------HHHHHHH-HHHHH
Q 018018          150 MDGGSLAD----------------FLK---KV----KTIPEEY------LAA---------------ICEQVLK-GLLYL  184 (362)
Q Consensus       150 ~~~gsL~~----------------~l~---~~----~~l~~~~------~~~---------------i~~ql~~-al~~L  184 (362)
                      ++|.++..                .+.   ..    ..+....      ...               ....+.. .+..+
T Consensus        77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (239)
T PF01636_consen   77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL  156 (239)
T ss_dssp             ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred             eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence            99987777                111   00    0000000      000               0111222 22333


Q ss_pred             Hh------CCCeEeecCCCCcEEEc-cCCcEEEeeccCCc
Q 018018          185 HH------EKHIIHRDLKPSNLLIN-HRGEVKITDFGVSA  217 (362)
Q Consensus       185 H~------~~~ivH~Dlkp~NIll~-~~~~vkl~DFg~a~  217 (362)
                      ++      ...++|+|+.|.||+++ .++.+-|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            21      25599999999999998 56777899999764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.57  E-value=8.3e-07  Score=78.29  Aligned_cols=134  Identities=15%  Similarity=0.221  Sum_probs=80.0

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCc--ceEEeeeEEecCeEEEEEeccCCC
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY--VVVCYQSFYSNGAISIILEYMDGG  153 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~--I~~~~~~~~~~~~~~lV~e~~~~g  153 (362)
                      ..||+|..+.||+.    .|..+++|.......   ...+.+|.++++.+..-+  +.+.+......+...+|||+++|.
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~   79 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFD---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK   79 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCC---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence            57899999999973    255688998765432   234577888777665322  345566666677788999999986


Q ss_pred             C-HHHHH--------------HH-----c----CCCCHHHHH-HHHH----------HHHHH-HHHHH---hCCCeEeec
Q 018018          154 S-LADFL--------------KK-----V----KTIPEEYLA-AICE----------QVLKG-LLYLH---HEKHIIHRD  194 (362)
Q Consensus       154 s-L~~~l--------------~~-----~----~~l~~~~~~-~i~~----------ql~~a-l~~LH---~~~~ivH~D  194 (362)
                      + +...+              .+     +    ...+..... .+..          .+... ..+|.   ....++|+|
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            3 21111              00     0    011111100 0100          01111 11221   123579999


Q ss_pred             CCCCcEEEccCCcEEEeeccCCc
Q 018018          195 LKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       195 lkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      +.|.||+++.++ +.++||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999998888 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.43  E-value=2.1e-06  Score=83.86  Aligned_cols=138  Identities=20%  Similarity=0.256  Sum_probs=89.6

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchH------------------------------HHHH------HHHHH
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES------------------------------ARRQ------IAQEL  119 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------------------------~~~~------~~~e~  119 (362)
                      +.||..+.|.|+.|+.+. |+.||||+-+....+.                              ..+.      |.+|+
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            679999999999999985 9999999865442211                              1111      22333


Q ss_pred             HHHh----cCCCCc------ceEEeeeEEecCeEEEEEeccCCCCHHHHH--HHcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 018018          120 KINQ----SSQCPY------VVVCYQSFYSNGAISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHE  187 (362)
Q Consensus       120 ~~~~----~l~hp~------I~~~~~~~~~~~~~~lV~e~~~~gsL~~~l--~~~~~l~~~~~~~i~~ql~~al~~LH~~  187 (362)
                      +-..    .+.|-+      |.++|-.  ....-.|+|||++|..+.+.-  .+ ..++...+...+.+...-+  +=. 
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~q--If~-  319 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLEQ--IFK-  319 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHHH--HHh-
Confidence            3222    233433      4444432  245678999999998776654  33 3555554444333332222  222 


Q ss_pred             CCeEeecCCCCcEEEcc----CCcEEEeeccCCcccc
Q 018018          188 KHIIHRDLKPSNLLINH----RGEVKITDFGVSAIMA  220 (362)
Q Consensus       188 ~~ivH~Dlkp~NIll~~----~~~vkl~DFg~a~~~~  220 (362)
                      .|++|.|-+|.||+++.    ++.+.+.|||+.....
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            68999999999999984    6689999999987654

>PLN02876 acyl-CoA dehydrogenase

Probab=98.35  E-value=5.4e-06  Score=86.75  Aligned_cols=81  Identities=16%  Similarity=0.217  Sum_probs=56.1

Q ss_pred             eeeeeeeeCCeEEEEEEEccCC--cEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcc--eEEeeeEEec---CeEEE
Q 018018           74 TIKVVGKGSGGIVQLVQHKWTG--QFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYV--VVCYQSFYSN---GAISI  145 (362)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I--~~~~~~~~~~---~~~~l  145 (362)
                      .++.++.|.+..+|++.....+  ..+++|+............+.+|+++++.+. |+++  .+++..+.+.   +..|+
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            3578899999999998765432  4678887654322222346788999988885 5554  6666665543   56889


Q ss_pred             EEeccCCCC
Q 018018          146 ILEYMDGGS  154 (362)
Q Consensus       146 V~e~~~~gs  154 (362)
                      ||||++|..
T Consensus       122 VME~v~G~~  130 (822)
T PLN02876        122 IMEYLEGRI  130 (822)
T ss_pred             EEEecCCcc
Confidence            999998864

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.33  E-value=7e-06  Score=73.25  Aligned_cols=135  Identities=14%  Similarity=0.097  Sum_probs=79.3

Q ss_pred             eeeeeCC-eEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeEEEEEeccCCCC
Q 018018           77 VVGKGSG-GIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGS  154 (362)
Q Consensus        77 ~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~~lV~e~~~~gs  154 (362)
                      .|..|.. +.||++...  +..+.+|+.....    ...+.+|+++++.+. +--+.+++......+..++||++++|.+
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~   78 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVP   78 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCcc
Confidence            3445555 788888653  4678889875432    234556777665553 2335566666655667899999999987


Q ss_pred             HHHHHH----------------HcCCC-------CHH--HHHHH-----------------------HHHHHHHHHHHH-
Q 018018          155 LADFLK----------------KVKTI-------PEE--YLAAI-----------------------CEQVLKGLLYLH-  185 (362)
Q Consensus       155 L~~~l~----------------~~~~l-------~~~--~~~~i-----------------------~~ql~~al~~LH-  185 (362)
                      +.....                .-..+       ...  .....                       ..+++..|.... 
T Consensus        79 l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  158 (244)
T cd05150          79 AAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP  158 (244)
T ss_pred             HhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence            764320                00011       100  00000                       111111111111 


Q ss_pred             --hCCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          186 --HEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       186 --~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                        ....++|+|+.|.||+++.++.+.|+||+.|.
T Consensus       159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence              01348999999999999988778899999764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=98.29  E-value=8e-08  Score=100.97  Aligned_cols=214  Identities=12%  Similarity=-0.014  Sum_probs=152.5

Q ss_pred             HHHHHHHHHHHHhcCCCCcceEEeeeEE--ecCeEEEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHH
Q 018018          111 ARRQIAQELKINQSSQCPYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYL  184 (362)
Q Consensus       111 ~~~~~~~e~~~~~~l~hp~I~~~~~~~~--~~~~~~lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~al~~L  184 (362)
                      .++....|.+..+...|+++...+.-..  +....+.+++|+.+|.+++.+-++    ..+.+.-+.....+.+.+..-+
T Consensus      1272 lkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ 1351 (2724)
T KOG1826|consen 1272 LKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVI 1351 (2724)
T ss_pred             HHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchh
Confidence            3444556666666778998876665433  346678999999999999999553    3455555666666657777777


Q ss_pred             HhCCC----eEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHH
Q 018018          185 HHEKH----IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL  260 (362)
Q Consensus       185 H~~~~----ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~  260 (362)
                      |+..+    .+|+++|+.|.+|..+-++|++++|+.+.............+++.|++|++...-.++.++|+|..|+.+|
T Consensus      1352 ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1352 LSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred             hhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence            76322    79999999999999999999999999985444444445567888999999999888999999999999999


Q ss_pred             HHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       261 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      ++..|..+|..        ..+..+..+.+.......+.-.|.+.-.....+|-+.-..||.-..++.-+.|
T Consensus      1432 ~rs~~n~~fi~--------flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~ 1495 (2724)
T KOG1826|consen 1432 LRSDGNAYFIF--------FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHF 1495 (2724)
T ss_pred             HHhcccHHHHH--------HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccc
Confidence            99988877731        11222333333333333333344555556666666666789998888887776

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.27  E-value=6e-06  Score=68.46  Aligned_cols=131  Identities=27%  Similarity=0.307  Sum_probs=91.2

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcce-EEeeeEEecCeEEEEEecc
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV-VCYQSFYSNGAISIILEYM  150 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~-~~~~~~~~~~~~~lV~e~~  150 (362)
                      ....+.|++|++|.||++..  .|..+|+|+-+.   ++.+..+..|++++..+...++. ++|.+    +..++.|||+
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~---ds~r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i   94 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRR---DSPRRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYI   94 (201)
T ss_pred             hhhhhhhhcccccEEEEeec--cCceEEEEEecC---CcchhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhh
Confidence            34567899999999999866  577999998653   34567788999998888766554 34433    2334559999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCC-CCcEEEccCCcEEEeeccCCccc
Q 018018          151 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK-PSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       151 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlk-p~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      .|.+|.++....   +.    +-...+++. +|.-+..||-|+.|. |..+++-.++.+.|+||..|+..
T Consensus        95 ~G~~L~~~~~~~---~r----k~l~~vlE~-a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          95 DGRPLGKLEIGG---DR----KHLLRVLEK-AYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             cCcchhhhhhcc---cH----HHHHHHHHH-HHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            998888776532   22    223344444 333344899999997 55555556669999999988743

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.21  E-value=4.9e-05  Score=64.98  Aligned_cols=126  Identities=25%  Similarity=0.359  Sum_probs=89.3

Q ss_pred             cCceeeeeeeeeCC-eEEEEEEEccCCcEEEEEEeec---ccc----------h-------HHHHHHHHHHHHHhcC---
Q 018018           70 EDIDTIKVVGKGSG-GIVQLVQHKWTGQFFALKVIQM---NVE----------E-------SARRQIAQELKINQSS---  125 (362)
Q Consensus        70 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~---~~~----------~-------~~~~~~~~e~~~~~~l---  125 (362)
                      .+++.++.||.|.- |.||+++.  +|+.||+|+++.   ...          +       ....-|..|.+...++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78999999999999 99999977  588999999421   100          0       1223466777765544   


Q ss_pred             CCCcc--eEEeeeEEec------------------CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Q 018018          126 QCPYV--VVCYQSFYSN------------------GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH  185 (362)
Q Consensus       126 ~hp~I--~~~~~~~~~~------------------~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH  185 (362)
                      .+.++  ++++++..-.                  ....||.||++...         .+    ...-+.+|++-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~----~~~~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PL----QIRDIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------cc----chhHHHHHHHHHHHHH
Confidence            45556  8888876321                  12467888876643         22    2334578888889999


Q ss_pred             hCCCeEeecCCCCcEEEccCCcEEEeeccCC
Q 018018          186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVS  216 (362)
Q Consensus       186 ~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a  216 (362)
                      . .||+-+|+++.|..   +  -+|+|||.+
T Consensus       182 k-~gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  182 K-LGIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             H-CCeeeccCcccccc---C--CEEEecccC
Confidence            8 99999999999987   2  489999854

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.20  E-value=7.9e-06  Score=72.56  Aligned_cols=73  Identities=10%  Similarity=0.014  Sum_probs=43.2

Q ss_pred             eeeeeeCCe-EEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCC---cceEEeeeEEec---CeEEEEEe
Q 018018           76 KVVGKGSGG-IVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP---YVVVCYQSFYSN---GAISIILE  148 (362)
Q Consensus        76 ~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp---~I~~~~~~~~~~---~~~~lV~e  148 (362)
                      +.++.|+.. .||.+     +..+++|+.+..   .....+.+|.+++..+...   .+...+......   ...+++|+
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~---~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~   74 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA---GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR   74 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCcc---chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence            567777776 48876     235778875432   2334677888887665421   233333332221   24588999


Q ss_pred             ccCCCCHH
Q 018018          149 YMDGGSLA  156 (362)
Q Consensus       149 ~~~~gsL~  156 (362)
                      +++|.++.
T Consensus        75 ~i~G~~l~   82 (235)
T cd05155          75 WLEGETAT   82 (235)
T ss_pred             eecCCCCC
Confidence            99987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.09  E-value=5.3e-05  Score=69.89  Aligned_cols=136  Identities=18%  Similarity=0.258  Sum_probs=94.7

Q ss_pred             eeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc----c--------------------hHH-HHHHHHHHHHHhcCCC--
Q 018018           75 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV----E--------------------ESA-RRQIAQELKINQSSQC--  127 (362)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~--------------------~~~-~~~~~~e~~~~~~l~h--  127 (362)
                      -..|..|--+.||.|... +|..+|||+++.+.    +                    ... .-....|++-+.+++.  
T Consensus       149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            356888999999998765 78889999986441    0                    001 1112345555555443  


Q ss_pred             ---CcceEEeeeEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc
Q 018018          128 ---PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH  204 (362)
Q Consensus       128 ---p~I~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~  204 (362)
                         |--+-+       ....|||+|+....-..-.-..-.++...+..+..|++.-+.-|-...++||.||+--|+|+ .
T Consensus       228 IP~PePIlL-------k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-h  299 (520)
T KOG2270|consen  228 IPCPEPILL-------KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-H  299 (520)
T ss_pred             CCCCCceee-------ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-E
Confidence               333322       23479999995422222222234688889999999999999999777899999999999999 7


Q ss_pred             CCcEEEeeccCCccc
Q 018018          205 RGEVKITDFGVSAIM  219 (362)
Q Consensus       205 ~~~vkl~DFg~a~~~  219 (362)
                      +|.+.++|.+.+...
T Consensus       300 dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  300 DGKLYIIDVSQSVEH  314 (520)
T ss_pred             CCEEEEEEccccccC
Confidence            899999999876543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.08  E-value=0.00011  Score=63.19  Aligned_cols=128  Identities=23%  Similarity=0.350  Sum_probs=86.4

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc---------------chHHHHHHHHHHHHHhcC------CCCcceEEe
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---------------EESARRQIAQELKINQSS------QCPYVVVCY  134 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~~~~e~~~~~~l------~hp~I~~~~  134 (362)
                      ..||+|+.-.||.  ++. +....||+.....               .....++..+|+.-...+      .+.+|.+++
T Consensus         7 ~~i~~G~~R~cy~--HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQ--HPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEE--CCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            5799999999976  443 3446688886654               011223444444433333      378899999


Q ss_pred             eeEEecCeEEEEEeccC------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC--
Q 018018          135 QSFYSNGAISIILEYMD------GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG--  206 (362)
Q Consensus       135 ~~~~~~~~~~lV~e~~~------~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~--  206 (362)
                      |..+++.-.-+|+|.+.      ..+|.+++.+ +.++. .....+.   +-..||-+ .+|+.+|++|.||++...+  
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~---~f~~~l~~-~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALD---EFKRYLLD-HHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHH---HHHHHHHH-cCCeecCCCcccEEEEecCCC
Confidence            99999988899998753      2368888855 45665 3333333   44556666 8899999999999996433  


Q ss_pred             --cEEEee
Q 018018          207 --EVKITD  212 (362)
Q Consensus       207 --~vkl~D  212 (362)
                        .+.|+|
T Consensus       158 ~~~lvlID  165 (199)
T PF10707_consen  158 EFRLVLID  165 (199)
T ss_pred             ceEEEEEe
Confidence              577777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PRK10593 hypothetical protein; Provisional

Probab=97.94  E-value=0.00025  Score=65.27  Aligned_cols=79  Identities=10%  Similarity=0.000  Sum_probs=52.3

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCC---CcceEEeeeEEe---cCeEEE
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC---PYVVVCYQSFYS---NGAISI  145 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h---p~I~~~~~~~~~---~~~~~l  145 (362)
                      ..-.+.||.|..+.||.....  +..+++|..+...   ....+..|+..++.+.-   ..+.++++.+..   .+..++
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L   90 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDS--QGNPMPLMARSFS---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL   90 (297)
T ss_pred             hheeeecCCccceeEEEEEcC--CCCEEEEEecccc---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence            344578999999999998653  2357778754211   12456677777766542   345666665543   467899


Q ss_pred             EEeccCCCCH
Q 018018          146 ILEYMDGGSL  155 (362)
Q Consensus       146 V~e~~~~gsL  155 (362)
                      |||+++|.++
T Consensus        91 VmE~i~G~~~  100 (297)
T PRK10593         91 LLERLRGVSV  100 (297)
T ss_pred             EEeccCCEec
Confidence            9999998764

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.84  E-value=6.9e-05  Score=64.03  Aligned_cols=99  Identities=26%  Similarity=0.219  Sum_probs=77.5

Q ss_pred             HHHHHHhcCCC-CcceEEeeeEEecCeEEEEEeccCCCCHHH---HHHHcCCCCHHHHHHHHHHHHHHHHHHHhC--CCe
Q 018018          117 QELKINQSSQC-PYVVVCYQSFYSNGAISIILEYMDGGSLAD---FLKKVKTIPEEYLAAICEQVLKGLLYLHHE--KHI  190 (362)
Q Consensus       117 ~e~~~~~~l~h-p~I~~~~~~~~~~~~~~lV~e~~~~gsL~~---~l~~~~~l~~~~~~~i~~ql~~al~~LH~~--~~i  190 (362)
                      .|.-+++.+.+ +++.+++|.+.+    ++|+||...+++..   .+......++..+.+++.++++.+.+++..  ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            46777777776 689999998742    67899998766542   222223568999999999999999999851  237


Q ss_pred             EeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          191 IHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       191 vH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      .-.|++++|+.++.++++|++|...+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            77899999999999999999999876544

Proteins in this uncharacterised family are described as transmembrane proteins.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.81  E-value=0.00033  Score=64.80  Aligned_cols=143  Identities=19%  Similarity=0.230  Sum_probs=79.0

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-----CCcceEEee---eEEecC
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-----CPYVVVCYQ---SFYSNG  141 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----hp~I~~~~~---~~~~~~  141 (362)
                      +....++.++.|....+|++...  +..+++|+........   .+..|.+++..+.     .|.++.-.+   .....+
T Consensus        22 ~~~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~~~---~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g   96 (307)
T TIGR00938        22 GELLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRVKAE---ELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG   96 (307)
T ss_pred             CCceeccccCCccccceEEEEeC--CCcEEEEEecCCCCHH---HHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence            34445677888888899988653  4468889875432222   2334444444432     233332111   111246


Q ss_pred             eEEEEEeccCCCCHH----H-------HHH---H-cCCC--------CHHH-----HH----------HHHHHHHHHHHH
Q 018018          142 AISIILEYMDGGSLA----D-------FLK---K-VKTI--------PEEY-----LA----------AICEQVLKGLLY  183 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~----~-------~l~---~-~~~l--------~~~~-----~~----------~i~~ql~~al~~  183 (362)
                      ..+++++|++|.++.    .       .+.   . ...+        ....     ..          .....+...+++
T Consensus        97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~  176 (307)
T TIGR00938        97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY  176 (307)
T ss_pred             eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence            678999999885432    1       110   0 0000        0000     00          001122334444


Q ss_pred             HHh------CCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          184 LHH------EKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       184 LH~------~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      +..      ..+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            432      2679999999999999988877899999763

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.79  E-value=0.00023  Score=63.01  Aligned_cols=75  Identities=20%  Similarity=0.205  Sum_probs=45.1

Q ss_pred             eeeeeeeCCeEEEEEEEcc-CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCc-ceEEeeeEEecCeEEEEEeccCC
Q 018018           75 IKVVGKGSGGIVQLVQHKW-TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY-VVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~-I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      ++.|..|-...+|++.... ++..|++|+.......  .....+|+.+++.+...+ ..+++..+.  +  .+||||++|
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G   76 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPG   76 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCC
Confidence            4678888888999987653 3578999986543111  112235666666654322 233333221  1  379999998


Q ss_pred             CCH
Q 018018          153 GSL  155 (362)
Q Consensus       153 gsL  155 (362)
                      .++
T Consensus        77 ~~l   79 (235)
T cd05157          77 RTL   79 (235)
T ss_pred             CcC
Confidence            765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.70  E-value=0.00063  Score=62.46  Aligned_cols=139  Identities=13%  Similarity=0.097  Sum_probs=78.7

Q ss_pred             eeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCc--ceEEeee------EEecCeEE
Q 018018           73 DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY--VVVCYQS------FYSNGAIS  144 (362)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~--I~~~~~~------~~~~~~~~  144 (362)
                      .-++.+..|....+|++..  ++..+++|+.... .   ...+..|+.++..+.+.+  +..++..      ....+..+
T Consensus        17 ~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~-~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~   90 (296)
T cd05153          17 LSFEGISAGIENTNYFVTT--DSGRYVLTLFEKV-S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA   90 (296)
T ss_pred             hheecccCccccceEEEEe--CCCcEEEEEcCCC-C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence            3456788888889998865  3457899987642 2   233445555555543221  3333221      12345678


Q ss_pred             EEEeccCCCCHHH----HHH----------H-cCCC----------CHHHH--H--------HHHHHHHHHHHHHHh---
Q 018018          145 IILEYMDGGSLAD----FLK----------K-VKTI----------PEEYL--A--------AICEQVLKGLLYLHH---  186 (362)
Q Consensus       145 lV~e~~~~gsL~~----~l~----------~-~~~l----------~~~~~--~--------~i~~ql~~al~~LH~---  186 (362)
                      +|++|++|.++..    ...          . ...+          .+...  .        .....+..++.++..   
T Consensus        91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~  170 (296)
T cd05153          91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP  170 (296)
T ss_pred             EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence            9999999876421    110          0 0000          00000  0        011112233344332   


Q ss_pred             ---CCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          187 ---EKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       187 ---~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                         ..+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence               2579999999999999887777899999764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.70  E-value=0.0017  Score=60.41  Aligned_cols=30  Identities=27%  Similarity=0.362  Sum_probs=25.8

Q ss_pred             CCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          188 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       188 ~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      .+++|+|+.|.||+++.+...-|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            589999999999999866556899999764

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.68  E-value=0.0014  Score=62.45  Aligned_cols=78  Identities=14%  Similarity=0.080  Sum_probs=51.9

Q ss_pred             eeeeeeeCCeEEEEEEEccCCcEEEEEEeecc----cc--hHHHHHHHHHHHHHhcCC---CCcceEEeeeEEecCeEEE
Q 018018           75 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN----VE--ESARRQIAQELKINQSSQ---CPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~--~~~~~~~~~e~~~~~~l~---hp~I~~~~~~~~~~~~~~l  145 (362)
                      .+.||.|.+..||.+.....++.++||.-...    ..  .....+...|.+.+..+.   ..++.+++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            46899999999999998643358999984311    01  123345566666666542   2456666655  4566889


Q ss_pred             EEeccCCCC
Q 018018          146 ILEYMDGGS  154 (362)
Q Consensus       146 V~e~~~~gs  154 (362)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.65  E-value=0.00017  Score=64.93  Aligned_cols=134  Identities=14%  Similarity=0.154  Sum_probs=72.5

Q ss_pred             eeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcc-eEEeeeEEecCeEEEEEeccCCCCH
Q 018018           77 VVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV-VVCYQSFYSNGAISIILEYMDGGSL  155 (362)
Q Consensus        77 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I-~~~~~~~~~~~~~~lV~e~~~~gsL  155 (362)
                      .+..|-...+|++.  .++..+++|+.......- .-...+|..+++.+...++ .+++..  ..  -++|+||++|.++
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~i~~--~~--~~~v~e~i~G~~~   75 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL-GVDRQREYQILQALSALGLAPKPILV--NE--HWLLVEWLEGEVI   75 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc-cCcHHHHHHHHHHHHhcCCCCceEEE--eC--CEEEEEeccCccc
Confidence            34567778899886  357788899754331111 0123556666666543222 222322  22  3689999998665


Q ss_pred             HHH--------------HHHc-------CCCCHH-HHHHHHHHH---------HHHHHHHHh-------CCCeEeecCCC
Q 018018          156 ADF--------------LKKV-------KTIPEE-YLAAICEQV---------LKGLLYLHH-------EKHIIHRDLKP  197 (362)
Q Consensus       156 ~~~--------------l~~~-------~~l~~~-~~~~i~~ql---------~~al~~LH~-------~~~ivH~Dlkp  197 (362)
                      ...              +.+-       .+++.. .+..+..++         ...+..+-.       ...++|+|+.|
T Consensus        76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~  155 (256)
T TIGR02721        76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA  155 (256)
T ss_pred             ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence            321              1110       111211 111211111         111222211       13589999999


Q ss_pred             CcEEEccCCcEEEeeccCCcc
Q 018018          198 SNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       198 ~NIll~~~~~vkl~DFg~a~~  218 (362)
                      .||+++.++ +.|+||..|..
T Consensus       156 ~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       156 YNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcEEEeCCC-CEEEeccccCc
Confidence            999998877 78999997643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.54  E-value=6.1e-05  Score=68.43  Aligned_cols=136  Identities=15%  Similarity=0.232  Sum_probs=93.0

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--------ch-----------H--HHHHHHHHHHHHhcCCCC--
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--------EE-----------S--ARRQIAQELKINQSSQCP--  128 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~-----------~--~~~~~~~e~~~~~~l~hp--  128 (362)
                      +.+++.||-|--+.||++-+. .|.+.++|+-+...        +.           .  .+-...+|...|+.+.-.  
T Consensus        94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            456789999999999999875 68889998643210        00           0  112234666667666431  


Q ss_pred             cceEEeeeEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcE
Q 018018          129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV  208 (362)
Q Consensus       129 ~I~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~v  208 (362)
                      -+.+.+    +....++|||++.|-+|...-.-      ..+..+...+..-+.-|-. +|+||+|+.--||++++++.+
T Consensus       173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~-~GlIHgDFNEFNimv~dd~~i  241 (465)
T KOG2268|consen  173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLAN-HGLIHGDFNEFNIMVKDDDKI  241 (465)
T ss_pred             CCCCcc----cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHH-cCceecccchheeEEecCCCE
Confidence            133333    34677899999998777655422      1233455556666667776 999999999999999999999


Q ss_pred             EEeeccCCccc
Q 018018          209 KITDFGVSAIM  219 (362)
Q Consensus       209 kl~DFg~a~~~  219 (362)
                      +++||-.....
T Consensus       242 ~vIDFPQmvS~  252 (465)
T KOG2268|consen  242 VVIDFPQMVST  252 (465)
T ss_pred             EEeechHhhcc
Confidence            99999865443

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.36  E-value=0.0016  Score=60.05  Aligned_cols=143  Identities=15%  Similarity=0.203  Sum_probs=80.5

Q ss_pred             eeeeeeeeeCCeEEEEEEEccCCcEEEEEEee-cccchHHHHHHHHHHHHHhcCCC--CcceEEeeeEEecC--eEEEEE
Q 018018           73 DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSSQC--PYVVVCYQSFYSNG--AISIIL  147 (362)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~~~~~~~~~~~~e~~~~~~l~h--p~I~~~~~~~~~~~--~~~lV~  147 (362)
                      .+++.+..|..-.+|.....  ++.+++. .+ ............+|+.+++.+.-  .-+...++.+.++.  ..+.||
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            34444444444455555443  7888888 33 23344455667788888777543  22334455555444  779999


Q ss_pred             eccCCCCHH------------------HHHHHcC--------------CCCHHHHHHHHHHH--------------HHHH
Q 018018          148 EYMDGGSLA------------------DFLKKVK--------------TIPEEYLAAICEQV--------------LKGL  181 (362)
Q Consensus       148 e~~~~gsL~------------------~~l~~~~--------------~l~~~~~~~i~~ql--------------~~al  181 (362)
                      +|++|..+.                  ++|..-.              ......+..+..+.              ..-.
T Consensus       105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~  184 (321)
T COG3173         105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI  184 (321)
T ss_pred             EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence            999883221                  1111000              00111111111111              1123


Q ss_pred             HHHHhC-------CCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          182 LYLHHE-------KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       182 ~~LH~~-------~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      .+++..       ..++|+|+.+.|++++.++-+=+.||+++..
T Consensus       185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            344321       3489999999999999998899999998765

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.32  E-value=0.0011  Score=61.42  Aligned_cols=106  Identities=21%  Similarity=0.244  Sum_probs=72.8

Q ss_pred             ecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          139 SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       139 ~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      +..+.|++|++- |+++...    ..-...++..++++.+..++-+.....+-|||+...||||+ +|+|-|+||-+++.
T Consensus       297 e~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             CceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            345567778876 4454322    23456788899999999998888767799999999999998 99999999999984


Q ss_pred             cccCCCCCCccccCCcccCcceecCCCCCccccHHHHH
Q 018018          219 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG  256 (362)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  256 (362)
                      -.....     +.-...--|-.+.| .-+..-+||-+-
T Consensus       371 ~~~q~~-----isy~rldhp~lF~G-~dd~QFeIYrlM  402 (488)
T COG5072         371 SYSQGI-----ISYNRLDHPDLFNG-VDDYQFEIYRLM  402 (488)
T ss_pred             ccCCce-----eeccccCchhhhcC-ccceeeeHHHHH
Confidence            332221     11112334545554 336777887643

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.22  E-value=0.0025  Score=58.00  Aligned_cols=30  Identities=23%  Similarity=0.574  Sum_probs=25.0

Q ss_pred             CeEeecCCCCcEEEccCCc-EEEeeccCCcc
Q 018018          189 HIIHRDLKPSNLLINHRGE-VKITDFGVSAI  218 (362)
Q Consensus       189 ~ivH~Dlkp~NIll~~~~~-vkl~DFg~a~~  218 (362)
                      .++|+|++|.||+++.+++ .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999987555 56999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.21  E-value=0.003  Score=58.14  Aligned_cols=76  Identities=18%  Similarity=0.098  Sum_probs=44.2

Q ss_pred             eeeeeeeCCeEEEEEEEcc------CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCc-ceEEeeeEEecCeEEEEE
Q 018018           75 IKVVGKGSGGIVQLVQHKW------TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY-VVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~-I~~~~~~~~~~~~~~lV~  147 (362)
                      ++.+..|-.-.+|++....      .++.+++|+.....  .......+|.+++..+...+ ..+++..+. +   .+|+
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~--~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~   76 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV--ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIE   76 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC--cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchh
Confidence            3556667777889887643      25789999975432  12233456666555543222 223343332 2   3589


Q ss_pred             eccCCCCHH
Q 018018          148 EYMDGGSLA  156 (362)
Q Consensus       148 e~~~~gsL~  156 (362)
                      +|++|.++.
T Consensus        77 e~i~G~~l~   85 (302)
T cd05156          77 EFIPSRTLT   85 (302)
T ss_pred             heeCCCcCC
Confidence            999887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.16  E-value=0.0044  Score=57.99  Aligned_cols=81  Identities=14%  Similarity=0.020  Sum_probs=49.3

Q ss_pred             eeeeeCCeEEEEEEEccCCcEEEEEEee----c-c-cchHHHHHHHHHHHHHhcCC--CC-cceEEeeeEEecCeEEEEE
Q 018018           77 VVGKGSGGIVQLVQHKWTGQFFALKVIQ----M-N-VEESARRQIAQELKINQSSQ--CP-YVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        77 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~----~-~-~~~~~~~~~~~e~~~~~~l~--hp-~I~~~~~~~~~~~~~~lV~  147 (362)
                      .||.|....||.+.+...++.++||.-.    . . ..+....+..-|...++...  .| .+.++|.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            4788999999999986444679999632    1 1 11223344455666655432  24 45556543  566778999


Q ss_pred             eccCCC-CHHHHH
Q 018018          148 EYMDGG-SLADFL  159 (362)
Q Consensus       148 e~~~~g-sL~~~l  159 (362)
                      |+++.. .|...+
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            999643 344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.98  E-value=0.0032  Score=60.79  Aligned_cols=166  Identities=20%  Similarity=0.233  Sum_probs=99.2

Q ss_pred             HHHHHHHHHHhcCCCCcceEEeeeEEe-cCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeE
Q 018018          113 RQIAQELKINQSSQCPYVVVCYQSFYS-NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII  191 (362)
Q Consensus       113 ~~~~~e~~~~~~l~hp~I~~~~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~iv  191 (362)
                      ..+.-....++.+.|+|...+...-.. .....+|+|++ +.||.+.+..+. +-.....              . +++.
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~-~~~~   89 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------A-HGVL   89 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------c-cccc
Confidence            446677788899999999998876542 34588899999 569999987744 2111110              1 2333


Q ss_pred             eecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCC
Q 018018          192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP  271 (362)
Q Consensus       192 H~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~  271 (362)
                      |-.     +       ++.+| -++.    ..   ....|                +++||||+|.++.++.-|...+..
T Consensus        90 ~~~-----~-------~~~td-~~~t----~~---~~~~~----------------pKsdVwsl~~i~~el~L~~~l~~~  133 (725)
T KOG1093|consen   90 HLN-----I-------IYITD-HFLT----KY---PSPIG----------------PKSDVWSLGFIILELYLGISLEAE  133 (725)
T ss_pred             eeh-----h-------hhccc-cccc----cC---CCCCC----------------cchhhhhHHHHHHHHHHhhHHHHH
Confidence            322     2       22333 1110    00   11111                399999999999999998766643


Q ss_pred             CccCCchhhHHHHHHHHhcCCCCC-------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          272 PEQQDGWTSFYELMEAIVDQPPPS-------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      ...    ....+.+.+........       .....++....++...|+...|..||...++.+|+-|...
T Consensus       134 ~~~----s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  134 LTE----SEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHH----HHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            221    11111111111100000       0012245567889999999999999999999999887544

>PLN02236 choline kinase

Probab=96.84  E-value=0.015  Score=54.77  Aligned_cols=138  Identities=14%  Similarity=0.148  Sum_probs=74.4

Q ss_pred             eeeeeeeeCCeEEEEEEEcc----CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcce-EEeeeEEecCeEEEEEe
Q 018018           74 TIKVVGKGSGGIVQLVQHKW----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV-VCYQSFYSNGAISIILE  148 (362)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~-~~~~~~~~~~~~~lV~e  148 (362)
                      .++.|..|-.-.+|++....    .++.|++|+..... +.... -.+|..+++.+...++. ++++.+. .+   .|.+
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v~e  113 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFD-RDDEIRTFECMSRHGQGPRLLGRFP-NG---RVEE  113 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-Ceeec-hHHHHHHHHHHHHcCCCCceEEEEC-Cc---eEEE
Confidence            34566667778899987432    24689999875442 21111 24566665554432222 3334332 22   5789


Q ss_pred             ccCCCCHHHH-------H-------HHc---C------CCCHHHHHHHHHHH-----------------HHHHHHH----
Q 018018          149 YMDGGSLADF-------L-------KKV---K------TIPEEYLAAICEQV-----------------LKGLLYL----  184 (362)
Q Consensus       149 ~~~~gsL~~~-------l-------~~~---~------~l~~~~~~~i~~ql-----------------~~al~~L----  184 (362)
                      |+++.++...       +       .+-   .      ......+..+..++                 ...+..|    
T Consensus       114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~  193 (344)
T PLN02236        114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL  193 (344)
T ss_pred             eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence            9877665421       1       100   0      01122222332111                 1111112    


Q ss_pred             Hh---CCCeEeecCCCCcEEEcc-CCcEEEeeccCCc
Q 018018          185 HH---EKHIIHRDLKPSNLLINH-RGEVKITDFGVSA  217 (362)
Q Consensus       185 H~---~~~ivH~Dlkp~NIll~~-~~~vkl~DFg~a~  217 (362)
                      ..   ...++|+|+++.||+++. ++.+.++||..|.
T Consensus       194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            11   135899999999999976 4689999998764

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.79  E-value=0.028  Score=53.67  Aligned_cols=82  Identities=21%  Similarity=0.131  Sum_probs=49.9

Q ss_pred             eeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc---cch---HHHHHHHHHHHHHhcCC---CCcceEEeeeEEecCeEE
Q 018018           74 TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN---VEE---SARRQIAQELKINQSSQ---CPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~---~~~~~~~~e~~~~~~l~---hp~I~~~~~~~~~~~~~~  144 (362)
                      ..+.||.|..-.||++.+.  +..++||.-...   ...   ....+...|+..++.+.   ..++.+++.++.  ...+
T Consensus        36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            4678899999999999873  456889975411   011   12233334455554432   246667776644  5578


Q ss_pred             EEEeccCC--CCHHHHH
Q 018018          145 IILEYMDG--GSLADFL  159 (362)
Q Consensus       145 lV~e~~~~--gsL~~~l  159 (362)
                      ++|||+++  ..+.+.+
T Consensus       112 lvME~L~~~~~ilr~~L  128 (418)
T PLN02756        112 IGMRYLEPPHIILRKGL  128 (418)
T ss_pred             EEEeecCCcceehhhhh
Confidence            89999976  2454444

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.76  E-value=0.012  Score=53.74  Aligned_cols=75  Identities=16%  Similarity=0.084  Sum_probs=44.3

Q ss_pred             eeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC---CCCcceEEeeeEEecCeEEEEEec
Q 018018           73 DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS---QCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l---~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +-.+.++.|....+|.+.  .+++.+.+|+-...    ....+..|+.-++.|   ..-.+.+.+......+..+||+||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~----~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~   93 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES----GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF   93 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG----GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChh----hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence            445778989999999887  57889999987622    223455566555555   334566777777777777999999


Q ss_pred             cCCC
Q 018018          150 MDGG  153 (362)
Q Consensus       150 ~~~g  153 (362)
                      ++.+
T Consensus        94 l~~~   97 (288)
T PF03881_consen   94 LEMG   97 (288)
T ss_dssp             ----
T ss_pred             ecCC
Confidence            9766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.63  E-value=0.099  Score=48.17  Aligned_cols=29  Identities=28%  Similarity=0.501  Sum_probs=25.4

Q ss_pred             CCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          188 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       188 ~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57999999999999987 678999999653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.59  E-value=0.016  Score=54.25  Aligned_cols=29  Identities=31%  Similarity=0.580  Sum_probs=25.2

Q ss_pred             eEeecCCCCcEEEcc-CCcEEEeeccCCcc
Q 018018          190 IIHRDLKPSNLLINH-RGEVKITDFGVSAI  218 (362)
Q Consensus       190 ivH~Dlkp~NIll~~-~~~vkl~DFg~a~~  218 (362)
                      ++|.|+.+.||++++ ++.++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            899999999999975 57899999997643

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.57  E-value=0.048  Score=50.41  Aligned_cols=31  Identities=16%  Similarity=0.276  Sum_probs=27.7

Q ss_pred             CCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       188 ~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      .+++|+|+.+.|++++.++.+.++||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4799999999999999999999999997643

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.50  E-value=0.02  Score=54.36  Aligned_cols=83  Identities=18%  Similarity=0.135  Sum_probs=52.8

Q ss_pred             eeeeeeeCCeEEEEEEEccCCcEEEEEEe----ecc-cchHHHHHHHHHHHHHhcCC--CC-cceEEeeeEEecCeEEEE
Q 018018           75 IKVVGKGSGGIVQLVQHKWTGQFFALKVI----QMN-VEESARRQIAQELKINQSSQ--CP-YVVVCYQSFYSNGAISII  146 (362)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~----~~~-~~~~~~~~~~~e~~~~~~l~--hp-~I~~~~~~~~~~~~~~lV  146 (362)
                      .+.||.|.-..||++.+...++.++||.-    +.. .-.....+..-|.+.++...  .| .+.++|.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            57889999999999998544567999963    211 11233455566666665542  34 45566643  56677899


Q ss_pred             EeccCCC-CHHHHH
Q 018018          147 LEYMDGG-SLADFL  159 (362)
Q Consensus       147 ~e~~~~g-sL~~~l  159 (362)
                      ||+++.. .|.+.+
T Consensus       112 MEdL~~~~ilR~~L  125 (409)
T PRK12396        112 MEDLSDHTILRTAL  125 (409)
T ss_pred             HHhCcccHHHHHHH
Confidence            9998643 344444

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.33  E-value=0.017  Score=50.17  Aligned_cols=102  Identities=18%  Similarity=0.161  Sum_probs=64.2

Q ss_pred             EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHH
Q 018018           97 FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQ  176 (362)
Q Consensus        97 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~q  176 (362)
                      +..+|+++...-.-....+..+.++++++.  .|+++..-  ....+-++.|.|-...             .....++.-
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------------i~~~N~i~a  149 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------------INFSNFITA  149 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------------cchhHHHHH
Confidence            344555543211112234566777776653  56666643  4455678889884311             011122223


Q ss_pred             HHHHHHHHHh-CCCeEeecCCCCcEEEccCCcEEEeeccC
Q 018018          177 VLKGLLYLHH-EKHIIHRDLKPSNLLINHRGEVKITDFGV  215 (362)
Q Consensus       177 l~~al~~LH~-~~~ivH~Dlkp~NIll~~~~~vkl~DFg~  215 (362)
                      -+.+|.-.|+ ..+.+|+|..|+||+-|..|.+||.|=++
T Consensus       150 gi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  150 GIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             hHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            3567888884 46799999999999999999999999775

The function of this family is unknown.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.29  E-value=0.012  Score=55.56  Aligned_cols=63  Identities=27%  Similarity=0.454  Sum_probs=48.2

Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG  206 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~  206 (362)
                      ..++-+|..|.++..+++. ...++.....++.-.+.|+-.+---.+++|.|++|.||++..+.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~  382 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK  382 (565)
T ss_pred             ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence            4566678888899999876 44566777788887888876554446899999999999996544

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.79  E-value=0.67  Score=43.20  Aligned_cols=28  Identities=21%  Similarity=0.304  Sum_probs=23.9

Q ss_pred             CCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          188 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       188 ~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      .+++|+|+.+.||+++ + .+.|+||+-+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            5789999999999995 4 57899999764

>PRK06148 hypothetical protein; Provisional

Probab=95.71  E-value=0.35  Score=52.19  Aligned_cols=31  Identities=26%  Similarity=0.549  Sum_probs=26.1

Q ss_pred             CCeEeecCCCCcEEEccCC--cEE-EeeccCCcc
Q 018018          188 KHIIHRDLKPSNLLINHRG--EVK-ITDFGVSAI  218 (362)
Q Consensus       188 ~~ivH~Dlkp~NIll~~~~--~vk-l~DFg~a~~  218 (362)
                      .++||+|+.+.||+++.++  ++. |+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999998775  555 999997644

>KOG2269 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=95.45  E-value=0.088  Score=48.40  Aligned_cols=86  Identities=23%  Similarity=0.258  Sum_probs=66.3

Q ss_pred             CCCCcceEEeeeEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc
Q 018018          125 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH  204 (362)
Q Consensus       125 l~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~  204 (362)
                      +.+|-++.+..       ..|||.|+...-+..---..-.++.+++.....|+..++..|-.+.-+||.|++--|+|+..
T Consensus       347 lpcP~vV~lkk-------hvLVMsFiGd~~~aAPkLK~v~l~d~E~~~aY~q~~~~M~~lY~Ec~LVHADlSEyN~Lw~~  419 (531)
T KOG2269|consen  347 LPCPQVVKLKK-------HVLVMSFIGDQGLAAPKLKNVELTDDERRNAYDQVQSIMCRLYKECLLVHADLSEYNLLWTP  419 (531)
T ss_pred             CCCCceeeeec-------ceEEEEeecCCCCCCccccccccChHHHHHHHHHHHHHHHHHHHhhheeecchhhhhheecC
Confidence            56788887654       47899998553333222223468999999999999999999976688999999999999966


Q ss_pred             CCcEEEeeccCCcc
Q 018018          205 RGEVKITDFGVSAI  218 (362)
Q Consensus       205 ~~~vkl~DFg~a~~  218 (362)
                      + .+.++|...+..
T Consensus       420 g-Kvw~IDVsQsve  432 (531)
T KOG2269|consen  420 G-KVWVIDVSQSVE  432 (531)
T ss_pred             C-ceEEEechhccC
Confidence            5 899999876543

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.44  E-value=0.16  Score=44.50  Aligned_cols=69  Identities=17%  Similarity=0.062  Sum_probs=44.0

Q ss_pred             eEEEEEEEccC-CcEEEEEEeecccchHHHHHHHHHHHHHhcC---CCCcceEEeeeEEecCeEEEEEeccCCCCHH
Q 018018           84 GIVQLVQHKWT-GQFFALKVIQMNVEESARRQIAQELKINQSS---QCPYVVVCYQSFYSNGAISIILEYMDGGSLA  156 (362)
Q Consensus        84 g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l---~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL~  156 (362)
                      |.|..+....+ ..++.+|+=.    ......+..|+.-++.+   +.-.+.+.+.+..+..+.|+|+||++-+.+.
T Consensus        27 G~inea~~v~dg~~~~FvK~n~----~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d   99 (286)
T COG3001          27 GDINEAWRLRDGTDPFFVKCNQ----REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD   99 (286)
T ss_pred             ccccceeEeecCCcceEEEecc----hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence            34433333333 4578888743    33345555666544443   4455677788888899999999999876664

>PTZ00384 choline kinase; Provisional

Probab=94.59  E-value=0.35  Score=46.17  Aligned_cols=29  Identities=24%  Similarity=0.264  Sum_probs=24.0

Q ss_pred             CCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          188 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       188 ~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      ..++|.|+-+.||+.+ ++.+.++||--|.
T Consensus       227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEec-CCCEEEEEecccc
Confidence            4589999999999974 5569999998653

>PRK10271 thiK thiamine kinase; Provisional

Probab=93.83  E-value=0.053  Score=46.04  Aligned_cols=29  Identities=21%  Similarity=0.418  Sum_probs=25.2

Q ss_pred             CeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          189 HIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       189 ~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      -.+|+|+.|.||+++.++ ++|+||+.|..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            379999999999997777 99999998754

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	362
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-63
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-61
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-61
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-59
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-59
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-59
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-59
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-59
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-59
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-58
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-46
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-45
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-42
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		6e-42
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-41
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-38
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-38
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-37
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-37
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-37
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-37
3a7f_A	303	Human Mst3 Kinase Length = 303		9e-37
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-37
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-36
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		4e-34
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-34
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-34
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-34
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-34
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		7e-34
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-34
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-33
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-33
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-32
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-31
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-31
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-31
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-31
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-31
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-31
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-31
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-31
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		9e-31
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-31
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-30
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-30
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-30
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-30
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-30
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-30
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-29
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-29
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		4e-29
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-28
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-28
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-28
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-28
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-28
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-27
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-27
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-27
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-27
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-27
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-26
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-26
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-26
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-25
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-25
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-25
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-25
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-25
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-25
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-25
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		7e-25
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		8e-25
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		8e-25
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-24
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-24
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-24
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-24
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-24
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-24
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-24
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-24
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-24
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-24
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-24
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-24
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-24
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-24
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-24
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		4e-24
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-24
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-24
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-24
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-24
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-24
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-24
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-24
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-24
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-24
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		6e-24
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-24
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-24
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-24
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-24
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-24
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-24
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		7e-24
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-24
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-24
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-24
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-24
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-24
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		8e-24
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		8e-24
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-24
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-24
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-24
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-23
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-23
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-23
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-23
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-23
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-23
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-23
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-23
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-23
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-23
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-23
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-23
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-23
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-23
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-23
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-23
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-23
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-23
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-23
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-23
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-23
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-23
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-23
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		4e-23
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-23
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-23
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-23
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-23
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-23
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-23
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-23
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-23
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-23
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-23
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-23
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-23
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-23
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-23
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-23
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		6e-23
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-23
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-23
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-23
4ae6_A	343	Structure And Function Of The Human Sperm-specific		8e-23
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-23
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-23
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-23
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		8e-23
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		8e-23
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-23
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-23
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		9e-23
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-23
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-23
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-23
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-23
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		9e-23
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-22
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-22
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-22
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-22
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-22
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-22
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-22
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-22
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-22
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-22
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-22
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-22
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-22
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-22
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-22
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-22
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-22
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-22
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-22
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-22
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-22
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-22
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-22
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-22
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-22
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-22
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-22
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-22
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-22
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-22
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-22
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-22
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-22
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-22
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-22
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-22
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-22
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-22
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-22
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-22
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-22
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-22
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-22
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-22
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-22
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-22
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-22
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-22
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-22
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		7e-22
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-22
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-22
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-22
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-22
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-22
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-22
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-22
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-21
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-21
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-21
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-21
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-21
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-21
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-21
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-21
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-21
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-21
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-21
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-21
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-21
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-21
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-21
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-21
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		3e-21
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-21
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-21
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-21
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-21
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		3e-21
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-21
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-21
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-21
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		9e-21
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		9e-21
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		9e-21
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-20
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-20
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-20
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-20
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-20
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-20
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-20
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-20
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-20
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-20
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-20
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-20
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-20
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-20
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-20
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-20
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-20
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-20
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-20
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-20
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-20
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-20
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-20
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-20
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-20
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-20
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-20
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-20
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-20
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-20
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-20
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-20
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-20
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-20
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-20
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-20
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-20
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-20
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-20
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-20
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-20
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-20
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-20
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-20
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-20
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-20
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-20
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-20
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-20
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-20
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		8e-20
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		8e-20
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		8e-20
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-20
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-20
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		8e-20
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-20
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-20
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-20
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-19
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-19
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-19
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-19
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-19
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-19
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-19
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-19
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-19
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-19
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-19
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-19
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-19
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-19
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-19
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-19
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-19
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-19
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-19
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-19
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-19
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-19
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-19
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		5e-19
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-19
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-19
3soa_A	444	Full-Length Human Camkii Length = 444		7e-19
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-19
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-19
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-19
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-18
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-18
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-18
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-18
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-18
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-18
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-18
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-18
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-18
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-18
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-18
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-18
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-18
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-18
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		5e-18
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		5e-18
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-18
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-18
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-18
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-18
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-18
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-18
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		7e-18
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-18
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-18
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-18
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		7e-18
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-18
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-18
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-18
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-18
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-18
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-18
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-18
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-18
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-18
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-18
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-18
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-18
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-18
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-18
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-18
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		9e-18
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-17
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-17
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-17
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-17
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-17
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-17
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-17
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-17
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-17
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-17
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-17
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-17
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-17
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-17
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-17
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-17
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-17
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-17
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-17
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-17
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-17
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-17
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-17
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-17
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-17
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-17
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-17
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-17
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-16
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-16
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-16
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-16
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-16
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-16
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-16
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-16
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-16
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-16
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-16
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-16
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-16
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-16
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-16
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-16
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-16
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		5e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		5e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		5e-16
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		5e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-16
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		6e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-16
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-16
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-16
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-16
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-16
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-16
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		7e-16
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-16
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-16
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-16
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		9e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-15
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-15
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-15
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-15
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-15
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-15
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-15
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-15
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-15
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-15
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-15
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-15
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-15
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-15
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-15
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-15
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-15
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		3e-15
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		3e-15
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-15
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		3e-15
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-15
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-15
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-15
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-15
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-15
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-15
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-15
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-15
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-15
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-15
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-15
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-15
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-15
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-15
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-15
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-15
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-15
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		6e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-15
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		6e-15
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-15
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-15
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		7e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		7e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-15
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-15
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		9e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-14
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-14
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-14
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-14
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-14
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-14
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-14
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-14
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-14
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-14
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-14
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-14
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-14
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-14
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-14
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-14
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-14
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-14
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-14
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-14
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-14
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-14
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-14
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-14
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-14
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-14
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-14
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-14
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-14
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-14
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-14
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-14
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-14
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-14
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-14
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-14
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-14
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-14
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-14
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-14
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-14
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-14
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-14
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-14
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-14
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-14
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-14
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-14
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-14
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-14
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-14
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-14
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-14
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-14
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-14
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-14
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-14
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-14
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-14
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-14
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-14
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-14
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-14
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-14
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-14
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-14
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-14
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-14
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-14
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-14
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-14
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-14
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-14
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-14
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-14
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-14
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-14
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-14
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-14
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-14
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-14
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-14
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-14
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-14
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-14
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-14
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-14
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		3e-14
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-14
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		3e-14
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-14
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-14
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-14
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-14
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-14
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-14
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-14
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-14
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-14
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-14
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-14
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-14
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-14
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-14
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-14
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-14
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-14
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		7e-14
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-14
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-14
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		8e-14
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-14
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		8e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-14
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		8e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-14
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		8e-14
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		9e-14
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-14
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		9e-14
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-13
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-13
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-13
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-13
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-13
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-13
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-13
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-13
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-13
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-13
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-13
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-13
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-13
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-13
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-13
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-13
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-13
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-13
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-13
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		6e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-13
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-13
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-13
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-13
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		8e-13
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-13
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-13
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		8e-13
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		8e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		8e-13
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-13
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-13
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		9e-13
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-13
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		9e-13
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-12
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-12
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-12
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-12
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-12
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-12
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-12
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-12
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-12
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-12
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		4e-12
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		4e-12
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-12
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-12
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		5e-12
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		6e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		9e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-11
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-11
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-11
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-11
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-11
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-11
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		2e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-11
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-11
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-11
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		4e-11
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-11
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-11
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-11
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-11
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-11
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-11
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-11
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-11
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-11
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		5e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-11
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		6e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		6e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-11
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-11
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-11
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		7e-11
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		7e-11
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-11
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-11
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-11
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		8e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		9e-11
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		9e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-10
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-10
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-10
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		4e-10
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-10
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-10
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-10
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		5e-10
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-10
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		5e-10
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-10
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-10
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-10
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		5e-10
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		6e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		6e-10
1fvr_A	327	Tie2 Kinase Domain Length = 327		6e-10
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-10
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		6e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-10

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  237 bits (604), Expect = 8e-63,   Method: Compositional matrix adjust.
 Identities = 115/261 (44%), Positives = 167/261 (63%), Gaps = 5/261 (1%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 85  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 145 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
Query: 269 YSPPEQQDGW---TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
             PP+ ++      + +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++
Sbjct: 203 IPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 262
Query: 326 LMTHPFLKMYGDLNVDLSEYF 346
           LM H F+K      VD + + 
Sbjct: 263 LMVHAFIKRSDAEEVDFAGWL 283

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score =  233 bits (594), Expect = 1e-61,   Method: Compositional matrix adjust.
 Identities = 114/258 (44%), Positives = 163/258 (63%), Gaps = 5/258 (1%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 44  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 103
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 104 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 163
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 164 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 221
Query: 269 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
                   G  + +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++LM 
Sbjct: 222 IG---SGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 278
Query: 329 HPFLKMYGDLNVDLSEYF 346
           H F+K      VD + + 
Sbjct: 279 HAFIKRSDAEEVDFAGWL 296

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score =  231 bits (589), Expect = 5e-61,   Method: Compositional matrix adjust.
 Identities = 114/258 (44%), Positives = 161/258 (62%), Gaps = 9/258 (3%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 28  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 87
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 88  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 147
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           K+ DFGVS  +      AN FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 148 KLCDFGVSGQLIDE--MANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 205
Query: 269 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
             P        + +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++LM 
Sbjct: 206 RPP-------MAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMV 258
Query: 329 HPFLKMYGDLNVDLSEYF 346
           H F+K      VD + + 
Sbjct: 259 HAFIKRSDAEEVDFAGWL 276

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score =  225 bits (574), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 117/293 (39%), Positives = 168/293 (57%), Gaps = 37/293 (12%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 87  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 146
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 147 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 206
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 207 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 264
Query: 269 YSPPEQQD------------------------------GWTS-----FYELMEAIVDQPP 293
             PP+ ++                              G  S      +EL++ IV++PP
Sbjct: 265 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 324
Query: 294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 346
           P  PS  FS EF  F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 325 PKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 377

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score =  225 bits (574), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 117/293 (39%), Positives = 168/293 (57%), Gaps = 37/293 (12%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 52  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 171
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 172 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
Query: 269 YSPPEQQD------------------------------GWTS-----FYELMEAIVDQPP 293
             PP+ ++                              G  S      +EL++ IV++PP
Sbjct: 230 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP 289
Query: 294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 346
           P  PS  FS EF  F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 290 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 342

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score =  225 bits (573), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 117/293 (39%), Positives = 168/293 (57%), Gaps = 37/293 (12%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 85  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 145 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
Query: 269 YSPPEQQD------------------------------GWTS-----FYELMEAIVDQPP 293
             PP+ ++                              G  S      +EL++ IV++PP
Sbjct: 203 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 262
Query: 294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 346
           P  PS  FS EF  F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 263 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 315

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score =  225 bits (573), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 117/293 (39%), Positives = 168/293 (57%), Gaps = 37/293 (12%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 85  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 145 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
Query: 269 YSPPEQQD------------------------------GWTS-----FYELMEAIVDQPP 293
             PP+ ++                              G  S      +EL++ IV++PP
Sbjct: 203 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 262
Query: 294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 346
           P  PS  FS EF  F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 263 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 315

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score =  225 bits (573), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 116/293 (39%), Positives = 167/293 (56%), Gaps = 37/293 (12%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 85  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 145 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
Query: 269 YSPPEQQDGWTSF-----------------------------------YELMEAIVDQPP 293
             PP+ ++    F                                   +EL++ IV++PP
Sbjct: 203 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 262
Query: 294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 346
           P  PS  FS EF  F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 263 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 315

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score =  225 bits (573), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 116/293 (39%), Positives = 167/293 (56%), Gaps = 37/293 (12%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           V HK +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 25  VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +MDGGSL   LKK   IPE+ L  +   V+KGL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 85  HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 144
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 145 KLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
Query: 269 YSPPEQQDGWTSF-----------------------------------YELMEAIVDQPP 293
             PP+ ++    F                                   +EL++ IV++PP
Sbjct: 203 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP 262
Query: 294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 346
           P  PS  FS EF  F++ C+ K P +R   ++LM H F+K      VD + + 
Sbjct: 263 PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWL 315

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score =  223 bits (568), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 114/297 (38%), Positives = 169/297 (56%), Gaps = 41/297 (13%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           VQH+ +G   A K+I + ++ + R QI +EL++      PY+V  Y +FYS+G ISI +E
Sbjct: 35  VQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 94
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +MDGGSL   LK+ K IPEE L  +   VL+GL YL  +  I+HRD+KPSN+L+N RGE+
Sbjct: 95  HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEI 154
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           K+ DFGVS  +  +   AN+FVGT +YM+PER+ G  Y  +SDIWS+GL L+E A G++P
Sbjct: 155 KLCDFGVSGQLIDS--MANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYP 212
Query: 269 YSPPEQQ-----------DG----------------------------WTSFYELMEAIV 289
             PP+ +           DG                              + +EL++ IV
Sbjct: 213 IPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIV 272
Query: 290 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 346
           ++PPP  P+  F+P+F  F++ C+ K P +R   + L  H F+K      VD + + 
Sbjct: 273 NEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLTNHTFIKRSEVEEVDFAGWL 329

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score =  181 bits (458), Expect = 7e-46,   Method: Compositional matrix adjust.
 Identities = 95/266 (35%), Positives = 155/266 (58%), Gaps = 17/266 (6%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIIL 147
           ++H  +GQ  A+K I+  V    ++++  +L I+ ++  CP+ V  Y + +  G + I +
Sbjct: 70  MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 129
Query: 148 EYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           E MD  SL  F K+V    +TIPE+ L  I   ++K L +LH +  +IHRD+KPSN+LIN
Sbjct: 130 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN 188
Query: 204 HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI----SGGKYGYKSDIWSLGLVL 259
             G+VK+ DFG+S  +  +  +     G   YM+PERI    +   Y  KSDIWSLG+ +
Sbjct: 189 ALGQVKMCDFGISGYLVDSVAK-TIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITM 247
Query: 260 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ 319
           +E A  +FPY      D W + ++ ++ +V++P P  P+D+FS EF  F S C++K  ++
Sbjct: 248 IELAILRFPY------DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKE 301
Query: 320 RLSAQELMTHPFLKMYGDLNVDLSEY 345
           R +  ELM HPF  ++     D++ +
Sbjct: 302 RPTYPELMQHPFFTLHESKGTDVASF 327

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score =  180 bits (456), Expect = 1e-45,   Method: Compositional matrix adjust.
 Identities = 95/266 (35%), Positives = 155/266 (58%), Gaps = 17/266 (6%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIIL 147
           ++H  +GQ  A+K I+  V    ++++  +L I+ ++  CP+ V  Y + +  G + I +
Sbjct: 26  MRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85
Query: 148 EYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           E MD  SL  F K+V    +TIPE+ L  I   ++K L +LH +  +IHRD+KPSN+LIN
Sbjct: 86  ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLIN 144
Query: 204 HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI----SGGKYGYKSDIWSLGLVL 259
             G+VK+ DFG+S  +     + +   G   YM+PERI    +   Y  KSDIWSLG+ +
Sbjct: 145 ALGQVKMCDFGISGYLVDDVAK-DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITM 203
Query: 260 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ 319
           +E A  +FPY      D W + ++ ++ +V++P P  P+D+FS EF  F S C++K  ++
Sbjct: 204 IELAILRFPY------DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKE 257
Query: 320 RLSAQELMTHPFLKMYGDLNVDLSEY 345
           R +  ELM HPF  ++     D++ +
Sbjct: 258 RPTYPELMQHPFFTLHESKGTDVASF 283

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 97/268 (36%), Positives = 149/268 (55%), Gaps = 21/268 (7%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEY 149
           HK +GQ  A+K I+  V+E  ++Q+  +L +  +SS CPY+V  Y + +  G   I +E 
Sbjct: 43  HKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102
Query: 150 MDGGSLADFLKKV-----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           M   S   F K V       IPEE L  I    +K L +L     IIHRD+KPSN+L++ 
Sbjct: 103 M-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDR 161
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI--SGGKYGY--KSDIWSLGLVLL 260
            G +K+ DFG+S  +  +  +     G   YM+PERI  S  + GY  +SD+WSLG+ L 
Sbjct: 162 SGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP---SAPSDQFSPEFCSFISACVQKEP 317
           E ATG+FPY        W S ++ +  +V   PP   ++   +FSP F +F++ C+ K+ 
Sbjct: 221 ELATGRFPYP------KWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDE 274
Query: 318 QQRLSAQELMTHPFLKMYGDLNVDLSEY 345
            +R   +EL+ HPF+ MY +  V+++ Y
Sbjct: 275 SKRPKYKELLKHPFILMYEERAVEVACY 302

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score =  167 bits (424), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 92/265 (34%), Positives = 148/265 (55%), Gaps = 17/265 (6%)
Query: 90  QHKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILE 148
           +H  +GQ  A+K I+  V    ++++  +L I+ ++  CP+ V  Y + +  G + I  E
Sbjct: 54  RHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGALFREGDVWICXE 113
Query: 149 YMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
             D  SL  F K+V    +TIPE+ L  I   ++K L +LH +  +IHRD+KPSN+LIN 
Sbjct: 114 LXDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA 172
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI----SGGKYGYKSDIWSLGLVLL 260
            G+VK  DFG+S  +     + +   G   Y +PERI    +   Y  KSDIWSLG+  +
Sbjct: 173 LGQVKXCDFGISGYLVDDVAK-DIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXI 231
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
           E A  +FPY      D W + ++ ++ +V++P P  P+D+FS EF  F S C++K  ++R
Sbjct: 232 ELAILRFPY------DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKER 285
Query: 321 LSAQELMTHPFLKMYGDLNVDLSEY 345
            +  EL  HPF  ++     D++ +
Sbjct: 286 PTYPELXQHPFFTLHESKGTDVASF 310

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 90/270 (33%), Positives = 153/270 (56%), Gaps = 18/270 (6%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIIL 147
           ++ + TG   A+K ++ +  +   ++I  +L +  +S  CPY+V C+ +F +N  + I +
Sbjct: 44  MRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103
Query: 148 EYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           E M  G+ A+ LKK     IPE  L  +   ++K L YL  +  +IHRD+KPSN+L++ R
Sbjct: 104 ELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLL 260
           G++K+ DFG+S  +     +  +  G   YM+PERI     +   Y  ++D+WSLG+ L+
Sbjct: 162 GQIKLCDFGISGRLVDDKAKDRS-AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLV 220
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ-FSPEFCSFISACVQKEPQQ 319
           E ATGQFPY          + +E++  ++ + PP  P    FS +F SF+  C+ K+ ++
Sbjct: 221 ELATGQFPYK------NCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRK 274
Query: 320 RLSAQELMTHPFLKMYGDLNVDLSEYFTDA 349
           R    +L+ H F+K Y  L VD++ +F D 
Sbjct: 275 RPKYNKLLEHSFIKRYETLEVDVASWFKDV 304

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 89/248 (35%), Positives = 138/248 (55%), Gaps = 19/248 (7%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 150
           HK TGQ  A+K + +   ES  ++I +E+ I Q    P+VV  Y S++ N  + I++EY 
Sbjct: 50  HKETGQIVAIKQVPV---ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYC 106
Query: 151 DGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 209
             GS++D ++ + KT+ E+ +A I +  LKGL YLH  + I HRD+K  N+L+N  G  K
Sbjct: 107 GAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKI-HRDIKAGNILLNTEGHAK 165
Query: 210 ITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY 269
           + DFGV+  +     + N  +GT  +M+PE I    Y   +DIWSLG+  +E A G+ PY
Sbjct: 166 LADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPY 225
Query: 270 SPPEQQDGWTSFYELMEAIV---DQPPPS-APSDQFSPEFCSFISACVQKEPQQRLSAQE 325
           +              M AI      PPP+    + +S  F  F+  C+ K P+QR +A +
Sbjct: 226 AD----------IHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQ 275
Query: 326 LMTHPFLK 333
           L+ HPF++
Sbjct: 276 LLQHPFVR 283

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 92/253 (36%), Positives = 139/253 (54%), Gaps = 14/253 (5%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           T +  A+K+I +   E     I QE+ +      PY+   + S+  +  + II+EY+ GG
Sbjct: 43  TKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGG 102
Query: 154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           S  D LK    + E Y+A I  ++LKGL YLH E+ I HRD+K +N+L++ +G+VK+ DF
Sbjct: 103 SALDLLKP-GPLEETYIATILREILKGLDYLHSERKI-HRDIKAANVLLSEQGDVKLADF 160
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 273
           GV+  +  T  + N FVGT  +M+PE I    Y +K+DIWSLG+  +E A G+    PP 
Sbjct: 161 GVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE----PP- 215
Query: 274 QQDGWTSFYELMEAIVDQPPPSAPS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
                 S    M  +   P  S P+   Q S  F  F+ AC+ K+P+ R +A+EL+ H F
Sbjct: 216 -----NSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDPRFRPTAKELLKHKF 270
Query: 332 LKMYGDLNVDLSE 344
           +  Y      L+E
Sbjct: 271 ITRYTKKTSFLTE 283

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 89/239 (37%), Positives = 133/239 (55%), Gaps = 10/239 (4%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           T +  A+K+I +   E     I QE+ +      PYV   Y S+  +  + II+EY+ GG
Sbjct: 51  TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 110
Query: 154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           S  D L+    + E  +A I  ++LKGL YLH EK I HRD+K +N+L++  GEVK+ DF
Sbjct: 111 SALDLLEP-GPLDETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADF 168
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 273
           GV+  +  T  + NTFVGT  +M+PE I    Y  K+DIWSLG+  +E A G+ P+S   
Sbjct: 169 GVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 228
Query: 274 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
                    +++  I    PP+   + +S     F+ AC+ KEP  R +A+EL+ H F+
Sbjct: 229 PM-------KVLFLIPKNNPPTLEGN-YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 279

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 89/239 (37%), Positives = 133/239 (55%), Gaps = 10/239 (4%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           T +  A+K+I +   E     I QE+ +      PYV   Y S+  +  + II+EY+ GG
Sbjct: 31  TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 90
Query: 154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           S  D L+    + E  +A I  ++LKGL YLH EK I HRD+K +N+L++  GEVK+ DF
Sbjct: 91  SALDLLEP-GPLDETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADF 148
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 273
           GV+  +  T  + NTFVGT  +M+PE I    Y  K+DIWSLG+  +E A G+ P+S   
Sbjct: 149 GVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 208
Query: 274 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
                    +++  I    PP+   + +S     F+ AC+ KEP  R +A+EL+ H F+
Sbjct: 209 PM-------KVLFLIPKNNPPTLEGN-YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 93/261 (35%), Positives = 143/261 (54%), Gaps = 30/261 (11%)
Query: 90  QHKWTGQFFALKVIQMNVEESARRQIAQELK-INQSSQCPYVVVCYQSFYS------NGA 142
           +H  TGQ  A+KV  M+V      +I QE+  + + S    +   Y +F        +  
Sbjct: 44  RHVKTGQLAAIKV--MDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101
Query: 143 ISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 200
           + +++E+   GS+ D +K  K  T+ EE++A IC ++L+GL +LH  K +IHRD+K  N+
Sbjct: 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK-VIHRDIKGQNV 160
Query: 201 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSL 255
           L+    EVK+ DFGVSA +  T G+ NTF+GT  +M+PE I+        Y +KSD+WSL
Sbjct: 161 LLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSL 220
Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYELMEA---IVDQPPPSAPSDQFSPEFCSFISAC 312
           G+  +E A G    +PP            M A   I   P P   S ++S +F SFI +C
Sbjct: 221 GITAIEMAEG----APP------LCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESC 270
Query: 313 VQKEPQQRLSAQELMTHPFLK 333
           + K   QR + ++LM HPF++
Sbjct: 271 LVKNHSQRPATEQLMKHPFIR 291

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  151 bits (381), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 89/239 (37%), Positives = 131/239 (54%), Gaps = 10/239 (4%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           T Q  A+K+I +   E     I QE+ +       YV   Y S+     + II+EY+ GG
Sbjct: 47  TQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGG 106
Query: 154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           S  D L+      E  +A + +++LKGL YLH EK I HRD+K +N+L++ +G+VK+ DF
Sbjct: 107 SALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKI-HRDIKAANVLLSEQGDVKLADF 164
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 273
           GV+  +  T  + NTFVGT  +M+PE I    Y  K+DIWSLG+  +E A G+ P S   
Sbjct: 165 GVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 224
Query: 274 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
                     ++  I    PP+   D F+  F  FI AC+ K+P  R +A+EL+ H F+
Sbjct: 225 PM-------RVLFLIPKNNPPTLVGD-FTKSFKEFIDACLNKDPSFRPTAKELLKHKFI 275

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 88/239 (36%), Positives = 132/239 (55%), Gaps = 10/239 (4%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           T +  A+K+I +   E     I QE+ +      PYV   Y S+  +  + II+EY+ GG
Sbjct: 46  TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 105
Query: 154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           S  D L+    + E  +A I  ++LKGL YLH EK I HRD+K +N+L++  GEVK+ DF
Sbjct: 106 SALDLLEP-GPLDETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADF 163
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 273
           GV+  +  T  + N FVGT  +M+PE I    Y  K+DIWSLG+  +E A G+ P+S   
Sbjct: 164 GVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 223
Query: 274 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
                    +++  I    PP+   + +S     F+ AC+ KEP  R +A+EL+ H F+
Sbjct: 224 PM-------KVLFLIPKNNPPTLEGN-YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 88/239 (36%), Positives = 132/239 (55%), Gaps = 10/239 (4%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           T +  A+K+I +   E     I QE+ +      PYV   Y S+  +  + II+EY+ GG
Sbjct: 31  TQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGG 90
Query: 154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           S  D L+    + E  +A I  ++LKGL YLH EK I HRD+K +N+L++  GEVK+ DF
Sbjct: 91  SALDLLEP-GPLDETQIATILREILKGLDYLHSEKKI-HRDIKAANVLLSEHGEVKLADF 148
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 273
           GV+  +  T  + N FVGT  +M+PE I    Y  K+DIWSLG+  +E A G+ P+S   
Sbjct: 149 GVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH 208
Query: 274 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
                    +++  I    PP+   + +S     F+ AC+ KEP  R +A+EL+ H F+
Sbjct: 209 PM-------KVLFLIPKNNPPTLEGN-YSKPLKEFVEACLNKEPSFRPTAKELLKHKFI 259

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  147 bits (371), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 86/251 (34%), Positives = 144/251 (57%), Gaps = 13/251 (5%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISII 146
           L + K +G+  A+K+  M++ +  RR++   E+ I +  Q   VV  Y+S+     + ++
Sbjct: 63  LAREKHSGRQVAVKM--MDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVL 120
Query: 147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           +E++ GG+L D + +V+ + EE +A +CE VL+ L YLH +  +IHRD+K  ++L+   G
Sbjct: 121 MEFLQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLHAQG-VIHRDIKSDSILLTLDG 178
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ 266
            VK++DFG  A ++    +    VGT  +M+PE IS   Y  + DIWSLG++++E   G+
Sbjct: 179 RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
Query: 267 FPYSPPEQQDGWTSFYELMEAIVDQPPPSAP-SDQFSPEFCSFISACVQKEPQQRLSAQE 325
            PY          S  + M+ + D PPP    S + SP    F+   + ++PQ+R +AQE
Sbjct: 239 PPYFS-------DSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQE 291
Query: 326 LMTHPFLKMYG 336
           L+ HPFL   G
Sbjct: 292 LLDHPFLLQTG 302

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 85/249 (34%), Positives = 138/249 (55%), Gaps = 17/249 (6%)
Query: 92  KWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 150
           K TG+  A+K  +M++ +  RR++   E+ I +      VV  Y S+     + +++E++
Sbjct: 67  KHTGKQVAVK--KMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFL 124
Query: 151 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 210
           +GG+L D +   + + EE +A +C  VL+ L YLH++  +IHRD+K  ++L+   G +K+
Sbjct: 125 EGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQG-VIHRDIKSDSILLTSDGRIKL 182
Query: 211 TDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY- 269
           +DFG  A ++    +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY 
Sbjct: 183 SDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYF 242
Query: 270 -SPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELM 327
             PP Q          M  I D  PP      + S     F+   + +EP QR +AQEL+
Sbjct: 243 NEPPLQA---------MRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQRATAQELL 293
Query: 328 THPFLKMYG 336
            HPFLK+ G
Sbjct: 294 GHPFLKLAG 302

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/247 (33%), Positives = 138/247 (55%), Gaps = 17/247 (6%)
Query: 94  TGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 152
           +G+  A+K  +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++G
Sbjct: 48  SGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 105
Query: 153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
           G+L D +   + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK++D
Sbjct: 106 GALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSD 163
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--S 270
           FG  A ++    +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   
Sbjct: 164 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 223
Query: 271 PPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
           PP          + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ H
Sbjct: 224 PP---------LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 274
Query: 330 PFLKMYG 336
           PFL   G
Sbjct: 275 PFLAKAG 281

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/247 (33%), Positives = 138/247 (55%), Gaps = 17/247 (6%)
Query: 94  TGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 152
           +G+  A+K  +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++G
Sbjct: 44  SGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101
Query: 153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
           G+L D +   + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK++D
Sbjct: 102 GALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSD 159
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--S 270
           FG  A ++    +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   
Sbjct: 160 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219
Query: 271 PPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
           PP          + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ H
Sbjct: 220 PP---------LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 270
Query: 330 PFLKMYG 336
           PFL   G
Sbjct: 271 PFLAKAG 277

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  141 bits (356), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 83/247 (33%), Positives = 138/247 (55%), Gaps = 17/247 (6%)
Query: 94  TGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 152
           +G+  A+K  +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++G
Sbjct: 55  SGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 112
Query: 153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
           G+L D +   + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK++D
Sbjct: 113 GALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSD 170
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--S 270
           FG  A ++    +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   
Sbjct: 171 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 230
Query: 271 PPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
           PP          + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ H
Sbjct: 231 PP---------LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 281
Query: 330 PFLKMYG 336
           PFL   G
Sbjct: 282 PFLAKAG 288

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 83/247 (33%), Positives = 138/247 (55%), Gaps = 17/247 (6%)
Query: 94  TGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 152
           +G+  A+K  +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++G
Sbjct: 53  SGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 110
Query: 153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
           G+L D +   + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK++D
Sbjct: 111 GALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSD 168
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--S 270
           FG  A ++    +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   
Sbjct: 169 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 228
Query: 271 PPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
           PP          + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ H
Sbjct: 229 PP---------LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 279
Query: 330 PFLKMYG 336
           PFL   G
Sbjct: 280 PFLAKAG 286

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 83/247 (33%), Positives = 138/247 (55%), Gaps = 17/247 (6%)
Query: 94  TGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 152
           +G+  A+K  +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++G
Sbjct: 98  SGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 155
Query: 153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
           G+L D +   + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK++D
Sbjct: 156 GALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSD 213
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--S 270
           FG  A ++    +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   
Sbjct: 214 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 273
Query: 271 PPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
           PP          + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ H
Sbjct: 274 PP---------LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324
Query: 330 PFLKMYG 336
           PFL   G
Sbjct: 325 PFLAKAG 331

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 83/247 (33%), Positives = 138/247 (55%), Gaps = 17/247 (6%)
Query: 94  TGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 152
           +G+  A+K  +M++ +  RR++   E+ I +  Q   VV  Y S+     + +++E+++G
Sbjct: 175 SGKLVAVK--KMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 232
Query: 153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
           G+L D +   + + EE +AA+C  VL+ L  LH +  +IHRD+K  ++L+ H G VK++D
Sbjct: 233 GALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQG-VIHRDIKSDSILLTHDGRVKLSD 290
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY--S 270
           FG  A ++    +    VGT  +M+PE IS   YG + DIWSLG++++E   G+ PY   
Sbjct: 291 FGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 350
Query: 271 PPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
           PP          + M+ I D  PP   +  + SP    F+   + ++P QR +A EL+ H
Sbjct: 351 PP---------LKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401
Query: 330 PFLKMYG 336
           PFL   G
Sbjct: 402 PFLAKAG 408

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 84/249 (33%), Positives = 135/249 (54%), Gaps = 14/249 (5%)
Query: 90  QHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 149
           ++K TG   A KVI+   EE     I  E++I  +   PY+V    ++Y +G + I++E+
Sbjct: 31  KNKETGALAAAKVIETKSEEELEDYIV-EIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 89
Query: 150 MDGGSL-ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
             GG++ A  L+  + + E  +  +C Q+L+ L +LH  K IIHRDLK  N+L+   G++
Sbjct: 90  CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH-SKRIIHRDLKAGNVLMTLEGDI 148
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECA 263
           ++ DFGVSA    T  + ++F+GT  +M+PE +         Y YK+DIWSLG+ L+E A
Sbjct: 149 RLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 208
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
                  PP  +        L++     PP      ++S EF  F+   + K P+ R SA
Sbjct: 209 Q----IEPPHHE--LNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSA 262
Query: 324 QELMTHPFL 332
            +L+ HPF+
Sbjct: 263 AQLLEHPFV 271

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 84/249 (33%), Positives = 135/249 (54%), Gaps = 14/249 (5%)
Query: 90  QHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 149
           ++K TG   A KVI+   EE     I  E++I  +   PY+V    ++Y +G + I++E+
Sbjct: 39  KNKETGALAAAKVIETKSEEELEDYIV-EIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97
Query: 150 MDGGSL-ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
             GG++ A  L+  + + E  +  +C Q+L+ L +LH  K IIHRDLK  N+L+   G++
Sbjct: 98  CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH-SKRIIHRDLKAGNVLMTLEGDI 156
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECA 263
           ++ DFGVSA    T  + ++F+GT  +M+PE +         Y YK+DIWSLG+ L+E A
Sbjct: 157 RLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA 216
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
                  PP  +        L++     PP      ++S EF  F+   + K P+ R SA
Sbjct: 217 Q----IEPPHHE--LNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSA 270
Query: 324 QELMTHPFL 332
            +L+ HPF+
Sbjct: 271 AQLLEHPFV 279

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  135 bits (339), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 77/242 (31%), Positives = 137/242 (56%), Gaps = 11/242 (4%)
Query: 94  TGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 152
           TGQ  A++  QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ G
Sbjct: 44  TGQEVAIR--QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
           GSL D + +   + E  +AA+C + L+ L +LH    +IHRD+K  N+L+   G VK+TD
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTD 159
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 272
           FG  A +     + +T VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY   
Sbjct: 160 FGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-- 217
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
             ++   + Y +     +  P     ++ S  F  F++ C+  + ++R SA+EL+ H FL
Sbjct: 218 -NENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
Query: 333 KM 334
           K+
Sbjct: 274 KI 275

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 137/242 (56%), Gaps = 11/242 (4%)
Query: 94  TGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 152
           TGQ  A++  QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ G
Sbjct: 44  TGQEVAIR--QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
           GSL D + +   + E  +AA+C + L+ L +LH    +IHRD+K  N+L+   G VK+TD
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTD 159
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 272
           FG  A +     + +  VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY   
Sbjct: 160 FGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-- 217
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
             ++   + Y +     +  P     ++ S  F  F++ C++ + ++R SA+EL+ H FL
Sbjct: 218 -NENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFL 273
Query: 333 KM 334
           K+
Sbjct: 274 KI 275

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 137/242 (56%), Gaps = 11/242 (4%)
Query: 94  TGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 152
           TGQ  A++  QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ G
Sbjct: 45  TGQEVAIR--QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 102
Query: 153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
           GSL D + +   + E  +AA+C + L+ L +LH    +IHRD+K  N+L+   G VK+TD
Sbjct: 103 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTD 160
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 272
           FG  A +     + +  VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY   
Sbjct: 161 FGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-- 218
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
             ++   + Y +     +  P     ++ S  F  F++ C++ + ++R SA+EL+ H FL
Sbjct: 219 -NENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFL 274
Query: 333 KM 334
           K+
Sbjct: 275 KI 276

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 135/268 (50%), Gaps = 16/268 (5%)
Query: 90  QHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 149
           Q+K T    A KVI    EE     +  E+ I  S   P +V    +FY    + I++E+
Sbjct: 57  QNKETSVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDAFYYENNLWILIEF 115
Query: 150 MDGGSL-ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
             GG++ A  L+  + + E  +  +C+Q L  L YLH  K IIHRDLK  N+L    G++
Sbjct: 116 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLDGDI 174
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECA 263
           K+ DFGVSA    T  + ++F+GT  +M+PE +         Y YK+D+WSLG+ L+E A
Sbjct: 175 KLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
                  PP  +        L++    +PP  A   ++S  F  F+  C++K    R + 
Sbjct: 235 E----IEPPHHE--LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTT 288
Query: 324 QELMTHPFLKMYGDLNVDLSEYFTDAGS 351
            +L+ HPF+ +  D N  + E   +A +
Sbjct: 289 SQLLQHPFVTV--DSNKPIRELIAEAKA 314

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 138/242 (57%), Gaps = 11/242 (4%)
Query: 94  TGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 152
           TGQ  A++  QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ G
Sbjct: 45  TGQEVAIR--QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 102
Query: 153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
           GSL D + +   + E  +AA+C + L+ L +LH    +IHR++K  N+L+   G VK+TD
Sbjct: 103 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRNIKSDNILLGMDGSVKLTD 160
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 272
           FG  A +     + +T VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY   
Sbjct: 161 FGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-- 218
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
             ++   + Y +     +  P     ++ S  F  F++ C++ + ++R SA+EL+ H FL
Sbjct: 219 -NENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELIQHQFL 274
Query: 333 KM 334
           K+
Sbjct: 275 KI 276

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 76/242 (31%), Positives = 136/242 (56%), Gaps = 11/242 (4%)
Query: 94  TGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 152
           TGQ  A++  QMN+++  +++ I  E+ + + ++ P +V    S+     + +++EY+ G
Sbjct: 44  TGQEVAIR--QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
           GSL D + +   + E  +AA+C + L+ L +LH    +IHRD+K  N+L+   G VK+TD
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTD 159
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 272
           FG  A +     + +  VGT  +M+PE ++   YG K DIWSLG++ +E   G+ PY   
Sbjct: 160 FGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-- 217
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
             ++   + Y +     +  P     ++ S  F  F++ C+  + ++R SA+EL+ H FL
Sbjct: 218 -NENPLRALYLIA---TNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
Query: 333 KM 334
           K+
Sbjct: 274 KI 275

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 136/255 (53%), Gaps = 22/255 (8%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQEL---KINQSSQCPYVVVCYQSFYSNGAIS 144
           LV+ K TG+++A+K+++  V   A+ ++A  L   ++ Q+S+ P++     SF ++  + 
Sbjct: 169 LVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 227
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
            ++EY +GG L   L + +   E+       +++  L YLH EK++++RDLK  NL+++ 
Sbjct: 228 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 287
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
            G +KITDFG+            TF GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 288 DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 347
Query: 265 GQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL- 321
           G+ P+   + +      +E  LME I  + P +       PE  S +S  ++K+P+QRL 
Sbjct: 348 GRLPFYNQDHE----KLFELILMEEI--RFPRT-----LGPEAKSLLSGLLKKDPKQRLG 396
Query: 322 ----SAQELMTHPFL 332
                A+E+M H F 
Sbjct: 397 GGSEDAKEIMQHRFF 411

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  132 bits (332), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 79/255 (30%), Positives = 136/255 (53%), Gaps = 22/255 (8%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQEL---KINQSSQCPYVVVCYQSFYSNGAIS 144
           LV+ K TG+++A+K+++  V   A+ ++A  L   ++ Q+S+ P++     SF ++  + 
Sbjct: 166 LVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
            ++EY +GG L   L + +   E+       +++  L YLH EK++++RDLK  NL+++ 
Sbjct: 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 284
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
            G +KITDFG+            TF GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 285 DGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 344
Query: 265 GQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL- 321
           G+ P+   + +      +E  LME I  + P +       PE  S +S  ++K+P+QRL 
Sbjct: 345 GRLPFYNQDHE----KLFELILMEEI--RFPRT-----LGPEAKSLLSGLLKKDPKQRLG 393
Query: 322 ----SAQELMTHPFL 332
                A+E+M H F 
Sbjct: 394 GGSEDAKEIMQHRFF 408

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  131 bits (329), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 134/268 (50%), Gaps = 16/268 (5%)
Query: 90  QHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 149
           Q+K T    A KVI    EE     +  E+ I  S   P +V    +FY    + I++E+
Sbjct: 57  QNKETSVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDAFYYENNLWILIEF 115
Query: 150 MDGGSL-ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
             GG++ A  L+  + + E  +  +C+Q L  L YLH  K IIHRDLK  N+L    G++
Sbjct: 116 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLDGDI 174
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECA 263
           K+ DFGVSA       + ++F+GT  +M+PE +         Y YK+D+WSLG+ L+E A
Sbjct: 175 KLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
                  PP  +        L++    +PP  A   ++S  F  F+  C++K    R + 
Sbjct: 235 E----IEPPHHE--LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTT 288
Query: 324 QELMTHPFLKMYGDLNVDLSEYFTDAGS 351
            +L+ HPF+ +  D N  + E   +A +
Sbjct: 289 SQLLQHPFVTV--DSNKPIRELIAEAKA 314

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 134/253 (52%), Gaps = 18/253 (7%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQEL---KINQSSQCPYVVVCYQSFYSNGAIS 144
           LV+ K TG+++A+K+++  V   A+ ++A  L   ++ Q+S+ P++     SF ++  + 
Sbjct: 28  LVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 86
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
            ++EY +GG L   L + +   E+       +++  L YLH EK++++RDLK  NL+++ 
Sbjct: 87  FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 146
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
            G +KITDFG+             F GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 147 DGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 206
Query: 265 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL--- 321
           G+ P+   + +  +     LME I  + P +       PE  S +S  ++K+P+QRL   
Sbjct: 207 GRLPFYNQDHEKLFELI--LMEEI--RFPRT-----LGPEAKSLLSGLLKKDPKQRLGGG 257
Query: 322 --SAQELMTHPFL 332
              A+E+M H F 
Sbjct: 258 SEDAKEIMQHRFF 270

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  130 bits (328), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 85/268 (31%), Positives = 133/268 (49%), Gaps = 16/268 (5%)
Query: 90  QHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 149
           Q+K T    A KVI    EE     +  E+ I  S   P +V    +FY    + I++E+
Sbjct: 57  QNKETSVLAAAKVIDTKSEEELEDYMV-EIDILASCDHPNIVKLLDAFYYENNLWILIEF 115
Query: 150 MDGGSL-ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
             GG++ A  L+  + + E  +  +C+Q L  L YLH  K IIHRDLK  N+L    G++
Sbjct: 116 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK-IIHRDLKAGNILFTLDGDI 174
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECA 263
           K+ DFGVSA       + + F+GT  +M+PE +         Y YK+D+WSLG+ L+E A
Sbjct: 175 KLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 234
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
                  PP  +        L++    +PP  A   ++S  F  F+  C++K    R + 
Sbjct: 235 E----IEPPHHE--LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTT 288
Query: 324 QELMTHPFLKMYGDLNVDLSEYFTDAGS 351
            +L+ HPF+ +  D N  + E   +A +
Sbjct: 289 SQLLQHPFVTV--DSNKPIRELIAEAKA 314

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 134/253 (52%), Gaps = 18/253 (7%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQEL---KINQSSQCPYVVVCYQSFYSNGAIS 144
           LV+ K TG+++A+K+++  V   A+ ++A  L   ++ Q+S+ P++     SF ++  + 
Sbjct: 27  LVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 85
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
            ++EY +GG L   L + +   E+       +++  L YLH EK++++RDLK  NL+++ 
Sbjct: 86  FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 145
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
            G +KITDFG+             F GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 146 DGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 205
Query: 265 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL--- 321
           G+ P+   + +  +     LME I  + P +       PE  S +S  ++K+P+QRL   
Sbjct: 206 GRLPFYNQDHEKLFELI--LMEEI--RFPRT-----LGPEAKSLLSGLLKKDPKQRLGGG 256
Query: 322 --SAQELMTHPFL 332
              A+E+M H F 
Sbjct: 257 SEDAKEIMQHRFF 269

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 134/253 (52%), Gaps = 18/253 (7%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQEL---KINQSSQCPYVVVCYQSFYSNGAIS 144
           LV+ K TG+++A+K+++  V   A+ ++A  L   ++ Q+S+ P++     SF ++  + 
Sbjct: 26  LVKEKATGRYYAMKILKKEVI-VAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 84
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
            ++EY +GG L   L + +   E+       +++  L YLH EK++++RDLK  NL+++ 
Sbjct: 85  FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK 144
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
            G +KITDFG+             F GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 145 DGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 204
Query: 265 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL--- 321
           G+ P+   + +  +     LME I  + P +       PE  S +S  ++K+P+QRL   
Sbjct: 205 GRLPFYNQDHEKLFELI--LMEEI--RFPRT-----LGPEAKSLLSGLLKKDPKQRLGGG 255
Query: 322 --SAQELMTHPFL 332
              A+E+M H F 
Sbjct: 256 SEDAKEIMQHRFF 268

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 76/228 (33%), Positives = 120/228 (52%), Gaps = 12/228 (5%)
Query: 99  ALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 156
           ALK +Q+   ++  AR    +E+ + +    P V+  Y SF  +  ++I+LE  D G L+
Sbjct: 61  ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120
Query: 157 DFLKKVKT----IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
             +K  K     IPE  +     Q+   L ++H  + ++HRD+KP+N+ I   G VK+ D
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH-SRRVMHRDIKPANVFITATGVVKLGD 179
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 272
            G+    +S +  A++ VGT  YMSPERI    Y +KSDIWSLG +L E A  Q P+   
Sbjct: 180 LGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
           +      + Y L + I     P  PSD +S E    ++ C+  +P++R
Sbjct: 240 K-----MNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 282

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 83/258 (32%), Positives = 132/258 (51%), Gaps = 32/258 (12%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K I +   +++  ++ +E++       P +V  Y SF     + ++++ + GGS+ D 
Sbjct: 44  AIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDI 103
Query: 159 LK--------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 210
           +K        K   + E  +A I  +VL+GL YLH    I HRD+K  N+L+   G V+I
Sbjct: 104 IKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI-HRDVKAGNILLGEDGSVQI 162
Query: 211 TDFGVSAIMA-----STSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECAT 264
            DFGVSA +A     + +    TFVGT  +M+PE +   + Y +K+DIWS G+  +E AT
Sbjct: 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 222
Query: 265 GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSDQ-------FSPEFCSFISACVQK 315
           G  PY   PP +         LM  + + PP      Q       +   F   IS C+QK
Sbjct: 223 GAAPYHKYPPMKV--------LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQK 274
Query: 316 EPQQRLSAQELMTHPFLK 333
           +P++R +A EL+ H F +
Sbjct: 275 DPEKRPTAAELLRHKFFQ 292

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 83/258 (32%), Positives = 132/258 (51%), Gaps = 32/258 (12%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K I +   +++  ++ +E++       P +V  Y SF     + ++++ + GGS+ D 
Sbjct: 39  AIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDI 98
Query: 159 LK--------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 210
           +K        K   + E  +A I  +VL+GL YLH    I HRD+K  N+L+   G V+I
Sbjct: 99  IKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQI-HRDVKAGNILLGEDGSVQI 157
Query: 211 TDFGVSAIMA-----STSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECAT 264
            DFGVSA +A     + +    TFVGT  +M+PE +   + Y +K+DIWS G+  +E AT
Sbjct: 158 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 217
Query: 265 GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSDQ-------FSPEFCSFISACVQK 315
           G  PY   PP +         LM  + + PP      Q       +   F   IS C+QK
Sbjct: 218 GAAPYHKYPPMKV--------LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQK 269
Query: 316 EPQQRLSAQELMTHPFLK 333
           +P++R +A EL+ H F +
Sbjct: 270 DPEKRPTAAELLRHKFFQ 287

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 136/255 (53%), Gaps = 23/255 (9%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAIS 144
           LV+ K TG+++A+K+++  V   A+ ++A    E ++ Q+++ P++     +F ++  + 
Sbjct: 23  LVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
            ++EY +GG L   L + +   EE       +++  L YLH  + +++RD+K  NL+++ 
Sbjct: 82  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDK 140
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
            G +KITDFG+     S      TF GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 141 DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 265 GQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL- 321
           G+ P+   + +      +E  LME I  + P +      SPE  S ++  ++K+P+QRL 
Sbjct: 201 GRLPFYNQDHE----RLFELILMEEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLG 249
Query: 322 ----SAQELMTHPFL 332
                A+E+M H F 
Sbjct: 250 GGPSDAKEVMEHRFF 264

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 136/255 (53%), Gaps = 23/255 (9%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAIS 144
           LV+ K TG+++A+K+++  V   A+ ++A    E ++ Q+++ P++     +F ++  + 
Sbjct: 26  LVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 84
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
            ++EY +GG L   L + +   EE       +++  L YLH  + +++RD+K  NL+++ 
Sbjct: 85  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDK 143
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
            G +KITDFG+     S      TF GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 144 DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 203
Query: 265 GQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL- 321
           G+ P+   + +      +E  LME I  + P +      SPE  S ++  ++K+P+QRL 
Sbjct: 204 GRLPFYNQDHE----RLFELILMEEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLG 252
Query: 322 ----SAQELMTHPFL 332
                A+E+M H F 
Sbjct: 253 GGPSDAKEVMEHRFF 267

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 76/255 (29%), Positives = 136/255 (53%), Gaps = 23/255 (9%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAIS 144
           LV+ K TG+++A+K+++  V   A+ ++A    E ++ Q+++ P++     +F ++  + 
Sbjct: 23  LVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
            ++EY +GG L   L + +   EE       +++  L YLH  + +++RD+K  NL+++ 
Sbjct: 82  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDK 140
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
            G +KITDFG+     S      TF GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 141 DGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 265 GQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL- 321
           G+ P+   + +      +E  LME I  + P +      SPE  S ++  ++K+P+QRL 
Sbjct: 201 GRLPFYNQDHE----RLFELILMEEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLG 249
Query: 322 ----SAQELMTHPFL 332
                A+E+M H F 
Sbjct: 250 GGPSDAKEVMEHRFF 264

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 141/279 (50%), Gaps = 23/279 (8%)
Query: 64  DNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELK 120
           D ++ + D D              LV+ K TG+++A+K+++  V   A+ ++A    E +
Sbjct: 4   DPKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESR 62
Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           + Q+++ P++     +F ++  +  ++EY +GG L   L + +   EE       +++  
Sbjct: 63  VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSA 122
Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L YLH  + +++RD+K  NL+++  G +KITDFG+     S       F GT  Y++PE 
Sbjct: 123 LEYLH-SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEV 181
Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPS 298
           +    YG   D W LG+V+ E   G+ P+   + +      +E  LME I  + P +   
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILMEEI--RFPRT--- 232
Query: 299 DQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFL 332
              SPE  S ++  ++K+P+QRL      A+E+M H F 
Sbjct: 233 --LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 269

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 135/255 (52%), Gaps = 23/255 (9%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAIS 144
           LV+ K TG+++A+K+++  V   A+ ++A    E ++ Q+++ P++     +F ++  + 
Sbjct: 23  LVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
            ++EY +GG L   L + +   EE       +++  L YLH  + +++RD+K  NL+++ 
Sbjct: 82  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDK 140
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
            G +KITDFG+     S       F GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 141 DGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 265 GQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL- 321
           G+ P+   + +      +E  LME I  + P +      SPE  S ++  ++K+P+QRL 
Sbjct: 201 GRLPFYNQDHE----RLFELILMEEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLG 249
Query: 322 ----SAQELMTHPFL 332
                A+E+M H F 
Sbjct: 250 GGPSDAKEVMEHRFF 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/255 (29%), Positives = 135/255 (52%), Gaps = 23/255 (9%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAIS 144
           LV+ K TG+++A+K+++  V   A+ ++A    E ++ Q+++ P++     +F ++  + 
Sbjct: 23  LVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
            ++EY +GG L   L + +   EE       +++  L YLH  + +++RD+K  NL+++ 
Sbjct: 82  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDK 140
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
            G +KITDFG+     S       F GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 141 DGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 265 GQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL- 321
           G+ P+   + +      +E  LME I  + P +      SPE  S ++  ++K+P+QRL 
Sbjct: 201 GRLPFYNQDHE----RLFELILMEEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLG 249
Query: 322 ----SAQELMTHPFL 332
                A+E+M H F 
Sbjct: 250 GGPSDAKEVMEHRFF 264

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 134/253 (52%), Gaps = 19/253 (7%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAIS 144
           LV+ K TG+++A+K+++  V   A+ ++A    E ++ Q+++ P++     +F ++  + 
Sbjct: 23  LVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
            ++EY +GG L   L + +   EE       +++  L YLH  + +++RD+K  NL+++ 
Sbjct: 82  FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH-SRDVVYRDIKLENLMLDK 140
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
            G +KITDFG+     S       F GT  Y++PE +    YG   D W LG+V+ E   
Sbjct: 141 DGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200
Query: 265 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL--- 321
           G+ P+   + +  +     LME I  + P +      SPE  S ++  ++K+P+QRL   
Sbjct: 201 GRLPFYNQDHERLFELI--LMEEI--RFPRT-----LSPEAKSLLAGLLKKDPKQRLGGG 251
Query: 322 --SAQELMTHPFL 332
              A+E+M H F 
Sbjct: 252 PSDAKEVMEHRFF 264

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  121 bits (304), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 142/290 (48%), Gaps = 27/290 (9%)
Query: 67  LNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQ---MNVEESARRQIAQELKINQ 123
           L L+D D              LV+ K T + +A++V++   +N +E       ++    Q
Sbjct: 49  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 124 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 183
           +S  P++V  +  F +   +  ++EY++GG L   +++ + +PEE+      ++   L Y
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
           LH E+ II+RDLK  N+L++  G +K+TD+G+           +TF GT NY++PE + G
Sbjct: 169 LH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 244 GKYGYKSDIWSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQPPPSAP 297
             YG+  D W+LG+++ E   G+ P+        P+Q      F  ++E  +  P     
Sbjct: 228 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---- 283
Query: 298 SDQFSPEFCSFISACVQKEPQQRLSAQ------ELMTHPFLKMYGDLNVD 341
               S +  S + + + K+P++RL         ++  HPF +     NVD
Sbjct: 284 --SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR-----NVD 326

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 138/282 (48%), Gaps = 22/282 (7%)
Query: 67  LNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQ---MNVEESARRQIAQELKINQ 123
           L L+D D              LV+ K T + +A+KV++   +N +E       ++    Q
Sbjct: 6   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 124 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 183
           +S  P++V  +  F +   +  ++EY++GG L   +++ + +PEE+      ++   L Y
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
           LH E+ II+RDLK  N+L++  G +K+TD+G+           + F GT NY++PE + G
Sbjct: 126 LH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 184
Query: 244 GKYGYKSDIWSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQPPPSAP 297
             YG+  D W+LG+++ E   G+ P+        P+Q      F  ++E  +  P     
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---- 240
Query: 298 SDQFSPEFCSFISACVQKEPQQRLSAQ------ELMTHPFLK 333
               S +  S + + + K+P++RL         ++  HPF +
Sbjct: 241 --SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 141/290 (48%), Gaps = 27/290 (9%)
Query: 67  LNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQ---MNVEESARRQIAQELKINQ 123
           L L+D D              LV+ K T + +A+KV++   +N +E       ++    Q
Sbjct: 2   LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 61
Query: 124 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 183
           +S  P++V  +  F +   +  ++EY++GG L   +++ + +PEE+      ++   L Y
Sbjct: 62  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
           LH E+ II+RDLK  N+L++  G +K+TD+G+           + F GT NY++PE + G
Sbjct: 122 LH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 180
Query: 244 GKYGYKSDIWSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQPPPSAP 297
             YG+  D W+LG+++ E   G+ P+        P+Q      F  ++E  +  P     
Sbjct: 181 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---- 236
Query: 298 SDQFSPEFCSFISACVQKEPQQRLSAQ------ELMTHPFLKMYGDLNVD 341
               S +  S + + + K+P++RL         ++  HPF +     NVD
Sbjct: 237 --SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR-----NVD 279

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 84/234 (35%), Positives = 124/234 (52%), Gaps = 29/234 (12%)
Query: 115 IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP----EEYL 170
           + +E+ +++  +   +V    SF  NG I I +E + GGSL+  L+  K  P    E+ +
Sbjct: 66  LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTI 124
Query: 171 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTF 229
               +Q+L+GL YL H+  I+HRD+K  N+LIN + G +KI+DFG S  +A  +    TF
Sbjct: 125 GFYTKQILEGLKYL-HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF 183
Query: 230 VGTYNYMSPERISGGKYGY--KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 287
            GT  YM+PE I  G  GY   +DIWSLG  ++E ATG+    PP        FYEL E 
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK----PP--------FYELGEP 231
Query: 288 IVD-------QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 334
                     +  P  P +  S E  +FI  C + +P +R  A +L+   FLK+
Sbjct: 232 QAAMFKVGMFKVHPEIP-ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKV 284

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 141/290 (48%), Gaps = 27/290 (9%)
Query: 67  LNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQ---MNVEESARRQIAQELKINQ 123
           L L+D D              LV+ K T + +A+KV++   +N +E       ++    Q
Sbjct: 17  LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 76
Query: 124 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 183
           +S  P++V  +  F +   +  ++EY++GG L   +++ + +PEE+      ++   L Y
Sbjct: 77  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
           LH E+ II+RDLK  N+L++  G +K+TD+G+           + F GT NY++PE + G
Sbjct: 137 LH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 195
Query: 244 GKYGYKSDIWSLGLVLLECATGQFPY------SPPEQQDGWTSFYELMEAIVDQPPPSAP 297
             YG+  D W+LG+++ E   G+ P+        P+Q      F  ++E  +  P     
Sbjct: 196 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR---- 251
Query: 298 SDQFSPEFCSFISACVQKEPQQRLSA------QELMTHPFLKMYGDLNVD 341
               S +  S + + + K+P++RL         ++  HPF +     NVD
Sbjct: 252 --SMSVKAASVLKSFLNKDPKERLGCLPQTGFADIQGHPFFR-----NVD 294

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 84/233 (36%), Positives = 123/233 (52%), Gaps = 29/233 (12%)
Query: 115 IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP----EEYL 170
           + +E+ +++  +   +V    SF  NG I I +E + GGSL+  L+  K  P    E+ +
Sbjct: 52  LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRS-KWGPLKDNEQTI 110
Query: 171 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTF 229
               +Q+L+GL YL H+  I+HRD+K  N+LIN + G +KI+DFG S  +A  +    TF
Sbjct: 111 GFYTKQILEGLKYL-HDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF 169
Query: 230 VGTYNYMSPERISGGKYGY--KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 287
            GT  YM+PE I  G  GY   +DIWSLG  ++E ATG+    PP        FYEL E 
Sbjct: 170 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK----PP--------FYELGEP 217
Query: 288 IVD-------QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
                     +  P  P +  S E  +FI  C + +P +R  A +L+   FLK
Sbjct: 218 QAAMFKVGMFKVHPEIP-ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 129/247 (52%), Gaps = 22/247 (8%)
Query: 94  TGQFFALKVIQ---MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 150
           +G  +A+KV++   + V +  R ++ ++  I      P+VV  + +F + G + +IL+++
Sbjct: 55  SGHLYAMKVLKKATLKVRDRVRTKMERD--ILADVNHPFVVKLHYAFQTEGKLYLILDFL 112
Query: 151 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 210
            GG L   L K     EE +     ++  GL +LH    II+RDLKP N+L++  G +K+
Sbjct: 113 RGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLH-SLGIIYRDLKPENILLDEEGHIKL 171
Query: 211 TDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS 270
           TDFG+S        +A +F GT  YM+PE ++   + + +D WS G+++ E  TG  P+ 
Sbjct: 172 TDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQ 231
Query: 271 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQF-SPEFCSFISACVQKEPQQRL-----SAQ 324
             ++++  T    +++A +  P       QF S E  S + A  ++ P  RL      A+
Sbjct: 232 GKDRKETMTL---ILKAKLGMP-------QFLSTEAQSLLRALFKRNPANRLGSGPDGAE 281
Query: 325 ELMTHPF 331
           E+  H F
Sbjct: 282 EIKRHVF 288

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 131/279 (46%), Gaps = 26/279 (9%)
Query: 63  SDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESA--RRQIAQELK 120
           S  Q  LED D              L + + +    ALKV+     E A    Q+ +E++
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVE 64
Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   
Sbjct: 65  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA 124
Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S + +T  GT +Y+ PE 
Sbjct: 125 LSYCH-SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEM 181
Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
           I G  +  K D+WSLG++  E   G     PP +   +   Y  +  +           +
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGM----PPFEAHTYQETYRRISRV-----------E 226
Query: 301 FS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFLK 333
           F+ P+F +      IS  ++    QRL+  E++ HP++K
Sbjct: 227 FTFPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 81/279 (29%), Positives = 130/279 (46%), Gaps = 26/279 (9%)
Query: 63  SDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESA--RRQIAQELK 120
           S  Q  LED D              L + + +    ALKV+     E A    Q+ +E++
Sbjct: 5   SKRQWTLEDFDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVE 64
Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   
Sbjct: 65  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANA 124
Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ PE 
Sbjct: 125 LSYCH-SKRVIHRDIKPENLLLGSNGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 181
Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
           I G  +  K D+WSLG++  E   G     PP +   +   Y  +  +           +
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGM----PPFEAHTYQETYRRISRV-----------E 226
Query: 301 FS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFLK 333
           F+ P+F +      IS  ++    QRL+  E++ HP++K
Sbjct: 227 FTFPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWIK 265

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 128/246 (52%), Gaps = 22/246 (8%)
Query: 96  QFFALKVIQ---MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 152
           Q +A+KV++   + V +  R ++ +++ +  +   P++V  + +F + G + +IL+++ G
Sbjct: 53  QLYAMKVLKKATLKVRDRVRTKMERDILVEVNH--PFIVKLHYAFQTEGKLYLILDFLRG 110
Query: 153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
           G L   L K     EE +     ++   L +LH    II+RDLKP N+L++  G +K+TD
Sbjct: 111 GDLFTRLSKEVMFTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTD 169
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 272
           FG+S        +A +F GT  YM+PE ++   +   +D WS G+++ E  TG  P+   
Sbjct: 170 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQF-SPEFCSFISACVQKEPQQRLSA-----QEL 326
           ++++  T    +++A +  P       QF SPE  S +    ++ P  RL A     +E+
Sbjct: 230 DRKETMTM---ILKAKLGMP-------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEI 279
Query: 327 MTHPFL 332
             H F 
Sbjct: 280 KRHSFF 285

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 128/246 (52%), Gaps = 22/246 (8%)
Query: 96  QFFALKVIQ---MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 152
           Q +A+KV++   + V +  R ++ +++ +  +   P++V  + +F + G + +IL+++ G
Sbjct: 54  QLYAMKVLKKATLKVRDRVRTKMERDILVEVNH--PFIVKLHYAFQTEGKLYLILDFLRG 111
Query: 153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
           G L   L K     EE +     ++   L +LH    II+RDLKP N+L++  G +K+TD
Sbjct: 112 GDLFTRLSKEVMFTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTD 170
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 272
           FG+S        +A +F GT  YM+PE ++   +   +D WS G+++ E  TG  P+   
Sbjct: 171 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 230
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQF-SPEFCSFISACVQKEPQQRLSA-----QEL 326
           ++++  T    +++A +  P       QF SPE  S +    ++ P  RL A     +E+
Sbjct: 231 DRKETMTM---ILKAKLGMP-------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEI 280
Query: 327 MTHPFL 332
             H F 
Sbjct: 281 KRHSFF 286

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 128/246 (52%), Gaps = 22/246 (8%)
Query: 96  QFFALKVIQ---MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 152
           Q +A+KV++   + V +  R ++ +++ +  +   P++V  + +F + G + +IL+++ G
Sbjct: 53  QLYAMKVLKKATLKVRDRVRTKMERDILVEVNH--PFIVKLHYAFQTEGKLYLILDFLRG 110
Query: 153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
           G L   L K     EE +     ++   L +LH    II+RDLKP N+L++  G +K+TD
Sbjct: 111 GDLFTRLSKEVMFTEEDVKFYLAELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTD 169
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 272
           FG+S        +A +F GT  YM+PE ++   +   +D WS G+++ E  TG  P+   
Sbjct: 170 FGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK 229
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQF-SPEFCSFISACVQKEPQQRLSA-----QEL 326
           ++++  T    +++A +  P       QF SPE  S +    ++ P  RL A     +E+
Sbjct: 230 DRKETMTM---ILKAKLGMP-------QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEI 279
Query: 327 MTHPFL 332
             H F 
Sbjct: 280 KRHSFF 285

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 135/278 (48%), Gaps = 26/278 (9%)
Query: 63  SDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELK 120
           S  Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++
Sbjct: 5   SKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 64
Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   
Sbjct: 65  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 124
Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ PE 
Sbjct: 125 LSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEM 181
Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
           I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +
Sbjct: 182 IEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------E 226
Query: 301 FS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
           F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 227 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 264

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 127/277 (45%), Gaps = 26/277 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI---QMNVEESARRQIAQELKI 121
            +  ++D D              L + K      ALKV+   Q+  +E    Q+ +E++I
Sbjct: 9   RKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEI 67
Query: 122 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 181
               + P ++  Y  F+    I ++LE+   G L   L+K     E+  A   E++   L
Sbjct: 68  QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 127
Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 241
            Y H E+ +IHRD+KP NLL+ ++GE+KI DFG S  + + S +     GT +Y+ PE I
Sbjct: 128 HYCH-ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMI 184
Query: 242 SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 301
            G  +  K D+W  G++  E   G  P+  P       S  E    IV+        D  
Sbjct: 185 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP-------SHTETHRRIVN-------VDLK 230
Query: 302 SPEFCS-----FISACVQKEPQQRLSAQELMTHPFLK 333
            P F S      IS  ++  P QRL  + +M HP++K
Sbjct: 231 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 127/277 (45%), Gaps = 26/277 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI---QMNVEESARRQIAQELKI 121
            +  ++D D              L + K      ALKV+   Q+  +E    Q+ +E++I
Sbjct: 10  RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLE-KEGVEHQLRREIEI 68
Query: 122 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 181
               + P ++  Y  F+    I ++LE+   G L   L+K     E+  A   E++   L
Sbjct: 69  QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADAL 128
Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 241
            Y H E+ +IHRD+KP NLL+ ++GE+KI DFG S  + + S +     GT +Y+ PE I
Sbjct: 129 HYCH-ERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRXMCGTLDYLPPEMI 185
Query: 242 SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 301
            G  +  K D+W  G++  E   G  P+  P       S  E    IV+        D  
Sbjct: 186 EGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP-------SHTETHRRIVN-------VDLK 231
Query: 302 SPEFCS-----FISACVQKEPQQRLSAQELMTHPFLK 333
            P F S      IS  ++  P QRL  + +M HP++K
Sbjct: 232 FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 268

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 8   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ PE I 
Sbjct: 128 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEXIE 184
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 185 GRXHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 229
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWI 265

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 129/261 (49%), Gaps = 19/261 (7%)
Query: 88  LVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           +VQ   T + +A+K +  Q  VE +  R + +EL+I Q  + P++V  + SF     + +
Sbjct: 33  IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFM 92
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAA-ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +++ + GG L   L++     EE +   ICE V+  L YL +++ IIHRD+KP N+L++ 
Sbjct: 93  VVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM-ALDYLQNQR-IIHRDMKPDNILLDE 150
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLE 261
            G V ITDF ++A++   + Q  T  GT  YM+PE  S   G  Y +  D WSLG+   E
Sbjct: 151 HGHVHITDFNIAAMLPRET-QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYE 209
Query: 262 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 321
              G+ PY            +     +V  P        +S E  S +   ++  P QR 
Sbjct: 210 LLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA------WSQEMVSLLKKLLEPNPDQRF 263
Query: 322 SA-QELMTHPFLKMYGDLNVD 341
           S   ++   P++    D+N D
Sbjct: 264 SQLSDVQNFPYM---NDINWD 281

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 135/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 4   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S + +T  GT +Y+ PE I 
Sbjct: 124 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDTLCGTLDYLPPEMIE 180
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 225
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 29  RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 88
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ PE I 
Sbjct: 149 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIE 205
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 250
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 251 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 135/281 (48%), Gaps = 26/281 (9%)
Query: 60  IKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQ 117
           ++    Q  LED +              L + K +    ALKV+ +  +E++    Q+ +
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 118 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 177
           E++I    + P ++  Y  F+    + +ILEY   G +   L+K+    E+  A    ++
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 237
              L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ 
Sbjct: 123 ANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLP 179
Query: 238 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 297
           PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +         
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV--------- 226
Query: 298 SDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
             +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 227 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 2   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 61
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 62  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 121
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ PE I 
Sbjct: 122 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIE 178
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 179 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 223
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 224 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 259

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ PE I 
Sbjct: 123 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIE 179
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 224
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 136/281 (48%), Gaps = 26/281 (9%)
Query: 60  IKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQ 117
           ++    Q  LED +              L + K +    ALKV+ +  +E++    Q+ +
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 118 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 177
           E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 237
              L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ 
Sbjct: 121 ANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLP 177
Query: 238 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 297
           PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +         
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV--------- 224
Query: 298 SDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
             +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 136/281 (48%), Gaps = 26/281 (9%)
Query: 60  IKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQ 117
           ++    Q  LED +              L + K +    ALKV+ +  +E++    Q+ +
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 118 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 177
           E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 122
Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 237
              L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ 
Sbjct: 123 ANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLP 179
Query: 238 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 297
           PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +         
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV--------- 226
Query: 298 SDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
             +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 227 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 20  RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 79
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 80  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 139
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ PE I 
Sbjct: 140 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIE 196
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 197 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 241
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 242 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 277

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 136/281 (48%), Gaps = 26/281 (9%)
Query: 60  IKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQ 117
           ++    Q  LED +              L + K +    ALKV+ +  +E++    Q+ +
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 118 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 177
           E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 237
              L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ 
Sbjct: 121 ANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLP 177
Query: 238 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 297
           PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +         
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV--------- 224
Query: 298 SDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
             +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 135/278 (48%), Gaps = 26/278 (9%)
Query: 63  SDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELK 120
           +  Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           I    + P ++  Y  F+ +  + +ILEY   G++   L+K+    E+  A    ++   
Sbjct: 61  IQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L Y H +K +IHRD+KP NLL+   GE+KI DFG S + A +S +A    GT +Y+ PE 
Sbjct: 121 LSYCHSKK-VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRA-ALCGTLDYLPPEM 177
Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
           I G  +  K D+WSLG++  E   G+ P+     QD +     +               +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV---------------E 222
Query: 301 FS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
           F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 223 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/276 (28%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 4   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S    + S +  T  GT +Y+ PE I 
Sbjct: 124 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWSC--HAPSSRRTTLSGTLDYLPPEMIE 180
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 225
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 133/275 (48%), Gaps = 26/275 (9%)
Query: 66  QLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKINQ 123
           Q  LED +              L + K      ALKV+ +  +E++    Q+ +E++I  
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 124 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 183
             + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L Y
Sbjct: 61  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 120
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
            H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +  T  GT +Y+ PE I G
Sbjct: 121 CH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTTLCGTLDYLPPEMIEG 177
Query: 244 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS- 302
             +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+ 
Sbjct: 178 RMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFTF 222
Query: 303 PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
           P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 223 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 257

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 29  RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 88
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 148
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S + +   GT +Y+ PE I 
Sbjct: 149 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEMIE 205
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 206 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 250
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 251 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 94  TGQFFALKVIQ-----MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           TG+ FA+KV++      N +++A  +   E  I +  + P++V    +F + G + +ILE
Sbjct: 44  TGKIFAMKVLKKAMIVRNAKDTAHTK--AERNILEEVKHPFIVDLIYAFQTGGKLYLILE 101
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           Y+ GG L   L++     E+       ++   L +LH +K II+RDLKP N+++NH+G V
Sbjct: 102 YLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH-QKGIIYRDLKPENIMLNHQGHV 160
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           K+TDFG+           +TF GT  YM+PE +    +    D WSLG ++ +  TG  P
Sbjct: 161 KLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
Query: 269 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----A 323
           ++   ++    +  ++++  ++ PP        + E    +   +++    RL      A
Sbjct: 221 FTGENRKK---TIDKILKCKLNLPP------YLTQEARDLLKKLLKRNAASRLGAGPGDA 271
Query: 324 QELMTHPFLK 333
            E+  HPF +
Sbjct: 272 GEVQAHPFFR 281

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 6   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S + +   GT +Y+ PE I 
Sbjct: 126 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRDDLCGTLDYLPPEMIE 182
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 227
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 228 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 79/278 (28%), Positives = 136/278 (48%), Gaps = 26/278 (9%)
Query: 63  SDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELK 120
           +  Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++
Sbjct: 1   AKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
           I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L Y H  K +IHRD+KP NLL+   GE+KI DFG S + A +S +A    GT +Y+ PE 
Sbjct: 121 LSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRA-ALCGTLDYLPPEM 177
Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
           I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +
Sbjct: 178 IEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------E 222
Query: 301 FS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
           F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 223 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 136/281 (48%), Gaps = 26/281 (9%)
Query: 60  IKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQ 117
           ++    Q  LED +              L + K +    ALKV+ +  +E++    Q+ +
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 118 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 177
           E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 237
              L Y H  K +IHRD+KP NLL+   GE+KI +FG S  + + S +  T  GT +Y+ 
Sbjct: 121 ANALSYCH-SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLP 177
Query: 238 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 297
           PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +         
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV--------- 224
Query: 298 SDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
             +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 118/222 (53%), Gaps = 17/222 (7%)
Query: 115 IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAI 173
           I +E++  Q  + P  +     +       +++EY   GS +D L+   K + E  +AA+
Sbjct: 101 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAV 159
Query: 174 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 233
               L+GL YLH   ++IHRD+K  N+L++  G VK+ DFG ++IMA     AN FVGT 
Sbjct: 160 THGALQGLAYLH-SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANXFVGTP 214
Query: 234 NYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 290
            +M+PE I     G+Y  K D+WSLG+  +E A  + P       +  ++ Y     I  
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYH----IAQ 267
Query: 291 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
              P+  S  +S  F +F+ +C+QK PQ R +++ L+ H F+
Sbjct: 268 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 73/222 (32%), Positives = 118/222 (53%), Gaps = 17/222 (7%)
Query: 115 IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAI 173
           I +E++  Q  + P  +     +       +++EY   GS +D L+   K + E  +AA+
Sbjct: 62  IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAV 120
Query: 174 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 233
               L+GL YLH   ++IHRD+K  N+L++  G VK+ DFG ++IMA     AN FVGT 
Sbjct: 121 THGALQGLAYLH-SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANXFVGTP 175
Query: 234 NYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 290
            +M+PE I     G+Y  K D+WSLG+  +E A  + P       +  ++ Y     I  
Sbjct: 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NMNAMSALYH----IAQ 228
Query: 291 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
              P+  S  +S  F +F+ +C+QK PQ R +++ L+ H F+
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ PE I 
Sbjct: 123 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTXLCGTLDYLPPEMIE 179
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 224
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 134/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 5   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 64
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI +FG S  + + S +  T  GT +Y+ PE I 
Sbjct: 125 YCH-SKRVIHRDIKPENLLLGSAGELKIANFGWS--VHAPSSRRTTLCGTLDYLPPEMIE 181
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 226
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 227 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 135/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 6   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 65
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 125
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S + A +S +A    GT +Y+ PE I 
Sbjct: 126 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRA-ALCGTLDYLPPEMIE 182
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 227
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 228 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 134/281 (47%), Gaps = 26/281 (9%)
Query: 60  IKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQ 117
           ++    Q  LED +              L + K +    ALKV+ +  +E++    Q+ +
Sbjct: 3   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 62
Query: 118 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 177
           E++I    + P ++  Y  F+    + +ILEY   G +   L+K+    E+  A    ++
Sbjct: 63  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL 122
Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 237
              L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ 
Sbjct: 123 ANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLXGTLDYLP 179
Query: 238 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 297
           PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +         
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV--------- 226
Query: 298 SDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
             +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 227 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ PE I 
Sbjct: 123 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTELCGTLDYLPPEMIE 179
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 224
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 128/251 (50%), Gaps = 22/251 (8%)
Query: 90  QHKWTGQFFALKVIQ------MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI 143
           +H+ TG   A+K++       ++V    RR+I Q LK+ +    P+++  YQ   +   I
Sbjct: 36  KHELTGHKVAVKILNRQKIRSLDVVGKIRREI-QNLKLFRH---PHIIKLYQVISTPSDI 91
Query: 144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
            +++EY+ GG L D++ K   + E+    + +Q+L G+ Y H    ++HRDLKP N+L++
Sbjct: 92  FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM-VVHRDLKPENVLLD 150
Query: 204 HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLEC 262
                KI DFG+S +M+       +  G+ NY +PE ISG  Y G + DIWS G++L   
Sbjct: 151 AHMNAKIADFGLSNMMSDGEFLRXS-CGSPNYAAPEVISGRLYAGPEVDIWSSGVILYAL 209
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
             G  P+   +     T F ++ + I   P         +P   S +   +Q +P +R +
Sbjct: 210 LCGTLPF---DDDHVPTLFKKICDGIFYTP------QYLNPSVISLLKHMLQVDPMKRAT 260
Query: 323 AQELMTHPFLK 333
            +++  H + K
Sbjct: 261 IKDIREHEWFK 271

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ PE I 
Sbjct: 123 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIE 179
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 224
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 4   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ PE I 
Sbjct: 124 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIE 180
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 225
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 132/264 (50%), Gaps = 23/264 (8%)
Query: 87  QLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           +L  H  T Q  ALK I  Q+  +     ++ +E+   +  + P+++  Y    +   I 
Sbjct: 26  KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIV 85
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +++EY  GG L D++ + K + E+      +Q++  + Y H  K I+HRDLKP NLL++ 
Sbjct: 86  MVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK-IVHRDLKPENLLLDD 143
Query: 205 RGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLEC 262
              VKI DFG+S IM  T G    T  G+ NY +PE I+G  Y G + D+WS G+VL   
Sbjct: 144 NLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVM 201
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
             G+ P+      +   + ++ + + V   P     D  SP   S I   +  +P QR++
Sbjct: 202 LVGRLPFD----DEFIPNLFKKVNSCVYVMP-----DFLSPGAQSLIRRMIVADPMQRIT 252
Query: 323 AQELMTHPFLKMYGDLNVDLSEYF 346
            QE+   P+       NV+L +Y 
Sbjct: 253 IQEIRRDPW------FNVNLPDYL 270

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 8   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 67
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 127
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ PE I 
Sbjct: 128 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIE 184
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 185 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 229
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 230 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ PE I 
Sbjct: 123 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIE 179
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 224
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 313 VQKEPQQRLSAQELMTHPFLK 333
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 3   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 62
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 122
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ PE I 
Sbjct: 123 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLCGTLDYLPPEMIE 179
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 224
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 313 VQKEPQQRLSAQELMTHPFLK 333
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 313 VQKEPQQRLSAQELMTHPFLK 333
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 20/251 (7%)
Query: 94  TGQFFALKV-----IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           TG+ +A+K      I+M   E+        L +  +  CP++V    +F++   +S IL+
Sbjct: 213 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
            M+GG L   L +     E  +     +++ GL ++H+ + +++RDLKP+N+L++  G V
Sbjct: 273 LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHV 331
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF 267
           +I+D G++   +     A+  VGT+ YM+PE +  G  Y   +D +SLG +L +   G  
Sbjct: 332 RISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
Query: 268 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----S 322
           P+   + +D        +   V+ P      D FSPE  S +   +Q++  +RL      
Sbjct: 390 PFRQHKTKDKHEIDRMTLTMAVELP------DSFSPELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 323 AQELMTHPFLK 333
           AQE+   PF +
Sbjct: 444 AQEVKESPFFR 454

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 20/251 (7%)
Query: 94  TGQFFALKV-----IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           TG+ +A+K      I+M   E+        L +  +  CP++V    +F++   +S IL+
Sbjct: 212 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 271
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
            M+GG L   L +     E  +     +++ GL ++H+ + +++RDLKP+N+L++  G V
Sbjct: 272 LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHV 330
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF 267
           +I+D G++   +     A+  VGT+ YM+PE +  G  Y   +D +SLG +L +   G  
Sbjct: 331 RISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 388
Query: 268 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----S 322
           P+   + +D        +   V+ P      D FSPE  S +   +Q++  +RL      
Sbjct: 389 PFRQHKTKDKHEIDRMTLTMAVELP------DSFSPELRSLLEGLLQRDVNRRLGCLGRG 442
Query: 323 AQELMTHPFLK 333
           AQE+   PF +
Sbjct: 443 AQEVKESPFFR 453

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 135/281 (48%), Gaps = 26/281 (9%)
Query: 60  IKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQ 117
           ++    Q  LED +              L + K +    ALKV+ +  +E++    Q+ +
Sbjct: 1   MESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRR 60
Query: 118 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 177
           E++I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++
Sbjct: 61  EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL 120
Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 237
              L Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ 
Sbjct: 121 ANALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLP 177
Query: 238 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 297
           PE I G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +         
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV--------- 224
Query: 298 SDQFS-PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
             +F+ P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 225 --EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 20/251 (7%)
Query: 94  TGQFFALKV-----IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           TG+ +A+K      I+M   E+        L +  +  CP++V    +F++   +S IL+
Sbjct: 213 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
            M+GG L   L +     E  +     +++ GL ++H+ + +++RDLKP+N+L++  G V
Sbjct: 273 LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHV 331
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF 267
           +I+D G++   +     A+  VGT+ YM+PE +  G  Y   +D +SLG +L +   G  
Sbjct: 332 RISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
Query: 268 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----S 322
           P+   + +D        +   V+ P      D FSPE  S +   +Q++  +RL      
Sbjct: 390 PFRQHKTKDKHEIDRMTLTMAVELP------DSFSPELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 323 AQELMTHPFLK 333
           AQE+   PF +
Sbjct: 444 AQEVKESPFFR 454

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/251 (27%), Positives = 126/251 (50%), Gaps = 20/251 (7%)
Query: 94  TGQFFALKV-----IQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           TG+ +A+K      I+M   E+        L +  +  CP++V    +F++   +S IL+
Sbjct: 213 TGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
            M+GG L   L +     E  +     +++ GL ++H+ + +++RDLKP+N+L++  G V
Sbjct: 273 LMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHV 331
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF 267
           +I+D G++   +     A+  VGT+ YM+PE +  G  Y   +D +SLG +L +   G  
Sbjct: 332 RISDLGLACDFSKKKPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
Query: 268 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----S 322
           P+   + +D        +   V+ P      D FSPE  S +   +Q++  +RL      
Sbjct: 390 PFRQHKTKDKHEIDRMTLTMAVELP------DSFSPELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 323 AQELMTHPFLK 333
           AQE+   PF +
Sbjct: 444 AQEVKESPFFR 454

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 77/276 (27%), Positives = 133/276 (48%), Gaps = 26/276 (9%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI-QMNVEESA-RRQIAQELKIN 122
            Q  LED +              L + K +    ALKV+ +  +E++    Q+ +E++I 
Sbjct: 5   RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 64
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
              + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L 
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 124
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           Y H  K +IHRD+KP NLL+   GE+KI DFG S  + + S +     GT +Y+ PE I 
Sbjct: 125 YCH-SKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRXXLCGTLDYLPPEMIE 181
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G  +  K D+WSLG++  E   G+    PP + + +   Y+ +  +           +F+
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGK----PPFEANTYQETYKRISRV-----------EFT 226
Query: 303 -PEFCS-----FISACVQKEPQQRLSAQELMTHPFL 332
            P+F +      IS  ++  P QR   +E++ HP++
Sbjct: 227 FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 313 VQKEPQQRLSAQELMTHPFLK 333
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 313 VQKEPQQRLSAQELMTHPFLK 333
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 313 VQKEPQQRLSAQELMTHPFLK 333
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 313 VQKEPQQRLSAQELMTHPFLK 333
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 313 VQKEPQQRLSAQELMTHPFLK 333
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 30  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 90  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 148
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 149 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 208 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 254
Query: 313 VQKEPQQRLSAQELMTHPFLK 333
           + K+P++R++ Q+ + HP++K
Sbjct: 255 LVKDPKKRMTIQDSLQHPWIK 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 30  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 90  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 148
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 149 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 208 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 254
Query: 313 VQKEPQQRLSAQELMTHPFLK 333
           + K+P++R++ Q+ + HP++K
Sbjct: 255 LVKDPKKRMTIQDSLQHPWIK 275

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 313 VQKEPQQRLSAQELMTHPFLK 333
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 313 VQKEPQQRLSAQELMTHPFLK 333
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 125/250 (50%), Gaps = 22/250 (8%)
Query: 94  TGQFFALKVIQ-----MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           TG+ FA+KV++      N +++A  +   E  I +  + P++V    +F + G + +ILE
Sbjct: 44  TGKIFAMKVLKKAMIVRNAKDTAHTK--AERNILEEVKHPFIVDLIYAFQTGGKLYLILE 101
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           Y+ GG L   L++     E+       ++   L +LH +K II+RDLKP N+++NH+G V
Sbjct: 102 YLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLH-QKGIIYRDLKPENIMLNHQGHV 160
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           K+TDFG+           + F GT  YM+PE +    +    D WSLG ++ +  TG  P
Sbjct: 161 KLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
Query: 269 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-----A 323
           ++   ++    +  ++++  ++ PP        + E    +   +++    RL      A
Sbjct: 221 FTGENRK---KTIDKILKCKLNLPP------YLTQEARDLLKKLLKRNAASRLGAGPGDA 271
Query: 324 QELMTHPFLK 333
            E+  HPF +
Sbjct: 272 GEVQAHPFFR 281

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/275 (26%), Positives = 129/275 (46%), Gaps = 12/275 (4%)
Query: 66  QLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQ 123
           Q+  ED D             QLV+HK + + +A+K++     ++ S      +E  I  
Sbjct: 71  QMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 130
Query: 124 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 183
            +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +V+  L  
Sbjct: 131 FANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDA 189
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMSPERIS 242
           +H    +IHRD+KP N+L++  G +K+ DFG    M  T     +T VGT +Y+SPE + 
Sbjct: 190 IH-SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLK 248
Query: 243 G----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 298
                G YG + D WS+G+ L E   G  P+        ++   +   ++   P  +  S
Sbjct: 249 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLC-FPEDAEIS 307
Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
                  C+F++   ++    R   +E+  HPF K
Sbjct: 308 KHAKNLICAFLTD--REVRLGRNGVEEIKQHPFFK 340

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 54  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 114 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 173
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G   T  GT  Y++PE
Sbjct: 174 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGATWTLCGTPEYLAPE 229
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 133/261 (50%), Gaps = 32/261 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPAFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 313 VQKEPQQRLSAQELMTHPFLK 333
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 135/268 (50%), Gaps = 32/268 (11%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG+ +A K I+     S+RR     +I +E+ I +  + P ++  +  F +   + 
Sbjct: 25  RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ E+      +Q+L G+ YL H K I H DLKP N+++  
Sbjct: 85  LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL-HSKRIAHFDLKPENIMLLD 143
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           +      +K+ DFG++  + + +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 144 KNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 202
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+  T+              SA +  F  E+ S        FI   
Sbjct: 203 ILLSGASPFLGETKQETLTNI-------------SAVNYDFDEEYFSNTSELAKDFIRRL 249
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGDLNV 340
           + K+P++R++  + + H ++K     NV
Sbjct: 250 LVKDPKRRMTIAQSLEHSWIKAIRRRNV 277

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 66/272 (24%), Positives = 129/272 (47%), Gaps = 14/272 (5%)
Query: 66  QLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKIN 122
           +L +ED +              L + K T QFFA+K ++ +V   ++     + ++  ++
Sbjct: 14  KLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 73
Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
            + + P++   + +F +   +  ++EY++GG L   ++               +++ GL 
Sbjct: 74  LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 133
Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           +LH  K I++RDLK  N+L++  G +KI DFG+         + N F GT +Y++PE + 
Sbjct: 134 FLH-SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILL 192
Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G KY +  D WS G++L E   GQ P+   ++++ + S        +    P  P     
Sbjct: 193 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS--------IRMDNPFYPR-WLE 243
Query: 303 PEFCSFISACVQKEPQQRLSAQ-ELMTHPFLK 333
            E    +     +EP++RL  + ++  HP  +
Sbjct: 244 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 275

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 73/257 (28%), Positives = 131/257 (50%), Gaps = 28/257 (10%)
Query: 94  TGQFFALKVIQ-------MNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           TG+ +A+KV++           E  R  RQ+ + ++     Q P++V  + +F +   + 
Sbjct: 81  TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-----QSPFLVTLHYAFQTETKLH 135
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +IL+Y++GG L   L + +   E  +     +++  L +LH +  II+RD+K  N+L++ 
Sbjct: 136 LILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH-KLGIIYRDIKLENILLDS 194
Query: 205 RGEVKITDFGVSA-IMASTSGQANTFVGTYNYMSPERISGGKYGYKS--DIWSLGLVLLE 261
            G V +TDFG+S   +A  + +A  F GT  YM+P+ + GG  G+    D WSLG+++ E
Sbjct: 195 NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254
Query: 262 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 321
             TG  P++   +++   S  E+   I+   PP     + S      I   + K+P++RL
Sbjct: 255 LLTGASPFTVDGEKN---SQAEISRRILKSEPPY--PQEMSALAKDLIQRLLMKDPKKRL 309
Query: 322 S-----AQELMTHPFLK 333
                 A E+  H F +
Sbjct: 310 GCGPRDADEIKEHLFFQ 326

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+HK TG  FA+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+HK TG  FA+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 70/242 (28%), Positives = 114/242 (47%), Gaps = 13/242 (5%)
Query: 94  TGQFFALKVIQMNVEESA--RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           TG   A+K+I       A   +++  E+KI+   + P ++  Y  F  +  + ++LE   
Sbjct: 35  TGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCH 94
Query: 152 GGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 210
            G +  +LK +VK   E        Q++ G+LYLH    I+HRDL  SNLL+     +KI
Sbjct: 95  NGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG-ILHRDLTLSNLLLTRNMNIKI 153
Query: 211 TDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS 270
            DFG++  +     +  T  GT NY+SPE  +   +G +SD+WSLG +      G+ P+ 
Sbjct: 154 ADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213
Query: 271 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 330
               ++           + D   PS      S E    I   +++ P  RLS   ++ HP
Sbjct: 214 TDTVKNTLNKV-----VLADYEMPSF----LSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264
Query: 331 FL 332
           F+
Sbjct: 265 FM 266

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+HK TG  FA+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 128/277 (46%), Gaps = 34/277 (12%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 150
           +K TG + ALK ++++ EE       +E+ + +  +   +V  Y   ++   ++++ E+M
Sbjct: 26  NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85
Query: 151 DGGSLADFL--KKVKTIPEEYLAAICE----QVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           D   L  ++  + V   P      + +    Q+L+GL + H  K I+HRDLKP NLLIN 
Sbjct: 86  DN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK-ILHRDLKPQNLLINK 143
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECA 263
           RG++K+ DFG++          ++ V T  Y +P+ + G + Y    DIWS G +L E  
Sbjct: 144 RGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203
Query: 264 TGQ--FPYSPPEQQ-------------DGWTSFYEL--MEAIVDQPPPSAPSDQFSPE-- 304
           TG+  FP +  E+Q               W S  +L      + Q PP        P   
Sbjct: 204 TGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTK 263
Query: 305 ------FCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
                    F+   +Q  P  RLSA++ + HP+   Y
Sbjct: 264 EPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLAGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/257 (27%), Positives = 129/257 (50%), Gaps = 19/257 (7%)
Query: 87  QLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVCYQSF--YSNGAI 143
           Q ++ K  G+    K +   ++ E+ ++ +  E+ + +  + P +V  Y      +N  +
Sbjct: 23  QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82
Query: 144 SIILEYMDGGSLADFL----KKVKTIPEEYLAAICEQVLKGLLYLHHEKH----IIHRDL 195
            I++EY +GG LA  +    K+ + + EE++  +  Q+   L   H        ++HRDL
Sbjct: 83  YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 196 KPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSL 255
           KP+N+ ++ +  VK+ DFG++ I+   +  A TFVGT  YMSPE+++   Y  KSDIWSL
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 315
           G +L E      P++   Q+       EL   I +      P  ++S E    I+  +  
Sbjct: 203 GCLLYELCALMPPFTAFSQK-------ELAGKIREGKFRRIPY-RYSDELNEIITRMLNL 254
Query: 316 EPQQRLSAQELMTHPFL 332
           +   R S +E++ +P +
Sbjct: 255 KDYHRPSVEEILENPLI 271

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 6/214 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 273
            I    Y    D W+LG+++ E A G  P+   E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADE 242

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 123/250 (49%), Gaps = 14/250 (5%)
Query: 88  LVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           L + K T QFFA+K ++ +V   ++     + ++  ++ + + P++   + +F +   + 
Sbjct: 35  LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
            ++EY++GG L   ++               +++ GL +LH  K I++RDLK  N+L++ 
Sbjct: 95  FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH-SKGIVYRDLKLDNILLDK 153
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
            G +KI DFG+         + N F GT +Y++PE + G KY +  D WS G++L E   
Sbjct: 154 DGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLI 213
Query: 265 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 324
           GQ P+   ++++ + S        +    P  P      E    +     +EP++RL  +
Sbjct: 214 GQSPFHGQDEEELFHS--------IRMDNPFYPR-WLEKEAKDLLVKLFVREPEKRLGVR 264
Query: 325 -ELMTHPFLK 333
            ++  HP  +
Sbjct: 265 GDIRQHPLFR 274

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 134/268 (50%), Gaps = 32/268 (11%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG+ +A K I+     S+RR     +I +E+ I +  + P ++  +  F +   + 
Sbjct: 46  RQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 105
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ E+      +Q+L G+ YL H K I H DLKP N+++  
Sbjct: 106 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL-HSKRIAHFDLKPENIMLLD 164
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           +      +K+ DFG++  + + +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 165 KNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 223
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+  T+              SA +  F  E+ S        FI   
Sbjct: 224 ILLSGASPFLGETKQETLTNI-------------SAVNYDFDEEYFSNTSELAKDFIRRL 270
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGDLNV 340
           + K+P++R+   + + H ++K     NV
Sbjct: 271 LVKDPKRRMXIAQSLEHSWIKAIRRRNV 298

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 78/248 (31%), Positives = 125/248 (50%), Gaps = 14/248 (5%)
Query: 88  LVQHKWTGQFFALKVI-QMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L + K +    ALKV+ +  +E E    Q+ +E++I      P ++  Y  FY    I +
Sbjct: 41  LAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYL 100
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ILEY   G L   L+K  T  E+  A I E++   L+Y H +K +IHRD+KP NLL+  +
Sbjct: 101 ILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKK-VIHRDIKPENLLLGLK 159
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
           GE+KI DFG S  + + S +  T  GT +Y+ PE I G  +  K D+W +G++  E   G
Sbjct: 160 GELKIADFGWS--VHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
               +PP +       Y  +  +  + P S P+          IS  ++  P +RL   +
Sbjct: 218 ----NPPFESASHNETYRRIVKVDLKFPASVPTGA-----QDLISKLLRHNPSERLPLAQ 268
Query: 326 LMTHPFLK 333
           +  HP+++
Sbjct: 269 VSAHPWVR 276

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLXGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 20  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 79
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 80  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 139
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 140 TFEYLH-SLDLIYRDLKPENLLIDEQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 195
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 196 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 34  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 126/256 (49%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 110 GLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN+FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSSDLWALGCIIYQLV 228
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 229 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 279
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 280 EEMEGYGPLKAHPFFE 295

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+HK TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + ++LEY  GG +   L+++    E +      Q++ 
Sbjct: 94  RIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +K+ DFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLLIDQQGYIKVADFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 54  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 114 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 173
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 174 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 229
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 28  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 87
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 88  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 147
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 148 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 203
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 204 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 126/256 (49%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 51  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 110
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 111 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 169
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN+FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 170 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 229
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 230 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 280
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 281 EEMEGYGPLKAHPFFE 296

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+HK TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+HK TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+HK TG  +A+K++  Q  V+         E 
Sbjct: 54  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 114 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 173
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 174 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 229
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+HK TG  +A+K++  Q  V+         E 
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 145
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 146 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 201
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 202 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+HK TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 126/256 (49%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 47  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 106
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 107 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 165
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN+FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 166 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 225
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 226 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 276
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 277 EEMEGYGPLKAHPFFE 292

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 81/266 (30%), Positives = 124/266 (46%), Gaps = 23/266 (8%)
Query: 87  QLVQHKWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           +L  H  TGQ  ALK+I   V   +  Q  I +E+   +  + P+++  Y    S   I 
Sbjct: 31  KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 90
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +++EY  G  L D++ +   + E+      +Q++  + Y H  K I+HRDLKP NLL++ 
Sbjct: 91  MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK-IVHRDLKPENLLLDE 148
Query: 205 RGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLEC 262
              VKI DFG+S IM  T G    T  G+ NY +PE ISG  Y G + D+WS G++L   
Sbjct: 149 HLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVM 206
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
              + P+   + +     F  +   +   P         SP     I   +   P  R+S
Sbjct: 207 LCRRLPF---DDESIPVLFKNISNGVYTLP------KFLSPGAAGLIKRMLIVNPLNRIS 257
Query: 323 AQELMTHPFLKMYGDLNVDLSEYFTD 348
             E+M   + K      VDL EY  +
Sbjct: 258 IHEIMQDDWFK------VDLPEYLLE 277

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 123/264 (46%), Gaps = 23/264 (8%)
Query: 87  QLVQHKWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           +L  H  TGQ  ALK+I   V   +  Q  I +E+   +  + P+++  Y    S   I 
Sbjct: 25  KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 84
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +++EY  G  L D++ +   + E+      +Q++  + Y H  K I+HRDLKP NLL++ 
Sbjct: 85  MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK-IVHRDLKPENLLLDE 142
Query: 205 RGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLEC 262
              VKI DFG+S IM  T G    T  G+ NY +PE ISG  Y G + D+WS G++L   
Sbjct: 143 HLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVM 200
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
              + P+   + +     F  +   +   P         SP     I   +   P  R+S
Sbjct: 201 LCRRLPF---DDESIPVLFKNISNGVYTLP------KFLSPGAAGLIKRMLIVNPLNRIS 251
Query: 323 AQELMTHPFLKMYGDLNVDLSEYF 346
             E+M   + K      VDL EY 
Sbjct: 252 IHEIMQDDWFK------VDLPEYL 269

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 123/264 (46%), Gaps = 23/264 (8%)
Query: 87  QLVQHKWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           +L  H  TGQ  ALK+I   V   +  Q  I +E+   +  + P+++  Y    S   I 
Sbjct: 30  KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 89
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +++EY  G  L D++ +   + E+      +Q++  + Y H  K I+HRDLKP NLL++ 
Sbjct: 90  MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK-IVHRDLKPENLLLDE 147
Query: 205 RGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLEC 262
              VKI DFG+S IM  T G    T  G+ NY +PE ISG  Y G + D+WS G++L   
Sbjct: 148 HLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVM 205
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
              + P+   + +     F  +   +   P         SP     I   +   P  R+S
Sbjct: 206 LCRRLPF---DDESIPVLFKNISNGVYTLP------KFLSPGAAGLIKRMLIVNPLNRIS 256
Query: 323 AQELMTHPFLKMYGDLNVDLSEYF 346
             E+M   + K      VDL EY 
Sbjct: 257 IHEIMQDDWFK------VDLPEYL 274

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NL+I+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLIIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IIISKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 229 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 279
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 280 EEMEGYGPLKAHPFFE 295

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 48  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 107
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 108 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 166
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 227 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 277
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 278 EEMEGYGPLKAHPFFE 293

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+HK TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+HK TG  +A+K++  Q  V+         E 
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 145
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 146 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 201
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 202 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 229 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 279
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 280 EEMEGYGPLKAHPFFE 295

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 48  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 107
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 108 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 166
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 227 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 277
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 278 EEMEGYGPLKAHPFFE 293

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 81/264 (30%), Positives = 123/264 (46%), Gaps = 23/264 (8%)
Query: 87  QLVQHKWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           +L  H  TGQ  ALK+I   V   +  Q  I +E+   +  + P+++  Y    S   I 
Sbjct: 21  KLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEII 80
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +++EY  G  L D++ +   + E+      +Q++  + Y H  K I+HRDLKP NLL++ 
Sbjct: 81  MVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK-IVHRDLKPENLLLDE 138
Query: 205 RGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLEC 262
              VKI DFG+S IM  T G    T  G+ NY +PE ISG  Y G + D+WS G++L   
Sbjct: 139 HLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVM 196
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
              + P+   + +     F  +   +   P         SP     I   +   P  R+S
Sbjct: 197 LCRRLPF---DDESIPVLFKNISNGVYTLP------KFLSPGAAGLIKRMLIVNPLNRIS 247
Query: 323 AQELMTHPFLKMYGDLNVDLSEYF 346
             E+M   + K      VDL EY 
Sbjct: 248 IHEIMQDDWFK------VDLPEYL 265

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 48  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 107
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 108 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 166
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 227 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 277
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 278 EEMEGYGPLKAHPFFE 293

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 51  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 110
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 111 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 169
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 170 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 229
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 230 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 280
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 281 EEMEGYGPLKAHPFFE 296

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 19  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 78
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 79  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 138
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+  T  GT  Y++PE
Sbjct: 139 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEYLAPE 194
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 195 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 124/254 (48%), Gaps = 20/254 (7%)
Query: 87  QLVQHKWTGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
            L++ +  G+++A+KV++  +    ++      E  +      P+++  + +F     I 
Sbjct: 23  HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +I++Y++GG L   L+K +  P         +V   L YLH  K II+RDLKP N+L++ 
Sbjct: 83  MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH-SKDIIYRDLKPENILLDK 141
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
            G +KITDFG +  +   +       GT +Y++PE +S   Y    D WS G+++ E   
Sbjct: 142 NGHIKITDFGFAKYVPDVT---YXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198
Query: 265 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL--- 321
           G   Y+P    +   ++ +++ A +  PP       F+ +    +S  + ++  QRL   
Sbjct: 199 G---YTPFYDSNTMKTYEKILNAELRFPP------FFNEDVKDLLSRLITRDLSQRLGNL 249
Query: 322 --SAQELMTHPFLK 333
               +++  HP+ K
Sbjct: 250 QNGTEDVKNHPWFK 263

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 28  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 87
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 88  GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 146
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 147 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 206
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 207 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 257
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 258 EEMEGYGPLKAHPFFE 273

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 132/261 (50%), Gaps = 32/261 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG+ +A K I+     S+RR     +I +E+ I +  + P ++  +  F +   + 
Sbjct: 32  RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 91
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ E+      +Q+L G+ YL H K I H DLKP N+++  
Sbjct: 92  LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL-HSKRIAHFDLKPENIMLLD 150
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           +      +K+ DFG++  + + +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 151 KNVPNPRIKLIDFGIAHKIEAGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+  T+              SA +  F  E+ S        FI   
Sbjct: 210 ILLSGASPFLGETKQETLTNI-------------SAVNYDFDEEYFSNTSELAKDFIRRL 256
Query: 313 VQKEPQQRLSAQELMTHPFLK 333
           + K+P++R+   + + H ++K
Sbjct: 257 LVKDPKRRMXIAQSLEHSWIK 277

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 48  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 107
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 108 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 166
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 227 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 277
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 278 EEMEGYGPLKAHPFFE 293

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 132/261 (50%), Gaps = 32/261 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+    +S+RR      I +E+ I +  Q P V+  ++ + +   + 
Sbjct: 31  REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +I E + GG L DFL + +++ EE      +Q+L G+ YL H   I H DLKP N+++  
Sbjct: 91  LIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL-HSLQIAHFDLKPENIMLLD 149
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           R      +KI DFG++  +   +   N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 150 RNVPKPRIKIIDFGLAHKIDFGNEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              SA + +F  E+ S        FI   
Sbjct: 209 ILLSGASPFLGDTKQETLANV-------------SAVNYEFEDEYFSNTSALAKDFIRRL 255
Query: 313 VQKEPQQRLSAQELMTHPFLK 333
           + K+P++R++ Q+ + HP++K
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIK 276

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 27  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 86
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 87  GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 145
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 146 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 205
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 206 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 256
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 257 EEMEGYGPLKAHPFFE 272

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 229 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 279
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 280 EEMEGYGPLKAHPFFE 295

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+  T  GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEYLAPE 209
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ + A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 26  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 86  GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 144
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 145 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 204
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 205 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 255
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 256 EEMEGYGPLKAHPFFE 271

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 126/255 (49%), Gaps = 18/255 (7%)
Query: 87  QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII 146
            LV+ + +G    +K I  +  +    QI  E+++ +S   P ++  ++ F     + I+
Sbjct: 39  HLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIV 98
Query: 147 LEYMDGGSLADFL----KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           +E  +GG L + +     + K + E Y+A + +Q++  L Y H  +H++H+DLKP N+L 
Sbjct: 99  METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH-SQHVVHKDLKPENILF 157
Query: 203 NH---RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL 259
                   +KI DFG++ +  S     N   GT  YM+PE +      +K DIWS G+V+
Sbjct: 158 QDTSPHSPIKIIDFGLAELFKSDEHSTNA-AGTALYMAPE-VFKRDVTFKCDIWSAGVVM 215
Query: 260 LECATGQFPYSPPEQQDGWTSFYELME-AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 318
               TG  P++        TS  E+ + A   +P  +      +P+    +   + K+P+
Sbjct: 216 YFLLTGCLPFT-------GTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPE 268
Query: 319 QRLSAQELMTHPFLK 333
           +R SA +++ H + K
Sbjct: 269 RRPSAAQVLHHEWFK 283

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 25  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 84
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 85  GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 143
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 144 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 203
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 204 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 254
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 255 EEMEGYGPLKAHPFFE 270

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 128/257 (49%), Gaps = 19/257 (7%)
Query: 87  QLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVCYQSF--YSNGAI 143
           Q ++ K  G+    K +   ++ E+ ++ +  E+ + +  + P +V  Y      +N  +
Sbjct: 23  QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82
Query: 144 SIILEYMDGGSLADFL----KKVKTIPEEYLAAICEQVLKGLLYLHHEKH----IIHRDL 195
            I++EY +GG LA  +    K+ + + EE++  +  Q+   L   H        ++HRDL
Sbjct: 83  YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 196 KPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSL 255
           KP+N+ ++ +  VK+ DFG++ I+   +  A  FVGT  YMSPE+++   Y  KSDIWSL
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 315
           G +L E      P++   Q+       EL   I +      P  ++S E    I+  +  
Sbjct: 203 GCLLYELCALMPPFTAFSQK-------ELAGKIREGKFRRIPY-RYSDELNEIITRMLNL 254
Query: 316 EPQQRLSAQELMTHPFL 332
           +   R S +E++ +P +
Sbjct: 255 KDYHRPSVEEILENPLI 271

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 32  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 91
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 92  GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 150
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 151 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 210
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 211 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 261
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 262 EEMEGYGPLKAHPFFE 277

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EYM GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +K+ DFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIKVADFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 130/260 (50%), Gaps = 32/260 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+     ++RR     +I +E+ I +    P ++  +  + +   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE   +  +Q+L G+ YLH +K I H DLKP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           +      +K+ DFG++  +       N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              +A S  F  EF S        FI   
Sbjct: 210 ILLSGASPFLGDTKQETLANI-------------TAVSYDFDEEFFSQTSELAKDFIRKL 256
Query: 313 VQKEPQQRLSAQELMTHPFL 332
           + KE ++RL+ QE + HP++
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EYM GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +K+ DFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIKVADFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 125/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 47  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 106
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 107 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 165
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 166 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 225
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 226 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 276
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 277 EEMEGYGPLKAHPFFE 292

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 83/284 (29%), Positives = 132/284 (46%), Gaps = 25/284 (8%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L + K TG   A+K+I+ +     S    +  E+ + +    P ++  Y+ F       +
Sbjct: 22  LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYL 81
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++E   GG L D +   +   E   A I +QVL G  YL H+ +I+HRDLKP NLL+  +
Sbjct: 82  VMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL-HKHNIVHRDLKPENLLLESK 140
Query: 206 GE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
                +KI DFG+SA      G+    +GT  Y++PE +   KY  K D+WS G++L   
Sbjct: 141 SRDALIKIVDFGLSAHF-EVGGKMKERLGTAYYIAPEVLR-KKYDEKCDVWSCGVILYIL 198
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD--QFSPEFCSFISACVQKEPQQR 320
             G  P+     Q       E+++ +        P D  Q S E    +   +  EP +R
Sbjct: 199 LCGYPPFGGQTDQ-------EILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKR 251
Query: 321 LSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLAT--LSNLSGF 362
           +SA+E + HP++  +       S+  TD G    T  L N+  F
Sbjct: 252 ISAEEALNHPWIVKF------CSQKHTDVGKHALTGALGNMKKF 289

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 124/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y  F  +  +  
Sbjct: 55  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYF 114
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 115 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 173
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 174 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 233
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 234 AGLPPFRAGNE---YLIFQKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 284
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 285 EEMEGYGPLKAHPFFE 300

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 127/260 (48%), Gaps = 27/260 (10%)
Query: 91  HKWTGQFFALKVIQMNVE-------ESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGA 142
           H+ TG  FA+K++++  E       E  R    +E  I  Q +  P+++    S+ S+  
Sbjct: 115 HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF 174
Query: 143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           + ++ + M  G L D+L +   + E+   +I   +L+ + +LH   +I+HRDLKP N+L+
Sbjct: 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH-ANNIVHRDLKPENILL 233
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK------YGYKSDIWSLG 256
           +   +++++DFG S  +     +     GT  Y++PE +          YG + D+W+ G
Sbjct: 234 DDNMQIRLSDFGFSCHL-EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACG 292
Query: 257 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAPS-DQFSPEFCSFISACV 313
           ++L     G  P+        W     LM  ++   Q   S+P  D  S      IS  +
Sbjct: 293 VILFTLLAGSPPF--------WHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLL 344
Query: 314 QKEPQQRLSAQELMTHPFLK 333
           Q +P+ RL+A++ + HPF +
Sbjct: 345 QVDPEARLTAEQALQHPFFE 364

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 118/241 (48%), Gaps = 12/241 (4%)
Query: 94  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T + FA KV+   M ++   + +++ E+ I++S   P+VV  +  F  +  + ++LE   
Sbjct: 66  TKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICR 125
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 211
             SL +  K+ K + E        Q ++G+ YLH+ + +IHRDLK  NL +N   +VKI 
Sbjct: 126 RRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGNLFLNDDMDVKIG 184
Query: 212 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 271
           DFG++  +     +  T  GT NY++PE +    + ++ DIWSLG +L     G+ P+  
Sbjct: 185 DFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE- 243
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
                  TS  +     + +   S P    +P   + I   +  +P  R S  EL+T  F
Sbjct: 244 -------TSCLKETYIRIKKNEYSVPR-HINPVASALIRRMLHADPTLRPSVAELLTDEF 295
Query: 332 L 332
Sbjct: 296 F 296

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++P 
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPA 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 124/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLV 228
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +      F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 229 AGLPPFRAGNEG---LIFAKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 279
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 280 EEMEGYGPLKAHPFFE 295

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 133/282 (47%), Gaps = 23/282 (8%)
Query: 63  SDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNV---EESARRQIAQEL 119
           S N+L +++ +              L + K TG  +A+KV++ +V   ++     + ++ 
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
            ++ +   P++   +  F +   +  ++E+++GG L   ++K +   E        +++ 
Sbjct: 76  ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS 135
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
            L++LH +K II+RDLK  N+L++H G  K+ DFG+            TF GT +Y++PE
Sbjct: 136 ALMFLH-DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAP 297
            +    YG   D W++G++L E   G  P+    + D       L EAI++     P+  
Sbjct: 195 ILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-------LFEAILNDEVVYPTWL 247
Query: 298 SDQFSPEFCSFISACVQKEPQQRLSA------QELMTHPFLK 333
            +  +    SF++    K P  RL +        ++ HPF K
Sbjct: 248 HEDATGILKSFMT----KNPTMRLGSLTQGGEHAILRHPFFK 285

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 112/223 (50%), Gaps = 14/223 (6%)
Query: 118 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICE 175
           E +I +     +VV    ++ +  A+ ++L  M+GG L   +  +     PE        
Sbjct: 234 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAA 293
Query: 176 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 235
           ++  GL  LH E+ I++RDLKP N+L++  G ++I+D G+ A+           VGT  Y
Sbjct: 294 EICCGLEDLHRER-IVYRDLKPENILLDDHGHIRISDLGL-AVHVPEGQTIKGRVGTVGY 351
Query: 236 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 295
           M+PE +   +Y +  D W+LG +L E   GQ P+    QQ       E +E +V + P  
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF----QQRKKKIKREEVERLVKEVPEE 407
Query: 296 APSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 333
             S++FSP+  S  S  + K+P +RL     SA+E+  HP  K
Sbjct: 408 Y-SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 127/257 (49%), Gaps = 19/257 (7%)
Query: 87  QLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVCYQSF--YSNGAI 143
           Q ++ K  G+    K +   ++ E+ ++ +  E+ + +  + P +V  Y      +N  +
Sbjct: 23  QKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82
Query: 144 SIILEYMDGGSLADFL----KKVKTIPEEYLAAICEQVLKGLLYLHHEKH----IIHRDL 195
            I++EY +GG LA  +    K+ + + EE++  +  Q+   L   H        ++HRDL
Sbjct: 83  YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 196 KPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSL 255
           KP+N+ ++ +  VK+ DFG++ I+      A  FVGT  YMSPE+++   Y  KSDIWSL
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSL 202
Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 315
           G +L E      P++   Q+       EL   I +      P  ++S E    I+  +  
Sbjct: 203 GCLLYELCALMPPFTAFSQK-------ELAGKIREGKFRRIPY-RYSDELNEIITRMLNL 254
Query: 316 EPQQRLSAQELMTHPFL 332
           +   R S +E++ +P +
Sbjct: 255 KDYHRPSVEEILENPLI 271

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NL+I+ +G +K+TDFG++       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGLA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 124/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 50  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 168
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 169 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +      F ++++   D P      ++F P+    +   +  +  +RL  
Sbjct: 229 AGLPPFRAGNEG---LIFAKIIKLEYDFP------EKFFPKARDLVEKLLVLDATKRLGC 279
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 280 EEMEGYGPLKAHPFFE 295

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH 186
           +VV    ++ +  A+ ++L  M+GG L   +  +     PE        ++  GL  LH 
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 246
           E+ I++RDLKP N+L++  G ++I+D G+ A+           VGT  YM+PE +   +Y
Sbjct: 305 ER-IVYRDLKPENILLDDHGHIRISDLGL-AVHVPEGQTIKGRVGTVGYMAPEVVKNERY 362
Query: 247 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 306
            +  D W+LG +L E   GQ P+    QQ       E +E +V + P    S++FSP+  
Sbjct: 363 TFSPDWWALGCLLYEMIAGQSPF----QQRKKKIKREEVERLVKEVPEEY-SERFSPQAR 417
Query: 307 SFISACVQKEPQQRL-----SAQELMTHPFLK 333
           S  S  + K+P +RL     SA+E+  HP  K
Sbjct: 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 123/256 (48%), Gaps = 20/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L +   T + +A+K+++    ++E+    + +E  +      P+ V  Y +F  +  +  
Sbjct: 53  LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 112
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            L Y   G L  +++K+ +  E        +++  L YLH  K IIHRDLKP N+L+N  
Sbjct: 113 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNED 171
Query: 206 GEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             ++ITDFG + +++  S Q  AN FVGT  Y+SPE ++       SD+W+LG ++ +  
Sbjct: 172 MHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 231
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+    +   +  F ++++   D P        F P+    +   +  +  +RL  
Sbjct: 232 AGLPPFRAGNE---YLIFQKIIKLEYDFPA------AFFPKARDLVEKLLVLDATKRLGC 282
Query: 324 QE------LMTHPFLK 333
           +E      L  HPF +
Sbjct: 283 EEMEGYGPLKAHPFFE 298

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           PS N   L+  D              LV+HK +G  +A+K++  Q  V+         E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT   ++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEALAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 153
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NLLI+ +G +K+ DFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLLIDQQGYIKVADFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 131/271 (48%), Gaps = 29/271 (10%)
Query: 92  KWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           K T    ALK I++  EE A     +E+ + +  +   +V  +   ++  +++++ EY+D
Sbjct: 24  KLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 83
Query: 152 GGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 210
              L  +L     I   + +     Q+L+GL Y H +K ++HRDLKP NLLIN RGE+K+
Sbjct: 84  K-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK-VLHRDLKPQNLLINERGELKL 141
Query: 211 TDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--F 267
            DFG++   +  +   +  V T  Y  P+ + G   Y  + D+W +G +  E ATG+  F
Sbjct: 142 ADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201
Query: 268 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ-----------------FSPEFCS--- 307
           P S  E+Q  +   + ++    ++  P   S++                  +P   S   
Sbjct: 202 PGSTVEEQLHF--IFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGA 259
Query: 308 -FISACVQKEPQQRLSAQELMTHPFLKMYGD 337
             ++  +Q E + R+SA++ M HPF    G+
Sbjct: 260 DLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 117/241 (48%), Gaps = 12/241 (4%)
Query: 94  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T + FA KV+   M ++   + +++ E+ I++S   P+VV  +  F  +  + ++LE   
Sbjct: 50  TKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICR 109
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 211
             SL +  K+ K + E        Q ++G+ YLH+ + +IHRDLK  NL +N   +VKI 
Sbjct: 110 RRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGNLFLNDDMDVKIG 168
Query: 212 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 271
           DFG++  +     +     GT NY++PE +    + ++ DIWSLG +L     G+ P+  
Sbjct: 169 DFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE- 227
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
                  TS  +     + +   S P    +P   + I   +  +P  R S  EL+T  F
Sbjct: 228 -------TSCLKETYIRIKKNEYSVPR-HINPVASALIRRMLHADPTLRPSVAELLTDEF 279
Query: 332 L 332
Sbjct: 280 F 280

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 104/185 (56%), Gaps = 4/185 (2%)
Query: 87  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           +L +H  TG+  A+K+I +  +  ++ +++ +E++I +    P +V  ++   +   + +
Sbjct: 29  KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 88
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           I+EY  GG + D+L     + E+   +   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 89  IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH-QKRIVHRDLKAENLLLDAD 147
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 264
             +KI DFG S    +  G+ +TF G+  Y +PE   G KY G + D+WSLG++L    +
Sbjct: 148 MNIKIADFGFSNEF-TVGGKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 206
Query: 265 GQFPY 269
           G  P+
Sbjct: 207 GSLPF 211

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 55/295 (18%)
Query: 95  GQFFALKVIQMNVEESARR----------------QIAQELKINQSSQCPYVVVCYQSFY 138
            +F+ALK  + ++ E  R                     EL+I    +  Y + C     
Sbjct: 54  NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIIT 113
Query: 139 SNGAISIILEYMDGGSLADF------LKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHI 190
           +   + II EYM+  S+  F      L K  T  IP + +  I + VL    Y+H+EK+I
Sbjct: 114 NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI 173
Query: 191 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG--GKYGY 248
            HRD+KPSN+L++  G VK++DFG S  M     + +   GTY +M PE  S      G 
Sbjct: 174 CHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSR--GTYEFMPPEFFSNESSYNGA 231
Query: 249 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI----VDQP------------ 292
           K DIWSLG+ L        P+S         S  EL   I    ++ P            
Sbjct: 232 KVDIWSLGICLYVMFYNVVPFSLK------ISLVELFNNIRTKNIEYPLDRNHFLYPLTN 285
Query: 293 PPSAPSDQF-SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV-DLSEY 345
             S  S+ F S E   F+   ++K P +R+++++ + H +L    D N+ DL E+
Sbjct: 286 KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL---ADTNIEDLREF 337

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 129/260 (49%), Gaps = 32/260 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+     ++RR     +I +E+ I +      V+  +  + +   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE   +  +Q+L G+ YLH +K I H DLKP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           +      +K+ DFG++  +       N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              +A S  F  EF S        FI   
Sbjct: 210 ILLSGASPFLGDTKQETLANI-------------TAVSYDFDEEFFSQTSELAKDFIRKL 256
Query: 313 VQKEPQQRLSAQELMTHPFL 332
           + KE ++RL+ QE + HP++
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 103/210 (49%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NL+I+ +G +++TDFG++       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLMIDQQGYIQVTDFGLA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 117/241 (48%), Gaps = 12/241 (4%)
Query: 94  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T + FA KV+   M ++   + +++ E+ I++S   P+VV  +  F  +  + ++LE   
Sbjct: 66  TKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICR 125
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 211
             SL +  K+ K + E        Q ++G+ YLH+ + +IHRDLK  NL +N   +VKI 
Sbjct: 126 RRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGNLFLNDDMDVKIG 184
Query: 212 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 271
           DFG++  +     +     GT NY++PE +    + ++ DIWSLG +L     G+ P+  
Sbjct: 185 DFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE- 243
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
                  TS  +     + +   S P    +P   + I   +  +P  R S  EL+T  F
Sbjct: 244 -------TSCLKETYIRIKKNEYSVPR-HINPVASALIRRMLHADPTLRPSVAELLTDEF 295
Query: 332 L 332
Sbjct: 296 F 296

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  101 bits (251), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 123/248 (49%), Gaps = 9/248 (3%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 150
           HK + Q FA+K+I   +E + +++I   LK+ +    P +V  ++ F+      +++E +
Sbjct: 32  HKKSNQAFAVKIISKRMEANTQKEITA-LKLCEGH--PNIVKLHEVFHDQLHTFLVMELL 88
Query: 151 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGE 207
           +GG L + +KK K   E   + I  +++  + ++H +  ++HRDLKP NLL    N   E
Sbjct: 89  NGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH-DVGVVHRDLKPENLLFTDENDNLE 147
Query: 208 VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF 267
           +KI DFG + +    +    T   T +Y +PE ++   Y    D+WSLG++L    +GQ 
Sbjct: 148 IKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQV 207
Query: 268 PYSPPEQQDGWTSFYELMEAIV--DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
           P+   ++    TS  E+M+ I   D           S E    I   +  +P +RL    
Sbjct: 208 PFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSG 267
Query: 326 LMTHPFLK 333
           L  + +L+
Sbjct: 268 LRYNEWLQ 275

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  100 bits (250), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 129/260 (49%), Gaps = 32/260 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+     ++RR     +I +E+ I +      V+  +  + +   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE   +  +Q+L G+ YLH +K I H DLKP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           +      +K+ DFG++  +       N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              +A S  F  EF S        FI   
Sbjct: 210 ILLSGASPFLGDTKQETLANI-------------TAVSYDFDEEFFSQTSELAKDFIRKL 256
Query: 313 VQKEPQQRLSAQELMTHPFL 332
           + KE ++RL+ QE + HP++
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 126/257 (49%), Gaps = 24/257 (9%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC-----PYVVVCYQSFYSNGAISI 145
           ++ TGQ FA+K++ +    S+     ++LK  ++S C     P++V   +++ S+G + +
Sbjct: 45  NRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHMLKHPHIVELLETYSSDGMLYM 103
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAIC----EQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + E+MDG  L   + K       Y  A+      Q+L+ L Y H + +IIHRD+KP N+L
Sbjct: 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-DNNIIHRDVKPENVL 162
Query: 202 INHR---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 258
           +  +     VK+ DFGV+  +  +   A   VGT ++M+PE +    YG   D+W  G++
Sbjct: 163 LASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
Query: 259 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFSPEFCSFISACVQKE 316
           L    +G  P+   +++        L E I+       P      S      +   +  +
Sbjct: 223 LFILLSGCLPFYGTKER--------LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLD 274
Query: 317 PQQRLSAQELMTHPFLK 333
           P +R++  E + HP+LK
Sbjct: 275 PAERITVYEALNHPWLK 291

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  100 bits (250), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 117/241 (48%), Gaps = 12/241 (4%)
Query: 94  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T + FA KV+   M ++   + +++ E+ I++S   P+VV  +  F  +  + ++LE   
Sbjct: 66  TKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICR 125
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 211
             SL +  K+ K + E        Q ++G+ YLH+ + +IHRDLK  NL +N   +VKI 
Sbjct: 126 RRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNR-VIHRDLKLGNLFLNDDMDVKIG 184
Query: 212 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 271
           DFG++  +     +     GT NY++PE +    + ++ DIWSLG +L     G+ P+  
Sbjct: 185 DFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE- 243
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
                  TS  +     + +   S P    +P   + I   +  +P  R S  EL+T  F
Sbjct: 244 -------TSCLKETYIRIKKNEYSVPR-HINPVASALIRRMLHADPTLRPSVAELLTDEF 295
Query: 332 L 332
Sbjct: 296 F 296

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 121/252 (48%), Gaps = 17/252 (6%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L + K TG   A+K+I+ +     S    +  E+ + +    P ++  Y+ F       +
Sbjct: 39  LCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYL 98
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++E   GG L D +   +   E   A I +QVL G  YL H+ +I+HRDLKP NLL+  +
Sbjct: 99  VMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL-HKHNIVHRDLKPENLLLESK 157
Query: 206 GE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
                +KI DFG+SA      G+    +GT  Y++PE +   KY  K D+WS G++L   
Sbjct: 158 SRDALIKIVDFGLSAHF-EVGGKMKERLGTAYYIAPEVLR-KKYDEKCDVWSCGVILYIL 215
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD--QFSPEFCSFISACVQKEPQQR 320
             G  P+     Q       E+++ +        P D  Q S E    +   +  EP +R
Sbjct: 216 LCGYPPFGGQTDQ-------EILKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKR 268
Query: 321 LSAQELMTHPFL 332
           +SA+E + HP++
Sbjct: 269 ISAEEALNHPWI 280

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++V    SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NL+I+ +G +++TDFG +       G+     GT  Y++PE
Sbjct: 153 TFEYLH-SLDLIYRDLKPENLMIDQQGYIQVTDFGFA---KRVKGRTWXLCGTPEYLAPE 208
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++     SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++     SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 104/186 (55%), Gaps = 4/186 (2%)
Query: 87  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           +L +H  TG+  A+K+I +  +  ++ +++ +E++I +    P +V  ++   +   + +
Sbjct: 32  KLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++EY  GG + D+L     + E+   A   Q++  + Y H +K+I+HRDLK  NLL++  
Sbjct: 92  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKYIVHRDLKAENLLLDGD 150
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 264
             +KI DFG S    +   + +TF G+  Y +PE   G KY G + D+WSLG++L    +
Sbjct: 151 MNIKIADFGFSNEF-TVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209
Query: 265 GQFPYS 270
           G  P+ 
Sbjct: 210 GSLPFD 215

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 6/210 (2%)
Query: 62  PSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVI--QMNVEESARRQIAQEL 119
           P+ N  +L+  +              LV+H  TG  +A+K++  Q  V+         E 
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I Q+   P++     SF  N  + +++EY  GG +   L+++    E +      Q++ 
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVL 153
Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
              YLH    +I+RDLKP NL+I+ +G +K+TDFG +       G+     GT  Y++PE
Sbjct: 154 TFEYLH-SLDLIYRDLKPENLMIDQQGYIKVTDFGFA---KRVKGRTWXLCGTPEYLAPE 209
Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPY 269
            I    Y    D W+LG+++ E A G  P+
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 129/260 (49%), Gaps = 32/260 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+     ++RR     +I +E+ I +      V+  +  + +   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE   +  +Q+L G+ YLH +K I H DLKP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           +      +K+ DFG++  +       N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              ++ S  F  EF S        FI   
Sbjct: 210 ILLSGASPFLGDTKQETLANI-------------TSVSYDFDEEFFSHTSELAKDFIRKL 256
Query: 313 VQKEPQQRLSAQELMTHPFL 332
           + KE ++RL+ QE + HP++
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 125/248 (50%), Gaps = 12/248 (4%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQ-ELKINQSSQCPYVVVCYQSFYSNGAISII 146
           LV+    G+ + +K I ++   S  R+ ++ E+ +  + + P +V   +SF  NG++ I+
Sbjct: 42  LVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101
Query: 147 LEYMDGGSLADFLKKVKTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           ++Y +GG L   +   K +   E+ +     Q+   L ++H  K I+HRD+K  N+ +  
Sbjct: 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK-ILHRDIKSQNIFLTK 160
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
            G V++ DFG++ ++ ST   A   +GT  Y+SPE      Y  KSDIW+LG VL E  T
Sbjct: 161 DGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220
Query: 265 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 324
            +  +     ++       +++ I    PP   S  +S +  S +S   ++ P+ R S  
Sbjct: 221 LKHAFEAGSMKN------LVLKIISGSFPPV--SLHYSYDLRSLVSQLFKRNPRDRPSVN 272
Query: 325 ELMTHPFL 332
            ++   F+
Sbjct: 273 SILEKGFI 280

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 9/216 (4%)
Query: 61  KPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQM--NVEESARRQIAQE 118
           K  D ++  ED +             QLV+HK T + +A+K++     ++ S      +E
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 119 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 178
             I   +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +V+
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVV 183
Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMS 237
             L  +H     IHRD+KP N+L++  G +K+ DFG    M      + +T VGT +Y+S
Sbjct: 184 LALDAIH-SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 242
Query: 238 PERISG----GKYGYKSDIWSLGLVLLECATGQFPY 269
           PE +      G YG + D WS+G+ L E   G  P+
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 103/185 (55%), Gaps = 4/185 (2%)
Query: 87  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           +L +H  TG+  A+K+I +  +  S+ +++ +E++I +    P +V  ++   +   + +
Sbjct: 31  KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 90
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++EY  GG + D+L     + E+   A   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 264
             +KI DFG S    +   + +TF G+  Y +PE   G KY G + D+WSLG++L    +
Sbjct: 150 MNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208
Query: 265 GQFPY 269
           G  P+
Sbjct: 209 GSLPF 213

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 9/216 (4%)
Query: 61  KPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQM--NVEESARRQIAQE 118
           K  D ++  ED +             QLV+HK T + +A+K++     ++ S      +E
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 119 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 178
             I   +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +V+
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVV 183
Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMS 237
             L  +H     IHRD+KP N+L++  G +K+ DFG    M      + +T VGT +Y+S
Sbjct: 184 LALDAIH-SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 242
Query: 238 PERISG----GKYGYKSDIWSLGLVLLECATGQFPY 269
           PE +      G YG + D WS+G+ L E   G  P+
Sbjct: 243 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 107/216 (49%), Gaps = 9/216 (4%)
Query: 61  KPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQM--NVEESARRQIAQE 118
           K  D ++  ED +             QLV+HK T + +A+K++     ++ S      +E
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 119 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 178
             I   +  P+VV  + +F  +  + +++EYM GG L + +     +PE++      +V+
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVV 178
Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTFVGTYNYMS 237
             L  +H     IHRD+KP N+L++  G +K+ DFG    M      + +T VGT +Y+S
Sbjct: 179 LALDAIH-SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 238 PERISG----GKYGYKSDIWSLGLVLLECATGQFPY 269
           PE +      G YG + D WS+G+ L E   G  P+
Sbjct: 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 129/260 (49%), Gaps = 32/260 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+     ++RR     +I +E+ I +      V+  +  + +   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE   +  +Q+L G+ YLH +K I H DLKP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           +      +K+ DFG++  +       N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              ++ S  F  EF S        FI   
Sbjct: 210 ILLSGASPFLGDTKQETLANI-------------TSVSYDFDEEFFSHTSELAKDFIRKL 256
Query: 313 VQKEPQQRLSAQELMTHPFL 332
           + KE ++RL+ QE + HP++
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 103/185 (55%), Gaps = 4/185 (2%)
Query: 87  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           +L +H  TG+  A+K+I +  +  S+ +++ +E++I +    P +V  ++   +   + +
Sbjct: 31  KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 90
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++EY  GG + D+L     + E+   A   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 264
             +KI DFG S    +   + +TF G+  Y +PE   G KY G + D+WSLG++L    +
Sbjct: 150 MNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208
Query: 265 GQFPY 269
           G  P+
Sbjct: 209 GSLPF 213

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 114/231 (49%), Gaps = 15/231 (6%)
Query: 109 ESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGAISIILEYMDGGSLADFLKKVKT 164
           +S R++  +E +  +  Q P +V  Y S+ S       I ++ E    G+L  +LK+ K 
Sbjct: 66  KSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKV 125
Query: 165 IPEEYLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINH-RGEVKITDFGVSAIMAST 222
              + L + C Q+LKGL +LH     IIHRDLK  N+ I    G VKI D G++ +  ++
Sbjct: 126 XKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185
Query: 223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 282
             +A   +GT  + +PE     KY    D+++ G   LE AT ++PYS  E Q+    + 
Sbjct: 186 FAKA--VIGTPEFXAPEXYE-EKYDESVDVYAFGXCXLEXATSEYPYS--ECQNAAQIYR 240
Query: 283 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
            +   +     P++      PE    I  C+++   +R S ++L+ H F +
Sbjct: 241 RVTSGV----KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 129/260 (49%), Gaps = 32/260 (12%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR-----QIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           + K TG  +A K I+     ++RR     +I +E+ I +      V+  +  + +   + 
Sbjct: 32  REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +ILE + GG L DFL + +++ EE   +  +Q+L G+ YLH +K I H DLKP N+++  
Sbjct: 92  LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK-IAHFDLKPENIMLLD 150
Query: 205 RG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           +      +K+ DFG++  +       N F GT  +++PE ++    G ++D+WS+G++  
Sbjct: 151 KNIPIPHIKLIDFGLAHEIEDGVEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--------FISAC 312
              +G  P+    +Q+   +              ++ S  F  EF S        FI   
Sbjct: 210 ILLSGASPFLGDTKQETLANI-------------TSVSYDFDEEFFSHTSELAKDFIRKL 256
Query: 313 VQKEPQQRLSAQELMTHPFL 332
           + KE ++RL+ QE + HP++
Sbjct: 257 LVKETRKRLTIQEALRHPWI 276

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 125/250 (50%), Gaps = 12/250 (4%)
Query: 88  LVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII 146
           L + K T    A+K+I+  +V  S+  ++ +E+ + +    P ++  Y  F       ++
Sbjct: 55  LCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114
Query: 147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           +E   GG L D +       E   A I +QVL G+ YL H+ +I+HRDLKP NLL+  + 
Sbjct: 115 MECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL-HKHNIVHRDLKPENLLLESKE 173
Query: 207 E---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
           +   +KI DFG+SA+  +   +    +GT  Y++PE +   KY  K D+WS+G++L    
Sbjct: 174 KDALIKIVDFGLSAVFENQK-KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILL 231
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G  P+     Q+      E  +   D P     S+         I   +Q + Q+R+SA
Sbjct: 232 AGYPPFGGQTDQEILRKV-EKGKYTFDSPEWKNVSEGAK----DLIKQMLQFDSQRRISA 286
Query: 324 QELMTHPFLK 333
           Q+ + HP++K
Sbjct: 287 QQALEHPWIK 296

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 116/241 (48%), Gaps = 12/241 (4%)
Query: 94  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T + FA K++   + ++   R +++ E+ I++S    +VV  +  F  N  + ++LE   
Sbjct: 41  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 100
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 211
             SL +  K+ K + E        Q++ G  YLH  + +IHRDLK  NL +N   EVKI 
Sbjct: 101 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIG 159
Query: 212 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 271
           DFG++  +     +  T  GT NY++PE +S   + ++ D+WS+G ++     G+ P+  
Sbjct: 160 DFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE- 218
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
                  TS  +     + +   S P    +P   S I   +Q +P  R +  EL+   F
Sbjct: 219 -------TSCLKETYLRIKKNEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEF 270
Query: 332 L 332
Sbjct: 271 F 271

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 116/241 (48%), Gaps = 12/241 (4%)
Query: 94  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T + FA K++   + ++   R +++ E+ I++S    +VV  +  F  N  + ++LE   
Sbjct: 41  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 100
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 211
             SL +  K+ K + E        Q++ G  YLH  + +IHRDLK  NL +N   EVKI 
Sbjct: 101 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIG 159
Query: 212 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 271
           DFG++  +     +  T  GT NY++PE +S   + ++ D+WS+G ++     G+ P+  
Sbjct: 160 DFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE- 218
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
                  TS  +     + +   S P    +P   S I   +Q +P  R +  EL+   F
Sbjct: 219 -------TSCLKETYLRIKKNEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEF 270
Query: 332 L 332
Sbjct: 271 F 271

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 103/185 (55%), Gaps = 4/185 (2%)
Query: 87  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           +L +H  TG+  A+++I +  +  S+ +++ +E++I +    P +V  ++   +   + +
Sbjct: 31  KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 90
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++EY  GG + D+L     + E+   A   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 264
             +KI DFG S    +   + +TF G+  Y +PE   G KY G + D+WSLG++L    +
Sbjct: 150 MNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208
Query: 265 GQFPY 269
           G  P+
Sbjct: 209 GSLPF 213

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 116/241 (48%), Gaps = 12/241 (4%)
Query: 94  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T + FA K++   + ++   R +++ E+ I++S    +VV  +  F  N  + ++LE   
Sbjct: 45  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 104
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 211
             SL +  K+ K + E        Q++ G  YLH  + +IHRDLK  NL +N   EVKI 
Sbjct: 105 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIG 163
Query: 212 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 271
           DFG++  +     +  T  GT NY++PE +S   + ++ D+WS+G ++     G+ P+  
Sbjct: 164 DFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE- 222
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
                  TS  +     + +   S P    +P   S I   +Q +P  R +  EL+   F
Sbjct: 223 -------TSCLKETYLRIKKNEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEF 274
Query: 332 L 332
Sbjct: 275 F 275

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 102/185 (55%), Gaps = 4/185 (2%)
Query: 87  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           +L +H  TG+  A+K+I +  +  ++ +++ +E++I +    P +V  ++   +   + +
Sbjct: 32  KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL 91
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           I+EY  GG + D+L     + E+   +   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 92  IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH-QKRIVHRDLKAENLLLDAD 150
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 264
             +KI DFG S    +  G+ + F G   Y +PE   G KY G + D+WSLG++L    +
Sbjct: 151 MNIKIADFGFSNEF-TVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 209
Query: 265 GQFPY 269
           G  P+
Sbjct: 210 GSLPF 214

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 123/267 (46%), Gaps = 27/267 (10%)
Query: 98  FALKVIQMNVEESA------RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----IIL 147
            A+KV++ ++          RR+      +N     P +V  Y +  +         I++
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNH----PAIVAVYDTGEAETPAGPLPYIVM 95
Query: 148 EYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           EY+DG +L D +     + P+  +  I +      L   H+  IIHRD+KP+N+LI+   
Sbjct: 96  EYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA--LNFSHQNGIIHRDVKPANILISATN 153
Query: 207 EVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
            VK+ DFG++  +A +     Q    +GT  Y+SPE+  G     +SD++SLG VL E  
Sbjct: 154 AVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
           TG+ P++      G +      + + + P PPSA  +  S +  + +   + K P+ R  
Sbjct: 214 TGEPPFT------GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 267
Query: 323 AQELMTHPFLKMYGDLNVDLSEYFTDA 349
               M    ++++     +  +  TDA
Sbjct: 268 TAAEMRADLVRVHNGEPPEAPKVLTDA 294

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 57/186 (30%), Positives = 103/186 (55%), Gaps = 4/186 (2%)
Query: 87  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           +L +H  TG+  A+K+I +  +  S+ +++ +E++I +    P +V  ++   +   + +
Sbjct: 24  KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 83
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++EY  GG + D+L     + E+   A   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 84  VMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 142
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 264
             +KI DFG S    +   + +TF G+  Y +PE   G KY G + D+WSLG++L    +
Sbjct: 143 MNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 201
Query: 265 GQFPYS 270
           G  P+ 
Sbjct: 202 GSLPFD 207

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 101/185 (54%), Gaps = 4/185 (2%)
Query: 87  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           +L +H  TG+  A+K+I +  +  S+ +++ +E++I +    P +V  ++   +   + +
Sbjct: 31  KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 90
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++EY  GG + D+L     + E+   A   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 264
             +KI DFG S    +   + + F G   Y +PE   G KY G + D+WSLG++L    +
Sbjct: 150 MNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208
Query: 265 GQFPY 269
           G  P+
Sbjct: 209 GSLPF 213

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 69/251 (27%), Positives = 125/251 (49%), Gaps = 22/251 (8%)
Query: 90  QHKWTGQFFALKVIQ------MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI 143
           +H+ TG   A+K++       ++V    +R+I Q LK+ +    P+++  YQ   +    
Sbjct: 31  EHQLTGHKVAVKILNRQKIRSLDVVGKIKREI-QNLKLFRH---PHIIKLYQVISTPTDF 86
Query: 144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
            +++EY+ GG L D++ K   + E     + +Q+L  + Y H    ++HRDLKP N+L++
Sbjct: 87  FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLD 145
Query: 204 HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLEC 262
                KI DFG+S +M S      T  G+ NY +PE ISG  Y G + DIWS G++L   
Sbjct: 146 AHMNAKIADFGLSNMM-SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYAL 204
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
             G  P+   + +   T F ++   +   P      +  +    + +   +Q +P +R +
Sbjct: 205 LCGTLPF---DDEHVPTLFKKIRGGVFYIP------EYLNRSVATLLMHMLQVDPLKRAT 255
Query: 323 AQELMTHPFLK 333
            +++  H + K
Sbjct: 256 IKDIREHEWFK 266

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 130/276 (47%), Gaps = 37/276 (13%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 147
           + + KW  +  A+K I+    ES R+    EL+       P +V  Y +  +   + +++
Sbjct: 24  VCKAKWRAKDVAIKQIE---SESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 78
Query: 148 EYMDGGSLADFLKKVKTIPEEYLAA----ICEQVLKGLLYLH--HEKHIIHRDLKPSNLL 201
           EY +GGSL + L   + +P  Y AA     C Q  +G+ YLH    K +IHRDLKP NLL
Sbjct: 79  EYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLL 137
Query: 202 INHRGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           +   G V KI DFG +  + +         G+  +M+PE   G  Y  K D++S G++L 
Sbjct: 138 LVAGGTVLKICDFGTACDIQT---HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILW 194
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
           E  T + P+     + G  +F  +M A+ +   P    +   P   S ++ C  K+P QR
Sbjct: 195 EVITRRKPFD----EIGGPAF-RIMWAVHNGTRPPLIKNLPKP-IESLMTRCWSKDPSQR 248
Query: 321 LSAQE---LMTHPFLKMYGDLNVDLSEYFTDAGSPL 353
            S +E   +MTH            L  YF  A  PL
Sbjct: 249 PSMEEIVKIMTH------------LMRYFPGADEPL 272

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 68/267 (25%), Positives = 123/267 (46%), Gaps = 27/267 (10%)
Query: 98  FALKVIQMNVEESA------RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----IIL 147
            A+KV++ ++          RR+      +N     P +V  Y +  +         I++
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNH----PAIVAVYDTGEAETPAGPLPYIVM 95
Query: 148 EYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           EY+DG +L D +     + P+  +  I +      L   H+  IIHRD+KP+N++I+   
Sbjct: 96  EYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA--LNFSHQNGIIHRDVKPANIMISATN 153
Query: 207 EVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
            VK+ DFG++  +A +     Q    +GT  Y+SPE+  G     +SD++SLG VL E  
Sbjct: 154 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
           TG+ P++      G +      + + + P PPSA  +  S +  + +   + K P+ R  
Sbjct: 214 TGEPPFT------GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 267
Query: 323 AQELMTHPFLKMYGDLNVDLSEYFTDA 349
               M    ++++     +  +  TDA
Sbjct: 268 TAAEMRADLVRVHNGEPPEAPKVLTDA 294

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 130/276 (47%), Gaps = 37/276 (13%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 147
           + + KW  +  A+K I+    ES R+    EL+       P +V  Y +  +   + +++
Sbjct: 25  VCKAKWRAKDVAIKQIE---SESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVM 79
Query: 148 EYMDGGSLADFLKKVKTIPEEYLAA----ICEQVLKGLLYLH--HEKHIIHRDLKPSNLL 201
           EY +GGSL + L   + +P  Y AA     C Q  +G+ YLH    K +IHRDLKP NLL
Sbjct: 80  EYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLL 138
Query: 202 INHRGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           +   G V KI DFG +  + +         G+  +M+PE   G  Y  K D++S G++L 
Sbjct: 139 LVAGGTVLKICDFGTACDIQT---HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILW 195
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
           E  T + P+     + G  +F  +M A+ +   P    +   P   S ++ C  K+P QR
Sbjct: 196 EVITRRKPFD----EIGGPAF-RIMWAVHNGTRPPLIKNLPKP-IESLMTRCWSKDPSQR 249
Query: 321 LSAQE---LMTHPFLKMYGDLNVDLSEYFTDAGSPL 353
            S +E   +MTH            L  YF  A  PL
Sbjct: 250 PSMEEIVKIMTH------------LMRYFPGADEPL 273

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 115/247 (46%), Gaps = 21/247 (8%)
Query: 112 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----IILEYMDGGSLADFLKKVKTI-P 166
           RR+      +N     P +V  Y +  +         I++EY+DG +L D +     + P
Sbjct: 60  RREAQNAAALNH----PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP 115
Query: 167 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-- 224
           +  +  I +      L   H+  IIHRD+KP+N++I+    VK+ DFG++  +A +    
Sbjct: 116 KRAIEVIADACQA--LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 225 -QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 283
            Q    +GT  Y+SPE+  G     +SD++SLG VL E  TG+ P++      G +    
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSV 227
Query: 284 LMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
             + + + P PPSA  +  S +  + +   + K P+ R      M    ++++     + 
Sbjct: 228 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEA 287
Query: 343 SEYFTDA 349
            +  TDA
Sbjct: 288 PKVLTDA 294

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 13/247 (5%)
Query: 91  HKWTGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           HK TG  FA K+I    + SAR  +++ +E +I +  Q P +V  + S        ++ +
Sbjct: 50  HKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE- 207
            + GG L + +   +   E   +   +Q+L+ + Y H    I+HR+LKP NLL+  + + 
Sbjct: 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKG 167
Query: 208 --VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
             VK+ DFG+ AI  + S   + F GT  Y+SPE +    Y    DIW+ G++L     G
Sbjct: 168 AAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
              Y P   +D    + ++     D P P    D  +PE  S I + +   P++R++A +
Sbjct: 227 ---YPPFWDEDQHRLYAQIKAGAYDYPSPEW--DTVTPEAKSLIDSMLTVNPKKRITADQ 281
Query: 326 LMTHPFL 332
            +  P++
Sbjct: 282 ALKVPWI 288

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 115/241 (47%), Gaps = 12/241 (4%)
Query: 94  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T + FA K++   + ++   R +++ E+ I++S    +VV  +  F  N  + ++LE   
Sbjct: 65  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 124
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 211
             SL +  K+ K + E        Q++ G  YLH  + +IHRDLK  NL +N   EVKI 
Sbjct: 125 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIG 183
Query: 212 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 271
           DFG++  +     +     GT NY++PE +S   + ++ D+WS+G ++     G+ P+  
Sbjct: 184 DFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE- 242
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
                  TS  +     + +   S P    +P   S I   +Q +P  R +  EL+   F
Sbjct: 243 -------TSCLKETYLRIKKNEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEF 294
Query: 332 L 332
Sbjct: 295 F 295

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 115/241 (47%), Gaps = 12/241 (4%)
Query: 94  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T + FA K++   + ++   R +++ E+ I++S    +VV  +  F  N  + ++LE   
Sbjct: 63  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 122
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 211
             SL +  K+ K + E        Q++ G  YLH  + +IHRDLK  NL +N   EVKI 
Sbjct: 123 RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIG 181
Query: 212 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 271
           DFG++  +     +     GT NY++PE +S   + ++ D+WS+G ++     G+ P+  
Sbjct: 182 DFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE- 240
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
                  TS  +     + +   S P    +P   S I   +Q +P  R +  EL+   F
Sbjct: 241 -------TSCLKETYLRIKKNEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEF 292
Query: 332 L 332
Sbjct: 293 F 293

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 122/266 (45%), Gaps = 25/266 (9%)
Query: 98  FALKVIQMNVEESA------RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS----IIL 147
            A+KV++ ++          RR+      +N     P +V  Y +  +         I++
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNH----PAIVAVYDTGEAETPAGPLPYIVM 95
Query: 148 EYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           EY+DG +L D +     + P+  +  I +      L   H+  IIHRD+KP+N++I+   
Sbjct: 96  EYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA--LNFSHQNGIIHRDVKPANIMISATN 153
Query: 207 EVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
            VK+ DFG++  +A +     Q    +GT  Y+SPE+  G     +SD++SLG VL E  
Sbjct: 154 AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 213
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
           TG+ P++         ++  + E   D  PPSA  +  S +  + +   + K P+ R   
Sbjct: 214 TGEPPFT--GDSPDSVAYQHVRE---DPIPPSARHEGLSADLDAVVLKALAKNPENRYQT 268
Query: 324 QELMTHPFLKMYGDLNVDLSEYFTDA 349
              M    ++++     +  +  TDA
Sbjct: 269 AAEMRADLVRVHNGEPPEAPKVLTDA 294

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 13/210 (6%)
Query: 145 IILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           I++EY+DG +L D +     + P+  +  I +      L   H+  IIHRD+KP+N++I+
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA--LNFSHQNGIIHRDVKPANIMIS 150
Query: 204 HRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
               VK+ DFG++  +A +     Q    +GT  Y+SPE+  G     +SD++SLG VL 
Sbjct: 151 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY 210
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQ 319
           E  TG+ P++      G +      + + + P PPSA  +  S +  + +   + K P+ 
Sbjct: 211 EVLTGEPPFT------GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPEN 264
Query: 320 RLSAQELMTHPFLKMYGDLNVDLSEYFTDA 349
           R      M    ++++     +  +  TDA
Sbjct: 265 RYQTAAEMRADLVRVHNGEPPEAPKVLTDA 294

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 125/252 (49%), Gaps = 16/252 (6%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 147
           + +W G   A+K++ M  +  A R  +  +E+ I +  + P +V+   +      +SI+ 
Sbjct: 55  RAEWHGSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113
Query: 148 EYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLIN 203
           EY+  GSL   L K    + + E    ++   V KG+ YLH+    I+HR+LK  NLL++
Sbjct: 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD 173
Query: 204 HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
            +  VK+ DFG+S + AST   + +  GT  +M+PE +       KSD++S G++L E A
Sbjct: 174 KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
           T Q P+       G  +  +++ A+  +          +P+  + I  C   EP +R S 
Sbjct: 234 TLQQPW-------GNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSF 286
Query: 324 QELMT--HPFLK 333
             +M    P +K
Sbjct: 287 ATIMDLLRPLIK 298

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 115/241 (47%), Gaps = 12/241 (4%)
Query: 94  TGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T + FA K++   + ++   R +++ E+ I++S    +VV  +  F  N  + ++LE   
Sbjct: 39  TKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCR 98
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 211
             SL +  K+ K + E        Q++ G  YLH  + +IHRDLK  NL +N   EVKI 
Sbjct: 99  RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR-VIHRDLKLGNLFLNEDLEVKIG 157
Query: 212 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSP 271
           DFG++  +     +     GT NY++PE +S   + ++ D+WS+G ++     G+ P+  
Sbjct: 158 DFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE- 216
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
                  TS  +     + +   S P    +P   S I   +Q +P  R +  EL+   F
Sbjct: 217 -------TSCLKETYLRIKKNEYSIPK-HINPVAASLIQKMLQTDPTARPTINELLNDEF 268
Query: 332 L 332
Sbjct: 269 F 269

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 13/247 (5%)
Query: 91  HKWTGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           HK TG  FA K+I    + SAR  +++ +E +I +  Q P +V  + S        ++ +
Sbjct: 27  HKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE- 207
            + GG L + +   +   E   +   +Q+L+ + Y H    I+HR+LKP NLL+  + + 
Sbjct: 86  LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKG 144
Query: 208 --VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
             VK+ DFG+ AI  + S   + F GT  Y+SPE +    Y    DIW+ G++L     G
Sbjct: 145 AAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
              Y P   +D    + ++     D P P    D  +PE  S I + +   P++R++A +
Sbjct: 204 ---YPPFWDEDQHRLYAQIKAGAYDYPSPEW--DTVTPEAKSLIDSMLTVNPKKRITADQ 258
Query: 326 LMTHPFL 332
            +  P++
Sbjct: 259 ALKVPWI 265

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/283 (24%), Positives = 129/283 (45%), Gaps = 20/283 (7%)
Query: 61  KPSDN--QLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNV---EESARRQI 115
           +PS+N  ++ L D +              L   K T + +A+K+++ +V   ++     +
Sbjct: 8   QPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTM 67
Query: 116 AQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICE 175
            ++  +    + P++   +  F +   +  ++EY++GG L   +++V    E        
Sbjct: 68  VEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAA 127
Query: 176 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 235
           ++  GL +LH ++ II+RDLK  N++++  G +KI DFG+             F GT +Y
Sbjct: 128 EISIGLFFLH-KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDY 186
Query: 236 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 295
           ++PE I+   YG   D W+ G++L E   GQ P+   + +D    F  +ME  V  P   
Sbjct: 187 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPF---DGEDEDELFQSIMEHNVSYP--- 240
Query: 296 APSDQFSPEFCSFISACVQKEPQQRLSA-----QELMTHPFLK 333
                 S E  S     + K P +RL       +++  H F +
Sbjct: 241 ---KSLSKEAVSICKGLMTKHPAKRLGCGPEGERDVREHAFFR 280

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 126/251 (50%), Gaps = 22/251 (8%)
Query: 90  QHKWTGQFFALKVIQ------MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI 143
           +H+ TG   A+K++       ++V    +R+I Q LK+ +    P+++  YQ   +    
Sbjct: 31  EHQLTGHKVAVKILNRQKIRSLDVVGKIKREI-QNLKLFRH---PHIIKLYQVISTPTDF 86
Query: 144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
            +++EY+ GG L D++ K   + E     + +Q+L  + Y H    ++HRDLKP N+L++
Sbjct: 87  FMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM-VVHRDLKPENVLLD 145
Query: 204 HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLEC 262
                KI DFG+S +M+      ++  G+ NY +PE ISG  Y G + DIWS G++L   
Sbjct: 146 AHMNAKIADFGLSNMMSDGEFLRDS-CGSPNYAAPEVISGRLYAGPEVDIWSCGVILYAL 204
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
             G  P+   + +   T F ++   +   P      +  +    + +   +Q +P +R +
Sbjct: 205 LCGTLPF---DDEHVPTLFKKIRGGVFYIP------EYLNRSVATLLMHMLQVDPLKRAT 255
Query: 323 AQELMTHPFLK 333
            +++  H + K
Sbjct: 256 IKDIREHEWFK 266

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 102/185 (55%), Gaps = 4/185 (2%)
Query: 87  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           +L +H  TG+  A+++I +  +  S+ +++ +E++I +    P +V  ++   +   + +
Sbjct: 31  KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYL 90
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++EY  GG + D+L     + E+   A   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 91  VMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 264
             +KI DFG S    +   + + F G+  Y +PE   G KY G + D+WSLG++L    +
Sbjct: 150 MNIKIADFGFSNEF-TFGNKLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208
Query: 265 GQFPY 269
           G  P+
Sbjct: 209 GSLPF 213

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 123/253 (48%), Gaps = 13/253 (5%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L + K TGQ  A+KVI      +++ +  + +E+++ +    P ++  Y+ F   G   +
Sbjct: 44  LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           + E   GG L D +   K   E   A I  QVL G+ Y+H  K I+HRDLKP NLL+  +
Sbjct: 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESK 162
Query: 206 GE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
            +   ++I DFG+S    ++    +  +GT  Y++PE +  G Y  K D+WS G++L   
Sbjct: 163 SKDANIRIIDFGLSTHFEASKKMKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYIL 220
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
            +G  P++   + D      E  +   + P     S+         I   +   P  R+S
Sbjct: 221 LSGCPPFNGANEYDILKKV-EKGKYTFELPQWKKVSESAK----DLIRKMLTYVPSMRIS 275
Query: 323 AQELMTHPFLKMY 335
           A++ + H +++ Y
Sbjct: 276 ARDALDHEWIQTY 288

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 13/247 (5%)
Query: 91  HKWTGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           HK TG  FA K+I    + SAR  +++ +E +I +  Q P +V  + S        ++ +
Sbjct: 27  HKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE- 207
            + GG L + +   +   E   +   +Q+L+ + Y H    I+HR+LKP NLL+  + + 
Sbjct: 86  LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKG 144
Query: 208 --VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
             VK+ DFG+ AI  + S   + F GT  Y+SPE +    Y    DIW+ G++L     G
Sbjct: 145 AAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
              Y P   +D    + ++     D P P    D  +PE  S I + +   P++R++A +
Sbjct: 204 ---YPPFWDEDQHRLYAQIKAGAYDYPSPEW--DTVTPEAKSLIDSMLTVNPKKRITADQ 258
Query: 326 LMTHPFL 332
            +  P++
Sbjct: 259 ALKVPWI 265

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 125/254 (49%), Gaps = 17/254 (6%)
Query: 87  QLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           +L++ K T +  A+K I+    ++E+ +R+I      ++S + P +V   +   +   ++
Sbjct: 37  RLMRDKLTKELVAVKYIERGAAIDENVQREIIN----HRSLRHPNIVRFKEVILTPTHLA 92
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           II+EY  GG L + +       E+      +Q+L G+ Y  H   I HRDLK  N L++ 
Sbjct: 93  IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYC-HSMQICHRDLKLENTLLDG 151
Query: 205 R--GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLE 261
                +KI DFG S   +    Q  + VGT  Y++PE +   +Y G  +D+WS G+ L  
Sbjct: 152 SPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYV 210
Query: 262 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD-QFSPEFCSFISACVQKEPQQR 320
              G +P+  PE+   +    + + ++      S P D + SPE C  IS     +P  R
Sbjct: 211 MLVGAYPFEDPEEPRDYRKTIQRILSV----KYSIPDDIRISPECCHLISRIFVADPATR 266
Query: 321 LSAQELMTHP-FLK 333
           +S  E+ TH  FLK
Sbjct: 267 ISIPEIKTHSWFLK 280

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 124/254 (48%), Gaps = 17/254 (6%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAIS 144
           L +HK    F+A+KV+Q    +++   + I  E  +  ++ + P++V  + SF +   + 
Sbjct: 56  LARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
            +L+Y++GG L   L++ +   E        ++   L YLH   +I++RDLKP N+L++ 
Sbjct: 116 FVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH-SLNIVYRDLKPENILLDS 174
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
           +G + +TDFG+       +   +TF GT  Y++PE +    Y    D W LG VL E   
Sbjct: 175 QGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLY 234
Query: 265 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 324
           G  P+             E+ + I+++P    P+   S      +   +QK+  +RL A+
Sbjct: 235 GLPPFYSRNTA-------EMYDNILNKPLQLKPNITNSAR--HLLEGLLQKDRTKRLGAK 285
Query: 325 ----ELMTHPFLKM 334
               E+ +H F  +
Sbjct: 286 DDFMEIKSHVFFSL 299

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 13/247 (5%)
Query: 91  HKWTGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           HK TG  FA K+I    + SAR  +++ +E +I +  Q P +V  + S        ++ +
Sbjct: 26  HKTTGLEFAAKIINTK-KLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 84
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE- 207
            + GG L + +   +   E   +   +Q+L+ + Y H    I+HR+LKP NLL+  + + 
Sbjct: 85  LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH-SNGIVHRNLKPENLLLASKAKG 143
Query: 208 --VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
             VK+ DFG+ AI  + S   + F GT  Y+SPE +    Y    DIW+ G++L     G
Sbjct: 144 AAVKLADFGL-AIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
              Y P   +D    + ++     D P P    D  +PE  S I + +   P++R++A +
Sbjct: 203 ---YPPFWDEDQHRLYAQIKAGAYDYPSPEW--DTVTPEAKSLIDSMLTVNPKKRITADQ 257
Query: 326 LMTHPFL 332
            +  P++
Sbjct: 258 ALKVPWI 264

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 128/256 (50%), Gaps = 19/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L + K TGQ  A+KVI      +++ +  + +E+++ +    P ++  Y+ F   G   +
Sbjct: 68  LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 127
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           + E   GG L D +   K   E   A I  QVL G+ Y+H  K I+HRDLKP NLL+  +
Sbjct: 128 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESK 186
Query: 206 GE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
            +   ++I DFG+S    ++    +  +GT  Y++PE +  G Y  K D+WS G++L   
Sbjct: 187 SKDANIRIIDFGLSTHFEASKKMKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYIL 244
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQ 319
            +G  P++   +       Y++++  V++   +    Q+   S      I   +   P  
Sbjct: 245 LSGCPPFNGANE-------YDILKK-VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSM 296
Query: 320 RLSAQELMTHPFLKMY 335
           R+SA++ + H +++ Y
Sbjct: 297 RISARDALDHEWIQTY 312

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 128/256 (50%), Gaps = 19/256 (7%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L + K TGQ  A+KVI      +++ +  + +E+++ +    P ++  Y+ F   G   +
Sbjct: 67  LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 126
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           + E   GG L D +   K   E   A I  QVL G+ Y+H  K I+HRDLKP NLL+  +
Sbjct: 127 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESK 185
Query: 206 GE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
            +   ++I DFG+S    ++    +  +GT  Y++PE +  G Y  K D+WS G++L   
Sbjct: 186 SKDANIRIIDFGLSTHFEASKKMKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYIL 243
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQ 319
            +G  P++   +       Y++++  V++   +    Q+   S      I   +   P  
Sbjct: 244 LSGCPPFNGANE-------YDILKK-VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSM 295
Query: 320 RLSAQELMTHPFLKMY 335
           R+SA++ + H +++ Y
Sbjct: 296 RISARDALDHEWIQTY 311

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/252 (28%), Positives = 123/252 (48%), Gaps = 16/252 (6%)
Query: 90  QHKWTGQFFALKVIQMNVEESARR--QIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 147
           + +W G   A+K++ M  +  A R  +  +E+ I +  + P +V+   +      +SI+ 
Sbjct: 55  RAEWHGSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113
Query: 148 EYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLIN 203
           EY+  GSL   L K    + + E    ++   V KG+ YLH+    I+HRDLK  NLL++
Sbjct: 114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVD 173
Query: 204 HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
            +  VK+ DFG+S + AS    +    GT  +M+PE +       KSD++S G++L E A
Sbjct: 174 KKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELA 233
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
           T Q P+       G  +  +++ A+  +          +P+  + I  C   EP +R S 
Sbjct: 234 TLQQPW-------GNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSF 286
Query: 324 QELMT--HPFLK 333
             +M    P +K
Sbjct: 287 ATIMDLLRPLIK 298

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 99/185 (53%), Gaps = 4/185 (2%)
Query: 87  QLVQHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           +L +H  TG+  A+K+I +  +  S+ +++ +E++I +    P +V  ++   +   + +
Sbjct: 31  KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYL 90
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           + EY  GG + D+L       E+   A   Q++  + Y H +K I+HRDLK  NLL++  
Sbjct: 91  VXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCH-QKFIVHRDLKAENLLLDAD 149
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECAT 264
             +KI DFG S    +   + + F G   Y +PE   G KY G + D+WSLG++L    +
Sbjct: 150 XNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS 208
Query: 265 GQFPY 269
           G  P+
Sbjct: 209 GSLPF 213

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 117/243 (48%), Gaps = 22/243 (9%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 173
            +  E++I +    P  ++  ++F+      I+LE M+GG L D +   K + E      
Sbjct: 200 NVETEIEILKKLNHP-CIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 258
Query: 174 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFV 230
             Q+L  + YLH E  IIHRDLKP N+L++ + E   +KITDFG S I+  TS    T  
Sbjct: 259 FYQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLC 316
Query: 231 GTYNYMSPE-RISGGKYGYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 287
           GT  Y++PE  +S G  GY    D WSLG++L  C +G  P+S    Q        L + 
Sbjct: 317 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQ 370
Query: 288 IVDQPPPSAPS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEY 345
           I        P    + S +    +   +  +P+ R + +E + HP+L+     + D+   
Sbjct: 371 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRK 425
Query: 346 FTD 348
           F D
Sbjct: 426 FQD 428

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 125/277 (45%), Gaps = 18/277 (6%)
Query: 65  NQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKI 121
           +++ L D +              L + K T + +A+K+++ +V   ++     + ++  +
Sbjct: 15  DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVL 74
Query: 122 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 181
               + P++   +  F +   +  ++EY++GG L   +++V    E +      ++  GL
Sbjct: 75  ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGL 134
Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 241
            +L   K II+RDLK  N++++  G +KI DFG+             F GT +Y++PE I
Sbjct: 135 FFLQ-SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII 193
Query: 242 SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 301
           +   YG   D W+ G++L E   GQ P+   E +D    F  +ME  V  P         
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPF---EGEDEDELFQSIMEHNVAYP------KSM 244
Query: 302 SPEFCSFISACVQKEPQQRLSA-----QELMTHPFLK 333
           S E  +     + K P +RL       +++  H F +
Sbjct: 245 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 190
           ++  ++F+      I+LE M+GG L D +   K + E        Q+L  + YLH E  I
Sbjct: 77  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 135
Query: 191 IHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKY 246
           IHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE  +S G  
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTA 194
Query: 247 GYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFS 302
           GY    D WSLG++L  C +G  P+S    Q        L + I        P    + S
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPEVWAEVS 248
Query: 303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 348
            +    +   +  +P+ R + +E + HP+L+     + D+   F D
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRKFQD 289

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 190
           ++  ++F+      I+LE M+GG L D +   K + E        Q+L  + YLH E  I
Sbjct: 77  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 135
Query: 191 IHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKY 246
           IHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE  +S G  
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTA 194
Query: 247 GYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFS 302
           GY    D WSLG++L  C +G  P+S    Q        L + I        P    + S
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPEVWAEVS 248
Query: 303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 348
            +    +   +  +P+ R + +E + HP+L+     + D+   F D
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRKFQD 289

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 123/253 (48%), Gaps = 13/253 (5%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L + K TGQ  A+KVI      +++ +  + +E+++ +    P ++  Y+ F   G   +
Sbjct: 50  LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 109
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           + E   GG L D +   K   E   A I  QVL G+ Y+H  K I+HRDLKP NLL+  +
Sbjct: 110 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK-IVHRDLKPENLLLESK 168
Query: 206 GE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
            +   ++I DFG+S    ++    +  +GT  Y++PE +  G Y  K D+WS G++L   
Sbjct: 169 SKDANIRIIDFGLSTHFEASKKMKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYIL 226
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
            +G  P++   + D      E  +   + P     S+         I   +   P  R+S
Sbjct: 227 LSGCPPFNGANEYDILKKV-EKGKYTFELPQWKKVSESAK----DLIRKMLTYVPSMRIS 281
Query: 323 AQELMTHPFLKMY 335
           A++ + H +++ Y
Sbjct: 282 ARDALDHEWIQTY 294

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 190
           ++  ++F+      I+LE M+GG L D +   K + E        Q+L  + YLH E  I
Sbjct: 77  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 135
Query: 191 IHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKY 246
           IHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE  +S G  
Sbjct: 136 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTA 194
Query: 247 GYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFS 302
           GY    D WSLG++L  C +G  P+S    Q        L + I        P    + S
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPEVWAEVS 248
Query: 303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 348
            +    +   +  +P+ R + +E + HP+L+     + D+   F D
Sbjct: 249 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRKFQD 289

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 75/243 (30%), Positives = 117/243 (48%), Gaps = 22/243 (9%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 173
            +  E++I +    P  ++  ++F+      I+LE M+GG L D +   K + E      
Sbjct: 186 NVETEIEILKKLNHP-CIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLY 244
Query: 174 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFV 230
             Q+L  + YLH E  IIHRDLKP N+L++ + E   +KITDFG S I+  TS    T  
Sbjct: 245 FYQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLC 302
Query: 231 GTYNYMSPE-RISGGKYGYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 287
           GT  Y++PE  +S G  GY    D WSLG++L  C +G  P+S    Q        L + 
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQ 356
Query: 288 IVDQPPPSAPS--DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEY 345
           I        P    + S +    +   +  +P+ R + +E + HP+L+     + D+   
Sbjct: 357 ITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRK 411
Query: 346 FTD 348
           F D
Sbjct: 412 FQD 414

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 119/254 (46%), Gaps = 18/254 (7%)
Query: 88  LVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           L + K T + +A+K+++ +V   ++     + ++  +    + P++   +  F +   + 
Sbjct: 359 LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
            ++EY++GG L   +++V    E +      ++  GL +L   K II+RDLK  N++++ 
Sbjct: 419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ-SKGIIYRDLKLDNVMLDS 477
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
            G +KI DFG+             F GT +Y++PE I+   YG   D W+ G++L E   
Sbjct: 478 EGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537
Query: 265 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA- 323
           GQ P+   E +D    F  +ME  V  P         S E  +     + K P +RL   
Sbjct: 538 GQAPF---EGEDEDELFQSIMEHNVAYP------KSMSKEAVAICKGLMTKHPGKRLGCG 588
Query: 324 ----QELMTHPFLK 333
               +++  H F +
Sbjct: 589 PEGERDIKEHAFFR 602

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 190
           ++  ++F+      I+LE M+GG L D +   K + E        Q+L  + YLH E  I
Sbjct: 76  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 134
Query: 191 IHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKY 246
           IHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE  +S G  
Sbjct: 135 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTA 193
Query: 247 GYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFS 302
           GY    D WSLG++L  C +G  P+S    Q        L + I        P    + S
Sbjct: 194 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPEVWAEVS 247
Query: 303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 348
            +    +   +  +P+ R + +E + HP+L+     + D+   F D
Sbjct: 248 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRKFQD 288

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 72/226 (31%), Positives = 110/226 (48%), Gaps = 21/226 (9%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 190
           ++  ++F+      I+LE M+GG L D +   K + E        Q+L  + YLH E  I
Sbjct: 83  IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-ENGI 141
Query: 191 IHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKY 246
           IHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE  +S G  
Sbjct: 142 IHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVGTA 200
Query: 247 GYKS--DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFS 302
           GY    D WSLG++L  C +G  P+S    Q        L + I        P    + S
Sbjct: 201 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPEVWAEVS 254
Query: 303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 348
            +    +   +  +P+ R + +E + HP+L+     + D+   F D
Sbjct: 255 EKALDLVKKLLVVDPKARFTTEEALRHPWLQ-----DEDMKRKFQD 295

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 119/244 (48%), Gaps = 12/244 (4%)
Query: 94  TGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
            GQ +A K+I    + SAR  +++ +E +I +  + P +V  + S    G   +I + + 
Sbjct: 46  AGQEYAAKIINTK-KLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVT 104
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEV 208
           GG L + +   +   E   +   +Q+L+ +L+ H +  ++HRDLKP NLL+  +     V
Sbjct: 105 GGELFEDIVAREYYSEADASHCIQQILEAVLHCH-QMGVVHRDLKPENLLLASKLKGAAV 163
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           K+ DFG++  +         F GT  Y+SPE +    YG   D+W+ G++L     G   
Sbjct: 164 KLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG--- 220
Query: 269 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
           Y P   +D    + ++     D P P    D  +PE    I+  +   P +R++A E + 
Sbjct: 221 YPPFWDEDQHRLYQQIKAGAYDFPSPE--WDTVTPEAKDLINKMLTINPSKRITAAEALK 278
Query: 329 HPFL 332
           HP++
Sbjct: 279 HPWI 282

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 129/263 (49%), Gaps = 22/263 (8%)
Query: 88  LVQHKWTGQFFALKVIQMN---VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           LV+ + TG+ FALK I+ +    + S   +IA   KI   +    +V     + S     
Sbjct: 27  LVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN----IVTLEDIYESTTHYY 82
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI-- 202
           ++++ + GG L D + +     E+  + + +QVL  + YLH E  I+HRDLKP NLL   
Sbjct: 83  LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH-ENGIVHRDLKPENLLYLT 141
Query: 203 -NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV--L 259
                ++ ITDFG+S +    +G  +T  GT  Y++PE ++   Y    D WS+G++  +
Sbjct: 142 PEENSKIMITDFGLSKM--EQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYI 199
Query: 260 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQ 319
           L C      Y P  ++     F ++ E   +   P    D  S     FI   ++K+P +
Sbjct: 200 LLCG-----YPPFYEETESKLFEKIKEGYYEFESPFW--DDISESAKDFICHLLEKDPNE 252
Query: 320 RLSAQELMTHPFLKMYGDLNVDL 342
           R + ++ ++HP++     L+ D+
Sbjct: 253 RYTCEKALSHPWIDGNTALHRDI 275

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 15/225 (6%)
Query: 118 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAI 173
           E KI       ++V    +F +   + +++  M+GG +   +  V        E      
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 174 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 233
             Q++ GL +LH +++II+RDLKP N+L++  G V+I+D G++  + +   +   + GT 
Sbjct: 295 TAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 234 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 293
            +M+PE + G +Y +  D ++LG+ L E    + P+    ++       EL + +++Q  
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRVLEQ-- 408
Query: 294 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 333
                D+FSP    F  A +QK+P++RL     S   L THP  +
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 15/225 (6%)
Query: 118 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAI 173
           E KI       ++V    +F +   + +++  M+GG +   +  V        E      
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 174 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 233
             Q++ GL +LH +++II+RDLKP N+L++  G V+I+D G++  + +   +   + GT 
Sbjct: 295 TAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 234 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 293
            +M+PE + G +Y +  D ++LG+ L E    + P+    ++       EL + +++Q  
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRVLEQ-- 408
Query: 294 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 333
                D+FSP    F  A +QK+P++RL     S   L THP  +
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 15/225 (6%)
Query: 118 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAI 173
           E KI       ++V    +F +   + +++  M+GG +   +  V        E      
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 174 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 233
             Q++ GL +LH +++II+RDLKP N+L++  G V+I+D G++  + +   +   + GT 
Sbjct: 295 TAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 234 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 293
            +M+PE + G +Y +  D ++LG+ L E    + P+    ++       EL + +++Q  
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRVLEQ-- 408
Query: 294 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 333
                D+FSP    F  A +QK+P++RL     S   L THP  +
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 121/250 (48%), Gaps = 12/250 (4%)
Query: 90  QHKWTGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           + + T Q +A+KVI + + +      I +E+++ +    P ++  ++    + +  I+ E
Sbjct: 42  KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-- 206
              GG L D + K K   E   A I +QV  G+ Y+ H+ +I+HRDLKP N+L+  +   
Sbjct: 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM-HKHNIVHRDLKPENILLESKEKD 160
Query: 207 -EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
            ++KI DFG+S      +   +  +GT  Y++PE +  G Y  K D+WS G++L    +G
Sbjct: 161 CDIKIIDFGLSTCFQQNTKMKDR-IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
             P+    + D      E  +   D P     SD         I   +   P  R++A +
Sbjct: 219 TPPFYGKNEYDILKRV-ETGKYAFDLPQWRTISDDAK----DLIRKMLTFHPSLRITATQ 273
Query: 326 LMTHPFLKMY 335
            + HP+++ Y
Sbjct: 274 CLEHPWIQKY 283

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 13/196 (6%)
Query: 145 IILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           I++EY+DG +L D +     + P+  +  I +      L   H+  IIHRD+KP+N++I+
Sbjct: 110 IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA--LNFSHQNGIIHRDVKPANIMIS 167
Query: 204 HRGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
               VK+ DFG++  +A +     Q    +GT  Y+SPE+  G     +SD++SLG VL 
Sbjct: 168 ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLY 227
Query: 261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQ 319
           E  TG+ P++      G +      + + + P PPSA  +  S +  + +   + K P+ 
Sbjct: 228 EVLTGEPPFT------GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPEN 281
Query: 320 RLSAQELMTHPFLKMY 335
           R      M    ++++
Sbjct: 282 RYQTAAEMRADLVRVH 297

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 125/259 (48%), Gaps = 16/259 (6%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 147
           L + K T +  A+K I     E     +  E+ +    + P +V     + S G + +I+
Sbjct: 36  LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL---INH 204
           + + GG L D + +     E   + +  QVL  + YL H+  I+HRDLKP NLL   ++ 
Sbjct: 96  QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL-HDLGIVHRDLKPENLLYYSLDE 154
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV--LLEC 262
             ++ I+DFG+S  M       +T  GT  Y++PE ++   Y    D WS+G++  +L C
Sbjct: 155 DSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
                 Y P   ++    F ++++A  +   P    D  S     FI   ++K+P++R +
Sbjct: 214 G-----YPPFYDENDAKLFEQILKAEYEFDSPYW--DDISDSAKDFIRHLMEKDPEKRFT 266
Query: 323 AQELMTHPFLKMYGDLNVD 341
            ++ + HP++   GD  +D
Sbjct: 267 CEQALQHPWIA--GDTALD 283

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 125/259 (48%), Gaps = 16/259 (6%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 147
           L + K T +  A+K I     E     +  E+ +    + P +V     + S G + +I+
Sbjct: 36  LAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL---INH 204
           + + GG L D + +     E   + +  QVL  + YL H+  I+HRDLKP NLL   ++ 
Sbjct: 96  QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL-HDLGIVHRDLKPENLLYYSLDE 154
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV--LLEC 262
             ++ I+DFG+S  M       +T  GT  Y++PE ++   Y    D WS+G++  +L C
Sbjct: 155 DSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
                 Y P   ++    F ++++A  +   P    D  S     FI   ++K+P++R +
Sbjct: 214 G-----YPPFYDENDAKLFEQILKAEYEFDSPYW--DDISDSAKDFIRHLMEKDPEKRFT 266
Query: 323 AQELMTHPFLKMYGDLNVD 341
            ++ + HP++   GD  +D
Sbjct: 267 CEQALQHPWIA--GDTALD 283

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 121/265 (45%), Gaps = 27/265 (10%)
Query: 94  TGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 152
           TGQ  A+K    + ++   ++IA +E+++ +  + P +V   + F     + ++ EY D 
Sbjct: 27  TGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH 86
Query: 153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
             L +  +  + +PE  + +I  Q L+ + + H + + IHRD+KP N+LI     +K+ D
Sbjct: 87  TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-KHNCIHRDVKPENILITKHSVIKLCD 145
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSP 271
           FG + ++   S   +  V T  Y SPE + G  +YG   D+W++G V  E  +G  P  P
Sbjct: 146 FGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWP 204
Query: 272 -------------------PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF----CSF 308
                              P  Q  +++        +  P    P +   P         
Sbjct: 205 GKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGL 264
Query: 309 ISACVQKEPQQRLSAQELMTHPFLK 333
           +  C+  +P +RL+ ++L+ HP+ +
Sbjct: 265 LKGCLHMDPTERLTCEQLLHHPYFE 289

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 112/225 (49%), Gaps = 15/225 (6%)
Query: 118 ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAI 173
           E KI       ++V    +F +   + +++  M+GG +   +  V        E      
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 174 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 233
             Q++ GL +LH +++II+RDLKP N+L++  G V+I+D G++  + +   +   + GT 
Sbjct: 295 TAQIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 234 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 293
            +M+PE + G +Y +  D ++LG+ L E    + P+    ++       EL + +++Q  
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK---VENKELKQRVLEQ-- 408
Query: 294 PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 333
                D+FSP    F  A +QK+P++RL     S   L THP  +
Sbjct: 409 AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 125/259 (48%), Gaps = 16/259 (6%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 147
           L + K T +  A+K I     E     +  E+ +    + P +V     + S G + +I+
Sbjct: 36  LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL---INH 204
           + + GG L D + +     E   + +  QVL  + YL H+  I+HRDLKP NLL   ++ 
Sbjct: 96  QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL-HDLGIVHRDLKPENLLYYSLDE 154
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV--LLEC 262
             ++ I+DFG+S  M       +T  GT  Y++PE ++   Y    D WS+G++  +L C
Sbjct: 155 DSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
                 Y P   ++    F ++++A  +   P    D  S     FI   ++K+P++R +
Sbjct: 214 G-----YPPFYDENDAKLFEQILKAEYEFDSPYW--DDISDSAKDFIRHLMEKDPEKRFT 266
Query: 323 AQELMTHPFLKMYGDLNVD 341
            ++ + HP++   GD  +D
Sbjct: 267 CEQALQHPWIA--GDTALD 283

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 64
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHE 65
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 124
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 125/259 (48%), Gaps = 16/259 (6%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 147
           L + K T +  A+K I     E     +  E+ +    + P +V     + S G + +I+
Sbjct: 36  LAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 95
Query: 148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL---INH 204
           + + GG L D + +     E   + +  QVL  + YL H+  I+HRDLKP NLL   ++ 
Sbjct: 96  QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL-HDLGIVHRDLKPENLLYYSLDE 154
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV--LLEC 262
             ++ I+DFG+S  M       +T  GT  Y++PE ++   Y    D WS+G++  +L C
Sbjct: 155 DSKIMISDFGLSK-MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
                 Y P   ++    F ++++A  +   P    D  S     FI   ++K+P++R +
Sbjct: 214 G-----YPPFYDENDAKLFEQILKAEYEFDSPYW--DDISDSAKDFIRHLMEKDPEKRFT 266
Query: 323 AQELMTHPFLKMYGDLNVD 341
            ++ + HP++   GD  +D
Sbjct: 267 CEQALQHPWIA--GDTALD 283

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 121/253 (47%), Gaps = 13/253 (5%)
Query: 88  LVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           L + K TGQ  A+KVI      +++ +  + +E+++ +    P +   Y+ F   G   +
Sbjct: 44  LCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYL 103
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           + E   GG L D +   K   E   A I  QVL G+ Y H  K I+HRDLKP NLL+  +
Sbjct: 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK-IVHRDLKPENLLLESK 162
Query: 206 GE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
            +   ++I DFG+S    ++    +  +GT  Y++PE +  G Y  K D+WS G++L   
Sbjct: 163 SKDANIRIIDFGLSTHFEASKKXKDK-IGTAYYIAPE-VLHGTYDEKCDVWSTGVILYIL 220
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
            +G  P++   + D      E  +   + P     S+         I   +   P  R+S
Sbjct: 221 LSGCPPFNGANEYDILKKV-EKGKYTFELPQWKKVSESAK----DLIRKXLTYVPSXRIS 275
Query: 323 AQELMTHPFLKMY 335
           A++ + H +++ Y
Sbjct: 276 ARDALDHEWIQTY 288

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 119/246 (48%), Gaps = 12/246 (4%)
Query: 94  TGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 152
           T Q +A+KVI + + +      I +E+++ +    P ++  ++    + +  I+ E   G
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVK 209
           G L D + K K   E   A I +QV  G+ Y+ H+ +I+HRDLKP N+L+  +    ++K
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYM-HKHNIVHRDLKPENILLESKEKDCDIK 164
Query: 210 ITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY 269
           I DFG+S      +   +  +GT  Y++PE +  G Y  K D+WS G++L    +G  P+
Sbjct: 165 IIDFGLSTCFQQNTKMKDR-IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPF 222
Query: 270 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
               + D      E  +   D P     SD         I   +   P  R++A + + H
Sbjct: 223 YGKNEYDILKRV-ETGKYAFDLPQWRTISDDAK----DLIRKMLTFHPSLRITATQCLEH 277
Query: 330 PFLKMY 335
           P+++ Y
Sbjct: 278 PWIQKY 283

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 112/249 (44%), Gaps = 25/249 (10%)
Query: 93  WTGQFFALKVIQMNVEESARRQI---AQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 149
           W G   A+K  + + +E   + I    QE K+    + P ++           + +++E+
Sbjct: 28  WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEF 87
Query: 150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK--HIIHRDLKPSNLLINHRGE 207
             GG L   L   K IP + L     Q+ +G+ YLH E    IIHRDLK SN+LI  + E
Sbjct: 88  ARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146
Query: 208 --------VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL 259
                   +KITDFG++     T+  +    G Y +M+PE I    +   SD+WS G++L
Sbjct: 147 NGDLSNKILKITDFGLAREWHRTTKMSAA--GAYAWMAPEVIRASMFSKGSDVWSYGVLL 204
Query: 260 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFISACVQKEPQ 318
            E  TG+ P+      DG    Y +    +  P PS       PE F   +  C   +P 
Sbjct: 205 WELLTGEVPF---RGIDGLAVAYGVAMNKLALPIPST-----CPEPFAKLMEDCWNPDPH 256
Query: 319 QRLSAQELM 327
            R S   ++
Sbjct: 257 SRPSFTNIL 265

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 119/246 (48%), Gaps = 12/246 (4%)
Query: 94  TGQFFALKVI-QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG 152
           T Q +A+KVI + + +      I +E+++ +    P ++  ++    + +  I+ E   G
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVK 209
           G L D + K K   E   A I +QV  G+ Y+ H+ +I+HRDLKP N+L+  +    ++K
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYM-HKHNIVHRDLKPENILLESKEKDCDIK 164
Query: 210 ITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY 269
           I DFG+S      +   +  +GT  Y++PE +  G Y  K D+WS G++L    +G  P+
Sbjct: 165 IIDFGLSTCFQQNTKMKDR-IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPF 222
Query: 270 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
               + D      E  +   D P     SD         I   +   P  R++A + + H
Sbjct: 223 YGKNEYDILKRV-ETGKYAFDLPQWRTISDDAK----DLIRKMLTFHPSLRITATQCLEH 277
Query: 330 PFLKMY 335
           P+++ Y
Sbjct: 278 PWIQKY 283

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 122/254 (48%), Gaps = 24/254 (9%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQC-----PYVVVCYQSFYSNGAISIILE 148
           TGQ FA+K++ +    S+     ++LK  ++S C     P++V   +++ S+G + ++ E
Sbjct: 48  TGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHMLKHPHIVELLETYSSDGMLYMVFE 106
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAIC----EQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +MDG  L   + K       Y  A+      Q+L+ L Y H + +IIHRD+KP  +L+  
Sbjct: 107 FMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-DNNIIHRDVKPHCVLLAS 165
Query: 205 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     VK+  FGV+  +  +   A   VGT ++M+PE +    YG   D+W  G++L  
Sbjct: 166 KENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFI 225
Query: 262 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFSPEFCSFISACVQKEPQQ 319
             +G  P+   +++        L E I+       P      S      +   +  +P +
Sbjct: 226 LLSGCLPFYGTKER--------LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAE 277
Query: 320 RLSAQELMTHPFLK 333
           R++  E + HP+LK
Sbjct: 278 RITVYEALNHPWLK 291

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 124
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 68/257 (26%), Positives = 124/257 (48%), Gaps = 24/257 (9%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC-----PYVVVCYQSFYSNGAISI 145
           ++ TGQ FA+K++ +    S+     ++LK  ++S C     P++V   +++ S+G + +
Sbjct: 47  NRETGQQFAVKIVDVAKFTSSPGLSTEDLK-REASICHMLKHPHIVELLETYSSDGMLYM 105
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAIC----EQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + E+MDG  L   + K       Y  A+      Q+L+ L Y H + +IIHRD+KP  +L
Sbjct: 106 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-DNNIIHRDVKPHCVL 164
Query: 202 INHR---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 258
           +  +     VK+  FGV+  +  +   A   VGT ++M+PE +    YG   D+W  G++
Sbjct: 165 LASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 224
Query: 259 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS--DQFSPEFCSFISACVQKE 316
           L    +G  P+   +++        L E I+       P      S      +   +  +
Sbjct: 225 LFILLSGCLPFYGTKER--------LFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLD 276
Query: 317 PQQRLSAQELMTHPFLK 333
           P +R++  E + HP+LK
Sbjct: 277 PAERITVYEALNHPWLK 293

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 124
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 124
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 124
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 122/263 (46%), Gaps = 26/263 (9%)
Query: 95  GQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           G+  ALK I+++ E+      A +E+ + +    P +V      +S   ++++ E+M+  
Sbjct: 45  GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK- 103
Query: 154 SLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
            L   L + KT + +  +     Q+L+G+ + H  + I+HRDLKP NLLIN  G +K+ D
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR-ILHRDLKPQNLLINSDGALKLAD 162
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FPY 269
           FG++             V T  Y +P+ + G  KY    DIWS+G +  E  TG+  FP 
Sbjct: 163 FGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222
Query: 270 SPPEQQ-------------DGWTSFYEL------MEAIVDQPPPSAPSDQFSPEFCSFIS 310
              + Q               W    EL         + ++ P S+    F  E    +S
Sbjct: 223 VTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLS 282
Query: 311 ACVQKEPQQRLSAQELMTHPFLK 333
             +  +P +R+SA++ M HP+ K
Sbjct: 283 NMLCFDPNKRISARDAMNHPYFK 305

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 125/263 (47%), Gaps = 28/263 (10%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELK---------INQSSQCPYVVVCYQSFYSNG 141
           HK T + +A+K+I +    S   +  QEL+         + + S  P ++    ++ +N 
Sbjct: 38  HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97
Query: 142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
              ++ + M  G L D+L +  T+ E+    I   +L+ +  LH + +I+HRDLKP N+L
Sbjct: 98  FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENIL 156
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK------YGYKSDIWSL 255
           ++    +K+TDFG S  +     +  +  GT +Y++PE I          YG + D+WS 
Sbjct: 157 LDDDMNIKLTDFGFSCQL-DPGEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV---DQPPPSAPSDQFSPEFCSFISAC 312
           G+++     G  P+        W     LM  ++   +    S   D +S      +S  
Sbjct: 216 GVIMYTLLAGSPPF--------WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRF 267
Query: 313 VQKEPQQRLSAQELMTHPFLKMY 335
           +  +PQ+R +A+E + HPF + Y
Sbjct: 268 LVVQPQKRYTAEEALAHPFFQQY 290

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 124
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 122/263 (46%), Gaps = 26/263 (9%)
Query: 95  GQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           G+  ALK I+++ E+      A +E+ + +    P +V      +S   ++++ E+M+  
Sbjct: 45  GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK- 103
Query: 154 SLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD 212
            L   L + KT + +  +     Q+L+G+ + H  + I+HRDLKP NLLIN  G +K+ D
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR-ILHRDLKPQNLLINSDGALKLAD 162
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FPY 269
           FG++             V T  Y +P+ + G  KY    DIWS+G +  E  TG+  FP 
Sbjct: 163 FGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222
Query: 270 SPPEQQ-------------DGWTSFYEL------MEAIVDQPPPSAPSDQFSPEFCSFIS 310
              + Q               W    EL         + ++ P S+    F  E    +S
Sbjct: 223 VTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLS 282
Query: 311 ACVQKEPQQRLSAQELMTHPFLK 333
             +  +P +R+SA++ M HP+ K
Sbjct: 283 NMLCFDPNKRISARDAMNHPYFK 305

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 122
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQP 209

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 65
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 124
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 5   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 64
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 123
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 124 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQP 210

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 124/262 (47%), Gaps = 14/262 (5%)
Query: 88  LVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL 147
           L + K TG+ FA+K I     +     I  E+ + +  +   +V     + S   + +++
Sbjct: 40  LAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVM 99
Query: 148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NH 204
           + + GG L D + +     E+  + +  QVL  + YLH    I+HRDLKP NLL    + 
Sbjct: 100 QLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHR-MGIVHRDLKPENLLYYSQDE 158
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV--LLEC 262
             ++ I+DFG+S  M       +T  GT  Y++PE ++   Y    D WS+G++  +L C
Sbjct: 159 ESKIMISDFGLSK-MEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 217
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
                 Y P   ++    F ++++A  +   P    D  S     FI   ++K+P +R +
Sbjct: 218 G-----YPPFYDENDSKLFEQILKAEYEFDSPYW--DDISDSAKDFIRNLMEKDPNKRYT 270
Query: 323 AQELMTHPFLKMYGDLNVDLSE 344
            ++   HP++     LN ++ E
Sbjct: 271 CEQAARHPWIAGDTALNKNIHE 292

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/251 (25%), Positives = 131/251 (52%), Gaps = 14/251 (5%)
Query: 92  KWTGQFFALKVIQMNVE-ESARRQIAQELKINQ-SSQCPYVVVCYQSFYSNGAISIILEY 149
           K TGQ +A K ++     +  R +I  E+ + + +  CP V+  ++ + +   I +ILEY
Sbjct: 51  KSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEY 110
Query: 150 MDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH--- 204
             GG +      +  + + E  +  + +Q+L+G+ YLH + +I+H DLKP N+L++    
Sbjct: 111 AAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH-QNNIVHLDLKPQNILLSSIYP 169
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
            G++KI DFG+S  +   + +    +GT  Y++PE ++       +D+W++G++     T
Sbjct: 170 LGDIKIVDFGMSRKIGH-ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228
Query: 265 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 324
              P+   + Q+   ++  + +  VD    +  S   S     FI + + K P++R +A+
Sbjct: 229 HTSPFVGEDNQE---TYLNISQVNVDYSEETFSS--VSQLATDFIQSLLVKNPEKRPTAE 283
Query: 325 ELMTHPFLKMY 335
             ++H +L+ +
Sbjct: 284 ICLSHSWLQQW 294

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 119/244 (48%), Gaps = 12/244 (4%)
Query: 94  TGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           TGQ +A K+I    + SAR  +++ +E +I +  + P +V  + S    G   ++ + + 
Sbjct: 28  TGQEYAAKIINTK-KLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVT 86
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---V 208
           GG L + +   +   E   +   +Q+L+ + + H    I+HRDLKP NLL+  + +   V
Sbjct: 87  GGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG-IVHRDLKPENLLLASKSKGAAV 145
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           K+ DFG++  +         F GT  Y+SPE +    YG   D+W+ G++L     G   
Sbjct: 146 KLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG--- 202
Query: 269 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
           Y P   +D    + ++     D P P    D  +PE    I+  +   P +R++A E + 
Sbjct: 203 YPPFWDEDQHRLYQQIKAGAYDFPSPEW--DTVTPEAKDLINKMLTINPAKRITASEALK 260
Query: 329 HPFL 332
           HP++
Sbjct: 261 HPWI 264

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 28/263 (10%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELK---------INQSSQCPYVVVCYQSFYSNG 141
           HK T + +A+K+I +    S   +  QEL+         + + S  P ++    ++ +N 
Sbjct: 38  HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97
Query: 142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
              ++ + M  G L D+L +  T+ E+    I   +L+ +  LH + +I+HRDLKP N+L
Sbjct: 98  FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENIL 156
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK------YGYKSDIWSL 255
           ++    +K+TDFG S  +     +     GT +Y++PE I          YG + D+WS 
Sbjct: 157 LDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 215
Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV---DQPPPSAPSDQFSPEFCSFISAC 312
           G+++     G  P+        W     LM  ++   +    S   D +S      +S  
Sbjct: 216 GVIMYTLLAGSPPF--------WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRF 267
Query: 313 VQKEPQQRLSAQELMTHPFLKMY 335
           +  +PQ+R +A+E + HPF + Y
Sbjct: 268 LVVQPQKRYTAEEALAHPFFQQY 290

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 28/263 (10%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELK---------INQSSQCPYVVVCYQSFYSNG 141
           HK T + +A+K+I +    S   +  QEL+         + + S  P ++    ++ +N 
Sbjct: 25  HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 84
Query: 142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
              ++ + M  G L D+L +  T+ E+    I   +L+ +  LH + +I+HRDLKP N+L
Sbjct: 85  FFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH-KLNIVHRDLKPENIL 143
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK------YGYKSDIWSL 255
           ++    +K+TDFG S  +     +     GT +Y++PE I          YG + D+WS 
Sbjct: 144 LDDDMNIKLTDFGFSCQL-DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWST 202
Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV---DQPPPSAPSDQFSPEFCSFISAC 312
           G+++     G  P+        W     LM  ++   +    S   D +S      +S  
Sbjct: 203 GVIMYTLLAGSPPF--------WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRF 254
Query: 313 VQKEPQQRLSAQELMTHPFLKMY 335
           +  +PQ+R +A+E + HPF + Y
Sbjct: 255 LVVQPQKRYTAEEALAHPFFQQY 277

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 119/244 (48%), Gaps = 12/244 (4%)
Query: 94  TGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           TGQ +A K+I    + SAR  +++ +E +I +  + P +V  + S    G   ++ + + 
Sbjct: 28  TGQEYAAKIINTK-KLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVT 86
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---V 208
           GG L + +   +   E   +   +Q+L+ + + H    I+HRDLKP NLL+  + +   V
Sbjct: 87  GGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG-IVHRDLKPENLLLASKSKGAAV 145
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           K+ DFG++  +         F GT  Y+SPE +    YG   D+W+ G++L     G   
Sbjct: 146 KLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG--- 202
Query: 269 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
           Y P   +D    + ++     D P P    D  +PE    I+  +   P +R++A E + 
Sbjct: 203 YPPFWDEDQHRLYQQIKAGAYDFPSPEW--DTVTPEAKDLINKMLTINPAKRITASEALK 260
Query: 329 HPFL 332
           HP++
Sbjct: 261 HPWI 264

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 4/207 (1%)
Query: 69  LEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D             QL  ++ T +  A+K++ M         I +E+ IN      
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHE 65
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 124
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 247 GYKS-DIWSLGLVLLECATGQFPYSPP 272
             +  D+WS G+VL     G+ P+  P
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQP 211

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 124/256 (48%), Gaps = 19/256 (7%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEY 149
           HK T   FA+K+I     + ++R   +E++I  +  Q P ++     +     + ++ E 
Sbjct: 43  HKATNMEFAVKII-----DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97
Query: 150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL-INHRGE- 207
           M GG L D + + K   E   +A+   + K + YLH +  ++HRDLKPSN+L ++  G  
Sbjct: 98  MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG-VVHRDLKPSNILYVDESGNP 156
Query: 208 --VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
             ++I DFG +  + + +G   T   T N+++PE +    Y    DIWSLG++L    TG
Sbjct: 157 ESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS---DQFSPEFCSFISACVQKEPQQRLS 322
             P++     +G     E + A +     S      +  S      +S  +  +P QRL+
Sbjct: 217 YTPFA-----NGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT 271
Query: 323 AQELMTHPFLKMYGDL 338
           A  ++ HP++  +  L
Sbjct: 272 AALVLRHPWIVHWDQL 287

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 114/256 (44%), Gaps = 29/256 (11%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           V H+ TG+   +K + +  +E  +R   +E+K+ +  + P V+      Y +  ++ I E
Sbjct: 29  VTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87
Query: 149 YMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE 207
           Y+ GG+L   +K + +  P     +  + +  G+ YLH   +IIHRDL   N L+     
Sbjct: 88  YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH-SMNIIHRDLNSHNCLVRENKN 146
Query: 208 VKITDFGVSAIMASTSGQAN--------------TFVGTYNYMSPERISGGKYGYKSDIW 253
           V + DFG++ +M     Q                T VG   +M+PE I+G  Y  K D++
Sbjct: 147 VVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVF 206
Query: 254 SLGLVLLECATGQFPYSP---PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 310
           S G+VL E   G+    P   P   D   +    ++      PP+ P     P F     
Sbjct: 207 SFGIVLCE-IIGRVNADPDYLPRTMDFGLNVRGFLDRYC---PPNCP-----PSFFPITV 257
Query: 311 ACVQKEPQQRLSAQEL 326
            C   +P++R S  +L
Sbjct: 258 RCCDLDPEKRPSFVKL 273

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 119/244 (48%), Gaps = 12/244 (4%)
Query: 94  TGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           TG  +A K+I    + SAR  +++ +E +I +  +   +V  + S    G   ++ + + 
Sbjct: 28  TGHEYAAKIINTK-KLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVT 86
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEV 208
           GG L + +   +   E   +   +Q+L+ +L+ H +  ++HRDLKP NLL+  +     V
Sbjct: 87  GGELFEDIVAREYYSEADASHCIQQILEAVLHCH-QMGVVHRDLKPENLLLASKCKGAAV 145
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           K+ DFG++  +         F GT  Y+SPE +    YG   DIW+ G++L     G   
Sbjct: 146 KLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG--- 202
Query: 269 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
           Y P   +D    + ++     D P P    D  +PE  + I+  +   P +R++A E + 
Sbjct: 203 YPPFWDEDQHKLYQQIKAGAYDFPSPE--WDTVTPEAKNLINQMLTINPAKRITAHEALK 260
Query: 329 HPFL 332
           HP++
Sbjct: 261 HPWV 264

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 121/266 (45%), Gaps = 33/266 (12%)
Query: 95  GQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           G+ FALK I++  E E       +E+ I +  +   +V  Y   ++   + ++ E++D  
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD 85
Query: 154 SLADFLKKVKTIPEEYLAAICE-----QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
                LKK+  + E  L ++       Q+L G+ Y H ++ ++HRDLKP NLLIN  GE+
Sbjct: 86  -----LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREGEL 139
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF 267
           KI DFG++        +    V T  Y +P+ + G  KY    DIWS+G +  E   G  
Sbjct: 140 KIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199
Query: 268 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSF------------------ 308
            +    + D     + ++     +  P+     ++ P F  +                  
Sbjct: 200 LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259
Query: 309 -ISACVQKEPQQRLSAQELMTHPFLK 333
            +S  ++ +P QR++A++ + H + K
Sbjct: 260 LLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 121/266 (45%), Gaps = 33/266 (12%)
Query: 95  GQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           G+ FALK I++  E E       +E+ I +  +   +V  Y   ++   + ++ E++D  
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD 85
Query: 154 SLADFLKKVKTIPEEYLAAICE-----QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
                LKK+  + E  L ++       Q+L G+ Y H ++ ++HRDLKP NLLIN  GE+
Sbjct: 86  -----LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREGEL 139
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF 267
           KI DFG++        +    V T  Y +P+ + G  KY    DIWS+G +  E   G  
Sbjct: 140 KIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAP 199
Query: 268 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSF------------------ 308
            +    + D     + ++     +  P+     ++ P F  +                  
Sbjct: 200 LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259
Query: 309 -ISACVQKEPQQRLSAQELMTHPFLK 333
            +S  ++ +P QR++A++ + H + K
Sbjct: 260 LLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 118/244 (48%), Gaps = 12/244 (4%)
Query: 94  TGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
            GQ +A  +I    + SAR  +++ +E +I +  + P +V  + S    G   +I + + 
Sbjct: 35  AGQEYAAMIINTK-KLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVT 93
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEV 208
           GG L + +   +   E   +   +Q+L+ +L+ H +  ++HR+LKP NLL+  +     V
Sbjct: 94  GGELFEDIVAREYYSEADASHCIQQILEAVLHCH-QMGVVHRNLKPENLLLASKLKGAAV 152
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           K+ DFG++  +         F GT  Y+SPE +    YG   D+W+ G++L     G   
Sbjct: 153 KLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG--- 209
Query: 269 YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
           Y P   +D    + ++     D P P    D  +PE    I+  +   P +R++A E + 
Sbjct: 210 YPPFWDEDQHRLYQQIKAGAYDFPSPEW--DTVTPEAKDLINKMLTINPSKRITAAEALK 267
Query: 329 HPFL 332
           HP++
Sbjct: 268 HPWI 271

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 119/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L DF+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 86  FL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 143
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 204 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 263
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 264 RSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 119/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 25  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 84
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L DF+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 85  FL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 142
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 143 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 202
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 203 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 262
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 263 RSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/266 (24%), Positives = 121/266 (45%), Gaps = 33/266 (12%)
Query: 95  GQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           G+ FALK I++  E E       +E+ I +  +   +V  Y   ++   + ++ E++D  
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD 85
Query: 154 SLADFLKKVKTIPEEYLAAICE-----QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
                LKK+  + E  L ++       Q+L G+ Y H ++ ++HRDLKP NLLIN  GE+
Sbjct: 86  -----LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-DRRVLHRDLKPQNLLINREGEL 139
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF 267
           KI DFG++        +    + T  Y +P+ + G  KY    DIWS+G +  E   G  
Sbjct: 140 KIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP 199
Query: 268 PYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEFCSF------------------ 308
            +    + D     + ++     +  P+     ++ P F  +                  
Sbjct: 200 LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGID 259
Query: 309 -ISACVQKEPQQRLSAQELMTHPFLK 333
            +S  ++ +P QR++A++ + H + K
Sbjct: 260 LLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 119/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L DF+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTEG 140
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/242 (26%), Positives = 118/242 (48%), Gaps = 12/242 (4%)
Query: 96  QFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           Q +A K+I    + SAR  +++ +E +I +  + P +V  + S    G   ++ + + GG
Sbjct: 57  QEYAAKIINTK-KLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGG 115
Query: 154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKI 210
            L + +   +   E   +    Q+L+ + ++H +  I+HRDLKP NLL+  +     VK+
Sbjct: 116 ELFEDIVAREYYSEADASHCIHQILESVNHIH-QHDIVHRDLKPENLLLASKCKGAAVKL 174
Query: 211 TDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS 270
            DFG++  +         F GT  Y+SPE +    YG   DIW+ G++L     G   Y 
Sbjct: 175 ADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG---YP 231
Query: 271 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 330
           P   +D    + ++     D P P    D  +PE  + I+  +   P +R++A + + HP
Sbjct: 232 PFWDEDQHKLYQQIKAGAYDFPSPEW--DTVTPEAKNLINQMLTINPAKRITADQALKHP 289
Query: 331 FL 332
           ++
Sbjct: 290 WV 291

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 123/256 (48%), Gaps = 19/256 (7%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEY 149
           HK T   FA+K+I     + ++R   +E++I  +  Q P ++     +     + ++ E 
Sbjct: 43  HKATNXEFAVKII-----DKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97
Query: 150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL-INHRGE- 207
             GG L D + + K   E   +A+   + K + YLH +  ++HRDLKPSN+L ++  G  
Sbjct: 98  XKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG-VVHRDLKPSNILYVDESGNP 156
Query: 208 --VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
             ++I DFG +  + + +G   T   T N+++PE +    Y    DIWSLG++L    TG
Sbjct: 157 ESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS---DQFSPEFCSFISACVQKEPQQRLS 322
             P++     +G     E + A +     S      +  S      +S  +  +P QRL+
Sbjct: 217 YTPFA-----NGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLT 271
Query: 323 AQELMTHPFLKMYGDL 338
           A  ++ HP++  +  L
Sbjct: 272 AALVLRHPWIVHWDQL 287

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 127/258 (49%), Gaps = 40/258 (15%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS---- 144
            +H+  G+ + +K ++ N  E A R++    K++  +   Y   C+  F  +   S    
Sbjct: 30  AKHRIDGKTYVIKRVKYN-NEKAEREVKALAKLDHVNIVHYNG-CWDGFDYDPETSSKNS 87
Query: 145 ---------IILEYMDGGSLADFLKKVKTIPEEYLAAI--CEQVLKGLLYLHHEKHIIHR 193
                    I +E+ D G+L  +++K +    + + A+   EQ+ KG+ Y+H +K +I+R
Sbjct: 88  SRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK-LINR 146
Query: 194 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIW 253
           DLKPSN+ +    +VKI DFG+   + +  G+     GT  YMSPE+IS   YG + D++
Sbjct: 147 DLKPSNIFLVDTKQVKIGDFGLVTSLKN-DGKRXRSKGTLRYMSPEQISSQDYGKEVDLY 205
Query: 254 SLGLVLLE----CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           +LGL+L E    C T  F  S          F +L + I+        SD F  +  + +
Sbjct: 206 ALGLILAELLHVCDTA-FETSK--------FFTDLRDGII--------SDIFDKKEKTLL 248
Query: 310 SACVQKEPQQRLSAQELM 327
              + K+P+ R +  E++
Sbjct: 249 QKLLSKKPEDRPNTSEIL 266

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 119/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++D   L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 86  HVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 143
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 204 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 263
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 264 RSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 149
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 37  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 93
Query: 150 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 94  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 152
Query: 209 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 153 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 207
Query: 261 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 308
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 208 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 263
Query: 309 ISACVQKEPQQRLSAQEL 326
           ++ C      QR S ++L
Sbjct: 264 MTECWNNNVNQRPSFRDL 281

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 149
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 38  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 94
Query: 150 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 95  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 153
Query: 209 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 154 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 208
Query: 261 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 308
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 264
Query: 309 ISACVQKEPQQRLSAQEL 326
           ++ C      QR S ++L
Sbjct: 265 MTECWNNNVNQRPSFRDL 282

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 149
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 41  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 97
Query: 150 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 98  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 156
Query: 209 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 211
Query: 261 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 308
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 212 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 267
Query: 309 ISACVQKEPQQRLSAQEL 326
           ++ C      QR S ++L
Sbjct: 268 MTECWNNNVNQRPSFRDL 285

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 149
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 56  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 112
Query: 150 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 113 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 171
Query: 209 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 172 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 226
Query: 261 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 308
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 227 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 282
Query: 309 ISACVQKEPQQRLSAQEL 326
           ++ C      QR S ++L
Sbjct: 283 MTECWNNNVNQRPSFRDL 300

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 149
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 69  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 125
Query: 150 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 126 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 184
Query: 209 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 185 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 239
Query: 261 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 308
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 240 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 295
Query: 309 ISACVQKEPQQRLSAQEL 326
           ++ C      QR S ++L
Sbjct: 296 MTECWNNNVNQRPSFRDL 313

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 149
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 56  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 112
Query: 150 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 113 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 171
Query: 209 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 172 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 226
Query: 261 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 308
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 227 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 282
Query: 309 ISACVQKEPQQRLSAQEL 326
           ++ C      QR S ++L
Sbjct: 283 MTECWNNNVNQRPSFRDL 300

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 149
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 44  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 100
Query: 150 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 101 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 159
Query: 209 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 160 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 214
Query: 261 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 308
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 215 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 270
Query: 309 ISACVQKEPQQRLSAQEL 326
           ++ C      QR S ++L
Sbjct: 271 MTECWNNNVNQRPSFRDL 288

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 149
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 38  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 94
Query: 150 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 95  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 153
Query: 209 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 154 KIGDFGLTKVLPQDKEFFKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 208
Query: 261 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 308
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 264
Query: 309 ISACVQKEPQQRLSAQEL 326
           ++ C      QR S ++L
Sbjct: 265 MTECWNNNVNQRPSFRDL 282

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 149
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 42  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 98
Query: 150 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 99  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 157
Query: 209 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 158 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 212
Query: 261 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 308
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 213 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 268
Query: 309 ISACVQKEPQQRLSAQEL 326
           ++ C      QR S ++L
Sbjct: 269 MTECWNNNVNQRPSFRDL 286

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 149
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 38  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 94
Query: 150 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 95  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 153
Query: 209 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 154 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 208
Query: 261 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 308
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 209 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 264
Query: 309 ISACVQKEPQQRLSAQEL 326
           ++ C      QR S ++L
Sbjct: 265 MTECWNNNVNQRPSFRDL 282

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 149
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 43  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 99
Query: 150 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 100 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 158
Query: 209 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 159 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 213
Query: 261 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 308
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 214 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 269
Query: 309 ISACVQKEPQQRLSAQEL 326
           ++ C      QR S ++L
Sbjct: 270 MTECWNNNVNQRPSFRDL 287

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 149
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 36  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 92
Query: 150 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 93  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 151
Query: 209 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 152 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 206
Query: 261 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 308
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 207 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 262
Query: 309 ISACVQKEPQQRLSAQEL 326
           ++ C      QR S ++L
Sbjct: 263 MTECWNNNVNQRPSFRDL 280

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 149
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 45  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 101
Query: 150 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 102 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 160
Query: 209 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 161 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 215
Query: 261 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 308
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 216 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 271
Query: 309 ISACVQKEPQQRLSAQEL 326
           ++ C      QR S ++L
Sbjct: 272 MTECWNNNVNQRPSFRDL 289

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 116/233 (49%), Gaps = 14/233 (6%)
Query: 48  IVSQTETEAPPLIKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQ--- 104
           I+   E   P   K    +L+ ED +              +V+ K   + FA+K++    
Sbjct: 52  ILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE 111
Query: 105 -MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK 163
            +   E+A  +  +++ +N  S+  ++   + +F  +  + ++++Y  GG L   L K +
Sbjct: 112 MLKRAETACFREERDVLVNGDSK--WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE 169
Query: 164 -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMAS 221
             +PEE       +++  +  +H + H +HRD+KP N+L++  G +++ DFG    +M  
Sbjct: 170 DRLPEEMARFYLAEMVIAIDSVH-QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228
Query: 222 TSGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPY 269
            + Q++  VGT +Y+SPE +       G+YG + D WSLG+ + E   G+ P+
Sbjct: 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 30  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 89
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 90  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 147
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 148 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTR 207
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 208 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 267
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 268 RSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 117/268 (43%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 24  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 83
Query: 149 Y--MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           +  MD     D    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 84  FLSMDLKKFMD-ASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTEG 141
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 142 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 202 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 261
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 262 RSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTR 200
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 27  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 86
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 87  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 144
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 145 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 204
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 205 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 264
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 265 RSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 117/268 (43%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 149 Y--MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           +  MD     D    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 86  FLSMDLKKFMD-ASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTEG 143
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 204 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 263
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 264 RSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 109/216 (50%), Gaps = 16/216 (7%)
Query: 66  QLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQ----IAQELKI 121
           QL+ ED +              +V+ K T + +A+K+  +N  E  +R       +E  +
Sbjct: 70  QLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKI--LNKWEMLKRAETACFREERDV 127
Query: 122 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKG 180
             +  C ++   + +F     + ++++Y  GG L   L K +  +PE+       +++  
Sbjct: 128 LVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLA 187
Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSP 238
           +  +H + H +HRD+KP N+L++  G +++ DFG S +  +  G  Q++  VGT +Y+SP
Sbjct: 188 IDSIH-QLHYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISP 245
Query: 239 ERISG-----GKYGYKSDIWSLGLVLLECATGQFPY 269
           E +       GKYG + D WSLG+ + E   G+ P+
Sbjct: 246 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 109/216 (50%), Gaps = 16/216 (7%)
Query: 66  QLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQ----IAQELKI 121
           QL+ ED +              +V+ K T + +A+K+  +N  E  +R       +E  +
Sbjct: 86  QLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKI--LNKWEMLKRAETACFREERDV 143
Query: 122 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKG 180
             +  C ++   + +F     + ++++Y  GG L   L K +  +PE+       +++  
Sbjct: 144 LVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLA 203
Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSP 238
           +  +H + H +HRD+KP N+L++  G +++ DFG S +  +  G  Q++  VGT +Y+SP
Sbjct: 204 IDSIH-QLHYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMNDDGTVQSSVAVGTPDYISP 261
Query: 239 ERISG-----GKYGYKSDIWSLGLVLLECATGQFPY 269
           E +       GKYG + D WSLG+ + E   G+ P+
Sbjct: 262 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 24  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 83
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 84  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 141
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 142 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 202 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 261
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 262 RSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 22  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 82  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 139
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 140 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 259
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 260 RSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 114/250 (45%), Gaps = 31/250 (12%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++ K TG   A+K +++ V        A+EL        P +V  Y +      ++I +E
Sbjct: 112 MEDKQTGFQCAVKKVRLEVFR------AEELMACAGLTSPRIVPLYGAVREGPWVNIFME 165
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-E 207
            ++GGSL   +K+   +PE+       Q L+GL YL H + I+H D+K  N+L++  G  
Sbjct: 166 LLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYL-HSRRILHGDVKADNVLLSSDGSH 224
Query: 208 VKITDFGVSAIMASTSGQANTFV------GTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
             + DFG  A+     G   + +      GT  +M+PE + G     K D+WS   ++L 
Sbjct: 225 AALCDFG-HAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLH 283
Query: 262 CATGQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSA---PSDQFSPEFCSFISACVQKE 316
              G  P         WT F+   L   I  +PPP     PS   +P     I   ++KE
Sbjct: 284 MLNGCHP---------WTQFFRGPLCLKIASEPPPVREIPPS--CAPLTAQAIQEGLRKE 332
Query: 317 PQQRLSAQEL 326
           P  R+SA EL
Sbjct: 333 PIHRVSAAEL 342

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 30  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 89
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 90  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 147
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 148 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 207
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 208 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 267
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 268 RSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 22  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 82  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 139
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 140 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 259
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 260 RSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/247 (28%), Positives = 122/247 (49%), Gaps = 14/247 (5%)
Query: 90  QHKWTGQFFALKVIQMNVEES-ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           + K T + +ALKV++  V++   R +I   L+++     P ++   + F +   IS++LE
Sbjct: 73  KQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH----PNIIKLKEIFETPTEISLVLE 128
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---R 205
            + GG L D + +     E   A   +Q+L+ + YLH E  I+HRDLKP NLL       
Sbjct: 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH-ENGIVHRDLKPENLLYATPAPD 187
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
             +KI DFG+S I+        T  GT  Y +PE + G  YG + D+WS+G++      G
Sbjct: 188 APLKIADFGLSKIVEHQV-LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
             P+   E+ D +  F  ++        P    D+ S      +   +  +P++RL+  +
Sbjct: 247 FEPFY-DERGDQFM-FRRILNCEYYFISPWW--DEVSLNAKDLVRKLIVLDPKKRLTTFQ 302
Query: 326 LMTHPFL 332
            + HP++
Sbjct: 303 ALQHPWV 309

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 25  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 84
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 85  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTEG 142
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 143 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 202
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 203 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 262
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 263 RSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 24  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 83
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 84  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 141
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 142 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 202 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 261
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 262 RSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 24  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 83
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 84  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPENLLINTEG 141
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 142 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 202 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 261
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 262 RSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 86  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 143
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 204 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 263
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 264 RSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 27  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 86
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 87  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 144
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 145 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 204
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 205 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 264
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 265 RSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 22  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 82  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 139
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 140 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 259
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 260 RSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/189 (32%), Positives = 101/189 (53%), Gaps = 25/189 (13%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAI--CEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           I +E+ D G+L  +++K +    + + A+   EQ+ KG+ Y+H +K +IHRDLKPSN+ +
Sbjct: 111 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK-LIHRDLKPSNIFL 169
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE- 261
               +VKI DFG+   + +  G+     GT  YMSPE+IS   YG + D+++LGL+L E 
Sbjct: 170 VDTKQVKIGDFGLVTSLKN-DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228
Query: 262 ---CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 318
              C T  F  S          F +L + I+        SD F  +  + +   + K+P+
Sbjct: 229 LHVCDTA-FETSK--------FFTDLRDGII--------SDIFDKKEKTLLQKLLSKKPE 271
Query: 319 QRLSAQELM 327
            R +  E++
Sbjct: 272 DRPNTSEIL 280

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 86  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 143
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 204 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 263
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 264 RSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 25  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 84
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 85  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 142
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 143 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 202
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 203 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 262
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 263 RSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 22  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 82  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 139
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 140 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 259
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 260 RSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 123/251 (49%), Gaps = 21/251 (8%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEY 149
           HK T   +A+KVI     + ++R  ++E++I  +  Q P ++     +     + ++ E 
Sbjct: 48  HKATNMEYAVKVI-----DKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTEL 102
Query: 150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL-INHRGE- 207
           M GG L D + + K   E   + +   + K + YLH +  ++HRDLKPSN+L ++  G  
Sbjct: 103 MRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG-VVHRDLKPSNILYVDESGNP 161
Query: 208 --VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
             ++I DFG +  + + +G   T   T N+++PE +    Y    DIWSLG++L     G
Sbjct: 162 ECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221
Query: 266 QFPYS--PPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRL 321
             P++  P +  +      E++  I            +  S      +S  +  +P QRL
Sbjct: 222 YTPFANGPSDTPE------EILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRL 275
Query: 322 SAQELMTHPFL 332
           +A++++ HP++
Sbjct: 276 TAKQVLQHPWV 286

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 26  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 85
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 86  FLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 143
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 144 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 203
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 204 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 263
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 264 RSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 10/198 (5%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKH 189
           ++ +  + +   ++I+ ++ +G SL   L   +T  E + L  I  Q  +G+ YLH  K 
Sbjct: 70  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-AKS 128
Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 244
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 129 IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 188
Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 304
            Y ++SD+++ G+VL E  TGQ PYS    +D      E++      P  S         
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVGRGSLSPDLSKVRSNCPKR 245
Query: 305 FCSFISACVQKEPQQRLS 322
               ++ C++K+  +R S
Sbjct: 246 MKRLMAECLKKKRDERPS 263

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 25  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 84
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 85  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 142
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 143 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 202
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 203 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 262
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 263 RSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 107/224 (47%), Gaps = 14/224 (6%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 171
           Q+ QE+ I +    P VV   +     +   + ++ E ++ G + + +  +K + E+   
Sbjct: 82  QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQAR 140
Query: 172 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 231
              + ++KG+ YLH++K IIHRD+KPSNLL+   G +KI DFGVS     +    +  VG
Sbjct: 141 FYFQDLIKGIEYLHYQK-IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVG 199
Query: 232 TYNYMSPERISGGKY---GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 288
           T  +M+PE +S  +    G   D+W++G+ L     GQ P+         +         
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEF 259
Query: 289 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
            DQP         + +    I+  + K P+ R+   E+  HP++
Sbjct: 260 PDQP-------DIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 24  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 83
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 84  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 141
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 142 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 201
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 202 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 261
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 262 RSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 118/268 (44%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 107/226 (47%), Gaps = 17/226 (7%)
Query: 89  VQHKWTGQFFALKVIQMNVEESAR----RQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
            + K T Q  A+K I++     A+    R   +E+K+ Q    P ++    +F     IS
Sbjct: 29  ARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           ++ ++M+             +   ++ A     L+GL YLH +  I+HRDLKP+NLL++ 
Sbjct: 89  LVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-QHWILHRDLKPNNLLLDE 147
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECA 263
            G +K+ DFG++    S +      V T  Y +PE + G + YG   D+W++G +L E  
Sbjct: 148 NGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207
Query: 264 TGQFPYSPPEQQ-DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 308
             + P+ P +   D  T  +E +           P+++  P+ CS 
Sbjct: 208 L-RVPFLPGDSDLDQLTRIFETL---------GTPTEEQWPDMCSL 243

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 123/250 (49%), Gaps = 19/250 (7%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISIILEY 149
           HK T   +A+KVI     + ++R  ++E++I  +  Q P ++     +     + ++ E 
Sbjct: 48  HKATNMEYAVKVI-----DKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTEL 102
Query: 150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL-INHRGE- 207
           M GG L D + + K   E   + +   + K + YLH +  ++HRDLKPSN+L ++  G  
Sbjct: 103 MRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQG-VVHRDLKPSNILYVDESGNP 161
Query: 208 --VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
             ++I DFG +  + + +G   T   T N+++PE +    Y    DIWSLG++L     G
Sbjct: 162 ECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLS 322
             P++     +G +   E +   +     +     +   S      +S  +  +P QRL+
Sbjct: 222 YTPFA-----NGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLT 276
Query: 323 AQELMTHPFL 332
           A++++ HP++
Sbjct: 277 AKQVLQHPWV 286

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 112/249 (44%), Gaps = 29/249 (11%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++ K TG   A+K +++ V        A+EL        P +V  Y +      ++I +E
Sbjct: 93  MEDKQTGFQCAVKKVRLEVFR------AEELMACAGLTSPRIVPLYGAVREGPWVNIFME 146
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-E 207
            ++GGSL   +K+   +PE+       Q L+GL YL H + I+H D+K  N+L++  G  
Sbjct: 147 LLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYL-HSRRILHGDVKADNVLLSSDGSH 205
Query: 208 VKITDFGVSAIMASTSGQANTFVGTY-----NYMSPERISGGKYGYKSDIWSLGLVLLEC 262
             + DFG +  +       +   G Y      +M+PE + G     K D+WS   ++L  
Sbjct: 206 AALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHM 265
Query: 263 ATGQFPYSPPEQQDGWTSFYE--LMEAIVDQPPPSA---PSDQFSPEFCSFISACVQKEP 317
             G  P         WT F+   L   I  +PPP     PS   +P     I   ++KEP
Sbjct: 266 LNGCHP---------WTQFFRGPLCLKIASEPPPVREIPPS--CAPLTAQAIQEGLRKEP 314
Query: 318 QQRLSAQEL 326
             R+SA EL
Sbjct: 315 IHRVSAAEL 323

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/274 (25%), Positives = 117/274 (42%), Gaps = 38/274 (13%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  ALK I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 22  RNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 149 --------YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 200
                   +MD  +L         IP   + +   Q+L+GL + H  + ++HRDLKP NL
Sbjct: 82  HVHQDLKTFMDASALTG-------IPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNL 133
Query: 201 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVL 259
           LIN  G +K+ DFG++             V T  Y +PE + G K Y    DIWSLG + 
Sbjct: 134 LINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIF 193
Query: 260 LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------- 305
            E  T +  +    + D     +  +    +   P   S   + P F             
Sbjct: 194 AEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVP 253
Query: 306 ------CSFISACVQKEPQQRLSAQELMTHPFLK 333
                  S +S  +  +P +R+SA+  + HPF +
Sbjct: 254 PLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/258 (29%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 149
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 39  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 95
Query: 150 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +  GSL D+L+K K  I    L     Q+ KG+ YL  +++I HR+L   N+L+ +   V
Sbjct: 96  LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRNLATRNILVENENRV 154
Query: 209 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 155 KIGDFGLTKVLPQDKEYYKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 209
Query: 261 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 308
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 210 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 265
Query: 309 ISACVQKEPQQRLSAQEL 326
           ++ C      QR S ++L
Sbjct: 266 MTECWNNNVNQRPSFRDL 283

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 117/247 (47%), Gaps = 11/247 (4%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           V  + TG  FA K + M   ES +  + +E++     + P +V  + +F  +  + +I E
Sbjct: 70  VTERATGNNFAAKFV-MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 128
Query: 149 YMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-- 205
           +M GG L + +  +   + E+       QV KGL ++H E + +H DLKP N++   +  
Sbjct: 129 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRS 187
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
            E+K+ DFG++A +        T  GT  + +PE   G   GY +D+WS+G++     +G
Sbjct: 188 NELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
             P+   E  D      +  +  +D    S      S +   FI   +  +P  R++  +
Sbjct: 247 LSPFG-GENDDETLRNVKSCDWNMDDSAFSG----ISEDGKDFIRKLLLADPNTRMTIHQ 301
Query: 326 LMTHPFL 332
            + HP+L
Sbjct: 302 ALEHPWL 308

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 122/253 (48%), Gaps = 15/253 (5%)
Query: 87  QLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           +L++ K + +  A+K I+    ++E+ +R+I      ++S + P +V   +   +   ++
Sbjct: 35  RLMRDKQSNELVAVKYIERGEKIDENVKREIIN----HRSLRHPNIVRFKEVILTPTHLA 90
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           I++EY  GG L + +       E+      +Q++ G+ Y  H   + HRDLK  N L++ 
Sbjct: 91  IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDG 149
Query: 205 R--GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLE 261
                +KI DFG S   +    Q  + VGT  Y++PE +   +Y G  +D+WS G+ L  
Sbjct: 150 SPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 208
Query: 262 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 321
              G +P+  PE+     +F + +  I++           SPE    IS     +P +R+
Sbjct: 209 MLVGAYPFEDPEEP---KNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRI 265
Query: 322 SAQELMTHP-FLK 333
           S  E+  H  FLK
Sbjct: 266 SIPEIRNHEWFLK 278

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 121/253 (47%), Gaps = 15/253 (5%)
Query: 87  QLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           +L++ K   +  A+K I+    ++E+ +R+I      ++S + P +V   +   +   ++
Sbjct: 36  RLMRDKQANELVAVKYIERGEKIDENVKREIIN----HRSLRHPNIVRFKEVILTPTHLA 91
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           I++EY  GG L + +       E+      +Q++ G+ Y  H   + HRDLK  N L++ 
Sbjct: 92  IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYA-HAMQVAHRDLKLENTLLDG 150
Query: 205 R--GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLE 261
                +KI DFG S   +    Q  + VGT  Y++PE +   +Y G  +D+WS G+ L  
Sbjct: 151 SPAPRLKIADFGYSK-ASVLHSQPKSAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 262 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 321
              G +P+  PE+     +F + +  I++           SPE    IS     +P +R+
Sbjct: 210 MLVGAYPFEDPEEP---KNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRI 266
Query: 322 SAQELMTHP-FLK 333
           S  E+  H  FLK
Sbjct: 267 SIPEIRNHEWFLK 279

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/259 (25%), Positives = 123/259 (47%), Gaps = 20/259 (7%)
Query: 109 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 168
           E    +I  E+ + +S   P ++  +  F       ++ E+ +GG L + +       E 
Sbjct: 87  EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 169 YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTSGQ 225
             A I +Q+L G+ YL H+ +I+HRD+KP N+L+ ++     +KI DFG+S+   S   +
Sbjct: 147 DAANIMKQILSGICYL-HKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF-SKDYK 204
Query: 226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM 285
               +GT  Y++PE +   KY  K D+WS G+++     G  P+     QD       ++
Sbjct: 205 LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------II 256
Query: 286 EAIVDQPPPSAPSD--QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS 343
           + +         +D    S E    I   +  +  +R +A+E +   ++K Y + N++ S
Sbjct: 257 KKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN-NINKS 315
Query: 344 EYFTDAGSPLATLSNLSGF 362
           +  T  G+    LSN+  F
Sbjct: 316 DQKTLCGA----LSNMRKF 330

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 112/238 (47%), Gaps = 13/238 (5%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A K+ +  VE+  R    QE++I +S   P ++  Y++F  N  I +++E   GG L + 
Sbjct: 39  AKKIPKYFVEDVDR--FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFER 96
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGV 215
           +   +   E   A I + VL  + Y  H+ ++ HRDLKP N L    +    +K+ DFG+
Sbjct: 97  VVHKRVFRESDAARIMKDVLSAVAYC-HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGL 155
Query: 216 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 275
           +A          T VGT  Y+SP+ +  G YG + D WS G+++     G  P+S P   
Sbjct: 156 AARF-KPGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDX 213
Query: 276 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
           +      E          P       SP+  S I   + K P+QR+++ + + H + +
Sbjct: 214 EVMLKIREGTFTF-----PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 123/258 (47%), Gaps = 38/258 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 149
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 41  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 97
Query: 150 MDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +  GSL D+L+   + I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 98  LPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 156
Query: 209 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 211
Query: 261 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 308
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 212 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 267
Query: 309 ISACVQKEPQQRLSAQEL 326
           ++ C      QR S ++L
Sbjct: 268 MTECWNNNVNQRPSFRDL 285

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 112/238 (47%), Gaps = 13/238 (5%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A K+ +  VE+  R    QE++I +S   P ++  Y++F  N  I +++E   GG L + 
Sbjct: 56  AKKIPKYFVEDVDR--FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFER 113
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGV 215
           +   +   E   A I + VL  + Y  H+ ++ HRDLKP N L    +    +K+ DFG+
Sbjct: 114 VVHKRVFRESDAARIMKDVLSAVAYC-HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGL 172
Query: 216 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 275
           +A          T VGT  Y+SP+ +  G YG + D WS G+++     G  P+S P   
Sbjct: 173 AARF-KPGKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDX 230
Query: 276 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
           +      E          P       SP+  S I   + K P+QR+++ + + H + +
Sbjct: 231 EVMLKIREGTFTF-----PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 283

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/247 (26%), Positives = 117/247 (47%), Gaps = 11/247 (4%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           V  + TG  FA K + M   ES +  + +E++     + P +V  + +F  +  + +I E
Sbjct: 176 VTERATGNNFAAKFV-MTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234
Query: 149 YMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-- 205
           +M GG L + +  +   + E+       QV KGL ++H E + +H DLKP N++   +  
Sbjct: 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRS 293
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
            E+K+ DFG++A +        T  GT  + +PE   G   GY +D+WS+G++     +G
Sbjct: 294 NELKLIDFGLTAHLDPKQSVKVT-TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
             P+   E  D      +  +  +D    S      S +   FI   +  +P  R++  +
Sbjct: 353 LSPFG-GENDDETLRNVKSCDWNMDDSAFSG----ISEDGKDFIRKLLLADPNTRMTIHQ 407
Query: 326 LMTHPFL 332
            + HP+L
Sbjct: 408 ALEHPWL 414

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 146
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 89  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 143
Query: 147 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 144 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 202
Query: 205 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 203 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 261
Query: 262 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 262 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 312
Query: 314 QKEPQQRLSAQELMTHPFL 332
           + EP QR++  E M HP++
Sbjct: 313 KTEPTQRMTITEFMNHPWI 331

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 146
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 39  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 93
Query: 147 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 94  MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 152
Query: 205 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 153 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 211
Query: 262 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 212 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 262
Query: 314 QKEPQQRLSAQELMTHPFL 332
           + EP QR++  E M HP++
Sbjct: 263 KTEPTQRMTITEFMNHPWI 281

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  AL  I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 23  RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 83  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 140
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 141 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 200
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 201 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 260
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 26/268 (9%)
Query: 90  QHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  AL  I+++ E E       +E+ + +    P +V      ++   + ++ E
Sbjct: 22  RNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81
Query: 149 YMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG 206
           ++    L  F+    +  IP   + +   Q+L+GL + H  + ++HRDLKP NLLIN  G
Sbjct: 82  FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR-VLHRDLKPQNLLINTEG 139
Query: 207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATG 265
            +K+ DFG++             V T  Y +PE + G K Y    DIWSLG +  E  T 
Sbjct: 140 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS-DQFSPEF------------------- 305
           +  +    + D     +  +    +   P   S   + P F                   
Sbjct: 200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 259
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            S +S  +  +P +R+SA+  + HPF +
Sbjct: 260 RSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 146
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 83  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 137
Query: 147 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 138 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 196
Query: 205 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 197 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 255
Query: 262 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 256 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 306
Query: 314 QKEPQQRLSAQELMTHPFL 332
           + EP QR++  E M HP++
Sbjct: 307 KTEPTQRMTITEFMNHPWI 325

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 146
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 37  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 91
Query: 147 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 92  MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 150
Query: 205 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 151 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 209
Query: 262 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 210 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 260
Query: 314 QKEPQQRLSAQELMTHPFL 332
           + EP QR++  E M HP++
Sbjct: 261 KTEPTQRMTITEFMNHPWI 279

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 113/226 (50%), Gaps = 29/226 (12%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+KV++   E++   ++ +E +I      PY+V    VC        A+ +++E   GG 
Sbjct: 41  AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-----ALMLVMEMAGGGP 95
Query: 155 LADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L  FL  K + IP   +A +  QV  G+ YL  EK+ +HRDL   N+L+ +R   KI+DF
Sbjct: 96  LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRDLAARNVLLVNRHYAKISDF 154
Query: 214 GVS-AIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G+S A+ A  S       G +   + +PE I+  K+  +SD+WS G+ + E  + GQ PY
Sbjct: 155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214
Query: 270 SP---PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 312
                PE      +F E  + +  + PP  P     PE  + +S C
Sbjct: 215 KKMKGPEV----MAFIEQGKRM--ECPPECP-----PELYALMSDC 249

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 146
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 38  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 92
Query: 147 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 93  MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 151
Query: 205 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 152 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 210
Query: 262 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 211 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 261
Query: 314 QKEPQQRLSAQELMTHPFL 332
           + EP QR++  E M HP++
Sbjct: 262 KTEPTQRMTITEFMNHPWI 280

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 146
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 37  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 91
Query: 147 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 92  MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 150
Query: 205 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 151 KRPNAILKLTDFGFAKETTSHNSLTEPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 209
Query: 262 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 210 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 260
Query: 314 QKEPQQRLSAQELMTHPFL 332
           + EP QR++  E M HP++
Sbjct: 261 KTEPTQRMTITEFMNHPWI 279

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 74/258 (28%), Positives = 124/258 (48%), Gaps = 38/258 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 149
           TG+  A+K +Q + EE  R    +E++I +S Q   +V    VCY +   N  + +I+E+
Sbjct: 41  TGEVVAVKKLQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEF 97
Query: 150 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +  GSL ++L+K K  I    L     Q+ KG+ YL  +++I HRDL   N+L+ +   V
Sbjct: 98  LPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI-HRDLATRNILVENENRV 156
Query: 209 KITDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           KI DFG++ ++            G++  F     + +PE ++  K+   SD+WS G+VL 
Sbjct: 157 KIGDFGLTKVLPQDKEXXKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLY 211
Query: 261 ECATG-QFPYSPPEQ--------QDGWTSFYELMEAIVDQ---PPPSAPSDQFSPEFCSF 308
           E  T  +   SPP +        + G    + L+E + +    P P    D    E    
Sbjct: 212 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPD----EIYMI 267
Query: 309 ISACVQKEPQQRLSAQEL 326
           ++ C      QR S ++L
Sbjct: 268 MTECWNNNVNQRPSFRDL 285

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 146
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 43  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 97
Query: 147 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 98  MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 156
Query: 205 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 157 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 215
Query: 262 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 216 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 266
Query: 314 QKEPQQRLSAQELMTHPFL 332
           + EP QR++  E M HP++
Sbjct: 267 KTEPTQRMTITEFMNHPWI 285

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 146
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 45  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 99
Query: 147 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 100 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 158
Query: 205 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 159 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 217
Query: 262 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 218 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 268
Query: 314 QKEPQQRLSAQELMTHPFL 332
           + EP QR++  E M HP++
Sbjct: 269 KTEPTQRMTITEFMNHPWI 287

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 146
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 39  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 93
Query: 147 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 94  MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 152
Query: 205 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 153 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 211
Query: 262 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 212 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 262
Query: 314 QKEPQQRLSAQELMTHPFL 332
           + EP QR++  E M HP++
Sbjct: 263 KTEPTQRMTITEFMNHPWI 281

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 146
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 44  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 98
Query: 147 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 99  MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 157
Query: 205 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 158 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 216
Query: 262 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 217 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 267
Query: 314 QKEPQQRLSAQELMTHPFL 332
           + EP QR++  E M HP++
Sbjct: 268 KTEPTQRMTITEFMNHPWI 286

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 101/189 (53%), Gaps = 13/189 (6%)
Query: 108 EESARRQIAQELKINQSSQCPY--VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI 165
           EE+ +R    E +++ SSQ  +  +V        +    +++EY++G +L+++++    +
Sbjct: 52  EETLKRF---EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPL 108
Query: 166 PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-G 224
             +       Q+L G+ + H +  I+HRD+KP N+LI+    +KI DFG++  ++ TS  
Sbjct: 109 SVDTAINFTNQILDGIKHAH-DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT 167
Query: 225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 284
           Q N  +GT  Y SPE+  G      +DI+S+G+VL E   G+ P+      +G T+    
Sbjct: 168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF------NGETAVSIA 221
Query: 285 MEAIVDQPP 293
           ++ I D  P
Sbjct: 222 IKHIQDSVP 230

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 146
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 53  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 107
Query: 147 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 108 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 166
Query: 205 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +K+TDFG +    S +         Y Y++PE +   KY    D+WSLG+++  
Sbjct: 167 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDMWSLGVIMYI 225
Query: 262 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 226 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 276
Query: 314 QKEPQQRLSAQELMTHPFL 332
           + EP QR++  E M HP++
Sbjct: 277 KTEPTQRMTITEFMNHPWI 295

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKH 189
           ++ +  + +   ++I+ ++ +G SL   L   +T  E + L  I  Q  +G+ YLH  K 
Sbjct: 82  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-AKS 140
Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 244
           IIHRDLK +N+ ++    VKI DFG++   +  SG  Q     G+  +M+PE I      
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 304
            Y ++SD+++ G+VL E  TGQ PYS    +D      E++      P  S         
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 305 FCSFISACVQKEPQQRLS 322
               ++ C++K+  +R S
Sbjct: 258 MKRLMAECLKKKRDERPS 275

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/276 (26%), Positives = 122/276 (44%), Gaps = 42/276 (15%)
Query: 89  VQHKWTGQFFALKVIQMN-----VEESARRQIA--QELKINQSSQCPYVVVCYQSFYSNG 141
            +++ T +  ALK ++++     V  SA R+I   +ELK         +V  +   +S+ 
Sbjct: 21  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN------IVRLHDVLHSDK 74
Query: 142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
            ++++ E+ D      F      +  E + +   Q+LKGL + H  ++++HRDLKP NLL
Sbjct: 75  KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-SRNVLHRDLKPQNLL 133
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLL 260
           IN  GE+K+ DFG++          +  V T  Y  P+ + G K Y    D+WS G +  
Sbjct: 134 INRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 193
Query: 261 ECATGQFPYSPPEQQDG----------------WTSFYELMEAIVDQPPPSAPSD----Q 300
           E A    P  P    D                 W S  +L +    +P P  P+      
Sbjct: 194 ELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY---KPYPMYPATTSLVN 250
Query: 301 FSPEFCS----FISACVQKEPQQRLSAQELMTHPFL 332
             P+  +     +   ++  P QR+SA+E + HP+ 
Sbjct: 251 VVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/251 (26%), Positives = 119/251 (47%), Gaps = 11/251 (4%)
Query: 87  QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII 146
           +L++ K + +  A+K I+    E     + +E+  ++S + P +V   +   +   ++I+
Sbjct: 36  RLMRDKQSNELVAVKYIERG--EKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIV 93
Query: 147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR- 205
           +EY  GG L + +       E+      +Q++ G+ Y  H   + HRDLK  N L++   
Sbjct: 94  MEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDGSP 152
Query: 206 -GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECA 263
              +KI DFG S   +    Q  + VGT  Y++PE +   +Y G  +D+WS G+ L    
Sbjct: 153 APRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
            G +P+  PE+     +F + +  I++           SPE    IS     +P +R+S 
Sbjct: 212 VGAYPFEDPEEP---KNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRISI 268
Query: 324 QELMTHP-FLK 333
            E+  H  FLK
Sbjct: 269 PEIRNHEWFLK 279

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 115/242 (47%), Gaps = 11/242 (4%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           TG   A K+I+    +  + ++  E+ +        ++  Y +F S   I +++EY+DGG
Sbjct: 113 TGLKLAAKIIKTRGMKD-KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171
Query: 154 SLAD-FLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG--EVKI 210
            L D  + +   + E       +Q+ +G+ ++ H+ +I+H DLKP N+L  +R   ++KI
Sbjct: 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHM-HQMYILHLDLKPENILCVNRDAKQIKI 230
Query: 211 TDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS 270
            DFG++            F GT  +++PE ++     + +D+WS+G++     +G  P+ 
Sbjct: 231 IDFGLARRYKPREKLKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFL 289
Query: 271 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 330
                +   +       + D+          S E   FIS  + KE   R+SA E + HP
Sbjct: 290 GDNDAETLNNILACRWDLEDE-----EFQDISEEAKEFISKLLIKEKSWRISASEALKHP 344
Query: 331 FL 332
           +L
Sbjct: 345 WL 346

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 189
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 66  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 124
Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERIS---GG 244
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 276
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 189
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 93  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 151
Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERIS---GG 244
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 276
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 243

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 189
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 68  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 126
Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERIS---GG 244
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 276
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 218

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKH 189
           ++ +  + +   ++I+ ++ +G SL   L   +T  E + L  I  Q  +G+ YLH  K 
Sbjct: 82  ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH-AKS 140
Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 244
           IIHRDLK +N+ ++    VKI DFG++   +  SG  Q     G+  +M+PE I      
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 304
            Y ++SD+++ G+VL E  TGQ PYS    +D      E++      P  S         
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 305 FCSFISACVQKEPQQRLS 322
               ++ C++K+  +R S
Sbjct: 258 MKRLMAECLKKKRDERPS 275

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 189
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 71  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 129
Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERI---SGG 244
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 276
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 221

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 189
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 71  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 129
Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERIS---GG 244
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 276
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 221

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 189
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 94  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 152
Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERIS---GG 244
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 276
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 244

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 7/152 (4%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 189
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 66  ILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 124
Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERIS---GG 244
           IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 276
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVC------YQSFYSNGAIS 144
           H+ TG+  A+K  +  +    R +   E++I +    P VV         Q    N    
Sbjct: 36  HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 95
Query: 145 IILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + +EY +GG L  +L + +    + E  +  +   +   L YLH E  IIHRDLKP N++
Sbjct: 96  LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH-ENRIIHRDLKPENIV 154
Query: 202 IN---HRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGGKYGYKSDIWSLGL 257
           +     R   KI D G +  +    G+  T FVGT  Y++PE +   KY    D WS G 
Sbjct: 155 LQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 212
Query: 258 VLLECATGQFPYSPPEQQDGW 278
           +  EC TG  P+ P  Q   W
Sbjct: 213 LAFECITGFRPFLPNWQPVQW 233

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVC------YQSFYSNGAIS 144
           H+ TG+  A+K  +  +    R +   E++I +    P VV         Q    N    
Sbjct: 35  HQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL 94
Query: 145 IILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + +EY +GG L  +L + +    + E  +  +   +   L YLH E  IIHRDLKP N++
Sbjct: 95  LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH-ENRIIHRDLKPENIV 153
Query: 202 IN---HRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGGKYGYKSDIWSLGL 257
           +     R   KI D G +  +    G+  T FVGT  Y++PE +   KY    D WS G 
Sbjct: 154 LQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 211
Query: 258 VLLECATGQFPYSPPEQQDGW 278
           +  EC TG  P+ P  Q   W
Sbjct: 212 LAFECITGFRPFLPNWQPVQW 232

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 91/194 (46%), Gaps = 27/194 (13%)
Query: 167 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 226
           EE +  +  Q+LKGL Y+H    ++HRDLKP NL +N   E+KI DFG++        + 
Sbjct: 125 EEKIQYLVYQMLKGLKYIH-SAGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEM 180
Query: 227 NTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY--- 282
             +V T  Y +PE I S   Y    DIWS+G ++ E  TG+  +   +  D  T      
Sbjct: 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 240
Query: 283 -----ELMEAIVD-------QPPPSAPSDQF-------SPEFCSFISACVQKEPQQRLSA 323
                E ++ + D       Q  P  P   F       SP+    +   ++ +  +RL+A
Sbjct: 241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA 300
Query: 324 QELMTHPFLKMYGD 337
            + +THPF + + D
Sbjct: 301 AQALTHPFFEPFRD 314

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 111/223 (49%), Gaps = 23/223 (10%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+KV++   E++   ++ +E +I      PY+V    VC        A+ +++E   GG 
Sbjct: 367 AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-----ALMLVMEMAGGGP 421
Query: 155 LADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L  FL  K + IP   +A +  QV  G+ YL  EK+ +HR+L   N+L+ +R   KI+DF
Sbjct: 422 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRNLAARNVLLVNRHYAKISDF 480
Query: 214 GVS-AIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G+S A+ A  S       G +   + +PE I+  K+  +SD+WS G+ + E  + GQ PY
Sbjct: 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
Query: 270 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 312
              ++  G      + +    + PP  P     PE  + +S C
Sbjct: 541 ---KKMKGPEVMAFIEQGKRMECPPECP-----PELYALMSDC 575

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 189
           ++ +  + +   ++I+ ++ +G SL   L   +T  + + L  I  Q  +G+ YLH  K+
Sbjct: 94  ILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH-AKN 152
Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERIS---GG 244
           IIHRD+K +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I      
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212
Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 304
            + ++SD++S G+VL E  TG+ PYS    +D       ++      P  S         
Sbjct: 213 PFSFQSDVYSYGIVLYELMTGELPYSHINNRD---QIIFMVGRGYASPDLSKLYKNCPKA 269
Query: 305 FCSFISACVQKEPQQR------LSAQELMTHPFLKM 334
               ++ CV+K  ++R      LS+ EL+ H   K+
Sbjct: 270 MKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKI 305

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 121/253 (47%), Gaps = 15/253 (5%)
Query: 87  QLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           +L++ K + +  A+K I+    ++E+ +R+I      ++S + P +V   +   +   ++
Sbjct: 36  RLMRDKQSNELVAVKYIERGEKIDENVKREIIN----HRSLRHPNIVRFKEVILTPTHLA 91
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           I++EY  GG L + +       E+      +Q++ G+ Y  H   + HRDLK  N L++ 
Sbjct: 92  IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDG 150
Query: 205 R--GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLE 261
                +KI  FG S   +    Q  + VGT  Y++PE +   +Y G  +D+WS G+ L  
Sbjct: 151 SPAPRLKICAFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 262 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 321
              G +P+  PE+     +F + +  I++           SPE    IS     +P +R+
Sbjct: 210 MLVGAYPFEDPEEP---KNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRI 266
Query: 322 SAQELMTHP-FLK 333
           S  E+  H  FLK
Sbjct: 267 SIPEIRNHEWFLK 279

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 91/194 (46%), Gaps = 27/194 (13%)
Query: 167 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 226
           EE +  +  Q+LKGL Y+H    ++HRDLKP NL +N   E+KI DFG++        + 
Sbjct: 143 EEKIQYLVYQMLKGLKYIH-SAGVVHRDLKPGNLAVNEDCELKILDFGLA---RHADAEM 198
Query: 227 NTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY--- 282
             +V T  Y +PE I S   Y    DIWS+G ++ E  TG+  +   +  D  T      
Sbjct: 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 258
Query: 283 -----ELMEAIVD-------QPPPSAPSDQF-------SPEFCSFISACVQKEPQQRLSA 323
                E ++ + D       Q  P  P   F       SP+    +   ++ +  +RL+A
Sbjct: 259 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA 318
Query: 324 QELMTHPFLKMYGD 337
            + +THPF + + D
Sbjct: 319 AQALTHPFFEPFRD 332

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 124/292 (42%), Gaps = 34/292 (11%)
Query: 92  KWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           K TG+ F  K I        +  +  E+ I      P ++  + +F     + +ILE++ 
Sbjct: 73  KATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLS 131
Query: 152 GGSLADFLKKVKTIPEEYLAAICE------QVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           GG L D     +   E+Y  +  E      Q  +GL ++H E  I+H D+KP N++   +
Sbjct: 132 GGELFD-----RIAAEDYKMSEAEVINYMRQACEGLKHMH-EHSIVHLDIKPENIMCETK 185
Query: 206 --GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
               VKI DFG+ A   +          T  + +PE +     G+ +D+W++G++     
Sbjct: 186 KASSVKIIDFGL-ATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
           +G  P++    +D   +   +     D           SPE   FI   +QKEP++RL+ 
Sbjct: 245 SGLSPFA---GEDDLETLQNVKRC--DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTV 299
Query: 324 QELMTHPFLK-------------MYGDLNVDLSEYFTDAGSPLATLSNLSGF 362
            + + HP+LK              Y  +   + E + D  +P   +  ++ F
Sbjct: 300 HDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANF 351

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 33/259 (12%)
Query: 96  QFFALKVIQMNVEE-------SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           Q +A+K +  N+EE       S R +IA   K+ Q S    ++  Y    ++  I +++E
Sbjct: 53  QIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME 108
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
                 L  +LKK K+I      +  + +L+ +  +H +  I+H DLKP+N LI   G +
Sbjct: 109 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIV-DGML 165
Query: 209 KITDFGVSAIMA--STSGQANTFVGTYNYMSPERISGGKYGYKS-----------DIWSL 255
           K+ DFG++  M   +TS   ++ VGT NYM PE I       ++           D+WSL
Sbjct: 166 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225
Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 315
           G +L     G+ P+     Q         + AI+D        D    +    +  C+++
Sbjct: 226 GCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 279
Query: 316 EPQQRLSAQELMTHPFLKM 334
           +P+QR+S  EL+ HP++++
Sbjct: 280 DPKQRISIPELLAHPYVQI 298

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 33/259 (12%)
Query: 96  QFFALKVIQMNVEE-------SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           Q +A+K +  N+EE       S R +IA   K+ Q S    ++  Y    ++  I +++E
Sbjct: 81  QIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME 136
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
                 L  +LKK K+I      +  + +L+ +  +H +  I+H DLKP+N LI   G +
Sbjct: 137 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GML 193
Query: 209 KITDFGVSAIMA--STSGQANTFVGTYNYMSPERISGGKYGYKS-----------DIWSL 255
           K+ DFG++  M   +TS   ++ VGT NYM PE I       ++           D+WSL
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 315
           G +L     G+ P+     Q         + AI+D        D    +    +  C+++
Sbjct: 254 GCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 307
Query: 316 EPQQRLSAQELMTHPFLKM 334
           +P+QR+S  EL+ HP++++
Sbjct: 308 DPKQRISIPELLAHPYVQI 326

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 33/259 (12%)
Query: 96  QFFALKVIQMNVEE-------SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           Q +A+K +  N+EE       S R +IA   K+ Q S    ++  Y    ++  I +++E
Sbjct: 37  QIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME 92
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
                 L  +LKK K+I      +  + +L+ +  +H +  I+H DLKP+N LI   G +
Sbjct: 93  -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GML 149
Query: 209 KITDFGVSAIMA--STSGQANTFVGTYNYMSPERISGGKYGYKS-----------DIWSL 255
           K+ DFG++  M   +TS   ++ VGT NYM PE I       ++           D+WSL
Sbjct: 150 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 209
Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 315
           G +L     G+ P+     Q         + AI+D        D    +    +  C+++
Sbjct: 210 GCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 263
Query: 316 EPQQRLSAQELMTHPFLKM 334
           +P+QR+S  EL+ HP++++
Sbjct: 264 DPKQRISIPELLAHPYVQI 282

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 121/253 (47%), Gaps = 15/253 (5%)
Query: 87  QLVQHKWTGQFFALKVIQM--NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           +L++ K + +  A+K I+    ++E+ +R+I      ++S + P +V   +   +   ++
Sbjct: 36  RLMRDKQSNELVAVKYIERGEKIDENVKREIIN----HRSLRHPNIVRFKEVILTPTHLA 91
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           I++EY  GG L + +       E+      +Q++ G+ Y  H   + HRDLK  N L++ 
Sbjct: 92  IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HAMQVCHRDLKLENTLLDG 150
Query: 205 R--GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLE 261
                +KI  FG S      S   +T VGT  Y++PE +   +Y G  +D+WS G+ L  
Sbjct: 151 SPAPRLKICAFGYSKSSVLHSQPKDT-VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYV 209
Query: 262 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL 321
              G +P+  PE+     +F + +  I++           SPE    IS     +P +R+
Sbjct: 210 MLVGAYPFEDPEEP---KNFRKTIHRILNVQYAIPDYVHISPECRHLISRIFVADPAKRI 266
Query: 322 SAQELMTHP-FLK 333
           S  E+  H  FLK
Sbjct: 267 SIPEIRNHEWFLK 279

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 33/259 (12%)
Query: 96  QFFALKVIQMNVEE-------SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           Q +A+K +  N+EE       S R +IA   K+ Q S    ++  Y    ++  I +++E
Sbjct: 34  QIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME 89
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
                 L  +LKK K+I      +  + +L+ +  +H +  I+H DLKP+N LI   G +
Sbjct: 90  -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIV-DGML 146
Query: 209 KITDFGVSAIMA--STSGQANTFVGTYNYMSPERISGGKYGYKS-----------DIWSL 255
           K+ DFG++  M   +TS   ++ VGT NYM PE I       ++           D+WSL
Sbjct: 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206
Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 315
           G +L     G+ P+     Q         + AI+D        D    +    +  C+++
Sbjct: 207 GCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 260
Query: 316 EPQQRLSAQELMTHPFLKM 334
           +P+QR+S  EL+ HP++++
Sbjct: 261 DPKQRISIPELLAHPYVQI 279

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 33/259 (12%)
Query: 96  QFFALKVIQMNVEE-------SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           Q +A+K +  N+EE       S R +IA   K+ Q S    ++  Y    ++  I +++E
Sbjct: 33  QIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME 88
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
                 L  +LKK K+I      +  + +L+ +  +H +  I+H DLKP+N LI   G +
Sbjct: 89  -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GML 145
Query: 209 KITDFGVSAIMA--STSGQANTFVGTYNYMSPERISGGKYGYKS-----------DIWSL 255
           K+ DFG++  M   +TS   ++ VGT NYM PE I       ++           D+WSL
Sbjct: 146 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 205
Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 315
           G +L     G+ P+     Q         + AI+D        D    +    +  C+++
Sbjct: 206 GCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 259
Query: 316 EPQQRLSAQELMTHPFLKM 334
           +P+QR+S  EL+ HP++++
Sbjct: 260 DPKQRISIPELLAHPYVQI 278

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 124/259 (47%), Gaps = 33/259 (12%)
Query: 96  QFFALKVIQMNVEE-------SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           Q +A+K +  N+EE       S R +IA   K+ Q S    ++  Y    ++  I +++E
Sbjct: 81  QIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME 136
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
                 L  +LKK K+I      +  + +L+ +  +H +  I+H DLKP+N LI   G +
Sbjct: 137 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GML 193
Query: 209 KITDFGVSAIMA--STSGQANTFVGTYNYMSPERISGGKYGYKS-----------DIWSL 255
           K+ DFG++  M   +TS   ++ VGT NYM PE I       ++           D+WSL
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 315
           G +L     G+ P+     Q         + AI+D        D    +    +  C+++
Sbjct: 254 GCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 307
Query: 316 EPQQRLSAQELMTHPFLKM 334
           +P+QR+S  EL+ HP++++
Sbjct: 308 DPKQRISIPELLAHPYVQI 326

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 121/276 (43%), Gaps = 42/276 (15%)
Query: 89  VQHKWTGQFFALKVIQMN-----VEESARRQIA--QELKINQSSQCPYVVVCYQSFYSNG 141
            +++ T +  ALK ++++     V  SA R+I   +ELK         +V  +   +S+ 
Sbjct: 21  AKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN------IVRLHDVLHSDK 74
Query: 142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
            ++++ E+ D      F      +  E + +   Q+LKGL + H  ++++HRDLKP NLL
Sbjct: 75  KLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-SRNVLHRDLKPQNLL 133
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLL 260
           IN  GE+K+ +FG++          +  V T  Y  P+ + G K Y    D+WS G +  
Sbjct: 134 INRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFA 193
Query: 261 ECATGQFPYSPPEQQDG----------------WTSFYELMEAIVDQPPPSAPSD----- 299
           E A    P  P    D                 W S  +L +    +P P  P+      
Sbjct: 194 ELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY---KPYPMYPATTSLVN 250
Query: 300 ---QFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
              + +      +   ++  P QR+SA+E + HP+ 
Sbjct: 251 VVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/327 (23%), Positives = 139/327 (42%), Gaps = 59/327 (18%)
Query: 87  QLVQHKWTGQFFALKVIQMNVEESARRQIA---QELKINQSSQCPYVVVCYQSFYSNGAI 143
            L ++K TG++  ++  ++N+E  +   +     EL +++    P +V    +F ++  +
Sbjct: 28  NLARYKPTGEYVTVR--RINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 85
Query: 144 SIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
            ++  +M  GS  D +    +  + E  +A I + VLK L Y+HH  ++ HR +K S++L
Sbjct: 86  WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYV-HRSVKASHIL 144
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYN--------YMSPERISGGKYGY--KSD 251
           I+  G+V ++    +  M S  GQ    V  +         ++SPE +     GY  KSD
Sbjct: 145 ISVDGKVYLSGLRSNLSMIS-HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 203
Query: 252 IWSLGLVLLECATGQFPYS--------------------------------PPEQQDGWT 279
           I+S+G+   E A G  P+                                  P +    +
Sbjct: 204 IYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANS 263
Query: 280 SFYELMEAIVDQP----PPSAPSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 334
              + +     +P     PS P  + FSP F  F+  C+Q+ P  R SA  L+ H F K 
Sbjct: 264 GLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK- 322
Query: 335 YGDLNVDLSEYFTDAGSPLATLSNLSG 361
              +    SE   +   P+  ++N  G
Sbjct: 323 --QIKRRASEALPELLRPVTPITNFEG 347

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/327 (23%), Positives = 139/327 (42%), Gaps = 59/327 (18%)
Query: 87  QLVQHKWTGQFFALKVIQMNVEESARRQIA---QELKINQSSQCPYVVVCYQSFYSNGAI 143
            L ++K TG++  ++  ++N+E  +   +     EL +++    P +V    +F ++  +
Sbjct: 44  NLARYKPTGEYVTVR--RINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101
Query: 144 SIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
            ++  +M  GS  D +    +  + E  +A I + VLK L Y+HH  ++ HR +K S++L
Sbjct: 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYV-HRSVKASHIL 160
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYN--------YMSPERISGGKYGY--KSD 251
           I+  G+V ++    +  M S  GQ    V  +         ++SPE +     GY  KSD
Sbjct: 161 ISVDGKVYLSGLRSNLSMIS-HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSD 219
Query: 252 IWSLGLVLLECATGQFPYS--------------------------------PPEQQDGWT 279
           I+S+G+   E A G  P+                                  P +    +
Sbjct: 220 IYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANS 279
Query: 280 SFYELMEAIVDQP----PPSAPSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 334
              + +     +P     PS P  + FSP F  F+  C+Q+ P  R SA  L+ H F K 
Sbjct: 280 GLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK- 338
Query: 335 YGDLNVDLSEYFTDAGSPLATLSNLSG 361
              +    SE   +   P+  ++N  G
Sbjct: 339 --QIKRRASEALPELLRPVTPITNFEG 363

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 131/292 (44%), Gaps = 56/292 (19%)
Query: 90  QHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVV---------VCYQSFY 138
           + + TGQ  A+K I    +V  +A+R + +ELKI +  +   ++         V Y  F 
Sbjct: 74  RRRLTGQQVAIKKIPNAFDVVTNAKRTL-RELKILKHFKHDNIIAIKDILRPTVPYGEFK 132
Query: 139 SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS 198
           S   + ++L+ M+   L   +   + +  E++     Q+L+GL Y+H    +IHRDLKPS
Sbjct: 133 S---VYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH-SAQVIHRDLKPS 187
Query: 199 NLLINHRGEVKITDFGVSAIMASTSGQANTF----VGTYNYMSPE-RISGGKYGYKSDIW 253
           NLL+N   E+KI DFG++  + ++  +   F    V T  Y +PE  +S  +Y    D+W
Sbjct: 188 NLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLW 247
Query: 254 SLGLVLLECATGQ--FPYSPPEQQDGWTSFYELMEAIVDQPPP----------------S 295
           S+G +  E    +  FP         +    +L+  ++  P P                S
Sbjct: 248 SVGCIFGEMLARRQLFP------GKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQS 301
Query: 296 APSDQFSP----------EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
            P  Q  P          +  S +   ++ EP  R+SA   + HPFL  Y D
Sbjct: 302 LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 83/152 (54%), Gaps = 7/152 (4%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 189
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 66  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 124
Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERIS---GG 244
           IIHRDLK +N+ ++    VKI DFG++   +  SG  Q     G+  +M+PE I      
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 276
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 83/152 (54%), Gaps = 7/152 (4%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 189
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 86  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 144
Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERIS---GG 244
           IIHRDLK +N+ ++    VKI DFG++   +  SG  Q     G+  +M+PE I      
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 204
Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 276
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 205 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 236

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 83/152 (54%), Gaps = 7/152 (4%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAICEQVLKGLLYLHHEKH 189
           ++ +  + +   ++I+ ++ +G SL   L  ++T  E   L  I  Q  +G+ YLH  K 
Sbjct: 94  ILLFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-AKS 152
Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERIS---GG 244
           IIHRDLK +N+ ++    VKI DFG++   +  SG  Q     G+  +M+PE I      
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 276
            Y ++SD+++ G+VL E  TGQ PYS    +D
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 244

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 56/293 (19%)
Query: 89  VQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVV---------VCYQSF 137
            + + TGQ  A+K I    +V  +A+R + +ELKI +  +   ++         V Y  F
Sbjct: 74  ARRRLTGQQVAIKKIPNAFDVVTNAKRTL-RELKILKHFKHDNIIAIKDILRPTVPYGEF 132
Query: 138 YSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
            S   + ++L+ M+   L   +   + +  E++     Q+L+GL Y+H    +IHRDLKP
Sbjct: 133 KS---VYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMH-SAQVIHRDLKP 187
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTF----VGTYNYMSPE-RISGGKYGYKSDI 252
           SNLL+N   E+KI DFG++  + ++  +   F    V T  Y +PE  +S  +Y    D+
Sbjct: 188 SNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDL 247
Query: 253 WSLGLVLLECATGQ--FPYSPPEQQDGWTSFYELMEAIVDQPPP---------------- 294
           WS+G +  E    +  FP         +    +L+  ++  P P                
Sbjct: 248 WSVGCIFGEMLARRQLFP------GKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQ 301
Query: 295 SAPSDQFSP----------EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
           S P  Q  P          +  S +   ++ EP  R+SA   + HPFL  Y D
Sbjct: 302 SLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 354

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 186
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 80  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 132
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 245
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 133 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 192
Query: 246 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 301
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 193 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 243
Query: 302 SPEFCSFISACVQKEPQQR 320
             E    +  C ++ P+ R
Sbjct: 244 --ELYQLMRLCWKERPEDR 260

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--LAAICEQVLKGLLYLHH 186
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 74  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 245
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 246 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 301
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 237
Query: 302 SPEFCSFISACVQKEPQQR 320
             E    +  C ++ P+ R
Sbjct: 238 --ELYQLMRLCWKERPEDR 254

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--LAAICEQVLKGLLYLHH 186
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 75  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 127
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 245
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 128 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 187
Query: 246 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 301
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 188 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 238
Query: 302 SPEFCSFISACVQKEPQQR 320
             E    +  C ++ P+ R
Sbjct: 239 --ELYQLMRLCWKERPEDR 255

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--LAAICEQVLKGLLYLHH 186
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 76  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 128
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 245
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 129 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 188
Query: 246 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 301
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 189 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 239
Query: 302 SPEFCSFISACVQKEPQQR 320
             E    +  C ++ P+ R
Sbjct: 240 --ELYQLMRLCWKERPEDR 256

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--LAAICEQVLKGLLYLHH 186
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 69  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 121
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 243
           E++ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 122 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 179
Query: 244 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 299
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 180 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 232
Query: 300 QFSPEFCSFISACVQKEPQQR 320
               E    +  C ++ P+ R
Sbjct: 233 ----ELYQLMRLCWKERPEDR 249

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 186
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 82  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 134
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 245
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 135 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 194
Query: 246 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 301
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 195 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 245
Query: 302 SPEFCSFISACVQKEPQQR 320
             E    +  C ++ P+ R
Sbjct: 246 --ELYQLMRLCWKERPEDR 262

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           L+K     T+ +  L  +   +  G+ YL  +   +HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYL-SDMGFVHRDLAARNILINSNLVCKVSDFGL 193
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--LAAICEQVLKGLLYLHH 186
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 83  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 135
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 245
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 136 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 195
Query: 246 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 301
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 196 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 246
Query: 302 SPEFCSFISACVQKEPQQR 320
             E    +  C ++ P+ R
Sbjct: 247 --ELYQLMRLCWKERPEDR 263

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--LAAICEQVLKGLLYLHH 186
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 74  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 245
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGT 186
Query: 246 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 301
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 237
Query: 302 SPEFCSFISACVQKEPQQR 320
             E    +  C ++ P+ R
Sbjct: 238 --ELYQLMRLCWKERPEDR 254

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--LAAICEQVLKGLLYLHH 186
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 80  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 132
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 243
           E++ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 133 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 190
Query: 244 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 299
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 243
Query: 300 QFSPEFCSFISACVQKEPQQR 320
               E    +  C ++ P+ R
Sbjct: 244 ----ELYQLMRLCWKERPEDR 260

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 25/199 (12%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--LAAICEQVLKGLLYLHH 186
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 74  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGK 245
           E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ G 
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGT 186
Query: 246 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 301
           +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P    
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE--- 237
Query: 302 SPEFCSFISACVQKEPQQR 320
             E    +  C ++ P+ R
Sbjct: 238 --ELYQLMRLCWKERPEDR 254

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--LAAICEQVLKGLLYLHH 186
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 79  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 131
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 243
           E++ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 132 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 189
Query: 244 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 299
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 190 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 242
Query: 300 QFSPEFCSFISACVQKEPQQR 320
               E    +  C ++ P+ R
Sbjct: 243 ----ELYQLMRLCWKERPEDR 259

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--LAAICEQVLKGLLYLHH 186
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 74  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 243
           E++ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 184
Query: 244 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 299
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 237
Query: 300 QFSPEFCSFISACVQKEPQQR 320
               E    +  C ++ P+ R
Sbjct: 238 ----ELYQLMRLCWKERPEDR 254

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 40/221 (18%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 133 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 190
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 191 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247
Query: 265 GQ--FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK------- 315
           G+  FP +     D      ++M  +   PP S  S   S E  ++I++  Q        
Sbjct: 248 GRTLFPGT-----DHINQLQQIMR-LTGTPPASVISRMPSHEARNYINSLPQMPKRNFAD 301
Query: 316 -------------------EPQQRLSAQELMTHPFLKMYGD 337
                              +  +R++A E + HP+   Y D
Sbjct: 302 VFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHD 342

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 193
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 193
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 193
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 193
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 75  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 134
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 135 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 191
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 192 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 251
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 252 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 300

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 65  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 124
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 125 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 181
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 182 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 241
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 242 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 290

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE--EYLAAICEQVLKGLLYLHH 186
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 84  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 136
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 243
           E++ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 137 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 194
Query: 244 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 299
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 195 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 247
Query: 300 QFSPEFCSFISACVQKEPQQR 320
               E    +  C ++ P+ R
Sbjct: 248 ----ELYQLMRLCWKERPEDR 264

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 111/252 (44%), Gaps = 33/252 (13%)
Query: 112 RRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIILEYMDGG---SLADFLKKV 162
           +R   +EL+I +  + P VV     FYSNG       ++++LEY+      +   + K  
Sbjct: 76  KRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLK 135
Query: 163 KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMAS 221
           +T+P   +     Q+L+ L Y+H    I HRD+KP NLL++   G +K+ DFG + I+ +
Sbjct: 136 QTMPMLLIKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194
Query: 222 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP---------- 268
                +     Y Y +PE I G   Y    DIWS G V+ E   GQ  FP          
Sbjct: 195 GEPNVSXICSRY-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE 253
Query: 269 ----YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS----PEFCSFISACVQKEPQQR 320
                  P ++   T     ME    Q  P   S  F     P+    IS  ++  P  R
Sbjct: 254 IIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR 313
Query: 321 LSAQELMTHPFL 332
           L+A E + HPF 
Sbjct: 314 LTAIEALCHPFF 325

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 75/294 (25%), Positives = 132/294 (44%), Gaps = 54/294 (18%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ-----SFYSNGAISI 145
           HK TG+  A+K I+   +     +  +E+KI +  +   ++  +      SF +   + I
Sbjct: 32  HKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91
Query: 146 ILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           I E M      D  + + T  + ++++     Q L+ +  LH   ++IHRDLKPSNLLIN
Sbjct: 92  IQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH-GSNVIHRDLKPSNLLIN 146
Query: 204 HRGEVKITDFGVSAIM-------ASTSGQAN---TFVGTYNYMSPE-RISGGKYGYKSDI 252
              ++K+ DFG++ I+       +  +GQ +    FV T  Y +PE  ++  KY    D+
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDV 206
Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP------------------- 293
           WS G +L E     F   P      +     L+  I+  P                    
Sbjct: 207 WSCGCILAEL----FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKS 262
Query: 294 ----PSAPSDQF----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 339
               P+AP ++     +P+    +   +  +P +R++A+E + HP+L+ Y D N
Sbjct: 263 LPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 48  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 107
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 108 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 164
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 165 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 224
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 225 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 273

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 88/176 (50%), Gaps = 10/176 (5%)
Query: 101 KVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           KV    + E A  +    +E ++      P +V  Y        I ++ E+M+ G L+D+
Sbjct: 33  KVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 92
Query: 159 LKKVKTI-PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 217
           L+  + +   E L  +C  V +G+ YL  E  +IHRDL   N L+     +K++DFG++ 
Sbjct: 93  LRTQRGLFAAETLLGMCLDVCEGMAYLE-EASVIHRDLAARNCLVGENQVIKVSDFGMTR 151
Query: 218 IMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 269
            +      ++T  GT     + SPE  S  +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 152 FVLDDQYTSST--GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY 205

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 109/232 (46%), Gaps = 34/232 (14%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLA 171
           QI ++LK ++  Q  Y VV  +  Y      I+ EYM+ GSL DFLK  + + +    L 
Sbjct: 56  QIMKKLKHDKLVQL-YAVVSEEPIY------IVTEYMNKGSLLDFLKDGEGRALKLPNLV 108
Query: 172 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANT 228
            +  QV  G+ Y+    +I HRDL+ +N+L+ +    KI DFG++ ++     T+ Q   
Sbjct: 109 DMAAQVAAGMAYIERMNYI-HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAK 167
Query: 229 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFP----------------YSP 271
           F     + +PE    G++  KSD+WS G++L E  T G+ P                Y  
Sbjct: 168 F--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM 225
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS--FISACVQKEPQQRL 321
           P  QD   S +ELM     + P   P+ ++   F    F +   Q +P + L
Sbjct: 226 PCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPGENL 277

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 123/259 (47%), Gaps = 33/259 (12%)
Query: 96  QFFALKVIQMNVEE-------SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           Q +A+K +  N+EE       S R +IA   K+ Q S    ++  Y    ++  I +++E
Sbjct: 81  QIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME 136
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
                 L  +LKK K+I      +  + +L+ +  +H +  I+H DLKP+N LI   G +
Sbjct: 137 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIVD-GML 193
Query: 209 KITDFGVSAIMA--STSGQANTFVGTYNYMSPERISGGKYGYKS-----------DIWSL 255
           K+ DFG++  M   +TS   ++ VG  NYM PE I       ++           D+WSL
Sbjct: 194 KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 315
           G +L     G+ P+     Q         + AI+D        D    +    +  C+++
Sbjct: 254 GCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 307
Query: 316 EPQQRLSAQELMTHPFLKM 334
           +P+QR+S  EL+ HP++++
Sbjct: 308 DPKQRISIPELLAHPYVQI 326

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 95/184 (51%), Gaps = 11/184 (5%)
Query: 92  KWTGQF-FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 150
           KW GQ+  A+K+I+      +  +  +E K+  +     +V  Y        I II EYM
Sbjct: 29  KWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 86
Query: 151 DGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 209
             G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L+N +G VK
Sbjct: 87  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVK 145
Query: 210 ITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATG 265
           ++DFG+S  +     TS + + F     +  PE +   K+  KSDIW+ G+++ E  + G
Sbjct: 146 VSDFGLSRYVLDDEYTSSRGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 203
Query: 266 QFPY 269
           + PY
Sbjct: 204 KMPY 207

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHH 186
           P +V  Y        I ++ E+M+ G L+D+L+  + +   E L  +C  V +G+ YL  
Sbjct: 60  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE- 118
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMSPERISG 243
           E  +IHRDL   N L+     +K++DFG++  +      ++T  GT     + SPE  S 
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSF 176
Query: 244 GKYGYKSDIWSLGLVLLEC-ATGQFPY 269
            +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPY 203

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 97  FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 156
             A+K ++    ESAR+   +E ++    Q  ++V  +        + ++ EYM  G L 
Sbjct: 50  LVAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 108
Query: 157 DFLK------KVKTIPEEY---------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
            FL+      K+    E+          L A+  QV  G++YL    H +HRDL   N L
Sbjct: 109 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCL 167
Query: 202 INHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL 259
           +     VKI DFG+S  + ST         +    +M PE I   K+  +SD+WS G+VL
Sbjct: 168 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 227
Query: 260 LECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 315
            E  T G+ P+   S  E  D  T   EL      + P + P     PE  + +  C Q+
Sbjct: 228 WEIFTYGKQPWYQLSNTEAIDCITQGREL------ERPRACP-----PEVYAIMRGCWQR 276
Query: 316 EPQQRLSAQEL 326
           EPQQR S +++
Sbjct: 277 EPQQRHSIKDV 287

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 119/266 (44%), Gaps = 33/266 (12%)
Query: 93  WTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 150
           W G+  A+K+     E+S  R+  +   + +   +   ++     S +S+  + +I  Y 
Sbjct: 58  WQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 117
Query: 151 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKPSNLLIN 203
           + GSL D+L+ + T+       I   +  GL +LH E         I HRDLK  N+L+ 
Sbjct: 118 EMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 176
Query: 204 HRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPE------RISGGKYGYKSDIW 253
             G+  I D G++ + + ++ Q     N  VGT  YM+PE      ++       + DIW
Sbjct: 177 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIW 236
Query: 254 SLGLVLLECATGQFP------YSPP--EQQDGWTSFYELMEAI-VDQPPPSAPSDQFS-P 303
           + GLVL E A           Y PP  +      SF ++ + + VDQ  P+ P+  FS P
Sbjct: 237 AFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDP 296
Query: 304 EFCS---FISACVQKEPQQRLSAQEL 326
              S    +  C  + P  RL+A  +
Sbjct: 297 TLTSLAKLMKECWYQNPSARLTALRI 322

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 106/237 (44%), Gaps = 18/237 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 193
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           + ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 ARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHH 186
           P +V  Y        I ++ E+M+ G L+D+L+  + +   E L  +C  V +G+ YL  
Sbjct: 62  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE- 120
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMSPERISG 243
           E  +IHRDL   N L+     +K++DFG++  +      ++T  GT     + SPE  S 
Sbjct: 121 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSF 178
Query: 244 GKYGYKSDIWSLGLVLLEC-ATGQFPY 269
            +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 179 SRYSSKSDVWSFGVLMWEVFSEGKIPY 205

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 97  FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 156
             A+K ++    ESAR+   +E ++    Q  ++V  +        + ++ EYM  G L 
Sbjct: 73  LVAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 131
Query: 157 DFLK------KVKTIPEEY---------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
            FL+      K+    E+          L A+  QV  G++YL    H +HRDL   N L
Sbjct: 132 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCL 190
Query: 202 INHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL 259
           +     VKI DFG+S  + ST         +    +M PE I   K+  +SD+WS G+VL
Sbjct: 191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 250
Query: 260 LECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 315
            E  T G+ P+   S  E  D  T   EL      + P + P     PE  + +  C Q+
Sbjct: 251 WEIFTYGKQPWYQLSNTEAIDCITQGREL------ERPRACP-----PEVYAIMRGCWQR 299
Query: 316 EPQQRLSAQEL 326
           EPQQR S +++
Sbjct: 300 EPQQRHSIKDV 310

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHH 186
           P +V  Y        I ++ E+M+ G L+D+L+  + +   E L  +C  V +G+ YL  
Sbjct: 65  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE- 123
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMSPERISG 243
           E  +IHRDL   N L+     +K++DFG++  +      ++T  GT     + SPE  S 
Sbjct: 124 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSF 181
Query: 244 GKYGYKSDIWSLGLVLLEC-ATGQFPY 269
            +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 182 SRYSSKSDVWSFGVLMWEVFSEGKIPY 208

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/251 (29%), Positives = 114/251 (45%), Gaps = 34/251 (13%)
Query: 97  FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 156
             A+K ++    ESAR+   +E ++    Q  ++V  +        + ++ EYM  G L 
Sbjct: 44  LVAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 102
Query: 157 DFLK------KVKTIPEEY---------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
            FL+      K+    E+          L A+  QV  G++YL    H +HRDL   N L
Sbjct: 103 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA-GLHFVHRDLATRNCL 161
Query: 202 INHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL 259
           +     VKI DFG+S  + ST         +    +M PE I   K+  +SD+WS G+VL
Sbjct: 162 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVL 221
Query: 260 LECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 315
            E  T G+ P+   S  E  D  T   EL      + P + P     PE  + +  C Q+
Sbjct: 222 WEIFTYGKQPWYQLSNTEAIDCITQGREL------ERPRACP-----PEVYAIMRGCWQR 270
Query: 316 EPQQRLSAQEL 326
           EPQQR S +++
Sbjct: 271 EPQQRHSIKDV 281

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 97  LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 155
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 156 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+  G   F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 214 EEIIGGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
Query: 333 K 333
           +
Sbjct: 259 Q 259

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 118/263 (44%), Gaps = 33/263 (12%)
Query: 93  WTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 150
           W G+  A+K+     E+S  R+  +   + +   +   ++     S +S+  + +I  Y 
Sbjct: 29  WQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88
Query: 151 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKPSNLLIN 203
           + GSL D+L+ + T+       I   +  GL +LH E         I HRDLK  N+L+ 
Sbjct: 89  EMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 147
Query: 204 HRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPE------RISGGKYGYKSDIW 253
             G+  I D G++ + + ++ Q     N  VGT  YM+PE      ++       + DIW
Sbjct: 148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIW 207
Query: 254 SLGLVLLECATGQFP------YSPP--EQQDGWTSFYELMEAI-VDQPPPSAPSDQFS-P 303
           + GLVL E A           Y PP  +      SF ++ + + VDQ  P+ P+  FS P
Sbjct: 208 AFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDP 267
Query: 304 EFCS---FISACVQKEPQQRLSA 323
              S    +  C  + P  RL+A
Sbjct: 268 TLTSLAKLMKECWYQNPSARLTA 290

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 118/263 (44%), Gaps = 33/263 (12%)
Query: 93  WTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 150
           W G+  A+K+     E+S  R+  +   + +   +   ++     S +S+  + +I  Y 
Sbjct: 29  WQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYH 88
Query: 151 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKPSNLLIN 203
           + GSL D+L+ + T+       I   +  GL +LH E         I HRDLK  N+L+ 
Sbjct: 89  EMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK 147
Query: 204 HRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPE------RISGGKYGYKSDIW 253
             G+  I D G++ + + ++ Q     N  VGT  YM+PE      ++       + DIW
Sbjct: 148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIW 207
Query: 254 SLGLVLLECATGQFP------YSPP--EQQDGWTSFYELMEAI-VDQPPPSAPSDQFS-P 303
           + GLVL E A           Y PP  +      SF ++ + + VDQ  P+ P+  FS P
Sbjct: 208 AFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDP 267
Query: 304 EFCS---FISACVQKEPQQRLSA 323
              S    +  C  + P  RL+A
Sbjct: 268 TLTSLAKLMKECWYQNPSARLTA 290

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 187
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 188 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+  G   F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 246 EEIIGGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290
Query: 333 K 333
           +
Sbjct: 291 Q 291

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHH 186
           P +V  Y        I ++ E+M+ G L+D+L+  + +   E L  +C  V +G+ YL  
Sbjct: 82  PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE- 140
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMSPERISG 243
           E  +IHRDL   N L+     +K++DFG++  +      ++T  GT     + SPE  S 
Sbjct: 141 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSF 198
Query: 244 GKYGYKSDIWSLGLVLLEC-ATGQFPY 269
            +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 199 SRYSSKSDVWSFGVLMWEVFSEGKIPY 225

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 187
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 188 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+  G   F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 246 EEIIGGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290
Query: 333 K 333
           +
Sbjct: 291 Q 291

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 188
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 189 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+  G   F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 247 EEIIGGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291
Query: 333 K 333
           +
Sbjct: 292 Q 292

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 188
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 189 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+  G   F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 247 EEIIGGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291
Query: 333 K 333
           +
Sbjct: 292 Q 292

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 188
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 189 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+  G   F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 247 EEIIGGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291
Query: 333 K 333
           +
Sbjct: 292 Q 292

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 187
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 188 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+  G   F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 246 EEIIGGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 290
Query: 333 K 333
           +
Sbjct: 291 Q 291

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 18/237 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           L+K     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 193
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
             ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 130 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 188
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 189 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 246
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+  G   F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 247 EEIIGGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291
Query: 333 K 333
           +
Sbjct: 292 Q 292

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 29/201 (14%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--LAAICEQVLKGLLYLHH 186
           Y VV  +  Y      II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++  
Sbjct: 70  YAVVTQEPIY------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 122
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISG 243
           E++ IHR+L+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ 
Sbjct: 123 ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF--PIKWTAPEAINY 180
Query: 244 GKYGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSD 299
           G +  KSD+WS G++L E  T G+ PY   + PE        Y ++       P + P  
Sbjct: 181 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR------PDNCPE- 233
Query: 300 QFSPEFCSFISACVQKEPQQR 320
               E    +  C ++ P+ R
Sbjct: 234 ----ELYQLMRLCWKERPEDR 250

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 132/294 (44%), Gaps = 54/294 (18%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ-----SFYSNGAISI 145
           HK TG+  A+K I+   +     +  +E+KI +  +   ++  +      SF +   + I
Sbjct: 32  HKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91
Query: 146 ILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           I E M      D  + + T  + ++++     Q L+ +  LH   ++IHRDLKPSNLLIN
Sbjct: 92  IQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH-GSNVIHRDLKPSNLLIN 146
Query: 204 HRGEVKITDFGVSAIM-------ASTSGQAN---TFVGTYNYMSPE-RISGGKYGYKSDI 252
              ++K+ DFG++ I+       +  +GQ +    +V T  Y +PE  ++  KY    D+
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDV 206
Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP------------------- 293
           WS G +L E     F   P      +     L+  I+  P                    
Sbjct: 207 WSCGCILAEL----FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKS 262
Query: 294 ----PSAPSDQF----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 339
               P+AP ++     +P+    +   +  +P +R++A+E + HP+L+ Y D N
Sbjct: 263 LPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 11/184 (5%)
Query: 92  KWTGQF-FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 150
           KW GQ+  A+K+I+      +  +  +E K+  +     +V  Y        I II EYM
Sbjct: 44  KWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101
Query: 151 DGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 209
             G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L+N +G VK
Sbjct: 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVK 160
Query: 210 ITDFGVSAIM---ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATG 265
           ++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G+++ E  + G
Sbjct: 161 VSDFGLSRYVLDDEETSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 218
Query: 266 QFPY 269
           + PY
Sbjct: 219 KMPY 222

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 40/251 (15%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K+++ N   S  R +  E  + +    P+V+  Y +   +G + +I+EY   GSL  F
Sbjct: 57  AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116
Query: 159 LKKVKTI------------------PEEY------LAAICEQVLKGLLYLHHEKHIIHRD 194
           L++ + +                  P+E       L +   Q+ +G+ YL  E  ++HRD
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMKLVHRD 175
Query: 195 LKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDI 252
           L   N+L+    ++KI+DFG+S  +           G     +M+ E +    Y  +SD+
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 253 WSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           WS G++L E  T G  PY   PPE+       + L++       P    D  S E    +
Sbjct: 236 WSFGVLLWEIVTLGGNPYPGIPPER------LFNLLKTGHRMERP----DNCSEEMYRLM 285
Query: 310 SACVQKEPQQR 320
             C ++EP +R
Sbjct: 286 LQCWKQEPDKR 296

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEEYLAAICEQVLKGLLYLHH 186
           P +V  Y        I ++ E+M+ G L+D+L+  + +   E L  +C  V +G+ YL  
Sbjct: 63  PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE- 121
Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMSPERISG 243
           E  +IHRDL   N L+     +K++DFG++  +      ++T  GT     + SPE  S 
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWASPEVFSF 179
Query: 244 GKYGYKSDIWSLGLVLLEC-ATGQFPY 269
            +Y  KSD+WS G+++ E  + G+ PY
Sbjct: 180 SRYSSKSDVWSFGVLMWEVFSEGKIPY 206

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 121/259 (46%), Gaps = 33/259 (12%)
Query: 96  QFFALKVIQMNVEE-------SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           Q +A+K +  N+EE       S R +IA   K+ Q S    ++  Y    ++  I +++E
Sbjct: 53  QIYAIKYV--NLEEADNQTLDSYRNEIAYLNKLQQHSD--KIIRLYDYEITDQYIYMVME 108
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
                 L  +LKK K+I      +  + +L+ +  +H +  I+H DLKP+N LI   G +
Sbjct: 109 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH-QHGIVHSDLKPANFLIV-DGML 165
Query: 209 KITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKYGYKS-----------DIWSL 255
           K+ DFG++  M         ++ VGT NYM PE I       ++           D+WSL
Sbjct: 166 KLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 225
Query: 256 GLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQK 315
           G +L     G+ P+     Q         + AI+D        D    +    +  C+++
Sbjct: 226 GCILYYMTYGKTPFQQIINQ------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKR 279
Query: 316 EPQQRLSAQELMTHPFLKM 334
           +P+QR+S  EL+ HP++++
Sbjct: 280 DPKQRISIPELLAHPYVQI 298

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 130 VVVCYQSFYSNGAISIILEYMDG-GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
           V+     F    +  +ILE M+    L DF+ +   + EE   +   QVL+ + + H+  
Sbjct: 75  VIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 134
Query: 189 HIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY- 246
            ++HRD+K  N+LI+ +RGE+K+ DFG  A++  T      F GT  Y  PE I   +Y 
Sbjct: 135 -VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYH 191
Query: 247 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 306
           G  + +WSLG++L +   G  P+   E+      F+                 + S E  
Sbjct: 192 GRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---------------QRVSSECQ 236
Query: 307 SFISACVQKEPQQRLSAQELMTHPFLK 333
             I  C+   P  R + +E+  HP+++
Sbjct: 237 HLIRWCLALRPSDRPTFEEIQNHPWMQ 263

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 44/231 (19%)
Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + +++E MD    A+  + +   +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 102 VYLVMELMD----ANLCQVIHMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 156
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  AST+     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 157 VKSDCTLKILDFGL-ARTASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 215
Query: 262 CATGQFPYSPPEQQDGW--------TSFYELMEAIVDQPP--------PSAPSDQFSPEF 305
              G   +   +  D W        T   E M A+  QP         P+ P   F   F
Sbjct: 216 LVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAAL--QPTVRNYVENRPAYPGIAFEELF 273
Query: 306 CSFI-------------------SACVQKEPQQRLSAQELMTHPFLKMYGD 337
             +I                   S  +  +P +R+S  E + HP++ ++ D
Sbjct: 274 PDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 324

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 11/184 (5%)
Query: 92  KWTGQF-FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 150
           KW GQ+  A+K+I+      +  +  +E K+  +     +V  Y        I II EYM
Sbjct: 24  KWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81
Query: 151 DGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 209
             G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L+N +G VK
Sbjct: 82  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVK 140
Query: 210 ITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATG 265
           ++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G+++ E  + G
Sbjct: 141 VSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 198
Query: 266 QFPY 269
           + PY
Sbjct: 199 KMPY 202

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 40/251 (15%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K+++ N   S  R +  E  + +    P+V+  Y +   +G + +I+EY   GSL  F
Sbjct: 57  AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116
Query: 159 LKKVKTI------------------PEEY------LAAICEQVLKGLLYLHHEKHIIHRD 194
           L++ + +                  P+E       L +   Q+ +G+ YL  E  ++HRD
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMSLVHRD 175
Query: 195 LKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDI 252
           L   N+L+    ++KI+DFG+S  +           G     +M+ E +    Y  +SD+
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 253 WSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           WS G++L E  T G  PY   PPE+       + L++       P    D  S E    +
Sbjct: 236 WSFGVLLWEIVTLGGNPYPGIPPER------LFNLLKTGHRMERP----DNCSEEMYRLM 285
Query: 310 SACVQKEPQQR 320
             C ++EP +R
Sbjct: 286 LQCWKQEPDKR 296

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 11/184 (5%)
Query: 92  KWTGQF-FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 150
           KW GQ+  A+K+I+      +  +  +E K+  +     +V  Y        I II EYM
Sbjct: 44  KWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101
Query: 151 DGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 209
             G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L+N +G VK
Sbjct: 102 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVK 160
Query: 210 ITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATG 265
           ++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G+++ E  + G
Sbjct: 161 VSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 218
Query: 266 QFPY 269
           + PY
Sbjct: 219 KMPY 222

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 11/184 (5%)
Query: 92  KWTGQF-FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 150
           KW GQ+  A+K+I+      +  +  +E K+  +     +V  Y        I II EYM
Sbjct: 28  KWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 85
Query: 151 DGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 209
             G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L+N +G VK
Sbjct: 86  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVK 144
Query: 210 ITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATG 265
           ++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G+++ E  + G
Sbjct: 145 VSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 202
Query: 266 QFPY 269
           + PY
Sbjct: 203 KMPY 206

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           ++ I+ EYM+   LA+ L++   + EE+      Q+L+GL Y+H   +++HRDLKP+NL 
Sbjct: 96  SVYIVQEYMET-DLANVLEQGPLL-EEHARLFMYQLLRGLKYIH-SANVLHRDLKPANLF 152
Query: 202 INHRGEV-KITDFGVSAIMA---STSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLG 256
           IN    V KI DFG++ IM    S  G  +  + T  Y SP   +S   Y    D+W+ G
Sbjct: 153 INTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 212
Query: 257 LVLLECATGQFPYS---------------PPEQQDGWTSFYELMEAIV--DQPPPSAPSD 299
            +  E  TG+  ++               P   ++       ++   +  D   P  P  
Sbjct: 213 CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLT 272
Query: 300 QFSP----EFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
           Q  P    E   F+   +   P  RL+A+E ++HP++ +Y
Sbjct: 273 QLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 112/251 (44%), Gaps = 40/251 (15%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K+++ N   S  R +  E  + +    P+V+  Y +   +G + +I+EY   GSL  F
Sbjct: 57  AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116
Query: 159 LKKVKTI------------------PEEY------LAAICEQVLKGLLYLHHEKHIIHRD 194
           L++ + +                  P+E       L +   Q+ +G+ YL  E  ++HRD
Sbjct: 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL-AEMKLVHRD 175
Query: 195 LKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDI 252
           L   N+L+    ++KI+DFG+S  +           G     +M+ E +    Y  +SD+
Sbjct: 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDV 235
Query: 253 WSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           WS G++L E  T G  PY   PPE+       + L++       P    D  S E    +
Sbjct: 236 WSFGVLLWEIVTLGGNPYPGIPPER------LFNLLKTGHRMERP----DNCSEEMYRLM 285
Query: 310 SACVQKEPQQR 320
             C ++EP +R
Sbjct: 286 LQCWKQEPDKR 296

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM+ GSL DFLK    K   +P+  
Sbjct: 62  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMNKGSLLDFLKGETGKYLRLPQ-- 112
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 113 LVDMSAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQG 171
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 172 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 225
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 320
           E     P PP  P           +  C +KEP++R
Sbjct: 226 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEER 256

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV      S   I I+ EYM  GSL DFLK    K   +P+  
Sbjct: 55  QVMKKLRHEKLVQL-YAVV------SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQ-- 105
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 106 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG 164
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 165 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 218
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 320
           E     P PP  P           +  C +KEP++R
Sbjct: 219 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEER 249

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 11/184 (5%)
Query: 92  KWTGQF-FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 150
           KW GQ+  A+K+I+      +  +  +E K+  +     +V  Y        I II EYM
Sbjct: 35  KWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 92
Query: 151 DGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 209
             G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L+N +G VK
Sbjct: 93  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVK 151
Query: 210 ITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATG 265
           ++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G+++ E  + G
Sbjct: 152 VSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 209
Query: 266 QFPY 269
           + PY
Sbjct: 210 KMPY 213

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 94/184 (51%), Gaps = 11/184 (5%)
Query: 92  KWTGQF-FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 150
           KW GQ+  A+K+I+      +  +  +E K+  +     +V  Y        I II EYM
Sbjct: 29  KWRGQYDVAIKMIKEG--SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 86
Query: 151 DGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVK 209
             G L ++L++++     + L  +C+ V + + YL   K  +HRDL   N L+N +G VK
Sbjct: 87  ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVK 145
Query: 210 ITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATG 265
           ++DFG+S  +     TS   + F     +  PE +   K+  KSDIW+ G+++ E  + G
Sbjct: 146 VSDFGLSRYVLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 203
Query: 266 QFPY 269
           + PY
Sbjct: 204 KMPY 207

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 97/183 (53%), Gaps = 24/183 (13%)
Query: 95  GQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGA-IS 144
           G+F ALK +++   E     S  R++A  L+  ++ + P VV    VC  S       ++
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95
Query: 145 IILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           ++ E++D   L  +L KV    +P E +  +  Q+L+GL +LH  + ++HRDLKP N+L+
Sbjct: 96  LVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILV 153
Query: 203 NHRGEVKITDFGVSAI----MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 258
              G++K+ DFG++ I    MA TS      V T  Y +PE +    Y    D+WS+G +
Sbjct: 154 TSSGQIKLADFGLARIYSFQMALTS-----VVVTLWYRAPEVLLQSSYATPVDLWSVGCI 208
Query: 259 LLE 261
             E
Sbjct: 209 FAE 211

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 14/176 (7%)
Query: 143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLVGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G+++ E 
Sbjct: 160 KSDATLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEM 218
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 318
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM+ GSL DFLK    K   +P+  
Sbjct: 62  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMNKGSLLDFLKGETGKYLRLPQ-- 112
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 113 LVDMSAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 171
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 172 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 225
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 320
           E     P PP  P           +  C +KEP++R
Sbjct: 226 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEER 256

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 32/231 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 231 QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGETGKYLRLPQ-- 281
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 282 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 341 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 394
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
           E     P PP  P           +  C +KEP++R + + L    FL+ Y
Sbjct: 395 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEERPTFEYL--QAFLEDY 438

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 117/257 (45%), Gaps = 44/257 (17%)
Query: 97  FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 156
             A+K ++ +  ++AR+   +E ++  + Q  ++V  Y        + ++ EYM  G L 
Sbjct: 45  LVAVKTLK-DASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 103
Query: 157 DFLKKVKTIPEEYLAA---------------ICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
            FL+     P+  L A               I +Q+  G++YL   +H +HRDL   N L
Sbjct: 104 KFLRAHG--PDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA-SQHFVHRDLATRNCL 160
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTY-----NYMSPERISGGKYGYKSDIWSLG 256
           +     VKI DFG+S  + ST       VG +      +M PE I   K+  +SD+WSLG
Sbjct: 161 VGENLLVKIGDFGMSRDVYSTDYYR---VGGHTMLPIRWMPPESIMYRKFTTESDVWSLG 217
Query: 257 LVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI----VDQPPPSAPSDQFSPEFCSFISA 311
           +VL E  T G+ P+          S  E++E I    V Q P + P + +       +  
Sbjct: 218 VVLWEIFTYGKQPWYQ-------LSNNEVIECITQGRVLQRPRTCPQEVY-----ELMLG 265
Query: 312 CVQKEPQQRLSAQELMT 328
           C Q+EP  R + + + T
Sbjct: 266 CWQREPHMRKNIKGIHT 282

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 115/259 (44%), Gaps = 33/259 (12%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 146
           +K T + FALK +Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 83  NKRTQEKFALKXLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 137
Query: 147 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
            E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 138 XECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLH-SINIAHRDVKPENLLYTS 196
Query: 205 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +K+TDFG +    S +         Y Y++PE +   KY    D WSLG++   
Sbjct: 197 KRPNAILKLTDFGFAKETTSHNSLTTPCYTPY-YVAPEVLGPEKYDKSCDXWSLGVIXYI 255
Query: 262 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 256 LLCGYPPFYSNHGLAISPGXKTRIRXGQYEF---------PNPEWSEVSEEVKXLIRNLL 306
Query: 314 QKEPQQRLSAQELMTHPFL 332
           + EP QR +  E   HP++
Sbjct: 307 KTEPTQRXTITEFXNHPWI 325

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 14/176 (7%)
Query: 143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLVGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G+++ E 
Sbjct: 160 KSDATLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEM 218
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 318
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 127/273 (46%), Gaps = 42/273 (15%)
Query: 95  GQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGA-IS 144
           G+F ALK +++   E     S  R++A  L+  ++ + P VV    VC  S       ++
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95
Query: 145 IILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           ++ E++D   L  +L KV    +P E +  +  Q+L+GL +LH  + ++HRDLKP N+L+
Sbjct: 96  LVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILV 153
Query: 203 NHRGEVKITDFGVSAI----MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 258
              G++K+ DFG++ I    MA TS      V T  Y +PE +    Y    D+WS+G +
Sbjct: 154 TSSGQIKLADFGLARIYSFQMALTS-----VVVTLWYRAPEVLLQSSYATPVDLWSVGCI 208
Query: 259 LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--------------SAPSDQFSPE 304
             E    +  +      D      +++    ++  P              + P ++F  +
Sbjct: 209 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 268
Query: 305 F----CSFISACVQKEPQQRLSAQELMTHPFLK 333
                   +  C+   P +R+SA   ++HP+ +
Sbjct: 269 IDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 32/231 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 314 QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGETGKYLRLPQ-- 364
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 365 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 424 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 477
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
           E     P PP  P           +  C +KEP++R + + L    FL+ Y
Sbjct: 478 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEERPTFEYLQA--FLEDY 521

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 58  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGETGKYLRLPQ-- 108
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 109 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 167
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 168 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 221
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 320
           E     P PP  P           +  C +KEP++R
Sbjct: 222 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEER 252

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 52  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 106
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 107 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 165
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 166 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 32/231 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 231 QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGETGKYLRLPQ-- 281
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 282 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 341 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 394
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
           E     P PP  P           +  C +KEP++R + + L    FL+ Y
Sbjct: 395 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEERPTFEYL--QAFLEDY 438

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 49  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 103
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 104 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 162
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 163 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 49  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGX 103
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 104 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 162
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 163 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 221

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/265 (26%), Positives = 117/265 (44%), Gaps = 26/265 (9%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
            G+ +A+K+I+     S  R   +   + Q      ++   + F  +    ++ E + GG
Sbjct: 37  NGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGG 96
Query: 154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKI 210
           S+   ++K K   E   + +   V   L +L H K I HRDLKP N+L     +   VKI
Sbjct: 97  SILAHIQKQKHFNEREASRVVRDVAAALDFL-HTKGIAHRDLKPENILCESPEKVSPVKI 155
Query: 211 TDFGVSAIMA-------STSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLV 258
            DF + + M         T+ +  T  G+  YM+PE +         Y  + D+WSLG+V
Sbjct: 156 CDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVV 215
Query: 259 LLECATGQFPYSPPEQQD-GW-------TSFYELMEAIVDQPP--PSAPSDQFSPEFCSF 308
           L    +G  P+      D GW           +L E+I +     P       S E    
Sbjct: 216 LYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDL 275
Query: 309 ISACVQKEPQQRLSAQELMTHPFLK 333
           IS  + ++ +QRLSA +++ HP+++
Sbjct: 276 ISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 50  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 104
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 105 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 164 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 51  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 105
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 106 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 164
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 97/183 (53%), Gaps = 24/183 (13%)
Query: 95  GQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVV----VCYQSFYSN-GAIS 144
           G+F ALK +++   E     S  R++A  L+  ++ + P VV    VC  S       ++
Sbjct: 37  GRFVALKRVRVQTGEEGMPLSTIREVAV-LRHLETFEHPNVVRLFDVCTVSRTDRETKLT 95
Query: 145 IILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           ++ E++D   L  +L KV    +P E +  +  Q+L+GL +LH  + ++HRDLKP N+L+
Sbjct: 96  LVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR-VVHRDLKPQNILV 153
Query: 203 NHRGEVKITDFGVSAI----MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 258
              G++K+ DFG++ I    MA TS      V T  Y +PE +    Y    D+WS+G +
Sbjct: 154 TSSGQIKLADFGLARIYSFQMALTS-----VVVTLWYRAPEVLLQSSYATPVDLWSVGCI 208
Query: 259 LLE 261
             E
Sbjct: 209 FAE 211

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 131/294 (44%), Gaps = 54/294 (18%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ-----SFYSNGAISI 145
           HK TG+  A+K I+   +     +  +E+KI +  +   ++  +      SF +   + I
Sbjct: 32  HKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYI 91
Query: 146 ILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           I E M      D  + + T  + ++++     Q L+ +  LH   ++IHRDLKPSNLLIN
Sbjct: 92  IQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH-GSNVIHRDLKPSNLLIN 146
Query: 204 HRGEVKITDFGVSAIM-------ASTSGQANTF---VGTYNYMSPE-RISGGKYGYKSDI 252
              ++K+ DFG++ I+       +  +GQ +     V T  Y +PE  ++  KY    D+
Sbjct: 147 SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDV 206
Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP------------------- 293
           WS G +L E     F   P      +     L+  I+  P                    
Sbjct: 207 WSCGCILAEL----FLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKS 262
Query: 294 ----PSAPSDQF----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 339
               P+AP ++     +P+    +   +  +P +R++A+E + HP+L+ Y D N
Sbjct: 263 LPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 102
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 88/185 (47%), Gaps = 10/185 (5%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +++   E  RR    E  I      P ++        +  + I+ EYM+ GSL  F
Sbjct: 54  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTF 113
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           LKK     T+ +  L  +   +  G+ YL    + +HRDL   N+LIN     K++DFG+
Sbjct: 114 LKKNDGQFTVIQ--LVGMLRGISAGMKYLSDMGY-VHRDLAARNILINSNLVCKVSDFGL 170
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           S ++      A T  G      + +PE I+  K+   SD+WS G+V+ E  + G+ PY  
Sbjct: 171 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWE 230
Query: 272 PEQQD 276
              QD
Sbjct: 231 MTNQD 235

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 92/179 (51%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 55  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 109
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 110 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 168
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 169 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 18/237 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +++   E  RR    E  I      P ++        +  + I+ E M+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 136
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           L+K     T+ +  L  +   +  G+ YL  +   +HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLS-DMGAVHRDLAARNILINSNLVCKVSDFGL 193
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 18/237 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +++   E  RR    E  I      P ++        +  + I+ E M+ GSL  F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 136
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           L+K     T+ +  L  +   +  G+ YL    ++ HRDL   N+LIN     K++DFG+
Sbjct: 137 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGL 193
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 194 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 254 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 302

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV  +  Y      I++EYM  GSL DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVIEYMSKGSLLDFLKGEMGKYLRLPQ-- 115
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG 174
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 320
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 102/230 (44%), Gaps = 42/230 (18%)
Query: 143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           + +++E MD  +L   +     +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYLVMELMDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
                +KI DFG+ A  A T+     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGL-ARTACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGEL 218
Query: 263 ATGQFPYSPPEQQDGW--------TSFYELMEAIVDQPP--------PSAPSDQFSPEFC 306
             G   +   +  D W        T   E M A+  QP         P  P  +F   F 
Sbjct: 219 VKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAAL--QPTVRNYVENRPKYPGIKFEELFP 276
Query: 307 SFI-------------------SACVQKEPQQRLSAQELMTHPFLKMYGD 337
            +I                   S  +  +P +R+S  E + HP++ ++ D
Sbjct: 277 DWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 326

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 30/216 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV  +  Y      I++EYM  GSL DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVIEYMSKGSLLDFLKGEMGKYLRLPQ-- 115
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 320
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 212
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNXG-VLHRDIKDENILIDLNRGELKLID 154
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 271
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 155 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 213 DEEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPW 257
Query: 332 LK 333
           ++
Sbjct: 258 MQ 259

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/267 (28%), Positives = 117/267 (43%), Gaps = 39/267 (14%)
Query: 92  KWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 149
           KW G+  A+KV     E S  R+  I Q + +   +   ++    +   S   + +I +Y
Sbjct: 57  KWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116
Query: 150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKPSNLLI 202
            + GSL D+LK   T+  + +  +    + GL +LH E         I HRDLK  N+L+
Sbjct: 117 HENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175
Query: 203 NHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERI--SGGKYGYKS----DI 252
              G   I D G++    S + +     NT VGT  YM PE +  S  +  ++S    D+
Sbjct: 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 235
Query: 253 WSLGLVLLE----CATG------QFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAP--- 297
           +S GL+L E    C +G      Q PY      D     YE M  IV   +  PS P   
Sbjct: 236 YSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD---PSYEDMREIVCIKKLRPSFPNRW 292
Query: 298 -SDQFSPEFCSFISACVQKEPQQRLSA 323
            SD+   +    ++ C    P  RL+A
Sbjct: 293 SSDECLRQMGKLMTECWAHNPASRLTA 319

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 53/161 (32%), Positives = 85/161 (52%), Gaps = 13/161 (8%)
Query: 117 QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAA 172
           +E  + ++ Q   +V  Y        I II EYM  GSL DFLK  +     +P+  L  
Sbjct: 57  EEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPK--LID 114
Query: 173 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTF 229
              Q+ +G+ Y+   K+ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F
Sbjct: 115 FSAQIAEGMAYIER-KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF 173
Query: 230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
                + +PE I+ G +  KSD+WS G++L E  T G+ PY
Sbjct: 174 --PIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIPY 212

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 21/223 (9%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY-MDGGSLADFLKKVKTIPEEYLAA 172
           ++A   K+      P V+     F +     ++LE  +    L D++ +   + E     
Sbjct: 84  EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143
Query: 173 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVG 231
              QV+  + + H  + ++HRD+K  N+LI+  RG  K+ DFG  A++         F G
Sbjct: 144 FFGQVVAAIQHCH-SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP--YTDFDG 200
Query: 232 TYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 290
           T  Y  PE IS  +Y    + +WSLG++L +   G  P+    ++D      E++EA + 
Sbjct: 201 TRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPF----ERD-----QEILEAELH 251
Query: 291 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
            P         SP+ C+ I  C+  +P  R S +E++  P+++
Sbjct: 252 FP------AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 106/234 (45%), Gaps = 24/234 (10%)
Query: 100 LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           LK   M VEE  +   + +E+K     Q   V      FY      II+E+M  G+L D+
Sbjct: 44  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IIIEFMTYGNLLDY 97
Query: 159 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 216
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 98  LRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 156
Query: 217 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PP 272
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY    P
Sbjct: 157 RLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDP 216
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
            Q       YEL+E       P    ++        + AC Q  P  R S  E+
Sbjct: 217 SQ------VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDRPSFAEI 260

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 18/237 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +++   E  RR    E  I      P ++        +  + I+ E M+ GSL  F
Sbjct: 48  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 107
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           L+K     T+ +  L  +   +  G+ YL    ++ HRDL   N+LIN     K++DFG+
Sbjct: 108 LRKHDAQFTVIQ--LVGMLRGIASGMKYLSDMGYV-HRDLAARNILINSNLVCKVSDFGL 164
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           S ++      A T  G      + SPE I+  K+   SD+WS G+VL E  + G+ PY  
Sbjct: 165 SRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWE 224
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
              QD       + E     PP   P+  +       +  C QK+   R   +++++
Sbjct: 225 MSNQD---VIKAVDEGYRLPPPMDCPAALY-----QLMLDCWQKDRNNRPKFEQIVS 273

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 124/297 (41%), Gaps = 34/297 (11%)
Query: 57  PPLIKPSDNQLNLEDIDTXXXXXXXXXXXXQLVQHKWTGQFFALKVIQMNVEESARRQ-- 114
           P +++  + +L  +D +              +V+ K TGQ +A+K+  MN  +  +R   
Sbjct: 48  PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKI--MNKWDMLKRGEV 105
Query: 115 --IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLA 171
               +E  +  +    ++   + +F     + +++EY  GG L   L K  + IP E   
Sbjct: 106 SCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR 165
Query: 172 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF-- 229
               +++  +  +H   ++ HRD+KP N+L++  G +++ DFG S +     G   +   
Sbjct: 166 FYLAEIVMAIDSVHRLGYV-HRDIKPDNILLDRCGHIRLADFG-SCLKLRADGTVRSLVA 223
Query: 230 VGTYNYMSPERISGGKYGY-------KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 282
           VGT +Y+SPE +     G        + D W+LG+   E   GQ P+      + +    
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283
Query: 283 ELME----AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQELMTHPFL 332
              E     +VD+  P    D      C          P+ RL    A +  THPF 
Sbjct: 284 HYKEHLSLPLVDEGVPEEARDFIQRLLCP---------PETRLGRGGAGDFRTHPFF 331

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 110/231 (47%), Gaps = 32/231 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 231 QVMKKLRHEKLVQL-YAVVSEEPIY------IVGEYMSKGSLLDFLKGETGKYLRLPQ-- 281
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 282 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 341 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 394
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
           E     P PP  P           +  C +KEP++R + + L    FL+ Y
Sbjct: 395 ERGYRMPCPPECPES-----LHDLMCQCWRKEPEERPTFEYL--QAFLEDY 438

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 41/205 (20%)
Query: 98  FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------------ISI 145
           +A+K I++   E AR ++ +E+K     + P +V  + ++                 + I
Sbjct: 33  YAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYI 92
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICE----QVLKGLLYLHHEKHIIHRDLKPSNLL 201
            ++     +L D++    TI EE   ++C     Q+ + + +LH  K ++HRDLKPSN+ 
Sbjct: 93  QMQLCRKENLKDWMNGRCTI-EERERSVCLHIFLQIAEAVEFLH-SKGLMHRDLKPSNIF 150
Query: 202 INHRGEVKITDFGVSAIM----------------ASTSGQANTFVGTYNYMSPERISGGK 245
                 VK+ DFG+   M                A  +GQ    VGT  YMSPE+I G  
Sbjct: 151 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQ----VGTKLYMSPEQIHGNS 206
Query: 246 YGYKSDIWSLGLVLLECATGQFPYS 270
           Y +K DI+SLGL+L E     +P+S
Sbjct: 207 YSHKVDIFSLGLILFELL---YPFS 228

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 14/176 (7%)
Query: 143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLVGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDATLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 318
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 127/278 (45%), Gaps = 46/278 (16%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS--------- 144
           +G+ +ALK +  N EE  R  I +   + + S  P +V     F S  +I          
Sbjct: 52  SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV----QFCSAASIGKEESDTGQA 107
Query: 145 --IILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPS 198
             ++L  +  G L +FLKK+++   +  + +  I  Q  + + ++H +K  IIHRDLK  
Sbjct: 108 EFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVE 167
Query: 199 NLLINHRGEVKITDFGVSAIMA-----STSGQANTFV-------GTYNYMSPERI---SG 243
           NLL++++G +K+ DFG +  ++     S S Q    V        T  Y +PE I   S 
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227
Query: 244 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP 303
              G K DIW+LG +L      Q P+     +DG          IV+      P D    
Sbjct: 228 FPIGEKQDIWALGCILYLLCFRQHPF-----EDGAKL------RIVNGKYSIPPHDTQYT 276
Query: 304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 341
            F S I A +Q  P++RLS  E++ H   ++    NV+
Sbjct: 277 VFHSLIRAMLQVNPEERLSIAEVV-HQLQEIAAARNVN 313

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 106/232 (45%), Gaps = 20/232 (8%)
Query: 100 LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           LK   M VEE  +   + +E+K     Q   V      FY      II+E+M  G+L D+
Sbjct: 47  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IIIEFMTYGNLLDY 100
Query: 159 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 216
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 101 LRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 159
Query: 217 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 274
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY   + 
Sbjct: 160 RLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 219
Query: 275 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
               +  YEL+E       P    ++        + AC Q  P  R S  E+
Sbjct: 220 ----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDRPSFAEI 263

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  K + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVKXQK-LTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 XELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 91/187 (48%), Gaps = 15/187 (8%)
Query: 145 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           II+E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 262 CAT-GQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQ 319
            AT G  PY   +     +  YEL+E     + P   P   +       + AC Q  P  
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSD 255
Query: 320 RLSAQEL 326
           R S  E+
Sbjct: 256 RPSFAEI 262

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 73  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 127
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 128 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 186
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 187 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 245

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 102 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 160
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 161 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 218
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 219 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263
Query: 333 K 333
           +
Sbjct: 264 Q 264

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 50  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 104
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 105 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G + ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 164 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 97/199 (48%), Gaps = 23/199 (11%)
Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEK 188
           +V   +  +   I II E+M  GSL DFLK  +    P   L     Q+ +G+ ++  ++
Sbjct: 72  LVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QR 130
Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGK 245
           + IHRDL+ +N+L++     KI DFG++ ++     T+ +   F     + +PE I+ G 
Sbjct: 131 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGS 188
Query: 246 YGYKSDIWSLGLVLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 301
           +  KSD+WS G++L+E  T G+ PY   S PE        Y +        P + P    
Sbjct: 189 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR------PENCPE--- 239
Query: 302 SPEFCSFISACVQKEPQQR 320
             E  + +  C +  P++R
Sbjct: 240 --ELYNIMMRCWKNRPEER 256

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 110/243 (45%), Gaps = 42/243 (17%)
Query: 110 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK-------- 161
           +AR+   +E ++  + Q  ++V  Y        + ++ EYM  G L  FL+         
Sbjct: 59  AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 118
Query: 162 VKTIPEEY--------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           V   P +         +  I  Q+  G++YL   +H +HRDL   N L+     VKI DF
Sbjct: 119 VDGQPRQAKGELGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVGANLLVKIGDF 177
Query: 214 GVSAIMASTSGQANTFVGTY-----NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQF 267
           G+S  + ST       VG +      +M PE I   K+  +SD+WS G++L E  T G+ 
Sbjct: 178 GMSRDVYSTD---YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 268 PYSPPEQQDGWTSFYELMEAI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
           P+          S  E++E I    V + P   P + +       +  C Q+EPQQRL+ 
Sbjct: 235 PWFQ-------LSNTEVIECITQGRVLERPRVCPKEVY-----DVMLGCWQREPQQRLNI 282
Query: 324 QEL 326
           +E+
Sbjct: 283 KEI 285

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 97  LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 155
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 156 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 214 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
Query: 333 K 333
           +
Sbjct: 259 Q 259

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 50  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 104
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 105 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G + ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 164 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 87/182 (47%), Gaps = 20/182 (10%)
Query: 154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 212
            L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ D
Sbjct: 99  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLID 157
Query: 213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSP 271
           FG  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+  
Sbjct: 158 FGSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 215
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
            E+      F+                 + S E    I  C+   P  R + +E+  HP+
Sbjct: 216 DEEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 260
Query: 332 LK 333
           ++
Sbjct: 261 MQ 262

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 144 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 202
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 203 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 260
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 261 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305
Query: 333 K 333
           +
Sbjct: 306 Q 306

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 13/186 (6%)
Query: 145 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           II+E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 262 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 256
Query: 321 LSAQEL 326
            S  E+
Sbjct: 257 PSFAEI 262

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I++ M  G 
Sbjct: 52  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLIMQLMPFGC 106
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 107 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 165
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G + ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 166 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 224

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 50  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 104
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 105 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 164 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 129 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 187
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 188 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 246 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290
Query: 333 K 333
           +
Sbjct: 291 Q 291

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   FV T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 58  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 112
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 113 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 171
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 172 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 230

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 101 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 159
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 160 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 217
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 218 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 262
Query: 333 K 333
           +
Sbjct: 263 Q 263

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 102 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 160
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 161 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 218
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 219 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263
Query: 333 K 333
           +
Sbjct: 264 Q 264

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 51  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 105
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 106 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 164
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV      S   I I+ EYM  GSL DFLK    K   +P+  
Sbjct: 56  QVMKKLRHEKLVQL-YAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 106
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 107 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 165
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 166 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 219
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 320
           E     P PP  P           +  C +K+P++R
Sbjct: 220 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 250

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 105/234 (44%), Gaps = 24/234 (10%)
Query: 100 LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D+
Sbjct: 44  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 97
Query: 159 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 216
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 98  LRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 156
Query: 217 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PP 272
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY    P
Sbjct: 157 RLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDP 216
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
            Q       YEL+E       P    ++        + AC Q  P  R S  E+
Sbjct: 217 SQ------VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDRPSFAEI 260

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   FV T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 115
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 320
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 102
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 51  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 105
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 106 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 164
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 102 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 160
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 161 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 218
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 219 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263
Query: 333 K 333
           +
Sbjct: 264 Q 264

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGX 102
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 90/186 (48%), Gaps = 13/186 (6%)
Query: 145 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           II+E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 91  IIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 149
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 150 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 209
Query: 262 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 210 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 261
Query: 321 LSAQEL 326
            S  E+
Sbjct: 262 PSFAEI 267

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 51  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 105
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 106 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 164
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 165 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 223

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 54  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 108
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 109 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 167
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 168 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 226

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 27/248 (10%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++ K TG   A+K +++ V         +EL        P +V  Y +      ++I +E
Sbjct: 91  MKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 144
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-E 207
            ++GGSL   +K++  +PE+       Q L+GL YL H + I+H D+K  N+L++  G  
Sbjct: 145 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL-HTRRILHGDVKADNVLLSSDGSR 203
Query: 208 VKITDFGVSAIMASTSGQANTFV------GTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
             + DFG  A+     G   + +      GT  +M+PE + G     K DIWS   ++L 
Sbjct: 204 AALCDFG-HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 262
Query: 262 CATGQFPYSPPEQQDGWTSFYE---LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 318
              G  P         WT ++     ++   + PP        +P     I   ++KEP 
Sbjct: 263 MLNGCHP---------WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPV 313
Query: 319 QRLSAQEL 326
            R SA EL
Sbjct: 314 HRASAMEL 321

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 102
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 27/248 (10%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++ K TG   A+K +++ V         +EL        P +V  Y +      ++I +E
Sbjct: 77  MKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-E 207
            ++GGSL   +K++  +PE+       Q L+GL YL H + I+H D+K  N+L++  G  
Sbjct: 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL-HTRRILHGDVKADNVLLSSDGSR 189
Query: 208 VKITDFGVSAIMASTSGQANTFV------GTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
             + DFG  A+     G   + +      GT  +M+PE + G     K DIWS   ++L 
Sbjct: 190 AALCDFG-HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 248
Query: 262 CATGQFPYSPPEQQDGWTSFYE---LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 318
              G  P         WT ++     ++   + PP        +P     I   ++KEP 
Sbjct: 249 MLNGCHP---------WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPV 299
Query: 319 QRLSAQEL 326
            R SA EL
Sbjct: 300 HRASAMEL 307

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  K + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVKXQK-LTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 91/182 (50%), Gaps = 18/182 (9%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMD 151
           TG   A+K +Q +  +  +R   +E++I ++    ++V      Y  G  ++ +++EY+ 
Sbjct: 38  TGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 96
Query: 152 GGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 210
            G L DFL++ +  +    L     Q+ KG+ YL   +  +HRDL   N+L+     VKI
Sbjct: 97  SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKI 155
Query: 211 TDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
            DFG++ ++            GQ+  F     + +PE +S   +  +SD+WS G+VL E 
Sbjct: 156 ADFGLAKLLPLDKDYYVVREPGQSPIF-----WYAPESLSDNIFSRQSDVWSFGVVLYEL 210
Query: 263 AT 264
            T
Sbjct: 211 FT 212

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/248 (27%), Positives = 110/248 (44%), Gaps = 27/248 (10%)
Query: 89  VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++ K TG   A+K +++ V         +EL        P +V  Y +      ++I +E
Sbjct: 93  MKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFME 146
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-E 207
            ++GGSL   +K++  +PE+       Q L+GL YL H + I+H D+K  N+L++  G  
Sbjct: 147 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYL-HTRRILHGDVKADNVLLSSDGSR 205
Query: 208 VKITDFGVSAIMASTSGQANTFV------GTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
             + DFG  A+     G   + +      GT  +M+PE + G     K DIWS   ++L 
Sbjct: 206 AALCDFG-HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 264
Query: 262 CATGQFPYSPPEQQDGWTSFYE---LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 318
              G  P         WT ++     ++   + PP        +P     I   ++KEP 
Sbjct: 265 MLNGCHP---------WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPV 315
Query: 319 QRLSAQEL 326
            R SA EL
Sbjct: 316 HRASAMEL 323

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV      S   I I+ EYM  GSL DFLK    K   +P+  
Sbjct: 54  QVMKKLRHEKLVQL-YAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 104
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 105 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 163
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 164 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 217
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 320
           E     P PP  P           +  C +K+P++R
Sbjct: 218 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 248

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 144 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 202
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 203 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 260
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 261 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305
Query: 333 K 333
           +
Sbjct: 306 Q 306

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 144 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 202
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 203 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 260
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 261 EEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 305
Query: 333 K 333
           +
Sbjct: 306 Q 306

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 14/176 (7%)
Query: 143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDATLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 318
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 106 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 163
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 164 SELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 221 GRTLFP 226

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 110 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 167
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 168 SELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 225 GRTLFP 230

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 74/126 (58%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 111 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 168
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T+ +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 169 CELKILDFGLA---RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 226 GRTLFP 231

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 55  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 109
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 110 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 168
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 169 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 42  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 96
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 97  LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 155
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 156 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 214

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  K + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVKSQK-LTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG+      T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 SELKILDFGLC---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 55  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 109
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 110 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 168
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 169 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 74/126 (58%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 111 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 168
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T+ +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 169 CELKILDFGLA---RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 226 GRTLFP 231

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 116 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 174
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 175 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 232
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 233 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 277
Query: 333 K 333
           +
Sbjct: 278 Q 278

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 117 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 175
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 176 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 234 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 278
Query: 333 K 333
           +
Sbjct: 279 Q 279

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 124 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 182
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 183 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 240
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 241 EEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 285
Query: 333 K 333
           +
Sbjct: 286 Q 286

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 91/182 (50%), Gaps = 18/182 (9%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMD 151
           TG   A+K +Q +  +  +R   +E++I ++    ++V      Y  G  ++ +++EY+ 
Sbjct: 39  TGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 97
Query: 152 GGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 210
            G L DFL++ +  +    L     Q+ KG+ YL   +  +HRDL   N+L+     VKI
Sbjct: 98  SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKI 156
Query: 211 TDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
            DFG++ ++            GQ+  F     + +PE +S   +  +SD+WS G+VL E 
Sbjct: 157 ADFGLAKLLPLDKDYYVVREPGQSPIF-----WYAPESLSDNIFSRQSDVWSFGVVLYEL 211
Query: 263 AT 264
            T
Sbjct: 212 FT 213

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV      S   I I+ EYM  GSL DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVV------SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQ-- 115
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 320
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 100 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 157
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   FV T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 158 CELKILDFGLA---RHTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 215 GRTLFP 220

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 116 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 174
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 175 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 232
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 233 EEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 277
Query: 333 K 333
           +
Sbjct: 278 Q 278

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 74/126 (58%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 111 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 168
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T+ +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 169 CELKILDFGLA---RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 226 GRTLFP 231

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/231 (28%), Positives = 109/231 (47%), Gaps = 32/231 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 232 QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 282
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG+  ++     T+ Q 
Sbjct: 283 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQG 341
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 342 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 395
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
           E     P PP  P           +  C +K+P++R + + L    FL+ Y
Sbjct: 396 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEERPTFEYL--QAFLEDY 439

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 117 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 175
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 176 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 234 EEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 278
Query: 333 K 333
           +
Sbjct: 279 Q 279

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 91/182 (50%), Gaps = 18/182 (9%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMD 151
           TG   A+K +Q +  +  +R   +E++I ++    ++V      Y  G  ++ +++EY+ 
Sbjct: 51  TGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLP 109
Query: 152 GGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 210
            G L DFL++ +  +    L     Q+ KG+ YL   +  +HRDL   N+L+     VKI
Sbjct: 110 SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKI 168
Query: 211 TDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
            DFG++ ++            GQ+  F     + +PE +S   +  +SD+WS G+VL E 
Sbjct: 169 ADFGLAKLLPLDKDYYVVREPGQSPIF-----WYAPESLSDNIFSRQSDVWSFGVVLYEL 223
Query: 263 AT 264
            T
Sbjct: 224 FT 225

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 92/191 (48%), Gaps = 23/191 (12%)
Query: 139 SNGAISIILEYMDGGSLADFLK----KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 194
           S   I I+ EYM  GSL DFLK    K   +P+  L  +  Q+  G+ Y+    ++ HRD
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ--LVDMAAQIASGMAYVERMNYV-HRD 139
Query: 195 LKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           L+ +N+L+      K+ DFG++ ++     T+ Q   F     + +PE    G++  KSD
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFTIKSD 197
Query: 252 IWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSFI 309
           +WS G++L E  T G+ PY     ++      + +E     P PP  P           +
Sbjct: 198 VWSFGILLTELTTKGRVPYPGMVNRE----VLDQVERGYRMPCPPECPES-----LHDLM 248
Query: 310 SACVQKEPQQR 320
             C +K+P++R
Sbjct: 249 CQCWRKDPEER 259

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 14/176 (7%)
Query: 143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDATLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 318
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 136 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 194
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 195 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 253 EEIIRGQVFFR---------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297
Query: 333 K 333
           +
Sbjct: 298 Q 298

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 117 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 175
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 176 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 234 EEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWM 278
Query: 333 K 333
           +
Sbjct: 279 Q 279

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 20/181 (11%)
Query: 155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF 213
           L DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DF
Sbjct: 149 LFDFITERGALQEELARSFFWQVLEAVRHCHNCG-VLHRDIKDENILIDLNRGELKLIDF 207
Query: 214 GVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPP 272
           G  A++  T      F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   
Sbjct: 208 GSGALLKDTV--YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 265
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           E+      F+                 + S E    I  C+   P  R + +E+  HP++
Sbjct: 266 EEIIRGQVFFR---------------QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 310
Query: 333 K 333
           +
Sbjct: 311 Q 311

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/126 (35%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  K + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 100 LVTHLMGADLNNIVKCAK-LTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 157
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 158 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 215 GRTLFP 220

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 93/180 (51%), Gaps = 16/180 (8%)
Query: 94  TGQFFALKVIQM-NVEE----SARRQIAQELKINQSSQCPYVV----VCYQSFYSNG-AI 143
           +G F ALK +++ N EE    S  R++A  L+  ++ + P VV    VC  S       +
Sbjct: 28  SGHFVALKSVRVPNGEEGLPISTVREVAL-LRRLEAFEHPNVVRLMDVCATSRTDREIKV 86
Query: 144 SIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           +++ E++D   L  +L K     +P E +  +  Q L+GL +LH    I+HRDLKP N+L
Sbjct: 87  TLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENIL 144
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +   G VK+ DFG++ I +     A   V T  Y +PE +    Y    D+WS+G +  E
Sbjct: 145 VTSGGTVKLADFGLARIYSYQMALAPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAE 203

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 102
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV      S   I I++EYM  G L DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVV------SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQ-- 115
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 320
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 109 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 166
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 167 XELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 224 GRTLFP 229

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 109 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 166
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 167 XELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 224 GRTLFP 229

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 93/187 (49%), Gaps = 23/187 (12%)
Query: 143 ISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 200
           I II E+M  GSL DFLK  +    P   L     Q+ +G+ ++  +++ IHRDL+ +N+
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANI 315
Query: 201 LINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 257
           L++     KI DFG++ ++     T+ +   F     + +PE I+ G +  KSD+WS G+
Sbjct: 316 LVSASLVCKIADFGLARVIEDNEYTAREGAKF--PIKWTAPEAINFGSFTIKSDVWSFGI 373
Query: 258 VLLECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
           +L+E  T G+ PY   S PE        Y +        P + P      E  + +  C 
Sbjct: 374 LLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR------PENCPE-----ELYNIMMRCW 422
Query: 314 QKEPQQR 320
           +  P++R
Sbjct: 423 KNRPEER 429

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI--ILEYMD 151
           TG+  A+K ++ +     R    QE+ I ++    +++         GA S+  ++EY+ 
Sbjct: 59  TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP 118
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 211
            GSL D+L +  +I    L    +Q+ +G+ YLH  +H IHRDL   N+L+++   VKI 
Sbjct: 119 LGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLH-AQHYIHRDLAARNVLLDNDRLVKIG 176
Query: 212 DFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE-- 261
           DFG++  +            G +  F     + +PE +   K+ Y SD+WS G+ L E  
Sbjct: 177 DFGLAKAVPEGHEXYRVREDGDSPVF-----WYAPECLKEYKFYYASDVWSFGVTLYELL 231
Query: 262 --CATGQFPYSPPEQQDGWTSFYELM 285
             C + Q   SPP      T F EL+
Sbjct: 232 THCDSSQ---SPP------TKFLELI 248

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 111 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 168
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 169 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 226 GRTLFP 231

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 105/232 (45%), Gaps = 20/232 (8%)
Query: 100 LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D+
Sbjct: 51  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 104
Query: 159 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 216
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 105 LRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 163
Query: 217 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 274
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY   + 
Sbjct: 164 RLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 223
Query: 275 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
               +  YEL+E       P    ++        + AC Q  P  R S  E+
Sbjct: 224 ----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDRPSFAEI 267

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 90/182 (49%), Gaps = 18/182 (9%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA--ISIILEYMD 151
           TG   A+K +Q +  +  +R   +E++I ++    ++V      Y  G   + +++EY+ 
Sbjct: 35  TGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLP 93
Query: 152 GGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 210
            G L DFL++ +  +    L     Q+ KG+ YL   +  +HRDL   N+L+     VKI
Sbjct: 94  SGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG-SRRCVHRDLAARNILVESEAHVKI 152
Query: 211 TDFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
            DFG++ ++            GQ+  F     + +PE +S   +  +SD+WS G+VL E 
Sbjct: 153 ADFGLAKLLPLDKDXXVVREPGQSPIF-----WYAPESLSDNIFSRQSDVWSFGVVLYEL 207
Query: 263 AT 264
            T
Sbjct: 208 FT 209

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 94/187 (50%), Gaps = 18/187 (9%)
Query: 95  GQFFALKVIQMNVEES----ARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISII 146
           G+   + V  M + E+    A ++I  E  +  S   P+V     +C  S      + +I
Sbjct: 74  GEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLI 128
Query: 147 LEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            + M  G L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+   
Sbjct: 129 TQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTP 187
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECA 263
             VKITDFG++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  
Sbjct: 188 QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 247
Query: 264 T-GQFPY 269
           T G  PY
Sbjct: 248 TFGSKPY 254

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 109 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 166
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 167 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 224 GRTLFP 229

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 103 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 160
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 161 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 217
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 218 GRTLFP 223

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 115 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 172
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 173 XELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 230 GRTLFP 235

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/234 (29%), Positives = 105/234 (44%), Gaps = 24/234 (10%)
Query: 100 LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D+
Sbjct: 44  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 97
Query: 159 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 216
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 98  LRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 156
Query: 217 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PP 272
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY    P
Sbjct: 157 RLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDP 216
Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
            Q       YEL+E       P    ++        + AC Q  P  R S  E+
Sbjct: 217 SQ------VYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDRPSFAEI 260

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 90/187 (48%), Gaps = 15/187 (8%)
Query: 145 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 262 CAT-GQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQ 319
            AT G  PY   +     +  YEL+E     + P   P   +       + AC Q  P  
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSD 255
Query: 320 RLSAQEL 326
           R S  E+
Sbjct: 256 RPSFAEI 262

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 106/233 (45%), Gaps = 22/233 (9%)
Query: 100 LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D+
Sbjct: 51  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 104
Query: 159 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 216
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 105 LRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 163
Query: 217 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 274
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY   + 
Sbjct: 164 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 223
Query: 275 QDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
               +  YEL+E     + P   P   +       + AC Q  P  R S  E+
Sbjct: 224 ----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSDRPSFAEI 267

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 106 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 163
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 164 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 221 GRTLFP 226

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 85/163 (52%), Gaps = 9/163 (5%)
Query: 109 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-ISIILEYMDGGSLADFLKKVKTIPE 167
           E  ++Q  QE+K+    Q   +V     F S+G  + ++  YM  GSL D L  +   P 
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELL-GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 168 ---EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--ST 222
                   I +    G+ +LH E H IHRD+K +N+L++     KI+DFG++      + 
Sbjct: 130 LSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
           +   +  VGT  YM+PE +  G+   KSDI+S G+VLLE  TG
Sbjct: 189 TVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG 230

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 88/180 (48%), Gaps = 14/180 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K++       A  +   E  I  S   P++V    VC         I ++ + M  G 
Sbjct: 48  AIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-----TIQLVTQLMPHGC 102
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L +++ + K  I  + L   C Q+ KG++YL  E+ ++HRDL   N+L+     VKITDF
Sbjct: 103 LLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE-ERRLVHRDLAARNVLVKSPNHVKITDF 161
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS 270
           G++ ++     + N   G     +M+ E I   K+ ++SD+WS G+ + E  T G  PY 
Sbjct: 162 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 109 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 166
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 167 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 224 GRTLFP 229

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 117/248 (47%), Gaps = 17/248 (6%)
Query: 89  VQHKWTGQFFALK--VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII 146
           V+ K  G+ +A+K  +      +   R++A+     +  Q P  V   Q++   G + + 
Sbjct: 76  VRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135
Query: 147 LEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
            E + G SL    +    ++PE  +       L  L +LH +  ++H D+KP+N+ +  R
Sbjct: 136 TE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG-LVHLDVKPANIFLGPR 193
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
           G  K+ DFG+  +   T+G      G   YM+PE +  G YG  +D++SLGL +LE A  
Sbjct: 194 GRCKLGDFGL-LVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACN 251
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
                 P   +GW    +L +  +   PP   +   S E  S +   ++ +P+ R +A+ 
Sbjct: 252 ---MELPHGGEGWQ---QLRQGYL---PPEFTAG-LSSELRSVLVMMLEPDPKLRATAEA 301
Query: 326 LMTHPFLK 333
           L+  P L+
Sbjct: 302 LLALPVLR 309

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 114 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 171
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 172 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 228
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 229 GRTLFP 234

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 110 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 167
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 168 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 225 GRTLFP 230

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 106 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 163
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 164 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 221 GRTLFP 226

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 110 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 167
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 168 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 225 GRTLFP 230

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 106 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 163
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 164 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 221 GRTLFP 226

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 145 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 262 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 256
Query: 321 LSAQEL 326
            S  E+
Sbjct: 257 PSFAEI 262

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 116 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 173
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 174 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 231 GRTLFP 236

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 100 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 157
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 158 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 215 GRTLFP 220

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 110 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 167
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 168 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 225 GRTLFP 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 116 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 173
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 174 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 231 GRTLFP 236

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 101 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 158
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 159 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 216 GRTLFP 221

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 116 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 173
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 174 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 231 GRTLFP 236

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/274 (23%), Positives = 124/274 (45%), Gaps = 31/274 (11%)
Query: 90  QHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVVVCYQSFYSNGAISIILE 148
           ++K TG+  A+K    + ++   ++IA +E+K+ +  +   +V   +         ++ E
Sbjct: 45  RNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104
Query: 149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           ++D   L D       +  + +     Q++ G+ + H   +IIHRD+KP N+L++  G V
Sbjct: 105 FVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH-SHNIIHRDIKPENILVSQSGVV 163
Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQF 267
           K+ DFG +  +A+     +  V T  Y +PE + G  KYG   D+W++G ++ E   G+ 
Sbjct: 164 KLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE- 222
Query: 268 PYSPPEQQDGWTSFYELM----------EAIVDQPPPSA-----------PSDQFSPEFC 306
           P  P +        Y +M          + + ++ P  A           P ++  P+  
Sbjct: 223 PLFPGDSD--IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLS 280
Query: 307 SFI----SACVQKEPQQRLSAQELMTHPFLKMYG 336
             +      C+  +P +R    EL+ H F +M G
Sbjct: 281 EVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 115 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 172
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 173 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 230 GRTLFP 235

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 101 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 158
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 159 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 216 GRTLFP 221

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 100 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 157
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 158 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 215 GRTLFP 220

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 102 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 159
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 160 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 216
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 217 GRTLFP 222

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 124 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 181
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 182 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 239 GRTLFP 244

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 106/233 (45%), Gaps = 22/233 (9%)
Query: 100 LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D+
Sbjct: 51  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 104
Query: 159 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 216
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 105 LRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 163
Query: 217 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 274
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY   + 
Sbjct: 164 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 223
Query: 275 QDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
               +  YEL+E     + P   P   +       + AC Q  P  R S  E+
Sbjct: 224 ----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSDRPSFAEI 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 145 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 262 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 256
Query: 321 LSAQEL 326
            S  E+
Sbjct: 257 PSFAEI 262

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 145 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 146
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 147 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 206
Query: 262 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 207 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 258
Query: 321 LSAQEL 326
            S  E+
Sbjct: 259 PSFAEI 264

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 115/259 (44%), Gaps = 54/259 (20%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV---CYQSFYS-NGAISII 146
           +K T + FALK++Q      ARR++    +   +SQCP++V     Y++ Y+    + I+
Sbjct: 39  NKRTQEKFALKMLQDC--PKARREVELHWR---ASQCPHIVRIVDVYENLYAGRKCLLIV 93
Query: 147 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +E +DGG L   ++    +   E   + I + + + + YLH   +I HRD+KP NLL   
Sbjct: 94  MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SINIAHRDVKPENLLYTS 152
Query: 205 R---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +K+TDFG +                      +  +G KY    D+WSLG+++  
Sbjct: 153 KRPNAILKLTDFGFA----------------------KETTGEKYDKSCDMWSLGVIMYI 190
Query: 262 CATGQFPY--------SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
              G  P+        SP  +       YE          P+    + S E    I   +
Sbjct: 191 LLCGYPPFYSNHGLAISPGMKTRIRMGQYEF---------PNPEWSEVSEEVKMLIRNLL 241
Query: 314 QKEPQQRLSAQELMTHPFL 332
           + EP QR++  E M HP++
Sbjct: 242 KTEPTQRMTITEFMNHPWI 260

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 127 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 184
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 185 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 242 GRTLFP 247

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 145 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 144
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 145 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 204
Query: 262 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 205 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 256
Query: 321 LSAQEL 326
            S  E+
Sbjct: 257 PSFAEI 262

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 123 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 180
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 181 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 238 GRTLFP 243

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 145 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 149
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 150 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 209
Query: 262 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 210 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 261
Query: 321 LSAQEL 326
            S  E+
Sbjct: 262 PSFAEI 267

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 145 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 99  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 157
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 158 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 217
Query: 262 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 218 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 269
Query: 321 LSAQEL 326
            S  E+
Sbjct: 270 PSFAEI 275

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 90/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 50  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 104
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 105 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 163
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G + ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 164 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 222

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 90/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 102
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 103 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 161
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G + ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 162 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 124 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 181
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 182 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 239 GRTLFP 244

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 123 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 180
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 181 CELKILDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 238 GRTLFP 243

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 145 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 90  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 148
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 149 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 208
Query: 262 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 209 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 260
Query: 321 LSAQEL 326
            S  E+
Sbjct: 261 PSFAEI 266

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 89/186 (47%), Gaps = 13/186 (6%)
Query: 145 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 146
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
                VK+ DFG+S +M   +  A+        + +PE ++  K+  KSD+W+ G++L E
Sbjct: 147 GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 206
Query: 262 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 207 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 258
Query: 321 LSAQEL 326
            S  E+
Sbjct: 259 PSFAEI 264

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 84/163 (51%), Gaps = 9/163 (5%)
Query: 109 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-ISIILEYMDGGSLADFLKKVKTIPE 167
           E  ++Q  QE+K+    Q   +V     F S+G  + ++  YM  GSL D L  +   P 
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELL-GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 168 ---EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--ST 222
                   I +    G+ +LH E H IHRD+K +N+L++     KI+DFG++      + 
Sbjct: 130 LSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 188
Query: 223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
           +      VGT  YM+PE +  G+   KSDI+S G+VLLE  TG
Sbjct: 189 TVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG 230

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 127 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 184
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 185 CELKILDFGLA---RHTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 242 GRTLFP 247

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 90/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 55  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 109
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 110 LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 168
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G + ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 169 GRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 227

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 88/179 (49%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K++       A  +   E  I  S   P++V    VC         I ++ + M  G 
Sbjct: 71  AIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-----TIQLVTQLMPHGC 125
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L +++ + K  I  + L   C Q+ KG++YL  E+ ++HRDL   N+L+     VKITDF
Sbjct: 126 LLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE-ERRLVHRDLAARNVLVKSPNHVKITDF 184
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++     + N   G     +M+ E I   K+ ++SD+WS G+ + E  T G  PY
Sbjct: 185 GLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 243

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV  +  Y      I+ EYM  GSL DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVVSEEPIY------IVTEYMSKGSLLDFLKGEMGKYLRLPQ-- 115
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL  +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 320
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 14/176 (7%)
Query: 143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           + I++E MD  +L+  ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYIVMELMDA-NLSQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 318
             G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/180 (32%), Positives = 93/180 (51%), Gaps = 16/180 (8%)
Query: 94  TGQFFALKVIQM-NVEE----SARRQIAQELKINQSSQCPYVV----VCYQSFYSNG-AI 143
           +G F ALK +++ N EE    S  R++A  L+  ++ + P VV    VC  S       +
Sbjct: 28  SGHFVALKSVRVPNGEEGLPISTVREVAL-LRRLEAFEHPNVVRLMDVCATSRTDREIKV 86
Query: 144 SIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           +++ E++D   L  +L K     +P E +  +  Q L+GL +LH    I+HRDLKP N+L
Sbjct: 87  TLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENIL 144
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +   G VK+ DFG++ I  S     +  V T  Y +PE +    Y    D+WS+G +  E
Sbjct: 145 VTSGGTVKLADFGLARIY-SYQMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE 203

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 91/179 (50%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+K ++      A ++I  E  +  S   P+V     +C  S      + +I + M  G 
Sbjct: 45  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGC 99
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D++++ K  I  +YL   C Q+ +G+ YL  ++ ++HRDL   N+L+     VKITDF
Sbjct: 100 LLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDF 158
Query: 214 GVSAIMASTSGQANTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++ +   + +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY
Sbjct: 159 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 217

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 85/177 (48%), Gaps = 16/177 (9%)
Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 262 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 318
              G   +   +  D W    E +           PS +F  +    +   V+  P+
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIEQL---------GTPSPEFMKKLQPTVRTYVENRPK 265

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/163 (34%), Positives = 83/163 (50%), Gaps = 9/163 (5%)
Query: 109 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-ISIILEYMDGGSLADFLKKVKTIPE 167
           E  ++Q  QE+K+    Q   +V     F S+G  + ++  YM  GSL D L  +   P 
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELL-GFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 123
Query: 168 ---EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 224
                   I +    G+ +LH E H IHRD+K +N+L++     KI+DFG++      + 
Sbjct: 124 LSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 182
Query: 225 QA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
                  VGT  YM+PE +  G+   KSDI+S G+VLLE  TG
Sbjct: 183 XVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG 224

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 106/236 (44%), Gaps = 18/236 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +++   E  RR    E  I      P VV           + I++E+M+ G+L  F
Sbjct: 75  AIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAF 134
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           L+K     T+ +  L  +   +  G+ YL    ++ HRDL   N+L+N     K++DFG+
Sbjct: 135 LRKHDGQFTVIQ--LVGMLRGIAAGMRYLADMGYV-HRDLAARNILVNSNLVCKVSDFGL 191
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           S ++        T  G      + +PE I   K+   SD+WS G+V+ E  + G+ PY  
Sbjct: 192 SRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD 251
Query: 272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
              QD       +++AI +     AP D         +  C QKE  +R   ++++
Sbjct: 252 MSNQD-------VIKAIEEGYRLPAPMD-CPAGLHQLMLDCWQKERAERPKFEQIV 299

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 30/216 (13%)
Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----KVKTIPEEY 169
           Q+ ++L+  +  Q  Y VV      S   I I+ EYM  G L DFLK    K   +P+  
Sbjct: 65  QVMKKLRHEKLVQL-YAVV------SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQ-- 115
Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQA 226
           L  +  Q+  G+ Y+    ++ HRDL+ +N+L+      K+ DFG++ ++     T+ Q 
Sbjct: 116 LVDMAAQIASGMAYVERMNYV-HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 174
Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
             F     + +PE    G++  KSD+WS G++L E  T G+ PY     ++      + +
Sbjct: 175 AKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQV 228
Query: 286 EAIVDQP-PPSAPSDQFSPEFCSFISACVQKEPQQR 320
           E     P PP  P           +  C +K+P++R
Sbjct: 229 ERGYRMPCPPECPES-----LHDLMCQCWRKDPEER 259

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 73/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI D+G++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDYGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 113 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 171
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 172 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 231
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        PEQ+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 232 LDQLNHILGILGSPEQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 291
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 292 LTFNPHKRIEVEQALAHPYLEQYYD 316

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 89/184 (48%), Gaps = 27/184 (14%)
Query: 143 ISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 200
           I II E+M  GSL DFLK  +    P   L     Q+ +G+ ++  +++ IHRDL+ +N+
Sbjct: 251 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE-QRNYIHRDLRAANI 309
Query: 201 LINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
           L++     KI DFG++ + A              + +PE I+ G +  KSD+WS G++L+
Sbjct: 310 LVSASLVCKIADFGLARVGAKFP---------IKWTAPEAINFGSFTIKSDVWSFGILLM 360
Query: 261 ECAT-GQFPY---SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE 316
           E  T G+ PY   S PE        Y +        P + P      E  + +  C +  
Sbjct: 361 EIVTYGRIPYPGMSNPEVIRALERGYRMPR------PENCPE-----ELYNIMMRCWKNR 409
Query: 317 PQQR 320
           P++R
Sbjct: 410 PEER 413

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/245 (28%), Positives = 111/245 (45%), Gaps = 25/245 (10%)
Query: 100 LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           LK   M VEE  +   + +E+K     Q   V      FY      I+ EYM  G+L D+
Sbjct: 65  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFY------IVTEYMPYGNLLDY 118
Query: 159 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 216
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 119 LRECNREEVTAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHVVKVADFGLS 177
Query: 217 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 274
            +M   +  A+        + +PE ++   +  KSD+W+ G++L E AT G  PY   + 
Sbjct: 178 RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 237
Query: 275 QDGWTSFYELME-AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH-PFL 332
               +  Y+L+E     + P   P     P+    + AC +  P  R S  E  TH  F 
Sbjct: 238 ----SQVYDLLEKGYRMEQPEGCP-----PKVYELMRACWKWSPADRPSFAE--THQAFE 286
Query: 333 KMYGD 337
            M+ D
Sbjct: 287 TMFHD 291

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K ++    +  RR    E  I      P ++           + II EYM+ GSL  F
Sbjct: 40  AIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAF 99
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           L+K     T+ +  L  +   +  G+ YL    ++ HRDL   N+L+N     K++DFG+
Sbjct: 100 LRKNDGRFTVIQ--LVGMLRGIGSGMKYLSDMSYV-HRDLAARNILVNSNLVCKVSDFGM 156
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           S ++      A T  G      + +PE I+  K+   SD+WS G+V+ E  + G+ PY  
Sbjct: 157 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 216
Query: 272 PEQQDGWTSFYELMEAIVDQPPP 294
              QD      + +E     PPP
Sbjct: 217 MSNQD----VIKAIEEGYRLPPP 235

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K ++    +  RR    E  I      P ++           + II EYM+ GSL  F
Sbjct: 61  AIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAF 120
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           L+K     T+ +  L  +   +  G+ YL  +   +HRDL   N+L+N     K++DFG+
Sbjct: 121 LRKNDGRFTVIQ--LVGMLRGIGSGMKYLS-DMSAVHRDLAARNILVNSNLVCKVSDFGM 177
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           S ++      A T  G      + +PE I+  K+   SD+WS G+V+ E  + G+ PY  
Sbjct: 178 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 237
Query: 272 PEQQDGWTSFYELMEAIVDQPPP 294
              QD      + +E     PPP
Sbjct: 238 MSNQD----VIKAIEEGYRLPPP 256

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 88/182 (48%), Gaps = 16/182 (8%)
Query: 145 IILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           II EYM+ G+L  FL+ K        L  +   +  G+ YL +  ++ HRDL   N+L+N
Sbjct: 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV-HRDLAARNILVN 181
Query: 204 HRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLL 260
                K++DFG+S ++        T  G      + +PE IS  K+   SD+WS G+V+ 
Sbjct: 182 SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 241
Query: 261 ECAT-GQFPYSPPEQQDGWT-SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQ 318
           E  T G+ PY        W  S +E+M+AI D      P D  S  +   +  C Q+E  
Sbjct: 242 EVMTYGERPY--------WELSNHEVMKAINDGFRLPTPMDCPSAIY-QLMMQCWQQERA 292
Query: 319 QR 320
           +R
Sbjct: 293 RR 294

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K ++    +  RR    E  I      P ++           + II EYM+ GSL  F
Sbjct: 46  AIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAF 105
Query: 159 LKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV 215
           L+K     T+ +  L  +   +  G+ YL    ++ HRDL   N+L+N     K++DFG+
Sbjct: 106 LRKNDGRFTVIQ--LVGMLRGIGSGMKYLSDMSYV-HRDLAARNILVNSNLVCKVSDFGM 162
Query: 216 SAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP 271
           S ++      A T  G      + +PE I+  K+   SD+WS G+V+ E  + G+ PY  
Sbjct: 163 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD 222
Query: 272 PEQQDGWTSFYELMEAIVDQPPP 294
              QD      + +E     PPP
Sbjct: 223 MSNQD----VIKAIEEGYRLPPP 241

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 13/161 (8%)
Query: 117 QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAA 172
           +E  + ++ Q   +V  Y        I II E+M  GSL DFLK  +     +P+  L  
Sbjct: 56  EEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPK--LID 113
Query: 173 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTF 229
              Q+ +G+ Y+   K+ IHRDL+ +N+L++     KI DFG++ ++     T+ +   F
Sbjct: 114 FSAQIAEGMAYIER-KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF 172
Query: 230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
                + +PE I+ G +  KS++WS G++L E  T G+ PY
Sbjct: 173 --PIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIPY 211

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 20/232 (8%)
Query: 100 LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D+
Sbjct: 48  LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 101
Query: 159 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 216
           L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S
Sbjct: 102 LRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLS 160
Query: 217 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 274
            +M   +  A         + +PE ++  K+  KSD+W+ G++L E AT G  PY   + 
Sbjct: 161 RLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 220
Query: 275 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
               +  YEL+E       P    ++        + AC Q  P  R S  E+
Sbjct: 221 ----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDRPSFAEI 264

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 35/260 (13%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 47  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 106
Query: 152 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 107 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 165
Query: 196 KPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKS 250
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL---PLKWMAPETIFDRVYTIQS 222
Query: 251 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 223 DVWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTM 275
Query: 310 SACVQKEPQQRLSAQELMTH 329
             C   EP QR +  EL+ H
Sbjct: 276 LDCWHGEPSQRPTFSELVEH 295

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 35/260 (13%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 56  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 152 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 174
Query: 196 KPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKS 250
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL---PLKWMAPETIFDRVYTIQS 231
Query: 251 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 232 DVWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTM 284
Query: 310 SACVQKEPQQRLSAQELMTH 329
             C   EP QR +  EL+ H
Sbjct: 285 LDCWHGEPSQRPTFSELVEH 304

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 106/233 (45%), Gaps = 22/233 (9%)
Query: 100 LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D+
Sbjct: 253 LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 306
Query: 159 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 216
           L++   + +    L  +  Q+   + YL  +K+ IHR+L   N L+     VK+ DFG+S
Sbjct: 307 LRECNRQEVSAVVLLYMATQISSAMEYLE-KKNFIHRNLAARNCLVGENHLVKVADFGLS 365
Query: 217 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 274
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY   + 
Sbjct: 366 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425
Query: 275 QDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
               +  YEL+E     + P   P   +       + AC Q  P  R S  E+
Sbjct: 426 ----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSDRPSFAEI 469

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 88/186 (47%), Gaps = 13/186 (6%)
Query: 145 IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           II E+M  G+L D+L++   + +    L  +  Q+   + YL  +K+ IHRDL   N L+
Sbjct: 87  IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRDLAARNCLV 145
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
                VK+ DFG+S +M   +  A         + +PE ++  K+  KSD+W+ G++L E
Sbjct: 146 GENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 205
Query: 262 CAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
            AT G  PY   +     +  YEL+E       P    ++        + AC Q  P  R
Sbjct: 206 IATYGMSPYPGIDL----SQVYELLEKDYRMERPEGCPEKVY----ELMRACWQWNPSDR 257
Query: 321 LSAQEL 326
            S  E+
Sbjct: 258 PSFAEI 263

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 29/210 (13%)
Query: 156 ADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           AD  K +KT  +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DF
Sbjct: 130 ADLYKLLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDF 188
Query: 214 GVSAIM---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--F 267
           G++ +       +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  F
Sbjct: 189 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF 248
Query: 268 P--------------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS---- 307
           P                 P Q+D       +    ++  P  +  P ++  P   S    
Sbjct: 249 PGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALD 308
Query: 308 FISACVQKEPQQRLSAQELMTHPFLKMYGD 337
            +   +   P +R+  ++ + HP+L+ Y D
Sbjct: 309 LLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +    V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFGLA---RHTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/182 (33%), Positives = 94/182 (51%), Gaps = 20/182 (10%)
Query: 94  TGQFFALKVIQM-NVEE----SARRQIAQELKINQSSQCPYVV----VCYQSFYSNG-AI 143
           +G F ALK +++ N EE    S  R++A  L+  ++ + P VV    VC  S       +
Sbjct: 28  SGHFVALKSVRVPNGEEGLPISTVREVAL-LRRLEAFEHPNVVRLMDVCATSRTDREIKV 86
Query: 144 SIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           +++ E++D   L  +L K     +P E +  +  Q L+GL +LH    I+HRDLKP N+L
Sbjct: 87  TLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPENIL 144
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTF--VGTYNYMSPERISGGKYGYKSDIWSLGLVL 259
           +   G VK+ DFG++ I    S Q   F  V T  Y +PE +    Y    D+WS+G + 
Sbjct: 145 VTSGGTVKLADFGLARIY---SYQMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 201
Query: 260 LE 261
            E
Sbjct: 202 AE 203

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 106 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 160
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS     FV T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 161 VKSDCTLKILDFGL-ARTAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 219
Query: 262 CATGQFPYSPPEQQDGWTSFYE 283
              G   +   +  D W    E
Sbjct: 220 MIKGGVLFPGTDHIDQWNKVIE 241

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/256 (28%), Positives = 119/256 (46%), Gaps = 28/256 (10%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAISI 145
           H+ TGQ  ALK++  +    AR+++       Q+S  P++V C    Y N       + I
Sbjct: 31  HRRTGQKCALKLLYDS--PKARQEVDHHW---QASGGPHIV-CILDVYENMHHGKRCLLI 84
Query: 146 ILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           I+E M+GG L   +++   +   E   A I   +   + +LH   +I HRD+KP NLL  
Sbjct: 85  IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH-SHNIAHRDVKPENLLYT 143
Query: 204 HRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
            + +   +K+TDFG +    +T     T   T  Y++PE +   KY    D+WSLG+++ 
Sbjct: 144 SKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 201
Query: 261 ECATGQFP--YSPPEQ--QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE 316
               G FP  YS   Q    G      L +     P  S    + S +    I   ++ +
Sbjct: 202 ILLCG-FPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS----EVSEDAKQLIRLLLKTD 256
Query: 317 PQQRLSAQELMTHPFL 332
           P +RL+  + M HP++
Sbjct: 257 PTERLTITQFMNHPWI 272

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           ++ E M GGS+   + K +   E   + + + V   L +LH+ K I HRDLKP N+L  H
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEH 146
Query: 205 RGE---VKITDFGVSAIMA-------STSGQANTFVGTYNYMSPERI-----SGGKYGYK 249
             +   VKI DFG+ + +         ++ +  T  G+  YM+PE +         Y  +
Sbjct: 147 PNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 250 SDIWSLGLVLLECATGQFPYSPPEQQD-GWT------SFYELMEAIVDQPPPSAPSDQFS 302
            D+WSLG++L    +G  P+      D GW       +   ++   + +     P   ++
Sbjct: 207 CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWA 266
Query: 303 PEFCS---FISACVQKEPQQRLSAQELMTHPFLK 333
              C+    IS  + ++ +QRLSA +++ HP+++
Sbjct: 267 HISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 117/255 (45%), Gaps = 26/255 (10%)
Query: 91  HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAISI 145
           H+ TGQ  ALK++  +    AR+++       Q+S  P++V C    Y N       + I
Sbjct: 50  HRRTGQKCALKLLYDS--PKARQEVDHHW---QASGGPHIV-CILDVYENMHHGKRCLLI 103
Query: 146 ILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           I+E M+GG L   +++   +   E   A I   +   + +LH   +I HRD+KP NLL  
Sbjct: 104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH-SHNIAHRDVKPENLLYT 162
Query: 204 HRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLL 260
            + +   +K+TDFG +    +T     T   T  Y++PE +   KY    D+WSLG+++ 
Sbjct: 163 SKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 220
Query: 261 ECATGQFPYSPPEQQD---GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEP 317
               G  P+     Q    G      L +     P  S    + S +    I   ++ +P
Sbjct: 221 ILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWS----EVSEDAKQLIRLLLKTDP 276
Query: 318 QQRLSAQELMTHPFL 332
            +RL+  + M HP++
Sbjct: 277 TERLTITQFMNHPWI 291

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 262 CATGQFPYSPPEQQDGWTSFYE 283
              G   +   +  D W    E
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 114/256 (44%), Gaps = 31/256 (12%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 56  TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 152 GGSLADFL--KKVKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN 199
            G+L+ +L  K+ + +P           E+L     QV KG+ +L   K  IHRDL   N
Sbjct: 116 FGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRK-XIHRDLAARN 174
Query: 200 LLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKSDIWS 254
           +L++ +  VKI DFG++  +         G A        +M+PE I    Y  +SD+WS
Sbjct: 175 ILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWS 231
Query: 255 LGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
            G++L E  + G  PY P  + D      E    + +     AP D  +PE    +  C 
Sbjct: 232 FGVLLWEIFSLGASPY-PGVKIDE-----EFXRRLKEGTRMRAP-DYTTPEMYQTMLDCW 284
Query: 314 QKEPQQRLSAQELMTH 329
             EP QR +  EL+ H
Sbjct: 285 HGEPSQRPTFSELVEH 300

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 29/206 (14%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLLIN   ++KI DFG++ I
Sbjct: 135 LLKSQQLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLINTTCDLKICDFGLARI 193
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G     V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 194 ADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 253
Query: 269 ----------YSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF-------CSFISA 311
                        P Q+D       +      Q  PS     ++  F          +  
Sbjct: 254 LDQLNHILGILGSPSQED-LNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDR 312
Query: 312 CVQKEPQQRLSAQELMTHPFLKMYGD 337
            +   P +R++ +E + HP+L+ Y D
Sbjct: 313 MLTFNPNKRITVEEALAHPYLEQYYD 338

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 35/260 (13%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 56  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 152 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 174
Query: 196 KPSNLLINHRGEVKITDFGVSAIM-----ASTSGQANTFVGTYNYMSPERISGGKYGYKS 250
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL---PLKWMAPETIFDRVYTIQS 231
Query: 251 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 232 DVWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTM 284
Query: 310 SACVQKEPQQRLSAQELMTH 329
             C   EP QR +  EL+ H
Sbjct: 285 LDCWHGEPSQRPTFSELVEH 304

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 111/241 (46%), Gaps = 23/241 (9%)
Query: 107 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE-YMDGGSLADFLKKVKTI 165
           +E+    ++  E+ I    +   ++     F + G   +++E +  G  L  F+ +   +
Sbjct: 68  IEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRL 127
Query: 166 PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 225
            E   + I  Q++  + YL   K IIHRD+K  N++I     +K+ DFG SA        
Sbjct: 128 DEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDFTIKLIDFG-SAAYLERGKL 185
Query: 226 ANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 284
             TF GT  Y +PE + G  Y G + ++WSLG+ L      + P+   E         E 
Sbjct: 186 FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE---------ET 236
Query: 285 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE 344
           +EA +       P    S E  S +S  +Q  P++R + ++L+T P++       V+L++
Sbjct: 237 VEAAIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ----PVNLAD 286
Query: 345 Y 345
           Y
Sbjct: 287 Y 287

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 105 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 159
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 160 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218
Query: 262 CATGQFPYSPPEQQDGWTSFYE 283
              G   +   +  D W    E
Sbjct: 219 MIKGGVLFPGTDHIDQWNKVIE 240

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/258 (28%), Positives = 113/258 (43%), Gaps = 33/258 (12%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 58  TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 117
Query: 152 GGSLADFLKK-----VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
            G+L+ +L+      V   PE         E+L     QV KG+ +L   K  IHRDL  
Sbjct: 118 FGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRK-XIHRDLAA 176
Query: 198 SNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
            N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +SD+
Sbjct: 177 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL---PLKWMAPETIFDRVYTIQSDV 233
Query: 253 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 311
           WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +  
Sbjct: 234 WSFGVLLWEIFSLGASPY-PGVKID-----EEFCRRLKEGTRMRAP-DYTTPEMYQTMLD 286
Query: 312 CVQKEPQQRLSAQELMTH 329
           C   EP QR +  EL+ H
Sbjct: 287 CWHGEPSQRPTFSELVEH 304

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 99/220 (45%), Gaps = 37/220 (16%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +++ +M G  L   +K  K + E+ +  +  Q+LKGL Y+H    IIHRDLKP NL +N 
Sbjct: 107 LVMPFM-GTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNE 163
Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECA 263
             E+KI DFG++        +    V T  Y +PE I +  +Y    DIWS+G ++ E  
Sbjct: 164 DCELKILDFGLA---RQADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220
Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPP-------------------PSAPSDQF--- 301
           TG+  +   +  D      E+M+ +   PP                   P      F   
Sbjct: 221 TGKTLFKGSDHLD---QLKEIMK-VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI 276
Query: 302 ----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
               SP   + +   +  + +QR++A E + HP+ +   D
Sbjct: 277 LTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 316

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 35/260 (13%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 56  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 152 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 116 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 174
Query: 196 KPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKS 250
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQS 231
Query: 251 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 232 DVWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTM 284
Query: 310 SACVQKEPQQRLSAQELMTH 329
             C   EP QR +  EL+ H
Sbjct: 285 LDCWHGEPSQRPTFSELVEH 304

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 113/259 (43%), Gaps = 34/259 (13%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 57  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 116
Query: 152 GGSLADFLKKVKT------IPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDLK 196
            G+L+ +L+  +        PE         E+L     QV KG+ +L   K  IHRDL 
Sbjct: 117 FGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDLA 175
Query: 197 PSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKSD 251
             N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +SD
Sbjct: 176 ARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL---PLKWMAPETIFDRVYTIQSD 232
Query: 252 IWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFIS 310
           +WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    + 
Sbjct: 233 VWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTML 285
Query: 311 ACVQKEPQQRLSAQELMTH 329
            C   EP QR +  EL+ H
Sbjct: 286 DCWHGEPSQRPTFSELVEH 304

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 106/233 (45%), Gaps = 22/233 (9%)
Query: 100 LKVIQMNVEESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           LK   M VEE  +   + +E+K     Q   V      FY      II E+M  G+L D+
Sbjct: 292 LKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY------IITEFMTYGNLLDY 345
Query: 159 LKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 216
           L++   + +    L  +  Q+   + YL  +K+ IHR+L   N L+     VK+ DFG+S
Sbjct: 346 LRECNRQEVNAVVLLYMATQISSAMEYLE-KKNFIHRNLAARNCLVGENHLVKVADFGLS 404
Query: 217 AIMASTSGQANTFVG-TYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 274
            +M   +  A+        + +PE ++  K+  KSD+W+ G++L E AT G  PY   + 
Sbjct: 405 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 464
Query: 275 QDGWTSFYELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
               +  YEL+E     + P   P   +       + AC Q  P  R S  E+
Sbjct: 465 ----SQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSDRPSFAEI 508

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 124 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 181
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DFG++     T  +    V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 182 CELKILDFGLA---RHTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 239 GRTLFP 244

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 35/260 (13%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 93  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 152
Query: 152 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 153 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 211
Query: 196 KPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKS 250
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQS 268
Query: 251 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 269 DVWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTM 321
Query: 310 SACVQKEPQQRLSAQELMTH 329
             C   EP QR +  EL+ H
Sbjct: 322 LDCWHGEPSQRPTFSELVEH 341

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/256 (27%), Positives = 112/256 (43%), Gaps = 31/256 (12%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 56  TXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 115
Query: 152 GGSLADFLKKVKT------------IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN 199
            G+L+ +L+  +             +  E+L     QV KG+ +L   K  IHRDL   N
Sbjct: 116 FGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRK-XIHRDLAARN 174
Query: 200 LLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKSDIWS 254
           +L++ +  VKI DFG++  +         G A        +M+PE I    Y  +SD+WS
Sbjct: 175 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQSDVWS 231
Query: 255 LGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACV 313
            G++L E  + G  PY P  + D      E    + +     AP D  +PE    +  C 
Sbjct: 232 FGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTMLDCW 284
Query: 314 QKEPQQRLSAQELMTH 329
             EP QR +  EL+ H
Sbjct: 285 HGEPSQRPTFSELVEH 300

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 112/260 (43%), Gaps = 35/260 (13%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I E+  
Sbjct: 47  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCK 106
Query: 152 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 107 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 165
Query: 196 KPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKS 250
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL---PLKWMAPETIFDRVYTIQS 222
Query: 251 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 223 DVWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTM 275
Query: 310 SACVQKEPQQRLSAQELMTH 329
             C   EP QR +  EL+ H
Sbjct: 276 LDCWHGEPSQRPTFSELVEH 295

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKIXDFGLARV 173
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 234 LDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 293
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 294 LTFNPHKRIEVEQALAHPYLEQYYD 318

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDFGLARV 173
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 234 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 293
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 294 LTFNPHKRIEVEQALAHPYLEQYYD 318

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMD 151
           TG+  A+K ++ +     R    QE+ I ++    +++         G  ++ +++EY+ 
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 211
            GSL D+L +  +I    L    +Q+ +G+ YLH  +H IHR+L   N+L+++   VKI 
Sbjct: 102 LGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLH-SQHYIHRNLAARNVLLDNDRLVKIG 159
Query: 212 DFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE-- 261
           DFG++  +            G +  F     + +PE +   K+ Y SD+WS G+ L E  
Sbjct: 160 DFGLAKAVPEGHEYYRVREDGDSPVF-----WYAPECLKEYKFYYASDVWSFGVTLYELL 214
Query: 262 --CATGQFPYSPPEQQDGWTSFYELM 285
             C + Q   SPP      T F EL+
Sbjct: 215 THCDSSQ---SPP------TKFLELI 231

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDFGLARV 173
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 234 LDQLNHILGILGSPSQEDLNXIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 293
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 294 LTFNPHKRIEVEQALAHPYLEQYYD 318

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 117 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 175
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 176 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 235
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 236 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 295
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 296 LTFNPHKRIEVEQALAHPYLEQYYD 320

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 123 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 181
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 182 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 241
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 242 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 301
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 302 LTFNPHKRIEVEQALAHPYLEQYYD 326

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 173
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 234 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 293
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 294 LTFNPHKRIEVEQALAHPYLEQYYD 318

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 35/260 (13%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I+E+  
Sbjct: 58  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCK 117
Query: 152 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 118 FGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 176
Query: 196 KPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKS 250
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 177 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQS 233
Query: 251 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 234 DVWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTM 286
Query: 310 SACVQKEPQQRLSAQELMTH 329
             C   EP QR +  EL+ H
Sbjct: 287 LDCWHGEPSQRPTFSELVEH 306

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 30/206 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMD 151
           TG+  A+K ++ +     R    QE+ I ++    +++         G  ++ +++EY+ 
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 211
            GSL D+L +  +I    L    +Q+ +G+ YLH  +H IHR+L   N+L+++   VKI 
Sbjct: 102 LGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLH-AQHYIHRNLAARNVLLDNDRLVKIG 159
Query: 212 DFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE-- 261
           DFG++  +            G +  F     + +PE +   K+ Y SD+WS G+ L E  
Sbjct: 160 DFGLAKAVPEGHEYYRVREDGDSPVF-----WYAPECLKEYKFYYASDVWSFGVTLYELL 214
Query: 262 --CATGQFPYSPPEQQDGWTSFYELM 285
             C + Q   SPP      T F EL+
Sbjct: 215 THCDSSQ---SPP------TKFLELI 231

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 117 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTSDLKICDFGLARV 175
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 176 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 235
Query: 269 ----------YSPPEQQDGWTSF-YELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 236 LDQLNHILGILGSPSQEDLNCGINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 295
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L  Y D
Sbjct: 296 LTFNPHKRIEVEQALAHPYLAQYYD 320

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 38/214 (17%)
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 211
           G  L + +K  + + +E++  +  Q+L+GL Y+H    IIHRDLKPSN+ +N   E++I 
Sbjct: 116 GADLNNIVKS-QALSDEHVQFLVYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDSELRIL 173
Query: 212 DFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FP 268
           DFG++        +   +V T  Y +PE  ++   Y    DIWS+G ++ E   G+  FP
Sbjct: 174 DFGLA---RQADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFP 230
Query: 269 YSPPEQQDGWTSFYELMEAIVDQPP------------------PSAPSDQFS-------P 303
            S     D       +ME +    P                  P  P    S       P
Sbjct: 231 GS-----DYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANP 285
Query: 304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
                +   +  +  QR+SA E + H +   Y D
Sbjct: 286 LAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHD 319

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 89/179 (49%), Gaps = 14/179 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+KV++ N    A ++I  E  +      PYV     +C  S      + ++ + M  G 
Sbjct: 50  AIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTS-----TVQLVTQLMPYGC 104
Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L D +++ +  +  + L   C Q+ KG+ YL  +  ++HRDL   N+L+     VKITDF
Sbjct: 105 LLDHVRENRGRLGSQDLLNWCMQIAKGMSYLE-DVRLVHRDLAARNVLVKSPNHVKITDF 163
Query: 214 GVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G++ ++    T   A+       +M+ E I   ++ ++SD+WS G+ + E  T G  PY
Sbjct: 164 GLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPY 222

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI  FG++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILGFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 100/235 (42%), Gaps = 24/235 (10%)
Query: 97  FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 156
           F A+K ++    E  RR    E  I      P V+        +  + II E+M+ GSL 
Sbjct: 63  FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 122
Query: 157 DFLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
            FL++     T+ +  L  +   +  G+ YL  + + +HRDL   N+L+N     K++DF
Sbjct: 123 SFLRQNDGQFTVIQ--LVGMLRGIAAGMKYL-ADMNYVHRDLAARNILVNSNLVCKVSDF 179
Query: 214 GVSAIMASTSGQANTFVGTY------NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQ 266
           G+S  +   +    T+           + +PE I   K+   SD+WS G+V+ E  + G+
Sbjct: 180 GLSRFLEDDTSDP-TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 238
Query: 267 FPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEFCSFISACVQKEPQQR 320
            PY     QD        +E     PPP   PS          +  C QK+   R
Sbjct: 239 RPYWDMTNQD----VINAIEQDYRLPPPMDCPS-----ALHQLMLDCWQKDRNHR 284

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDFGLARV 177
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI D G++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDAGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 120 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 178
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 179 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 238
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 239 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 298
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 299 LTFNPHKRIEVEQALAHPYLEQYYD 323

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 121 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 179
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 180 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 239
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 240 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 299
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 300 LTFNPHKRIEVEQALAHPYLEQYYD 324

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 112 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 170
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 171 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 230
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 231 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 290
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 291 LTFNPHKRIEVEQALAHPYLEQYYD 315

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTXDLKICDFGLARV 177
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 112/260 (43%), Gaps = 35/260 (13%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I E+  
Sbjct: 47  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCK 106
Query: 152 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 107 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 165
Query: 196 KPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKS 250
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQS 222
Query: 251 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 223 DVWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTM 275
Query: 310 SACVQKEPQQRLSAQELMTH 329
             C   EP QR +  EL+ H
Sbjct: 276 LDCWHGEPSQRPTFSELVEH 295

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 37/205 (18%)
Query: 161 KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 220
           K + + +E++  +  Q+L+GL Y+H    IIHRDLKPSN+ +N   E++I DFG++    
Sbjct: 124 KCQALSDEHVQFLVYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDSELRILDFGLA---R 179
Query: 221 STSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDG 277
               +   +V T  Y +PE  ++   Y    DIWS+G ++ E   G+  FP S     D 
Sbjct: 180 QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGS-----DY 234
Query: 278 WTSFYELMEAIVDQPP------------------PSAPSDQFS-------PEFCSFISAC 312
                 +ME +    P                  P  P    S       P     +   
Sbjct: 235 IDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRM 294
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +  +  QR+SA E + H +   Y D
Sbjct: 295 LVLDSDQRVSAAEALAHAYFSQYHD 319

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 112/260 (43%), Gaps = 35/260 (13%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
           T +  A+K+++     S  R +  ELKI  +       V +        G + +I E+  
Sbjct: 47  TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCK 106
Query: 152 GGSLADFLKK-------VKTIPE---------EYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            G+L+ +L+         K  PE         E+L     QV KG+ +L   K  IHRDL
Sbjct: 107 FGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-CIHRDL 165
Query: 196 KPSNLLINHRGEVKITDFGVSAIMAS-----TSGQANTFVGTYNYMSPERISGGKYGYKS 250
              N+L++ +  VKI DFG++  +         G A        +M+PE I    Y  +S
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL---PLKWMAPETIFDRVYTIQS 222
Query: 251 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
           D+WS G++L E  + G  PY P  + D      E    + +     AP D  +PE    +
Sbjct: 223 DVWSFGVLLWEIFSLGASPY-PGVKIDE-----EFCRRLKEGTRMRAP-DYTTPEMYQTM 275
Query: 310 SACVQKEPQQRLSAQELMTH 329
             C   EP QR +  EL+ H
Sbjct: 276 LDCWHGEPSQRPTFSELVEH 295

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 113 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 171
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 172 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 231
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 232 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 291
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 292 LTFNPHKRIEVEQALAHPYLEQYYD 316

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 115 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 173
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 174 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 233
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 234 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 293
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 294 LTFNPHKRIEVEQALAHPYLEQYYD 318

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI D G++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDRGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKCQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 122/267 (45%), Gaps = 41/267 (15%)
Query: 96  QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-------------GA 142
           +++A+K I+   E+ +   I  E+ +  S    YVV  Y ++                  
Sbjct: 32  RYYAIKKIRHTEEKLS--TILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89
Query: 143 ISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 200
           + I +EY + G+L D +  + +    +EY   +  Q+L+ L Y+H +  IIHRDLKP N+
Sbjct: 90  LFIQMEYCENGTLYDLIHSENLNQQRDEYWR-LFRQILEALSYIHSQG-IIHRDLKPMNI 147
Query: 201 LINHRGEVKITDFGV--------------SAIMASTSGQANTFVGTYNYMSPERISG-GK 245
            I+    VKI DFG+              S  +  +S    + +GT  Y++ E + G G 
Sbjct: 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH 207
Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 305
           Y  K D++SLG++  E     +P+S   ++    +  + + ++  + PP    ++   E 
Sbjct: 208 YNEKIDMYSLGIIFFEMI---YPFSTGMER---VNILKKLRSVSIEFPPDFDDNKMKVE- 260
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFL 332
              I   +  +P +R  A+ L+   +L
Sbjct: 261 KKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI DF ++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDFYLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 135 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 193
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 194 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 253
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 254 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 313
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 314 LTFNPHKRIEVEQALAHPYLEQYYD 338

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 117 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 175
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G    +V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 176 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 235
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 236 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 295
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L  Y D
Sbjct: 296 LTFNPHKRIEVEQALAHPYLAQYYD 320

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 72/126 (57%), Gaps = 8/126 (6%)
Query: 146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y+H    IIHRDLKPSNL +N  
Sbjct: 104 LVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIH-SADIIHRDLKPSNLAVNED 161
Query: 206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECAT 264
            E+KI D G++     T  +   +V T  Y +PE  ++   Y    DIWS+G ++ E  T
Sbjct: 162 CELKILDGGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218
Query: 265 GQ--FP 268
           G+  FP
Sbjct: 219 GRTLFP 224

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 88/205 (42%), Gaps = 37/205 (18%)
Query: 161 KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 220
           K + + +E++  +  Q+L+GL Y+H    IIHRDLKPSN+ +N   E++I DFG++    
Sbjct: 116 KCQALSDEHVQFLVYQLLRGLKYIH-SAGIIHRDLKPSNVAVNEDCELRILDFGLA---R 171
Query: 221 STSGQANTFVGTYNYMSPE-RISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDG 277
               +   +V T  Y +PE  ++   Y    DIWS+G ++ E   G+  FP S     D 
Sbjct: 172 QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGS-----DY 226
Query: 278 WTSFYELMEAIVDQPP------------------PSAPSDQFS-------PEFCSFISAC 312
                 +ME +    P                  P  P    S       P     +   
Sbjct: 227 IDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRM 286
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +  +  QR+SA E + H +   Y D
Sbjct: 287 LVLDSDQRVSAAEALAHAYFSQYHD 311

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLXGIKHLH-SAGIIHRDLKPSNIV 158
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDXTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 262 CATGQFPYSPPEQQDGWTSFY--------ELMEAI-------VDQPPPSA---------- 296
               +  +   +  D W            E M+ +       V+  P  A          
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 297 ---PSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLKMYGD 337
              P+D    +  +      +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 326

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 12/212 (5%)
Query: 112 RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 171
           R +  +E +     Q P+VV  +     +G + +    ++G  LA  L++   +      
Sbjct: 78  RTRXQREARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAV 137
Query: 172 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV-SAIMASTSGQANTFV 230
           AI  Q+    L   H     HRD+KP N+L++      + DFG+ SA       Q    V
Sbjct: 138 AIVRQI-GSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV 196
Query: 231 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 290
           GT  Y +PER S     Y++DI++L  VL EC TG    SPP Q D  +    +  A ++
Sbjct: 197 GTLYYXAPERFSESHATYRADIYALTCVLYECLTG----SPPYQGDQLS----VXGAHIN 248
Query: 291 Q--PPPSAPSDQFSPEFCSFISACVQKEPQQR 320
           Q  P PS         F + I+    K P+ R
Sbjct: 249 QAIPRPSTVRPGIPVAFDAVIARGXAKNPEDR 280

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 115/265 (43%), Gaps = 34/265 (12%)
Query: 96  QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL 155
           Q  A+K ++   E   R +   E  +    Q P VV        +  +S+I  Y   G L
Sbjct: 57  QAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 116
Query: 156 ADFL---------------KKVKTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS 198
            +FL               + VK+   P +++  +  Q+  G+ YL    H++H+DL   
Sbjct: 117 HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA-QIAAGMEYLS-SHHVVHKDLATR 174
Query: 199 NLLINHRGEVKITDFGV--SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 256
           N+L+  +  VKI+D G+      A         +    +M+PE I  GK+   SDIWS G
Sbjct: 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYG 234
Query: 257 LVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC-SFISACVQ 314
           +VL E  + G  PY     QD       ++E I ++     P D   P +  + +  C  
Sbjct: 235 VVLWEVFSYGLQPYCGYSNQD-------VVEMIRNRQVLPCPDD--CPAWVYALMIECWN 285
Query: 315 KEPQQRLSAQELMTHPFLKMYGDLN 339
           + P +R   +++  H  L+ +G+L+
Sbjct: 286 EFPSRRPRFKDI--HSRLRAWGNLS 308

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 97  VYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLXGIKHLH-SAGIIHRDLKPSNIV 151
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 152 VKSDXTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 262 CATGQFPYSPPEQQDGWTSFYE 283
               +  +   +  D W    E
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIE 232

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 31/209 (14%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH---------HEKHIIHRDL 195
           +I  + + GSL+DFLK    +    L  I E + +GL YLH         H+  I HRD+
Sbjct: 99  LITAFHEKGSLSDFLK-ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDI 157
Query: 196 KPSNLLINHRGEVKITDFGVSAIMAS--TSGQANTFVGTYNYMSPERISGG-----KYGY 248
           K  N+L+ +     I DFG++    +  ++G  +  VGT  YM+PE + G          
Sbjct: 158 KSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFL 217
Query: 249 KSDIWSLGLVLLE----CATGQFPYS----PPEQQDGWT-SFYELMEAIVDQPPPSAPSD 299
           + D++++GLVL E    C     P      P E++ G   S  ++ E +V +       D
Sbjct: 218 RIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD 277
Query: 300 QFSPE-----FCSFISACVQKEPQQRLSA 323
            +         C  I  C   + + RLSA
Sbjct: 278 YWQKHAGMAMLCETIEECWDHDAEARLSA 306

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLXGIKHLH-SAGIIHRDLKPSNIV 158
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDXTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 262 CATGQFPYSPPEQQDGWTSFY--------ELMEAI-------VDQPPPSA---------- 296
               +  +   +  D W            E M+ +       V+  P  A          
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 297 ---PSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLKMYGD 337
              P+D    +  +      +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 326

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 114/255 (44%), Gaps = 32/255 (12%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMD 151
           TG+  A+K ++       R    +E++I ++    ++V         G  ++ +++EY+ 
Sbjct: 37  TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 96
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 211
            GSL D+L +   +    L    +Q+ +G+ YLH  +H IHR L   N+L+++   VKI 
Sbjct: 97  LGSLRDYLPR-HCVGLAQLLLFAQQICEGMAYLH-AQHYIHRALAARNVLLDNDRLVKIG 154
Query: 212 DFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE-- 261
           DFG++  +            G +  F     + +PE +   K+ Y SD+WS G+ L E  
Sbjct: 155 DFGLAKAVPEGHEYYRVREDGDSPVF-----WYAPECLKECKFYYASDVWSFGVTLYELL 209
Query: 262 --CATGQFPYSPPEQQDGWT-------SFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 312
             C + Q P++   +  G T          EL+E     P P    D+   E    +  C
Sbjct: 210 TYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRP----DRCPCEIYHLMKNC 265
Query: 313 VQKEPQQRLSAQELM 327
            + E   R + Q L+
Sbjct: 266 WETEASFRPTFQNLV 280

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 28/235 (11%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K ++    E  RR+   E  I    + P ++       ++  + I+ E+M+ G+L  F
Sbjct: 48  AIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSF 107
Query: 159 LK----KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 214
           L+    +   I    L  +   +  G+ YL  E   +HRDL   N+L+N     K++DFG
Sbjct: 108 LRLNDGQFTVI---QLVGMLRGIASGMRYLA-EMSYVHRDLAARNILVNSNLVCKVSDFG 163
Query: 215 VSAIMASTSG---QANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFP 268
           +S  +   S    + ++  G     + +PE I+  K+   SD WS G+V+ E  + G+ P
Sbjct: 164 LSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223
Query: 269 YSPPEQQDGWTSF---YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
           Y     QD   +    Y L       PPP  P+          +  C QK+   R
Sbjct: 224 YWDMSNQDVINAIEQDYRL------PPPPDCPTS-----LHQLMLDCWQKDRNAR 267

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 73/142 (51%), Gaps = 7/142 (4%)
Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS      V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDCTLKILDFGL-ARTAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 262 CATGQFPYSPPEQQDGWTSFYE 283
              G   +   +  D W    E
Sbjct: 218 MIKGGVLFPGTDHIDQWNKVIE 239

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 40/229 (17%)
Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYLVMELMD----ANLXQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDXTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 262 CATGQFPYSPPEQQDGWTSFY--------ELMEAI-------VDQPPPSA---------- 296
               +  +   +  D W            E M+ +       V+  P  A          
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 277
Query: 297 ---PSDQFSPEFCS-----FISACVQKEPQQRLSAQELMTHPFLKMYGD 337
              P+D    +  +      +S  +  +P +R+S  + + HP++ ++ D
Sbjct: 278 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 326

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 114/255 (44%), Gaps = 32/255 (12%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AISIILEYMD 151
           TG+  A+K ++       R    +E++I ++    ++V         G  ++ +++EY+ 
Sbjct: 36  TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVP 95
Query: 152 GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT 211
            GSL D+L +   +    L    +Q+ +G+ YLH  +H IHR L   N+L+++   VKI 
Sbjct: 96  LGSLRDYLPR-HCVGLAQLLLFAQQICEGMAYLH-AQHYIHRALAARNVLLDNDRLVKIG 153
Query: 212 DFGVSAIM--------ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE-- 261
           DFG++  +            G +  F     + +PE +   K+ Y SD+WS G+ L E  
Sbjct: 154 DFGLAKAVPEGHEYYRVREDGDSPVF-----WYAPECLKECKFYYASDVWSFGVTLYELL 208
Query: 262 --CATGQFPYSPPEQQDGWT-------SFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 312
             C + Q P++   +  G T          EL+E     P P    D+   E    +  C
Sbjct: 209 TYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRP----DRCPCEIYHLMKNC 264
Query: 313 VQKEPQQRLSAQELM 327
            + E   R + Q L+
Sbjct: 265 WETEASFRPTFQNLV 279

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 12/179 (6%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL-EYMDGGSLAD 157
           A+K ++    E  RR    E  I      P ++   +   + G +++I+ EYM+ GSL  
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL-EGVVTRGRLAMIVTEYMENGSLDT 139
Query: 158 FLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 214
           FL+      TI +  L  +   V  G+ YL    ++ HRDL   N+L++     K++DFG
Sbjct: 140 FLRTHDGQFTIMQ--LVGMLRGVGAGMRYLSDLGYV-HRDLAARNVLVDSNLVCKVSDFG 196
Query: 215 VSAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 269
           +S ++      A T  G      + +PE I+   +   SD+WS G+V+ E  A G+ PY
Sbjct: 197 LSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           ++ E M GGS+   + K +   E   + + + V   L +LH+ K I HRDLKP N+L  H
Sbjct: 88  LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEH 146
Query: 205 RGE---VKITDFGVSAIMA-------STSGQANTFVGTYNYMSPERI-----SGGKYGYK 249
             +   VKI DF + + +         ++ +  T  G+  YM+PE +         Y  +
Sbjct: 147 PNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 250 SDIWSLGLVLLECATGQFPYSPPEQQD-GWT------SFYELMEAIVDQPPPSAPSDQFS 302
            D+WSLG++L    +G  P+      D GW       +   ++   + +     P   ++
Sbjct: 207 CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWA 266
Query: 303 PEFCS---FISACVQKEPQQRLSAQELMTHPFLK 333
              C+    IS  + ++ +QRLSA +++ HP+++
Sbjct: 267 HISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 90/183 (49%), Gaps = 19/183 (10%)
Query: 94  TGQFFALKVIQM--------NVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNG 141
           +G F ALK +++         +  S  R++A  L+  ++ + P VV    VC  S     
Sbjct: 33  SGHFVALKSVRVPNGGGGGGGLPISTVREVAL-LRRLEAFEHPNVVRLMDVCATSRTDRE 91
Query: 142 -AISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS 198
             ++++ E++D   L  +L K     +P E +  +  Q L+GL +LH    I+HRDLKP 
Sbjct: 92  IKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH-ANCIVHRDLKPE 149
Query: 199 NLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 258
           N+L+   G VK+ DFG++ I  S        V T  Y +PE +    Y    D+WS+G +
Sbjct: 150 NILVTSGGTVKLADFGLARIY-SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCI 208
Query: 259 LLE 261
             E
Sbjct: 209 FAE 211

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 142 VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 196
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 197 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 255
Query: 262 CATGQFPYSPPEQQDGWTSFYE 283
               +  +   +  D W    E
Sbjct: 256 MVRHKILFPGRDYIDQWNKVIE 277

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 32/237 (13%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K ++    E  RR+   E  I    + P ++       ++  + I+ E+M+ G+L  F
Sbjct: 46  AIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSF 105
Query: 159 LK----KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 214
           L+    +   I    L  +   +  G+ YL  E   +HRDL   N+L+N     K++DFG
Sbjct: 106 LRLNDGQFTVI---QLVGMLRGIASGMRYLA-EMSYVHRDLAARNILVNSNLVCKVSDFG 161
Query: 215 VSAIMASTSGQANTFVGTY------NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQF 267
           +S  +   S    T+  +        + +PE I+  K+   SD WS G+V+ E  + G+ 
Sbjct: 162 LSRFLEENSSDP-TYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGER 220
Query: 268 PYSPPEQQDGWTSFYELMEAIVDQ----PPPSAPSDQFSPEFCSFISACVQKEPQQR 320
           PY     QD       ++ AI       PPP  P+          +  C QK+   R
Sbjct: 221 PYWDMSNQD-------VINAIEQDYRLPPPPDCPTS-----LHQLMLDCWQKDRNAR 265

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 97/187 (51%), Gaps = 17/187 (9%)
Query: 92  KWTGQF-FALKVIQM-NVEESARRQIAQEL-KINQSSQCPYVVVCYQSFYSNGAISIILE 148
           KW GQ+  A+K+I+  ++ E    Q AQ + K++      +  VC + +     I I+ E
Sbjct: 28  KWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEY----PIYIVTE 83
Query: 149 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRG 206
           Y+  G L ++L+   K +    L  +C  V +G+ +L  E H  IHRDL   N L++   
Sbjct: 84  YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL--ESHQFIHRDLAARNCLVDRDL 141
Query: 207 EVKITDFGVSAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLEC- 262
            VK++DFG++  +     Q  + VGT     + +PE     KY  KSD+W+ G+++ E  
Sbjct: 142 CVKVSDFGMTRYVLDD--QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF 199
Query: 263 ATGQFPY 269
           + G+ PY
Sbjct: 200 SLGKMPY 206

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 105 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 160
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 161 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 263 ATGQFPYSPPEQQDGWTSFYE 283
              +  +   +  D W    E
Sbjct: 220 VRHKILFPGRDYIDQWNKVIE 240

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDXTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 262 CATGQFPYSPPEQQDGWTSFYE 283
               +  +   +  D W    E
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIE 239

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 103 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 158
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 159 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 217
Query: 263 ATGQFPYSPPEQQDGWTSFYE 283
              +  +   +  D W    E
Sbjct: 218 VRHKILFPGRDYIDQWNKVIE 238

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 262 CATGQFPYSPPEQQDGWTSFYE 283
               +  +   +  D W    E
Sbjct: 218 MVRHKILFPGRDYIDQWNKVIE 239

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 104 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 159
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 160 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 263 ATGQFPYSPPEQQDGWTSFYE 283
              +  +   +  D W    E
Sbjct: 219 VRHKILFPGRDYIDQWNKVIE 239

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + +++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 105 VYLVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 159
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 160 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218
Query: 262 CATGQFPYSPPEQQDGWTSFYE 283
               +  +   +  D W    E
Sbjct: 219 MVRHKILFPGRDYIDQWNKVIE 240

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           + I++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 98  VYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 153
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    D+WS+G ++ E 
Sbjct: 154 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEM 212
Query: 263 ATGQFPYSPPEQQDGWTSFYE 283
              +  +   +  D W    E
Sbjct: 213 VCHKILFPGRDYIDQWNKVIE 233

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 97  VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 152
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 153 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
Query: 263 ATGQFPYSPPEQQDGWTSFYE 283
              +  +   +  D W    E
Sbjct: 212 VRHKILFPGRDYIDQWNKVIE 232

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 98  VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 153
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 154 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 212
Query: 263 ATGQFPYSPPEQQDGWTSFYE 283
              +  +   +  D W    E
Sbjct: 213 VRHKILFPGRDYIDQWNKVIE 233

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 53/179 (29%), Positives = 87/179 (48%), Gaps = 12/179 (6%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL-EYMDGGSLAD 157
           A+K ++    E  RR    E  I      P ++   +   + G +++I+ EYM+ GSL  
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL-EGVVTRGRLAMIVTEYMENGSLDT 139
Query: 158 FLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 214
           FL+      TI +  L  +   V  G+ YL    ++ HRDL   N+L++     K++DFG
Sbjct: 140 FLRTHDGQFTIMQ--LVGMLRGVGAGMRYLSDLGYV-HRDLAARNVLVDSNLVCKVSDFG 196
Query: 215 VSAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 269
           +S ++      A T  G      + +PE I+   +   SD+WS G+V+ E  A G+ PY
Sbjct: 197 LSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY 255

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 142 VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 197
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 198 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
Query: 263 ATGQFPYSPPEQQDGWTSFYE 283
              +  +   +  D W    E
Sbjct: 257 VRHKILFPGRDYIDQWNKVIE 277

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 74/142 (52%), Gaps = 7/142 (4%)
Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 109 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 163
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS     +V T  Y +PE I G  Y    D+WS+G ++ E
Sbjct: 164 VKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGE 222
Query: 262 CATGQFPYSPPEQQDGWTSFYE 283
               +  +   +  D W    E
Sbjct: 223 MVCHKILFPGRDYIDQWNKVIE 244

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 73/141 (51%), Gaps = 5/141 (3%)
Query: 143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           + +++E MD  +L   ++    +  E ++ +  Q+L G+ +LH    IIHRDLKPSN+++
Sbjct: 98  VYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIVV 153
Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
                +KI DFG+ A  A TS     +V T  Y +PE I G  Y    DIWS+G ++ E 
Sbjct: 154 KSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 212
Query: 263 ATGQFPYSPPEQQDGWTSFYE 283
              +  +   +  D W    E
Sbjct: 213 VRHKILFPGRDYIDQWNKVIE 233

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 119 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G     V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 178 ADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 298 LTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 27/205 (13%)
Query: 159 LKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
           L K + +  +++     Q+L+GL Y+H   +++HRDLKPSNLL+N   ++KI DFG++ +
Sbjct: 120 LLKTQHLSNDHICYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNTTCDLKICDFGLARV 178
Query: 219 M---ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---- 268
                  +G     V T  Y +PE +   K Y    DIWS+G +L E  + +  FP    
Sbjct: 179 ADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 238
Query: 269 ----------YSPPEQQD-GWTSFYELMEAIVDQPPPS-APSDQFSPEFCS----FISAC 312
                        P Q+D       +    ++  P  +  P ++  P   S     +   
Sbjct: 239 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 298
Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +   P +R+  ++ + HP+L+ Y D
Sbjct: 299 LTFNPHKRIEVEQALAHPYLEQYYD 323

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/163 (33%), Positives = 82/163 (50%), Gaps = 9/163 (5%)
Query: 109 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-ISIILEYMDGGSLADFLKKVKTIPE 167
           E  ++Q  QE+K+    Q   +V     F S+G  + ++  Y   GSL D L  +   P 
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELL-GFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP 120
Query: 168 ---EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 224
                   I +    G+ +LH E H IHRD+K +N+L++     KI+DFG++      + 
Sbjct: 121 LSWHXRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ 179
Query: 225 QA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG 265
               +  VGT  Y +PE +  G+   KSDI+S G+VLLE  TG
Sbjct: 180 XVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITG 221

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 109/238 (45%), Gaps = 27/238 (11%)
Query: 106 NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI 165
           N E + +++I    ++   +    V V Y        + +++EY     +    + + ++
Sbjct: 48  NGEANVKKEIQLLRRLRHKNVIQLVDVLYNE--EKQKMYMVMEY----CVCGMQEMLDSV 101
Query: 166 PEEYLAAICE------QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 219
           PE+    +C+      Q++ GL YLH +  I+H+D+KP NLL+   G +KI+  GV+  +
Sbjct: 102 PEKRFP-VCQAHGYFCQLIDGLEYLHSQG-IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159
Query: 220 A--STSGQANTFVGTYNYMSPERISGGKY--GYKSDIWSLGLVLLECATGQFPYSPPEQQ 275
              +      T  G+  +  PE  +G     G+K DIWS G+ L    TG +P+      
Sbjct: 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE----- 214
Query: 276 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
               + Y+L E I  +   + P D   P     +   ++ EP +R S +++  H + +
Sbjct: 215 --GDNIYKLFENI-GKGSYAIPGD-CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 101/241 (41%), Gaps = 50/241 (20%)
Query: 140 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           NG   +++  + G +L   +KK   + IP  Y+  I +Q+L GL Y+H    IIH D+KP
Sbjct: 101 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP 160
Query: 198 SNLLIN------HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
            N+L+       +  ++KI D G +         +   + T  Y SPE + G  +G  +D
Sbjct: 161 ENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS---IQTREYRSPEVLLGAPWGCGAD 217
Query: 252 IWSLGLVLLECATGQFPYSPPE------QQDGWTSFYELMEAIVD--------------- 290
           IWS   ++ E  TG F + P E        D      EL+  +                 
Sbjct: 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 277
Query: 291 ------------QPPPSAPSDQF------SPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
                        P     ++++      + E   F+S  +Q +P++R  A  L+ HP+L
Sbjct: 278 RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337
Query: 333 K 333
           K
Sbjct: 338 K 338

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/241 (25%), Positives = 101/241 (41%), Gaps = 50/241 (20%)
Query: 140 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           NG   +++  + G +L   +KK   + IP  Y+  I +Q+L GL Y+H    IIH D+KP
Sbjct: 101 NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP 160
Query: 198 SNLLIN------HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
            N+L+       +  ++KI D G +         +   + T  Y SPE + G  +G  +D
Sbjct: 161 ENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS---IQTREYRSPEVLLGAPWGCGAD 217
Query: 252 IWSLGLVLLECATGQFPYSPPE------QQDGWTSFYELMEAIVD--------------- 290
           IWS   ++ E  TG F + P E        D      EL+  +                 
Sbjct: 218 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNS 277
Query: 291 ------------QPPPSAPSDQF------SPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
                        P     ++++      + E   F+S  +Q +P++R  A  L+ HP+L
Sbjct: 278 RGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337
Query: 333 K 333
           K
Sbjct: 338 K 338

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 113/263 (42%), Gaps = 34/263 (12%)
Query: 96  QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL 155
           Q  A+K ++   E   R +   E  +    Q P VV        +  +S+I  Y   G L
Sbjct: 40  QAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 99
Query: 156 ADFL---------------KKVKTI--PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS 198
            +FL               + VK+   P +++  +  Q+  G+ YL    H++H+DL   
Sbjct: 100 HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA-QIAAGMEYLS-SHHVVHKDLATR 157
Query: 199 NLLINHRGEVKITDFGV--SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 256
           N+L+  +  VKI+D G+      A         +    +M+PE I  GK+   SDIWS G
Sbjct: 158 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYG 217
Query: 257 LVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC-SFISACVQ 314
           +VL E  + G  PY     QD       ++E I ++     P D   P +  + +  C  
Sbjct: 218 VVLWEVFSYGLQPYCGYSNQD-------VVEMIRNRQVLPCPDD--CPAWVYALMIECWN 268
Query: 315 KEPQQRLSAQELMTHPFLKMYGD 337
           + P +R   +++  H  L+ +G+
Sbjct: 269 EFPSRRPRFKDI--HSRLRAWGN 289

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 76/149 (51%), Gaps = 20/149 (13%)
Query: 140 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  + +     NT  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEAL 231
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 24/235 (10%)
Query: 97  FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 156
           F A+K ++    E  RR    E  I      P V+        +  + II E+M+ GSL 
Sbjct: 37  FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 96
Query: 157 DFLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
            FL++     T+ +  L  +   +  G+ YL  + + +HR L   N+L+N     K++DF
Sbjct: 97  SFLRQNDGQFTVIQ--LVGMLRGIAAGMKYL-ADMNYVHRALAARNILVNSNLVCKVSDF 153
Query: 214 GVSAIMASTSGQANTFVGTY------NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQ 266
           G+S  +   +    T+           + +PE I   K+   SD+WS G+V+ E  + G+
Sbjct: 154 GLSRFLEDDTSDP-TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 212
Query: 267 FPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEFCSFISACVQKEPQQR 320
            PY     QD        +E     PPP   PS          +  C QK+   R
Sbjct: 213 RPYWDMTNQD----VINAIEQDYRLPPPMDCPS-----ALHQLMLDCWQKDRNHR 258

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 101/192 (52%), Gaps = 21/192 (10%)
Query: 90  QHKWTGQFFALKVIQMNVEESARRQIA-QELKINQSSQCPYVV----VCYQ--SFYSN-- 140
           +H+ TGQ  ALK + M  E+      A +E+KI Q  +   VV    +C    S Y+   
Sbjct: 38  RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 97
Query: 141 GAISIILEYMD---GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           G+I ++ ++ +    G L++ L K  T+ E  +  + + +L GL Y+H  K I+HRD+K 
Sbjct: 98  GSIYLVFDFCEHDLAGLLSNVLVKF-TLSE--IKRVMQMLLNGLYYIHRNK-ILHRDMKA 153
Query: 198 SNLLINHRGEVKITDFGVS-AIMASTSGQANTF---VGTYNYMSPERISGGK-YGYKSDI 252
           +N+LI   G +K+ DFG++ A   + + Q N +   V T  Y  PE + G + YG   D+
Sbjct: 154 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDL 213
Query: 253 WSLGLVLLECAT 264
           W  G ++ E  T
Sbjct: 214 WGAGCIMAEMWT 225

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/267 (24%), Positives = 121/267 (45%), Gaps = 41/267 (15%)
Query: 96  QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-------------GA 142
           +++A+K I+   E+ +   I  E+ +  S    YVV  Y ++                  
Sbjct: 32  RYYAIKKIRHTEEKLS--TILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89
Query: 143 ISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 200
           + I +EY +  +L D +  + +    +EY   +  Q+L+ L Y+H +  IIHRDLKP N+
Sbjct: 90  LFIQMEYCENRTLYDLIHSENLNQQRDEYWR-LFRQILEALSYIHSQG-IIHRDLKPMNI 147
Query: 201 LINHRGEVKITDFGV--------------SAIMASTSGQANTFVGTYNYMSPERISG-GK 245
            I+    VKI DFG+              S  +  +S    + +GT  Y++ E + G G 
Sbjct: 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGH 207
Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 305
           Y  K D++SLG++  E     +P+S   ++    +  + + ++  + PP    ++   E 
Sbjct: 208 YNEKIDMYSLGIIFFEMI---YPFSTGMER---VNILKKLRSVSIEFPPDFDDNKMKVE- 260
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFL 332
              I   +  +P +R  A+ L+   +L
Sbjct: 261 KKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 101/192 (52%), Gaps = 21/192 (10%)
Query: 90  QHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVV----VCYQ--SFYSN-- 140
           +H+ TGQ  ALK + M N +E       +E+KI Q  +   VV    +C    S Y+   
Sbjct: 37  RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96
Query: 141 GAISIILEYMD---GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           G+I ++ ++ +    G L++ L K  T+ E  +  + + +L GL Y+H  K I+HRD+K 
Sbjct: 97  GSIYLVFDFCEHDLAGLLSNVLVKF-TLSE--IKRVMQMLLNGLYYIHRNK-ILHRDMKA 152
Query: 198 SNLLINHRGEVKITDFGVS-AIMASTSGQANTF---VGTYNYMSPERISGGK-YGYKSDI 252
           +N+LI   G +K+ DFG++ A   + + Q N +   V T  Y  PE + G + YG   D+
Sbjct: 153 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDL 212
Query: 253 WSLGLVLLECAT 264
           W  G ++ E  T
Sbjct: 213 WGAGCIMAEMWT 224

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 101/192 (52%), Gaps = 21/192 (10%)
Query: 90  QHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVV----VCYQ--SFYSN-- 140
           +H+ TGQ  ALK + M N +E       +E+KI Q  +   VV    +C    S Y+   
Sbjct: 38  RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 97
Query: 141 GAISIILEYMD---GGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           G+I ++ ++ +    G L++ L K  T+ E  +  + + +L GL Y+H  K I+HRD+K 
Sbjct: 98  GSIYLVFDFCEHDLAGLLSNVLVKF-TLSE--IKRVMQMLLNGLYYIHRNK-ILHRDMKA 153
Query: 198 SNLLINHRGEVKITDFGVS-AIMASTSGQANTF---VGTYNYMSPERISGGK-YGYKSDI 252
           +N+LI   G +K+ DFG++ A   + + Q N +   V T  Y  PE + G + YG   D+
Sbjct: 154 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDL 213
Query: 253 WSLGLVLLECAT 264
           W  G ++ E  T
Sbjct: 214 WGAGCIMAEMWT 225

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 73/142 (51%), Gaps = 7/142 (4%)
Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS      V T  Y +PE I G  Y    DIWS+G ++ E
Sbjct: 159 VKSDCTLKILDFGL-ARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217
Query: 262 CATGQFPYSPPEQQDGWTSFYE 283
               +  +   +  D W    E
Sbjct: 218 MVCHKILFPGRDYIDQWNKVIE 239

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 140 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEAL 231
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 13/162 (8%)
Query: 179 KGLLYLHH--EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV-GTYNY 235
           +GL YLH   +  IIHRD+K +N+L++   E  + DFG++ +M          V GT  +
Sbjct: 150 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 236 MSPERISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQD-----GWTSFY---ELM 285
           ++PE +S GK   K+D++  G++LLE  TGQ  F  +     D      W       + +
Sbjct: 210 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 269
Query: 286 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
           EA+VD        D+   +       C Q  P +R    E++
Sbjct: 270 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 311

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 23/203 (11%)
Query: 96  QFFALKVIQMNVEESARRQIAQELKI------NQSSQCPYVVVCYQSFYSNGAISIILEY 149
           Q  ALK+++   E+   RQ A+E++I              V+   ++F     I +  E 
Sbjct: 123 QHVALKMVRN--EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFEL 180
Query: 150 MDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           +   +L + +KK K    ++P   +      +L+ L  LH  + IIH DLKP N+L+  +
Sbjct: 181 LSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQ 236
Query: 206 GE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
           G   +K+ DFG S        +  T + +  Y +PE I G +YG   D+WSLG +L E  
Sbjct: 237 GRSGIKVIDFGSSCY---EHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
Query: 264 TGQFPYSPPEQQ-DGWTSFYELM 285
           TG +P  P E + D      EL+
Sbjct: 294 TG-YPLLPGEDEGDQLACMIELL 315

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 70/139 (50%), Gaps = 11/139 (7%)
Query: 145 IILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 200
           +I +YM+ G+L   L        ++  E    IC    +GL YLH  + IIHRD+K  N+
Sbjct: 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSINI 170
Query: 201 LINHRGEVKITDFGVSAIMASTSGQAN---TFVGTYNYMSPERISGGKYGYKSDIWSLGL 257
           L++     KITDFG+S    +  GQ +      GT  Y+ PE    G+   KSD++S G+
Sbjct: 171 LLDENFVPKITDFGISK-KGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229
Query: 258 VLLE--CATGQFPYSPPEQ 274
           VL E  CA      S P +
Sbjct: 230 VLFEVLCARSAIVQSLPRE 248

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 140 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEAL 231
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 124/301 (41%), Gaps = 73/301 (24%)
Query: 96  QFFALKVIQMNVEESARRQIAQELKI------NQSSQCPYVVVCYQSFYSNGAISIILEY 149
           Q  ALK+++   E+   RQ A+E++I              V+   ++F     I +  E 
Sbjct: 123 QHVALKMVRN--EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFEL 180
Query: 150 MDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           +   +L + +KK K    ++P   +      +L+ L  LH  + IIH DLKP N+L+  +
Sbjct: 181 LSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQ 236
Query: 206 GE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
           G   +K+ DFG S        +  T + +  Y +PE I G +YG   D+WSLG +L E  
Sbjct: 237 GRSGIKVIDFGSSCY---EHQRVYTXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
Query: 264 TGQFPYSPPEQQ-DGWTSFYELM----EAIVDQ--------------------------- 291
           TG +P  P E + D      EL+    + ++D                            
Sbjct: 294 TG-YPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSXKGYPRYCTVTTLSDGSV 352
Query: 292 --------------PPPS-----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
                         PP S     A      P F  F+  C++ +P  R++  + + HP+L
Sbjct: 353 VLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412
Query: 333 K 333
           +
Sbjct: 413 R 413

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 21/192 (10%)
Query: 90  QHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVVVCYQ--SFYSNGA 142
           +H+ TGQ  ALK + M  E+     +A R+I     +   +    + +C    S Y+   
Sbjct: 38  RHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 97
Query: 143 ISIIL-----EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
            SI L     E+   G L++ L K  T+ E  +  + + +L GL Y+H  K I+HRD+K 
Sbjct: 98  ASIYLVFDFCEHDLAGLLSNVLVKF-TLSE--IKRVMQMLLNGLYYIHRNK-ILHRDMKA 153
Query: 198 SNLLINHRGEVKITDFGVS-AIMASTSGQANTF---VGTYNYMSPERISGGK-YGYKSDI 252
           +N+LI   G +K+ DFG++ A   + + Q N +   V T  Y  PE + G + YG   D+
Sbjct: 154 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDL 213
Query: 253 WSLGLVLLECAT 264
           W  G ++ E  T
Sbjct: 214 WGAGCIMAEMWT 225

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 53  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 112
Query: 159 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 113 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 171
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 172 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 231
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 232 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 283
Query: 326 LMT 328
           +++
Sbjct: 284 IIS 286

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 103/226 (45%), Gaps = 39/226 (17%)
Query: 99  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 157
           A+K+++   + S R  +  ELK+  Q      +V    +   +G I +I EY   G L +
Sbjct: 79  AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138
Query: 158 FLKK-----------------------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 194
           +L+                        +  +  E L     QV KG+ +L   K  +HRD
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD 197
Query: 195 LKPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYK 249
           L   N+L+ H   VKI DFG++  + S S     G A   V    +M+PE +  G Y  K
Sbjct: 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV---KWMAPESLFEGIYTIK 254
Query: 250 SDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEA--IVDQP 292
           SD+WS G++L E  + G  PY P    D   +FY+L++    +DQP
Sbjct: 255 SDVWSYGILLWEIFSLGVNPY-PGIPVDA--NFYKLIQNGFKMDQP 297

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 52/98 (53%), Gaps = 13/98 (13%)
Query: 176 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF------ 229
           Q+ + + +LH  K ++HRDLKPSN+       VK+ DFG+   M     +          
Sbjct: 172 QIAEAVEFLH-SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 230 ------VGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
                 VGT  YMSPE+I G  Y +K DI+SLGL+L E
Sbjct: 231 ATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 73/142 (51%), Gaps = 7/142 (4%)
Query: 143 ISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           + I++E MD    A+  + ++  +  E ++ +  Q+L G+ +LH    IIHRDLKPSN++
Sbjct: 104 VYIVMELMD----ANLCQVIQMELDHERMSYLLYQMLCGIKHLH-SAGIIHRDLKPSNIV 158
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
           +     +KI DFG+ A  A TS      V T  Y +PE I G  Y    D+WS+G ++ E
Sbjct: 159 VKSDCTLKILDFGL-ARTAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGE 217
Query: 262 CATGQFPYSPPEQQDGWTSFYE 283
               +  +   +  D W    E
Sbjct: 218 MVCHKILFPGRDYIDQWNKVIE 239

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 100/228 (43%), Gaps = 26/228 (11%)
Query: 90  QHKWTGQFFALKVIQ----MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           +HK TG  FA+KV      +   +   R+     K+N  +      +  ++   +  +  
Sbjct: 29  RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL-- 86
Query: 146 ILEYMDGGSLADFLKK---VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL- 201
           I+E+   GSL   L++      +PE     +   V+ G+ +L  E  I+HR++KP N++ 
Sbjct: 87  IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-ENGIVHRNIKPGNIMR 145
Query: 202 -INHRGE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG--------KYGYKS 250
            I   G+   K+TDFG +  +     Q  +  GT  Y+ P+             KYG   
Sbjct: 146 VIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204
Query: 251 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 298
           D+WS+G+     ATG  P+ P E   G     E+M  I+   P  A S
Sbjct: 205 DLWSIGVTFYHAATGSLPFRPFE---GPRRNKEVMYKIITGKPSGAIS 249

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 26/228 (11%)
Query: 90  QHKWTGQFFALKVIQ----MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI 145
           +HK TG  FA+KV      +   +   R+     K+N  +      +  ++   +  +  
Sbjct: 29  RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL-- 86
Query: 146 ILEYMDGGSLADFLKK---VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL- 201
           I+E+   GSL   L++      +PE     +   V+ G+ +L  E  I+HR++KP N++ 
Sbjct: 87  IMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR-ENGIVHRNIKPGNIMR 145
Query: 202 -INHRGE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG--------KYGYKS 250
            I   G+   K+TDFG +  +     Q     GT  Y+ P+             KYG   
Sbjct: 146 VIGEDGQSVYKLTDFGAARELEDDE-QFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204
Query: 251 DIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 298
           D+WS+G+     ATG  P+ P E   G     E+M  I+   P  A S
Sbjct: 205 DLWSIGVTFYHAATGSLPFRPFE---GPRRNKEVMYKIITGKPSGAIS 249

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 93/191 (48%), Gaps = 21/191 (10%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 157
           A+K+++ +  E     +  E+++ +   +   ++    +   +G + +I+EY   G+L +
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLRE 130
Query: 158 FLK-----------KVKTIPEEY-----LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           +L+            +  +PEE      L +   Q+ +G+ YL  +K  IHRDL   N+L
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-CIHRDLAARNVL 189
Query: 202 INHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVL 259
           +     +KI DFG++  + +      T  G     +M+PE +    Y ++SD+WS G+++
Sbjct: 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249
Query: 260 LECAT-GQFPY 269
            E  T G  PY
Sbjct: 250 WEIFTLGGSPY 260

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +  +     R +   E  + +   C +VV             +++E M  G L  +
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 159 LKKVKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   V
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTV 169
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  
Sbjct: 170 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229
Query: 266 QFPY 269
           + PY
Sbjct: 230 EQPY 233

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +  +     R +   E  + +   C +VV             +++E M  G L  +
Sbjct: 48  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 107
Query: 159 LKKVKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   V
Sbjct: 108 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTV 166
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  
Sbjct: 167 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 226
Query: 266 QFPY 269
           + PY
Sbjct: 227 EQPY 230

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 140 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 218
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 219 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 277
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 278 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 21/185 (11%)
Query: 97  FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 156
             A+K  +  +    + +  QE +I +    P +V           I I++E + GG   
Sbjct: 141 LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200
Query: 157 DFLK------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 210
            FL+      +VKT     L  +      G+ YL   K  IHRDL   N L+  +  +KI
Sbjct: 201 TFLRTEGARLRVKT-----LLQMVGDAAAGMEYLE-SKCCIHRDLAARNCLVTEKNVLKI 254
Query: 211 TDFGVS-----AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-AT 264
           +DFG+S      + A++ G     V    + +PE ++ G+Y  +SD+WS G++L E  + 
Sbjct: 255 SDFGMSREEADGVXAASGGLRQVPV---KWTAPEALNYGRYSSESDVWSFGILLWETFSL 311
Query: 265 GQFPY 269
           G  PY
Sbjct: 312 GASPY 316

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 140 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 100 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 159
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 160 LASQK-CIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 218
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 219 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 247

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +  +     R +   E  + +   C +VV             +++E M  G L  +
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 159 LKKVKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   V
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTV 169
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  
Sbjct: 170 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229
Query: 266 QFPY 269
           + PY
Sbjct: 230 EQPY 233

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 140 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 140 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 140 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 105 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 164
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 165 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 223
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 224 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 252

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 44  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 103
Query: 159 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 104 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 162
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 163 KIGDFGMTRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 222
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
           + PY     +      + +   ++D+P      D         +  C Q  P+ R S  E
Sbjct: 223 EQPYQGLSNEQ--VLRFVMEGGLLDKP------DNCPDMLLELMRMCWQYNPKMRPSFLE 274
Query: 326 LMT 328
           +++
Sbjct: 275 IIS 277

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 21/185 (11%)
Query: 97  FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLA 156
             A+K  +  +    + +  QE +I +    P +V           I I++E + GG   
Sbjct: 141 LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 200
Query: 157 DFLK------KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKI 210
            FL+      +VKT     L  +      G+ YL   K  IHRDL   N L+  +  +KI
Sbjct: 201 TFLRTEGARLRVKT-----LLQMVGDAAAGMEYLE-SKCCIHRDLAARNCLVTEKNVLKI 254
Query: 211 TDFGVS-----AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-AT 264
           +DFG+S      + A++ G     V    + +PE ++ G+Y  +SD+WS G++L E  + 
Sbjct: 255 SDFGMSREEADGVYAASGGLRQVPV---KWTAPEALNYGRYSSESDVWSFGILLWETFSL 311
Query: 265 GQFPY 269
           G  PY
Sbjct: 312 GASPY 316

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 99  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 157
           A+K+++       +  +  ELKI +   Q   +V    +    G + +I EY   G L +
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 158 FLKKVK-----------TIPEEYLAA-----ICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           FL++ +             PEE L++        QV +G+ +L   K+ IHRD+   N+L
Sbjct: 140 FLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVL 198
Query: 202 INHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLG 256
           + +    KI DFG++  + + S     G A   V    +M+PE I    Y  +SD+WS G
Sbjct: 199 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYG 255
Query: 257 LVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFISACVQ 314
           ++L E  + G  PY         + FY+L++       P+     F+P+   S + AC  
Sbjct: 256 ILLWEIFSLGLNPYPGILVN---SKFYKLVKDGYQMAQPA-----FAPKNIYSIMQACWA 307
Query: 315 KEPQQRLSAQELMT 328
            EP  R + Q++ +
Sbjct: 308 LEPTHRPTFQQICS 321

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 140 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 102 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 161
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 162 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 220
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 221 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 249

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 13/162 (8%)
Query: 179 KGLLYLHH--EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV-GTYNY 235
           +GL YLH   +  IIHRD+K +N+L++   E  + DFG++ +M          V G   +
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGH 201
Query: 236 MSPERISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQD-----GWTSFY---ELM 285
           ++PE +S GK   K+D++  G++LLE  TGQ  F  +     D      W       + +
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261
Query: 286 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
           EA+VD        D+   +       C Q  P +R    E++
Sbjct: 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 115/285 (40%), Gaps = 56/285 (19%)
Query: 101 KVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 160
           K+ Q+N ++  R  I  E+++ +    P +   Y+ +     I +++E   GG L D L 
Sbjct: 63  KIRQINPKDVER--IKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120
Query: 161 ---------------KVKTIP-------------------------EEYLAAICEQVLKG 180
                          K +  P                         E+ ++ I  Q+   
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180
Query: 181 LLYLHHEKHIIHRDLKPSNLLI--NHRGEVKITDFGVSA-IMASTSGQ---ANTFVGTYN 234
           L YLH++  I HRD+KP N L   N   E+K+ DFG+S       +G+     T  GT  
Sbjct: 181 LHYLHNQG-ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239
Query: 235 YMSPERI--SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP 292
           +++PE +  +   YG K D WS G++L     G  P+  P   D  T    L + +  + 
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPF--PGVNDADTISQVLNKKLCFEN 297
Query: 293 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
           P     +  SP     +S  + +   +R  A   + HP++  + D
Sbjct: 298 P---NYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 109/268 (40%), Gaps = 38/268 (14%)
Query: 93  WTGQ----FFALKVIQMNVEES--ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII 146
           W  Q    F A+K+  +  ++S  + R+I     +   +   ++    +       + +I
Sbjct: 32  WKAQLMNDFVAVKIFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSNLEVELWLI 91
Query: 147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH----------HEKHIIHRDLK 196
             + D GSL D+LK    I    L  + E + +GL YLH          H+  I HRD K
Sbjct: 92  TAFHDKGSLTDYLKG-NIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFK 150
Query: 197 PSNLLINHRGEVKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGG-----KYGYK 249
             N+L+       + DFG++         G  +  VGT  YM+PE + G          +
Sbjct: 151 SKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR 210
Query: 250 SDIWSLGLVLLE----CATGQFPYS----PPEQQDGWT-SFYELMEAIVDQPPPSAPSDQ 300
            D++++GLVL E    C     P      P E++ G   S  EL E +V +       D 
Sbjct: 211 IDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEEIGQHPSLEELQEVVVHKKMRPTIKDH 270
Query: 301 F-----SPEFCSFISACVQKEPQQRLSA 323
           +       + C  I  C   + + RLSA
Sbjct: 271 WLKHPGLAQLCVTIEECWDHDAEARLSA 298

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/263 (26%), Positives = 111/263 (42%), Gaps = 33/263 (12%)
Query: 93  WTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM 150
           W G+  A+K+     E+S  R+  I   + +   +   ++     S  S+  + +I  Y 
Sbjct: 29  WHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYH 88
Query: 151 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKPSNLLIN 203
           + GSL DFL++ +T+       +      GL +LH E         I HRD K  N+L+ 
Sbjct: 89  EHGSLYDFLQR-QTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVK 147
Query: 204 HRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERI-----SGGKYGYK-SDIW 253
              +  I D G++ + +  S       N  VGT  YM+PE +     +     YK +DIW
Sbjct: 148 SNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIW 207
Query: 254 SLGLVLLECATGQF------PYSPP--EQQDGWTSFYELMEAI-VDQPPPSAP----SDQ 300
           + GLVL E A           Y PP  +      SF ++ + + VDQ  P+ P    +D 
Sbjct: 208 AFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSFEDMKKVVCVDQQTPTIPNRLAADP 267
Query: 301 FSPEFCSFISACVQKEPQQRLSA 323
                   +  C    P  RL+A
Sbjct: 268 VLSGLAQMMRECWYPNPSARLTA 290

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 67/138 (48%), Gaps = 9/138 (6%)
Query: 145 IILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 200
           +I +YM+ G+L   L        ++  E    IC    +GL YLH  + IIHRD+K  N+
Sbjct: 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSINI 170
Query: 201 LINHRGEVKITDFGVS--AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 258
           L++     KITDFG+S        +       GT  Y+ PE    G+   KSD++S G+V
Sbjct: 171 LLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVV 230
Query: 259 LLE--CATGQFPYSPPEQ 274
           L E  CA      S P +
Sbjct: 231 LFEVLCARSAIVQSLPRE 248

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 23/203 (11%)
Query: 96  QFFALKVIQMNVEESARRQIAQELKI------NQSSQCPYVVVCYQSFYSNGAISIILEY 149
           Q  ALK+++   E+   RQ A+E++I              V+   ++F     I +  E 
Sbjct: 123 QHVALKMVRN--EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFEL 180
Query: 150 MDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR 205
           +   +L + +KK K    ++P   +      +L+ L  LH  + IIH DLKP N+L+  +
Sbjct: 181 LSM-NLYELIKKNKFQGFSLP--LVRKFAHSILQCLDALHKNR-IIHCDLKPENILLKQQ 236
Query: 206 GE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
           G   +K+ DFG S        +    + +  Y +PE I G +YG   D+WSLG +L E  
Sbjct: 237 GRSGIKVIDFGSSCY---EHQRVYXXIQSRFYRAPEVILGARYGMPIDMWSLGCILAELL 293
Query: 264 TGQFPYSPPEQQ-DGWTSFYELM 285
           TG +P  P E + D      EL+
Sbjct: 294 TG-YPLLPGEDEGDQLACMIELL 315

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 68/133 (51%), Gaps = 7/133 (5%)
Query: 140 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
            G + I+ EYM  GSL D+L+      +  + L      V + + YL    + +HRDL  
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAA 317
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 257
            N+L++     K++DFG++   +ST       V    + +PE +   K+  KSD+WS G+
Sbjct: 318 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGI 374
Query: 258 VLLECAT-GQFPY 269
           +L E  + G+ PY
Sbjct: 375 LLWEIYSFGRVPY 387

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 75/149 (50%), Gaps = 20/149 (13%)
Query: 140 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     ++I DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 68/133 (51%), Gaps = 7/133 (5%)
Query: 140 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
            G + I+ EYM  GSL D+L+      +  + L      V + + YL    + +HRDL  
Sbjct: 72  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAA 130
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 257
            N+L++     K++DFG++   +ST       V    + +PE +   K+  KSD+WS G+
Sbjct: 131 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGI 187
Query: 258 VLLECAT-GQFPY 269
           +L E  + G+ PY
Sbjct: 188 LLWEIYSFGRVPY 200

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 50  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 109
Query: 159 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 110 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 168
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 169 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 228
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 229 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 280
Query: 326 LMT 328
           +++
Sbjct: 281 IIS 283

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 68/133 (51%), Gaps = 7/133 (5%)
Query: 140 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
            G + I+ EYM  GSL D+L+      +  + L      V + + YL    + +HRDL  
Sbjct: 87  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAA 145
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 257
            N+L++     K++DFG++   +ST       V    + +PE +   K+  KSD+WS G+
Sbjct: 146 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGI 202
Query: 258 VLLECAT-GQFPY 269
           +L E  + G+ PY
Sbjct: 203 LLWEIYSFGRVPY 215

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 53  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 112
Query: 159 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 113 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 171
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 172 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 231
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 232 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 283
Query: 326 LMT 328
           +++
Sbjct: 284 IIS 286

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 119/267 (44%), Gaps = 41/267 (15%)
Query: 96  QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-------------GA 142
           +++A+K I+   E+ +   I  E+ +  S    YVV  Y ++                  
Sbjct: 32  RYYAIKKIRHTEEKLS--TILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKST 89
Query: 143 ISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 200
           + I  EY +  +L D +  + +    +EY   +  Q+L+ L Y+H +  IIHR+LKP N+
Sbjct: 90  LFIQXEYCENRTLYDLIHSENLNQQRDEYWR-LFRQILEALSYIHSQG-IIHRNLKPXNI 147
Query: 201 LINHRGEVKITDFGV--------------SAIMASTSGQANTFVGTYNYMSPERISG-GK 245
            I+    VKI DFG+              S  +  +S    + +GT  Y++ E + G G 
Sbjct: 148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGH 207
Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 305
           Y  K D +SLG++  E     +P+S   ++    +  + + ++  + PP    ++   E 
Sbjct: 208 YNEKIDXYSLGIIFFEXI---YPFSTGXER---VNILKKLRSVSIEFPPDFDDNKXKVE- 260
Query: 306 CSFISACVQKEPQQRLSAQELMTHPFL 332
              I   +  +P +R  A+ L+   +L
Sbjct: 261 KKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 46  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 105
Query: 159 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 106 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 164
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 165 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 224
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 225 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 276
Query: 326 LMT 328
           +++
Sbjct: 277 IIS 279

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 52  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 111
Query: 159 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 112 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 170
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 171 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 230
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 231 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 282
Query: 326 LMT 328
           +++
Sbjct: 283 IIS 285

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 81  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 140
Query: 159 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 141 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 199
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 200 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 259
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 260 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 311
Query: 326 LMT 328
           +++
Sbjct: 312 IIS 314

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 52  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 111
Query: 159 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 112 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 170
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 171 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 230
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 231 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 282
Query: 326 LMT 328
           +++
Sbjct: 283 IIS 285

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 29/204 (14%)
Query: 98  FALKVIQ-MNVEESARRQIA--QELKINQSSQCPYVVVCYQSFYSNG--AISIILEYM-- 150
           +ALK I+   +  SA R+IA  +ELK       P V+   + F S+    + ++ +Y   
Sbjct: 51  YALKQIEGTGISMSACREIALLRELK------HPNVISLQKVFLSHADRKVWLLFDYAEH 104
Query: 151 DGGSLADFLKKVKT------IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN- 203
           D   +  F +  K       +P   + ++  Q+L G+ YLH    ++HRDLKP+N+L+  
Sbjct: 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH-ANWVLHRDLKPANILVMG 163
Query: 204 ---HRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYGYKS-DIWSLG 256
               RG VKI D G + +  S        +  V T+ Y +PE + G ++  K+ DIW++G
Sbjct: 164 EGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIG 223
Query: 257 LVLLECATGQFPYSPPEQQDGWTS 280
            +  E  T + P     Q+D  TS
Sbjct: 224 CIFAELLTSE-PIFHCRQEDIKTS 246

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 22/243 (9%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 59  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 118
Query: 159 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 119 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 177
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 238 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 289
Query: 326 LMT 328
           +++
Sbjct: 290 IIS 292

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 82/184 (44%), Gaps = 14/184 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +  +     R +   E  + +   C +VV             +++E M  G L  +
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 159 LKKVKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   V
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTV 169
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T+       G     +M+PE +  G +   SD+WS G+VL E  +  
Sbjct: 170 KIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229
Query: 266 QFPY 269
           + PY
Sbjct: 230 EQPY 233

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 116/259 (44%), Gaps = 46/259 (17%)
Query: 99  ALKVIQMNVEESARRQIAQELKI-----NQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           A+K+++ +   + R  +  ELK+     N  +    +  C       G   +I EY   G
Sbjct: 57  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----IGGPTLVITEYCCYG 112
Query: 154 SLADFLKK-------VKTIPE-----------EYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            L +FL++        KT P            E L +   QV KG+ +L   K+ IHRDL
Sbjct: 113 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDL 171
Query: 196 KPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKS 250
              N+L+ H    KI DFG++  + + S     G A   V    +M+PE I    Y ++S
Sbjct: 172 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNCVYTFES 228
Query: 251 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM-EAIVDQPPPSAPSDQFSPEFCSF 308
           D+WS G+ L E  + G  PY P    D  + FY+++ E      P  AP++ +       
Sbjct: 229 DVWSYGIFLWELFSLGSSPY-PGMPVD--SKFYKMIKEGFRMLSPEHAPAEMY-----DI 280
Query: 309 ISACVQKEPQQRLSAQELM 327
           +  C   +P +R + ++++
Sbjct: 281 MKTCWDADPLKRPTFKQIV 299

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 112/252 (44%), Gaps = 34/252 (13%)
Query: 99  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 157
           A+K+++       +  +  ELKI +   Q   +V    +    G + +I EY   G L +
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 158 FLKKVK--------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           FL++                T+    L     QV +G+ +L   K+ IHRD+   N+L+ 
Sbjct: 140 FLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLT 198
Query: 204 HRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 258
           +    KI DFG++  + + S     G A   V    +M+PE I    Y  +SD+WS G++
Sbjct: 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGIL 255
Query: 259 LLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFISACVQKE 316
           L E  + G  PY         + FY+L++       P+     F+P+   S + AC   E
Sbjct: 256 LWEIFSLGLNPYPGILVN---SKFYKLVKDGYQMAQPA-----FAPKNIYSIMQACWALE 307
Query: 317 PQQRLSAQELMT 328
           P  R + Q++ +
Sbjct: 308 PTHRPTFQQICS 319

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 112/252 (44%), Gaps = 34/252 (13%)
Query: 99  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 157
           A+K+++       +  +  ELKI +   Q   +V    +    G + +I EY   G L +
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 158 FLKKVKTIPE--------------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           FL++   + E                L     QV +G+ +L   K+ IHRD+   N+L+ 
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLT 198
Query: 204 HRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLV 258
           +    KI DFG++  + + S     G A   V    +M+PE I    Y  +SD+WS G++
Sbjct: 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGIL 255
Query: 259 LLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFISACVQKE 316
           L E  + G  PY         + FY+L++       P+     F+P+   S + AC   E
Sbjct: 256 LWEIFSLGLNPYPGILVN---SKFYKLVKDGYQMAQPA-----FAPKNIYSIMQACWALE 307
Query: 317 PQQRLSAQELMT 328
           P  R + Q++ +
Sbjct: 308 PTHRPTFQQICS 319

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 116/259 (44%), Gaps = 46/259 (17%)
Query: 99  ALKVIQMNVEESARRQIAQELKI-----NQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           A+K+++ +   + R  +  ELK+     N  +    +  C       G   +I EY   G
Sbjct: 80  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----IGGPTLVITEYCCYG 135
Query: 154 SLADFLKK-------VKTIPE-----------EYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            L +FL++        KT P            E L +   QV KG+ +L   K+ IHRDL
Sbjct: 136 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDL 194
Query: 196 KPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKS 250
              N+L+ H    KI DFG++  + + S     G A   V    +M+PE I    Y ++S
Sbjct: 195 AARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPV---KWMAPESIFNCVYTFES 251
Query: 251 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM-EAIVDQPPPSAPSDQFSPEFCSF 308
           D+WS G+ L E  + G  PY P    D  + FY+++ E      P  AP++ +       
Sbjct: 252 DVWSYGIFLWELFSLGSSPY-PGMPVD--SKFYKMIKEGFRMLSPEHAPAEMY-----DI 303
Query: 309 ISACVQKEPQQRLSAQELM 327
           +  C   +P +R + ++++
Sbjct: 304 MKTCWDADPLKRPTFKQIV 322

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +  +     R +   E  + +   C +VV             +++E M  G L  +
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 159 LKKVKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   V
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTV 169
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  
Sbjct: 170 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229
Query: 266 QFPY 269
           + PY
Sbjct: 230 EQPY 233

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 116/259 (44%), Gaps = 46/259 (17%)
Query: 99  ALKVIQMNVEESARRQIAQELKI-----NQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           A+K+++ +   + R  +  ELK+     N  +    +  C       G   +I EY   G
Sbjct: 80  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----IGGPTLVITEYCCYG 135
Query: 154 SLADFLKK-------VKTIPE-----------EYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            L +FL++        KT P            E L +   QV KG+ +L   K+ IHRDL
Sbjct: 136 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDL 194
Query: 196 KPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKS 250
              N+L+ H    KI DFG++  + + S     G A   V    +M+PE I    Y ++S
Sbjct: 195 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNCVYTFES 251
Query: 251 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM-EAIVDQPPPSAPSDQFSPEFCSF 308
           D+WS G+ L E  + G  PY P    D  + FY+++ E      P  AP++ +       
Sbjct: 252 DVWSYGIFLWELFSLGSSPY-PGMPVD--SKFYKMIKEGFRMLSPEHAPAEMY-----DI 303
Query: 309 ISACVQKEPQQRLSAQELM 327
           +  C   +P +R + ++++
Sbjct: 304 MKTCWDADPLKRPTFKQIV 322

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 116/259 (44%), Gaps = 46/259 (17%)
Query: 99  ALKVIQMNVEESARRQIAQELKI-----NQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           A+K+++ +   + R  +  ELK+     N  +    +  C       G   +I EY   G
Sbjct: 73  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----IGGPTLVITEYCCYG 128
Query: 154 SLADFLKK-------VKTIPE-----------EYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            L +FL++        KT P            E L +   QV KG+ +L   K+ IHRDL
Sbjct: 129 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDL 187
Query: 196 KPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKS 250
              N+L+ H    KI DFG++  + + S     G A   V    +M+PE I    Y ++S
Sbjct: 188 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNCVYTFES 244
Query: 251 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM-EAIVDQPPPSAPSDQFSPEFCSF 308
           D+WS G+ L E  + G  PY P    D  + FY+++ E      P  AP++ +       
Sbjct: 245 DVWSYGIFLWELFSLGSSPY-PGMPVD--SKFYKMIKEGFRMLSPEHAPAEMY-----DI 296
Query: 309 ISACVQKEPQQRLSAQELM 327
           +  C   +P +R + ++++
Sbjct: 297 MKTCWDADPLKRPTFKQIV 315

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 116/259 (44%), Gaps = 46/259 (17%)
Query: 99  ALKVIQMNVEESARRQIAQELKI-----NQSSQCPYVVVCYQSFYSNGAISIILEYMDGG 153
           A+K+++ +   + R  +  ELK+     N  +    +  C       G   +I EY   G
Sbjct: 75  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----IGGPTLVITEYCCYG 130
Query: 154 SLADFLKK-------VKTIPE-----------EYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            L +FL++        KT P            E L +   QV KG+ +L   K+ IHRDL
Sbjct: 131 DLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDL 189
Query: 196 KPSNLLINHRGEVKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKS 250
              N+L+ H    KI DFG++  + + S     G A   V    +M+PE I    Y ++S
Sbjct: 190 AARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV---KWMAPESIFNCVYTFES 246
Query: 251 DIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELM-EAIVDQPPPSAPSDQFSPEFCSF 308
           D+WS G+ L E  + G  PY P    D  + FY+++ E      P  AP++ +       
Sbjct: 247 DVWSYGIFLWELFSLGSSPY-PGMPVD--SKFYKMIKEGFRMLSPEHAPAEMY-----DI 298
Query: 309 ISACVQKEPQQRLSAQELM 327
           +  C   +P +R + ++++
Sbjct: 299 MKTCWDADPLKRPTFKQIV 317

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 74/149 (49%), Gaps = 20/149 (13%)
Query: 140 NGAISIILEYMDGGSLADFLKKVKTI-----------PEEYLAA-----ICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+  +             PEE L++        QV +G+ Y
Sbjct: 106 DGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEY 165
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 166 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEAL 224
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
               Y ++SD+WS G++L E  T G  PY
Sbjct: 225 FDRIYTHQSDVWSFGVLLWEIFTLGGSPY 253

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 112/248 (45%), Gaps = 30/248 (12%)
Query: 99  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 157
           A+K+++       +  +  ELKI +   Q   +V    +    G + +I EY   G L +
Sbjct: 72  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 131
Query: 158 FLKKV----------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE 207
           FL++           + +    L     QV +G+ +L   K+ IHRD+   N+L+ +   
Sbjct: 132 FLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLTNGHV 190
Query: 208 VKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
            KI DFG++  + + S     G A   V    +M+PE I    Y  +SD+WS G++L E 
Sbjct: 191 AKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEI 247
Query: 263 -ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFISACVQKEPQQR 320
            + G  PY         + FY+L++       P+     F+P+   S + AC   EP  R
Sbjct: 248 FSLGLNPYPGILVN---SKFYKLVKDGYQMAQPA-----FAPKNIYSIMQACWALEPTHR 299
Query: 321 LSAQELMT 328
            + Q++ +
Sbjct: 300 PTFQQICS 307

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 117 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 175
Query: 198 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 176 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 235
Query: 253 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 307
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 236 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 283
Query: 308 FISACVQKEPQQR 320
            ++ C Q +P+ R
Sbjct: 284 IMTQCWQHQPEDR 296

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 112/248 (45%), Gaps = 30/248 (12%)
Query: 99  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 157
           A+K+++       +  +  ELKI +   Q   +V    +    G + +I EY   G L +
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 158 FLKKV----------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE 207
           FL++           + +    L     QV +G+ +L   K+ IHRD+   N+L+ +   
Sbjct: 140 FLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLTNGHV 198
Query: 208 VKITDFGVSAIMASTS-----GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
            KI DFG++  + + S     G A   V    +M+PE I    Y  +SD+WS G++L E 
Sbjct: 199 AKIGDFGLARDIMNDSNYIVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEI 255
Query: 263 -ATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE-FCSFISACVQKEPQQR 320
            + G  PY         + FY+L++       P+     F+P+   S + AC   EP  R
Sbjct: 256 FSLGLNPYPGILVN---SKFYKLVKDGYQMAQPA-----FAPKNIYSIMQACWALEPTHR 307
Query: 321 LSAQELMT 328
            + Q++ +
Sbjct: 308 PTFQQICS 315

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 111 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 169
Query: 198 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 170 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 229
Query: 253 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 307
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 230 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 277
Query: 308 FISACVQKEPQQR 320
            ++ C Q +P+ R
Sbjct: 278 IMTQCWQHQPEDR 290

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +  +     R +   E  + +   C +VV             +++E M  G L  +
Sbjct: 50  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 109
Query: 159 LKKVKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E          + +  +  ++  G+ YL+ +K  +HRDL   N ++ H   V
Sbjct: 110 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRDLAARNCMVAHDFTV 168
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  
Sbjct: 169 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 228
Query: 266 QFPY 269
           + PY
Sbjct: 229 EQPY 232

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 100/243 (41%), Gaps = 22/243 (9%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 49  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 108
Query: 159 LKKVK-------TIPEEYLAAICE---QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++        +    L+ + +   ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 109 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 167
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 168 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 227
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 228 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 279
Query: 326 LMT 328
           +++
Sbjct: 280 IIS 282

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 137 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 195
Query: 198 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 196 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 255
Query: 253 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 307
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 256 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 303
Query: 308 FISACVQKEPQQR 320
            ++ C Q +P+ R
Sbjct: 304 IMTQCWQHQPEDR 316

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 111 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 169
Query: 198 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 170 RNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 229
Query: 253 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 307
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 230 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 277
Query: 308 FISACVQKEPQQR 320
            ++ C Q +P+ R
Sbjct: 278 IMTQCWQHQPEDR 290

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 127 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 185
Query: 198 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 186 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 245
Query: 253 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 307
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 246 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 293
Query: 308 FISACVQKEPQQR 320
            ++ C Q +P+ R
Sbjct: 294 IMTQCWQHQPEDR 306

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 112 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 167
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 110
Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 226
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 111 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYK 169
Query: 227 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 269
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 111 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 169
Query: 198 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 170 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 229
Query: 253 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 307
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 230 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 277
Query: 308 FISACVQKEPQQR 320
            ++ C Q +P+ R
Sbjct: 278 IMTQCWQHQPEDR 290

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 102 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 160
Query: 198 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 161 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 220
Query: 253 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 307
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 221 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 268
Query: 308 FISACVQKEPQQR 320
            ++ C Q +P+ R
Sbjct: 269 IMTQCWQHQPEDR 281

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 112 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 167
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 414 KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 468
Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 226
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 469 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527
Query: 227 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 269
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 573

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 125 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 183
Query: 198 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 184 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 243
Query: 253 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 307
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 244 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 291
Query: 308 FISACVQKEPQQR 320
            ++ C Q +P+ R
Sbjct: 292 IMTQCWQHQPEDR 304

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 110 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 168
Query: 198 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 169 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 228
Query: 253 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 307
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 229 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 276
Query: 308 FISACVQKEPQQR 320
            ++ C Q +P+ R
Sbjct: 277 IMTQCWQHQPEDR 289

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 74/149 (49%), Gaps = 20/149 (13%)
Query: 140 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 183
           +G + +I+ Y   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 125 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 183
Query: 198 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 184 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 243
Query: 253 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 307
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 244 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 291
Query: 308 FISACVQKEPQQR 320
            ++ C Q +P+ R
Sbjct: 292 IMTQCWQHQPEDR 304

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 112 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 167
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 415 KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 469
Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 226
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 470 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 528
Query: 227 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 269
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 529 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 574

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 117/283 (41%), Gaps = 44/283 (15%)
Query: 94  TGQFFALK-VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISII 146
           +G+  A+K V+Q    ++   QI ++L       C  V + Y  FYS+G       ++++
Sbjct: 44  SGELVAIKKVLQGKAFKNRELQIMRKL-----DHCNIVRLRY-FFYSSGEKKDEVYLNLV 97
Query: 147 LEYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           L+Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++
Sbjct: 98  LDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLD 156
Query: 204 HRGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE 261
               V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E
Sbjct: 157 PDTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAE 215
Query: 262 CATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSD 299
              GQ  FP                +P  +Q       +T F      I   P       
Sbjct: 216 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--AFPQIKAHPWTKVFRP 273
Query: 300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
           +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 274 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 40/133 (30%), Positives = 67/133 (50%), Gaps = 7/133 (5%)
Query: 140 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
            G + I+ EYM  GSL D+L+      +  + L      V + + YL    + +HRDL  
Sbjct: 78  KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAA 136
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 257
            N+L++     K++DFG++   +ST       V    + +PE +    +  KSD+WS G+
Sbjct: 137 RNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALREAAFSTKSDVWSFGI 193
Query: 258 VLLECAT-GQFPY 269
           +L E  + G+ PY
Sbjct: 194 LLWEIYSFGRVPY 206

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 112 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 167
           + ++  E  + Q    PY+V    +C        +  +++E  + G L  +L++ + + +
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGIC-----EAESWMLVMEMAELGPLNKYLQQNRHVKD 126
Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 226
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 127 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 227 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 269
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 112 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 167
           + ++  E  + Q    PY+V    +C        +  +++E  + G L  +L++ + + +
Sbjct: 72  KDELLAEANVMQQLDNPYIVRMIGIC-----EAESWMLVMEMAELGPLNKYLQQNRHVKD 126
Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 226
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 127 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 227 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 269
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 112 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 167
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 70  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 124
Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 226
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 125 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 183
Query: 227 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 269
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 184 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 229

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 100/243 (41%), Gaps = 22/243 (9%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 59  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 118
Query: 159 LKKVK-------TIPEEYLAAICE---QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++        +    L+ + +   ++  G+ YL+  K  +HRDL   N ++     V
Sbjct: 119 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCMVAEDFTV 177
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 237
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
           + PY     +        +ME  +   P + P   F       +  C Q  P+ R S  E
Sbjct: 238 EQPYQGLSNEQ---VLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLE 289
Query: 326 LMT 328
           +++
Sbjct: 290 IIS 292

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 140 NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 95  DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 154
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 155 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 213
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 298
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 214 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 267
Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELM 327
           +    E    +  C    P QR + ++L+
Sbjct: 268 N----ELYMMMRDCWHAVPSQRPTFKQLV 292

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 32/205 (15%)
Query: 87  QLVQHKWTGQFFALKVIQMNVE---ESARR--QIAQELKINQSSQCPYVVVCYQSFYSNG 141
           + + HK  G+  A+K+++ NV+   E+AR   Q+ + L     +     V   + F  +G
Sbjct: 32  ECIDHKAGGRHVAVKIVK-NVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90
Query: 142 AISIILEYMDGGSLADFLKKVKTIP--EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN 199
            I I+ E + G S  DF+K+   +P   +++  +  Q+ K + +LH  K + H DLKP N
Sbjct: 91  HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK-LTHTDLKPEN 148
Query: 200 LLI---------------NHRG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           +L                + R     ++K+ DFG +          +T V T +Y +PE 
Sbjct: 149 ILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY---DDEHHSTLVSTRHYRAPEV 205
Query: 241 ISGGKYGYKSDIWSLGLVLLECATG 265
           I    +    D+WS+G +L+E   G
Sbjct: 206 ILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 112 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 167
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 62  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 116
Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 226
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 117 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175
Query: 227 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 269
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 221

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 122/284 (42%), Gaps = 46/284 (16%)
Query: 94  TGQFFALK-VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISII 146
           +G+  A+K V+Q    ++   QI ++L       C  V + Y  FYS+G       ++++
Sbjct: 44  SGELVAIKKVLQGKAFKNRELQIMRKL-----DHCNIVRLRY-FFYSSGEKKDEVYLNLV 97
Query: 147 LEYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           L+Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++
Sbjct: 98  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLD 156
Query: 204 HRGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLL 260
               V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL 
Sbjct: 157 PDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 261 ECATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPS 298
           E   GQ  FP                +P  +Q       +T F      I   P      
Sbjct: 215 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF--AFPQIKAHPWTKVFR 272
Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
            +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 273 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 112 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 167
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 50  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 104
Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 226
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 105 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 163
Query: 227 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 269
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 164 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 209

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 140 NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 99  DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 158
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 159 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 217
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 298
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 218 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 271
Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELM 327
           +    E    +  C    P QR + ++L+
Sbjct: 272 N----ELYMMMRDCWHAVPSQRPTFKQLV 296

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 140 NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 207 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 265
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 298
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 266 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 319
Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELM 327
           +    E    +  C    P QR + ++L+
Sbjct: 320 N----ELYMMMRDCWHAVPSQRPTFKQLV 344

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 140 NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 106 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 165
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 166 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 224
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 298
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 225 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 278
Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELM 327
           +    E    +  C    P QR + ++L+
Sbjct: 279 N----ELYMMMRDCWHAVPSQRPTFKQLV 303

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 78/168 (46%), Gaps = 17/168 (10%)
Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----T 222
           E+L     QV KG+ +L   K  IHRDL   N+L++ +  VKI DFG++  +        
Sbjct: 191 EHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 249
Query: 223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSF 281
            G A        +M+PE I    Y  +SD+WS G++L E  + G  PY P  + D     
Sbjct: 250 KGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKIDE---- 301
Query: 282 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
            E    + +     AP D  +PE    +  C   EP QR +  EL+ H
Sbjct: 302 -EFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 347

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 140 NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 98  DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 157
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 158 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 216
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 298
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 217 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 270
Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELM 327
           +    E    +  C    P QR + ++L+
Sbjct: 271 N----ELYMMMRDCWHAVPSQRPTFKQLV 295

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 140 NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 91  DGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEY 150
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 151 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 209
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 298
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 210 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 263
Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELM 327
           +    E    +  C    P QR + ++L+
Sbjct: 264 N----ELYMMMRDCWHAVPSQRPTFKQLV 288

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 78/168 (46%), Gaps = 17/168 (10%)
Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----T 222
           E+L     QV KG+ +L   K  IHRDL   N+L++ +  VKI DFG++  +        
Sbjct: 193 EHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 251
Query: 223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSF 281
            G A        +M+PE I    Y  +SD+WS G++L E  + G  PY P  + D     
Sbjct: 252 KGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-PGVKIDE---- 303
Query: 282 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
            E    + +     AP D  +PE    +  C   EP QR +  EL+ H
Sbjct: 304 -EFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 112 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 167
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 56  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 110
Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 226
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 111 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 169
Query: 227 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 269
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 215

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 140 NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 106 DGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEY 165
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 166 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 224
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 298
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 225 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 278
Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELM 327
           +    E    +  C    P QR + ++L+
Sbjct: 279 N----ELYMMMRDCWHAVPSQRPTFKQLV 303

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 13/176 (7%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH 186
           Y+V   + F     + ++ E M   +L D L+    + +         +Q+   LL+L  
Sbjct: 117 YIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 187 -EKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
            E  IIH DLKP N+L+ +  R  +KI DFG S  +     Q    + +  Y SPE + G
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX---IQSRFYRSPEVLLG 232
Query: 244 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM----EAIVDQPPPS 295
             Y    D+WSLG +L+E  TG+  +S   + D      E++      I+DQ P +
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           I++E M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 125 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 183
Query: 198 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 184 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 243
Query: 253 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 307
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 244 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 291
Query: 308 FISACVQKEPQQR 320
            ++ C Q +P+ R
Sbjct: 292 IMTQCWQHQPEDR 304

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 86/166 (51%), Gaps = 14/166 (8%)
Query: 112 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 167
           + ++  E  + Q    PY+V    +C    +      +++E  + G L  +L++ + + +
Sbjct: 52  KDELLAEANVMQQLDNPYIVRMIGICEAESWM-----LVMEMAELGPLNKYLQQNRHVKD 106
Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQA 226
           + +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S A+ A  +   
Sbjct: 107 KNIIELVHQVSMGMKYLE-ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165
Query: 227 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPY 269
               G +   + +PE I+  K+  KSD+WS G+++ E  + GQ PY
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY 211

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 43/149 (28%), Positives = 74/149 (49%), Gaps = 20/149 (13%)
Query: 140 NGAISIILEYMDGGSLADFLK-----------KVKTIPEEY-----LAAICEQVLKGLLY 183
           +G + +I+ Y   G+L ++L+            +  +PEE      L +   Q+ +G+ Y
Sbjct: 113 DGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEY 172
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  + +      T  G     +M+PE +
Sbjct: 173 LASQK-CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEAL 231
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
               Y ++SD+WS G+++ E  T G  PY
Sbjct: 232 FDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 122/284 (42%), Gaps = 46/284 (16%)
Query: 94  TGQFFALK-VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISII 146
           +G+  A+K V+Q    ++   QI ++L       C  V + Y  FYS+G       ++++
Sbjct: 44  SGELVAIKKVLQGKAFKNRELQIMRKL-----DHCNIVRLRY-FFYSSGEKKDEVYLNLV 97
Query: 147 LEYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           L+Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++
Sbjct: 98  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLD 156
Query: 204 HRGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLL 260
               V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL 
Sbjct: 157 PDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 261 ECATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPS 298
           E   GQ  FP                +P  +Q       +T F      I   P      
Sbjct: 215 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFR 272
Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
            +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 273 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 37/271 (13%)
Query: 87  QLVQHKWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           ++ + KW G+  A+K+     E S  R+  I Q + +   +   ++    +   +   + 
Sbjct: 57  EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKP 197
           ++ +Y + GSL D+L +  T+  E +  +      GL +LH E         I HRDLK 
Sbjct: 117 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 175
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERISGG------KYG 247
            N+L+   G   I D G++    S +       N  VGT  YM+PE +         +  
Sbjct: 176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 235
Query: 248 YKSDIWSLGLVLLE----CATG------QFPYSPPEQQDGWTSFYELMEAIVDQP-PPSA 296
            ++DI+++GLV  E    C+ G      Q PY      D   S  E+ + + +Q   P+ 
Sbjct: 236 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD--PSVEEMRKVVCEQKLRPNI 293
Query: 297 PSDQFSPE----FCSFISACVQKEPQQRLSA 323
           P+   S E        +  C       RL+A
Sbjct: 294 PNRWQSCEALRVMAKIMRECWYANGAARLTA 324

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 83/193 (43%), Gaps = 30/193 (15%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           I++E M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 110 ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 168
Query: 198 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
            N L+   G     KI DFG++  +  AS   +    +    +M PE    G +  K+D 
Sbjct: 169 RNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 228
Query: 253 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 307
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 229 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 276
Query: 308 FISACVQKEPQQR 320
            ++ C Q +P+ R
Sbjct: 277 IMTQCWQHQPEDR 289

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 76/168 (45%), Gaps = 17/168 (10%)
Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----T 222
           E+L     QV KG+ +L   K  IHRDL   N+L++ +  VKI DFG++  +        
Sbjct: 198 EHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 256
Query: 223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSF 281
            G A        +M+PE I    Y  +SD+WS G++L E  + G  PY       G    
Sbjct: 257 KGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKID 307
Query: 282 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
            E    + +     AP D  +PE    +  C   EP QR +  EL+ H
Sbjct: 308 EEFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 354

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 76/168 (45%), Gaps = 17/168 (10%)
Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-----T 222
           E+L     QV KG+ +L   K  IHRDL   N+L++ +  VKI DFG++  +        
Sbjct: 200 EHLICYSFQVAKGMEFLASRK-CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 258
Query: 223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTSF 281
            G A        +M+PE I    Y  +SD+WS G++L E  + G  PY       G    
Sbjct: 259 KGDARL---PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKID 309
Query: 282 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
            E    + +     AP D  +PE    +  C   EP QR +  EL+ H
Sbjct: 310 EEFCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 356

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 13/176 (7%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH 186
           Y+V   + F     + ++ E M   +L D L+    + +         +Q+   LL+L  
Sbjct: 98  YIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 156
Query: 187 -EKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
            E  IIH DLKP N+L+ +  R  +KI DFG S  +     Q    + +  Y SPE + G
Sbjct: 157 PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQX---IQSRFYRSPEVLLG 213
Query: 244 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM----EAIVDQPPPS 295
             Y    D+WSLG +L+E  TG+  +S   + D      E++      I+DQ P +
Sbjct: 214 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 269

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 37/271 (13%)
Query: 87  QLVQHKWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           ++ + KW G+  A+K+     E S  R+  I Q + +   +   ++    +   +   + 
Sbjct: 44  EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 103
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKP 197
           ++ +Y + GSL D+L +  T+  E +  +      GL +LH E         I HRDLK 
Sbjct: 104 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 162
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERISGG------KYG 247
            N+L+   G   I D G++    S +       N  VGT  YM+PE +         +  
Sbjct: 163 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 222
Query: 248 YKSDIWSLGLVLLE----CATG------QFPYSPPEQQDGWTSFYELMEAIVDQP-PPSA 296
            ++DI+++GLV  E    C+ G      Q PY      D   S  E+ + + +Q   P+ 
Sbjct: 223 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD--PSVEEMRKVVCEQKLRPNI 280
Query: 297 PSDQFSPE----FCSFISACVQKEPQQRLSA 323
           P+   S E        +  C       RL+A
Sbjct: 281 PNRWQSCEALRVMAKIMRECWYANGAARLTA 311

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 82/176 (46%), Gaps = 13/176 (7%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH 186
           Y+V   + F     + ++ E M   +L D L+    + +         +Q+   LL+L  
Sbjct: 117 YIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 187 -EKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
            E  IIH DLKP N+L+ +  R  +KI DFG S  +     Q    + +  Y SPE + G
Sbjct: 176 PELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQRIYQX---IQSRFYRSPEVLLG 232
Query: 244 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM----EAIVDQPPPS 295
             Y    D+WSLG +L+E  TG+  +S   + D      E++      I+DQ P +
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/243 (23%), Positives = 97/243 (39%), Gaps = 22/243 (9%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +        R +   E  + +   C +VV             +I+E M  G L  +
Sbjct: 46  AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 105
Query: 159 LKKVKTIPEE----------YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E            +  +  ++  G+ YL+  K  +HRDL   N  +     V
Sbjct: 106 LRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANK-FVHRDLAARNCXVAEDFTV 164
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +MSPE +  G +   SD+WS G+VL E AT  
Sbjct: 165 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 224
Query: 266 QFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
           + PY     +      + +   ++D+P      D         +  C Q  P+ R S  E
Sbjct: 225 EQPYQGLSNEQ--VLRFVMEGGLLDKP------DNCPDMLLELMRMCWQYNPKMRPSFLE 276
Query: 326 LMT 328
           +++
Sbjct: 277 IIS 279

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 82/193 (42%), Gaps = 30/193 (15%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 209
Query: 198 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
            N L+   G     KI DFG++  +  A    +    +    +M PE    G +  K+D 
Sbjct: 210 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 269
Query: 253 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 307
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 270 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 317
Query: 308 FISACVQKEPQQR 320
            ++ C Q +P+ R
Sbjct: 318 IMTQCWQHQPEDR 330

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 147
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 78  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132
Query: 148 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 133 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 191
Query: 205 RGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE 261
              V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL E
Sbjct: 192 DTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 249
Query: 262 CATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSD 299
              GQ  FP                +P  +Q       +T F      I   P       
Sbjct: 250 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRP 307
Query: 300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
           +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 308 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 350

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 37/271 (13%)
Query: 87  QLVQHKWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           ++ + KW G+  A+K+     E S  R+  I Q + +   +   ++    +   +   + 
Sbjct: 21  EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 80
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKP 197
           ++ +Y + GSL D+L +  T+  E +  +      GL +LH E         I HRDLK 
Sbjct: 81  LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 139
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERISGG------KYG 247
            N+L+   G   I D G++    S +       N  VGT  YM+PE +         +  
Sbjct: 140 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 199
Query: 248 YKSDIWSLGLVLLE----CATG------QFPYSPPEQQDGWTSFYELMEAIVDQP-PPSA 296
            ++DI+++GLV  E    C+ G      Q PY      D   S  E+ + + +Q   P+ 
Sbjct: 200 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD--PSVEEMRKVVCEQKLRPNI 257
Query: 297 PSDQFSPE----FCSFISACVQKEPQQRLSA 323
           P+   S E        +  C       RL+A
Sbjct: 258 PNRWQSCEALRVMAKIMRECWYANGAARLTA 288

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLH 185
           Y  +C +       I +I+E++  GSL ++L K K    + ++   A+  Q+ KG+ YL 
Sbjct: 88  YKGICTED--GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV--QICKGMDYLG 143
Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN----YMSPERI 241
             +++ HRDL   N+L+    +VKI DFG++  +  T  +  T     +    + +PE +
Sbjct: 144 SRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 242 SGGKYGYKSDIWSLGLVLLE----CATGQFPYS-------PPEQQDGWTSFYELMEAIVD 290
              K+   SD+WS G+ L E    C +   P +       P   Q   T     ++    
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR 261
Query: 291 QP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
            P PP+ P + +       +  C + +P  R S Q L+
Sbjct: 262 LPCPPNCPDEVY-----QLMRKCWEFQPSNRTSFQNLI 294

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 111/266 (41%), Gaps = 37/266 (13%)
Query: 92  KWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 149
           KW G+  A+K+     E S  R+  I Q + +   +   ++    +   +   + ++ +Y
Sbjct: 23  KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82
Query: 150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKPSNLLI 202
            + GSL D+L +  T+  E +  +      GL +LH E         I HRDLK  N+L+
Sbjct: 83  HEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 141
Query: 203 NHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERISGG------KYGYKSDI 252
              G   I D G++    S +       N  VGT  YM+PE +         +   ++DI
Sbjct: 142 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 201
Query: 253 WSLGLVLLE----CATG------QFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQF 301
           +++GLV  E    C+ G      Q PY      D   S  E+ + + +Q   P+ P+   
Sbjct: 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD--PSVEEMRKVVCEQKLRPNIPNRWQ 259
Query: 302 SPE----FCSFISACVQKEPQQRLSA 323
           S E        +  C       RL+A
Sbjct: 260 SCEALRVMAKIMRECWYANGAARLTA 285

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 82/193 (42%), Gaps = 30/193 (15%)
Query: 145 IILEYMDGGSLADFLKKVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           I+LE M GG L  FL++ +  P +        L  +   +  G  YL  E H IHRD+  
Sbjct: 128 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE-ENHFIHRDIAA 186
Query: 198 SNLLINHRGE---VKITDFGVSAIM--ASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
            N L+   G     KI DFG++  +  A    +    +    +M PE    G +  K+D 
Sbjct: 187 RNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDT 246
Query: 253 WSLGLVLLEC-ATGQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCS 307
           WS G++L E  + G  PY     Q       E++E +       PP + P   +      
Sbjct: 247 WSFGVLLWEIFSLGYMPYPSKSNQ-------EVLEFVTSGGRMDPPKNCPGPVY-----R 294
Query: 308 FISACVQKEPQQR 320
            ++ C Q +P+ R
Sbjct: 295 IMTQCWQHQPEDR 307

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 75/136 (55%), Gaps = 11/136 (8%)
Query: 142 AISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 200
           ++ ++ +Y+  GSL D +++ +  +  + L     Q+ KG+ YL  E  ++HR+L   N+
Sbjct: 106 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE-EHGMVHRNLAARNV 164
Query: 201 LINHRGEVKITDFGVSAIMASTSGQ-----ANTFVGTYNYMSPERISGGKYGYKSDIWSL 255
           L+    +V++ DFGV+ ++     Q     A T +    +M+ E I  GKY ++SD+WS 
Sbjct: 165 LLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMALESIHFGKYTHQSDVWSY 221
Query: 256 GLVLLECAT-GQFPYS 270
           G+ + E  T G  PY+
Sbjct: 222 GVTVWELMTFGAEPYA 237

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 32/209 (15%)
Query: 140 NGAISIILEYMDGGSLADFLKKVKTIPEEY----------------LAAICEQVLKGLLY 183
           +G + +I+EY   G+L ++L+  +    EY                L +   QV +G+ Y
Sbjct: 106 DGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 165
Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT--YNYMSPERI 241
           L  +K  IHRDL   N+L+     +KI DFG++  +        T  G     +M+PE +
Sbjct: 166 LASKK-CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEAL 224
Query: 242 SGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PPEQQDGWTSFYELMEAIVDQPPPSAPS 298
               Y ++SD+WS G++L E  T G  PY   P E+       ++L++       PS  +
Sbjct: 225 FDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE------LFKLLKEGHRMDKPSNCT 278
Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELM 327
           +    E    +  C    P QR + ++L+
Sbjct: 279 N----ELYMMMRDCWHAVPSQRPTFKQLV 303

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/266 (25%), Positives = 111/266 (41%), Gaps = 37/266 (13%)
Query: 92  KWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY 149
           KW G+  A+K+     E S  R+  I Q + +   +   ++    +   +   + ++ +Y
Sbjct: 24  KWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 83
Query: 150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKPSNLLI 202
            + GSL D+L +  T+  E +  +      GL +LH E         I HRDLK  N+L+
Sbjct: 84  HEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 142
Query: 203 NHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERISGG------KYGYKSDI 252
              G   I D G++    S +       N  VGT  YM+PE +         +   ++DI
Sbjct: 143 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 202
Query: 253 WSLGLVLLE----CATG------QFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQF 301
           +++GLV  E    C+ G      Q PY      D   S  E+ + + +Q   P+ P+   
Sbjct: 203 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD--PSVEEMRKVVCEQKLRPNIPNRWQ 260
Query: 302 SPE----FCSFISACVQKEPQQRLSA 323
           S E        +  C       RL+A
Sbjct: 261 SCEALRVMAKIMRECWYANGAARLTA 286

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/271 (24%), Positives = 114/271 (42%), Gaps = 37/271 (13%)
Query: 87  QLVQHKWTGQFFALKVIQMNVEESARRQ--IAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           ++ + KW G+  A+K+     E S  R+  I Q + +   +   ++    +   +   + 
Sbjct: 24  EVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 83
Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-------KHIIHRDLKP 197
           ++ +Y + GSL D+L +  T+  E +  +      GL +LH E         I HRDLK 
Sbjct: 84  LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKS 142
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQA----NTFVGTYNYMSPERISGG------KYG 247
            N+L+   G   I D G++    S +       N  VGT  YM+PE +         +  
Sbjct: 143 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESF 202
Query: 248 YKSDIWSLGLVLLE----CATG------QFPYSPPEQQDGWTSFYELMEAIVDQP-PPSA 296
            ++DI+++GLV  E    C+ G      Q PY      D   S  E+ + + +Q   P+ 
Sbjct: 203 KRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD--PSVEEMRKVVCEQKLRPNI 260
Query: 297 PSDQFSPE----FCSFISACVQKEPQQRLSA 323
           P+   S E        +  C       RL+A
Sbjct: 261 PNRWQSCEALRVMAKIMRECWYANGAARLTA 291

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 147
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 57  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 111
Query: 148 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 112 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 170
Query: 205 RGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE 261
              V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL E
Sbjct: 171 DTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 228
Query: 262 CATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSD 299
              GQ  FP                +P  +Q       +T F      I   P       
Sbjct: 229 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRP 286
Query: 300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
           +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 287 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 329

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 147
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 49  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 103
Query: 148 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 104 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 162
Query: 205 RGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE 261
              V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL E
Sbjct: 163 DTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 220
Query: 262 CATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSD 299
              GQ  FP                +P  +Q       +T F      I   P       
Sbjct: 221 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRP 278
Query: 300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
           +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 279 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 321

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +  +     R +   E  + +   C +VV             +++E M  G L  +
Sbjct: 52  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 111
Query: 159 LKKVKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E          + +  +  ++  G+ YL+ +K  +HR+L   N ++ H   V
Sbjct: 112 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRNLAARNCMVAHDFTV 170
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  
Sbjct: 171 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 230
Query: 266 QFPY 269
           + PY
Sbjct: 231 EQPY 234

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/184 (23%), Positives = 81/184 (44%), Gaps = 14/184 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K +  +     R +   E  + +   C +VV             +++E M  G L  +
Sbjct: 51  AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSY 110
Query: 159 LKKVKTIPE----------EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           L+ ++   E          + +  +  ++  G+ YL+ +K  +HR+L   N ++ H   V
Sbjct: 111 LRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK-FVHRNLAARNCMVAHDFTV 169
Query: 209 KITDFGVSAIMASTSGQANTFVGT--YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-G 265
           KI DFG++  +  T        G     +M+PE +  G +   SD+WS G+VL E  +  
Sbjct: 170 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA 229
Query: 266 QFPY 269
           + PY
Sbjct: 230 EQPY 233

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 147
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 72  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 126
Query: 148 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 127 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 185
Query: 205 RGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE 261
              V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL E
Sbjct: 186 DTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 243
Query: 262 CATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSD 299
              GQ  FP                +P  +Q       +T F      I   P       
Sbjct: 244 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRP 301
Query: 300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
           +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 302 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 344

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 147
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 80  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 134
Query: 148 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 135 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 193
Query: 205 RGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE 261
              V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL E
Sbjct: 194 DTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 251
Query: 262 CATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSD 299
              GQ  FP                +P  +Q       +T F      I   P       
Sbjct: 252 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRP 309
Query: 300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
           +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 310 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 352

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 42  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 100
Query: 159 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 217
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 101 LQVRKFSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 218 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 275
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 160 YMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219
Query: 276 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 220 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 147
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 44  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98
Query: 148 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 99  DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 157
Query: 205 RGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE 261
              V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL E
Sbjct: 158 DTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 215
Query: 262 CATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSD 299
              GQ  FP                +P  +Q       +T F      I   P       
Sbjct: 216 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRP 273
Query: 300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
           +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 274 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLH 185
           Y  +C +       I +I+E++  GSL ++L K K    + ++   A+  Q+ KG+ YL 
Sbjct: 76  YKGICTED--GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV--QICKGMDYLG 131
Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN----YMSPERI 241
             +++ HRDL   N+L+    +VKI DFG++  +  T  +  T     +    + +PE +
Sbjct: 132 SRQYV-HRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 242 SGGKYGYKSDIWSLGLVLLE----CATGQFPYS-------PPEQQDGWTSFYELMEAIVD 290
              K+   SD+WS G+ L E    C +   P +       P   Q   T     ++    
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR 249
Query: 291 QP-PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
            P PP+ P + +       +  C + +P  R S Q L+
Sbjct: 250 LPCPPNCPDEVY-----QLMRKCWEFQPSNRTSFQNLI 282

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 122/284 (42%), Gaps = 46/284 (16%)
Query: 94  TGQFFALK-VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISII 146
           +G+  A+K V+Q    ++   QI ++L       C  V + Y  FYS+G       ++++
Sbjct: 82  SGELVAIKKVLQDKRFKNRELQIMRKL-----DHCNIVRLRY-FFYSSGEKKDEVYLNLV 135
Query: 147 LEYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
           L+Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++
Sbjct: 136 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLD 194
Query: 204 HRGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLL 260
               V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL 
Sbjct: 195 PDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 252
Query: 261 ECATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPS 298
           E   GQ  FP                +P  +Q       +T F      I   P      
Sbjct: 253 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFR 310
Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
            +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 311 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 354

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/283 (26%), Positives = 120/283 (42%), Gaps = 44/283 (15%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 147
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 123 SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 177
Query: 148 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 178 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 236
Query: 205 RGEV-KITDFGVSAIMASTSGQAN-TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLE 261
              V K+ DFG +  +    G+ N +++ +  Y +PE I G   Y    D+WS G VL E
Sbjct: 237 DTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 294
Query: 262 CATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSD 299
              GQ  FP                +P  +Q       +T F      I   P       
Sbjct: 295 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRP 352
Query: 300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
           +  PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 353 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 395

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 147
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 52  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 106
Query: 148 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 107 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 165
Query: 205 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC 262
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 166 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 224
Query: 263 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 300
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 225 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 282
Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 283 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 324

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 75/136 (55%), Gaps = 11/136 (8%)
Query: 142 AISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 200
           ++ ++ +Y+  GSL D +++ +  +  + L     Q+ KG+ YL  E  ++HR+L   N+
Sbjct: 88  SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE-EHGMVHRNLAARNV 146
Query: 201 LINHRGEVKITDFGVSAIMASTSGQ-----ANTFVGTYNYMSPERISGGKYGYKSDIWSL 255
           L+    +V++ DFGV+ ++     Q     A T +    +M+ E I  GKY ++SD+WS 
Sbjct: 147 LLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI---KWMALESIHFGKYTHQSDVWSY 203
Query: 256 GLVLLECAT-GQFPYS 270
           G+ + E  T G  PY+
Sbjct: 204 GVTVWELMTFGAEPYA 219

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 147
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 63  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 117
Query: 148 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 118 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 176
Query: 205 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC 262
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 177 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 235
Query: 263 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 300
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 236 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 293
Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 294 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 335

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 147
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 56  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 110
Query: 148 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 111 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 169
Query: 205 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC 262
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 170 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 228
Query: 263 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 300
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 229 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 286
Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 287 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 328

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 147
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 56  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 110
Query: 148 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 111 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 169
Query: 205 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC 262
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 170 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 228
Query: 263 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 300
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 229 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 286
Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 287 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 328

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 147
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 45  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 99
Query: 148 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 100 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 158
Query: 205 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC 262
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 159 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 217
Query: 263 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 300
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 218 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 275
Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 276 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 317

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 147
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 44  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98
Query: 148 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 99  DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 157
Query: 205 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC 262
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 216
Query: 263 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 300
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 217 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 274
Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 275 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 147
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 44  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 98
Query: 148 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 99  DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 157
Query: 205 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC 262
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 216
Query: 263 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 300
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 217 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 274
Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 275 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 147
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 48  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 102
Query: 148 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 103 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 161
Query: 205 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC 262
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 162 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 220
Query: 263 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 300
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 221 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 278
Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 279 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 320

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 147
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 78  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132
Query: 148 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 133 DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 191
Query: 205 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC 262
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 192 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 250
Query: 263 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 300
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 251 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 308
Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 309 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 350

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 115/282 (40%), Gaps = 42/282 (14%)
Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------ISIIL 147
           +G+  A+K +  +     +R   +EL+I +      +V     FYS+G       ++++L
Sbjct: 44  SGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVL 98
Query: 148 EYMDGG--SLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           +Y+      +A    + K T+P  Y+     Q+ + L Y+H    I HRD+KP NLL++ 
Sbjct: 99  DYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDP 157
Query: 205 RGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC 262
              V K+ DFG +  +       +     Y Y +PE I G   Y    D+WS G VL E 
Sbjct: 158 DTAVLKLCDFGSAKQLVRGEPNVSXICSRY-YRAPELIFGATDYTSSIDVWSAGCVLAEL 216
Query: 263 ATGQ--FP---------------YSPPEQQ-----DGWTSFYELMEAIVDQPPPSAPSDQ 300
             GQ  FP                +P  +Q       +T F      I   P       +
Sbjct: 217 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK--FPQIKAHPWTKVFRPR 274
Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL 342
             PE  +  S  ++  P  RL+  E   H F     D NV L
Sbjct: 275 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKL 316

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 69/138 (50%), Gaps = 6/138 (4%)
Query: 139 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 102 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 160
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQA-NTFVGT---YNYMSPERISGGKYGYKSDIW 253
            N +++ +  VK+ DFG++  M      + +   G      +M+ E +   K+  KSD+W
Sbjct: 161 RNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 220
Query: 254 SLGLVLLECATGQFPYSP 271
           S G++L E  T   P  P
Sbjct: 221 SFGVLLWELMTRGAPPYP 238

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 422 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 480
Query: 159 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 217
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 481 LQVRKFSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539
Query: 218 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 275
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599
Query: 276 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 600 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 642

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 32/205 (15%)
Query: 87  QLVQHKWTGQFFALKVIQMNVE---ESARR--QIAQELKINQSSQCPYVVVCYQSFYSNG 141
           + + HK  G+  A+K+++ NV+   E+AR   Q+ + L     +     V   + F  +G
Sbjct: 32  ECIDHKAGGRHVAVKIVK-NVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90
Query: 142 AISIILEYMDGGSLADFLKKVKTIP--EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN 199
            I I+ E + G S  DF+K+   +P   +++  +  Q+ K + +LH  K + H DLKP N
Sbjct: 91  HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK-LTHTDLKPEN 148
Query: 200 LLI---------------NHRG----EVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           +L                + R     ++K+ DFG +          +T V   +Y +PE 
Sbjct: 149 ILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY---DDEHHSTLVXXRHYRAPEV 205
Query: 241 ISGGKYGYKSDIWSLGLVLLECATG 265
           I    +    D+WS+G +L+E   G
Sbjct: 206 ILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 20/201 (9%)
Query: 88  LVQHKWTGQFFALKVI---QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS 144
           LV+    G F+ALK I   +    E A+R+       N  +    V  C +   +     
Sbjct: 47  LVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106
Query: 145 IILEYMDGGSLADFLKKVKT----IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL 200
           ++L +   G+L + ++++K     + E+ +  +   + +GL  +H  K   HRDLKP+N+
Sbjct: 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH-AKGYAHRDLKPTNI 165
Query: 201 LINHRGEVKITDFGV---SAIMASTSGQANTFVG------TYNYMSPERISGGKYGY--- 248
           L+   G+  + D G    + I    S QA T         T +Y +PE  S   +     
Sbjct: 166 LLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDE 225
Query: 249 KSDIWSLGLVLLECATGQFPY 269
           ++D+WSLG VL     G+ PY
Sbjct: 226 RTDVWSLGCVLYAMMFGEGPY 246

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 42  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 100
Query: 159 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 217
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 101 LQVRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 218 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 275
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 160 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219
Query: 276 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 220 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 16/143 (11%)
Query: 139 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 103 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 161
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN---------YMSPERISGGKYGY 248
            N +++ +  VK+ DFG++  M         +   +N         +M+ E +   K+  
Sbjct: 162 RNCMLDEKFTVKVADFGLARDMYDKE-----YYSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 249 KSDIWSLGLVLLECATGQFPYSP 271
           KSD+WS G++L E  T   P  P
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYP 239

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 42  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 100
Query: 159 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 217
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 101 LQVRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 159
Query: 218 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 275
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 160 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219
Query: 276 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 220 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 70  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 128
Query: 159 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 217
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 129 LQVRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 187
Query: 218 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 275
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 188 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 247
Query: 276 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 248 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 290

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 90/229 (39%), Gaps = 65/229 (28%)
Query: 173 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT---- 228
           +  Q++K + YLH    ++HRD+KPSN+L+N    VK+ DFG+S    +     N     
Sbjct: 114 VVYQLIKVIKYLH-SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 229 -----------------FVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP 268
                            +V T  Y +PE + G  KY    D+WSLG +L E   G+  FP
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP 232
Query: 269 YSP--------------PEQQD--------GWTSFYELMEAIVDQPPPSAPSDQFSP--- 303
            S               P  +D          T    L E +  +   S   D F+    
Sbjct: 233 GSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKV--EIRQSNKRDIFTKWKN 290
Query: 304 -------------EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 339
                        E    +   +Q  P +R+SA + + HPF+ ++ + N
Sbjct: 291 LLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 47  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 105
Query: 159 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 217
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 106 LQVRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164
Query: 218 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 275
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224
Query: 276 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 225 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 267

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 45  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 103
Query: 159 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 217
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 104 LQVRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 162
Query: 218 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 275
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 163 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 222
Query: 276 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 223 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 265

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 139 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 121 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 179
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN---------YMSPERISGGKYGY 248
            N +++ +  VK+ DFG++  M         +   +N         +M+ E +   K+  
Sbjct: 180 RNCMLDEKFTVKVADFGLARDMYDKE-----YYSVHNKTGAKLPVKWMALESLQTQKFTT 234
Query: 249 KSDIWSLGLVLLECAT-GQFPY 269
           KSD+WS G++L E  T G  PY
Sbjct: 235 KSDVWSFGVLLWELMTRGAPPY 256

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 139 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 122 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 180
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN---------YMSPERISGGKYGY 248
            N +++ +  VK+ DFG++  M         +   +N         +M+ E +   K+  
Sbjct: 181 RNCMLDEKFTVKVADFGLARDMYDKE-----YYSVHNKTGAKLPVKWMALESLQTQKFTT 235
Query: 249 KSDIWSLGLVLLECAT-GQFPY 269
           KSD+WS G++L E  T G  PY
Sbjct: 236 KSDVWSFGVLLWELMTRGAPPY 257

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 16/143 (11%)
Query: 139 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 103 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 161
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN---------YMSPERISGGKYGY 248
            N +++ +  VK+ DFG++  M         +   +N         +M+ E +   K+  
Sbjct: 162 RNCMLDEKFTVKVADFGLARDMYDKE-----YYSVHNKTGAKLPVKWMALESLQTQKFTT 216
Query: 249 KSDIWSLGLVLLECATGQFPYSP 271
           KSD+WS G++L E  T   P  P
Sbjct: 217 KSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 16/143 (11%)
Query: 139 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 102 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 160
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN---------YMSPERISGGKYGY 248
            N +++ +  VK+ DFG++  M         +   +N         +M+ E +   K+  
Sbjct: 161 RNCMLDEKFTVKVADFGLARDMYDKE-----YYSVHNKTGAKLPVKWMALESLQTQKFTT 215
Query: 249 KSDIWSLGLVLLECATGQFPYSP 271
           KSD+WS G++L E  T   P  P
Sbjct: 216 KSDVWSFGVLLWELMTRGAPPYP 238

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 44  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 102
Query: 159 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 217
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 103 LQVRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 161
Query: 218 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 275
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 162 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 221
Query: 276 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 222 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 264

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 42  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 100
Query: 159 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 217
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 101 LQVRKFSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSATDCVKLGDFGLSR 159
Query: 218 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 275
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 160 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 219
Query: 276 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 220 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 39  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 97
Query: 159 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 217
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 98  LQVRKYSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156
Query: 218 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 275
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216
Query: 276 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 217 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 259

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 16/143 (11%)
Query: 139 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 95  SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 153
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN---------YMSPERISGGKYGY 248
            N +++ +  VK+ DFG++  M         +   +N         +M+ E +   K+  
Sbjct: 154 RNCMLDEKFTVKVADFGLARDMYDKE-----YYSVHNKTGAKLPVKWMALESLQTQKFTT 208
Query: 249 KSDIWSLGLVLLECATGQFPYSP 271
           KSD+WS G++L E  T   P  P
Sbjct: 209 KSDVWSFGVLLWELMTRGAPPYP 231

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 16/143 (11%)
Query: 139 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 101 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 159
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN---------YMSPERISGGKYGY 248
            N +++ +  VK+ DFG++  M         +   +N         +M+ E +   K+  
Sbjct: 160 RNCMLDEKFTVKVADFGLARDMYDKE-----YYSVHNKTGAKLPVKWMALESLQTQKFTT 214
Query: 249 KSDIWSLGLVLLECATGQFPYSP 271
           KSD+WS G++L E  T   P  P
Sbjct: 215 KSDVWSFGVLLWELMTRGAPPYP 237

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 100/233 (42%), Gaps = 17/233 (7%)
Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           A+K  +    +S R +  QE    +    P++V        N  + II+E    G L  F
Sbjct: 422 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSF 480
Query: 159 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 217
           L+  K ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S 
Sbjct: 481 LQVRKFSLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSATDCVKLGDFGLSR 539
Query: 218 IMA-STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 275
            M  ST  +A+       +M+PE I+  ++   SD+W  G+ + E    G  P+   +  
Sbjct: 540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599
Query: 276 D--GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           D  G     E +       PP+ P     P   S ++ C   +P +R    EL
Sbjct: 600 DVIGRIENGERLPM-----PPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 642

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 69/137 (50%), Gaps = 7/137 (5%)
Query: 139 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 100 SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 158
Query: 198 SNLLINHRGEVKITDFGVSAIMASTS-GQANTFVGT---YNYMSPERISGGKYGYKSDIW 253
            N +++ +  VK+ DFG++  M        +   G      +M+ E +   K+  KSD+W
Sbjct: 159 RNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVW 218
Query: 254 SLGLVLLECAT-GQFPY 269
           S G++L E  T G  PY
Sbjct: 219 SFGVLLWELMTRGAPPY 235

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 69/143 (48%), Gaps = 16/143 (11%)
Query: 139 SNGAISIILEYMDGGSLADFLKKVKTIPE-EYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
           S G+  ++L YM  G L +F++     P  + L     QV KG+ YL  +K  +HRDL  
Sbjct: 98  SEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK-FVHRDLAA 156
Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN---------YMSPERISGGKYGY 248
            N +++ +  VK+ DFG++  M         +   +N         +M+ E +   K+  
Sbjct: 157 RNCMLDEKFTVKVADFGLARDMYDKE-----YYSVHNKTGAKLPVKWMALESLQTQKFTT 211
Query: 249 KSDIWSLGLVLLECATGQFPYSP 271
           KSD+WS G++L E  T   P  P
Sbjct: 212 KSDVWSFGVLLWELMTRGAPPYP 234

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 119/279 (42%), Gaps = 43/279 (15%)
Query: 99  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 157
           A+K ++    +   R  A EL++  +    P ++    +    G + + +EY   G+L D
Sbjct: 46  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 105
Query: 158 FLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           FL+K +                T+  + L      V +G+ YL  +K  IHRDL   N+L
Sbjct: 106 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNIL 164
Query: 202 INHRGEVKITDFGVS----AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 257
           +      KI DFG+S      +  T G+         +M+ E ++   Y   SD+WS G+
Sbjct: 165 VGENYVAKIADFGLSRGQEVYVKKTMGRLPV-----RWMAIESLNYSVYTTNSDVWSYGV 219
Query: 258 VLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE 316
           +L E  + G  PY       G T   EL E +        P +    E    +  C +++
Sbjct: 220 LLWEIVSLGGTPYC------GMTCA-ELYEKLPQGYRLEKPLN-CDDEVYDLMRQCWREK 271
Query: 317 PQQRLS-AQELMTHPFL----KMYGDLNVDLSEYFTDAG 350
           P +R S AQ L++   +    K Y  +N  L E FT AG
Sbjct: 272 PYERPSFAQILVSLNRMLEERKTY--VNTTLYEKFTYAG 308

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 119/279 (42%), Gaps = 43/279 (15%)
Query: 99  ALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 157
           A+K ++    +   R  A EL++  +    P ++    +    G + + +EY   G+L D
Sbjct: 56  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 115
Query: 158 FLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL 201
           FL+K +                T+  + L      V +G+ YL  +K  IHRDL   N+L
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNIL 174
Query: 202 INHRGEVKITDFGVS----AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL 257
           +      KI DFG+S      +  T G+         +M+ E ++   Y   SD+WS G+
Sbjct: 175 VGENYVAKIADFGLSRGQEVYVKKTMGRLPV-----RWMAIESLNYSVYTTNSDVWSYGV 229
Query: 258 VLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE 316
           +L E  + G  PY       G T   EL E +        P +    E    +  C +++
Sbjct: 230 LLWEIVSLGGTPYC------GMTCA-ELYEKLPQGYRLEKPLN-CDDEVYDLMRQCWREK 281
Query: 317 PQQRLS-AQELMTHPFL----KMYGDLNVDLSEYFTDAG 350
           P +R S AQ L++   +    K Y  +N  L E FT AG
Sbjct: 282 PYERPSFAQILVSLNRMLEERKTY--VNTTLYEKFTYAG 318

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 92/194 (47%), Gaps = 18/194 (9%)
Query: 87  QLVQHKWTGQFFALK-VIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA--- 142
           QL + K TG   A+K VIQ     +   QI Q+L +      P +V     FY+ G    
Sbjct: 40  QLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHH---PNIVQLQSYFYTLGERDR 96
Query: 143 ----ISIILEYMDGG---SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK-HIIHRD 194
               +++++EY+         ++ ++    P   +     Q+++ +  LH    ++ HRD
Sbjct: 97  RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRD 156
Query: 195 LKPSNLLINHR-GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDI 252
           +KP N+L+N   G +K+ DFG SA   S S     ++ +  Y +PE I G + Y    DI
Sbjct: 157 IKPHNVLVNEADGTLKLCDFG-SAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDI 215
Query: 253 WSLGLVLLECATGQ 266
           WS+G +  E   G+
Sbjct: 216 WSVGCIFAEMMLGE 229

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 140 NGAISIILEYMDG---GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLK 196
           N  +++I+EY+       L  F++  ++IP   ++    Q+ + + ++H    I HRD+K
Sbjct: 110 NKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIK 168
Query: 197 PSNLLINHR-GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWS 254
           P NLL+N +   +K+ DFG +  +  +          + Y +PE + G  +Y    D+WS
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRF-YRAPELMLGATEYTPSIDLWS 227
Query: 255 LGLVLLECATGQFPYSPPEQQDGWTSFYELM-----EAIVDQPP-------PSAPSDQFS 302
           +G V  E   G+  +S     D      ++M     E ++   P       P+  +  + 
Sbjct: 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR 287
Query: 303 ---PE-----FCSFISACVQKEPQQRLSAQELMTHPFL 332
              PE         +   ++ EP  R++  E M HPF 
Sbjct: 288 KILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 49/167 (29%), Positives = 81/167 (48%), Gaps = 13/167 (7%)
Query: 165 IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 224
           I  E L +   QV +G+ +L   K  IHRDL   N+L++    VKI DFG++  +     
Sbjct: 196 ITMEDLISYSFQVARGMEFLSSRK-CIHRDLAARNILLSENNVVKICDFGLARDIYKNPD 254
Query: 225 ---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC-ATGQFPYSPPEQQDGWTS 280
              + +T +    +M+PE I    Y  KSD+WS G++L E  + G  PY   +  + + S
Sbjct: 255 YVRKGDTRL-PLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCS 313
Query: 281 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
              L E +  + P  +     +PE    +  C  ++P++R    EL+
Sbjct: 314 --RLREGMRMRAPEYS-----TPEIYQIMLDCWHRDPKERPRFAELV 353
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	362
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-145
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-142
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-141
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-137
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-136
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-90
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-89
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-85
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-85
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-85
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-85
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	8e-85
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-84
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-84
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-84
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-82
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	8e-81
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-80
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-80
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-80
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-79
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-77
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-77
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	7e-77
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-75
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-75
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-74
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-74
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	6e-67
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-65
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-64
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-64
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-63
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-62
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	8e-62
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-61
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-59
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-58
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-57
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-57
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-56
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-56
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-56
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-55
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	3e-55
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-55
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-55
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-55
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-54
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-54
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-54
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-54
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-54
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-54
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-54
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-54
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-54
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-54
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-54
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-53
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-53
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-53
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-53
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	4e-53
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-53
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-53
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-53
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-53
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-52
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-52
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-52
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-52
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-52
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-52
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-52
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-52
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-52
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-52
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	5e-52
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-52
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-51
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-51
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-51
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-51
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-51
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-51
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-51
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-50
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-50
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-50
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-50
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-50
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-50
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-49
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-49
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-49
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-49
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-49
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-49
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-49
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	8e-49
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-48
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-48
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-48
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-48
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-48
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-48
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-47
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-47
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-47
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-47
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-47
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-47
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-47
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-46
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-46
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-46
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-46
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-46
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-45
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-45
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-45
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-45
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-44
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-44
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-44
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-44
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-43
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-43
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-43
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-40
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-40
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-40
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-39
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-39
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-38
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-38
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-37
3niz_A	311	Rhodanese family protein; structural genomics, str	5e-37
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-36
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-36
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-36
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-36
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-36
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-35
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-34
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-34
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-33
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-33
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	6e-33
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	3e-32
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-32
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-32
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-31
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-31
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-31
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-31
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-31
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-30
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-30
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-30
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	3e-30
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-30
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-30
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-30
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-30
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-30
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-30
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-30
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-29
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-29
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-29
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-29
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-29
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-29
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-29
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-29
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	5e-29
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-29
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-29
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	7e-29
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-29
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-29
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	9e-29
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-28
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-28
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-28
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-28
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-28
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-28
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-28
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-28
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-27
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-27
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-27
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-27
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-27
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-27
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-27
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-27
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	3e-27
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	3e-27
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-27
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	4e-27
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-27
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-27
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-27
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	9e-27
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-26
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-26
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-26
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-26
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-25
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-25
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-25
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-24
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-24
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-24
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-24
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-23
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-23
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-23
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-23
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-23
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-16
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	9e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	9e-15
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-12
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	6e-04

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  414 bits (1066), Expect = e-145
 Identities = 124/325 (38%), Positives = 182/325 (56%), Gaps = 37/325 (11%)

Query: 60  IKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQEL 119
            K    +L  +D + I  +G G+GG+V  V HK +G   A K+I + ++ + R QI +EL
Sbjct: 23  QKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIREL 82

Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           ++      PY+V  Y +FYS+G ISI +E+MDGGSL   LKK   IPE+ L  +   V+K
Sbjct: 83  QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 142

Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
           GL YL  +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPE
Sbjct: 143 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPE 200

Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD----------------------- 276
           R+ G  Y  +SDIWS+GL L+E A G++P  PP+ ++                       
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260

Query: 277 ------------GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 324
                          + +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   +
Sbjct: 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 320

Query: 325 ELMTHPFLKMYGDLNVDLSEYFTDA 349
           +LM H F+K      VD + +    
Sbjct: 321 QLMVHAFIKRSDAEEVDFAGWLCST 345

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  404 bits (1041), Expect = e-142
 Identities = 100/292 (34%), Positives = 169/292 (57%), Gaps = 17/292 (5%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN-QS 124
           ++  +D++ I  +G+G+ G+V+ ++H  +GQ  A+K I+  V    ++++  +L I+ ++
Sbjct: 3   EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRT 62

Query: 125 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKG 180
             CP+ V  Y + +  G + I +E MD  SL  F K+V    +TIPE+ L  I   ++K 
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           L +LH +  +IHRD+KPSN+LIN  G+VK+ DFG+S  +       +   G   YM+PER
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD-DVAKDIDAGCKPYMAPER 180

Query: 241 ISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA 296
           I+       Y  KSDIWSLG+ ++E A  +FPY        W + ++ ++ +V++P P  
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDS------WGTPFQQLKQVVEEPSPQL 234

Query: 297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 348
           P+D+FS EF  F S C++K  ++R +  ELM HPF  ++     D++ +   
Sbjct: 235 PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVASFVKL 286

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  393 bits (1011), Expect = e-137
 Identities = 92/296 (31%), Positives = 161/296 (54%), Gaps = 14/296 (4%)

Query: 60  IKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQEL 119
           I     Q  + D++ +  +G G+ G V  ++ + TG   A+K ++ +  +   ++I  +L
Sbjct: 15  IGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDL 74

Query: 120 KIN-QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 178
            +  +S  CPY+V C+ +F +N  + I +E M   +     +    IPE  L  +   ++
Sbjct: 75  DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIV 134

Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 238
           K L YL  +  +IHRD+KPSN+L++ RG++K+ DFG+S  +     + +   G   YM+P
Sbjct: 135 KALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCAAYMAP 193

Query: 239 ERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 293
           ERI     +   Y  ++D+WSLG+ L+E ATGQFPY          + +E++  ++ + P
Sbjct: 194 ERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN------CKTDFEVLTKVLQEEP 247

Query: 294 PSAPSDQ-FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 348
           P  P    FS +F SF+  C+ K+ ++R    +L+ H F+K Y  L VD++ +F D
Sbjct: 248 PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKD 303

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  389 bits (1002), Expect = e-136
 Identities = 101/296 (34%), Positives = 157/296 (53%), Gaps = 21/296 (7%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQS 124
               ED+  +  +G+G+ G V  + HK +GQ  A+K I+  V+E  ++Q+  +L +  +S
Sbjct: 18  DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRS 77

Query: 125 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-----TIPEEYLAAICEQVLK 179
           S CPY+V  Y + +  G   I +E M   S   F K V       IPEE L  I    +K
Sbjct: 78  SDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVK 136

Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
            L +L     IIHRD+KPSN+L++  G +K+ DFG+S  +  +  +     G   YM+PE
Sbjct: 137 ALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD-AGCRPYMAPE 195

Query: 240 RISGGK----YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS 295
           RI        Y  +SD+WSLG+ L E ATG+FPY        W S ++ +  +V   PP 
Sbjct: 196 RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK------WNSVFDQLTQVVKGDPPQ 249

Query: 296 APSD---QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 348
             +    +FSP F +F++ C+ K+  +R   +EL+ HPF+ MY +  V+++ Y   
Sbjct: 250 LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCK 305

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  271 bits (695), Expect = 8e-90
 Identities = 83/291 (28%), Positives = 134/291 (46%), Gaps = 12/291 (4%)

Query: 50  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--V 107
              + +    ++P      L +    K +G+G    V        G   ALK +Q+   +
Sbjct: 12  PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71

Query: 108 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---- 163
           +  AR    +E+ + +    P V+  Y SF  +  ++I+LE  D G L+  +K  K    
Sbjct: 72  DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR 131

Query: 164 TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 223
            IPE  +     Q+   L ++H  + ++HRD+KP+N+ I   G VK+ D G+    +S +
Sbjct: 132 LIPERTVWKYFVQLCSALEHMH-SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190

Query: 224 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 283
             A++ VGT  YMSPERI    Y +KSDIWSLG +L E A  Q P+          + Y 
Sbjct: 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-----YGDKMNLYS 245

Query: 284 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM 334
           L + I     P  PSD +S E    ++ C+  +P++R     +        
Sbjct: 246 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  271 bits (694), Expect = 4e-89
 Identities = 71/271 (26%), Positives = 131/271 (48%), Gaps = 12/271 (4%)

Query: 68  NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQ 126
           ++E    ++ +G+GS G   LV+    G+ + +K I +  +    R +  +E+ +  + +
Sbjct: 22  SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK 81

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYL 184
            P +V   +SF  NG++ I+++Y +GG L   +   K     E+ +     Q+   L ++
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 185 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 244
           H ++ I+HRD+K  N+ +   G V++ DFG++ ++ ST   A   +GT  Y+SPE     
Sbjct: 142 H-DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200

Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 304
            Y  KSDIW+LG VL E  T +  +          S   L+  I+    P      +S +
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFE-------AGSMKNLVLKIISGSFPPVSL-HYSYD 252

Query: 305 FCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
             S +S   ++ P+ R S   ++   F+   
Sbjct: 253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  260 bits (667), Expect = 1e-85
 Identities = 98/269 (36%), Positives = 142/269 (52%), Gaps = 20/269 (7%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 129
           E    ++ +GKGS G V       T +  A+K+I +   E     I QE+ +      PY
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 81

Query: 130 VVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 189
           V   Y S+  +  + II+EY+ GGS  D L+    + E  +A I  ++LKGL YLH EK 
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK- 139

Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 249
            IHRD+K +N+L++  GEVK+ DFGV+  +  T  + NTFVGT  +M+PE I    Y  K
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 199

Query: 250 SDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA---IVDQPPPSAPSDQFSPE 304
           +DIWSLG+  +E A G+ P+S   P            M+    I    PP+     +S  
Sbjct: 200 ADIWSLGITAIELARGEPPHSELHP------------MKVLFLIPKNNPPTL-EGNYSKP 246

Query: 305 FCSFISACVQKEPQQRLSAQELMTHPFLK 333
              F+ AC+ KEP  R +A+EL+ H F+ 
Sbjct: 247 LKEFVEACLNKEPSFRPTAKELLKHKFIL 275

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  259 bits (665), Expect = 2e-85
 Identities = 84/275 (30%), Positives = 146/275 (53%), Gaps = 23/275 (8%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVV 131
              + +G+G+ G V       TGQ  A++  QMN+++  +++ I  E+ + + ++ P +V
Sbjct: 23  TRFEKIGQGASGTVYTAMDVATGQEVAIR--QMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
               S+     + +++EY+ GGSL D + +   + E  +AA+C + L+ L +LH    +I
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLH-SNQVI 138

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           HRD+K  N+L+   G VK+TDFG  A +     + +T VGT  +M+PE ++   YG K D
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVD 198

Query: 252 IWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA---IVDQPPPS-APSDQFSPEF 305
           IWSLG++ +E   G+ PY    P            + A   I     P     ++ S  F
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENP------------LRALYLIATNGTPELQNPEKLSAIF 246

Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 340
             F++ C++ + ++R SA+EL+ H FLK+   L+ 
Sbjct: 247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSS 281

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  259 bits (663), Expect = 5e-85
 Identities = 95/273 (34%), Positives = 149/273 (54%), Gaps = 23/273 (8%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 134
           ++ +G+GS G V    HK TGQ  A+K + +  +     +I +E+ I Q    P+VV  Y
Sbjct: 34  LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ---EIIKEISIMQQCDSPHVVKYY 90

Query: 135 QSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHR 193
            S++ N  + I++EY   GS++D ++   KT+ E+ +A I +  LKGL YLH     IHR
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH-FMRKIHR 149

Query: 194 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIW 253
           D+K  N+L+N  G  K+ DFGV+  +  T  + NT +GT  +M+PE I    Y   +DIW
Sbjct: 150 DIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIW 209

Query: 254 SLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA---IVDQPPPS-APSDQFSPEFCS 307
           SLG+  +E A G+ PY+   P            M A   I   PPP+    + +S  F  
Sbjct: 210 SLGITAIEMAEGKPPYADIHP------------MRAIFMIPTNPPPTFRKPELWSDNFTD 257

Query: 308 FISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 340
           F+  C+ K P+QR +A +L+ HPF++    +++
Sbjct: 258 FVKQCLVKSPEQRATATQLLQHPFVRSAKGVSI 290

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  259 bits (664), Expect = 6e-85
 Identities = 97/282 (34%), Positives = 149/282 (52%), Gaps = 34/282 (12%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVC 133
           +++VG G+ G V   +H  TGQ  A+KV  M+V      +I QE+ +  + S    +   
Sbjct: 29  VELVGNGTYGQVYKGRHVKTGQLAAIKV--MDVTGDEEEEIKQEINMLKKYSHHRNIATY 86

Query: 134 YQSFYSNGAIS------IILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLH 185
           Y +F             +++E+   GS+ D +K  K  T+ EE++A IC ++L+GL +LH
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 146

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI---- 241
            +  +IHRD+K  N+L+    EVK+ DFGVSA +  T G+ NTF+GT  +M+PE I    
Sbjct: 147 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE 205

Query: 242 -SGGKYGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA---IVDQPPPS 295
                Y +KSD+WSLG+  +E A G  P     P            M A   I   P P 
Sbjct: 206 NPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP------------MRALFLIPRNPAPR 253

Query: 296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
             S ++S +F SFI +C+ K   QR + ++LM HPF++   +
Sbjct: 254 LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  259 bits (663), Expect = 8e-85
 Identities = 92/273 (33%), Positives = 152/273 (55%), Gaps = 23/273 (8%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQ-IAQELKINQSSQCPYVV 131
           D+   +G+GS GIV L + K +G+  A+K   M++ +  RR+ +  E+ I +  Q   VV
Sbjct: 48  DSYVKIGEGSTGIVCLAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHFNVV 105

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
             Y+S+     + +++E++ GG+L D + +   + EE +A +CE VL+ L YLH  + +I
Sbjct: 106 EMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLH-AQGVI 163

Query: 192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           HRD+K  ++L+   G VK++DFG  A ++    +  + VGT  +M+PE IS   Y  + D
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVD 223

Query: 252 IWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA---IVDQPPPS-APSDQFSPEF 305
           IWSLG++++E   G+ PY    P            ++A   + D PPP    S + SP  
Sbjct: 224 IWSLGIMVIEMVDGEPPYFSDSP------------VQAMKRLRDSPPPKLKNSHKVSPVL 271

Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDL 338
             F+   + ++PQ+R +AQEL+ HPFL   G  
Sbjct: 272 RDFLERMLVRDPQERATAQELLDHPFLLQTGLP 304

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  257 bits (658), Expect = 3e-84
 Identities = 74/288 (25%), Positives = 126/288 (43%), Gaps = 18/288 (6%)

Query: 50  SQTETEAPPLIKPSDNQ-LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NV 107
             +ET   P   PS  +    +    +  +G GS G V  V+ K  G+ +A+K       
Sbjct: 36  EASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR 95

Query: 108 EESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTI 165
               R +   E+  ++   Q P  V   Q++   G + +  E   G SL    +    ++
Sbjct: 96  GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASL 154

Query: 166 PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 225
           PE  +       L  L +LH  + ++H D+KP+N+ +  RG  K+ DFG+   +  T+G 
Sbjct: 155 PEAQVWGYLRDTLLALAHLH-SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGA 212

Query: 226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM 285
                G   YM+PE + G  YG  +D++SLGL +LE A        P   +GW    +L 
Sbjct: 213 GEVQEGDPRYMAPELLQGS-YGTAADVFSLGLTILEVACN---MELPHGGEGW---QQLR 265

Query: 286 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
           +  +            S E  S +   ++ +P+ R +A+ L+  P L+
Sbjct: 266 QGYLPPEFT----AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  255 bits (654), Expect = 7e-84
 Identities = 87/297 (29%), Positives = 148/297 (49%), Gaps = 27/297 (9%)

Query: 57  PPLIKPSDNQLNLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQI 115
               +     L+  ++ + +  +G G+ G V   ++K TG   A KVI+   EE      
Sbjct: 5   SREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-LEDY 63

Query: 116 AQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAIC 174
             E++I  +   PY+V    ++Y +G + I++E+  GG++   + ++ + + E  +  +C
Sbjct: 64  IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVC 123

Query: 175 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN 234
            Q+L+ L +LH  K IIHRDLK  N+L+   G++++ DFGVSA    T  + ++F+GT  
Sbjct: 124 RQMLEALNFLH-SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY 182

Query: 235 YMSPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA 287
           +M+PE +         Y YK+DIWSLG+ L+E A  + P+    P            M  
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------------MRV 230

Query: 288 ---IVDQPPPS-APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 340
              I    PP+     ++S EF  F+   + K P+ R SA +L+ HPF+        
Sbjct: 231 LLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKA 287

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  254 bits (652), Expect = 8e-84
 Identities = 77/278 (27%), Positives = 136/278 (48%), Gaps = 19/278 (6%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQC 127
            ED + +  +G GS G  Q ++ K  G+    K +   ++ E+ ++ +  E+ + +  + 
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64

Query: 128 PYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGL 181
           P +V  Y      +N  + I++EY +GG LA  + K       + EE++  +  Q+   L
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 182 LYLHHEK----HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 237
              H        ++HRDLKP+N+ ++ +  VK+ DFG++ I+   +  A TFVGT  YMS
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184

Query: 238 PERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 297
           PE+++   Y  KSDIWSLG +L E      P++         S  EL   I +      P
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-------AFSQKELAGKIREGKFRRIP 237

Query: 298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
             ++S E    I+  +  +   R S +E++ +P +  +
Sbjct: 238 Y-RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  252 bits (645), Expect = 1e-82
 Identities = 65/287 (22%), Positives = 122/287 (42%), Gaps = 38/287 (13%)

Query: 65  NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS 124
           ++    D   I+++G G  G V   +H+  G+ + +K ++ N       +  +E+K    
Sbjct: 6   DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN-----NEKAEREVKALAK 60

Query: 125 SQCPYVVVCYQSFYSNGAIS----------------IILEYMDGGSLADFLKKVK--TIP 166
                +V     +                       I +E+ D G+L  +++K +   + 
Sbjct: 61  LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120

Query: 167 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 226
           +     + EQ+ KG+ Y+H  K +I+RDLKPSN+ +    +VKI DFG+   + +   + 
Sbjct: 121 KVLALELFEQITKGVDYIH-SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG-KR 178

Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 286
               GT  YMSPE+IS   YG + D+++LGL+L E           E         +   
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT--AFETS-------KFFT 229

Query: 287 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
            + D        D F  +  + +   + K+P+ R +  E++    + 
Sbjct: 230 DLRDGIIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  249 bits (637), Expect = 8e-81
 Identities = 78/303 (25%), Positives = 129/303 (42%), Gaps = 31/303 (10%)

Query: 47  RIVSQTETEAPPLIKPSDNQLNLEDIDTIK------VVGKGSGGIVQLVQHKWTGQFFAL 100
           R+  +TE     L+      ++ E  + +        VG+GS G V  ++ K TG   A+
Sbjct: 29  RLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAV 88

Query: 101 KVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK 160
           K +++ V         +EL        P +V  Y +      ++I +E ++GGSL   +K
Sbjct: 89  KKVRLEVFRV------EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK 142

Query: 161 KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIM 219
           ++  +PE+       Q L+GL YL H + I+H D+K  N+L++  G    + DFG +  +
Sbjct: 143 QMGCLPEDRALYYLGQALEGLEYL-HTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201

Query: 220 AS-----TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQ 274
                  +    +   GT  +M+PE + G     K DIWS   ++L    G      P  
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC----HP-- 255

Query: 275 QDGWTSFYEL--MEAIVDQPPPSAPS-DQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
              WT ++       I  +PPP        +P     I   ++KEP  R SA EL     
Sbjct: 256 ---WTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG 312

Query: 332 LKM 334
             +
Sbjct: 313 KAL 315

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  247 bits (633), Expect = 1e-80
 Identities = 89/301 (29%), Positives = 146/301 (48%), Gaps = 40/301 (13%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 126
           +N +D +  +V+G G+  +VQ        +  A+K I +   +++  ++ +E++      
Sbjct: 12  INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK--------KVKTIPEEYLAAICEQVL 178
            P +V  Y SF     + ++++ + GGS+ D +K        K   + E  +A I  +VL
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA-----NTFVGTY 233
           +GL YLH     IHRD+K  N+L+   G V+I DFGVSA +A+           TFVGT 
Sbjct: 132 EGLEYLHKNGQ-IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 234 NYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA--- 287
            +M+PE +   + Y +K+DIWS G+  +E ATG  PY   PP            M+    
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP------------MKVLML 238

Query: 288 IVDQPPPS--------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 339
            +   PPS            ++   F   IS C+QK+P++R +A EL+ H F +   +  
Sbjct: 239 TLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298

Query: 340 V 340
            
Sbjct: 299 F 299

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  246 bits (629), Expect = 3e-80
 Identities = 74/268 (27%), Positives = 125/268 (46%), Gaps = 22/268 (8%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVCY 134
             +G+GS   V       T    A   +Q   + +S R++  +E ++ +  Q P +V  Y
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 135 QSFY----SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH-HEKH 189
            S+         I ++ E M  G+L  +LK+ K +  + L + C Q+LKGL +LH     
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151

Query: 190 IIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 248
           IIHRDLK  N+ I    G VKI D G++ +  ++   A   +GT  +M+PE      Y  
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEEK-YDE 208

Query: 249 KSDIWSLGLVLLECATGQFPYS---PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 305
             D+++ G+ +LE AT ++PYS      Q         +   +     P++      PE 
Sbjct: 209 SVDVYAFGMCMLEMATSEYPYSECQNAAQ---------IYRRVTSGVKPASFDKVAIPEV 259

Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
              I  C+++   +R S ++L+ H F +
Sbjct: 260 KEIIEGCIRQNKDERYSIKDLLNHAFFQ 287

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  246 bits (631), Expect = 9e-80
 Identities = 85/304 (27%), Positives = 138/304 (45%), Gaps = 30/304 (9%)

Query: 47  RIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN 106
           R  S  + +   L    D +    D+  I   G GS G V   +     +  A+K +  +
Sbjct: 34  RAGSLKDPDVAELFFKDDPEKLFSDLREI---GHGSFGAVYFARDVRNSEVVAIKKMSYS 90

Query: 107 VEESA--RRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 164
            ++S    + I +E++  Q  + P  +     +       +++EY  G +        K 
Sbjct: 91  GKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP 150

Query: 165 IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 224
           + E  +AA+    L+GL YL H  ++IHRD+K  N+L++  G VK+ DFG ++IMA    
Sbjct: 151 LQEVEIAAVTHGALQGLAYL-HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA---- 205

Query: 225 QANTFVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWT 279
            AN+FVGT  +M+PE I       Y  K D+WSLG+  +E A  + P             
Sbjct: 206 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------- 258

Query: 280 SFYELMEA---IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 336
                M A   I     P+  S  +S  F +F+ +C+QK PQ R +++ L+ H F+    
Sbjct: 259 -----MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313

Query: 337 DLNV 340
              V
Sbjct: 314 PPTV 317

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  243 bits (622), Expect = 4e-79
 Identities = 90/294 (30%), Positives = 143/294 (48%), Gaps = 22/294 (7%)

Query: 50  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE 109
            ++  E        +     ++     V+GKG+ GIV   +        A+K I      
Sbjct: 2   MRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR 61

Query: 110 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK---TIP 166
            ++  + +E+ +++  +   +V    SF  NG I I +E + GGSL+  L+         
Sbjct: 62  YSQ-PLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120

Query: 167 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQ 225
           E+ +    +Q+L+GL YLH +  I+HRD+K  N+LIN + G +KI+DFG S  +A  +  
Sbjct: 121 EQTIGFYTKQILEGLKYLH-DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179

Query: 226 ANTFVGTYNYMSPERISGGKYGY--KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 283
             TF GT  YM+PE I  G  GY   +DIWSLG  ++E ATG+    PP     +    E
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK----PP-----FYELGE 230

Query: 284 LMEAI----VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
              A+    + +  P  P +  S E  +FI  C + +P +R  A +L+   FLK
Sbjct: 231 PQAAMFKVGMFKVHPEIP-ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK 283

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  238 bits (610), Expect = 3e-77
 Identities = 68/292 (23%), Positives = 118/292 (40%), Gaps = 38/292 (13%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           L D + I+ +G+G  G+V   ++K     +A+K I++   E AR ++ +E+K     + P
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP 63

Query: 129 YVVVCYQSFYSNGAIS------------IILEYMDGGSLADFLKKVKT---IPEEYLAAI 173
            +V  + ++                   I ++     +L D++    T           I
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 174 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF---- 229
             Q+ + + +LH  K ++HRDLKPSN+       VK+ DFG+   M     +        
Sbjct: 124 FLQIAEAVEFLH-SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182

Query: 230 --------VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 281
                   VGT  YMSPE+I G  Y +K DI+SLGL+L E         P          
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------PFS---TQMER 233

Query: 282 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
              +  + +   P   + Q  P     +   +   P +R  A  ++ +   +
Sbjct: 234 VRTLTDVRNLKFPPLFT-QKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  238 bits (609), Expect = 3e-77
 Identities = 64/285 (22%), Positives = 111/285 (38%), Gaps = 42/285 (14%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQS-SQCPYVVV 132
           ++ +G G  G V     +  G  +A+K  +         +   +E+  +    Q  +VV 
Sbjct: 16  LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYLHHEK 188
            + ++  +  + I  EY +GGSLAD + +         E  L  +  QV +GL Y+H   
Sbjct: 76  YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH-SM 134

Query: 189 HIIHRDLKPSNLLINHRGE-------------------VKITDFGVSAIMASTSGQANTF 229
            ++H D+KPSN+ I+                        KI D G    ++S        
Sbjct: 135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----QVE 190

Query: 230 VGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 288
            G   +++ E +     +  K+DI++L L ++  A  +     P   D W         I
Sbjct: 191 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE---PLPRNGDQW-------HEI 240

Query: 289 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
                P  P    S EF   +   +  +P++R SA  L+ H  L 
Sbjct: 241 RQGRLPRIP-QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  238 bits (608), Expect = 7e-77
 Identities = 67/298 (22%), Positives = 118/298 (39%), Gaps = 43/298 (14%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
             D + I V+G+G+ G V   ++    +++A+K I+    E     I  E+ +  S    
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQ 62

Query: 129 YVVVCYQSFYSNGAIS-------------IILEYMDGGSLADFLKKVKTIPEEYLAA-IC 174
           YVV  Y ++                    I +EY + G+L D +       +      + 
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 175 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST------------ 222
            Q+L+ L Y+H  + IIHRDLKP N+ I+    VKI DFG++  +  +            
Sbjct: 123 RQILEALSYIH-SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 223 --SGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT 279
             S    + +GT  Y++ E + G G Y  K D++SLG++  E                  
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM--------- 232

Query: 280 SFYELMEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
               +++ +       P    D         I   +  +P +R  A+ L+   +L + 
Sbjct: 233 ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  234 bits (598), Expect = 3e-75
 Identities = 70/286 (24%), Positives = 126/286 (44%), Gaps = 26/286 (9%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKI--N 122
            +       +K +G G    V  V ++   Q +A+K + +   +         E+     
Sbjct: 24  SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 82

Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
                  ++  Y    ++  I +++E      L  +LKK K+I      +  + +L+ + 
Sbjct: 83  LQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 141

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--STSGQANTFVGTYNYMSPER 240
            +H +  I+H DLKP+N LI   G +K+ DFG++  M   +TS   ++ VGT NYM PE 
Sbjct: 142 TIH-QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 241 ISG-----------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 289
           I              K   KSD+WSLG +L     G+ P+          +    + AI+
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------QQIINQISKLHAII 253

Query: 290 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
           D        D    +    +  C++++P+QR+S  EL+ HP++++ 
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  235 bits (601), Expect = 3e-75
 Identities = 70/286 (24%), Positives = 126/286 (44%), Gaps = 26/286 (9%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKI--N 122
            +       +K +G G    V  V ++   Q +A+K + +   +         E+     
Sbjct: 5   SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63

Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
                  ++  Y    ++  I +++E      L  +LKK K+I      +  + +L+ + 
Sbjct: 64  LQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 122

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--STSGQANTFVGTYNYMSPER 240
            +H +  I+H DLKP+N LI   G +K+ DFG++  M   +TS   ++ VGT NYM PE 
Sbjct: 123 TIH-QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180

Query: 241 ISG-----------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 289
           I              K   KSD+WSLG +L     G+ P+          +    + AI+
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------QQIINQISKLHAII 234

Query: 290 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
           D        D    +    +  C++++P+QR+S  EL+ HP++++ 
Sbjct: 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  235 bits (600), Expect = 1e-74
 Identities = 75/319 (23%), Positives = 125/319 (39%), Gaps = 52/319 (16%)

Query: 75  IKVVGKGSG--GIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVV 131
           + V+GKG      V L ++K TG++  ++ I +          +  EL +++    P +V
Sbjct: 30  LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLHHEKH 189
               +F ++  + ++  +M  GS  D +    +  + E  +A I + VLK L Y+HH  +
Sbjct: 90  PYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGY 149

Query: 190 IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-------FVGTYNYMSPERIS 242
           + HR +K S++LI+  G+V ++    +  M S   +           V    ++SPE + 
Sbjct: 150 V-HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208

Query: 243 GGKYGY--KSDIWSLGLVLLECATGQFPYS---------------PPEQQDGWTSFYE-- 283
               GY  KSDI+S+G+   E A G  P+                 P   D  T   E  
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEEL 268

Query: 284 --------------------LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
                                        P       FSP F  F+  C+Q+ P  R SA
Sbjct: 269 TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA 328

Query: 324 QELMTHPFLKMYGDLNVDL 342
             L+ H F K       + 
Sbjct: 329 STLLNHSFFKQIKRRASEA 347

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  233 bits (595), Expect = 8e-74
 Identities = 69/286 (24%), Positives = 125/286 (43%), Gaps = 26/286 (9%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKI--N 122
            +       +K +G G    V  V ++   Q +A+K + +   +         E+     
Sbjct: 52  SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110

Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
                  ++  Y    ++  I +++E      L  +LKK K+I      +  + +L+ + 
Sbjct: 111 LQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--STSGQANTFVGTYNYMSPER 240
            +H +  I+H DLKP+N LI   G +K+ DFG++  M   +TS   ++ VG  NYM PE 
Sbjct: 170 TIH-QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227

Query: 241 ISG-----------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 289
           I              K   KSD+WSLG +L     G+ P+          +    + AI+
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------QQIINQISKLHAII 281

Query: 290 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
           D        D    +    +  C++++P+QR+S  EL+ HP++++ 
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  212 bits (543), Expect = 6e-67
 Identities = 61/285 (21%), Positives = 117/285 (41%), Gaps = 28/285 (9%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 125
            ++ +    I+ +G+G    V LV+    G F+ALK I  + E+  R +  +E  +++  
Sbjct: 25  IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLF 83

Query: 126 QCPYVVVCYQSFY----SNGAISIILEYMDGGSLADFLKKVKT----IPEEYLAAICEQV 177
             P ++           +     ++L +   G+L + ++++K     + E+ +  +   +
Sbjct: 84  NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM---------ASTSGQANT 228
            +GL  +H  K   HRDLKP+N+L+   G+  + D G              A T      
Sbjct: 144 CRGLEAIH-AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202

Query: 229 FVGTYNYMSPERISGGKY---GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM 285
              T +Y +PE  S   +     ++D+WSLG VL     G+ PY      D      + +
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY------DMVFQKGDSV 256

Query: 286 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 330
              V        S + S      +++ +  +P QR     L++  
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  207 bits (528), Expect = 4e-65
 Identities = 81/276 (29%), Positives = 131/276 (47%), Gaps = 22/276 (7%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI------QMNVEESARRQIAQEL 119
           Q  LED +  + +GKG  G V L + K +    ALKV+      +  VE     Q+ +E+
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH----QLRREV 60

Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
           +I    + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++  
Sbjct: 61  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120

Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
            L Y H  K +IHRD+KP NLL+   GE+KI DFG S    + S +     GT +Y+ PE
Sbjct: 121 ALSYCH-SKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSSRRTDLCGTLDYLPPE 177

Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD 299
            I G  +  K D+WSLG++  E   G     PP + + +   Y+ +  +    P      
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVG----KPPFEANTYQETYKRISRVEFTFPDF---- 229

Query: 300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
             +      IS  ++  P QR   +E++ HP++   
Sbjct: 230 -VTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  205 bits (525), Expect = 1e-64
 Identities = 83/281 (29%), Positives = 132/281 (46%), Gaps = 22/281 (7%)

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI------QMNVEESARRQ 114
           +    +  ++D D  + +GKG  G V L + K      ALKV+      +  VE     Q
Sbjct: 5   EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH----Q 60

Query: 115 IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 174
           + +E++I    + P ++  Y  F+    I ++LE+   G L   L+K     E+  A   
Sbjct: 61  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120

Query: 175 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN 234
           E++   L Y H E+ +IHRD+KP NLL+ ++GE+KI DFG S    + S +  T  GT +
Sbjct: 121 EELADALHYCH-ERKVIHRDIKPENLLMGYKGELKIADFGWSVH--APSLRRRTMCGTLD 177

Query: 235 YMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP 294
           Y+ PE I G  +  K D+W  G++  E   G     PP      T  +  +  +  + PP
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG----MPPFDSPSHTETHRRIVNVDLKFPP 233

Query: 295 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
                  S      IS  ++  P QRL  + +M HP++K  
Sbjct: 234 F-----LSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  207 bits (529), Expect = 2e-64
 Identities = 78/332 (23%), Positives = 127/332 (38%), Gaps = 53/332 (15%)

Query: 48  IVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI---- 103
           I+S             +    + D   I+ + +G    + L +     +F+ALK      
Sbjct: 9   ILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSL 66

Query: 104 ------------QMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD 151
                            +S       EL+I    +  Y + C     +   + II EYM+
Sbjct: 67  LEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYME 126

Query: 152 GGSLADFLKK--------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN 203
             S+  F +            IP + +  I + VL    Y+H+EK+I HRD+KPSN+L++
Sbjct: 127 NDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD 186

Query: 204 HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLE 261
             G VK++DFG S  M     +     GTY +M PE  S      G K DIWSLG+ L  
Sbjct: 187 KNGRVKLSDFGESEYM--VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYV 244

Query: 262 CATGQFPYSPPEQQDGWTSFYELMEAIV-----------------DQPPPSAPSDQFSPE 304
                 P+          S  EL   I                       +  ++  S E
Sbjct: 245 MFYNVVPF------SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNE 298

Query: 305 FCSFISACVQKEPQQRLSAQELMTHPFLKMYG 336
              F+   ++K P +R+++++ + H +L    
Sbjct: 299 DIDFLKLFLRKNPAERITSEDALKHEWLADTN 330

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  204 bits (521), Expect = 6e-63
 Identities = 84/288 (29%), Positives = 138/288 (47%), Gaps = 26/288 (9%)

Query: 58  PLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQI 115
           P +   +  +N +  + ++ +GKGS G V +VQ   T + +A+K +  Q  VE +  R +
Sbjct: 3   PPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV 62

Query: 116 AQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLA 171
            +EL+I Q  + P++V  + SF     + ++++ + GG L   L++     EE    +  
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF-- 120

Query: 172 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 231
            ICE V+  L YL   + IIHRD+KP N+L++  G V ITDF ++A++     Q  T  G
Sbjct: 121 -ICELVM-ALDYLQ-NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITTMAG 176

Query: 232 TYNYMSPE---RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 288
           T  YM+PE      G  Y +  D WSLG+   E   G+ PY             E++   
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS----SKEIVHTF 232

Query: 289 VDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRL-SAQELMTHPFLK 333
                  PSA    +S E  S +   ++  P QR     ++   P++ 
Sbjct: 233 ETTVVTYPSA----WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  201 bits (513), Expect = 1e-62
 Identities = 69/281 (24%), Positives = 125/281 (44%), Gaps = 15/281 (5%)

Query: 55  EAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESAR 112
           E P ++    +  +       + +GKG       +    T + FA K++   + ++   R
Sbjct: 3   EIPEVLV---DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR 59

Query: 113 RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAA 172
            +++ E+ I++S    +VV  +  F  N  + ++LE     SL +  K+ K + E     
Sbjct: 60  EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 119

Query: 173 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT 232
              Q++ G  YLH    +IHRDLK  NL +N   EVKI DFG++  +     +     GT
Sbjct: 120 YLRQIVLGCQYLH-RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGT 178

Query: 233 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP 292
            NY++PE +S   + ++ D+WS+G ++     G+ P+   E      ++  + +     P
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKNEYSIP 235

Query: 293 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
                    +P   S I   +Q +P  R +  EL+   F  
Sbjct: 236 K------HINPVAASLIQKMLQTDPTARPTINELLNDEFFT 270

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  200 bits (510), Expect = 8e-62
 Identities = 69/287 (24%), Positives = 126/287 (43%), Gaps = 17/287 (5%)

Query: 50  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI---QMN 106
           +    E P ++    +  +       + +GKG       +    T + FA K++    + 
Sbjct: 24  APPAKEIPEVLV---DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL- 79

Query: 107 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 166
           ++   R +++ E+ I++S    +VV  +  F  N  + ++LE     SL +  K+ K + 
Sbjct: 80  LKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALT 139

Query: 167 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 226
           E        Q++ G  YLH    +IHRDLK  NL +N   EVKI DFG++  +     + 
Sbjct: 140 EPEARYYLRQIVLGCQYLH-RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198

Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 286
               GT NY++PE +S   + ++ D+WS+G ++     G+ P+   E      ++  + +
Sbjct: 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKK 255

Query: 287 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
                P         +P   S I   +Q +P  R +  EL+   F  
Sbjct: 256 NEYSIPK------HINPVAASLIQKMLQTDPTARPTINELLNDEFFT 296

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  197 bits (504), Expect = 1e-61
 Identities = 76/277 (27%), Positives = 124/277 (44%), Gaps = 13/277 (4%)

Query: 62  PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQEL 119
            +     +ED     ++GKGS   V   +   TG   A+K+I      +    +++  E+
Sbjct: 3   ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62

Query: 120 KINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVL 178
           KI+   + P ++  Y  F  +  + ++LE    G +  +LK +VK   E        Q++
Sbjct: 63  KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122

Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 238
            G+LYLH    I+HRDL  SNLL+     +KI DFG++  +     +  T  GT NY+SP
Sbjct: 123 TGMLYLH-SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISP 181

Query: 239 ERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 298
           E  +   +G +SD+WSLG +      G     PP   D   +    +     + P     
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIG----RPPFDTDTVKNTLNKVVLADYEMPSF--- 234

Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
              S E    I   +++ P  RLS   ++ HPF+   
Sbjct: 235 --LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  195 bits (497), Expect = 8e-59
 Identities = 61/277 (22%), Positives = 112/277 (40%), Gaps = 27/277 (9%)

Query: 71  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPY 129
                 V+G G+ G + + +  +  +  A+K I       A R    E+++  +S + P 
Sbjct: 25  SFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPECFSFADR----EVQLLRESDEHPN 79

Query: 130 VVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
           V+  + +        I +E     +L +++ +K           + +Q   GL +L H  
Sbjct: 80  VIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHL-HSL 137

Query: 189 HIIHRDLKPSNLLINHRGE-----VKITDFGVSAIMA---STSGQANTFVGTYNYMSPER 240
           +I+HRDLKP N+LI+           I+DFG+   +A    +  + +   GT  +++PE 
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 241 ISG---GKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA 296
           +S        Y  DI+S G V     + G  P+    Q+        ++           
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-----ANILLGACSLDCLH- 251

Query: 297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
           P           I   +  +PQ+R SA+ ++ HPF  
Sbjct: 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFW 288

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  189 bits (483), Expect = 5e-58
 Identities = 60/298 (20%), Positives = 111/298 (37%), Gaps = 45/298 (15%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV 132
               ++G+G+   V   +HK TG  FA+KV              +E ++ +      +V 
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 133 CYQSF--YSNGAISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHE 187
            +      +     +I+E+   GSL   L++      +PE     +   V+ G+ +L  E
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL-RE 130

Query: 188 KHIIHRDLKPSNLLI----NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
             I+HR++KP N++     + +   K+TDFG +  +     Q  +  GT  Y+ P+    
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYER 189

Query: 244 G--------KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV------ 289
                    KYG   D+WS+G+     ATG  P+ P E         E+M  I+      
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR---RNKEVMYKIITGKPSG 246

Query: 290 -----------------DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 330
                            D P   + S          ++  ++ + ++     +     
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  188 bits (481), Expect = 1e-57
 Identities = 77/302 (25%), Positives = 132/302 (43%), Gaps = 36/302 (11%)

Query: 50  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--V 107
               +       P   +   ED    K++G+GS   V L +   T + +A+K+++    +
Sbjct: 10  PGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHII 69

Query: 108 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 167
           +E+    + +E  +      P+ V  Y +F  +  +   L Y   G L  +++K+ +  E
Sbjct: 70  KENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDE 129

Query: 168 E----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS--AIMAS 221
                Y A    +++  L YLH  K IIHRDLKP N+L+N    ++ITDFG +      S
Sbjct: 130 TCTRFYTA----EIVSALEYLH-GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 184

Query: 222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP-YSPPEQQDGWTS 280
              +AN+FVGT  Y+SPE ++       SD+W+LG ++ +   G  P  +  E       
Sbjct: 185 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------- 237

Query: 281 FYELMEAIVDQP---PPSAPSDQFSPEFCSFISACVQKEPQQRL------SAQELMTHPF 331
            Y + + I+      P       F P+    +   +  +  +RL          L  HPF
Sbjct: 238 -YLIFQKIIKLEYDFPEK-----FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

Query: 332 LK 333
            +
Sbjct: 292 FE 293

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  189 bits (481), Expect = 1e-57
 Identities = 52/240 (21%), Positives = 97/240 (40%), Gaps = 26/240 (10%)

Query: 109 ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI--- 165
            S     + +++          V   Q       + I ++     +L D++ +  ++   
Sbjct: 102 PSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR 161

Query: 166 PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ 225
                  I  Q+ + + +LH  K ++HRDLKPSN+       VK+ DFG+   M     +
Sbjct: 162 EHGVCLHIFIQIAEAVEFLH-SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220

Query: 226 ANTF------------VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE 273
                           VGT  YMSPE+I G  Y +K DI+SLGL+L E     + +S   
Sbjct: 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL---YSFSTQM 277

Query: 274 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
           ++        ++  + +   P   + Q  P+    +   +   P +R  A +++ +   +
Sbjct: 278 ER------VRIITDVRNLKFPLLFT-QKYPQEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  187 bits (477), Expect = 1e-56
 Identities = 82/309 (26%), Positives = 149/309 (48%), Gaps = 31/309 (10%)

Query: 45  GVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQH---KWTGQFFALK 101
           G ++++         +     ++ +E+ + +KV+G G+ G V LV+      TG+ +A+K
Sbjct: 29  GEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK 88

Query: 102 VIQMNVEESARRQIAQ---ELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLAD 157
           V++        +       E ++     Q P++V  + +F +   + +IL+Y++GG L  
Sbjct: 89  VLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFT 148

Query: 158 FLKKVKTIPEE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
            L + +   E     Y+     +++  L +LH +  II+RD+K  N+L++  G V +TDF
Sbjct: 149 HLSQRERFTEHEVQIYVG----EIVLALEHLH-KLGIIYRDIKLENILLDSNGHVVLTDF 203

Query: 214 GVS-AIMASTSGQANTFVGTYNYMSPERISGGKYGY-KS-DIWSLGLVLLECATGQFP-Y 269
           G+S   +A  + +A  F GT  YM+P+ + GG  G+ K+ D WSLG+++ E  TG  P  
Sbjct: 204 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 263

Query: 270 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQ 324
              E+        E+   I+   PP       S      I   + K+P++RL      A 
Sbjct: 264 VDGEKNSQ----AEISRRILKSEPPYPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDAD 317

Query: 325 ELMTHPFLK 333
           E+  H F +
Sbjct: 318 EIKEHLFFQ 326

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  186 bits (474), Expect = 1e-56
 Identities = 72/270 (26%), Positives = 128/270 (47%), Gaps = 13/270 (4%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ 135
           K +G+GS  I +   HK + Q FA+K+I   +E + +++I   LK       P +V  ++
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEI-TALK--LCEGHPNIVKLHE 73

Query: 136 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            F+      +++E ++GG L + +KK K   E   + I  +++  + ++H +  ++HRDL
Sbjct: 74  VFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH-DVGVVHRDL 132

Query: 196 KPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           KP NLL     +   +KI DFG + +    +    T   T +Y +PE ++   Y    D+
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDL 192

Query: 253 WSLGLVL--LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSF 308
           WSLG++L  +    GQ P+   ++    TS  E+M+ I               S E    
Sbjct: 193 WSLGVILYTMLS--GQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDL 250

Query: 309 ISACVQKEPQQRLSAQELMTHPFLKMYGDL 338
           I   +  +P +RL    L  + +L+    L
Sbjct: 251 IQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  189 bits (482), Expect = 2e-56
 Identities = 83/295 (28%), Positives = 152/295 (51%), Gaps = 24/295 (8%)

Query: 50  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNV 107
           +    E    +    +++ + + + +K++GKG+ G V LV+ K TG+++A+K+++  + V
Sbjct: 128 NSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIV 187

Query: 108 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 167
            +        E ++ Q+S+ P++     SF ++  +  ++EY +GG L   L + +   E
Sbjct: 188 AKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSE 247

Query: 168 E----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 223
           +    Y A    +++  L YLH EK++++RDLK  NL+++  G +KITDFG+        
Sbjct: 248 DRARFYGA----EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303

Query: 224 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE 283
               TF GT  Y++PE +    YG   D W LG+V+ E   G+ P+   + +       +
Sbjct: 304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------K 356

Query: 284 LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 333
           L E I+ +      +    PE  S +S  ++K+P+QRL      A+E+M H F  
Sbjct: 357 LFELILMEEIRFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  183 bits (466), Expect = 2e-55
 Identities = 84/302 (27%), Positives = 135/302 (44%), Gaps = 37/302 (12%)

Query: 50  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQH---KWTGQFFALKVIQ-M 105
           S  E      +K    + +    + +KV+G+GS G V LV+        Q +A+KV++  
Sbjct: 4   SIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKA 63

Query: 106 NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI 165
            ++   R +   E  I      P++V  + +F + G + +IL+++ GG L   L K    
Sbjct: 64  TLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF 123

Query: 166 PEE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 221
            EE    YLA    ++   L +LH    II+RDLKP N+L++  G +K+TDFG+S     
Sbjct: 124 TEEDVKFYLA----ELALALDHLH-SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178

Query: 222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF 281
              +A +F GT  YM+PE ++   +   +D WS G+++ E  TG      P        F
Sbjct: 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT----LP--------F 226

Query: 282 Y-----ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPF 331
                 E M  I+            SPE  S +    ++ P  RL       +E+  H F
Sbjct: 227 QGKDRKETMTMILKAKLGMPQF--LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

Query: 332 LK 333
             
Sbjct: 285 FS 286

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  184 bits (469), Expect = 3e-55
 Identities = 82/298 (27%), Positives = 141/298 (47%), Gaps = 35/298 (11%)

Query: 52  TETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNVEE 109
             ++   L   S+      D   +KV+GKGS G V L +HK    F+A+KV+Q    +++
Sbjct: 20  APSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKK 79

Query: 110 SARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 168
              + I  E  +  ++ + P++V  + SF +   +  +L+Y++GG L   L++ +   E 
Sbjct: 80  KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP 139

Query: 169 ----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 224
               Y A    ++   L YLH   +I++RDLKP N+L++ +G + +TDFG+       + 
Sbjct: 140 RARFYAA----EIASALGYLH-SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194

Query: 225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-- 282
             +TF GT  Y++PE +    Y    D W LG VL E   G     PP        FY  
Sbjct: 195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL----PP--------FYSR 242

Query: 283 ---ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL----SAQELMTHPFLK 333
              E+ + I+++P    P+   +      +   +QK+  +RL       E+ +H F  
Sbjct: 243 NTAEMYDNILNKPLQLKPN--ITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  191 bits (486), Expect = 3e-55
 Identities = 76/289 (26%), Positives = 136/289 (47%), Gaps = 34/289 (11%)

Query: 63  SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKV------IQMNVEESAR--RQ 114
            +  L + D    +++G+G  G V   +   TG+ +A+K            E  A   R 
Sbjct: 182 LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241

Query: 115 IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YL 170
           +   L +  +  CP++V    +F++   +S IL+ M+GG L   L +     E     Y 
Sbjct: 242 M---LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYA 298

Query: 171 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV 230
           A    +++ GL ++H  + +++RDLKP+N+L++  G V+I+D G++     +  + +  V
Sbjct: 299 A----EIILGLEHMH-NRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV 351

Query: 231 GTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 289
           GT+ YM+PE +  G  Y   +D +SLG +L +   G      P +Q      +E+    +
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH----SPFRQHKTKDKHEIDRMTL 407

Query: 290 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 333
                    D FSPE  S +   +Q++  +RL      AQE+   PF +
Sbjct: 408 TMAVEL--PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 454

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  182 bits (465), Expect = 4e-55
 Identities = 82/294 (27%), Positives = 137/294 (46%), Gaps = 39/294 (13%)

Query: 60  IKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQH---KWTGQFFALKVIQMNVEESARRQIA 116
           +     ++  E  + ++V+GKG  G V  V+      TG+ FA+KV++  +     +  A
Sbjct: 7   VNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTA 66

Query: 117 Q---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----Y 169
               E  I +  + P++V    +F + G + +ILEY+ GG L   L++     E+    Y
Sbjct: 67  HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126

Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 229
           LA    ++   L +LH +K II+RDLKP N+++NH+G VK+TDFG+           +TF
Sbjct: 127 LA----EISMALGHLH-QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF 181

Query: 230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-----EL 284
            GT  YM+PE +    +    D WSLG ++ +  TG     PP        F      + 
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA----PP--------FTGENRKKT 229

Query: 285 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 333
           ++ I+       P    + E    +   +++    RL      A E+  HPF +
Sbjct: 230 IDKILKCKLNLPPY--LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  183 bits (465), Expect = 7e-55
 Identities = 42/307 (13%), Positives = 84/307 (27%), Gaps = 41/307 (13%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESAR--RQIAQELKINQSSQCPYVVVC 133
           + +  G   +V LV+     + FALKV  M  E S     ++ +                
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 134 YQSF--------------------------YSNGAISIILEYMDG------GSLADFLKK 161
                                         Y+     +++            +L      
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 162 VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 221
                   L  +  Q+++    L   K ++H    P NL I   G + + D      + +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQS-KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246

Query: 222 TSGQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT 279
                        Y   E ++     + +  + W LGL +        P+         +
Sbjct: 247 RG---PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGS 303

Query: 280 SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP-FLKMYGDL 338
                +                     + I   +  + ++RL   E M  P FL++  ++
Sbjct: 304 WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEI 363

Query: 339 NVDLSEY 345
           +  LS  
Sbjct: 364 SSSLSTG 370

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  182 bits (463), Expect = 1e-54
 Identities = 80/279 (28%), Positives = 147/279 (52%), Gaps = 25/279 (8%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNVEESARRQIAQELKINQ 123
           ++ + D D +K++GKG+ G V LV+ K TG+++A+K+++  + + +        E ++ Q
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 124 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVLK 179
           +++ P++     +F ++  +  ++EY +GG L   L + +   EE    Y A    +++ 
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA----EIVS 116

Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
            L YLH  + +++RD+K  NL+++  G +KITDFG+     S      TF GT  Y++PE
Sbjct: 117 ALEYLH-SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175

Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD 299
            +    YG   D W LG+V+ E   G+ P+   + +        L E I+ +      + 
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEEIRFPRT- 227

Query: 300 QFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 333
             SPE  S ++  ++K+P+QRL      A+E+M H F  
Sbjct: 228 -LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  180 bits (459), Expect = 2e-54
 Identities = 75/285 (26%), Positives = 121/285 (42%), Gaps = 41/285 (14%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 126
               D+   +V+GKG  G    V H+ TG+   +K + +  +E  +R   +E+K+ +  +
Sbjct: 7   FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCLE 65

Query: 127 CPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGL 181
            P V+    V Y+       ++ I EY+ GG+L   +K + +  P     +  + +  G+
Sbjct: 66  HPNVLKFIGVLYKD----KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM 121

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN-------------- 227
            YLH   +IIHRDL   N L+     V + DFG++ +M     Q                
Sbjct: 122 AYLH-SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180

Query: 228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQD---GWTSFY 282
           T VG   +M+PE I+G  Y  K D++S G+VL E        P   P   D       F 
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL 240

Query: 283 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
           +         PP+ P     P F      C   +P++R S  +L 
Sbjct: 241 DR------YCPPNCP-----PSFFPITVRCCDLDPEKRPSFVKLE 274

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  180 bits (458), Expect = 2e-54
 Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 30/277 (10%)

Query: 63  SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN 122
           S + ++ ++I+  +VVG+G+ G+V     KW  +  A+K I+    ES R+    EL+  
Sbjct: 1   SLHMIDYKEIEVEEVVGRGAFGVVCKA--KWRAKDVAIKQIE---SESERKAFIVELRQL 55

Query: 123 QSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFL---KKVKTIPEEYLAAICE 175
                P +V     C           +++EY +GGSL + L   + +      +  + C 
Sbjct: 56  SRVNHPNIVKLYGACLNPVC------LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109

Query: 176 QVLKGLLYLHHEK--HIIHRDLKPSNLLINHRGEV-KITDFGVSAIMASTSGQANTFVGT 232
           Q  +G+ YLH  +   +IHRDLKP NLL+   G V KI DFG +  + +         G+
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNNKGS 166

Query: 233 YNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP 292
             +M+PE   G  Y  K D++S G++L E  T + P+      +     + +M A+ +  
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF-----DEIGGPAFRIMWAVHNGT 221

Query: 293 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
            P    +       S ++ C  K+P QR S +E++  
Sbjct: 222 RPPLIKN-LPKPIESLMTRCWSKDPSQRPSMEEIVKI 257

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  182 bits (463), Expect = 3e-54
 Identities = 60/297 (20%), Positives = 111/297 (37%), Gaps = 45/297 (15%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV 132
               ++G+G+   V   +HK TG  FA+KV              +E ++ +      +V 
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVK 71

Query: 133 CYQSF--YSNGAISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHE 187
            +      +     +I+E+   GSL   L++      +PE     +   V+ G+ +L  E
Sbjct: 72  LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL-RE 130

Query: 188 KHIIHRDLKPSNLLI----NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
             I+HR++KP N++     + +   K+TDFG +  +     Q  +  GT  Y+ P+    
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-QFVSLYGTEEYLHPDMYER 189

Query: 244 G--------KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV------ 289
                    KYG   D+WS+G+     ATG  P+ P E         E+M  I+      
Sbjct: 190 AVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR---RNKEVMYKIITGKPSG 246

Query: 290 -----------------DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
                            D P   + S          ++  ++ + ++     +    
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  184 bits (470), Expect = 3e-54
 Identities = 83/302 (27%), Positives = 143/302 (47%), Gaps = 21/302 (6%)

Query: 68  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSS 125
           +L ++   +K +G G+ G V L + K T    A+K+I+  +V  S+  ++ +E+ + +  
Sbjct: 34  HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
             P ++  Y  F       +++E   GG L D +       E   A I +QVL G+ YL 
Sbjct: 94  DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL- 152

Query: 186 HEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           H+ +I+HRDLKP NLL+  + +   +KI DFG+SA+  +   +    +GT  Y++PE + 
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-KMKERLGTAYYIAPEVLR 211

Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQ 300
             KY  K D+WS+G++L     G  P+     Q       E++  +        S     
Sbjct: 212 -KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-------EILRKVEKGKYTFDSPEWKN 263

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLS 360
            S      I   +Q + Q+R+SAQ+ + HP++K          E   +  S    + N+ 
Sbjct: 264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC----SKKESGIELPSLANAIENMR 319

Query: 361 GF 362
            F
Sbjct: 320 KF 321

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  185 bits (472), Expect = 4e-54
 Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 33/288 (11%)

Query: 65  NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKV------IQMNVEESARRQIAQE 118
             +  +     +V+G+G  G V   Q K TG+ +A K        +    + A      E
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM----VE 235

Query: 119 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSL----ADFLKKVKTIPEE----YL 170
            KI       ++V    +F +   + +++  M+GG +     +  +      E     Y 
Sbjct: 236 KKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295

Query: 171 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV 230
           A    Q++ GL +LH +++II+RDLKP N+L++  G V+I+D G++  + +   +   + 
Sbjct: 296 A----QIVSGLEHLH-QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA 350

Query: 231 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD 290
           GT  +M+PE + G +Y +  D ++LG+ L E    +    P   +       EL + +++
Sbjct: 351 GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR---GPFRARGEKVENKELKQRVLE 407

Query: 291 QPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 333
           Q       D+FSP    F  A +QK+P++RL     S   L THP  +
Sbjct: 408 QAVTY--PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  180 bits (459), Expect = 4e-54
 Identities = 81/286 (28%), Positives = 151/286 (52%), Gaps = 22/286 (7%)

Query: 63  SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNVEESARRQIAQELK 120
           + + L L+D D ++V+G+GS   V LV+ K T + +A+KV++  +  ++     +  E  
Sbjct: 2   AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61

Query: 121 I-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICE 175
           +  Q+S  P++V  +  F +   +  ++EY++GG L   +++ + +PEE    Y A    
Sbjct: 62  VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA---- 117

Query: 176 QVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY 235
           ++   L YLH E+ II+RDLK  N+L++  G +K+TD+G+           +TF GT NY
Sbjct: 118 EISLALNYLH-ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNY 176

Query: 236 MSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW--TSFYELMEAIVDQPP 293
           ++PE + G  YG+  D W+LG+++ E   G+ P+      D     +   L + I+++  
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 236

Query: 294 PSAPSDQFSPEFCSFISACVQKEPQQRL------SAQELMTHPFLK 333
               S   S +  S + + + K+P++RL         ++  HPF +
Sbjct: 237 RIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  180 bits (459), Expect = 4e-54
 Identities = 79/297 (26%), Positives = 132/297 (44%), Gaps = 42/297 (14%)

Query: 55  EAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKV------IQMNVE 108
           E          +L +ED    K++GKGS G V L + K T QFFA+K       +  +  
Sbjct: 2   ELNKERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDV 61

Query: 109 ESAR--RQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 166
           E     +++        + + P++   + +F +   +  ++EY++GG L   ++      
Sbjct: 62  ECTMVEKRVLS-----LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD 116

Query: 167 EE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 222
                 Y A    +++ GL +LH  K I++RDLK  N+L++  G +KI DFG+       
Sbjct: 117 LSRATFYAA----EIILGLQFLH-SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171

Query: 223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 282
             + NTF GT +Y++PE + G KY +  D WS G++L E   GQ     P        F+
Sbjct: 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ----SP--------FH 219

Query: 283 -----ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-SAQELMTHPFLK 333
                EL  +I    P          E    +     +EP++RL    ++  HP  +
Sbjct: 220 GQDEEELFHSIRMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  180 bits (459), Expect = 5e-54
 Identities = 83/303 (27%), Positives = 134/303 (44%), Gaps = 44/303 (14%)

Query: 50  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--V 107
              E        PS N   L+  D IK +G GS G V LV+HK +G  +A+K++     V
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80

Query: 108 EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPE 167
           +         E +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140

Query: 168 E----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 223
                Y A    Q++    YLH    +I+RDLKP NLLI+ +G +++TDFG +  +    
Sbjct: 141 PHARFYAA----QIVLTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---K 192

Query: 224 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY- 282
           G+  T  GT   ++PE I    Y    D W+LG+++ E A G     PP        F+ 
Sbjct: 193 GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY----PP--------FFA 240

Query: 283 ----ELMEAIVDQP---PPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHP 330
               ++ E IV      P       FS +    +   +Q +  +R         ++  H 
Sbjct: 241 DQPIQIYEKIVSGKVRFPSH-----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295

Query: 331 FLK 333
           +  
Sbjct: 296 WFA 298

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  182 bits (463), Expect = 7e-54
 Identities = 65/292 (22%), Positives = 118/292 (40%), Gaps = 46/292 (15%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCY 134
           K++G GS G V   Q  + G+  A+K + ++  + A      E+K+  +S   P V+  Y
Sbjct: 21  KILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFCDIALM----EIKLLTESDDHPNVIRYY 75

Query: 135 QSFYSNGAISIILEYMDGGSLADFLKK-------VKTIPEEYLAAICEQVLKGLLYLHHE 187
            S  ++  + I LE     +L D ++        +K   E    ++  Q+  G+ +LH  
Sbjct: 76  CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH-S 133

Query: 188 KHIIHRDLKPSNLLINHRGE-------------VKITDFGVSAIM----ASTSGQANTFV 230
             IIHRDLKP N+L++                 + I+DFG+   +    +S     N   
Sbjct: 134 LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPS 193

Query: 231 GTYNYMSPERISGG-------KYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY 282
           GT  + +PE +          +     DI+S+G V     + G+ P+     ++      
Sbjct: 194 GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-----S 248

Query: 283 ELMEAIVD-QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
            ++  I                E    IS  +  +P +R +A +++ HP   
Sbjct: 249 NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  180 bits (458), Expect = 7e-54
 Identities = 77/299 (25%), Positives = 136/299 (45%), Gaps = 36/299 (12%)

Query: 52  TETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEE 109
           T T +      + +++ L D + + V+GKGS G V L + K T + +A+K++   + +++
Sbjct: 2   TNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 61

Query: 110 SARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE 168
                   E ++     + P++   +  F +   +  ++EY++GG L   +++V    E 
Sbjct: 62  DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP 121

Query: 169 ----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 224
               Y A I      GL +L   K II+RDLK  N++++  G +KI DFG+         
Sbjct: 122 HAVFYAAEIAI----GLFFLQ-SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV 176

Query: 225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-- 282
              TF GT +Y++PE I+   YG   D W+ G++L E   GQ     P        F   
Sbjct: 177 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ----AP--------FEGE 224

Query: 283 ---ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 333
              EL ++I++       S   S E  +     + K P +RL       +++  H F +
Sbjct: 225 DEDELFQSIMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  181 bits (461), Expect = 1e-53
 Identities = 80/308 (25%), Positives = 138/308 (44%), Gaps = 46/308 (14%)

Query: 53  ETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESAR 112
           +   P +++  + +L  +D + +KV+G+G+   V +V+ K TGQ +A+K++    +   R
Sbjct: 44  QWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW-DMLKR 102

Query: 113 RQIAQ---ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV-KTIPEE 168
            +++    E  +  +    ++   + +F     + +++EY  GG L   L K  + IP E
Sbjct: 103 GEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE 162

Query: 169 ----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTS 223
               YLA   E V+  +  + H    +HRD+KP N+L++  G +++ DFG    + A  +
Sbjct: 163 MARFYLA---EIVM-AIDSV-HRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217

Query: 224 GQANTFVGTYNYMSPERISG-------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 276
            ++   VGT +Y+SPE +         G YG + D W+LG+   E   GQ     P    
Sbjct: 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ----TP---- 269

Query: 277 GWTSFY-----ELMEAIVDQP---PPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQE 325
               FY     E    IV            +    E   FI   +   P+ RL    A +
Sbjct: 270 ----FYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCP-PETRLGRGGAGD 324

Query: 326 LMTHPFLK 333
             THPF  
Sbjct: 325 FRTHPFFF 332

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  178 bits (453), Expect = 1e-53
 Identities = 74/285 (25%), Positives = 132/285 (46%), Gaps = 28/285 (9%)

Query: 48  IVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHK--WTGQFFALKVI-Q 104
           I +         +   D  +   D++  + +G GS G V    H+  W G   A+K++ +
Sbjct: 15  IPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTV----HRAEWHGSDVAVKILME 70

Query: 105 MNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--- 161
            +       +  +E+ I +  + P +V+   +      +SI+ EY+  GSL   L K   
Sbjct: 71  QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130

Query: 162 VKTIPEEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMA 220
            + + E    ++   V KG+ YLH+    I+HR+LK  NLL++ +  VK+ DFG+S + A
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190

Query: 221 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS 280
           ST   + +  GT  +M+PE +       KSD++S G++L E AT Q P+          +
Sbjct: 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG-------NLN 243

Query: 281 FYELMEAIVDQ-----PPPSAPSDQFSPEFCSFISACVQKEPQQR 320
             +++ A+  +      P +       P+  + I  C   EP +R
Sbjct: 244 PAQVVAAVGFKCKRLEIPRNLN-----PQVAAIIEGCWTNEPWKR 283

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  185 bits (471), Expect = 3e-53
 Identities = 68/292 (23%), Positives = 113/292 (38%), Gaps = 29/292 (9%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV 132
           +  + +G G  G V    H+ TG+  A+K  +  +    R +   E++I +    P VV 
Sbjct: 17  EMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVS 76

Query: 133 CYQ------SFYSNGAISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLY 183
             +          N    + +EY +GG L  +L + +    + E  +  +   +   L Y
Sbjct: 77  AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136

Query: 184 LHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           LH E  IIHRDLKP N+++     R   KI D G +  +         FVGT  Y++PE 
Sbjct: 137 LH-ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTEFVGTLQYLAPEL 194

Query: 241 ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---------------LM 285
           +   KY    D WS G +  EC TG  P+ P  Q   W                     +
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAV 254

Query: 286 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
           +     P P+  S   + +   ++   +    +QR +  +       +    
Sbjct: 255 KFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  177 bits (451), Expect = 3e-53
 Identities = 65/292 (22%), Positives = 117/292 (40%), Gaps = 39/292 (13%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 129
             +  ++V  +G  G V   Q     ++ A+K+  +  ++S + +   E+      +   
Sbjct: 24  MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNE--YEVYSLPGMKHEN 79

Query: 130 VV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
           ++       +    +  + +I  + + GSL+DFLK    +    L  I E + +GL YLH
Sbjct: 80  ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLH 138

Query: 186 HEKH---------IIHRDLKPSNLLINHRGEVKITDFGVSAIM--ASTSGQANTFVGTYN 234
            +           I HRD+K  N+L+ +     I DFG++       ++G  +  VGT  
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198

Query: 235 YMSPERISGG-----KYGYKSDIWSLGLVLLECATGQFPYS--------PPEQQDGWTSF 281
           YM+PE + G          + D++++GLVL E A+              P E++ G    
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258

Query: 282 YELMEAIVDQ------PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
            E M+ +V                      C  I  C   + + RLSA  + 
Sbjct: 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  177 bits (451), Expect = 4e-53
 Identities = 81/321 (25%), Positives = 135/321 (42%), Gaps = 42/321 (13%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS- 124
           +L    +   +V+ +G    V   Q   +G+ +ALK +  N EE   R I QE+   +  
Sbjct: 24  ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKL 82

Query: 125 SQCPYVVVCYQSFY-------SNGAISIILEYMDGGSLADFLKKVKT---IPEEYLAAIC 174
           S  P +V    +         +  A  ++L  +  G L +FLKK+++   +  + +  I 
Sbjct: 83  SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF 142

Query: 175 EQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN------ 227
            Q  + + ++H +K  IIHRDLK  NLL++++G +K+ DFG +  ++     +       
Sbjct: 143 YQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202

Query: 228 ------TFVGTYNYMSPERI---SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 278
                 T   T  Y +PE I   S    G K DIW+LG +L      Q P          
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP---------- 252

Query: 279 TSFYE-LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
             F +     IV+      P D     F S I A +Q  P++RLS  E++     ++   
Sbjct: 253 --FEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ-EIAAA 309

Query: 338 LNVDLSEYFTDAGSPLATLSN 358
            NV+     T+         +
Sbjct: 310 RNVNPKSPITELLEQNGGYGS 330

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  176 bits (450), Expect = 4e-53
 Identities = 77/287 (26%), Positives = 136/287 (47%), Gaps = 44/287 (15%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA---QELKIN 122
           + +L+D   ++ +G GS G V L++ +  G+++A+KV++  +     +Q+     E  + 
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVR-LKQVEHTNDERLML 60

Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEE----YLAAICEQVL 178
                P+++  + +F     I +I++Y++GG L   L+K +  P      Y A    +V 
Sbjct: 61  SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA----EVC 116

Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 238
             L YLH  K II+RDLKP N+L++  G +KITDFG +  +        T  GT +Y++P
Sbjct: 117 LALEYLH-SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TYTLCGTPDYIAP 172

Query: 239 ERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP 293
           E +S   Y    D WS G+++ E   G      P        FY     +  E I++   
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGY----TP--------FYDSNTMKTYEKILNAEL 220

Query: 294 --PSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 333
             P      F+ +    +S  + ++  QRL       +++  HP+ K
Sbjct: 221 RFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 263

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  181 bits (461), Expect = 5e-53
 Identities = 79/303 (26%), Positives = 140/303 (46%), Gaps = 23/303 (7%)

Query: 68  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQS 124
              D     +V+GKGS G V L + K TGQ  A+KVI      +++ +  + +E+++ + 
Sbjct: 23  IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82

Query: 125 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL 184
              P ++  Y+ F   G   ++ E   GG L D +   K   E   A I  QVL G+ Y+
Sbjct: 83  LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYM 142

Query: 185 HHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 241
            H+  I+HRDLKP NLL+  + +   ++I DFG+S    ++  +    +GT  Y++PE +
Sbjct: 143 -HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-KMKDKIGTAYYIAPEVL 200

Query: 242 SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSD 299
             G Y  K D+WS G++L    +G  P++   +        ++++ +             
Sbjct: 201 H-GTYDEKCDVWSTGVILYILLSGCPPFNGANEY-------DILKKVEKGKYTFELPQWK 252

Query: 300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNL 359
           + S      I   +   P  R+SA++ + H +++ Y    +       D  S    + N+
Sbjct: 253 KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQIS-----VDVPSLDNAILNI 307

Query: 360 SGF 362
             F
Sbjct: 308 RQF 310

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  179 bits (456), Expect = 5e-53
 Identities = 83/307 (27%), Positives = 155/307 (50%), Gaps = 22/307 (7%)

Query: 42  NKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALK 101
              G  I  + E         + + L L+D D ++V+G+GS   V LV+ K T + +A++
Sbjct: 24  GAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMR 83

Query: 102 VIQ--MNVEESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF 158
           V++  +  ++     +  E  +  Q+S  P++V  +  F +   +  ++EY++GG L   
Sbjct: 84  VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 143

Query: 159 LKKVKTIPEE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 214
           +++ + +PEE    Y A    ++   L YLH E+ II+RDLK  N+L++  G +K+TD+G
Sbjct: 144 MQRQRKLPEEHARFYSA----EISLALNYLH-ERGIIYRDLKLDNVLLDSEGHIKLTDYG 198

Query: 215 VSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQ 274
           +           +TF GT NY++PE + G  YG+  D W+LG+++ E   G+ P+     
Sbjct: 199 MCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258

Query: 275 QDGWT--SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL------SAQEL 326
            D     +   L + I+++      S   S +  S + + + K+P++RL         ++
Sbjct: 259 SDNPDQNTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADI 316

Query: 327 MTHPFLK 333
             HPF +
Sbjct: 317 QGHPFFR 323

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  177 bits (451), Expect = 8e-53
 Identities = 77/297 (25%), Positives = 143/297 (48%), Gaps = 27/297 (9%)

Query: 50  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNV 107
            ++  E   +   S N+L +++ + I+V+GKGS G V L + K TG  +A+KV++  + +
Sbjct: 3   KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62

Query: 108 EESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 166
           ++        E +I + +   P++   +  F +   +  ++E+++GG L   ++K +   
Sbjct: 63  QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD 122

Query: 167 EE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 222
           E     Y A    +++  L++L H+K II+RDLK  N+L++H G  K+ DFG+       
Sbjct: 123 EARARFYAA----EIISALMFL-HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177

Query: 223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 282
                TF GT +Y++PE +    YG   D W++G++L E   G  P+    +        
Sbjct: 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------- 230

Query: 283 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL------SAQELMTHPFLK 333
           +L EAI++             +    + + + K P  RL          ++ HPF K
Sbjct: 231 DLFEAILNDEVVYPTW--LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK 285

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  175 bits (446), Expect = 1e-52
 Identities = 75/292 (25%), Positives = 116/292 (39%), Gaps = 39/292 (13%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 129
            DI  ++ VGKG  G V      W G+  A+K+     E+S  R+   EL      +   
Sbjct: 8   RDITLLECVGKGRYGEVWRG--SWQGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHEN 63

Query: 130 VV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
           ++        S +S+  + +I  Y + GSL D+L+   T+       I   +  GL +LH
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLH 122

Query: 186 HEKH-------IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA----NTFVGTYN 234
            E         I HRDLK  N+L+   G+  I D G++ + + ++ Q     N  VGT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 235 YMSPERISG------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ----DGWT----S 280
           YM+PE +             + DIW+ GLVL E A         E              S
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPS 242

Query: 281 FYELMEAIVDQ---P--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
           F ++ + +      P  P    SD         +  C  + P  RL+A  + 
Sbjct: 243 FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  178 bits (454), Expect = 1e-52
 Identities = 89/336 (26%), Positives = 142/336 (42%), Gaps = 49/336 (14%)

Query: 32  GTFMDGDLLVN------KDGVRI----------VSQTETEAPPLIKPSDNQLNLEDI-DT 74
           GTF++ +L+         +   I          V    T     + P      L D    
Sbjct: 84  GTFVNTELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKA----LRDEYIM 139

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVI-------QMNVEESARRQIAQELKINQSSQC 127
            K +G G+ G V+L   + T +  A+++I           E      +  E++I +    
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 187
           P ++     F+      I+LE M+GG L D +   K + E        Q+L  + YL HE
Sbjct: 200 PCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL-HE 257

Query: 188 KHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG- 243
             IIHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE +   
Sbjct: 258 NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSV 316

Query: 244 --GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI----VDQPPPSAP 297
               Y    D WSLG++L  C +G  P+S    Q        L + I     +  P    
Sbjct: 317 GTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPE--V 368

Query: 298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
             + S +    +   +  +P+ R + +E + HP+L+
Sbjct: 369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 404

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  176 bits (449), Expect = 1e-52
 Identities = 69/272 (25%), Positives = 122/272 (44%), Gaps = 21/272 (7%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ 135
           + +G GS  + +   HK T   FA+K+I  + +     +I     + +  Q P ++    
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIIDKS-KRDPTEEIE---ILLRYGQHPNIITLKD 83

Query: 136 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            +     + ++ E M GG L D + + K   E   +A+   + K + YLH  + ++HRDL
Sbjct: 84  VYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH-AQGVVHRDL 142

Query: 196 KPSNLLINHRGE----VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           KPSN+L          ++I DFG +  + + +G   T   T N+++PE +    Y    D
Sbjct: 143 KPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACD 202

Query: 252 IWSLGLVLLECATGQFP-YSPPEQQDGWTSFYELMEAI----VDQPPPSAPSDQFSPEFC 306
           IWSLG++L    TG  P  + P+         E++  I              +  S    
Sbjct: 203 IWSLGVLLYTMLTGYTPFANGPDDTP-----EEILARIGSGKFSLSGG--YWNSVSDTAK 255

Query: 307 SFISACVQKEPQQRLSAQELMTHPFLKMYGDL 338
             +S  +  +P QRL+A  ++ HP++  +  L
Sbjct: 256 DLVSKMLHVDPHQRLTAALVLRHPWIVHWDQL 287

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  176 bits (449), Expect = 1e-52
 Identities = 73/306 (23%), Positives = 134/306 (43%), Gaps = 35/306 (11%)

Query: 52  TETEAPPLIKPSDNQLNLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVI---QMNV 107
                  ++  +D+ +  ED+ +  +V+GKG   +V+   ++ TGQ FA+K++   +   
Sbjct: 5   ISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTS 64

Query: 108 EESARRQ-IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 166
                 + + +E  I    + P++V   +++ S+G + ++ E+MDG  L   + K     
Sbjct: 65  SPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAG 124

Query: 167 EEYL----AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIM 219
             Y     +    Q+L+ L Y H + +IIHRD+KP  +L+  +     VK+  FGV+  +
Sbjct: 125 FVYSEAVASHYMRQILEALRYCH-DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183

Query: 220 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVL--LECATGQFPYSPPEQQDG 277
             +   A   VGT ++M+PE +    YG   D+W  G++L  L           P     
Sbjct: 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG------CLP----- 232

Query: 278 WTSFY----ELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
              FY     L E I+              S      +   +  +P +R++  E + HP+
Sbjct: 233 ---FYGTKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPW 289

Query: 332 LKMYGD 337
           LK    
Sbjct: 290 LKERDR 295

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  181 bits (462), Expect = 1e-52
 Identities = 82/291 (28%), Positives = 135/291 (46%), Gaps = 33/291 (11%)

Query: 61  KPSDNQ-LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKV------IQMNVEESARR 113
           K  + Q +        +V+GKG  G V   Q + TG+ +A K        +   E  A  
Sbjct: 174 KWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL- 232

Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI--PEE--- 168
               E +I +     +VV    ++ +  A+ ++L  M+GG L   +  +     PE    
Sbjct: 233 ---NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAV 289

Query: 169 -YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 227
            Y A    ++  GL  LH  + I++RDLKP N+L++  G ++I+D G++  +        
Sbjct: 290 FYAA----EICCGLEDLH-RERIVYRDLKPENILLDDHGHIRISDLGLAVHV-PEGQTIK 343

Query: 228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEA 287
             VGT  YM+PE +   +Y +  D W+LG +L E   GQ   SP +Q+       E+   
Sbjct: 344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ---SPFQQRKKKIKREEVERL 400

Query: 288 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 333
           + + P     S++FSP+  S  S  + K+P +RL     SA+E+  HP  K
Sbjct: 401 VKEVPEEY--SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  174 bits (443), Expect = 2e-52
 Identities = 70/273 (25%), Positives = 128/273 (46%), Gaps = 33/273 (12%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVI---QMNVEESARRQIAQELKINQSSQCPYVVV 132
           + +GKG+  +V+   HK TG  FA K+I   +++  +  +  + +E +I +  Q P +V 
Sbjct: 12  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK--LEREARICRKLQHPNIVR 69

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            + S        ++ + + GG L + +   +   E   +   +Q+L+ + Y H    I+H
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH-SNGIVH 128

Query: 193 RDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 249
           R+LKP NLL+  + +   VK+ DFG++  + + S   + F GT  Y+SPE +    Y   
Sbjct: 129 RNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187

Query: 250 SDIWSLGLVL--LECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP--PSAPSDQ 300
            DIW+ G++L  L                G+  F+      L   I       PS   D 
Sbjct: 188 VDIWACGVILYILLV--------------GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 233

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
            +PE  S I + +   P++R++A + +  P++ 
Sbjct: 234 VTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  176 bits (447), Expect = 2e-52
 Identities = 67/353 (18%), Positives = 126/353 (35%), Gaps = 73/353 (20%)

Query: 51  QTETEAPPLIKPSDNQLNLEDIDTI-KVVGKGSGGIVQLVQHKWTGQFFALKVI----QM 105
              +    L     + L L+    +   +G+GS G+V++     T    A+K++      
Sbjct: 6   HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65

Query: 106 NVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI 165
            +      +I  E+++ +    P +   Y+ +     I +++E   GG L D L      
Sbjct: 66  QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125

Query: 166 P----------------------------------------EEYLAAICEQVLKGLLYLH 185
                                                    E+ ++ I  Q+   L YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185

Query: 186 HEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTS----GQANTFVGTYNYMSPE 239
             + I HRD+KP N L +      +K+ DFG+S      +        T  GT  +++PE
Sbjct: 186 -NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE 244

Query: 240 --RISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQP 292
               +   YG K D WS G++L     G    + P        F      + +  ++++ 
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMG----AVP--------FPGVNDADTISQVLNKK 292

Query: 293 P--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS 343
               +   +  SP     +S  + +   +R  A   + HP++  + D    +S
Sbjct: 293 LCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKIYKMS 345

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  179 bits (456), Expect = 3e-52
 Identities = 72/302 (23%), Positives = 141/302 (46%), Gaps = 21/302 (6%)

Query: 68  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSS 125
              +  + + ++GKGS G V   + + T Q +A+KVI   + +      I +E+++ +  
Sbjct: 19  TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL 78

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
             P ++  ++    + +  I+ E   GG L D + K K   E   A I +QV  G+ Y+ 
Sbjct: 79  DHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM- 137

Query: 186 HEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERIS 242
           H+ +I+HRDLKP N+L+  + +   +KI DFG+S      + +    +GT  Y++PE + 
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPEVLR 196

Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQ 300
            G Y  K D+WS G++L    +G  P+    +        ++++ +              
Sbjct: 197 -GTYDEKCDVWSAGVILYILLSGTPPFYGKNEY-------DILKRVETGKYAFDLPQWRT 248

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLS 360
            S +    I   +   P  R++A + + HP+++ Y      +S+  +      + ++N+ 
Sbjct: 249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE----SAMTNIR 304

Query: 361 GF 362
            F
Sbjct: 305 QF 306

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  173 bits (441), Expect = 3e-52
 Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 26/272 (9%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVI---QMNVEESARRQIAQELKINQSSQCPYVVV 132
             +G+GS G V++   K T    A K I    +   +  ++    E++I +S   P ++ 
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ----EIEIMKSLDHPNIIR 70

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
            Y++F  N  I +++E   GG L + +   +   E   A I + VL  + Y  H+ ++ H
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC-HKLNVAH 129

Query: 193 RDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYK 249
           RDLKP N L         +K+ DFG++A          T VGT  Y+SP+ +  G YG +
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-MMRTKVGTPYYVSPQVLE-GLYGPE 187

Query: 250 SDIWSLGLVL--LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEF 305
            D WS G+++  L C  G  P+S P          E+M  I +     P       SP+ 
Sbjct: 188 CDEWSAGVMMYVLLC--GYPPFSAPTDS-------EVMLKIREGTFTFPEKDWLNVSPQA 238

Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
            S I   + K P+QR+++ + + H + +    
Sbjct: 239 ESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  178 bits (452), Expect = 3e-52
 Identities = 78/305 (25%), Positives = 139/305 (45%), Gaps = 42/305 (13%)

Query: 53  ETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEES 110
           E   P   K    +L+ ED + +KV+G+G+ G V +V+ K   + FA+K++     ++ +
Sbjct: 57  EWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRA 116

Query: 111 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTI-PEE- 168
                 +E  +  +    ++   + +F  +  + ++++Y  GG L   L K +   PEE 
Sbjct: 117 ETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM 176

Query: 169 ---YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IMASTSG 224
              YLA   E V+  +  +H + H +HRD+KP N+L++  G +++ DFG    +M   + 
Sbjct: 177 ARFYLA---EMVI-AIDSVH-QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 231

Query: 225 QANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT 279
           Q++  VGT +Y+SPE +       G+YG + D WSLG+ + E   G+     P       
Sbjct: 232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE----TP------- 280

Query: 280 SFY-----ELMEAIVDQPPP-SAPSD--QFSPEFCSFISACVQKEPQQRL---SAQELMT 328
            FY     E    I++       P+     S      I   +    + RL     ++   
Sbjct: 281 -FYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICS-REHRLGQNGIEDFKK 338

Query: 329 HPFLK 333
           HPF  
Sbjct: 339 HPFFS 343

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  175 bits (446), Expect = 5e-52
 Identities = 43/304 (14%), Positives = 86/304 (28%), Gaps = 64/304 (21%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVI------QMNVEESARRQIAQ------------ 117
            V+G+           + TG+ F + V         N  +  + ++ +            
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 118 ---------ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMD--------GGSLADFLK 160
                       + +  Q   ++           +S    Y          G  L     
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 161 KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 220
             K++       +  QV++ L  LHH   ++H  L+P +++++ RG V +T F       
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDIVLDQRGGVFLTGFEH----L 253

Query: 221 STSGQANTFVGTYNYMSPERIS-----------GGKYGYKSDIWSLGLVLLECATGQFPY 269
              G       +  +  PE  +                +  D W+LGLV+        P 
Sbjct: 254 VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI 313

Query: 270 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
           +               E I                  + +   ++   + RL   + M  
Sbjct: 314 TKDAA-------LGGSEWIFRSCK------NIPQPVRALLEGFLRYPKEDRLLPLQAMET 360

Query: 330 PFLK 333
           P  +
Sbjct: 361 PEYE 364

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  176 bits (449), Expect = 5e-52
 Identities = 86/308 (27%), Positives = 141/308 (45%), Gaps = 42/308 (13%)

Query: 48  IVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV 107
           I +        + K  D ++  ED + +KV+G+G+ G VQLV+HK T + +A+K++    
Sbjct: 47  IDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF- 105

Query: 108 EESARRQIA---QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 164
           E   R   A   +E  I   +  P+VV  + +F  +  + +++EYM GG L + +     
Sbjct: 106 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD- 164

Query: 165 IPEE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA-IM 219
           +PE+    Y A    +V+  L  + H    IHRD+KP N+L++  G +K+ DFG    + 
Sbjct: 165 VPEKWARFYTA----EVVLALDAI-HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219

Query: 220 ASTSGQANTFVGTYNYMSPERISG----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ 275
                + +T VGT +Y+SPE +      G YG + D WS+G+ L E   G      P   
Sbjct: 220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD----TP--- 272

Query: 276 DGWTSFY-----ELMEAIVD--QPPPSAPSDQFSPEFCSFISACVQKEPQQRL---SAQE 325
                FY          I++          +  S E  + I A    + + RL     +E
Sbjct: 273 -----FYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICA-FLTDREVRLGRNGVEE 326

Query: 326 LMTHPFLK 333
           +  H F K
Sbjct: 327 IKRHLFFK 334

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  173 bits (441), Expect = 1e-51
 Identities = 77/315 (24%), Positives = 129/315 (40%), Gaps = 40/315 (12%)

Query: 48  IVSQTETEAPPLIKPSDNQ-LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN 106
           ++ Q+++       P   Q    + I  +K +GKG  G V +   KW G+  A+KV    
Sbjct: 14  LIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMG--KWRGEKVAVKVFFTT 71

Query: 107 VEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKV 162
            E S  R+   E+      +   ++       +   S   + +I +Y + GSL D+LK  
Sbjct: 72  EEASWFRE--TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS- 128

Query: 163 KTIPEEYLAAICEQVLKGLLYLHHEKH-------IIHRDLKPSNLLINHRGEVKITDFGV 215
            T+  + +  +    + GL +LH E         I HRDLK  N+L+   G   I D G+
Sbjct: 129 TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188

Query: 216 SAIMASTSGQA----NTFVGTYNYMSPERISGG------KYGYKSDIWSLGLVLLECATG 265
           +    S + +     NT VGT  YM PE +         +    +D++S GL+L E A  
Sbjct: 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

Query: 266 QFPYSP-PEQQDGWT-------SFYELMEAIVDQ---P--PPSAPSDQFSPEFCSFISAC 312
                   E Q  +        S+ ++ E +  +   P  P    SD+   +    ++ C
Sbjct: 249 CVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC 308

Query: 313 VQKEPQQRLSAQELM 327
               P  RL+A  + 
Sbjct: 309 WAHNPASRLTALRVK 323

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  180 bits (459), Expect = 2e-51
 Identities = 75/296 (25%), Positives = 137/296 (46%), Gaps = 26/296 (8%)

Query: 50  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNV 107
               T +      + +++ L D + + V+GKGS G V L + K T + +A+K++   + +
Sbjct: 321 KTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVI 380

Query: 108 EESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP 166
           ++        E ++     + P++   +  F +   +  ++EY++GG L   +++V    
Sbjct: 381 QDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFK 440

Query: 167 EE----YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 222
           E     Y A I      GL +L   K II+RDLK  N++++  G +KI DFG+       
Sbjct: 441 EPHAVFYAAEIAI----GLFFLQ-SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495

Query: 223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY 282
                TF GT +Y++PE I+   YG   D W+ G++L E   GQ P+   ++        
Sbjct: 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------- 548

Query: 283 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 333
           EL ++I++       S   S E  +     + K P +RL       +++  H F +
Sbjct: 549 ELFQSIMEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 602

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  171 bits (436), Expect = 3e-51
 Identities = 57/294 (19%), Positives = 113/294 (38%), Gaps = 39/294 (13%)

Query: 58  PLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM------NVEESA 111
              K     L   +I+  K +GKG  G+V   +        A+K + +            
Sbjct: 7   EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66

Query: 112 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIP 166
            ++  +E+ I  +   P +V    + +          +++E++  G L   L  K   I 
Sbjct: 67  FQEFQREVFIMSNLNHPNIVKLYGLMHNPPR------MVMEFVPCGDLYHRLLDKAHPIK 120

Query: 167 EEYLAAICEQVLKGLLYLHHEKH-IIHRDLKPSNLLINHRGE-----VKITDFGVSAIMA 220
                 +   +  G+ Y+ ++   I+HRDL+  N+ +    E      K+ DFG+S    
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV 180

Query: 221 STSGQANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYS--PPEQQD 276
            +       +G + +M+PE I      Y  K+D +S  ++L    TG+ P+      +  
Sbjct: 181 HSVS---GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-- 235

Query: 277 GWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
                 + +  I ++   P+ P D   P   + I  C   +P++R     ++  
Sbjct: 236 -----IKFINMIREEGLRPTIPED-CPPRLRNVIELCWSGDPKKRPHFSYIVKE 283

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  171 bits (435), Expect = 3e-51
 Identities = 69/266 (25%), Positives = 128/266 (48%), Gaps = 16/266 (6%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSSQCPYVVVCY 134
            ++GKGS G V   + + T Q +A+KVI   + +      I +E+++ +    P ++  +
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 135 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 194
           +    + +  I+ E   GG L D + K K   E   A I +QV  G+ Y+ H+ +I+HRD
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM-HKHNIVHRD 146

Query: 195 LKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           LKP N+L+  + +   +KI DFG+S      + +    +GT  Y++PE +  G Y  K D
Sbjct: 147 LKPENILLESKEKDCDIKIIDFGLSTCFQQNT-KMKDRIGTAYYIAPE-VLRGTYDEKCD 204

Query: 252 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCSFI 309
           +WS G++L    +G  P+    +        ++++ +               S +    I
Sbjct: 205 VWSAGVILYILLSGTPPFYGKNEY-------DILKRVETGKYAFDLPQWRTISDDAKDLI 257

Query: 310 SACVQKEPQQRLSAQELMTHPFLKMY 335
              +   P  R++A + + HP+++ Y
Sbjct: 258 RKMLTFHPSLRITATQCLEHPWIQKY 283

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  171 bits (435), Expect = 5e-51
 Identities = 72/283 (25%), Positives = 132/283 (46%), Gaps = 36/283 (12%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVI--------QMNVEESARRQIAQELKINQS-SQ 126
           +++G+G   +V+   HK T + +A+K+I             +  R    +E+ I +  S 
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 186
            P ++    ++ +N    ++ + M  G L D+L +  T+ E+    I   +L+ +  LH 
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALH- 141

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-- 244
           + +I+HRDLKP N+L++    +K+TDFG S  +     +     GT +Y++PE I     
Sbjct: 142 KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEIIECSMN 200

Query: 245 ----KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP-- 293
                YG + D+WS G+++     G    SPP        F+      ++  I+      
Sbjct: 201 DNHPGYGKEVDMWSTGVIMYTLLAG----SPP--------FWHRKQMLMLRMIMSGNYQF 248

Query: 294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 336
            S   D +S      +S  +  +PQ+R +A+E + HPF + Y 
Sbjct: 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  172 bits (439), Expect = 5e-51
 Identities = 73/300 (24%), Positives = 131/300 (43%), Gaps = 37/300 (12%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSSQCPYVVVCY 134
           + +GKG+  +V+   HK TG  FA K+I    +     +++ +E +I +  Q P +V  +
Sbjct: 35  EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLH 94

Query: 135 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 194
            S        ++ + + GG L + +   +   E   +   +Q+L+ + Y H    I+HR+
Sbjct: 95  DSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH-SNGIVHRN 153

Query: 195 LKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           LKP NLL+  + +   VK+ DFG++  +  +    + F GT  Y+SPE +    Y    D
Sbjct: 154 LKPENLLLASKAKGAAVKLADFGLAIEVNDSE-AWHGFAGTPGYLSPEVLKKDPYSKPVD 212

Query: 252 IWSLGLVL--LECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP--PSAPSDQFS 302
           IW+ G++L  L                G+  F+      L   I       PS   D  +
Sbjct: 213 IWACGVILYILLV--------------GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 258

Query: 303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSPLATLSNLSGF 362
           PE  S I + +   P++R++A + +  P++     +          A     T+  L  F
Sbjct: 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV--------ASAIHRQDTVDCLKKF 310

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  176 bits (447), Expect = 9e-51
 Identities = 71/314 (22%), Positives = 134/314 (42%), Gaps = 35/314 (11%)

Query: 68  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVI------------QMNVEESARRQ 114
            + +    ++ +G G+ G V L + K      A+KVI                 E    +
Sbjct: 33  KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92

Query: 115 IAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAIC 174
           I  E+ + +S   P ++  +  F       ++ E+ +GG L + +       E   A I 
Sbjct: 93  IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIM 152

Query: 175 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVG 231
           +Q+L G+ YL H+ +I+HRD+KP N+L+ ++     +KI DFG+S+  +    +    +G
Sbjct: 153 KQILSGICYL-HKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRDRLG 210

Query: 232 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP-YSPPEQQDGWTSFYELMEAIVD 290
           T  Y++PE +   KY  K D+WS G+++     G  P     +Q        ++++ +  
Sbjct: 211 TAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ--------DIIKKVEK 261

Query: 291 QPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 348
                        S E    I   +  +  +R +A+E +   ++K Y +         +D
Sbjct: 262 GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINK-----SD 316

Query: 349 AGSPLATLSNLSGF 362
             +    LSN+  F
Sbjct: 317 QKTLCGALSNMRKF 330

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  170 bits (434), Expect = 1e-50
 Identities = 80/275 (29%), Positives = 126/275 (45%), Gaps = 28/275 (10%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVI-------QMNVEESARRQIAQELKINQSSQCP 128
           K +G G+ G V+L   + T +  A+K+I           E      +  E++I +    P
Sbjct: 16  KTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHP 75

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            ++     F +     I+LE M+GG L D +   K + E        Q+L  + YLH E 
Sbjct: 76  CIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLH-EN 133

Query: 189 HIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-- 243
            IIHRDLKP N+L++ + E   +KITDFG S I+  TS    T  GT  Y++PE +    
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-LMRTLCGTPTYLAPEVLVSVG 192

Query: 244 -GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI----VDQPPPSAPS 298
              Y    D WSLG++L  C +G  P+S    Q        L + I     +  P     
Sbjct: 193 TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ------VSLKDQITSGKYNFIPE--VW 244

Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
            + S +    +   +  +P+ R + +E + HP+L+
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  169 bits (430), Expect = 1e-50
 Identities = 73/282 (25%), Positives = 121/282 (42%), Gaps = 39/282 (13%)

Query: 68  NLEDIDTIKVVGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEE---SARRQIAQELKIN 122
           +  ++   +++G G  G V    ++  W G   A+K  + + +E        + QE K+ 
Sbjct: 5   DFAELTLEEIIGIGGFGKV----YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60

Query: 123 QSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 178
              + P ++    VC +       + +++E+  GG L   L   K IP + L     Q+ 
Sbjct: 61  AMLKHPNIIALRGVCLKE----PNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIA 115

Query: 179 KGLLYLHHEK--HIIHRDLKPSNLLINHRGE--------VKITDFGVSAIMASTSGQANT 228
           +G+ YLH E    IIHRDLK SN+LI  + E        +KITDFG++     T+    +
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--KMS 173

Query: 229 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI 288
             G Y +M+PE I    +   SD+WS G++L E  TG+ P+       G      +   +
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF------RGID-GLAVAYGV 226

Query: 289 VDQ-PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
                    PS      F   +  C   +P  R S   ++  
Sbjct: 227 AMNKLALPIPST-CPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  174 bits (442), Expect = 2e-50
 Identities = 68/275 (24%), Positives = 125/275 (45%), Gaps = 28/275 (10%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSSQCPYVVVCY 134
           + +GKG+  +V+       GQ +A  +I    +     +++ +E +I +  + P +V  +
Sbjct: 17  EELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 76

Query: 135 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 194
            S    G   +I + + GG L + +   +   E   +   +Q+L+ +L+ H +  ++HR+
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH-QMGVVHRN 135

Query: 195 LKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           LKP NLL+  + +   VK+ DFG++  +         F GT  Y+SPE +    YG   D
Sbjct: 136 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVD 195

Query: 252 IWSLGLVL--LECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP--PSAPSDQFS 302
           +W+ G++L  L    G   Y P         F+      L + I       PS   D  +
Sbjct: 196 LWACGVILYILLV--G---YPP---------FWDEDQHRLYQQIKAGAYDFPSPEWDTVT 241

Query: 303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
           PE    I+  +   P +R++A E + HP++     
Sbjct: 242 PEAKDLINKMLTINPSKRITAAEALKHPWISHRST 276

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  170 bits (432), Expect = 3e-50
 Identities = 68/263 (25%), Positives = 128/263 (48%), Gaps = 15/263 (5%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSSQCPYVVVCY 134
           K +GKG+   V+L +H  TG+  A+K+I    +  ++ +++ +E++I +    P +V  +
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80

Query: 135 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 194
           +   +   + +I+EY  GG + D+L     + E+   +   Q++  + Y H +K I+HRD
Sbjct: 81  EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH-QKRIVHRD 139

Query: 195 LKPSNLLINHRGEVKITDFGVSAIMASTSGQA-NTFVGTYNYMSPERISGGKY-GYKSDI 252
           LK  NLL++    +KI DFG S     T G   + F G   Y +PE   G KY G + D+
Sbjct: 140 LKAENLLLDADMNIKIADFGFSNEF--TVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDV 197

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 312
           WSLG++L    +G  P+   + Q+       ++      P         S +  + +   
Sbjct: 198 WSLGVILYTLVSGSLPF---DGQNLKELRERVLRGKYRIPF------YMSTDCENLLKRF 248

Query: 313 VQKEPQQRLSAQELMTHPFLKMY 335
           +   P +R + +++M   ++   
Sbjct: 249 LVLNPIKRGTLEQIMKDRWINAG 271

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  169 bits (430), Expect = 4e-50
 Identities = 67/277 (24%), Positives = 117/277 (42%), Gaps = 36/277 (12%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVI---------QMNVEESARRQIAQELKINQSSQ 126
            ++GKG  G V            A+KVI          ++   +   ++A   K+     
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 127 CPYVVVCYQSFYSNGAISIILEY-MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
            P V+     F +     ++LE  +    L D++ +   + E        QV+  + + H
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156

Query: 186 HEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 244
             + ++HRD+K  N+LI+  RG  K+ DFG  A++         F GT  Y  PE IS  
Sbjct: 157 S-RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDFDGTRVYSPPEWISRH 213

Query: 245 KY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY---ELMEAIVDQPPPSAPSDQ 300
           +Y    + +WSLG++L +   G  P            F    E++EA +  P        
Sbjct: 214 QYHALPATVWSLGILLYDMVCGDIP------------FERDQEILEAELHFPA------H 255

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
            SP+ C+ I  C+  +P  R S +E++  P+++   +
Sbjct: 256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  168 bits (429), Expect = 4e-50
 Identities = 79/283 (27%), Positives = 134/283 (47%), Gaps = 34/283 (12%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ 135
           +V+G G+   V LV+ + TG+ FALK I+ +        +  E+ + +  +   +V    
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR-DSSLENEIAVLKKIKHENIVTLED 73

Query: 136 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            + S     ++++ + GG L D + +     E+  + + +QVL  + YLH E  I+HRDL
Sbjct: 74  IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLH-ENGIVHRDL 132

Query: 196 KPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           KP NLL     E   + ITDFG+S +  +  G  +T  GT  Y++PE ++   Y    D 
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEVLAQKPYSKAVDC 190

Query: 253 WSLGLVL--LECATGQFPYSPPEQQDGWTSFY-----ELMEAI----VDQPPPSAPSDQF 301
           WS+G++   L C  G   Y P         FY     +L E I     +   P    D  
Sbjct: 191 WSIGVITYILLC--G---YPP---------FYEETESKLFEKIKEGYYEFESP--FWDDI 234

Query: 302 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE 344
           S     FI   ++K+P +R + ++ ++HP++     L+ D+  
Sbjct: 235 SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYP 277

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  168 bits (427), Expect = 1e-49
 Identities = 74/289 (25%), Positives = 123/289 (42%), Gaps = 38/289 (13%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVI---QMNVEESARRQIAQELKI-NQSSQCPYVV 131
            V+G+G+   VQ   +  T Q +A+K+I     ++     R    E+++  Q      V+
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR----EVEMLYQCQGHRNVL 74

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
              + F       ++ E M GGS+   + K +   E   + + + V   L +LH  K I 
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH-NKGIA 133

Query: 192 HRDLKPSNLLINHRGE---VKITDFGVSAIM-------ASTSGQANTFVGTYNYMSPE-- 239
           HRDLKP N+L  H  +   VKI DF + + +         ++ +  T  G+  YM+PE  
Sbjct: 134 HRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV 193

Query: 240 ---RISGGKYGYKSDIWSLGLVL--LECATGQFP-YSPPEQQDGWTSFY-------ELME 286
                    Y  + D+WSLG++L  L    G  P         GW            L E
Sbjct: 194 EAFSEEASIYDKRCDLWSLGVILYILLS--GYPPFVGRCGSDCGWDRGEACPACQNMLFE 251

Query: 287 AIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
           +I +     P       S      IS  + ++ +QRLSA +++ HP+++
Sbjct: 252 SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  167 bits (425), Expect = 1e-49
 Identities = 69/289 (23%), Positives = 122/289 (42%), Gaps = 39/289 (13%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVI-------------------------QMNVEE 109
              +GKGS G+V+L  ++    ++A+KV+                               
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 110 SARRQIAQELKINQSSQCPYVVVCYQ--SFYSNGAISIILEYMDGGSLADFLKKVKTIPE 167
               Q+ QE+ I +    P VV   +     +   + ++ E ++ G + +       + E
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-LSE 136

Query: 168 EYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 227
           +      + ++KG+ YLH+ + IIHRD+KPSNLL+   G +KI DFGVS     +    +
Sbjct: 137 DQARFYFQDLIKGIEYLHY-QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLS 195

Query: 228 TFVGTYNYMSPERISGGKYGY---KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL 284
             VGT  +M+PE +S  +  +     D+W++G+ L     GQ P+      D       L
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF-----MD--ERIMCL 248

Query: 285 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
              I  Q          + +    I+  + K P+ R+   E+  HP++ 
Sbjct: 249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  168 bits (428), Expect = 1e-49
 Identities = 74/278 (26%), Positives = 122/278 (43%), Gaps = 30/278 (10%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVCY 134
           +V+G G  G V    H+ TGQ  ALK++          +  QE+    Q+S  P++V   
Sbjct: 35  QVLGLGVNGKVLECFHRRTGQKCALKLL------YDSPKARQEVDHHWQASGGPHIVCIL 88

Query: 135 QSF----YSNGAISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
             +    +    + II+E M+GG L   +  +  +   E   A I   +   + +LH   
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH-SH 147

Query: 189 HIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
           +I HRD+KP NLL   + +   +K+TDFG +     T     T   T  Y++PE +   K
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNALQTPCYTPYYVAPEVLGPEK 205

Query: 246 YGYKSDIWSLGLVL--LECATGQFP-YSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQ 300
           Y    D+WSLG+++  L C  G  P YS   Q         +   I       P+    +
Sbjct: 206 YDKSCDMWSLGVIMYILLC--GFPPFYSNTGQA----ISPGMKRRIRLGQYGFPNPEWSE 259

Query: 301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL 338
            S +    I   ++ +P +RL+  + M HP++     +
Sbjct: 260 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  168 bits (427), Expect = 1e-49
 Identities = 72/293 (24%), Positives = 125/293 (42%), Gaps = 34/293 (11%)

Query: 73  DTIKVVGKGSGGIVQLVQHKWTGQFFALKVI-------QMNVEESARRQIAQELKINQSS 125
            T+  +G G+ G V     K   +   +K I          +E+    ++  E+ I    
Sbjct: 27  STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86

Query: 126 QCPYVVVCYQSFYSNGAISIILE-YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL 184
           +   ++     F + G   +++E +  G  L  F+ +   + E   + I  Q++  + YL
Sbjct: 87  EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146

Query: 185 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA-NTFVGTYNYMSPERISG 243
              K IIHRD+K  N++I     +K+ DFG +A +    G+   TF GT  Y +PE + G
Sbjct: 147 R-LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTFCGTIEYCAPEVLMG 203

Query: 244 GKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL---MEAIVDQPPPSAPSD 299
             Y G + ++WSLG+ L      + P            F EL   +EA +  P       
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENP------------FCELEETVEAAIHPPYL----- 246

Query: 300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSP 352
             S E  S +S  +Q  P++R + ++L+T P++    +L     E       P
Sbjct: 247 -VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKP 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  168 bits (426), Expect = 3e-49
 Identities = 67/293 (22%), Positives = 113/293 (38%), Gaps = 39/293 (13%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
              I   + +GKG  G V     KW G+  A+K+     E S  R+   E+      +  
Sbjct: 41  ARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHE 96

Query: 129 YVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL 184
            ++       +   +   + ++ +Y + GSL D+L +  T+  E +  +      GL +L
Sbjct: 97  NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHL 155

Query: 185 HHEKH-------IIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA----NTFVGTY 233
           H E         I HRDLK  N+L+   G   I D G++    S +       N  VGT 
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

Query: 234 NYMSPERISG------GKYGYKSDIWSLGLVLLECATGQFPYS-PPEQQDGW-------T 279
            YM+PE +         +   ++DI+++GLV  E A          + Q  +        
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275

Query: 280 SFYELMEAIVDQ---P--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
           S  E+ + + +Q   P  P    S +        +  C       RL+A  + 
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  165 bits (420), Expect = 5e-49
 Identities = 64/263 (24%), Positives = 119/263 (45%), Gaps = 10/263 (3%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 134
           ++ +G+G+ G VQL  ++ T +  A+K++ M         I +E+ IN+      VV  Y
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71

Query: 135 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 194
                     + LEY  GG L D ++    +PE        Q++ G++YLH    I HRD
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRD 130

Query: 195 LKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY-GYKSD 251
           +KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++     D
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190

Query: 252 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 311
           +WS G+VL     G+ P+      D  +   +      ++     P  +      + +  
Sbjct: 191 VWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244

Query: 312 CVQKEPQQRLSAQELMTHPFLKM 334
            + + P  R++  ++    +   
Sbjct: 245 ILVENPSARITIPDIKKDRWYNK 267

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  167 bits (425), Expect = 7e-49
 Identities = 71/281 (25%), Positives = 133/281 (47%), Gaps = 39/281 (13%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVI-------QMNVEESARRQIAQELKINQS-SQC 127
            V+G+G   +V+   H+ TG  FA+K++            E  R    +E  I +  +  
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 187
           P+++    S+ S+  + ++ + M  G L D+L +   + E+   +I   +L+ + +LH  
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH-A 218

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG--- 244
            +I+HRDLKP N+L++   +++++DFG S  +     +     GT  Y++PE +      
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-KLRELCGTPGYLAPEILKCSMDE 277

Query: 245 ---KYGYKSDIWSLGLVL--LECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP- 293
               YG + D+W+ G++L  L    G    SPP        F+      ++  I++    
Sbjct: 278 THPGYGKEVDLWACGVILFTLLA--G----SPP--------FWHRRQILMLRMIMEGQYQ 323

Query: 294 -PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
             S   D  S      IS  +Q +P+ RL+A++ + HPF +
Sbjct: 324 FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  165 bits (419), Expect = 8e-49
 Identities = 68/269 (25%), Positives = 129/269 (47%), Gaps = 24/269 (8%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ 135
           + +G G+ G V LV+ + +G    +K I  +  +    QI  E+++ +S   P ++  ++
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87

Query: 136 SFYSNGAISIILEYMDGGSLADFL----KKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
            F     + I++E  +GG L + +     + K + E Y+A + +Q++  L Y  H +H++
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF-HSQHVV 146

Query: 192 HRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 248
           H+DLKP N+L         +KI DFG++ +  S    +    GT  YM+PE        +
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-HSTNAAGTALYMAPEVFK-RDVTF 204

Query: 249 KSDIWSLGLVL--LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPE 304
           K DIWS G+V+  L    G  P++    +       E+ +    + P          +P+
Sbjct: 205 KCDIWSAGVVMYFLLT--GCLPFTGTSLE-------EVQQKATYKEPNYAVECRP-LTPQ 254

Query: 305 FCSFISACVQKEPQQRLSAQELMTHPFLK 333
               +   + K+P++R SA +++ H + K
Sbjct: 255 AVDLLKQMLTKDPERRPSAAQVLHHEWFK 283

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  164 bits (418), Expect = 1e-48
 Identities = 66/279 (23%), Positives = 122/279 (43%), Gaps = 35/279 (12%)

Query: 68  NLEDIDTIKVVGKGSGGIVQLVQHK--WTGQFFALKVIQM-NVEESARRQIAQELKINQS 124
               I   + +G GS G V    +K  W G   A+K++ +        +    E+ + + 
Sbjct: 22  PDGQITVGQRIGSGSFGTV----YKGKWHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRK 76

Query: 125 SQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLK 179
           ++   ++           +   ++I+ ++ +G SL   L   +T    + L  I  Q  +
Sbjct: 77  TRHVNILLFMGYS-----TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131

Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST--SGQANTFVGTYNYMS 237
           G+ YLH  K IIHRDLK +N+ ++    VKI DFG++   +    S Q     G+  +M+
Sbjct: 132 GMDYLH-AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190

Query: 238 PERI---SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ--- 291
           PE I       Y ++SD+++ G+VL E  TGQ PYS         +  +++E +      
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIEMVGRGSLS 244

Query: 292 -PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
                  S+         ++ C++K+  +R S   ++  
Sbjct: 245 PDLSKVRSN-CPKRMKRLMAECLKKKRDERPSFPRILAE 282

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  165 bits (420), Expect = 1e-48
 Identities = 70/302 (23%), Positives = 123/302 (40%), Gaps = 28/302 (9%)

Query: 44  DGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI 103
            G  +    +  A  L    + +          ++G G  G V            A+K +
Sbjct: 17  RGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHV 76

Query: 104 -----QMNVEESARRQIAQELKINQ--SSQCPYVVVCYQSFYSNGAISIILEYMDG-GSL 155
                    E     ++  E+ + +  SS    V+     F    +  +ILE  +    L
Sbjct: 77  EKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDL 136

Query: 156 ADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFG 214
            DF+ +   + EE   +   QVL+ + + H+   ++HRD+K  N+LI+ +RGE+K+ DFG
Sbjct: 137 FDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFG 195

Query: 215 VSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPE 273
             A++         F GT  Y  PE I   +Y G  + +WSLG++L +   G  P+   E
Sbjct: 196 SGALL--KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF---E 250

Query: 274 QQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
             +      E++   V          + S E    I  C+   P  R + +E+  HP+++
Sbjct: 251 HDE------EIIRGQVFFRQ------RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 298

Query: 334 MY 335
             
Sbjct: 299 DV 300

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  165 bits (421), Expect = 1e-48
 Identities = 70/283 (24%), Positives = 132/283 (46%), Gaps = 34/283 (12%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKI-NQSSQCPYVVVC 133
           K +G+G   +V+    K TGQ +A K ++     +  R +I  E+ +   +  CP V+  
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 134 YQSFYSNGAISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
           ++ + +   I +ILEY  GG +      +  + + E  +  + +Q+L+G+ YLH + +I+
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH-QNNIV 153

Query: 192 HRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 248
           H DLKP N+L++       +KI DFG+S  +   + +    +GT  Y++PE ++      
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSRKI-GHACELREIMGTPEYLAPEILNYDPITT 212

Query: 249 KSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP--PSAPS 298
            +D+W++G+   +LL   T     SP         F      E    I            
Sbjct: 213 ATDMWNIGIIAYMLL---TH---TSP---------FVGEDNQETYLNISQVNVDYSEETF 257

Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD 341
              S     FI + + K P++R +A+  ++H +L+ +   N+ 
Sbjct: 258 SSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  164 bits (417), Expect = 7e-48
 Identities = 75/266 (28%), Positives = 126/266 (47%), Gaps = 22/266 (8%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ 135
             +G+G+  IV   + K T + +ALKV++  V++     +  E+ +      P ++   +
Sbjct: 59  SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI---VRTEIGVLLRLSHPNIIKLKE 115

Query: 136 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL 195
            F +   IS++LE + GG L D + +     E   A   +Q+L+ + YLH E  I+HRDL
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLH-ENGIVHRDL 174

Query: 196 KPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI 252
           KP NLL         +KI DFG+S I+        T  GT  Y +PE + G  YG + D+
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIV-EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDM 233

Query: 253 WSLGLVL--LECATGQFP-YSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPEFCS 307
           WS+G++   L C  G  P Y     Q        +   I++      S   D+ S     
Sbjct: 234 WSVGIITYILLC--GFEPFYDERGDQ-------FMFRRILNCEYYFISPWWDEVSLNAKD 284

Query: 308 FISACVQKEPQQRLSAQELMTHPFLK 333
            +   +  +P++RL+  + + HP++ 
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWVT 310

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  162 bits (412), Expect = 8e-48
 Identities = 73/293 (24%), Positives = 137/293 (46%), Gaps = 37/293 (12%)

Query: 68  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVI---QMNVEESA--RRQIAQELKI 121
            +ED  +  + +G G   IV+  + K TG+ +A K I   +++       R +I +E+ I
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 122 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 181
            +  + P ++  +  F +   + +ILE + GG L DFL + +++ E+      +Q+L G+
Sbjct: 62  LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGE----VKITDFGVSAIMASTSGQANTFVGTYNYMS 237
            YL H K I H DLKP N+++  +      +K+ DFG++  +     +     GT  +++
Sbjct: 122 HYL-HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI-EAGNEFKNIFGTPEFVA 179

Query: 238 PERISGGKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIV 289
           PE ++    G ++D+WS+G+   +LL   +G    SP         F      E +  I 
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILL---SG---ASP---------FLGETKQETLTNIS 224

Query: 290 DQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 340
                         S     FI   + K+P++R++  + + H ++K     NV
Sbjct: 225 AVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNV 277

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  162 bits (413), Expect = 1e-47
 Identities = 60/284 (21%), Positives = 119/284 (41%), Gaps = 33/284 (11%)

Query: 68  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 126
            L +     + +G+G  GIV       + + +  K +   V+ + +  + +E+ I   ++
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIAR 59

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADF-LKKVKTIPEEYLAAICEQVLKGLLYLH 185
              ++  ++SF S   + +I E++ G  + +        + E  + +   QV + L +LH
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119

Query: 186 HEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
              +I H D++P N++   R    +KI +FG +  +               Y +PE    
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPEVHQH 177

Query: 244 GKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP-- 293
                 +D+WSLG    VLL   +G    +P         F      +++E I++     
Sbjct: 178 DVVSTATDMWSLGTLVYVLL---SG---INP---------FLAETNQQIIENIMNAEYTF 222

Query: 294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
                 + S E   F+   + KE + R++A E + HP+LK   +
Sbjct: 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  162 bits (413), Expect = 1e-47
 Identities = 64/263 (24%), Positives = 119/263 (45%), Gaps = 10/263 (3%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 134
           ++ +G+G+ G VQL  ++ T +  A+K++ M         I +E+ IN+      VV  Y
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFY 71

Query: 135 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 194
                     + LEY  GG L D ++    +PE        Q++ G++YLH    I HRD
Sbjct: 72  GHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRD 130

Query: 195 LKPSNLLINHRGEVKITDFGVSAIMASTSGQA--NTFVGTYNYMSPERISGGKY-GYKSD 251
           +KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++     D
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190

Query: 252 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 311
           +WS G+VL     G+ P+      D  +   +      ++     P  +      + +  
Sbjct: 191 VWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244

Query: 312 CVQKEPQQRLSAQELMTHPFLKM 334
            + + P  R++  ++    +   
Sbjct: 245 ILVENPSARITIPDIKKDRWYNK 267

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  162 bits (412), Expect = 2e-47
 Identities = 73/283 (25%), Positives = 131/283 (46%), Gaps = 40/283 (14%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVI-----QMNVEESARRQIAQELKINQSSQCPYV 130
           + +G G   IV+  + K TG  +A K I     + +    +R +I +E+ I +      V
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77

Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 190
           +  +  + +   + +ILE + GG L DFL + +++ EE   +  +Q+L G+ YL H K I
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL-HTKKI 136

Query: 191 IHRDLKPSNLLINHRGE----VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 246
            H DLKP N+++  +      +K+ DFG++  +     +     GT  +++PE ++    
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGTPEFVAPEIVNYEPL 195

Query: 247 GYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-----ELMEAI----VDQPPP 294
           G ++D+WS+G+   +LL   +G    SP         F      E +  I     D    
Sbjct: 196 GLEADMWSIGVITYILL---SG---ASP---------FLGDTKQETLANITSVSYDFDEE 240

Query: 295 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
                  S     FI   + KE ++RL+ QE + HP++    +
Sbjct: 241 --FFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN 281

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  163 bits (414), Expect = 2e-47
 Identities = 74/279 (26%), Positives = 131/279 (46%), Gaps = 40/279 (14%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVI-----QMNVEESARRQIAQELKINQSSQCPYV 130
           + +G G   IV+  + K TG  +A K I     + +     R +I +E+ I +    P +
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77

Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 190
           +  +  + +   + +ILE + GG L DFL + +++ EE   +  +Q+L G+ YL H K I
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL-HTKKI 136

Query: 191 IHRDLKPSNLLINHRGE----VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 246
            H DLKP N+++  +      +K+ DFG++  +     +     GT  +++PE ++    
Sbjct: 137 AHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI-EDGVEFKNIFGTPEFVAPEIVNYEPL 195

Query: 247 GYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-----ELMEAI----VDQPPP 294
           G ++D+WS+G+   +LL   +G    SP         F      E +  I     D    
Sbjct: 196 GLEADMWSIGVITYILL---SG---ASP---------FLGDTKQETLANITAVSYDFDEE 240

Query: 295 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
                Q S     FI   + KE ++RL+ QE + HP++ 
Sbjct: 241 --FFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT 277

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  162 bits (411), Expect = 2e-47
 Identities = 60/282 (21%), Positives = 119/282 (42%), Gaps = 36/282 (12%)

Query: 68  NLEDIDTIKVVGKGSGGIVQLVQHK--WTGQFFALKVIQM-NVEESARRQIAQELKINQS 124
             E ++  +++GKG  G V    +   W G+  A+++I +    E   +   +E+   + 
Sbjct: 31  PFEQLEIGELIGKGRFGQV----YHGRWHGEV-AIRLIDIERDNEDQLKAFKREVMAYRQ 85

Query: 125 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLY 183
           ++   VV+   +  S   ++II     G +L   ++  K  +       I ++++KG+ Y
Sbjct: 86  TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGY 145

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST-----SGQANTFVGTYNYMSP 238
           LH  K I+H+DLK  N+  ++ G+V ITDFG+ +I           +     G   +++P
Sbjct: 146 LH-AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

Query: 239 ERISGGK---------YGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFYELMEA 287
           E I             +   SD+++LG +  E    ++P+   P E          ++  
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA---------IIWQ 254

Query: 288 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
           +     P+        E    +  C   E ++R +  +LM  
Sbjct: 255 MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  164 bits (417), Expect = 2e-47
 Identities = 47/321 (14%), Positives = 92/321 (28%), Gaps = 56/321 (17%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVI------------QMNVEESARRQIAQELKINQ 123
            V+G+           + TG+ F + V             QM  E    R +       Q
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 124 SSQCPYVVVCYQSFYSNGAISII-------------------LEYMDGGSLADFLKKV-- 162
           +      +  +          +I                       +  +  + L     
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 163 --KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM- 219
             K++       +  QV++ L  LHH   ++H  L+P +++++ RG V +T F       
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHH-YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 220 ASTSGQANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQ 274
           AS               +   +           +  D W+LGL +        P +    
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD-- 320

Query: 275 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP-FLK 333
                +     E I                  + +   ++   + RL   + M  P + +
Sbjct: 321 -----AALGGSEWIFRSCKN------IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369

Query: 334 MYGDLNVDLSEYFTDAGSPLA 354
           +  +L+  L  Y TD      
Sbjct: 370 LRTELSAALPLYQTDGEPTRE 390

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  162 bits (412), Expect = 3e-47
 Identities = 76/295 (25%), Positives = 138/295 (46%), Gaps = 41/295 (13%)

Query: 68  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVI-----QMNVEESARRQIAQELKI 121
           N++D  DT + +G G   +V+  + K TG  +A K I     + +    +R  I +E+ I
Sbjct: 8   NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 122 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 181
            +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE      +Q+L G+
Sbjct: 68  LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 127

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGE----VKITDFGVSAIMASTSGQANTFVGTYNYMS 237
            YL H   I H DLKP N+++  R      +KI DFG++  +     +     GT  +++
Sbjct: 128 YYL-HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFKNIFGTPEFVA 185

Query: 238 PERISGGKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-----ELMEAI- 288
           PE ++    G ++D+WS+G+   +LL   +G    SP         F      E +  + 
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILL---SG---ASP---------FLGDTKQETLANVS 230

Query: 289 ---VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 340
               +           S     FI   + K+P++R++ Q+ + HP++K       
Sbjct: 231 AVNYEFEDE--YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 283

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  162 bits (411), Expect = 1e-46
 Identities = 71/284 (25%), Positives = 126/284 (44%), Gaps = 32/284 (11%)

Query: 68  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 126
           ++ D  D ++ +G G+ G+V     K TG+ F  K I        +  +  E+ I     
Sbjct: 48  SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLH 106

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLLYLH 185
            P ++  + +F     + +ILE++ GG L D +  +   + E  +     Q  +GL ++H
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH 166

Query: 186 HEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
            E  I+H D+KP N++   +    VKI DFG++  + +          T  + +PE +  
Sbjct: 167 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEFAAPEIVDR 224

Query: 244 GKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP-- 293
              G+ +D+W++G+   VLL   +G    SP         F      E ++ +       
Sbjct: 225 EPVGFYTDMWAIGVLGYVLL---SG---LSP---------FAGEDDLETLQNVKRCDWEF 269

Query: 294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
                   SPE   FI   +QKEP++RL+  + + HP+LK    
Sbjct: 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  158 bits (401), Expect = 3e-46
 Identities = 70/262 (26%), Positives = 129/262 (49%), Gaps = 14/262 (5%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVC 133
             +G G+ G V++ +H+ TG   A+K++  Q         +I +E++  +  + P+++  
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR 193
           YQ   +     +++EY+ GG L D++ K   + E     + +Q+L  + Y H    ++HR
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR-HMVVHR 135

Query: 194 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDI 252
           DLKP N+L++     KI DFG+S +M S      T  G+ NY +PE ISG  Y G + DI
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDI 194

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 312
           WS G++L     G  P+   + +   T F ++   +   P         +    + +   
Sbjct: 195 WSCGVILYALLCGTLPF---DDEHVPTLFKKIRGGVFYIPE------YLNRSVATLLMHM 245

Query: 313 VQKEPQQRLSAQELMTHPFLKM 334
           +Q +P +R + +++  H + K 
Sbjct: 246 LQVDPLKRATIKDIREHEWFKQ 267

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  164 bits (417), Expect = 4e-46
 Identities = 69/308 (22%), Positives = 129/308 (41%), Gaps = 35/308 (11%)

Query: 51  QTETEAPPLIKPSDNQLNLEDI----DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN 106
               +      P   ++  + +    D  + +G G+ G+V  V  + TG  FA K +   
Sbjct: 134 NYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP 193

Query: 107 VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTI 165
            E   +  + +E++     + P +V  + +F  +  + +I E+M GG L + +  +   +
Sbjct: 194 HESD-KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKM 252

Query: 166 PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTS 223
            E+       QV KGL ++H E + +H DLKP N++   +    +K+ DFG++A +    
Sbjct: 253 SEDEAVEYMRQVCKGLCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPK 310

Query: 224 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTS 280
                  GT  + +PE   G   GY +D+WS+G+   +LL   +G    SP         
Sbjct: 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL---SG---LSP--------- 355

Query: 281 FY-----ELMEAIVDQPP--PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
           F      E +  +         +     S +   FI   +  +P  R++  + + HP+L 
Sbjct: 356 FGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT 415

Query: 334 MYGDLNVD 341
                  D
Sbjct: 416 PGNAPGRD 423

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  157 bits (400), Expect = 4e-46
 Identities = 44/266 (16%), Positives = 100/266 (37%), Gaps = 31/266 (11%)

Query: 68  NLEDIDTIKVVGKGSGGIVQLVQHK--WTGQFFALKVIQM-NVEESARRQIAQELKINQS 124
           + + ++ +  + +   G +     K  W G    +KV+++ +      R   +E    + 
Sbjct: 8   DFKQLNFLTKLNENHSGEL----WKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRI 63

Query: 125 SQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVL 178
              P V+     C      +   ++I  +M  GSL + L       + +         + 
Sbjct: 64  FSHPNVLPVLGACQSPPAPH--PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121

Query: 179 KGLLYLH-HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMS 237
           +G+ +LH  E  I    L   +++I+     +I+   V     S        +    +++
Sbjct: 122 RGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-----MYAPAWVA 176

Query: 238 PERISGGKYGY---KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP 294
           PE +           +D+WS  ++L E  T + P++        ++    M+  ++   P
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA------DLSNMEIGMKVALEGLRP 230

Query: 295 SAPSDQFSPEFCSFISACVQKEPQQR 320
           + P    SP     +  C+ ++P +R
Sbjct: 231 TIPPG-ISPHVSKLMKICMNEDPAKR 255

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  161 bits (408), Expect = 4e-46
 Identities = 76/276 (27%), Positives = 125/276 (45%), Gaps = 25/276 (9%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ 135
           +V+G G  G V  + +K T + FALK++Q      ARR++    +    SQCP++V    
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRA---SQCPHIVRIVD 122

Query: 136 SF----YSNGAISIILEYMDGGSLAD--FLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 189
            +         + I++E +DGG L      +  +   E   + I + + + + YLH   +
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SIN 181

Query: 190 IIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 246
           I HRD+KP NLL   +     +K+TDFG +    ++     T   T  Y++PE +   KY
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TSHNSLTTPCYTPYYVAPEVLGPEKY 240

Query: 247 GYKSDIWSLGLVL--LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFS 302
               D+WSLG+++  L C  G   Y P     G      +   I       P+    + S
Sbjct: 241 DKSCDMWSLGVIMYILLC--G---YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 295

Query: 303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL 338
            E    I   ++ EP QR++  E M HP++     +
Sbjct: 296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  158 bits (401), Expect = 1e-45
 Identities = 64/319 (20%), Positives = 114/319 (35%), Gaps = 62/319 (19%)

Query: 60  IKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEESARRQIAQ 117
              S+  L+L+++  ++++G+G  G V    +K     +  A+KV       + R+    
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAV----YKGSLDERPVAVKVF----SFANRQNFIN 54

Query: 118 ELKINQSS--QCPYVVVCY-----QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYL 170
           E  I +    +   +          +        +++EY   GSL  +L    T      
Sbjct: 55  EKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSS 113

Query: 171 AAICEQVLKGLLYLHHEKH--------IIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 222
             +   V +GL YLH E          I HRDL   N+L+ + G   I+DFG+S  +   
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 223 --------SGQANTFVGTYNYMSPERISG-------GKYGYKSDIWSLGLVLLECATG-- 265
                      A + VGT  YM+PE + G            + D+++LGL+  E      
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 266 -----------QFPYSPPEQQDGWTSFYELMEAIVDQ------PPPSAPSDQFSPEFCSF 308
                      Q  +          +F ++   +  +      P     +          
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHP--TFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291

Query: 309 ISACVQKEPQQRLSAQELM 327
           I  C  ++ + RL+AQ   
Sbjct: 292 IEDCWDQDAEARLTAQXAE 310

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  157 bits (399), Expect = 1e-45
 Identities = 56/188 (29%), Positives = 84/188 (44%), Gaps = 15/188 (7%)

Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           + +  ++G  LA  L++   +      AI  Q+   L   H      HRD+KP N+L++ 
Sbjct: 111 VDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH-AAGATHRDVKPENILVSA 169

Query: 205 RGEVKITDFG-VSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECA 263
                + DFG  SA       Q    VGT  YM+PER S     Y++DI++L  VL EC 
Sbjct: 170 DDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECL 229

Query: 264 TGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD---QFSPEFCSFISACVQKEPQQR 320
           TG  PY       G      +M A ++Q  P  PS         F + I+  + K P+ R
Sbjct: 230 TGSPPY------QGDQ--LSVMGAHINQAIPR-PSTVRPGIPVAFDAVIARGMAKNPEDR 280

Query: 321 -LSAQELM 327
            ++  +L 
Sbjct: 281 YVTCGDLS 288

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  158 bits (402), Expect = 2e-45
 Identities = 71/263 (26%), Positives = 123/263 (46%), Gaps = 10/263 (3%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 134
           +K +G G+ G+ +L++ K T +  A+K I      +    + +E+  ++S + P +V   
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFK 82

Query: 135 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 194
           +   +   ++II+EY  GG L + +       E+      +Q+L G+ Y H    I HRD
Sbjct: 83  EVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS-MQICHRD 141

Query: 195 LKPSNLLI--NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSD 251
           LK  N L+  +    +KI DFG S        Q  + VGT  Y++PE +   +Y G  +D
Sbjct: 142 LKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTVGTPAYIAPEVLLRQEYDGKIAD 200

Query: 252 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA 311
           +WS G+ L     G +P+   E  +    + + ++ I+          + SPE C  IS 
Sbjct: 201 VWSCGVTLYVMLVGAYPF---EDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISR 257

Query: 312 CVQKEPQQRLSAQELMTHPFLKM 334
               +P  R+S  E+ TH +   
Sbjct: 258 IFVADPATRISIPEIKTHSWFLK 280

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  158 bits (401), Expect = 2e-45
 Identities = 69/279 (24%), Positives = 126/279 (45%), Gaps = 31/279 (11%)

Query: 71  DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV 130
            +   +++G G  G V   +   TG   A K+I+    +  + ++  E+ +        +
Sbjct: 90  TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD-KEEVKNEISVMNQLDHANL 148

Query: 131 VVCYQSFYSNGAISIILEYMDGGSLAD-FLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH 189
           +  Y +F S   I +++EY+DGG L D  + +   + E       +Q+ +G+ ++H + +
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH-QMY 207

Query: 190 IIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYG 247
           I+H DLKP N+L  +R    +KI DFG++        +     GT  +++PE ++     
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRY-KPREKLKVNFGTPEFLAPEVVNYDFVS 266

Query: 248 YKSDIWSLGL---VLLECATGQFPYSPPEQQDGWTSFY-----ELMEAIVDQPP--PSAP 297
           + +D+WS+G+   +LL   +G    SP         F      E +  I+          
Sbjct: 267 FPTDMWSVGVIAYMLL---SG---LSP---------FLGDNDAETLNNILACRWDLEDEE 311

Query: 298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG 336
               S E   FIS  + KE   R+SA E + HP+L  + 
Sbjct: 312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  154 bits (391), Expect = 1e-44
 Identities = 52/209 (24%), Positives = 98/209 (46%), Gaps = 21/209 (10%)

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 187
             +V        +    +++EY++G +L+++++    +  +       Q+L G+ +  H+
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH-AHD 129

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFG-VSAIMASTSGQANTFVGTYNYMSPERISGGKY 246
             I+HRD+KP N+LI+    +KI DFG   A+  ++  Q N  +GT  Y SPE+  G   
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT 189

Query: 247 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI----VDQPPPSAPSD--- 299
              +DI+S+G+VL E   G+ P+      +G T+      +I    +    P+  +D   
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPF------NGETAV-----SIAIKHIQDSVPNVTTDVRK 238

Query: 300 QFSPEFCSFISACVQKEPQQR-LSAQELM 327
                  + I    +K+   R  + QE+ 
Sbjct: 239 DIPQSLSNVILRATEKDKANRYKTIQEMK 267

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  154 bits (392), Expect = 3e-44
 Identities = 78/263 (29%), Positives = 131/263 (49%), Gaps = 15/263 (5%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVC 133
           + +G+GS G V+L  H  T Q  ALK I  Q+  +     ++ +E+   +  + P+++  
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR 193
           Y    +   I +++EY  GG L D++ + K + E+      +Q++  + Y H    I+HR
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR-HKIVHR 132

Query: 194 DLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDI 252
           DLKP NLL++    VKI DFG+S IM +      T  G+ NY +PE I+G  Y G + D+
Sbjct: 133 DLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDV 191

Query: 253 WSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 312
           WS G+VL     G+ P+   + +     F ++   +   P         SP   S I   
Sbjct: 192 WSCGIVLYVMLVGRLPF---DDEFIPNLFKKVNSCVYVMPD------FLSPGAQSLIRRM 242

Query: 313 VQKEPQQRLSAQELMTHPFLKMY 335
           +  +P QR++ QE+   P+  + 
Sbjct: 243 IVADPMQRITIQEIRRDPWFNVN 265

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  153 bits (388), Expect = 4e-44
 Identities = 64/274 (23%), Positives = 121/274 (44%), Gaps = 28/274 (10%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVI---QMNVEESARRQIAQELKINQSSQCPYVVV 132
            ++G+GS G V+ V    T    A+K++   ++    +    + +E+++ +  +   V+ 
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 133 CYQ--SFYSNGAISIILEYMDGGS--LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
                       + +++EY   G   + D + + K  P         Q++ GL YLH  +
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHS-Q 128

Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGK- 245
            I+H+D+KP NLL+   G +KI+  GV+  +   +      T  G+  +  PE  +G   
Sbjct: 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDT 188

Query: 246 Y-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD---QPPPSAPSDQF 301
           + G+K DIWS G+ L    TG +P+      +G  + Y+L E I       P        
Sbjct: 189 FSGFKVDIWSAGVTLYNITTGLYPF------EG-DNIYKLFENIGKGSYAIPGD-----C 236

Query: 302 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
            P     +   ++ EP +R S +++  H + +  
Sbjct: 237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK 270

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  156 bits (395), Expect = 1e-43
 Identities = 76/278 (27%), Positives = 138/278 (49%), Gaps = 14/278 (5%)

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQE 118
           +  D ++ +        +G G+ G V++ +H+ TG   A+K++  Q         +I +E
Sbjct: 7   QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE 66

Query: 119 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 178
           ++  +  + P+++  YQ   +   I +++EY+ GG L D++ K   + E+    + +Q+L
Sbjct: 67  IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL 126

Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 238
            G+ Y H    ++HRDLKP N+L++     KI DFG+S +M S      T  G+ NY +P
Sbjct: 127 SGVDYCHR-HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFLRTSCGSPNYAAP 184

Query: 239 ERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 297
           E ISG  Y G + DIWS G++L     G  P+   +     T F ++ + I   P     
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPF---DDDHVPTLFKKICDGIFYTPQ---- 237

Query: 298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
               +P   S +   +Q +P +R + +++  H + K  
Sbjct: 238 --YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  150 bits (382), Expect = 4e-43
 Identities = 54/188 (28%), Positives = 95/188 (50%), Gaps = 12/188 (6%)

Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           I++EY+DG +L D +     +  +    +     + L +  H+  IIHRD+KP+N++I+ 
Sbjct: 93  IVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF-SHQNGIIHRDVKPANIMISA 151

Query: 205 RGEVKITDFGVSAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLE 261
              VK+ DFG++  +A +     Q    +GT  Y+SPE+  G     +SD++SLG VL E
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211

Query: 262 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFISACVQKEPQQR 320
             TG+ P+       G +      + + + P  PSA  +  S +  + +   + K P+ R
Sbjct: 212 VLTGEPPF------TGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265

Query: 321 -LSAQELM 327
             +A E+ 
Sbjct: 266 YQTAAEMR 273

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  152 bits (385), Expect = 4e-43
 Identities = 46/302 (15%), Positives = 97/302 (32%), Gaps = 40/302 (13%)

Query: 57  PPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVI-QMNVEES 110
           P +   ++ QL  + +    ++G+G+   V              Q F LKV    N  E 
Sbjct: 52  PAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE- 110

Query: 111 ARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK-----TI 165
                 Q ++  + S     +  Y +        ++ E    G+L + +   K      +
Sbjct: 111 -FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVM 169

Query: 166 PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-----------GEVKITDFG 214
           P+  + +   ++L  +  +H +  IIH D+KP N ++ +              + + D G
Sbjct: 170 PQGLVISFAMRMLYMIEQVH-DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLG 228

Query: 215 VSAIMAS--TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 272
            S  M              T  +   E +S   + Y+ D + +   +     G +     
Sbjct: 229 QSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM--KV 286

Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
           + + G      L   +      +            F    +       L + +L+     
Sbjct: 287 KNEGGECKPEGLFRRLPHLDMWN-----------EFFHVMLNIPDCHHLPSLDLLRQKLK 335

Query: 333 KM 334
           K+
Sbjct: 336 KV 337

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  144 bits (366), Expect = 2e-40
 Identities = 69/318 (21%), Positives = 134/318 (42%), Gaps = 34/318 (10%)

Query: 49  VSQTETEAPPLIKPSDNQLNLEDID---TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM 105
           +          +      L  + ++    + +VG+GS G+V   ++K TG+  A+K    
Sbjct: 1   MGHHHHHHSSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE 60

Query: 106 NVEESARRQIAQ-ELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 164
           + ++   ++IA  E+K+ +  +   +V   +         ++ E++D  ++ D L+    
Sbjct: 61  SDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPN 119

Query: 165 -IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS 223
            +  + +     Q++ G+ + H   +IIHRD+KP N+L++  G VK+ DFG +  +A+  
Sbjct: 120 GLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178

Query: 224 GQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP--------Y--- 269
              +  V T  Y +PE + G   YG   D+W++G ++ E   G+  FP        Y   
Sbjct: 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238

Query: 270 ----SPPEQQDGWTSFYELMEAI-VDQPPPSAPSD------QFSPEFCSFISACVQKEPQ 318
               +   +      F +      V  P             + S         C+  +P 
Sbjct: 239 MCLGNLIPRH--QELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPD 296

Query: 319 QRLSAQELMTHPFLKMYG 336
           +R    EL+ H F +M G
Sbjct: 297 KRPFCAELLHHDFFQMDG 314

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  142 bits (361), Expect = 5e-40
 Identities = 71/292 (24%), Positives = 132/292 (45%), Gaps = 31/292 (10%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ-ELKINQSSQC 127
           +E  + I  +G+GS G+V   +++ TGQ  A+K    + ++   ++IA  E+++ +  + 
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHH 186
           P +V   + F     + ++ EY D  ++   L + +  +PE  + +I  Q L+ + + H 
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH- 119

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK- 245
           + + IHRD+KP N+LI     +K+ DFG + ++   S   +  V T  Y SPE + G   
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ 179

Query: 246 YGYKSDIWSLGLVLLECATGQ--FP--------Y-------SPPEQQDGWTSFYELMEAI 288
           YG   D+W++G V  E  +G   +P        Y           +      F       
Sbjct: 180 YGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRH--QQVFSTNQYFS 237

Query: 289 -VDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
            V  P P             S      +  C+  +P +RL+ ++L+ HP+ +
Sbjct: 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  143 bits (363), Expect = 8e-40
 Identities = 69/322 (21%), Positives = 123/322 (38%), Gaps = 70/322 (21%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-----------NQ 123
           ++ +G G    V L +        A+K+++ +  +        E+K+             
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKED 81

Query: 124 SSQCPYVVVCYQSFYSNGAIS----IILEYMDGGSLADFLKK--VKTIPEEYLAAICEQV 177
           S    +++     F   G       ++ E + G +L   +KK   + IP  Y+  I +Q+
Sbjct: 82  SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQL 140

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINH------RGEVKITDFGVSAIMASTSGQANTFVG 231
           L GL Y+H    IIH D+KP N+L+          ++KI D G +             + 
Sbjct: 141 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---CWYDEHYTNSIQ 197

Query: 232 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---LMEAI 288
           T  Y SPE + G  +G  +DIWS   ++ E  TG F +  P++   +T   +    +  +
Sbjct: 198 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF-EPDEGHSYTKDDDHIAQIIEL 256

Query: 289 VDQPPPS-------------------------------------APSDQFSPEFCSFISA 311
           + + P                                         S   + E   F+S 
Sbjct: 257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 316

Query: 312 CVQKEPQQRLSAQELMTHPFLK 333
            +Q +P++R  A  L+ HP+LK
Sbjct: 317 MLQLDPRKRADAGGLVNHPWLK 338

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  139 bits (353), Expect = 4e-39
 Identities = 73/285 (25%), Positives = 120/285 (42%), Gaps = 47/285 (16%)

Query: 68  NLEDIDTI-KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 126
            ++D     +V+G G  G V  + +K T + FALK++       ARR++    +    SQ
Sbjct: 15  IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--QDCPKARREVELHWRA---SQ 69

Query: 127 CPYVVVCYQSF----YSNGAISIILEYMDGGSLAD--FLKKVKTIPEEYLAAICEQVLKG 180
           CP++V     +         + I++E +DGG L      +  +   E   + I + + + 
Sbjct: 70  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSGQANTFVGTYNYMS 237
           + YLH   +I HRD+KP NLL   +     +K+TDFG                      +
Sbjct: 130 IQYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFG---------------------FA 167

Query: 238 PERISGGKYGYKSDIWSLGLVL--LECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-- 293
            E  +G KY    D+WSLG+++  L C  G   Y P     G      +   I       
Sbjct: 168 KE-TTGEKYDKSCDMWSLGVIMYILLC--G---YPPFYSNHGLAISPGMKTRIRMGQYEF 221

Query: 294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL 338
           P+    + S E    I   ++ EP QR++  E M HP++     +
Sbjct: 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 266

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  145 bits (368), Expect = 7e-39
 Identities = 50/215 (23%), Positives = 81/215 (37%), Gaps = 34/215 (15%)

Query: 145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
           I++EY+ G SL     +   +P     A   ++L  L YLH    +++ DLKP N+++  
Sbjct: 161 IVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLH-SIGLVYNDLKPENIMLTE 217

Query: 205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT 264
              +K+ D G      S         GT  + +PE +  G     +DI+++G  L     
Sbjct: 218 EQ-LKLIDLGA----VSRINSFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTL 271

Query: 265 GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQR-LSA 323
                      +G           VD  P   P  +    +   +   +  +P+QR  +A
Sbjct: 272 DLPTR------NG---------RYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTA 316

Query: 324 QELMTHPFLKMYGDLNVDLSEYFT-DAGSPLATLS 357
           +E        M   L   L E    D G P   LS
Sbjct: 317 EE--------MSAQLTGVLREVVAQDTGVPRPGLS 343

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  138 bits (350), Expect = 2e-38
 Identities = 69/297 (23%), Positives = 114/297 (38%), Gaps = 47/297 (15%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE--------SARRQIA--QELKINQS 124
           +  +G G+ G V   +   +G F ALK +++            S  R++A  + L+   +
Sbjct: 14  VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE---A 70

Query: 125 SQCPYVV-----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQV 177
            + P VV                ++++ E++D   L  +L K     +P E +  +  Q 
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF 129

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF---VGTYN 234
           L+GL +LH    I+HRDLKP N+L+   G VK+ DFG    +A            V T  
Sbjct: 130 LRGLDFLHA-NCIVHRDLKPENILVTSGGTVKLADFG----LARIYSYQMALTPVVVTLW 184

Query: 235 YMSPERISGGKYGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------QDGWT 279
           Y +PE +    Y    D+WS+G +  E    +  F   S  +Q            +D W 
Sbjct: 185 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 244

Query: 280 SFYELMEAIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
               L         P                 +   +   P +R+SA   + H +L 
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  138 bits (351), Expect = 2e-38
 Identities = 80/319 (25%), Positives = 136/319 (42%), Gaps = 55/319 (17%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE----SARRQIAQELKINQS 124
           +E    +  +G+G+   V   + K T    ALK I++  EE    +A R    E+ + + 
Sbjct: 1   METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR----EVSLLKD 56

Query: 125 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLY 183
            +   +V  +   ++  +++++ EY+D   L  +L      I    +     Q+L+GL Y
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAY 115

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA-STSGQANTF---VGTYNYMSPE 239
            H  + ++HRDLKP NLLIN RGE+K+ DFG    +A + S    T+   V T  Y  P+
Sbjct: 116 CHR-QKVLHRDLKPQNLLINERGELKLADFG----LARAKSIPTKTYDNEVVTLWYRPPD 170

Query: 240 RISGGK-YGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------QDGWTSFYE 283
            + G   Y  + D+W +G +  E ATG+  FP  +  EQ            ++ W     
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230

Query: 284 LMEAIVDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
             E      P            +   +    ++  +Q E + R+SA++ M HP       
Sbjct: 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP------- 283

Query: 338 LNVDLSEYFTDAGSPLATL 356
                  +F   G  +  L
Sbjct: 284 -------FFLSLGERIHKL 295

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  134 bits (340), Expect = 5e-37
 Identities = 79/297 (26%), Positives = 133/297 (44%), Gaps = 43/297 (14%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQ 123
           +E    ++ VG+G+ G+V   +    G+  ALK I+++ E+     +A R    E+ + +
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIR----EISLLK 74

Query: 124 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLL 182
               P +V      +S   ++++ E+M+   L   L + KT + +  +     Q+L+G+ 
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVA 133

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTF---VGTYNYMSP 238
           + H    I+HRDLKP NLLIN  G +K+ DFG    +A   G    ++   V T  Y +P
Sbjct: 134 HCHQ-HRILHRDLKPQNLLINSDGALKLADFG----LARAFGIPVRSYTHEVVTLWYRAP 188

Query: 239 ERISGGK-YGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------QDGWTSFY 282
           + + G K Y    DIWS+G +  E  TG+  FP  +  +Q               W    
Sbjct: 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQ 248

Query: 283 ELMEAIVDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
           EL                      F  E    +S  +  +P +R+SA++ M HP+ K
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  133 bits (337), Expect = 2e-36
 Identities = 69/295 (23%), Positives = 122/295 (41%), Gaps = 45/295 (15%)

Query: 75  IKVVGKGSGGIVQLVQH-KWTGQFFALKVIQMNVEE-----SARRQIA--QELKINQSSQ 126
           +  +G+G+ G V   +  K  G+F ALK +++   E     S  R++A  + L+   + +
Sbjct: 16  VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE---TFE 72

Query: 127 CPYVV-----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLK 179
            P VV                ++++ E++D   L  +L KV    +P E +  +  Q+L+
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLR 131

Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF---VGTYNYM 236
           GL +LH    ++HRDLKP N+L+   G++K+ DFG    +A            V T  Y 
Sbjct: 132 GLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFG----LARIYSFQMALTSVVVTLWYR 186

Query: 237 SPERISGGKYGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------QDGWTSF 281
           +PE +    Y    D+WS+G +  E    +  F   S  +Q            ++ W   
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246

Query: 282 YELMEAIVDQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
             L                           +  C+   P +R+SA   ++HP+ +
Sbjct: 247 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  135 bits (341), Expect = 3e-36
 Identities = 89/360 (24%), Positives = 144/360 (40%), Gaps = 49/360 (13%)

Query: 18  SSEEASFTKFLTKSGTFMDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKV 77
           ++  A   K + +   F    +  +KDG ++ +   T      +P +           KV
Sbjct: 7   TTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVS-----YTDTKV 61

Query: 78  VGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF 137
           +G GS G+V   +   +G+  A+K +  +     R     EL+I +      +V     F
Sbjct: 62  IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-----ELQIMRKLDHCNIVRLRYFF 116

Query: 138 YSNGA------ISIILEYMDG---GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
           YS+G       ++++L+Y+          + +  +T+P  Y+     Q+ + L Y+H   
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-F 175

Query: 189 HIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGGK- 245
            I HRD+KP NLL++     +K+ DFG SA      G+ N  ++ +  Y +PE I G   
Sbjct: 176 GICHRDIKPQNLLLDPDTAVLKLCDFG-SA-KQLVRGEPNVSYICSRYYRAPELIFGATD 233

Query: 246 YGYKSDIWSLGLVLLECATGQ--FPY---------------SPPEQQ-DGWTSFYELMEA 287
           Y    D+WS G VL E   GQ  FP                +P  +Q       Y   E 
Sbjct: 234 YTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY--TEF 291

Query: 288 IVDQPPPSAPSDQF----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS 343
              Q      +  F     PE  +  S  ++  P  RL+  E   H F     D NV L 
Sbjct: 292 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLP 351

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  132 bits (334), Expect = 3e-36
 Identities = 71/299 (23%), Positives = 136/299 (45%), Gaps = 46/299 (15%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQ 123
           ++  + ++ +G+G+ G V   +++ T +  ALK ++++ ++     SA R    E+ + +
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR----EICLLK 56

Query: 124 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLL 182
             +   +V  +   +S+  ++++ E+ D   L  +       +  E + +   Q+LKGL 
Sbjct: 57  ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTF---VGTYNYMSP 238
           + H  ++++HRDLKP NLLIN  GE+K+ +FG    +A   G     +   V T  Y  P
Sbjct: 116 FCHS-RNVLHRDLKPQNLLINRNGELKLANFG----LARAFGIPVRCYSAEVVTLWYRPP 170

Query: 239 ERISGGK-YGYKSDIWSLGLVLLECATGQFPY------------------SPPEQQDGWT 279
           + + G K Y    D+WS G +  E A    P                   +P E+Q  W 
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQ--WP 228

Query: 280 SFYELMEAIV--DQPPPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
           S  +L +       P  ++  +     +      +   ++  P QR+SA+E + HP+  
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  131 bits (333), Expect = 3e-36
 Identities = 76/302 (25%), Positives = 132/302 (43%), Gaps = 45/302 (14%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQ 123
           +E    ++ +G+G+ G+V   Q+   G+ FALK I++  E+     +  R    E+ I +
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIR----EISILK 55

Query: 124 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLL 182
             +   +V  Y   ++   + ++ E++D   L   L   +  +      +   Q+L G+ 
Sbjct: 56  ELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTF---VGTYNYMSP 238
           Y H  + ++HRDLKP NLLIN  GE+KI DFG    +A   G     +   + T  Y +P
Sbjct: 115 YCHD-RRVLHRDLKPQNLLINREGELKIADFG----LARAFGIPVRKYTHEIVTLWYRAP 169

Query: 239 ERISGGK-YGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------QDGWTSFY 282
           + + G K Y    DIWS+G +  E   G   FP  S  +Q               W +  
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229

Query: 283 ELMEAIVDQP--PPSAPSDQF---SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
           EL +   +     P                 +S  ++ +P QR++A++ + H + K   +
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK---E 286

Query: 338 LN 339
            N
Sbjct: 287 NN 288

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  132 bits (334), Expect = 5e-36
 Identities = 81/299 (27%), Positives = 133/299 (44%), Gaps = 50/299 (16%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE----SARRQIAQELKINQSSQCPYV 130
           ++ +G G+   V    +K TG + ALK ++++ EE    +A R    E+ + +  +   +
Sbjct: 10  LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR----EISLMKELKHENI 65

Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT------IPEEYLAAICEQVLKGLLYL 184
           V  Y   ++   ++++ E+MD   L  ++           +    +     Q+L+GL + 
Sbjct: 66  VRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 185 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-QANTF---VGTYNYMSPER 240
           H    I+HRDLKP NLLIN RG++K+ DFG    +A   G   NTF   V T  Y +P+ 
Sbjct: 125 HE-NKILHRDLKPQNLLINKRGQLKLGDFG----LARAFGIPVNTFSSEVVTLWYRAPDV 179

Query: 241 ISGGK-YGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------QDGWTSFYEL 284
           + G + Y    DIWS G +L E  TG+  FP  +  EQ            +  W S  +L
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239

Query: 285 MEAIVDQP--PPSAPSDQFSPEFCSFISA--------CVQKEPQQRLSAQELMTHPFLK 333
            +   +    PP        P     +           +Q  P  RLSA++ + HP+  
Sbjct: 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFA 298

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  131 bits (331), Expect = 1e-35
 Identities = 68/320 (21%), Positives = 125/320 (39%), Gaps = 46/320 (14%)

Query: 50  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE 109
           +QT+      +  + +  +++    I  +G+G+ G V       T +  A+K I++  EE
Sbjct: 14  AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE 73

Query: 110 -----SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT 164
                +A R    E+ + +  Q   ++      + N  + +I EY +   L  ++ K   
Sbjct: 74  EGVPGTAIR----EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD 128

Query: 165 IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-----HRGEVKITDFGVSAIM 219
           +    + +   Q++ G+ + H  +  +HRDLKP NLL++         +KI DFG    +
Sbjct: 129 VSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDFG----L 183

Query: 220 ASTSG-QANTF---VGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FPYSPP 272
           A   G     F   + T  Y  PE + G + Y    DIWS+  +  E       FP    
Sbjct: 184 ARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243

Query: 273 EQQ-------------DGWTSFYELMEAIVDQPPPSAPS------DQFSPEFCSFISACV 313
             Q               W     L +     P     +           E    ++A +
Sbjct: 244 IDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAML 303

Query: 314 QKEPQQRLSAQELMTHPFLK 333
           + +P +R+SA+  + HP+  
Sbjct: 304 EMDPVKRISAKNALEHPYFS 323

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  129 bits (327), Expect = 1e-34
 Identities = 69/312 (22%), Positives = 124/312 (39%), Gaps = 55/312 (17%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 134
            ++ G+G+ G VQL + K TG   A+K +  +      R++ Q ++       P +V   
Sbjct: 28  ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNREL-QIMQDLAVLHHPNIVQLQ 85

Query: 135 QSFYSNGA-------ISIILEYMDGGSLADFLKKV--------KTIPEEYLAAICEQVLK 179
             FY+ G        +++++EY+        L +            P   +     Q+++
Sbjct: 86  SYFYTLGERDRRDIYLNVVMEYVP----DT-LHRCCRNYYRRQVAPPPILIKVFLFQLIR 140

Query: 180 GLLYLHHEKH-IIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTSGQANT-FVGTYNYM 236
            +  LH     + HRD+KP N+L+N   G +K+ DFG SA    +  + N  ++ +  Y 
Sbjct: 141 SIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG-SA-KKLSPSEPNVAYICSRYYR 198

Query: 237 SPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP---Y------------SPPEQQ-DG 277
           +PE I G + Y    DIWS+G +  E   G+  F                  P  +    
Sbjct: 199 APELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK 258

Query: 278 WTSFYELMEAIVDQPPPSAPSDQF-------SPEFCSFISACVQKEPQQRLSAQELMTHP 330
               +   +  +        S+ F       + E    +SA +Q  P++R+   E + HP
Sbjct: 259 LNPSH--TDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP 316

Query: 331 FLKMYGDLNVDL 342
           +     D    L
Sbjct: 317 YFDELHDPATKL 328

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  126 bits (320), Expect = 7e-34
 Identities = 72/301 (23%), Positives = 127/301 (42%), Gaps = 43/301 (14%)

Query: 64  DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE--------SARRQI 115
           D +   +  + +  +G+G    V   + K T Q  A+K I++            +A R  
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALR-- 61

Query: 116 AQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAIC 174
             E+K+ Q    P ++    +F     IS++ ++M+   L   +K     +   ++ A  
Sbjct: 62  --EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM 118

Query: 175 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN-TF---V 230
              L+GL YLH +  I+HRDLKP+NLL++  G +K+ DFG    +A + G  N  +   V
Sbjct: 119 LMTLQGLEYLH-QHWILHRDLKPNNLLLDENGVLKLADFG----LAKSFGSPNRAYTHQV 173

Query: 231 GTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP-YSPPEQ------------ 274
            T  Y +PE + G + YG   D+W++G +L E        P  S  +Q            
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT 233

Query: 275 QDGWTSFYELMEAIVDQPPPSAP-SDQF---SPEFCSFISACVQKEPQQRLSAQELMTHP 330
           ++ W     L + +  +  P  P    F     +    I       P  R++A + +   
Sbjct: 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293

Query: 331 F 331
           +
Sbjct: 294 Y 294

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  126 bits (320), Expect = 2e-33
 Identities = 68/297 (22%), Positives = 118/297 (39%), Gaps = 31/297 (10%)

Query: 42  NKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALK 101
            +    +  ++       +      LN ED+   + +G+G+ G V   + +      A+K
Sbjct: 88  TQQP--LTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVK 145

Query: 102 VIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLAD 157
             +  +    + +  QE +I +    P +V    VC Q       I I++E + GG    
Sbjct: 146 SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK----QPIYIVMELVQGGDFLT 201

Query: 158 FLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 216
           FL+     +  + L  +      G+ YL   K  IHRDL   N L+  +  +KI+DFG+S
Sbjct: 202 FLRTEGARLRVKTLLQMVGDAAAGMEYLE-SKCCIHRDLAARNCLVTEKNVLKISDFGMS 260

Query: 217 AIMASTSGQANTFVGTYNY--MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPE 273
              A     A+  +        +PE ++ G+Y  +SD+WS G++L E  + G  PY    
Sbjct: 261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY---- 316

Query: 274 QQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
                ++  +  E +        P   P           +  C   EP QR S   +
Sbjct: 317 --PNLSN-QQTREFVEKGGRLPCPELCP-----DAVFRLMEQCWAYEPGQRPSFSTI 365

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  127 bits (320), Expect = 2e-33
 Identities = 91/320 (28%), Positives = 136/320 (42%), Gaps = 50/320 (15%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 134
            KV+G GS G+V   +   + +  A+K +  +     R     EL+I +  + P VV   
Sbjct: 45  CKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKNR-----ELQIMRIVKHPNVVDLK 98

Query: 135 QSFYSNGA------ISIILEYMDG---GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
             FYSNG       ++++LEY+      +   + K  +T+P   +     Q+L+ L Y+H
Sbjct: 99  AFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH 158

Query: 186 HEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISG 243
               I HRD+KP NLL++   G +K+ DFG SA     +G+ N  ++ +  Y +PE I G
Sbjct: 159 -SIGICHRDIKPQNLLLDPPSGVLKLIDFG-SA-KILIAGEPNVSYICSRYYRAPELIFG 215

Query: 244 GK-YGYKSDIWSLGLVLLECATGQ--FPY---------------SPPEQQ-DGWTSFYEL 284
              Y    DIWS G V+ E   GQ  FP                +P  +Q       Y  
Sbjct: 216 ATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNY-- 273

Query: 285 MEAIVDQPPPSAPSDQF----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV 340
           ME    Q  P   S  F     P+    IS  ++  P  RL+A E + HPF         
Sbjct: 274 MEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEA 333

Query: 341 DLSEYFTDAGSPLATLSNLS 360
            +       G  L  L N +
Sbjct: 334 RMP-----NGRELPPLFNWT 348

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  125 bits (316), Expect = 6e-33
 Identities = 72/359 (20%), Positives = 123/359 (34%), Gaps = 104/359 (28%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQ----CP 128
           I+ +G G    V L       +F A+KV++      E+A  +I     +  S        
Sbjct: 42  IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101

Query: 129 YVVVCYQSFYSNGA----ISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLL 182
            VV     F  +G     I ++ E + G  L  ++ K   + +P   +  I +QVL+GL 
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160

Query: 183 YLHHEKHIIHRDLKPSNLLIN--------------------------------------- 203
           YLH +  IIH D+KP N+L++                                       
Sbjct: 161 YLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220

Query: 204 ----------HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIW 253
                      + +VKI D G +             + T  Y S E + G  Y   +DIW
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQTRQYRSLEVLIGSGYNTPADIW 277

Query: 254 SLGLVLLECATGQFPYSPPEQQDGWTSFYEL--MEAIVDQPPP-----SAPSDQF----- 301
           S   +  E ATG + + P   ++       +  +  ++ + P         S +F     
Sbjct: 278 STACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKG 337

Query: 302 ---------------------------SPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
                                      +  F  F+   ++  P++R +A E + HP+L 
Sbjct: 338 DLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  123 bits (310), Expect = 3e-32
 Identities = 69/314 (21%), Positives = 120/314 (38%), Gaps = 60/314 (19%)

Query: 68  NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKIN 122
            +   + +  +G+G+ G V   +H+ TGQ  ALK + M  E+     +A R+I    KI 
Sbjct: 15  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI----KIL 70

Query: 123 QSSQCPYVV----VCY----QSFYSNGAISIILEYMDGGSLADFLKKV-----KTIPEEY 169
           Q  +   VV    +C           G+I ++ ++ +     D L  +            
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HD-LAGLLSNVLVKFTLSE 125

Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANT 228
           +  + + +L GL Y+H    I+HRD+K +N+LI   G +K+ DFG++ A   + + Q N 
Sbjct: 126 IKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 229 F---VGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FPY------------- 269
           +   V T  Y  PE + G + YG   D+W  G ++ E  T                    
Sbjct: 185 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244

Query: 270 --SPPEQQDGWTSFYELMEAIVDQPPPSAPSD--------QFSPEFCSFISACVQKEPQQ 319
             S   +   W +          +                   P     I   +  +P Q
Sbjct: 245 CGSITPEV--WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302

Query: 320 RLSAQELMTHPFLK 333
           R+ + + + H F  
Sbjct: 303 RIDSDDALNHDFFW 316

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  122 bits (308), Expect = 3e-32
 Identities = 76/298 (25%), Positives = 129/298 (43%), Gaps = 42/298 (14%)

Query: 61  KPSDNQLNL---EDIDTIKVVGKGSGGIVQLVQHKWTGQFF------ALKVIQMNVEESA 111
            P+   L +    +   IKV+G G+ G V   +  W  +        A+K ++      A
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTV--YKGLWIPEGEKVKIPVAIKELREATSPKA 60

Query: 112 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIP 166
            ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  I 
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIG 115

Query: 167 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 226
            +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   + 
Sbjct: 116 SQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174

Query: 227 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYE 283
           +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY      DG  +  E
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY------DGIPA-SE 227

Query: 284 LMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
           +   +        PP         +    +  C   +   R   +EL+   F KM  D
Sbjct: 228 ISSILEKGERLPQPPICT-----IDVYMIMRKCWMIDADSRPKFRELIIE-FSKMARD 279

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  121 bits (305), Expect = 4e-32
 Identities = 67/297 (22%), Positives = 121/297 (40%), Gaps = 32/297 (10%)

Query: 54  TEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQL----VQHKWTGQFFALKVIQMNVEE 109
           +E  P  +          +  I+ +G+G  G V+L     +   TG+  A+K ++     
Sbjct: 5   SEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG 64

Query: 110 SARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-T 164
           +    + +E++I ++     +V    +C +   +   I +I+E++  GSL ++L K K  
Sbjct: 65  NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG--IKLIMEFLPSGSLKEYLPKNKNK 122

Query: 165 IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG 224
           I  +       Q+ KG+ YL   +  +HRDL   N+L+    +VKI DFG++  + +   
Sbjct: 123 INLKQQLKYAVQICKGMDYLG-SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181

Query: 225 QANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTS 280
                        + +PE +   K+   SD+WS G+ L E  T      SP         
Sbjct: 182 YYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241

Query: 281 FY-------ELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
                     L+  + +      PP+ P      E    +  C + +P  R S Q L
Sbjct: 242 PTHGQMTVTRLVNTLKEGKRLPCPPNCP-----DEVYQLMRKCWEFQPSNRTSFQNL 293

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  120 bits (303), Expect = 2e-31
 Identities = 59/298 (19%), Positives = 121/298 (40%), Gaps = 45/298 (15%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS-SQCPYVVVC 133
           ++ +G+G    V    +    +   +K+++   ++  +R    E+KI ++    P ++  
Sbjct: 41  VRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR----EIKILENLRGGPNIITL 96

Query: 134 YQSFY--SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHII 191
                   +   +++ E+++     DF +  +T+ +  +     ++LK L Y H    I+
Sbjct: 97  ADIVKDPVSRTPALVFEHVNN---TDFKQLYQTLTDYDIRFYMYEILKALDYCH-SMGIM 152

Query: 192 HRDLKPSNLLINH-RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYK 249
           HRD+KP N++I+H   ++++ D+G+ A       + N  V +  +  PE +   + Y Y 
Sbjct: 153 HRDVKPHNVMIDHEHRKLRLIDWGL-AEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYS 211

Query: 250 SDIWSLGLVLLECATGQFPYSP-----------------PEQQDGWTSFYELMEA--IVD 290
            D+WSLG +L      + P+                    +  D +   Y +       D
Sbjct: 212 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD-YIDKYNIELDPRFND 270

Query: 291 QPP-----------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
                          S      SPE   F+   ++ + Q RL+A+E M HP+      
Sbjct: 271 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  122 bits (308), Expect = 2e-31
 Identities = 66/297 (22%), Positives = 119/297 (40%), Gaps = 35/297 (11%)

Query: 35  MDGDLLVNKDGVRIVSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT 94
            D D L  +     V +    A      S   LN++++  ++ +GKG  G V  +   + 
Sbjct: 158 TDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDV--MLGDYR 215

Query: 95  GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYM 150
           G   A+K I+    ++  +    E  +    +   +V    V  +     G + I+ EYM
Sbjct: 216 GNKVAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE---KGGLYIVTEYM 269

Query: 151 DGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
             GSL D+L+      +  + L      V + + YL    + +HRDL   N+L++     
Sbjct: 270 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-GNNFVHRDLAARNVLVSEDNVA 328

Query: 209 KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQF 267
           K++DFG++   +ST       V    + +PE +   K+  KSD+WS G++L E  + G+ 
Sbjct: 329 KVSDFGLTKEASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRV 385

Query: 268 PYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
           PY             +++  +        P   P     P     +  C   +   R
Sbjct: 386 PY------PRIPL-KDVVPRVEKGYKMDAPDGCP-----PAVYDVMKNCWHLDAATR 430

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  118 bits (299), Expect = 4e-31
 Identities = 69/330 (20%), Positives = 126/330 (38%), Gaps = 68/330 (20%)

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-------ALKVIQMNVEESARR 113
            P + ++  E I   + +G+GS G+V   +    G          A+K +        R 
Sbjct: 16  VPDEWEVAREKITMSRELGQGSFGMV--YEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73

Query: 114 QIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY 169
           +   E  + +   C +VV    V  Q         +I+E M  G L  +L+ ++      
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPAMANN 129

Query: 170 ----------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 219
                     +  +  ++  G+ YL+     +HRDL   N ++     VKI DFG++  +
Sbjct: 130 PVLAPPSLSKMIQMAGEIADGMAYLN-ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 188

Query: 220 ASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQ 266
             T          Y Y            MSPE +  G +   SD+WS G+VL E AT  +
Sbjct: 189 YETD---------Y-YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 238

Query: 267 FPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
            PY       G ++  +++  +++      P + P           +  C Q  P+ R S
Sbjct: 239 QPYQ------GLSNE-QVLRFVMEGGLLDKPDNCP-----DMLFELMRMCWQYNPKMRPS 286

Query: 323 AQELMTHPFLKMYGDLNVDLSEYFTDAGSP 352
             E+++    +       ++S Y+++    
Sbjct: 287 FLEIISS-IKEEMEPGFREVSFYYSEENKL 315

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  118 bits (299), Expect = 5e-31
 Identities = 72/299 (24%), Positives = 126/299 (42%), Gaps = 35/299 (11%)

Query: 61  KPSDN-QLNLEDIDTIKVVGKGSGGIVQL----VQHKWTGQFFALKVIQMNVEESARRQI 115
            P D    +   +  I+ +G+G  G V L      +  TG+  A+K ++ +     R   
Sbjct: 21  GPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGW 80

Query: 116 AQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLA 171
            QE+ I ++    +++     C  +  ++  + +++EY+  GSL D+L +  +I    L 
Sbjct: 81  KQEIDILRTLYHEHIIKYKGCCEDAGAAS--LQLVMEYVPLGSLRDYLPR-HSIGLAQLL 137

Query: 172 AICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG 231
              +Q+ +G+ YLH  +H IHRDL   N+L+++   VKI DFG++  +            
Sbjct: 138 LFAQQICEGMAYLH-AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED 196

Query: 232 TYN---YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT-------S 280
             +   + +PE +   K+ Y SD+WS G+ L E  T      SPP +            +
Sbjct: 197 GDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMT 256

Query: 281 FYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
              L E +        P   P      E    +  C + E   R + + L   P LK  
Sbjct: 257 VLRLTELLERGERLPRPDKCP-----AEVYHLMKNCWETEASFRPTFENL--IPILKTV 308

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  119 bits (301), Expect = 7e-31
 Identities = 65/326 (19%), Positives = 119/326 (36%), Gaps = 72/326 (22%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI------NQSSQCP 128
             ++GKGS G V     +   ++ A+K+I+ N + +   Q   E+++      + +    
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIK-NKK-AFLNQAQIEVRLLELMNKHDTEMKY 116

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHH 186
           Y+V   + F     + ++ E +   +L D L+      +         +Q+   LL+L  
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175

Query: 187 EK-HIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
            +  IIH DLKP N+L+ +  R  +KI DFG S+       +   ++ +  Y SPE + G
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLG--QRIYQYIQSRFYRSPEVLLG 232

Query: 244 GKYGYKSDIWSLGLVLLECATGQ--FP--------------------------------- 268
             Y    D+WSLG +L+E  TG+  F                                  
Sbjct: 233 MPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFF 292

Query: 269 -------YSPPEQQDG-----WTSFYELMEAIVDQPPPSAPSDQFSPE--------FCSF 308
                  ++  + +DG          +L   +  +                     F   
Sbjct: 293 EKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL 352

Query: 309 ISACVQKEPQQRLSAQELMTHPFLKM 334
           I   +  +P+ R+     + H F K 
Sbjct: 353 ILRMLDYDPKTRIQPYYALQHSFFKK 378

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  117 bits (296), Expect = 1e-30
 Identities = 70/331 (21%), Positives = 119/331 (35%), Gaps = 51/331 (15%)

Query: 49  VSQTETEAPPLIKPSDN-QLNLEDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQ 104
                 E P     S   ++    I   K++G G  G V   +L          A+K ++
Sbjct: 27  AEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALK 86

Query: 105 MNVEESARRQIAQELKINQSSQCPYVV----VCYQS--FYSNGAISIILEYMDGGSLADF 158
               E  RR    E  I      P ++    V  +           I+ EYM+ GSL  F
Sbjct: 87  AGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM------IVTEYMENGSLDTF 140

Query: 159 LKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 217
           L+          L  +   V  G+ YL  +   +HRDL   N+L++     K++DFG+S 
Sbjct: 141 LRTHDGQFTIMQLVGMLRGVGAGMRYLS-DLGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199

Query: 218 IMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPE 273
           ++      A T  G      + +PE I+   +   SD+WS G+V+ E    G+ PY    
Sbjct: 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPY---- 255

Query: 274 QQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
                T+  +++ ++ +      P   P           +  C  K+  QR    ++++ 
Sbjct: 256 --WNMTN-RDVISSVEEGYRLPAPMGCP-----HALHQLMLDCWHKDRAQRPRFSQIVSV 307

Query: 330 PFLKMYGDLNVDLSEYFTDAGSPLATLSNLS 360
                       L          L   + +S
Sbjct: 308 ------------LDALIRSP-ESLRATATVS 325

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  118 bits (297), Expect = 2e-30
 Identities = 77/312 (24%), Positives = 128/312 (41%), Gaps = 45/312 (14%)

Query: 66  QLNLEDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN 122
           +L+  +I   KVVG G  G V   +L          A+K +++   E  RR    E  I 
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIM 100

Query: 123 QSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQV 177
                P ++    V  +S      + I+ EYM+ GSL  FL+K         L  +   +
Sbjct: 101 GQFDHPNIIRLEGVVTKS----KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YN 234
             G+ YL  +   +HRDL   N+LIN     K++DFG+  ++      A T  G      
Sbjct: 157 ASGMKYLS-DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215

Query: 235 YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD--- 290
           + SPE I+  K+   SD+WS G+VL E  + G+ PY         ++  ++++A+ +   
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPY------WEMSN-QDVIKAVDEGYR 268

Query: 291 -QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA 349
             PP   P           +  C QK+   R   +++++             L +   + 
Sbjct: 269 LPPPMDCP-----AALYQLMLDCWQKDRNNRPKFEQIVSI------------LDKLIRNP 311

Query: 350 GSPLATLSNLSG 361
           GS     S  + 
Sbjct: 312 GSLKIITSAAAR 323

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  116 bits (292), Expect = 3e-30
 Identities = 60/266 (22%), Positives = 111/266 (41%), Gaps = 35/266 (13%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 125
            LN++++  ++ +GKG  G V  +   + G   A+K I+    ++  +    E  +    
Sbjct: 17  ALNMKELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIK---NDATAQAFLAEASVMTQL 71

Query: 126 QCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLK 179
           +   +V    V  +     G + I+ EYM  GSL D+L+      +  + L      V +
Sbjct: 72  RHSNLVQLLGVIVEE---KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 128

Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPE 239
            + YL    + +HRDL   N+L++     K++DFG++   +ST       V    + +PE
Sbjct: 129 AMEYLE-GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPE 184

Query: 240 RISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPP 294
            +   K+  KSD+WS G++L E  + G+ PY             +++  +        P 
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPY------PRIPL-KDVVPRVEKGYKMDAPD 237

Query: 295 SAPSDQFSPEFCSFISACVQKEPQQR 320
             P     P     +  C   +   R
Sbjct: 238 GCP-----PAVYEVMKNCWHLDAAMR 258

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  117 bits (296), Expect = 3e-30
 Identities = 63/282 (22%), Positives = 108/282 (38%), Gaps = 49/282 (17%)

Query: 70  EDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 126
             +   +V+G+G  G V    L+ +       A+K +    +     Q   E  I +   
Sbjct: 89  LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 148

Query: 127 CPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGL 181
            P V+    +C +S    G+  ++L YM  G L +F++        + L     QV KG+
Sbjct: 149 HPNVLSLLGICLRS---EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 205

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY------ 235
            +L   K  +HRDL   N +++ +  VK+ DFG++  M              +       
Sbjct: 206 KFLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE--------FDSVHNKTGA 256

Query: 236 ------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI 288
                 M+ E +   K+  KSD+WS G++L E  T G  PY          +F ++   +
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP------DVNTF-DITVYL 309

Query: 289 VD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           +       P   P           +  C   + + R S  EL
Sbjct: 310 LQGRRLLQPEYCP-----DPLYEVMLKCWHPKAEMRPSFSEL 346

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  117 bits (295), Expect = 3e-30
 Identities = 69/330 (20%), Positives = 124/330 (37%), Gaps = 84/330 (25%)

Query: 75  IKVVGKGS-GGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI------NQSSQC 127
           +  +G+G+ G +V+ + HK  G+  A+K+++ NV+         E+++         +  
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-NVD-RYCEAARSEIQVLEHLNTTDPNST 76

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLH 185
              V   + F  +G I I+ E + G S  DF+K+        +++  +  Q+ K + +LH
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH 135

Query: 186 HEKHIIHRDLKPSNLLINH-------------------RGEVKITDFGVSAIMASTSGQA 226
               + H DLKP N+L                        ++K+ DFG SA         
Sbjct: 136 -SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SATYDDE--HH 191

Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ--FP-YSPPEQQDGWTSFYE 283
           +T V T +Y +PE I    +    D+WS+G +L+E   G   FP +   E          
Sbjct: 192 STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH-------LA 244

Query: 284 LMEAIVDQPPPS---------------------------------------APSDQFSPE 304
           +ME I+   P                                            D     
Sbjct: 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHER 304

Query: 305 FCSFISACVQKEPQQRLSAQELMTHPFLKM 334
               I   ++ +P +R++ +E + HPF  +
Sbjct: 305 LFDLIQKMLEYDPAKRITLREALKHPFFDL 334

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  117 bits (294), Expect = 3e-30
 Identities = 72/290 (24%), Positives = 121/290 (41%), Gaps = 35/290 (12%)

Query: 70  EDIDTIKVVGKGSGGIVQL----VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 125
             +  I  +GKG+ G V+L         TG   A+K +Q +  +  +R   +E++I ++ 
Sbjct: 23  RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKAL 81

Query: 126 QCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKG 180
              ++V    V Y     +  + +++EY+  G L DFL++ +  +    L     Q+ KG
Sbjct: 82  HSDFIVKYRGVSYGPGRQS--LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKG 139

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMS 237
           + YL   +  +HRDL   N+L+     VKI DFG++ ++                  + +
Sbjct: 140 MEYLG-SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198

Query: 238 PERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY-------ELMEAIV 289
           PE +S   +  +SD+WS G+VL E  T      SP  +                L+E + 
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258

Query: 290 D----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
           +      PP+ P      E    +  C    PQ R S   L   P L M 
Sbjct: 259 EGQRLPAPPACP-----AEVHELMKLCWAPSPQDRPSFSAL--GPQLDML 301

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  117 bits (294), Expect = 3e-30
 Identities = 68/271 (25%), Positives = 111/271 (40%), Gaps = 34/271 (12%)

Query: 67  LNLEDIDTIKVVGKGSGGIV---QLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKIN 122
           ++   +   KV+G G  G V    L       +   A+K ++    E  R     E  I 
Sbjct: 41  IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 100

Query: 123 QSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQV 177
                  ++    V  +       + II EYM+ G+L  FL++         L  +   +
Sbjct: 101 GQFSHHNIIRLEGVISKY----KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGI 156

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YN 234
             G+ YL    + +HRDL   N+L+N     K++DFG+S ++        T  G      
Sbjct: 157 AAGMKYLA-NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215

Query: 235 YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD--- 290
           + +PE IS  K+   SD+WS G+V+ E  T G+ PY         ++ +E+M+AI D   
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY------WELSN-HEVMKAINDGFR 268

Query: 291 -QPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
              P   P           +  C Q+E  +R
Sbjct: 269 LPTPMDCP-----SAIYQLMMQCWQQERARR 294

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  115 bits (290), Expect = 6e-30
 Identities = 67/285 (23%), Positives = 115/285 (40%), Gaps = 38/285 (13%)

Query: 59  LIKPSDNQLNLEDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESARRQI 115
           +I PS   ++       +V+G+G  G V    L+ +       A+K +    +     Q 
Sbjct: 19  VIGPSSLIVHFN-----EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 73

Query: 116 AQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYL 170
             E  I +    P V+    +C +S    G+  ++L YM  G L +F++        + L
Sbjct: 74  LTEGIIMKDFSHPNVLSLLGICLRS---EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 130

Query: 171 AAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS-AIMASTSGQANTF 229
                QV KG+ YL   K  +HRDL   N +++ +  VK+ DFG++  +        +  
Sbjct: 131 IGFGLQVAKGMKYLA-SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189

Query: 230 VGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
            G      +M+ E +   K+  KSD+WS G++L E  T G  PY          +F ++ 
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP------DVNTF-DIT 242

Query: 286 EAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
             ++       P   P           +  C   + + R S  EL
Sbjct: 243 VYLLQGRRLLQPEYCP-----DPLYEVMLKCWHPKAEMRPSFSEL 282

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  116 bits (293), Expect = 6e-30
 Identities = 65/322 (20%), Positives = 110/322 (34%), Gaps = 70/322 (21%)

Query: 75  IKVVGKGS-GGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI------NQSSQC 127
           +  +G+G+ G +V+ + H       ALK+I+ NV    R     E+ +            
Sbjct: 24  VGNLGEGTFGKVVECLDHARGKSQVALKIIR-NVG-KYREAARLEINVLKKIKEKDKENK 81

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLH 185
              V+    F  +G + I  E + G +  +FLK+   +  P  ++  +  Q+   L +LH
Sbjct: 82  FLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH 140

Query: 186 HEKHIIHRDLKPSNLLINH-------------------RGEVKITDFGVSAIMASTSGQA 226
             + + H DLKP N+L  +                      +++ DFG SA         
Sbjct: 141 ENQ-LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATFDHE--HH 196

Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ--FPYS-------------- 270
            T V T +Y  PE I    +    D+WS+G +L E   G   F                 
Sbjct: 197 TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG 256

Query: 271 -PPEQ-----------QDGWTSFYELMEAIVDQPPPSAPSDQ-------FSPEFCSFISA 311
             P               G   + E             P             +    +  
Sbjct: 257 PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRR 316

Query: 312 CVQKEPQQRLSAQELMTHPFLK 333
            ++ +P QR++  E + HPF  
Sbjct: 317 MLEFDPAQRITLAEALLHPFFA 338

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  115 bits (289), Expect = 7e-30
 Identities = 60/279 (21%), Positives = 122/279 (43%), Gaps = 38/279 (13%)

Query: 60  IKPSDNQLNLEDID-TIKVVGKGSGGIVQLVQHKWTGQFF----ALKVIQMNV-EESARR 113
           I+P +  L+ + +    K +G G+ G V+  +  +  +      A+K+++    + + + 
Sbjct: 6   IRPKEVYLDRKLLTLEDKELGSGNFGTVK--KGYYQMKKVVKTVAVKILKNEANDPALKD 63

Query: 114 QIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY 169
           ++  E  + Q    PY+V    +C        +  +++E  + G L  +L++ + + ++ 
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGICEAE-----SWMLVMEMAELGPLNKYLQQNRHVKDKN 118

Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 229
           +  +  QV  G+ YL  E + +HRDL   N+L+  +   KI+DFG+S  + +        
Sbjct: 119 IIELVHQVSMGMKYL-EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 177

Query: 230 VGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM 285
                   + +PE I+  K+  KSD+WS G+++ E  + GQ PY       G     E+ 
Sbjct: 178 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY------RGMKG-SEVT 230

Query: 286 EAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
             +        P   P      E    ++ C   + + R
Sbjct: 231 AMLEKGERMGCPAGCP-----REMYDLMNLCWTYDVENR 264

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  117 bits (296), Expect = 8e-30
 Identities = 77/318 (24%), Positives = 135/318 (42%), Gaps = 48/318 (15%)

Query: 27  FLTKSGTFMDGDLLV-----NKDGV--RIVSQTETEAPPLIKPSDN--QLNLEDIDTIKV 77
           ++T    F     LV     + DG+  R+ +   T  P     + +  ++  E +     
Sbjct: 132 YITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVK 191

Query: 78  VGKGSGGIVQLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----V 132
           +G+G  G V      W G    A+K ++      +     QE ++ +  +   +V    V
Sbjct: 192 LGQGCFGEV--WMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHI 190
             +       I I+ EYM  GSL DFLK    K +    L  +  Q+  G+ Y+    + 
Sbjct: 248 VSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-RMNY 301

Query: 191 IHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYG 247
           +HRDL+ +N+L+      K+ DFG++ ++     T+ Q   F     + +PE    G++ 
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFT 359

Query: 248 YKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFS 302
            KSD+WS G++L E  T G+ PY       G  +  E+++ +        PP  P     
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYP------GMVN-REVLDQVERGYRMPCPPECP----- 407

Query: 303 PEFCSFISACVQKEPQQR 320
                 +  C +KEP++R
Sbjct: 408 ESLHDLMCQCWRKEPEER 425

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  115 bits (291), Expect = 1e-29
 Identities = 68/313 (21%), Positives = 110/313 (35%), Gaps = 63/313 (20%)

Query: 50  SQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGS-----GGIVQLVQHKWTGQFFALKVIQ 104
                           ++  ++I  I+ +G G+      G V  + +  +    A+K + 
Sbjct: 51  PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 110

Query: 105 MNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLK 160
               E        E  I        +V    V  QS        I+LE M GG L  FL+
Sbjct: 111 EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS----LPRFILLELMAGGDLKSFLR 166

Query: 161 KVKTIPEEY-------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKI 210
           + +  P +        L  +   +  G  YL  E H IHRD+   N L+   G     KI
Sbjct: 167 ETRPRPSQPSSLAMLDLLHVARDIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKI 225

Query: 211 TDFGVSAIMASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLV 258
            DFG++  +             Y Y            M PE    G +  K+D WS G++
Sbjct: 226 GDFGMARDIYRAG---------Y-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 275

Query: 259 LLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACV 313
           L E  + G  PY         ++  E++E +       PP + P           ++ C 
Sbjct: 276 LWEIFSLGYMPYP------SKSN-QEVLEFVTSGGRMDPPKNCP-----GPVYRIMTQCW 323

Query: 314 QKEPQQRLSAQEL 326
           Q +P+ R +   +
Sbjct: 324 QHQPEDRPNFAII 336

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  114 bits (287), Expect = 2e-29
 Identities = 62/275 (22%), Positives = 109/275 (39%), Gaps = 41/275 (14%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-----ALKVIQMNV--EESARRQIAQEL 119
           +  +D+  ++ +G GS G+V+  + +W          A+K ++ +V  +  A     +E+
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVR--RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREV 72

Query: 120 KINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAIC 174
               S     ++    V          + ++ E    GSL D L+K +       L+   
Sbjct: 73  NAMHSLDHRNLIRLYGVVLTP-----PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127

Query: 175 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT-- 232
            QV +G+ YL   K  IHRDL   NLL+  R  VKI DFG+   +               
Sbjct: 128 VQVAEGMGYLE-SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186

Query: 233 -YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD 290
            + + +PE +    + + SD W  G+ L E  T GQ P+       G     +++  I  
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW------IGLNG-SQILHKIDK 239

Query: 291 Q-----PPPSAPSDQFSPEFCSFISACVQKEPQQR 320
           +      P   P      +  + +  C   +P+ R
Sbjct: 240 EGERLPRPEDCP-----QDIYNVMVQCWAHKPEDR 269

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  117 bits (295), Expect = 2e-29
 Identities = 67/284 (23%), Positives = 113/284 (39%), Gaps = 35/284 (12%)

Query: 51  QTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES 110
              T           ++   DI     +G G  G V     K      A+K   +  +  
Sbjct: 201 NKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTM 258

Query: 111 ARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKV--KT 164
              +  +E  + +  + P +V    VC +         II E+M  G+L D+L++   + 
Sbjct: 259 EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE----PPFYIITEFMTYGNLLDYLRECNRQE 314

Query: 165 IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS--- 221
           +    L  +  Q+   + YL  +K+ IHR+L   N L+     VK+ DFG+S +M     
Sbjct: 315 VSAVVLLYMATQISSAMEYLE-KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY 373

Query: 222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTS 280
           T+     F     + +PE ++  K+  KSD+W+ G++L E AT G  PY       G   
Sbjct: 374 TAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------PGIDL 425

Query: 281 FYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
             ++ E +      + P   P      +    + AC Q  P  R
Sbjct: 426 -SQVYELLEKDYRMERPEGCP-----EKVYELMRACWQWNPSDR 463

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  114 bits (288), Expect = 2e-29
 Identities = 79/321 (24%), Positives = 134/321 (41%), Gaps = 46/321 (14%)

Query: 61  KPSDNQLNL---EDIDTIKVVGKGSGGIVQLVQHKWTGQFF------ALKVIQMNVEESA 111
            P+   L +    +   IKV+G G+ G V   +  W  +        A+K ++      A
Sbjct: 3   APNQALLRILKETEFKKIKVLGSGAFGTV--YKGLWIPEGEKVKIPVAIKELREATSPKA 60

Query: 112 RRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIP 166
            ++I  E  +  S   P+V     +C  S      + +I + M  G L D++++ K  I 
Sbjct: 61  NKEILDEAYVMASVDNPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDNIG 115

Query: 167 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 226
            +YL   C Q+ KG+ YL  ++ ++HRDL   N+L+     VKITDFG++ ++ +   + 
Sbjct: 116 SQYLLNWCVQIAKGMNYLE-DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY 174

Query: 227 NTFVGTY--NYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYE 283
           +   G     +M+ E I    Y ++SD+WS G+ + E  T G  PY      DG  +  E
Sbjct: 175 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY------DGIPA-SE 227

Query: 284 LMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 339
           +   +        PP         +    +  C   +   R   +EL+   F KM     
Sbjct: 228 ISSILEKGERLPQPPICT-----IDVYMIMVKCWMIDADSRPKFRELIIE-FSKMA---- 277

Query: 340 VDLSEYFTDAGSPLATLSNLS 360
            D   Y    G     L + +
Sbjct: 278 RDPQRYLVIQGDERMHLPSPT 298

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  113 bits (284), Expect = 3e-29
 Identities = 57/282 (20%), Positives = 107/282 (37%), Gaps = 54/282 (19%)

Query: 70  EDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 126
           ED+   +++G+G  G V       HK      A+K  + +     + +   E  I ++  
Sbjct: 12  EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 127 CPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGL 181
            P++V    +            II+E    G L  +L++ K ++    L     Q+ K +
Sbjct: 72  HPHIVKLIGII-----EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY------ 235
            YL    + +HRD+   N+L+     VK+ DFG+S  +              +Y      
Sbjct: 127 AYLE-SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE-----------DYYKASVT 174

Query: 236 ------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI 288
                 MSPE I+  ++   SD+W   + + E  + G+ P+          +  +++  +
Sbjct: 175 RLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPF------FWLEN-KDVIGVL 227

Query: 289 VD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
                   P   P     P   + ++ C   +P  R    EL
Sbjct: 228 EKGDRLPKPDLCP-----PVLYTLMTRCWDYDPSDRPRFTEL 264

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  115 bits (290), Expect = 4e-29
 Identities = 78/324 (24%), Positives = 127/324 (39%), Gaps = 77/324 (23%)

Query: 75  IKVVGKGS-GGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI------NQSSQC 127
           +KV+GKGS G +V+   HK   Q  ALK+++ N +    RQ A+E++I            
Sbjct: 102 LKVIGKGSFGQVVKAYDHK-VHQHVALKMVR-NEK-RFHRQAAEEIRILEHLRKQDKDNT 158

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLH 185
             V+   ++F     I +  E +   +L + +KK K        +      +L+ L  LH
Sbjct: 159 MNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217

Query: 186 HEKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTY----NYMSPE 239
             + IIH DLKP N+L+    R  +K+ DFG       +S   +  V TY     Y +PE
Sbjct: 218 KNR-IIHCDLKPENILLKQQGRSGIKVIDFG-------SSCYEHQRVYTYIQSRFYRAPE 269

Query: 240 RISGGKYGYKSDIWSLGLVLLECATGQ--FPYS---------------PP---------- 272
            I G +YG   D+WSLG +L E  TG    P                 P           
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA 329

Query: 273 ------EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCS-----------------FI 309
                 +    + +   L +  V      +   +      S                 F+
Sbjct: 330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFL 389

Query: 310 SACVQKEPQQRLSAQELMTHPFLK 333
             C++ +P  R++  + + HP+L+
Sbjct: 390 KQCLEWDPAVRMTPGQALRHPWLR 413

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  116 bits (293), Expect = 4e-29
 Identities = 76/318 (23%), Positives = 131/318 (41%), Gaps = 48/318 (15%)

Query: 27  FLTKSGTFMDGDLLV-----NKDGV----RIVSQTETEAPPLIKPSDNQLNLEDIDTIKV 77
           ++T    F     LV     + DG+      V  T       +     ++  E +     
Sbjct: 215 YITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVK 274

Query: 78  VGKGSGGIVQLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----V 132
           +G+G  G V      W G    A+K ++      +     QE ++ +  +   +V    V
Sbjct: 275 LGQGCFGEV--WMGTWNGTTRVAIKTLKPG--TMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHI 190
             +       I I+ EYM  GSL DFLK    K +    L  +  Q+  G+ Y+    + 
Sbjct: 331 VSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE-RMNY 384

Query: 191 IHRDLKPSNLLINHRGEVKITDFGVSAIMAS---TSGQANTFVGTYNYMSPERISGGKYG 247
           +HRDL+ +N+L+      K+ DFG++ ++     T+ Q   F     + +PE    G++ 
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTAPEAALYGRFT 442

Query: 248 YKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFS 302
            KSD+WS G++L E  T G+ PY       G  +  E+++ +        PP  P     
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYP------GMVN-REVLDQVERGYRMPCPPECP----- 490

Query: 303 PEFCSFISACVQKEPQQR 320
                 +  C +KEP++R
Sbjct: 491 ESLHDLMCQCWRKEPEER 508

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  114 bits (287), Expect = 5e-29
 Identities = 73/307 (23%), Positives = 133/307 (43%), Gaps = 48/307 (15%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSSQCPYVVVC 133
             ++G+G+ G+V    HK TG+  A+K I+  +    A R   +E+KI +  +   ++  
Sbjct: 16  KSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR-TLREIKILKHFKHENIITI 74

Query: 134 YQSFYSNGA-----ISIILEYMDGGSLADFLKKVKTIP--EEYLAAICEQVLKGLLYLHH 186
           +     +       + II E M      D  + + T    ++++     Q L+ +  LH 
Sbjct: 75  FNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLH- 129

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYM---------- 236
             ++IHRDLKPSNLLIN   ++K+ DFG++ I+  ++   +   G  + M          
Sbjct: 130 GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR 189

Query: 237 SPERI-SGGKYGYKSDIWSLGLVLLECATGQ--FP---Y------------SPPEQQDGW 278
           +PE + +  KY    D+WS G +L E    +  FP   Y            +P    D  
Sbjct: 190 APEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLR 249

Query: 279 TSFYELMEAIVDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
                     +   P    +       + +P+    +   +  +P +R++A+E + HP+L
Sbjct: 250 CIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL 309

Query: 333 KMYGDLN 339
           + Y D N
Sbjct: 310 QTYHDPN 316

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  114 bits (288), Expect = 5e-29
 Identities = 71/329 (21%), Positives = 121/329 (36%), Gaps = 76/329 (23%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 134
            K +G GS GIV  V    +G+ FALK     V +  R +  +EL I +      ++   
Sbjct: 12  GKTLGTGSFGIVCEVFDIESGKRFALK----KVLQDPRYKN-RELDIMKVLDHVNIIKLV 66

Query: 135 QSFYSNGA--------------------------------------ISIILEYMDG---G 153
             FY+ G                                       +++I+EY+      
Sbjct: 67  DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126

Query: 154 SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITD 212
            L  F++  ++IP   ++    Q+ + + ++H    I HRD+KP NLL+N     +K+ D
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS-LGICHRDIKPQNLLVNSKDNTLKLCD 185

Query: 213 FGVSAIMASTSGQANT-FVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQ--FP 268
           FG SA       + +  ++ +  Y +PE + G  +Y    D+WS+G V  E   G+  F 
Sbjct: 186 FG-SA-KKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS 243

Query: 269 ---Y------------SPPEQQ-DGWTSFYELMEAIVDQPPPSAPSDQFS----PEFCSF 308
                           +P ++Q       Y   E                          
Sbjct: 244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHY--TEVRFPTLKAKDWRKILPEGTPSLAIDL 301

Query: 309 ISACVQKEPQQRLSAQELMTHPFLKMYGD 337
           +   ++ EP  R++  E M HPF     +
Sbjct: 302 LEQILRYEPDLRINPYEAMAHPFFDHLRN 330

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  112 bits (282), Expect = 6e-29
 Identities = 28/252 (11%), Positives = 62/252 (24%), Gaps = 34/252 (13%)

Query: 77  VVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQELKINQSSQCPYVVVCY 134
             G                +  AL  +  Q  + +   ++             P V    
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 135 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 194
              ++     ++ E++ GGSL +      +          + +       H    +    
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVG--AIRAMQSLAAAADAAH-RAGVALSI 154

Query: 195 LKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWS 254
             PS + ++  G+V +                         M            + DI  
Sbjct: 155 DHPSRVRVSIDGDVVLAYPA--------------------TMPDA-------NPQDDIRG 187

Query: 255 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 314
           +G  L      ++P      + G                P+        +  +  +  VQ
Sbjct: 188 IGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP--IEPADIDRDIPFQISAVAARSVQ 245

Query: 315 KEPQQRLSAQEL 326
            +   R ++  L
Sbjct: 246 GDGGIRSASTLL 257

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  113 bits (284), Expect = 6e-29
 Identities = 62/307 (20%), Positives = 110/307 (35%), Gaps = 55/307 (17%)

Query: 52  TETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQM-NV 107
                    K  D  ++   +   K++G+G  G V    L Q   T    A+K +++ N 
Sbjct: 16  PRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS 75

Query: 108 EESARRQIAQELKINQSSQCPYVV----VCYQS-FYSNGAISIILEYMDGGSLADFLKKV 162
            +    +   E    +    P V+    VC +          +IL +M  G L  +L   
Sbjct: 76  SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS 135

Query: 163 KTIPEEY------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 216
           +            L      +  G+ YL   ++ +HRDL   N ++     V + DFG+S
Sbjct: 136 RLETGPKHIPLQTLLKFMVDIALGMEYLS-NRNFLHRDLAARNCMLRDDMTVCVADFGLS 194

Query: 217 AIMASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT 264
             + S           Y Y            ++ E ++   Y  KSD+W+ G+ + E AT
Sbjct: 195 KKIYSGD---------Y-YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

Query: 265 -GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQ 319
            G  PY       G  +  E+ + ++     + P          E    + +C + +P  
Sbjct: 245 RGMTPYP------GVQNH-EMYDYLLHGHRLKQPEDCL-----DELYEIMYSCWRTDPLD 292

Query: 320 RLSAQEL 326
           R +   L
Sbjct: 293 RPTFSVL 299

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  113 bits (284), Expect = 7e-29
 Identities = 67/301 (22%), Positives = 111/301 (36%), Gaps = 63/301 (20%)

Query: 62  PSDNQLNLEDIDTIKVVGKGS-----GGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA 116
               ++  ++I  I+ +G G+      G V  + +  +    A+K +     E       
Sbjct: 22  SDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 81

Query: 117 QELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--- 169
            E  I        +V    V  Q    +    I++E M GG L  FL++ +  P +    
Sbjct: 82  MEALIISKFNHQNIVRCIGVSLQ----SLPRFILMELMAGGDLKSFLRETRPRPSQPSSL 137

Query: 170 ----LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMAST 222
               L  +   +  G  YL  E H IHRD+   N L+   G     KI DFG++  +   
Sbjct: 138 AMLDLLHVARDIACGCQYL-EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196

Query: 223 SGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           S         Y Y            M PE    G +  K+D WS G++L E  + G  PY
Sbjct: 197 S---------Y-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY 246

Query: 270 SPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
                    ++  E++E +       PP + P           ++ C Q +P+ R +   
Sbjct: 247 P------SKSN-QEVLEFVTSGGRMDPPKNCP-----GPVYRIMTQCWQHQPEDRPNFAI 294

Query: 326 L 326
           +
Sbjct: 295 I 295

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  112 bits (282), Expect = 7e-29
 Identities = 70/292 (23%), Positives = 134/292 (45%), Gaps = 37/292 (12%)

Query: 49  VSQTETEAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-ALKVIQMNV 107
           +      +   +     +++ +D+  +K +G G  G+V     KW GQ+  A+K+I+   
Sbjct: 3   LGSKNAPSTAGLGYGSWEIDPKDLTFLKELGTGQFGVV--KYGKWRGQYDVAIKMIKEGS 60

Query: 108 EESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK 163
              +  +  +E K+  +     +V    VC +       I II EYM  G L ++L++++
Sbjct: 61  --MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ----RPIFIITEYMANGCLLNYLREMR 114

Query: 164 -TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 222
                + L  +C+ V + + YL   K  +HRDL   N L+N +G VK++DFG+S  +   
Sbjct: 115 HRFQTQQLLEMCKDVCEAMEYLE-SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173

Query: 223 SGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 278
              ++   G+     +  PE +   K+  KSDIW+ G+++ E  + G+ PY      + +
Sbjct: 174 EYTSSV--GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY------ERF 225

Query: 279 TSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           T+  E  E I        P  A       +  + + +C  ++  +R + + L
Sbjct: 226 TN-SETAEHIAQGLRLYRPHLAS-----EKVYTIMYSCWHEKADERPTFKIL 271

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  112 bits (283), Expect = 8e-29
 Identities = 64/294 (21%), Positives = 112/294 (38%), Gaps = 58/294 (19%)

Query: 70  EDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSS 125
           +     +++GKG  G V   QL Q   +    A+K+++ ++   S   +  +E    +  
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 126 QCPYVV----VCYQS--FYSNGAISIILEYMDGGSLADFLKKVK------TIPEEYLAAI 173
             P+V     V  +S          +IL +M  G L  FL   +       +P + L   
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 174 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 233
              +  G+ YL   ++ IHRDL   N ++     V + DFG+S  + S            
Sbjct: 143 MVDIACGMEYLS-SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSG----------- 190

Query: 234 NY-------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT 279
           +Y             ++ E ++   Y   SD+W+ G+ + E  T GQ PY+      G  
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYA------GIE 244

Query: 280 SFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
           +  E+   ++     + PP         E    +  C   +P+QR S   L   
Sbjct: 245 NA-EIYNYLIGGNRLKQPPECM-----EEVYDLMYQCWSADPKQRPSFTCLRME 292

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  116 bits (291), Expect = 9e-29
 Identities = 74/289 (25%), Positives = 125/289 (43%), Gaps = 36/289 (12%)

Query: 49  VSQTETEAPPLIKPSDNQLNLEDIDTIKVV-GKGSGGIV---QLVQHKWTGQFFALKVIQ 104
           V ++    P  +K     L  +++    +  G G+ G V        K      A+KV++
Sbjct: 314 VFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDV-AIKVLK 372

Query: 105 MNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLK 160
              E++   ++ +E +I      PY+V    VC        A+ +++E   GG L  FL 
Sbjct: 373 QGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-----QAEALMLVMEMAGGGPLHKFLV 427

Query: 161 KVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 219
             +  IP   +A +  QV  G+ YL  EK+ +HR+L   N+L+ +R   KI+DFG+S  +
Sbjct: 428 GKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486

Query: 220 ASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ 275
            +                + +PE I+  K+  +SD+WS G+ + E  + GQ PY      
Sbjct: 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY------ 540

Query: 276 DGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
                  E+M  I      + PP  P     PE  + +S C   + + R
Sbjct: 541 KKMKG-PEVMAFIEQGKRMECPPECP-----PELYALMSDCWIYKWEDR 583

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  113 bits (284), Expect = 1e-28
 Identities = 76/334 (22%), Positives = 121/334 (36%), Gaps = 88/334 (26%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-----NQSSQCPY 129
           I+ +G G+ G V L QH    +++A+KV++ N++    R    E  I     N       
Sbjct: 40  IRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-NIK-KYTRSAKIEADILKKIQNDDINNNN 97

Query: 130 VVVCYQSFYSNGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHE 187
           +V  +  F     + +I E + G SL + + +        E +   C ++LK L YL  +
Sbjct: 98  IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR-K 155

Query: 188 KHIIHRDLKPSNLLINH-------------------------RGEVKITDFGVSAIMAST 222
             + H DLKP N+L++                             +K+ DFG  A   S 
Sbjct: 156 MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-CATFKSD 214

Query: 223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ--FPYSPPEQQDGWTS 280
                + + T  Y +PE I    +   SD+WS G VL E  TG   F      +      
Sbjct: 215 --YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH----- 267

Query: 281 FYELMEAIVDQPPP---------------------------------------SAPSDQF 301
              +ME+I+   P                                          P  + 
Sbjct: 268 -LAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326

Query: 302 S--PEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
                FC F+ + +Q +P  R S  EL+ H FL+
Sbjct: 327 IKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  111 bits (280), Expect = 2e-28
 Identities = 76/282 (26%), Positives = 125/282 (44%), Gaps = 34/282 (12%)

Query: 70  EDIDTIKVVGKGSGGIVQL----VQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 125
             +  ++ +GKG+ G V++         TG+  A+K +Q + E    R   +E++I +S 
Sbjct: 10  RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSL 68

Query: 126 QCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKG 180
           Q   +V    VCY +      + +I+EY+  GSL D+L+K K  I    L     Q+ KG
Sbjct: 69  QHDNIVKYKGVCYSA--GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG 126

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYMS 237
           + YL   K  IHRDL   N+L+ +   VKI DFG++ ++                  + +
Sbjct: 127 MEYLG-TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185

Query: 238 PERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT--------SFYELMEAI 288
           PE ++  K+   SD+WS G+VL E  T  +   SPP +               + L+E +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245

Query: 289 VD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
            +      P   P      E    ++ C      QR S ++L
Sbjct: 246 KNNGRLPRPDGCP-----DEIYMIMTECWNNNVNQRPSFRDL 282

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  111 bits (279), Expect = 2e-28
 Identities = 65/286 (22%), Positives = 114/286 (39%), Gaps = 54/286 (18%)

Query: 66  QLNLEDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN 122
           ++  E I+  + +G+G  G V     +  +      A+K  +    +S R +  QE    
Sbjct: 11  EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM 70

Query: 123 QSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQV 177
           +    P++V    V  ++      + II+E    G L  FL+  K ++    L     Q+
Sbjct: 71  RQFDHPHIVKLIGVITEN-----PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 125

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY-- 235
              L YL   K  +HRD+   N+L++    VK+ DFG+S  M  +            Y  
Sbjct: 126 STALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-----------TYYK 173

Query: 236 ----------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYEL 284
                     M+PE I+  ++   SD+W  G+ + E    G  P+       G  +  ++
Sbjct: 174 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF------QGVKN-NDV 226

Query: 285 MEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           +  I +      PP+ P     P   S ++ C   +P +R    EL
Sbjct: 227 IGRIENGERLPMPPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 267

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  111 bits (279), Expect = 2e-28
 Identities = 66/235 (28%), Positives = 108/235 (45%), Gaps = 31/235 (13%)

Query: 99  ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGS 154
           A+KV++   E++   ++ +E +I      PY+V    VC        A+ +++E   GG 
Sbjct: 41  AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-----ALMLVMEMAGGGP 95

Query: 155 LADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDF 213
           L  FL   +  IP   +A +  QV  G+ YL  EK+ +HRDL   N+L+ +R   KI+DF
Sbjct: 96  LHKFLVGKREEIPVSNVAELLHQVSMGMKYLE-EKNFVHRDLAARNVLLVNRHYAKISDF 154

Query: 214 GVSAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
           G+S  + +                + +PE I+  K+  +SD+WS G+ + E  + GQ PY
Sbjct: 155 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 214

Query: 270 SPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
                        E+M  I      + PP  P     PE  + +S C   + + R
Sbjct: 215 ------KKMKG-PEVMAFIEQGKRMECPPECP-----PELYALMSDCWIYKWEDR 257

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  111 bits (279), Expect = 4e-28
 Identities = 78/314 (24%), Positives = 134/314 (42%), Gaps = 38/314 (12%)

Query: 42  NKDGVRIVSQTETEAPPLIKPSDNQ----LNLEDIDTIKVVGKGSGGIVQL----VQHKW 93
           + D     ++       +    +++         +  ++ +GKG+ G V++         
Sbjct: 9   HHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDN 68

Query: 94  TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEY 149
           TG+  A+K +Q + E    R   +E++I +S Q   +V    VCY +   N  + +I+EY
Sbjct: 69  TGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN--LKLIMEY 125

Query: 150 MDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEV 208
           +  GSL D+L+K K  I    L     Q+ KG+ YL   K  IHRDL   N+L+ +   V
Sbjct: 126 LPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG-TKRYIHRDLATRNILVENENRV 184

Query: 209 KITDFGVSAIMASTSGQANTFVGT---YNYMSPERISGGKYGYKSDIWSLGLVLLECAT- 264
           KI DFG++ ++                  + +PE ++  K+   SD+WS G+VL E  T 
Sbjct: 185 KIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 244

Query: 265 GQFPYSPPEQQDGWT--------SFYELMEAIVD----QPPPSAPSDQFSPEFCSFISAC 312
            +   SPP +               + L+E + +      P   P      E    ++ C
Sbjct: 245 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCP-----DEIYMIMTEC 299

Query: 313 VQKEPQQRLSAQEL 326
                 QR S ++L
Sbjct: 300 WNNNVNQRPSFRDL 313

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  112 bits (283), Expect = 5e-28
 Identities = 67/269 (24%), Positives = 118/269 (43%), Gaps = 39/269 (14%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKINQSS 125
           +  E +   K +G G  G V      +      A+K +       +      E  + ++ 
Sbjct: 185 IPRESLKLEKKLGAGQFGEV--WMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTL 240

Query: 126 QCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLK 179
           Q   +V    V  +       I II E+M  GSL DFLK  +    P   L     Q+ +
Sbjct: 241 QHDKLVKLHAVVTKE-----PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 295

Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYM 236
           G+ ++  +++ IHRDL+ +N+L++     KI DFG++ ++      A    G      + 
Sbjct: 296 GMAFIE-QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE--GAKFPIKWT 352

Query: 237 SPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----Q 291
           +PE I+ G +  KSD+WS G++L+E  T G+ PY       G ++  E++ A+       
Sbjct: 353 APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYP------GMSN-PEVIRALERGYRMP 405

Query: 292 PPPSAPSDQFSPEFCSFISACVQKEPQQR 320
            P + P      E  + +  C +  P++R
Sbjct: 406 RPENCP-----EELYNIMMRCWKNRPEER 429

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  109 bits (276), Expect = 5e-28
 Identities = 67/314 (21%), Positives = 121/314 (38%), Gaps = 71/314 (22%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-------ALKVIQMNVEESARRQIAQE 118
           +++L  +  ++ +G+   G V   +    G          A+K ++   E   R +   E
Sbjct: 5   EISLSAVRFMEELGEDRFGKV--YKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62

Query: 119 LKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY----- 169
             +    Q P VV    V  +       +S+I  Y   G L +FL       +       
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKD----QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118

Query: 170 -----------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
                         +  Q+  G+ YL    H++H+DL   N+L+  +  VKI+D G+   
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLS-SHHVVHKDLATRNVLVYDKLNVKISDLGLFRE 177

Query: 219 MASTSGQANTFVGTYN----------YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQF 267
           + +           Y           +M+PE I  GK+   SDIWS G+VL E  + G  
Sbjct: 178 VYAAD--------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 229

Query: 268 PYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSA 323
           PY       G+++  +++E I +      P   P         + +  C  + P +R   
Sbjct: 230 PYC------GYSN-QDVVEMIRNRQVLPCPDDCP-----AWVYALMIECWNEFPSRRPRF 277

Query: 324 QELMTHPFLKMYGD 337
           +++  H  L+ +G+
Sbjct: 278 KDI--HSRLRAWGN 289

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  110 bits (276), Expect = 5e-28
 Identities = 58/282 (20%), Positives = 104/282 (36%), Gaps = 49/282 (17%)

Query: 70  EDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 126
               + +V+GKG  G+V   + +         A+K +    E        +E  + +   
Sbjct: 21  VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80

Query: 127 CPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGL 181
            P V+    +        G   ++L YM  G L  F++  +     + L +   QV +G+
Sbjct: 81  HPNVLALIGIMLPP---EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM 137

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY------ 235
            YL  E+  +HRDL   N +++    VK+ DFG++  +             Y+       
Sbjct: 138 EYLA-EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE--------YYSVQQHRHA 188

Query: 236 ------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAI 288
                  + E +   ++  KSD+WS G++L E  T G  PY           F +L   +
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR------HIDPF-DLTHFL 241

Query: 289 VD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
                   P   P           +  C + +P  R + + L
Sbjct: 242 AQGRRLPQPEYCP-----DSLYQVMQQCWEADPAVRPTFRVL 278

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  108 bits (273), Expect = 1e-27
 Identities = 69/277 (24%), Positives = 124/277 (44%), Gaps = 37/277 (13%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKINQS 124
           +L  E+I  +K +G G  G+V     KW GQ+  A+K   +     +  +  QE +    
Sbjct: 4   ELKREEITLLKELGSGQFGVV--KLGKWKGQYDVAVK--MIKEGSMSEDEFFQEAQTMMK 59

Query: 125 SQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLK 179
              P +V    VC +       I I+ EY+  G L ++L+     +    L  +C  V +
Sbjct: 60  LSHPKLVKFYGVCSKE----YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCE 115

Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYM 236
           G+ +L      IHRDL   N L++    VK++DFG++  +      ++   GT     + 
Sbjct: 116 GMAFLE-SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV--GTKFPVKWS 172

Query: 237 SPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----Q 291
           +PE     KY  KSD+W+ G+++ E  + G+ PY      D +T+  E++  +       
Sbjct: 173 APEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY------DLYTN-SEVVLKVSQGHRLY 225

Query: 292 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
            P  A            + +C  + P++R + Q+L++
Sbjct: 226 RPHLAS-----DTIYQIMYSCWHELPEKRPTFQQLLS 257

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  108 bits (272), Expect = 1e-27
 Identities = 66/275 (24%), Positives = 123/275 (44%), Gaps = 37/275 (13%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKINQS 124
            ++  ++  ++ +G G  G+V      W  +   A+K I+      +     +E ++   
Sbjct: 4   VIDPSELTFVQEIGSGQFGLV--HLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMK 59

Query: 125 SQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLK 179
              P +V    VC +       I ++ E+M+ G L+D+L+  +     E L  +C  V +
Sbjct: 60  LSHPKLVQLYGVCLEQ----APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115

Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNYM 236
           G+ YL  E  +IHRDL   N L+     +K++DFG++  +      ++T  GT     + 
Sbjct: 116 GMAYLE-EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST--GTKFPVKWA 172

Query: 237 SPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----Q 291
           SPE  S  +Y  KSD+WS G+++ E  + G+ PY      +  ++  E++E I       
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPY------ENRSN-SEVVEDISTGFRLY 225

Query: 292 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
            P  A            ++ C ++ P+ R +   L
Sbjct: 226 KPRLAS-----THVYQIMNHCWRERPEDRPAFSRL 255

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  109 bits (275), Expect = 1e-27
 Identities = 72/315 (22%), Positives = 117/315 (37%), Gaps = 68/315 (21%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-------N----- 122
           +K +G G  G+V         +  A+K I +   +S +    +E+KI       N     
Sbjct: 16  LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKH-ALREIKIIRRLDHDNIVKVF 74

Query: 123 --QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---KTIPEEYLAAICEQV 177
                    +     S     ++ I+ EYM+     D L  V     + EE+      Q+
Sbjct: 75  EILGPSGSQLTDDVGSLTELNSVYIVQEYME----TD-LANVLEQGPLLEEHARLFMYQL 129

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSGQANT---FVGTY 233
           L+GL Y+H   +++HRDLKP+NL IN     +KI DFG++ IM             + T 
Sbjct: 130 LRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTK 188

Query: 234 NYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQ--FP---Y------------SPPEQQ 275
            Y SP  + S   Y    D+W+ G +  E  TG+  F                    E  
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE-- 246

Query: 276 DGWTSFYELMEAI-------VDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLS 322
                  E  + +       +                  S E   F+   +   P  RL+
Sbjct: 247 -------EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT 299

Query: 323 AQELMTHPFLKMYGD 337
           A+E ++HP++ +Y  
Sbjct: 300 AEEALSHPYMSIYSF 314

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  109 bits (275), Expect = 1e-27
 Identities = 58/269 (21%), Positives = 111/269 (41%), Gaps = 38/269 (14%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFF------ALKVIQMNVEESARRQIAQELKINQ 123
            ++  +KV+G G  G V   +  W  +         +KVI+      + + +   +    
Sbjct: 13  TELRKLKVLGSGVFGTV--HKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70

Query: 124 SSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVL 178
           S    ++V    +C  S     ++ ++ +Y+  GSL D +++ +  +  + L     Q+ 
Sbjct: 71  SLDHAHIVRLLGLCPGS-----SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125

Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY--NYM 236
           KG+ YL  E  ++HR+L   N+L+    +V++ DFGV+ ++     Q           +M
Sbjct: 126 KGMYYLE-EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184

Query: 237 SPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----Q 291
           + E I  GKY ++SD+WS G+ + E  T G  PY       G     E+ + +       
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPY------AGLRL-AEVPDLLEKGERLA 237

Query: 292 PPPSAPSDQFSPEFCSFISACVQKEPQQR 320
            P          +    +  C   +   R
Sbjct: 238 QPQICT-----IDVYMVMVKCWMIDENIR 261

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  110 bits (276), Expect = 2e-27
 Identities = 77/298 (25%), Positives = 129/298 (43%), Gaps = 47/298 (15%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVV 131
              VG G+ G V     K +G+  A+K +       E  A+R   +EL + +  Q   V+
Sbjct: 29  PTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQSEIFAKR-AYRELLLLKHMQHENVI 86

Query: 132 VCYQSFYSNGAIS------IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLY 183
                F    ++       +++ +M      D L+K+      EE +  +  Q+LKGL Y
Sbjct: 87  GLLDVFTPASSLRNFYDFYLVMPFMQ----TD-LQKIMGLKFSEEKIQYLVYQMLKGLKY 141

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERI- 241
           +H    ++HRDLKP NL +N   E+KI DFG    +A  +    T +V T  Y +PE I 
Sbjct: 142 IH-SAGVVHRDLKPGNLAVNEDCELKILDFG----LARHADAEMTGYVVTRWYRAPEVIL 196

Query: 242 SGGKYGYKSDIWSLGLVLLECATGQ--FPYS--------------PPEQQDGWTSFYELM 285
           S   Y    DIWS+G ++ E  TG+  F                  P  +       +  
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA 256

Query: 286 EAIVDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
           ++ +   P +   D      + SP+    +   ++ +  +RL+A + +THPF + + D
Sbjct: 257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  110 bits (276), Expect = 2e-27
 Identities = 78/325 (24%), Positives = 132/325 (40%), Gaps = 54/325 (16%)

Query: 56  APPLIKPSDNQLNLEDID--------TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV 107
           +PP  +    +  +             ++ VG G+ G V       TG   A+K +    
Sbjct: 3   SPPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRP 61

Query: 108 ---EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS------IILEYMDGGSLADF 158
              E  A+R   +EL++ +  +   V+     F  +  +       +++ +M      D 
Sbjct: 62  FQSELFAKR-AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TDL 116

Query: 159 LKKVKTIP--EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS 216
            K +K     E+ +  +  Q+LKGL Y+H    IIHRDLKP NL +N   E+KI DFG  
Sbjct: 117 GKLMKHEKLGEDRIQFLVYQMLKGLRYIH-AAGIIHRDLKPGNLAVNEDCELKILDFG-- 173

Query: 217 AIMASTSGQANT-FVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQ--FPYS-- 270
             +A  +    T +V T  Y +PE I +  +Y    DIWS+G ++ E  TG+  F  S  
Sbjct: 174 --LARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231

Query: 271 ------------PPEQQDGWTSFYELMEAIVDQPPPSAPSD------QFSPEFCSFISAC 312
                        P  +       +  +  +   P     D        SP   + +   
Sbjct: 232 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 291

Query: 313 VQKEPQQRLSAQELMTHPFLKMYGD 337
           +  + +QR++A E + HP+ +   D
Sbjct: 292 LVLDAEQRVTAGEALAHPYFESLHD 316

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  112 bits (282), Expect = 2e-27
 Identities = 67/292 (22%), Positives = 118/292 (40%), Gaps = 40/292 (13%)

Query: 54  TEAPPLIKPSDNQ--LNLEDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVE 108
            E      PS     +  E I+  + +G+G  G V     +  +      A+K  +    
Sbjct: 372 DEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS 431

Query: 109 ESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK- 163
           +S R +  QE    +    P++V    V  ++      + II+E    G L  FL+  K 
Sbjct: 432 DSVREKFLQEALTMRQFDHPHIVKLIGVITEN-----PVWIIMELCTLGELRSFLQVRKF 486

Query: 164 TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-- 221
           ++    L     Q+   L YL   K  +HRD+   N+L++    VK+ DFG+S  M    
Sbjct: 487 SLDLASLILYAYQLSTALAYLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545

Query: 222 --TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGW 278
              + +    +    +M+PE I+  ++   SD+W  G+ + E    G  P+       G 
Sbjct: 546 YYKASKGKLPI---KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF------QGV 596

Query: 279 TSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
            +  +++  I +      PP+ P     P   S ++ C   +P +R    EL
Sbjct: 597 KN-NDVIGRIENGERLPMPPNCP-----PTLYSLMTKCWAYDPSRRPRFTEL 642

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  109 bits (275), Expect = 2e-27
 Identities = 69/296 (23%), Positives = 121/296 (40%), Gaps = 42/296 (14%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES--ARRQIAQELKINQSSQCPYVVV 132
           +  VG G+ G V       TG   A+K +    +    A+R   +EL++ +  +   V+ 
Sbjct: 34  LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIG 92

Query: 133 CYQSFYSNGAIS------IILEYMDGGSLADFLKKVKTIP--EEYLAAICEQVLKGLLYL 184
               F    ++       ++   M     AD    VK     ++++  +  Q+L+GL Y+
Sbjct: 93  LLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 148

Query: 185 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI-SG 243
           H    IIHRDLKPSNL +N   E+KI DFG++     T+ +   +V T  Y +PE + + 
Sbjct: 149 H-SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVATRWYRAPEIMLNW 204

Query: 244 GKYGYKSDIWSLGLVLLECATGQ--FPYS--------------PPEQQDGWTSFYELMEA 287
             Y    DIWS+G ++ E  TG+  FP +               P  +       E    
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 264

Query: 288 IVDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
            +         +        +P     +   +  +  +R++A + + H +   Y D
Sbjct: 265 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  107 bits (270), Expect = 3e-27
 Identities = 68/270 (25%), Positives = 119/270 (44%), Gaps = 39/270 (14%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKINQS 124
           ++  E +  ++ +G G  G V      + G    A+K +       +      E  + + 
Sbjct: 9   EVPRETLKLVERLGAGQFGEV--WMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQ 64

Query: 125 SQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVL 178
            Q   +V    V      +   I II EYM+ GSL DFLK      +    L  +  Q+ 
Sbjct: 65  LQHQRLVRLYAVV-----TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119

Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT---YNY 235
           +G+ ++  E++ IHRDL+ +N+L++     KI DFG++ ++      A    G      +
Sbjct: 120 EGMAFIE-ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE--GAKFPIKW 176

Query: 236 MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD---- 290
            +PE I+ G +  KSD+WS G++L E  T G+ PY       G T+  E+++ +      
Sbjct: 177 TAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY------PGMTN-PEVIQNLERGYRM 229

Query: 291 QPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
             P + P      E    +  C ++ P+ R
Sbjct: 230 VRPDNCP-----EELYQLMRLCWKERPEDR 254

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  108 bits (272), Expect = 3e-27
 Identities = 52/190 (27%), Positives = 79/190 (41%), Gaps = 25/190 (13%)

Query: 148 EYMDGGSLADFL---KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH 204
            YM  GSL D L        +       I +    G+ +LH E H IHRD+K +N+L++ 
Sbjct: 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH-ENHHIHRDIKSANILLDE 168

Query: 205 RGEVKITDFGVSAIMASTSGQANT--FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLEC 262
               KI+DFG++      +    T   VGT  YM+PE +  G+   KSDI+S G+VLLE 
Sbjct: 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEI 227

Query: 263 ATGQFPYSPPEQQD---GWTSFY----ELMEAIVDQPPPSAPS-DQFSPE----FCSFIS 310
            TG        +               + +E  +D         +           S  S
Sbjct: 228 ITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYID------KKMNDADSTSVEAMYSVAS 281

Query: 311 ACVQKEPQQR 320
            C+ ++  +R
Sbjct: 282 QCLHEKKNKR 291

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  109 bits (274), Expect = 3e-27
 Identities = 76/308 (24%), Positives = 128/308 (41%), Gaps = 55/308 (17%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVV 131
           +K +G G+ GIV         +  A+K +       +  A+R   +EL + +      ++
Sbjct: 30  LKPIGSGAQGIVCAAYDAILERNVAIKKL-SRPFQNQTHAKR-AYRELVLMKCVNHKNII 87

Query: 132 VCYQSFYSNGAIS------IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLY 183
                F    ++       I++E MD    A+ L +V    +  E ++ +  Q+L G+ +
Sbjct: 88  GLLNVFTPQKSLEEFQDVYIVMELMD----AN-LCQVIQMELDHERMSYLLYQMLCGIKH 142

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
           LH    IIHRDLKPSN+++     +KI DFG+ A  A TS     +V T  Y +PE I G
Sbjct: 143 LH-SAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILG 200

Query: 244 GKYGYKSDIWSLGLVLLECATGQ--FPYS--------------PPEQQDGWT-------- 279
             Y    DIWS+G ++ E   G   FP +               P  +            
Sbjct: 201 MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 260

Query: 280 ----------SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
                     SF +L    V  P  S  +   + +    +S  +  +  +R+S  E + H
Sbjct: 261 VENRPKYAGYSFEKLFPD-VLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319

Query: 330 PFLKMYGD 337
           P++ ++ D
Sbjct: 320 PYINVWYD 327

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  107 bits (270), Expect = 4e-27
 Identities = 67/275 (24%), Positives = 116/275 (42%), Gaps = 37/275 (13%)

Query: 62  PSDNQ--LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQEL 119
           P+ ++  +   DI     +G G  G V   +  W      + V  +  +     +  +E 
Sbjct: 3   PNYDKWEMERTDITMKHKLGGGQYGEV--YEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 60

Query: 120 KINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAI 173
            + +  + P +V    VC +         II E+M  G+L D+L++   + +    L  +
Sbjct: 61  AVMKEIKHPNLVQLLGVCTRE----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116

Query: 174 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGT- 232
             Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S +M   +  A+   G  
Sbjct: 117 ATQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA--GAK 173

Query: 233 --YNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIV 289
               + +PE ++  K+  KSD+W+ G++L E AT G  PY       G     ++ E + 
Sbjct: 174 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------PGIDL-SQVYELLE 226

Query: 290 D----QPPPSAPSDQFSPEFCSFISACVQKEPQQR 320
                + P   P      +    + AC Q  P  R
Sbjct: 227 KDYRMERPEGCP-----EKVYELMRACWQWNPSDR 256

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  108 bits (273), Expect = 4e-27
 Identities = 64/298 (21%), Positives = 120/298 (40%), Gaps = 42/298 (14%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQ-MNVEESARRQIAQELKINQSSQCPYVVVC 133
           +  +G+G+ G+V            A+K I     +   +R   +E+KI    +   ++  
Sbjct: 32  LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR-TLREIKILLRFRHENIIGI 90

Query: 134 YQSFYSNGA-----ISIILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLH 185
                +        + I+ + M+     D L K+   + +  +++     Q+L+GL Y+H
Sbjct: 91  NDIIRAPTIEQMKDVYIVQDLME----TD-LYKLLKTQHLSNDHICYFLYQILRGLKYIH 145

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT---FVGTYNYMSPERI- 241
              +++HRDLKPSNLL+N   ++KI DFG++ +             +V T  Y +PE + 
Sbjct: 146 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 204

Query: 242 SGGKYGYKSDIWSLGLVLLECATGQ--FPYS--------------PPEQQDGWTSFYELM 285
           +   Y    DIWS+G +L E  + +  FP                 P Q+D         
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264

Query: 286 EAIVDQPPPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
              +   P                +    +   +   P +R+  ++ + HP+L+ Y D
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  109 bits (275), Expect = 6e-27
 Identities = 72/308 (23%), Positives = 127/308 (41%), Gaps = 55/308 (17%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES---ARRQIAQELKINQSSQCPYVV 131
           +K +G G+ GIV         +  A+K +     ++   A+R   +EL + +      ++
Sbjct: 67  LKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKR-AYRELVLMKCVNHKNII 124

Query: 132 VCYQSFYSNGAIS------IILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLY 183
                F     +       +++E MD    A+ L +V    +  E ++ +  Q+L G+ +
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMD----AN-LCQVIQMELDHERMSYLLYQMLCGIKH 179

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
           LH    IIHRDLKPSN+++     +KI DFG+ A  A TS     +V T  Y +PE I G
Sbjct: 180 LH-SAGIIHRDLKPSNIVVKSDCTLKILDFGL-ARTAGTSFMMTPYVVTRYYRAPEVILG 237

Query: 244 GKYGYKSDIWSLGLVLLECATGQ--FPYS--------------PPEQQDGWT-------- 279
             Y    DIWS+G ++ E    +  FP                 P  +            
Sbjct: 238 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 297

Query: 280 ----------SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
                     +F +L       P  S  +   + +    +S  +  +P +R+S  + + H
Sbjct: 298 VENRPKYAGLTFPKLFPD-SLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356

Query: 330 PFLKMYGD 337
           P++ ++ D
Sbjct: 357 PYINVWYD 364

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  107 bits (269), Expect = 8e-27
 Identities = 86/340 (25%), Positives = 133/340 (39%), Gaps = 75/340 (22%)

Query: 32  GTFMDGDLLVNKDGVRIVSQTET-EAPPLIKPSDN-QLNLEDIDTIKVVGKGSGGIVQLV 89
           G    G  L   +G     Q    E P     +    +   DI     +G+G+ G V   
Sbjct: 1   GAMGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKV--F 58

Query: 90  QHKWTGQFF-------ALKVIQMNVEESARRQIAQELKINQSSQCPYVV----VCYQSFY 138
             +             A+K ++    ESAR+   +E ++    Q  ++V    VC +   
Sbjct: 59  LAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEG-- 115

Query: 139 SNGAISIILEYMDGGSLADFLKK---------------VKTIPEEYLAAICEQVLKGLLY 183
               + ++ EYM  G L  FL+                   +    L A+  QV  G++Y
Sbjct: 116 --RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVY 173

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY-------- 235
           L    H +HRDL   N L+     VKI DFG+S  + ST          Y Y        
Sbjct: 174 LA-GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---------Y-YRVGGRTML 222

Query: 236 ----MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD 290
               M PE I   K+  +SD+WS G+VL E  T G+ P+         ++  E ++ I  
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY------QLSN-TEAIDCITQ 275

Query: 291 ----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
               + P + P     PE  + +  C Q+EPQQR S +++
Sbjct: 276 GRELERPRACP-----PEVYAIMRGCWQREPQQRHSIKDV 310

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  107 bits (269), Expect = 9e-27
 Identities = 56/196 (28%), Positives = 86/196 (43%), Gaps = 29/196 (14%)

Query: 148 EYMDGGSLADFLKKVKTIPEEYL-----AAICEQVLKGLLYLHHEK--HIIHRDLKPSNL 200
            YM  GS+A  L++ +   +  L       I     +GL YLH      IIHRD+K +N+
Sbjct: 107 PYMANGSVASCLRE-RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANI 165

Query: 201 LINHRGEVKITDFGVSAIMASTSGQANTFV-GTYNYMSPERISGGKYGYKSDIWSLGLVL 259
           L++   E  + DFG++ +M        T V GT  +++PE +S GK   K+D++  G++L
Sbjct: 166 LLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVML 225

Query: 260 LECATGQFPY---SPPEQQDG----WTSFYELME-----AIVDQPPPSAPSDQFSPEFCS 307
           LE  TGQ  +         D     W     L++     A+VD        +    E   
Sbjct: 226 LELITGQRAFDLARLANDDDVMLLDWV--KGLLKEKKLEALVD---VDLQGNYKDEEVEQ 280

Query: 308 FI---SACVQKEPQQR 320
            I     C Q  P +R
Sbjct: 281 LIQVALLCTQSSPMER 296

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  107 bits (270), Expect = 1e-26
 Identities = 57/316 (18%), Positives = 109/316 (34%), Gaps = 70/316 (22%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQ----------ELKINQS 124
            + +  GS G V        G   A+K +   V +     I            E+++   
Sbjct: 27  QRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH 85

Query: 125 SQCPYV-----VVCYQSFYSNGAISIILEYMDGGSLADFLKKV-----KTIPEEYLAAIC 174
              P +     +  +    +   + ++ E M      D L +V       I  +++    
Sbjct: 86  FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TD-LAQVIHDQRIVISPQHIQYFM 140

Query: 175 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN 234
             +L GL  LH E  ++HRDL P N+L+    ++ I DF + A   +       +V    
Sbjct: 141 YHILLGLHVLH-EAGVVHRDLHPGNILLADNNDITICDFNL-AREDTADANKTHYVTHRW 198

Query: 235 YMSPERI-SGGKYGYKSDIWSLGLVLLECATGQ--FP---Y------------SPPEQQD 276
           Y +PE +     +    D+WS G V+ E    +  F    +            +P     
Sbjct: 199 YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI--- 255

Query: 277 GWTSFYELMEAI--------VDQPPPSAPSDQF-------SPEFCSFISACVQKEPQQRL 321
                 E +           +     + P+  +        P     I+  ++  PQ+R+
Sbjct: 256 ------EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309

Query: 322 SAQELMTHPFLKMYGD 337
           S ++ + HP+ +   D
Sbjct: 310 STEQALRHPYFESLFD 325

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  107 bits (269), Expect = 3e-26
 Identities = 65/317 (20%), Positives = 121/317 (38%), Gaps = 68/317 (21%)

Query: 78  VGKGSGGIVQLVQHK--WTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVV--- 131
           VG+G+ G V   + K     + +ALK I+   +  SA R+I     + +  + P V+   
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREI----ALLRELKHPNVISLQ 84

Query: 132 -VCYQSFYSNGAISIILEY--------MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
            V      ++  + ++ +Y        +     +   KK   +P   + ++  Q+L G+ 
Sbjct: 85  KVFLSH--ADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 183 YLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVS---AIMASTSGQANTFVGTYNY 235
           YLH    ++HRDLKP+N+L+      RG VKI D G +             +  V T+ Y
Sbjct: 143 YLH-ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201

Query: 236 MSPERISGGK-YGYKSDIWSLGLVLLECATGQ--FP-------YSPPEQQD--------- 276
            +PE + G + Y    DIW++G +  E  T +  F         S P   D         
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 261

Query: 277 ---------GWTS---FYELMEAIVDQPPPSAPSDQFSPEFCSFISA--------CVQKE 316
                              LM+        +    ++  +      +         +  +
Sbjct: 262 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 321

Query: 317 PQQRLSAQELMTHPFLK 333
           P +R+++++ M  P+  
Sbjct: 322 PIKRITSEQAMQDPYFL 338

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  105 bits (264), Expect = 5e-26
 Identities = 57/197 (28%), Positives = 83/197 (42%), Gaps = 35/197 (17%)

Query: 148 EYMDGGSLADFLKKVKTIPEEYLA-----AICEQVLKGLLYLHHEKHIIHRDLKPSNLLI 202
           +YM+ G+L   L     +P   ++      IC    +GL YLH  + IIHRD+K  N+L+
Sbjct: 115 KYMENGNLKRHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLH-TRAIIHRDVKSINILL 172

Query: 203 NHRGEVKITDFGVSAIMASTSGQANTFV-----GTYNYMSPERISGGKYGYKSDIWSLGL 257
           +     KITDFG+S           T +     GT  Y+ PE    G+   KSD++S G+
Sbjct: 173 DENFVPKITDFGISKKGTELD---QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGV 229

Query: 258 VLLECATGQFP--YSPPEQQDG---WTSFY---ELMEAIVDQPPPSAPS--DQFSPE--- 304
           VL E    +     S P +      W         +E IVD      P+  D+  PE   
Sbjct: 230 VLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD------PNLADKIRPESLR 283

Query: 305 -FCSFISACVQKEPQQR 320
            F      C+    + R
Sbjct: 284 KFGDTAVKCLALSSEDR 300

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  104 bits (262), Expect = 6e-26
 Identities = 75/301 (24%), Positives = 123/301 (40%), Gaps = 74/301 (24%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFF-------ALKVIQMNVEESARRQIAQELKIN 122
            DI   + +G+G+ G V     +             A+K ++ +   +AR+   +E ++ 
Sbjct: 15  RDIVLKRELGEGAFGKV--FLAECYNLSPTKDKMLVAVKALK-DPTLAARKDFQREAELL 71

Query: 123 QSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK----------------V 162
            + Q  ++V    VC         + ++ EYM  G L  FL+                  
Sbjct: 72  TNLQHEHIVKFYGVCGDG----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK 127

Query: 163 KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 222
             +    +  I  Q+  G++YL   +H +HRDL   N L+     VKI DFG+S  + ST
Sbjct: 128 GELGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYST 186

Query: 223 SGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY 269
                     Y Y            M PE I   K+  +SD+WS G++L E  T G+ P+
Sbjct: 187 D---------Y-YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236

Query: 270 SPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQE 325
                    ++  E++E I      + P   P      E    +  C Q+EPQQRL+ +E
Sbjct: 237 F------QLSN-TEVIECITQGRVLERPRVCP-----KEVYDVMLGCWQREPQQRLNIKE 284

Query: 326 L 326
           +
Sbjct: 285 I 285

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  104 bits (261), Expect = 1e-25
 Identities = 57/226 (25%), Positives = 88/226 (38%), Gaps = 57/226 (25%)

Query: 132 VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--------------LAAICEQV 177
            C       G + +I EY   G L +FL++   + E                L     QV
Sbjct: 118 ACTH----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY-- 235
            +G+ +L   K+ IHRD+   N+L+ +    KI DFG++  + + S          NY  
Sbjct: 174 AQGMAFLA-SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS----------NYIV 222

Query: 236 ----------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYEL 284
                     M+PE I    Y  +SD+WS G++L E  + G  PY       G     + 
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP------GILVNSKF 276

Query: 285 MEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
            + + D      P  AP         S + AC   EP  R + Q++
Sbjct: 277 YKLVKDGYQMAQPAFAP-----KNIYSIMQACWALEPTHRPTFQQI 317

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  103 bits (259), Expect = 3e-25
 Identities = 73/326 (22%), Positives = 115/326 (35%), Gaps = 83/326 (25%)

Query: 55  EAPPLIKPSDNQ--LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF-------ALKVIQM 105
             P L+ P          +I+ ++ +G+G+ G V   Q +  G          A+K+++ 
Sbjct: 30  RMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRV--FQARAPGLLPYEPFTMVAVKMLKE 87

Query: 106 NVEESARRQIAQELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK 161
                 +    +E  +      P +V    VC         + ++ EYM  G L +FL+ 
Sbjct: 88  EASADMQADFQREAALMAEFDNPNIVKLLGVCAVG----KPMCLLFEYMAYGDLNEFLRS 143

Query: 162 ------------------------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKP 197
                                      +       I  QV  G+ YL  E+  +HRDL  
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL-SERKFVHRDLAT 202

Query: 198 SNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNY------------MSPERISGGK 245
            N L+     VKI DFG+S  + S           Y Y            M PE I   +
Sbjct: 203 RNCLVGENMVVKIADFGLSRNIYSAD---------Y-YKADGNDAIPIRWMPPESIFYNR 252

Query: 246 YGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQ 300
           Y  +SD+W+ G+VL E  + G  PY       G     E++  + D      P + P   
Sbjct: 253 YTTESDVWAYGVVLWEIFSYGLQPYY------GMAH-EEVIYYVRDGNILACPENCP--- 302

Query: 301 FSPEFCSFISACVQKEPQQRLSAQEL 326
              E  + +  C  K P  R S   +
Sbjct: 303 --LELYNLMRLCWSKLPADRPSFCSI 326

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  101 bits (255), Expect = 7e-25
 Identities = 71/302 (23%), Positives = 116/302 (38%), Gaps = 72/302 (23%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFF-------ALKVIQMNVEESARRQIAQELKIN 122
           + +   K +G+G+ G V  ++    G          A+K+++     S  R +  ELKI 
Sbjct: 27  DRLKLGKPLGRGAFGQV--IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 84

Query: 123 QSSQC-PYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK---------------- 161
                   VV     C +     G + +I+E+   G+L+ +L+                 
Sbjct: 85  IHIGHHLNVVNLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141

Query: 162 VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 221
              +  E+L     QV KG+ +L   +  IHRDL   N+L++ +  VKI DFG++  +  
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200

Query: 222 TSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFP 268
                       +Y            M+PE I    Y  +SD+WS G++L E  + G  P
Sbjct: 201 DP----------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

Query: 269 YSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 324
           Y       G     E    + +    + P         PE    +  C   EP QR +  
Sbjct: 251 YP------GVKIDEEFCRRLKEGTRMRAPDYTT-----PEMYQTMLDCWHGEPSQRPTFS 299

Query: 325 EL 326
           EL
Sbjct: 300 EL 301

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  100 bits (252), Expect = 2e-24
 Identities = 71/304 (23%), Positives = 116/304 (38%), Gaps = 75/304 (24%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFF-------ALKVIQMNVEESARRQIAQELKI- 121
             +   K +G G+ G V  V+    G          A+K+++ +   + R  +  ELK+ 
Sbjct: 23  NRLSFGKTLGAGAFGKV--VEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVL 80

Query: 122 NQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK---------------- 161
           +       +V     C       G   +I EY   G L +FL++                
Sbjct: 81  SYLGNHMNIVNLLGACTI----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136

Query: 162 --VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 219
                +  E L +   QV KG+ +L   K+ IHRDL   N+L+ H    KI DFG++  +
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 220 ASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQ 266
            + S          NY            M+PE I    Y ++SD+WS G+ L E  + G 
Sbjct: 196 KNDS----------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245

Query: 267 FPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
            PY       G     +  + I +      P  AP      E    +  C   +P +R +
Sbjct: 246 SPYP------GMPVDSKFYKMIKEGFRMLSPEHAP-----AEMYDIMKTCWDADPLKRPT 294

Query: 323 AQEL 326
            +++
Sbjct: 295 FKQI 298

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  101 bits (253), Expect = 3e-24
 Identities = 72/334 (21%), Positives = 129/334 (38%), Gaps = 77/334 (23%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKI-NQSSQCPYV 130
           +K +GKG+ GIV     + TG+  A+K I  +       A+R   +E+ I  + S    +
Sbjct: 14  VKKLGKGAYGIVWKSIDRRTGEVVAVKKI-FDAFQNSTDAQR-TFREIMILTELSGHENI 71

Query: 131 VVCYQSFYSNG--AISIILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLH 185
           V       ++    + ++ +YM+     D L  V     +   +   +  Q++K + YLH
Sbjct: 72  VNLLNVLRADNDRDVYLVFDYME----TD-LHAVIRANILEPVHKQYVVYQLIKVIKYLH 126

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN----------- 234
               ++HRD+KPSN+L+N    VK+ DFG+S    +     N    + N           
Sbjct: 127 -SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185

Query: 235 ----------YMSPERI-SGGKYGYKSDIWSLGLVLLECATGQ--FPYS----------- 270
                     Y +PE +    KY    D+WSLG +L E   G+  FP S           
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245

Query: 271 -------------------------PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 305
                                      + +   ++  ++     +      P    + E 
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305

Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 339
              +   +Q  P +R+SA + + HPF+ ++ + N
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 99.7 bits (249), Expect = 7e-24
 Identities = 68/327 (20%), Positives = 128/327 (39%), Gaps = 79/327 (24%)

Query: 70  EDIDTIKVVGKGSGGIV------QLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKIN 122
           + +   K +G+G+ G V       + + K       A+K+++ +  E     +  E+++ 
Sbjct: 35  DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94

Query: 123 QSSQC-PYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-------- 169
           +       ++     C Q    +G + +I+EY   G+L ++L+  +    EY        
Sbjct: 95  KMIGKHKNIINLLGACTQ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150

Query: 170 --------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS 221
                   L +   Q+ +G+ YL   +  IHRDL   N+L+     +KI DFG++  + +
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYL-ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209

Query: 222 TSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFP 268
                        Y            M+PE +    Y ++SD+WS G+++ E  T G  P
Sbjct: 210 ID----------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

Query: 269 YSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQ 324
           Y       G     EL + + +      P +        E    +  C    P QR + +
Sbjct: 260 YP------GIPV-EELFKLLKEGHRMDKPANCT-----NELYMMMRDCWHAVPSQRPTFK 307

Query: 325 EL-------MTHPFLKMYGDLNVDLSE 344
           +L       +T    + Y DL+  L +
Sbjct: 308 QLVEDLDRILTLTTNEEYLDLSQPLEQ 334

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  100 bits (250), Expect = 8e-24
 Identities = 64/304 (21%), Positives = 118/304 (38%), Gaps = 76/304 (25%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFF---------ALKVIQMNVEESARRQIAQELK 120
           + +   K +G+G  G V  V  +  G            A+K+++ +  E     +  E++
Sbjct: 81  DKLTLGKPLGEGCFGQV--VMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEME 138

Query: 121 INQSSQC-PYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY------ 169
           + +       ++     C Q    +G + +I+EY   G+L ++L+  +    EY      
Sbjct: 139 MMKMIGKHKNIINLLGACTQ----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINR 194

Query: 170 ----------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 219
                     L +   Q+ +G+ YL   +  IHRDL   N+L+     +KI DFG++  +
Sbjct: 195 VPEEQMTFKDLVSCTYQLARGMEYLA-SQKCIHRDLAARNVLVTENNVMKIADFGLARDI 253

Query: 220 ASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQ 266
            +             Y            M+PE +    Y ++SD+WS G+++ E  T G 
Sbjct: 254 NNID----------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG 303

Query: 267 FPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLS 322
            PY       G     EL + + +      P +        E    +  C    P QR +
Sbjct: 304 SPYP------GIPV-EELFKLLKEGHRMDKPANCT-----NELYMMMRDCWHAVPSQRPT 351

Query: 323 AQEL 326
            ++L
Sbjct: 352 FKQL 355

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 74/358 (20%), Positives = 132/358 (36%), Gaps = 87/358 (24%)

Query: 27  FLTKSGTFMDGDLLVN---KDGVRIVSQTETEAPPLIKPSDNQLNL--------EDIDTI 75
             T++  F       +    D     ++       L   S+ +L          + +   
Sbjct: 15  PTTENLYFNGMGYYHHHHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLG 74

Query: 76  KVVGKGSGGIV------QLVQHKWTGQFF-ALKVIQMNVEESARRQIAQELKINQSSQC- 127
           K +G+G+ G V       L + K       A+K+++ +  E     +  E+++ +     
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 128 PYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY-------------- 169
             ++     C Q    +G + +I+EY   G+L ++L+  +    EY              
Sbjct: 135 KNIINLLGACTQ----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 190

Query: 170 --LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN 227
             L +   QV +G+ YL   K  IHRDL   N+L+     +KI DFG++  +        
Sbjct: 191 KDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID---- 245

Query: 228 TFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYS--PP 272
                  Y            M+PE +    Y ++SD+WS G++L E  T G  PY   P 
Sbjct: 246 ------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299

Query: 273 EQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           E         EL + + +      P +        E    +  C    P QR + ++L
Sbjct: 300 E---------ELFKLLKEGHRMDKPSNCT-----NELYMMMRDCWHAVPSQRPTFKQL 343

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 50/297 (16%), Positives = 100/297 (33%), Gaps = 66/297 (22%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--------EESARRQIAQ 117
           ++  ED+   + +G+G+   +   +          ++ +  V          +      +
Sbjct: 4   KIRNEDLIFNESLGQGTFTKIF--KGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61

Query: 118 ELKINQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAA 172
              +       ++V    VC           ++ E++  GSL  +LKK K  I   +   
Sbjct: 62  AASMMSKLSHKHLVLNYGVCVCG----DENILVQEFVKFGSLDTYLKKNKNCINILWKLE 117

Query: 173 ICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--------VKITDFGVSAIMASTSG 224
           + +Q+   + +L  E  +IH ++   N+L+    +        +K++D G+S  +     
Sbjct: 118 VAKQLAAAMHFL-EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176

Query: 225 QANTFVGTYNY------MSPERIS-GGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD 276
                            + PE I         +D WS G  L E  + G  P S      
Sbjct: 177 ----------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS------ 220

Query: 277 GWTSFYELMEAIVD-----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT 328
              S    ++   D      P           E  + I+ C+  EP  R S + ++ 
Sbjct: 221 ALDS-QRKLQFYEDRHQLPAPKA--------AELANLINNCMDYEPDHRPSFRAIIR 268

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 98.1 bits (245), Expect = 2e-23
 Identities = 67/309 (21%), Positives = 119/309 (38%), Gaps = 81/309 (26%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFF-------ALKVIQMNVEESARRQIAQELKIN 122
           +++   K +G+G  G V  V+               A+K+++ N   S  R +  E  + 
Sbjct: 23  KNLVLGKTLGEGEFGKV--VKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVL 80

Query: 123 QSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEY--------- 169
           +    P+V+     C Q    +G + +I+EY   GSL  FL++ + +   Y         
Sbjct: 81  KQVNHPHVIKLYGACSQ----DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNS 136

Query: 170 ---------------LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 214
                          L +   Q+ +G+ YL  E  ++HRDL   N+L+    ++KI+DFG
Sbjct: 137 SSLDHPDERALTMGDLISFAWQISQGMQYL-AEMKLVHRDLAARNILVAEGRKMKISDFG 195

Query: 215 VSAIMASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLEC 262
           +S  +              +Y            M+ E +    Y  +SD+WS G++L E 
Sbjct: 196 LSRDVYEED----------SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEI 245

Query: 263 AT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEP 317
            T G  PY       G      L   +      + P +        E    +  C ++EP
Sbjct: 246 VTLGGNPYP------GIPP-ERLFNLLKTGHRMERPDNCS-----EEMYRLMLQCWKQEP 293

Query: 318 QQRLSAQEL 326
            +R    ++
Sbjct: 294 DKRPVFADI 302

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 97.7 bits (244), Expect = 2e-23
 Identities = 71/310 (22%), Positives = 120/310 (38%), Gaps = 63/310 (20%)

Query: 54  TEAPPLIKPSDN-QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF----ALKVIQMNVE 108
                   P+    L+  DI    V+G+G+ G V  ++ +          A+K ++    
Sbjct: 8   HHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQV--LKARIKKDGLRMDAAIKRMKEYAS 65

Query: 109 ESARRQIAQELKI-NQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK-- 161
           +   R  A EL++  +    P ++     C       G + + +EY   G+L DFL+K  
Sbjct: 66  KDDHRDFAGELEVLCKLGHHPNIINLLGACEH----RGYLYLAIEYAPHGNLLDFLRKSR 121

Query: 162 --------------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE 207
                           T+  + L      V +G+ YL  +K  IHRDL   N+L+     
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENYV 180

Query: 208 VKITDFGVSAIMASTSGQANTFVGTYN------YMSPERISGGKYGYKSDIWSLGLVLLE 261
            KI DFG+S            +V          +M+ E ++   Y   SD+WS G++L E
Sbjct: 181 AKIADFGLSR-------GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 233

Query: 262 CAT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKE 316
             + G  PY       G T   EL E +      + P +        E    +  C +++
Sbjct: 234 IVSLGGTPYC------GMTC-AELYEKLPQGYRLEKPLNCD-----DEVYDLMRQCWREK 281

Query: 317 PQQRLSAQEL 326
           P +R S  ++
Sbjct: 282 PYERPSFAQI 291

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 99.1 bits (247), Expect = 3e-23
 Identities = 71/346 (20%), Positives = 115/346 (33%), Gaps = 85/346 (24%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVV 131
             ++G+GS G V L   K T +  A+K +   +       +R I +E+ I    +  Y++
Sbjct: 31  KHLIGRGSYGYVYLAYDKNTEKNVAIKKV-NRMFEDLIDCKR-ILREITILNRLKSDYII 88

Query: 132 VCYQSFYSNGAIS-----IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 186
             Y     +  +      I+LE  D   L    K    + EE++  I   +L G  ++H 
Sbjct: 89  RLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIH- 146

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN------------ 234
           E  IIHRDLKP+N L+N    VK+ DFG++  + S            N            
Sbjct: 147 ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206

Query: 235 ----------YMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQD-----GW 278
                     Y +PE I   + Y    DIWS G +  E       +            G 
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGS 266

Query: 279 TSFYELMEAIVDQPPPSAPSDQF----------SPEFCSFI-SACVQK------------ 315
           + F    +    +    +  DQ           + +    I    V K            
Sbjct: 267 SCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN 326

Query: 316 ----------------------EPQQRLSAQELMTHPFLKMYGDLN 339
                                  P +R++  + + HP+LK      
Sbjct: 327 LKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 98.7 bits (246), Expect = 4e-23
 Identities = 67/354 (18%), Positives = 110/354 (31%), Gaps = 93/354 (26%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES---ARRQIAQELKINQSSQCPYV- 130
             ++G GS G V     K   +  A+K I   V E     +R I +E+ I       +V 
Sbjct: 58  RHLIGTGSYGHVCEAYDKLEKRVVAIKKIL-RVFEDLIDCKR-ILREIAILNRLNHDHVV 115

Query: 131 ----VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 186
               +V  +       + ++LE  D        +    + E ++  +   +L G+ Y+H 
Sbjct: 116 KVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH- 173

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYN------------ 234
              I+HRDLKP+N L+N    VK+ DFG++  +       +    +              
Sbjct: 174 SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT 233

Query: 235 ---------------YMSPERI-SGGKYGYKSDIWSLGLVLLECATGQ------------ 266
                          Y +PE I     Y    D+WS+G +  E                 
Sbjct: 234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293

Query: 267 -FP----YSPPEQQDGWTSFYELMEAIVDQ----------P------------------- 292
            FP    +     Q     F        DQ          P                   
Sbjct: 294 LFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRI 353

Query: 293 -PPSAPSD------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 339
            P    +D        S +    +   +   P +R++  E + HPF K      
Sbjct: 354 FPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 97.0 bits (242), Expect = 6e-23
 Identities = 76/309 (24%), Positives = 118/309 (38%), Gaps = 80/309 (25%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFF-------ALKVIQMNVEESARRQIAQELKI- 121
           E+++  KV+G G+ G V  +     G          A+K+++   + S R  +  ELK+ 
Sbjct: 45  ENLEFGKVLGSGAFGKV--MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMM 102

Query: 122 NQSSQCPYVV----VCYQSFYSNGAISIILEYMDGGSLADFLKK---------------- 161
            Q      +V     C      +G I +I EY   G L ++L+                 
Sbjct: 103 TQLGSHENIVNLLGACTL----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 158

Query: 162 -------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 214
                  +  +  E L     QV KG+ +L   K  +HRDL   N+L+ H   VKI DFG
Sbjct: 159 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE-FKSCVHRDLAARNVLVTHGKVVKICDFG 217

Query: 215 VSAIMASTSGQANTFVGTYNY------------MSPERISGGKYGYKSDIWSLGLVLLEC 262
           ++  + S S          NY            M+PE +  G Y  KSD+WS G++L E 
Sbjct: 218 LARDIMSDS----------NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

Query: 263 AT-GQFPYSPPEQQDGWTSFYELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEP 317
            + G  PY       G        + I +      P  A       E    + +C   + 
Sbjct: 268 FSLGVNPYP------GIPVDANFYKLIQNGFKMDQPFYAT-----EEIYIIMQSCWAFDS 316

Query: 318 QQRLSAQEL 326
           ++R S   L
Sbjct: 317 RKRPSFPNL 325

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 52/270 (19%), Positives = 92/270 (34%), Gaps = 38/270 (14%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 134
            K +G G  G++ L       +  A  V+   VE      +  ELK  Q       +  +
Sbjct: 42  GKKIGSGGFGLIYLAFPTNKPEKDARHVV--KVEYQENGPLFSELKFYQRVAKKDCIKKW 99

Query: 135 QSFYSNGAISIILEY----------------MD--GGSLADFLKKVKTIPEEYLAAICEQ 176
                   + I L Y                M+  G  L     +  T  +  +  +  +
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIR 159

Query: 177 VLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT--DFGVSAIMASTS-------GQAN 227
           +L  L Y+H E   +H D+K +NLL+ ++   ++   D+G+S                  
Sbjct: 160 MLDVLEYIH-ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRK 218

Query: 228 TFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYS--PPEQQDGWTSFY 282
              GT  + S   +    G     +SD+  LG  +L    G+ P+     +     T+  
Sbjct: 219 GHNGTIEFTS---LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKT 275

Query: 283 ELMEAIVDQPPPSAPSDQFSPEFCSFISAC 312
            L++ +       APS     E   F+   
Sbjct: 276 NLLDELPQSVLKWAPSGSSCCEIAQFLVCA 305

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 78.8 bits (194), Expect = 1e-16
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 27/168 (16%)

Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF 229
           L     QV KG+ +L   +  IHRDL   N+L++ +  VKI DFG    +A    +   +
Sbjct: 195 LICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNVVKICDFG----LARDIYKDPDY 249

Query: 230 VGTYN------YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY 282
           V   +      +M+PE I    Y  +SD+WS G++L E  + G  PY       G     
Sbjct: 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP------GVKIDE 303

Query: 283 ELMEAIVD----QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQEL 326
           E    + +    + P         PE    +  C   EP QR +  EL
Sbjct: 304 EFCRRLKEGTRMRAPDYTT-----PEMYQTMLDCWHGEPSQRPTFSEL 346

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 77.8 bits (192), Expect = 2e-16
 Identities = 49/213 (23%), Positives = 84/213 (39%), Gaps = 29/213 (13%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVC 133
            + +G+GS G++    +    Q  A   I+     S   Q+  E +     + C  +   
Sbjct: 15  GRRIGEGSFGVIFEGTNLLNNQQVA---IKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKK------VKTIPEEYLAAICEQVLKGLLYLHHE 187
           Y          ++++ + G SL D L        VKT+     A   +Q+L  +  +H E
Sbjct: 72  YYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTV-----AMAAKQMLARVQSIH-E 124

Query: 188 KHIIHRDLKPSNLLI-----NHRGEVKITDFGVSA--IMASTSG-----QANTFVGTYNY 235
           K +++RD+KP N LI      +   + + DFG+        T       +     GT  Y
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184

Query: 236 MSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           MS     G +   + D+ +LG V +    G  P
Sbjct: 185 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 76.3 bits (188), Expect = 9e-16
 Identities = 49/212 (23%), Positives = 88/212 (41%), Gaps = 27/212 (12%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 134
            K +G G+ G ++L ++ +T ++ A+K+  M           +  K   S     +   Y
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS--GDGIPQVY 71

Query: 135 QSFYSNGAISIILEYMDGGSLADFLKK------VKTIPEEYLAAICEQVLKGLLYLHHEK 188
                    +++LE + G SL D          +KT+       I  Q++  + Y+H  K
Sbjct: 72  YFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTV-----LMIAIQLISRMEYVH-SK 124

Query: 189 HIIHRDLKPSNLLI-----NHRGEVKITDFGVSA--IMASTS-----GQANTFVGTYNYM 236
           ++I+RD+KP N LI       +  + I DF ++   I   T       +  +  GT  YM
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM 184

Query: 237 SPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
           S     G +   + D+ +LG + +    G  P
Sbjct: 185 SINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 51/211 (24%), Positives = 83/211 (39%), Gaps = 27/211 (12%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVC 133
            + +G GS G + L      G+  A   I++   ++   Q+  E KI         +   
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVA---IKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKK------VKTIPEEYLAAICEQVLKGLLYLHHE 187
                      +++E + G SL D          +KT+       + +Q++  + Y+H  
Sbjct: 71  RWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTV-----LLLADQMISRIEYIH-S 123

Query: 188 KHIIHRDLKPSNLLI---NHRGEVKITDFGVSA--IMASTSG-----QANTFVGTYNYMS 237
           K+ IHRD+KP N L+        V I DFG++     A T       +     GT  Y S
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183

Query: 238 PERISGGKYGYKSDIWSLGLVLLECATGQFP 268
                G +   + D+ SLG VL+    G  P
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 73.8 bits (180), Expect = 6e-15
 Identities = 48/337 (14%), Positives = 90/337 (26%), Gaps = 76/337 (22%)

Query: 60  IKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN------------- 106
             P  + L  E +   + +G+G  G V   Q        A+K+I +              
Sbjct: 10  PVPFSHCLPTEKLQRCEKIGEGVFGEV--FQTIADHTPVAIKIIAIEGPDLVNGSHQKTF 67

Query: 107 ---VEESARRQIAQELKINQSSQCPYVVVCY----------------------------- 134
              + E    +    L     ++    +                                
Sbjct: 68  EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127

Query: 135 -QSFYSNGAISIILEYMDGG-SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
              F+ +  + I+LE+  GG  L     K+ ++      +I  Q+   L          H
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLAT--AKSILHQLTASLAVAEASLRFEH 185

Query: 193 RDLKPSNLLINHRGEVKITD-----------FGVSAIMASTSGQANTFVGTYNYMSPER- 240
           RDL   N+L+      K+              G+   +   +       G   +      
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMD 245

Query: 241 --ISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSF---YELMEAIVDQPPPS 295
             +  G   Y+ DI+ L         G++    P     W  +     L +        +
Sbjct: 246 EDLFTGDGDYQFDIYRLMKKENNNRWGEY---HPYSNVLWLHYLTDKMLKQMTFKTKCNT 302

Query: 296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
               Q   +   F    +        SA +L+    L
Sbjct: 303 PAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 74.3 bits (182), Expect = 9e-15
 Identities = 47/211 (22%), Positives = 85/211 (40%), Gaps = 27/211 (12%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI-NQSSQCPYVVVC 133
            + +G GS G + L  +  T +  A+K+  +  +     Q+  E KI         +   
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP---QLLYESKIYRILQGGTGIPNV 68

Query: 134 YQSFYSNGAISIILEYMDGGSLADFLKK------VKTIPEEYLAAICEQVLKGLLYLHHE 187
                      ++++ + G SL D          +KT+       + +Q++  + ++H  
Sbjct: 69  RWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTV-----LMLADQMINRVEFVH-S 121

Query: 188 KHIIHRDLKPSNLLI---NHRGEVKITDFGVSAI-MASTSGQ------ANTFVGTYNYMS 237
           K  +HRD+KP N L+       +V I DFG++     +++ Q           GT  Y S
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS 181

Query: 238 PERISGGKYGYKSDIWSLGLVLLECATGQFP 268
                G +   + D+ SLG VL+    G  P
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 71.7 bits (176), Expect = 4e-14
 Identities = 39/228 (17%), Positives = 79/228 (34%), Gaps = 41/228 (17%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQF--------FALKVIQMNVEESARRQIAQELKINQSSQ 126
                + + GI+       T           F+LK+      ++   ++  E    Q + 
Sbjct: 47  KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL------DAKDGRLFNEQNFFQRAA 100

Query: 127 CPYVVVCYQSFYSNGAISIILEY-------------MD--GGSLADFLKKV--KTIPEEY 169
            P  V  ++  YS   ++I                 +   G SL   L       + E  
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERS 160

Query: 170 LAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI--NHRGEVKITDFGVSAIMASTS---- 223
           +  +  ++L  L +LH E   +H ++   N+ +    + +V +  +G +     +     
Sbjct: 161 VLQVACRLLDALEFLH-ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVA 219

Query: 224 ---GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP 268
              G  +   G   ++S +   G     +SD+ SLG  +L+   G  P
Sbjct: 220 YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 66.3 bits (162), Expect = 3e-12
 Identities = 47/272 (17%), Positives = 96/272 (35%), Gaps = 39/272 (14%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESAR-RQIAQELKINQSSQCPYVVVC 133
              +G+G  G + L     + +        +   E +    +  ELK  Q +  P  +  
Sbjct: 40  GLPIGQGGFGCIYLADMN-SSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQK 98

Query: 134 YQSFYSNGAISI------------ILEY----MD--GGSLADFLKKV-KTIPEEYLAAIC 174
           +        + +               Y    MD  G  L    +   K    + +  + 
Sbjct: 99  WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLS 158

Query: 175 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT--DFGVSAIMASTSGQA------ 226
            ++L  L Y+H E   +H D+K SNLL+N++   ++   D+G++                
Sbjct: 159 LRILDILEYIH-EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP 217

Query: 227 -NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPY-----SPPEQQDGWTS 280
                GT  + S +  +G     + D+  LG  +++  TG  P+      P   +D    
Sbjct: 218 KRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIR 277

Query: 281 FYELMEAIVDQPPPSAPSDQFSPEFCSFISAC 312
           + E + +++D+     P+     E   ++   
Sbjct: 278 YRENIASLMDK---CFPAANAPGEIAKYMETV 306

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258

 Score = 40.0 bits (93), Expect = 6e-04
 Identities = 14/89 (15%), Positives = 30/89 (33%), Gaps = 7/89 (7%)

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
             P              + +     D       ++  + + E  +  I   V++ +  L+
Sbjct: 133 SVPQPYTYM-----KNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLY 187

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFG 214
            E  ++H DL   N++     +V   D G
Sbjct: 188 QEAELVHADLSEYNIMYID--KVYFIDMG 214

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	362
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.78
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.42
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.28
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.09
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.96
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.79
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.77
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.61
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.4
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.37
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.3
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.26
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.02
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.01
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.98
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.8
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.65
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.55
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.51
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.29
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.2
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.04
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.97
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.84
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.57
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.38
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.21
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.69
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	88.33
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.78
2x6h_A	696	GH13170P, VPS34, phosphotidylinositol 3 kinase 59F	83.28
3ls8_A	614	Phosphatidylinositol 3-kinase catalytic subunit ty	81.16

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.5e-66  Score=476.41  Aligned_cols=264  Identities=28%  Similarity=0.469  Sum_probs=235.0

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      ...++|++++.||+|+||+||+|+++.+|+.||||++++..  +......+.+|+++++.++||||++++++|.+++.+|
T Consensus        29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~y  108 (311)
T 4aw0_A           29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY  108 (311)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            34578999999999999999999999999999999997542  2334577899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC-
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-  223 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~-  223 (362)
                      +|||||+||+|.+++++.+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+.+.... 
T Consensus       109 ivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          109 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            999999999999999999999999999999999999999998 999999999999999999999999999998875332 


Q ss_pred             -CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018018          224 -GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  302 (362)
Q Consensus       224 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (362)
                       ....+.+||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+       ..+++.++......  .+..++
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~-------~~~~~~~i~~~~~~--~p~~~s  258 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN-------EGLIFAKIIKLEYD--FPEKFF  258 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCC--CCTTCC
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCCCC--CCcccC
Confidence             34566799999999999999999999999999999999999999997643       23455566555432  346799


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHH------HHcCCcccccCCCCC
Q 018018          303 PEFCSFISACVQKEPQQRLSAQE------LMTHPFLKMYGDLNV  340 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~e------il~hp~~~~~~~~~~  340 (362)
                      +++.+||.+||++||++|||++|      +++||||++..+..+
T Consensus       259 ~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l  302 (311)
T 4aw0_A          259 PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  302 (311)
T ss_dssp             HHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             HHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence            99999999999999999999987      689999999877654

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.8e-66  Score=480.08  Aligned_cols=260  Identities=27%  Similarity=0.473  Sum_probs=225.7

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      .+++|++++.||+|+||+||+|+++.+|+.||||+++.. ........+.+|+++++.++||||+++++++.+++.+|+|
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV  101 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV  101 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            468999999999999999999999999999999999765 3455677899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          147 LEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      ||||+||+|.+++...  ..+++..++.++.|++.||+|||+ +||+||||||+|||++.+|++||+|||+|+.......
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD-RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            9999999999999754  357999999999999999999998 9999999999999999999999999999987754433


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+       ..+++.++.....++ .+..++++
T Consensus       181 ~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~-------~~~~~~~i~~~~~~~-~~~~~s~~  252 (350)
T 4b9d_A          181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS-------MKNLVLKIISGSFPP-VSLHYSYD  252 (350)
T ss_dssp             HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHTCCCC-CCTTSCHH
T ss_pred             cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC-------HHHHHHHHHcCCCCC-CCccCCHH
Confidence            4456789999999999999999999999999999999999999997643       235555666555433 45679999


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          305 FCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      +.+||.+||+.||++|||++|+++||||+..-
T Consensus       253 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence            99999999999999999999999999997643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.6e-65  Score=473.99  Aligned_cols=258  Identities=33%  Similarity=0.596  Sum_probs=229.3

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +.|++++.||+|+||+||+|+++.+|+.||||+++.... .....+.+|+.+++.++||||+++++++.+++.+||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            679999999999999999999999999999999976532 2345678999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      |+||+|.+++.+ ..+++..++.++.|++.||+|||+ +||+||||||+|||++.+|++||+|||+|+..........+.
T Consensus       153 ~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~  230 (346)
T 4fih_A          153 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  230 (346)
T ss_dssp             CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             CCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccccc
Confidence            999999999976 679999999999999999999998 999999999999999999999999999999876666666778


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-CCCCCCCCCHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSF  308 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  308 (362)
                      +||+.|||||++.+..|+.++|||||||++|||++|++||.+.+.       .+.+..+..... ....+..+++++.+|
T Consensus       231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~~~~~~~~~~~s~~~~dl  303 (346)
T 4fih_A          231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDNLPPRLKNLHKVSPSLKGF  303 (346)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSSCCCCSCGGGSCHHHHHH
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcCCCCCCCccccCCHHHHHH
Confidence            999999999999999999999999999999999999999976432       234444443332 233445789999999


Q ss_pred             HHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          309 ISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      |.+||+.||++|||++|+++||||+....
T Consensus       304 i~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          304 LDRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence            99999999999999999999999987653

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.6e-65  Score=466.36  Aligned_cols=260  Identities=30%  Similarity=0.480  Sum_probs=221.9

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEc---cCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      .+.++|++++.||+|+||+||+|++.   .+++.||||+++... .......+.+|+++++.++||||+++++++.+++.
T Consensus        21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            45578999999999999999999874   468899999997552 22223467889999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      +|+|||||+||+|.+++.+.+.+++..++.++.|++.||+|||+ +||+||||||+|||++.+|++||+|||+|+.....
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS-LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            99999999999999999999999999999999999999999998 99999999999999999999999999999876655


Q ss_pred             CCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018018          223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  302 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (362)
                      .....+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+.       .+++..+.....+  .+..++
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~~~--~p~~~s  250 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-------KETMTMILKAKLG--MPQFLS  250 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC--CCTTSC
T ss_pred             CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-------HHHHHHHHcCCCC--CCCcCC
Confidence            5566778999999999999999999999999999999999999999987433       3455555555433  346799


Q ss_pred             HHHHHHHHHhhhcCcCCCCC-----HHHHHcCCcccccC
Q 018018          303 PEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYG  336 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt-----~~eil~hp~~~~~~  336 (362)
                      +++.+||.+||+.||++|||     ++|+++||||+..+
T Consensus       251 ~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          251 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence            99999999999999999998     58999999999865

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.8e-64  Score=456.42  Aligned_cols=254  Identities=31%  Similarity=0.522  Sum_probs=210.9

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++...  .......+.+|+++++.++||||+++++++.+++.+|+|
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            478999999999999999999999999999999997652  334456789999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      |||+ +|+|.+++.+.+++++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+..... ...
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~-~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~  168 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHR-HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFL  168 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCChHHeEECCCCCEEEeecCCCeecCCC-Ccc
Confidence            9999 67999999999999999999999999999999998 99999999999999999999999999999876433 334


Q ss_pred             CccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          227 NTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      .+.+||+.|||||++.+..| +.++||||+||++|+|++|+.||.+.+       ..++...+.....+  .+..+++++
T Consensus       169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~-------~~~~~~~i~~~~~~--~p~~~s~~~  239 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDES-------IPVLFKNISNGVYT--LPKFLSPGA  239 (275)
T ss_dssp             ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHTCCC--CCTTSCHHH
T ss_pred             CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCC-------HHHHHHHHHcCCCC--CCCCCCHHH
Confidence            56799999999999999886 589999999999999999999997632       23455555554432  346789999


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          306 CSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      .+||.+||+.||++|||++|+++||||+.
T Consensus       240 ~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          240 AGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            99999999999999999999999999974

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.6e-64  Score=455.31  Aligned_cols=253  Identities=30%  Similarity=0.502  Sum_probs=221.6

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe----cCeEEEE
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGAISII  146 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~----~~~~~lV  146 (362)
                      |++.+.||+|+||+||+|.+..++..||+|++... ........+.+|+++++.++||||+++++++.+    ...+|+|
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            36778899999999999999999999999999754 345566789999999999999999999999875    3568999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCC--eEeecCCCCcEEEcc-CCcEEEeeccCCcccccCC
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLINH-RGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~~-~~~vkl~DFg~a~~~~~~~  223 (362)
                      ||||+||+|.+++.+.+.+++..++.++.|++.||+|||+ +|  |+||||||+|||++. ++++||+|||+|+...  .
T Consensus       108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~-~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~--~  184 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--A  184 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC--T
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC--C
Confidence            9999999999999999999999999999999999999998 77  999999999999974 7899999999997643  2


Q ss_pred             CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          224 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                      ....+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.+      ....+...+.....+...+...++
T Consensus       185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~------~~~~~~~~i~~~~~~~~~~~~~~~  257 (290)
T 3fpq_A          185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQIYRRVTSGVKPASFDKVAIP  257 (290)
T ss_dssp             TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC------cHHHHHHHHHcCCCCCCCCccCCH
Confidence            34456789999999999875 69999999999999999999999997543      223455666666555556677899


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      ++.+||.+||+.||++|||++|+++||||+.
T Consensus       258 ~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            9999999999999999999999999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=9.5e-64  Score=475.46  Aligned_cols=258  Identities=33%  Similarity=0.596  Sum_probs=229.7

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +.|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+|+.+++.++||||++++++|.+++.+||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC-SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            569999999999999999999999999999999976532 2345688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      |+||+|.+++.. ..+++..++.++.|++.||+|||+ +||+||||||+|||++.+|++||+|||+|+.+........+.
T Consensus       230 ~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~-~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~  307 (423)
T 4fie_A          230 LEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHA-QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  307 (423)
T ss_dssp             CTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCC
T ss_pred             CCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccc
Confidence            999999999976 679999999999999999999998 999999999999999999999999999999876666666778


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-CCCCCCCCCCHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSPEFCSF  308 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  308 (362)
                      +||+.|||||++.+..|+.++|||||||++|||++|..||.+.+.       .+.+..+.... .....+..+++++.+|
T Consensus       308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-------~~~~~~i~~~~~~~~~~~~~~s~~~~dl  380 (423)
T 4fie_A          308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDNLPPRLKNLHKVSPSLKGF  380 (423)
T ss_dssp             EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCCCSCTTSSCHHHHHH
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHcCCCCCCcccccCCHHHHHH
Confidence            999999999999999999999999999999999999999976432       23444444333 2333456789999999


Q ss_pred             HHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          309 ISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      |.+||+.||++|||++|+|+||||+....
T Consensus       381 i~~~L~~dP~~R~ta~ell~Hp~~~~~~~  409 (423)
T 4fie_A          381 LDRLLVRDPAQRATAAELLKHPFLAKAGP  409 (423)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHHcCCChhHCcCHHHHhcCHHhcCCCC
Confidence            99999999999999999999999998654

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.2e-62  Score=455.81  Aligned_cols=258  Identities=28%  Similarity=0.434  Sum_probs=222.5

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ..+.|++.+.||+|+||+||+|+++.+|+.||||+++....      ..+|+.+++.++||||+++++++.+++.+||||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm  129 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM  129 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            45789999999999999999999999999999999976522      246999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC-cEEEeeccCCcccccCCC--
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSG--  224 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-~vkl~DFg~a~~~~~~~~--  224 (362)
                      |||+||+|.+++++.+.+++..++.++.|++.||+|||+ +||+||||||+|||++.+| ++||+|||+|+.......  
T Consensus       130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~-~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~  208 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT-RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK  208 (336)
T ss_dssp             CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred             eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence            999999999999998999999999999999999999998 9999999999999999887 699999999987653321  


Q ss_pred             ---CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC-CCCCCC
Q 018018          225 ---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQ  300 (362)
Q Consensus       225 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  300 (362)
                         .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+....       ...+.....+ ...+..
T Consensus       209 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~i~~~~~~~~~~~~~  281 (336)
T 4g3f_A          209 SLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-------CLKIASEPPPIREIPPS  281 (336)
T ss_dssp             -----CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-------HHHHHHSCCGGGGSCTT
T ss_pred             ceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-------HHHHHcCCCCchhcCcc
Confidence               12345899999999999999999999999999999999999999987655432       2233333322 234568


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHH-------------HcCCcccccCCCC
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQEL-------------MTHPFLKMYGDLN  339 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~ei-------------l~hp~~~~~~~~~  339 (362)
                      +++++.+||.+||++||++|||+.|+             ++|||++.+.+..
T Consensus       282 ~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          282 CAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCC
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCC
Confidence            99999999999999999999999998             5799998886643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.2e-61  Score=442.99  Aligned_cols=257  Identities=26%  Similarity=0.403  Sum_probs=207.8

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC--------
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--------  141 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~--------  141 (362)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++....+.....+.+|+++++.++||||+++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            579999999999999999999999999999999987766777788999999999999999999999987654        


Q ss_pred             ----eEEEEEeccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeecc
Q 018018          142 ----AISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG  214 (362)
Q Consensus       142 ----~~~lV~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg  214 (362)
                          .+|+|||||++|+|.+++.....   .++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~-~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH-CcCccccCcHHHeEECCCCcEEEccCc
Confidence                37999999999999999987654   4556789999999999999998 999999999999999999999999999


Q ss_pred             CCcccccCCC------------CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHH
Q 018018          215 VSAIMASTSG------------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY  282 (362)
Q Consensus       215 ~a~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~  282 (362)
                      +|+.......            ...+.+||+.|||||++.+..|+.++|||||||++|||++   ||...      ....
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~------~~~~  234 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ------MERV  234 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH------HHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc------cHHH
Confidence            9987653321            1234589999999999999999999999999999999996   77532      1222


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          283 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ..+..+.....++ .....++.+.+||.+||+.||++|||++|+++||||+..+.
T Consensus       235 ~~~~~~~~~~~p~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~  288 (299)
T 4g31_A          235 RTLTDVRNLKFPP-LFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF  288 (299)
T ss_dssp             HHHHHHHTTCCCH-HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred             HHHHHHhcCCCCC-CCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence            3334444433322 22345677889999999999999999999999999997653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-59  Score=446.69  Aligned_cols=263  Identities=26%  Similarity=0.413  Sum_probs=219.1

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe------cCe
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS------NGA  142 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~------~~~  142 (362)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++.. ........+.+|+++++.++||||+++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            6899999999999999999999999999999999765 334456778899999999999999999998753      367


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      +|+|||||+ |+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+.+...
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHS-AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            999999996 6899999988999999999999999999999998 99999999999999999999999999999876432


Q ss_pred             ----CCCCCccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-----
Q 018018          223 ----SGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-----  292 (362)
Q Consensus       223 ----~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-----  292 (362)
                          .....+.+||+.|||||++.+.. |+.++||||+||++|||++|++||.+.+..+..   ..+........     
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l---~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL---QLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH---HHHHHHHCCCCGGGTC
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH---HHHHHhcCCCChHHhh
Confidence                22345679999999999988754 699999999999999999999999875432211   11111111000     


Q ss_pred             -------------CCCC-------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          293 -------------PPSA-------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       293 -------------~~~~-------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                                   .+..       ....+++++.+||.+||++||++|||++|+|+||||+.+.+
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                         0000       01357899999999999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=7.7e-60  Score=432.23  Aligned_cols=258  Identities=27%  Similarity=0.434  Sum_probs=220.2

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEc-----cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      ++..++|.+.+.||+|+||+||++++.     .++..||||+++.. .....+++.+|+++++.++||||+++++++.++
T Consensus         9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~   87 (299)
T 4asz_A            9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   87 (299)
T ss_dssp             BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            456789999999999999999999875     35789999999754 455678899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc
Q 018018          141 GAISIILEYMDGGSLADFLKKV-------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE  207 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~  207 (362)
                      +.+++|||||++|+|.+++...             ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.+++
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS-QHFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGC
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccCHhhEEECCCCc
Confidence            9999999999999999999764             369999999999999999999998 99999999999999999999


Q ss_pred             EEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHH
Q 018018          208 VKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYEL  284 (362)
Q Consensus       208 vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~  284 (362)
                      +||+|||+|+.......  ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+.       .++
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-------~~~  239 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-------NEV  239 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-------HHH
Confidence            99999999986543322  1233579999999999999999999999999999999999 8999987432       345


Q ss_pred             HHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          285 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      +..+..+..+ ..+..+++++.+||.+||+.||++|||++|+  |+|++..
T Consensus       240 ~~~i~~~~~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~  287 (299)
T 4asz_A          240 IECITQGRVL-QRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL  287 (299)
T ss_dssp             HHHHHHTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred             HHHHHcCCCC-CCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence            5555555443 3456799999999999999999999999999  5576543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.5e-59  Score=464.56  Aligned_cols=264  Identities=27%  Similarity=0.491  Sum_probs=228.2

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-----chHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-----EESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      .+.+++|++++.||+|+||+||+|+++.+|+.||||++++..     ..........++.+++.++||||++++++|.+.
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~  264 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP  264 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence            567899999999999999999999999999999999997541     122233344556778889999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          141 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      +.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||+ +||+||||||+|||++.+|++||+|||+|+...
T Consensus       265 ~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~-~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          265 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            9999999999999999999999999999999999999999999998 999999999999999999999999999998764


Q ss_pred             cCCCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          221 STSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      .  ....+.+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+..+    ..++...+.....  ..+.
T Consensus       344 ~--~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~----~~~i~~~i~~~~~--~~p~  415 (689)
T 3v5w_A          344 K--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTLTMAV--ELPD  415 (689)
T ss_dssp             S--CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC----HHHHHHHHHHCCC--CCCT
T ss_pred             C--CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHhhcCCCC--CCCc
Confidence            3  34566799999999999975 579999999999999999999999997654332    2344444444433  2346


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCC-----HHHHHcCCcccccCCC
Q 018018          300 QFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGDL  338 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt-----~~eil~hp~~~~~~~~  338 (362)
                      .+++++.+||.+||++||++|++     ++||++||||++.++.
T Consensus       416 ~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~  459 (689)
T 3v5w_A          416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ  459 (689)
T ss_dssp             TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHH
T ss_pred             cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHH
Confidence            79999999999999999999998     7999999999987643

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.6e-59  Score=426.49  Aligned_cols=255  Identities=23%  Similarity=0.364  Sum_probs=210.6

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ..+++..+++++.+.||+|+||+||+++..   ..||||+++.. .+....+.+.+|+.+++.++||||+++++++. ++
T Consensus        29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~  104 (307)
T 3omv_A           29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KD  104 (307)
T ss_dssp             CCCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             cCcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CC
Confidence            356788899999999999999999999764   35999998754 44566788999999999999999999999765 56


Q ss_pred             eEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          142 AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      .++||||||++|+|.+++... .++++..+..++.|++.||+|||+ ++|+||||||+|||++.++++||+|||+|+...
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA-KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            789999999999999999754 679999999999999999999998 999999999999999999999999999998764


Q ss_pred             cCC--CCCCccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--
Q 018018          221 STS--GQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--  293 (362)
Q Consensus       221 ~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--  293 (362)
                      ...  ......+||+.|||||++.+   +.|+.++|||||||++|||+||+.||.+.+..      ..+...+.....  
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~------~~~~~~~~~~~~~p  257 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNR------DQIIFMVGRGYASP  257 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH------HHHHHHHHTTCCCC
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChH------HHHHHHHhcCCCCC
Confidence            322  23455689999999999864   45899999999999999999999999764331      122333333222  


Q ss_pred             -CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          294 -PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       294 -~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                       .+..+..+++++.+||.+||+.||++|||+.|+++
T Consensus       258 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          258 DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence             23345678999999999999999999999998754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.8e-59  Score=428.72  Aligned_cols=256  Identities=23%  Similarity=0.377  Sum_probs=220.7

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEc-----cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS  139 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~  139 (362)
                      .++...++++.+.||+|+||+||+++..     .+++.||||+++........++|.+|+.+++.++||||+++++++.+
T Consensus        21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  100 (308)
T 4gt4_A           21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK  100 (308)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence            3567788999999999999999999853     46789999999866556667889999999999999999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEc
Q 018018          140 NGAISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN  203 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~  203 (362)
                      ++.+++|||||++|+|.+++...                ..+++..+..++.|++.||+|||+ ++|+||||||+|||++
T Consensus       101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS-HHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCccccceEEC
Confidence            99999999999999999999642                358999999999999999999998 9999999999999999


Q ss_pred             cCCcEEEeeccCCcccccCC--CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhh
Q 018018          204 HRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTS  280 (362)
Q Consensus       204 ~~~~vkl~DFg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~  280 (362)
                      .++++||+|||+|+......  ......+||+.|||||++.++.|+.++|||||||++|||+| |..||.+.+.      
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~------  253 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN------  253 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH------
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH------
Confidence            99999999999998764332  22345689999999999999999999999999999999999 8999987533      


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          281 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                       .+++..+..+..+ +.+..+++++.+|+.+||+.||++|||+.||+++
T Consensus       254 -~~~~~~i~~~~~~-~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          254 -QDVVEMIRNRQVL-PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             -HHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -HHHHHHHHcCCCC-CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             3455555555443 3456799999999999999999999999999874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2e-58  Score=428.40  Aligned_cols=255  Identities=29%  Similarity=0.424  Sum_probs=213.1

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEc-----cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS  139 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~  139 (362)
                      ..+..+++.+.+.||+|+||+||+++..     .+++.||||+++.. +....++|.+|+++++.++||||+++++++.+
T Consensus        36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~  114 (329)
T 4aoj_A           36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTE  114 (329)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            3466788999999999999999999864     36889999999754 45567889999999999999999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc
Q 018018          140 NGAISIILEYMDGGSLADFLKKV---------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH  204 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~  204 (362)
                      ...+++|||||++|+|.+++...               .++++..+..++.|++.||+|||+ ++|+||||||+|||++.
T Consensus       115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG-LHFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEET
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecccccHhhEEECC
Confidence            99999999999999999999753               358999999999999999999998 99999999999999999


Q ss_pred             CCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhH
Q 018018          205 RGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSF  281 (362)
Q Consensus       205 ~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~  281 (362)
                      ++++||+|||+|+.......  .....+||+.|||||++.+..|+.++|||||||++|||+| |+.||.+.+.       
T Consensus       194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-------  266 (329)
T 4aoj_A          194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-------  266 (329)
T ss_dssp             TTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-------
T ss_pred             CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-------
Confidence            99999999999987643322  2234679999999999999999999999999999999999 8999986432       


Q ss_pred             HHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          282 YELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .+++..+..+.. ...+..+++++.+||.+||+.||++|||++||+++
T Consensus       267 ~~~~~~i~~g~~-~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          267 TEAIDCITQGRE-LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCC-CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            244455554443 33456799999999999999999999999999764

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=6.9e-58  Score=430.46  Aligned_cols=259  Identities=23%  Similarity=0.360  Sum_probs=207.8

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEc---cCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ++|++.+.||+|+||+||+|+++   .+++.||+|++.....   ..++.+|+++++.+ +||||+++++++.+.+.+|+
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            67999999999999999999875   3578999999865432   34578899999887 69999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC-CcEEEeeccCCcccccCC-
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTS-  223 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~-~~vkl~DFg~a~~~~~~~-  223 (362)
                      ||||++||+|.+++.   .+++.+++.++.|++.||+|||+ +||+||||||+|||++.+ +.+||+|||+|+...... 
T Consensus        98 vmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~-~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~  173 (361)
T 4f9c_A           98 AMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI  173 (361)
T ss_dssp             EEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred             EEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH-CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence            999999999999984   59999999999999999999998 999999999999999877 799999999997653221 


Q ss_pred             ---------------------------CCCCccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccC
Q 018018          224 ---------------------------GQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQ  275 (362)
Q Consensus       224 ---------------------------~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~  275 (362)
                                                 ....+.+||+.|+|||++.+.. |+.++||||+||++|||++|+.||...+..
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~  253 (361)
T 4f9c_A          174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD  253 (361)
T ss_dssp             GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence                                       1123458999999999998764 899999999999999999999999654321


Q ss_pred             -CchhhHHH-------------------------------HHHHHhc--------------CCCCCCCCCCCCHHHHHHH
Q 018018          276 -DGWTSFYE-------------------------------LMEAIVD--------------QPPPSAPSDQFSPEFCSFI  309 (362)
Q Consensus       276 -~~~~~~~~-------------------------------~~~~~~~--------------~~~~~~~~~~~~~~~~~li  309 (362)
                       +....+..                               ....+..              .......+..+++++.+||
T Consensus       254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl  333 (361)
T 4f9c_A          254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL  333 (361)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred             HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence             10000000                               0010000              0001122356889999999


Q ss_pred             HHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          310 SACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      .+||++||++|||++|+|+||||+..
T Consensus       334 ~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          334 DKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             HHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHCcCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.7e-57  Score=448.83  Aligned_cols=260  Identities=25%  Similarity=0.445  Sum_probs=228.6

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      .+++|++++.||+|+||.||+|+++.+|+.||+|++... .......+.+|+.+++.++||||++++++|.+...+|+||
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~-~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~  233 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  233 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc-chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence            468999999999999999999999999999999999765 3344567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC--CcEEEeeccCCcccccCCC
Q 018018          148 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       148 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~vkl~DFg~a~~~~~~~~  224 (362)
                      |||+||+|.+++.. .+.+++..++.++.|++.||+|||+ +||+||||||+|||++.+  +.+||+|||+|+.+... .
T Consensus       234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-~  311 (573)
T 3uto_A          234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-Q  311 (573)
T ss_dssp             ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-S
T ss_pred             eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-C
Confidence            99999999999964 4689999999999999999999998 999999999999999854  89999999999886533 3


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCCCCCCC
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFS  302 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  302 (362)
                      .....+||+.|||||++.+..|+.++|||||||++|+|++|..||.+.+.       .+.+..+....  .+......++
T Consensus       312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s  384 (573)
T 3uto_A          312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETLRNVKSCDWNMDDSAFSGIS  384 (573)
T ss_dssp             EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTCCCCCSGGGTTSC
T ss_pred             ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-------HHHHHHHHhCCCCCCcccccCCC
Confidence            34567899999999999999999999999999999999999999987433       34455554443  2333446789


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      +++.+||.+||+.||++|||++|+|+||||+....
T Consensus       385 ~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          385 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            99999999999999999999999999999987654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.6e-58  Score=428.85  Aligned_cols=258  Identities=26%  Similarity=0.393  Sum_probs=221.3

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccC-----CcEEEEEEeecccchHHHHHHHHHHHHHhcCCC-CcceEEeeeE
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT-----GQFFALKVIQMNVEESARRQIAQELKINQSSQC-PYVVVCYQSF  137 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-p~I~~~~~~~  137 (362)
                      .+++..++|++.+.||+|+||+||+|++...     ++.||||+++........+.+.+|++++..++| |||+++++++
T Consensus        58 ~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~  137 (353)
T 4ase_A           58 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC  137 (353)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence            4678889999999999999999999997654     368999999877666777889999999999876 8999999998


Q ss_pred             Eec-CeEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcE
Q 018018          138 YSN-GAISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  200 (362)
Q Consensus       138 ~~~-~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NI  200 (362)
                      .+. ..+++|||||++|+|.++++..                ..+++..+..++.|++.||+|||+ ++|+||||||+||
T Consensus       138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~-~~iiHRDLK~~NI  216 (353)
T 4ase_A          138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNI  216 (353)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred             EecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh-CCeecCccCccce
Confidence            764 5789999999999999999753                348999999999999999999998 9999999999999


Q ss_pred             EEccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCc
Q 018018          201 LINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDG  277 (362)
Q Consensus       201 ll~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~  277 (362)
                      |++.++++||+|||+|+.......  .....+||+.|||||++.+..|+.++|||||||++|||+| |..||.+.+..+ 
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-  295 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-  295 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999999999987654332  2344679999999999999999999999999999999998 999998754321 


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          278 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                           .+...+..+.. ...+..+++++.+||.+||+.||++|||+.|+++|
T Consensus       296 -----~~~~~i~~g~~-~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          296 -----EFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             -----HHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----HHHHHHHcCCC-CCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence                 23333433333 33456789999999999999999999999999987

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.7e-54  Score=401.73  Aligned_cols=260  Identities=30%  Similarity=0.571  Sum_probs=230.2

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      +..++|++++.||+|+||+||+|+++.+|+.||+|+++...  .......+.+|+.+++.++||||+++++.+.+.+.++
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            46789999999999999999999999999999999997542  2334567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      +||||++||+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+.......
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  160 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence            999999999999999998999999999999999999999998 9999999999999999999999999999987555555


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.       ..+...+.....  ..+..++++
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~~--~~p~~~s~~  231 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILMEEI--RFPRTLSPE  231 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC--CCCTTSCHH
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCC--CCCCCCCHH
Confidence            56677999999999999999999999999999999999999999976432       234444443332  234578999


Q ss_pred             HHHHHHHhhhcCcCCCC-----CHHHHHcCCcccccC
Q 018018          305 FCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      +.+||.+||+.||++||     +++|+++||||+...
T Consensus       232 ~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence            99999999999999999     999999999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.9e-54  Score=400.27  Aligned_cols=261  Identities=26%  Similarity=0.479  Sum_probs=230.4

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      +...++|++.+.||+|+||.||+|++..+|+.||||++... ........+.+|+++++.++||||+++++++.+.+..+
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence            44568999999999999999999999999999999999765 34556678899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      +||||+++++|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++++||+|||++...... .
T Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~  168 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ-KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-G  168 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-C
T ss_pred             EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-C
Confidence            999999999999999988999999999999999999999998 99999999999999999999999999999765433 3


Q ss_pred             CCCccccCCcccCcceecCCCCC-ccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          225 QANTFVGTYNYMSPERISGGKYG-YKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                      .....+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+       ..++...+......  .+..+++
T Consensus       169 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-------~~~~~~~i~~~~~~--~p~~~s~  239 (328)
T 3fe3_A          169 KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------LKELRERVLRGKYR--IPFYMST  239 (328)
T ss_dssp             GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCC--CCTTSCH
T ss_pred             ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC-------HHHHHHHHHhCCCC--CCCCCCH
Confidence            44567899999999999988875 79999999999999999999997643       23444555444432  3356899


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ++.+||.+||+.||++|||++|+++||||+...+
T Consensus       240 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~  273 (328)
T 3fe3_A          240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE  273 (328)
T ss_dssp             HHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence            9999999999999999999999999999987643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.5e-55  Score=410.06  Aligned_cols=263  Identities=28%  Similarity=0.534  Sum_probs=222.6

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcC-CCCcceEEeeeEEec
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSN  140 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~  140 (362)
                      ...+..++|++++.||+|+||+||+|+++.+|+.||||+++...  .......+.+|..++..+ +||||+++++++.+.
T Consensus        17 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~   96 (353)
T 3txo_A           17 SNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP   96 (353)
T ss_dssp             ------CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             cCCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC
Confidence            34567899999999999999999999999999999999997642  233456678899999887 699999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          141 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ..+|+||||++||+|.+++.....+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+...
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD-KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            9999999999999999999998999999999999999999999998 999999999999999999999999999998755


Q ss_pred             cCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          221 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      .........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.       .++...+......  .+..
T Consensus       176 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~~~--~p~~  246 (353)
T 3txo_A          176 CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-------DDLFEAILNDEVV--YPTW  246 (353)
T ss_dssp             C---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC--CCTT
T ss_pred             cCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCC--CCCC
Confidence            555556677899999999999998999999999999999999999999987433       2445555544432  2356


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCH------HHHHcCCcccccC
Q 018018          301 FSPEFCSFISACVQKEPQQRLSA------QELMTHPFLKMYG  336 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~------~eil~hp~~~~~~  336 (362)
                      +++++.+||.+||++||++||++      +|+++||||+...
T Consensus       247 ~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~  288 (353)
T 3txo_A          247 LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID  288 (353)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred             CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence            89999999999999999999999      8999999998764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=8.3e-55  Score=414.61  Aligned_cols=269  Identities=28%  Similarity=0.542  Sum_probs=228.8

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecC
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNG  141 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~  141 (362)
                      ..+..++|++++.||+|+||+||+|+++.+++.||+|+++...  .......+..|..++..+ +||||+++++++.+..
T Consensus        47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~  126 (396)
T 4dc2_A           47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES  126 (396)
T ss_dssp             --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence            4567899999999999999999999999999999999998652  233445678888888765 8999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .+++||||++||+|..++.....+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+....
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            999999999999999999998999999999999999999999998 9999999999999999999999999999987555


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc--hhhHHHHHHHHhcCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG--WTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      ........+||+.|+|||++.+..++.++|||||||++|||++|..||......+.  ......+...+.....  ..+.
T Consensus       206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~  283 (396)
T 4dc2_A          206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPR  283 (396)
T ss_dssp             TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC--CCCT
T ss_pred             CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc--CCCC
Confidence            55566778999999999999999999999999999999999999999975432211  1122234444444433  2345


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCH------HHHHcCCcccccC
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSA------QELMTHPFLKMYG  336 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~------~eil~hp~~~~~~  336 (362)
                      .+++++.+||++||+.||++||++      +|+++||||+...
T Consensus       284 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~  326 (396)
T 4dc2_A          284 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  326 (396)
T ss_dssp             TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred             cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence            789999999999999999999985      8999999998765

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.8e-54  Score=398.37  Aligned_cols=254  Identities=23%  Similarity=0.296  Sum_probs=198.3

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC----eEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG----AISI  145 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~----~~~l  145 (362)
                      .+|.+.+.||+|+||+||++++  +|+.||||+++.....  ......|+..+..++||||+++++++.+++    .+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence            5688899999999999999987  6899999998754222  222334666667889999999999998654    5899


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--------CeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK--------HIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~--------~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      |||||++|+|.++++. .++++..+..++.|++.||+|||+ +        +|+||||||+|||++.++++||+|||+|+
T Consensus        79 V~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~-~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHM-EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHC-CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-hhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999999999999986 579999999999999999999997 5        89999999999999999999999999998


Q ss_pred             ccccCCC----CCCccccCCcccCcceecCC------CCCccccHHHHHHHHHHHHcCCCCCCCCccCC--------chh
Q 018018          218 IMASTSG----QANTFVGTYNYMSPERISGG------KYGYKSDIWSLGLVLLECATGQFPYSPPEQQD--------GWT  279 (362)
Q Consensus       218 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~elltg~~pf~~~~~~~--------~~~  279 (362)
                      .......    .....+||+.|||||++.+.      .++.++|||||||++|||+||..||.......        ...
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            7654332    22345899999999999764      36789999999999999999988765432211        112


Q ss_pred             hHHHHHHHHhcCCCCCCCCCC-----CCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          280 SFYELMEAIVDQPPPSAPSDQ-----FSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ....+...+......+..+..     .+..+.+|+.+||+.||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            233444444444433332222     23468899999999999999999999863

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.6e-53  Score=391.37  Aligned_cols=261  Identities=30%  Similarity=0.568  Sum_probs=227.5

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .++|++.+.||+|+||+||++.+..+|+.||+|++..... .....+.+|+.+++.++||||+++++.+...+..++|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ-PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc-cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            4789999999999999999999999999999999875532 234568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      |+++++|.+++.. ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++............
T Consensus        98 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  175 (297)
T 3fxz_A           98 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (297)
T ss_dssp             CCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             CCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence            9999999999987 479999999999999999999998 99999999999999999999999999999877655555566


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018018          229 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  308 (362)
Q Consensus       229 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  308 (362)
                      .+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..      ................+..+++.+.+|
T Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~l  249 (297)
T 3fxz_A          176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTPELQNPEKLSAIFRDF  249 (297)
T ss_dssp             CCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred             ccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCCCCCCccccCHHHHHH
Confidence            78999999999999999999999999999999999999999764321      122222223333334456789999999


Q ss_pred             HHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          309 ISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      |.+||+.||++|||++|+++||||+.....
T Consensus       250 i~~~l~~dp~~Rps~~ell~h~~~~~~~~~  279 (297)
T 3fxz_A          250 LNRCLEMDVEKRGSAKELLQHQFLKIAKPL  279 (297)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             HHHHccCChhHCcCHHHHhhChhhcccCcc
Confidence            999999999999999999999999877543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.9e-53  Score=398.98  Aligned_cols=268  Identities=28%  Similarity=0.538  Sum_probs=230.9

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCe
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~  142 (362)
                      .+..++|++++.||+|+||.||+|+++.+++.||+|+++..  ........+.+|..++..+ +||||+++++++.+...
T Consensus         5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~   84 (345)
T 3a8x_A            5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR   84 (345)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence            45678999999999999999999999999999999999765  2445567788999999887 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      +|+||||+++|+|.+++.....+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+.....
T Consensus        85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE-RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999999999999988899999999999999999999998 99999999999999999999999999999875544


Q ss_pred             CCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc--hhhHHHHHHHHhcCCCCCCCCCC
Q 018018          223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG--WTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|..||......+.  ......+...+.....  ..+..
T Consensus       164 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~--~~p~~  241 (345)
T 3a8x_A          164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI--RIPRS  241 (345)
T ss_dssp             TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC--CCCTT
T ss_pred             CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC--CCCCC
Confidence            4556677999999999999999999999999999999999999999975322111  1122233444444332  23457


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCH------HHHHcCCcccccC
Q 018018          301 FSPEFCSFISACVQKEPQQRLSA------QELMTHPFLKMYG  336 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~------~eil~hp~~~~~~  336 (362)
                      +++++.+||.+||+.||++||++      +|+++||||+...
T Consensus       242 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  283 (345)
T 3a8x_A          242 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  283 (345)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred             CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence            89999999999999999999995      8999999998765

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.2e-54  Score=400.92  Aligned_cols=262  Identities=29%  Similarity=0.511  Sum_probs=227.4

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecC
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNG  141 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~  141 (362)
                      ..+..++|++.+.||+|+||.||+|+++.+|+.||||+++...  .......+..|..++..+ +||||+++++.+.+..
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            3467799999999999999999999999999999999997542  123345677888888765 8999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .+|+||||++||+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+....
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            999999999999999999988999999999999999999999998 9999999999999999999999999999987554


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.       .++...+.....  ..+..+
T Consensus       171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~~--~~p~~~  241 (345)
T 1xjd_A          171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSIRMDNP--FYPRWL  241 (345)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC--CCCTTS
T ss_pred             CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHhCCC--CCCccc
Confidence            44456677999999999999999999999999999999999999999976433       234444444432  234578


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHH-HHHcCCcccccC
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQ-ELMTHPFLKMYG  336 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~-eil~hp~~~~~~  336 (362)
                      ++++.+||.+||+.||++||++. ++++||||+...
T Consensus       242 s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~  277 (345)
T 1xjd_A          242 EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN  277 (345)
T ss_dssp             CHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             CHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence            99999999999999999999998 999999998775

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4e-53  Score=397.79  Aligned_cols=262  Identities=27%  Similarity=0.500  Sum_probs=227.9

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecC
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNG  141 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~  141 (362)
                      ..+..++|++++.||+|+||.||+|+++.+|+.||||+++...  .......+..|..++..+ +||+|+++++.+.+.+
T Consensus        15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   94 (353)
T 2i0e_A           15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   94 (353)
T ss_dssp             ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred             CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence            3467799999999999999999999999999999999997542  223456678899999887 7999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .+|+||||++||+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+....
T Consensus        95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            999999999999999999988899999999999999999999998 9999999999999999999999999999987554


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.       .++...+......  .+..+
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~~~--~p~~~  244 (353)
T 2i0e_A          174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIMEHNVA--YPKSM  244 (353)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC--CCTTS
T ss_pred             CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhCCCC--CCCCC
Confidence            44456677899999999999999999999999999999999999999976432       2444555444332  34578


Q ss_pred             CHHHHHHHHHhhhcCcCCCCC-----HHHHHcCCcccccC
Q 018018          302 SPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYG  336 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt-----~~eil~hp~~~~~~  336 (362)
                      ++++.+||.+||+.||++||+     ++++++||||+...
T Consensus       245 s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~  284 (353)
T 2i0e_A          245 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  284 (353)
T ss_dssp             CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred             CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence            999999999999999999994     69999999998754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-53  Score=390.34  Aligned_cols=257  Identities=28%  Similarity=0.540  Sum_probs=227.0

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      +..++|++++.||+|+||.||+|++..+|+.||+|+++...  .......+.+|..+++.++||||+++++.+.+...+|
T Consensus         3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~   82 (318)
T 1fot_A            3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF   82 (318)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred             CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence            46789999999999999999999999999999999997542  1223466789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      +||||++||+|.+++.....+++..++.++.|++.||+|||+ +||+||||||+||+++.++++||+|||+++....   
T Consensus        83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---  158 (318)
T 1fot_A           83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---  158 (318)
T ss_dssp             EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred             EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChheEEEcCCCCEEEeecCcceecCC---
Confidence            999999999999999998899999999999999999999998 9999999999999999999999999999986542   


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.       ......+......  .+..++++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~--~p~~~~~~  229 (318)
T 1fot_A          159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEKILNAELR--FPPFFNED  229 (318)
T ss_dssp             CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHCCCC--CCTTSCHH
T ss_pred             ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCC--CCCCCCHH
Confidence            34456899999999999999999999999999999999999999976432       2344444444322  33578999


Q ss_pred             HHHHHHHhhhcCcCCCC-----CHHHHHcCCcccccC
Q 018018          305 FCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      +.+||.+||+.||++||     +++|+++||||+...
T Consensus       230 ~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~  266 (318)
T 1fot_A          230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  266 (318)
T ss_dssp             HHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             HHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence            99999999999999999     999999999998754

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=9.1e-53  Score=396.52  Aligned_cols=259  Identities=27%  Similarity=0.435  Sum_probs=226.2

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch-----HHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      .++|++.+.||+|+||.||+|+++.+|+.||+|+++.....     .....+.+|+.+++.++||||+++++++.+...+
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            46799999999999999999999999999999999765322     1356789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC----cEEEeeccCCccc
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIM  219 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~----~vkl~DFg~a~~~  219 (362)
                      ++||||++||+|.+++.....+++..+..++.|++.||.|||+ +||+||||||+||+++.++    .+||+|||++...
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            9999999999999999988899999999999999999999998 9999999999999998777    7999999999876


Q ss_pred             ccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC--CC
Q 018018          220 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--AP  297 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  297 (362)
                      ... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.       .+....+.......  ..
T Consensus       170 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~  241 (361)
T 2yab_A          170 EDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANITAVSYDFDEEF  241 (361)
T ss_dssp             CTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTCCCCCHHH
T ss_pred             CCC-CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCCCCchh
Confidence            532 234556899999999999999999999999999999999999999976432       23444444443222  22


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      +..+++.+.+||.+||+.||++|||++|+++||||+..+
T Consensus       242 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            356889999999999999999999999999999998654

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.8e-52  Score=383.11  Aligned_cols=264  Identities=23%  Similarity=0.406  Sum_probs=218.3

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +++|++.+.||+|+||+||+|++..+++.||+|+++.. ........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence            36899999999999999999999999999999999765 33445677889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          148 EYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       148 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      ||+++ ++.+++. ..+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++.........
T Consensus        81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~-~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCC
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccc
Confidence            99986 5655554 46789999999999999999999998 999999999999999999999999999998776555555


Q ss_pred             CccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC------------
Q 018018          227 NTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP------------  293 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------------  293 (362)
                      ....||+.|+|||++.+.. ++.++|||||||++|+|++|..||......  ......+.........            
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH--HHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH--HHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            6678999999999998766 899999999999999999988875432211  1111122221111100            


Q ss_pred             -----------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          294 -----------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       294 -----------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                                 .......+++++.+||.+||+.||++|||++|+++||||+.++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                       0011235789999999999999999999999999999999875

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.3e-52  Score=405.56  Aligned_cols=259  Identities=26%  Similarity=0.434  Sum_probs=226.5

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      .++|++.+.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            378999999999999999999999999999999997653 3445677899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEc---cCCcEEEeeccCCcccccCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN---HRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~---~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      ||+.||+|.+++.....+++..+..++.|++.||+|||+ +||+||||||+|||++   .++.+||+|||+|........
T Consensus        90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~-~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~  168 (444)
T 3soa_A           90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ-MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ  168 (444)
T ss_dssp             CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence            999999999999998999999999999999999999998 9999999999999998   457899999999987765554


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCCCCCCC
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFS  302 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  302 (362)
                      .....+||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.       ......+....  .+......++
T Consensus       169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s  241 (444)
T 3soa_A          169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-------HRLYQQIKAGAYDFPSPEWDTVT  241 (444)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-------HHHHHHHHhCCCCCCccccccCC
Confidence            55667899999999999999999999999999999999999999976432       23344444332  2333446789


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      +++.+||.+||+.||++|||++|+++||||+..
T Consensus       242 ~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          242 PEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            999999999999999999999999999999754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2e-52  Score=392.81  Aligned_cols=260  Identities=28%  Similarity=0.484  Sum_probs=229.6

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      .....++|++++.||+|+||.||+|++..+|+.||+|+++...  .......+.+|+.+++.++||||+++++.+.+...
T Consensus        36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  115 (350)
T 1rdq_E           36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN  115 (350)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            3456799999999999999999999999999999999997542  22345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      +|+||||++||+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++.... 
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-  193 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-  193 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred             EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence            99999999999999999998999999999999999999999998 9999999999999999999999999999987543 


Q ss_pred             CCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018018          223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  302 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (362)
                        .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.       .+....+......  .+..++
T Consensus       194 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~--~p~~~~  262 (350)
T 1rdq_E          194 --RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-------IQIYEKIVSGKVR--FPSHFS  262 (350)
T ss_dssp             --CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC--CCTTCC
T ss_pred             --CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-------HHHHHHHHcCCCC--CCCCCC
Confidence              23456899999999999999999999999999999999999999976432       2444555544332  345789


Q ss_pred             HHHHHHHHHhhhcCcCCCCC-----HHHHHcCCcccccCC
Q 018018          303 PEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYGD  337 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt-----~~eil~hp~~~~~~~  337 (362)
                      +++.+||.+||+.||++||+     ++|+++||||+..++
T Consensus       263 ~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w  302 (350)
T 1rdq_E          263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDW  302 (350)
T ss_dssp             HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCH
T ss_pred             HHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCH
Confidence            99999999999999999998     999999999987653

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.4e-52  Score=396.76  Aligned_cols=262  Identities=29%  Similarity=0.499  Sum_probs=221.9

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHH-HhcCCCCcceEEeeeEEecC
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKI-NQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~-~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ..+..++|++++.||+|+||.||+++++.+++.||||+++...  .......+..|..+ ++.++||||+++++.+.+.+
T Consensus        33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~  112 (373)
T 2r5t_A           33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD  112 (373)
T ss_dssp             TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred             CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence            3567799999999999999999999999999999999997653  23344566777776 57789999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .+|+||||++||+|.+++.....+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+++....
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS-LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            999999999999999999998999999999999999999999998 9999999999999999999999999999987555


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.       .++...+.....  ..+..+
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-------~~~~~~i~~~~~--~~~~~~  262 (373)
T 2r5t_A          192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-------AEMYDNILNKPL--QLKPNI  262 (373)
T ss_dssp             CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-------HHHHHHHHHSCC--CCCSSS
T ss_pred             CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhccc--CCCCCC
Confidence            55556678999999999999999999999999999999999999999976433       234444444432  234578


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCH----HHHHcCCcccccC
Q 018018          302 SPEFCSFISACVQKEPQQRLSA----QELMTHPFLKMYG  336 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~----~eil~hp~~~~~~  336 (362)
                      ++++.+||.+||+.||++||++    +++++||||+...
T Consensus       263 ~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          263 TNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             CHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence            9999999999999999999987    6999999998765

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=7.7e-53  Score=391.44  Aligned_cols=261  Identities=26%  Similarity=0.453  Sum_probs=222.2

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .++|++.+.||+|+||.||++.+..+++.||+|++...........+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            47899999999999999999999999999999999766544555778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC--CCC
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQA  226 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~--~~~  226 (362)
                      |+++++|.+++.....+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++......  ...
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence            99999999999888889999999999999999999998 999999999999999999999999999997654222  223


Q ss_pred             CccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          227 NTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      ...+||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+...      ..................+++.+
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  238 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEKKTYLNPWKKIDSAP  238 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTS------HHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             CCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHHhcccccCCccccCCHHH
Confidence            45689999999999988776 789999999999999999999997654432      11222222333333346789999


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          306 CSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      .+||.+||+.||++|||++|+++||||+...
T Consensus       239 ~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          239 LALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            9999999999999999999999999998654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.2e-52  Score=396.55  Aligned_cols=267  Identities=28%  Similarity=0.509  Sum_probs=231.2

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      ....+..++|++++.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+.
T Consensus         8 ~~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~   87 (384)
T 4fr4_A            8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE   87 (384)
T ss_dssp             CCCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            355678899999999999999999999999999999999987542  223456788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          141 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ..+|+||||+.||+|.+++.....+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+...
T Consensus        88 ~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~-~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           88 EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN-QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            9999999999999999999998899999999999999999999998 999999999999999999999999999998754


Q ss_pred             cCCCCCCccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          221 STSGQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      . .......+||+.|+|||++.+   ..++.++|||||||++|+|++|..||.......    .......+.....  ..
T Consensus       167 ~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~----~~~~~~~~~~~~~--~~  239 (384)
T 4fr4_A          167 R-ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS----SKEIVHTFETTVV--TY  239 (384)
T ss_dssp             T-TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC----HHHHHHHHHHCCC--CC
T ss_pred             C-CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc----HHHHHHHHhhccc--CC
Confidence            3 334566789999999999874   458999999999999999999999997654432    2233344333332  23


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCC-HHHHHcCCcccccCC
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLS-AQELMTHPFLKMYGD  337 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt-~~eil~hp~~~~~~~  337 (362)
                      +..+++++.+||.+||+.||++||+ ++++++||||+...+
T Consensus       240 p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w  280 (384)
T 4fr4_A          240 PSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW  280 (384)
T ss_dssp             CTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred             CCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence            4578999999999999999999998 899999999987653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.7e-53  Score=403.89  Aligned_cols=266  Identities=29%  Similarity=0.478  Sum_probs=225.1

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      .+..++|++++.||+|+||+||+|+++.+++.||+|+++...  .......+.+|+.+++.++||||+++++++.+...+
T Consensus        65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~  144 (410)
T 3v8s_A           65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL  144 (410)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence            456789999999999999999999999999999999997531  111234577899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      |+||||++||+|.+++.. ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+......
T Consensus       145 ~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~-~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~  222 (410)
T 3v8s_A          145 YMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHS-MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  222 (410)
T ss_dssp             EEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC
Confidence            999999999999999976 579999999999999999999998 999999999999999999999999999998764332


Q ss_pred             C-CCCccccCCcccCcceecCCC----CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCC
Q 018018          224 G-QANTFVGTYNYMSPERISGGK----YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSA  296 (362)
Q Consensus       224 ~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~  296 (362)
                      . ...+.+||+.|+|||++.+..    ++.++|||||||++|||++|..||.+.+..       .....+....  ...+
T Consensus       223 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-------~~~~~i~~~~~~~~~p  295 (410)
T 3v8s_A          223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-------GTYSKIMNHKNSLTFP  295 (410)
T ss_dssp             EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTHHHHCCCC
T ss_pred             cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-------hHHHHHHhccccccCC
Confidence            2 234678999999999998765    789999999999999999999999864432       2333332211  1222


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCC--CCCHHHHHcCCcccccCCCCC
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYGDLNV  340 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~--Rpt~~eil~hp~~~~~~~~~~  340 (362)
                      ....+++++.+||.+||+.+|++  ||+++||++||||+...+...
T Consensus       296 ~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~  341 (410)
T 3v8s_A          296 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWE  341 (410)
T ss_dssp             TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCST
T ss_pred             CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHH
Confidence            23478999999999999999998  999999999999998765443

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=5.1e-52  Score=395.43  Aligned_cols=291  Identities=25%  Similarity=0.407  Sum_probs=228.9

Q ss_pred             CCCccCceeeeeeeee--CCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           66 QLNLEDIDTIKVVGKG--SGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      ....++|++.+.||+|  +||.||++++..+|+.||||+++.. ........+.+|+.+++.++||||+++++++.+.+.
T Consensus        21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE  100 (389)
T ss_dssp             CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence            3467899999999999  9999999999999999999999765 334566788899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          143 ISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      +++||||+++++|.+++...  ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++....
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999999999876  679999999999999999999998 999999999999999999999999999886543


Q ss_pred             cCC-------CCCCccccCCcccCcceecC--CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH-HHHHHh-
Q 018018          221 STS-------GQANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE-LMEAIV-  289 (362)
Q Consensus       221 ~~~-------~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~-~~~~~~-  289 (362)
                      ...       ......+||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.+.......... ...... 
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            221       12233478999999999988  5799999999999999999999999987554332111000 000000 


Q ss_pred             -----------------------------------cCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          290 -----------------------------------DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       290 -----------------------------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                                                         ........+..+++++.+||.+||+.||++|||++|+++||||+.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~  339 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  339 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGG
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHH
Confidence                                               000011234567899999999999999999999999999999998


Q ss_pred             cCCCCCCHHHHHHHhCCCccccccCC
Q 018018          335 YGDLNVDLSEYFTDAGSPLATLSNLS  360 (362)
Q Consensus       335 ~~~~~~~l~~~~~~~~~~~~~~~~~~  360 (362)
                      .......   .+....+|+.++.++.
T Consensus       340 ~~~~~~~---~~~~~~~~~~~~~~~~  362 (389)
T 3gni_B          340 IKRRASE---ALPELLRPVTPITNFE  362 (389)
T ss_dssp             C---CCS---SHHHHTTTCCCCC---
T ss_pred             Hhhcchh---hhhhhhcCCCcccccc
Confidence            8654332   2233456666666554

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.5e-52  Score=387.44  Aligned_cols=267  Identities=27%  Similarity=0.464  Sum_probs=219.4

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      ..+.-.++|++++.||+|+||+||++++. +|+.||+|+++... .......+.+|+.+++.++||||+++++++.+...
T Consensus        15 ~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   93 (311)
T 3niz_A           15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC   93 (311)
T ss_dssp             CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred             eecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence            34455689999999999999999999985 58999999987552 33345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          143 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .++||||+++ +|.+++... ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++....
T Consensus        94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A           94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQ-HRILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            9999999975 888888654 469999999999999999999998 9999999999999999999999999999987765


Q ss_pred             CCCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC----
Q 018018          222 TSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA----  296 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----  296 (362)
                      .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+...   .+.... ....+..    
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~-~~~~~~~~~~~  247 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP---KIFSIL-GTPNPREWPQV  247 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH---HHHHHH-CCCCTTTSGGG
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHH-CCCChHHhhhh
Confidence            5445556688999999999977 568999999999999999999999998765543222   222221 1111110    


Q ss_pred             ---------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          297 ---------------------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       297 ---------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                                           ....+++++.+||.+||++||++|||++|+++||||+....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  309 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP  309 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence                                 12346789999999999999999999999999999998753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.1e-52  Score=386.52  Aligned_cols=262  Identities=29%  Similarity=0.480  Sum_probs=216.8

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEc---cCCcEEEEEEeeccc---chHHHHHHHHHHHHHhcCCCCcceEEeeeEE
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNV---EESARRQIAQELKINQSSQCPYVVVCYQSFY  138 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~  138 (362)
                      ..+..++|++.+.||+|+||.||++++.   .+|+.||+|+++...   .......+.+|+.+++.++||||+++++.+.
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            4566799999999999999999999985   689999999997652   2234566789999999999999999999999


Q ss_pred             ecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          139 SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       139 ~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      +.+.+++||||+++++|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++.
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ-KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            999999999999999999999988999999999999999999999998 9999999999999999999999999999986


Q ss_pred             cccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          219 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      ...........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.       ......+.....  ..+
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~~--~~p  241 (327)
T 3a62_A          171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-------KKTIDKILKCKL--NLP  241 (327)
T ss_dssp             --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCC--CCC
T ss_pred             cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCC--CCC
Confidence            55444445567899999999999999999999999999999999999999986433       233344443332  233


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHcCCcccccC
Q 018018          299 DQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      ..+++++.+||.+||+.||++||     +++|+++||||+...
T Consensus       242 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~  284 (327)
T 3a62_A          242 PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN  284 (327)
T ss_dssp             TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred             CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence            56899999999999999999999     899999999998764

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.2e-52  Score=405.11  Aligned_cols=264  Identities=30%  Similarity=0.560  Sum_probs=219.8

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ...+..++|++++.||+|+||.||+|++..+|+.||||+++..  ........+.+|+.+++.++||||+.+++++.+.+
T Consensus       142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~  221 (446)
T 4ejn_A          142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD  221 (446)
T ss_dssp             --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred             ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence            3456778999999999999999999999999999999999754  23344567789999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .+++||||+++|+|.+++.....+++..++.++.|++.||+|||+.+||+||||||+|||++.++.+||+|||+|+....
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            99999999999999999999899999999999999999999999547999999999999999999999999999987555


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.       ......+......  .+..+
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-------~~~~~~i~~~~~~--~p~~~  372 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------EKLFELILMEEIR--FPRTL  372 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCC--CCTTS
T ss_pred             CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHHhCCCC--CCccC
Confidence            55555667899999999999999999999999999999999999999976432       2334444433322  34578


Q ss_pred             CHHHHHHHHHhhhcCcCCCC-----CHHHHHcCCcccccC
Q 018018          302 SPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      ++++.+||.+||+.||++||     |++|+++||||+...
T Consensus       373 ~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~  412 (446)
T 4ejn_A          373 GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV  412 (446)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence            99999999999999999999     999999999999864

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-52  Score=384.30  Aligned_cols=260  Identities=27%  Similarity=0.475  Sum_probs=217.8

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch-------------------------HHHHHHHHHHH
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-------------------------SARRQIAQELK  120 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------------------~~~~~~~~e~~  120 (362)
                      .+..++|++.+.||+|+||.||+|++..+++.||||++......                         .....+.+|+.
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   88 (298)
T 2zv2_A            9 CVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIA   88 (298)
T ss_dssp             -CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHH
T ss_pred             ceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHH
Confidence            35568999999999999999999999999999999998754211                         12356889999


Q ss_pred             HHhcCCCCcceEEeeeEEe--cCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCC
Q 018018          121 INQSSQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS  198 (362)
Q Consensus       121 ~~~~l~hp~I~~~~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~  198 (362)
                      +++.++||||+++++++.+  ....++||||+++++|.+++.. ..+++..++.++.|++.||+|||+ +|++||||||+
T Consensus        89 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~  166 (298)
T 2zv2_A           89 ILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHY-QKIIHRDIKPS  166 (298)
T ss_dssp             HHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGG
T ss_pred             HHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHH
Confidence            9999999999999999886  5789999999999999886543 679999999999999999999998 99999999999


Q ss_pred             cEEEccCCcEEEeeccCCcccccCCCCCCccccCCcccCcceecCCC---CCccccHHHHHHHHHHHHcCCCCCCCCccC
Q 018018          199 NLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLECATGQFPYSPPEQQ  275 (362)
Q Consensus       199 NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~elltg~~pf~~~~~~  275 (362)
                      ||+++.++.+||+|||+++.............||+.|+|||++.+..   ++.++|||||||++|+|++|..||.+..  
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~--  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER--  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS--
T ss_pred             HEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc--
Confidence            99999999999999999987654444445568999999999998765   3788999999999999999999997632  


Q ss_pred             CchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          276 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                           .......+............+++++.+||.+||+.||++|||+.|+++||||+.
T Consensus       245 -----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~  298 (298)
T 2zv2_A          245 -----IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR  298 (298)
T ss_dssp             -----HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred             -----HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence                 223344444444444444678999999999999999999999999999999963

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2e-52  Score=394.00  Aligned_cols=281  Identities=44%  Similarity=0.803  Sum_probs=243.5

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      .++..++|++.+.||+|+||.||++.+..+++.||+|++...........+.+|+.+++.++||||+++++++.+.+..+
T Consensus        28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  107 (360)
T 3eqc_A           28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS  107 (360)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEE
Confidence            45667899999999999999999999999999999999987767777888999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      +||||+++++|.+++.....+++..+..++.|++.||+|||+.+||+||||||+||+++.++.+||+|||++......  
T Consensus       108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999999999998899999999999999999999998239999999999999999999999999998765332  


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc---------------------------
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG---------------------------  277 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~---------------------------  277 (362)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.                           
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN  265 (360)
T ss_dssp             C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred             cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence            23446799999999999999999999999999999999999999976432110                           


Q ss_pred             --------hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHH
Q 018018          278 --------WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFT  347 (362)
Q Consensus       278 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~  347 (362)
                              .....+....+.....+......+++++.+||.+||+.||++|||++|+++||||+......++...++.
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~  343 (360)
T 3eqc_A          266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLC  343 (360)
T ss_dssp             --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCCCHHHHHH
T ss_pred             ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhhhHHHHHh
Confidence                    0112234444555555555556789999999999999999999999999999999999999998888764

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.9e-52  Score=391.95  Aligned_cols=258  Identities=27%  Similarity=0.446  Sum_probs=224.9

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++... ........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            36899999999999999999999999999999999765 34455677899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC---cEEEeeccCCcccccCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMASTSG  224 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~---~vkl~DFg~a~~~~~~~~  224 (362)
                      ||+.+|+|.+++.....+++..+..++.|++.||+|||+ +||+||||||+||+++.++   .+||+|||++...... .
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-~  185 (362)
T 2bdw_A          108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-E  185 (362)
T ss_dssp             CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-C
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-c
Confidence            999999999999888899999999999999999999998 9999999999999998654   5999999999876533 2


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CCCCCCCCC
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFS  302 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  302 (362)
                      .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.       ..+...+.....  +...+..++
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~  258 (362)
T 2bdw_A          186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYAQIKAGAYDYPSPEWDTVT  258 (362)
T ss_dssp             SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCCCTTGGGGSC
T ss_pred             ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCCCCCcccccCCC
Confidence            34456899999999999999999999999999999999999999976432       233444433332  223335689


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      +++.+||.+||+.||++|||++++++||||+..
T Consensus       259 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          259 PEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999999753

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.7e-52  Score=385.07  Aligned_cols=265  Identities=25%  Similarity=0.461  Sum_probs=208.3

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .++|++++.||+|+||.||++.+..+|+.||+|+++..........+.+|+.+++.++||||+++++++.+++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            47899999999999999999999999999999999866544445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          149 YMDGGSLADFLKKV------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       149 ~~~~gsL~~~l~~~------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      |++ ++|.+++...      ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE-NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            998 5999999754      358999999999999999999998 99999999999999999999999999999876544


Q ss_pred             CCCCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--------
Q 018018          223 SGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--------  293 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------  293 (362)
                      ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.   ...+.........        
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~  238 (317)
T 2pmi_A          162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWPSVTK  238 (317)
T ss_dssp             CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCGGGGG
T ss_pred             cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhhhhhh
Confidence            4445566899999999999874 689999999999999999999999987543221   1111111111000        


Q ss_pred             --------------------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          294 --------------------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       294 --------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                                          .+.....+++++.+||.+||+.||++|||++|+++||||+.+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH  303 (317)
T ss_dssp             CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred             hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence                                001123578899999999999999999999999999999987654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.2e-52  Score=387.65  Aligned_cols=263  Identities=27%  Similarity=0.399  Sum_probs=205.0

Q ss_pred             cCceee---eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeEEE
Q 018018           70 EDIDTI---KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        70 ~~~~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~~l  145 (362)
                      ++|++.   +.||+|+||.||+|.+..+++.||||++...    ....+.+|+.+++.+. ||||+++++++.+....++
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~l   83 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFL   83 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEE
Confidence            445554   7899999999999999999999999998643    3356678999999887 9999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC---cEEEeeccCCcccccC
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAIMAST  222 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~---~vkl~DFg~a~~~~~~  222 (362)
                      ||||+++++|.+++.....+++..++.++.|++.||+|||+ +||+||||||+||+++.++   .+||+|||+++.....
T Consensus        84 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           84 VMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD-VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             EECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             EEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            99999999999999998999999999999999999999998 9999999999999998766   8999999999876555


Q ss_pred             CCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC--CCC
Q 018018          223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP--SDQ  300 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  300 (362)
                      .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+.........+....+..+......  +..
T Consensus       163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (325)
T 3kn6_A          163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKN  242 (325)
T ss_dssp             ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHT
T ss_pred             CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccC
Confidence            555566788999999999999999999999999999999999999998766544444555666666655443221  235


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      +++++.+||.+||+.||++|||++|+++||||+....
T Consensus       243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~  279 (325)
T 3kn6_A          243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ  279 (325)
T ss_dssp             SCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred             CCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence            8999999999999999999999999999999987654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.7e-52  Score=390.93  Aligned_cols=264  Identities=28%  Similarity=0.463  Sum_probs=216.9

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ....++|++.+.||+|+||+||++++..+++.||||++.....  ....+.+|+.+++.++||||+++++++.+....++
T Consensus        16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l   93 (361)
T 3uc3_A           16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI   93 (361)
T ss_dssp             CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEE
Confidence            3456899999999999999999999999999999999975422  23457799999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc--EEEeeccCCcccccCC
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGVSAIMASTS  223 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~--vkl~DFg~a~~~~~~~  223 (362)
                      ||||+.+|+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++.  +||+|||+|+..... 
T Consensus        94 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~-~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-  171 (361)
T 3uc3_A           94 IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHS-MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-  171 (361)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence            99999999999999988999999999999999999999998 99999999999999987765  999999998754322 


Q ss_pred             CCCCccccCCcccCcceecCCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018018          224 GQANTFVGTYNYMSPERISGGKYGYK-SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  302 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (362)
                      ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....   .......+.......+....++
T Consensus       172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~s  248 (361)
T 3uc3_A          172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD---YRKTIQRILSVKYSIPDDIRIS  248 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC---HHHHHHHHHTTCCCCCTTSCCC
T ss_pred             CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH---HHHHHHHHhcCCCCCCCcCCCC
Confidence            23445679999999999998888665 8999999999999999999987655433   3344555555544444445789


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      +++.+||.+||+.||++|||++|+++||||...-
T Consensus       249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~  282 (361)
T 3uc3_A          249 PECCHLISRIFVADPATRISIPEIKTHSWFLKNL  282 (361)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHhCcchhcCC
Confidence            9999999999999999999999999999996553

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.3e-52  Score=390.06  Aligned_cols=256  Identities=30%  Similarity=0.487  Sum_probs=221.2

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+....++
T Consensus         7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   86 (336)
T 3h4j_B            7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM   86 (336)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence            4578999999999999999999999999999999987542  12224578899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      ||||+ +|+|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||++...... ..
T Consensus        87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-~~  163 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR-HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NF  163 (336)
T ss_dssp             EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-BT
T ss_pred             EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-cc
Confidence            99999 67999999888999999999999999999999998 99999999999999999999999999999876433 33


Q ss_pred             CCccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          226 ANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+........       .+..  .....+..++++
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~-------~i~~--~~~~~p~~~s~~  234 (336)
T 3h4j_B          164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK-------KVNS--CVYVMPDFLSPG  234 (336)
T ss_dssp             TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC-------CCCS--SCCCCCTTSCHH
T ss_pred             cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH-------HHHc--CCCCCcccCCHH
Confidence            456689999999999998876 789999999999999999999997654332111       1111  122334678999


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          305 FCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      +.+||++||+.||++|||++|+++||||+..
T Consensus       235 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          235 AQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence            9999999999999999999999999999753

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.2e-52  Score=398.99  Aligned_cols=266  Identities=26%  Similarity=0.435  Sum_probs=223.2

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      .+..++|++++.||+|+||.||+++++.+|+.||||+++...  .......+.+|..++..++||||+++++++.+...+
T Consensus        57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYL  136 (412)
T ss_dssp             SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEE
Confidence            456789999999999999999999999999999999997531  122334578899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          144 SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      |+||||++||+|.+++.+. ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+.....
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR-LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            9999999999999999875 489999999999999999999998 99999999999999999999999999999876543


Q ss_pred             CC-CCCccccCCcccCcceec-------CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC---
Q 018018          223 SG-QANTFVGTYNYMSPERIS-------GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ---  291 (362)
Q Consensus       223 ~~-~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---  291 (362)
                      .. .....+||+.|+|||++.       +..|+.++|||||||++|||++|+.||.+.+..       +....+...   
T Consensus       216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-------~~~~~i~~~~~~  288 (412)
T 2vd5_A          216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-------ETYGKIVHYKEH  288 (412)
T ss_dssp             SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHTHHHH
T ss_pred             CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-------HHHHHHHhcccC
Confidence            32 234568999999999987       457899999999999999999999999875432       222222211   


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhcCcCCC---CCHHHHHcCCcccccCCCCC
Q 018018          292 PPPSAPSDQFSPEFCSFISACVQKEPQQR---LSAQELMTHPFLKMYGDLNV  340 (362)
Q Consensus       292 ~~~~~~~~~~~~~~~~li~~~L~~dP~~R---pt~~eil~hp~~~~~~~~~~  340 (362)
                      ...+.....+++++.+||++||+ +|++|   |+++|+++||||+..++..+
T Consensus       289 ~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          289 LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence            11122235789999999999999 99998   59999999999988766544

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.1e-52  Score=402.91  Aligned_cols=270  Identities=24%  Similarity=0.446  Sum_probs=225.4

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      .+..++|++++.||+|+||+||+++++.+++.||+|+++...  .......+.+|..++..++||||+++++++.+...+
T Consensus        70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEE
Confidence            456789999999999999999999999999999999997531  112223478899999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          144 SIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      |+||||++||+|.+++.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+.....
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ-LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHh-CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            999999999999999987 5789999999999999999999998 99999999999999999999999999999766443


Q ss_pred             CC-CCCccccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018018          223 SG-QANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  296 (362)
Q Consensus       223 ~~-~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
                      .. .....+||+.|+|||++.     ...|+.++|||||||++|||++|+.||.+.+..+.   ...++........ +.
T Consensus       229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~---~~~i~~~~~~~~~-p~  304 (437)
T 4aw2_A          229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET---YGKIMNHKERFQF-PT  304 (437)
T ss_dssp             SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHTHHHHCCC-CS
T ss_pred             CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHH---HHhhhhccccccC-Cc
Confidence            32 234468999999999987     56789999999999999999999999987543211   1112111111122 22


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCC--CCCHHHHHcCCcccccCCCCC
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQ--RLSAQELMTHPFLKMYGDLNV  340 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~--Rpt~~eil~hp~~~~~~~~~~  340 (362)
                      ....+++++.+||++||+.+|++  |++++|+++||||+..++..+
T Consensus       305 ~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence            23468999999999999998888  999999999999998776544

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.1e-52  Score=390.90  Aligned_cols=259  Identities=26%  Similarity=0.446  Sum_probs=221.6

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc----hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE----ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      .++|++.+.||+|+||+||+|.+..+|+.||||++.....    ......+.+|+.+++.++||||+++++++.+.+.++
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            4689999999999999999999999999999999864321    113567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc---EEEeeccCCc
Q 018018          145 IILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSA  217 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~---vkl~DFg~a~  217 (362)
                      +||||+++++|.+++...    ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++.   +||+|||++.
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            999999999999888543    358999999999999999999998 99999999999999987654   9999999998


Q ss_pred             ccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC--
Q 018018          218 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--  295 (362)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--  295 (362)
                      ............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+..        ......+.......  
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~i~~~~~~~~~  253 (351)
T 3c0i_A          182 QLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--------ERLFEGIIKGKYKMNP  253 (351)
T ss_dssp             ECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH--------HHHHHHHHHTCCCCCH
T ss_pred             EecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH--------HHHHHHHHcCCCCCCc
Confidence            77654444556789999999999999999999999999999999999999997632        12333333333221  


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       296 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      .....+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus       254 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~  294 (351)
T 3c0i_A          254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD  294 (351)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence            12246889999999999999999999999999999997643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-51  Score=384.18  Aligned_cols=259  Identities=27%  Similarity=0.452  Sum_probs=223.7

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch-----HHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|+++.....     .....+.+|+.+++.++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            36799999999999999999999999999999999765322     1356788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC----cEEEeeccCCccc
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIM  219 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~----~vkl~DFg~a~~~  219 (362)
                      ++||||+++++|.+++.....+++..++.++.|++.||.|||+ +||+||||||+||+++.++    .+||+|||+++..
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHH-CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence            9999999999999999988899999999999999999999998 9999999999999998887    8999999999876


Q ss_pred             ccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CCCC
Q 018018          220 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAP  297 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  297 (362)
                      ... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+...       .+....+.....  +...
T Consensus       169 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~  240 (326)
T 2y0a_A          169 DFG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANVSAVNYEFEDEY  240 (326)
T ss_dssp             CTT-SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHTCCCCCHHH
T ss_pred             CCC-CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH-------HHHHHHHHhcCCCcCccc
Confidence            433 234456899999999999999999999999999999999999999976432       123333322222  1112


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ...+++.+.+||.+||+.||++|||++|+++||||+...
T Consensus       241 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          241 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             cccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            346789999999999999999999999999999998654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-51  Score=380.02  Aligned_cols=266  Identities=25%  Similarity=0.467  Sum_probs=216.6

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +++|++++.||+|+||+||+|++..+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            478999999999999999999999999999999986653 3445677889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      ||+++++|.+++.....+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++...........
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK-HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            999999999999888899999999999999999999998 9999999999999999999999999999987665544455


Q ss_pred             ccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC---------------
Q 018018          228 TFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ---------------  291 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---------------  291 (362)
                      ...||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+.+..+..    ..+......               
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL----YLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHHHHhccccccccccccccccc
Confidence            6689999999999976 56899999999999999999999999875443211    111111110               


Q ss_pred             ---CCCCC--------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          292 ---PPPSA--------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       292 ---~~~~~--------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                         ..+..        ....+++++.+||.+||+.||++|||++|+++||||++..+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence               00000        0135788999999999999999999999999999999886543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-51  Score=376.47  Aligned_cols=261  Identities=25%  Similarity=0.446  Sum_probs=212.2

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +++|++++.||+|+||+||++++ .+|+.||+|+++... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence            36899999999999999999998 679999999987553 2233467889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          148 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       148 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      ||+++ +|.+++... ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++.........
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  157 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY  157 (288)
T ss_dssp             ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccc
Confidence            99976 999999764 679999999999999999999998 999999999999999999999999999998765444444


Q ss_pred             CccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC-----------
Q 018018          227 NTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-----------  294 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------  294 (362)
                      ....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+   ...............           
T Consensus       158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T 1ob3_A          158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTELPKY  234 (288)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhccccc
Confidence            556789999999999764 58999999999999999999999998654321   111222211111000           


Q ss_pred             ------------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          295 ------------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       295 ------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                                  ......+++++.+||.+||+.||++|||++|+++||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             ccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                        01124578999999999999999999999999999999864

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-52  Score=384.86  Aligned_cols=257  Identities=21%  Similarity=0.354  Sum_probs=223.0

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .++|++.+.||+|+||.||+|.+..+++.||+|+++..  ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK--GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC--cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            47899999999999999999999999999999998754  3345668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc--CCcEEEeeccCCcccccCCCC
Q 018018          149 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       149 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~--~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      |+++++|.+++... ..+++..++.++.|++.||.|||+ +||+||||||+||+++.  ++.+||+|||+++..... ..
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-~~  159 (321)
T 1tki_A           82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DN  159 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CE
T ss_pred             eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-Cc
Confidence            99999999999765 479999999999999999999998 99999999999999987  789999999999876432 23


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC--CCCCCCH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFSP  303 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  303 (362)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.       ......+........  ....+++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~  232 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIMNAEYTFDEEAFKEISI  232 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-------HHHHHHHHcCCCCCChhhhccCCH
Confidence            3456799999999999998899999999999999999999999976432       234444444333221  2346899


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ++.+||.+||+.||++|||+.|+++||||+...
T Consensus       233 ~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            999999999999999999999999999997653

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.8e-52  Score=385.59  Aligned_cols=268  Identities=26%  Similarity=0.455  Sum_probs=214.1

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      +++|.+++.||+|+||+||++++..+++.||+|+++..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            36899999999999999999999999999999999765444333456689999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          149 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       149 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      |+.+ +|.+++... ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++..........
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  158 (324)
T 3mtl_A           81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR-QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD  158 (324)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence            9975 999988765 459999999999999999999998 9999999999999999999999999999987655444455


Q ss_pred             ccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC---------
Q 018018          228 TFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP---------  297 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------  297 (362)
                      ...||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+    ....+......+.....         
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (324)
T 3mtl_A          159 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE----QLHFIFRILGTPTEETWPGILSNEEF  234 (324)
T ss_dssp             ----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred             cccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHHhCCCChHhchhhhcchhh
Confidence            5688999999999987 568999999999999999999999998754321    12222222222111111         


Q ss_pred             ----------------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCH
Q 018018          298 ----------------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL  342 (362)
Q Consensus       298 ----------------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l  342 (362)
                                      ...+++++.+||.+||+.||++|||++|+++||||+...+....+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~  295 (324)
T 3mtl_A          235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKL  295 (324)
T ss_dssp             HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSS
T ss_pred             cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccC
Confidence                            124688999999999999999999999999999999887755443

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.1e-52  Score=388.30  Aligned_cols=259  Identities=26%  Similarity=0.414  Sum_probs=221.8

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      .++|++.+.||+|+||.||+|.++.+|+.||||+++....     ...+|++++..+ +||||+++++++.+....|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            4789999999999999999999999999999999976532     234566777665 7999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC----CcEEEeeccCCcccccCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR----GEVKITDFGVSAIMASTS  223 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~----~~vkl~DFg~a~~~~~~~  223 (362)
                      ||++||+|.+++...+.+++..+..++.|++.||+|||+ +||+||||||+||++..+    +.+||+|||+++......
T Consensus        96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~-~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~  174 (342)
T 2qr7_A           96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHA-QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN  174 (342)
T ss_dssp             CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence            999999999999988899999999999999999999998 999999999999998543    359999999998776555


Q ss_pred             CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--CCCCCCC
Q 018018          224 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQF  301 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  301 (362)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......    ...++...+..+...  ...+..+
T Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          175 GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD----TPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS----CHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC----CHHHHHHHHccCCcccCccccccC
Confidence            5556678999999999999888999999999999999999999999764321    223444555444332  2234678


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ++++.+||.+||+.||++|||++++++||||..+..
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~  286 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ  286 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence            999999999999999999999999999999987753

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=8.3e-51  Score=377.42  Aligned_cols=257  Identities=35%  Similarity=0.633  Sum_probs=223.1

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEecc
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYM  150 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~  150 (362)
                      .|...+.||+|+||.||++++..+|+.||||++.... ......+.+|+.+++.++||||+++++.+......++||||+
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  124 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL  124 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc-hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence            4778889999999999999999999999999997553 233466889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccc
Q 018018          151 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV  230 (362)
Q Consensus       151 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~  230 (362)
                      ++++|.+++.. ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++..............
T Consensus       125 ~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  202 (321)
T 2c30_A          125 QGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHA-QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV  202 (321)
T ss_dssp             CSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred             CCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccccc
Confidence            99999999875 579999999999999999999998 9999999999999999999999999999987665444455678


Q ss_pred             cCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC-CCCCCCCCHHHHHHH
Q 018018          231 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-SAPSDQFSPEFCSFI  309 (362)
Q Consensus       231 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li  309 (362)
                      ||+.|+|||++.+..++.++||||||+++|+|++|..||...+.       ......+.....+ ......+++.+.++|
T Consensus       203 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~li  275 (321)
T 2c30_A          203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP-------VQAMKRLRDSPPPKLKNSHKVSPVLRDFL  275 (321)
T ss_dssp             SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSSCCCCTTGGGSCHHHHHHH
T ss_pred             CCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhcCCCCCcCccccCCHHHHHHH
Confidence            99999999999999999999999999999999999999976432       2233333333322 223346789999999


Q ss_pred             HHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          310 SACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      .+||+.||++|||++|+++||||+....
T Consensus       276 ~~~l~~dp~~Rps~~ell~hp~~~~~~~  303 (321)
T 2c30_A          276 ERMLVRDPQERATAQELLDHPFLLQTGL  303 (321)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSGGGGGCCC
T ss_pred             HHHccCChhhCcCHHHHhcChhhccCCC
Confidence            9999999999999999999999987653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.2e-50  Score=368.98  Aligned_cols=262  Identities=27%  Similarity=0.441  Sum_probs=227.1

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      .++|++.+.||+|+||.||++.+..+|+.||+|++... ........+.+|+.+++.++||||+++++.+.+....++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            47899999999999999999999999999999999765 34455677899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc---EEEeeccCCcccccCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSG  224 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~---vkl~DFg~a~~~~~~~~  224 (362)
                      ||+++++|.+++.....+++..+..++.|++.||+|||+ +|++||||||+||+++.++.   +||+|||++...... .
T Consensus        85 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-~  162 (284)
T 3kk8_A           85 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS-NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-E  162 (284)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-C
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-c
Confidence            999999999999988999999999999999999999998 99999999999999987665   999999999766433 2


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCCCCCCC
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFS  302 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  302 (362)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+.       ......+....  .+......++
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T 3kk8_A          163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-------HRLYAQIKAGAYDYPSPEWDTVT  235 (284)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch-------hHHHHHHHhccccCCchhhcccC
Confidence            33456799999999999999999999999999999999999999976432       12333333222  2333345789


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                      +++.+||.+||+.||++|||++|+++||||++..+..
T Consensus       236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  272 (284)
T 3kk8_A          236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA  272 (284)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence            9999999999999999999999999999998776543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.5e-51  Score=382.08  Aligned_cols=267  Identities=22%  Similarity=0.363  Sum_probs=211.2

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      ....++|++.+.||+|+||+||++++..+++.||||+++... .......+.+|+.+++.++||||+++++++.+....+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            456789999999999999999999999999999999997653 3334566789999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEc-----cCCcEEEeeccCCccc
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-----HRGEVKITDFGVSAIM  219 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~-----~~~~vkl~DFg~a~~~  219 (362)
                      +||||+++ +|.+++.....+++..++.++.|++.||+|||+ +||+||||||+||+++     .++.+||+|||+++..
T Consensus       110 lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~  187 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS-RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF  187 (329)
T ss_dssp             EEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred             EEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence            99999975 999999998899999999999999999999998 9999999999999994     4556999999999876


Q ss_pred             ccCCCCCCccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC--
Q 018018          220 ASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA--  296 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--  296 (362)
                      ..........+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+   .................  
T Consensus       188 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~  264 (329)
T 3gbz_A          188 GIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID---QLFKIFEVLGLPDDTTWPG  264 (329)
T ss_dssp             C-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSTT
T ss_pred             CCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH---HHHHHHHHhCCCchhhhhh
Confidence            55544555668899999999998754 8999999999999999999999997754321   12222222111110000  


Q ss_pred             ----------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          297 ----------------------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       297 ----------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                                            ....+++++.+||.+||+.||++|||++|+++||||+....
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  327 (329)
T 3gbz_A          265 VTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF  327 (329)
T ss_dssp             GGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred             hhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence                                  00116789999999999999999999999999999998653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.9e-51  Score=370.43  Aligned_cols=262  Identities=30%  Similarity=0.461  Sum_probs=224.3

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc--hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      .++.+++|++.+.||+|+||.||++.+..++..||+|++.....  ......+.+|+.+++.++||||+++++++.+...
T Consensus         4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   83 (279)
T 3fdn_A            4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR   83 (279)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence            45678999999999999999999999999999999999865422  2235678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      .++||||+++++|.+++.....+++..+..++.|++.||+|||+ +|++||||||+||+++.++.++|+|||++......
T Consensus        84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-TTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            99999999999999999988999999999999999999999998 99999999999999999999999999988654322


Q ss_pred             CCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018018          223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  302 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (362)
                        ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+.       ......+.....  ..+..++
T Consensus       163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~--~~~~~~~  231 (279)
T 3fdn_A          163 --RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRVEF--TFPDFVT  231 (279)
T ss_dssp             -------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCC--CCCTTSC
T ss_pred             --cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-------HHHHHHHHhCCC--CCCCcCC
Confidence              23456789999999999999999999999999999999999999976432       223333333222  2345688


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      +.+.+||.+||+.||++|||++|+++||||+...+.
T Consensus       232 ~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~  267 (279)
T 3fdn_A          232 EGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK  267 (279)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred             HHHHHHHHHHhccChhhCCCHHHHhhCccccCCccC
Confidence            999999999999999999999999999999876543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6.6e-51  Score=382.39  Aligned_cols=265  Identities=27%  Similarity=0.409  Sum_probs=212.7

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      ...++|++.+.||+|+||.||+|++..+++.||||+++...   ....+.+|+.+++.++||||+++++++.+....++|
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            34578999999999999999999999999999999997543   345678899999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc---CCcEEEeeccCCcccccCC
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---~~~vkl~DFg~a~~~~~~~  223 (362)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||+ +||+||||||+||+++.   ++.+||+|||+++..... 
T Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-  204 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE-NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-  204 (349)
T ss_dssp             ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-
Confidence            9999999999999988889999999999999999999998 99999999999999975   889999999999865432 


Q ss_pred             CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CCCCCCCC
Q 018018          224 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQF  301 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  301 (362)
                      ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......      ......+.....  +......+
T Consensus       205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~i~~~~~~~~~~~~~~~  278 (349)
T 2w4o_A          205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD------QFMFRRILNCEYYFISPWWDEV  278 (349)
T ss_dssp             --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH------HHHHHHHHTTCCCCCTTTTTTS
T ss_pred             cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc------HHHHHHHHhCCCccCCchhhhC
Confidence            2334567999999999999999999999999999999999999999764321      123334433322  22334678


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCH
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL  342 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l  342 (362)
                      +.++.+||.+||+.||++|||+.|+++||||+........+
T Consensus       279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~  319 (349)
T 2w4o_A          279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFVHM  319 (349)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCSCC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchhhh
Confidence            99999999999999999999999999999999877655543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.8e-51  Score=397.67  Aligned_cols=268  Identities=23%  Similarity=0.322  Sum_probs=202.8

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec-----Ce
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GA  142 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~-----~~  142 (362)
                      .++|++++.||+|+||+||+|.+..+++.||||++... ........+.+|+.+++.++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            47899999999999999999999999999999998654 3445567899999999999999999999998533     57


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      +|+||||+. ++|.+++.....+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+.....
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHS-AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            999999984 6999999988899999999999999999999998 99999999999999999999999999999876422


Q ss_pred             C---------------------------CCCCccccCCcccCccee-cCCCCCccccHHHHHHHHHHHHc----------
Q 018018          223 S---------------------------GQANTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECAT----------  264 (362)
Q Consensus       223 ~---------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~ellt----------  264 (362)
                      .                           ......+||+.|+|||++ .+..|+.++|||||||++|||++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            1                           123446789999999986 45679999999999999999999          


Q ss_pred             -CCCCCCCCccCCc----------------hhhHHHHHHHHhcCCC-------------------C-------CCCCCCC
Q 018018          265 -GQFPYSPPEQQDG----------------WTSFYELMEAIVDQPP-------------------P-------SAPSDQF  301 (362)
Q Consensus       265 -g~~pf~~~~~~~~----------------~~~~~~~~~~~~~~~~-------------------~-------~~~~~~~  301 (362)
                       |+++|.+.+....                .......+..+...+.                   +       .......
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             6677765431100                0000111111111000                   0       0112356


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      ++++.+||.+||+.||++|||++|+|+||||+.+...
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~  406 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA  406 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence            8999999999999999999999999999999988643

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-50  Score=383.72  Aligned_cols=259  Identities=25%  Similarity=0.435  Sum_probs=223.0

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc-hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            478999999999999999999999999999999997653 3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc--CCcEEEeeccCCcccccCCCC
Q 018018          149 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       149 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~--~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      |+.+++|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+|||++.  ++.+||+|||+++..... ..
T Consensus       129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~  206 (387)
T 1kob_A          129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EI  206 (387)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SC
T ss_pred             cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecccchHHeEEecCCCCceEEEecccceecCCC-cc
Confidence            99999999999765 479999999999999999999998 99999999999999974  467999999999876432 22


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCCCCCCCH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSP  303 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  303 (362)
                      ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.       .+....+....  .+......+++
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~  279 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LETLQNVKRCDWEFDEDAFSSVSP  279 (387)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred             eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCccccccCCH
Confidence            3345799999999999999999999999999999999999999986432       22333333222  22333457899


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ++.+||.+||+.||++|||++|+++||||+....
T Consensus       280 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  313 (387)
T 1kob_A          280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS  313 (387)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence            9999999999999999999999999999987543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.5e-51  Score=382.66  Aligned_cols=255  Identities=26%  Similarity=0.403  Sum_probs=214.0

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC-------
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-------  141 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~-------  141 (362)
                      .++|++.+.||+|+||.||+|++..+|+.||||+++..........+.+|+.+++.++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            3679999999999999999999999999999999987666667788999999999999999999999886543       


Q ss_pred             --------------------------------------------------eEEEEEeccCCCCHHHHHHHcCC---CCHH
Q 018018          142 --------------------------------------------------AISIILEYMDGGSLADFLKKVKT---IPEE  168 (362)
Q Consensus       142 --------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~---l~~~  168 (362)
                                                                        ..++||||+++++|.+++.....   .++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              38999999999999999987543   4666


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC------------CCCCccccCCccc
Q 018018          169 YLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS------------GQANTFVGTYNYM  236 (362)
Q Consensus       169 ~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~------------~~~~~~~gt~~y~  236 (362)
                      .++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++......            ......+||+.|+
T Consensus       165 ~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  243 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHS-KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM  243 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred             HHHHHHHHHHHHHHHHHh-CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence            789999999999999998 999999999999999999999999999998765432            1223457999999


Q ss_pred             CcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 018018          237 SPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKE  316 (362)
Q Consensus       237 aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  316 (362)
                      |||++.+..++.++|||||||++|+|++|..|+.         ..............+ ......++++.+||.+||+.|
T Consensus       244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~---------~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~  313 (332)
T 3qd2_B          244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM---------ERVRIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPS  313 (332)
T ss_dssp             CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH---------HHHHHHHHHHTTCCC-HHHHHHCHHHHHHHHHHHCSS
T ss_pred             ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh---------HHHHHHHHhhccCCC-cccccCChhHHHHHHHHccCC
Confidence            9999999999999999999999999999876652         222333333333322 122345678899999999999


Q ss_pred             cCCCCCHHHHHcCCcccc
Q 018018          317 PQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       317 P~~Rpt~~eil~hp~~~~  334 (362)
                      |++|||++|+++||||++
T Consensus       314 p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          314 PTERPEATDIIENAIFEN  331 (332)
T ss_dssp             GGGSCCHHHHHHSTTCCC
T ss_pred             CCcCCCHHHHhhchhhhc
Confidence            999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=9.4e-51  Score=368.01  Aligned_cols=262  Identities=26%  Similarity=0.452  Sum_probs=225.9

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .++|++.+.||+|+||.||++.+..+++.||+|++...........+.+|+.+++.++||||+++++.+.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            36899999999999999999999999999999999866555566789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC--CCC
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQA  226 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~--~~~  226 (362)
                      |+++++|.+++.....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.+||+|||++.......  ...
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence            99999999999887889999999999999999999998 999999999999999999999999999997654322  223


Q ss_pred             CccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          227 NTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      ....|++.|+|||++.+..+ +.++||||||+++|+|++|..||.......      ..................+++.+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~  238 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEKKTYLNPWKKIDSAP  238 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTS------HHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHH------HHHHHhhhcccccCchhhcCHHH
Confidence            45678999999999988775 789999999999999999999997754432      11222222222223345689999


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          306 CSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      .+||.+||+.||++|||++|+++||||+....
T Consensus       239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          239 LALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence            99999999999999999999999999987654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=9.9e-51  Score=399.90  Aligned_cols=265  Identities=27%  Similarity=0.462  Sum_probs=229.6

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      .+..++|++.+.||+|+||.||+|+++.+|+.||||+++...  .......+.+|+.+++.++||||+++++.+.+...+
T Consensus       181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEE
Confidence            456789999999999999999999999999999999997542  122346788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          144 SIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      |+||||++||+|.+++...    ..+++..++.++.|++.||.|||+ +||+||||||+|||++.+|++||+|||+++..
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~-~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ-RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH-cCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            9999999999999999763    369999999999999999999998 99999999999999999999999999999876


Q ss_pred             ccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          220 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      ..........+||+.|+|||++.+..++.++|||||||++|||++|..||.+......   ..++...+.....  ..+.
T Consensus       340 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~---~~~~~~~i~~~~~--~~p~  414 (543)
T 3c4z_A          340 KAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE---NKELKQRVLEQAV--TYPD  414 (543)
T ss_dssp             CTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC---HHHHHHHHHHCCC--CCCT
T ss_pred             cCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh---HHHHHHHHhhccc--CCCc
Confidence            6544445567899999999999999999999999999999999999999987543322   2334444444432  2346


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCC-----HHHHHcCCcccccC
Q 018018          300 QFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYG  336 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt-----~~eil~hp~~~~~~  336 (362)
                      .+++++.+||.+||+.||++||+     ++++++||||+...
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~  456 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS  456 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence            78999999999999999999996     58999999999764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=8.7e-51  Score=370.80  Aligned_cols=256  Identities=27%  Similarity=0.497  Sum_probs=214.4

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .++|.+.+.||+|+||.||++++..++..+|+|++...........+.+|+++++.++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            37899999999999999999999999999999999876555556788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEE---ccCCcEEEeeccCCccccc
Q 018018          149 YMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       149 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll---~~~~~vkl~DFg~a~~~~~  221 (362)
                      |+++++|.+++..    ...+++..++.++.|++.||+|||+ +||+||||||+||++   +.++.+||+|||++.....
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS-QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            9999999999854    3689999999999999999999998 999999999999999   4567899999999976543


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh-cCCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV-DQPPPSAPSDQ  300 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  300 (362)
                      . .......||+.|+|||++. +.++.++||||||+++|+|++|..||.+.+.       ........ ...........
T Consensus       180 ~-~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~  250 (285)
T 3is5_A          180 D-EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-------EEVQQKATYKEPNYAVECRP  250 (285)
T ss_dssp             --------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCC--CC
T ss_pred             c-ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-------HHHHhhhccCCcccccccCc
Confidence            3 2344567999999999986 5689999999999999999999999976432       12222222 22222223345


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      +++++.+||.+||+.||++|||++|+++||||+.
T Consensus       251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            7899999999999999999999999999999985

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=6.7e-51  Score=402.38  Aligned_cols=264  Identities=28%  Similarity=0.487  Sum_probs=227.4

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      .+..++|++.+.||+|+||.||+|++..+|+.||+|++....  .......+.+|+.+++.++||||+++++.+.+...+
T Consensus       180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence            356789999999999999999999999999999999997542  222345678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          144 SIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      |+||||++||+|.+++...+  .+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+....
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~-~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR-ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999999997754  49999999999999999999998 9999999999999999999999999999987643


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      . ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+........   .+...+....  ...+..+
T Consensus       339 ~-~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~---~i~~~i~~~~--~~~p~~~  412 (576)
T 2acx_A          339 G-QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EVERLVKEVP--EEYSERF  412 (576)
T ss_dssp             T-CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH---HHHHHHHHCC--CCCCTTS
T ss_pred             C-ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH---HHHHHhhccc--ccCCccC
Confidence            2 23345689999999999999999999999999999999999999998765433222   3333333332  2234678


Q ss_pred             CHHHHHHHHHhhhcCcCCCC-----CHHHHHcCCcccccC
Q 018018          302 SPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      ++++.+||.+||+.||++||     +++|+++||||+...
T Consensus       413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~  452 (576)
T 2acx_A          413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN  452 (576)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred             CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence            99999999999999999999     899999999998754

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.9e-51  Score=412.91  Aligned_cols=261  Identities=27%  Similarity=0.500  Sum_probs=230.2

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCe
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~  142 (362)
                      .+..++|++++.||+|+||.||++++..+++.||||+++...  .......+..|..++..+ +||+|+.+++.+.+.+.
T Consensus       337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~  416 (674)
T 3pfq_A          337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR  416 (674)
T ss_dssp             ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred             cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence            456789999999999999999999999999999999997542  223446678888888876 69999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      +|+||||++||+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+.....
T Consensus       417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  495 (674)
T 3pfq_A          417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQS-KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD  495 (674)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred             EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence            99999999999999999998999999999999999999999998 99999999999999999999999999999875555


Q ss_pred             CCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018018          223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  302 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (362)
                      .......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+.       .++...+......  .+..++
T Consensus       496 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~~~--~p~~~s  566 (674)
T 3pfq_A          496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-------DELFQSIMEHNVA--YPKSMS  566 (674)
T ss_dssp             TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHSSCCC--CCTTSC
T ss_pred             CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-------HHHHHHHHhCCCC--CCccCC
Confidence            5556678999999999999999999999999999999999999999987433       3555666655433  345799


Q ss_pred             HHHHHHHHHhhhcCcCCCCCH-----HHHHcCCcccccC
Q 018018          303 PEFCSFISACVQKEPQQRLSA-----QELMTHPFLKMYG  336 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~-----~eil~hp~~~~~~  336 (362)
                      +++.+||.+||+.||++||++     +||++||||+..+
T Consensus       567 ~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~  605 (674)
T 3pfq_A          567 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID  605 (674)
T ss_dssp             HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred             HHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence            999999999999999999998     9999999998765

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.7e-51  Score=398.18  Aligned_cols=261  Identities=28%  Similarity=0.480  Sum_probs=228.5

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ...+..++|.+.+.||+|+||.||+|++..+|+.||||+++...  .......+.+|+.+++.++||||+++++++.+..
T Consensus        10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~   89 (476)
T 2y94_A           10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS   89 (476)
T ss_dssp             CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            44566789999999999999999999999999999999997542  1223567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .+++||||+++|+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHR-HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            999999999999999999988899999999999999999999998 9999999999999999999999999999987643


Q ss_pred             CCCCCCccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      . ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.       ......+..+...  .+..
T Consensus       169 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-------~~~~~~i~~~~~~--~p~~  238 (476)
T 2y94_A          169 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-------PTLFKKICDGIFY--TPQY  238 (476)
T ss_dssp             T-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-------HHHHHHHHTTCCC--CCTT
T ss_pred             c-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-------HHHHHHHhcCCcC--CCcc
Confidence            2 33456689999999999998776 7899999999999999999999976432       2344555544432  3456


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      +++++.+||.+||+.||++|||++|+++||||+..
T Consensus       239 ~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          239 LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             CCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            89999999999999999999999999999999753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.7e-50  Score=367.87  Aligned_cols=261  Identities=26%  Similarity=0.365  Sum_probs=229.6

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ...+|.+.+.||+|+||.||++.+..+++.||+|++...  ........+.+|+.+++.++||||+++++++.+.+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            458899999999999999999999999999999998765  244566788999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      ||||+++++|.+++.....+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++.........
T Consensus        93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  171 (294)
T 2rku_A           93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  171 (294)
T ss_dssp             EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence            99999999999999988899999999999999999999998 99999999999999999999999999999876544444


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|..||.....       .+....+....  ...+..+++.+
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~--~~~~~~~~~~~  242 (294)
T 2rku_A          172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYLRIKKNE--YSIPKHINPVA  242 (294)
T ss_dssp             BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTC--CCCCTTSCHHH
T ss_pred             cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHhhcc--CCCccccCHHH
Confidence            5567899999999999999999999999999999999999999976432       22233333332  22345788999


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          306 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      .++|.+||+.||++|||++|+++||||+.....
T Consensus       243 ~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  275 (294)
T 2rku_A          243 ASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  275 (294)
T ss_dssp             HHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             HHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence            999999999999999999999999999866543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.2e-51  Score=387.41  Aligned_cols=262  Identities=26%  Similarity=0.450  Sum_probs=207.8

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecC--eEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNG--AIS  144 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~--~~~  144 (362)
                      .++|++++.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++.+. ||||+++++++...+  .+|
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            47899999999999999999999999999999998654 34455677889999999997 999999999987544  799


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC--
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST--  222 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~--  222 (362)
                      +||||+. ++|..++.. ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+.....  
T Consensus        88 lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  164 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHS-GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR  164 (388)
T ss_dssp             EEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred             EEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHh-CCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence            9999997 599999987 689999999999999999999998 99999999999999999999999999999865321  


Q ss_pred             -------------------CCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHH
Q 018018          223 -------------------SGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY  282 (362)
Q Consensus       223 -------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~  282 (362)
                                         .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+...   
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~---  241 (388)
T 3oz6_A          165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLE---  241 (388)
T ss_dssp             CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---
T ss_pred             ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---
Confidence                               112234689999999999987 678999999999999999999999998754432111   


Q ss_pred             HHHHHHhcCCCC------------------------------------------CCCCCCCCHHHHHHHHHhhhcCcCCC
Q 018018          283 ELMEAIVDQPPP------------------------------------------SAPSDQFSPEFCSFISACVQKEPQQR  320 (362)
Q Consensus       283 ~~~~~~~~~~~~------------------------------------------~~~~~~~~~~~~~li~~~L~~dP~~R  320 (362)
                      .+.. ....+..                                          ......+++++.+||.+||+.||++|
T Consensus       242 ~i~~-~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          242 RIIG-VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHH-HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHH-hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence            1111 1110000                                          00123678999999999999999999


Q ss_pred             CCHHHHHcCCcccccCC
Q 018018          321 LSAQELMTHPFLKMYGD  337 (362)
Q Consensus       321 pt~~eil~hp~~~~~~~  337 (362)
                      ||++|+++||||+.+..
T Consensus       321 ~t~~e~l~Hp~~~~~~~  337 (388)
T 3oz6_A          321 ISANDALKHPFVSIFHN  337 (388)
T ss_dssp             CCHHHHTTSTTTTTTCC
T ss_pred             CCHHHHhCCHHHHHhcC
Confidence            99999999999987653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9.4e-51  Score=370.64  Aligned_cols=274  Identities=36%  Similarity=0.662  Sum_probs=218.2

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHH-HHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA-RRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      ++..++|++.+.||+|+||.||++++..+|+.||+|+++....... ...+.++...++.++||||+++++++.+.+..+
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~   82 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW   82 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence            4677999999999999999999999999999999999976644433 344455555688899999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC-CeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          145 IILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~-~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      +||||+++ +|.+++..    ...+++..++.++.|++.||+|||+ + |++||||||+||+++.++.+||+|||++...
T Consensus        83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            99999975 88887754    4689999999999999999999998 7 9999999999999999999999999999776


Q ss_pred             ccCCCCCCccccCCcccCccee----cCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018018          220 ASTSGQANTFVGTYNYMSPERI----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  295 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (362)
                      .... ......||+.|+|||++    .+..++.++||||+|+++|+|++|..||.....      .............+.
T Consensus       161 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~~~  233 (290)
T 3fme_A          161 VDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT------PFQQLKQVVEEPSPQ  233 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC------HHHHHHHHHHSCCCC
T ss_pred             cccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc------hHHHHHHHhccCCCC
Confidence            4332 23345799999999996    556789999999999999999999999975321      122333333444444


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHHH
Q 018018          296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD  348 (362)
Q Consensus       296 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~~  348 (362)
                      .....+++++.+||.+||+.||++|||++|+++||||+...+...+...+++.
T Consensus       234 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~~~~~~~~~~~  286 (290)
T 3fme_A          234 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKGTDVASFVKL  286 (290)
T ss_dssp             CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCCCHHHHHHH
T ss_pred             cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcccccCHHHHHHH
Confidence            45567899999999999999999999999999999999988888888877664

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-51  Score=376.45  Aligned_cols=263  Identities=24%  Similarity=0.422  Sum_probs=208.6

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc----hHHHHHHHHHHHHHhcC---CCCcceEEeeeEEe
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE----ESARRQIAQELKINQSS---QCPYVVVCYQSFYS  139 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~~e~~~~~~l---~hp~I~~~~~~~~~  139 (362)
                      +..++|++.+.||+|+||+||++++..+++.||||+++....    ......+.+|+.+++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            345899999999999999999999999999999999874421    11123445566655554   59999999999887


Q ss_pred             cC-----eEEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEee
Q 018018          140 NG-----AISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD  212 (362)
Q Consensus       140 ~~-----~~~lV~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~D  212 (362)
                      ..     ..++||||+. ++|.+++.....  +++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA-NCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEcCCCCEEEee
Confidence            65     5899999997 599999987654  9999999999999999999998 9999999999999999999999999


Q ss_pred             ccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       213 Fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                      ||+|+..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+   ....+..... ..
T Consensus       164 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~-~~  238 (308)
T 3g33_A          164 FGLARIYSYQ-MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLIG-LP  238 (308)
T ss_dssp             CSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHHC-CC
T ss_pred             CccccccCCC-cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhC-CC
Confidence            9999865432 33455689999999999999999999999999999999999999998754322   1112222221 11


Q ss_pred             CCCC----------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          293 PPSA----------------------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       293 ~~~~----------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ....                      ....+++++.+||.+||+.||++|||++|+++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            1110                      1135788999999999999999999999999999998754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.7e-50  Score=375.04  Aligned_cols=260  Identities=27%  Similarity=0.425  Sum_probs=225.1

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch-----HHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      .++|++.+.||+|+||.||+|++..+|+.||+|+++.....     .....+.+|+.+++.++||||+++++.+.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            47899999999999999999999999999999999765322     1356789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC----cEEEeeccCCccc
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIM  219 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~----~vkl~DFg~a~~~  219 (362)
                      ++||||+++++|.+++.....+++..++.++.|++.||+|||+ +|++||||||+||+++.++    .+||+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT-KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence            9999999999999999988899999999999999999999998 9999999999999999888    7999999999876


Q ss_pred             ccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC--CC
Q 018018          220 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--AP  297 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~  297 (362)
                      ... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+...       .+....+.......  ..
T Consensus       170 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~  241 (321)
T 2a2a_A          170 EDG-VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANITSVSYDFDEEF  241 (321)
T ss_dssp             CTT-CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHTTCCCCCHHH
T ss_pred             Ccc-ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhcccccChhh
Confidence            533 233456799999999999999999999999999999999999999976432       23333443332211  12


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ...+++.+.+||.+||+.||++|||++|+++||||+....
T Consensus       242 ~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~  281 (321)
T 2a2a_A          242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDN  281 (321)
T ss_dssp             HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSH
T ss_pred             hcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCc
Confidence            2467899999999999999999999999999999987653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-50  Score=367.49  Aligned_cols=259  Identities=28%  Similarity=0.475  Sum_probs=198.9

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ..++|++.+.||+|+||.||++++..+|+.||+|++....  .......+.+|+.+++.++||||+++++.+.+....++
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYL   88 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEE
Confidence            4578999999999999999999999999999999987542  12234678899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          146 ILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      ||||+++++|.+++... ..+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++........
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS-HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             EEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             EEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            99999999999999875 679999999999999999999998 9999999999999999999999999999987654444


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......       .........  ...+..++++
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~--~~~~~~~~~~  238 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN-------TLNKVVLAD--YEMPSFLSIE  238 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSSC--CCCCTTSCHH
T ss_pred             cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH-------HHHHHhhcc--cCCccccCHH
Confidence            4455679999999999999899999999999999999999999997654322       112222111  2234568899


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          305 FCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      +.+||.+||+.||++|||++++++||||+...
T Consensus       239 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          239 AKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            99999999999999999999999999998754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-50  Score=372.08  Aligned_cols=253  Identities=26%  Similarity=0.394  Sum_probs=208.4

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHH-hcCCCCcceEEeeeEEecCeEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~-~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ..++|++.+.||+|+||+||+|++..+|+.||||++... ...........|+..+ +..+||||+++++++.+.+..++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            347899999999999999999999999999999998654 2233334444455444 44599999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          146 ILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      ||||+ +++|.+++... ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||++...... .
T Consensus       135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~  211 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS-QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-G  211 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEECCCCCEEEccceeeeecccC-C
Confidence            99999 56999988664 469999999999999999999998 99999999999999999999999999998776433 2


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      ......||+.|+|||++.+ .++.++|||||||++|||++|..||...          .....+.....+......++++
T Consensus       212 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~  280 (311)
T 3p1a_A          212 AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGWQQLRQGYLPPEFTAGLSSE  280 (311)
T ss_dssp             ---CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHHHHHTTTCCCHHHHTTSCHH
T ss_pred             CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHHHHHhccCCCcccccCCCHH
Confidence            3345579999999999886 7999999999999999999997666442          1222333333333344578999


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          305 FCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      +.+||.+||+.||++|||++|+++||||+.
T Consensus       281 l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          281 LRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            999999999999999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.2e-50  Score=386.82  Aligned_cols=269  Identities=25%  Similarity=0.355  Sum_probs=214.1

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec-----Ce
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GA  142 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~-----~~  142 (362)
                      .++|++.+.||+|+||.||+|.+..+++.||||+++.. ........+.+|+.+++.++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            48899999999999999999999999999999999754 3445567899999999999999999999998766     67


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      +|+||||+. ++|.+++.....+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+.....
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~-~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~  182 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE-SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE  182 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred             EEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence            999999996 5999999988889999999999999999999998 99999999999999999999999999999876433


Q ss_pred             CC----------------------CCCccccCCcccCccee-cCCCCCccccHHHHHHHHHHHHcCCCCC----------
Q 018018          223 SG----------------------QANTFVGTYNYMSPERI-SGGKYGYKSDIWSLGLVLLECATGQFPY----------  269 (362)
Q Consensus       223 ~~----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~elltg~~pf----------  269 (362)
                      ..                      .....+||+.|+|||++ .+..++.++|||||||++|||++|..||          
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~  262 (432)
T 3n9x_A          183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL  262 (432)
T ss_dssp             ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCS
T ss_pred             ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccccc
Confidence            21                      23567899999999986 5566999999999999999999854444          


Q ss_pred             -CCCccCC--------------chhhHHHHHH--------------------HHhcCCCCCC-----CCCCCCHHHHHHH
Q 018018          270 -SPPEQQD--------------GWTSFYELME--------------------AIVDQPPPSA-----PSDQFSPEFCSFI  309 (362)
Q Consensus       270 -~~~~~~~--------------~~~~~~~~~~--------------------~~~~~~~~~~-----~~~~~~~~~~~li  309 (362)
                       .+.+...              .......++.                    .+........     ....+++++.+||
T Consensus       263 f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl  342 (432)
T 3n9x_A          263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLL  342 (432)
T ss_dssp             CCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHH
T ss_pred             CCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHH
Confidence             3322100              0000001111                    1111111000     0135789999999


Q ss_pred             HHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          310 SACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                      .+||+.||++|||++|+++||||+.+.+..
T Consensus       343 ~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~  372 (432)
T 3n9x_A          343 ESMLKFNPNKRITIDQALDHPYLKDVRKKK  372 (432)
T ss_dssp             HHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred             HHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence            999999999999999999999999886544

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=7.3e-50  Score=365.23  Aligned_cols=259  Identities=29%  Similarity=0.475  Sum_probs=222.5

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe----cC
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS----NG  141 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~----~~  141 (362)
                      .....|.+.+.||+|+||.||++.+..++..||+|++... ........+.+|+.+++.++||||+++++++..    ..
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence            3456689999999999999999999999999999998765 345567789999999999999999999998875    45


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCC--eEeecCCCCcEEEc-cCCcEEEeeccCCcc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLIN-HRGEVKITDFGVSAI  218 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~-~~~~vkl~DFg~a~~  218 (362)
                      .+++||||+++++|.+++.....+++..++.++.|++.||.|||+ +|  ++||||||+||+++ .++.+||+|||++..
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHc-CCCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            689999999999999999998999999999999999999999998 88  99999999999997 789999999999865


Q ss_pred             cccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          219 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      ...  .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.....      .......+.....+....
T Consensus       182 ~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~~~  252 (290)
T 1t4h_A          182 KRA--SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN------AAQIYRRVTSGVKPASFD  252 (290)
T ss_dssp             CCT--TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS------HHHHHHHHTTTCCCGGGG
T ss_pred             ccc--cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc------HHHHHHHHhccCCccccC
Confidence            432  23344579999999998874 589999999999999999999999976432      234445555555555556


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      ...++++.+||.+||+.||++|||++|+++||||+..
T Consensus       253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            6778999999999999999999999999999999863

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.9e-50  Score=384.77  Aligned_cols=260  Identities=27%  Similarity=0.435  Sum_probs=209.1

Q ss_pred             CccCceee-eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHH-hcCCCCcceEEeeeEEe----cC
Q 018018           68 NLEDIDTI-KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYS----NG  141 (362)
Q Consensus        68 ~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~-~~l~hp~I~~~~~~~~~----~~  141 (362)
                      ..++|.+. +.||+|+||+||++.+..+|+.||||+++..      ..+.+|+.++ +..+||||+++++++..    ..
T Consensus        59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~  132 (400)
T 1nxk_A           59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK  132 (400)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence            35778887 7899999999999999999999999998643      2455677765 55689999999998875    67


Q ss_pred             eEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc---CCcEEEeeccCC
Q 018018          142 AISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVS  216 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---~~~vkl~DFg~a  216 (362)
                      .+|+||||++||+|.+++....  .+++..++.++.|++.||.|||+ +||+||||||+|||++.   ++.+||+|||++
T Consensus       133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            7999999999999999998643  59999999999999999999998 99999999999999987   789999999999


Q ss_pred             cccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018018          217 AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  296 (362)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
                      +..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.............+. ......+..
T Consensus       212 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~-~~~~~~~~~  289 (400)
T 1nxk_A          212 KETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-MGQYEFPNP  289 (400)
T ss_dssp             EECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH-HTCCCCCTT
T ss_pred             cccCCC-CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH-cCcccCCCc
Confidence            865432 234456899999999999999999999999999999999999999987654332222222211 112222333


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ....+++++.+||.+||+.||++|||++|+++||||....
T Consensus       290 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  329 (400)
T 1nxk_A          290 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  329 (400)
T ss_dssp             TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred             ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence            3457899999999999999999999999999999997654

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.6e-50  Score=366.18  Aligned_cols=261  Identities=31%  Similarity=0.494  Sum_probs=226.7

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      ..+..++|++.+.||+|+||.||++++..+++.||+|++....  .......+.+|+.+++.++||||+++++++.+.+.
T Consensus         9 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   88 (284)
T 2vgo_A            9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR   88 (284)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             cchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE
Confidence            4567799999999999999999999999999999999986542  12234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      .++||||+++++|.+++.....+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++......
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE-RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            99999999999999999988899999999999999999999998 99999999999999999999999999998765432


Q ss_pred             CCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCC
Q 018018          223 SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS  302 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (362)
                        ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+.       ......+.....  ..+..++
T Consensus       168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~--~~~~~~~  236 (284)
T 2vgo_A          168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH-------TETHRRIVNVDL--KFPPFLS  236 (284)
T ss_dssp             --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCC--CCCTTSC
T ss_pred             --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH-------hHHHHHHhcccc--CCCCcCC
Confidence              23456799999999999999999999999999999999999999976432       223333433332  2335689


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      +++.++|.+||+.||++|||++++++||||+....
T Consensus       237 ~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          237 DGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             HHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            99999999999999999999999999999986643

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.2e-50  Score=369.91  Aligned_cols=268  Identities=35%  Similarity=0.573  Sum_probs=232.4

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .+.|++.+.||+|+||.||++.+..+++.||+|++...........+.+|+.+++.++||||+++++.+.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            46799999999999999999999999999999999876555567789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      |+++++|.+++.. ..+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.+||+|||++............
T Consensus       101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  178 (303)
T 3a7i_A          101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHS-EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT  178 (303)
T ss_dssp             CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence            9999999999976 679999999999999999999998 99999999999999999999999999999877655444556


Q ss_pred             cccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018018          229 FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  308 (362)
Q Consensus       229 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  308 (362)
                      ..|++.|+|||++.+..++.++||||||+++|+|++|..||.....       ......+.... ++.....+++.+.+|
T Consensus       179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~-~~~~~~~~~~~l~~l  250 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP-------MKVLFLIPKNN-PPTLEGNYSKPLKEF  250 (303)
T ss_dssp             CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSC-CCCCCSSCCHHHHHH
T ss_pred             cCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH-------HHHHHHhhcCC-CCCCccccCHHHHHH
Confidence            7899999999999999999999999999999999999999976432       12222333332 233456789999999


Q ss_pred             HHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHH
Q 018018          309 ISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF  346 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~  346 (362)
                      |.+||+.||++|||++++++||||.......-.+.+.+
T Consensus       251 i~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~~~~  288 (303)
T 3a7i_A          251 VEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELI  288 (303)
T ss_dssp             HHHHCCSSGGGSCCHHHHTTCHHHHHHCCCGGGGHHHH
T ss_pred             HHHHcCCChhhCcCHHHHhhChhhhcCCCccHHHHHHH
Confidence            99999999999999999999999987765554444433

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.9e-50  Score=365.28  Aligned_cols=257  Identities=28%  Similarity=0.411  Sum_probs=221.9

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .++|++.+.||+|+||.||++.+..++..+|+|++..... .....+.+|+.+++.++||||+++++.+.+....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV-EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc-chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            3679999999999999999999999999999999876532 235678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEE---ccCCcEEEeeccCCcccccCCCC
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll---~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      |+++++|.+++.....+++..++.++.|++.||+|||+ +|++||||||+||++   +.++.+||+|||++...... ..
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-~~  164 (277)
T 3f3z_A           87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KM  164 (277)
T ss_dssp             CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-SC
T ss_pred             ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-cc
Confidence            99999999999988999999999999999999999998 999999999999999   78889999999999775433 33


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC--CCCCCCH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA--PSDQFSP  303 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  303 (362)
                      .....||+.|+|||++.+. ++.++||||||+++|+|++|..||...+.       .+....+........  ....+++
T Consensus       165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~  236 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD-------SEVMLKIREGTFTFPEKDWLNVSP  236 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred             hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCCCCCchhhhcCCH
Confidence            4556799999999998764 89999999999999999999999976433       233334433332221  1236789


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      .+.+||.+||+.||++|||+.++++||||+..-
T Consensus       237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            999999999999999999999999999997643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.6e-50  Score=396.13  Aligned_cols=262  Identities=27%  Similarity=0.479  Sum_probs=224.4

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      .++|++.+.||+|+||+||+|++..+++.||||++.... .......+.+|+.+++.++||||+++++++.+...+++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            488999999999999999999999999999999986542 2233567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEc---cCCcEEEeeccCCcccccCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN---HRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~---~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      ||+.+++|.+++.....+++..++.++.|++.||.|||+ +||+||||||+|||++   .++.+||+|||+|+..... .
T Consensus       101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~  178 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-T  178 (486)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred             EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-C
Confidence            999999999999888999999999999999999999998 9999999999999995   4567999999999876433 2


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--CCCCCCCC
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFS  302 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  302 (362)
                      .....+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.       .+....+......  .+.+..++
T Consensus       179 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s  250 (486)
T 3mwu_A          179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVETGKYAFDLPQWRTIS  250 (486)
T ss_dssp             ---CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCSCSGGGGGSC
T ss_pred             ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCCcccCCCC
Confidence            3445689999999999986 599999999999999999999999977433       2344444444322  22335689


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCC
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNV  340 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~  340 (362)
                      +++.+||.+||+.||++|||+.++++||||+.+.....
T Consensus       251 ~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~  288 (486)
T 3mwu_A          251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETP  288 (486)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCc
Confidence            99999999999999999999999999999998876543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6e-50  Score=373.72  Aligned_cols=260  Identities=26%  Similarity=0.370  Sum_probs=228.6

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      ....+|.+.+.||+|+||.||++.+..+++.||+|++...  ........+.+|+.+++.++||||+++++++.+.+..+
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            3457899999999999999999999999999999998765  24456778899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      +||||+.+++|.+++.....+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++........
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR-NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            999999999999999988899999999999999999999998 9999999999999999999999999999987654444


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      ......||+.|+|||++.+..++.++||||||+++|+|++|..||.....       .+....+.....  ..+..+++.
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~--~~~~~~~~~  267 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-------KETYLRIKKNEY--SIPKHINPV  267 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCC--CCCTTSCHH
T ss_pred             cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-------HHHHHHHhcCCC--CCCccCCHH
Confidence            55567899999999999999999999999999999999999999976432       122223322222  234578899


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          305 FCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      +.+||.+||+.||++|||++|+++||||+...
T Consensus       268 ~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          268 AASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence            99999999999999999999999999997654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=7.2e-50  Score=367.82  Aligned_cols=263  Identities=27%  Similarity=0.446  Sum_probs=224.3

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .++|.+.+.||+|+||.||++++..+|+.||+|+++... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP-AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc-ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            368999999999999999999999999999999997552 2234568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEE---ccCCcEEEeeccCCcccccCCCC
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll---~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+ +|++||||||+||++   +.++.+||+|||++.....  ..
T Consensus        87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~--~~  163 (304)
T 2jam_A           87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHE-NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GI  163 (304)
T ss_dssp             CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--BT
T ss_pred             cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--Cc
Confidence            99999999999888899999999999999999999998 999999999999999   7788999999999875432  22


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CCCCCCCCCH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSP  303 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  303 (362)
                      .....|++.|+|||++.+..++.++||||||+++|+|++|..||.....       ......+.....  +......+++
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~~  236 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-------SKLFEKIKEGYYEFESPFWDDISE  236 (304)
T ss_dssp             THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred             cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCCCCccccccCCH
Confidence            3445789999999999999999999999999999999999999976432       233334433322  2333467899


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCH
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDL  342 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l  342 (362)
                      ++.+||.+||+.||++|||++|+++||||+.......++
T Consensus       237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~~  275 (304)
T 2jam_A          237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDI  275 (304)
T ss_dssp             HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSCCCCC
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcCccccCCCcccccc
Confidence            999999999999999999999999999998876544443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.3e-50  Score=394.03  Aligned_cols=263  Identities=24%  Similarity=0.430  Sum_probs=209.3

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec------C
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------G  141 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~------~  141 (362)
                      .++|++++.||+|+||+||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            57899999999999999999999999999999999765 3445567889999999999999999999998654      4


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .+|+||||+.+ +|.+.+..  .+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+....
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            67999999976 67777654  59999999999999999999998 9999999999999999999999999999987643


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH---------------H
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM---------------E  286 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~---------------~  286 (362)
                      . ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+..+.+..+....               .
T Consensus       217 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~  295 (464)
T 3ttj_A          217 S-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  295 (464)
T ss_dssp             C-CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHH
T ss_pred             C-cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhh
Confidence            2 23455789999999999999999999999999999999999999998765432222111110               0


Q ss_pred             HHhcCCCCCCC-------CCC-----------CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          287 AIVDQPPPSAP-------SDQ-----------FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       287 ~~~~~~~~~~~-------~~~-----------~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ......+....       +..           .++++.+||.+||++||++|||++|+++||||+.+.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          296 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             HHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             hHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence            01111000000       000           146789999999999999999999999999998764

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2e-50  Score=373.28  Aligned_cols=266  Identities=27%  Similarity=0.411  Sum_probs=214.1

Q ss_pred             cCceee-eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhc-CCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTI-KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS-SQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~-l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +.|++. +.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++.. .+||||+++++++.+.+..++||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            678885 78999999999999999999999999997653 3345678899999887 57999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc---EEEeeccCCcccccCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIMASTSG  224 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~---vkl~DFg~a~~~~~~~~  224 (362)
                      ||+++++|.+++.....+++..++.++.|++.||+|||+ +||+||||||+||+++.++.   +||+|||++........
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  169 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN-KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD  169 (316)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred             EcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence            999999999999988899999999999999999999998 99999999999999988776   99999999876542211


Q ss_pred             -------CCCccccCCcccCcceecC-----CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc-hh-------hHHHH
Q 018018          225 -------QANTFVGTYNYMSPERISG-----GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG-WT-------SFYEL  284 (362)
Q Consensus       225 -------~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~-~~-------~~~~~  284 (362)
                             .....+||+.|+|||++.+     ..++.++|||||||++|+|++|..||.+....+. |.       ....+
T Consensus       170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  249 (316)
T 2ac3_A          170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNML  249 (316)
T ss_dssp             ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHH
T ss_pred             cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHH
Confidence                   1233569999999999875     5588999999999999999999999987543221 11       11223


Q ss_pred             HHHHhcCCCCCC--CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          285 MEAIVDQPPPSA--PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       285 ~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ...+.......+  ....+++++.+||.+||+.||++|||++|+++||||+....
T Consensus       250 ~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          250 FESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             HHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             HHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence            444444332221  12468899999999999999999999999999999997644

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.1e-51  Score=381.61  Aligned_cols=265  Identities=25%  Similarity=0.427  Sum_probs=217.9

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ..+++|++.+.||+|+||.||++++..+|+.||+|++... ........+.+|+.+++.++||||+++++++.+.+..++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence            4678999999999999999999999999999999998655 344556778899999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      ||||+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+++........
T Consensus       102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  180 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHS-HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV  180 (331)
T ss_dssp             EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHH-CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence            99999999999988887899999999999999999999998 99999999999999999999999999999876655545


Q ss_pred             CCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc--------------
Q 018018          226 ANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD--------------  290 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--------------  290 (362)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+.   ..........              
T Consensus       181 ~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          181 YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ---LYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ---CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCChhhhhHhhhccc
Confidence            5566899999999999875 689999999999999999999999987543221   1111111100              


Q ss_pred             --CC-CCC--------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          291 --QP-PPS--------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       291 --~~-~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                        .. .+.        .....+++.+.+||.+||+.||++|||++|+++||||+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence              00 000        0113578999999999999999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.8e-50  Score=394.42  Aligned_cols=261  Identities=25%  Similarity=0.419  Sum_probs=223.2

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch------------HHHHHHHHHHHHHhcCCCCcceEEee
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE------------SARRQIAQELKINQSSQCPYVVVCYQ  135 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------~~~~~~~~e~~~~~~l~hp~I~~~~~  135 (362)
                      ..++|.+++.||+|+||+||+|++..+++.||+|+++.....            .....+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            347899999999999999999999999999999999764211            23567889999999999999999999


Q ss_pred             eEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC---cEEEee
Q 018018          136 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITD  212 (362)
Q Consensus       136 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~---~vkl~D  212 (362)
                      ++.+...+++||||+++|+|.+++.....+++..++.++.|++.||+|||+ +||+||||||+||+++.++   .+||+|
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHK-HNIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            999999999999999999999999988999999999999999999999998 9999999999999998776   699999


Q ss_pred             ccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       213 Fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                      ||+|...... ......+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+.       .+....+....
T Consensus       193 fg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~  263 (504)
T 3q5i_A          193 FGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND-------QDIIKKVEKGK  263 (504)
T ss_dssp             CTTCEECCTT-SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCC
T ss_pred             CCCCEEcCCC-CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCC
Confidence            9999876433 23455689999999999874 699999999999999999999999987433       24444444443


Q ss_pred             CCCC--CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          293 PPSA--PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       293 ~~~~--~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      ....  .+..+++++.+||.+||+.||++|||++|+++||||+.+...
T Consensus       264 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  311 (504)
T 3q5i_A          264 YYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN  311 (504)
T ss_dssp             CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred             CCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence            3221  235789999999999999999999999999999999887654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.6e-50  Score=375.67  Aligned_cols=261  Identities=26%  Similarity=0.445  Sum_probs=217.5

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCC--CcceEEeeeEEecCeE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQC--PYVVVCYQSFYSNGAI  143 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h--p~I~~~~~~~~~~~~~  143 (362)
                      +..++|++.+.||+|+||.||++.+. +++.||||++... ........+.+|+.++..++|  |||+++++++.+....
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~   84 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI   84 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence            45678999999999999999999885 6899999999765 345556788999999999976  9999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ++|||+ .+++|.+++.....+++..+..++.|++.||+|||+ +||+||||||+|||++ ++.+||+|||+++......
T Consensus        85 ~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~-~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           85 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            999995 577999999998999999999999999999999998 9999999999999995 7889999999998764332


Q ss_pred             C--CCCccccCCcccCcceecC-----------CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc
Q 018018          224 G--QANTFVGTYNYMSPERISG-----------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD  290 (362)
Q Consensus       224 ~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  290 (362)
                      .  .....+||+.|+|||++.+           ..++.++|||||||++|+|++|..||.....      ..........
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~------~~~~~~~~~~  235 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAIID  235 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHHC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh------HHHHHHHHhc
Confidence            2  2335679999999999864           6789999999999999999999999975322      1233444444


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          291 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       291 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      .......+...++++.+||.+||+.||++|||+.|+++||||+....
T Consensus       236 ~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  282 (343)
T 3dbq_A          236 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  282 (343)
T ss_dssp             TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred             CCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence            44445556677889999999999999999999999999999986543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-50  Score=379.70  Aligned_cols=264  Identities=24%  Similarity=0.435  Sum_probs=218.2

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc----chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV----EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      .++|++.+.||+|+||.||++.+..+++.||+|++....    .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            478999999999999999999999999999999987542    3345678999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc----------------------------------------CCCCHHHHHHHHHHHHHHHHHH
Q 018018          145 IILEYMDGGSLADFLKKV----------------------------------------KTIPEEYLAAICEQVLKGLLYL  184 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~----------------------------------------~~l~~~~~~~i~~ql~~al~~L  184 (362)
                      +||||+++|+|.+++...                                        ..+++..++.++.|++.||+||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            999999999999998521                                        1236788899999999999999


Q ss_pred             HhCCCeEeecCCCCcEEEccCC--cEEEeeccCCcccccCCC----CCCccccCCcccCcceecC--CCCCccccHHHHH
Q 018018          185 HHEKHIIHRDLKPSNLLINHRG--EVKITDFGVSAIMASTSG----QANTFVGTYNYMSPERISG--GKYGYKSDIWSLG  256 (362)
Q Consensus       185 H~~~~ivH~Dlkp~NIll~~~~--~vkl~DFg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG  256 (362)
                      |+ +||+||||||+||+++.++  .+||+|||+++.......    ......||+.|+|||++.+  ..++.++||||||
T Consensus       185 H~-~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG  263 (345)
T 3hko_A          185 HN-QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG  263 (345)
T ss_dssp             HH-TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHH
T ss_pred             HH-CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHH
Confidence            98 9999999999999998777  899999999986543222    2345679999999999976  6789999999999


Q ss_pred             HHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC--CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          257 LVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       257 ~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      |++|+|++|..||.+.+..       .....+.......  .....+++++.+||.+||+.||++|||+.++++||||+.
T Consensus       264 ~il~el~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~  336 (345)
T 3hko_A          264 VLLHLLLMGAVPFPGVNDA-------DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQ  336 (345)
T ss_dssp             HHHHHHHHSSCSSCCSSHH-------HHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHT
T ss_pred             HHHHHHHHCCCCCCCCChH-------HHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhcc
Confidence            9999999999999765332       2333333333222  222347899999999999999999999999999999998


Q ss_pred             cCCCCC
Q 018018          335 YGDLNV  340 (362)
Q Consensus       335 ~~~~~~  340 (362)
                      +.+.-.
T Consensus       337 ~~~~~~  342 (345)
T 3hko_A          337 FSDKIY  342 (345)
T ss_dssp             TSSCSS
T ss_pred             ChHhhE
Confidence            876543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=9.7e-51  Score=397.42  Aligned_cols=262  Identities=29%  Similarity=0.493  Sum_probs=226.6

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      ...++|++.+.||+|+||.||+|++..+|+.||||++....  .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            34578999999999999999999999999999999986542  2344677899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEE---ccCCcEEEeeccCCccccc
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll---~~~~~vkl~DFg~a~~~~~  221 (362)
                      +||||+.+++|.+++.....+++..+..++.|++.||+|||+ +||+||||||+||++   +.++.+||+|||+|+....
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  181 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK-NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA  181 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence            999999999999999988999999999999999999999998 999999999999999   5678999999999876543


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC--CCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--APSD  299 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  299 (362)
                      . ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.       .+....+.......  +.+.
T Consensus       182 ~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~  252 (484)
T 3nyv_A          182 S-KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE-------YDILKKVEKGKYTFELPQWK  252 (484)
T ss_dssp             C-CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCSGGGG
T ss_pred             c-cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHcCCCCCCCcccc
Confidence            2 23345679999999999976 699999999999999999999999987433       23444444443322  2335


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      .+++++.+||.+||+.||++|||++|+++||||+.+...
T Consensus       253 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~  291 (484)
T 3nyv_A          253 KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE  291 (484)
T ss_dssp             GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccc
Confidence            689999999999999999999999999999999887653

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.1e-50  Score=369.21  Aligned_cols=257  Identities=28%  Similarity=0.427  Sum_probs=211.0

Q ss_pred             CCCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           62 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        62 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      .....+..++|++.+.||+|+||+||++++  +|+.||+|++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus        29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  106 (309)
T 3p86_A           29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP  106 (309)
T ss_dssp             ---CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             cccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            345567789999999999999999999976  58899999987653 455567899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcCC---CCHHHHHHHHHHHHHHHHHHHhCCC--eEeecCCCCcEEEccCCcEEEeeccC
Q 018018          141 GAISIILEYMDGGSLADFLKKVKT---IPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLINHRGEVKITDFGV  215 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~~---l~~~~~~~i~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~vkl~DFg~  215 (362)
                      ...++||||+++++|.+++.....   +++..++.++.|++.||+|||+ +|  |+||||||+||+++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~  185 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGL  185 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT-SSSCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred             CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCEECCCCChhhEEEeCCCcEEECCCCC
Confidence            999999999999999999987543   9999999999999999999998 89  99999999999999999999999999


Q ss_pred             CcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018018          216 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  295 (362)
Q Consensus       216 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (362)
                      ++.............||+.|+|||++.+..++.++|||||||++|+|++|..||...+.       .+....+.......
T Consensus       186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~-------~~~~~~~~~~~~~~  258 (309)
T 3p86_A          186 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP-------AQVVAAVGFKCKRL  258 (309)
T ss_dssp             ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH-------HHHHHHHHHSCCCC
T ss_pred             CccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhcCCCC
Confidence            98665444445567899999999999999999999999999999999999999976433       23333333333344


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       296 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+..+++++.+||.+||+.||++|||++++++
T Consensus       259 ~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          259 EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            456789999999999999999999999999987

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.3e-50  Score=377.94  Aligned_cols=260  Identities=28%  Similarity=0.443  Sum_probs=214.8

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-----CCcceEEeeeE
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-----CPYVVVCYQSF  137 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----hp~I~~~~~~~  137 (362)
                      ....+..++|++.+.||+|+||+||+|++..+++.||||+++..  .........|+.+++.+.     ||||+++++.+
T Consensus        28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~  105 (360)
T 3llt_A           28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF  105 (360)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEE
T ss_pred             ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeeccccee
Confidence            34445568999999999999999999999999999999998743  344556778888888876     99999999999


Q ss_pred             EecCeEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc-----------
Q 018018          138 YSNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-----------  204 (362)
Q Consensus       138 ~~~~~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-----------  204 (362)
                      ...+..++||||+ +++|.+++....  .+++..++.++.|++.||+|||+ +||+||||||+|||++.           
T Consensus       106 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~~~~~  183 (360)
T 3llt_A          106 MYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLITVR  183 (360)
T ss_dssp             EETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred             eECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCcccEEEccccccccccchh
Confidence            9999999999999 889999998754  59999999999999999999998 99999999999999975           


Q ss_pred             --------------CCcEEEeeccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCC
Q 018018          205 --------------RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS  270 (362)
Q Consensus       205 --------------~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~  270 (362)
                                    ++.+||+|||+|+....   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             CTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             cccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCC
Confidence                          78999999999976432   2345688999999999999999999999999999999999999998


Q ss_pred             CCccCCchhhHHHHHHHHhcCCCC-----------------------------------------CCCCCCCCHHHHHHH
Q 018018          271 PPEQQDGWTSFYELMEAIVDQPPP-----------------------------------------SAPSDQFSPEFCSFI  309 (362)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~li  309 (362)
                      ..+..+    ....+.......+.                                         +......++.+.+||
T Consensus       261 ~~~~~~----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  336 (360)
T 3llt_A          261 THEHME----HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL  336 (360)
T ss_dssp             CSSHHH----HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred             CCcHHH----HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence            654321    11122221111100                                         000011247788999


Q ss_pred             HHhhhcCcCCCCCHHHHHcCCccc
Q 018018          310 SACVQKEPQQRLSAQELMTHPFLK  333 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~hp~~~  333 (362)
                      .+||+.||++|||++|+|+||||+
T Consensus       337 ~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          337 YSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHhcCChhhCCCHHHHhcCcccC
Confidence            999999999999999999999996

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.7e-50  Score=393.52  Aligned_cols=257  Identities=30%  Similarity=0.477  Sum_probs=218.6

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      .++|++++.||+|+||+||+|++..++..||+|+++... .......+.+|+.+++.++||||+++++++.+...+++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            367999999999999999999999999999999997652 2233567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC---CcEEEeeccCCcccccCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~---~~vkl~DFg~a~~~~~~~~  224 (362)
                      ||+.+|+|.+++.....+++..++.++.|++.||+|||+ +||+||||||+|||++..   +.+||+|||+|...... .
T Consensus       116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~  193 (494)
T 3lij_A          116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK-HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-K  193 (494)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-B
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-c
Confidence            999999999999988999999999999999999999998 999999999999999764   45999999999876533 2


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--CCCCCCCC
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFS  302 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  302 (362)
                      .....+||+.|+|||++. +.++.++||||+||++|+|++|..||.+.+.       .++...+......  ...+..++
T Consensus       194 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s  265 (494)
T 3lij_A          194 KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-------QEILRKVEKGKYTFDSPEWKNVS  265 (494)
T ss_dssp             CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCCCSGGGTTSC
T ss_pred             cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCchhcccCC
Confidence            345568999999999986 4699999999999999999999999987433       2344444444322  23345789


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      +.+.+||.+||+.||++|||++|+++||||+..
T Consensus       266 ~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          266 EGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            999999999999999999999999999999765

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2e-49  Score=363.37  Aligned_cols=263  Identities=27%  Similarity=0.468  Sum_probs=223.7

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--------chHHHHHHHHHHHHHhcCC-CCcceEEeeeEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--------EESARRQIAQELKINQSSQ-CPYVVVCYQSFY  138 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~  138 (362)
                      ..++|++.+.||+|+||.||++.+..+|+.||||+++...        .......+.+|+.+++.+. ||||+++++.+.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4589999999999999999999999999999999997542        1234567889999999985 999999999999


Q ss_pred             ecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          139 SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       139 ~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      .....++||||+++++|.+++.....+++..++.++.|++.||.|||+ +|++|+||||+||+++.++.+||+|||++..
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  173 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  173 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence            999999999999999999999988899999999999999999999998 9999999999999999999999999999977


Q ss_pred             cccCCCCCCccccCCcccCcceec------CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          219 MASTSGQANTFVGTYNYMSPERIS------GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                      .... .......|++.|+|||++.      ...++.++||||||+++|+|++|..||...+.       ......+....
T Consensus       174 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~  245 (298)
T 1phk_A          174 LDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------MLMLRMIMSGN  245 (298)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTC
T ss_pred             cCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-------HHHHHHHhcCC
Confidence            5432 2344567899999999985      45689999999999999999999999976432       22333333332


Q ss_pred             CC--CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          293 PP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       293 ~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                      ..  ......+++.+.+||.+||+.||++|||++|+++||||+......
T Consensus       246 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~  294 (298)
T 1phk_A          246 YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE  294 (298)
T ss_dssp             CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC---
T ss_pred             cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchh
Confidence            22  222346889999999999999999999999999999999876543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-50  Score=381.14  Aligned_cols=263  Identities=27%  Similarity=0.423  Sum_probs=212.1

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec------C
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------G  141 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~------~  141 (362)
                      .++|++++.||+|+||.||++.+..+|+.||||++... ........+.+|+.+++.++||||+++++++...      .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            47899999999999999999999999999999998654 3445567889999999999999999999998765      3


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .+|+||||+ +++|.+++.. ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++....
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            469999999 7799999987 679999999999999999999998 9999999999999999999999999999987542


Q ss_pred             CCCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH----------------
Q 018018          222 TSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL----------------  284 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~----------------  284 (362)
                         .....++|+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+...                
T Consensus       181 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~  257 (367)
T 1cm8_A          181 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE  257 (367)
T ss_dssp             ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred             ---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHH
Confidence               2445688999999999987 67999999999999999999999999875443221111110                


Q ss_pred             ----HHHHhcCC--CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          285 ----MEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       285 ----~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                          +.......  .........++++.+||.+||+.||++|||++|+++||||+.+.+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~  316 (367)
T 1cm8_A          258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD  316 (367)
T ss_dssp             HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred             HHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcC
Confidence                00000000  001122457899999999999999999999999999999988754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.4e-49  Score=373.25  Aligned_cols=256  Identities=31%  Similarity=0.520  Sum_probs=221.2

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +.|+..+.||+|+||+||+|++..+|+.||||++...  ........+.+|+++++.++||||+++++++.+....++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            5699999999999999999999999999999999764  23445678899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          148 EYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       148 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      ||+. |+|.+++. ....+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||++.....    .
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A  207 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----B
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC----C
Confidence            9997 58888885 45689999999999999999999998 9999999999999999999999999999976542    2


Q ss_pred             CccccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          227 NTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                      ...+||+.|+|||++.   ++.++.++|||||||++|||++|..||.+.+.       ......+.....+......+++
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~  280 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPALQSGHWSE  280 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCCCCCTTSCH
T ss_pred             CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-------HHHHHHHHhcCCCCCCCCCCCH
Confidence            3467999999999985   56789999999999999999999999976432       1223334444444445567899


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      .+.+||.+||+.||++|||++++++||||......
T Consensus       281 ~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~  315 (348)
T 1u5q_A          281 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  315 (348)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence            99999999999999999999999999999876543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.2e-49  Score=360.53  Aligned_cols=252  Identities=23%  Similarity=0.327  Sum_probs=212.5

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      .++|++.+.||+|+||+||++.+..+++.||+|+++.. ........+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            36899999999999999999999999999999999765 3344566788899988888 899999999999999999999


Q ss_pred             EeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC-----------------
Q 018018          147 LEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-----------------  205 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~-----------------  205 (362)
                      |||+++++|.+++...    ..+++..++.++.|++.||+|||+ +||+||||||+||+++.+                 
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~  168 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS-MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWAS  168 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEC-------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeecCCCHHHEEEcCCCCCcccccccccccccC
Confidence            9999999999999765    679999999999999999999998 999999999999999844                 


Q ss_pred             --CcEEEeeccCCcccccCCCCCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHH
Q 018018          206 --GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY  282 (362)
Q Consensus       206 --~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~  282 (362)
                        ..+||+|||++......    ....||+.|+|||++.+. .++.++|||||||++|+|++|..|+...+         
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---------  235 (289)
T 1x8b_A          169 NKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---------  235 (289)
T ss_dssp             -CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---------
T ss_pred             CceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---------
Confidence              47999999998876432    234689999999999876 56789999999999999999988775421         


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          283 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                       ....+..... +..+..+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus       236 -~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  287 (289)
T 1x8b_A          236 -QWHEIRQGRL-PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS  287 (289)
T ss_dssp             -HHHHHHTTCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred             -HHHHHHcCCC-CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence             1222333332 334567899999999999999999999999999999998753

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.1e-49  Score=379.44  Aligned_cols=261  Identities=26%  Similarity=0.441  Sum_probs=217.7

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCC--CCcceEEeeeEEecCeE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQ--CPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~--hp~I~~~~~~~~~~~~~  143 (362)
                      +...+|++.+.||+|+||.||++.+.. ++.||||++... ........+.+|+.+++.++  ||||+++++++.....+
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            445679999999999999999999875 999999999765 34556778999999999986  59999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ++||| +.+++|.+++.....+++..+..++.|++.||.|||+ +||+||||||+|||+ .++.+||+|||+++......
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~ivHrDlkp~NIll-~~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCCGGGEEE-SSSCEEECCCSSSCCC----
T ss_pred             EEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCHHHEEE-ECCeEEEEecCccccccCCC
Confidence            99999 5578999999998899999999999999999999998 999999999999999 46899999999998764332


Q ss_pred             C--CCCccccCCcccCcceecC-----------CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc
Q 018018          224 G--QANTFVGTYNYMSPERISG-----------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD  290 (362)
Q Consensus       224 ~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  290 (362)
                      .  .....+||+.|+|||++.+           ..++.++|||||||++|+|++|..||.....      ....+..+..
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~~~~~  282 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAIID  282 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC------HHHHHHHHHC
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH------HHHHHHHHhC
Confidence            2  2345689999999999875           4689999999999999999999999975322      1233444454


Q ss_pred             CCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          291 QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       291 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      .......+...++++.+||.+||+.||++|||+.|+++||||+....
T Consensus       283 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~  329 (390)
T 2zmd_A          283 PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  329 (390)
T ss_dssp             TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred             ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence            44444445567889999999999999999999999999999986653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-49  Score=368.53  Aligned_cols=262  Identities=34%  Similarity=0.621  Sum_probs=215.4

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEe-----
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYS-----  139 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~-----  139 (362)
                      ....++|++.+.||+|+||.||++++..+|+.||||++.....  ....+.+|+.+++.+ +||||+++++.+..     
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            3456889999999999999999999999999999999875532  235678899999888 79999999999886     


Q ss_pred             -cCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCC
Q 018018          140 -NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  216 (362)
Q Consensus       140 -~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a  216 (362)
                       ....++||||+++++|.+++...  ..+++..++.++.|++.||.|||+ +|++|+||||+||+++.++.+||+|||++
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ-HKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence             56899999999999999999764  579999999999999999999998 99999999999999999999999999999


Q ss_pred             cccccCCCCCCccccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC
Q 018018          217 AIMASTSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ  291 (362)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  291 (362)
                      ..............|++.|+|||++.     +..++.++|||||||++|+|++|..||.+.+.       ......+...
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~  249 (326)
T 2x7f_A          177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-------MRALFLIPRN  249 (326)
T ss_dssp             C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHS
T ss_pred             eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHhhcC
Confidence            87654444445568999999999987     56689999999999999999999999976432       1222333344


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          292 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       292 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ..+......+++.+.+||.+||+.||++|||++++++||||+....
T Consensus       250 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          250 PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence            4444455678999999999999999999999999999999987754

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.4e-50  Score=380.80  Aligned_cols=280  Identities=25%  Similarity=0.406  Sum_probs=215.4

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe-------
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-------  139 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~-------  139 (362)
                      ....+|++.+.||+|+||+||+|++..+|+.||||++.....     ...+|+.+++.++||||+++++++..       
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            345789999999999999999999999999999999865422     22379999999999999999998854       


Q ss_pred             -------------------------------cCeEEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHH
Q 018018          140 -------------------------------NGAISIILEYMDGGSLADFLK----KVKTIPEEYLAAICEQVLKGLLYL  184 (362)
Q Consensus       140 -------------------------------~~~~~lV~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~ql~~al~~L  184 (362)
                                                     ...+++||||+++ +|.+.+.    ....+++..++.++.|++.||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           3348999999985 8777664    357899999999999999999999


Q ss_pred             HhCCCeEeecCCCCcEEEc-cCCcEEEeeccCCcccccCCCCCCccccCCcccCcceecCCC-CCccccHHHHHHHHHHH
Q 018018          185 HHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLEC  262 (362)
Q Consensus       185 H~~~~ivH~Dlkp~NIll~-~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el  262 (362)
                      |+ +||+||||||+||+++ .++.+||+|||+|+..... .......+|+.|+|||++.+.. ++.++||||+||++|+|
T Consensus       158 H~-~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          158 HS-LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             HT-TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HH-CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence            98 9999999999999997 6889999999999876433 3345568899999999988754 89999999999999999


Q ss_pred             HcCCCCCCCCccCCchhhHHHHHHHHhcC---------------CCCC--------CCCCCCCHHHHHHHHHhhhcCcCC
Q 018018          263 ATGQFPYSPPEQQDGWTSFYELMEAIVDQ---------------PPPS--------APSDQFSPEFCSFISACVQKEPQQ  319 (362)
Q Consensus       263 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~---------------~~~~--------~~~~~~~~~~~~li~~~L~~dP~~  319 (362)
                      ++|+.||.+.+..+.   ...++......               ..+.        ..+..+++++.+||.+||+.||++
T Consensus       236 l~g~~pf~~~~~~~~---~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  312 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQ---LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL  312 (383)
T ss_dssp             HHSSCSSCCSSHHHH---HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred             HhCCCCCCCCChHHH---HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence            999999987543321   11222111100               0000        023457899999999999999999


Q ss_pred             CCCHHHHHcCCcccccCC-------CCCCHHHHHHHhCCCccccccCC
Q 018018          320 RLSAQELMTHPFLKMYGD-------LNVDLSEYFTDAGSPLATLSNLS  360 (362)
Q Consensus       320 Rpt~~eil~hp~~~~~~~-------~~~~l~~~~~~~~~~~~~~~~~~  360 (362)
                      |||+.|+++||||+...+       .+..+++   ....+++++++++
T Consensus       313 R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  357 (383)
T 3eb0_A          313 RINPYEAMAHPFFDHLRNSYESEVKNNSNFPH---GVNQNIPQLFNFS  357 (383)
T ss_dssp             SCCHHHHHTSGGGHHHHHC---------------------CCCCSCCC
T ss_pred             CCCHHHHhcCHHHHHHHhhccccccccccCCC---cccCCCCCCCCCC
Confidence            999999999999987643       2222222   2235677788775

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.2e-50  Score=361.68  Aligned_cols=261  Identities=26%  Similarity=0.449  Sum_probs=216.2

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ...+..++|.+.+.||+|+||.||++++..+|+.||+|++....  .......+.+|+.+++.++||||+++++.+.+.+
T Consensus         5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   84 (276)
T 2h6d_A            5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT   84 (276)
T ss_dssp             --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            34556789999999999999999999999999999999987542  2233567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ..++||||+++++|.+++.....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.+||+|||++.....
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR-HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            999999999999999999988899999999999999999999998 9999999999999999999999999999877543


Q ss_pred             CCCCCCccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      . .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||.....       ......+.....  ..+..
T Consensus       164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~--~~~~~  233 (276)
T 2h6d_A          164 G-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-------PTLFKKIRGGVF--YIPEY  233 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC--CCCTT
T ss_pred             C-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-------HHHHHHhhcCcc--cCchh
Confidence            2 22344578999999999998776 6899999999999999999999976322       233334433332  23456


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      +++.+.++|.+||+.||++|||++|+++||||+..
T Consensus       234 ~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          234 LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             cCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            88999999999999999999999999999999764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.3e-50  Score=378.53  Aligned_cols=253  Identities=25%  Similarity=0.415  Sum_probs=212.2

Q ss_pred             eeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCCC
Q 018018           74 TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGG  153 (362)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~g  153 (362)
                      ..+.||+|+||.||++.+..+|+.||+|+++... ......+.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG-MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc-cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            3678999999999999999999999999997653 345567899999999999999999999999999999999999999


Q ss_pred             CHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEE--ccCCcEEEeeccCCcccccCCCCCCccc
Q 018018          154 SLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI--NHRGEVKITDFGVSAIMASTSGQANTFV  230 (362)
Q Consensus       154 sL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll--~~~~~vkl~DFg~a~~~~~~~~~~~~~~  230 (362)
                      +|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+|||+  +.++.+||+|||+++...... .....+
T Consensus       172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~~~~  249 (373)
T 2x4f_A          172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLKVNF  249 (373)
T ss_dssp             EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCCCCC
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-cccccc
Confidence            999988654 579999999999999999999998 999999999999999  566789999999998764332 334557


Q ss_pred             cCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCCCCCCCHHHHHH
Q 018018          231 GTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSPEFCSF  308 (362)
Q Consensus       231 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l  308 (362)
                      ||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..       +....+....  .+......+++++.+|
T Consensus       250 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~~~~~~~~~l  322 (373)
T 2x4f_A          250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-------ETLNNILACRWDLEDEEFQDISEEAKEF  322 (373)
T ss_dssp             SSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-------HHHHHHHHTCCCSCSGGGTTSCHHHHHH
T ss_pred             CCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHhccCCCChhhhccCCHHHHHH
Confidence            999999999999999999999999999999999999999765332       2333333322  2222335689999999


Q ss_pred             HHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          309 ISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      |.+||+.||++|||++|+++||||+...
T Consensus       323 i~~~L~~dp~~Rps~~e~l~hp~~~~~~  350 (373)
T 2x4f_A          323 ISKLLIKEKSWRISASEALKHPWLSDHK  350 (373)
T ss_dssp             HHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred             HHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence            9999999999999999999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.7e-49  Score=362.68  Aligned_cols=263  Identities=22%  Similarity=0.384  Sum_probs=219.2

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      +..++|++.+.||+|+||.||++++..+++.||+|++...  ........+.+|+.+++.++||||+++++++.+.+..+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            3457899999999999999999999999999999998654  34556778999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      +||||+++++|.+++...+++++..++.++.|++.||+|||+ +|++||||||+||+++.++++||+|||+++.......
T Consensus        88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD-MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            999999999999999998999999999999999999999998 9999999999999999999999999999987643322


Q ss_pred             -CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC---CCCCC
Q 018018          225 -QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS---APSDQ  300 (362)
Q Consensus       225 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  300 (362)
                       ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..       ...........+.   .....
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~  239 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV-------SIAIKHIQDSVPNVTTDVRKD  239 (294)
T ss_dssp             --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH-------HHHHHHHSSCCCCHHHHSCTT
T ss_pred             cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHHhhccCCCcchhcccC
Confidence             234457999999999999999999999999999999999999999764321       2222222222221   23456


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      +++.+.++|.+||+.||++||+..+.+.+.|.+...+
T Consensus       240 ~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          240 IPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             CCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            8999999999999999999997777777777665543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.5e-49  Score=373.95  Aligned_cols=256  Identities=27%  Similarity=0.519  Sum_probs=219.8

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-------hHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecC
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-------ESARRQIAQELKINQSS-QCPYVVVCYQSFYSNG  141 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~  141 (362)
                      ++|++.+.||+|+||.||+|.+..+|+.||||+++....       ......+.+|+.+++.+ +||||+++++++....
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            579999999999999999999999999999999876531       23356788999999998 7999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ..++||||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++.....
T Consensus       174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA-NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            999999999999999999988899999999999999999999998 9999999999999999999999999999887653


Q ss_pred             CCCCCCccccCCcccCcceecC------CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISG------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  295 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (362)
                      . ......+||+.|+|||++.+      ..++.++|||||||++|+|++|..||...+.       ......+.......
T Consensus       253 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~-------~~~~~~i~~~~~~~  324 (365)
T 2y7j_A          253 G-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ-------ILMLRMIMEGQYQF  324 (365)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCC
T ss_pred             C-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCCCC
Confidence            3 33455689999999999863      3588999999999999999999999976432       23333333333222


Q ss_pred             --CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          296 --APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       296 --~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                        ..+..+++.+.+||.+||+.||++|||++++++||||+.
T Consensus       325 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          325 SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence              122467899999999999999999999999999999973

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-50  Score=375.91  Aligned_cols=264  Identities=23%  Similarity=0.374  Sum_probs=213.1

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch----HHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE----SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      ..++|++.+.||+|+||.||++++..+|+.||||+++.....    .....+.+|+.+++.++||||+++++++.+....
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            357899999999999999999999999999999998754221    2234678999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          144 SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      ++||||+++ +|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++.....
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHH-CCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            999999986 899888764 468999999999999999999998 99999999999999999999999999999877655


Q ss_pred             CCCCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC-----
Q 018018          223 SGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA-----  296 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  296 (362)
                      .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+   .................     
T Consensus       166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~  242 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCS  242 (346)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTS
T ss_pred             cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHcCCCChhhhhhhcc
Confidence            5555667899999999999764 48999999999999999999999997754321   11222222211110000     


Q ss_pred             -----------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          297 -----------------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       297 -----------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                                       ....+++++.+||.+||+.||++|||++|+++||||+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~  299 (346)
T 1ua2_A          243 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  299 (346)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             CcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence                             0145678999999999999999999999999999998754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.9e-50  Score=377.14  Aligned_cols=251  Identities=25%  Similarity=0.422  Sum_probs=218.4

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-------hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-------ESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      .++|++.+.||+|+||.||++.+..+++.||||+++....       ......+.+|+.+++.++||||+++++++.+.+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            3689999999999999999999999999999999976521       123445778999999999999999999999999


Q ss_pred             eEEEEEeccCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          142 AISIILEYMDGG-SLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       142 ~~~lV~e~~~~g-sL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ..++||||+.+| +|.+++.....+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++...
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  181 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL-KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE  181 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence            999999998766 999999998899999999999999999999998 999999999999999999999999999998764


Q ss_pred             cCCCCCCccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          221 STSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      .. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......             ...  ....+.
T Consensus       182 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------------~~~--~~~~~~  245 (335)
T 3dls_A          182 RG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------VEA--AIHPPY  245 (335)
T ss_dssp             TT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-------------TTT--CCCCSS
T ss_pred             CC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-------------Hhh--ccCCCc
Confidence            33 23445679999999999998887 88999999999999999999999753221             111  122234


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      .+++++.+||.+||+.||++|||++++++||||+...
T Consensus       246 ~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  282 (335)
T 3dls_A          246 LVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV  282 (335)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence            6899999999999999999999999999999997643

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=9.5e-50  Score=362.88  Aligned_cols=261  Identities=25%  Similarity=0.448  Sum_probs=221.1

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch-----HHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      ++|++.+.||+|+||.||++++..+|+.||+|+++.....     .....+.+|+.+++.++||||+++++.+.+....+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            6799999999999999999999999999999998765221     13567899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC----cEEEeeccCCcccc
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMA  220 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~----~vkl~DFg~a~~~~  220 (362)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+ +|++||||||+||+++.++    .+||+|||++....
T Consensus        85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS-KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            999999999999999988899999999999999999999998 9999999999999998877    89999999998754


Q ss_pred             cCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--CCCC
Q 018018          221 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPS  298 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  298 (362)
                      ... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.+.+.       .+....+......  ....
T Consensus       164 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~  235 (283)
T 3bhy_A          164 AGN-EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-------QETLTNISAVNYDFDEEYF  235 (283)
T ss_dssp             ---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCCCCCHHHH
T ss_pred             CCC-cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-------HHHHHHhHhcccCCcchhc
Confidence            332 23445789999999999999999999999999999999999999976432       2233333332221  1122


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                      ..+++.+.+||.+||+.||++|||++++++||||+......
T Consensus       236 ~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          236 SNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             TTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             ccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence            46789999999999999999999999999999998765444

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-50  Score=376.40  Aligned_cols=268  Identities=28%  Similarity=0.506  Sum_probs=224.1

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEc---cCCcEEEEEEeeccc---chHHHHHHHHHHHHHhcC-CCCcceEEee
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNV---EESARRQIAQELKINQSS-QCPYVVVCYQ  135 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l-~hp~I~~~~~  135 (362)
                      ....+..++|++.+.||+|+||.||++++.   .+++.||||+++...   .......+.+|+.+++.+ +||||+++++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  126 (355)
T 1vzo_A           47 HAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY  126 (355)
T ss_dssp             CCCCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred             ccccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEE
Confidence            344567799999999999999999999984   589999999986542   222334567788888888 6999999999


Q ss_pred             eEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccC
Q 018018          136 SFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  215 (362)
Q Consensus       136 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~  215 (362)
                      .+......++||||+++++|.+++.....+++..++.++.|++.||.|||+ +||+||||||+|||++.++++||+|||+
T Consensus       127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          127 AFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             EEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             EEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence            999999999999999999999999988899999999999999999999998 9999999999999999999999999999


Q ss_pred             CcccccCC-CCCCccccCCcccCcceecCC--CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          216 SAIMASTS-GQANTFVGTYNYMSPERISGG--KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       216 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                      ++...... ......+||+.|+|||++.+.  .++.++|||||||++|+|++|..||.........   ..+...+....
T Consensus       206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~~  282 (355)
T 1vzo_A          206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRILKSE  282 (355)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHHHHCC
T ss_pred             CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH---HHHHHHHhccC
Confidence            97653222 233456899999999999863  4789999999999999999999999765443322   23333443333


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHcCCcccccC
Q 018018          293 PPSAPSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       293 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      .  ..+..+++.+.+||.+||+.||++||     |++|+++||||+...
T Consensus       283 ~--~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~  329 (355)
T 1vzo_A          283 P--PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  329 (355)
T ss_dssp             C--CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             C--CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence            2  23457899999999999999999999     999999999998764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.5e-50  Score=385.14  Aligned_cols=258  Identities=29%  Similarity=0.456  Sum_probs=208.5

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-------chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-------EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      .++|.+.+.||+|+||+||+|.+..+++.||||++....       .......+.+|+.+++.++||||+++++++. ..
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AE  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SS
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            478999999999999999999999999999999987542       1122335789999999999999999999864 56


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC---cEEEeeccCCcc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVKITDFGVSAI  218 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~---~vkl~DFg~a~~  218 (362)
                      ..++||||+++++|.+++.....+++..++.++.|++.||+|||+ +||+||||||+|||++.++   .+||+|||+|+.
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            689999999999999999888899999999999999999999998 9999999999999997544   599999999987


Q ss_pred             cccCCCCCCccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC-
Q 018018          219 MASTSGQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP-  294 (362)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-  294 (362)
                      .... ......+||+.|+|||++.+   ..++.++|||||||++|+|++|..||........      +...+...... 
T Consensus       292 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~------~~~~i~~~~~~~  364 (419)
T 3i6u_A          292 LGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQITSGKYNF  364 (419)
T ss_dssp             CC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC------HHHHHHTTCCCC
T ss_pred             cCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH------HHHHHhcCCCCC
Confidence            6532 23445689999999999864   5688899999999999999999999986544321      22222222221 


Q ss_pred             -CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          295 -SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       295 -~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                       +.....+++.+.+||.+||+.||++|||++|+++||||+..
T Consensus       365 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence             11234688999999999999999999999999999999865

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.2e-49  Score=373.66  Aligned_cols=265  Identities=25%  Similarity=0.388  Sum_probs=215.3

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEe-------
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYS-------  139 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~-------  139 (362)
                      ..++|++.+.||+|+||.||+|++..+|+.||+|++.... .......+.+|+.+++.++||||+++++++..       
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            4589999999999999999999999999999999986552 22334567799999999999999999999886       


Q ss_pred             -cCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          140 -NGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       140 -~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                       .+.+++||||+.+ +|.+.+... ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+|+
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  172 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDGVLKLADFGLAR  172 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence             4568999999976 777777553 679999999999999999999998 999999999999999999999999999998


Q ss_pred             ccccCC----CCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          218 IMASTS----GQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       218 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                      ......    .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..    .....+.......
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~----~~~~~i~~~~~~~  248 (351)
T 3mi9_A          173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ----HQLALISQLCGSI  248 (351)
T ss_dssp             ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCCC
T ss_pred             cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHHhCCC
Confidence            764222    22344578999999999976 45899999999999999999999999875432    1222222222222


Q ss_pred             CCCCCCCC---------------------------CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          293 PPSAPSDQ---------------------------FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       293 ~~~~~~~~---------------------------~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      .+...+..                           .++.+.+||.+||+.||++|||++|+++||||+.....
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence            22111110                           26789999999999999999999999999999876543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.4e-49  Score=365.75  Aligned_cols=262  Identities=35%  Similarity=0.609  Sum_probs=219.2

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      ...++|++.+.||+|+||.||++.+..+|+.||+|++....   ....+.+|+.+++.++||||+++++.+...+..++|
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            34578999999999999999999999999999999997543   235688999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          147 LEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       147 ~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      |||+++++|.+++. ....+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.+||+|||++.........
T Consensus       103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF-MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK  181 (314)
T ss_dssp             EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred             eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence            99999999999997 45689999999999999999999998 99999999999999999999999999999876655444


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      .....|++.|+|||++.+..++.++||||||+++|+|++|..||...+..      ................+..+++.+
T Consensus       182 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l  255 (314)
T 3com_A          182 RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM------RAIFMIPTNPPPTFRKPELWSDNF  255 (314)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred             cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCcccCCcccCCHHH
Confidence            55668999999999999999999999999999999999999999764321      111111222222222345678999


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          306 CSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      .+||.+||+.||++|||+.++++||||+.....
T Consensus       256 ~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~  288 (314)
T 3com_A          256 TDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV  288 (314)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred             HHHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence            999999999999999999999999999877543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-49  Score=370.33  Aligned_cols=263  Identities=26%  Similarity=0.450  Sum_probs=219.1

Q ss_pred             cCceee-eeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeEEEE
Q 018018           70 EDIDTI-KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        70 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~~lV  146 (362)
                      ++|.+. +.||+|+||.||++.+..+++.||+|+++... .......+.+|+.++..+. ||||+++++++.+....++|
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv  107 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI  107 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence            567776 89999999999999999999999999987652 2334567889999998885 69999999999999999999


Q ss_pred             EeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc---CCcEEEeeccCCccccc
Q 018018          147 LEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVSAIMAS  221 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---~~~vkl~DFg~a~~~~~  221 (362)
                      |||+.+++|.+++..  ...+++..++.++.|++.||+|||+ +||+||||||+||+++.   ++.+||+|||+++....
T Consensus       108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~-~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ-NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            999999999999854  3679999999999999999999998 99999999999999987   78999999999987643


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh--cCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAPSD  299 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  299 (362)
                      .. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...+..       .....+.  ....+.....
T Consensus       187 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~~i~~~~~~~~~~~~~  258 (327)
T 3lm5_A          187 AC-ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ-------ETYLNISQVNVDYSEETFS  258 (327)
T ss_dssp             --------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-------HHHHHHHHTCCCCCTTTTT
T ss_pred             cc-ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-------HHHHHHHhcccccCchhhc
Confidence            32 334567999999999999999999999999999999999999999764332       2222222  2223333446


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCC
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVD  341 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~  341 (362)
                      .+++.+.+||.+||+.||++|||++++++||||+.+...++.
T Consensus       259 ~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~~  300 (327)
T 3lm5_A          259 SVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF  300 (327)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC-
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccccccc
Confidence            789999999999999999999999999999999998766553

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.4e-49  Score=370.88  Aligned_cols=266  Identities=22%  Similarity=0.382  Sum_probs=219.5

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec-----CeE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAI  143 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~-----~~~  143 (362)
                      ..+|++.+.||+|+||.||++.+..+++.||||++...........+.+|+++++.++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            368999999999999999999999999999999998666666678899999999999999999999988654     478


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ++||||+.+ +|.+++.. ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++......
T Consensus       106 ~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          106 YIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            999999975 99999976 579999999999999999999998 999999999999999999999999999998765332


Q ss_pred             C---CCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH--------------
Q 018018          224 G---QANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM--------------  285 (362)
Q Consensus       224 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~--------------  285 (362)
                      .   .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+....              
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            2   12446899999999987654 48999999999999999999999998765443222211110              


Q ss_pred             ---HHHhcCCCCCC-----CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          286 ---EAIVDQPPPSA-----PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       286 ---~~~~~~~~~~~-----~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                         ...........     ....+++++.+||.+||++||++|||++|+++||||+.+.+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence               00000000000     12457899999999999999999999999999999988743

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.1e-49  Score=365.94  Aligned_cols=262  Identities=32%  Similarity=0.573  Sum_probs=217.9

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      ..++|++.+.||+|+||.||++++..+++.||+|++... .......+.+|+.+++.++||||+++++.+...+..++||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC-CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            347899999999999999999999999999999998754 2334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          148 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       148 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++..........
T Consensus        96 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS-KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR  174 (302)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred             EeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence            99999999999875 4679999999999999999999998 999999999999999999999999999876543333334


Q ss_pred             CccccCCcccCccee-----cCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc-CCCCCCCCCC
Q 018018          227 NTFVGTYNYMSPERI-----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD-QPPPSAPSDQ  300 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  300 (362)
                      ....||+.|+|||++     .+..++.++||||||+++|+|++|..||...+..       ........ .......+..
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~  247 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-------RVLLKIAKSDPPTLLTPSK  247 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH-------HHHHHHHHSCCCCCSSGGG
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HHHHHHhccCCcccCCccc
Confidence            456789999999998     4667899999999999999999999999764321       22222322 2222334466


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      ++..+.++|.+||+.||++|||++++++||||+...+.
T Consensus       248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  285 (302)
T 2j7t_A          248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN  285 (302)
T ss_dssp             SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred             cCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence            88999999999999999999999999999999987653

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.8e-50  Score=371.94  Aligned_cols=263  Identities=24%  Similarity=0.415  Sum_probs=215.8

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC----
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG----  141 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~----  141 (362)
                      ..++|++.+.||+|+||.||++++..+++.||||+++..  .+......+.+|+.+++.++||||+++++.+....    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            347899999999999999999999999999999999765  34455678899999999999999999999887654    


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ..++||||+++++|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++....
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCCCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence            349999999999999999988999999999999999999999998 9999999999999999999999999999987643


Q ss_pred             CCC---CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-CCCC
Q 018018          222 TSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PSAP  297 (362)
Q Consensus       222 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  297 (362)
                      ...   ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..      ............ +...
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~~~~~  242 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIPPSAR  242 (311)
T ss_dssp             -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCCHHHH
T ss_pred             cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCCcccc
Confidence            322   223457899999999999999999999999999999999999999764321      111222222221 1122


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ...+++++.++|.+||+.||++||++.+++.|+|++....
T Consensus       243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  282 (311)
T 3ork_A          243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG  282 (311)
T ss_dssp             STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHTT
T ss_pred             cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhcC
Confidence            3568999999999999999999999999999999976543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=368.73  Aligned_cols=260  Identities=22%  Similarity=0.356  Sum_probs=215.5

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC--eEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AIS  144 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~--~~~  144 (362)
                      ...++|++.+.||+|+||+||++.+..+++.||||+++..........+.+|+.+++.++||||+++++++....  ..+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            345789999999999999999999999999999999976544445677889999999999999999999988655  789


Q ss_pred             EEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEE----ccCCcEEEeeccCCc
Q 018018          145 IILEYMDGGSLADFLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSA  217 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll----~~~~~vkl~DFg~a~  217 (362)
                      +||||+++++|.+++....   .+++..++.++.|++.||+|||+ +||+||||||+||++    +.++.+||+|||+++
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            9999999999999997643   39999999999999999999998 999999999999999    777889999999998


Q ss_pred             ccccCCCCCCccccCCcccCcceec--------CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh
Q 018018          218 IMASTSGQANTFVGTYNYMSPERIS--------GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV  289 (362)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~  289 (362)
                      ...... ......||+.|+|||++.        +..++.++|||||||++|+|++|..||...+....   ..+.+..+.
T Consensus       165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~  240 (319)
T 4euu_A          165 ELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR---NKEVMYKII  240 (319)
T ss_dssp             ECCTTC-CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG---CHHHHHHHH
T ss_pred             ecCCCC-ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch---hHHHHHHHh
Confidence            765432 334567999999999986        57789999999999999999999999976443222   123333333


Q ss_pred             cCCCC-----------------------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCc
Q 018018          290 DQPPP-----------------------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  331 (362)
Q Consensus       290 ~~~~~-----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~  331 (362)
                      ...++                       ......+++.+.+||++||+.||++|||++|+++||-
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            22221                       1112234567889999999999999999999999974

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.3e-49  Score=372.92  Aligned_cols=257  Identities=21%  Similarity=0.376  Sum_probs=220.5

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEc-------cCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEee
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHK-------WTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQ  135 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~  135 (362)
                      ...+..++|++.+.||+|+||.||+|++.       .++..||+|+++..........+.+|+.+++.+ +||||+++++
T Consensus        75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            45667899999999999999999999874       345689999998776677778899999999999 8999999999


Q ss_pred             eEEecCeEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCc
Q 018018          136 SFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN  199 (362)
Q Consensus       136 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~N  199 (362)
                      ++.+.+.+|+||||+++|+|.+++....                .+++..+..++.|++.||+|||+ +||+||||||+|
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~N  233 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARN  233 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGG
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeccccchhh
Confidence            9999999999999999999999998653                47999999999999999999998 999999999999


Q ss_pred             EEEccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCC
Q 018018          200 LLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD  276 (362)
Q Consensus       200 Ill~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~  276 (362)
                      ||++.++.+||+|||+++.......  ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.. 
T Consensus       234 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~-  312 (370)
T 2psq_A          234 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-  312 (370)
T ss_dssp             EEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-
T ss_pred             EEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH-
Confidence            9999999999999999986643322  2233467889999999999999999999999999999999 99999875432 


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          277 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                            ++...+..... ...+..+++++.++|.+||+.||++|||+.|++++
T Consensus       313 ------~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          313 ------ELFKLLKEGHR-MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             ------GHHHHHHTTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------HHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                  23333333332 33446789999999999999999999999999874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=5.1e-50  Score=367.83  Aligned_cols=267  Identities=32%  Similarity=0.573  Sum_probs=197.2

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      ..+..++|++.+.||+|+||.||++.+..+++.||||++...........+.+|+.+++.++||||+++++.+...+..+
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            45677899999999999999999999999999999999876544555677889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHH--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCC
Q 018018          145 IILEYMDGGSLADFLKK--------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  216 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~--------~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a  216 (362)
                      +||||+++++|.+++..        ...+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK-NGQIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence            99999999999999974        3569999999999999999999998 99999999999999999999999999998


Q ss_pred             cccccCCC-----CCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc
Q 018018          217 AIMASTSG-----QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD  290 (362)
Q Consensus       217 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~  290 (362)
                      ........     ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.......      ........
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~  242 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK------VLMLTLQN  242 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HHHHHHTS
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh------HHHHHhcc
Confidence            76543221     1234578999999999876 568999999999999999999999997754322      11111111


Q ss_pred             CCC-------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          291 QPP-------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       291 ~~~-------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      ...       .......+++++.+||.+||+.||++|||++++++||||+.....
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  297 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK  297 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC------
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCC
Confidence            111       112235678999999999999999999999999999999887654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=4.3e-49  Score=378.99  Aligned_cols=266  Identities=27%  Similarity=0.409  Sum_probs=213.1

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec------C
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------G  141 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~------~  141 (362)
                      ...+|++.+.||+|+||.||++++..+|+.||||++....     ....+|+++++.++||||+++++++...      .
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~  126 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV  126 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT-----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc-----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence            3467999999999999999999999999999999986542     1234799999999999999999987542      2


Q ss_pred             eEEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC-CcEEEeeccCC
Q 018018          142 AISIILEYMDGGSLADFLK----KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVS  216 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~-~~vkl~DFg~a  216 (362)
                      .+++||||+++ +|.+.+.    ....+++..++.++.|++.||+|||+ +||+||||||+|||++.+ +.+||+|||+|
T Consensus       127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            37799999976 7766664    34689999999999999999999998 999999999999999965 57899999999


Q ss_pred             cccccCCCCCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc-----
Q 018018          217 AIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD-----  290 (362)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-----  290 (362)
                      +..... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+   ...+++..+..     
T Consensus       205 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~---~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          205 KQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD---QLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             EECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCSCCHHH
T ss_pred             hhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHHH
Confidence            876433 234456889999999999775 69999999999999999999999998754322   22222221110     


Q ss_pred             -----C-----CCCCC--------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHH
Q 018018          291 -----Q-----PPPSA--------PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE  344 (362)
Q Consensus       291 -----~-----~~~~~--------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~  344 (362)
                           .     ..+..        ....+++++.+||.+||+.||++|||+.|+++||||+...+....+++
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~  352 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPN  352 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTT
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccccccCCC
Confidence                 0     00000        123568999999999999999999999999999999988776665543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.8e-49  Score=360.87  Aligned_cols=264  Identities=32%  Similarity=0.516  Sum_probs=216.2

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      .+..++|.....||+|+||.||++.+..+++.||+|+++.. .......+.+|+.+++.++||||+++++.+.+.+..++
T Consensus        18 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   96 (295)
T 2clq_A           18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER-DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI   96 (295)
T ss_dssp             EECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC-CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC-chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence            34456666777999999999999999999999999998765 33455778999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc-CCcEEEeeccCCccccc
Q 018018          146 ILEYMDGGSLADFLKKV---KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-RGEVKITDFGVSAIMAS  221 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~---~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-~~~vkl~DFg~a~~~~~  221 (362)
                      ||||+++++|.+++...   ..+++..+..++.|++.||.|||+ +|++|+||||+||+++. ++.+||+|||++.....
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD-NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh-CCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            99999999999999865   256799999999999999999998 99999999999999987 89999999999987654


Q ss_pred             CCCCCCccccCCcccCcceecCCC--CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      .........|++.|+|||++.+..  ++.++||||||+++|+|++|..||......    . ........ ....+..+.
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~-~~~~~~~~-~~~~~~~~~  249 (295)
T 2clq_A          176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEP----Q-AAMFKVGM-FKVHPEIPE  249 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSH----H-HHHHHHHH-HCCCCCCCT
T ss_pred             CCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCch----h-HHHHhhcc-ccccccccc
Confidence            444445668999999999997654  889999999999999999999999653221    1 11111111 122233456


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      .+++++.+||.+||+.||++|||++++++||||+....
T Consensus       250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence            78999999999999999999999999999999987654

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.5e-49  Score=359.39  Aligned_cols=261  Identities=29%  Similarity=0.499  Sum_probs=221.2

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe--cCeEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAIS  144 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~--~~~~~  144 (362)
                      ..++|++.+.||+|+||.||++.+..+++.||+|++... ........+.+|+.+++.++||||+++++.+.+  ....+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            357999999999999999999999999999999999765 345567789999999999999999999998754  67899


Q ss_pred             EEEeccCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCC-----eEeecCCCCcEEEccCCcEEEeeccC
Q 018018          145 IILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLLYLHHEKH-----IIHRDLKPSNLLINHRGEVKITDFGV  215 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~----~~l~~~~~~~i~~ql~~al~~LH~~~~-----ivH~Dlkp~NIll~~~~~vkl~DFg~  215 (362)
                      +||||+++++|.+++...    ..+++..++.++.|++.||+|||+ +|     ++||||||+||+++.++.+||+|||+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-HC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc-ccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            999999999999999754    349999999999999999999998 88     99999999999999999999999999


Q ss_pred             CcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018018          216 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  295 (362)
Q Consensus       216 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (362)
                      ++.............|++.|+|||++.+..++.++||||||+++|+|++|..||...+.       ......+.....+ 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~i~~~~~~-  234 (279)
T 2w5a_A          163 ARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREGKFR-  234 (279)
T ss_dssp             HHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCC-
T ss_pred             heeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-------HHHHHHHhhcccc-
Confidence            87654333223345789999999999999999999999999999999999999976432       2334444444332 


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       296 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ..+..+++++.++|.+||+.||++|||++|+++|+|+..-..
T Consensus       235 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~  276 (279)
T 2w5a_A          235 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH  276 (279)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred             cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence            334578999999999999999999999999999999976543

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.8e-49  Score=376.36  Aligned_cols=276  Identities=28%  Similarity=0.438  Sum_probs=217.3

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe-----
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA-----  142 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~-----  142 (362)
                      ...+|.+.+.||+|+||+||+|++..++. +|+|++.....     ...+|+.+++.++||||+++++++...+.     
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~  111 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV  111 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence            34689999999999999999999987666 88887754321     12368999999999999999999865443     


Q ss_pred             -EEEEEeccCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEc-cCCcEEEeeccCC
Q 018018          143 -ISIILEYMDGGSLADFLK----KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGVS  216 (362)
Q Consensus       143 -~~lV~e~~~~gsL~~~l~----~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~-~~~~vkl~DFg~a  216 (362)
                       +++||||+++ ++...+.    ....+++..++.++.|++.||+|||+ +||+||||||+|||++ .++.+||+|||+|
T Consensus       112 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~-~~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          112 FLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS-IGICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence             8899999987 4444432    35689999999999999999999998 9999999999999999 7999999999999


Q ss_pred             cccccCCCCCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc-----
Q 018018          217 AIMASTSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD-----  290 (362)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-----  290 (362)
                      +..... .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+.   ...+......     
T Consensus       190 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          190 KILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ---LVEIIKVLGTPSREQ  265 (394)
T ss_dssp             EECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHHH
T ss_pred             ccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCCHHH
Confidence            876433 334456889999999999775 589999999999999999999999987543321   1122211100     


Q ss_pred             ----------CCCCC--------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHHHhCCC
Q 018018          291 ----------QPPPS--------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAGSP  352 (362)
Q Consensus       291 ----------~~~~~--------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~~~~~~  352 (362)
                                ...+.        .....+++++.+||.+||+.||++|||+.|+++||||+...+....+++     ..+
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~-----~~~  340 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPN-----GRE  340 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSCCCCTT-----SSC
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccccccCCC-----CCC
Confidence                      00000        0123478999999999999999999999999999999998877766655     456


Q ss_pred             ccccccCC
Q 018018          353 LATLSNLS  360 (362)
Q Consensus       353 ~~~~~~~~  360 (362)
                      ++++++++
T Consensus       341 ~~~~~~~~  348 (394)
T 4e7w_A          341 LPPLFNWT  348 (394)
T ss_dssp             CCCSCCCC
T ss_pred             CCCcCCCC
Confidence            66666553

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.9e-49  Score=367.50  Aligned_cols=277  Identities=36%  Similarity=0.669  Sum_probs=210.2

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHH-HHhcCCCCcceEEeeeEEecCe
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELK-INQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~-~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      .+.+..++|++.+.||+|+||.||++.+..+|+.||||+++..........+..|+. +++.++||||+++++++.+.+.
T Consensus        16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~   95 (327)
T 3aln_A           16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD   95 (327)
T ss_dssp             EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred             hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence            456677999999999999999999999999999999999987655555566666666 6788899999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCC-CeEeecCCCCcEEEccCCcEEEeeccCC
Q 018018          143 ISIILEYMDGGSLADFLKK-----VKTIPEEYLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINHRGEVKITDFGVS  216 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~ql~~al~~LH~~~-~ivH~Dlkp~NIll~~~~~vkl~DFg~a  216 (362)
                      .++||||+.+ +|.+++..     ...+++..+..++.|++.||.|||+ + |++||||||+||+++.++.+||+|||++
T Consensus        96 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~  173 (327)
T 3aln_A           96 CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGIS  173 (327)
T ss_dssp             EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH-HHSCCCSCCCGGGEEEETTTEEEECCCSSS
T ss_pred             eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc-cCCEeECCCCHHHEEEcCCCCEEEccCCCc
Confidence            9999999975 88888864     5689999999999999999999998 7 9999999999999999999999999999


Q ss_pred             cccccCCCCCCccccCCcccCccee----cCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          217 AIMASTSGQANTFVGTYNYMSPERI----SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                      +...... ......||+.|+|||++    .+..++.++||||||+++|+|++|..||......      ...........
T Consensus       174 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~  246 (327)
T 3aln_A          174 GQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV------FDQLTQVVKGD  246 (327)
T ss_dssp             CC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------------CCCCCSC
T ss_pred             eeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH------HHHHHHHhcCC
Confidence            7764332 23334789999999998    4567899999999999999999999999764321      11111222222


Q ss_pred             CC---CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHHHh
Q 018018          293 PP---SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA  349 (362)
Q Consensus       293 ~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~~~  349 (362)
                      .+   ......+++.+.+||.+||+.||++|||+.++++||||....+....+..+++..
T Consensus       247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~  306 (327)
T 3aln_A          247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKI  306 (327)
T ss_dssp             CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCCCHHHHHHHH
T ss_pred             CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhHHHHHHHHHHH
Confidence            21   1223468999999999999999999999999999999999888877777666553

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.1e-49  Score=359.21  Aligned_cols=260  Identities=27%  Similarity=0.490  Sum_probs=222.6

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.... .......+.+|+.+++.++||||+++++.+.+....++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            478999999999999999999999999999999987552 2334567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC---CcEEEeeccCCcccccCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~---~~vkl~DFg~a~~~~~~~~  224 (362)
                      ||+++++|.+++.....+++..++.++.|++.||.|||+ +|++||||||+||+++.+   +.+||+|||++....... 
T Consensus       101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-  178 (287)
T 2wei_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK-HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-  178 (287)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-
T ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-
Confidence            999999999999888899999999999999999999998 999999999999999764   469999999987654332 


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCC--CCCCCCC
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPS--APSDQFS  302 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  302 (362)
                      ......|++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.       ......+.......  .....++
T Consensus       179 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T 2wei_A          179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-------YDILKRVETGKYAFDLPQWRTIS  250 (287)
T ss_dssp             SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCCCCCSGGGTTSC
T ss_pred             ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCCCCCchhhhhcC
Confidence            3344568999999999876 489999999999999999999999976432       23334444333222  2235689


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      +++.++|.+||+.||++|||++|+++||||+.+.++
T Consensus       251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~  286 (287)
T 2wei_A          251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE  286 (287)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCCC
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHhcCHHHhccccC
Confidence            999999999999999999999999999999987653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.6e-48  Score=359.78  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=217.7

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      +..++|.+.+.||+|+||+||++.+..+++.||+|++... +......+.+|+.+++.++||||+++++++.+++..++|
T Consensus         7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A            7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            4668999999999999999999999999999999998543 566678899999999999999999999999999999999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          147 LEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      |||+++++|.+++.. ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++........
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  164 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS-MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ  164 (310)
T ss_dssp             EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence            999999999999987 5689999999999999999999998 99999999999999999999999999999876433221


Q ss_pred             C--------------CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc--hhhHHHHHHHHh
Q 018018          226 A--------------NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG--WTSFYELMEAIV  289 (362)
Q Consensus       226 ~--------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~--~~~~~~~~~~~~  289 (362)
                      .              ...+||+.|+|||++.+..++.++||||||+++|+|++|..||........  ..........  
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~--  242 (310)
T 3s95_A          165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR--  242 (310)
T ss_dssp             ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH--
T ss_pred             ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc--
Confidence            1              145799999999999999999999999999999999999999876433221  1111122111  


Q ss_pred             cCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          290 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                            ..+..+++.+.++|.+||+.||++|||++++++  |++.
T Consensus       243 ------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~  279 (310)
T 3s95_A          243 ------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET  279 (310)
T ss_dssp             ------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             ------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence                  113467889999999999999999999999987  5543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.1e-49  Score=374.58  Aligned_cols=262  Identities=25%  Similarity=0.414  Sum_probs=199.0

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec------Ce
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GA  142 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~------~~  142 (362)
                      ++|++++.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++...      ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            7899999999999999999999999999999998754 3445667888999999999999999999988653      56


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      .++|+|++ +++|.+++.. ..+++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++.... 
T Consensus       109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~-~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~-  184 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-  184 (367)
T ss_dssp             CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred             EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCeeeCCCCHhhEEECCCCCEEEeeccccccccc-
Confidence            89999999 6799999876 689999999999999999999998 9999999999999999999999999999976542 


Q ss_pred             CCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH----------------
Q 018018          223 SGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM----------------  285 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~----------------  285 (362)
                        .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+....                
T Consensus       185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  262 (367)
T 2fst_X          185 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  262 (367)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHH
T ss_pred             --cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHH
Confidence              2345689999999999987 678999999999999999999999998755422111111110                


Q ss_pred             HHHhcCCC--CC----CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          286 EAIVDQPP--PS----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       286 ~~~~~~~~--~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ........  +.    ......++++.+||.+||+.||++|||++|+++||||+.+.+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          263 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             HHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence            00000000  00    011346889999999999999999999999999999987754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.5e-50  Score=379.69  Aligned_cols=262  Identities=14%  Similarity=0.128  Sum_probs=197.2

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHH---HHHhcCCCCcceEEe-------ee
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQEL---KINQSSQCPYVVVCY-------QS  136 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~---~~~~~l~hp~I~~~~-------~~  136 (362)
                      ..+|++.+.||+|+||.||++++..+|+.||||+++...  .......+.+|+   ..++. +||||++++       +.
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            456999999999999999999999999999999998763  344556677774   45555 799988755       34


Q ss_pred             EEec-----------------CeEEEEEeccCCCCHHHHHHHc-CCCCHHHH------HHHHHHHHHHHHHHHhCCCeEe
Q 018018          137 FYSN-----------------GAISIILEYMDGGSLADFLKKV-KTIPEEYL------AAICEQVLKGLLYLHHEKHIIH  192 (362)
Q Consensus       137 ~~~~-----------------~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~------~~i~~ql~~al~~LH~~~~ivH  192 (362)
                      +...                 ..+++||||++ ++|.+++... ..+++..+      ..++.|++.||+|||+ +||+|
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~-~~ivH  217 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS-KGLVH  217 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH-TTEEE
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH-CCCcc
Confidence            4332                 34899999998 7999999764 34555555      6778999999999998 99999


Q ss_pred             ecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCCcccCcceecC--CCCCccccHHHHHHHHHHHHcCCCCCC
Q 018018          193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPYS  270 (362)
Q Consensus       193 ~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~elltg~~pf~  270 (362)
                      |||||+|||++.++.+||+|||+|+.....   .....+|+.|+|||++.+  ..++.++|||||||++|+|++|+.||.
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTR---GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTCE---EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCCC---ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999999865422   224466799999999988  679999999999999999999999998


Q ss_pred             CCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          271 PPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ..............................+++.+.+||.+||+.||++|||++++++||||+...
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence            764321100000000001111222223357899999999999999999999999999999998763

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.4e-48  Score=363.80  Aligned_cols=264  Identities=27%  Similarity=0.423  Sum_probs=218.0

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec-----CeE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-----GAI  143 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~-----~~~  143 (362)
                      .++|++.+.||+|+||.||++.+..+|+.||||+++..........+.+|+.+++.++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            478999999999999999999999999999999997666666677889999999999999999999987654     779


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ++||||+. ++|.+++.. ..+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++......
T Consensus        90 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~-~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHG-SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA  166 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence            99999997 599999887 679999999999999999999998 999999999999999999999999999998764322


Q ss_pred             C----------CCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          224 G----------QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       224 ~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                      .          .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.    ...+.......
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~  242 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ----LLLIFGIIGTP  242 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHHHCCC
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHHHhCCC
Confidence            1          1223578999999998765 6789999999999999999999999987543211    11111111110


Q ss_pred             C----------------------CC-----CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          293 P----------------------PS-----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       293 ~----------------------~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                      .                      .+     .....+++++.+||.+||+.||++|||++|+++||||+.+.+.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence            0                      00     01236789999999999999999999999999999999887654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.4e-49  Score=362.39  Aligned_cols=277  Identities=33%  Similarity=0.642  Sum_probs=215.5

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHH-HHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESA-RRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      .+...++|++.+.||+|+||.||++.+..+|+.||||++........ .+.+..+..+++.++||||+++++++.+....
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~   99 (318)
T 2dyl_A           20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV   99 (318)
T ss_dssp             EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence            34567899999999999999999999999999999999987644433 34444555678889999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCC-CeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          144 SIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~-~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ++||||+ ++.+..+... ...+++..+..++.|++.||.|||+ + |++||||||+||+++.++.+||+|||++.....
T Consensus       100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-HHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            9999999 5566666654 4689999999999999999999997 5 999999999999999999999999999876543


Q ss_pred             CCCCCCccccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC-CC
Q 018018          222 TSGQANTFVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP-PS  295 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~  295 (362)
                      .. ......|++.|+|||++.     +..++.++||||||+++|+|++|..||.....      ..+....+..... ..
T Consensus       178 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~  250 (318)
T 2dyl_A          178 DK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT------DFEVLTKVLQEEPPLL  250 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHHHHSCCCCC
T ss_pred             Cc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc------cHHHHHHHhccCCCCC
Confidence            22 233457899999999994     45689999999999999999999999975322      1233333333322 22


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHHHhC
Q 018018          296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDAG  350 (362)
Q Consensus       296 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~~~~  350 (362)
                      .....+++++.+||.+||+.||++|||++++++||||+.+....+++..|+.+..
T Consensus       251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~  305 (318)
T 2dyl_A          251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVASWFKDVM  305 (318)
T ss_dssp             CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHSCCCHHHHHHHHH
T ss_pred             CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcccccchhHHHhhccc
Confidence            2334689999999999999999999999999999999999999999999998854

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.5e-48  Score=376.19  Aligned_cols=258  Identities=29%  Similarity=0.471  Sum_probs=211.0

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC------CCCcceEEeeeEEecC
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS------QCPYVVVCYQSFYSNG  141 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l------~hp~I~~~~~~~~~~~  141 (362)
                      ...+|++.+.||+|+||.||+|.+..+++.||||+++..  ......+.+|+.+++.+      .|+||+.+++.+....
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            346899999999999999999999999999999999753  33445666777776665      6789999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc--EEEeeccCCc
Q 018018          142 AISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--VKITDFGVSA  217 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~--vkl~DFg~a~  217 (362)
                      .+++||||+. ++|.+++....  .+++..++.++.|++.||+|||+ +||+||||||+|||++.++.  +||+|||+|.
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK-NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-HTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            9999999996 59999997754  59999999999999999999998 89999999999999999887  9999999997


Q ss_pred             ccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC----
Q 018018          218 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP----  293 (362)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----  293 (362)
                      ...   ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+...   .+.... ..+.    
T Consensus       251 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~---~i~~~~-~~p~~~~~  323 (429)
T 3kvw_A          251 YEH---QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA---CMIELL-GMPSQKLL  323 (429)
T ss_dssp             ETT---CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHH-CCCCHHHH
T ss_pred             ecC---CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHc-CCCCHHHH
Confidence            643   23445689999999999999999999999999999999999999998764432211   111111 0000    


Q ss_pred             ---------------C----------------------------C-------CCCCCCCHHHHHHHHHhhhcCcCCCCCH
Q 018018          294 ---------------P----------------------------S-------APSDQFSPEFCSFISACVQKEPQQRLSA  323 (362)
Q Consensus       294 ---------------~----------------------------~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~  323 (362)
                                     +                            +       ......++++.+||.+||++||++|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence                           0                            0       0112347889999999999999999999


Q ss_pred             HHHHcCCcccccC
Q 018018          324 QELMTHPFLKMYG  336 (362)
Q Consensus       324 ~eil~hp~~~~~~  336 (362)
                      +|+|+||||+...
T Consensus       404 ~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          404 GQALRHPWLRRRL  416 (429)
T ss_dssp             HHHHTSTTTC---
T ss_pred             HHHhCChhhccCC
Confidence            9999999998753

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.1e-49  Score=373.19  Aligned_cols=257  Identities=25%  Similarity=0.416  Sum_probs=205.2

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC------
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG------  141 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~------  141 (362)
                      .++|++.+.||+|+||.||+|.+..+++.||||++... ........+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            47899999999999999999999999999999999764 34455677889999999999999999999987654      


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ..++||||+.+ +|.+++.  ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+|+....
T Consensus       104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHH-CCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            78999999975 8888886  469999999999999999999998 9999999999999999999999999999986543


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--------
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--------  293 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------  293 (362)
                      . ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+       ....+.....        
T Consensus       180 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-------~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          180 S-FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-------QWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHC-CCCCCHHHHT
T ss_pred             c-cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHHHhCCCCHHHHH
Confidence            2 22345689999999999999999999999999999999999999998754321       1111111100        


Q ss_pred             -------------CCCC-------------C------CCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          294 -------------PSAP-------------S------DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       294 -------------~~~~-------------~------~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                                   +...             +      ...++++.+||.+||+.||++|||++|+++||||+.+.+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~  327 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD  327 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence                         0000             0      001467899999999999999999999999999987643

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2e-50  Score=382.94  Aligned_cols=250  Identities=17%  Similarity=0.208  Sum_probs=204.5

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHH---HHhcCCCCcceEEe-------e
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELK---INQSSQCPYVVVCY-------Q  135 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~---~~~~l~hp~I~~~~-------~  135 (362)
                      ..++|++.+.||+|+||.||+|++..+|+.||||+++..  ........+.+|+.   +++.++||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            357899999999999999999999999999999999754  23445677889994   55566899999988       5


Q ss_pred             eEEecC-----------------eEEEEEeccCCCCHHHHHHHcCCCCH-------HHHHHHHHHHHHHHHHHHhCCCeE
Q 018018          136 SFYSNG-----------------AISIILEYMDGGSLADFLKKVKTIPE-------EYLAAICEQVLKGLLYLHHEKHII  191 (362)
Q Consensus       136 ~~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~~l~~-------~~~~~i~~ql~~al~~LH~~~~iv  191 (362)
                      ++.+.+                 ..|+||||+ +|+|.+++...+.+++       ..++.++.|++.||+|||+ +||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~iv  228 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLV  228 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh-CCee
Confidence            554443                 389999999 5799999987655555       8888999999999999998 9999


Q ss_pred             eecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCCcccCcceecCC-----------CCCccccHHHHHHHHH
Q 018018          192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-----------KYGYKSDIWSLGLVLL  260 (362)
Q Consensus       192 H~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~~l~  260 (362)
                      ||||||+|||++.++.+||+|||+|+....   .....+| +.|+|||++.+.           .++.++|||||||++|
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            999999999999999999999999986432   3345577 999999999887           8999999999999999


Q ss_pred             HHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          261 ECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       261 elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ||++|+.||.+.........       +..      ....+++++.+||.+||+.||++|||+.|+++||||+...
T Consensus       305 elltg~~Pf~~~~~~~~~~~-------~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEW-------IFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHSSCCC------CCSGG-------GGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             HHHHCCCCCcccccccchhh-------hhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence            99999999976544332211       111      1246889999999999999999999999999999998753

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.2e-48  Score=363.51  Aligned_cols=256  Identities=23%  Similarity=0.366  Sum_probs=218.6

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCc---EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      ..++..++|.+.+.||+|+||.||++.+..+++   .||||+++..........+.+|+.+++.++||||+++++++.+.
T Consensus        43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            345678999999999999999999999986555   59999998776777778899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          141 GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      ...++||||+++++|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++..
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD-LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            9999999999999999999754 689999999999999999999998 99999999999999999999999999999876


Q ss_pred             ccCCCC---CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018018          220 ASTSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  295 (362)
Q Consensus       220 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (362)
                      ......   .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...       ......+..... .
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-------~~~~~~~~~~~~-~  273 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN-------RDVISSVEEGYR-L  273 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HHHHHHHHTTCC-C
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHcCCC-C
Confidence            543222   122345778999999998899999999999999999999 9999976432       234444444332 3


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       296 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+..+++.+.+||.+||+.||++|||+.++++
T Consensus       274 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          274 PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            344678999999999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-48  Score=360.75  Aligned_cols=259  Identities=24%  Similarity=0.380  Sum_probs=222.3

Q ss_pred             CCCCCCCccCceeeeeeeeeCCeEEEEEEEc-----cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeee
Q 018018           62 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQS  136 (362)
Q Consensus        62 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~  136 (362)
                      .....+..++|.+.+.||+|+||.||++.+.     .++..||+|+++..........+.+|+.+++.++||||++++++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            3456677899999999999999999999983     45689999999877667777889999999999999999999999


Q ss_pred             EEecCeEEEEEeccCCCCHHHHHHHcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCCeEe
Q 018018          137 FYSNGAISIILEYMDGGSLADFLKKVKT------------------------IPEEYLAAICEQVLKGLLYLHHEKHIIH  192 (362)
Q Consensus       137 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~------------------------l~~~~~~~i~~ql~~al~~LH~~~~ivH  192 (362)
                      +.+.+..++||||+++++|.+++.....                        +++..++.++.|++.||+|||+ +|++|
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH  173 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE-MKLVH  173 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH-TTEEC
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH-CCCcc
Confidence            9999999999999999999999987543                        8999999999999999999998 99999


Q ss_pred             ecCCCCcEEEccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCC
Q 018018          193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPY  269 (362)
Q Consensus       193 ~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf  269 (362)
                      |||||+||+++.++.+||+|||++........  ......+++.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999986643322  2233467889999999999889999999999999999999 99999


Q ss_pred             CCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          270 SPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .+....       .+...+.... ....+..+++++.++|.+||+.||++|||+++++++
T Consensus       254 ~~~~~~-------~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          254 PGIPPE-------RLFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             TTCCGG-------GHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHH-------HHHHHhhcCC-cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            875442       2223333332 233456789999999999999999999999999875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.1e-49  Score=372.79  Aligned_cols=259  Identities=27%  Similarity=0.414  Sum_probs=218.9

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEE-----EccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeee
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQ-----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQS  136 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~  136 (362)
                      ..+++..++|++.+.||+|+||.||+++     +..+++.||||+++..........+.+|+.++..+ +||||++++++
T Consensus        15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~   94 (359)
T 3vhe_A           15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   94 (359)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeee
Confidence            3456778999999999999999999999     55677899999998776666778899999999998 78999999999


Q ss_pred             EEecC-eEEEEEeccCCCCHHHHHHHcCC---------------------------------------------------
Q 018018          137 FYSNG-AISIILEYMDGGSLADFLKKVKT---------------------------------------------------  164 (362)
Q Consensus       137 ~~~~~-~~~lV~e~~~~gsL~~~l~~~~~---------------------------------------------------  164 (362)
                      +.+.+ ..++||||+++|+|.+++.....                                                   
T Consensus        95 ~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (359)
T 3vhe_A           95 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS  174 (359)
T ss_dssp             ECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred             eecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence            88754 48999999999999999976533                                                   


Q ss_pred             ---------------CCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC--CCC
Q 018018          165 ---------------IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QAN  227 (362)
Q Consensus       165 ---------------l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~--~~~  227 (362)
                                     +++..++.++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++.......  ...
T Consensus       175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (359)
T 3vhe_A          175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG  253 (359)
T ss_dssp             ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred             hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH-CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence                           8999999999999999999998 9999999999999999999999999999986543322  233


Q ss_pred             ccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHH
Q 018018          228 TFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC  306 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (362)
                      ...||+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+      .....+.... ....+..+++++.
T Consensus       254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~-~~~~~~~~~~~l~  326 (359)
T 3vhe_A          254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGT-RMRAPDYTTPEMY  326 (359)
T ss_dssp             -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHHHHHHHTC-CCCCCTTCCHHHH
T ss_pred             ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHHHHHHcCC-CCCCCCCCCHHHH
Confidence            4568899999999999999999999999999999998 999997754331      2222222222 2334467899999


Q ss_pred             HHHHHhhhcCcCCCCCHHHHHcC
Q 018018          307 SFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       307 ~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ++|.+||+.||++|||++|+++|
T Consensus       327 ~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          327 QTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCChhhCCCHHHHHHH
Confidence            99999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=6.3e-49  Score=372.73  Aligned_cols=258  Identities=24%  Similarity=0.349  Sum_probs=220.8

Q ss_pred             CCCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           62 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        62 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ...+.+..++|++.+.||+|+||.||++++..+++.||||+++..........+.+|+++++.++||||+++++++...+
T Consensus       106 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  185 (377)
T 3cbl_A          106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ  185 (377)
T ss_dssp             CCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             ccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence            34567788999999999999999999999999999999999986656666778899999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          142 AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ +|++||||||+|||++.++.+||+|||+++...
T Consensus       186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES-KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            999999999999999999765 469999999999999999999998 999999999999999999999999999997643


Q ss_pred             cCCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          221 STSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       221 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      .....  .....+++.|+|||++.++.++.++|||||||++|||++ |..||.+.+.       .+....+.... ....
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-------~~~~~~~~~~~-~~~~  336 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-------QQTREFVEKGG-RLPC  336 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-------HHHHHHHHTTC-CCCC
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCC-CCCC
Confidence            22111  112235778999999998899999999999999999998 9999976432       22333333332 2334


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +..+++++.+||.+||+.||++|||++++++
T Consensus       337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            5678999999999999999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.8e-49  Score=365.36  Aligned_cols=258  Identities=30%  Similarity=0.473  Sum_probs=212.4

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-------chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-------EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      ++|++.+.||+|+||.||++.+..+++.||||++....       .......+.+|+.+++.++||||+++++++... .
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-D   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-c
Confidence            68999999999999999999999999999999986542       122344678999999999999999999987654 4


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc---EEEeeccCCccc
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGVSAIM  219 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~---vkl~DFg~a~~~  219 (362)
                      .++||||+++++|.+++.....+++..++.++.|++.||.|||+ +|++||||||+||+++.++.   +||+|||++...
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHE-NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence            89999999999999999888899999999999999999999998 99999999999999987664   999999999765


Q ss_pred             ccCCCCCCccccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--
Q 018018          220 ASTSGQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--  294 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--  294 (362)
                      .... ......||+.|+|||++.   +..++.++|||||||++|+|++|..||........      +...+......  
T Consensus       168 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~~  240 (322)
T 2ycf_A          168 GETS-LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS------LKDQITSGKYNFI  240 (322)
T ss_dssp             CCCH-HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC------HHHHHHHTCCCCC
T ss_pred             cccc-ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH------HHHHHHhCccccC
Confidence            4321 123457899999999974   56789999999999999999999999976544322      11122222211  


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          295 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       295 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      +.....+++.+.+||.+||+.||++|||++++++||||+...
T Consensus       241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence            112246789999999999999999999999999999998764

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.8e-48  Score=362.38  Aligned_cols=258  Identities=21%  Similarity=0.370  Sum_probs=212.3

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEe--cCeEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYS--NGAISI  145 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~--~~~~~l  145 (362)
                      .++|++.+.||+|+||.||+|++..+++.||+|+++...    ...+.+|+.+++.++ ||||+++++++.+  ....++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            478999999999999999999999999999999987442    356889999999997 9999999999987  678999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC-cEEEeeccCCcccccCCC
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSG  224 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-~vkl~DFg~a~~~~~~~~  224 (362)
                      ||||+.+++|.+++.   .+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+|+..... .
T Consensus       111 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~  185 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-Q  185 (330)
T ss_dssp             EEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT-C
T ss_pred             EEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC-C
Confidence            999999999999885   48999999999999999999998 9999999999999999777 8999999999865433 2


Q ss_pred             CCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHH---------HHhcCC--
Q 018018          225 QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME---------AIVDQP--  292 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~---------~~~~~~--  292 (362)
                      ......|+..|+|||++.+ ..++.++|||||||++|+|++|..||.......  ........         .+....  
T Consensus       186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~  263 (330)
T 3nsz_A          186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY--DQLVRIAKVLGTEDLYDYIDKYNIE  263 (330)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH--HHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred             ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH--HHHHHHHHhcCCchhhhHHHHhccc
Confidence            3445688999999999987 668999999999999999999999995432211  11111110         010000  


Q ss_pred             --------------------CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          293 --------------------PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       293 --------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                                          ........+++++.+||.+||+.||++|||++|+++||||+...+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~  328 (330)
T 3nsz_A          264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  328 (330)
T ss_dssp             CCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred             cccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence                                011112237899999999999999999999999999999987653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-49  Score=373.14  Aligned_cols=261  Identities=23%  Similarity=0.363  Sum_probs=221.7

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEE-----EccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQ-----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS  139 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~  139 (362)
                      .++..++|++.+.||+|+||.||+++     +..+++.||||+++..........+.+|+.+++.++||||+++++++.+
T Consensus        66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            35667899999999999999999999     4457789999999876666677789999999999999999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC---cEE
Q 018018          140 NGAISIILEYMDGGSLADFLKKVK-------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG---EVK  209 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~---~vk  209 (362)
                      ....++||||+++|+|.+++....       .+++..++.++.|++.||+|||+ +||+||||||+|||++.++   .+|
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEEecCCCCceEE
Confidence            999999999999999999997653       58999999999999999999998 9999999999999998555   599


Q ss_pred             EeeccCCcccccCC--CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHH
Q 018018          210 ITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELME  286 (362)
Q Consensus       210 l~DFg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~  286 (362)
                      |+|||+|+......  .......||+.|+|||++.+..++.++|||||||++|||++ |..||...+.       .++..
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-------~~~~~  297 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLE  297 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHH
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHH
Confidence            99999997653322  22334578999999999999999999999999999999998 9999976432       24444


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          287 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      .+..... ...+..+++.+.+||.+||+.||++|||++++++|.++..
T Consensus       298 ~i~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          298 FVTSGGR-MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHcCCC-CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            4444433 3335678999999999999999999999999999988743

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.9e-49  Score=373.36  Aligned_cols=260  Identities=27%  Similarity=0.414  Sum_probs=210.4

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC--------CCcceEEeeeEE-
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ--------CPYVVVCYQSFY-  138 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~--------hp~I~~~~~~~~-  138 (362)
                      ..++|++.+.||+|+||+||+|++..+++.||||+++..  ......+.+|+.+++.++        |+||+++++.+. 
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            357899999999999999999999999999999998743  445567888999888875        788999999987 


Q ss_pred             ---ecCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC-CeEeecCCCCcEEEccCC------
Q 018018          139 ---SNGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINHRG------  206 (362)
Q Consensus       139 ---~~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~-~ivH~Dlkp~NIll~~~~------  206 (362)
                         +...+++||||+ +++|.+++...  ..+++..++.++.|++.||+|||+ + ||+||||||+|||++.++      
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT-KCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-hCCEecCCCCHHHeeEeccchhhhhh
Confidence               556899999999 55777777554  569999999999999999999998 7 999999999999998775      


Q ss_pred             -------------------------------------------cEEEeeccCCcccccCCCCCCccccCCcccCcceecC
Q 018018          207 -------------------------------------------EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG  243 (362)
Q Consensus       207 -------------------------------------------~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  243 (362)
                                                                 .+||+|||+|.....   .....+||+.|+|||++.+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~---~~~~~~gt~~y~aPE~~~~  267 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK---HFTEDIQTRQYRSLEVLIG  267 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB---CSCSCCSCGGGCCHHHHHT
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc---cCccCCCCCcccCChhhcC
Confidence                                                       799999999977543   2344578999999999999


Q ss_pred             CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH--HHHHhcCCCC---------------------------
Q 018018          244 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--MEAIVDQPPP---------------------------  294 (362)
Q Consensus       244 ~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~---------------------------  294 (362)
                      ..++.++|||||||++|+|++|..||.+.+..+.......+  +.......+.                           
T Consensus       268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (397)
T 1wak_A          268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP  347 (397)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred             CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence            99999999999999999999999999876554332221111  1111111000                           


Q ss_pred             ----------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          295 ----------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       295 ----------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                                .......++.+.+||.+||+.||++|||++|+++||||+.
T Consensus       348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                      0011223467889999999999999999999999999973

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.7e-48  Score=361.57  Aligned_cols=269  Identities=23%  Similarity=0.335  Sum_probs=200.2

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCc---EEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEe
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYS  139 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~  139 (362)
                      +..+..++|++.+.||+|+||.||+|++..++.   .||+|+++... .......+.+|+.+++.++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            445667899999999999999999999887765   89999987652 34556789999999999999999999999887


Q ss_pred             cCeE------EEEEeccCCCCHHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc
Q 018018          140 NGAI------SIILEYMDGGSLADFLKKVK------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE  207 (362)
Q Consensus       140 ~~~~------~lV~e~~~~gsL~~~l~~~~------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~  207 (362)
                      ....      ++||||+.+++|.+++....      .+++..++.++.|++.||+|||+ +|++||||||+||+++.++.
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS-RNFIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTSC
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc-CCcccCCCCcceEEEcCCCC
Confidence            6655      99999999999999996543      69999999999999999999998 99999999999999999999


Q ss_pred             EEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHH
Q 018018          208 VKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYEL  284 (362)
Q Consensus       208 vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~  284 (362)
                      +||+|||+|+.......  ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..       +.
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-------~~  248 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA-------EI  248 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------GH
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH-------HH
Confidence            99999999987643322  1223456788999999999999999999999999999999 99999875543       22


Q ss_pred             HHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCC-------HHHHHcCCcccccCCCCCC
Q 018018          285 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLS-------AQELMTHPFLKMYGDLNVD  341 (362)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt-------~~eil~hp~~~~~~~~~~~  341 (362)
                      ...+..... ...+..+++++.+||.+||+.||++|||       +++++.|||+....+..+.
T Consensus       249 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~  311 (323)
T 3qup_A          249 YNYLIGGNR-LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLY  311 (323)
T ss_dssp             HHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------------
T ss_pred             HHHHhcCCC-CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCC
Confidence            333333332 3334578999999999999999999999       8889999999887665443

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.1e-48  Score=360.30  Aligned_cols=260  Identities=23%  Similarity=0.420  Sum_probs=212.9

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEE-ccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCC------cceEEeeeEEe
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQH-KWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP------YVVVCYQSFYS  139 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp------~I~~~~~~~~~  139 (362)
                      +..++|++.+.||+|+||.||++.+ ..+++.||+|+++..  ......+.+|+.+++.++|+      +|+++++.+..
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            3457999999999999999999998 568899999998743  34456677888888776554      59999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc-------------
Q 018018          140 NGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-------------  204 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-------------  204 (362)
                      .+..++||||+ +++|.+++....  ++++..++.++.|++.||+|||+ +||+||||||+||+++.             
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999999 789999998765  68999999999999999999998 99999999999999987             


Q ss_pred             ------CCcEEEeeccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCch
Q 018018          205 ------RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW  278 (362)
Q Consensus       205 ------~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~  278 (362)
                            ++.+||+|||+++....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+  
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE--  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH--
T ss_pred             ccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH--
Confidence                  66899999999976432   2345688999999999999999999999999999999999999998654321  


Q ss_pred             hhHHHHHHHHhcCCCC---------------------------------------CCCCCCCCHHHHHHHHHhhhcCcCC
Q 018018          279 TSFYELMEAIVDQPPP---------------------------------------SAPSDQFSPEFCSFISACVQKEPQQ  319 (362)
Q Consensus       279 ~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~li~~~L~~dP~~  319 (362)
                        ....+.......+.                                       .......++++.+||.+||+.||++
T Consensus       242 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          242 --HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             --HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             --HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence              11222222211100                                       0011223567899999999999999


Q ss_pred             CCCHHHHHcCCcccccCC
Q 018018          320 RLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       320 Rpt~~eil~hp~~~~~~~  337 (362)
                      |||++|+++||||+...+
T Consensus       320 Rpt~~ell~hp~f~~~~~  337 (339)
T 1z57_A          320 RITLREALKHPFFDLLKK  337 (339)
T ss_dssp             SCCHHHHTTSGGGGGGGC
T ss_pred             ccCHHHHhcCHHHHHHhc
Confidence            999999999999987654

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.2e-48  Score=362.82  Aligned_cols=272  Identities=24%  Similarity=0.423  Sum_probs=215.1

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEc-cCCcEEEEEEeecccch-HHHHHHHHHHHHHhcC---CCCcceEEeeeEE-----
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHK-WTGQFFALKVIQMNVEE-SARRQIAQELKINQSS---QCPYVVVCYQSFY-----  138 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~~~~l---~hp~I~~~~~~~~-----  138 (362)
                      .++|++.+.||+|+||.||++++. .+|+.||+|+++..... .....+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            478999999999999999999995 67899999998754221 1123345566665554   8999999999887     


Q ss_pred             ecCeEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCC
Q 018018          139 SNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  216 (362)
Q Consensus       139 ~~~~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a  216 (362)
                      .....++||||+. ++|.+++....  .+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCHHHeEEcCCCCEEEecCccc
Confidence            5677999999997 59999998753  49999999999999999999998 99999999999999999999999999999


Q ss_pred             cccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC----
Q 018018          217 AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP----  292 (362)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----  292 (362)
                      +...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+   ....+........    
T Consensus       168 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          168 RIYSFQM-ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCCCGGG-GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCGGGS
T ss_pred             ccccCCC-CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCCCcccC
Confidence            7654322 3345678999999999999999999999999999999999999998754321   1112222111000    


Q ss_pred             -----------------CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHH
Q 018018          293 -----------------PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF  346 (362)
Q Consensus       293 -----------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~  346 (362)
                                       ........+++.+.+||.+||+.||++|||+.|+++||||+........+...+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~~~~~~~  314 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKENLDSHL  314 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCCCCC-----
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchhhhhhccCC
Confidence                             001123467899999999999999999999999999999998877655555443

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.6e-48  Score=365.90  Aligned_cols=258  Identities=23%  Similarity=0.375  Sum_probs=222.8

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEcc-------CCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEe
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKW-------TGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCY  134 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~  134 (362)
                      ..+++..++|.+.+.||+|+||.||+|++..       .+..||+|+++..........+.+|+++++.+ +||||++++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~  141 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL  141 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence            4556778999999999999999999999754       33579999998776777778899999999999 899999999


Q ss_pred             eeEEecCeEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCC
Q 018018          135 QSFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS  198 (362)
Q Consensus       135 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~  198 (362)
                      +++.+.+..++||||+++|+|.+++....                .+++..++.++.|++.||+|||+ +||+||||||+
T Consensus       142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~  220 (382)
T 3tt0_A          142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAAR  220 (382)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGG
T ss_pred             eeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCcc
Confidence            99999999999999999999999998754                49999999999999999999998 99999999999


Q ss_pred             cEEEccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccC
Q 018018          199 NLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ  275 (362)
Q Consensus       199 NIll~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~  275 (362)
                      |||++.++.+||+|||+|+.......  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+. 
T Consensus       221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~-  299 (382)
T 3tt0_A          221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-  299 (382)
T ss_dssp             GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred             eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH-
Confidence            99999999999999999987654322  2334467889999999999999999999999999999999 9999976432 


Q ss_pred             CchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          276 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                            .++...+..... ...+..+++++.+||.+||+.||++|||++|++++
T Consensus       300 ------~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          300 ------EELFKLLKEGHR-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             ------HHHHHHHHTTCC-CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ------HHHHHHHHcCCC-CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                  234444444433 33446789999999999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5.7e-49  Score=368.38  Aligned_cols=262  Identities=30%  Similarity=0.496  Sum_probs=221.6

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch----------------HHHHHHHHHHHHHhcCCCCc
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE----------------SARRQIAQELKINQSSQCPY  129 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------~~~~~~~~e~~~~~~l~hp~  129 (362)
                      ....++|++.+.||+|+||.||++.+  +|+.||+|++......                .....+.+|+.+++.++|||
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~  104 (348)
T 2pml_X           27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY  104 (348)
T ss_dssp             CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred             ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence            34468999999999999999999999  8999999998754211                11277899999999999999


Q ss_pred             ceEEeeeEEecCeEEEEEeccCCCCHHHH------HHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEE
Q 018018          130 VVVCYQSFYSNGAISIILEYMDGGSLADF------LKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLL  201 (362)
Q Consensus       130 I~~~~~~~~~~~~~~lV~e~~~~gsL~~~------l~~--~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIl  201 (362)
                      |+++++++.+.+..++||||+++++|.++      +..  ...+++..++.++.|++.||+|||+.+|++||||||+||+
T Consensus       105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL  184 (348)
T ss_dssp             BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred             cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence            99999999999999999999999999998      655  5789999999999999999999996489999999999999


Q ss_pred             EccCCcEEEeeccCCcccccCCCCCCccccCCcccCcceecCC-CCCc-cccHHHHHHHHHHHHcCCCCCCCCccCCchh
Q 018018          202 INHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KYGY-KSDIWSLGLVLLECATGQFPYSPPEQQDGWT  279 (362)
Q Consensus       202 l~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~~l~elltg~~pf~~~~~~~~~~  279 (362)
                      ++.++.+||+|||++......  ......|++.|+|||++.+. .++. ++||||||+++|+|++|..||......    
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----  258 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL----  258 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred             EcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence            999999999999999875433  34456789999999999887 6666 999999999999999999999865432    


Q ss_pred             hHHHHHHHHhcCCCCCCC-----------------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          280 SFYELMEAIVDQPPPSAP-----------------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                        .+....+.......+.                 ...+++++.+||.+||+.||++|||++|+++||||+....
T Consensus       259 --~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~  331 (348)
T 2pml_X          259 --VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI  331 (348)
T ss_dssp             --HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred             --HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence              2344444444332221                 1568999999999999999999999999999999987653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3e-48  Score=367.31  Aligned_cols=261  Identities=26%  Similarity=0.434  Sum_probs=211.1

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE-----
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI-----  143 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~-----  143 (362)
                      ++|.+.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++......     
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            7899999999999999999999999999999999765 3445567889999999999999999999999876654     


Q ss_pred             -EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          144 -SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       144 -~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                       ++||||+. ++|.+++.  ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++.... 
T Consensus       122 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-  196 (371)
T 4exu_A          122 FYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-  196 (371)
T ss_dssp             CEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred             EEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence             99999997 58888874  459999999999999999999998 9999999999999999999999999999976542 


Q ss_pred             CCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH-----------------
Q 018018          223 SGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL-----------------  284 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~-----------------  284 (362)
                        .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...                 
T Consensus       197 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  274 (371)
T 4exu_A          197 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  274 (371)
T ss_dssp             -----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHH
T ss_pred             --CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhh
Confidence              2345678999999999987 67899999999999999999999999875432211111100                 


Q ss_pred             ---HHHHhcCCCC--CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          285 ---MEAIVDQPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       285 ---~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                         ..........  ......+++++.+||.+||+.||++|||++|+++||||+.+.+
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  332 (371)
T 4exu_A          275 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  332 (371)
T ss_dssp             HHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence               0000000000  0012357899999999999999999999999999999987653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-48  Score=362.66  Aligned_cols=256  Identities=24%  Similarity=0.354  Sum_probs=220.4

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEc-----cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS  139 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~  139 (362)
                      ..+..++|++.+.||+|+||.||++++.     .+++.||+|+++..........+.+|+.+++.++||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            3567789999999999999999999987     35589999999877666777889999999999999999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecC
Q 018018          140 NGAISIILEYMDGGSLADFLKKV------------------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL  195 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dl  195 (362)
                      .+..++||||+++++|.+++...                        ..+++..++.++.|++.||.|||+ +||+||||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dl  200 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDL  200 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCC
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCC
Confidence            99999999999999999999764                        579999999999999999999998 99999999


Q ss_pred             CCCcEEEccCCcEEEeeccCCcccccCC--CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCC
Q 018018          196 KPSNLLINHRGEVKITDFGVSAIMASTS--GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPP  272 (362)
Q Consensus       196 kp~NIll~~~~~vkl~DFg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~  272 (362)
                      ||+||+++.++.+||+|||+++......  .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            9999999999999999999987654322  12234567899999999998899999999999999999999 99999764


Q ss_pred             ccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +.       .+....+.....+ ..+..+++++.+||.+||+.||++|||+.+++++
T Consensus       281 ~~-------~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          281 AH-------EEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             CH-------HHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             Ch-------HHHHHHHhCCCcC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            32       2344444444332 3446789999999999999999999999999763

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=8e-48  Score=353.91  Aligned_cols=258  Identities=25%  Similarity=0.436  Sum_probs=215.2

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc---hHHHHHHHHHHHHHhcCCCCcceEEeeeEE--ecCeE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE---ESARRQIAQELKINQSSQCPYVVVCYQSFY--SNGAI  143 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~--~~~~~  143 (362)
                      .++|++.+.||+|+||.||++.+..+++.||+|+++....   ......+.+|+.+++.++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            4789999999999999999999999999999999975421   235677899999999999999999999884  45689


Q ss_pred             EEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          144 SIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ++||||+.++ |.+++..  ...+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.....
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~-~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS-QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH-CCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            9999999875 8887765  4579999999999999999999998 9999999999999999999999999999977543


Q ss_pred             CC--CCCCccccCCcccCcceecCCC--CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          222 TS--GQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       222 ~~--~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      ..  .......||+.|+|||++.+..  ++.++||||||+++|+|++|..||.+.+       .......+.....  ..
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-------~~~~~~~i~~~~~--~~  232 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-------IYKLFENIGKGSY--AI  232 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS-------HHHHHHHHHHCCC--CC
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch-------HHHHHHHHhcCCC--CC
Confidence            22  2223457899999999998754  3789999999999999999999997643       2234444444332  23


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      +..+++.+.+||.+||+.||++|||++|+++||||+....
T Consensus       233 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          233 PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            4578999999999999999999999999999999976643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-48  Score=363.13  Aligned_cols=260  Identities=26%  Similarity=0.359  Sum_probs=216.5

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEc-----cCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeE
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSF  137 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~  137 (362)
                      .+++..++|++.+.||+|+||.||++++.     .++..||+|+++..........+.+|+.+++.+ +||||+++++++
T Consensus        39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            45677899999999999999999999973     356789999998665555667899999999999 899999999999


Q ss_pred             EecCeEEEEEeccCCCCHHHHHHHcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeec
Q 018018          138 YSNGAISIILEYMDGGSLADFLKKVK-----------------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRD  194 (362)
Q Consensus       138 ~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~D  194 (362)
                      ...+..++||||+++|+|.+++....                       .+++..++.++.|++.||+|||+ +||+|||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~D  197 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD  197 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCcccCC
Confidence            99999999999999999999997643                       37999999999999999999998 9999999


Q ss_pred             CCCCcEEEccCCcEEEeeccCCcccccCCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCC
Q 018018          195 LKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP  271 (362)
Q Consensus       195 lkp~NIll~~~~~vkl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~  271 (362)
                      |||+||+++.++.+||+|||++.........  .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            9999999999999999999999876543321  233467889999999999999999999999999999998 9999987


Q ss_pred             CccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCc
Q 018018          272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  331 (362)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~  331 (362)
                      .....      ... ...........+..+++++.+||.+||+.||++|||+.++++|..
T Consensus       278 ~~~~~------~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          278 IPVDA------NFY-KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             CCCSH------HHH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCcHH------HHH-HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            54321      112 222222333345678999999999999999999999999998654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2e-47  Score=352.32  Aligned_cols=258  Identities=31%  Similarity=0.532  Sum_probs=210.2

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      .....++|++.+.||+|+||.||++.+..+|+.||+|+++..  ........+.+|+.+++.++||||+++++.+...+.
T Consensus        27 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~  106 (310)
T 2wqm_A           27 GYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE  106 (310)
T ss_dssp             TTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             ccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc
Confidence            345678999999999999999999999999999999999753  345567788999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          143 ISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      .++||||+++++|.+++..    ...+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++..
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS-RRVMHRDIKPANVFITATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence            9999999999999999964    4679999999999999999999998 9999999999999999999999999999987


Q ss_pred             cccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          219 MASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       219 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      ............|++.|+|||++.+..++.++||||||+++|+|++|..||.+...     ........+.....+....
T Consensus       186 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~  260 (310)
T 2wqm_A          186 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----NLYSLCKKIEQCDYPPLPS  260 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-----CHHHHHHHHHTTCSCCCCT
T ss_pred             ecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-----hHHHHHHHhhcccCCCCcc
Confidence            65544444556789999999999999999999999999999999999999975432     2234445555555444455


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+++++.+||.+||+.||++|||+.++++
T Consensus       261 ~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          261 DHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            678999999999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1e-47  Score=352.68  Aligned_cols=264  Identities=23%  Similarity=0.353  Sum_probs=216.8

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEE----EccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEE
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQ----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY  138 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~  138 (362)
                      ....+....|++.+.||+|+||.||+|+    +..+++.||+|+++..........+.+|+.+++.++||||+++++++.
T Consensus        14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (302)
T 4e5w_A           14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT   93 (302)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence            3455667889999999999999999999    567899999999986655555678899999999999999999999988


Q ss_pred             ec--CeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccC
Q 018018          139 SN--GAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  215 (362)
Q Consensus       139 ~~--~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~  215 (362)
                      +.  ..+++||||+++++|.+++.. ...+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~  172 (302)
T 4e5w_A           94 EDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGS-RQYVHRDLAARNVLVESEHQVKIGDFGL  172 (302)
T ss_dssp             C---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             cCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhc-CCcccCCCchheEEEcCCCCEEECcccc
Confidence            76  678999999999999999954 4679999999999999999999998 9999999999999999999999999999


Q ss_pred             CcccccCCC---CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------cCCchhhHHHH
Q 018018          216 SAIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE--------QQDGWTSFYEL  284 (362)
Q Consensus       216 a~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~--------~~~~~~~~~~~  284 (362)
                      +........   ......||..|+|||++.+..++.++||||||+++|+|++|..|+....        ...........
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            987654332   2334568888999999999899999999999999999999999875421        11112223333


Q ss_pred             HHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          285 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ........ ....+..+++++.+||.+||+.||++|||++++++
T Consensus       253 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          253 VNTLKEGK-RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHHhccC-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            44444333 33345678999999999999999999999999976

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.2e-48  Score=353.82  Aligned_cols=261  Identities=28%  Similarity=0.444  Sum_probs=212.4

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEE----EccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe-
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQ----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-  139 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~-  139 (362)
                      .++..++|++++.||+|+||+||+++    +..+++.||+|++... .......+.+|+.+++.++||||+++++++.. 
T Consensus         5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            45677999999999999999999998    5678999999998754 45556789999999999999999999998864 


Q ss_pred             -cCeEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          140 -NGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       140 -~~~~~lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                       ...+++||||+++++|.+++.... .+++..+..++.|++.||+|||+ +|++||||||+||+++.++++||+|||+++
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence             356899999999999999997754 59999999999999999999998 999999999999999999999999999998


Q ss_pred             ccccCCC---CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCcc---------CCchhhHHHHH
Q 018018          218 IMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQ---------QDGWTSFYELM  285 (362)
Q Consensus       218 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~---------~~~~~~~~~~~  285 (362)
                      .......   ......++..|+|||++.+..++.++||||||+++|+|++|..||.....         ...........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            7643322   12234577789999999999999999999999999999999999865321         11111122333


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          286 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+.... ....+..+++++.+||.+||+.||++|||+.|+++
T Consensus       243 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          243 ELLKNNG-RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             HHHHTTC-CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhccC-cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            3333333 33345678999999999999999999999999975

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.4e-47  Score=351.28  Aligned_cols=255  Identities=27%  Similarity=0.458  Sum_probs=208.4

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe----------
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS----------  139 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~----------  139 (362)
                      ++|++.+.||+|+||.||++++..+++.||||+++..  ......+.+|+.+++.++||||+++++.+.+          
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            6799999999999999999999999999999998643  4556788999999999999999999998765          


Q ss_pred             ---cCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccC
Q 018018          140 ---NGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGV  215 (362)
Q Consensus       140 ---~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~  215 (362)
                         ....++||||+++++|.+++... ..+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS-QGIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh-CCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence               46789999999999999999864 367899999999999999999998 9999999999999999999999999999


Q ss_pred             CcccccC--------------CCCCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhh
Q 018018          216 SAIMAST--------------SGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS  280 (362)
Q Consensus       216 a~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~  280 (362)
                      +......              ........|++.|+|||++.+. .++.++|||||||++|+|++   ||...      ..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~------~~  233 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG------ME  233 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH------HH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc------hh
Confidence            9765422              1123345789999999999864 68999999999999999998   55421      12


Q ss_pred             HHHHHHHHhcC--CCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          281 FYELMEAIVDQ--PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       281 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      .......+...  ..++......++.+.++|.+||+.||++|||++++++||||+...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (303)
T 1zy4_A          234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH  291 (303)
T ss_dssp             HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred             HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence            22333333332  233344566788899999999999999999999999999997653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.6e-48  Score=356.08  Aligned_cols=259  Identities=25%  Similarity=0.382  Sum_probs=220.2

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEE-----ccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeee
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQH-----KWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQS  136 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~  136 (362)
                      ..+++..++|.+.+.||+|+||.||++++     ..+++.||+|+++..........+.+|+.+++.+ +||||++++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            34567789999999999999999999985     4567899999998776666678899999999999 89999999999


Q ss_pred             EEecCeEEEEEeccCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCC
Q 018018          137 FYSNGAISIILEYMDGGSLADFLKKVK------------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPS  198 (362)
Q Consensus       137 ~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~  198 (362)
                      +.+.+..++||||+++|+|.+++....                  .+++..++.++.|++.||+|||+ +|++||||||+
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~  174 (313)
T 1t46_A           96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAAR  174 (313)
T ss_dssp             ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGG
T ss_pred             EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCccc
Confidence            999999999999999999999997654                  48999999999999999999998 99999999999


Q ss_pred             cEEEccCCcEEEeeccCCcccccCCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccC
Q 018018          199 NLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQ  275 (362)
Q Consensus       199 NIll~~~~~vkl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~  275 (362)
                      ||+++.++.+||+|||++.........  .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            999999999999999999876543321  233457889999999999999999999999999999999 99999775432


Q ss_pred             CchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          276 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .   .....   ... ......+..+++++.++|.+||+.||++|||+.|++++
T Consensus       255 ~---~~~~~---~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          255 S---KFYKM---IKE-GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             H---HHHHH---HHH-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             h---HHHHH---hcc-CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            1   11122   222 22233346789999999999999999999999999874

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.2e-47  Score=364.46  Aligned_cols=261  Identities=26%  Similarity=0.433  Sum_probs=208.0

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CC-----cceEEeeeEEecC
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CP-----YVVVCYQSFYSNG  141 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp-----~I~~~~~~~~~~~  141 (362)
                      ..++|++.+.||+|+||+||+|.+..+++.||||+++..  ......+..|+.+++.++ |+     +|+.+++.+....
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            458999999999999999999999999999999999743  334556677777777664 44     5999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh-CCCeEeecCCCCcEEEc--cCCcEEEeeccCC
Q 018018          142 AISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHH-EKHIIHRDLKPSNLLIN--HRGEVKITDFGVS  216 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~-~~~ivH~Dlkp~NIll~--~~~~vkl~DFg~a  216 (362)
                      ..++||||+. ++|.+++...  ..+++..++.++.|++.||.|||+ ..||+||||||+|||++  .++.+||+|||+|
T Consensus       130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            9999999996 4999999875  469999999999999999999994 37999999999999995  4778999999999


Q ss_pred             cccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC----
Q 018018          217 AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP----  292 (362)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~----  292 (362)
                      +....   .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+..   ..+........    
T Consensus       209 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~---~~i~~~~~~~~~~~~  282 (382)
T 2vx3_A          209 CQLGQ---RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQM---NKIVEVLGIPPAHIL  282 (382)
T ss_dssp             EETTC---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCSCCHHHH
T ss_pred             eeccc---ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHHH
Confidence            87643   234568999999999999999999999999999999999999999875432211   11111110000    


Q ss_pred             -------------C----------------CCCCCCC-------------------------CCHHHHHHHHHhhhcCcC
Q 018018          293 -------------P----------------PSAPSDQ-------------------------FSPEFCSFISACVQKEPQ  318 (362)
Q Consensus       293 -------------~----------------~~~~~~~-------------------------~~~~~~~li~~~L~~dP~  318 (362)
                                   +                .+.....                         .++++.+||.+||++||+
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~  362 (382)
T 2vx3_A          283 DQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPK  362 (382)
T ss_dssp             TTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTT
T ss_pred             HhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChh
Confidence                         0                0000000                         013789999999999999


Q ss_pred             CCCCHHHHHcCCcccccCC
Q 018018          319 QRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       319 ~Rpt~~eil~hp~~~~~~~  337 (362)
                      +|||++|+|+||||+...+
T Consensus       363 ~Rpta~e~L~hp~f~~~~~  381 (382)
T 2vx3_A          363 TRIQPYYALQHSFFKKTAD  381 (382)
T ss_dssp             TSCCHHHHTTSGGGCC---
T ss_pred             hCCCHHHHhcCcccccCCC
Confidence            9999999999999987654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.5e-48  Score=357.43  Aligned_cols=263  Identities=27%  Similarity=0.435  Sum_probs=208.2

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEE----------
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY----------  138 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~----------  138 (362)
                      .++|++.+.||+|+||.||++.+..+++.||+|++... +......+.+|+.+++.++||||+++++++.          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT-DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC-ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            47899999999999999999999999999999998755 4556678899999999999999999998763          


Q ss_pred             ----ecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEc-cCCcEEEeec
Q 018018          139 ----SNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDF  213 (362)
Q Consensus       139 ----~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~-~~~~vkl~DF  213 (362)
                          +....++||||+. |+|.+++.. +++++..++.++.|++.||+|||+ +|++||||||+||+++ .++.+||+||
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~Df  165 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHS-ANVLHRDLKPANLFINTEDLVLKIGDF  165 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEEcCCCCeEEEccC
Confidence                4478999999997 599999975 679999999999999999999998 9999999999999997 5679999999


Q ss_pred             cCCcccccCC---CCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHH-
Q 018018          214 GVSAIMASTS---GQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI-  288 (362)
Q Consensus       214 g~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~-  288 (362)
                      |+++......   .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+.   ........ 
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~  242 (320)
T 2i6l_A          166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ---MQLILESIP  242 (320)
T ss_dssp             TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHSC
T ss_pred             ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcC
Confidence            9998764321   22334567999999998866 6789999999999999999999999987543211   11111110 


Q ss_pred             ---------------------hcCCCC--CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          289 ---------------------VDQPPP--SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       289 ---------------------~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                                           ......  ......+++++.+||.+||+.||++|||++|+++||||+.+...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence                                 000000  01124588999999999999999999999999999999977543

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.2e-47  Score=354.44  Aligned_cols=265  Identities=26%  Similarity=0.432  Sum_probs=215.9

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCC--CCcceEEeeeEEecC
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQ--CPYVVVCYQSFYSNG  141 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~--hp~I~~~~~~~~~~~  141 (362)
                      ..+..++|++.+.||+|+||.||++.+. +++.||+|++... ........+.+|+.+++.++  ||||+++++++.+..
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~  101 (313)
T 3cek_A           23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ  101 (313)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred             eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence            3456688999999999999999999986 5899999999765 34556678899999999987  599999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ..++||| +.+++|.+++.....+++..++.++.|++.||.|||+ +|++||||||+||+++ ++.+||+|||+++....
T Consensus       102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ-HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred             EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence            9999999 5577999999998899999999999999999999998 9999999999999995 58999999999987643


Q ss_pred             CCC--CCCccccCCcccCcceecC-----------CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHH
Q 018018          222 TSG--QANTFVGTYNYMSPERISG-----------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI  288 (362)
Q Consensus       222 ~~~--~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~  288 (362)
                      ...  ......|++.|+|||++.+           ..++.++||||||+++|+|++|..||.....      ........
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~------~~~~~~~~  252 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN------QISKLHAI  252 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS------HHHHHHHH
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH------HHHHHHHH
Confidence            322  1234578999999999876           4688999999999999999999999975422      12233344


Q ss_pred             hcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCC
Q 018018          289 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN  339 (362)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~  339 (362)
                      .........+...++++.++|.+||+.||++|||++|+++||||+......
T Consensus       253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  303 (313)
T 3cek_A          253 IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV  303 (313)
T ss_dssp             HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC----
T ss_pred             HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCch
Confidence            444444444566789999999999999999999999999999998765433

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.7e-48  Score=366.84  Aligned_cols=269  Identities=24%  Similarity=0.399  Sum_probs=203.5

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe----
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA----  142 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~----  142 (362)
                      ...++|++.+.||+|+||.||++++..+|+.||||++....  .......+++..+..++||||+++++++...+.    
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~   97 (360)
T 3e3p_A           20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR   97 (360)
T ss_dssp             HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT--TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred             hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc--cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence            35689999999999999999999999999999999986542  222345667777888899999999999876444    


Q ss_pred             ---EEEEEeccCCCCHHHHH----HHcCCCCHHHHHHHHHHHHHHHHHHH--hCCCeEeecCCCCcEEEcc-CCcEEEee
Q 018018          143 ---ISIILEYMDGGSLADFL----KKVKTIPEEYLAAICEQVLKGLLYLH--HEKHIIHRDLKPSNLLINH-RGEVKITD  212 (362)
Q Consensus       143 ---~~lV~e~~~~gsL~~~l----~~~~~l~~~~~~~i~~ql~~al~~LH--~~~~ivH~Dlkp~NIll~~-~~~vkl~D  212 (362)
                         .++||||+++ +|...+    .....+++..++.++.|++.||.|||  + +||+||||||+|||++. ++.+||+|
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~-~~ivH~Dlkp~NIll~~~~~~~kl~D  175 (360)
T 3e3p_A           98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCD  175 (360)
T ss_dssp             CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT-TCCBCSCCCGGGEEEETTTTEEEECC
T ss_pred             ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC-CCeecCcCCHHHEEEeCCCCcEEEee
Confidence               8999999986 555444    34568999999999999999999999  8 99999999999999996 89999999


Q ss_pred             ccCCcccccCCCCCCccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC
Q 018018          213 FGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ  291 (362)
Q Consensus       213 Fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  291 (362)
                      ||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+....   ...+.......
T Consensus       176 fg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~  251 (360)
T 3e3p_A          176 FGSAKKLSPSE-PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ---LHEIVRVLGCP  251 (360)
T ss_dssp             CTTCBCCCTTS-CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCC
T ss_pred             CCCceecCCCC-CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH---HHHHHHHcCCC
Confidence            99998765332 344567899999999987654 89999999999999999999999987543221   11121111000


Q ss_pred             -----------CC---------------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHH
Q 018018          292 -----------PP---------------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS  343 (362)
Q Consensus       292 -----------~~---------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~  343 (362)
                                 ..               ........++++.+||.+||+.||++|||+.|+++||||+...+....++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~~~~  329 (360)
T 3e3p_A          252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLP  329 (360)
T ss_dssp             CHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTCCCT
T ss_pred             CHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccccCC
Confidence                       00               01112235688999999999999999999999999999998876555443

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.4e-48  Score=347.45  Aligned_cols=254  Identities=24%  Similarity=0.433  Sum_probs=216.4

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      .+.+..++|++.+.||+|+||.||++.+. +++.||+|++......  ...+.+|+.+++.++||||+++++++.+....
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (269)
T 4hcu_A            4 KWVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   80 (269)
T ss_dssp             -CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             cEEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence            34567789999999999999999999987 5778999999765322  35688999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          144 SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      ++||||+++++|.+++... ..+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHh-CCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            9999999999999999654 568999999999999999999998 99999999999999999999999999999765432


Q ss_pred             C-CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          223 S-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       223 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      . .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.       ......+..... ...+..
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~  231 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGFR-LYKPRL  231 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCC-CCCCTT
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-------HHHHHHHhcCcc-CCCCCc
Confidence            2 12334456788999999998999999999999999999999 9999976432       234444444322 334466


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +++.+.+++.+||+.||++|||+.++++|
T Consensus       232 ~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          232 ASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            89999999999999999999999999875

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=8.3e-48  Score=361.63  Aligned_cols=261  Identities=26%  Similarity=0.427  Sum_probs=211.3

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe------
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA------  142 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~------  142 (362)
                      ++|.+.+.||+|+||.||+|.+..+|+.||||++... ........+.+|+.+++.++||||+++++++.....      
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            7899999999999999999999999999999999765 344556788999999999999999999999886643      


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      .++||||+. ++|.+++..  .+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++.... 
T Consensus       104 ~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~-  178 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHS-AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-  178 (353)
T ss_dssp             CEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred             EEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEeECCCCcEEEeecccccCCCC-
Confidence            599999997 588888753  69999999999999999999998 9999999999999999999999999999976532 


Q ss_pred             CCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH-----------------
Q 018018          223 SGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL-----------------  284 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~-----------------  284 (362)
                        ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+...                 
T Consensus       179 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  256 (353)
T 3coi_A          179 --EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAA  256 (353)
T ss_dssp             -------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHH
T ss_pred             --CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHH
Confidence              2344678999999999887 67899999999999999999999999875432111111100                 


Q ss_pred             ---HHHHhcCC--CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          285 ---MEAIVDQP--PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       285 ---~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                         ........  ........+++++.+||.+||+.||++|||++++++||||+.+.+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          257 KSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             HHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence               00000000  011123467899999999999999999999999999999987654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.9e-47  Score=345.10  Aligned_cols=253  Identities=25%  Similarity=0.389  Sum_probs=214.8

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      .++..++|++.+.||+|+||.||++.+. ++..||+|+++.....  ...+.+|+.+++.++||||+++++++.+....+
T Consensus         3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (268)
T 3sxs_A            3 MELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIY   79 (268)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             eEechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceE
Confidence            3567799999999999999999999876 5778999999765322  356889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          145 IILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      +||||+++++|.+++.... .+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++.......
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES-HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH-TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            9999999999999997754 59999999999999999999998 999999999999999999999999999987654332


Q ss_pred             C-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          224 G-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       224 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                      . ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.       ......+..... ...+...
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~-~~~~~~~  230 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN-------SEVVLKVSQGHR-LYRPHLA  230 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHHHTTCC-CCCCTTS
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh-------HHHHHHHHcCCC-CCCCCcC
Confidence            1 2233456778999999998899999999999999999999 9999976432       233333333332 3334567


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ++.+.++|.+||+.||++|||+.++++|
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          231 SDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8999999999999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8.8e-48  Score=359.29  Aligned_cols=260  Identities=27%  Similarity=0.395  Sum_probs=187.0

Q ss_pred             CccCceeee-eeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe----cCe
Q 018018           68 NLEDIDTIK-VVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGA  142 (362)
Q Consensus        68 ~~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~----~~~  142 (362)
                      ..++|.+.+ .||+|+||+||++.+..+|+.||||++...  .....++   ...++.+.||||+++++++..    ...
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~---~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEV---DHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHH---HHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHH---HHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            458899965 699999999999999999999999998653  2222222   233566799999999999876    456


Q ss_pred             EEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc---CCcEEEeeccCCc
Q 018018          143 ISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVSA  217 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---~~~vkl~DFg~a~  217 (362)
                      .++||||+++|+|.+++....  .+++..++.++.|++.||.|||+ +||+||||||+||+++.   ++.+||+|||+++
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS-HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            899999999999999998753  69999999999999999999998 99999999999999976   4459999999997


Q ss_pred             ccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          218 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.................. .....+...
T Consensus       180 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~  256 (336)
T 3fhr_A          180 ETTQN--ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL-GQYGFPNPE  256 (336)
T ss_dssp             EC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------CCCTTT
T ss_pred             ecccc--ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc-cccccCchh
Confidence            65432  234567899999999999889999999999999999999999999765443221111111111 111223333


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ...+++++.+||.+||+.||++|||++|+++||||+...
T Consensus       257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             STTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             hccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence            457899999999999999999999999999999997653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.3e-47  Score=353.63  Aligned_cols=260  Identities=23%  Similarity=0.367  Sum_probs=222.7

Q ss_pred             CCCCCCCCccCceeeeeeeeeCCeEEEEEEEc-----cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEee
Q 018018           61 KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ  135 (362)
Q Consensus        61 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~  135 (362)
                      .+..+++..++|++.+.||+|+||.||++++.     .+++.||+|++...........+.+|+.+++.++||||+++++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            34566778899999999999999999999886     4678999999987666666778999999999999999999999


Q ss_pred             eEEecCeEEEEEeccCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC
Q 018018          136 SFYSNGAISIILEYMDGGSLADFLKKV----------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR  205 (362)
Q Consensus       136 ~~~~~~~~~lV~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~  205 (362)
                      ++.+....++||||+++++|.+++...          ..+++..+..++.|++.||.|||+ +||+||||||+||+++.+
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~NIli~~~  174 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAED  174 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTT
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH-CCCccCCCccceEEEcCC
Confidence            999999999999999999999999753          457999999999999999999998 999999999999999999


Q ss_pred             CcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHH
Q 018018          206 GEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFY  282 (362)
Q Consensus       206 ~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~  282 (362)
                      +.+||+|||+++.......  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.       .
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~  247 (322)
T 1p4o_A          175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-------E  247 (322)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-------H
T ss_pred             CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH-------H
Confidence            9999999999986543322  1233467889999999999899999999999999999999 8999976432       2


Q ss_pred             HHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          283 ELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .....+..... ...+..+++.+.+||.+||+.||++|||+.|+++|
T Consensus       248 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          248 QVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            34444444333 23346789999999999999999999999999987

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.6e-47  Score=348.36  Aligned_cols=255  Identities=24%  Similarity=0.405  Sum_probs=215.0

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      ..+.+..++|++.+.||+|+||.||++.+. ++..||+|+++.....  ...+.+|+++++.++||||+++++++.+...
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence            456778899999999999999999999886 6778999999765322  3568899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          143 ISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.....
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHH-CCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            9999999999999999976 5679999999999999999999998 9999999999999999999999999999976543


Q ss_pred             CC-CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          222 TS-GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       222 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      .. .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...+.       ......+.... ....+.
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~-------~~~~~~~~~~~-~~~~~~  244 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQGL-RLYRPH  244 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHHHHTTC-CCCCCT
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh-------hHHHHHHhccc-CCCCCC
Confidence            22 12233456788999999998899999999999999999998 9999976433       23334444332 233446


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ..++.+.++|.+||+.||++|||++++++|
T Consensus       245 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          245 LASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            788999999999999999999999999976

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.3e-47  Score=348.81  Aligned_cols=256  Identities=24%  Similarity=0.356  Sum_probs=207.1

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccC---CcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      +.++..++|++.+.||+|+||.||++.+..+   +..||+|+++..........+.+|+.+++.++||||+++++++ .+
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~   87 (281)
T 1mp8_A            9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE   87 (281)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CS
T ss_pred             ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-cc
Confidence            4456779999999999999999999998654   4579999987766667778899999999999999999999987 45


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          141 GAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      +..++||||+++++|.+++.... .+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++..
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeecccccHHHEEECCCCCEEECcccccccc
Confidence            67899999999999999998654 79999999999999999999998 99999999999999999999999999999876


Q ss_pred             ccCCC-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          220 ASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       220 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      ..... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....       .....+..... ...
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~-------~~~~~i~~~~~-~~~  238 (281)
T 1mp8_A          167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGER-LPM  238 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------GHHHHHHTTCC-CCC
T ss_pred             CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH-------HHHHHHHcCCC-CCC
Confidence            43322 1233456789999999998899999999999999999997 99999875443       22333333332 234


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +..+++.+.++|.+||+.||++|||+.+++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            56789999999999999999999999999864

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.3e-47  Score=355.87  Aligned_cols=257  Identities=21%  Similarity=0.372  Sum_probs=218.7

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEc-------cCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEee
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHK-------WTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQ  135 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~  135 (362)
                      .+.+..++|++.+.||+|+||.||++++.       .++..||+|+++..........+.+|+.+++.+ +||||+++++
T Consensus        29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  108 (334)
T 2pvf_A           29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG  108 (334)
T ss_dssp             TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence            45677799999999999999999999975       467789999998776667778899999999999 8999999999


Q ss_pred             eEEecCeEEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCc
Q 018018          136 SFYSNGAISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN  199 (362)
Q Consensus       136 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~N  199 (362)
                      ++.+.+..++||||+++++|.+++....                .+++..++.++.|++.||+|||+ +|++||||||+|
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~N  187 (334)
T 2pvf_A          109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS-QKCIHRDLAARN  187 (334)
T ss_dssp             EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGG
T ss_pred             EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCccce
Confidence            9999999999999999999999998653                38999999999999999999998 999999999999


Q ss_pred             EEEccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCC
Q 018018          200 LLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD  276 (362)
Q Consensus       200 Ill~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~  276 (362)
                      |+++.++.+||+|||+++.......  ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.  
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--  265 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--  265 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH--
Confidence            9999999999999999987653322  2233457889999999998889999999999999999999 9999976432  


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          277 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                           .++...+..... ...+..+++++.++|.+||+.||++|||+.|++++
T Consensus       266 -----~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          266 -----EELFKLLKEGHR-MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             -----HHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----HHHHHHHhcCCC-CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                 233333333332 23346789999999999999999999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.4e-47  Score=346.33  Aligned_cols=251  Identities=25%  Similarity=0.457  Sum_probs=204.4

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc---hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE---ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      ++..++|++.+.||+|+||.||++.+.  ++.||+|+++....   ......+.+|+.+++.++||||+++++++.+.+.
T Consensus         3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (271)
T 3dtc_A            3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN   80 (271)
T ss_dssp             BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred             ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence            356789999999999999999999874  88999999875532   2234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCC---eEeecCCCCcEEEcc--------CCcEEEe
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH---IIHRDLKPSNLLINH--------RGEVKIT  211 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~---ivH~Dlkp~NIll~~--------~~~vkl~  211 (362)
                      .++||||+++++|.+++.. ..+++..++.++.|++.||+|||+ +|   ++||||||+||+++.        ++.+||+
T Consensus        81 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~-~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~  158 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHD-EAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT  158 (271)
T ss_dssp             CEEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHH-SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred             eEEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence            9999999999999999864 689999999999999999999998 88   999999999999986        7789999


Q ss_pred             eccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC
Q 018018          212 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ  291 (362)
Q Consensus       212 DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  291 (362)
                      |||++.......  .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+.       ..........
T Consensus       159 Dfg~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------~~~~~~~~~~  229 (271)
T 3dtc_A          159 DFGLAREWHRTT--KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG-------LAVAYGVAMN  229 (271)
T ss_dssp             CCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH-------HHHHHHHHTS
T ss_pred             cCCccccccccc--ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHhhhcC
Confidence            999997654332  2345789999999999998999999999999999999999999976432       2333344444


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          292 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       292 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ......+..+++.+.++|.+||+.||++|||+.|+++|
T Consensus       230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          230 KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            44455567889999999999999999999999999875

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=367.22  Aligned_cols=263  Identities=22%  Similarity=0.384  Sum_probs=194.5

Q ss_pred             cCcee-eeeeeeeCCeEEEEEEEc--cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe--cCeEE
Q 018018           70 EDIDT-IKVVGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAIS  144 (362)
Q Consensus        70 ~~~~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~--~~~~~  144 (362)
                      +.|++ .++||+|+||+||+|++.  .+++.||||++......   ..+.+|+.+++.++||||+++++++..  ...++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC---HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC---HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            44555 457999999999999966  56889999998754322   357789999999999999999999964  67899


Q ss_pred             EEEeccCCCCHHHHHHHc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEE----ccCCcEEEe
Q 018018          145 IILEYMDGGSLADFLKKV---------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKIT  211 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~---------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll----~~~~~vkl~  211 (362)
                      +||||+.+ +|.+++...         ..+++..++.++.|++.||+|||+ +||+||||||+|||+    +.++.+||+
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA-NWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99999965 888888532         249999999999999999999998 999999999999999    677899999


Q ss_pred             eccCCcccccCC---CCCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCc------hhhH
Q 018018          212 DFGVSAIMASTS---GQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG------WTSF  281 (362)
Q Consensus       212 DFg~a~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~------~~~~  281 (362)
                      |||+|+......   ......+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+......      ....
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            999998765322   223456899999999999874 589999999999999999999999976543210      1111


Q ss_pred             HHHHHHHhcCCCCCC---------------------------------CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          282 YELMEAIVDQPPPSA---------------------------------PSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       282 ~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+...+. .+....                                 .....++.+.+||.+||++||++|||++|+|+
T Consensus       255 ~~i~~~~g-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          255 DRIFNVMG-FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHC-CCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhhC-CCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11222111 111000                                 01123678999999999999999999999999


Q ss_pred             CCcccccCCC
Q 018018          329 HPFLKMYGDL  338 (362)
Q Consensus       329 hp~~~~~~~~  338 (362)
                      ||||+.....
T Consensus       334 hp~f~~~~~~  343 (405)
T 3rgf_A          334 DPYFLEDPLP  343 (405)
T ss_dssp             SGGGTSSSCC
T ss_pred             ChhhccCCCC
Confidence            9999876543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9e-48  Score=357.78  Aligned_cols=254  Identities=25%  Similarity=0.388  Sum_probs=206.2

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcE----EEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF----FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      .+..++|++.+.||+|+||+||++++..+++.    ||+|.++..........+.+|+.+++.++||||+++++++.+. 
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   89 (327)
T 3poz_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   89 (327)
T ss_dssp             ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred             hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence            45678999999999999999999999877775    4777776554455567899999999999999999999998765 


Q ss_pred             eEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          142 AISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ..++|++|+.+|+|.+++.. ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+...
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            47899999999999999977 4679999999999999999999998 999999999999999999999999999998764


Q ss_pred             cCCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          221 STSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       221 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      .....  .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.....       +...+.... ....
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~~~~~~-~~~~  240 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGE-RLPQ  240 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTC-CCCC
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH-------HHHHHHcCC-CCCC
Confidence            33322  223456889999999999999999999999999999999 999998754321       222222222 2334


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +..++.++.+++.+||+.||++|||+.+++++
T Consensus       241 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            46789999999999999999999999999876

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.6e-47  Score=355.04  Aligned_cols=261  Identities=24%  Similarity=0.379  Sum_probs=211.6

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCC-cEEEEEEeecccchHHHHHHHHHHHHHhcCCCCc------ceEEeeeEEe
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTG-QFFALKVIQMNVEESARRQIAQELKINQSSQCPY------VVVCYQSFYS  139 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~------I~~~~~~~~~  139 (362)
                      ...++|++.+.||+|+||+||+|.+..++ +.||+|+++..  ......+.+|+.+++.++|++      ++.+++.+..
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            34589999999999999999999998777 68999998743  344566778888888876654      8999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEE---------------
Q 018018          140 NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---------------  202 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll---------------  202 (362)
                      .+..++||||+ +++|.+++...  ..+++..++.++.|++.||+|||+ +||+||||||+|||+               
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE-NQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCCHHHEEEecccccccccccccc
Confidence            99999999999 56787877654  379999999999999999999998 999999999999999               


Q ss_pred             ----ccCCcEEEeeccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCch
Q 018018          203 ----NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW  278 (362)
Q Consensus       203 ----~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~  278 (362)
                          +.++.+||+|||+++....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+  
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--  246 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE--  246 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred             cccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence                5678999999999976432   2345689999999999999999999999999999999999999998654321  


Q ss_pred             hhHHHHHHHHhcCCCC---------------------------------------CCCCCCCCHHHHHHHHHhhhcCcCC
Q 018018          279 TSFYELMEAIVDQPPP---------------------------------------SAPSDQFSPEFCSFISACVQKEPQQ  319 (362)
Q Consensus       279 ~~~~~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~li~~~L~~dP~~  319 (362)
                        ....+.......+.                                       .......++++.+||.+||+.||++
T Consensus       247 --~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          247 --HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             --HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             --HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence              11222222211100                                       0011122457889999999999999


Q ss_pred             CCCHHHHHcCCcccccCCC
Q 018018          320 RLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       320 Rpt~~eil~hp~~~~~~~~  338 (362)
                      |||++|+++||||+...+.
T Consensus       325 Rpt~~e~l~hp~f~~~~~~  343 (355)
T 2eu9_A          325 RITLAEALLHPFFAGLTPE  343 (355)
T ss_dssp             SCCHHHHTTSGGGGGCCHH
T ss_pred             CcCHHHHhcChhhcCCChh
Confidence            9999999999999987643

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-47  Score=363.70  Aligned_cols=256  Identities=26%  Similarity=0.398  Sum_probs=207.6

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEc---cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      ..++...+|++.+.||+|+||.||++++.   .++..||||+++........+.+.+|+.+++.++||||+++++++.+.
T Consensus        39 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  118 (373)
T 2qol_A           39 AKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS  118 (373)
T ss_dssp             SCBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             HhhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            44667789999999999999999999887   457789999998776677778899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          141 GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      ...++||||+++++|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++..
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD-MGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            9999999999999999999765 479999999999999999999998 99999999999999999999999999999876


Q ss_pred             ccCCCCC---CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018018          220 ASTSGQA---NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  295 (362)
Q Consensus       220 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (362)
                      .......   ....+++.|+|||++.+..++.++|||||||++|||++ |..||...+.       .+....+..... .
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-------~~~~~~i~~~~~-~  269 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-------QDVIKAVDEGYR-L  269 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-------HHHHHHHHTTEE-C
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCC-C
Confidence            5432211   22345778999999999999999999999999999998 9999976432       233333333322 2


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       296 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+..++..+.+||.+||+.||++|||++++++
T Consensus       270 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          270 PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            234578899999999999999999999999976

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.1e-47  Score=342.77  Aligned_cols=250  Identities=16%  Similarity=0.273  Sum_probs=214.2

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEec--
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN--  140 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~--  140 (362)
                      ...+..++|++.+.||+|+||.||++++.  ++.||+|+++... .......+.+|+.+++.++||||+++++++.+.  
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence            34567899999999999999999999984  8899999997653 455667899999999999999999999998876  


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCC--eEeecCCCCcEEEccCCcEEEeeccCC
Q 018018          141 GAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLINHRGEVKITDFGVS  216 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~vkl~DFg~a  216 (362)
                      ...++||||+++|+|.+++....  .+++..+..++.|++.||+|||+ +|  ++||||||+||+++.++.++|+|||++
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT-SSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc-CCCceecCCCccceEEEcCCcceeEEeccce
Confidence            78999999999999999998765  48999999999999999999998 89  999999999999999999999999986


Q ss_pred             cccccCCCCCCccccCCcccCcceecCCCCCc---cccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC
Q 018018          217 AIMASTSGQANTFVGTYNYMSPERISGGKYGY---KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP  293 (362)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  293 (362)
                      ...     ......||+.|+|||++.+..++.   ++||||||+++|+|++|..||.+.+.       ............
T Consensus       161 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~  228 (271)
T 3kmu_A          161 FSF-----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-------MEIGMKVALEGL  228 (271)
T ss_dssp             CTT-----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-------HHHHHHHHHSCC
T ss_pred             eee-----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-------HHHHHHHHhcCC
Confidence            542     223457899999999998766544   79999999999999999999976432       233333443444


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       294 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .+..+..+++++.++|.+||+.||++|||++++++
T Consensus       229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          229 RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            44556789999999999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.8e-47  Score=348.94  Aligned_cols=257  Identities=19%  Similarity=0.263  Sum_probs=214.1

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~l  145 (362)
                      +..++|++.+.||+|+||.||++.+..+|+.||+|++.....   ...+.+|+.+++.+ +|++|+.+++.+.+....++
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            445789999999999999999999999999999999865422   23567888888888 79999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc-----EEEeeccCCccc
Q 018018          146 ILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE-----VKITDFGVSAIM  219 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~-----vkl~DFg~a~~~  219 (362)
                      ||||+ +++|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+||+++.++.     +||+|||+++..
T Consensus        84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHh-CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            99999 889999998754 69999999999999999999998 99999999999999987776     999999999876


Q ss_pred             ccCCC-------CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          220 ASTSG-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       220 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                      .....       ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..........+........
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  241 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence            54322       23456799999999999999999999999999999999999999987654433322222222222221


Q ss_pred             CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          293 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       293 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                       .......+++++.++|.+||+.||++|||++++++.
T Consensus       242 -~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          242 -LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             -HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             -HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence             112234688999999999999999999999999763

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.7e-47  Score=354.93  Aligned_cols=257  Identities=26%  Similarity=0.380  Sum_probs=218.4

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCc-----EEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeE
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ-----FFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSF  137 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~  137 (362)
                      ..++..++|.+.+.||+|+||.||++.+..++.     .||+|+++..........+.+|+.+++.+ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            466778999999999999999999999876654     79999998776666778899999999999 899999999999


Q ss_pred             EecCeEEEEEeccCCCCHHHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEc
Q 018018          138 YSNGAISIILEYMDGGSLADFLKKV--------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN  203 (362)
Q Consensus       138 ~~~~~~~lV~e~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~  203 (362)
                      .+.+..++||||+++|+|.+++...              ..+++..++.++.|++.||+|||+ +||+||||||+||+++
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS-KNCIHRDVAARNVLLT  198 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGCEEE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc-CCcccCCcccceEEEC
Confidence            9999999999999999999999653              358999999999999999999998 9999999999999999


Q ss_pred             cCCcEEEeeccCCcccccCCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhh
Q 018018          204 HRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTS  280 (362)
Q Consensus       204 ~~~~vkl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~  280 (362)
                      .++.+||+|||++.........  .....+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+.....   .
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~  275 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS---K  275 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH---H
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH---H
Confidence            9999999999999866433221  233457889999999999899999999999999999998 999997654321   1


Q ss_pred             HHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          281 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ......    .......+...++.+.+||.+||+.||++|||+.++++
T Consensus       276 ~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          276 FYKLVK----DGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             HHHHHH----HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHh----cCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            112221    12223334567899999999999999999999999987

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.1e-47  Score=345.69  Aligned_cols=253  Identities=21%  Similarity=0.379  Sum_probs=212.4

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch---HH---HHHHHHHHHHHhcCCCCcceEEeeeEE
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE---SA---RRQIAQELKINQSSQCPYVVVCYQSFY  138 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~---~~~~~~e~~~~~~l~hp~I~~~~~~~~  138 (362)
                      ..+..++|++.+.||+|+||.||++++..+++.||+|++......   ..   ...+.+|+.+++.++||||+++++.+.
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   93 (287)
T 4f0f_A           14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH   93 (287)
T ss_dssp             CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred             hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence            346678999999999999999999999999999999998654221   11   167899999999999999999999886


Q ss_pred             ecCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCC--eEeecCCCCcEEEccCCc-----EEE
Q 018018          139 SNGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLINHRGE-----VKI  210 (362)
Q Consensus       139 ~~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~-----vkl  210 (362)
                      +..  ++||||+++++|.+++... ..+++..++.++.|++.||+|||+ +|  ++||||||+||+++.++.     +||
T Consensus        94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~-~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHh-CCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            555  6999999999999888654 579999999999999999999998 89  999999999999988776     999


Q ss_pred             eeccCCcccccCCCCCCccccCCcccCcceec--CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHH
Q 018018          211 TDFGVSAIMASTSGQANTFVGTYNYMSPERIS--GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI  288 (362)
Q Consensus       211 ~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~  288 (362)
                      +|||+++....   ......||+.|+|||++.  ...++.++|||||||++|+|++|..||.......     .......
T Consensus       171 ~Dfg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~  242 (287)
T 4f0f_A          171 ADFGLSQQSVH---SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFINMI  242 (287)
T ss_dssp             CCCTTCBCCSS---CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-----HHHHHHH
T ss_pred             CCCCccccccc---cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-----HHHHHHH
Confidence            99999875432   334567999999999984  4557899999999999999999999997654321     2233334


Q ss_pred             hcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          289 VDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ......+..+..+++++.++|.+||+.||++|||++|+++
T Consensus       243 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            4444445566789999999999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=7.3e-48  Score=364.02  Aligned_cols=264  Identities=27%  Similarity=0.439  Sum_probs=208.6

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-----------CCcceEEe
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-----------CPYVVVCY  134 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----------hp~I~~~~  134 (362)
                      .+..++|++.+.||+|+||.||+|++..+++.||||+++..  ......+.+|+.+++.+.           ||||++++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            34568999999999999999999999999999999998743  334566778888887765           89999999


Q ss_pred             eeEEecC----eEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC-CeEeecCCCCcEEEcc---
Q 018018          135 QSFYSNG----AISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEK-HIIHRDLKPSNLLINH---  204 (362)
Q Consensus       135 ~~~~~~~----~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~-~ivH~Dlkp~NIll~~---  204 (362)
                      +.+...+    .+++||||+ +++|.+++...  ..+++..+..++.|++.||+|||+ + ||+||||||+|||++.   
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~-~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR-RCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCEECSCCSGGGEEEEEEET
T ss_pred             HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh-cCCEEecCCChHHeEEeccCC
Confidence            9988654    799999999 78999999863  459999999999999999999998 7 9999999999999954   


Q ss_pred             ---CCcEEEeeccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhh-
Q 018018          205 ---RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTS-  280 (362)
Q Consensus       205 ---~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~-  280 (362)
                         .+.+||+|||++.....   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+....... 
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcCcceEEEcccccccccCC---CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence               34799999999976543   23445789999999999999999999999999999999999999986543221111 


Q ss_pred             --HHHHHHHHhcCCC------------------------------------CCCCCCCCCHHHHHHHHHhhhcCcCCCCC
Q 018018          281 --FYELMEAIVDQPP------------------------------------PSAPSDQFSPEFCSFISACVQKEPQQRLS  322 (362)
Q Consensus       281 --~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  322 (362)
                        ...+.......+.                                    ....+..+++++.+||.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence              1111111110000                                    00111234567899999999999999999


Q ss_pred             HHHHHcCCcccccC
Q 018018          323 AQELMTHPFLKMYG  336 (362)
Q Consensus       323 ~~eil~hp~~~~~~  336 (362)
                      ++|+++||||+...
T Consensus       328 ~~ell~hp~f~~~~  341 (373)
T 1q8y_A          328 AGGLVNHPWLKDTL  341 (373)
T ss_dssp             HHHHHTCGGGTTCT
T ss_pred             HHHHhhChhhhccc
Confidence            99999999998753

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.4e-47  Score=355.67  Aligned_cols=260  Identities=24%  Similarity=0.357  Sum_probs=209.4

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC-
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-  141 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~-  141 (362)
                      ....+...+|++.+.||+|+||+||++++.  ++.||||+++..  .........|+.+++.++||||+++++++.+.. 
T Consensus        17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (322)
T 3soc_A           17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQ--DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS   92 (322)
T ss_dssp             CCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGG--GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             cccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecC--chHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence            344567799999999999999999999875  899999998754  233445566888999999999999999998754 


Q ss_pred             ---eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC----------CeEeecCCCCcEEEccCCcE
Q 018018          142 ---AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK----------HIIHRDLKPSNLLINHRGEV  208 (362)
Q Consensus       142 ---~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~----------~ivH~Dlkp~NIll~~~~~v  208 (362)
                         .+++||||+++|+|.++++. ..+++..++.++.|++.||+|||+ .          ||+||||||+||+++.++.+
T Consensus        93 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A           93 VDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred             CCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCCeE
Confidence               47999999999999999977 569999999999999999999998 8          99999999999999999999


Q ss_pred             EEeeccCCcccccCCC--CCCccccCCcccCcceecCC-----CCCccccHHHHHHHHHHHHcCCCCCCCCccCCch---
Q 018018          209 KITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGG-----KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW---  278 (362)
Q Consensus       209 kl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~---  278 (362)
                      ||+|||+|+.......  ......||+.|+|||++.+.     .++.++|||||||++|+|++|+.||.+.......   
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            9999999977654332  23346799999999999873     4667899999999999999999999875443211   


Q ss_pred             ------hhHHHHHHHHhcCCCCCCCCC-----CCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          279 ------TSFYELMEAIVDQPPPSAPSD-----QFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       279 ------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                            .....+..........+....     ..++++.+||.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                  122233333333333322222     12345999999999999999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.7e-47  Score=356.20  Aligned_cols=253  Identities=20%  Similarity=0.310  Sum_probs=210.3

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      .++|++.+.||+|+||.||++++..+|+.||||++.....   ...+.+|+.+++.+ +||||+++++++.+....++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            4789999999999999999999999999999999875432   23577899999999 8999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc-----EEEeeccCCccccc
Q 018018          148 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE-----VKITDFGVSAIMAS  221 (362)
Q Consensus       148 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~-----vkl~DFg~a~~~~~  221 (362)
                      ||+ +++|.+++.. ...+++..++.++.|++.||+|||+ +||+||||||+||+++.++.     +||+|||+|+....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~  162 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS-KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYID  162 (330)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBC
T ss_pred             EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeec
Confidence            999 8899999987 4689999999999999999999998 99999999999999998887     99999999987644


Q ss_pred             CCCC-------CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018018          222 TSGQ-------ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP  294 (362)
Q Consensus       222 ~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  294 (362)
                      ....       ....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.......+........ .
T Consensus       163 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~  241 (330)
T 2izr_A          163 PETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATP-I  241 (330)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSC-H
T ss_pred             CCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCC-H
Confidence            3321       2456899999999999999999999999999999999999999987654332222222222111111 1


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          295 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       295 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ......++ ++.++|..||+.||++||+++++++
T Consensus       242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            11122344 9999999999999999999999876

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-46  Score=347.68  Aligned_cols=253  Identities=26%  Similarity=0.372  Sum_probs=206.0

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ..++|++.+.||+|+||.||++.+..+++.||+|+++..  ........+.+|+.+++.++||||+++++++...+..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            468999999999999999999999999999999998755  234456789999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC-C
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS-G  224 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~-~  224 (362)
                      ||||+++++|.+++.....+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++....... .
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHA-AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence            99999999999999988899999999999999999999998 999999999999999999999999999987654332 1


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-CCCCCCCCCCH
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-PPSAPSDQFSP  303 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  303 (362)
                      ......|++.|+|||++.+..++.++||||||+++|+|++|..||...+.       ......+.... .+......+++
T Consensus       191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-------SVMGAHINQAIPRPSTVRPGIPV  263 (309)
T ss_dssp             ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-------HHHHHHHHSCCCCGGGTSTTCCT
T ss_pred             cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-------HHHHHHhccCCCCccccCCCCCH
Confidence            23345789999999999999999999999999999999999999976432       12222222222 22234567899


Q ss_pred             HHHHHHHHhhhcCcCCCC-CHHHHHc
Q 018018          304 EFCSFISACVQKEPQQRL-SAQELMT  328 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rp-t~~eil~  328 (362)
                      ++.++|.+||+.||++|| |++++++
T Consensus       264 ~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          264 AFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            999999999999999999 7777764

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=9.5e-48  Score=362.23  Aligned_cols=261  Identities=20%  Similarity=0.312  Sum_probs=204.1

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc----------chHHHHHHHHHHHHHhcCCCCcceEEeeeEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV----------EESARRQIAQELKINQSSQCPYVVVCYQSFY  138 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~  138 (362)
                      .++|.+.+.||+|+||.||++.+.. |..||||++....          +......+.+|+.+++.++||||+++++++.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            4789999999999999999999864 9999999985432          2334578999999999999999999999985


Q ss_pred             e-----cCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEee
Q 018018          139 S-----NGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITD  212 (362)
Q Consensus       139 ~-----~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~D  212 (362)
                      .     ...+++||||+. |+|.+++... ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|
T Consensus       100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dlkp~NIl~~~~~~~kl~D  177 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE-AGVVHRDLHPGNILLADNNDITICD  177 (362)
T ss_dssp             ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH-CcCEecCCChHHEEEcCCCCEEEEe
Confidence            4     346899999997 5888888654 479999999999999999999998 9999999999999999999999999


Q ss_pred             ccCCcccccCCCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc-
Q 018018          213 FGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD-  290 (362)
Q Consensus       213 Fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-  290 (362)
                      ||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+..   ..+...... 
T Consensus       178 fg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~  253 (362)
T 3pg1_A          178 FNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL---NKIVEVVGTP  253 (362)
T ss_dssp             TTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCC
T ss_pred             cCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCC
Confidence            9999754432 23345678999999999987 67899999999999999999999999875432111   111111100 


Q ss_pred             ------------------CCCCC-------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          291 ------------------QPPPS-------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       291 ------------------~~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                                        .....       ......++.+.+||.+||+.||++|||++|+++||||+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence                              00000       01235678999999999999999999999999999998763

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.7e-48  Score=358.65  Aligned_cols=254  Identities=26%  Similarity=0.390  Sum_probs=216.1

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch-----HHHHHHHHHHHHHhcCC--CCcceEEeeeE
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSSQ--CPYVVVCYQSF  137 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l~--hp~I~~~~~~~  137 (362)
                      .....++|++.+.||+|+||.||++++..+++.||||+++.....     .....+.+|+.+++.++  |+||+++++.+
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            344568899999999999999999999999999999999755221     12345667888888886  59999999999


Q ss_pred             EecCeEEEEEeccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEc-cCCcEEEeeccC
Q 018018          138 YSNGAISIILEYMDG-GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFGV  215 (362)
Q Consensus       138 ~~~~~~~lV~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~-~~~~vkl~DFg~  215 (362)
                      .+.+..++|||++.+ ++|.+++.....+++..++.++.|++.||+|||+ +||+||||||+||+++ .++.+||+|||+
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~  196 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGS  196 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence            999999999999976 8999999988999999999999999999999998 9999999999999999 788999999999


Q ss_pred             CcccccCCCCCCccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018018          216 SAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP  294 (362)
Q Consensus       216 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  294 (362)
                      ++.....  ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...+         .    .....  
T Consensus       197 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---------~----~~~~~--  259 (320)
T 3a99_A          197 GALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---------E----IIRGQ--  259 (320)
T ss_dssp             CEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------H----HHHCC--
T ss_pred             ccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh---------h----hhccc--
Confidence            9876432  3344679999999999987766 688999999999999999999996521         1    11111  


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          295 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       295 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ......+++++.+||.+||+.||++|||++|+++||||+..-
T Consensus       260 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          260 VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            223457899999999999999999999999999999998774

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6.3e-47  Score=346.05  Aligned_cols=257  Identities=21%  Similarity=0.346  Sum_probs=213.5

Q ss_pred             CCCCCCCccCceeee-eeeeeCCeEEEEEE--EccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeE
Q 018018           62 PSDNQLNLEDIDTIK-VVGKGSGGIVQLVQ--HKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSF  137 (362)
Q Consensus        62 ~~~~~~~~~~~~~~~-~lg~G~~g~V~~~~--~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~  137 (362)
                      +....+...+|++.+ .||+|+||.||++.  ...+++.||+|+++... .......+.+|+.+++.++||||+++++++
T Consensus         8 ~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   87 (291)
T 1xbb_A            8 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC   87 (291)
T ss_dssp             ---CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            345566778999998 99999999999995  45678899999997653 344567899999999999999999999988


Q ss_pred             EecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          138 YSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       138 ~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                       ..+..++||||+++++|.+++.....+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++.
T Consensus        88 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           88 -EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             -ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             -CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHh-CCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence             677899999999999999999998889999999999999999999998 999999999999999999999999999998


Q ss_pred             ccccCCCC---CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCC
Q 018018          218 IMASTSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPP  293 (362)
Q Consensus       218 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  293 (362)
                      ........   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.       ......+.....
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~  238 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGER  238 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCC
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCC
Confidence            76433221   122346788999999998889999999999999999999 9999976433       233333433332


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       294 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                       ...+..+++.+.++|.+||+.||++|||+.++++
T Consensus       239 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          239 -MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             3345678999999999999999999999999975

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.1e-48  Score=355.69  Aligned_cols=254  Identities=25%  Similarity=0.423  Sum_probs=205.7

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch-----HHHHHHHHHHHHHhcC----CCCcceEEeee
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----SARRQIAQELKINQSS----QCPYVVVCYQS  136 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~e~~~~~~l----~hp~I~~~~~~  136 (362)
                      +...++|++.+.||+|+||.||++++..+++.||||+++.....     .....+.+|+.++..+    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            44458899999999999999999999999999999998755221     1233455788887777    89999999999


Q ss_pred             EEecCeEEEEEec-cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEc-cCCcEEEeecc
Q 018018          137 FYSNGAISIILEY-MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN-HRGEVKITDFG  214 (362)
Q Consensus       137 ~~~~~~~~lV~e~-~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~-~~~~vkl~DFg  214 (362)
                      +.+.+..++|+|| +.+++|.+++.....+++..++.++.|++.||+|||+ +|++||||||+||+++ .++.+||+|||
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~kl~dfg  185 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS-RGVVHRDIKDENILIDLRRGCAKLIDFG  185 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-HTEECCCCSGGGEEEETTTTEEEECCCS
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecCCChhhEEEeCCCCeEEEEEcc
Confidence            9999999999999 7889999999988899999999999999999999998 9999999999999999 78999999999


Q ss_pred             CCcccccCCCCCCccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC
Q 018018          215 VSAIMASTSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP  293 (362)
Q Consensus       215 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  293 (362)
                      ++......  ......|+..|+|||++.+..+ +.++||||||+++|+|++|+.||....         ...    ... 
T Consensus       186 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~~----~~~-  249 (312)
T 2iwi_A          186 SGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ---------EIL----EAE-  249 (312)
T ss_dssp             SCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---------HHH----HTC-
T ss_pred             hhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH---------HHh----hhc-
Confidence            99876432  3345678999999999987766 458999999999999999999996421         111    111 


Q ss_pred             CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       294 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                       ...+..+++.+.++|.+||+.||++|||++|+++||||+...+
T Consensus       250 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          250 -LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             -cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence             2234578999999999999999999999999999999987654

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.4e-47  Score=353.64  Aligned_cols=254  Identities=26%  Similarity=0.392  Sum_probs=213.7

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEE--EEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCe
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF--ALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~  142 (362)
                      .+..++|++.+.||+|+||.||++++..++..+  |+|.++..........+.+|+.+++.+ +||||+++++++.+.+.
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  100 (327)
T 1fvr_A           21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY  100 (327)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence            466789999999999999999999999888865  999987655556667899999999999 89999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC
Q 018018          143 ISIILEYMDGGSLADFLKKVK----------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG  206 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~  206 (362)
                      .++||||+++++|.+++....                .+++..++.++.|++.||.|||+ +|++||||||+||+++.++
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGG
T ss_pred             eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCccceEEEcCCC
Confidence            999999999999999997654                79999999999999999999998 9999999999999999999


Q ss_pred             cEEEeeccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHH
Q 018018          207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELM  285 (362)
Q Consensus       207 ~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~  285 (362)
                      .+||+|||+++..... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.       .+..
T Consensus       180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~  251 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-------AELY  251 (327)
T ss_dssp             CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHH
T ss_pred             eEEEcccCcCcccccc-ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-------HHHH
Confidence            9999999998754322 22233467889999999998889999999999999999998 9999976432       2344


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          286 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ..+..... ...+..+++++.+||.+||+.||++|||+++++++
T Consensus       252 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          252 EKLPQGYR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             HHGGGTCC-CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhhcCCC-CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            44444332 23345789999999999999999999999999886

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.7e-47  Score=353.38  Aligned_cols=258  Identities=27%  Similarity=0.411  Sum_probs=217.7

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEE-----ccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeE
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQH-----KWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSF  137 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~  137 (362)
                      ...+..++|++.+.||+|+||.||++++     ..+++.||+|+++..........+.+|+.++..+ +||||+++++.+
T Consensus        21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            3456778999999999999999999985     3567899999998776666777899999999998 689999999998


Q ss_pred             EecC-eEEEEEeccCCCCHHHHHHHcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcE
Q 018018          138 YSNG-AISIILEYMDGGSLADFLKKVKT----------------IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  200 (362)
Q Consensus       138 ~~~~-~~~lV~e~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NI  200 (362)
                      ...+ .+++||||+++++|.+++.....                +++..++.++.|++.||.|||+ +|++||||||+||
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~i~H~dikp~Ni  179 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNI  179 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGE
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceE
Confidence            7654 59999999999999999987543                8999999999999999999998 9999999999999


Q ss_pred             EEccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCc
Q 018018          201 LINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDG  277 (362)
Q Consensus       201 ll~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~  277 (362)
                      +++.++.+||+|||+++.......  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+..... 
T Consensus       180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-  258 (316)
T 2xir_A          180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-  258 (316)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-
T ss_pred             EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH-
Confidence            999999999999999986643322  1234567889999999999999999999999999999998 999997654321 


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          278 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                           .....+..... ...+..+++++.++|.+||+.||++|||+.++++|
T Consensus       259 -----~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          259 -----EFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             -----HHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----HHHHHhccCcc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence                 22223332222 23345689999999999999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-47  Score=344.32  Aligned_cols=257  Identities=25%  Similarity=0.373  Sum_probs=217.7

Q ss_pred             CCCCccCceeee-eeeeeCCeEEEEEEEc--cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           65 NQLNLEDIDTIK-VVGKGSGGIVQLVQHK--WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        65 ~~~~~~~~~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ..+..++|.+.+ .||+|+||.||++.+.  .++..||+|+++..........+.+|+.+++.++||||+++++++ ..+
T Consensus         4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            4 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             ccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            345678888887 9999999999999864  467889999998776667778899999999999999999999988 567


Q ss_pred             eEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          142 AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHH-CCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            799999999999999999654 569999999999999999999998 999999999999999999999999999998764


Q ss_pred             cCCC---CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018018          221 STSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  296 (362)
Q Consensus       221 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
                      ....   ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.       .+....+..... ..
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~~i~~~~~-~~  233 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------PEVMAFIEQGKR-ME  233 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-------HHHHHHHHTTCC-CC
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHhcCCc-CC
Confidence            3322   1223456889999999998889999999999999999998 9999976543       133334433332 33


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCc
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  331 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~  331 (362)
                      .+..+++++.++|.+||+.||++|||+.++++|.+
T Consensus       234 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          234 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            44678999999999999999999999999998744

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.3e-47  Score=345.40  Aligned_cols=259  Identities=25%  Similarity=0.407  Sum_probs=201.9

Q ss_pred             CCCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           62 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        62 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      ....++..++|++.+.||+|+||.||++++.   ..+|+|+++... .......+.+|+.+++.++||||+.++++ ...
T Consensus        16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~-~~~   91 (289)
T 3og7_A           16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STA   91 (289)
T ss_dssp             --CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE-ECS
T ss_pred             CCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee-ccC
Confidence            3456788899999999999999999999764   359999997653 45566789999999999999999999985 456


Q ss_pred             CeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          141 GAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      ...++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++...
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~-~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA-KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCccceEEECCCCCEEEccceecccc
Confidence            778999999999999999954 4579999999999999999999998 99999999999999999999999999998765


Q ss_pred             ccCC--CCCCccccCCcccCcceec---CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018018          220 ASTS--GQANTFVGTYNYMSPERIS---GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP  294 (362)
Q Consensus       220 ~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  294 (362)
                      ....  .......||+.|+|||++.   +..++.++||||||+++|+|++|..||......   ................
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~  247 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIEMVGRGSLSPDL  247 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH---HHHHHHHHHTSCCCCT
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH---HHHHHHhcccccCcch
Confidence            4322  2234457899999999987   567899999999999999999999999765332   1122222222222222


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          295 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       295 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ......+++++.+||.+||+.||++|||++++++
T Consensus       248 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            3334578899999999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=2e-47  Score=355.25  Aligned_cols=260  Identities=23%  Similarity=0.351  Sum_probs=216.2

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEE-----EccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQ-----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      ++..++|++.+.||+|+||.||+++     +..++..||||++...........+.+|+.+++.++||||+++++++.+.
T Consensus        26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            4567899999999999999999999     55678899999997666666777899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc---CCcEEE
Q 018018          141 GAISIILEYMDGGSLADFLKKVK-------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKI  210 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~-------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---~~~vkl  210 (362)
                      ...++||||+++++|.+++....       .+++..++.++.|++.||.|||+ +|++||||||+||+++.   +..+||
T Consensus       106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~-~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE-NHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh-CCeecCcCCHhHEEEecCCCcceEEE
Confidence            99999999999999999998753       48999999999999999999998 99999999999999984   446999


Q ss_pred             eeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHH
Q 018018          211 TDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEA  287 (362)
Q Consensus       211 ~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~  287 (362)
                      +|||++........  ......+++.|+|||++.+..++.++||||||+++|+|++ |..||.....       ......
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-------~~~~~~  257 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-------QEVLEF  257 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHH
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-------HHHHHH
Confidence            99999876543221  2234567899999999998899999999999999999998 9999976432       233444


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          288 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      +..... ...+..+++.+.++|.+||+.||++|||+.++++|.|+-.
T Consensus       258 ~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          258 VTSGGR-MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhcCCC-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            444332 2334678999999999999999999999999999988743

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.5e-48  Score=357.59  Aligned_cols=255  Identities=22%  Similarity=0.340  Sum_probs=211.3

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcE----EEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF----FALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      ..+..++|++.+.||+|+||+||++.+..+++.    ||+|++...........+.+|+.+++.++||||+++++++. .
T Consensus         8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   86 (325)
T 3kex_A            8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G   86 (325)
T ss_dssp             CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred             hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence            345678999999999999999999999888775    77777654433334456778999999999999999999875 5


Q ss_pred             CeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          141 GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      ...++||||+.+|+|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++++||+|||+++..
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE-HGMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHH-TTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHh-CCCCCCccchheEEECCCCeEEECCCCccccc
Confidence            6789999999999999999764 579999999999999999999998 99999999999999999999999999999876


Q ss_pred             ccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018018          220 ASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  296 (362)
Q Consensus       220 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
                      .....  ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+....       +....+.... ...
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~-~~~  237 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-------EVPDLLEKGE-RLA  237 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-------HHHHHHHTTC-BCC
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-------HHHHHHHcCC-CCC
Confidence            43332  2234567889999999999999999999999999999999 99999875432       2233333322 233


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .+..+++++.++|.+||+.||++|||+.++++|
T Consensus       238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          238 QPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            345678899999999999999999999999886

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.3e-47  Score=346.95  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=219.3

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      ..+++..++|++.+.||+|+||.||++.+..++..||+|++...  ......+.+|+.+++.++||||+++++++.+...
T Consensus         6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   83 (288)
T 3kfa_A            6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED--TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   83 (288)
T ss_dssp             CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC--STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35667889999999999999999999999999999999998754  3345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          143 ISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      .++||||+++++|.+++...  ..+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++....
T Consensus        84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH-HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH-CCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            99999999999999999874  459999999999999999999998 999999999999999999999999999998765


Q ss_pred             cCCC-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          221 STSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       221 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      .... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..    .   ....+... .....+
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~----~---~~~~~~~~-~~~~~~  234 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----Q---VYELLEKD-YRMERP  234 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----G---HHHHHHTT-CCCCCC
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----H---HHHHHhcc-CCCCCC
Confidence            3322 2233456889999999999999999999999999999999 99999875432    1   22222222 223344


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+++.+.+||.+||+.||++|||++++++
T Consensus       235 ~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            678999999999999999999999999976

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-46  Score=350.39  Aligned_cols=257  Identities=25%  Similarity=0.352  Sum_probs=213.0

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCC----cEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTG----QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS  139 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~  139 (362)
                      ..++...+|.+.+.||+|+||.||++.+..++    ..||+|+++..........+.+|+.+++.++||||+++++.+.+
T Consensus        38 ~~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           38 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             cccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            34567789999999999999999999987553    36999999876666677789999999999999999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          140 NGAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      .+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||+++.
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            99999999999999999999764 679999999999999999999998 9999999999999999999999999999987


Q ss_pred             cccCCCC---CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018018          219 MASTSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPP  294 (362)
Q Consensus       219 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  294 (362)
                      .......   .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.       .+....+..... 
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-------~~~~~~~~~~~~-  268 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-------HEVMKAINDGFR-  268 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCC-
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-------HHHHHHHHCCCc-
Confidence            6533221   122346788999999999999999999999999999999 9999976432       234444444432 


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          295 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       295 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ...+..+++.+.++|.+||+.||++||++.+++++
T Consensus       269 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          269 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            23345789999999999999999999999999875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.1e-46  Score=363.38  Aligned_cols=248  Identities=24%  Similarity=0.414  Sum_probs=211.4

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC-e
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG-A  142 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~-~  142 (362)
                      .+.+..++|++.+.||+|+||.||++...  |+.||||+++...   ....+.+|+.+++.++||||+++++++.... .
T Consensus       187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            45678899999999999999999999874  7899999997543   3467899999999999999999999987665 7


Q ss_pred             EEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          143 ISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      .++||||+++|+|.+++...+.  +++..+..++.|++.||+|||+ +|++||||||+|||++.++.+||+|||+++...
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            9999999999999999987654  7999999999999999999998 999999999999999999999999999998543


Q ss_pred             cCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          221 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      ..   .....+++.|+|||++.+..++.++|||||||++|||++ |..||...+..+       +...+..+. ....+.
T Consensus       341 ~~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~~-~~~~p~  409 (450)
T 1k9a_A          341 ST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPRVEKGY-KMDAPD  409 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT-------HHHHHHTTC-CCCCCT
T ss_pred             cc---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCC-CCCCCC
Confidence            22   223367889999999999999999999999999999998 999998755432       233333332 233456


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .+++++.+||.+||+.||++|||+.++++
T Consensus       410 ~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          410 GCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            78999999999999999999999999975

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.2e-46  Score=339.45  Aligned_cols=253  Identities=24%  Similarity=0.429  Sum_probs=215.8

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      +.+..++|++.+.||+|+||.||++.+. +++.||+|+++.....  ...+.+|+.+++.++||||+++++.+.+.+..+
T Consensus         3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            4567789999999999999999999986 6788999999765332  356889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          145 IILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      +||||+++++|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++.......
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            999999999999999775 568999999999999999999998 999999999999999999999999999987653221


Q ss_pred             -CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCC
Q 018018          224 -GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF  301 (362)
Q Consensus       224 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (362)
                       .......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+.       .+....+..... ...+..+
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~i~~~~~-~~~~~~~  230 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-------SEVVEDISTGFR-LYKPRLA  230 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCC-CCCCTTS
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-------HHHHHHHhcCCc-CCCCccC
Confidence             12233467789999999998899999999999999999999 8999976432       233444444332 2334568


Q ss_pred             CHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          302 SPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       302 ~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ++.+.+++.+||+.||++|||+.+++++
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          231 STHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999999874

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.6e-47  Score=352.03  Aligned_cols=254  Identities=25%  Similarity=0.388  Sum_probs=207.3

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEE----EEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF----ALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      .+..++|++.+.||+|+||.||++.+..+++.+    |+|.+...........+.+|+.+++.++||||+++++++... 
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-   89 (327)
T 3lzb_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   89 (327)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-
T ss_pred             ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-
Confidence            356689999999999999999999998888754    667665554555667899999999999999999999988765 


Q ss_pred             eEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          142 AISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ..++|++|+.+|+|.+++.. ...+++..++.++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++...
T Consensus        90 ~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh-CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            48899999999999999976 4579999999999999999999998 999999999999999999999999999998764


Q ss_pred             cCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          221 STSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       221 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      ....  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+....+       ....+.... ....
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~~-~~~~  240 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGE-RLPQ  240 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHHTTC-CCCC
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcCC-CCCC
Confidence            3322  2233456789999999999999999999999999999999 999998754422       222222222 2334


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +..+++++.++|.+||+.||++|||+.|+++.
T Consensus       241 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          241 PPICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            56789999999999999999999999999873

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-46  Score=350.29  Aligned_cols=261  Identities=25%  Similarity=0.420  Sum_probs=217.3

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEE----EccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEE--e
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQ----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY--S  139 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~--~  139 (362)
                      .+..++|++.+.||+|+||.||+++    +..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.  +
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   97 (327)
T 3lxl_A           19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS-GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG   97 (327)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC-CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence            4567899999999999999999999    5678999999999765 4455677999999999999999999999886  4


Q ss_pred             cCeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          140 NGAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      ....++||||+++++|.+++.. ...+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++..
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A           98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGS-RRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCChhhEEECCCCCEEEccccccee
Confidence            5679999999999999999976 4569999999999999999999998 9999999999999999999999999999987


Q ss_pred             cccCCC---CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccC--------CchhhHHHHHHH
Q 018018          219 MASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ--------DGWTSFYELMEA  287 (362)
Q Consensus       219 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~--------~~~~~~~~~~~~  287 (362)
                      ......   ......+|+.|+|||++.+..++.++||||||+++|+|++|..||......        ............
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            643322   223346788899999999988999999999999999999999998653321        111122233333


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          288 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +.... ....+..+++++.+||.+||+.||++|||+++++++
T Consensus       257 ~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          257 LEEGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhccc-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33333 333456789999999999999999999999999654

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=8.1e-47  Score=350.20  Aligned_cols=263  Identities=23%  Similarity=0.287  Sum_probs=214.5

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ....++|++.+.||+|+||.||++++. +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC-CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            335688999999999999999999975 6899999998755 33456678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          146 ILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ||||+++++|.+++....    .+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++....
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT-RAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC-CCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999999999999996543    58999999999999999999998 9999999999999999999999999999976543


Q ss_pred             CCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC------
Q 018018          222 TSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP------  293 (362)
Q Consensus       222 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~------  293 (362)
                      ...  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+.................      
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDP  271 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSS
T ss_pred             ccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcCh
Confidence            221  223456899999999999889999999999999999999999999876554432222111111111111      


Q ss_pred             --CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCc
Q 018018          294 --PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  331 (362)
Q Consensus       294 --~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~  331 (362)
                        ........+..+.+++.+||+.||++|||+.|+++|..
T Consensus       272 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          272 NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence              11112234567889999999999999999999998643

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.5e-47  Score=346.26  Aligned_cols=248  Identities=20%  Similarity=0.326  Sum_probs=208.1

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCC-------cEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTG-------QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY  138 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~  138 (362)
                      ++..++|++.+.||+|+||+||++.+..++       ..||+|++... .......+.+|+.+++.++||||+++++++.
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA-HRNYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG-GGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            456789999999999999999999998877       47999998654 3345577899999999999999999999999


Q ss_pred             ecCeEEEEEeccCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc--------EE
Q 018018          139 SNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE--------VK  209 (362)
Q Consensus       139 ~~~~~~lV~e~~~~gsL~~~l~~~~~-l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~--------vk  209 (362)
                      +.+..++||||+++++|.+++..... +++..+..++.|++.||.|||+ +|++||||||+||+++.++.        +|
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE-NTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh-CCeECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999999999987654 9999999999999999999998 99999999999999998887        99


Q ss_pred             EeeccCCcccccCCCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcC-CCCCCCCccCCchhhHHHHHHH
Q 018018          210 ITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATG-QFPYSPPEQQDGWTSFYELMEA  287 (362)
Q Consensus       210 l~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg-~~pf~~~~~~~~~~~~~~~~~~  287 (362)
                      |+|||++.....    .....|++.|+|||++.+ ..++.++||||||+++|+|++| .+||...+.       ......
T Consensus       162 l~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-------~~~~~~  230 (289)
T 4fvq_A          162 LSDPGISITVLP----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-------QRKLQF  230 (289)
T ss_dssp             ECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-------HHHHHH
T ss_pred             eccCcccccccC----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-------HHHHHH
Confidence            999999865432    233468899999999988 6789999999999999999995 455544221       112222


Q ss_pred             HhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          288 IVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ....   ...+...++++.+||.+||+.||++|||+.++++|
T Consensus       231 ~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          231 YEDR---HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HHTT---CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hhcc---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            2221   22234567889999999999999999999999875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.5e-46  Score=348.20  Aligned_cols=262  Identities=25%  Similarity=0.389  Sum_probs=214.2

Q ss_pred             CCCCCccCc-eeeeeeeeeCCeEEEEEE----EccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEE
Q 018018           64 DNQLNLEDI-DTIKVVGKGSGGIVQLVQ----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY  138 (362)
Q Consensus        64 ~~~~~~~~~-~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~  138 (362)
                      +..+...+| ++++.||+|+||+||++.    +..+++.||||+++..........+.+|+.+++.++||||+++++++.
T Consensus        24 ~~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  103 (318)
T 3lxp_A           24 DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCE  103 (318)
T ss_dssp             CCCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence            333333455 999999999999998875    345788999999987766677788999999999999999999999998


Q ss_pred             e--cCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCC
Q 018018          139 S--NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  216 (362)
Q Consensus       139 ~--~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a  216 (362)
                      +  ...+++||||+++++|.+++.. ..+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++
T Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~-~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          104 DAGAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHA-QHYIHRDLAARNVLLDNDRLVKIGDFGLA  181 (318)
T ss_dssp             ETTTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             cCCCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEEcCCCCEEECCcccc
Confidence            7  4678999999999999999977 459999999999999999999998 99999999999999999999999999999


Q ss_pred             cccccCCC---CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccC--------CchhhHHHHH
Q 018018          217 AIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ--------DGWTSFYELM  285 (362)
Q Consensus       217 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~--------~~~~~~~~~~  285 (362)
                      ........   ......+|..|+|||++.+..++.++||||||+++|+|++|..||......        ........+.
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  261 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT  261 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence            87654322   123456788899999999989999999999999999999999999753211        0111112222


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          286 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+.. ......+..+++++.+||.+||+.||++|||++|+++
T Consensus       262 ~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          262 ELLER-GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHhc-ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            33333 3334445688999999999999999999999999985

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.5e-46  Score=341.76  Aligned_cols=255  Identities=22%  Similarity=0.309  Sum_probs=211.5

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEcc---CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKW---TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ..+..++|.+.+.||+|+||.||++.+..   ++..||+|+++..........+.+|+.+++.++||||+++++++.+ +
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   85 (281)
T 3cc6_A            7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E   85 (281)
T ss_dssp             CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S
T ss_pred             ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence            45667899999999999999999998654   3446999999877666677889999999999999999999998764 5


Q ss_pred             eEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          142 AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++....
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES-INCVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHH-CCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            678999999999999999765 469999999999999999999998 999999999999999999999999999988764


Q ss_pred             cCCC-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          221 STSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       221 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      .... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+    .   ...+..... ...+
T Consensus       165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~----~---~~~~~~~~~-~~~~  236 (281)
T 3cc6_A          165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----V---IGVLEKGDR-LPKP  236 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG----H---HHHHHHTCC-CCCC
T ss_pred             cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH----H---HHHHhcCCC-CCCC
Confidence            3322 2233456889999999998899999999999999999998 999997654322    1   222222222 2234


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ..+++.+.++|.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            5689999999999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.7e-46  Score=341.87  Aligned_cols=254  Identities=21%  Similarity=0.308  Sum_probs=208.1

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeE-EecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF-YSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~-~~~~~~~lV~  147 (362)
                      .++|++.+.||+|+||.||++++..+++.||||++....   ....+.+|+.+++.++|++++..+..+ ......++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            378999999999999999999999999999999876442   223577899999999987766555544 6778899999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEE---ccCCcEEEeeccCCcccccCC
Q 018018          148 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       148 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll---~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ||+ +++|.+++.. ...+++..+..++.|++.||.|||+ +||+||||||+||++   +.++.+||+|||+++......
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  162 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence            999 8899999985 4679999999999999999999998 999999999999999   789999999999998765432


Q ss_pred             C-------CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018018          224 G-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  296 (362)
Q Consensus       224 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
                      .       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.................... ..
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~  241 (296)
T 4hgt_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-EV  241 (296)
T ss_dssp             TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-HH
T ss_pred             cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-hh
Confidence            2       223567999999999999999999999999999999999999999876655444444444333332221 11


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ....+++++.+||.+||+.||++|||++++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            22467899999999999999999999999976

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.3e-46  Score=343.37  Aligned_cols=252  Identities=26%  Similarity=0.388  Sum_probs=200.4

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhc--CCCCcceEEeeeEEe----c
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS--SQCPYVVVCYQSFYS----N  140 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~hp~I~~~~~~~~~----~  140 (362)
                      ...++|++.+.||+|+||+||++++  +++.||||++....    ...+..|.+++..  ++||||+++++.+..    .
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~   78 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSS   78 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence            4568999999999999999999987  68999999986542    2344555665555  899999999998654    3


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeEeecCCCCcEEEccCCcEEEee
Q 018018          141 GAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH--------HEKHIIHRDLKPSNLLINHRGEVKITD  212 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH--------~~~~ivH~Dlkp~NIll~~~~~vkl~D  212 (362)
                      ...++||||+++|+|.++++. ..+++..+..++.|++.||+|||        + +||+||||||+|||++.++.+||+|
T Consensus        79 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           79 TQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK-PAIAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             EEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB-CEEECSCCCGGGEEECTTSCEEECC
T ss_pred             ceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC-CCeecCCCChHhEEEcCCCCEEEee
Confidence            568999999999999999965 67999999999999999999999        7 8999999999999999999999999


Q ss_pred             ccCCcccccCCCC----CCccccCCcccCcceecCC------CCCccccHHHHHHHHHHHHcC----------CCCCCCC
Q 018018          213 FGVSAIMASTSGQ----ANTFVGTYNYMSPERISGG------KYGYKSDIWSLGLVLLECATG----------QFPYSPP  272 (362)
Q Consensus       213 Fg~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~elltg----------~~pf~~~  272 (362)
                      ||+|+........    .....||+.|+|||++.+.      .++.++|||||||++|||++|          ..||...
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            9999765433322    2345799999999999886      455799999999999999999          8888765


Q ss_pred             ccCCchhhHHHHHHHHhcCCCCCCCC-----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          273 EQQDGWTSFYELMEAIVDQPPPSAPS-----DQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ......  ..............+..+     ...++++.+||.+||+.||++|||++++++
T Consensus       237 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          237 VPNDPS--FEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             SCSSCC--HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCCcc--hhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            443321  122222222222222211     224577999999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.2e-47  Score=370.38  Aligned_cols=254  Identities=24%  Similarity=0.359  Sum_probs=217.9

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      .+++...+|++.+.||+|+||.||++.+..++..||||+++....  ....+.+|+.+++.++||||+++++++.+...+
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            456778899999999999999999999999999999999875532  356789999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          144 SIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  370 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG  370 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCChhhEEECCCCcEEEeecccceeccC
Confidence            9999999999999999864  468999999999999999999998 9999999999999999999999999999987643


Q ss_pred             CCC-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          222 TSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       222 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      ... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..    .   +...+... .....+.
T Consensus       371 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~----~---~~~~~~~~-~~~~~~~  442 (495)
T 1opk_A          371 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----Q---VYELLEKD-YRMERPE  442 (495)
T ss_dssp             CCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG----G---HHHHHHTT-CCCCCCT
T ss_pred             CceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH----H---HHHHHHcC-CCCCCCC
Confidence            221 2223456789999999998899999999999999999999 99999875432    1   22223222 2233456


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .+++.+.+||.+||+.||++|||+.++++
T Consensus       443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          443 GCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            78999999999999999999999999976

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.8e-46  Score=339.42  Aligned_cols=254  Identities=21%  Similarity=0.309  Sum_probs=210.2

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeE-EecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF-YSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~-~~~~~~~lV~  147 (362)
                      .++|++.+.||+|+||.||++++..+|+.||+|++......   ..+.+|+.+++.++|++++..+..+ ......++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            47899999999999999999999999999999998755322   3578899999999987766555444 5678889999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEE---ccCCcEEEeeccCCcccccCC
Q 018018          148 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       148 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll---~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ||+ +++|.+++.. ...+++..+..++.|++.||+|||+ +|++||||||+||++   +.++.+||+|||++.......
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            999 8899999974 4679999999999999999999998 999999999999999   488999999999998765433


Q ss_pred             C-------CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018018          224 G-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  296 (362)
Q Consensus       224 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
                      .       ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.................... ..
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~  241 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-EV  241 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-HH
T ss_pred             cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-HH
Confidence            2       124567999999999999999999999999999999999999999876544433333333333322221 11


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ....+++++.++|.+||+.||++|||++++++
T Consensus       242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            23468899999999999999999999999976

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.8e-46  Score=345.13  Aligned_cols=258  Identities=22%  Similarity=0.329  Sum_probs=205.9

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEcc---CCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEE
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKW---TGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFY  138 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~  138 (362)
                      ....+..++|.+.+.||+|+||.||++.+..   ++..||+|+++.. ........+.+|+.+++.++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            3445677899999999999999999998765   4558999998755 34455678999999999999999999999987


Q ss_pred             ecC-----eEEEEEeccCCCCHHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc
Q 018018          139 SNG-----AISIILEYMDGGSLADFLKK------VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE  207 (362)
Q Consensus       139 ~~~-----~~~lV~e~~~~gsL~~~l~~------~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~  207 (362)
                      +..     ..++||||+++++|.+++..      ...+++..++.++.|++.||.|||+ +|++||||||+||+++.++.
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN-RNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT-TTCCCCCCSGGGEEECTTSC
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCCc
Confidence            654     45999999999999999943      3569999999999999999999998 99999999999999999999


Q ss_pred             EEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHH
Q 018018          208 VKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYEL  284 (362)
Q Consensus       208 vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~  284 (362)
                      +||+|||++........  ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......       ..
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-------~~  258 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH-------EM  258 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG-------GH
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH-------HH
Confidence            99999999977643321  2233457889999999999999999999999999999999 99999775442       22


Q ss_pred             HHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          285 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ...+..... ...+..+++.+.++|.+||+.||++|||+.+++++
T Consensus       259 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          259 YDYLLHGHR-LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HHHHHTTCC-CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCC-CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            333333332 33346789999999999999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.1e-46  Score=339.52  Aligned_cols=245  Identities=27%  Similarity=0.429  Sum_probs=211.2

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe----------
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS----------  139 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~----------  139 (362)
                      .+|++.+.||+|+||.||++.+..+++.||+|+++...     ..+.+|+.+++.++||||+++++++..          
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            67999999999999999999999999999999997653     246689999999999999999998754          


Q ss_pred             ------cCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEe
Q 018018          140 ------NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKIT  211 (362)
Q Consensus       140 ------~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~  211 (362)
                            ...+++||||+++++|.+++...  ..+++..++.++.|++.||.|||+ +|++||||||+||+++.++.+||+
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~kl~  164 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS-KKLINRDLKPSNIFLVDTKQVKIG  164 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEEC
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCCHHHEEEcCCCCEEEC
Confidence                  45689999999999999999754  679999999999999999999998 999999999999999999999999


Q ss_pred             eccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC
Q 018018          212 DFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ  291 (362)
Q Consensus       212 DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~  291 (362)
                      |||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||..         .......+...
T Consensus       165 Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~---------~~~~~~~~~~~  234 (284)
T 2a19_B          165 DFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE---------TSKFFTDLRDG  234 (284)
T ss_dssp             CCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH---------HHHHHHHHHTT
T ss_pred             cchhheeccccc-cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh---------HHHHHHHhhcc
Confidence            999998765432 33445799999999999999999999999999999999999988742         12233333333


Q ss_pred             CCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          292 PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       292 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      .    .+..+++.+.++|.+||+.||++|||+.|+++|.|.-.
T Consensus       235 ~----~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          235 I----ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             c----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            2    23568899999999999999999999999999987643

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.3e-46  Score=339.18  Aligned_cols=249  Identities=21%  Similarity=0.316  Sum_probs=208.3

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCc---EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE-EEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI-SII  146 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~-~lV  146 (362)
                      .|.+.+.||+|+||+||++.+..++.   .+|+|++...........+.+|+.+++.++||||+++++++.+.... ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45667999999999999999765555   79999998766667778899999999999999999999999866555 999


Q ss_pred             EeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC--
Q 018018          147 LEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--  223 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~--  223 (362)
                      |||+.+++|.+++.. ...+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++......  
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE-QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            999999999999976 4678999999999999999999998 999999999999999999999999999997654322  


Q ss_pred             --CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCC-CCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          224 --GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ-FPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       224 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                        .......+++.|+|||.+.+..++.++||||||+++|+|++|. +||...+..       .....+.... ....+..
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-------~~~~~~~~~~-~~~~~~~  252 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-------DLTHFLAQGR-RLPQPEY  252 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-------GHHHHHHTTC-CCCCCTT
T ss_pred             ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-------HHHHHhhcCC-CCCCCcc
Confidence              2233456789999999999999999999999999999999955 445443321       2223333332 2334567


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +++.+.++|.+||+.||++|||++++++
T Consensus       253 ~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          253 CPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            8999999999999999999999999976

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-47  Score=363.33  Aligned_cols=258  Identities=22%  Similarity=0.362  Sum_probs=212.3

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC--eEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG--AIS  144 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~--~~~  144 (362)
                      ...++|.+.+.||+|+||+||+|.+..+|+.||||+++..........+.+|+++++.++||||+++++++.+..  ..+
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            345789999999999999999999999999999999976544445677889999999999999999999988654  789


Q ss_pred             EEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEE----ccCCcEEEeeccCCc
Q 018018          145 IILEYMDGGSLADFLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI----NHRGEVKITDFGVSA  217 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll----~~~~~vkl~DFg~a~  217 (362)
                      +||||+++|+|.+++....   .+++..++.++.|++.||+|||+ +||+||||||+||++    +.++.+||+|||+++
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE-NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            9999999999999997643   39999999999999999999998 999999999999999    777789999999998


Q ss_pred             ccccCCCCCCccccCCcccCcceecC--------CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHh
Q 018018          218 IMASTSGQANTFVGTYNYMSPERISG--------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV  289 (362)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~  289 (362)
                      ...... ......||+.|+|||++.+        ..++.++|||||||++|+|++|+.||.........   .+.+..+.
T Consensus       165 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~---~~~~~~~~  240 (396)
T 4eut_A          165 ELEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN---KEVMYKII  240 (396)
T ss_dssp             ECCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC---HHHHHHHH
T ss_pred             EccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch---HHHHHHHh
Confidence            764332 3345679999999999865        56788999999999999999999999765433222   23344444


Q ss_pred             cCCCCC-----------------------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          290 DQPPPS-----------------------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       290 ~~~~~~-----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .+.++.                       .....+++.+.++|.+||++||++|||+++++++
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            333211                       1112345678899999999999999999998543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=347.85  Aligned_cols=255  Identities=23%  Similarity=0.348  Sum_probs=208.4

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe----cCe
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGA  142 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~----~~~  142 (362)
                      +..++|++.+.||+|+||.||++++..+|+.||+|++... .......+.+|+.+++.++||||+++++++..    ...
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence            4568899999999999999999999999999999998654 44566788999999999999999999998873    357


Q ss_pred             EEEEEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          143 ISIILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      .++||||+.+++|.+++..    ...+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++..
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA-KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            8999999999999999976    4679999999999999999999998 9999999999999999999999999999876


Q ss_pred             cccCCCC---------CCccccCCcccCcceecCCC---CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHH
Q 018018          219 MASTSGQ---------ANTFVGTYNYMSPERISGGK---YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME  286 (362)
Q Consensus       219 ~~~~~~~---------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  286 (362)
                      .......         .....||+.|+|||++.+..   ++.++||||||+++|+|++|..||........  .   ...
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~---~~~  258 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD--S---VAL  258 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS--C---HHH
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc--h---hhH
Confidence            5321111         12235799999999997654   68999999999999999999999964221111  1   111


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          287 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .... .........+++++.++|.+||+.||++|||+++++++
T Consensus       259 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          259 AVQN-QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHHC-C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             Hhhc-cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            1122 22223345789999999999999999999999999985

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.5e-46  Score=362.31  Aligned_cols=254  Identities=24%  Similarity=0.387  Sum_probs=214.3

Q ss_pred             CCCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           62 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        62 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ...+++..++|++.+.||+|+||.||++.+. ++..||||+++....  ....+.+|+.+++.++||||+++++++. ..
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            3456778899999999999999999999986 577899999976432  3567899999999999999999999876 67


Q ss_pred             eEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          142 AISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      ..++||||+.+|+|.+++...  ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ-RNYIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            789999999999999999753  478999999999999999999998 99999999999999999999999999999875


Q ss_pred             ccCCC-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          220 ASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       220 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      ..... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+.       .++...+..... ...
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~~-~~~  406 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-------PEVIRALERGYR-MPR  406 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-------HHHHHHHHHTCC-CCC
T ss_pred             CCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCC-CCC
Confidence            43211 1223456788999999998899999999999999999999 9999976433       233333333322 233


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +..+++++.+||.+||+.||++|||++++++
T Consensus       407 ~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          407 PENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            4678999999999999999999999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.5e-46  Score=353.12  Aligned_cols=257  Identities=16%  Similarity=0.235  Sum_probs=203.8

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccC-----CcEEEEEEeecccchHH----------HHHHHHHHHHHhcCCCCcce
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWT-----GQFFALKVIQMNVEESA----------RRQIAQELKINQSSQCPYVV  131 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~----------~~~~~~e~~~~~~l~hp~I~  131 (362)
                      ...++|++.+.||+|+||.||++.+..+     ++.||||++........          ...+..|+..+..++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            4457999999999999999999998764     57899999876532111          12344566677888999999


Q ss_pred             EEeeeEEec----CeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEc--c
Q 018018          132 VCYQSFYSN----GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN--H  204 (362)
Q Consensus       132 ~~~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~--~  204 (362)
                      ++++++...    ...++||||+ +++|.+++... ..+++..++.++.|++.||+|||+ +||+||||||+|||++  .
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~-~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE-HEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEEESSC
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCeEEecCCHHHEEEecCC
Confidence            999998765    5589999999 89999999876 689999999999999999999998 9999999999999999  8


Q ss_pred             CCcEEEeeccCCcccccCCCC-------CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc
Q 018018          205 RGEVKITDFGVSAIMASTSGQ-------ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG  277 (362)
Q Consensus       205 ~~~vkl~DFg~a~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~  277 (362)
                      ++.+||+|||+|+........       ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            899999999999776433221       1334699999999999999999999999999999999999999985332211


Q ss_pred             hhhHHH-----HHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          278 WTSFYE-----LMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       278 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ......     ....+...   ......+++++.++|..||+.||++||+++++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDK---CFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHH---HSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhhhhHHHHHHH---hcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            110000     00111111   1112467899999999999999999999999976

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.8e-47  Score=352.96  Aligned_cols=268  Identities=21%  Similarity=0.318  Sum_probs=212.4

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      .++..++|.+.+.||+|+||.||++++. +|+.||||++...........+.+|+.+++.++||||+++++++.+....+
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  103 (326)
T 3uim_A           25 LQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL  103 (326)
T ss_dssp             HHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred             HHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence            3456789999999999999999999854 689999999876544333446889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---CeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          145 IILEYMDGGSLADFLKKVK----TIPEEYLAAICEQVLKGLLYLHHEK---HIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~----~l~~~~~~~i~~ql~~al~~LH~~~---~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      +||||+.+|+|.+++....    .+++..+..++.|++.||+|||+ +   |++||||||+||+++.++.+||+|||++.
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~  182 (326)
T 3uim_A          104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD-HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK  182 (326)
T ss_dssp             EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH-SSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence            9999999999999997643    49999999999999999999998 8   99999999999999999999999999998


Q ss_pred             ccccCCC-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCC-chhhHHHHHHHHhcCCC--
Q 018018          218 IMASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD-GWTSFYELMEAIVDQPP--  293 (362)
Q Consensus       218 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~--  293 (362)
                      ....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....... .................  
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (326)
T 3uim_A          183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE  262 (326)
T ss_dssp             ECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCST
T ss_pred             ccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhh
Confidence            7643332 2334569999999999998899999999999999999999999996321110 11111122211111110  


Q ss_pred             -------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          294 -------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       294 -------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                             ........++.+.+++.+||+.||++|||+.|+++|-+-..
T Consensus       263 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          263 ALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             TSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             hhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence                   11111223367899999999999999999999999865433

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.1e-47  Score=353.92  Aligned_cols=259  Identities=19%  Similarity=0.242  Sum_probs=204.9

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEcc---CCcEEEEEEeecccchH----------HHHHHHHHHHHHhcCCCCcceE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKW---TGQFFALKVIQMNVEES----------ARRQIAQELKINQSSQCPYVVV  132 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~----------~~~~~~~e~~~~~~l~hp~I~~  132 (362)
                      .+..++|++.+.||+|+||.||+|.+..   ++..+|+|++.......          ....+.+|+..++.++||||++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            3456889999999999999999999987   78899999987653211          1134667888899999999999


Q ss_pred             EeeeEEe----cCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC--
Q 018018          133 CYQSFYS----NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG--  206 (362)
Q Consensus       133 ~~~~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~--  206 (362)
                      +++.+..    ....++||||+ +++|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHE-NEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEESSSTT
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCcCHHHEEEccCCCC
Confidence            9999988    78899999999 89999999887899999999999999999999998 9999999999999999887  


Q ss_pred             cEEEeeccCCcccccCCC-------CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchh
Q 018018          207 EVKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWT  279 (362)
Q Consensus       207 ~vkl~DFg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~  279 (362)
                      .+||+|||+|+.......       ......||+.|+|||++.+..++.++|||||||++|+|++|..||......  ..
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~  268 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD--PV  268 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC--HH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc--cH
Confidence            999999999977643221       113457999999999999999999999999999999999999999642221  11


Q ss_pred             hHHHHHHHHhcCCCC----CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          280 SFYELMEAIVDQPPP----SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       280 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .............+.    ......+++++.++|.+||+.||++|||++++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          269 AVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            122222222221111    0112368899999999999999999999999976

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1e-45  Score=335.71  Aligned_cols=253  Identities=25%  Similarity=0.413  Sum_probs=213.3

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      .++++..++|++.+.||+|+||.||++.+. ++..||+|+++....  ....+.+|+.+++.++||||+++++.+. .+.
T Consensus         6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   81 (279)
T 1qpc_A            6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEP   81 (279)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCC
Confidence            356777899999999999999999999975 567899999875432  2457889999999999999999999876 566


Q ss_pred             EEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          143 ISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      .++||||+++++|.+++....  .+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++....
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence            899999999999999997543  79999999999999999999998 999999999999999999999999999998764


Q ss_pred             cCCC-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          221 STSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       221 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      .... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+.       .+....+.... ....+
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-------~~~~~~~~~~~-~~~~~  232 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-------PEVIQNLERGY-RMVRP  232 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTC-CCCCC
T ss_pred             CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-------HHHHHHHhccc-CCCCc
Confidence            3321 2233456789999999998889999999999999999999 9999976432       23334443332 23344


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+++++.++|.+||+.||++|||++++++
T Consensus       233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          233 DNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            678999999999999999999999999976

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1e-45  Score=338.82  Aligned_cols=251  Identities=24%  Similarity=0.322  Sum_probs=207.6

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCC---cEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEE-ecCeEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTG---QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY-SNGAIS  144 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~-~~~~~~  144 (362)
                      ..+|++.+.||+|+||.||++.+..++   ..+|+|.+...........+.+|+.+++.++||||+++++++. .++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            356899999999999999999975433   3689999987666677788999999999999999999999854 567889


Q ss_pred             EEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          145 IILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      +||||+++++|.+++.. ...+++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+++......
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            99999999999999975 4568999999999999999999998 999999999999999999999999999998664322


Q ss_pred             C----CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          224 G----QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       224 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      .    ......+|+.|+|||++.+..++.++||||||+++|+|++ +.+||...+..+       ......... ....+
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~-------~~~~~~~~~-~~~~~  254 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGR-RLLQP  254 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT-------HHHHHHTTC-CCCCC
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhcCC-CCCCC
Confidence            1    2233467889999999999999999999999999999999 667776544332       222222222 23334


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+++.+.++|.+||+.||++|||+.++++
T Consensus       255 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          255 EYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            678999999999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.2e-46  Score=337.61  Aligned_cols=249  Identities=25%  Similarity=0.419  Sum_probs=204.2

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec-C
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN-G  141 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~-~  141 (362)
                      ..+.+..++|++.+.||+|+||.||++++  +|+.||+|+++...   ....+.+|+.+++.++||||+++++.+.+. +
T Consensus        14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (278)
T 1byg_A           14 SGWALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   88 (278)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             ccccCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCC
Confidence            45567889999999999999999999987  48899999987542   456788999999999999999999986544 5


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKT--IPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~--l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      ..++||||+++++|.+++.....  +++..+..++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++...
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           89 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence            78999999999999999976543  8999999999999999999998 99999999999999999999999999998765


Q ss_pred             ccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          220 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      ...   .....+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..       .....+.... ....+
T Consensus       168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-------~~~~~~~~~~-~~~~~  236 (278)
T 1byg_A          168 SST---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPRVEKGY-KMDAP  236 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-------GHHHHHTTTC-CCCCC
T ss_pred             ccc---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-------HHHHHHhcCC-CCCCc
Confidence            432   223467889999999998899999999999999999998 99999765432       2223333332 23345


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+++.+.++|.+||+.||++|||+.++++
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            678999999999999999999999999976

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.8e-46  Score=343.74  Aligned_cols=262  Identities=28%  Similarity=0.439  Sum_probs=213.9

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEE----EccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQ----HKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS  139 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~  139 (362)
                      ...+..++|++.+.||+|+||.||+++    +..+++.||+|++... .......+.+|+.+++.++||||+++++.+..
T Consensus        35 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  113 (326)
T 2w1i_A           35 PTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS-TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS  113 (326)
T ss_dssp             --CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC-CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred             ccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence            345667899999999999999999998    4668999999999764 44556789999999999999999999998765


Q ss_pred             c--CeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCC
Q 018018          140 N--GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVS  216 (362)
Q Consensus       140 ~--~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a  216 (362)
                      .  ...++||||+++++|.+++... ..+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||++
T Consensus       114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGT-KRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            4  3789999999999999999875 469999999999999999999998 99999999999999999999999999999


Q ss_pred             cccccCCC---CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCcc---------CCchhhHHHH
Q 018018          217 AIMASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQ---------QDGWTSFYEL  284 (362)
Q Consensus       217 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~---------~~~~~~~~~~  284 (362)
                      ........   ......++..|+|||++.+..++.++||||||+++|+|++|..||.....         .........+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            87654322   12234577889999999988899999999999999999999999864311         0001111223


Q ss_pred             HHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          285 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ...+..... ...+..+++++.+||.+||+.||++|||+.|+++
T Consensus       273 ~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          273 IELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHhhcCCC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            333333322 3345678999999999999999999999999985

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.4e-46  Score=347.04  Aligned_cols=266  Identities=23%  Similarity=0.335  Sum_probs=198.4

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHH--HhcCCCCcceEEeeeEEe--
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKI--NQSSQCPYVVVCYQSFYS--  139 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~--~~~l~hp~I~~~~~~~~~--  139 (362)
                      ...+..++|++.+.||+|+||.||+++.  +++.||||+++....    ..+..|.++  +..++||||+++++.+..  
T Consensus         7 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~   80 (336)
T 3g2f_A            7 EPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANR----QNFINEKNIYRVPLMEHDNIARFIVGDERVT   80 (336)
T ss_dssp             --CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             CCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccch----hhHHHHHHHHHHHhccCcchhhheecccccc
Confidence            3456789999999999999999999976  689999999875422    233334444  455899999999975542  


Q ss_pred             ---cCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---------CeEeecCCCCcEEEccCCc
Q 018018          140 ---NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK---------HIIHRDLKPSNLLINHRGE  207 (362)
Q Consensus       140 ---~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~---------~ivH~Dlkp~NIll~~~~~  207 (362)
                         ...+++||||+++|+|.+++.. ...++..+..++.|++.||+|||+ +         ||+||||||+|||++.++.
T Consensus        81 ~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~~~~~~~ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           81 ADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHT-ELPRGDHYKPAISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             TTSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHC-CBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred             cCCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHh-hhccccccccceeecccccceEEEcCCCc
Confidence               3367899999999999999976 455999999999999999999998 8         9999999999999999999


Q ss_pred             EEEeeccCCcccccCC--------CCCCccccCCcccCcceecC-------CCCCccccHHHHHHHHHHHHcCCCCCCCC
Q 018018          208 VKITDFGVSAIMASTS--------GQANTFVGTYNYMSPERISG-------GKYGYKSDIWSLGLVLLECATGQFPYSPP  272 (362)
Q Consensus       208 vkl~DFg~a~~~~~~~--------~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~elltg~~pf~~~  272 (362)
                      +||+|||+|+......        ......+||+.|+|||++.+       ..++.++|||||||++|||++|..||...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            9999999998764321        12234579999999999987       45678999999999999999997766443


Q ss_pred             ccCCch-----------hhHHHHHHHHhcCCCCCCCCCC------CCHHHHHHHHHhhhcCcCCCCCHHHH------HcC
Q 018018          273 EQQDGW-----------TSFYELMEAIVDQPPPSAPSDQ------FSPEFCSFISACVQKEPQQRLSAQEL------MTH  329 (362)
Q Consensus       273 ~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~li~~~L~~dP~~Rpt~~ei------l~h  329 (362)
                      ......           ................+..+..      +++++.+||.+||+.||++|||+.|+      +.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            322111           1111122222222222222222      34479999999999999999999999      556


Q ss_pred             CcccccCC
Q 018018          330 PFLKMYGD  337 (362)
Q Consensus       330 p~~~~~~~  337 (362)
                      +|-++...
T Consensus       319 ~~~~~~~~  326 (336)
T 3g2f_A          319 IWERNKSV  326 (336)
T ss_dssp             CCCC----
T ss_pred             HHHhcccC
Confidence            77776543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-45  Score=342.11  Aligned_cols=252  Identities=27%  Similarity=0.415  Sum_probs=199.3

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhc--CCCCcceEEeeeEEec----C
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS--SQCPYVVVCYQSFYSN----G  141 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~hp~I~~~~~~~~~~----~  141 (362)
                      ..++|++.+.||+|+||.||++++.  ++.||||++....    ......|.+++..  ++||||+++++.+...    .
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           35 IAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             cccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            3578999999999999999999875  8999999986442    2233445555544  5899999999998877    7


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC--------CeEeecCCCCcEEEccCCcEEEeec
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK--------HIIHRDLKPSNLLINHRGEVKITDF  213 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~--------~ivH~Dlkp~NIll~~~~~vkl~DF  213 (362)
                      ..++||||+++|+|.++++. ..+++..++.++.|++.||+|||+ +        ||+||||||+||+++.++.+||+||
T Consensus       109 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~-~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHT-EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHS-CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred             ceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH-hhhhhccCCCEEecccchHHEEECCCCCEEEEeC
Confidence            89999999999999999976 579999999999999999999997 7        9999999999999999999999999


Q ss_pred             cCCcccccCCCC----CCccccCCcccCcceecCCCCCcc------ccHHHHHHHHHHHHcC----------CCCCCCCc
Q 018018          214 GVSAIMASTSGQ----ANTFVGTYNYMSPERISGGKYGYK------SDIWSLGLVLLECATG----------QFPYSPPE  273 (362)
Q Consensus       214 g~a~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~~l~elltg----------~~pf~~~~  273 (362)
                      |+|+........    .....||+.|+|||++.+..++..      +|||||||++|||++|          ..||....
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~  266 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV  266 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence            999766433322    234579999999999988776654      9999999999999999          67776544


Q ss_pred             cCCchhhHHHHHHHHhcCCCCCCCC-----CCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          274 QQDGWTSFYELMEAIVDQPPPSAPS-----DQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .....  ..............+..+     ..+++++.+||.+||+.||++|||+.++++|
T Consensus       267 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          267 PSDPS--YEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CSSCC--HHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CCCCc--hhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            33321  222222222222222222     2456679999999999999999999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-46  Score=351.72  Aligned_cols=251  Identities=24%  Similarity=0.318  Sum_probs=201.6

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCC---cEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEE-ecCeEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTG---QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFY-SNGAISI  145 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~-~~~~~~l  145 (362)
                      ..|.+.+.||+|+||.||++++..++   ..||+|.++..........+.+|+.+++.++||||+++++++. .++..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            45788899999999999999976443   3689999876666667788999999999999999999999865 4568899


Q ss_pred             EEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          146 ILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      ||||+++|+|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+++.......
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH-CCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            99999999999999764 468999999999999999999998 9999999999999999999999999999986543221


Q ss_pred             ----CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          225 ----QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       225 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                          ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||...+..+       ....+..... ...+.
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~-------~~~~~~~~~~-~~~p~  319 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRR-LLQPE  319 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC-------HHHHHHTTCC-CCCCT
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH-------HHHHHHcCCC-CCCCC
Confidence                1233457789999999999999999999999999999999 788887654432       1222233322 23346


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .+++.+.++|.+||+.||++|||+.+++++
T Consensus       320 ~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          320 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            789999999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.9e-46  Score=344.79  Aligned_cols=253  Identities=29%  Similarity=0.396  Sum_probs=194.2

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeeeEE-----
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFY-----  138 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~-----  138 (362)
                      .++...+|++.+.||+|+||.||++++..+++.||+|++... .......+.+|+.++..+. ||||+++++.+.     
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~  101 (337)
T 3ll6_A           23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN-EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE  101 (337)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES-SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred             eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC-chHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence            345567899999999999999999999999999999998654 4455667889999999986 999999999884     


Q ss_pred             ---ecCeEEEEEeccCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCCC--eEeecCCCCcEEEccCCcEEE
Q 018018          139 ---SNGAISIILEYMDGGSLADFLKK---VKTIPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLINHRGEVKI  210 (362)
Q Consensus       139 ---~~~~~~lV~e~~~~gsL~~~l~~---~~~l~~~~~~~i~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~~~~~vkl  210 (362)
                         ....+++||||+. |+|.+++..   ...+++..++.++.|++.||+|||+ +|  ++||||||+||+++.++.+||
T Consensus       102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT-SSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCCCEEEccCCcccEEECCCCCEEE
Confidence               3455899999996 699998865   4679999999999999999999998 88  999999999999999999999


Q ss_pred             eeccCCcccccCCCC------------CCccccCCcccCccee---cCCCCCccccHHHHHHHHHHHHcCCCCCCCCccC
Q 018018          211 TDFGVSAIMASTSGQ------------ANTFVGTYNYMSPERI---SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQ  275 (362)
Q Consensus       211 ~DFg~a~~~~~~~~~------------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~  275 (362)
                      +|||+++........            .....||+.|+|||++   .+..++.++|||||||++|+|++|..||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            999999876533221            1244689999999998   5667899999999999999999999999753321


Q ss_pred             CchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCc
Q 018018          276 DGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF  331 (362)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~  331 (362)
                             .    ..............++.+.+||.+||+.||++|||++|+++|-+
T Consensus       260 -------~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          260 -------R----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             -----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             -------H----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence                   1    11122223334567788999999999999999999999999754

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.6e-46  Score=348.60  Aligned_cols=250  Identities=17%  Similarity=0.240  Sum_probs=205.8

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEcc--------CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceE--------
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKW--------TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVV--------  132 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~--------  132 (362)
                      .++|++.+.||+|+||.||++++..        +++.||+|++...      ..+.+|+.+++.++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            5899999999999999999999987        4889999998754      35778999999999999887        


Q ss_pred             -------EeeeEEe-cCeEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEE
Q 018018          133 -------CYQSFYS-NGAISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI  202 (362)
Q Consensus       133 -------~~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll  202 (362)
                             +++.+.. ....++||||+ +++|.+++...  ..+++..++.++.|++.||+|||+ +||+||||||+||++
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE-NEYVHGNVTAENIFV  192 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCCGGGEEE
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh-CCccCCCCCHHHEEE
Confidence                   5666665 78899999999 89999999875  789999999999999999999998 999999999999999


Q ss_pred             ccCC--cEEEeeccCCcccccCCC-------CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Q 018018          203 NHRG--EVKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPE  273 (362)
Q Consensus       203 ~~~~--~vkl~DFg~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~  273 (362)
                      +.++  .+||+|||+++.......       ......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9988  999999999977653322       1234579999999999999999999999999999999999999997653


Q ss_pred             cCCchhhHHHHHHHHhcCCCCC----CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          274 QQDGWTSFYELMEAIVDQPPPS----APSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..  ...+..............    .....+++++.+||.+||+.||++|||++++++
T Consensus       273 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          273 PN--TEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TC--HHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cC--HHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            22  122333333333222211    112357899999999999999999999999976

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.1e-46  Score=338.90  Aligned_cols=254  Identities=24%  Similarity=0.365  Sum_probs=205.7

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEcc-CCc--EEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKW-TGQ--FFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      .+..++|++.+.||+|+||+||++++.. +++  .||+|+++...  .......+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            4567899999999999999999998643 333  68999987542  345667899999999999999999999988765


Q ss_pred             CeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          141 GAISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      . .++||||+++++|.+++... ..+++..+..++.|++.||.|||+ +|++|+||||+||+++.++.+||+|||++...
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~-~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHh-CCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            4 89999999999999999764 579999999999999999999998 99999999999999999999999999999876


Q ss_pred             ccCCC---CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018018          220 ASTSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  295 (362)
Q Consensus       220 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (362)
                      .....   ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.       ......+.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-------~~~~~~~~~~~~~~  244 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILHKIDKEGERL  244 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTSCCCC
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-------HHHHHHHHccCCCC
Confidence            43322   1223467888999999998889999999999999999999 9999976432       24445555444444


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       296 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+..+++++.++|.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          245 PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            555688999999999999999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2e-45  Score=370.00  Aligned_cols=252  Identities=21%  Similarity=0.341  Sum_probs=207.6

Q ss_pred             CCccCceee-eeeeeeCCeEEEEEEE--ccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           67 LNLEDIDTI-KVVGKGSGGIVQLVQH--KWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        67 ~~~~~~~~~-~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      +....+.+. +.||+|+||.||++.+  ..+++.||||+++.. .+.....++.+|+.+++.++||||+++++++. ...
T Consensus       365 ~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~  443 (635)
T 4fl3_A          365 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AES  443 (635)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSS
T ss_pred             ccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCC
Confidence            333444443 4799999999999954  456789999999765 33445678999999999999999999999885 556


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      .++||||+.+|+|.+++.....+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+.....
T Consensus       444 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~  522 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  522 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred             EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHH-CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence            89999999999999999988899999999999999999999998 99999999999999999999999999999876433


Q ss_pred             CC---CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          223 SG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       223 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      ..   ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.       .++...+..... ...+
T Consensus       523 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-------~~~~~~i~~~~~-~~~p  594 (635)
T 4fl3_A          523 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGER-MGCP  594 (635)
T ss_dssp             ------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCC-CCCC
T ss_pred             ccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCC-CCCC
Confidence            22   1223356788999999999999999999999999999998 9999987543       234444444432 3345


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ..+++++.+||.+||+.||++|||++++++
T Consensus       595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          595 AGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            678999999999999999999999999975

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2.7e-45  Score=355.81  Aligned_cols=254  Identities=24%  Similarity=0.376  Sum_probs=209.5

Q ss_pred             CCCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           62 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        62 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ...+++..++|++.+.||+|+||.||++.+.. +..||||+++....  ....+.+|+.+++.++||||+++++++.+ +
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~  251 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  251 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence            34567788999999999999999999999874 56799999976432  24578999999999999999999998765 7


Q ss_pred             eEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          142 AISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      ..++||||+++|+|.+++..  ...+++..+..++.|++.||+|||+ +|++||||||+|||++.++.+||+|||+++..
T Consensus       252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  330 (452)
T 1fmk_A          252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLI  330 (452)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCChhhEEECCCCCEEECCCccceec
Confidence            78999999999999999964  3579999999999999999999998 99999999999999999999999999999876


Q ss_pred             ccCCC-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          220 ASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       220 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      ..... ......++..|+|||++.+..++.++||||||+++|||++ |..||.+...       .+....+..+.. ...
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~~-~~~  402 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYR-MPC  402 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCC-CCC
T ss_pred             CCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCC-CCC
Confidence            43221 1223456789999999998999999999999999999999 9999976432       234444444332 233


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +..+++.+.+||.+||+.||++|||++++++
T Consensus       403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          403 PPECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            4678999999999999999999999999976

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=6.8e-46  Score=358.20  Aligned_cols=254  Identities=24%  Similarity=0.369  Sum_probs=192.6

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEEEEe
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      +.|.+.+.||+|+||+||.+ ...+|+.||||++....    ...+.+|+.++..+ +||||+++++.+.+....++|||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            44556788999999999865 45689999999987542    24567889988765 89999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCC-------CHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC-------------CcE
Q 018018          149 YMDGGSLADFLKKVKTI-------PEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-------------GEV  208 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l-------~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~-------------~~v  208 (362)
                      |+. |+|.+++......       ++..+..++.|++.||+|||+ +||+||||||+|||++.+             +.+
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS-LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-CCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            996 5999999865433       233457899999999999998 999999999999999754             489


Q ss_pred             EEeeccCCcccccCCC----CCCccccCCcccCcceecC-------CCCCccccHHHHHHHHHHHHc-CCCCCCCCccCC
Q 018018          209 KITDFGVSAIMASTSG----QANTFVGTYNYMSPERISG-------GKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD  276 (362)
Q Consensus       209 kl~DFg~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~  276 (362)
                      ||+|||+|+.......    .....+||+.|+|||++.+       ..++.++|||||||++|||++ |..||.+.... 
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-  246 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR-  246 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-
Confidence            9999999987654322    1234579999999999976       568999999999999999999 99999653221 


Q ss_pred             chhhHHHHHHHHhcCCC-CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          277 GWTSFYELMEAIVDQPP-PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       277 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                          ...+......... .......+++++.+||.+||+.||++|||+.++++||||...
T Consensus       247 ----~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          247 ----ESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             ----HHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             ----HHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence                1112111111111 111112345789999999999999999999999999999643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=338.56  Aligned_cols=248  Identities=29%  Similarity=0.501  Sum_probs=201.9

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      .+..++|++.+.||+|+||.||++++.  ++.||+|++...   .....+.+|+.+++.++||||+++++.+.  +..++
T Consensus         4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~l   76 (307)
T 2eva_A            4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCL   76 (307)
T ss_dssp             BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEE
T ss_pred             cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEE
Confidence            356789999999999999999999874  789999998643   34567899999999999999999999876  45799


Q ss_pred             EEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC--CCeEeecCCCCcEEEccCCc-EEEeeccCCccc
Q 018018          146 ILEYMDGGSLADFLKKVK---TIPEEYLAAICEQVLKGLLYLHHE--KHIIHRDLKPSNLLINHRGE-VKITDFGVSAIM  219 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~ql~~al~~LH~~--~~ivH~Dlkp~NIll~~~~~-vkl~DFg~a~~~  219 (362)
                      ||||+++++|.+++....   .++...+..++.|++.||+|||+.  +||+||||||+||+++.++. +||+|||++...
T Consensus        77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~  156 (307)
T 2eva_A           77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI  156 (307)
T ss_dssp             EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred             EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence            999999999999998654   478999999999999999999963  58999999999999998886 799999998765


Q ss_pred             ccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          220 ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      ...   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......     ............. +....
T Consensus       157 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~-~~~~~  227 (307)
T 2eva_A          157 QTH---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-----AFRIMWAVHNGTR-PPLIK  227 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-----HHHHHHHHHTTCC-CCCBT
T ss_pred             ccc---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-----HHHHHHHHhcCCC-CCccc
Confidence            322   23446899999999999999999999999999999999999999754322     1122223333332 33446


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .+++.+.++|.+||+.||++|||+++++++
T Consensus       228 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          228 NLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            789999999999999999999999999873

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=366.71  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=208.6

Q ss_pred             CCCccCceeee-eeeeeCCeEEEEEEEcc--CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           66 QLNLEDIDTIK-VVGKGSGGIVQLVQHKW--TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        66 ~~~~~~~~~~~-~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      .+..+++.+.+ .||+|+||.||++.+..  ++..||||+++..........+.+|+++++.++||||+++++++.. +.
T Consensus       331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred             eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence            34456666666 89999999999998763  5567999999876555567789999999999999999999999875 67


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          143 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      +++||||+.+|+|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+....
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH-CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            99999999999999999654 569999999999999999999998 9999999999999999999999999999987643


Q ss_pred             CCCC---CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          222 TSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       222 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      ....   .....+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..       ++...+..+.. ...
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-------~~~~~i~~~~~-~~~  560 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-------EVMAFIEQGKR-MEC  560 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-------HHHHHHHTTCC-CCC
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHcCCC-CCC
Confidence            2211   122345689999999999999999999999999999998 99999875432       34444444432 334


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +..+++++.+||.+||+.||++|||++++++
T Consensus       561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            4678999999999999999999999999854

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=347.93  Aligned_cols=251  Identities=16%  Similarity=0.186  Sum_probs=202.5

Q ss_pred             CCCCCCCCccCceeeeeeeeeCCeEEEEE-----EEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC---CCcceE
Q 018018           61 KPSDNQLNLEDIDTIKVVGKGSGGIVQLV-----QHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ---CPYVVV  132 (362)
Q Consensus        61 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---hp~I~~  132 (362)
                      .....++..++|.+.+.||+|+||+||+|     .+..+++.||+|+++...    ..++..|..+++.++   |+||+.
T Consensus        56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~  131 (365)
T 3e7e_A           56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMK  131 (365)
T ss_dssp             SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred             cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhh
Confidence            34455677789999999999999999999     467789999999997543    234566666666665   899999


Q ss_pred             EeeeEEecCeEEEEEeccCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc---
Q 018018          133 CYQSFYSNGAISIILEYMDGGSLADFLKK-----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---  204 (362)
Q Consensus       133 ~~~~~~~~~~~~lV~e~~~~gsL~~~l~~-----~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---  204 (362)
                      +++.+...+..++||||+++|+|.+++..     ...+++..++.++.|++.||+|||+ +||+||||||+|||++.   
T Consensus       132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~-~~ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD-CEIIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCSGGGEEECGGGT
T ss_pred             hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh-CCeecCCCCHHHEEeccccc
Confidence            99999999999999999999999999974     4679999999999999999999998 99999999999999998   


Q ss_pred             --------CCcEEEeeccCCcccccC--CCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCcc
Q 018018          205 --------RGEVKITDFGVSAIMAST--SGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQ  274 (362)
Q Consensus       205 --------~~~vkl~DFg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~  274 (362)
                              ++.+||+|||+|+.....  .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                    899999999999765422  2233456899999999999999999999999999999999999999965433


Q ss_pred             CCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          275 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .. +.         .....   .....++.+.+++..||+.+|.+|++..+.+.+
T Consensus       291 ~~-~~---------~~~~~---~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          291 GE-CK---------PEGLF---RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             TE-EE---------ECSCC---TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             Cc-ee---------echhc---cccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence            21 00         00111   111346778899999999999999765555444

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=9.9e-45  Score=332.96  Aligned_cols=238  Identities=28%  Similarity=0.464  Sum_probs=192.2

Q ss_pred             CccCceee-eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHH-hcCCCCcceEEeeeEEe----cC
Q 018018           68 NLEDIDTI-KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKIN-QSSQCPYVVVCYQSFYS----NG  141 (362)
Q Consensus        68 ~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~-~~l~hp~I~~~~~~~~~----~~  141 (362)
                      ..++|.+. +.||+|+||.||++.+..+++.||+|+++..      ..+.+|+.++ +..+||||+++++.+..    ..
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   88 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK   88 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence            45778887 7899999999999999999999999998743      3456777776 66799999999999887    77


Q ss_pred             eEEEEEeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc---CCcEEEeeccCC
Q 018018          142 AISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVS  216 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~--~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---~~~vkl~DFg~a  216 (362)
                      ..++||||+++++|.+++....  .+++..++.++.|++.||+|||+ +|++||||||+||+++.   ++.+||+|||++
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~-~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            8999999999999999998754  69999999999999999999998 99999999999999998   789999999998


Q ss_pred             cccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--C
Q 018018          217 AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--P  294 (362)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~  294 (362)
                      ....                      +..++.++|||||||++|+|++|..||.+.........   ....+.....  +
T Consensus       168 ~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~  222 (299)
T 3m2w_A          168 KETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKTRIRMGQYEFP  222 (299)
T ss_dssp             EECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC---SCCSSCTTCCSSC
T ss_pred             cccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH---HHHHHhhccccCC
Confidence            6432                      24578899999999999999999999976433211000   0000000000  0


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          295 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       295 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ......+++++.+||.+||+.||++|||++|+++||||+....
T Consensus       223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~  265 (299)
T 3m2w_A          223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  265 (299)
T ss_dssp             HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred             chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence            0111467899999999999999999999999999999977653

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=356.43  Aligned_cols=254  Identities=23%  Similarity=0.337  Sum_probs=196.9

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~l  145 (362)
                      +...+|.+.+.||+|+||+|+ +....+|+.||||++......    .+.+|+.+++.+ +||||+++++.+.+....|+
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~-~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l   95 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYI   95 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEE-EEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred             EccEEEecCCeeecCcCEEEE-EEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence            344679999999999999976 455668999999998654222    245788899888 79999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC-----CcEEEeeccCCccc
Q 018018          146 ILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-----GEVKITDFGVSAIM  219 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~-----~~vkl~DFg~a~~~  219 (362)
                      ||||+. |+|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+||+++.+     ..+||+|||+|+..
T Consensus        96 v~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A           96 AIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS-LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             EEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH-TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             EEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH-CcCEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            999996 59999997653 45666778999999999999998 999999999999999532     35889999999876


Q ss_pred             ccCC---CCCCccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCC
Q 018018          220 ASTS---GQANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQP  292 (362)
Q Consensus       220 ~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  292 (362)
                      ....   ......+||+.|+|||++.+   ..++.++|||||||++|||++ |..||.....        ..........
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~--------~~~~~~~~~~  245 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ--------RQANILLGAC  245 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT--------HHHHHHTTCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH--------HHHHHHhccC
Confidence            5332   22344679999999999984   567889999999999999999 9999964321        1111122111


Q ss_pred             C-C-CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          293 P-P-SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       293 ~-~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      . . .......+..+.+||.+||+.||++|||++|+++||||...
T Consensus       246 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          246 SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            1 1 11122345568899999999999999999999999999764

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.6e-45  Score=333.81  Aligned_cols=254  Identities=25%  Similarity=0.345  Sum_probs=206.5

Q ss_pred             CceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc---cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           71 DIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN---VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        71 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      .|...+.||+|+||.||++.+  +++.||+|++...   ........+.+|+.+++.++||||+++++++.+.+..++||
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  109 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY  109 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence            344568999999999999986  6889999998654   23456778999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          148 EYMDGGSLADFLKK---VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       148 e~~~~gsL~~~l~~---~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+ +|++||||||+||+++.++.+||+|||++........
T Consensus       110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~-~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE-NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ  188 (307)
T ss_dssp             ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred             EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc-CCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence            99999999999974   3569999999999999999999998 9999999999999999999999999999876543222


Q ss_pred             --CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHH-------HHhcCCCCC
Q 018018          225 --QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME-------AIVDQPPPS  295 (362)
Q Consensus       225 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~-------~~~~~~~~~  295 (362)
                        ......||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+.....       ....... .
T Consensus       189 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  266 (307)
T 2nru_A          189 TVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-N  266 (307)
T ss_dssp             CEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC-S
T ss_pred             cccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc-c
Confidence              1234578999999999875 589999999999999999999999987655433322222111       1111111 1


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       296 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ......++.+.+++.+||+.||++|||+.+++++
T Consensus       267 ~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          267 DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1223345678999999999999999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.8e-46  Score=343.16  Aligned_cols=273  Identities=22%  Similarity=0.323  Sum_probs=212.8

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ....+..++|++.+.||+|+||.||++.+..   .+|+|+++... .......+.+|+.+++.++||||+++++.+.+..
T Consensus        26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             GGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             ccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            4566778999999999999999999998853   49999987542 2333456778999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          142 AISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ..++||||+++++|.+++.... .+++..++.++.|++.||+|||+ +|++||||||+||+++ ++.+||+|||+++...
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~  180 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA-KGILHKDLKSKNVFYD-NGKVVITDFGLFSISG  180 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHH-TTCCCCCCCSTTEEEC---CCEECCCSCCC---
T ss_pred             ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCChhhEEEe-CCCEEEeecCCccccc
Confidence            9999999999999999998754 79999999999999999999998 9999999999999997 7899999999987653


Q ss_pred             cC-----CCCCCccccCCcccCcceecC---------CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHH
Q 018018          221 ST-----SGQANTFVGTYNYMSPERISG---------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME  286 (362)
Q Consensus       221 ~~-----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~  286 (362)
                      ..     ........|++.|+|||++.+         ..++.++||||||+++|+|++|..||.....       .....
T Consensus       181 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~  253 (319)
T 2y4i_B          181 VLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-------EAIIW  253 (319)
T ss_dssp             -------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-------HHHHH
T ss_pred             cccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH
Confidence            21     112233468999999999875         4578999999999999999999999976432       23444


Q ss_pred             HHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHHHh
Q 018018          287 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA  349 (362)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~~~  349 (362)
                      .+.....+......+++++.++|.+||+.||++|||+.++++  .++........++..=.+|
T Consensus       254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~~~~~~~~~~~~~~  314 (319)
T 2y4i_B          254 QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLPKRNRRLSHPGHFW  314 (319)
T ss_dssp             HHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC--------------
T ss_pred             HhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHHHhhccCCCCcccc
Confidence            555555555555578899999999999999999999999987  5555555554444443333

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.6e-46  Score=375.07  Aligned_cols=267  Identities=25%  Similarity=0.405  Sum_probs=212.6

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe------cC
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS------NG  141 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~------~~  141 (362)
                      ..++|++.+.||+|+||.||++.+..+|+.||||+++..........+.+|+.+++.++||||+++++++..      .+
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            458899999999999999999999999999999999876667777889999999999999999999988654      67


Q ss_pred             eEEEEEeccCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc---EEEeeccC
Q 018018          142 AISIILEYMDGGSLADFLKKVK---TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE---VKITDFGV  215 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~---~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~---vkl~DFg~  215 (362)
                      ..++||||+++|+|.+++....   .+++..++.++.|++.||+|||+ +||+||||||+||+++.++.   +||+|||+
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs-~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE-NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH-TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            7899999999999999998754   69999999999999999999998 99999999999999997765   99999999


Q ss_pred             CcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHH--HHHHHH-----
Q 018018          216 SAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFY--ELMEAI-----  288 (362)
Q Consensus       216 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~--~~~~~~-----  288 (362)
                      +...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+......|....  ......     
T Consensus       171 a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~  249 (676)
T 3qa8_A          171 AKELDQG-ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDD  249 (676)
T ss_dssp             CCBTTSC-CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCC
T ss_pred             ccccccc-cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhh
Confidence            9876433 23445689999999999999999999999999999999999999997532110000000  000000     


Q ss_pred             hc--------CCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          289 VD--------QPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       289 ~~--------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ..        .+.+......+++.+.+||.+||++||++|||++++++||||+...
T Consensus       250 l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~  305 (676)
T 3qa8_A          250 LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD  305 (676)
T ss_dssp             CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred             hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence            00        0111122334678899999999999999999999999999997654

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.5e-45  Score=339.03  Aligned_cols=251  Identities=25%  Similarity=0.361  Sum_probs=205.0

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhc--CCCCcceEEeeeEEecC----e
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQS--SQCPYVVVCYQSFYSNG----A  142 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~--l~hp~I~~~~~~~~~~~----~  142 (362)
                      .++|++.+.||+|+||.||++++  +|+.||||++...    ....+.+|.+++..  ++||||+++++.+....    .
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~  114 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ  114 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence            47899999999999999999987  5899999998643    23456778888776  78999999999988775    8


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCeEeecCCCCcEEEccCCcEEEeecc
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH--------HEKHIIHRDLKPSNLLINHRGEVKITDFG  214 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH--------~~~~ivH~Dlkp~NIll~~~~~vkl~DFg  214 (362)
                      .++||||+++|+|.+++.. ..+++..++.++.|++.||+|||        + +|++||||||+||+++.++++||+|||
T Consensus       115 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~-~~ivH~Dlkp~NIll~~~~~~kL~Dfg  192 (342)
T 1b6c_B          115 LWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK-PAIAHRDLKSKNILVKKNGTCCIADLG  192 (342)
T ss_dssp             EEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB-CEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             eEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc-CCeeeCCCCHHHEEECCCCCEEEEECC
Confidence            9999999999999999976 57999999999999999999999        7 899999999999999999999999999


Q ss_pred             CCcccccCCC----CCCccccCCcccCcceecCCC------CCccccHHHHHHHHHHHHcC----------CCCCCCCcc
Q 018018          215 VSAIMASTSG----QANTFVGTYNYMSPERISGGK------YGYKSDIWSLGLVLLECATG----------QFPYSPPEQ  274 (362)
Q Consensus       215 ~a~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~~l~elltg----------~~pf~~~~~  274 (362)
                      ++........    ......||+.|+|||++.+..      ++.++|||||||++|+|++|          ..||.....
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~  272 (342)
T 1b6c_B          193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  272 (342)
T ss_dssp             TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence            9977654332    234457999999999998753      34789999999999999999          788876544


Q ss_pred             CCchhhHHHHHHHHhcCCCCCCCCC-----CCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          275 QDGWTSFYELMEAIVDQPPPSAPSD-----QFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .+.  ....+...+......+..+.     ..++.+.+||.+||+.||++|||++++++|
T Consensus       273 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          273 SDP--SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             SSC--CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             Ccc--cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            321  22334444433333222221     234578999999999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7.6e-45  Score=359.60  Aligned_cols=255  Identities=24%  Similarity=0.374  Sum_probs=214.6

Q ss_pred             CCCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           62 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        62 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ...+++..++|++.+.||+|+||.||++.+.. +..||||+++....  ....+.+|+.+++.++||||+++++++.+ .
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  334 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence            34567788999999999999999999999864 56799999976532  24578999999999999999999998765 7


Q ss_pred             eEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          142 AISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      ..++||||+.+|+|.+++..  ...+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCeeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            78999999999999999964  3579999999999999999999998 99999999999999999999999999999875


Q ss_pred             ccCCC-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          220 ASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       220 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      ..... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+...       .++...+..+.. ...
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-------~~~~~~i~~~~~-~~~  485 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-------REVLDQVERGYR-MPC  485 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-------HHHHHHHHTTCC-CCC
T ss_pred             CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCC-CCC
Confidence            43211 1223456789999999998899999999999999999999 9999976432       234444444332 233


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +..+++.+.+||.+||+.||++|||++++++.
T Consensus       486 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          486 PPECPESLHDLMCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            46789999999999999999999999999763

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.4e-44  Score=352.36  Aligned_cols=254  Identities=22%  Similarity=0.298  Sum_probs=210.0

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCC-CcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC-PYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-p~I~~~~~~~~~~~~~~lV~  147 (362)
                      .++|++.+.||+|+||.||++++..+++.||||++......   ..+..|+++++.+.| ++|..+..++.+....++||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            47899999999999999999999999999999998755322   347789999999887 55656666667888999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEE---ccCCcEEEeeccCCcccccCC
Q 018018          148 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       148 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll---~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      ||+ +++|.+++.. ...+++..++.++.||+.||+|||+ +||+||||||+|||+   +.++.+||+|||+++......
T Consensus        83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~-~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~  160 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHS-KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS  160 (483)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence            999 8899999985 4689999999999999999999998 999999999999999   688999999999998765433


Q ss_pred             CC-------CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018018          224 GQ-------ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  296 (362)
Q Consensus       224 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
                      ..       .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+..+......... ..
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~~  239 (483)
T 3sv0_A          161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI-EA  239 (483)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH-HH
T ss_pred             cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH-HH
Confidence            21       22568999999999999999999999999999999999999999876654433333333333222211 11


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ....+++++.+||..||+.||++||+++++++
T Consensus       240 l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            12467899999999999999999999998865

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.2e-44  Score=360.46  Aligned_cols=255  Identities=24%  Similarity=0.349  Sum_probs=213.4

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccC---CcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      ...+..++|++.+.||+|+||.||++.+..+   +..||+|+++..........+.+|+.+++.++||||+++++++. +
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-S
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-c
Confidence            4456678999999999999999999998653   45799999877666677788999999999999999999999874 5


Q ss_pred             CeEEEEEeccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          141 GAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      +..++||||+++|+|.+++.... .+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++..
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDikp~NILl~~~~~vkL~DFG~a~~~  541 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  541 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECCCCCCCSC
T ss_pred             CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh-CCccccccchHhEEEeCCCCEEEEecCCCeec
Confidence            67899999999999999998654 69999999999999999999998 99999999999999999999999999999876


Q ss_pred             ccCCC-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          220 ASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       220 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      ..... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.       .+....+..... ...
T Consensus       542 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-------~~~~~~i~~~~~-~~~  613 (656)
T 2j0j_A          542 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-------NDVIGRIENGER-LPM  613 (656)
T ss_dssp             CC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHHTCC-CCC
T ss_pred             CCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHcCCC-CCC
Confidence            43322 1223456789999999998899999999999999999997 9999976433       233344443332 223


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +..+++.+.+||.+||+.||++|||+.++++
T Consensus       614 ~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          614 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            4678999999999999999999999999976

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.7e-45  Score=350.87  Aligned_cols=251  Identities=17%  Similarity=0.204  Sum_probs=198.0

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch--HHHHHHHHHHHHHhcCCC-Ccce-------------
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE--SARRQIAQELKINQSSQC-PYVV-------------  131 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h-p~I~-------------  131 (362)
                      ....|...+.||+|+||+||+|++..+|+.||||+++.....  ...+.+.+|+.+++.+.| .+..             
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            345688889999999999999999999999999998744222  235678899999998877 2211             


Q ss_pred             --------EEeeeEEe-----cCeEEEEEeccCCCCHHHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCeE
Q 018018          132 --------VCYQSFYS-----NGAISIILEYMDGGSLADFLKK-------VKTIPEEYLAAICEQVLKGLLYLHHEKHII  191 (362)
Q Consensus       132 --------~~~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~-------~~~l~~~~~~~i~~ql~~al~~LH~~~~iv  191 (362)
                              .+...+..     ...++++|+++ +++|.++++.       ...+++..+..++.|++.||+|||+ +||+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ii  233 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH-YGLV  233 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH-TTEE
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcc
Confidence                    11111111     23467888877 5699999852       2357888999999999999999998 9999


Q ss_pred             eecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCccccCCcccCccee----------cCCCCCccccHHHHHHHHHH
Q 018018          192 HRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI----------SGGKYGYKSDIWSLGLVLLE  261 (362)
Q Consensus       192 H~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwslG~~l~e  261 (362)
                      ||||||+|||++.++.+||+|||+++.....   ....+| +.|+|||++          .+..++.++|||||||++|+
T Consensus       234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e  309 (413)
T 3dzo_A          234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW  309 (413)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred             cCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence            9999999999999999999999998765433   445577 999999999          56668999999999999999


Q ss_pred             HHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          262 CATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       262 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      |++|+.||...+.......       +..      ....+++++.+||.+||+.||++|||+.++++||||+...+
T Consensus       310 lltg~~Pf~~~~~~~~~~~-------~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~  372 (413)
T 3dzo_A          310 IWCADLPNTDDAALGGSEW-------IFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT  372 (413)
T ss_dssp             HHHSSCCCCTTGGGSCSGG-------GGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred             HHHCCCCCCCcchhhhHHH-------HHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence            9999999987654332221       111      12367899999999999999999999999999999987644

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.5e-45  Score=339.61  Aligned_cols=246  Identities=21%  Similarity=0.227  Sum_probs=193.0

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-------chHHHHHHHHHHHHHhcCC---------CCcc
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-------EESARRQIAQELKINQSSQ---------CPYV  130 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~---------hp~I  130 (362)
                      +..++|++.+.||+|+||+||+|++  +|+.||||+++...       .......+.+|+.+++.++         ||||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            4568899999999999999999988  68999999997652       2223456777888777764         6666


Q ss_pred             eEEeeeE-----------------Ee-------------cCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHH
Q 018018          131 VVCYQSF-----------------YS-------------NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG  180 (362)
Q Consensus       131 ~~~~~~~-----------------~~-------------~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~a  180 (362)
                      +.+.+.+                 .+             ...+|+||||+.+|++.+.+.. ..+++..++.++.|++.|
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence            6665543                 32             6889999999999977666644 678999999999999999


Q ss_pred             HHHHH-hCCCeEeecCCCCcEEEccCC--------------------cEEEeeccCCcccccCCCCCCccccCCcccCcc
Q 018018          181 LLYLH-HEKHIIHRDLKPSNLLINHRG--------------------EVKITDFGVSAIMASTSGQANTFVGTYNYMSPE  239 (362)
Q Consensus       181 l~~LH-~~~~ivH~Dlkp~NIll~~~~--------------------~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE  239 (362)
                      |+||| + +||+||||||+|||++.++                    .+||+|||+|+....     ...+||+.|+|||
T Consensus       174 L~~lH~~-~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~aPE  247 (336)
T 2vuw_A          174 LAVAEAS-LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMDED  247 (336)
T ss_dssp             HHHHHHH-HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTCSG
T ss_pred             HHHHHHh-CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeecccChh
Confidence            99999 8 9999999999999999887                    899999999987643     2458999999999


Q ss_pred             eecCCCCCccccHHHHHHH-HHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-C----CCCCCCCCCHHHHHHHHHhh
Q 018018          240 RISGGKYGYKSDIWSLGLV-LLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-P----PSAPSDQFSPEFCSFISACV  313 (362)
Q Consensus       240 ~~~~~~~~~~~DiwslG~~-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~li~~~L  313 (362)
                      ++.+.. +.++||||++++ .+++++|..||.+.      .........+.... .    .......+++++.+||++||
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L  320 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTML  320 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGG
T ss_pred             hhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHh
Confidence            998766 899999998777 77888899998431      00011222322111 1    11112346788999999999


Q ss_pred             hcCcCCCCCHHHHH-cCCccc
Q 018018          314 QKEPQQRLSAQELM-THPFLK  333 (362)
Q Consensus       314 ~~dP~~Rpt~~eil-~hp~~~  333 (362)
                      ++|     |++|++ +||||+
T Consensus       321 ~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          321 NFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             GSS-----SHHHHHHHCGGGC
T ss_pred             ccC-----CHHHHHhcCCCcC
Confidence            987     999999 999996

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9.5e-44  Score=361.50  Aligned_cols=245  Identities=20%  Similarity=0.294  Sum_probs=205.8

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEcc-CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe---
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKW-TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA---  142 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~---  142 (362)
                      +..++|++.+.||+|+||+||++.+.. +|+.||||++...........+.+|+.+++.++||||+++++++...+.   
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            445899999999999999999999976 7899999998766666677789999999999999999999999987665   


Q ss_pred             --EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          143 --ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       143 --~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                        .|+||||++|++|.+++..  .+++..++.++.|++.||.|||+ +||+||||||+|||++.+ .+||+|||+++...
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~-~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             EEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             ceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHH-CCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence              7999999999999998765  89999999999999999999998 999999999999999875 89999999998754


Q ss_pred             cCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          221 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      ..    ...+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+......               ........
T Consensus       233 ~~----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~---------------~~~~~~~~  292 (681)
T 2pzi_A          233 SF----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL---------------PEDDPVLK  292 (681)
T ss_dssp             CC----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC---------------CTTCHHHH
T ss_pred             cC----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc---------------cccccccc
Confidence            32    456799999999998765 48999999999999999999998875322110               00000112


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      .++.+.+||.+||+.||++||+..+.+.|+|+...
T Consensus       293 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          293 TYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             HCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            35789999999999999999999999999987543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.6e-42  Score=313.50  Aligned_cols=228  Identities=13%  Similarity=0.088  Sum_probs=189.9

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      +..++|++.+.||+|+||.||++++..+++.||||++....  .......+.+|+.++..++||||+++++++.+.+..|
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~  107 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL  107 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence            44578999999999999999999999999999999997653  3556688999999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      +||||++|++|.++++.  .....++..++.|++.||+|||+ +||+||||||+||+++.++.+||+++|          
T Consensus       108 lv~e~~~g~~L~~~l~~--~~~~~~~~~i~~ql~~aL~~lH~-~givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          108 VVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHR-AGVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             EEEECCCEEEHHHHHTT--CCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EEEEecCCCCHHHHHhc--CCChHHHHHHHHHHHHHHHHHHH-CCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            99999999999999965  34666789999999999999998 999999999999999999999998554          


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--CCCCCCCC
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFS  302 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  302 (362)
                                |++       .++.++|||||||++|+|++|+.||.+.+..+......    .......+  ......++
T Consensus       175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~  233 (286)
T 3uqc_A          175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE----RDTAGQPIEPADIDRDIP  233 (286)
T ss_dssp             ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC----BCTTSCBCCHHHHCTTSC
T ss_pred             ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH----HHhccCCCChhhcccCCC
Confidence                      223       37899999999999999999999998765433110000    00011111  11235688


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +++.++|.+||+.||++| |+.|+++.
T Consensus       234 ~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          234 FQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            999999999999999999 99999873

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=8.5e-37  Score=303.25  Aligned_cols=187  Identities=15%  Similarity=0.188  Sum_probs=140.1

Q ss_pred             eeeeeCCeEEEEEEEccCCcEEEEEEeeccc---------chHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCeEEEE
Q 018018           77 VVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---------EESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        77 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~~~lV  146 (362)
                      ..+.|++|.+..++....|+.||+|++....         .+...+++.+|+++++++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            4567888888888888889999999997541         234457799999999998 699999999999999999999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCC
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      |||++|++|.+++...+++++.   .++.||+.||+|+|+ +|||||||||+|||++.+|++||+|||+|+.........
T Consensus       321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~-~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEK-QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHH-TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHH-CCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            9999999999999998888875   588999999999998 999999999999999999999999999998876666666


Q ss_pred             CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCC
Q 018018          227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFP  268 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~p  268 (362)
                      .+.+||+.|+|||++.+ .+...+|+||+|++++++.++..+
T Consensus       397 ~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             HHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             cCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            67899999999999986 467889999999998888765443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=8.4e-30  Score=251.60  Aligned_cols=184  Identities=18%  Similarity=0.208  Sum_probs=145.3

Q ss_pred             eeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-------chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           73 DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-------EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ...+.||+|+||.||++  ...+..+++|+.....       .....+.+.+|+++++.++||||+.+..++......++
T Consensus       339 ~~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            44578999999999999  4468899999864321       11234568999999999999999965555567778899


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      ||||+++++|.+++..        +..++.|++.||+|||+ +||+||||||+|||++.  ++||+|||+|+........
T Consensus       417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~-~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHK-NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHH-TTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHH-CcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            9999999999999886        67899999999999998 99999999999999988  9999999999876543221


Q ss_pred             -------CCccccCCcccCcceecC--CCCCccccHHHHHHHHHHHHcCCCCC
Q 018018          226 -------ANTFVGTYNYMSPERISG--GKYGYKSDIWSLGLVLLECATGQFPY  269 (362)
Q Consensus       226 -------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~elltg~~pf  269 (362)
                             ....+||+.|+|||++.+  ..|+..+|+|+..+-..+-+.++-+|
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence                   135689999999999987  56888899999998888887766555

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2.6e-26  Score=208.59  Aligned_cols=145  Identities=19%  Similarity=0.168  Sum_probs=116.1

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch-----------------HHHHHHHHHHHHHhcCCCCcceEEe
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE-----------------SARRQIAQELKINQSSQCPYVVVCY  134 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----------------~~~~~~~~e~~~~~~l~hp~I~~~~  134 (362)
                      |.+.+.||+|+||.||++.+ .+|+.||+|+++.....                 .....+.+|+.+++.++|   +.+.
T Consensus        92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~  167 (282)
T 1zar_A           92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP  167 (282)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred             EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence            34559999999999999999 78999999998643211                 245678899999999984   4444


Q ss_pred             eeEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeecc
Q 018018          135 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG  214 (362)
Q Consensus       135 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg  214 (362)
                      +.+. .+..++||||++|++|.+ +..      .....++.|++.||.|||+ +||+||||||+|||++ ++.+||+|||
T Consensus       168 ~~~~-~~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~-~giiHrDlkp~NILl~-~~~vkl~DFG  237 (282)
T 1zar_A          168 KVYA-WEGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVS-EEGIWIIDFP  237 (282)
T ss_dssp             CEEE-EETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEE-TTEEEECCCT
T ss_pred             eEEe-ccceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHH-CCCEeCCCCHHHEEEE-CCcEEEEECC
Confidence            4433 355699999999999988 421      2355799999999999998 9999999999999999 9999999999


Q ss_pred             CCcccccCCCCCCccccCCcccCcceecC
Q 018018          215 VSAIMASTSGQANTFVGTYNYMSPERISG  243 (362)
Q Consensus       215 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  243 (362)
                      +|+.             +..++|||.+..
T Consensus       238 ~a~~-------------~~~~~a~e~l~r  253 (282)
T 1zar_A          238 QSVE-------------VGEEGWREILER  253 (282)
T ss_dssp             TCEE-------------TTSTTHHHHHHH
T ss_pred             CCeE-------------CCCCCHHHHHHH
Confidence            9863             334788988753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=2.6e-22  Score=179.87  Aligned_cols=138  Identities=17%  Similarity=0.248  Sum_probs=108.2

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcE--EEEEEeecccch-----------------------HHHHHHHHHHHHHhcCC
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQF--FALKVIQMNVEE-----------------------SARRQIAQELKINQSSQ  126 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~-----------------------~~~~~~~~e~~~~~~l~  126 (362)
                      |.+.+.||+|+||.||+|.+..+|+.  ||||+++.....                       .....+.+|+.++..+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            67889999999999999999778999  999997643111                       12246788999998888


Q ss_pred             CCcc--eEEeeeEEecCeEEEEEeccCC-C----CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-hCCCeEeecCCCC
Q 018018          127 CPYV--VVCYQSFYSNGAISIILEYMDG-G----SLADFLKKVKTIPEEYLAAICEQVLKGLLYLH-HEKHIIHRDLKPS  198 (362)
Q Consensus       127 hp~I--~~~~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH-~~~~ivH~Dlkp~  198 (362)
                      |++|  ...+..    ...++||||+.+ |    +|.++...   .++..+..++.|++.||.||| + +||+||||||+
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~-~givHrDlkp~  200 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQE-AELVHADLSEY  200 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHT-SCEECSSCSTT
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHH-CCEEeCCCCHH
Confidence            7754  233321    356899999942 3    67766433   345678899999999999999 7 99999999999


Q ss_pred             cEEEccCCcEEEeeccCCccc
Q 018018          199 NLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       199 NIll~~~~~vkl~DFg~a~~~  219 (362)
                      |||++.  .++|+|||+|...
T Consensus       201 NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          201 NIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SEEESS--SEEECCCTTCEET
T ss_pred             HEEEcC--cEEEEECcccccC
Confidence            999987  9999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.78  E-value=4.9e-19  Score=165.73  Aligned_cols=138  Identities=17%  Similarity=0.184  Sum_probs=99.5

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc----------------h-H----HHHHHHHHHHHHhcCCCCcc
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE----------------E-S----ARRQIAQELKINQSSQCPYV  130 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------------~-~----~~~~~~~e~~~~~~l~hp~I  130 (362)
                      |.+...||.|++|.||+|.+. +|+.||||+++....                . .    .+.....|...+..+.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            889999999999999999985 699999999764310                0 0    01112345666666544443


Q ss_pred             eEEeeeEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC----
Q 018018          131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----  206 (362)
Q Consensus       131 ~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~----  206 (362)
                      ....- +.. ...++||||++|++|..+..      ...+..++.|++.+|.+||+ +|||||||||.|||++.++    
T Consensus       176 ~vp~p-~~~-~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~-~gIVHrDLKp~NILl~~dgd~~d  246 (397)
T 4gyi_A          176 PVPEP-IAQ-SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAK-HGLIHGDFNEFNILIREEKDAED  246 (397)
T ss_dssp             SCCCE-EEE-ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEEEEECSSC
T ss_pred             CCCee-eec-cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHH-CCCcCCCCCHHHEEEeCCCCccc
Confidence            21111 111 12379999999988865432      22456789999999999998 9999999999999998877    


Q ss_pred             ------cEEEeeccCCccc
Q 018018          207 ------EVKITDFGVSAIM  219 (362)
Q Consensus       207 ------~vkl~DFg~a~~~  219 (362)
                            .+.|+||+.+...
T Consensus       247 ~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          247 PSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             TTSEEEEEEECCCTTCEET
T ss_pred             ccccccceEEEEeCCcccC
Confidence                  4899999987654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.42  E-value=5.3e-13  Score=119.11  Aligned_cols=141  Identities=16%  Similarity=0.115  Sum_probs=108.9

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +..|.+...++.|+++.||.+...  +..+++|+...... .....+.+|+.+++.+. +..+.++++.+.+.+..|+||
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            356888888999999999998753  68999999864311 11234778888887764 566778888888889999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------------------
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE----------------------------------------  187 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~----------------------------------------  187 (362)
                      ||++|.+|.+.+.     +......++.++.++|+.||+-                                        
T Consensus        90 e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (263)
T 3tm0_A           90 SEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF  164 (263)
T ss_dssp             ECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred             EecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence            9999999887631     2223457889999999999970                                        


Q ss_pred             ------------------CCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          188 ------------------KHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       188 ------------------~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                                        ..++|+|++|.||+++.++.+.|+||+.+.
T Consensus       165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                              348999999999999776556799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.31  E-value=2.5e-12  Score=114.15  Aligned_cols=134  Identities=13%  Similarity=0.039  Sum_probs=95.4

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCc--ceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY--VVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~--I~~~~~~~~~~~~~~lV~  147 (362)
                      ..+.+....+.|..+.||++.. .+|..+++|+....    ....+.+|+.+++.+.+.+  +.+++.....++..++||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence            4555544444666799999965 46778999997643    1234667777777665433  456777777778899999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCC--------------------------------------
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH--------------------------------------  189 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~--------------------------------------  189 (362)
                      ||++|.+|.  ..   ..+   ...++.+++..|..||+ ..                                      
T Consensus        95 e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           95 GEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHT-LDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             ECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTT-SCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             EecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhC-CCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            999998874  11   122   23567777777888876 32                                      


Q ss_pred             --------------------eEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          190 --------------------IIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       190 --------------------ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                                          ++|+|++|.||+++.++.+.|+||+.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                9999999999999776666799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.28  E-value=9.3e-12  Score=116.34  Aligned_cols=142  Identities=16%  Similarity=0.233  Sum_probs=104.6

Q ss_pred             eeeeeeeeeCCeEEEEEEEccCCcEEEEEEee--cccchHHHHHHHHHHHHHhcCCC--CcceEEeeeEEec---CeEEE
Q 018018           73 DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ--MNVEESARRQIAQELKINQSSQC--PYVVVCYQSFYSN---GAISI  145 (362)
Q Consensus        73 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~~e~~~~~~l~h--p~I~~~~~~~~~~---~~~~l  145 (362)
                      ..++.|+.|.++.||++...  +..+++|+..  ..........+.+|+.+++.+..  ..+.+++..+.+.   +..|+
T Consensus        41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~  118 (359)
T 3dxp_A           41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY  118 (359)
T ss_dssp             CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred             ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence            34678999999999998764  5688999876  33222234567788888888763  4466777776655   45899


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH---------------------------------------  186 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~---------------------------------------  186 (362)
                      ||||++|.++.+..  ...++......++.+++++|+.||+                                       
T Consensus       119 vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             EEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             EEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            99999987775421  2347788889999999999999996                                       


Q ss_pred             ------------------CCCeEeecCCCCcEEEccCCc--EEEeeccCCcc
Q 018018          187 ------------------EKHIIHRDLKPSNLLINHRGE--VKITDFGVSAI  218 (362)
Q Consensus       187 ------------------~~~ivH~Dlkp~NIll~~~~~--vkl~DFg~a~~  218 (362)
                                        ...++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              146999999999999987753  68999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.09  E-value=9.9e-11  Score=106.78  Aligned_cols=182  Identities=18%  Similarity=0.256  Sum_probs=119.7

Q ss_pred             eeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCc--ceEEeeeEEecC---eEEEEEe
Q 018018           75 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPY--VVVCYQSFYSNG---AISIILE  148 (362)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~--I~~~~~~~~~~~---~~~lV~e  148 (362)
                      ++.++.|....||.+.     ..+++|+.+..   .....+.+|..+++.+ .+..  +...+.......   ..|+||+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence            3568999999999863     45889986432   3456788888888766 3322  333333322222   3588999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-----------------------------------------  187 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~-----------------------------------------  187 (362)
                      +++|.++.....  ..++..+...++.|++..++.||+-                                         
T Consensus        97 ~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A           97 KIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             CCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             ccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            999988876433  3577888888888888888888850                                         


Q ss_pred             ----------------CCeEeecCCCCcEEEcc--CCcEEEeeccCCcccccCCCCCCccccCCcc---cCcceecC---
Q 018018          188 ----------------KHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSGQANTFVGTYNY---MSPERISG---  243 (362)
Q Consensus       188 ----------------~~ivH~Dlkp~NIll~~--~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y---~aPE~~~~---  243 (362)
                                      ..++|+|++|.||+++.  ++.+.|+||+.+.......    .......+   ..|+....   
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~----Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN----DFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH----HHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH----HHHHHHhhccccCHHHHHHHHH
Confidence                            23799999999999988  4568899999876532110    00000011   12222111   


Q ss_pred             --CC---------CCccccHHHHHHHHHHHHcCCCCCC
Q 018018          244 --GK---------YGYKSDIWSLGLVLLECATGQFPYS  270 (362)
Q Consensus       244 --~~---------~~~~~DiwslG~~l~elltg~~pf~  270 (362)
                        +.         .....+.|+++.++|.+.+|..+|.
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence              01         1123589999999999999987763

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.79  E-value=9.3e-08  Score=85.21  Aligned_cols=133  Identities=14%  Similarity=0.075  Sum_probs=94.1

Q ss_pred             eeeeeCCe-EEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeEEEEEeccCCCC
Q 018018           77 VVGKGSGG-IVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILEYMDGGS  154 (362)
Q Consensus        77 ~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~~lV~e~~~~gs  154 (362)
                      .+..|..+ .||.+.....+..+++|+-+..    ....+.+|...++.+. +-.+.+++..+.+.+..++|||+++|.+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            44555554 7999888877888999986533    3455777888776654 2235567777788899999999999988


Q ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------------
Q 018018          155 LADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE-----------------------------------------------  187 (362)
Q Consensus       155 L~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~-----------------------------------------------  187 (362)
                      +.+.....    ......++.++...|..||+.                                               
T Consensus       107 ~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          107 AFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             ccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            87765431    122334555666666666520                                               


Q ss_pred             ----------CCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          188 ----------KHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       188 ----------~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                                ..++|+|+.+.||+++.++.+-|+||+.+.
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                      127999999999999877777799999764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.77  E-value=1e-07  Score=86.78  Aligned_cols=134  Identities=19%  Similarity=0.228  Sum_probs=91.4

Q ss_pred             eeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCC---cceEEeeeEE-ecCeEEEEEecc
Q 018018           75 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP---YVVVCYQSFY-SNGAISIILEYM  150 (362)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp---~I~~~~~~~~-~~~~~~lV~e~~  150 (362)
                      ++.++.|....||.+     |..+++|+-+   .......+.+|..+++.+.+.   .+.+.+.... ..+..++||+|+
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~---~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i   95 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPK---SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV   95 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEES---SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecC---CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence            466888998999988     5668899853   234456788999998887642   2445554443 345678999999


Q ss_pred             CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 018018          151 DGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH--------------------------------------------  186 (362)
Q Consensus       151 ~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~--------------------------------------------  186 (362)
                      +|.++....-  ..++......++.|+...|+.||+                                            
T Consensus        96 ~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A           96 QGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             CSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             CCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            9988876321  233444444555555555555543                                            


Q ss_pred             ---------------CCCeEeecCCCCcEEEcc---CCc-EEEeeccCCcc
Q 018018          187 ---------------EKHIIHRDLKPSNLLINH---RGE-VKITDFGVSAI  218 (362)
Q Consensus       187 ---------------~~~ivH~Dlkp~NIll~~---~~~-vkl~DFg~a~~  218 (362)
                                     ...++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           124699999999999987   355 58999998754

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.40  E-value=5.5e-07  Score=84.95  Aligned_cols=78  Identities=14%  Similarity=0.068  Sum_probs=47.9

Q ss_pred             eeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc---h---HHHHHHHHHHHHHhcCCC--C-cceEEeeeEEecCeEE
Q 018018           74 TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE---E---SARRQIAQELKINQSSQC--P-YVVVCYQSFYSNGAIS  144 (362)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~---~~~~~~~~e~~~~~~l~h--p-~I~~~~~~~~~~~~~~  144 (362)
                      ..+.||.|..+.||++....+++.+++|.......   +   .....+..|.++++.+..  + .+..++..  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            45789999999999998766678999998653211   0   112345667777765532  3 33455543  445568


Q ss_pred             EEEeccCCC
Q 018018          145 IILEYMDGG  153 (362)
Q Consensus       145 lV~e~~~~g  153 (362)
                      +||||+++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.30  E-value=1.2e-05  Score=73.63  Aligned_cols=31  Identities=16%  Similarity=0.371  Sum_probs=27.7

Q ss_pred             CCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       187 ~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      ...++|+|+++.||+++.++.+.|+||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            3689999999999999888899999999764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.26  E-value=1.7e-06  Score=80.29  Aligned_cols=84  Identities=11%  Similarity=0.122  Sum_probs=49.5

Q ss_pred             eeeeee-eeeCCeEEEEEEEcc------CCcEEEEEEeecccc--hHHHHHHHHHHHHHhcCCC---CcceEEeeeEEec
Q 018018           73 DTIKVV-GKGSGGIVQLVQHKW------TGQFFALKVIQMNVE--ESARRQIAQELKINQSSQC---PYVVVCYQSFYSN  140 (362)
Q Consensus        73 ~~~~~l-g~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h---p~I~~~~~~~~~~  140 (362)
                      ...+.| +.|....+|++....      ++..+++|+......  ......+.+|+.+++.+..   -.+.+++....+.
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            345678 888889999887641      266799998654320  0001234555555554421   2344555544433


Q ss_pred             ---CeEEEEEeccCCCCHH
Q 018018          141 ---GAISIILEYMDGGSLA  156 (362)
Q Consensus       141 ---~~~~lV~e~~~~gsL~  156 (362)
                         +..++||||++|.++.
T Consensus       103 ~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTTSSCEEEEECCCCBCCC
T ss_pred             CccCCceEEEEecCCCChh
Confidence               4578999999886543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.02  E-value=2.2e-05  Score=74.62  Aligned_cols=76  Identities=13%  Similarity=0.180  Sum_probs=45.3

Q ss_pred             CCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcccc--CCcccCcceecCC---CCCccccHHHHHHHHHHH
Q 018018          188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG--TYNYMSPERISGG---KYGYKSDIWSLGLVLLEC  262 (362)
Q Consensus       188 ~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DiwslG~~l~el  262 (362)
                      ..++|+|++|.||+++.++ ++|+||+.+....... .......  ...|++|+.....   ......++.++...+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            6799999999999998776 9999999876532110 0000010  1245555544311   112234455777777777


Q ss_pred             HcC
Q 018018          263 ATG  265 (362)
Q Consensus       263 ltg  265 (362)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            664

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.01  E-value=5.2e-05  Score=68.97  Aligned_cols=76  Identities=16%  Similarity=0.068  Sum_probs=56.6

Q ss_pred             eeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC---CCcceEEeeeEEecCeEEEEEecc
Q 018018           74 TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ---CPYVVVCYQSFYSNGAISIILEYM  150 (362)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~---hp~I~~~~~~~~~~~~~~lV~e~~  150 (362)
                      -.+.|+.|....+|++..  ++..+++|+....    ....+..|+..++.+.   ...+.+.+......+..++||||+
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            457799999999999875  4778999987643    2445677777766653   245667777666778899999999


Q ss_pred             CCCCH
Q 018018          151 DGGSL  155 (362)
Q Consensus       151 ~~gsL  155 (362)
                      +|.++
T Consensus       114 ~G~~~  118 (312)
T 3jr1_A          114 NKSKN  118 (312)
T ss_dssp             CCCCC
T ss_pred             cCCCC
Confidence            98764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.98  E-value=0.0001  Score=62.64  Aligned_cols=136  Identities=18%  Similarity=0.181  Sum_probs=93.2

Q ss_pred             CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcccc
Q 018018          153 GSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVG  231 (362)
Q Consensus       153 gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~~g  231 (362)
                      .||.+.|+. ..+++++++|.++.|.+.+|.-+-..+.-..+=+.|..|++..+|.|-+.+ +.+.            ..
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~   99 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AG   99 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------cc
Confidence            489999975 468999999999999999987762112212344557999999999998774 2110            11


Q ss_pred             CCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHH
Q 018018          232 TYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISA  311 (362)
Q Consensus       232 t~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  311 (362)
                      ...+.|||... ...+.+.=|||||+++|..+--..|                          ......+++.+.+||..
T Consensus       100 ~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~--------------------------e~eE~eLS~~LE~LL~~  152 (229)
T 2yle_A          100 EPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK--------------------------ENEERELSPPLEQLIDH  152 (229)
T ss_dssp             -------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC--------------------------TTEEECCCHHHHHHHHH
T ss_pred             ccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC--------------------------cccchhhCHHHHHHHHH
Confidence            22466888764 3456788899999999999873322                          12235789999999999


Q ss_pred             hhhc-------------------------CcCCCCCHHHHHc
Q 018018          312 CVQK-------------------------EPQQRLSAQELMT  328 (362)
Q Consensus       312 ~L~~-------------------------dP~~Rpt~~eil~  328 (362)
                      |..-                         .+..|.+.++|++
T Consensus       153 Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~  194 (229)
T 2yle_A          153 MANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK  194 (229)
T ss_dssp             HTTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred             HHhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence            9865                         2468889998875

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.80  E-value=4.4e-05  Score=68.99  Aligned_cols=29  Identities=24%  Similarity=0.260  Sum_probs=24.9

Q ss_pred             CeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          189 HIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       189 ~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      .++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4899999999999 5677899999997754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.65  E-value=0.00027  Score=64.16  Aligned_cols=142  Identities=17%  Similarity=0.208  Sum_probs=75.7

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-----CCCcceEEe-e--eEEecCeE
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS-----QCPYVVVCY-Q--SFYSNGAI  143 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-----~hp~I~~~~-~--~~~~~~~~  143 (362)
                      ...++.|+.|....+|++...  +..+++|+.......   ..+..|..+++.+     ..|.++... +  .....+..
T Consensus        24 ~~~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~   98 (322)
T 2ppq_A           24 LTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP   98 (322)
T ss_dssp             EEEEEEECC---EEEEEEEES--SCCEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred             ceEeeccCCCcccceEEEEeC--CccEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence            344577888888999998764  336889998652111   2233444444333     334444221 1  11234678


Q ss_pred             EEEEeccCCCCHH-----H------HH---HHc-CC--------CCHHHHHH---------------HHHHHHHHHHHHH
Q 018018          144 SIILEYMDGGSLA-----D------FL---KKV-KT--------IPEEYLAA---------------ICEQVLKGLLYLH  185 (362)
Q Consensus       144 ~lV~e~~~~gsL~-----~------~l---~~~-~~--------l~~~~~~~---------------i~~ql~~al~~LH  185 (362)
                      ++|++|++|.++.     .      .+   ... ..        ........               +...+...++.+.
T Consensus        99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~  178 (322)
T 2ppq_A           99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA  178 (322)
T ss_dssp             EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred             EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence            9999999886531     1      11   110 01        11110000               0011333445554


Q ss_pred             h------CCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          186 H------EKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       186 ~------~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      .      ..+++|+|+++.||+++.++.+.|+||+.+..
T Consensus       179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            2      14699999999999998766568999997643

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.55  E-value=0.00058  Score=61.06  Aligned_cols=80  Identities=10%  Similarity=0.014  Sum_probs=52.4

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCC---CcceEEeeeEEecCeEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC---PYVVVCYQSFYSNGAISII  146 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h---p~I~~~~~~~~~~~~~~lV  146 (362)
                      .+..-++.+|.|..+.||+++.. +|+.|++|+-.... ......+..|+..++.+.-   -.+.+.+..  +  .-++|
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~-~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv   88 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDA-PALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLA   88 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTC-CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCC-cchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEE
Confidence            34556788999999999999864 78999999865332 1122346677777766532   123344433  2  23789


Q ss_pred             EeccCCCCH
Q 018018          147 LEYMDGGSL  155 (362)
Q Consensus       147 ~e~~~~gsL  155 (362)
                      |||+.++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999987653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.51  E-value=0.00019  Score=65.68  Aligned_cols=31  Identities=29%  Similarity=0.458  Sum_probs=27.1

Q ss_pred             CCeEeecCCCCcEEEccC----CcEEEeeccCCcc
Q 018018          188 KHIIHRDLKPSNLLINHR----GEVKITDFGVSAI  218 (362)
Q Consensus       188 ~~ivH~Dlkp~NIll~~~----~~vkl~DFg~a~~  218 (362)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            569999999999999874    6899999998754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.29  E-value=0.0019  Score=58.70  Aligned_cols=137  Identities=13%  Similarity=0.110  Sum_probs=74.2

Q ss_pred             eeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-----CCcceEEee--eEEecCeEEEEEe
Q 018018           76 KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-----CPYVVVCYQ--SFYSNGAISIILE  148 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----hp~I~~~~~--~~~~~~~~~lV~e  148 (362)
                      ..++ |....||++... +|+.+++|+.+....  ....+..|..+++.+.     .|.++..-+  .....+..++||+
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~  107 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP  107 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEE
Confidence            4566 778899987653 566799999863311  1223444555544432     233332211  1223567789999


Q ss_pred             ccCCCCHH-----H------HH---HH---cC------CCCHHHH----------------------HHHHHHHHHHHHH
Q 018018          149 YMDGGSLA-----D------FL---KK---VK------TIPEEYL----------------------AAICEQVLKGLLY  183 (362)
Q Consensus       149 ~~~~gsL~-----~------~l---~~---~~------~l~~~~~----------------------~~i~~ql~~al~~  183 (362)
                      |++|.++.     .      .+   ..   ..      ..+....                      ...+.+++..+..
T Consensus       108 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~  187 (328)
T 1zyl_A          108 SVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTA  187 (328)
T ss_dssp             CCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHH
Confidence            99875431     1      11   00   00      1121111                      1112222222222


Q ss_pred             HH---hCCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          184 LH---HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       184 LH---~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      +-   ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       188 ~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          188 HWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            21   124589999999999998 4 899999987643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.20  E-value=0.0009  Score=63.59  Aligned_cols=74  Identities=16%  Similarity=0.117  Sum_probs=45.8

Q ss_pred             eeeeeeeeCCeEEEEEEEcc-------CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcc-eEEeeeEEecCeEEE
Q 018018           74 TIKVVGKGSGGIVQLVQHKW-------TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV-VVCYQSFYSNGAISI  145 (362)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I-~~~~~~~~~~~~~~l  145 (362)
                      .++.|+.|....+|++....       ++..+++|+......   ...+.+|..+++.+...++ .++++.+.  +  .+
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~  149 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GR  149 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EE
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CE
Confidence            45678888889999998653       257899999743211   1233457776665532222 34554432  2  28


Q ss_pred             EEeccCCCC
Q 018018          146 ILEYMDGGS  154 (362)
Q Consensus       146 V~e~~~~gs  154 (362)
                      |++|++|.+
T Consensus       150 v~e~l~G~~  158 (429)
T 1nw1_A          150 LEEYIPSRP  158 (429)
T ss_dssp             EECCCCEEE
T ss_pred             EEEEeCCcc
Confidence            999998644

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.04  E-value=0.0053  Score=56.27  Aligned_cols=31  Identities=19%  Similarity=0.428  Sum_probs=27.5

Q ss_pred             CCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       188 ~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4699999999999998888899999987654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.97  E-value=0.0012  Score=61.15  Aligned_cols=76  Identities=18%  Similarity=0.188  Sum_probs=40.6

Q ss_pred             eeeeeeeeCCeEEEEEEEcc--------CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCc-ceEEeeeEEecCeEE
Q 018018           74 TIKVVGKGSGGIVQLVQHKW--------TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY-VVVCYQSFYSNGAIS  144 (362)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~-I~~~~~~~~~~~~~~  144 (362)
                      ..+.|+.|..-.+|++....        .+..+++|+....... . .....|..+++.+...+ ..+++..+  .+  +
T Consensus        37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~  110 (369)
T 3c5i_A           37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-L-YNTISEFEVYKTMSKYKIAPQLLNTF--NG--G  110 (369)
T ss_dssp             EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-T-SCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred             EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-e-ecHHHHHHHHHHHHhcCCCCceEEec--CC--c
Confidence            34677888888999998653        1368999987543211 1 11245555555443222 23444332  22  6


Q ss_pred             EEEeccCCCCH
Q 018018          145 IILEYMDGGSL  155 (362)
Q Consensus       145 lV~e~~~~gsL  155 (362)
                      +||+|++|.++
T Consensus       111 ~v~e~i~G~~l  121 (369)
T 3c5i_A          111 RIEEWLYGDPL  121 (369)
T ss_dssp             EEEECCCSEEC
T ss_pred             EEEEEecCCcC
Confidence            89999987543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.84  E-value=0.0014  Score=61.03  Aligned_cols=138  Identities=13%  Similarity=0.101  Sum_probs=76.8

Q ss_pred             eeeeeeeCCeEEEEEEEcc-------CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCc-ceEEeeeEEecCeEEEE
Q 018018           75 IKVVGKGSGGIVQLVQHKW-------TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY-VVVCYQSFYSNGAISII  146 (362)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~-I~~~~~~~~~~~~~~lV  146 (362)
                      ++.|..|....+|++....       ++..+++|+.....  .....+.+|..+++.+.-.+ ..++++.+.  +  .+|
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v  128 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRL  128 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccE
Confidence            3567778888899988742       35789999853211  11234457777776553211 234444433  2  299


Q ss_pred             EeccCCCCHHH--------------HHHH---c-----CCCC--HHHHHHHHHHHHH-------------------HHHH
Q 018018          147 LEYMDGGSLAD--------------FLKK---V-----KTIP--EEYLAAICEQVLK-------------------GLLY  183 (362)
Q Consensus       147 ~e~~~~gsL~~--------------~l~~---~-----~~l~--~~~~~~i~~ql~~-------------------al~~  183 (362)
                      |||++|.+|..              .+.+   .     +...  ...+..+..++-.                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            99998755421              1111   0     1111  3445555544322                   2233


Q ss_pred             HH----h---CCCeEeecCCCCcEEEccC----CcEEEeeccCCcc
Q 018018          184 LH----H---EKHIIHRDLKPSNLLINHR----GEVKITDFGVSAI  218 (362)
Q Consensus       184 LH----~---~~~ivH~Dlkp~NIll~~~----~~vkl~DFg~a~~  218 (362)
                      |.    .   ...++|+|+.+.||+++.+    +.+.|+||..|..
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            32    1   1359999999999999876    6899999997643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.57  E-value=0.01  Score=56.77  Aligned_cols=76  Identities=20%  Similarity=0.225  Sum_probs=45.3

Q ss_pred             eeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcc-eEEeeeEEecCeEEEEEeccCC
Q 018018           74 TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYV-VVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I-~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      .++.|+.|-...+|++.....+..+++|+....... .. ...+|..+++.+...++ .++++.+.  +  .+|+||++|
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G  185 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-II-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG  185 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence            456788888899999987644578999987433211 10 11467777766654333 35555542  2  259999987


Q ss_pred             CCH
Q 018018          153 GSL  155 (362)
Q Consensus       153 gsL  155 (362)
                      .+|
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            444

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.21  E-value=0.083  Score=49.81  Aligned_cols=29  Identities=34%  Similarity=0.624  Sum_probs=25.8

Q ss_pred             CeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          189 HIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       189 ~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      .++|+|+.+.||+ +.++.+.|+||..|..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            4899999999999 7888999999998753

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=93.69  E-value=0.28  Score=45.80  Aligned_cols=29  Identities=24%  Similarity=0.500  Sum_probs=24.8

Q ss_pred             eEeecCCCCcEEE------ccCCcEEEeeccCCcc
Q 018018          190 IIHRDLKPSNLLI------NHRGEVKITDFGVSAI  218 (362)
Q Consensus       190 ivH~Dlkp~NIll------~~~~~vkl~DFg~a~~  218 (362)
                      ++|+|+.+.||++      ++++.+.++||-.|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      4467799999998754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=88.33  E-value=1  Score=38.01  Aligned_cols=116  Identities=10%  Similarity=0.085  Sum_probs=78.3

Q ss_pred             CCCcceEEeeeEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC
Q 018018          126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR  205 (362)
Q Consensus       126 ~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~  205 (362)
                      .||+++.. ..-.+++.+.+.++.-+.  ...+-. -..++....++++.+++....+++.   -+|--|+|+||+++.+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~~-ik~~~~~eKlr~l~ni~~l~~~~~~---r~tf~L~P~NL~f~~~  115 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDN--HTPFDN-IKSFTKNEKLRYLLNIKNLEEVNRT---RYTFVLAPDELFFTRD  115 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTT--SEEGGG-GGGSCHHHHHHHHHHGGGGGGGGGS---SEECCCSGGGEEECTT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcc--cCCHHH-HHhcCHHHHHHHHHHHHHHHHHhcC---ceEEEEecceEEEcCC
Confidence            67888866 445556666665554432  222211 2457889999999999998866654   5899999999999999


Q ss_pred             CcEEEeeccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCC
Q 018018          206 GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYS  270 (362)
Q Consensus       206 ~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~  270 (362)
                      +.+++.=-|+-..                 ++|.     ..+...=.-..=|++..+++++..|.
T Consensus       116 ~~p~i~~RGik~~-----------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          116 GLPIAKTRGLQNV-----------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             SCEEESCCEETTT-----------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             CCEEEEEccCccC-----------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999998775322                 1221     11222223366788899999988884

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.78  E-value=1.3  Score=37.51  Aligned_cols=114  Identities=11%  Similarity=0.131  Sum_probs=78.1

Q ss_pred             CCCcceEEeeeEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHH-HHHhCCCeEeecCCCCcEEEcc
Q 018018          126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL-YLHHEKHIIHRDLKPSNLLINH  204 (362)
Q Consensus       126 ~hp~I~~~~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~-~LH~~~~ivH~Dlkp~NIll~~  204 (362)
                      .||++ . ...-.+++.+.+.++.-+++-=...+   ..++..+.++++.+++.... +++.   -+|--++|+||+++.
T Consensus        48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~~~---r~tf~l~P~NL~f~~  119 (219)
T 4ano_A           48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHSAR---RLIFIVCPENLMFNR  119 (219)
T ss_dssp             SCSSS-E-EEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCCSS---SEECCCCGGGEEECT
T ss_pred             cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhhhC---ceeEEEeCceEEEeC
Confidence            57877 3 33345667777777665443223333   45889999999999998888 6654   689999999999999


Q ss_pred             CCcEEEeeccCCcccccCCCCCCccccCCcccCcceecCCCCCccccH-HHHHHHHHHHHcCCCCCC
Q 018018          205 RGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDI-WSLGLVLLECATGQFPYS  270 (362)
Q Consensus       205 ~~~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~~l~elltg~~pf~  270 (362)
                      ++.+++.-.|+-..                 ++|..     .+. .|. -..=|++..++.++..|.
T Consensus       120 ~~~p~i~hRGi~~~-----------------lpP~e-----~~e-e~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          120 ALEPFFLHVGVKES-----------------LPPDE-----WDD-ERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             TCCEEESCCEETTT-----------------BSSCS-----CCH-HHHHHHHHHHHHHHTTCSSCHH
T ss_pred             CCcEEEEEcCCccc-----------------CCCCC-----CCH-HHHHHHHHHHHHHHHcCCCCHH
Confidence            99999998885321                 22321     111 233 366788888998887774

>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A*

Probab=83.28  E-value=28  Score=34.60  Aligned_cols=44  Identities=23%  Similarity=0.320  Sum_probs=31.7

Q ss_pred             HHHHHHHHHHH--HHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          169 YLAAICEQVLK--GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       169 ~~~~i~~ql~~--al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      .+..++++++-  .+.|+   .||  +|-+++||||+.+|++.=+|||.+-
T Consensus       530 ar~nF~~SlA~~Svv~YI---LGl--GDRH~~NILid~tG~v~HIDFG~~f  575 (696)
T 2x6h_A          530 VMDTYIKSCAGYCVITYL---LGV--GDRHLDNLLLTTNGKLFHIDFGYIL  575 (696)
T ss_dssp             HHHHHHHHHHHHHHHHHH---HTC--CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred             HHHHHHHHHHHHHHHHHH---ccC--CCCCCcceEEeCCCCEEEEeehhhh
Confidence            34455555443  24444   334  7899999999999999999999863

>3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A

Probab=81.16  E-value=28  Score=34.02  Aligned_cols=45  Identities=22%  Similarity=0.341  Sum_probs=32.7

Q ss_pred             HHHHHHHHHHHH--HHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          168 EYLAAICEQVLK--GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       168 ~~~~~i~~ql~~--al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      .....+++.++-  .+.|+   .||  +|=+++|||++.+|++.=+|||.+-
T Consensus       455 ~a~~nF~~S~A~ySvv~YI---LGi--gDRH~~NILld~tG~v~HIDFG~~f  501 (614)
T 3ls8_A          455 EVMDTYVKSCAGYCVITYI---LGV--GDRHLDNLLLTKTGKLFHIDFGYIL  501 (614)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTC--CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred             HHHHHHHHHHHHHhHhhee---eec--cCCCCcceeEcCCCCEeeeehHHhh
Confidence            344555555443  34555   344  6889999999999999999999863

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	362
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-95
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-80
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-78
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-78
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-78
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-77
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	5e-77
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-75
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-72
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-72
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-72
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-71
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-70
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-69
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-67
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-66
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-66
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-66
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-65
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-65
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-64
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-63
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-63
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-61
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-61
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-60
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-60
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-60
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-60
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-59
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-59
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-59
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-58
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-58
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-58
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-58
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	6e-58
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-57
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-57
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-57
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-56
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-56
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-56
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-55
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-54
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-53
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-53
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-53
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-52
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-51
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-50
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-49
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-46
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-43
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-21

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  283 bits (726), Expect = 5e-95
 Identities = 123/318 (38%), Positives = 181/318 (56%), Gaps = 37/318 (11%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 125
           +L  +D + I  +G G+GG+V  V HK +G   A K+I + ++ + R QI +EL++    
Sbjct: 2   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 61

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
             PY+V  Y +FYS+G ISI +E+MDGGSL   LKK   IPE+ L  +   V+KGL YL 
Sbjct: 62  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
            +  I+HRD+KPSN+L+N RGE+K+ DFGVS  +  +   AN+FVGT +YMSPER+ G  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH 179

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQD----------------------------- 276
           Y  +SDIWS+GL L+E A G++P  PP+ ++                             
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239

Query: 277 ------GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHP 330
                    + +EL++ IV++PPP  PS  FS EF  F++ C+ K P +R   ++LM H 
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299

Query: 331 FLKMYGDLNVDLSEYFTD 348
           F+K      VD + +   
Sbjct: 300 FIKRSDAEEVDFAGWLCS 317

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (624), Expect = 2e-80
 Identities = 76/274 (27%), Positives = 136/274 (49%), Gaps = 19/274 (6%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCP 128
           ED + +  +G GS G  Q ++ K  G+    K +   ++ E+ ++ +  E+ + +  + P
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 129 YVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKV----KTIPEEYLAAICEQVLKGLL 182
            +V  Y      +N  + I++EY +GG LA  + K     + + EE++  +  Q+   L 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 183 YLH----HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 238
             H        ++HRDLKP+N+ ++ +  VK+ DFG++ I+   +  A  FVGT  YMSP
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 239 ERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 298
           E+++   Y  KSDIWSLG +L E      P++   Q+       EL   I +      P 
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-------ELAGKIREGKFRRIP- 235

Query: 299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL 332
            ++S E    I+  +  +   R S +E++ +P +
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (613), Expect = 1e-78
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 10/268 (3%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           +ED D ++ +G+G+ G VQL  ++ T +  A+K++ M         I +E+ IN+     
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHE 63

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            VV  Y          + LEY  GG L D ++    +PE        Q++ G++YLH   
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-I 122

Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKY 246
            I HRD+KP NLL++ R  +KI+DFG++ +    + +   N   GT  Y++PE +   ++
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 247 -GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 305
                D+WS G+VL     G+ P+      D  +   +      ++     P  +     
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236

Query: 306 CSFISACVQKEPQQRLSAQELMTHPFLK 333
            + +   + + P  R++  ++    +  
Sbjct: 237 LALLHKILVENPSARITIPDIKKDRWYN 264

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (610), Expect = 3e-78
 Identities = 80/270 (29%), Positives = 129/270 (47%), Gaps = 14/270 (5%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQ 123
           Q  LED +  + +GKG  G V L + K +    ALKV+      +     Q+ +E++I  
Sbjct: 2   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61

Query: 124 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 183
             + P ++  Y  F+    + +ILEY   G++   L+K+    E+  A    ++   L Y
Sbjct: 62  HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
            H  K +IHRD+KP NLL+   GE+KI DFG S    S+  +  T  GT +Y+ PE I G
Sbjct: 122 CH-SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRTTLCGTLDYLPPEMIEG 178

Query: 244 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP 303
             +  K D+WSLG++  E   G+ P+          ++ E  + I          D  + 
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEAN-------TYQETYKRISRVEFT--FPDFVTE 229

Query: 304 EFCSFISACVQKEPQQRLSAQELMTHPFLK 333
                IS  ++  P QR   +E++ HP++ 
Sbjct: 230 GARDLISRLLKHNPSQRPMLREVLEHPWIT 259

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  239 bits (612), Expect = 3e-78
 Identities = 87/278 (31%), Positives = 139/278 (50%), Gaps = 15/278 (5%)

Query: 67  LNLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSS 125
           LN ED  + I  +G G+ G V   Q+K T    A KVI    EE        E+ I  S 
Sbjct: 8   LNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE-LEDYMVEIDILASC 66

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLLYL 184
             P +V    +FY    + I++E+  GG++   + +  + + E  +  +C+Q L  L YL
Sbjct: 67  DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 185 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI--- 241
           H +  IIHRDLK  N+L    G++K+ DFGVSA    T  + ++F+GT  +M+PE +   
Sbjct: 127 H-DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 185

Query: 242 --SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD 299
                 Y YK+D+WSLG+ L+E A  + P+              L++    +PP  A   
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPH------HELNPMRVLLKIAKSEPPTLAQPS 239

Query: 300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
           ++S  F  F+  C++K    R +  +L+ HPF+ +  +
Sbjct: 240 RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSN 277

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  237 bits (607), Expect = 2e-77
 Identities = 79/265 (29%), Positives = 139/265 (52%), Gaps = 9/265 (3%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 134
            + +G+G+ G V       TGQ  A++ + +  ++  +  I  E+ + + ++ P +V   
Sbjct: 25  FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ-QQPKKELIINEILVMRENKNPNIVNYL 83

Query: 135 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 194
            S+     + +++EY+ GGSL D + +   + E  +AA+C + L+ L +LH    +IHRD
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLH-SNQVIHRD 141

Query: 195 LKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWS 254
           +K  N+L+   G VK+TDFG  A +     + +T VGT  +M+PE ++   YG K DIWS
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201

Query: 255 LGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQ 314
           LG++ +E   G+ PY              L     +  P     ++ S  F  F++ C+ 
Sbjct: 202 LGIMAIEMIEGEPPY------LNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 315 KEPQQRLSAQELMTHPFLKMYGDLN 339
            + ++R SA+EL+ H FLK+   L+
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLS 280

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  237 bits (606), Expect = 5e-77
 Identities = 76/264 (28%), Positives = 130/264 (49%), Gaps = 17/264 (6%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEES--ARRQIAQELKINQSSQCPYVVV 132
           ++ +G GS G V   +     +  A+K +  + ++S    + I +E++  Q  + P  + 
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79

Query: 133 CYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIH 192
               +       +++EY  G +        K + E  +AA+    L+GL YL H  ++IH
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL-HSHNMIH 138

Query: 193 RDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG---GKYGYK 249
           RD+K  N+L++  G VK+ DFG ++IMA      N+FVGT  +M+PE I     G+Y  K
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPA----NSFVGTPYWMAPEVILAMDEGQYDGK 194

Query: 250 SDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI 309
            D+WSLG+  +E A  + P                +  I     P+  S  +S  F +F+
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAM-------SALYHIAQNESPALQSGHWSEYFRNFV 247

Query: 310 SACVQKEPQQRLSAQELMTHPFLK 333
            +C+QK PQ R +++ L+ H F+ 
Sbjct: 248 DSCLQKIPQDRPTSEVLLKHRFVL 271

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  232 bits (594), Expect = 1e-75
 Identities = 75/265 (28%), Positives = 128/265 (48%), Gaps = 16/265 (6%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQCPYVVVCY 134
             +G+GS   V       T    A   +Q   + +S R++  +E ++ +  Q P +V  Y
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 135 QSFYS----NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH- 189
            S+ S       I ++ E M  G+L  +LK+ K +  + L + C Q+LKGL +LH     
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 134

Query: 190 IIHRDLKPSNLLINHR-GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGY 248
           IIHRDLK  N+ I    G VKI D G++ +  ++   A   +GT  +M+PE     KY  
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--FAKAVIGTPEFMAPEMYEE-KYDE 191

Query: 249 KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF 308
             D+++ G+ +LE AT ++PYS         +  ++   +     P++      PE    
Sbjct: 192 SVDVYAFGMCMLEMATSEYPYS------ECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245

Query: 309 ISACVQKEPQQRLSAQELMTHPFLK 333
           I  C+++   +R S ++L+ H F +
Sbjct: 246 IEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  224 bits (573), Expect = 4e-72
 Identities = 74/287 (25%), Positives = 134/287 (46%), Gaps = 15/287 (5%)

Query: 68  NLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 126
           ++ DI D   V+G G+   V L + K T +  A+K I     E     +  E+ +    +
Sbjct: 6   DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 186
            P +V     + S G + +I++ + GG L D + +     E   + +  QVL  + YL H
Sbjct: 66  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYL-H 124

Query: 187 EKHIIHRDLKPSNLLI---NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
           +  I+HRDLKP NLL    +   ++ I+DFG+S +    S   +T  GT  Y++PE ++ 
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-VLSTACGTPGYVAPEVLAQ 183

Query: 244 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAPSDQF 301
             Y    D WS+G++      G  P+             +L E I+  +    S   D  
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPFYDENDA-------KLFEQILKAEYEFDSPYWDDI 236

Query: 302 SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTD 348
           S     FI   ++K+P++R + ++ + HP++     L+ ++ +  ++
Sbjct: 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSE 283

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (571), Expect = 5e-72
 Identities = 73/274 (26%), Positives = 133/274 (48%), Gaps = 20/274 (7%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQC 127
           ED    K++G+GS   V L +   T + +A+K+++    ++E+    + +E  +      
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 187
           P+ V  Y +F  +  +   L Y   G L  +++K+ +  E        +++  L YL H 
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL-HG 126

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA--STSGQANTFVGTYNYMSPERISGGK 245
           K IIHRDLKP N+L+N    ++ITDFG + +++  S   +AN+FVGT  Y+SPE ++   
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 305
               SD+W+LG ++ +   G  P+    +       Y + + I+         ++F P+ 
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPPFRAGNE-------YLIFQKIIKLEYD--FPEKFFPKA 237

Query: 306 CSFISACVQKEPQQRLSAQE------LMTHPFLK 333
              +   +  +  +RL  +E      L  HPF +
Sbjct: 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  226 bits (576), Expect = 6e-72
 Identities = 68/272 (25%), Positives = 125/272 (45%), Gaps = 15/272 (5%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
           L+  D  + +G G+ G+V  V  + TG  FA K + M   ES +  + +E++     + P
Sbjct: 25  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV-MTPHESDKETVRKEIQTMSVLRHP 83

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHE 187
            +V  + +F  +  + +I E+M GG L + +  +   + E+       QV KGL ++H E
Sbjct: 84  TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH-E 142

Query: 188 KHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
            + +H DLKP N++   +   E+K+ DFG++A +           GT  + +PE   G  
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVAEGKP 201

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAPSDQFSP 303
            GY +D+WS+G++     +G  P+             E +  +   D     +     S 
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDD-------ETLRNVKSCDWNMDDSAFSGISE 254

Query: 304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
           +   FI   +  +P  R++  + + HP+L   
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  221 bits (565), Expect = 2e-71
 Identities = 71/283 (25%), Positives = 136/283 (48%), Gaps = 26/283 (9%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--------ESARRQIAQELKI 121
           E+ +  +++G+G   +V+   HK T + +A+K+I +           +  R    +E+ I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 122 NQS-SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKG 180
            +  S  P ++    ++ +N    ++ + M  G L D+L +  T+ E+    I   +L+ 
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPER 240
           +  L H+ +I+HRDLKP N+L++    +K+TDFG S  +     +     GT +Y++PE 
Sbjct: 123 ICAL-HKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-KLREVCGTPSYLAPEI 180

Query: 241 ISGG------KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQP 292
           I          YG + D+WS G+++     G  P+   +Q         ++  I+  +  
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-------LMLRMIMSGNYQ 233

Query: 293 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
             S   D +S      +S  +  +PQ+R +A+E + HPF + Y
Sbjct: 234 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (561), Expect = 4e-70
 Identities = 74/269 (27%), Positives = 134/269 (49%), Gaps = 14/269 (5%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV---EESARRQIAQELKINQSS 125
           +ED    K++GKGS G V L + K T QFFA+K ++ +V   ++     + ++  ++ + 
Sbjct: 1   IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
           + P++   + +F +   +  ++EY++GG L   ++               +++ GL +LH
Sbjct: 61  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
             K I++RDLK  N+L++  G +KI DFG+         + NTF GT +Y++PE + G K
Sbjct: 121 -SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF 305
           Y +  D WS G++L E   GQ P+   +++       EL  +I    P          E 
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-------ELFHSIRMDNPF--YPRWLEKEA 230

Query: 306 CSFISACVQKEPQQRLSA-QELMTHPFLK 333
              +     +EP++RL    ++  HP  +
Sbjct: 231 KDLLVKLFVREPEKRLGVRGDIRQHPLFR 259

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  218 bits (555), Expect = 6e-69
 Identities = 66/270 (24%), Positives = 123/270 (45%), Gaps = 15/270 (5%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCP 128
            +  D ++ +G G+ G+V     K TG+ F  K I        +  +  E+ I      P
Sbjct: 28  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHP 86

Query: 129 YVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLLYLHHE 187
            ++  + +F     + +ILE++ GG L D +  +   + E  +     Q  +GL ++H E
Sbjct: 87  KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH-E 145

Query: 188 KHIIHRDLKPSNLLI--NHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
             I+H D+KP N++        VKI DFG++  + +          T  + +PE +    
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-NPDEIVKVTTATAEFAAPEIVDREP 204

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAPSDQFSP 303
            G+ +D+W++G++     +G  P++  +         E ++ +   D           SP
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-------ETLQNVKRCDWEFDEDAFSSVSP 257

Query: 304 EFCSFISACVQKEPQQRLSAQELMTHPFLK 333
           E   FI   +QKEP++RL+  + + HP+LK
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLK 287

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (539), Expect = 7e-67
 Identities = 56/264 (21%), Positives = 116/264 (43%), Gaps = 16/264 (6%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 134
            + +G+G  GIV       + + +  K +   V+ + +  + +E+ I   ++   ++  +
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIARHRNILHLH 67

Query: 135 QSFYSNGAISIILEYMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHR 193
           +SF S   + +I E++ G  + + +      + E  + +   QV + L +LH   +I H 
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH-SHNIGHF 126

Query: 194 DLKPSNLLINHRGE--VKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSD 251
           D++P N++   R    +KI +FG +  +               Y +PE          +D
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPEVHQHDVVSTATD 185

Query: 252 IWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ--PPPSAPSDQFSPEFCSFI 309
           +WSLG ++    +G  P+     Q       +++E I++           + S E   F+
Sbjct: 186 MWSLGTLVYVLLSGINPFLAETNQ-------QIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 310 SACVQKEPQQRLSAQELMTHPFLK 333
              + KE + R++A E + HP+LK
Sbjct: 239 DRLLVKERKSRMTASEALQHPWLK 262

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  212 bits (540), Expect = 2e-66
 Identities = 73/278 (26%), Positives = 136/278 (48%), Gaps = 20/278 (7%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQ-----MNVEESARRQIAQELKI 121
           L + D    +++G+G  G V   +   TG+ +A+K +      M   E+        L +
Sbjct: 1   LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60

Query: 122 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 181
             +  CP++V    +F++   +S IL+ M+GG L   L +     E  +     +++ GL
Sbjct: 61  VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 241
            ++ H + +++RDLKP+N+L++  G V+I+D G++     +  + +  VGT+ YM+PE +
Sbjct: 121 EHM-HNRFVVYRDLKPANILLDEHGHVRISDLGLACDF--SKKKPHASVGTHGYMAPEVL 177

Query: 242 SGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ 300
             G  Y   +D +SLG +L +   G  P+   + +D     +E+    +         D 
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTLTMAVE--LPDS 231

Query: 301 FSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLK 333
           FSPE  S +   +Q++  +RL      AQE+   PF +
Sbjct: 232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 2e-66
 Identities = 64/270 (23%), Positives = 122/270 (45%), Gaps = 15/270 (5%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSS 125
           +    I   + +G GS G V   +        A+K++ +        +    E+ + + +
Sbjct: 5   IPDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61

Query: 126 QCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYL 184
           +   +++    + +   ++I+ ++ +G SL   L  ++T      L  I  Q  +G+ YL
Sbjct: 62  RHVNILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120

Query: 185 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERIS 242
           H  K IIHRDLK +N+ ++    VKI DFG++ + +  SG  Q     G+  +M+PE I 
Sbjct: 121 HA-KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 243 G---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD 299
                 Y ++SD+++ G+VL E  TGQ PYS    +D       ++      P  S    
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD---QIIFMVGRGYLSPDLSKVRS 236

Query: 300 QFSPEFCSFISACVQKEPQQRLSAQELMTH 329
                    ++ C++K+  +R    +++  
Sbjct: 237 NCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  210 bits (535), Expect = 4e-66
 Identities = 78/274 (28%), Positives = 141/274 (51%), Gaps = 17/274 (6%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQS 124
           + + D D +K++GKG+ G V LV+ K TG+++A+K+++  V   +        E ++ Q+
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61

Query: 125 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYL 184
           ++ P++     +F ++  +  ++EY +GG L   L + +   EE       +++  L Y 
Sbjct: 62  TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY- 120

Query: 185 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 244
            H + +++RD+K  NL+++  G +KITDFG+     S      TF GT  Y++PE +   
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 304
            YG   D W LG+V+ E   G+ P+   + +        L E I+ +          SPE
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-------RLFELILMEEIR--FPRTLSPE 231

Query: 305 FCSFISACVQKEPQQRLS-----AQELMTHPFLK 333
             S ++  ++K+P+QRL      A+E+M H F  
Sbjct: 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 3e-65
 Identities = 61/266 (22%), Positives = 112/266 (42%), Gaps = 19/266 (7%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 126
           LN++++  ++ +GKG  G V L  ++  G   A+K I+    ++  +    E  +    +
Sbjct: 4   LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK---NDATAQAFLAEASVMTQLR 58

Query: 127 CPYVVVCYQSFY-SNGAISIILEYMDGGSLADFL--KKVKTIPEEYLAAICEQVLKGLLY 183
              +V          G + I+ EYM  GSL D+L  +    +  + L      V + + Y
Sbjct: 59  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 118

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
           L    + +HRDL   N+L++     K++DFG++   +ST    +T      + +PE +  
Sbjct: 119 LEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALRE 174

Query: 244 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP 303
            K+  KSD+WS G++L E  +      P           +++  +       AP D   P
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRI------PLKDVVPRVEKGYKMDAP-DGCPP 227

Query: 304 EFCSFISACVQKEPQQRLSAQELMTH 329
                +  C   +   R S  +L   
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (527), Expect = 6e-65
 Identities = 72/267 (26%), Positives = 123/267 (46%), Gaps = 17/267 (6%)

Query: 76  KVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQ 135
           +V+G G  G V  + +K T + FALK++Q      ARR++    +    SQCP++V    
Sbjct: 18  QVLGLGINGKVLQIFNKRTQEKFALKMLQDC--PKARREVELHWRA---SQCPHIVRIVD 72

Query: 136 SFYS----NGAISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKH 189
            + +       + I++E +DGG L   ++    +   E   + I + + + + YLH   +
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-SIN 131

Query: 190 IIHRDLKPSNLLINHR---GEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 246
           I HRD+KP NLL   +     +K+TDFG  A   ++     T   T  Y++PE +   KY
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGF-AKETTSHNSLTTPCYTPYYVAPEVLGPEKY 190

Query: 247 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 306
               D+WSLG+++     G  P+               +  +     P+    + S E  
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-MGQYEFPNPEWSEVSEEVK 249

Query: 307 SFISACVQKEPQQRLSAQELMTHPFLK 333
             I   ++ EP QR++  E M HP++ 
Sbjct: 250 MLIRNLLKTEPTQRMTITEFMNHPWIM 276

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  204 bits (519), Expect = 6e-64
 Identities = 72/272 (26%), Positives = 128/272 (47%), Gaps = 20/272 (7%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQ 126
           L+D   ++ +G GS G V L++ +  G+++A+KV++    V          E  +     
Sbjct: 3   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 186
            P+++  + +F     I +I++Y++GG L   L+K +  P         +V   L YLH 
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH- 121

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 246
            K II+RDLKP N+L++  G +KITDFG +  +   +    T  GT +Y++PE +S   Y
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT---YTLCGTPDYIAPEVVSTKPY 178

Query: 247 GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFC 306
               D WS G+++ E   G  P+             +  E I++          F+ +  
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFYDSNTM-------KTYEKILNAELR--FPPFFNEDVK 229

Query: 307 SFISACVQKEPQQRL-----SAQELMTHPFLK 333
             +S  + ++  QRL       +++  HP+ K
Sbjct: 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 1e-63
 Identities = 74/281 (26%), Positives = 139/281 (49%), Gaps = 21/281 (7%)

Query: 65  NQLNLEDI-DTIKVVGKGSGGIVQLVQHKWTGQFFALKVI-----QMNVEESARRQIAQE 118
            Q N++D  DT + +G G   +V+  + K TG  +A K I     + +    +R  I +E
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63

Query: 119 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 178
           + I +  Q P V+  ++ + +   + +ILE + GG L DFL + +++ EE      +Q+L
Sbjct: 64  VSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQIL 123

Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGE----VKITDFGVSAIMASTSGQANTFVGTYN 234
            G+ Y  H   I H DLKP N+++  R      +KI DFG++  +   + +     GT  
Sbjct: 124 NGVYY-LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-EFKNIFGTPE 181

Query: 235 YMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAI--VDQP 292
           +++PE ++    G ++D+WS+G++     +G  P+    +Q       E +  +  V+  
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-------ETLANVSAVNYE 234

Query: 293 PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
                    S     FI   + K+P++R++ Q+ + HP++K
Sbjct: 235 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  201 bits (512), Expect = 2e-63
 Identities = 67/272 (24%), Positives = 127/272 (46%), Gaps = 19/272 (6%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVV 132
            +++G G    V L +     +  A+KV++ ++  + S   +  +E +   +   P +V 
Sbjct: 12  GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71

Query: 133 CYQSFYSNGAIS----IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEK 188
            Y +  +         I++EY+DG +L D +     +  +    +     + L + H + 
Sbjct: 72  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH-QN 130

Query: 189 HIIHRDLKPSNLLINHRGEVKITDFGVSAIMA---STSGQANTFVGTYNYMSPERISGGK 245
            IIHRD+KP+N++I+    VK+ DFG++  +A   ++  Q    +GT  Y+SPE+  G  
Sbjct: 131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190

Query: 246 YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV--DQPPPSAPSDQFSP 303
              +SD++SLG VL E  TG+ P++         S   +    V  D  PPSA  +  S 
Sbjct: 191 VDARSDVYSLGCVLYEVLTGEPPFT-------GDSPVSVAYQHVREDPIPPSARHEGLSA 243

Query: 304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
           +  + +   + K P+ R      M    ++++
Sbjct: 244 DLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 1e-61
 Identities = 63/285 (22%), Positives = 113/285 (39%), Gaps = 25/285 (8%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN----VEESARRQIAQELKINQSSQCPYV 130
           +  +G+G    V   + K T Q  A+K I++      ++   R   +E+K+ Q    P +
Sbjct: 3   LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62

Query: 131 VVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 190
           +    +F     IS++ ++M+             +   ++ A     L+GL YLH +  I
Sbjct: 63  IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-QHWI 121

Query: 191 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-YGYK 249
           +HRDLKP+NLL++  G +K+ DFG++    S +      V T  Y +PE + G + YG  
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVG 181

Query: 250 SDIWSLGLVLLECATGQFPYSPPEQQD---------------GWTSFYELMEAIVDQPPP 294
            D+W++G +L E              D                W     L + +  +  P
Sbjct: 182 VDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241

Query: 295 SAPSDQF----SPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY 335
             P          +    I       P  R++A + +   +    
Sbjct: 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 3e-61
 Identities = 58/280 (20%), Positives = 119/280 (42%), Gaps = 24/280 (8%)

Query: 65  NQLNLEDIDTIKVVGKGSGGIVQLVQH--KWTGQFFALKVIQMNV-EESARRQIAQELKI 121
             L LED    K +G G+ G V+   +  K   +  A+K+++    + + + ++  E  +
Sbjct: 6   KLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANV 61

Query: 122 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 181
            Q    PY+V          +  +++E  + G L  +L++ + + ++ +  +  QV  G+
Sbjct: 62  MQQLDNPYIVRMI-GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGM 120

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT---FVGTYNYMSP 238
            YL    + +HRDL   N+L+  +   KI+DFG+S  + +                + +P
Sbjct: 121 KYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 179

Query: 239 ERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 297
           E I+  K+  KSD+WS G+++ E  + GQ PY   +         E+   +        P
Sbjct: 180 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-------EVTAMLEKGERMGCP 232

Query: 298 SDQFSPEFCSFISACVQKEPQQRLSAQELMT---HPFLKM 334
           +     E    ++ C   + + R     +     + +  +
Sbjct: 233 AG-CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (496), Expect = 3e-61
 Identities = 64/266 (24%), Positives = 123/266 (46%), Gaps = 15/266 (5%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 126
           ++ +D+  +K +G G  G+V+  + +      A+K+I       +  +  +E K+  +  
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMI--KEGSMSEDEFIEEAKVMMNLS 57

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLH 185
              +V  Y        I II EYM  G L ++L+        + L  +C+ V + + YL 
Sbjct: 58  HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISGG 244
             K  +HRDL   N L+N +G VK++DFG+S  +      ++        +  PE +   
Sbjct: 118 S-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 245 KYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP 303
           K+  KSDIW+ G+++ E  + G+ PY      + +T+  E  E I        P    S 
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPY------ERFTN-SETAEHIAQGLRLYRPHL-ASE 228

Query: 304 EFCSFISACVQKEPQQRLSAQELMTH 329
           +  + + +C  ++  +R + + L+++
Sbjct: 229 KVYTIMYSCWHEKADERPTFKILLSN 254

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 3e-60
 Identities = 68/269 (25%), Positives = 117/269 (43%), Gaps = 28/269 (10%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-----EESARRQIAQELKINQ--SSQC 127
             ++G G  G V            A+K ++ +      E     ++  E+ + +  SS  
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGS-LADFLKKVKTIPEEYLAAICEQVLKGLLYLHH 186
             V+     F    +  +ILE  +    L DF+ +   + EE   +   QVL+ + + H 
Sbjct: 69  SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH- 127

Query: 187 EKHIIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK 245
              ++HRD+K  N+LI+ +RGE+K+ DFG  A++  T      F GT  Y  PE I   +
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHR 185

Query: 246 Y-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 304
           Y G  + +WSLG++L +   G  P+   E         E++   V          + S E
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDE---------EIIRGQVFFRQ------RVSSE 230

Query: 305 FCSFISACVQKEPQQRLSAQELMTHPFLK 333
               I  C+   P  R + +E+  HP+++
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 3e-60
 Identities = 69/280 (24%), Positives = 122/280 (43%), Gaps = 24/280 (8%)

Query: 65  NQLNLEDIDTIKVVGKGSGGIVQLVQHKWT--GQFFALKVIQMNVEESARRQIAQELKIN 122
           + L + DI     +G G+ G V+   ++        A+KV++   E++   ++ +E +I 
Sbjct: 8   DNLLIADI----ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 63

Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGL 181
                PY+V       +   + +++E   GG L  FL  K + IP   +A +  QV  G+
Sbjct: 64  HQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 122

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN---TFVGTYNYMSP 238
            YL   K+ +HRDL   N+L+ +R   KI+DFG+S  + +                + +P
Sbjct: 123 KYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAP 181

Query: 239 ERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP 297
           E I+  K+  +SD+WS G+ + E  + GQ PY             E+M  I        P
Sbjct: 182 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYK-------KMKGPEVMAFIEQGKRMECP 234

Query: 298 SDQFSPEFCSFISACVQKEPQQRLSAQEL---MTHPFLKM 334
            +   PE  + +S C   + + R     +   M   +  +
Sbjct: 235 PE-CPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  193 bits (492), Expect = 4e-60
 Identities = 64/276 (23%), Positives = 109/276 (39%), Gaps = 19/276 (6%)

Query: 64  DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELK 120
             ++++  +   +V+G G  G V     K  G+   F A+K ++    E  RR    E  
Sbjct: 20  AKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEAS 79

Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF-LKKVKTIPEEYLAAICEQVLK 179
           I      P V+        +  + II E+M+ GSL  F  +         L  +   +  
Sbjct: 80  IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139

Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-----FVGTYN 234
           G+ YL    + +HRDL   N+L+N     K++DFG+S  +   +                
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198

Query: 235 YMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPP 293
           + +PE I   K+   SD+WS G+V+ E  + G+ PY     Q       +++ AI     
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-------DVINAIEQDYR 251

Query: 294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
              P D         +  C QK+   R    +++  
Sbjct: 252 LPPPMD-CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  195 bits (495), Expect = 5e-60
 Identities = 78/280 (27%), Positives = 131/280 (46%), Gaps = 20/280 (7%)

Query: 61  KPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVI--QMNVEESARRQIAQE 118
            PS N   L+  D IK +G GS G V LV+HK +G  +A+K++  Q  V+         E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91

Query: 119 LKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVL 178
            +I Q+   P++V    SF  N  + +++EY+ GG +   L+++    E +      Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151

Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 238
               YLH    +I+RDLKP NLLI+ +G +++TDFG +  +    G+  T  GT   ++P
Sbjct: 152 LTFEYLH-SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV---KGRTWTLCGTPEALAP 207

Query: 239 ERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS 298
           E I    Y    D W+LG+++ E A G  P+   +         ++ E IV         
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-------QIYEKIVSGKVR--FP 258

Query: 299 DQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLK 333
             FS +    +   +Q +  +R         ++  H +  
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 1e-59
 Identities = 59/265 (22%), Positives = 108/265 (40%), Gaps = 13/265 (4%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 126
           ++  ++  ++ +G G  G+V L          A+K I       +     +E ++     
Sbjct: 2   IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTI--REGAMSEEDFIEEAEVMMKLS 58

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADF-LKKVKTIPEEYLAAICEQVLKGLLYLH 185
            P +V  Y        I ++ E+M+ G L+D+   +      E L  +C  V +G+ YL 
Sbjct: 59  HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 186 HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS-TSGQANTFVGTYNYMSPERISGG 244
            E  +IHRDL   N L+     +K++DFG++  +       +        + SPE  S  
Sbjct: 119 -EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177

Query: 245 KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE 304
           +Y  KSD+WS G+++ E  +               S  E++E I        P    S  
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIP------YENRSNSEVVEDISTGFRLYKPRL-ASTH 230

Query: 305 FCSFISACVQKEPQQRLSAQELMTH 329
               ++ C ++ P+ R +   L+  
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 1e-59
 Identities = 65/271 (23%), Positives = 116/271 (42%), Gaps = 17/271 (6%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 126
           +  E +  ++ +G G  G V +  +       A+K +       +      E  + +  Q
Sbjct: 10  VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQ 66

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIP--EEYLAAICEQVLKGLLYL 184
              +V  Y +  +   I II EYM+ GSL DFLK    I      L  +  Q+ +G+ ++
Sbjct: 67  HQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125

Query: 185 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISG 243
             E++ IHRDL+ +N+L++     KI DFG++ ++      A         + +PE I+ 
Sbjct: 126 E-ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 244 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP 303
           G +  KSD+WS G++L E  T      P        +  E+++ +        P D    
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGM------TNPEVIQNLERGYRMVRP-DNCPE 237

Query: 304 EFCSFISACVQKEPQQRLSAQEL--MTHPFL 332
           E    +  C ++ P+ R +   L  +   F 
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 4e-59
 Identities = 73/307 (23%), Positives = 123/307 (40%), Gaps = 31/307 (10%)

Query: 66  QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFF--ALKVIQMNVEESARRQIAQELKI-N 122
            L+  DI    V+G+G+ G V   + K  G     A+K ++    +   R  A EL++  
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65

Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK----------------VKTIP 166
           +    P ++    +    G + + +EY   G+L DFL+K                  T+ 
Sbjct: 66  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 167 EEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQA 226
            + L      V +G+ YL  +K  IHRDL   N+L+      KI DFG+S        + 
Sbjct: 126 SQQLLHFAADVARGMDYLS-QKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYVKK 183

Query: 227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELME 286
                   +M+ E ++   Y   SD+WS G++L E  +               +  EL E
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM------TCAELYE 237

Query: 287 AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH--PFLKMYGD-LNVDLS 343
            +        P +    E    +  C +++P +R S  +++      L+     +N  L 
Sbjct: 238 KLPQGYRLEKPLN-CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLY 296

Query: 344 EYFTDAG 350
           E FT AG
Sbjct: 297 EKFTYAG 303

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  189 bits (481), Expect = 1e-58
 Identities = 64/274 (23%), Positives = 108/274 (39%), Gaps = 13/274 (4%)

Query: 57  PPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIA 116
           P        ++   DI     +G G  G V     K      A+K ++ +  E    +  
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFL 61

Query: 117 QELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL--KKVKTIPEEYLAAIC 174
           +E  + +  + P +V             II E+M  G+L D+L     + +    L  + 
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121

Query: 175 EQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFV-GTY 233
            Q+   + YL  +K+ IHRDL   N L+     VK+ DFG+S +M   +  A+       
Sbjct: 122 TQISSAMEYLE-KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180

Query: 234 NYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP 293
            + +PE ++  K+  KSD+W+ G++L E AT      P           ++ E +     
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKDYR 234

Query: 294 PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
              P      +    + AC Q  P  R S  E+ 
Sbjct: 235 MERPEG-CPEKVYELMRACWQWNPSDRPSFAEIH 267

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 2e-58
 Identities = 71/288 (24%), Positives = 125/288 (43%), Gaps = 24/288 (8%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQC 127
           +E+   ++ +G+G+ G+V   ++K TG+  ALK I+++ E E       +E+ + +    
Sbjct: 1   MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKT-IPEEYLAAICEQVLKGLLYLHH 186
           P +V      ++   + ++ E++             T IP   + +   Q+L+GL + H 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119

Query: 187 EKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKY 246
              ++HRDLKP NLLIN  G +K+ DFG++             V T  Y +PE + G KY
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 247 -GYKSDIWSLGLVLLECATGQFPYSPPEQQD---------------GWTSFYELMEAIVD 290
                DIWSLG +  E  T +  +    + D                W     + +    
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 291 QP-----PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
            P       S        +  S +S  +  +P +R+SA+  + HPF +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 2e-58
 Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 40/295 (13%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF-----FALKVIQMNVEESARRQIAQELKI 121
              E+++  KV+G G+ G V         +       A+K+++   + S R  +  ELK+
Sbjct: 34  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 93

Query: 122 -NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKK------------------- 161
             Q      +V    +   +G I +I EY   G L ++L+                    
Sbjct: 94  MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 162 ----VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA 217
               +  +  E L     QV KG+ +L   K  +HRDL   N+L+ H   VKI DFG++ 
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLE-FKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212

Query: 218 IMASTSGQA--NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQ 274
            + S S             +M+PE +  G Y  KSD+WS G++L E  + G  PY     
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272

Query: 275 QDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
                        ++            + E    + +C   + ++R S   L + 
Sbjct: 273 D-------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 4e-58
 Identities = 77/284 (27%), Positives = 142/284 (50%), Gaps = 21/284 (7%)

Query: 65  NQLNLEDIDTIKVVGKGSGGIVQLVQH---KWTGQFFALKVI---QMNVEESARRQIAQE 118
            ++ +E+ + +KV+G G+ G V LV+      TG+ +A+KV+    +  +         E
Sbjct: 19  EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 78

Query: 119 LKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQV 177
            ++     Q P++V  + +F +   + +IL+Y++GG L   L + +   E  +     ++
Sbjct: 79  RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 138

Query: 178 LKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ-ANTFVGTYNYM 236
           +  L +  H+  II+RD+K  N+L++  G V +TDFG+S    +   + A  F GT  YM
Sbjct: 139 VLALEH-LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 237 SPERISGGKYGY--KSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP 294
           +P+ + GG  G+    D WSLG+++ E  TG  P++   +++   S  E+   I+   PP
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSEPP 254

Query: 295 SAPSDQFSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLK 333
                + S      I   + K+P++RL      A E+  H F +
Sbjct: 255 --YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  188 bits (478), Expect = 4e-58
 Identities = 59/289 (20%), Positives = 103/289 (35%), Gaps = 39/289 (13%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQS 124
            +I+ ++ +G+G+ G V   +             A+K+++       +    +E  +   
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 125 SQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKV---------------------- 162
              P +V           + ++ EYM  G L +FL+ +                      
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 163 --KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA 220
               +       I  QV  G+ YL   K  +HRDL   N L+     VKI DFG+S  + 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERK-FVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 221 STSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGW 278
           S               +M PE I   +Y  +SD+W+ G+VL E  +           +  
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE-- 249

Query: 279 TSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
               E++  + D    + P +    E  + +  C  K P  R S   + 
Sbjct: 250 ----EVIYYVRDGNILACP-ENCPLELYNLMRLCWSKLPADRPSFCSIH 293

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 6e-58
 Identities = 66/292 (22%), Positives = 131/292 (44%), Gaps = 24/292 (8%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQC 127
           ++  + ++ +G+G+ G V   +++ T +  ALK +++ + +E       +E+ + +  + 
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 187
             +V  +   +S+  ++++ E+ D      F      +  E + +   Q+LKGL + H  
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS- 119

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGK-Y 246
           ++++HRDLKP NLLIN  GE+K+ +FG++          +  V T  Y  P+ + G K Y
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 247 GYKSDIWSLGLVLLECATGQFPYSPPE----------------QQDGWTSFYELMEAIVD 290
               D+WS G +  E A    P  P                   ++ W S  +L +    
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 291 QPPPSAPS-----DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
              P+  S      + +      +   ++  P QR+SA+E + HP+   +  
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 6e-58
 Identities = 63/270 (23%), Positives = 108/270 (40%), Gaps = 16/270 (5%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKV----IQMNVEESARRQIAQELKIN 122
           L   +   IKV+G G+ G V        G+   + V    ++      A ++I  E  + 
Sbjct: 6   LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65

Query: 123 QSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLL 182
            S   P+V        ++    I      G  L    +    I  +YL   C Q+ KG+ 
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 125

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT--FVGTYNYMSPER 240
           YL   + ++HRDL   N+L+     VKITDFG++ ++ +   + +         +M+ E 
Sbjct: 126 YLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 241 ISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD 299
           I    Y ++SD+WS G+ + E  T G  PY      DG  +  E+   +        P  
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPY------DGIPA-SEISSILEKGERLPQPPI 237

Query: 300 QFSPEFCSFISACVQKEPQQRLSAQELMTH 329
             + +    +  C   +   R   +EL+  
Sbjct: 238 -CTIDVYMIMVKCWMIDADSRPKFRELIIE 266

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 1e-57
 Identities = 60/272 (22%), Positives = 112/272 (41%), Gaps = 17/272 (6%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ 126
           +  E +     +G+G  G V +     T +  A+K +       +     QE ++ +  +
Sbjct: 14  IPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTL--KPGTMSPEAFLQEAQVMKKLR 70

Query: 127 CPYVVVCYQSFYSNGAISIILEYMDGGSLADF--LKKVKTIPEEYLAAICEQVLKGLLYL 184
              +V  Y +  S   I I+ EYM  GSL DF   +  K +    L  +  Q+  G+ Y+
Sbjct: 71  HEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 185 HHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT-FVGTYNYMSPERISG 243
               + +HRDL+ +N+L+      K+ DFG++ ++      A         + +PE    
Sbjct: 130 ER-MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 188

Query: 244 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP 303
           G++  KSD+WS G++L E  T      P           E+++ +        P +    
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGM------VNREVLDQVERGYRMPCPPE-CPE 241

Query: 304 EFCSFISACVQKEPQQRLSAQEL--MTHPFLK 333
                +  C +KEP++R + + L      +  
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  187 bits (474), Expect = 1e-57
 Identities = 68/287 (23%), Positives = 125/287 (43%), Gaps = 24/287 (8%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQC 127
           +E    ++ +G+G+ G+V   Q+   G+ FALK I++  E E       +E+ I +  + 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59

Query: 128 PYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 187
             +V  Y   ++   + ++ E++D             +      +   Q+L G+ Y H +
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH-D 118

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG-GKY 246
           + ++HRDLKP NLLIN  GE+KI DFG++        +    + T  Y +P+ + G  KY
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 247 GYKSDIWSLGLVLLECATGQFPYSPPEQQD---------------GWTSFYELMEAIVDQ 291
               DIWS+G +  E   G   +    + D                W +  EL +   + 
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 292 P-----PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
                 P  +            +S  ++ +P QR++A++ + H + K
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 3e-57
 Identities = 63/271 (23%), Positives = 105/271 (38%), Gaps = 16/271 (5%)

Query: 65  NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ----FFALKVIQMNVEESARRQIAQELK 120
            +++   +   KV+G G  G V     K +        A+K ++    E  R     E  
Sbjct: 2   TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 61

Query: 121 INQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADF-LKKVKTIPEEYLAAICEQVLK 179
           I        ++           + II EYM+ G+L  F  +K        L  +   +  
Sbjct: 62  IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121

Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF---VGTYNYM 236
           G+ Y     + +HRDL   N+L+N     K++DFG+S ++        T         + 
Sbjct: 122 GMKY-LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 237 SPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA 296
           +PE IS  K+   SD+WS G+V+ E  T               S +E+M+AI D      
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERP------YWELSNHEVMKAINDGFRLPT 234

Query: 297 PSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
           P D         +  C Q+E  +R    +++
Sbjct: 235 PMD-CPSAIYQLMMQCWQQERARRPKFADIV 264

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 8e-57
 Identities = 66/302 (21%), Positives = 117/302 (38%), Gaps = 38/302 (12%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQM-NVEESARRQIAQELKINQSSQC 127
           +   + +  +G+G+ G V   +H+ TGQ  ALK + M N +E       +E+KI Q  + 
Sbjct: 9   VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68

Query: 128 PYVVVCYQSFYS--------NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLK 179
             VV   +   +         G+I ++ ++ +          +       +  + + +L 
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 180 GLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM----ASTSGQANTFVGTYNY 235
           GL Y+H    I+HRD+K +N+LI   G +K+ DFG++        S   +    V T  Y
Sbjct: 129 GLYYIH-RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 236 MSPERISGGK-YGYKSDIWSLGLVLLECATGQFPY-----------------SPPEQQDG 277
             PE + G + YG   D+W  G ++ E  T                      S   +   
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247

Query: 278 WTSFYELMEAIV------DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPF 331
               YEL E +        +      +    P     I   +  +P QR+ + + + H F
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307

Query: 332 LK 333
             
Sbjct: 308 FW 309

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-56
 Identities = 62/293 (21%), Positives = 118/293 (40%), Gaps = 31/293 (10%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQH-KWTGQFFALKVIQM-NVEESARRQIAQELKINQ---S 124
           +  + +  +G+G+ G V   +  K  G+F ALK +++   EE       +E+ + +   +
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 125 SQCPYVVVCYQSFYS-----NGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVL 178
            + P VV  +             ++++ E++D        K     +P E +  +  Q+L
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 179 KGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSP 238
           +GL +LH    ++HRDLKP N+L+   G++K+ DFG++ I  S      + V T  Y +P
Sbjct: 127 RGLDFLH-SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAP 184

Query: 239 ERISGGKYGYKSDIWSLGLVLLECATGQFPYS------------------PPEQQDGWTS 280
           E +    Y    D+WS+G +  E    +  +                     E      +
Sbjct: 185 EVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 244

Query: 281 FYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLK 333
                       P               +  C+   P +R+SA   ++HP+ +
Sbjct: 245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 4e-56
 Identities = 60/293 (20%), Positives = 121/293 (41%), Gaps = 32/293 (10%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVV--- 131
           +  +G+G+ G+V            A+K I     ++  ++  +E+KI    +   ++   
Sbjct: 13  LSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIN 72

Query: 132 -VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHI 190
            +             ++ ++ G  L   LK  + +  +++     Q+L+GL Y+ H  ++
Sbjct: 73  DIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYI-HSANV 130

Query: 191 IHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMSPERISGG-KY 246
           +HRDLKPSNLL+N   ++KI DFG++ +             +V T  Y +PE +     Y
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190

Query: 247 GYKSDIWSLGLVLLECATGQFPY-----------------SPPEQQDGWTSFYELMEAIV 289
               DIWS+G +L E  + +  +                 SP ++        +    ++
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250

Query: 290 DQP-----PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
             P     P +        +    +   +   P +R+  ++ + HP+L+ Y D
Sbjct: 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  183 bits (464), Expect = 5e-56
 Identities = 53/275 (19%), Positives = 104/275 (37%), Gaps = 19/275 (6%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 134
            + +G GS G + L      G+  A+K+  +   ++   Q+  E KI +  Q    +   
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECV---KTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 135 QSFYSNG-AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHR 193
           +   + G    +++E +       F    +    + +  + +Q++  + Y+H  K+ IHR
Sbjct: 69  RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH-SKNFIHR 127

Query: 194 DLKPSNLLINHRG---EVKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERISG 243
           D+KP N L+        V I DFG++               +     GT  Y S     G
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187

Query: 244 GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP 303
            +   + D+ SLG VL+    G  P+   +       +  + E  +  P        +  
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG-YPS 246

Query: 304 EFCSFISACVQKEPQQRLSAQ---ELMTHPFLKMY 335
           EF ++++ C       +       +L  + F +  
Sbjct: 247 EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 2e-55
 Identities = 60/268 (22%), Positives = 106/268 (39%), Gaps = 14/268 (5%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHK---WTGQFFALKVIQMNVEESARRQIAQELKINQ 123
           +  E I+  + +G+G  G V    +          A+K  +    +S R +  QE    +
Sbjct: 4   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR 63

Query: 124 SSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKGLL 182
               P++V       +   + II+E    G L  FL  +  ++    L     Q+   L 
Sbjct: 64  QFDHPHIVKLI-GVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 122

Query: 183 YLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM-ASTSGQANTFVGTYNYMSPERI 241
           YL   K  +HRD+   N+L++    VK+ DFG+S  M  ST  +A+       +M+PE I
Sbjct: 123 YLE-SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 181

Query: 242 SGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQF 301
           +  ++   SD+W  G+ + E                     +++  I +      P +  
Sbjct: 182 NFRRFTSASDVWMFGVCMWEILMHGVKPFQ------GVKNNDVIGRIENGERLPMPPN-C 234

Query: 302 SPEFCSFISACVQKEPQQRLSAQELMTH 329
            P   S ++ C   +P +R    EL   
Sbjct: 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 4e-55
 Identities = 59/271 (21%), Positives = 106/271 (39%), Gaps = 19/271 (7%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNV--EESARRQIAQELKI 121
           +  +D+  ++ +G GS G+V+  +           A+K ++ +V  +  A     +E+  
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 122 NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFL-KKVKTIPEEYLAAICEQVLKG 180
             S     ++  Y        + ++ E    GSL D L K         L+    QV +G
Sbjct: 65  MHSLDHRNLIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ---ANTFVGTYNYMS 237
           + YL   K  IHRDL   NLL+  R  VKI DFG+   +                + + +
Sbjct: 124 MGYLE-SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182

Query: 238 PERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA 296
           PE +    + + SD W  G+ L E  T GQ P+          +  +++  I  +     
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI-------GLNGSQILHKIDKEGERLP 235

Query: 297 PSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
             +    +  + +  C   +P+ R +   L 
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 4e-55
 Identities = 61/295 (20%), Positives = 111/295 (37%), Gaps = 33/295 (11%)

Query: 59  LIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQ-----HKWTGQFFALKVIQMNVEESARR 113
           L      +     +   K +G G+ G V                 A+K+++ +   + R 
Sbjct: 12  LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE 71

Query: 114 QIAQELKI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK--------- 163
            +  ELK+ +       +V    +    G   +I EY   G L +FL++ +         
Sbjct: 72  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131

Query: 164 ---------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG 214
                     +  E L +   QV KG+ +L   K+ IHRDL   N+L+ H    KI DFG
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARNILLTHGRITKICDFG 190

Query: 215 VSAIMASTSGQANT--FVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPP 272
           ++  + + S             +M+PE I    Y ++SD+WS G+ L E  +      P 
Sbjct: 191 LARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250

Query: 273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
              D           ++ +       +    E    +  C   +P +R + ++++
Sbjct: 251 MPVD------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (456), Expect = 9e-55
 Identities = 63/317 (19%), Positives = 120/317 (37%), Gaps = 38/317 (11%)

Query: 55  EAPPLIKPSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEE 109
            A  +  P + ++  E I   + +G+GS G+V     K           A+K +      
Sbjct: 5   SAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM 64

Query: 110 SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVK------ 163
             R +   E  + +   C +VV             +I+E M  G L  +L+ ++      
Sbjct: 65  RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN 124

Query: 164 ----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM 219
                     +  +  ++  G+ YL+     +HRDL   N ++     VKI DFG++  +
Sbjct: 125 PVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 183

Query: 220 --ASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG 277
                  +    +    +MSPE +  G +   SD+WS G+VL E AT           + 
Sbjct: 184 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE- 242

Query: 278 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT------HPF 331
                +++  +++      P D         +  C Q  P+ R S  E+++       P 
Sbjct: 243 -----QVLRFVMEGGLLDKP-DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296

Query: 332 LKMYGDLNVDLSEYFTD 348
            +       ++S Y+++
Sbjct: 297 FR-------EVSFYYSE 306

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 4e-54
 Identities = 74/316 (23%), Positives = 118/316 (37%), Gaps = 41/316 (12%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 134
            KV+G GS G+V   +   +G+  A+K +  +     +R   +EL+I +      +V   
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLR 79

Query: 135 QSFYSNGA------ISIILEYMDGGSLA---DFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
             FYS+G       ++++L+Y+          + +  +T+P  Y+     Q+ + L Y+H
Sbjct: 80  YFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH 139

Query: 186 HEKHIIHRDLKPSNLLINHRGEV-KITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG 244
               I HRD+KP NLL++    V K+ DFG +  +       +     Y           
Sbjct: 140 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198

Query: 245 KYGYKSDIWSLGLVLLECATGQFPYS------------------PPEQQDGWTSFYELME 286
            Y    D+WS G VL E   GQ  +                     EQ       Y   +
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258

Query: 287 --AIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE 344
              I   P       +  PE  +  S  ++  P  RL+  E   H F     D NV L  
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPN 318

Query: 345 YFTDAGSPLATLSNLS 360
                G     L N +
Sbjct: 319 -----GRDTPALFNFT 329

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 6e-54
 Identities = 63/288 (21%), Positives = 120/288 (41%), Gaps = 36/288 (12%)

Query: 67  LNLEDIDTIKVVGKGSGGIVQLVQHKWT-------GQFFALKVIQMNVEESARRQIAQEL 119
           L  + +   K +G+G+ G V L +               A+K+++ +  E     +  E+
Sbjct: 10  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 69

Query: 120 KI-NQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLK----------------KV 162
           ++     +   ++    +   +G + +I+EY   G+L ++L+                  
Sbjct: 70  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 163 KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST 222
           + +  + L +   QV +G+ YL   K  IHRDL   N+L+     +KI DFG++  +   
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 223 SGQANTFV--GTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWT 279
                T        +M+PE +    Y ++SD+WS G++L E  T G  PY          
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP-------GV 241

Query: 280 SFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
              EL + + +      PS+  + E    +  C    P QR + ++L+
Sbjct: 242 PVEELFKLLKEGHRMDKPSN-CTNELYMMMRDCWHAVPSQRPTFKQLV 288

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 2e-53
 Identities = 70/293 (23%), Positives = 119/293 (40%), Gaps = 32/293 (10%)

Query: 62  PSDNQLNLEDIDTIKVVGKGSGGIV-----QLVQHKWTGQFFALKVIQMNVEESARRQIA 116
            S  +   + +   K +G+G+ G V       +    T +  A+K+++     S  R + 
Sbjct: 5   ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 64

Query: 117 QELKINQSSQCPYVVVCYQSFY--SNGAISIILEYMDGGSLADFLKKVK----------- 163
            ELKI         VV          G + +I+E+   G+L+ +L+  +           
Sbjct: 65  SELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124

Query: 164 -----TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAI 218
                 +  E+L     QV KG+ +L   +  IHRDL   N+L++ +  VKI DFG++  
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNILLSEKNVVKICDFGLARD 183

Query: 219 MAS--TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD 276
           +       +         +M+PE I    Y  +SD+WS G++L E  +      P  + D
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243

Query: 277 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
                      + +     AP D  +PE    +  C   EP QR +  EL+ H
Sbjct: 244 EE-----FCRRLKEGTRMRAP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 2e-53
 Identities = 65/292 (22%), Positives = 109/292 (37%), Gaps = 39/292 (13%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY 129
             I   + +GKG  G V     KW G+  A+K+     E S  R+   E+      +   
Sbjct: 3   RTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSSREERSWFREA--EIYQTVMLRHEN 58

Query: 130 VV----VCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH 185
           ++       +   +   + ++ +Y + GSL D+L +  T+  E +  +      GL +LH
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLH 117

Query: 186 -------HEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS----TSGQANTFVGTYN 234
                   +  I HRDLK  N+L+   G   I D G++    S         N  VGT  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 235 YMSPERISG------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQD--------GWTS 280
           YM+PE +         +   ++DI+++GLV  E A         E              S
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 281 FYELMEAIVDQ-----PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM 327
             E+ + + +Q      P    S +        +  C       RL+A  + 
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  176 bits (446), Expect = 2e-53
 Identities = 51/284 (17%), Positives = 97/284 (34%), Gaps = 17/284 (5%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCY 134
            + +G+GS G++    +    Q  A+K      +    R   +  K+   + C  +   Y
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKL--LAGCTGIPNVY 67

Query: 135 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD 194
                     ++++ +            +    + +A   +Q+L  +  +H EK +++RD
Sbjct: 68  YFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH-EKSLVYRD 126

Query: 195 LKPSNLLIN-----HRGEVKITDFGVSAIMASTSG-------QANTFVGTYNYMSPERIS 242
           +KP N LI      +   + + DFG+                +     GT  YMS     
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186

Query: 243 GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFS 302
           G +   + D+ +LG V +    G  P+   +       +  + E     P     +  F 
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG-FP 245

Query: 303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYF 346
            EF  ++                L    F K+   LN    E F
Sbjct: 246 EEFYKYMHYARNLAFDATPDYDYLQGL-FSKVLERLNTTEDENF 288

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 7e-52
 Identities = 62/280 (22%), Positives = 109/280 (38%), Gaps = 22/280 (7%)

Query: 59  LIKPSDNQLNLEDIDTIKVVGKGSGGIV---QLVQHKWTGQFFALKVIQMNVEESARRQI 115
           +I PS   ++       +V+G+G  G V    L+ +       A+K +    +     Q 
Sbjct: 21  VIGPSSLIVHFN-----EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF 75

Query: 116 AQELKINQSSQCPYVVVCYQSFY-SNGAISIILEYMDGGSLADFLKKVKTIPEEY-LAAI 173
             E  I +    P V+        S G+  ++L YM  G L +F++     P    L   
Sbjct: 76  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 135

Query: 174 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF---- 229
             QV KG+      K  +HRDL   N +++ +  VK+ DFG++  M      +       
Sbjct: 136 GLQVAKGM-KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194

Query: 230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIV 289
                +M+ E +   K+  KSD+WS G++L E  T   P  P        + +++   ++
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV------NTFDITVYLL 248

Query: 290 DQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH 329
                  P           +  C   + + R S  EL++ 
Sbjct: 249 QGRRLLQPEY-CPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  171 bits (434), Expect = 3e-51
 Identities = 59/325 (18%), Positives = 129/325 (39%), Gaps = 47/325 (14%)

Query: 47  RIVSQTETEAPPLIKPSDNQL----NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKV 102
           R+ +   T  P      ++ +    N +D   ++ +G+G    V    +    +   +K+
Sbjct: 8   RVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI 67

Query: 103 IQMNVEESARRQIAQELKINQS-SQCPYVVVCYQSFYS--NGAISIILEYMDGGSLADFL 159
           ++       +++I +E+KI ++    P ++          +   +++ E+++        
Sbjct: 68  LK----PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 123

Query: 160 KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAI 218
           +    + +  +     ++LK L Y H    I+HRD+KP N++I+H   ++++ D+G++  
Sbjct: 124 QT---LTDYDIRFYMYEILKALDYCH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179

Query: 219 MASTSGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSP------ 271
                 + N  V +  +  PE +   + Y Y  D+WSLG +L      + P+        
Sbjct: 180 YHPGQ-EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 238

Query: 272 ----------PEQQDGWTSFYELMEAI-------------VDQPPPSAPSDQFSPEFCSF 308
                      E    +   Y +                  ++   S      SPE   F
Sbjct: 239 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDF 298

Query: 309 ISACVQKEPQQRLSAQELMTHPFLK 333
           +   ++ + Q RL+A+E M HP+  
Sbjct: 299 LDKLLRYDHQSRLTAREAMEHPYFY 323

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 2e-50
 Identities = 71/293 (24%), Positives = 127/293 (43%), Gaps = 36/293 (12%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVC 133
           ++ VG G+ G V       TG   A+K +    + E   ++  +EL++ +  +   V+  
Sbjct: 23  LQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGL 82

Query: 134 YQSFYSNGAIS------IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHE 187
              F  +  +       +++ +M  G+    L K + + E+ +  +  Q+LKGL Y+H  
Sbjct: 83  LDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH-A 139

Query: 188 KHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGG-KY 246
             IIHRDLKP NL +N   E+KI DFG++        +   +V T  Y +PE I    +Y
Sbjct: 140 AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVVTRWYRAPEVILNWMRY 196

Query: 247 GYKSDIWSLGLVLLECATGQFPY-----------------SPPEQQDGWTSFYELMEAIV 289
               DIWS+G ++ E  TG+  +                 +PP +        E    + 
Sbjct: 197 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 256

Query: 290 DQP-----PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD 337
             P       ++     SP   + +   +  + +QR++A E + HP+ +   D
Sbjct: 257 GLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 2e-49
 Identities = 62/309 (20%), Positives = 121/309 (39%), Gaps = 45/309 (14%)

Query: 69  LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQC 127
           L+    +K +G G+ GIV         +  A+K +    + ++  ++  +EL + +    
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75

Query: 128 PYVVVCYQSFYSNGA------ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGL 181
             ++     F           + +++E MD         +   +  E ++ +  Q+L G+
Sbjct: 76  KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 132

Query: 182 LYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERI 241
            +LH    IIHRDLKPSN+++     +KI DFG++     TS     +V T  Y +PE I
Sbjct: 133 KHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYVVTRYYRAPEVI 190

Query: 242 SGGKYGYKSDIWSLGLVLLECATGQFPY-------------------SPPEQQDGWTSFY 282
            G  Y    DIWS+G ++ E    +  +                    P   +    +  
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250

Query: 283 ELMEAIVDQPPPSAPS--------------DQFSPEFCSFISACVQKEPQQRLSAQELMT 328
             +E        + P                  + +    +S  +  +P +R+S  + + 
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

Query: 329 HPFLKMYGD 337
           HP++ ++ D
Sbjct: 311 HPYINVWYD 319

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 6e-46
 Identities = 64/299 (21%), Positives = 122/299 (40%), Gaps = 34/299 (11%)

Query: 70  EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCP 128
           E    +  VG G+ G V       TG   A+K +    +     ++  +EL++ +  +  
Sbjct: 18  ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77

Query: 129 YVVVCYQSFYSNGAIS-----IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLY 183
            V+     F    ++       ++ ++ G  L + +K  + + ++++  +  Q+L+GL Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 136

Query: 184 LHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISG 243
           +H    IIHRDLKPSNL +N   E+KI DFG++        +   +V T  Y +PE +  
Sbjct: 137 IH-SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLN 192

Query: 244 GK-YGYKSDIWSLGLVLLECATGQFPY-----------------SPPEQQDGWTSFYELM 285
              Y    DIWS+G ++ E  TG+  +                 +P  +     S     
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252

Query: 286 EAIVDQP-----PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLN 339
             I           +      +P     +   +  +  +R++A + + H +   Y D +
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  150 bits (380), Expect = 5e-43
 Identities = 71/318 (22%), Positives = 122/318 (38%), Gaps = 62/318 (19%)

Query: 75  IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQ-------SS 125
           ++ +G G    V L +        A+K+++ +    E+A  +I    ++N        S 
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 126 QCPYVVVCYQSFY---SNGAISIILEYMDGGSLADFLKKVK--TIPEEYLAAICEQVLKG 180
              +++     F     NG   +++  + G +L   +KK +   IP  Y+  I +Q+L G
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 181 LLYLHHEKHIIHRDLKPSNLLINHRG------EVKITDFGVSAIMASTSGQANTFVGTYN 234
           L Y+H    IIH D+KP N+L+          ++KI D G +             + T  
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC---WYDEHYTNSIQTRE 194

Query: 235 YMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP 294
           Y SPE + G  +G  +DIWS   ++ E  TG F + P E          + + I      
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 254

Query: 295 SAP---------------------------------------SDQFSPEFCSFISACVQK 315
            +                                        S   + E   F+S  +Q 
Sbjct: 255 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 314

Query: 316 EPQQRLSAQELMTHPFLK 333
           +P++R  A  L+ HP+LK
Sbjct: 315 DPRKRADAGGLVNHPWLK 332

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.8 bits (214), Expect = 8e-21
 Identities = 36/211 (17%), Positives = 71/211 (33%), Gaps = 41/211 (19%)

Query: 72  IDTI-KVVGKGSGGIVQLVQHKWTGQFFALKVI-----------------QMNVEESARR 113
           +D I K++G+G    V     +       +K                    ++    A R
Sbjct: 1   VDAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIR 59

Query: 114 QIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAI 173
               E +  Q  Q   V   Y    +    ++++E +D         ++  +  E    +
Sbjct: 60  SARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAK-------ELYRVRVENPDEV 108

Query: 174 CEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTFVGTY 233
            + +L+ +   +H + I+H DL   N+L++  G + I DF  S  +     +        
Sbjct: 109 LDMILEEVAKFYH-RGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWR------EI 160

Query: 234 NYMSPERIS---GGKYGYKSDIWSLGLVLLE 261
                  I       Y  + DI S    +L+
Sbjct: 161 LERDVRNIITYFSRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	362
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.57
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.12
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.97
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.2
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.94
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.91

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-65  Score=469.43  Aligned_cols=282  Identities=44%  Similarity=0.801  Sum_probs=244.0

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ++..++|++++.||+|+||+||+|++..+|+.||+|+++..........+.+|+.+++.++||||++++++|.+.+.+|+
T Consensus         2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45668999999999999999999999999999999999877666677889999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      ||||++||+|.+++.+.+.+++..++.++.|++.||.|||+.+||+||||||+|||++.++++||+|||+|+.....  .
T Consensus        82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~  159 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--M  159 (322)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--T
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--c
Confidence            99999999999999998999999999999999999999997348999999999999999999999999999876432  3


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCc----------------------------
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDG----------------------------  277 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~----------------------------  277 (362)
                      ..+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+....                            
T Consensus       160 ~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (322)
T d1s9ja_         160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS  239 (322)
T ss_dssp             C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------
T ss_pred             cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccc
Confidence            4567999999999999999999999999999999999999999976543210                            


Q ss_pred             -------hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHHHHHHh
Q 018018          278 -------WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSEYFTDA  349 (362)
Q Consensus       278 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~~~~~~  349 (362)
                             .....+.........++......+++++.+||.+||+.||++|||++|+++||||+..+...+++..+++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~d~~~~~~~~  318 (322)
T d1s9ja_         240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCST  318 (322)
T ss_dssp             ------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCCCHHHHHHHH
T ss_pred             cccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcccccHHHHHHHH
Confidence                   011122333334444444444567899999999999999999999999999999999999999999987643

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-64  Score=453.86  Aligned_cols=260  Identities=26%  Similarity=0.461  Sum_probs=223.8

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++..........+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            47899999999999999999999999999999999876555556778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC--CCC
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--GQA  226 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~--~~~  226 (362)
                      |+++|+|.+++.....+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+......  ...
T Consensus        84 y~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~-~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          84 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG-IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             ccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence            99999999999888899999999999999999999998 999999999999999999999999999998764332  234


Q ss_pred             CccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          227 NTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      ...+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.......      ..................+++++
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~s~~~  236 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC------QEYSDWKEKKTYLNPWKKIDSAP  236 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS------HHHHHHHTTCTTSTTGGGSCHHH
T ss_pred             cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH------HHHHHHhcCCCCCCccccCCHHH
Confidence            55789999999999998876 578999999999999999999997654322      22223333333344456789999


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          306 CSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      .+||.+||+.||++|||++|+++||||+..
T Consensus       237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         237 LALLHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence            999999999999999999999999999754

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-63  Score=448.01  Aligned_cols=257  Identities=31%  Similarity=0.479  Sum_probs=228.6

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      ++.+++|++++.||+|+||+||+|+++.+|+.||+|++....  +......+.+|+++++.++||||+++++++.+++.+
T Consensus         2 ~~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~   81 (263)
T d2j4za1           2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV   81 (263)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CcchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEE
Confidence            345789999999999999999999999999999999987542  233456788999999999999999999999999999


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      |+||||+++|+|.+++.....+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+....  
T Consensus        82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~-~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--  158 (263)
T d2j4za1          82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS-KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--  158 (263)
T ss_dssp             EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC--
T ss_pred             EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH-CCeeeeeeccccceecCCCCEeecccceeeecCC--
Confidence            9999999999999999998999999999999999999999998 9999999999999999999999999999986543  


Q ss_pred             CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          224 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                      ......+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.       .+....+.....  ..+..+++
T Consensus       159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~--~~p~~~s~  229 (263)
T d2j4za1         159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-------QETYKRISRVEF--TFPDFVTE  229 (263)
T ss_dssp             CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHTTCC--CCCTTSCH
T ss_pred             CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-------HHHHHHHHcCCC--CCCccCCH
Confidence            234556899999999999999999999999999999999999999976432       344455544443  23467899


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      ++.+||.+||+.||++|||++|+++||||+.
T Consensus       230 ~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         230 GARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            9999999999999999999999999999974

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-63  Score=450.61  Aligned_cols=258  Identities=30%  Similarity=0.571  Sum_probs=227.3

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      ++|++++.||+|+||+||+|++..+|+.||||+++..... ..+.+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            5799999999999999999999999999999999765332 346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      |+||+|.+++.. ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+............
T Consensus        99 ~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~  176 (293)
T d1yhwa1          99 LAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHS-NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (293)
T ss_dssp             CTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred             cCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence            999999998876 579999999999999999999998 999999999999999999999999999998876555556677


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFI  309 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  309 (362)
                      +||+.|+|||++.+..|+.++||||+||++|+|++|..||.+.+..      ..+........+....+..+++++.+||
T Consensus       177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~~~~~~~~~s~~~~~li  250 (293)
T d1yhwa1         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTPELQNPEKLSAIFRDFL  250 (293)
T ss_dssp             CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSCCCSSGGGSCHHHHHHH
T ss_pred             ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCCCCCCcccCCHHHHHHH
Confidence            8999999999999999999999999999999999999999764321      1222223333333444567899999999


Q ss_pred             HHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          310 SACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       310 ~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      .+||+.||++|||++|+++||||+...
T Consensus       251 ~~~L~~dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         251 NRCLDMDVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             HHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHccCChhHCcCHHHHhcCHhhCCCC
Confidence            999999999999999999999998654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-62  Score=445.31  Aligned_cols=263  Identities=28%  Similarity=0.498  Sum_probs=228.7

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      ..++|++++.||+|+||+||+|+++.+|+.||||+++...  ++.....+.+|+++++.++||||+++++++.+++.+|+
T Consensus         6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred             CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence            4478999999999999999999999999999999997542  23345678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC--
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS--  223 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~--  223 (362)
                      ||||++||+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+......  
T Consensus        86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG-KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcc-ccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            99999999999999999999999999999999999999998 999999999999999999999999999998765332  


Q ss_pred             CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          224 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                      ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.       .++...+.....  ..+..+++
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~--~~p~~~s~  235 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-------YLIFQKIIKLEY--DFPEKFFP  235 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHTTCC--CCCTTCCH
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-------HHHHHHHHcCCC--CCCccCCH
Confidence            234456899999999999999999999999999999999999999986432       344555555443  23467899


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHH------HHcCCcccccCCCCC
Q 018018          304 EFCSFISACVQKEPQQRLSAQE------LMTHPFLKMYGDLNV  340 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~e------il~hp~~~~~~~~~~  340 (362)
                      ++.+||.+||+.||++|||++|      +++||||+...+..+
T Consensus       236 ~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l  278 (288)
T d1uu3a_         236 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  278 (288)
T ss_dssp             HHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHh
Confidence            9999999999999999999987      689999998765544

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-61  Score=449.01  Aligned_cols=260  Identities=30%  Similarity=0.571  Sum_probs=233.8

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      +.+++|++++.||+|+||+||+|+++.+|+.||||++++..  .......+.+|+.+++.++||||+++++++.+...+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            56789999999999999999999999999999999997652  2334577889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      +||||++||+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.+|++||+|||+|+.......
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~-~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~  160 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS-RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  160 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhh-cCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence            999999999999999999999999999999999999999998 9999999999999999999999999999987765555


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      .....+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+.       .++...+.....  ..+..++++
T Consensus       161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-------~~~~~~i~~~~~--~~p~~~s~~  231 (337)
T d1o6la_         161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-------ERLFELILMEEI--RFPRTLSPE  231 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC--CCCTTSCHH
T ss_pred             ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-------HHHHHHHhcCCC--CCCccCCHH
Confidence            66778999999999999999999999999999999999999999987543       344555555443  234679999


Q ss_pred             HHHHHHHhhhcCcCCCCC-----HHHHHcCCcccccC
Q 018018          305 FCSFISACVQKEPQQRLS-----AQELMTHPFLKMYG  336 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt-----~~eil~hp~~~~~~  336 (362)
                      +.+||.+||++||++|++     ++|+++||||+...
T Consensus       232 ~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~  268 (337)
T d1o6la_         232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHHHHHhhccCCchhhcccccccHHHHHcCcccccCC
Confidence            999999999999999994     99999999998753

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-62  Score=439.94  Aligned_cols=255  Identities=29%  Similarity=0.519  Sum_probs=212.2

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe--cCeEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS--NGAISI  145 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~--~~~~~l  145 (362)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++.. .++.....+.+|+++++.++||||+++++++.+  ++.+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            47899999999999999999999999999999999765 345567789999999999999999999998864  567899


Q ss_pred             EEeccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCC-----eEeecCCCCcEEEccCCcEEEeeccCC
Q 018018          146 ILEYMDGGSLADFLKK----VKTIPEEYLAAICEQVLKGLLYLHHEKH-----IIHRDLKPSNLLINHRGEVKITDFGVS  216 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~----~~~l~~~~~~~i~~ql~~al~~LH~~~~-----ivH~Dlkp~NIll~~~~~vkl~DFg~a  216 (362)
                      |||||++|+|.+++.+    ...+++..++.++.|++.||+|||+ +|     |+||||||+|||++.++.+||+|||+|
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a  161 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR-RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  161 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH-HCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence            9999999999999864    4679999999999999999999998 55     999999999999999999999999999


Q ss_pred             cccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018018          217 AIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  296 (362)
Q Consensus       217 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
                      +............+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+.       .++...+.....+ .
T Consensus       162 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-------~~~~~~i~~~~~~-~  233 (269)
T d2java1         162 RILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-------KELAGKIREGKFR-R  233 (269)
T ss_dssp             HHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHTCCC-C
T ss_pred             eecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-------HHHHHHHHcCCCC-C
Confidence            8876555555667899999999999999999999999999999999999999976432       2444555544443 3


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcc
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFL  332 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  332 (362)
                      .+..+++++.+||.+||+.||++|||++|+++|||+
T Consensus       234 ~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         234 IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            456799999999999999999999999999999996

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-62  Score=444.09  Aligned_cols=257  Identities=32%  Similarity=0.568  Sum_probs=223.3

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +.|++++.||+|+||+||+|+++.+|+.||||+++... ....+.+.+|+++++.++||||+++++++.+++.+++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            56899999999999999999999999999999997653 33456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCc
Q 018018          150 MDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANT  228 (362)
Q Consensus       150 ~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~  228 (362)
                      +++|+|.+++.+ ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++++||+|||+|+..........+
T Consensus        91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~-~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD-NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence            999999999765 4679999999999999999999998 99999999999999999999999999999876544444456


Q ss_pred             cccCCcccCcceec-----CCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC-CCCCCCCCCCC
Q 018018          229 FVGTYNYMSPERIS-----GGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ-PPPSAPSDQFS  302 (362)
Q Consensus       229 ~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  302 (362)
                      .+||+.|+|||++.     +..|+.++|||||||++|+|++|+.||.+.+..+       .+..+... .+....+..++
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~-------~~~~i~~~~~~~~~~~~~~s  242 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSEPPTLAQPSRWS  242 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG-------HHHHHHHSCCCCCSSGGGSC
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH-------HHHHHHcCCCCCCCccccCC
Confidence            78999999999984     4568999999999999999999999998754432       23333333 23333456789


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      +++.+||.+||+.||++|||++|+++||||+..
T Consensus       243 ~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         243 SNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999999999999754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-61  Score=434.25  Aligned_cols=252  Identities=30%  Similarity=0.507  Sum_probs=220.4

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe----cCeEEEE
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS----NGAISII  146 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~----~~~~~lV  146 (362)
                      |+..+.||+|+||+||+|++..+++.||+|++... ........+.+|+++++.++||||+++++++.+    ...+|+|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            46677899999999999999999999999998765 345566789999999999999999999999875    3568999


Q ss_pred             EeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCC--eEeecCCCCcEEEc-cCCcEEEeeccCCcccccCC
Q 018018          147 LEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKH--IIHRDLKPSNLLIN-HRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       147 ~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~--ivH~Dlkp~NIll~-~~~~vkl~DFg~a~~~~~~~  223 (362)
                      |||+++|+|.+++.+...+++..++.++.|++.||+|||+ ++  |+||||||+|||++ .++.+||+|||+|+....  
T Consensus        91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~-~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--  167 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--  167 (270)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHT-SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--
T ss_pred             EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHH-CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--
Confidence            9999999999999998999999999999999999999998 78  99999999999996 578999999999976432  


Q ss_pred             CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCH
Q 018018          224 GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSP  303 (362)
Q Consensus       224 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (362)
                      ......+||+.|+|||++.+ .|+.++|||||||++|||++|+.||....      ....+...+.....+...+...++
T Consensus       168 ~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~------~~~~~~~~i~~~~~~~~~~~~~~~  240 (270)
T d1t4ha_         168 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ------NAAQIYRRVTSGVKPASFDKVAIP  240 (270)
T ss_dssp             TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS------SHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc------cHHHHHHHHHcCCCCcccCccCCH
Confidence            23456789999999999876 59999999999999999999999997542      223455666666555556677899


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHcCCccc
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMTHPFLK  333 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~  333 (362)
                      ++.+||.+||+.||++|||++|+++||||+
T Consensus       241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            999999999999999999999999999996

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.3e-62  Score=445.96  Aligned_cols=265  Identities=27%  Similarity=0.425  Sum_probs=213.1

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      +.|++.+.||+|+||+||+|+++.+|+.||||++...........+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            66999999999999999999999999999999998765455556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEc---cCCcEEEeeccCCcccccCCCCC
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN---HRGEVKITDFGVSAIMASTSGQA  226 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~---~~~~vkl~DFg~a~~~~~~~~~~  226 (362)
                      |+||+|.+++...+.+++..+..++.|++.||+|||+ +||+||||||+||++.   .++.+||+|||+|+..... ...
T Consensus        89 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~-~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-~~~  166 (307)
T d1a06a_          89 VSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD-LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SVL  166 (307)
T ss_dssp             CCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred             cCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhh-ceeeeEEecccceeecccCCCceEEEeccceeEEccCC-Cee
Confidence            9999999999998899999999999999999999998 9999999999999995   4789999999999865432 334


Q ss_pred             CccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CCCCCCCCCHH
Q 018018          227 NTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PSAPSDQFSPE  304 (362)
Q Consensus       227 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  304 (362)
                      .+.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+...       .+....+.....  +......++++
T Consensus       167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~~  239 (307)
T d1a06a_         167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-------AKLFEQILKAEYEFDSPYWDDISDS  239 (307)
T ss_dssp             ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHhccCCCCCCccccCCCHH
Confidence            567899999999999999999999999999999999999999976432       234444444432  23345679999


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHH
Q 018018          305 FCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLS  343 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~  343 (362)
                      +.+||.+||+.||++|||++|+++||||++.......+.
T Consensus       240 ~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~  278 (307)
T d1a06a_         240 AKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIH  278 (307)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCCCCCCH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCccccccc
Confidence            999999999999999999999999999987554444333

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.3e-61  Score=440.43  Aligned_cols=257  Identities=30%  Similarity=0.489  Sum_probs=227.1

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +.|+.++.||+|+||+||+|++..+|+.||||+++...  .....+.+.+|+++++.++||||+++++++.+++.+|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45999999999999999999999999999999997653  3455678999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      |||.+|+|..++....++++..++.++.|++.||.|||+ +||+||||||+|||++.++++||+|||+|+....    ..
T Consensus        95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~~  169 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHS-HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----AN  169 (309)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BC
T ss_pred             EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCEeccCCCcceEEECCCCCEEEeecccccccCC----CC
Confidence            999999998888888899999999999999999999998 9999999999999999999999999999976532    34


Q ss_pred             ccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          228 TFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      ..+||+.|+|||++.+   +.|+.++|||||||++|||++|..||.+.+.       .+.+..+.....+......++++
T Consensus       170 ~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~s~~  242 (309)
T d1u5ra_         170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-------MSALYHIAQNESPALQSGHWSEY  242 (309)
T ss_dssp             CCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-------HHHHHHHHHSCCCCCSCTTSCHH
T ss_pred             ccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-------HHHHHHHHhCCCCCCCCCCCCHH
Confidence            5689999999999864   4589999999999999999999999976432       23445555555555556778999


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCC
Q 018018          305 FCSFISACVQKEPQQRLSAQELMTHPFLKMYGDL  338 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~  338 (362)
                      +.+||.+||+.||++|||++|+++||||+.....
T Consensus       243 ~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~  276 (309)
T d1u5ra_         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP  276 (309)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred             HHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCc
Confidence            9999999999999999999999999999875443

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3e-60  Score=436.89  Aligned_cols=256  Identities=28%  Similarity=0.542  Sum_probs=228.7

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      .+++|++++.||+|+||+||+|+++.+|+.||||+++...  .......+.+|+.+++.++||||+++++++.+.+.+|+
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            5689999999999999999999999999999999997542  23345678999999999999999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      ||||+.||+|..++.....+++..++.++.|++.||+|||+ +||+||||||+|||++.+|++||+|||+|+....   .
T Consensus        82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---~  157 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS-KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---V  157 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---C
T ss_pred             EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhcc-CcEEccccCchheeEcCCCCEEEecCccceEecc---c
Confidence            99999999999999999999999999999999999999998 9999999999999999999999999999987643   3


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      ..+.+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.+.       .+....+.....  ..+..+++++
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-------~~~~~~i~~~~~--~~p~~~s~~~  228 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-------MKTYEKILNAEL--RFPPFFNEDV  228 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHCCC--CCCTTSCHHH
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-------HHHHHHHHcCCC--CCCCCCCHHH
Confidence            3457899999999999999999999999999999999999999986432       344555554443  2345789999


Q ss_pred             HHHHHHhhhcCcCCCC-----CHHHHHcCCcccccC
Q 018018          306 CSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      .++|.+||+.||++|+     |++++++||||+...
T Consensus       229 ~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~  264 (316)
T d1fota_         229 KDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV  264 (316)
T ss_dssp             HHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             HHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence            9999999999999996     999999999998764

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5e-60  Score=441.03  Aligned_cols=259  Identities=25%  Similarity=0.444  Sum_probs=226.0

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      .+++|++++.||+|+||.||+|+++.+|+.||||++... .......+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus        24 il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm  102 (350)
T d1koaa2          24 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY  102 (350)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC-SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc-chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            468999999999999999999999999999999999765 3344577899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc--CCcEEEeeccCCcccccCCC
Q 018018          148 EYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH--RGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       148 e~~~~gsL~~~l~-~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~--~~~vkl~DFg~a~~~~~~~~  224 (362)
                      |||+||+|.+++. ..+.+++..++.++.||+.||+|||+ +||+||||||+|||++.  ++.+||+|||+|+..... .
T Consensus       103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-~  180 (350)
T d1koaa2         103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE-NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-Q  180 (350)
T ss_dssp             CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-S
T ss_pred             EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh-cCCeeeeechhHeeeccCCCCeEEEeecchheecccc-c
Confidence            9999999999995 45679999999999999999999998 99999999999999964  578999999999876533 2


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCCCCCCC
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFS  302 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  302 (362)
                      .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.       .+.+..+....  .+......++
T Consensus       181 ~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s  253 (350)
T d1koaa2         181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-------DETLRNVKSCDWNMDDSAFSGIS  253 (350)
T ss_dssp             CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCCCSCCGGGGGCC
T ss_pred             ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCcccccCCC
Confidence            34457899999999999999999999999999999999999999976432       23444444333  2233345689


Q ss_pred             HHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          303 PEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       303 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      +++.+||.+||+.||++|||++|+++||||+...
T Consensus       254 ~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         254 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            9999999999999999999999999999998764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-60  Score=431.06  Aligned_cols=259  Identities=27%  Similarity=0.455  Sum_probs=225.2

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-----hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-----ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++....     ......+.+|+.+++.++||||+++++++.+...+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            679999999999999999999999999999999975421     224578899999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC----cEEEeeccCCcccc
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG----EVKITDFGVSAIMA  220 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~----~vkl~DFg~a~~~~  220 (362)
                      +|||||++|+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+||+++.++    .+||+|||+|+...
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~-~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS-LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhh-cceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            999999999999999998999999999999999999999998 9999999999999998776    59999999998764


Q ss_pred             cCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--CCCC
Q 018018          221 STSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPS  298 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  298 (362)
                      .. ....+..||+.|+|||++.+..++.++||||+||++|||++|..||.+.+.       .+....+......  ...+
T Consensus       169 ~~-~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~  240 (293)
T d1jksa_         169 FG-NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK-------QETLANVSAVNYEFEDEYF  240 (293)
T ss_dssp             TS-CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHTTCCCCCHHHH
T ss_pred             CC-ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH-------HHHHHHHHhcCCCCCchhc
Confidence            33 334556899999999999999999999999999999999999999986432       2344444444332  2223


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                      ..+++++.+||.+||+.||++|||++|+++||||+....
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~  279 (293)
T d1jksa_         241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT  279 (293)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC---
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCh
Confidence            578999999999999999999999999999999987543

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.1e-59  Score=438.90  Aligned_cols=258  Identities=25%  Similarity=0.437  Sum_probs=225.6

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .++|++++.||+|+||+||+|++..+|+.||||+++... ......+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc-hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            478999999999999999999999999999999997653 3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEc--cCCcEEEeeccCCcccccCCCC
Q 018018          149 YMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLIN--HRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       149 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~--~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      ||+||+|.+++... .++++.+++.++.|++.||+|||+ +||+||||||+|||++  .++.+||+|||+|+..... ..
T Consensus       107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~-~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~~  184 (352)
T d1koba_         107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE-HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EI  184 (352)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SC
T ss_pred             cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCeeecccccccccccccCCCeEEEeecccceecCCC-Cc
Confidence            99999999987654 479999999999999999999998 9999999999999997  5789999999999876533 33


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--CCCCCCCCCCH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--PPSAPSDQFSP  303 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  303 (362)
                      .....||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+.       .+.+..+....  .+......+++
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~  257 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD-------LETLQNVKRCDWEFDEDAFSSVSP  257 (352)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH-------HHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred             eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCCcccccCCCH
Confidence            4556899999999999999999999999999999999999999976433       23444444333  23334567999


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      ++.+||.+||++||++|||++|+++||||+...
T Consensus       258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            999999999999999999999999999998643

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.3e-60  Score=442.00  Aligned_cols=261  Identities=27%  Similarity=0.504  Sum_probs=223.3

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-----chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-----EESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      +++++|++++.||+|+||.||+|++..+|+.||||++....     ..........++.+++.++||||+++++++.+.+
T Consensus         1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~   80 (364)
T d1omwa3           1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD   80 (364)
T ss_dssp             CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence            35789999999999999999999999999999999986431     1122233345577888889999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .+|+||||++||+|.+++.....+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+....
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~-~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN-RFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHH-CCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            999999999999999999999999999999999999999999998 9999999999999999999999999999987643


Q ss_pred             CCCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                      .  .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.+.+..+    ...+......  .+...+..
T Consensus       160 ~--~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~----~~~~~~~~~~--~~~~~~~~  231 (364)
T d1omwa3         160 K--KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD----KHEIDRMTLT--MAVELPDS  231 (364)
T ss_dssp             S--CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC----HHHHHHHSSS--CCCCCCSS
T ss_pred             C--cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHhccc--CCCCCCCC
Confidence            3  3455689999999999975 568999999999999999999999998754432    2233333322  23344567


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCC-----HHHHHcCCcccccC
Q 018018          301 FSPEFCSFISACVQKEPQQRLS-----AQELMTHPFLKMYG  336 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt-----~~eil~hp~~~~~~  336 (362)
                      +++++.+||.+||+.||++|||     ++|+++||||++..
T Consensus       232 ~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~  272 (364)
T d1omwa3         232 FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  272 (364)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred             CCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence            9999999999999999999999     79999999998764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-59  Score=437.66  Aligned_cols=257  Identities=28%  Similarity=0.487  Sum_probs=228.8

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEE
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAIS  144 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~  144 (362)
                      ..+++|++++.||+|+||+||+|+++.+|+.||||+++...  .......+.+|+++++.++||||+++++++.+...++
T Consensus        38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  117 (350)
T d1rdqe_          38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence            34689999999999999999999999999999999987542  2234567889999999999999999999999999999


Q ss_pred             EEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC
Q 018018          145 IILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       145 lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~  224 (362)
                      +||||+.+|+|..++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++++||+|||+|+....   
T Consensus       118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~-~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---  193 (350)
T d1rdqe_         118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS-LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---  193 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred             cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence            999999999999999998999999999999999999999998 9999999999999999999999999999987643   


Q ss_pred             CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          225 QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      ...+.+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+       .......+......  .+..++++
T Consensus       194 ~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~-------~~~~~~~i~~~~~~--~p~~~s~~  264 (350)
T d1rdqe_         194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ-------PIQIYEKIVSGKVR--FPSHFSSD  264 (350)
T ss_dssp             CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS-------HHHHHHHHHHCCCC--CCTTCCHH
T ss_pred             ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC-------HHHHHHHHhcCCCC--CCccCCHH
Confidence            3345789999999999999999999999999999999999999997643       23445555555433  34579999


Q ss_pred             HHHHHHHhhhcCcCCCC-----CHHHHHcCCcccccC
Q 018018          305 FCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      +.+||++||+.||++|+     |++|+++||||+...
T Consensus       265 ~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~  301 (350)
T d1rdqe_         265 LKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             HHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             HHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence            99999999999999995     999999999998764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.9e-59  Score=420.98  Aligned_cols=258  Identities=27%  Similarity=0.490  Sum_probs=224.7

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc--------hHHHHHHHHHHHHHhcCC-CCcceEEeeeEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE--------ESARRQIAQELKINQSSQ-CPYVVVCYQSFYS  139 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~  139 (362)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++....        ......+.+|+.+++.++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            4789999999999999999999999999999999976521        234456889999999997 9999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          140 NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      ++.+|+||||+++|+|.++++..+.+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+|+..
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~-~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCcccccccceEEEcCCCCeEEccchheeEc
Confidence            99999999999999999999999999999999999999999999998 99999999999999999999999999999876


Q ss_pred             ccCCCCCCccccCCcccCcceecC------CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC
Q 018018          220 ASTSGQANTFVGTYNYMSPERISG------GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP  293 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  293 (362)
                      ... ......+||+.|+|||.+.+      ..++.++||||+||++|+|++|+.||.+.+.       ......+.....
T Consensus       161 ~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-------~~~~~~i~~~~~  232 (277)
T d1phka_         161 DPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-------MLMLRMIMSGNY  232 (277)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHTCC
T ss_pred             cCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-------HHHHHHHHhCCC
Confidence            543 33455789999999999853      3478899999999999999999999987543       233344443332


Q ss_pred             --CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          294 --PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       294 --~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                        +......+|+++.+||.+||+.||++|||++|+++||||+.+
T Consensus       233 ~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         233 QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence              333345799999999999999999999999999999999865

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-59  Score=432.05  Aligned_cols=257  Identities=29%  Similarity=0.512  Sum_probs=226.1

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc--chHHHHHHHHHHHHH-hcCCCCcceEEeeeEEecCeEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV--EESARRQIAQELKIN-QSSQCPYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~-~~l~hp~I~~~~~~~~~~~~~~l  145 (362)
                      +++|++++.||+|+||+||+|+++.+|+.||||+++...  .......+..|..++ +.++||||+++++++.+++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            478999999999999999999999999999999997542  222334556666655 57899999999999999999999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      ||||+++|+|.+++.....+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+........
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~-~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~  159 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS-KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  159 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH-TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccCcccceeecCCCceeccccchhhhccccccc
Confidence            99999999999999999999999999999999999999998 99999999999999999999999999999877666666


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      ....+||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+.+.       .++...+....+  ..+..+++++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-------~~~~~~i~~~~~--~~p~~~s~~~  230 (320)
T d1xjda_         160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-------EELFHSIRMDNP--FYPRWLEKEA  230 (320)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHCCC--CCCTTSCHHH
T ss_pred             ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-------HHHHHHHHcCCC--CCCccCCHHH
Confidence            6667899999999999999999999999999999999999999986432       344555544433  3346789999


Q ss_pred             HHHHHHhhhcCcCCCCCHH-HHHcCCccccc
Q 018018          306 CSFISACVQKEPQQRLSAQ-ELMTHPFLKMY  335 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~-eil~hp~~~~~  335 (362)
                      .+||.+||+.||++|||++ |+++||||+..
T Consensus       231 ~dli~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         231 KDLLVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence            9999999999999999995 89999999875

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-59  Score=426.72  Aligned_cols=259  Identities=23%  Similarity=0.360  Sum_probs=214.1

Q ss_pred             eeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccch----HHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEec
Q 018018           74 TIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEE----SARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEY  149 (362)
Q Consensus        74 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~  149 (362)
                      .+++||+|+||+||+|+++.+|+.||||+++.....    .....+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            568999999999999999999999999998755222    2235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCCcc
Q 018018          150 MDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQANTF  229 (362)
Q Consensus       150 ~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~~~  229 (362)
                      +.++++..+......+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+............
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~-~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~  160 (299)
T d1ua2a_          82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ-HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ  160 (299)
T ss_dssp             CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred             hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc-cceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence            9988877777777889999999999999999999998 999999999999999999999999999998876665566677


Q ss_pred             ccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--------------
Q 018018          230 VGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--------------  294 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--------------  294 (362)
                      +||+.|+|||++.+. .|+.++||||+||++|||++|.+||.+.+..+.   ...+..........              
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChhhccchhccchhhhh
Confidence            899999999998754 579999999999999999999999987544321   11122111110000              


Q ss_pred             ----C----CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          295 ----S----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       295 ----~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                          .    .....+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p  287 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP  287 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence                0    00135688999999999999999999999999999998754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-58  Score=424.71  Aligned_cols=256  Identities=21%  Similarity=0.372  Sum_probs=222.4

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      .++|++++.||+|+||+||+|.++.+|+.||||+++....  ....+.+|+++++.++||||+++++++.+++.+|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            4789999999999999999999999999999999976532  33567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC--CcEEEeeccCCcccccCCCC
Q 018018          149 YMDGGSLADFLKKVK-TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR--GEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~-~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~--~~vkl~DFg~a~~~~~~~~~  225 (362)
                      ||+||+|.+++...+ .+++.+++.++.|++.||+|||+ +||+||||||+|||++.+  ..+||+|||+++.... ...
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~-~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-~~~  159 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS-HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDN  159 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT-TCE
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-cCCCcccccccceeecCCCceEEEEcccchhhcccc-CCc
Confidence            999999999998654 79999999999999999999998 999999999999999854  4899999999987543 223


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC--CCCCCCCCH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP--SAPSDQFSP  303 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  303 (362)
                      ....++|+.|+|||.+.+..|+.++||||+||++|+|++|..||.+.+.       .++...+......  ......+++
T Consensus       160 ~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~~s~  232 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-------QQIIENIMNAEYTFDEEAFKEISI  232 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-------HHHHHHHHHTCCCCCHHHHTTSCH
T ss_pred             ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHhCCCCCChhhccCCCH
Confidence            4556899999999999999999999999999999999999999987433       2444444444322  222346899


Q ss_pred             HHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          304 EFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       304 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      ++.+||.+||+.||++|||++|+++||||+..
T Consensus       233 ~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            99999999999999999999999999999643

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-57  Score=414.64  Aligned_cols=264  Identities=26%  Similarity=0.488  Sum_probs=216.9

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-hHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-ESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +++|++++.||+|+||+||+|++..+|+.||||+++.... +.....+.+|+++++.++||||+++++++.+...+|+||
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence            4799999999999999999999999999999999976532 234567889999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHH--HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCC
Q 018018          148 EYMDGGSLADFLK--KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQ  225 (362)
Q Consensus       148 e~~~~gsL~~~l~--~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~  225 (362)
                      ||+.+ ++.+++.  ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+........
T Consensus        81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~-~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~  158 (298)
T d1gz8a_          81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS-HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT  158 (298)
T ss_dssp             ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred             eecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc-CCEEccccCchheeecccCcceeccCCcceeccCCccc
Confidence            99976 5555553  34679999999999999999999998 99999999999999999999999999999887666666


Q ss_pred             CCccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC----------
Q 018018          226 ANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP----------  294 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------  294 (362)
                      .....||+.|+|||++.... ++.++||||+||++|+|++|+.||.+.+..+   ...............          
T Consensus       159 ~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~  235 (298)
T d1gz8a_         159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID---QLFRIFRTLGTPDEVVWPGVTSMPD  235 (298)
T ss_dssp             TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH---HHHHHHHhcCCCchhhccccccccc
Confidence            66778999999999987766 4889999999999999999999998654321   111111111110000          


Q ss_pred             ------C-------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          295 ------S-------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       295 ------~-------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                            .       .....+++++.+||.+||+.||++|||++|+++||||+...+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             CCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             cccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence                  0       001246789999999999999999999999999999987744

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-58  Score=424.18  Aligned_cols=257  Identities=28%  Similarity=0.440  Sum_probs=212.0

Q ss_pred             ccCceeee-eeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHh-cCCCCcceEEeeeEEe----cCe
Q 018018           69 LEDIDTIK-VVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQ-SSQCPYVVVCYQSFYS----NGA  142 (362)
Q Consensus        69 ~~~~~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~-~l~hp~I~~~~~~~~~----~~~  142 (362)
                      .++|+++. .||+|+||+||+|++..+|+.||||+++..      ..+.+|+.++. .++||||++++++|.+    ...
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            57899875 599999999999999999999999998743      34667888754 5689999999999875    467


Q ss_pred             EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc---CCcEEEeeccCCc
Q 018018          143 ISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVSA  217 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---~~~vkl~DFg~a~  217 (362)
                      +|+|||||+||+|.+++...  ..+++..++.++.|++.||+|||+ +||+||||||+|||++.   ++.+||+|||+|+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~-~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS-INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH-cCCccccccccccccccccccccccccccceee
Confidence            99999999999999999764  469999999999999999999998 99999999999999985   4679999999998


Q ss_pred             ccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCC--CC
Q 018018          218 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPP--PS  295 (362)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~  295 (362)
                      ..... ......+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.+......   .+...+.....  +.
T Consensus       163 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         163 ETTSH-NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMGQYEFPN  238 (335)
T ss_dssp             ECCCC-CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSSSCCT
T ss_pred             eccCC-CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhcCCCCCCC
Confidence            76543 34456789999999999999999999999999999999999999997654432111   12222222211  11


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       296 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                      .....+++++.+||.+||+.||++|||++|+++||||+...
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            22235789999999999999999999999999999996544

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-57  Score=409.97  Aligned_cols=258  Identities=24%  Similarity=0.389  Sum_probs=210.5

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      ++++..++|++.+.||+|+||+||+++..   ..||||+++.. .+....+.+.+|+.+++.++||||+++++++. +..
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~   77 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ   77 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence            56788899999999999999999999753   46999999755 34556788999999999999999999998764 567


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          143 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      +++||||+++|+|.+++... ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+....
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA-KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc-CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            89999999999999999754 579999999999999999999998 9999999999999999999999999999987653


Q ss_pred             CCC--CCCccccCCcccCcceecC---CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018018          222 TSG--QANTFVGTYNYMSPERISG---GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  296 (362)
Q Consensus       222 ~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
                      ...  ......||+.|+|||++.+   ..|+.++|||||||++|||+||+.||.+.+..   .............+....
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~---~~~~~~~~~~~~~p~~~~  233 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR---DQIIFMVGRGYLSPDLSK  233 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHHHHHTSCCCCGGG
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH---HHHHHHHhcCCCCCcchh
Confidence            322  3345689999999999965   34899999999999999999999999865332   111222222111222223


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .+..+++++.+||.+||+.||++|||++|++++
T Consensus       234 ~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            456789999999999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-57  Score=418.43  Aligned_cols=258  Identities=26%  Similarity=0.364  Sum_probs=217.0

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCCc-----EEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeE
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ-----FFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSF  137 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~  137 (362)
                      .+++..++|++.+.||+|+||+||+|++..+++     .||+|++...........+.+|+.++..+ +||||+++++++
T Consensus        31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~  110 (325)
T d1rjba_          31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  110 (325)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence            356777899999999999999999999876543     69999987665666667889999999887 899999999999


Q ss_pred             EecCeEEEEEeccCCCCHHHHHHHc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeec
Q 018018          138 YSNGAISIILEYMDGGSLADFLKKV-----------------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRD  194 (362)
Q Consensus       138 ~~~~~~~lV~e~~~~gsL~~~l~~~-----------------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~D  194 (362)
                      .+.+.+++|||||++|+|.+++...                       ..+++..++.++.|++.||+|||+ +||+|||
T Consensus       111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~-~~IiHRD  189 (325)
T d1rjba_         111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF-KSCVHRD  189 (325)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH-TTEEETT
T ss_pred             eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh-CCeeecc
Confidence            9999999999999999999999754                       248999999999999999999998 9999999


Q ss_pred             CCCCcEEEccCCcEEEeeccCCcccccCCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCC
Q 018018          195 LKPSNLLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSP  271 (362)
Q Consensus       195 lkp~NIll~~~~~vkl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~  271 (362)
                      |||+||+++.++++||+|||+|+........  ..+..||+.|+|||++.++.|+.++|||||||++|||+| |..||.+
T Consensus       190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876544332  234578999999999999999999999999999999998 8999987


Q ss_pred             CccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          272 PEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .+..       ..+..+.........+..+++++.+||.+||+.||++|||++||++|
T Consensus       270 ~~~~-------~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         270 IPVD-------ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCCS-------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHH-------HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5443       22223333333444567889999999999999999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-57  Score=411.44  Aligned_cols=261  Identities=23%  Similarity=0.331  Sum_probs=221.8

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      ..+++..++|++.+.||+|+||+||+|++..+|+.||||+++.+..  ..+++.+|+++++.++||||+++++++.+.+.
T Consensus        10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (287)
T d1opja_          10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   87 (287)
T ss_dssp             CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCe
Confidence            3577888999999999999999999999999999999999876532  34578999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          143 ISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      +++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+...
T Consensus        88 ~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~-~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          88 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH-CCcccCccccCeEEECCCCcEEEccccceeecC
Confidence            99999999999999999764  578999999999999999999998 999999999999999999999999999998765


Q ss_pred             cCCCC-CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          221 STSGQ-ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       221 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      ..... .....|++.|+|||++.+..|+.++||||+||++|||++|..||.....      ...+...+... .....+.
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~------~~~~~~~i~~~-~~~~~~~  239 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYELLEKD-YRMERPE  239 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC------HHHHHHHHHTT-CCCCCCT
T ss_pred             CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch------HHHHHHHHhcC-CCCCCCc
Confidence            43322 2334688999999999999999999999999999999997666543221      22333333333 3344556


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      .+++++.+||.+||+.||++|||++|+++  +|+..
T Consensus       240 ~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~  273 (287)
T d1opja_         240 GCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM  273 (287)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred             cchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence            89999999999999999999999999965  55443

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.3e-57  Score=412.74  Aligned_cols=261  Identities=25%  Similarity=0.422  Sum_probs=214.8

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +++|++++.||+|+||+||+|+++ +|+.||||+++... .+.....+.+|+.+++.++||||+++++.+.+++..++++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence            479999999999999999999986 78999999997653 3334577899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      +|+.++.+..+....+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|...........
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD-RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhcc-CcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            999887777777778899999999999999999999998 9999999999999999999999999999988766555556


Q ss_pred             ccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--------------
Q 018018          228 TFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--------------  292 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------  292 (362)
                      ...+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+.+..+.   ............              
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ---LMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             eecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCChhhccchhhhhhcc
Confidence            67899999999998765 469999999999999999999999987543221   111111111100              


Q ss_pred             ---------CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          293 ---------PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       293 ---------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                               ........+++.+.+||.+||+.||++|||++|+++||||+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                     001113457889999999999999999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-57  Score=409.26  Aligned_cols=248  Identities=25%  Similarity=0.389  Sum_probs=213.3

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-----hHHHHHHHHHHHHHhcCC--CCcceEEeeeEEecCe
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-----ESARRQIAQELKINQSSQ--CPYVVVCYQSFYSNGA  142 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~e~~~~~~l~--hp~I~~~~~~~~~~~~  142 (362)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++....     .....++.+|+.+++.++  ||||+++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            679999999999999999999999999999999875421     112234668999998876  8999999999999999


Q ss_pred             EEEEEeccCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccC-CcEEEeeccCCcccc
Q 018018          143 ISIILEYMDG-GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHR-GEVKITDFGVSAIMA  220 (362)
Q Consensus       143 ~~lV~e~~~~-gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~-~~vkl~DFg~a~~~~  220 (362)
                      .++||||+.+ +++.+++.....+++..++.++.|++.||+|||+ +||+||||||+|||++.+ +.+||+|||+|+...
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~-~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN-CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH-CCCccccCcccceEEecCCCeEEECccccceecc
Confidence            9999999975 6889999988999999999999999999999998 999999999999999854 799999999997654


Q ss_pred             cCCCCCCccccCCcccCcceecCCCC-CccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          221 STSGQANTFVGTYNYMSPERISGGKY-GYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       221 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      .  ....+.+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.+.+             .+....  ...+.
T Consensus       163 ~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------------~i~~~~--~~~~~  225 (273)
T d1xwsa_         163 D--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------------EIIRGQ--VFFRQ  225 (273)
T ss_dssp             S--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------------HHHHCC--CCCSS
T ss_pred             c--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------------HHhhcc--cCCCC
Confidence            3  23456789999999999987765 677999999999999999999997521             111222  22345


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      .+|+++.+||.+||+.||++|||++|+++||||++.
T Consensus       226 ~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         226 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             CCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            789999999999999999999999999999999875

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-56  Score=409.31  Aligned_cols=255  Identities=25%  Similarity=0.408  Sum_probs=209.9

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCc---EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCe
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~  142 (362)
                      ++..++|++.+.||+|+||+||+|+++.+++   .||||++.........+.+.+|+.+++.++||||+++++++.+++.
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            4567889999999999999999999987665   6899998777677777889999999999999999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          143 ISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      +++||||+++|+|.+++... +.+++.++..++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+....
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~-~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD-MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh-CCCccCccccceEEECCCCcEEECCcccceEccC
Confidence            99999999999999988764 579999999999999999999998 9999999999999999999999999999987653


Q ss_pred             CCCC-----CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCC
Q 018018          222 TSGQ-----ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPS  295 (362)
Q Consensus       222 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (362)
                      ....     .....||+.|+|||.+.++.++.++|||||||++|||+| |..||.+.+.       .++...+.....+ 
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~-------~~~~~~i~~~~~~-  252 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-------QDVINAIEQDYRL-  252 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTTCCC-
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCC-
Confidence            3221     122457899999999999999999999999999999998 8999976433       2444555444333 


Q ss_pred             CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          296 APSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       296 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ..+..+++++.+||.+||+.||++|||+.|++++
T Consensus       253 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         253 PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            3446789999999999999999999999999875

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-56  Score=403.83  Aligned_cols=259  Identities=25%  Similarity=0.402  Sum_probs=219.6

Q ss_pred             CCccCceeeee-eeeeCCeEEEEEEEcc--CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           67 LNLEDIDTIKV-VGKGSGGIVQLVQHKW--TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        67 ~~~~~~~~~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      +..++|.+.+. ||+|+||+||+|.++.  ++..||||+++........+++.+|+++++.++||||+++++++.+ +.+
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~   83 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL   83 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence            45577888885 9999999999998764  4558999999877677778889999999999999999999998864 568


Q ss_pred             EEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          144 SIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      ++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+|+.....
T Consensus        84 ~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~-~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE-KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh-CCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            999999999999999865 4679999999999999999999998 99999999999999999999999999999876543


Q ss_pred             CC---CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          223 SG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       223 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      ..   ......||+.|+|||++.++.++.++|||||||++|||+| |..||.+.+.       .++...+..+..+ ..+
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-------~~~~~~i~~~~~~-~~p  234 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-------PEVMAFIEQGKRM-ECP  234 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-------HHHHHHHHTTCCC-CCC
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-------HHHHHHHHcCCCC-CCC
Confidence            32   2234578999999999999999999999999999999998 9999986533       2344455544433 345


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHH---HcCCccccc
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQEL---MTHPFLKMY  335 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~ei---l~hp~~~~~  335 (362)
                      ..+++++.+||.+||+.||++|||+.+|   |+|+|+...
T Consensus       235 ~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~  274 (285)
T d1u59a_         235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  274 (285)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence            6799999999999999999999999888   677887433

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=403.93  Aligned_cols=248  Identities=21%  Similarity=0.357  Sum_probs=207.9

Q ss_pred             eeeeeeCCeEEEEEEEc--cCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEEeccCC
Q 018018           76 KVVGKGSGGIVQLVQHK--WTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIILEYMDG  152 (362)
Q Consensus        76 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~e~~~~  152 (362)
                      +.||+|+||+||+|.+.  .+++.||||+++.. .+....+++.+|++++++++||||+++++++. .+..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence            47999999999999864  35678999999754 34456678999999999999999999999885 4567899999999


Q ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC---CCCcc
Q 018018          153 GSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG---QANTF  229 (362)
Q Consensus       153 gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~---~~~~~  229 (362)
                      |+|.+++.....+++..+..++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+.......   .....
T Consensus        92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE-SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHh-CCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            9999999998999999999999999999999998 9999999999999999999999999999987643322   12335


Q ss_pred             ccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHH
Q 018018          230 VGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSF  308 (362)
Q Consensus       230 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  308 (362)
                      .||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+.       .++...+..+.. ...+..+|+++.+|
T Consensus       171 ~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~-------~~~~~~i~~~~~-~~~p~~~~~~~~~l  242 (277)
T d1xbba_         171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-------SEVTAMLEKGER-MGCPAGCPREMYDL  242 (277)
T ss_dssp             CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-------HHHHHHHHTTCC-CCCCTTCCHHHHHH
T ss_pred             CCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH-------HHHHHHHHcCCC-CCCCcccCHHHHHH
Confidence            78999999999999999999999999999999998 8999986432       234444444433 33456799999999


Q ss_pred             HHHhhhcCcCCCCCHHHH---HcCCccc
Q 018018          309 ISACVQKEPQQRLSAQEL---MTHPFLK  333 (362)
Q Consensus       309 i~~~L~~dP~~Rpt~~ei---l~hp~~~  333 (362)
                      |.+||+.||++|||++++   |+|+|++
T Consensus       243 i~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         243 MNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             HHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            999999999999999998   4666654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.1e-56  Score=401.38  Aligned_cols=257  Identities=25%  Similarity=0.431  Sum_probs=212.3

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC----eE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG----AI  143 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~----~~  143 (362)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++..  .+......+.+|+.+++.++||||+++++++....    .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            6799999999999999999999999999999999765  34556678999999999999999999999988654    38


Q ss_pred             EEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCC
Q 018018          144 SIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTS  223 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~  223 (362)
                      |+||||++|++|.+++...+.+++.+++.++.|++.||+|||+ +||+||||||+|||++.++.++|+|||.+.......
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~-~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQ-NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHh-CCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            9999999999999999999999999999999999999999998 999999999999999999999999999987654322


Q ss_pred             ---CCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcC-CC-CCCCC
Q 018018          224 ---GQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQ-PP-PSAPS  298 (362)
Q Consensus       224 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~  298 (362)
                         ......+||+.|+|||++.+..++.++||||+||++|+|+||+.||.+.+.       .+........ .. +....
T Consensus       166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-------~~~~~~~~~~~~~~~~~~~  238 (277)
T d1o6ya_         166 NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-------VSVAYQHVREDPIPPSARH  238 (277)
T ss_dssp             -------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHCCCCCGGGTS
T ss_pred             ccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-------HHHHHHHHhcCCCCCchhc
Confidence               234456899999999999999999999999999999999999999976432       2333333332 22 22345


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      ..+|+++.+||.+||+.||++||+..+.+.|+|.+-
T Consensus       239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            678999999999999999999995555556777653

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=401.16  Aligned_cols=265  Identities=23%  Similarity=0.395  Sum_probs=225.9

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +++|++++.||+|+||+||+|++..+|+.||||+++... .......+.+|+.+++.++||||+++++.+.+....++|+
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence            478999999999999999999999999999999997653 4456788999999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCCCCC
Q 018018          148 EYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSGQAN  227 (362)
Q Consensus       148 e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~~~~  227 (362)
                      +++.+++|..++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||.|+..........
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~-~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS-RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhc-CCEeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence            999999999999988999999999999999999999998 9999999999999999999999999999988766555556


Q ss_pred             ccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC--------------
Q 018018          228 TFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP--------------  292 (362)
Q Consensus       228 ~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--------------  292 (362)
                      ...+++.|+|||++.+.. ++.++||||+||++|||++|+.||......   ......+.......              
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---DDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH---HHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCH---HHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence            667889999999988765 699999999999999999999997543221   11112222211111              


Q ss_pred             ----------CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          293 ----------PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       293 ----------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                                ........+++.+.+||++||+.||++|||++|+|+||||+.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence                      111223457889999999999999999999999999999997754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-56  Score=400.01  Aligned_cols=259  Identities=24%  Similarity=0.388  Sum_probs=217.9

Q ss_pred             CCCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           62 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        62 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ..++++..++|++.+.||+|+||.||+|+++ +++.||||+++....  ..+.+.+|+.+++.++||||+++++++. ++
T Consensus         5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~   80 (272)
T d1qpca_           5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVT-QE   80 (272)
T ss_dssp             TCTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             CCCeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC--CHHHHHHHHHHHHhCCCCCEeEEEeeec-cC
Confidence            3466788899999999999999999999986 678899999975432  3457899999999999999999999765 56


Q ss_pred             eEEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          142 AISIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      ..++||||+++|+|.+++...  .++++..+..++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+..
T Consensus        81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~-~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~  159 (272)
T d1qpca_          81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE-RNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (272)
T ss_dssp             SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCccchhheeeecccceeeccccceEEc
Confidence            679999999999999987433  469999999999999999999998 99999999999999999999999999999876


Q ss_pred             ccCCC-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCC-CCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          220 ASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQF-PYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       220 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      ..... ......||+.|+|||++.++.++.++|||||||++|||+||.. ||...+       ..++...+..+.. ...
T Consensus       160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~~~~~~~i~~~~~-~~~  231 (272)
T d1qpca_         160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLERGYR-MVR  231 (272)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHTTCC-CCC
T ss_pred             cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------HHHHHHHHHhcCC-CCC
Confidence            54322 2344578999999999999999999999999999999999654 454322       2344455554433 334


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc--CCccc
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMT--HPFLK  333 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~  333 (362)
                      +..+++++.+||.+||+.||++|||++++++  |+||.
T Consensus       232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            5689999999999999999999999999998  77775

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-56  Score=410.46  Aligned_cols=264  Identities=23%  Similarity=0.391  Sum_probs=209.9

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccC-CcEEEEEEeecccc-hHHHHHHHHHHHHHhc---CCCCcceEEeeeEEe----
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWT-GQFFALKVIQMNVE-ESARRQIAQELKINQS---SQCPYVVVCYQSFYS----  139 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~---l~hp~I~~~~~~~~~----  139 (362)
                      .++|++++.||+|+||+||+|++..+ ++.||||+++.... +.....+.+|+.+++.   .+||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            37899999999999999999999765 66799999875522 2222344556666554   589999999998853    


Q ss_pred             -cCeEEEEEeccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          140 -NGAISIILEYMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       140 -~~~~~lV~e~~~~gsL~~~l~-~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                       ...++++|||+.++.+..... ....+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~-~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS-HRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh-CCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence             357899999998876654443 34579999999999999999999998 999999999999999999999999999987


Q ss_pred             ccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCC-----
Q 018018          218 IMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQP-----  292 (362)
Q Consensus       218 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-----  292 (362)
                      ..... ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+.   ............     
T Consensus       165 ~~~~~-~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         165 IYSFQ-MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CCCGG-GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCGGGSC
T ss_pred             hhccc-ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhhCCCchhccc
Confidence            65432 344567899999999999999999999999999999999999999987543221   111222111100     


Q ss_pred             ----------------CCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          293 ----------------PPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       293 ----------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                                      ........+++.+.+||.+||++||++|||++|+++||||+..+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~  301 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  301 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence                            011123467899999999999999999999999999999987753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-56  Score=397.30  Aligned_cols=250  Identities=24%  Similarity=0.434  Sum_probs=204.1

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +.++|++++.||+|+||+||++++. +++.||||+++....  ..+++.+|+++++.++||||+++++++.+++..++||
T Consensus         3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~   79 (263)
T d1sm2a_           3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   79 (263)
T ss_dssp             CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC--cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence            4578999999999999999999986 577899999875432  3457899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC-C
Q 018018          148 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-Q  225 (362)
Q Consensus       148 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~-~  225 (362)
                      ||+++|+|.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++++||+|||+|+....... .
T Consensus        80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~-~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE-ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH-TTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhc-cceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            999999999998654 568999999999999999999998 9999999999999999999999999999987654332 2


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      .....||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+       ..++...+..+.. ...+..++++
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-------~~~~~~~i~~~~~-~~~p~~~~~~  230 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-------NSEVVEDISTGFR-LYKPRLASTH  230 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-------HHHHHHHHHHTCC-CCCCTTSCHH
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCC-------HHHHHHHHHhcCC-CCCccccCHH
Confidence            334578999999999999999999999999999999999 566665432       2234444444433 3334678999


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          305 FCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +.+||.+||+.||++|||++|+++|
T Consensus       231 l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         231 VYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHH
Confidence            9999999999999999999999986

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-55  Score=392.38  Aligned_cols=250  Identities=25%  Similarity=0.408  Sum_probs=217.7

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeEEEEE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~~lV~  147 (362)
                      +.++|++++.||+|+||+||+++++ +++.||||+++....  ...++.+|+.+++.++||||+++++++.+++.+++||
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~--~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~   78 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM--SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   78 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS--CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC--CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence            4478999999999999999999985 788999999986532  2357899999999999999999999999999999999


Q ss_pred             eccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC-C
Q 018018          148 EYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-Q  225 (362)
Q Consensus       148 e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~-~  225 (362)
                      ||+++|+|.+++.. ...+++..+..++.|++.||+|||+ +||+||||||+||+++.++.+||+|||+|+....... .
T Consensus        79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~-~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES-KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH-TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhh-cCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            99999999999754 4679999999999999999999998 9999999999999999999999999999987654333 2


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPE  304 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (362)
                      .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+.       .++...+..+.. ...+...+++
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-------~~~~~~i~~~~~-~~~p~~~~~~  229 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-------SETAEHIAQGLR-LYRPHLASEK  229 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-------HHHHHHHHTTCC-CCCCTTCCHH
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-------HHHHHHHHhCCC-CCCcccccHH
Confidence            334678999999999999999999999999999999998 8999976432       345555555443 3445688999


Q ss_pred             HHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          305 FCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       305 ~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +.+||.+||+.||++|||++++++|
T Consensus       230 l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         230 VYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHH
Confidence            9999999999999999999999987

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-55  Score=410.49  Aligned_cols=268  Identities=26%  Similarity=0.384  Sum_probs=213.6

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec------CeE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN------GAI  143 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~------~~~  143 (362)
                      -+|+.+++||+|+||+||+|++..+|+.||||+++....     ...+|+++++.++||||+++++++...      .++
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            479999999999999999999999999999999976522     234799999999999999999998643      358


Q ss_pred             EEEEeccCCCCHHHHH---HHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC-cEEEeeccCCccc
Q 018018          144 SIILEYMDGGSLADFL---KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIM  219 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l---~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-~vkl~DFg~a~~~  219 (362)
                      ++||||++++.+..+.   .....+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+|+..
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~-~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS-FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999999865433332   345679999999999999999999998 9999999999999999775 8999999999876


Q ss_pred             ccCCCCCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH--------HHHH--
Q 018018          220 ASTSGQANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--------MEAI--  288 (362)
Q Consensus       220 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~--------~~~~--  288 (362)
                      ... ....+.+||+.|+|||.+.+ ..|+.++||||+||++|||++|..||...+..+....+...        ....  
T Consensus       174 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  252 (350)
T d1q5ka_         174 VRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP  252 (350)
T ss_dssp             CTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC
T ss_pred             cCC-cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhcc
Confidence            433 34455789999999999876 46899999999999999999999999765432211111100        0000  


Q ss_pred             --hcCCCC--------CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCCCCCCHHH
Q 018018          289 --VDQPPP--------SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGDLNVDLSE  344 (362)
Q Consensus       289 --~~~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~l~~  344 (362)
                        .....+        ......+++++.+||.+||++||++|||++|+++||||+...+.++.+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~~~~~  318 (350)
T d1q5ka_         253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPN  318 (350)
T ss_dssp             ---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCTTCCCTT
T ss_pred             chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCCCCCCCC
Confidence              000000        11234578999999999999999999999999999999998887777665

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-55  Score=394.50  Aligned_cols=256  Identities=23%  Similarity=0.345  Sum_probs=209.9

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccC---CcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEec
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWT---GQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSN  140 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~  140 (362)
                      ++++..++|++.+.||+|+||.||+|++..+   +..||||+++..........+.+|+.+++.++||||+++++++. +
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~   79 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   79 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            3567778999999999999999999998654   34689999877667777888999999999999999999999885 5


Q ss_pred             CeEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          141 GAISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       141 ~~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      +.+++||||+++|+|.+++.. ...+++..++.++.|++.||+|||+ +|++||||||+||+++.++.+||+|||+|+..
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES-KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc-cCeeccccchhheeecCCCcEEEccchhheec
Confidence            778999999999999998765 4579999999999999999999998 99999999999999999999999999999876


Q ss_pred             ccCCC-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          220 ASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       220 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..       ++...+..+..+ ..
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-------~~~~~i~~~~~~-~~  230 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-------DVIGRIENGERL-PM  230 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-------GHHHHHHTTCCC-CC
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH-------HHHHHHHcCCCC-CC
Confidence            53322 2344578999999999999999999999999999999998 89999875543       234444444433 34


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +..+++++.+||.+||+.||++|||++|+++|
T Consensus       231 ~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            56899999999999999999999999999876

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=400.77  Aligned_cols=262  Identities=24%  Similarity=0.372  Sum_probs=211.5

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe--------
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS--------  139 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~--------  139 (362)
                      .++|++++.||+|+||+||+|++..+|+.||||++... ..+.....+.+|+.+++.++||||+.+++.+..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            58999999999999999999999999999999998655 233345678899999999999999999998754        


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          140 NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      ...+++||||+.++.+.........+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+|+..
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~-~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR-NKILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhcc-CCEEecCcCchheeecCCCcEEeeecceeeec
Confidence            45689999999887777666777889999999999999999999998 99999999999999999999999999999765


Q ss_pred             ccCC----CCCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018018          220 ASTS----GQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP  294 (362)
Q Consensus       220 ~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  294 (362)
                      ....    ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.+..+    ....+........+
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~----~~~~i~~~~~~~~~  243 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH----QLALISQLCGSITP  243 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH----HHHHHHHHHCCCCT
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH----HHHHHHHhcCCCCh
Confidence            4322    223446899999999998765 68999999999999999999999997644321    11222222222111


Q ss_pred             CCCCC---------------------------CCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          295 SAPSD---------------------------QFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       295 ~~~~~---------------------------~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      .....                           ..++++.+||.+||++||++|||++|+++||||+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~  311 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD  311 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence            11000                           126678899999999999999999999999999853

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-54  Score=392.43  Aligned_cols=255  Identities=24%  Similarity=0.305  Sum_probs=210.0

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCC----cEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTG----QFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ++..+.|+..++||+|+||.||+|..+.++    ..||||+++....+....++.+|+.+++.++||||+++++++.+..
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~   82 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK   82 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence            345578999999999999999999987654    4799999987767777778999999999999999999999999999


Q ss_pred             eEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          142 AISIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ..++||||+.++++.+++... ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+...
T Consensus        83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~-~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN-MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc-cccccCccccceEEECCCCeEEEcccchhhccc
Confidence            999999999999999988654 679999999999999999999998 999999999999999999999999999998764


Q ss_pred             cCCCC---CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          221 STSGQ---ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       221 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                      .....   .....||+.|+|||++.++.++.++|||||||++|||+++..||....      ...++...+..+..+ ..
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~------~~~~~~~~i~~~~~~-~~  234 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL------SNHEVMKAINDGFRL-PT  234 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC------CHHHHHHHHHTTCCC-CC
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccC------CHHHHHHHHhccCCC-CC
Confidence            43222   233468999999999999999999999999999999999655554321      123445555554433 34


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      +..+++++.+||.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         235 PMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             chhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            5678999999999999999999999999977

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-55  Score=407.32  Aligned_cols=262  Identities=26%  Similarity=0.418  Sum_probs=210.3

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC------
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG------  141 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~------  141 (362)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++.. .++.....+.+|+++++.++||||++++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            47899999999999999999999999999999999765 34556678899999999999999999999987654      


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .+|+||||+ +.+|..+++. ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+....
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~-~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHA-AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCcchhhcccccccccccccceeccCC
Confidence            579999999 5578777655 689999999999999999999998 9999999999999999999999999999987543


Q ss_pred             CCCCCCccccCCcccCcceecCC-CCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH----------------
Q 018018          222 TSGQANTFVGTYNYMSPERISGG-KYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL----------------  284 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~----------------  284 (362)
                         .....+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+........                
T Consensus       174 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (346)
T d1cm8a_         174 ---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE  250 (346)
T ss_dssp             ---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHH
T ss_pred             ---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchh
Confidence               34556899999999998774 5689999999999999999999999875432211111110                


Q ss_pred             ----HHHHhcC--CCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccC
Q 018018          285 ----MEAIVDQ--PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYG  336 (362)
Q Consensus       285 ----~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~  336 (362)
                          .......  .........+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                0000000  001112346789999999999999999999999999999998754

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=400.32  Aligned_cols=264  Identities=28%  Similarity=0.517  Sum_probs=224.8

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEE---ccCCcEEEEEEeeccc---chHHHHHHHHHHHHHhcCCC-CcceEEeeeEEe
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQH---KWTGQFFALKVIQMNV---EESARRQIAQELKINQSSQC-PYVVVCYQSFYS  139 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~---~~~~~~~~~~e~~~~~~l~h-p~I~~~~~~~~~  139 (362)
                      +.+++|++++.||+|+||+||+|++   +.+|+.||||+++...   +......+.+|++++++++| |||+++++.+.+
T Consensus        21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            5679999999999999999999987   4468999999986541   23345668899999999977 899999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          140 NGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      ...+++||||+.+|+|.+++...+.+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+..
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~-~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK-LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             CCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhc-CCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            99999999999999999999999999999999999999999999998 99999999999999999999999999999876


Q ss_pred             ccC-CCCCCccccCCcccCcceecCCC--CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018018          220 AST-SGQANTFVGTYNYMSPERISGGK--YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  296 (362)
Q Consensus       220 ~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
                      ... .....+..|++.|+|||.+.+..  ++.++|||||||++|+|++|..||.+.+..+...   .+.........  .
T Consensus       180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~---~i~~~~~~~~~--~  254 (322)
T d1vzoa_         180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA---EISRRILKSEP--P  254 (322)
T ss_dssp             CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH---HHHHHHHHCCC--C
T ss_pred             cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcccCCC--C
Confidence            433 23345678999999999997654  6889999999999999999999998776554332   33333333332  2


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCC-----CHHHHHcCCcccccC
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRL-----SAQELMTHPFLKMYG  336 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rp-----t~~eil~hp~~~~~~  336 (362)
                      .+..+++++.+||.+||++||++||     |++|+++||||+...
T Consensus       255 ~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~  299 (322)
T d1vzoa_         255 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  299 (322)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence            3457899999999999999999999     589999999998754

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-54  Score=391.56  Aligned_cols=263  Identities=22%  Similarity=0.328  Sum_probs=214.5

Q ss_pred             CCCCCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           62 PSDNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        62 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ..+++++.++|++.+.||+|+||.||+|+++. ++.||||+++....  ....+.+|+.+++.++||||+++++++. ++
T Consensus         9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~   84 (285)
T d1fmka3           9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EE   84 (285)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             CcceEcCHHHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEe-cC
Confidence            45677888999999999999999999999874 46799999975532  2357899999999999999999999885 55


Q ss_pred             eEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccc
Q 018018          142 AISIILEYMDGGSLADFLKK--VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIM  219 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~--~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~  219 (362)
                      ..++||||+++|+|..++..  ...+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+..
T Consensus        85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~-~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~  163 (285)
T d1fmka3          85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER-MNYVHRDLRAANILVGENLVCKVADFGLARLI  163 (285)
T ss_dssp             SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred             CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh-hheecccccceEEEECCCCcEEEcccchhhhc
Confidence            68999999999999998854  4679999999999999999999998 99999999999999999999999999999876


Q ss_pred             ccCCC-CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCC
Q 018018          220 ASTSG-QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPS  298 (362)
Q Consensus       220 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  298 (362)
                      ..... ......||+.|+|||.+.++.++.++|||||||++|||++|..||....      ...+++..+..... ...+
T Consensus       164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~------~~~~~~~~i~~~~~-~~~~  236 (285)
T d1fmka3         164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM------VNREVLDQVERGYR-MPCP  236 (285)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC------CHHHHHHHHHTTCC-CCCC
T ss_pred             cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCC------CHHHHHHHHHhcCC-CCCC
Confidence            43322 2334578999999999999999999999999999999999655544321      22344444444433 3345


Q ss_pred             CCCCHHHHHHHHHhhhcCcCCCCCHHHHHc--CCcccccC
Q 018018          299 DQFSPEFCSFISACVQKEPQQRLSAQELMT--HPFLKMYG  336 (362)
Q Consensus       299 ~~~~~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~~~~  336 (362)
                      ..+++++.+||.+||+.||++|||+++|+.  |+||+...
T Consensus       237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            689999999999999999999999999988  88887653

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-54  Score=404.97  Aligned_cols=266  Identities=22%  Similarity=0.368  Sum_probs=211.8

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC----eEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG----AISI  145 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~----~~~l  145 (362)
                      ++|++++.||+|+||+||+|++..+|+.||||+++..........+.+|+.+++.++||||+++++++....    ..++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            679999999999999999999999999999999987666667778999999999999999999999987543    2344


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC-
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG-  224 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~-  224 (362)
                      +++|+.+|+|.+++.. ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+|+....... 
T Consensus        88 l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~-~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~  165 (345)
T d1pmea_          88 LVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH  165 (345)
T ss_dssp             EEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred             EEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence            4556668899999976 579999999999999999999998 9999999999999999999999999999987643322 


Q ss_pred             --CCCccccCCcccCcceecC-CCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHH----------------
Q 018018          225 --QANTFVGTYNYMSPERISG-GKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELM----------------  285 (362)
Q Consensus       225 --~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~----------------  285 (362)
                        .....+||+.|+|||++.. ..++.++||||+||++|+|++|+.||.+.+..+.........                
T Consensus       166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (345)
T d1pmea_         166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA  245 (345)
T ss_dssp             CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred             ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence              2345679999999999855 457899999999999999999999998754322111111000                


Q ss_pred             -HHHhcCCCCC-----CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          286 -EAIVDQPPPS-----APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       286 -~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                       ..........     .....+++++.+||.+||+.||++|||++|+|+||||+....
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~  303 (345)
T d1pmea_         246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD  303 (345)
T ss_dssp             HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred             hcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence             0000000000     112357889999999999999999999999999999985543

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-54  Score=394.10  Aligned_cols=258  Identities=26%  Similarity=0.386  Sum_probs=205.7

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEcc-----CCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeE
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSF  137 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~  137 (362)
                      .+++..++|++.+.||+|+||.||+|++..     +++.||||+++........+.+.+|..++.++ +|+||+.+++.+
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            445777899999999999999999999754     45689999998766666667788888777665 689999999887


Q ss_pred             Eec-CeEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcE
Q 018018          138 YSN-GAISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNL  200 (362)
Q Consensus       138 ~~~-~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NI  200 (362)
                      .+. ..+++|||||++|+|.+++...                ..+++..+..++.|++.||+|||+ +||+||||||+||
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~ivHrDlKp~NI  165 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS-RKCIHRDLAARNI  165 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGE
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh-CCCcCCcCCccce
Confidence            654 5689999999999999999653                348999999999999999999998 9999999999999


Q ss_pred             EEccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcC-CCCCCCCccCCc
Q 018018          201 LINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFPYSPPEQQDG  277 (362)
Q Consensus       201 ll~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg-~~pf~~~~~~~~  277 (362)
                      |++.++++||+|||+|+.......  ......||+.|+|||++.++.++.++||||+||++|||++| ..||.+.+..+ 
T Consensus       166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~-  244 (299)
T d1ywna1         166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-  244 (299)
T ss_dssp             EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-
T ss_pred             eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999999999987654332  23446799999999999999999999999999999999986 56786544321 


Q ss_pred             hhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          278 WTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                           .+...+..+. .+..+..+++++.+||.+||+.||++|||++|+++|
T Consensus       245 -----~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         245 -----EFCRRLKEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             -----HHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----HHHHHHhcCC-CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                 2233333333 234456789999999999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-54  Score=397.33  Aligned_cols=252  Identities=25%  Similarity=0.388  Sum_probs=207.5

Q ss_pred             CccCceeeeeeeeeCCeEEEEEEEccCCc----EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecCeE
Q 018018           68 NLEDIDTIKVVGKGSGGIVQLVQHKWTGQ----FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNGAI  143 (362)
Q Consensus        68 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~~~  143 (362)
                      +..+|++++.||+|+||+||+|++..+|+    +||+|.++...+....+++.+|+.+++.++||||+++++++.+ +..
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~   85 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STV   85 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCe
Confidence            34679999999999999999999988876    5888888766555667889999999999999999999999875 467


Q ss_pred             EEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          144 SIILEYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      +++++|+.+|+|.+++... ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++++||+|||+|+.....
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~-~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED-RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH-cCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            7889999999999988664 679999999999999999999998 99999999999999999999999999999876543


Q ss_pred             CCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCC
Q 018018          223 SGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSD  299 (362)
Q Consensus       223 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (362)
                      ...  .....||+.|+|||++.++.|+.++|||||||++|||+| |..||.+.+..       ++...+..+.. ...+.
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-------~~~~~i~~~~~-~~~p~  236 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-------EISSILEKGER-LPQPP  236 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-------GHHHHHHHTCC-CCCCT
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHcCCC-CCCCc
Confidence            322  233468999999999999999999999999999999998 89999765432       22233333332 23346


Q ss_pred             CCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          300 QFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       300 ~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .+++++.+||.+||+.||++|||+.|+++|
T Consensus       237 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         237 ICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            789999999999999999999999999988

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.7e-53  Score=394.56  Aligned_cols=260  Identities=21%  Similarity=0.362  Sum_probs=210.9

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEe--cCeEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYS--NGAISI  145 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~--~~~~~l  145 (362)
                      .++|++++.||+|+||+||+|++..+|+.||||+++...    .+++.+|+.+++.+. ||||+++++++..  ...+++
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            478999999999999999999999999999999987542    356788999999985 9999999999874  466999


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC-cEEEeeccCCcccccCCC
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG-EVKITDFGVSAIMASTSG  224 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~-~vkl~DFg~a~~~~~~~~  224 (362)
                      ||||+.+++|..+.   +.+++..++.++.|++.||+|||+ +||+||||||+|||++.++ .+||+|||+|+..... .
T Consensus       110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~-~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-~  184 (328)
T d3bqca1         110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHS-MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-Q  184 (328)
T ss_dssp             EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHH-TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-C
T ss_pred             EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhh-cccccccccccceEEcCCCCeeeecccccceeccCC-C
Confidence            99999999987763   579999999999999999999998 9999999999999998655 6999999999876533 3


Q ss_pred             CCCccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCc-hhhHHHHH---------HHHhcC--
Q 018018          225 QANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDG-WTSFYELM---------EAIVDQ--  291 (362)
Q Consensus       225 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~-~~~~~~~~---------~~~~~~--  291 (362)
                      .....++|+.|+|||.+.+.. ++.++||||+||++|+|++|..||........ ...+....         ......  
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            455668999999999988754 79999999999999999999999976443211 00111000         000000  


Q ss_pred             -----------------CCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          292 -----------------PPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       292 -----------------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                                       .........+++++.+||++||++||++|||++|+|+||||+...+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~  327 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK  327 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence                             0111122347889999999999999999999999999999997654

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-53  Score=390.36  Aligned_cols=259  Identities=24%  Similarity=0.343  Sum_probs=221.0

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEc-----cCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS  139 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~  139 (362)
                      .++..++|++++.||+|+||+||+|+.+     .+++.||||+++.........++.+|+.+++.++||||+++++++.+
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3456688999999999999999999975     35678999999877677778889999999999999999999999999


Q ss_pred             cCeEEEEEeccCCCCHHHHHHHc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecC
Q 018018          140 NGAISIILEYMDGGSLADFLKKV------------------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDL  195 (362)
Q Consensus       140 ~~~~~lV~e~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dl  195 (362)
                      ....++||||+++|+|.+++...                        ..+++..+..++.|++.||+|||+ +|++||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~-~~ivHrDl  166 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE-RKFVHRDL  166 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCC
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc-CCeEeeEE
Confidence            99999999999999999999643                        248999999999999999999998 99999999


Q ss_pred             CCCcEEEccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCC-CCCCCC
Q 018018          196 KPSNLLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ-FPYSPP  272 (362)
Q Consensus       196 kp~NIll~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~-~pf~~~  272 (362)
                      ||+|||++.++++||+|||+|+.......  ...+..|++.|+|||.+.+..|+.++|||||||++|||++|. +||.+.
T Consensus       167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~  246 (301)
T d1lufa_         167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  246 (301)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence            99999999999999999999986643322  223467899999999999999999999999999999999985 677664


Q ss_pred             ccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccc
Q 018018          273 EQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKM  334 (362)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  334 (362)
                      +.       .++...+..+.. +..+..+++++.+||.+||+.||++|||+.||++  +++.
T Consensus       247 ~~-------~e~~~~v~~~~~-~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~--~L~~  298 (301)
T d1lufa_         247 AH-------EEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQR  298 (301)
T ss_dssp             CH-------HHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             CH-------HHHHHHHHcCCC-CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH--HHHH
Confidence            32       345566666554 3445689999999999999999999999999954  4443

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=384.96  Aligned_cols=253  Identities=23%  Similarity=0.359  Sum_probs=205.8

Q ss_pred             CCccCceeeeeeeeeCCeEEEEEEEccC-C--cEEEEEEeecc--cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC
Q 018018           67 LNLEDIDTIKVVGKGSGGIVQLVQHKWT-G--QFFALKVIQMN--VEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG  141 (362)
Q Consensus        67 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~--~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~  141 (362)
                      ++.++|++++.||+|+||.||+|+...+ +  ..||||+++..  .++...+.+.+|+.+++.++||||+++++++.+ .
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            3558899999999999999999986533 3  36899998755  344556789999999999999999999999865 5


Q ss_pred             eEEEEEeccCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccc
Q 018018          142 AISIILEYMDGGSLADFLKK-VKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMA  220 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~-~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~  220 (362)
                      ..++||||+++|++.+++.. .+.+++..+..++.|++.||.|||+ +||+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~-~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES-KRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhh-CCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            67899999999999988755 4579999999999999999999998 999999999999999999999999999998764


Q ss_pred             cCCC---CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCC
Q 018018          221 STSG---QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSA  296 (362)
Q Consensus       221 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (362)
                      ....   ......|+..|+|||++.+..++.++|||||||++|||+| |..||.+.+.       .+....+......+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-------~~~~~~i~~~~~~~~  235 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-------SQILHKIDKEGERLP  235 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-------HHHHHHHHTSCCCCC
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-------HHHHHHHHhCCCCCC
Confidence            4332   2233467889999999999999999999999999999998 8999976432       345566665655555


Q ss_pred             CCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          297 PSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       297 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      .+..+++.+.+||.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            66789999999999999999999999999963

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=389.47  Aligned_cols=254  Identities=26%  Similarity=0.374  Sum_probs=214.0

Q ss_pred             CCCccCceeeeeeeeeCCeEEEEEEEccCCcE--EEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeEEecCe
Q 018018           66 QLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQF--FALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSFYSNGA  142 (362)
Q Consensus        66 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~~~~~~  142 (362)
                      .++.++|++.+.||+|+||+||+|+++.+|..  ||||.++........+.+.+|++++..+ +||||+++++++.+.+.
T Consensus         6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_           6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            35678999999999999999999999988874  6778776555555677899999999998 79999999999999999


Q ss_pred             EEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC
Q 018018          143 ISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG  206 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~  206 (362)
                      +++||||+++|+|.+++...                ..+++..+..++.|++.||.|||+ +||+||||||+|||++.++
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~-~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ-KQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH-TTEECSCCSGGGEEECGGG
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc-CCccccccccceEEEcCCC
Confidence            99999999999999999643                578999999999999999999998 9999999999999999999


Q ss_pred             cEEEeeccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCC-CCCCCCccCCchhhHHHHH
Q 018018          207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQ-FPYSPPEQQDGWTSFYELM  285 (362)
Q Consensus       207 ~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~-~pf~~~~~~~~~~~~~~~~  285 (362)
                      .+||+|||+|+...... ......||..|+|||.+.++.++.++|||||||++|||++|. +||.+.+       ..++.
T Consensus       165 ~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-------~~~~~  236 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELY  236 (309)
T ss_dssp             CEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHH
T ss_pred             ceEEccccccccccccc-cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-------HHHHH
Confidence            99999999997654332 334557899999999999999999999999999999999965 5776533       33555


Q ss_pred             HHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          286 EAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ..+..+.. +..+..+++++.+||.+||+.||++|||++|+++|
T Consensus       237 ~~i~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         237 EKLPQGYR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             HHGGGTCC-CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCC-CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            66555543 33456789999999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-53  Score=385.98  Aligned_cols=256  Identities=23%  Similarity=0.377  Sum_probs=216.7

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEccCC-------cEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEee
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHKWTG-------QFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQ  135 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~  135 (362)
                      .+.+..++|++++.||+|+||.||+|++..++       ..||||+++.........++.+|...+.++ +||||+++++
T Consensus         7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~   86 (299)
T d1fgka_           7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG   86 (299)
T ss_dssp             TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence            36678899999999999999999999976554       479999998877777778899999888777 8999999999


Q ss_pred             eEEecCeEEEEEeccCCCCHHHHHHHc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCc
Q 018018          136 SFYSNGAISIILEYMDGGSLADFLKKV----------------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN  199 (362)
Q Consensus       136 ~~~~~~~~~lV~e~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~N  199 (362)
                      ++.+++..++||||+.+|+|.+++...                ..+++..++.++.|++.||+|||+ +||+||||||+|
T Consensus        87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~-~~ivHrDiKp~N  165 (299)
T d1fgka_          87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS-KKCIHRDLAARN  165 (299)
T ss_dssp             EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred             ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh-CCEEeeeecccc
Confidence            999999999999999999999999654                358999999999999999999998 999999999999


Q ss_pred             EEEccCCcEEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCC
Q 018018          200 LLINHRGEVKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD  276 (362)
Q Consensus       200 Ill~~~~~vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~  276 (362)
                      ||++.++.+||+|||+++.......  ......+++.|+|||.+.++.|+.++|||||||++|||++ |.+||.+.+.  
T Consensus       166 iLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~--  243 (299)
T d1fgka_         166 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV--  243 (299)
T ss_dssp             EEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--
T ss_pred             eeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH--
Confidence            9999999999999999987754332  2344678999999999999999999999999999999998 7899976432  


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          277 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                           ..+...+..+.. +..+..+++++.+||.+||+.||++|||+.|+++
T Consensus       244 -----~~~~~~i~~~~~-~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         244 -----EELFKLLKEGHR-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             -----HHHHHHHHTTCC-CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----HHHHHHHHcCCC-CCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence                 244444444433 4455789999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-53  Score=381.40  Aligned_cols=248  Identities=24%  Similarity=0.417  Sum_probs=204.9

Q ss_pred             CCCCccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe-cCeE
Q 018018           65 NQLNLEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-NGAI  143 (362)
Q Consensus        65 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~-~~~~  143 (362)
                      ++++.++|++++.||+|+||.||+|..  .|..||||+++.+   ...+.+.+|+++++.++||||+++++++.+ .+.+
T Consensus         2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            578889999999999999999999987  4789999999754   234678899999999999999999998864 4668


Q ss_pred             EEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          144 SIILEYMDGGSLADFLKKV--KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       144 ~lV~e~~~~gsL~~~l~~~--~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      ++||||+++|+|.+++...  ..+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~-~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG-NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc-CceeccccchHhheecCCCCEeecccccceecCC
Confidence            9999999999999999654  359999999999999999999998 9999999999999999999999999999976543


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCC
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQ  300 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (362)
                         ......+|+.|+|||++.++.++.++|||||||++|||+| |++||...+..       ++...+..+..+ ..+..
T Consensus       156 ---~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~-------~~~~~i~~~~~~-~~~~~  224 (262)
T d1byga_         156 ---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPRVEKGYKM-DAPDG  224 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG-------GHHHHHTTTCCC-CCCTT
T ss_pred             ---CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH-------HHHHHHHcCCCC-CCCcc
Confidence               2344578899999999999999999999999999999998 78888764332       233344443333 34567


Q ss_pred             CCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          301 FSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       301 ~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      +++++.+||.+||+.||++|||+.+++++
T Consensus       225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            89999999999999999999999999874

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=385.45  Aligned_cols=262  Identities=23%  Similarity=0.356  Sum_probs=225.7

Q ss_pred             CCCCCCccCceeeeeeeeeCCeEEEEEEEcc-----CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeE
Q 018018           63 SDNQLNLEDIDTIKVVGKGSGGIVQLVQHKW-----TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSF  137 (362)
Q Consensus        63 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~  137 (362)
                      .++++..++|++.+.||+|+||+||+|.+..     ++..||||+++..........+.+|+.+++.++||||+++++.+
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            4678888999999999999999999998753     45789999998776666777899999999999999999999999


Q ss_pred             EecCeEEEEEeccCCCCHHHHHHHc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCc
Q 018018          138 YSNGAISIILEYMDGGSLADFLKKV----------KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGE  207 (362)
Q Consensus       138 ~~~~~~~lV~e~~~~gsL~~~l~~~----------~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~  207 (362)
                      ..+...++||||+.+|+|.+++...          ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.+++
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~-~~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA-NKFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH-TTCBCSCCSGGGEEECTTCC
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh-CCeeeceEcCCceeecCCce
Confidence            9999999999999999999998643          347899999999999999999998 99999999999999999999


Q ss_pred             EEEeeccCCcccccCCC--CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcC-CCCCCCCccCCchhhHHHH
Q 018018          208 VKITDFGVSAIMASTSG--QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATG-QFPYSPPEQQDGWTSFYEL  284 (362)
Q Consensus       208 vkl~DFg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg-~~pf~~~~~~~~~~~~~~~  284 (362)
                      +||+|||+|+.......  ......||+.|+|||.+.++.++.++||||||+++|||+|| ..||.+.+       ..+.
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~-------~~~~  244 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------NEQV  244 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-------HHHH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCC-------HHHH
Confidence            99999999987654332  22334789999999999999999999999999999999997 57786533       2345


Q ss_pred             HHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc------CCccc
Q 018018          285 MEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT------HPFLK  333 (362)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~------hp~~~  333 (362)
                      ...+..+.. ...+..+++.+.+||.+||+.||++|||++++++      +|+|+
T Consensus       245 ~~~i~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~  298 (308)
T d1p4oa_         245 LRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR  298 (308)
T ss_dssp             HHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred             HHHHHhCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCc
Confidence            555555544 3345678999999999999999999999999998      66664

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-52  Score=385.71  Aligned_cols=257  Identities=24%  Similarity=0.359  Sum_probs=219.4

Q ss_pred             CCCCCccCceeeeeeeeeCCeEEEEEEEc-----cCCcEEEEEEeecccchHHHHHHHHHHHHHhcC-CCCcceEEeeeE
Q 018018           64 DNQLNLEDIDTIKVVGKGSGGIVQLVQHK-----WTGQFFALKVIQMNVEESARRQIAQELKINQSS-QCPYVVVCYQSF  137 (362)
Q Consensus        64 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~hp~I~~~~~~~  137 (362)
                      .+++..++|++.+.||+|+||.||+|+..     .+++.||||+++..........+.+|+.+++.+ +||||+++++++
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            46678899999999999999999999863     466799999998776677777899999999998 699999999999


Q ss_pred             EecCeEEEEEeccCCCCHHHHHHHcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCc
Q 018018          138 YSNGAISIILEYMDGGSLADFLKKVK------------------TIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSN  199 (362)
Q Consensus       138 ~~~~~~~lV~e~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~N  199 (362)
                      .+....++|||||++|+|.+++....                  .+++..+..++.|++.||+|||+ +|++||||||+|
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~-~~ivHrDLKp~N  175 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS-KNCIHRDLAARN  175 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh-CCeeeccccccc
Confidence            99999999999999999999997543                  58999999999999999999998 999999999999


Q ss_pred             EEEccCCcEEEeeccCCcccccCCCC--CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHc-CCCCCCCCccCC
Q 018018          200 LLINHRGEVKITDFGVSAIMASTSGQ--ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECAT-GQFPYSPPEQQD  276 (362)
Q Consensus       200 Ill~~~~~vkl~DFg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~ellt-g~~pf~~~~~~~  276 (362)
                      |+++.++.+|++|||+++........  ....+||+.|+|||.+.++.++.++|||||||++|||+| |.+||...+.. 
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~-  254 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-  254 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH-
Confidence            99999999999999999876543322  234578999999999999999999999999999999999 56666554332 


Q ss_pred             chhhHHHHHHHHhcCCCCCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          277 GWTSFYELMEAIVDQPPPSAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                            ..+..+.....++..+..+++.+.+||.+||+.||++|||++++++
T Consensus       255 ------~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         255 ------SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             ------HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ------HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                  2222233333344455678999999999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-53  Score=396.07  Aligned_cols=261  Identities=24%  Similarity=0.362  Sum_probs=210.6

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeeccc-chHHHHHHHHHHHHHhcCCCCcceEEeeeEEe-----cCe
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNV-EESARRQIAQELKINQSSQCPYVVVCYQSFYS-----NGA  142 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~-----~~~  142 (362)
                      .++|++++.||+|+||+||+|++..+|+.||||+++... +......+.+|+.+++.++||||+++++++..     ...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            378999999999999999999999999999999997653 34455678999999999999999999998863     334


Q ss_pred             EEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccC
Q 018018          143 ISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAST  222 (362)
Q Consensus       143 ~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~  222 (362)
                      .+++++|+.+|+|.+++.. +++++..++.++.|++.||+|||+ +||+||||||+|||++.++.+|++|||+|..... 
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~-~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-  173 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHS-ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-  173 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHH-TTCCCCCCCGGGEEECTTCCEEECCC----CCTG-
T ss_pred             eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHh-CCCcccccCCccccccccccccccccchhcccCc-
Confidence            5666777889999999965 579999999999999999999998 9999999999999999999999999999876532 


Q ss_pred             CCCCCccccCCcccCcceecCCC-CCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhc-----------
Q 018018          223 SGQANTFVGTYNYMSPERISGGK-YGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVD-----------  290 (362)
Q Consensus       223 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-----------  290 (362)
                        ...+..|++.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+.....   ..+......           
T Consensus       174 --~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~  248 (348)
T d2gfsa1         174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL---KLILRLVGTPGAELLKKISS  248 (348)
T ss_dssp             --GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCHHHHTTCCC
T ss_pred             --ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCChHHhhhccc
Confidence              344567899999999977754 689999999999999999999999875432111   111111100           


Q ss_pred             --------CCCCC------CCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCcccccCC
Q 018018          291 --------QPPPS------APSDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMYGD  337 (362)
Q Consensus       291 --------~~~~~------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  337 (362)
                              .....      .....+++++.+||++||+.||++|||++|+|+||||+.+.+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence                    00000      012357899999999999999999999999999999987653

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=398.62  Aligned_cols=262  Identities=24%  Similarity=0.425  Sum_probs=201.9

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecc-cchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe------cC
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN-VEESARRQIAQELKINQSSQCPYVVVCYQSFYS------NG  141 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~------~~  141 (362)
                      .++|++++.||+|+||+||+|++..+|+.||||+++.. .+......+.+|+.+++.++||||++++++|..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            37899999999999999999999999999999999765 345556778999999999999999999999863      37


Q ss_pred             eEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCccccc
Q 018018          142 AISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMAS  221 (362)
Q Consensus       142 ~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~  221 (362)
                      .+|+||||+.+ ++.+.+.  ..+++..++.++.|++.||+|||+ +||+||||||+|||++.++.+|++|||+++....
T Consensus        96 ~~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~-~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1          96 DVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHS-AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             EEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH-TTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             eeEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhh-cccccccCCccccccccccceeeechhhhhcccc
Confidence            89999999976 4555443  579999999999999999999998 9999999999999999999999999999876543


Q ss_pred             CCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHH---------------HHH
Q 018018          222 TSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYE---------------LME  286 (362)
Q Consensus       222 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~---------------~~~  286 (362)
                       .......++|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.......+..               ...
T Consensus       172 -~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (355)
T d2b1pa1         172 -SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred             -ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence             3344556899999999999999999999999999999999999999987543221111100               001


Q ss_pred             HHhcCCCCCCC------------------CCCCCHHHHHHHHHhhhcCcCCCCCHHHHHcCCccccc
Q 018018          287 AIVDQPPPSAP------------------SDQFSPEFCSFISACVQKEPQQRLSAQELMTHPFLKMY  335 (362)
Q Consensus       287 ~~~~~~~~~~~------------------~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  335 (362)
                      ...........                  ....++++.+||++||+.||++||||+|+|+||||+.+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            11111110000                  01135678999999999999999999999999999864

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-51  Score=373.41  Aligned_cols=247  Identities=23%  Similarity=0.319  Sum_probs=206.9

Q ss_pred             eeeeeeeCCeEEEEEEEccCCc---EEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEe-cCeEEEEEecc
Q 018018           75 IKVVGKGSGGIVQLVQHKWTGQ---FFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYS-NGAISIILEYM  150 (362)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~-~~~~~lV~e~~  150 (362)
                      .++||+|+||+||++++..++.   .||||+++...+.....++.+|++++++++||||+++++++.+ ++..++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            5789999999999999876532   6899999876677777889999999999999999999998775 56899999999


Q ss_pred             CCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeeccCCcccccCCC----C
Q 018018          151 DGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFGVSAIMASTSG----Q  225 (362)
Q Consensus       151 ~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~~~~~~~----~  225 (362)
                      ++|+|.+++... ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.......    .
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~-~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~  190 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS-KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN  190 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH-TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTC
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcc-cCcccCCccHHhEeECCCCCEEEecccchhhcccccccccee
Confidence            999999998754 467889999999999999999998 9999999999999999999999999999987643322    2


Q ss_pred             CCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCCCCCCCHHH
Q 018018          226 ANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAPSDQFSPEF  305 (362)
Q Consensus       226 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (362)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|..||......      .++...+..+.. +..+..+++++
T Consensus       191 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~------~~~~~~i~~g~~-~~~p~~~~~~l  263 (311)
T d1r0pa_         191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT------FDITVYLLQGRR-LLQPEYCPDPL  263 (311)
T ss_dssp             TTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------------CHHHHHTTCC-CCCCTTCCHHH
T ss_pred             cccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH------HHHHHHHHcCCC-CCCcccCcHHH
Confidence            23357899999999999999999999999999999999988777653221      233344444443 33456789999


Q ss_pred             HHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          306 CSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       306 ~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      .+||.+||+.||++|||+.||++|
T Consensus       264 ~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         264 YEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-50  Score=368.27  Aligned_cols=259  Identities=21%  Similarity=0.305  Sum_probs=205.4

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCc-ceEEeeeEEecCeEEEEEe
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY-VVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~-I~~~~~~~~~~~~~~lV~e  148 (362)
                      ++|++.+.||+|+||+||+|++..+|+.||||+++....   ..++..|+++++.++|++ |+.+...+.+....++|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            579999999999999999999999999999999876532   235778999999998766 5555666678889999999


Q ss_pred             ccCCCCHHHHHH-HcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc---CCcEEEeeccCCcccccCCC
Q 018018          149 YMDGGSLADFLK-KVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH---RGEVKITDFGVSAIMASTSG  224 (362)
Q Consensus       149 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~---~~~vkl~DFg~a~~~~~~~~  224 (362)
                      |+. +++.+.+. ....+++..+..++.|++.||+|||+ +||+||||||+|||++.   +..+||+|||+|+.......
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          84 LLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS-KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             CCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHH-TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             EcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHH-CCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            995 56666664 45689999999999999999999998 99999999999999864   45799999999987754322


Q ss_pred             -------CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCCCCC
Q 018018          225 -------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPPSAP  297 (362)
Q Consensus       225 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (362)
                             .....+||+.|+|||++.+..++.++|||||||++|||++|..||......................+ .+..
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  240 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP-IEVL  240 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC-HHHH
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC-hhHh
Confidence                   23456899999999999999999999999999999999999999987655443333322222222221 1222


Q ss_pred             CCCCCHHHHHHHHHhhhcCcCCCCCHHH---HHcCCcccc
Q 018018          298 SDQFSPEFCSFISACVQKEPQQRLSAQE---LMTHPFLKM  334 (362)
Q Consensus       298 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e---il~hp~~~~  334 (362)
                      ...+|+++.++|..||+.||++||++++   +++|+|.+.
T Consensus       241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            3578999999999999999999999874   577877644

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-50  Score=365.61  Aligned_cols=255  Identities=23%  Similarity=0.290  Sum_probs=197.4

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCcceEEeeeEEecC----eEEE
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQCPYVVVCYQSFYSNG----AISI  145 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~I~~~~~~~~~~~----~~~l  145 (362)
                      ++|.+.+.||+|+||.||+++.  +|+.||||+++.....  ......|+..+..++||||+++++++.+.+    .+++
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            5788999999999999999986  6899999998654221  122234555556789999999999988654    6899


Q ss_pred             EEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh-------CCCeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          146 ILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHH-------EKHIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       146 V~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~-------~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      ||||+++|+|.+++++ ..+++..+..++.|++.||+|||+       .+||+||||||+|||++.++++||+|||+++.
T Consensus        79 v~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            9999999999999987 579999999999999999999996       26999999999999999999999999999987


Q ss_pred             cccCCC----CCCccccCCcccCcceecCCC------CCccccHHHHHHHHHHHHcCCCCCCCCccCC--------chhh
Q 018018          219 MASTSG----QANTFVGTYNYMSPERISGGK------YGYKSDIWSLGLVLLECATGQFPYSPPEQQD--------GWTS  280 (362)
Q Consensus       219 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~~l~elltg~~pf~~~~~~~--------~~~~  280 (362)
                      ......    .....+||+.|+|||++.+..      ++.++|||||||++|||+||..||.......        ....
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            654332    234568999999999987643      5778999999999999999988875432211        1112


Q ss_pred             HHHHHHHHhcCCCCCCCCCC-----CCHHHHHHHHHhhhcCcCCCCCHHHHHcC
Q 018018          281 FYELMEAIVDQPPPSAPSDQ-----FSPEFCSFISACVQKEPQQRLSAQELMTH  329 (362)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~L~~dP~~Rpt~~eil~h  329 (362)
                      ..............+..+..     ....+.+|+.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            33344444443332222222     22358899999999999999999999763

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=4.3e-49  Score=358.96  Aligned_cols=254  Identities=19%  Similarity=0.255  Sum_probs=209.3

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCC-CcceEEeeeEEecCeEEEEE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC-PYVVVCYQSFYSNGAISIIL  147 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-p~I~~~~~~~~~~~~~~lV~  147 (362)
                      .++|++.+.||+|+||+||+|++..+|+.||||+++...+.   ..+.+|++.++.+.| +||+.+++.+.+....++||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            36899999999999999999999999999999998654322   345677788888775 89999999999999999999


Q ss_pred             eccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEcc-----CCcEEEeeccCCccccc
Q 018018          148 EYMDGGSLADFLKKV-KTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINH-----RGEVKITDFGVSAIMAS  221 (362)
Q Consensus       148 e~~~~gsL~~~l~~~-~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~-----~~~vkl~DFg~a~~~~~  221 (362)
                      ||+ +++|.+++... ..++..++..++.|++.||+|||+ +||+||||||+|||++.     ++.+||+|||+|+....
T Consensus        81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~-~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE-KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHT-TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             Eec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHH-CCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            999 67999999765 479999999999999999999998 99999999999999964     57899999999987643


Q ss_pred             CCC-------CCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHHHHHHhcCCCC
Q 018018          222 TSG-------QANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYELMEAIVDQPPP  294 (362)
Q Consensus       222 ~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  294 (362)
                      ...       .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+............+...... ...
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~-~~~  237 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS-TPL  237 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH-SCH
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC-CCh
Confidence            221       234468999999999999999999999999999999999999999876554433322222222221 111


Q ss_pred             CCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHHc
Q 018018          295 SAPSDQFSPEFCSFISACVQKEPQQRLSAQELMT  328 (362)
Q Consensus       295 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil~  328 (362)
                      ......+|+++.+++..|+..+|++||+++.+.+
T Consensus       238 ~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         238 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            2223568899999999999999999999887754

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.1e-47  Score=356.70  Aligned_cols=262  Identities=24%  Similarity=0.386  Sum_probs=196.7

Q ss_pred             ccCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-----------CCcceEEeeeE
Q 018018           69 LEDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-----------CPYVVVCYQSF  137 (362)
Q Consensus        69 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----------hp~I~~~~~~~  137 (362)
                      ..+|++++.||+|+||+||+|++..+|+.||||+++..  ......+.+|+.+++.++           |+||+++++++
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~--~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~   89 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   89 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc--ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence            35699999999999999999999999999999999754  233455677777776654           57899999887


Q ss_pred             Ee--cCeEEEEEeccCCCCH-HHHH--HHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCC------
Q 018018          138 YS--NGAISIILEYMDGGSL-ADFL--KKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRG------  206 (362)
Q Consensus       138 ~~--~~~~~lV~e~~~~gsL-~~~l--~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~------  206 (362)
                      ..  ....++++.++..+.. ....  .....+++..++.++.|++.||+|||+..||+||||||+|||++.++      
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence            64  4566777776655433 3323  23457899999999999999999999768999999999999998765      


Q ss_pred             cEEEeeccCCcccccCCCCCCccccCCcccCcceecCCCCCccccHHHHHHHHHHHHcCCCCCCCCccCCchhhHHHH--
Q 018018          207 EVKITDFGVSAIMASTSGQANTFVGTYNYMSPERISGGKYGYKSDIWSLGLVLLECATGQFPYSPPEQQDGWTSFYEL--  284 (362)
Q Consensus       207 ~vkl~DFg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~elltg~~pf~~~~~~~~~~~~~~~--  284 (362)
                      .++++|||.|.....   .....+||+.|+|||++.+..++.++||||+||++++|++|+.||.+.+...........  
T Consensus       170 ~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         170 QIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eeeEeeccccccccc---ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence            399999999876532   335568999999999999999999999999999999999999999865433221111111  


Q ss_pred             -HHHHhc-----------------CC-C------------------CCCCCCCCCHHHHHHHHHhhhcCcCCCCCHHHHH
Q 018018          285 -MEAIVD-----------------QP-P------------------PSAPSDQFSPEFCSFISACVQKEPQQRLSAQELM  327 (362)
Q Consensus       285 -~~~~~~-----------------~~-~------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~eil  327 (362)
                       +..+..                 .. .                  ........++++.+||.+||++||++|||++|+|
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence             111100                 00 0                  0001122456789999999999999999999999


Q ss_pred             cCCccccc
Q 018018          328 THPFLKMY  335 (362)
Q Consensus       328 ~hp~~~~~  335 (362)
                      +||||+..
T Consensus       327 ~Hp~f~~~  334 (362)
T d1q8ya_         327 NHPWLKDT  334 (362)
T ss_dssp             TCGGGTTC
T ss_pred             cCcccCCC
Confidence            99999855

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=2.1e-26  Score=195.16  Aligned_cols=166  Identities=19%  Similarity=0.179  Sum_probs=122.3

Q ss_pred             ceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccc-----------------hHHHHHHHHHHHHHhcCCCCcceEEe
Q 018018           72 IDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVE-----------------ESARRQIAQELKINQSSQCPYVVVCY  134 (362)
Q Consensus        72 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----------------~~~~~~~~~e~~~~~~l~hp~I~~~~  134 (362)
                      +.+.+.||+|+||+||+|++. +|+.||||+++....                 .........|...+..+.|++++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            346799999999999999985 789999998764311                 11234456788888999999998877


Q ss_pred             eeEEecCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCCeEeecCCCCcEEEccCCcEEEeecc
Q 018018          135 QSFYSNGAISIILEYMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLHHEKHIIHRDLKPSNLLINHRGEVKITDFG  214 (362)
Q Consensus       135 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH~~~~ivH~Dlkp~NIll~~~~~vkl~DFg  214 (362)
                      +..    ..+++|||+++..+.       .++...+..++.|++.+|+|||+ +||+||||||+|||++++ .++|+|||
T Consensus        81 ~~~----~~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~-~giiHrDiKP~NILv~~~-~~~liDFG  147 (191)
T d1zara2          81 AWE----GNAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYH-RGIVHGDLSQYNVLVSEE-GIWIIDFP  147 (191)
T ss_dssp             EEE----TTEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHH-TTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred             Eec----CCEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhh-CCEEEccCChhheeeeCC-CEEEEECC
Confidence            642    237999999876543       35566678899999999999998 999999999999999854 58999999


Q ss_pred             CCcccccCCCCCCccccCCcccCcc-----eecCCCCCccccHHHHHHHH
Q 018018          215 VSAIMASTSGQANTFVGTYNYMSPE-----RISGGKYGYKSDIWSLGLVL  259 (362)
Q Consensus       215 ~a~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DiwslG~~l  259 (362)
                      +|+....+...        .|....     .+..+.|+.++|+||+.--+
T Consensus       148 ~a~~~~~~~~~--------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         148 QSVEVGEEGWR--------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TCEETTSTTHH--------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             CcccCCCCCcH--------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            98765422210        111110     01235688999999986544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.57  E-value=8.1e-08  Score=83.00  Aligned_cols=140  Identities=16%  Similarity=0.104  Sum_probs=86.9

Q ss_pred             cCceeeeeeeeeCCeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-CCcceEEeeeEEecCeEEEEEe
Q 018018           70 EDIDTIKVVGKGSGGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-CPYVVVCYQSFYSNGAISIILE  148 (362)
Q Consensus        70 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-hp~I~~~~~~~~~~~~~~lV~e  148 (362)
                      +.|.+.+..+.++.+.||.+.  .++..+++|+...... .....+.+|...+..+. +--+.+++....+++..++||+
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~-~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~   90 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc-cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence            456666655555567899875  3567788998754421 12223556666655442 2224455666677889999999


Q ss_pred             ccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 018018          149 YMDGGSLADFLKKVKTIPEEYLAAICEQVLKGLLYLH-------------------------------------------  185 (362)
Q Consensus       149 ~~~~gsL~~~l~~~~~l~~~~~~~i~~ql~~al~~LH-------------------------------------------  185 (362)
                      +++|.++.+.....     .....++.++.+.++.||                                           
T Consensus        91 ~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T d1j7la_          91 EADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred             eccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence            99988776543211     111222333333333333                                           


Q ss_pred             ----------h-----CCCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          186 ----------H-----EKHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       186 ----------~-----~~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                                .     ...++|+|+.|.||+++.++.+-|+||+.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                      1     0127999999999999877667799999764

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.12  E-value=4.1e-06  Score=76.68  Aligned_cols=78  Identities=10%  Similarity=-0.017  Sum_probs=46.5

Q ss_pred             eeeeeeeCCeEEEEEEEccCCcEEEEEEeecc------cchHHHHHHHHHHHHHhcCC-C--CcceEEeeeEEecCeEEE
Q 018018           75 IKVVGKGSGGIVQLVQHKWTGQFFALKVIQMN------VEESARRQIAQELKINQSSQ-C--PYVVVCYQSFYSNGAISI  145 (362)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~~~~~~e~~~~~~l~-h--p~I~~~~~~~~~~~~~~l  145 (362)
                      .+.||.|..-.||++.+..+++.+++|.-...      .......+...|++.++.+. +  ..+.+++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            46789999999999998878889999974321      01111223445666554432 2  335555543  5566789


Q ss_pred             EEeccCCCC
Q 018018          146 ILEYMDGGS  154 (362)
Q Consensus       146 V~e~~~~gs  154 (362)
                      |||++.+..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.97  E-value=1.3e-05  Score=68.13  Aligned_cols=74  Identities=11%  Similarity=0.005  Sum_probs=47.1

Q ss_pred             eeeeeC-CeEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCCC--CcceEEeeeEEecCeEEEEEeccCCC
Q 018018           77 VVGKGS-GGIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQC--PYVVVCYQSFYSNGAISIILEYMDGG  153 (362)
Q Consensus        77 ~lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h--p~I~~~~~~~~~~~~~~lV~e~~~~g  153 (362)
                      .+..|. .+.||++... ++..+++|.......    ..+..|...++.+..  -.+.+++....+++..++||++++|.
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~   91 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ   91 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence            444454 3688988764 566788998654422    234455555544322  22556667677788899999999876


Q ss_pred             CH
Q 018018          154 SL  155 (362)
Q Consensus       154 sL  155 (362)
                      ++
T Consensus        92 ~~   93 (255)
T d1nd4a_          92 DL   93 (255)
T ss_dssp             ET
T ss_pred             cc
Confidence            55

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.20  E-value=0.00038  Score=61.36  Aligned_cols=130  Identities=15%  Similarity=0.130  Sum_probs=71.8

Q ss_pred             eEEEEEEEccCCcEEEEEEeecccchHHHHHHHHHHHHHhcCC-----CCcceEEe--eeEEecCeEEEEEeccCCCCH-
Q 018018           84 GIVQLVQHKWTGQFFALKVIQMNVEESARRQIAQELKINQSSQ-----CPYVVVCY--QSFYSNGAISIILEYMDGGSL-  155 (362)
Q Consensus        84 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-----hp~I~~~~--~~~~~~~~~~lV~e~~~~gsL-  155 (362)
                      =.||+++. .+|..|++|+.+....  ...++..|+..+..|.     .+..+..-  ..+...+..+.+++++.|..+ 
T Consensus        36 N~vy~v~~-~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          36 NRVYQFQD-EDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SEEEEECC-TTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             ceeEEEEc-CCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            47999877 4788999999875421  2344555666554442     22222211  123456778999999976432 


Q ss_pred             ----HHHHH---------H---c------CC-------------------CCHH---HHHHHHHHHHHHHHHHHh---CC
Q 018018          156 ----ADFLK---------K---V------KT-------------------IPEE---YLAAICEQVLKGLLYLHH---EK  188 (362)
Q Consensus       156 ----~~~l~---------~---~------~~-------------------l~~~---~~~~i~~ql~~al~~LH~---~~  188 (362)
                          ..+..         .   .      ..                   ++..   .....+.++...+.-.-.   ..
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence                11111         0   0      01                   1111   122233333333332211   24


Q ss_pred             CeEeecCCCCcEEEccCCcEEEeeccCCcc
Q 018018          189 HIIHRDLKPSNLLINHRGEVKITDFGVSAI  218 (362)
Q Consensus       189 ~ivH~Dlkp~NIll~~~~~vkl~DFg~a~~  218 (362)
                      +++|+|+.+.|||++. + ..++||+-+..
T Consensus       193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeC-C-ceEEechhccc
Confidence            6999999999999963 4 45899997753

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.94  E-value=0.0029  Score=54.96  Aligned_cols=30  Identities=23%  Similarity=0.293  Sum_probs=26.8

Q ss_pred             CCeEeecCCCCcEEEccCCcEEEeeccCCc
Q 018018          188 KHIIHRDLKPSNLLINHRGEVKITDFGVSA  217 (362)
Q Consensus       188 ~~ivH~Dlkp~NIll~~~~~vkl~DFg~a~  217 (362)
                      .|++|+|+.+.||+++.+...-|.||+.|.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            579999999999999888777899999864

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.91  E-value=0.024  Score=50.75  Aligned_cols=74  Identities=19%  Similarity=0.135  Sum_probs=45.5

Q ss_pred             eeeeeeeCCeEEEEEEEcc-------CCcEEEEEEeecccchHHHHHHHHHHHHHhcCCCCc-ceEEeeeEEecCeEEEE
Q 018018           75 IKVVGKGSGGIVQLVQHKW-------TGQFFALKVIQMNVEESARRQIAQELKINQSSQCPY-VVVCYQSFYSNGAISII  146 (362)
Q Consensus        75 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~hp~-I~~~~~~~~~~~~~~lV  146 (362)
                      ++.|+.|-.=.+|++....       ..+.|.+++.-.. .. . ....+|..+++.+.-.+ ..++++.+.  +  .+|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~-~-idr~~E~~i~~~ls~~gl~Pkll~~~~--~--g~I  119 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET-E-SHLVAESVIFTLLSERHLGPKLYGIFS--G--GRL  119 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC-H-HHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc-ch-h-hHHHHHHHHHHHHHhCCCCCeEEEEcC--C--ceE
Confidence            3678888888999998753       2456878876522 21 1 23446777766654223 335555543  2  678


Q ss_pred             EeccCCCCH
Q 018018          147 LEYMDGGSL  155 (362)
Q Consensus       147 ~e~~~~gsL  155 (362)
                      +||++|.++
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987544